<SEC-DOCUMENT>0001060955-22-000005.txt : 20220301
<SEC-HEADER>0001060955-22-000005.hdr.sgml : 20220301
<ACCEPTANCE-DATETIME>20220301170046
ACCESSION NUMBER:		0001060955-22-000005
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		155
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220301
DATE AS OF CHANGE:		20220301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		22699337

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>iclr-20211231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:e141d476-ae09-4ec9-a80f-baeacfb8f81a,g:a196524c-1dde-4a8b-8796-f0fa7ce72378,d:6df4b473ec484136b91516d30b1a0b24--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iclr="http://www.iconplc.com/20211231" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iclr-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80L2ZyYWc6ODMzZjhkMWY4YTE0NGFkZjgyYTgzZTBjOTEyYTU1YWIvdGFibGU6ZDkxNDZjYmYxNGNjNDI2MzhjYTUzNTk0ZDBhYjE4ZGIvdGFibGVyYW5nZTpkOTE0NmNiZjE0Y2M0MjYzOGNhNTM1OTRkMGFiMThkYl8xLTEtMS0xLTM2MjQ4_855218ed-2ccc-4242-b5ea-8d2f3be63dce">false</ix:nonNumeric><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80L2ZyYWc6ODMzZjhkMWY4YTE0NGFkZjgyYTgzZTBjOTEyYTU1YWIvdGFibGU6ZDkxNDZjYmYxNGNjNDI2MzhjYTUzNTk0ZDBhYjE4ZGIvdGFibGVyYW5nZTpkOTE0NmNiZjE0Y2M0MjYzOGNhNTM1OTRkMGFiMThkYl8yLTEtMS0xLTM2MjQ4_699e300b-5b51-4bd7-9e41-50e062be39fb">2021</ix:nonNumeric><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80L2ZyYWc6ODMzZjhkMWY4YTE0NGFkZjgyYTgzZTBjOTEyYTU1YWIvdGFibGU6ZDkxNDZjYmYxNGNjNDI2MzhjYTUzNTk0ZDBhYjE4ZGIvdGFibGVyYW5nZTpkOTE0NmNiZjE0Y2M0MjYzOGNhNTM1OTRkMGFiMThkYl8zLTEtMS0xLTM2MjQ4_da3a8372-3e64-4d23-8457-e1a886b7812c">FY</ix:nonNumeric><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80L2ZyYWc6ODMzZjhkMWY4YTE0NGFkZjgyYTgzZTBjOTEyYTU1YWIvdGFibGU6ZDkxNDZjYmYxNGNjNDI2MzhjYTUzNTk0ZDBhYjE4ZGIvdGFibGVyYW5nZTpkOTE0NmNiZjE0Y2M0MjYzOGNhNTM1OTRkMGFiMThkYl80LTEtMS0xLTM2MjQ4_77ac5a63-ee22-4050-922f-544b755c0cc1">0001060955</ix:nonNumeric><ix:nonNumeric contextRef="i19db711be5e345a3a0c59dabb49c870c_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzQ2NDQ_8b84bb10-99f4-411b-a818-270432b50926">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7b15ff89-21bb-47d6-8b93-387dc069fe0d">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7ee1e415-4195-48f3-aa9c-3b52eaebf0fd">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iclr-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i412657424e8a46e09c66a2345306a17a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib6f10a8ae3df4827be9831c930c77331_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2fff4332a1d4c0698311a5bd0290b3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7acc5e38562846649f0134d3bdc33705_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-27</xbrli:startDate><xbrli:endDate>2021-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ifdac2dc9cabd4d0d9b3df33a7ae8822e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-10</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19229e729ec74c57a20161ea7ce568f9_D20210701-20211109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-11-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-29</xbrli:startDate><xbrli:endDate>2021-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8f0b47b5969447b80a94a01cfae1776_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cb2372376cf46b9a240ab10ece87d9c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8206c39f2c184b8bb182915d7fa1390b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i82b500db472f497aa1b840c473c52982_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61027c17b46042b1b491d04374d1f997_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cd379f284664447a1d6537e6eb39f2e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ad54f2c49046fdacfa10fdbb3eb49a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib573afa6334547daa0d3c19f31f8dbef_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3e24d855ba14a97a64dd8c818215580_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0c29cae9c2c47cdbf7580c35f3f4e38_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1855db4bb0b4dbb98b316a593a03fa6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67da3acc2801492294d95197efa72153_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa0833c316264e0ea3f2e1469249cc7b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1f8d018bbf94621ae5409b6eda9be54_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68a8df88a51a4914b34c331af346e762_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c9c424a36dd4a109577161d2940b41b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e62c0f5e8c74f1aa308fbbfc8707376_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6d50f7cd15643d798684811166d0ba9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750b3a109f9044d3af3bdc0259dc0293_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa2834e916024d02918294df579c7494_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94be34191abe4629b7ebef1ad29ea857_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0962b68ff61246e5a9f5b9e8d38e3989_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90ce1847176642a7a8d12c476ee2b2d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc0b7e51cfbd494db946ce79e9bb7c29_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02a3c3f480da466f979b83dd7f24aaa6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f26675e42484470a39567b27487f173_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17db85087b8349beb2ce7a3c58760e87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if485c36ee8d54bf0a345ece247288e1c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c2f810ef5f14db3a7c717dc50d0207d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6be1e93cc2e4a22825aee8e63f813bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a8bfe01d1774f4e96679362547f99f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica03b62926534e1c96e97c487693f9b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfbb11854a164b7bb15d92889e4c2bb4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd6e0d8b7e5144638aef2b48835ca0f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5839a28afffc48f8a9ce6fc8cd0b1215_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7670eea39a0649e3b66786e7d2cf4f1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>iclr:Employee</xbrli:measure></xbrli:unit><xbrli:unit id="location"><xbrli:measure>iclr:Location</xbrli:measure></xbrli:unit><xbrli:unit id="country"><xbrli:measure>iclr:Country</xbrli:measure></xbrli:unit><xbrli:context id="iccd478baae434af395e71d177b28bd2e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50822bc1a62345aca0219ef6e28bf127_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad57efdbfd9c4bd3a89a3bbc5b80f396_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherGeographicLocationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a7dd4344dd34202b588af91a6812de7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2987d6914a1d4cc68e8c95d19b068254_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57ebfffca8f94564b236e3cf355daa0a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f2e7237f254495a965fa61e435b32cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98447e8a7c144589ae3d680ab7ea1f11_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2e9789e124d454fb74080cfc1ea1d70_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34a011f87a9d4997aa40aa4d09a4fc8d_I20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MeDiNovaResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">iclr:TermDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34fdb5db483e4be88aed63d7fba68086_D20180101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic87e1dcfa6f645709ebb66f6f1e00a7d_D20180101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b2e8fe7b204f0c9abe56bd2cd862ae_I20200724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d3fa59c20354798b3fe32fbe88700c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib27d114693994c1bbb27bce87b357b48_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i727c1622461843c1a81f8f6fb66f40aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i391000958f6f4ad4b03f663ad0a01ee6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca96102037f405a834d371c8285ea8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a2e822e6e146128cc9a04440ccd362_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a9a1d8583f64d51af91b99d7a6b4135_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86eec55be971443da0d8c545532a4f94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dbf4b780c904be2bf1341d2e01a6247_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dd17c1d14eb4336b8de511f325caec7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2760f7ce2844eeb9454a223b0d6bdd9_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c3d250f7b48429daff67944653a547e_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fdaf7dd9b454d2b8940cc6620aa6239_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20ad6864825548d6963d2ca543226afa_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34c5cbb5923847049004e8c7917d853b_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i653318d9e6234778be8ddf6cd1ffc904_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea4c19eacf6342068eda7cdb8712f339_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i502149ae91374acc8a5f8e388394c164_I20200122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de8b4b9115b4c429dc042e5ecb81b66_I20200122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7fa7bd0b2d84f9bb5d970eebb2b2cc0_I20200122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i586effbcf5d3481cb59812fdb908734f_D20200122-20200122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-22</xbrli:startDate><xbrli:endDate>2020-01-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdff042d535e43268017baca8988f1a5_D20200122-20200122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-22</xbrli:startDate><xbrli:endDate>2020-01-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd05d6e491a44874be7f139b3e968b8d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic93da52af8c448b795d98224ecc5b70b_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616118ad6d404416b3fa77b7e269701f_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ec6866f5ee348deb48316da2665156b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08c50c20b0824778afb5ac1731634e8a_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42dfcdcf3ee74f698b4cc05d9992198b_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5baf4cdf019f4d0082973e733aaf95ff_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1704b22ade43460f8a75f94af7619d42_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b46d27d792a425aa8aa8c08a233f77e_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b4e53fcd7342a8bab594419987a4b2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2ea2f6a48cb4ba19857680cfba954e9_D20200122-20200122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-22</xbrli:startDate><xbrli:endDate>2020-01-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00c03d2629a049ada2da2d86c94ddd58_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31f39dce85e49bda0b0796d89773f47_D20200123-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-23</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1001c2ebac745e5abfbd3e906c6f1d0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf72293147ed4ca08c6367f48b6a674e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b91c2328484f58921510f5691f05a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27d941fab37b403093cfa434f63692f7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b89aca039eb4e798c4afcd95f0f1b09_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i216dac94d38a475db23d353853c31110_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i213553f0a50c4dd38db19e9a04a338ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic55595e1f75246f1aadac4c6ddd9900e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee612b419754414e8828f427b68f7002_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia159cefdf37f4364a9843092cf3a2325_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27a855a3bed8480bab49ff8e8735587d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:HighYieldBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49cd9b5fb069425c885e4e858a9cd7db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c04b88d67624c00974b95408ed71c3c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9509a32705e43b195f8a5dee756c081_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iece79a92c4da478a8144d377620226a2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d7dd97703d84c88a35a15329488f10f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2722f8b4561c498cb1416e166b7ad02c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63bf8a993c2147649f1d3f6fb9bebb7c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic522ae4b5b4b4ec5b45ddca4c8a8a60f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e1ef306fa1d450b985b7cfbaf9ce6f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eef861e44254199911aaf8a9ce379f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40941b5fcb9547c4aec232ca49dbee5a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37cabf6d514a484e8c75d7747a3e6cee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21d1d31dbff94254ae22cf50de458c51_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib955eed4b9ce4d00a2bd4e2ce7b5a191_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf105ea7475a47ae9ce9c72b2859f1b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9487d796fcc149dbb3f7bcd120e40e56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:LAndGLifeGPBFAllWorldEquityIndexFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id748b57582fe44e5b3492d06beea0921_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:LAndGLifeGPBFAllWorldEquityIndexFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77d9586a1ce944dd8bc0eb9cfc5adc1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:LAndGLifeDCActiveCorporateBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie033646e348048399b773047abffe484_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:LAndGLifeDCActiveCorporateBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64cfe0b0c94c43f6b451b69b6c85fb20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:StoneHarborHighYieldBondFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1216803a75bf46db999c06ae0853a289_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:StoneHarborHighYieldBondFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i517f5d381f324edebe16b610b9162167_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:NinetyOneGlobalTotalReturnCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dda409457ee4051a9ab0dd254b58fe5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:NinetyOneGlobalTotalReturnCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7054f2015f4b71993232abe485627d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:StoneHarborMultiAssetCreditPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ac9953fae724a3596870ee57bc6901a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:StoneHarborMultiAssetCreditPortfolioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf8195e9a7884d23b49443cc99b9ce4b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:BaringsEuropeanLoanFundBuyAndHoldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id45f53eaf45c4c91b83e80ae121a0eda_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:BaringsEuropeanLoanFundBuyAndHoldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6eb058c3c334fa9bc0c1e5cd98974fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77b64280f32c462596b287ec2de84d69_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b045e97c954a34891096fb9cf8d23b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0c8fd01370246349a9908b32d1373e7_I20140507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:AptivSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-05-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec677308af14edcacc6c913d5dd56c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87320a0e379947f09f57eb63148701a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i536575760ce54ae2893373d1d02dc0d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1f40d11c0c8476391b481d08399f03b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68dd1b4a3d3641879b1d63d1751d2f6a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03867c06634a4d5ab2189dd7fe751c3d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00041bfad6e143b8a90b3fb840be4f61_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e1bbc1869b4151944d394318356ae3_I20170213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82ba7a6e4424420f8f44f4aaed17b2c2_I20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id13244e709104dbb91bd8e7035149dd0_I20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9238ad4bc0c9411fa4d50e26b14d2e1f_D20170214-20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f3c204e0dce42b98babf937edce3e3e_D20170214-20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ef196657454b409ef6b9ff50ada92e_D20170214-20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:OptionPlans2008Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ae564697d142d9bd558468bc6260be_I20030117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2003-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00bc75888c8147eba2c8e5dde8818f99_D20030117-20030117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2003-01-17</xbrli:startDate><xbrli:endDate>2003-01-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e4e19cbbee143049fbca064c93a8efc_D19970101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1997-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718ff08202614127a3831397cc22d119_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDate2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d541f61a07d4ac29868fce496e97445_I20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2020LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief51d6a7563d4bc8ab4a279609f4a22d_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2018LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic851a23a9692444896ff76991dcb6a7c_I20130923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:A2013LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbca4abf2817496684bb2ab04067235b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7ea21c26dac40328506c0cba3319723_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i953fc3f9f5114324bcd9a4293c83b977_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib049563e613d4855a95f4886886e70d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a89202c30764a8e9ad0c13560be2ae0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc6762b3d2c402e97ea3771e8aeb750_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22c88a1dd7ca45d48c661d231dd100b2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6de01c93a2fb457e98a862dc99d4abdd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eb517873331422d82ddeb24ae81abab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f9f44ae168e404abf9f671dd8805b74_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8a3088705f84bc0ba8f033ac2ceb1b4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbcd9f1bcda345dca2a0d46fb1c81d47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671a1d31e3054ac49e3a79c6e68909c4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d77c5373ca24c15b6733894571c4107_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7a8bb4ad4a743548875aefa396266a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08fa3aedb11a4eae933e80b642a4260d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19db711be5e345a3a0c59dabb49c870c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7db9820d8aa244e2852525ef7396441a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46b83645e00244b685127e098dab3ac7_D20150511-20150511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-05-11</xbrli:startDate><xbrli:endDate>2015-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i092c95b988b148d88d0639ad4cfc0a58_I20150511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i454968911a6a4e2aa2a973ab9436c62a_I20190516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13e925d1823c400d84b4408ce6181505_D20190101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iclr:NonexecutiveDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4af659507f244f3be56ce1d3a1e11dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfcb074b2ed840d0889e5704a9ace54e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id023f7897c634581b20db0f0c13adc57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id13136d269d54783b5556de26f903c56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21ce434056744af495320d8e2505e585_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5199d2dbdbd4fe9afdad9bb0b6011c8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i289f65e4064e4e14973a986310115295_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cf76ea842904bb687cb878a30fd91b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib87cf475a42848d990b63ce6c940842c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0e29a847bcb402b8b35bd56be034dca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib014ca4b61704308b759eb2b4e4cbe13_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e2c7ebf97b43da88211b323320aa76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1846e9d35064408781a6a5388df65c41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54544aae1c2043709f665f7d1cc9eebf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302f632b409e431a99d19fa4a3ec38d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb358d140d045a48a95a6f2a26b3d5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceBasedGrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8aedbfe82f84258b4f5fb8ae5be9756_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3104d5908eb42a781a65f9e3b34447b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1a4ebf926a04a1399759e8c4dd65228_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5c3ba2a7a9949e4b4296e482b3406d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia28188c5a298446189940f3d7538dc9f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e7f286996a495b9fbebdd313a6affa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c449fefc2cd4b4399d71b4faba625e0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7b5db980b4e4123a417be9e69e6a306_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9da48aa526a04e8c802268f3ee3f55f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie59648bd657b4adbaa014e0c1010eef4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>iclr:vote</xbrli:measure></xbrli:unit><xbrli:context id="i10a8b70f27484636b98e9821a55c5304_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00c3280bc64040eb92d3e3380fb6b522_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if98fe533fad34c48891d45c338b523fb_D20160722-20160722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-22</xbrli:startDate><xbrli:endDate>2016-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c25c9fbdc24c8e8f96527346976256_I20161003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-10-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd957ddedf34e7eb4e6d9840ebd08ab_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bc02d64aa5f4b4d8b36a740dd3bc014_I20190108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia044a3b1cbe441bc85cbe89198164aad_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53e8433bda4546de9704023960c6b72f_D20191231-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-31</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3d7547a1a224157af8991715ce82080_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8ff896c629e4b8490976274f366db14_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b675ea0523544f39cc9dc1c1d30c495_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc9dba39f11143b7a99700fa9154586e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aabd4a6d84543e59b0b347ddb8394d7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd1b1b778ce1423d993f536ec42792a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b603335e3c141be945379a94b120638_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1def15985c34968963f6b9121b38e63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i844861916668498588f0491ce84b368e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7ad5c604007471b856dd9490f6f5c80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2022to2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf376e140f446a785d5f08cdd6bfebc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20362040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i983be088cf6b46e6ac433beda8d697ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecd57dd26a63495fb590d21da1ee1dd2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2022To2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7a5026822b54a889031ee7975200e68_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2029To2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i441eef7611ae4627900c2aa94e200087_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c96a63b4834593b815f76192244271_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2022to2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4899bcc705b74b12bfb11fcc895a643d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20362040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9da9a786e8de49f39d28567667a24931_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5533029580bc4f90b5489c2ed50c777c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e5f687cc39462f8d659f4d701f5ac0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i896d44f274c24721bd6b58ccbd470666_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae97c86e7991410685e37fea162dced3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iclr:A2021RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia73c34c13a8742aa9e45adff138292ef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iclr:A2021RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie267803461c24ea8b3916fbd1ae6771c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dc5a2134f884432820063e1b886264a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id23f0621c3b244fd89bd3711026df87b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f1dd5a84134d2894c1da8788efa67c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9faa218b12a4b3cbf68ef2876caf309_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3b459699c0644968482717272d94004_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia579ed66ea164732848f24e059ca35c5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82ad39f10bb41e4a084c8444e8989e2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b0fe21c6d5f44e195d836fd2b3861df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0595a59077864be3995b98eb22ddb2b8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf29ed6c91d7496d942630ab211f4988_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i485faa3e5fc04aacbcde0602daee7a53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b863197bb30417a90a009a4abea9561_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e2bfed171104f319e9a84bb08cd25c7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice57c280ae3940bca26f984dc95288ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28103989f8142d59279653ff6548119_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45550d1365114ceeb217ab47d70cb97c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if73f3bd5251f468199c2f39f63ce992f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb97c73d747941d58453e74f92d14e13_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb24ee78b3b34864be5c6ac9dba168fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>iclr:segment</xbrli:measure></xbrli:unit><xbrli:context id="iaf7560d016044c24b3bdac4149860edf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedf131d1b8644060b1d2530e00834656_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74f149fe5aaf499d867e3e597050ca23_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6939b2d79b084dc0a660f3b73a074210_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ddd5c933e7b4f74b37135036f3084df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i555b937d50554bbdb3d03c3c137d6aa2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i639f5002243748caaade65a18fa1abd4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibadbd19679bc427dba0f5f5ae0f7fd8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57430deb2fc84136b5fd0563c9976335_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9169f6af6160491cb03265cd3846ea11_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84dbafe769b9418dae1e4cb9de53c5e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a66c15d3893461486dcf165a1add471_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e8457bcc7054ec4a4014e91fdf31028_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75873ccb8a5c422b9bf776cba332d63d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38942652cf84800b863e3e7022c6277_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e95612f074040ca8329b4a89d847966_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c03db364d544bbd8c5f621de598194c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ee2cf622d234c2aa3264bc99d1d99f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0acaa265f49241d68f4649867f4f00a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i452b01c0112d4ccd9b653f71e8f9dcbb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa28345cbd8749e8a4e0f211a8ca39ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c04ffd49dae4f0992771a4e20c9df7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorANotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21502e982c90437c9bfab920645d67a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorANotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a8f70dc107f44d0b434efabb00c6480_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorBNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6231795e2c4c7b85a8443de30f290a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorBNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb0064f5e15c4dab8c532e6ad71f7603_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82f9f7da96f842ad91fb773f1d6c7517_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86b692f1ce7e413c834c8a2488e2c0ac_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0abb09c8d394db38d57f51554da92af_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58d47ddfc2141cabb5fab1f21a38d72_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5a30f909b8e4e1fba6812998b6bf24d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83f4a5e20174093b9f01e04ee9c1d6d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if05006669b12476d9fce3bf96834b1c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3fdf86501a24ebcbc7842721c5fffa2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a42a3fb378b499bba8795f930f41618_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5dd5a8e35954342aeb8de12c5800669_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f5d4c306fa444b4bdb0bf1fe82e8279_D20201208-20201208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorNotes2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-08</xbrli:startDate><xbrli:endDate>2020-12-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4a6b701f2454838a6d52713b838fb03_D20201208-20201208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-08</xbrli:startDate><xbrli:endDate>2020-12-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>iclr:tranche</xbrli:measure></xbrli:unit><xbrli:context id="i52b4c03037324b8685b2023af8543025_I20201208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorANotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc237be9542b46be97a5052ea2194da9_I20201208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorBNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61d39490d9d341c6a04dd22b7c2e3548_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorNotes2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c29619485354cb987ceeeec9f4fd1ad_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorNotes2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i071a74bae9594a1c88d29e82ccf0ce67_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">iclr:AccountingStandardsUpdate202108Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e15468a473f4c8da1405b2a6d723f2a_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">iclr:AccountingStandardsUpdate202108Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3368954c9a64c52b38aa3707ffc38a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i968ed30311b94d908cfbb9557550531c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4794a4624e34b81aaa3d969dd0bc3b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie76f68691f174c19a8058971dbcc477c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0813a3b3dd0749b2b2e5f5ef20260483_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a1e9760cab4726b37a107bc29fd4cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id23d592eefe04b35928d0cc687d6a2ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05316c63db6641378950248cee4a1582_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i509ce783c2ea4a39bdebdb581d6ed480_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9315b0dbc9034bb8aee3c7fc387583e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ccacdd571674f36bbf5930a33df99f2_I20220218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf645606cd69465ab48f7e54e02bf243_D20220101-20220301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6df4b473ec484136b91516d30b1a0b24_1"></div><div style="min-height:31.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">WASHINGTON, D.C.20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">______________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI1_5675ed70-f41c-4701-aefd-c56dc0a139a9">20-F</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTMw_60e75eb8-e450-4984-8419-1841c4486c54">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration statement pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTEw_c13b3c6b-d5c4-4178-b3db-99ca15b9f386">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Annual report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended: <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zODY_62f93544-323c-4397-b2b2-1a1f1fb7ed16"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zODY_2197e99e-1cdc-4c5e-9ff2-637535604e4a">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI2_2f17b5bc-0dad-430e-9202-faf03047cb5d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentShellCompanyReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI3_cafb89e8-3af1-4dcb-a655-4f51421a870f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> Shell company report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTEx_a0bbe5f6-b783-4681-9385-ab2b5ce172d9">333-08704</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ICON PUBLIC LIMITED COMPANY</span></div><div style="margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"></td><td style="width:28.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Exact name of Registrant as Specified in its Charter)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV8xLTEtMS0xLTM2MjQ4_b0b89b38-dc21-472a-854e-544896bb596b">ICON PLC</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Translation of Registrant&#8217;s name into English)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV80LTEtMS0xLTM2MjQ4_9ae391c0-bf3b-4796-89b9-41ccaabe3eed">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV83LTEtMS0xLTM2MjQ4_40ad60d7-6496-4459-884c-2fe635fa3a8f">South County Business Park,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV84LTEtMS0xLTM2MjQ4_6bdac5f6-5f85-470a-b630-06ca91458e40">Leopardstown,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV85LTEtMS0xLTM2MjQ4_2073c2bc-6345-4891-92c0-a485fcde9d1f">Dublin 18, D18 X5R3,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV85LTItMS0xLTM2MjQ4_83f6afe3-a27b-4d25-a9ce-39cc089c29c5">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:ContactPersonnelName" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE3_09bef33e-596f-4a33-b354-62fd8ceee52c">Brendan Brennan</ix:nonNumeric>, Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTIw_56180847-a63e-4599-bce3-1f01ec9f4e42">South County Business Park</ix:nonNumeric>, <ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE4_2c5b49f5-f6fb-4500-849f-a36ace2f293e">Leopardstown</ix:nonNumeric>, <ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTEy_38881283-d248-4c4f-b11f-530c418b720b">Dublin 18</ix:nonNumeric>, <ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8yMTk5MDIzMjU5NTA0_27bba55b-e473-4464-add1-9b7f779d7c75"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8yMTk5MDIzMjU5NTA0_9d0961cc-9fb8-4cce-b671-230595a38364">D18 X5R3</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE5_b0f6225d-8a27-4210-b2e0-261dbbf53c59">Ireland</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:ContactPersonnelEmailAddress" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTEz_69e0f9d9-0c84-4472-a4cd-3b28d94fe94d">Brendan.Brennan@iconplc.com</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTIx_8ba4146e-2749-452b-81b9-16fef41e5406">353</ix:nonNumeric>-<ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTIy_3d26bee7-4b55-47cb-8f61-bd7f0ebe6876">1</ix:nonNumeric>-<ix:nonNumeric contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTA2_8c5d7bf7-95f0-4c8c-ae41-22657d5e15c4">291-2000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name, telephone number, email and/or facsimile number and address of Company contact person)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered or to be registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.154%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.155%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Name of exchange on which registered</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OWFiMzk2Y2EyODU1NGZiNTk1Y2Y1ODAyNjhlMDJjYmMvdGFibGVyYW5nZTo5YWIzOTZjYTI4NTU0ZmI1OTVjZjU4MDI2OGUwMmNiY18xLTAtMS0xLTM2MjQ4_6b4a7462-62fa-4eac-a4d1-707bab7b9874">ORDINARY SHARES, PAR VALUE &#8364;0.06 EACH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OWFiMzk2Y2EyODU1NGZiNTk1Y2Y1ODAyNjhlMDJjYmMvdGFibGVyYW5nZTo5YWIzOTZjYTI4NTU0ZmI1OTVjZjU4MDI2OGUwMmNiY18xLTEtMS0xLTM2MjQ4_893e1401-9990-40bc-bafd-cbb7845f0caa">ICLR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OWFiMzk2Y2EyODU1NGZiNTk1Y2Y1ODAyNjhlMDJjYmMvdGFibGVyYW5nZTo5YWIzOTZjYTI4NTU0ZmI1OTVjZjU4MDI2OGUwMmNiY18xLTItMS0xLTM2MjQ4_f8baef3d-e4ef-40dd-819f-d15a3ebabb55">NASDAQ Global Select Market</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 115.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities registered or to be registered pursuant to section 12(g) of the Act:</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Title of each class</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NONE&#160;</span></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 115.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:&#160;</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NONE&#160;</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Title of class)&#160;</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <ix:nonFraction unitRef="shares" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8xMjA5_d3078a8e-b4e8-40d1-9fc4-e69f526cc9d3">81,554,683</ix:nonFraction> Ordinary Shares.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as determined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTIz_8dfb88ea-8d8e-4f39-ac73-553298d696b7">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160; &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI0_574a7ff0-5ff8-4b50-9dc6-b6079a1b77bc">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI4_e75f0899-e552-4748-95e5-8eec7e840f66">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months: <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI5_37a05d08-9784-41ab-a78c-462808c5081f">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non- accelerated filer.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE0_2f144bc3-6565-41e0-bb0b-60ab0e848b76">Large accelerated filer</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE1_309db595-387b-451a-815f-5b94573d5734">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE2_1891a428-5ae4-453c-a0a1-166b5bbc5f85">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">  &#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:DocumentAccountingStandard" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTA3_f4c84c4d-466c-47fc-afea-cf5ea741e900">U.S. GAAP</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; International Financial Reporting Standards as issued &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     &#160;&#160;&#160;&#160;Other </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-indent:164.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> by the International Accounting Standards Board </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17 </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> Item 18 </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTA5_2f9d6378-0b00-4060-9f46-c5acca7b6575">&#9746;</ix:nonNumeric></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_10">General Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_10">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_13">Cautionary Statement</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_13">1</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_19">Item 1. Identity of Directors, Senior Management and Advisors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_22">Item 2. Offer Statistics and Expected Timetable</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_22">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_25">Item 3. Key Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_25">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_28">Item 4. Information on the Company</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_28">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_31">Item 4A. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_31">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_34">Item 5. Operating and Financial Review and Prospects</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_34">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_37">Item 6. Directors, Senior Management and Employees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_37">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_40">Item 7. Major Shareholders and Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_40">85</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_43">Item 8. Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_43">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_46">Item 9. The Offer and Listing</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_46">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_49">Item 10. Additional Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_49">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_52">Item 11. Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_52">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_55">Item 12. Description of Securities Other than Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_55">97</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_61">Item 13. Defaults, Dividend Arrearages and Delinquencies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_61">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_64">Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_64">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_67">Item 15. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_67">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_70">Item 16. Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_70">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_73">Item 16A. Audit Committee Financial Expert</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_73">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_76">Item 16B. Code of Ethical Conduct</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_76">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_79">Item 16C. Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_79">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_82">Item 16D. Exemptions from the Listing Standards for Audit Committees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_82">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_85">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_85">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_88">Item 16F. Changes in Registrant&#8217;s Certifying Accountant</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_88">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_91">Item 16G. Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_91">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_94">Item 16H. Mine Safety Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_94">100</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_100">Item 17. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_100">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_103">Item 18. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_103">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_106">Item 19. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_106">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_229">Index to Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_229">157</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_226">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_226">158</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">General Information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As used herein, &#8220;ICON plc&#8221;, &#8220;ICON&#8221;, "ICON Group" the &#8220;Company&#8221; and &#8220;we&#8221;, "our" or &#8220;us&#8221; refer to ICON public limited company and its consolidated subsidiaries, unless the context requires otherwise.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unless otherwise indicated, ICON plc&#8217;s financial statements and other financial data contained in this Form 20-F are presented in United States dollars (&#8220;$&#8221;) and are prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In this Form 20-F, references to "U.S. dollars", "U.S.$" or "$" are to the lawful currency of the United States, references to &#8220;euro&#8221; or &#8220;&#8364;&#8221; are to the European single currency adopted by nineteen members of the European Union, references to "pound sterling", "sterling", "&#163;", "pence" or "p" are to the lawful currency of the United Kingdom. ICON publishes its consolidated financial statements in U.S. dollars.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 1, 2021, the Company completed the Acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences Group ("the Acquisition" and "the Merger"). Upon completion of the Acquisition, PRA and its subsidiaries became wholly owned subsidiaries within the ICON Group. The financial statements presented in this Form 20-F reflect the results of the combined Company for the six month period since the Merger completion on July 1, 2021. The results of PRA in the period prior to July 1, 2021 are not reflected in this Form 20-F, other than where clearly stated and required by GAAP.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> Cautionary Statement Regarding Forward-looking Statements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Statements included herein which are not historical facts are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;).&#160;Forward-looking statements may be identified by the use of future tense or other forward looking words such as &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;should&#8221;, &#8220;may&#8221;, &#8220;strategy&#8221;, or other variations or comparable terminology. The forward looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, our results could be materially adversely affected. The risks and uncertainties include, but are not limited to, dependence on the pharmaceutical industry and certain clients, the need to regularly win projects and then to execute them efficiently and correctly, the challenges presented by rapid growth, our expectations concerning the ongoing impact of the novel coronavirus identified as 'COVID-19' on our operational results, the challenges associated with the integration of the PRA,  competition and the continuing consolidation of the industry, the dependence on certain key executives, changes in the regulatory environment and other factors identified in the Company&#8217;s United States Securities and Exchange Commission filings and in the &#8220;Risk Factors&#8221; included on pages 5 through 23. The Company has no obligation under the PSLRA to update any forward looking statements and does not intend to do so.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part I</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_19"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Identity of Directors, Senior Management and Advisors.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_22"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Offer Statistics and Expected Timetable.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_25"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">.&#160; Key Information.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Company updates</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Health Sciences, Inc. - Merger Completion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 1, 2021, ICON completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences Group ("the Acquisition" and "the Merger"). The combined Group retained the name ICON and brought together approximately 38,000 employees (as at the Merger date) across the globe, creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organizations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of ICON. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total value of the Merger consideration is $12.0&#160;billion and has resulted in the recognition of goodwill of $8.1&#160;billion, intangible assets of $4.9&#160;billion and an associated deferred tax liability of $1.1&#160;billion. The accounting for the Merger remains provisional for the year ended December&#160;31, 2021 and the Company expects to finalize the accounting by June 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA&#8217;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is LIBOR plus an applicable margin of 2.50%, in each case, with a step down of 0.25% if the first lien net leverage ratio is equal to or less than 4.00 to 1.00. The senior secured term loan facility is subject to a LIBOR floor of 0.50%. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the credit agreement) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes (see below), subject to other permitted liens.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 27, 2021, the Company repaid $13.8&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.4&#160;million. On November&#160;10, 2021, the Company achieved a net leverage ratio of less than 4 times and the margin applicable to the senior secured term loan was reduced by 0.25% with the overall rate reducing from 3.0% to 2.75%. On December 29, 2021, the Company repaid $500.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.8&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December&#160;31, 2021, no amounts have been drawn under the revolving loan facility with the exception of $4.1&#160;million letters of credit given to landlords to guarantee lease arrangements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500.0&#160;million in aggregate principal amount of 2.875% senior secured notes due July 2026 (the &#8220;Senior Secured Notes&#8221;) in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. The proceeds from the Offering and borrowings made under the Senior Secured Credit Facilities, together with cash on hand, were used to (i) fund the cash consideration payable by ICON for the Merger, (ii) repay existing indebtedness of ICON and PRA and (iii) pay fees and expenses related to the Merger. The Senior Secured Notes are guaranteed on a senior secured basis by ICON and its direct and indirect subsidiaries that guarantee the Senior Secured Credit Facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Repayment of the 2020 Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 8, 2020, the Company issued new senior notes, (the "2020 Senior Notes") for aggregate gross proceeds of $350.0 million in the private placement market. The 2020 Senior Notes were issued in two tranches: Series A Notes of $275.0 million at a fixed interest rate of 2.32% and Series B Notes of $75.0 million at a fixed interest rate of 2.43%. The effective interest rate was adjusted by the impact of an interest rate cash flow hedge which was entered into in advance of the rate fixing date. This cash flow hedge was deemed to be fully effective in accordance with ASC 815 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Derivatives and Hedging'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The realized loss related to this derivative was recorded within other comprehensive income and amortized over the life of the 2020 Senior Notes. The effective rate on the 2020 Senior Notes was fixed at 2.41%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Merger with PRA, the Company was required to repay the 2020 Senior Notes prior to entering into the Senior Secured Credit Facilities and the Senior Secured Notes. The 2020 Senior Notes were repaid on July 1, 2021 inclusive of early repayment charges. The total repayment on July 1, 2021 was $364.0 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board Appointments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of the Merger, Mr. Colin Shannon and Dr. Linda Grais, who both served on the PRA Board, joined ICON&#8217;s Board of Directors with effect from July 1, 2021. Their biographies are set out on page 72.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Assessment of COVID-19 impact on the business</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the period since December 31, 2020, the Company has continued to experience a return to positive growth in revenue and net income as a result of the ongoing recovery from the global COVID-19 pandemic. At this point in time, there still remains some degree of uncertainty relating to the long-term effect of COVID-19 on the Company and when it will be possible for business activity to return to normal operating levels. Although the impact of the global COVID-19 pandemic on the business is reducing, the emergence of COVID-19 variants of concern continue to create restrictions on the ability to ensure laboratory samples are collected and analyzed on time, the ability to monitor clinical trials, the ability of patients or service providers to travel, and our ability to travel, as a result of the outbreak.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has continued to successfully mobilize its vaccine resources to address the COVID-19 global threat, including its ability to conduct home-based trials to minimize infection. In addition, the Company is currently providing clinical monitoring and safety oversight on numerous COVID-19 trials for both the private and government sectors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share repurchase program</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, 1,235,218 ordinary shares were redeemed by the Company for a total consideration of $175.0 million. During the year ended&#160;December&#160;31, 2021, no ordinary shares were redeemed by the Company under this buyback program. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required by Irish Company law.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.    Capitalization and indebtedness</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents our capitalization as at December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,501,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,436,312</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">348,477</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share Capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,733,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">617,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other undenominated capital </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,937)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,416,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,262,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,066,827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,850,236</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Capitalization</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,503,139</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,198,713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company&#8217;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock. The Company also drew down debt of $6,015 million in order to finance the cash portion of the Merger consideration, of which, $514 million has been repaid by December&#160;31, 2021 from cash generated by the Company in the period since the completion of the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.    Reasons for the offer and use of proceeds</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.    Risk Factors</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Various risk factors that are relevant to our business and the services we provide are outlined below. The occurrence of any of these events may materially and adversely affect our business operations, financial condition and results of operations and future prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_1917"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Below is a summary of some of the principal risks that could adversely affect our business, operations and financial results:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Business and Operations</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We depend on a limited number of customers and a loss of, or significant decrease in, business from one or more of them could affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our financial results may be adversely impacted if we under price our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we fail to attract or retain key personnel, our performance may suffer.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The combined Company may be unable to retain employees through the integration period which could disrupt the integration plan, cause disruption to day-to-day activities and result in additional costs to the business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A disease outbreak, epidemic or pandemic such as COVID-19, could adversely affect our business performance. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber-attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">ICON may be unable to realize anticipated cost and tax synergies and expects to incur substantial expenses related to the Merger.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Improper performance of our services could adversely impact our reputation and our financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We have only a limited ability to protect our intellectual property rights and these rights are important to our success.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We act as authorized representative or legal representative for some clients pursuant to certain EU legislation. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on third parties to provide certain data and other information to us. Our suppliers or providers might increase our cost to obtain, restrict our use of or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on third parties for important products, services and licenses to certain technology and intellectual property rights, if there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Industry</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We operate in a highly competitive and dynamic market.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may be adversely affected by industry, customer or therapeutic concentration.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Financial Results and Financial Position</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our exposure to exchange rate fluctuations could adversely affect our results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exposed to various risks in relation to our cash and cash equivalents and short term investments.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Changes in accounting standards may adversely affect our financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Political, Legal or Regulatory Environment</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may lose business opportunities as a result of health care reform and the expansion of managed care organizations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The unrest in Eastern Europe could adversely affect our results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may lose business as a result of changes in the regulatory environment.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We are subject to political, regulatory, operational and legal risks associated with our international operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("Bribery Act") and similar anti-corruption laws in other jurisdictions as well as laws and regulations relating to trade compliance and economic sanctions.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Environmental, social and governance matters may impact our business and reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Indebtedness</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We have incurred substantial additional indebtedness in connection with the Merger , which could impair our flexibility and access to capital and could adversely affect the combined Company&#8217;s business, financial condition or results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Covenants in our credit agreement and the indenture governing the Senior Secured Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on our senior secured term loan facility, in the event that the Company draws down on the revolving credit facility or in respect of any future issuances of debt.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The phasing out of LIBOR may affect our interest expense with respect to borrowings under the Senior Secured Facilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Common Stock</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Volatility in the market price of our common stock could lead to losses by investors.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If securities analysts or industry analysts do not publish reports about our business or if they downgrade our stock or our sector, our stock price and trading volumes could decline. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">An investor's return may be reduced if we lose our foreign private issuer status. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We do not expect to pay any cash dividends for the foreseeable future.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC"), may be subject to Irish stamp duty.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_1864"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Business and Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We depend on a limited number of customers and a loss of, or significant decrease in, business from one or more of them could affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, 31.6% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.0% of revenue for the year. During the year ended December&#160;31, 2020, 39.1% of our revenues were derived from our top five customers, with one customer contributing more than 10% of our revenues during the period (12.1%).&#160;No other customer contributed more than 10% of our revenues during this period. During the year ended December&#160;31, 2019, 37.6% of our revenues were derived from our top five customers, with two customer contributing more than 10% of our revenues during the period (the largest contributing 12.5% and the second largest contributing 10.2%). No other customer contributed more than 10% of our revenues during this period (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 17 - Disaggregation of revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in the consolidated financial statements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. If we lose clients, we may not be able to attract new ones and if we lose individual projects, we may not be able to replace them. The loss of, or a significant decrease in, business from one or more of these key customers could have a material adverse impact on our results of operations and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Many of our contracts are long-term fixed price or fixed unit price contracts for services. As a result, variations in the timing and progress of large contracts may materially adversely affect our results of operations. Revenue recognized on these service contracts are based on an assessment of progress towards completion being the cost of time and other third party costs as a percentage of total estimated time and other third party costs to deliver our services. As a result, variations in the timing and progress of large contracts may materially adversely affect our results of operations. Estimating time and costs to complete requires judgment and includes consideration of the complexity of the study, the number of geographical sites where trials are to be conducted and the number of patients to be recruited at each site. We regularly review the estimated hours on each contract to determine if the budget accurately reflects the agreed tasks to be performed, taking into account the state of progress at the time of review. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We bear the risk of cost overruns unless the scope of activity is revised from the contract specifications and we are able to negotiate a contract modification. We endeavor to ensure that any changes in scope are appropriately monitored and change orders or contract modifications are promptly negotiated and documented for changes in scope.&#160;If we fail to successfully negotiate change orders for changes in the resources required or the scope of the work to be performed, and the costs of performance of these contracts exceeded their fixed fees, it could materially adversely affect our operations and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our clients may discontinue using our services completely or cancel some projects either without notice or upon short notice. The termination or delay of a large contract, or of multiple contracts, could have a material adverse effect on our revenue and profitability. Historically, clients have canceled or discontinued projects and may in the future cancel their contracts with us for reasons including, amongst others:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">the failure of products being tested to satisfy safety or efficacy requirements;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">unexpected or undesired clinical results of the product;&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decision that a particular study is no longer necessary or viable;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">poor project performance, quality concerns, insufficient patient enrollment or investigator recruitment; and&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">production problems resulting in shortages of the drug.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result, contract terminations, delays or other changes are part of our clinical services business. In the event of termination, our contracts often provide for fees for winding down the trial but these fees may not be sufficient for us to maintain our margins, and termination may result in lower resource utilization rates. In addition, we may not realize the full benefits of our unsatisfied performance obligation of contractually committed services if our clients cancel, delay or reduce their commitments under our contracts with them.  Therefore, the loss, early termination or delay of a large contract or contracts could adversely affect our revenues and profitability.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business is dependent on our ability to generate new business awards from new and existing customers and maintain existing customer contracts. If we were unable to generate new business awards on a timely basis and contract for those awards, that could have a material impact on our business, financial condition, results of operations or cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A key element of our growth strategy is the successful development and marketing of new services or entering new markets that complement or expand our existing business.  As we develop new services or enter new markets, we may not have or be able to adequately build the competencies necessary to perform such services satisfactorily, may not receive market acceptance for such services or may face increased competition. If we are unable to succeed in developing new services, entering new markets or attracting a client base for our new services or in new markets, we will be unable to implement this element of our growth strategy, and our future business, reputation, results of operations could be adversely impacted. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we fail to attract or retain key personnel, our performance may suffer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business, future success and ability to continue to expand operations depends upon our ability to attract, hire, train and retain qualified professional, scientific and technical operating people. We compete for qualified professionals with other Clinical Research Organizations (&#8220;CROs&#8221;), temporary staffing agencies and the in-house departments of pharmaceutical, biotechnology and medical device companies. An inability to attract and retain a sufficient number of high caliber clinical research professionals (in particular, key personnel and executives) at an acceptable cost would impact our ability to provide our services, our future performance and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The successful completion of clinical trials is dependent upon the ability to recruit suitable and willing patients on which to test the drug under study. The availability of suitable patients for enrollment on studies is dependent upon many factors including, amongst others, the size of the patient population, the design of the study protocol, eligibility criteria, the referral practices of physicians, the perceived risks and benefits of the drug under study and the availability of alternative medication, including medication undergoing separate clinical trials.&#160;Insufficient or inappropriate patient enrollment may result in the termination or delay of a study which could have a material adverse impact on our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is focused on continuing to develop its expertise in patient recruitment with the establishment in 2020 of Accellacare, a global clinical research network, offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trails. The focus is on making it easier for the site and the patient to actively participate in a trial to ensure increased predictability, enrollment and retention. Our site and patient solutions group includes upfront planning of site and patient management including identification, enrollment and engagement.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Improved site selection is achieved through:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">leading technology to identify where the patients are that match the protocol;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">assessment of the qualification of sites based on real data;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">partnerships with leading technology vendors and developing the capability to enable EMR interrogation into clinical insights such as sub-populations and larger pre-screened pool where the technology and regulations are enabled.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The burden on the site, in ensuring patient enrollment and engagement, is achieved through integrated site networks. ICON has a number of site alliance partners. During 2018, we enhanced our site and patient recruitment capabilities with an expansion of the PMG Research network through a partnership with the DuPage Medical Group. During 2019, we further enhanced our site and patient recruitment abilities through the strategic acquisitions of MeDiNova and CRN. In 2020, we entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), with a third party. Oncacare operates as a specialized oncology site network in the US and EMEA regions. The new site network is focused on implementing a range of commercial models with specialist oncology healthcare providers in the US and EMEA, to accelerate the recruitment and retention of patients into oncology trials. The oncology site network operates as a joint venture between the Company and a third party company which has extensive experience in developing and running a site network. We also use digital solutions to drive site performance, including pre-screening, eConsent, learning management, document tracking and management with key applications.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We contract with physicians located in hospitals, clinics or other similar sites, who serve as investigators in conducting clinical trials to test new drugs on their patients. Investigators supervise administration of the study drug to patients during the course of the clinical trial. The successful conduct of a clinical trial is dependent upon the integrity, experience and capabilities of the investigators conducting the trial. Insufficient investigator recruitment, which in turn may lead to insufficient or inappropriate patient enrollment, may result in the termination or delay of a study which could have a material adverse impact on our results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The combined Company may face challenges retaining employees through the integration period which could delay the integration plan, cause disruption to day-to-day activities and result in additional costs to the business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> The attraction, development and retention of our talent is critical to the success of the combined Company, and we are working to strengthen processes around these areas to minimize retention risk and support a successful integration. The Company, led by the Chief Human Resource Officer, is taking meaningful action to retain employees. Through our annual Talent Review process we have identified opportunities for improvement as it relates to employee retention. Our 2022 People Plans have set specific goals for each functional area in terms of three critical areas: talent attraction, development and retention. However, we can provide no assurances that our efforts in this respect will be successful.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business. We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. Our success depends on the knowledge, capabilities, and quality of our people.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In recent years, extreme weather events and changing weather patterns such as storms, flooding, droughts and temperature changes have become more common. As a result, we are potentially exposed to varying natural disaster or extreme weather risks such as hurricanes, tornadoes, droughts or floods, or other events that may result from the impact of climate change on the environment, such as sea level rise. As a result, we could experience increased costs, business interruptions, destruction of facilities, and loss of life, all of which could have a material adverse effect on our business, financial condition, or results of operations. The potential impacts of climate change may also include increased operating costs associated with additional regulatory requirements and investments in reducing energy, water use and greenhouse gas emissions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A disease outbreak, epidemic or pandemic such as COVID-19, could adversely affect our business performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A disease outbreak, such as influenza, coronavirus, or other biological attack could negatively impact our operations. We could experience restrictions on our ability to travel, or the ability of patients or other service providers to travel, to monitor our clinical trials and to ensure laboratory samples are collected and analyzed on time as a result of an outbreak. The potential impact of an epidemic or pandemic may also result in increased operating costs and result in a requirement to increase investment in impact prevention.      </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">COVID-19 has, and may continue to, affect our business performance, and could adversely affect the economies and financial markets worldwide, resulting in an economic downturn that could impact our business, financial condition and results of operations. The Company has experienced volatility on our operations as a result of the global spread of COVID-19, including restrictions on our ability to ensure laboratory samples are collected and analyzed on time, our ability to monitor our clinical trials, the ability of patients or other service providers to travel, and our ability to travel. We have also experienced costs associated with impact prevention.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 outbreak continues to evolve. While our site network and office facilities have predominantly re-opened, the extent to which the outbreak and emergence of new variants of concern may continue to impact our business will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of COVID-19, additional phases of the outbreak, travel restrictions and actions to contain the outbreak or treat its impact, such as social distancing and quarantines or lock-downs, business closures or business disruptions and the effectiveness of actions taken throughout the world to contain and treat the disease. We may also be required or choose to take temporary measures intended to help minimize the risk of infection from the virus for our employees, including temporarily requiring all employees to work remotely, suspending all non-essential travel worldwide and discouraging attendance at industry events, industry and other conferences, and in-person work-related meetings, which could negatively affect our business and cannot presently be predicted with confidence.  </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber-attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the global nature of our business and our reliance on information systems to provide our services, we use web-enabled and other integrated information systems in delivering our services. We will continue to increase the use of these systems&#160;and such systems will either be developed internally or provided in conjunction with third parties. We also provide access to similar information systems to certain clients in connection with the services we provide them. As the use, scope and complexity of our information systems continue to grow, we are exposed to, and will increasingly be exposed to, the risks inherent in the development, integration and ongoing operation of evolving information systems, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">disruption or failure of data centers, telecommunications facilities or other key infrastructure platforms;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">security breaches, cyber-attacks or other failures or malfunctions in our application or information systems or their associated hardware or other systems that we have access to, or that we rely upon, or that have access to our systems; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">security breaches, cyber-attacks or malfunctions with key suppliers or partners who we rely on to provide services to customers; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">excessive costs, excessive delays or other deficiencies in, or problems with, systems development and deployment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The materialization of any of these risks may impede our ability to provide services, the processing of data, the delivery of databases and services and the day-to-day management of our business and could result in the corruption, loss or unauthorized disclosure of proprietary, confidential or other data, as well as reputational harm. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While we have cybersecurity controls and disaster recovery plans in place, they might not adequately protect us in the event of a system failure, security breach or cyber-attack. Despite any precautions we take, damage from fire, floods, hurricanes, power loss, telecommunications failures, computer viruses, information system security breaches, cyber-attacks and similar events that impact on our various computer facilities could result in interruptions in the flow of data to our servers and from our servers to our clients. Corruption or loss of data may result in the need to repeat a trial at no cost to the client, but at significant cost to us, or result in the termination of one or more contracts, legal proceedings or claims against us or damage to our reputation. Additionally, significant delays in system enhancements or inadequate performance of new or upgraded systems once completed could damage our reputation and harm our business. Long-term disruptions in the infrastructure caused by events such as security breaches, cyber-attacks, natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism, particularly involving cities in which we have offices, could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unauthorized disclosure of sensitive or confidential data, whether through system failure or employee negligence, fraud or misappropriation, could damage our reputation and cause us to lose clients. Similarly, despite investing in information and cyber-security controls there is a risk that unauthorized access to our information systems or those we develop for our clients, whether by our employees or third parties, including a cyber-attack by computer programmers and hackers who may attack ICON systems, develop and deploy viruses, worms, ransomware or other malicious software programs could result in negative publicity, significant remediation costs, legal liability, loss of customers and damage to our reputation and could have a material adverse effect on our results of operations and financial results. In addition, our liability insurance might not be sufficient in type, the cover provided or amount to adequately cover us against claims related to security breaches, cyber-attacks and other related breaches. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our information systems and those of third parties which we utilize may face increased cybersecurity risks due to the COVID-19 pandemic, including from the significant number of employees that are working remotely or otherwise impacted by stay-at-home orders.&#160;Additional remote access points provide new potential vulnerabilities to cybercriminals. Employees of ICON and third parties may be more susceptible to social engineering efforts, and to phishing attempts which can disguise malware as a legitimate effort to circulate important information relating to COVID-19.&#160; </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additionally, ICON completed the Merger with PRA on July 1, 2021 and, as a result, the IT landscape and physical footprint of the Company has increased significantly. As the organization invests in the consolidation of offices, data centers, IT systems and business services a significant amount of due diligence has been completed to understand the IT landscape and increased attack surface. While the organization continues with substantial integration efforts a failure to effectively manage these activities in a timely and cost-effective manner may result in disruption to our business and negatively affect our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Continued efficient operation of our business requires that we implement standardized global business processes and evolve our information systems to enable this implementation. We have continued to undertake significant programs to optimize business processes with respect to our services. A failure to effectively manage the implementation and adapt to new processes designed into these new or upgraded systems in a timely and cost-effective manner may result in disruption to our business and negatively affect our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have entered into agreements with certain vendors to provide systems development and integration services that develop or license to us the IT platform for programs to optimize our business processes. If such vendors fail to perform as required or if there are substantial delays in developing, implementing and updating the IT platform, our customer delivery may be impaired and we may have to make substantial further investments, internally or with third parties, to achieve our objectives. Additionally, our progress may be limited by parties with existing or claimed patents who seek to prevent us from using preferred technology or seek license payments from us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Meeting our objectives is dependent on a number of factors which may not take place as we anticipate, including obtaining adequate technology-enabled services, creating IT-enabled services that our customers will find desirable and implementing our business model with respect to these services. We are continuing to develop opportunities for automation across ICON using state of the art automation tools including Robotic Process Automation (RPA), the development of new applications and capabilities, and enabling deeper integration across our digital ecosystem. If we do not keep pace with rapid technological changes in the CRO industry, our products and services may become less competitive or even obsolete. This applies in particular to our ICONIK, Firecrest, ADDPLAN, Integrated Dataverse (IDV&#174;) and One Search services. Also, increased requirements for investment in information technology may negatively impact our financial condition, including profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to pursue business transformation initiatives to embed technology and innovation and deliver operational efficiencies. As part of these initiatives, we seek to improve our productivity, flexibility, quality, functionality and cost savings by our on-going investment in global technologies, continuous improvement of our business processes and functions to deliver economies of scale. These initiatives may not deliver their intended gains or be completed in a timely manner which may adversely impact our competitiveness and our ability to meet our growth objectives and therefore, could adversely affect our business and operating results, including profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We develop and maintain computer run and web based interactive response technologies to automatically manage the randomization of patients in trials, assign the study drug and adjust the dosage when required for patients enrolled in trials we support. An error in the design, programming or validation of these systems could lead to inappropriate assignment or dosing of patients, which could give rise to patient safety issues and invalidation of the trial and/or liability claims against the Company, amongst other things, any of which could have a material effect on our financial condition and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made a number of acquisitions, including the Merger, and continue to review new acquisition opportunities. If we are unable to identify suitable acquisition targets, complete an acquisition or successfully integrate an acquired company or business, our business may be disrupted. The success of an acquisition will depend upon, among other things, our ability to:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">effectively and quickly assimilate the operations and services or products of the acquired company or business;&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">integrate acquired personnel;&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">retain and motivate key employees;&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">retain customers; and&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">minimize the diversion of management's attention from other business concerns.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event that the operations of an acquired company or business do not meet our performance expectations, we may have to restructure the acquired company or business or write-off the value of some, or all, of the assets of the acquired company or business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">ICON may be unable to realize anticipated cost and tax synergies and expects to incur substantial expenses related to the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON expects to generate run rate cost synergies of approximately $150 million and tax savings from the combined target effective tax rate; both to be realized within approximately four years after completion of the Merger. ICON&#8217;s ability to achieve such estimated cost and tax synergies in the timeframe described, or at all, is subject to various assumptions by ICON&#8217;s management, which may or may not prove to be accurate, as well as the incurrence of costs in ICON&#8217;s operations that offset all or a portion of such cost synergies. As a consequence, ICON may not be able to realize all of these cost and tax synergies within the timeframe expected or at all. In addition, ICON may incur additional or unexpected costs in order to realize these cost and tax synergies. ICON&#8217;s ability to realize tax synergies is subject to uncertainties. Failure to achieve the expected cost and tax synergies could significantly reduce the expected benefits associated with the Merger. In addition, ICON has incurred and will incur substantial expenses in connection with completion of the Merger. ICON expects to continue to incur non-recurring costs associated with consummating the Merger, combining the operations of the two companies and achieving the desired cost synergies. These fees and costs have been, and will continue to be, substantial. The substantial majority of nonrecurring expenses will consist of transaction costs related to the Merger and include, among others, fees paid to financial, legal and accounting advisors, employee benefit costs and filing fees. Such costs, as well as other unanticipated costs and expenses, could have a material adverse effect on the financial condition and operating results of ICON following the completion of the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Improper performance of our services could adversely impact our reputation and our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The performance of clinical development services is complex and time-consuming. We may make mistakes in conducting a clinical trial that could negatively impact or damage the usefulness of the clinical trial or cause the results to be reported improperly.  If the clinical trial results are compromised, we could be subject to significant costs or liability, which could have an adverse impact on our ability to perform our services. Large clinical trials are costly, and while we endeavor to contractually limit our exposure to such risks, improper performance of our services could have an adverse effect on our financial condition, damage our reputation and result in the cancellation of current contracts or failure to obtain new contracts from affected or other clients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The biopharmaceutical industry is highly competitive, with biopharmaceutical companies each seeking to persuade payers, providers and patients that their drug therapies are better and more cost-effective than competing therapies marketed or being developed by competing companies. In addition to the adverse competitive interests that biopharmaceutical companies have with each other, biopharmaceutical companies also have adverse interests with respect to drug selection and reimbursement with other participants in the healthcare industry, including payers and providers. Biopharmaceutical companies also compete to be first to market with new drug therapies. We regularly provide services to biopharmaceutical companies who compete with each other and we sometimes provide services to such customers regarding competing drugs in development. Our existing or future relationships with our biopharmaceutical customers may therefore deter other biopharmaceutical customers from using our services or may result in our customers seeking to place limits on our ability to serve other biopharmaceutical industry participants. In addition, our further expansion into the broader healthcare market may adversely impact our relationships with biopharmaceutical customers and such customers may elect not to use our services, reduce the scope of services that we provide to them or seek to place restrictions on our ability to serve customers in the broader healthcare market with interests that are adverse to theirs. Any loss of customers or reductions in the level of revenues from a customer could have a material adverse effect on our results of operations, business and prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We have only a limited ability to protect our intellectual property rights and these rights are important to our success.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends, in part, upon our ability to develop, use and protect our proprietary methodologies, analytics, systems, technologies and other intellectual property. Existing laws of the various countries in which we provide services or solutions offer only limited protection of our intellectual property rights, and the protection in some countries may be very limited. We rely upon a combination of trade secrets, confidentiality policies, non-disclosure, invention assignment and other contractual arrangements and patent, copyright and trademark laws, to protect our intellectual property rights. These laws are subject to change at any time and certain agreements may not be fully enforceable, which could further restrict our ability to protect our innovations. Intellectual property rights may not prevent competitors from independently developing services similar to, or duplicative, of ours. Further, the steps we take in this regard might not be adequate to prevent or deter infringement or other misappropriation of our intellectual property by competitors, former employees or other third parties and we might not be able to detect unauthorized use of, or take appropriate and timely steps to enforce our intellectual property rights. Enforcing our rights might also require considerable time, money and oversight and we may not be successful in enforcing our rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The biopharmaceutical industry has a history of intellectual property litigation, and these lawsuits will likely continue in the future. Accordingly, we may face patent infringement legal proceedings by companies that have patents for similar business processes or other legal proceedings alleging infringement of their intellectual property rights. Legal proceedings relating to intellectual property could be expensive, take significant time and divert management&#8217;s attention from other business concerns, regardless of the outcome of the litigation. If we do not prevail in an infringement lawsuit brought against us, we might have to pay substantial damages and we could be required to stop the infringing activity or obtain a license to use technology on unfavorable terms. Any infringement or other legal processing related to intellectual property could have a material adverse effect on our operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We act as authorized representative or legal representative for some clients pursuant to certain EU legislation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We act as authorized representative pursuant to Medical Devices Directive 93/42/EEC&#160;(&#8220;MDD&#8221;) and Active Implantable Medical Devices Directive 90/385/EEC (&#8220;AIMD&#8221;) for certain clients who are located outside of the European Union. Medical Devices Regulation 2017/745 (&#8220;MDR&#8221;) replaced MDD on May 26, 2020 and provides for increased responsibility, and accordingly increased risk, for authorized representatives. As authorized representative, we act on behalf of medical device manufacturers in relation to specified tasks with regard to their obligations under MDR. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also act as legal representative pursuant to MDD and AIMD, and will continue to do so pursuant to MDR, for certain clients who are located outside of the European Union with respect to clinical trials being carried out by those clients in the European Union. As legal representative, we are responsible for ensuring compliance with the client&#8217;s obligations pursuant to MDR and we are the addressee for all communications with the client provided for under MDR. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide these services subject to certain terms and conditions which are contained in our agreements with clients pertaining to these services. We aim to reduce any potential liability associated with these activities by seeking contractual indemnification from our clients and by maintaining an appropriate level of insurance cover. However, there is no guarantee that the specific insurance will be available or that a client will fulfill its obligations in relation to their indemnity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to provide certain data and other information to us. Our suppliers or providers might increase our cost to obtain, restrict our use of or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our services are derived from, or include, the use of data we collect from third parties. We have several data suppliers that provide us with a broad and diverse scope of information that we collect, use in our business and sell.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We generally enter into long-term contractual arrangements with many of our data suppliers. At the time we enter into a new data supply contract or renew an existing contract, suppliers may increase our cost to obtain and use the data provided by such supplier, increase restrictions on our ability to use or sell such data, or altogether refuse to license the data to us. Also, our data suppliers may fail to meet or adhere to our quality control standards or fail to deliver the data to us. Although no single supplier is material to our business, if suppliers that collectively provide a significant amount of the data we receive or use were to increase our costs to obtain or use such data, further restrict our access to or use of such data, fail to meet or adhere to our quality control standards, refuse to provide or fail to deliver data to us, our ability to provide data-dependent services to our clients may be adversely impacted, which could have a material adverse effect on our business, results of operations, financial condition or cash flow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties for important products, services and licenses to certain technology and intellectual property rights, if there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We depend on certain third parties to provide us with products and services critical to our business. Such services include, among others, suppliers of drugs for patients participating in trials, suppliers of kits for use in our laboratories, suppliers of reagents for use in our testing equipment and providers of maintenance services for our equipment. The failure of any of these third parties to adequately provide the required products or services, or to do so in compliance with applicable regulatory requirements, could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Some of our services rely on intellectual property, technology and other similar property owned and/or controlled by third parties. Our licenses to this property and technology could terminate or expire and we might not be able to replace these licenses in a timely manner. Also, we might not be able to renew these licenses on similar terms and conditions. Failure to renew these licenses, or renewals of these licenses on less advantageous terms, could have a material adverse effect on our business, results of operations, financial condition or cash flow.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_1907"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_1880"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are dependent upon the ability and willingness of the pharmaceutical, biotechnology and medical device companies to continue to spend on research and development and to outsource the services that we provide. We are therefore subject to risks, uncertainties and trends that affect companies in these industries that we do not control. We have benefited to date from the tendency of pharmaceutical, biotechnology and medical device companies to outsource clinical research projects. Any downturn in these industries or reduction in spending or outsourcing could materially adversely affect our business. The following could each result in such a downturn:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.35pt">if pharmaceutical, biotechnology or medical device companies expanded upon their in-house clinical or development capabilities, they would be less likely to utilize our services;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.35pt">if governmental regulations were changed, it could affect the ability of our clients to operate profitably, which may lead to a decrease in research spending and therefore this could have a material adverse effect on our business; and</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:19.35pt">if unfavorable economic conditions or disruptions in the credit and capital markets negatively impacted our clients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large pharmaceutical companies are continually seeking to drive efficiencies in their development processes to both reduce costs associated with the development of new drug candidates and accelerate time to market. As a result, large pharmaceutical companies, in particular, are increasingly looking to consolidate the number of outsource providers with which they engage, with many entering strategic partnership arrangements with a limited number of outsource providers.&#160;The failure to enter strategic partnership arrangements with customers or the loss of existing customers as a result of them entering strategic partnership arrangements with our competitors could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain pharmaceutical companies have begun to collaborate in seeking to develop new drug candidates. Increased collaboration amongst pharmaceutical companies may lead to fewer research opportunities, which in turn may lead to fewer outsource opportunities for companies within the CRO industry. A reduction in outsource opportunities as a result of this increased collaboration could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive and dynamic market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is highly competitive. In particular, we compete with other large global CROs for strategic relationships with large pharmaceutical companies. If we are unable to retain and renew existing strategic relationships and win new strategic relationships, there could be a material adverse impact on our results. Similarly, we compete with other CROs for work which comes outside of these strategic relationships and being unable to win work outside of these strategic relationships would have a material adverse impact on our results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The type and depth of services provided by CROs has changed in recent years. Failure to develop and market new services or expand existing service offerings could adversely affect our business and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New entrants may also enter the market which would further increase competition and could adversely affect our business and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by industry, customer or therapeutic concentration.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide services to biopharmaceutical, biotechnology, medical device and government organizations and our revenue is dependent on expenditures by these customers.  Our business could therefore be adversely impacted by mergers, consolidation, business failures, distress in financial markets or other factors resulting in a decrease in the number of potential customers or therapeutic products being developed through the drug development progress. There has been consolidation in the biopharmaceutical market in recent years. If the number of our potential customers were to decline in the future, they may be able to negotiate price discounts or other terms for services that are less favorable to us than they have been historically. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_1902"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Financial Results and Financial Position</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our results of operations in any quarter can fluctuate or differ from expected or forecast results depending upon or due to, among other things, the number and scope of ongoing client projects, the commencement, postponement, variation,&#160;cancellation or termination of projects in a quarter, the mix of activity, cost overruns, employee hiring, employee attrition and other factors. Our revenue in any period is directly related to the number of employees who were working on billable projects together with investigator activity during that period. We may be unable to compensate for periods of under-utilization during one part of a fiscal period by earning revenue during another part of that period. We believe that operating results for any particular quarter are not necessarily a meaningful indicator of future results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Also, if in future quarters, we are unable to continue to deliver operational efficiencies and our expenses grow faster than our revenues, our operating margins, profitability and overall financial condition may be materially adversely impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our exposure to exchange rate fluctuations could adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contracts with clients are sometimes denominated in currencies other than the currency in which we incur expenses related to such contracts. Where expenses are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material adverse effect on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we are also subject to translation exposures as our consolidated financial results are presented in U.S. dollars, while the local results of a certain number of our subsidiaries are prepared in currencies other than U.S. dollars, including, amongst others, the pound sterling and the euro. Accordingly, changes in exchange rates between the U.S. dollar and those other currencies will affect the translation of subsidiary companies' financial results into U.S. dollars in reporting our consolidated financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our quarterly effective tax rate has depended and will continue to depend on the geographic distribution of our taxable earnings amongst the multiple tax jurisdictions in which we operate and the tax law in those jurisdictions. Changes in the geographic mix of our results of operations amongst these jurisdictions may have a significant impact on our effective tax rate from quarter to quarter. As a result of the Merger and associated transaction and integration costs, the effective tax rate may fluctuate, which may have a significant impact on our financial results. Changes in tax law in one or more jurisdictions could also have a significant impact on our tax rate and results. In addition, as we operate in multiple tax jurisdictions, we may be subject to audits in certain jurisdictions. These audits may involve complex issues which could require an extended period of time for resolution. The resolution of audit issues may lead to differences, additional taxes, fines or penalties which could have a material adverse impact on our effective tax rate and our consolidated financial results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation is the amount of awards that has not yet converted to revenue. This value is not necessarily a meaningful predictor of future results due to the potential for the cancellation or delay of projects included in the unsatisfied performance obligation.&#160;No assurances can be given that we will be able to realize this unsatisfied performance obligation in full as revenue. A failure to realize these awards could have a material adverse impact on our results of operations. In addition, as the length and complexity of projects increases, the rate at which awards convert to revenue may be slower than in the past. A significant reduction in the rate of conversion could have a material impact on our results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The Company is exposed to various risks in relation to our cash and cash equivalents and short term investments.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s treasury function manages our available cash resources and invests significant cash balances in various financial institutions to try to ensure optimum returns for our surplus cash balances.&#160;These balances are classified as cash and cash equivalents or short term investments depending on the maturity of the related investment. Cash and cash equivalents comprise cash and highly liquid investments with maturities of three months or less.&#160;Short term investments comprise highly liquid investments with maturities of greater than three months and minimum &#8220;A-&#8221; rated fixed and floating rate securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;Given the global nature of our business, we are exposed to various risks in relation to these balances including liquidity risk, credit risk associated with the counterparties with whom we invest, interest rate risk on floating rate securities, sovereign risk (our principle sovereign risk relates to investments in U.S. Treasury funds) and other factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we have not recognized any significant losses to date on our cash and cash equivalents or short term investments, any significant declines in their market values could have a material adverse effect on our financial position and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Changes in accounting standards may adversely affect our financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We prepare our financial statements in accordance with generally accepted accounting principles in the United States of America ("US GAAP") which are revised on an on-going basis by the authoritative bodies. It is possible that future accounting standard updates may require changes to the accounting treatment that we apply in preparation of our financial statements. These changes may also require significant changes to our reporting systems. These updates may result in unexpected variability in the timing of recognition of revenue or expenses and therefore in our operating results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_1895"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Political, Legal or Regulatory Environment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may lose business opportunities as a result of healthcare reform and the expansion of managed care organizations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Numerous governments, including the U.S. government, have undertaken efforts to control growing healthcare costs through legislation, regulation and voluntary agreements with medical care providers and drug companies. If these efforts are successful, pharmaceutical, biotechnology and medical device companies may react by spending less on research and development and therefore this could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to healthcare reform proposals, the expansion of managed care organizations in the health care market may result in reduced spending on research and development. Managed care organizations' efforts to cut costs by limiting expenditures on pharmaceuticals and medical devices could result in pharmaceutical, biotechnology and medical device companies spending less on research and development. If this were to occur, we would have fewer business opportunities and our revenues could decrease, possibly materially.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our results of operations and financial conditions could be affected by changes in healthcare spending and policy.&#160; The healthcare industry is subject to changing political, regulatory and other influences. It is possible that legislation will be introduced and passed in the United States repealing, modifying or invalidating the current healthcare reform legislation, in whole or in part, and signed into law. Because of the continued uncertainty about the implementation of the current healthcare reform legislation, including the potential for further legal challenges or repeal of that legislation, we cannot quantify or predict with any certainty the likely impact of the&#160;current&#160;healthcare&#160;reform legislation&#160;or its repeal on the healthcare sector, on our customers and ultimately on our financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">The unrest in Eastern Europe could adversely affect our results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The current unrest in Eastern Europe has led to, among other things, hardship and the imposition of international economic sanctions aimed at the region. While the situation is subject to change, there remains the possibility of additional and harsher sanctions if the conflict intensifies. If that were to happen, our operations in the region may be severely curtailed or eliminated, which could adversely affect our results of operations. In addition, if the current unrest broadens or further escalates, our operations may be severely curtailed, which could adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may lose business as a result of changes in the regulatory environment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Various regulatory bodies throughout the world may enact legislation, rules and guidance which could introduce changes to the regulatory environment for drug development and research. The adoption and implementation of such legislation, rules and guidance is difficult to predict and therefore could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The U.S. Food and Drug Administration, ("FDA"), and other regulatory and government authorities and agencies inspect and audit us from time to time to ensure that we comply with their regulations and guidelines, including environmental, health and safety matters, and other requirements imposed in connection with the performance of government contracts.&#160; We must comply with the applicable regulatory requirements governing the conduct of clinical trials and contracting with the government in all countries in which we operate. If we fail to comply with any of these requirements we could suffer some or all of:&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">termination of or delay in any research;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">disqualification of data;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">denial of the right to conduct business;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">criminal penalties;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">financial penalties;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">other enforcement actions including debarment from government contracts;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">loss of clients and/or business; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">litigation from clients and/or patients and/or regulatory authorities and/or other affected third parties, and resulting material penalties, damages and costs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We are subject to political, regulatory, operational and legal risks associated with our international operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of a small group of organizations with the capability and expertise to conduct clinical trials on a global basis. We believe that this capability to provide our services globally in most major and developing pharmaceutical markets enhances our ability to compete for new business from large multinational pharmaceutical, biotechnology and medical device companies. We have expanded geographically in the past and intend to continue expanding in regions that have the potential to increase our client base or increase our investigator and patient populations. We expect that revenues earned in emerging markets will continue to account for an increasing portion of our total revenues.&#160;However, emerging market operations may present several risks, including civil disturbances, health concerns, cultural differences such as employment, regulatory and business practices, compliance with economic sanctions, laws and regulations, volatility in gross domestic product, economic and governmental instability, the potential for nationalization of private assets and the imposition of exchange controls. In addition, operating globally means the Company faces the challenges associated with coordinating its services across different countries, time zones and cultures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the political and regulatory environment in the international markets in which we operate such as price or exchange controls could impact our revenue and profitability and could lead to penalties, sanctions and reputational damages if we are not compliant with those regulations. Political uncertainty and a lack of institutional continuity in some of the emerging, developing or other countries in which we operate could affect the orderly operation of markets in these economies.&#160;In addition, in countries with a large and complicated structure of government and administration, national, regional, local and other governmental bodies may issue inconsistent decisions and opinions that could increase our cost of regulatory compliance and/or have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Uncertainty of the legal environment in some emerging countries could also limit our ability to enforce our rights.&#160;In certain emerging and developing countries we enjoy less comprehensive protection for some of our rights, including intellectual property rights, which could undermine our competitive position. Proceedings to enforce our future patent rights, if any, in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If any of the above risks or similar risks associated with our international operations were to materialize, our results of operations and financial condition could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("Bribery Act") and similar anti-corruption laws in other jurisdictions as well as laws and regulations relating to trade compliance and economic sanctions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FCPA, UK Bribery Act of 2010 and similar anti-corruption laws in other jurisdictions prohibit us and our officers, directors, employees and third parties acting on our behalf, including agents, from corruptly offering, promising, authorizing, or providing anything of value to a "foreign official" for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. In addition, the FCPA imposes certain books, records and accounting control obligations on public companies and other issuers. The UK Bribery Act also prohibits "commercial" bribery and accepting bribes. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our global business operations also must be conducted in compliance with applicable export controls and economic sanctions laws and regulations, including those administered by the U.S. Department of the Treasury&#8217;s (the &#8220;U.S. Treasury&#8221;) Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, the European Union, Her Majesty&#8217;s Treasury and other relevant sanctions authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our internal policies mandate compliance with these anti-corruption and economic sanctions laws. We also operate in many jurisdictions in which bribery or corruption can be common and compliance with anti-bribery laws may conflict with local customs and practices. Despite our training and compliance program safeguards, we cannot assure that our internal control policies, procedures and safeguards will protect us from acts in violation of anti-corruption and economic sanctions laws committed by employees or other third parties associated with us and our continued expansion, including in developing countries, could increase such risk in the future. Violations of anti-corruption and economic sanctions laws, or even allegations of such violations, could disrupt our business and result in a material adverse effect on our financial condition, results of operations, cash flows and reputation. For example, violations of anti-corruption and economic sanctions laws can result in restatements of, or irregularities in, our financial statements, disgorgement of profits, related stockholder lawsuits as well as severe criminal or civil sanctions. In some cases, companies that violate anti-corruption and economic sanctions laws might be debarred by the U.S. government and/or lose their U.S. export privileges. In addition, the U.S. government or other governments may seek to hold us liable for successor liability of anti-corruption and economic sanctions laws committed by companies that we acquire or in which we invest. Changes in anti-corruption and economic sanctions laws or enforcement priorities could also result in increased compliance requirements and related costs which could materially adversely affect our business, financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The confidentiality, collection, use and disclosure of personal data, including clinical trial patient-specific information, is subject to governmental regulation generally in the country that the personal data was collected or used. For example, United States federal regulations under the Health Insurance Portability and Accountability Act of 1996, or ("HIPAA"), and as amended in 2014 by the Health Information Technology for Economic and Clinical Health (&#8220;HITECH&#8221;) Act, require individuals&#8217; written authorization, in addition to any required informed consent, before Protected Health Information may be used for research. HIPAA specifies standards for de-identifications and for limited data sets. We are both directly and indirectly affected by the privacy provisions surrounding individual authorizations because many investigators and organizations with whom we are involved in clinical trials and in our services are directly subject to them as a HIPAA &#8220;covered entity&#8221; and because we obtain identifiable health information from third parties that are subject to such regulations. As there are some instances where we are a HIPAA &#8220;business associate&#8221; of a &#8220;covered entity&#8221;, we can also be directly liable to the covered entity for mishandling protected health information and, under HIPAA&#8217;s enforcement scheme, we can be subject to up to $1.5 million per year in civil penalties for each HIPAA violation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The European data protection framework was significantly revised in 2018 with the coming into force of the General Data Protection Regulation ('GDPR') containing new provisions specifically directed at the processing of health information, including sanctions of up to 4% of worldwide gross revenue and extra-territoriality measures intended to bring non-EU companies under the proposed regulation. After GDPR implementation, we are receiving increased volumes and breadth of data protection/privacy queries from both sponsors and strategic alliance partners and anticipate that this will continue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the regulators in the European Union, or ("EU"), personal data includes any information that relates to an identified or identifiable natural person with health information carrying special obligations, including obtaining the explicit consent from the individual for collection, use or disclosure of the information. EU regulations also apply to the personal data of EU data subjects traveling or living outside the EU. In addition, we are subject to EU rules with respect to cross-border transfers of such data out of the EU. The United States, the EU and its member states and other countries where we have operations, such as Japan, South Korea, Malaysia, the Philippines, Russia and Singapore, continue to issue new privacy and data protection rules and regulations that relate to personal data and health information. Failure to comply with certain certification/registration and annual re-certification/registration provisions associated with these data protection and privacy regulations and rules in various jurisdictions, or to resolve any serious privacy complaints, could subject us to regulatory sanctions, criminal prosecution or civil liability. Federal, state and foreign governments are contemplating, have proposed or have adopted additional legislation governing the collection, possession, use or dissemination of personal data, such as personal health information and personal financial data as well as security breach notification rules for loss or theft of such data. Additional legislation or regulation of this type might, among other things, require us to implement new security measures and processes or bring within the legislation or regulation de-identified health or other personal data, each of which may require substantial expenditures or limit our ability to offer some of our services. Additionally, if we violate applicable laws, regulations or duties relating to the use, privacy or security of personal data, we could be subject to civil liability or criminal prosecution, be forced to alter our business practices or suffer reputational harm. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with governmental regulations, comply with federal and state health-care fraud and abuse laws and regulations, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Employee misconduct could also involve the improper use of information obtained in the course of clinical studies or data or documentation fraud or manipulation, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant fines or other sanctions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues from our government customers are derived from sales to federal, state and local governmental departments and agencies through various contracts. Sales to public segment customers are highly regulated. Noncompliance with contract provisions, government procurement regulations or other applicable laws or regulations (including but not limited to the False Claims Act) could result in civil, criminal and administrative liability, including substantial monetary fines or damages, termination of government contracts or other public segment customer contracts, and suspension, debarment or ineligibility from doing business with the government and other customers in the public segment. In addition, generally contracts in the public segment are terminable at any time for convenience of the contracting agency or upon default. The effect of any of these possible actions by any governmental department or agency could adversely affect our business, results of operations or cash flows. In addition, the adoption of new or modified procurement regulations and other requirements may increase our compliance costs and reduce our gross margins, which could have a negative effect on our business, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We may face legal claims involving stockholders, consumers, clinical trial subjects, competitors, regulators and other parties. As described in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Legal Proceedings'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in Part A, Item 8 of this Form 20-F, we are engaged in legal proceedings. Litigation and other legal proceedings are inherently uncertain, and adverse rulings could occur, including monetary damages, or an injunction stopping us from engaging in business practices, or requiring other remedies, including, but not limited to, compulsory licensing of patents. In addition, the combined Company may be exposed to increased litigation from stockholders, customers, suppliers, consumers and other third parties due to the combination of ICON&#8217;s business and PRA&#8217;s business following the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Customer Claims</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we breach the terms of an agreement with a customer (for example if we fail to comply with the agreement, all applicable regulations or Good Clinical Practice) this could result in claims against us for substantial damages which could have a material adverse effect on our business. As we provide staff to deliver our services, there is a risk that our management, quality and control structures fail to quickly detect a failure by one or more employees or contractors to comply with all applicable regulations and Good Clinical Practice and our internal requirements and standard operating procedures thereby exposing us to the risk of claims by customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims relating to Investigators</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We contract with physicians who serve as investigators in conducting clinical trials to test new drugs on their patients. These patients will generally have underlying health conditions and this testing creates the risk of liability for personal injury to the patient or the risk of a serious adverse event occurring. Although investigators are generally required by law to maintain their own liability insurance, we could be named in lawsuits and incur expenses arising from any professional malpractice or other actions brought against the investigators with whom we contract.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indemnification from Customers</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indemnifications provided by our customers&#160;against the risk of liability for personal injury to or death of the patients arising from a study drug vary from customer to customer and from trial to trial and may not be sufficient in scope or amount, or our customer&#160;may not have the financial ability to fulfill their indemnification obligations. Furthermore, we would be liable for our own negligence and negligence of our employees which could lead to litigation from customers or action or enforcement by regulatory authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Insurance</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain what we believe is an appropriate level of worldwide Professional Liability/Error and Omissions Insurance. In the future we may be unable to maintain or continue our current insurance coverage on the same or similar terms. If we are liable for a claim or settlement that is beyond the level of insurance coverage, we may be responsible for paying all or part of any award or settlement amount. Also, the insurance policies contain exclusions which mean that the policy will not respond or provide cover in certain circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims to Date</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To date, we have not been subject to any liability claims that are expected to have a material effect on our business; however, there can be no assurance that we will not become subject to such claims in the future or that such claims will not have a material effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and governance matters may impact our business and reputation.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Increasingly, in addition to the importance of their financial performance, companies are being judged by their performance on a variety of environmental, social and governance ('ESG') matters, which are considered to contribute to the long-term sustainability of companies&#8217; performance. A variety of organizations measure the performance of companies on such ESG topics, and the results of these assessments are widely publicized. Customer's may have specific ESG related requirements or targets and if we fail to meet these targets we may lose business. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Topics taken into account in such assessments include, among others, the Company&#8217;s efforts and impacts on climate change and human rights, ethics and compliance with law, and the role of the Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">mpany&#8217;s board of directors in supervising various sustainability issues. We actively manage a broad range of such ESG matters, taking into consideration their expected impact on the sustainability of our business over time, and the potential impact of our business on society and the environment. However, in light of investors&#8217; increased focus on ESG matters, there can be no certainty that we will manage such issues successfully, or that we will successfully meet society&#8217;s perceived expectations as to our proper role. Any failure or perceived failure by us in this regard could have a material adverse effect on our reputation and on our business, share price, financial condition, or results of operations, including the sustainability of our business over time.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_1875"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We have incurred substantial additional indebtedness in connection with the Merger, which could impair our flexibility and access to capital and could adversely affect the combined Company&#8217;s business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Following completion of the Merger and the other transactions contemplated by the Merger Agreement, the Company has a substantial amount of debt. ICON borrowed approximately $6,015 million in order to pay PRA stockholders the cash consideration due to them as merger consideration under the Merger Agreement, pay related fees and transaction costs in connection with the transactions, and refinance existing indebtedness. This increased level of borrowings could adversely affect the Company in a number of ways, including, but not limited to, by placing us at a competitive disadvantage compared to our competitors that have less debt, causing us to incur substantial fees from time to time in connection with debt amendments or refinancing, making it more difficult for the Company to satisfy its obligations with respect to its debt or to its trade or other creditors, requiring a substantial portion of the Company&#8217;s cash flows from operations for the payment of interest on the Company&#8217;s debt, reducing the Company&#8217;s flexibility to respond to changing business and economic conditions, and reducing funds available for the Company&#8217;s investments in research and development, capital expenditures and other activities. If ICON cannot service its debt, it may have to take actions such as selling assets, seeking additional debt or equity, or reducing or delaying capital expenditures, strategic acquisitions, investments and alliances.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, ICON&#8217;s increased level of indebtedness could adversely affect ICON&#8217;s credit rating, which could result in increased borrowing costs for the Company in the future. No assurances can be made that ICON will be able to refinance any indebtedness incurred in connection with the Merger on terms acceptable to it or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Covenants in our credit agreement and the indenture governing the Senior Secured Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities and the indenture include certain customary covenants that limit our ability to, amongst other things, subject to certain exceptions:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">make dividends, investments and other restricted payments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">enter into sale and leaseback transactions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">incur or assume liens or additional debt;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">dispose of assets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">engage in mergers or reorganizations; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">enter into certain types of transactions with affiliates.</span></div><div style="text-align:justify;text-indent:43.2pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The revolving credit facility also includes a financial covenant that requires us to comply with a maximum consolidated leverage ratio. Our ability to comply with this financial covenant may be affected by events beyond our control.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on our senior secured term loan facility, in the event that the Company draws down on the revolving credit facility or in respect of any future issuances of debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is LIBOR plus an applicable margin of 2.50%, in each case, with a step down of 0.25% if the first lien net leverage ratio is equal to or less than 4.00 to 1.00. The senior secured term loan facility is subject to a LIBOR floor of 0.50%. On November&#160;10, 2021, the Company achieved a net leverage ratio of less than 4 times and the margin applicable to the senior secured term loan was reduced by 0.25% with the overall rate reducing from 3.0% to 2.75%. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) LIBOR (or an alternative reference rate) plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders of under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December&#160;31, 2021, no amounts have been drawn under the revolving loan facility with the exception of $4.1&#160;million letters of credit given to landlords to guarantee lease arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to monitor the phasing out of LIBOR. We have engaged with our lenders on the implications of the change and will continue to discuss with them as replacement rates for LIBOR become more prevalent in the syndicated lending market. The Company is therefore subject to interest rate volatility in respect of the senior secured term loan facility, any future draw down on the Revolving Credit Facility or in respect of any future issuances of debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The phasing out of LIBOR may affect our interest expense with respect to borrowings under the Senior Secured Facilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 27, 2017, the U.K. Financial Conduct Authority (the &#8220;FCA&#8221;) announced that it intends to end the use of LIBOR effective after December 31, 2021 as the benchmark rate that many banks and issuers use to set interest rates for loans, securities, derivative contracts and other financial instruments. Recognizing the need to replace LIBOR, authorities in the United States convened the Alternative Reference Rates Committee (&#8220;ARRC&#8221;) in 2014 to identify a replacement for LIBOR with respect to indebtedness denominated in U.S. Dollars. In 2017, the ARRC identified the Secured Overnight Financing Rate (&#8220;SOFR&#8221;), and in April 2018, the Federal Reserve Bank of New York began publishing SOFR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. Although the U.S. Treasury-backed overnight repo market is highly liquid, there is currently no robust market for determining forward-looking, SOFR term rates. Because SOFR is an overnight risk-free rate, whereas LIBOR has various terms and an embedded credit charge, the transition from LIBOR to SOFR will require adjustments, which may continue to vary for certain forms of indebtedness and financial instruments as the relevant markets adapt to SOFR&#8217;s implementation. Similar alternative benchmark replacements will be required to be implemented in respect of indebtedness and other financial instruments that are currently based on LIBOR quotes for currencies other than the U.S. Dollar.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or the base rate (as elected by the borrower), plus an applicable margin.  The credit agreement also provides that LIBOR may be replaced by a SOFR-based rate for borrowings in U.S. Dollars upon (i) the FCA ceasing to provide LIBOR for U.S. Dollars or announcing that LIBOR is no longer representative or (ii) an early election by the Company and the administrative agent under our credit agreement to transition from LIBOR.  We will continue to work with the administrative agent and other lenders to determine whether, and when, we expect to transition to a SOFR-based rate prior to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">LIBOR being formally phased out for the applicable tenors. This transition may impact our interest expense with respect to borrowings under the Senior Secured Credit Facilities.  In addition, the phase-out of LIBOR may impact the financial markets as a whole.  As such, the consequences of the phase-out of LIBOR cannot be entirely predicted at this time.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_1870"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Common Stock</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Volatility in the market price of our common stock could lead to losses by investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The market price of our common stock has experienced volatility in the past and may experience volatility in the future which could lead to losses for investors. Factors impacting volatility in the market price of our common stock include, amongst others:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">general market and economic conditions;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">our results of operations; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">issuance of new or changed securities analysts&#8217; reports or recommendations;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">developments impacting the industry or our competitors;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">declines in the market prices of stocks generally;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">strategic actions by us or our competitors; </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.81pt">announcements by us or our competitors of significant contracts, new products, acquisitions, joint marketing relationships, joint ventures, other strategic relationships or capital commitments;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">the public's reaction to press releases, other public announcements by us or third parties, including our filings with the SEC;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">guidance, if any, that we provide to the public, any changes in this guidance or failure to meet this guidance;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">changes in the credit rating of our debt;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">sale, or anticipated sale, of large blocks of our stock;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">additions or departures of key personnel;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">regulatory or political developments;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">litigation and governmental investigations;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">changing economic conditions;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">exchange rate fluctuations; </span></div><div style="padding-left:18pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">changes in accounting principles; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">other events or factors, including those resulting from natural disasters, war, acts of terrorism or responses to those events.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, stock markets have from time to time experienced significant price and volume fluctuations unrelated to the operating performance of particular companies. Future fluctuations in stock markets may lead to volatility in the market price of our common stock which could lead to losses by investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If securities analysts or industry analysts do not publish reports about our business or if they downgrade our stock or our sector, our stock price and trading volumes could decline. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The trading market for common stock depends in part on the research and reports that industry or financial analysts publish about us, our business or industry. We do not control these analysts. If one or more of the analysts who do cover us downgrade our stock or our industry or the stock of any of our competitors, or publish inaccurate or unfavorable research about our business or industry, the price of our stock could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, we could lose visibility in the market, which in turn could cause our stock price or trading volume to decline. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investment returns may be reduced if we lose our foreign private issuer status. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a &#8220;foreign private issuer,&#8221; as such term is defined in Rule 405 under the U.S. Securities Act 1933, and, therefore, we are not required to file quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC. In addition, the proxy rules and Section 16 reporting and short-swing profit recapture rules are not applicable to us. If we lose our status as a foreign private issuer by our election or otherwise and we become subject to the full reporting regime of the United States securities laws, we will be subject to additional reporting obligations and proxy solicitation obligations under the Exchange Act and our officers, directors and 10% shareholders would become subject to the short-swing profit rules. The imposition of these reporting rules would increase our costs and the obligations of those affected by the short-swing rules.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay any cash dividends for the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We currently do not expect to declare dividends on our common stock and have not done so in the past. We continue to anticipate that our earnings will be used to provide working capital, to support operations, to make debt repayments and to finance the growth and development of our business. They may also be used to continue our share repurchase program. Any determination to declare or pay dividends in the future will be at the discretion of our board of directors, subject to relevant laws and dependent on a number of factors, including our earnings, capital requirements and overall financial condition. Therefore, the only opportunity for stockholders to achieve a return on their investment may be if the market price of our common stock appreciates and shares are sold at a profit. The market price for our common stock may not appreciate and may fall below the price stockholders paid for such common stock. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC"), may be subject to Irish stamp duty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transfers of ICON ordinary shares effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC") should not be subject to Irish stamp duty where ICON ordinary shares are traded through DTC, either directly or through brokers that hold such shares on behalf of customers through DTC. However, if ICON ordinary shares are held as of record rather than beneficially through DTC, any transfer of ICON ordinary shares could be subject to Irish stamp duty (currently at the rate of 1% of the higher of the price paid or the market value of the shares acquired). Payment of Irish stamp duty is generally a legal obligation of the transferee. The potential for Irish stamp duty to arise could adversely affect the price of ICON ordinary shares.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_28"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Information on the Company.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">History and development</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON public limited company (&#8220;ICON plc&#8221;) is a clinical research organization (&#8220;CRO&#8221;), founded in Dublin, Ireland in 1990. Over thirty years we have grown significantly to become a leading global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations.  Our mission is to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a public limited company in Ireland and operate under the Irish Companies Acts. Our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000. Our website is www.iconplc.com. Additionally, the SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our service offering includes clinical development, functional outsourcing and laboratory services. Our clinical development services include all phases of development (Phases I-IV), peri and post approval, data solutions and site and patient access services. Our laboratory services include a range of high value testing services, including bionanalytical, biomarker, vaccine, good manufacturing practice ('GMP') and central laboratory services. We also offer full-service and functional service partnerships to our customers.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since ICON was founded, the Company has expanded through organic growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process and to broaden the service portfolio and add scale to existing services. On July 1, 2021, the Company completed the Acquisition of PRA which has transformed the scale and capabilities of the Company. The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The combined Company retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organizations.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:36pt"><img src="iclr-20211231_g1.jpg" alt="iclr-20211231_g1.jpg" style="height:263px;margin-bottom:5pt;vertical-align:text-bottom;width:633px"/></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Recent investments, which continue to strengthen our service offerings to meet the needs of our customers include: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">On July 1, 2021, the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences Group ("the Acquisition" and "the Merger"). Upon completion of the Acquisition,  PRA became a wholly owned subsidiary within the ICON Group.  ICON&#8217;s Acquisition of PRA has brought together two high-quality, innovative, growing organizations with similar cultures and values to create one of the world&#8217;s leading healthcare intelligence and clinical contract research organizations. The total value of the Merger consideration is $12.0&#160;billion and has resulted in the recognition of goodwill of $8.1&#160;billion, intangible assets of $4.9&#160;billion and an associated deferred tax liability of $1.1&#160;billion.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With approximately 38,330 employees across the globe, the new ICON has established relationships with a majority of the world&#8217;s top pharmaceutical and biotech companies. We believe the Company now has the expertise, technology, and data assets to lead the industry into a new paradigm for bringing clinical research to more patients and enabling expanded capabilities for customers. We believe the Merger will deliver a transformational effect on ICON through:</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Scale:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> With a deeper clinical, commercialization and consulting services portfolio, a broader geographic footprint, depth in therapeutic expertise, and data-driven healthcare technology, the Company can deliver enhanced globally scaled expertise &amp; solutions for all customers and patients. </span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Focus:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Company will have a singular focus on clinical research and commercialization, leveraging transformational technology and innovation to execute clinical trials from Phase 1 to post-approval studies with the highest quality, expertise and speed. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Speed to market</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Our extensive services portfolio, digital and data technology capabilities, and enhanced access to more diverse patient populations, have been combined with flexible delivery approaches and partnership models &#8211; all with the aim of reducing development time and costs.</span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Flexible partnership models:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ICON has partnerships with a majority of world&#8217;s top biopharma and biotech companies worldwide. ICON is a global leader in Functional Service Provision and a top global provider of full service clinical research. </span></div><div style="padding-left:72pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Differentiated DCT platform, healthcare intelligence &amp; technology:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The new ICON can deliver differentiated decentralized and hybrid trial solutions through a suite of capabilities, including mobile health, commercial connected health platforms, real world data and information solutions, a global site network, home health services and wearables expertise.</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Access to patients:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The new ICON offers customers enhanced access to a larger global pool of more diverse patients through its global site network (Accellacare), specialized oncology network (Oncacare), a pediatric site network, in-home clinical services and a network of six Phase I clinical research units across the United States and Europe. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">On September 3, 2020, as part of an internal initiative, ICON announced that it was launching Accellacare, a global clinical research network offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The site network includes previously acquired PMG Research in the US and MeDiNova Research in EMEA;</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">On July 24, 2020 a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), with a third party. Oncacare operates a specialized oncology site network in the US and EMEA regions. The new site network focuses on implementing a range of commercial models with specialist oncology healthcare providers in the US and EMEA to accelerate the recruitment and retention of patients into oncology trials. The oncology site network operates as a joint venture between the Company and a third party company which has extensive experience in developing and running a site network. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The third party to the joint venture has the right to sell the 51% majority voting share capital exclusively to the Company in a two and half year period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025 (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 3 - Investments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in the consolidated financial statements);</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">On January 22, 2020 a subsidiary of the Company, ICON Investments Limited, acquired 100% of the equity share capital of MedPass International ("MedPass"). MedPass is the leading European medical device CRO, regulatory and reimbursement consultancy, that specializes in medical device development and market access. The acquisition of MedPass further enhances ICON&#8217;s Medical Device and Diagnostic Research services, through the addition of new regulatory and clinical capabilities in Europe. The integration of MedPass&#8217;s services brings noted expertise in complex class 3 medical devices, interventional cardiology and structural heart devices. The total consideration was $47.6 million;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">On September 24, 2019 a subsidiary of the Company, ICON Clinical Research LLC, acquired a 100% interest in Clinical Research Networks ("CRN"). Founded in 2003 and operating from its headquarters in Illinois, USA and Gdansk, Poland, CRN is a leading provider of at-home trial services and site support services from study start-up to closeout for Phase I-IV global studies. CRN will grow ICON's patient recruitment capabilities globally and complements ICON's site network (now called Accellacare) in the USA, PMG Research and the recently acquired site network in EMEA, MeDiNova. The consideration to acquire the 100% interest was cash of $35.3 million and contingent consideration which was initially estimated at a fair value of $2.5 million. During 2020, the contingent consideration was settled at fair value in the amount of $0.5 million. The change in fair value has been recorded in the selling, general and administrative expense line of the Consolidated Statement of Operations;</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">On May 23, 2019 a subsidiary of the Company, ICON Clinical Research (U.K.) Limited, acquired a majority shareholding in MeDiNova, a site network with research sites in key markets in Europe and Africa. The consideration to acquire the majority shareholding was cash of $54.1 million (excluding a working capital adjustment of $0.5 million). The contingent consideration was paid in October 2019. The acquisition further enhances ICON's patient recruitment capabilities in EMEA and complements ICON's existing site network in the USA, PMG Research. ICON had the right to acquire the remaining shares in the company and on March 9, 2020 ICON exercised its option to call the outstanding shares in the noncontrolling interest to take 100% ownership of MeDiNova. Effective from this date, the noncontrolling interest was derecognized and a liability was recognized, representing the assessment of the redemption value of the noncontrolling interest. This liability was settled on July 17, 2020 for $43.9 million; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">On January 25, 2019 a subsidiary of the Company, ICON Laboratory Services, Inc., acquired 100% of the share capital of MolecularMD Corp. ("MMD"). The consideration was $42.2 million. MMD is a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology. It is a recognized leader in the analytical development and clinical validation of molecular diagnostic assays. It offers a comprehensive test menu in immuno-oncology development and services also include companion diagnostic development services. The acquisition enhances ICON&#8217;s laboratory offering in molecular diagnostic testing and brings to ICON expanded testing platforms, including next generation sequencing, and immunohistochemistry (IHC);</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Business Overview</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is a leading global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer a full range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process, from compound selection to Phase I-IV clinical studies. We earn revenue by providing a number of different services to our customers. Those services are integral components of the clinical development process and include clinical trial management, consulting, contract staffing, data solutions and laboratory services. Since the completion of the Merger, the Company also now offers a standalone data solutions service via it's Symphony Health Solutions ("Symphony" or "Symphony Health") business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><img src="iclr-20211231_g2.jpg" alt="iclr-20211231_g2.jpg" style="height:340px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development. We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in the major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full-service solution. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Following the completion of the Merger with PRA on July,1 2021, ICON is now a substantially larger company at December&#160;31, 2021 compared to previous years. At December&#160;31, 2021, we employed approximately 38,330 employees in 142 locations in 53 countries. During the year ended December&#160;31, 2021, we derived approximately 47.1%, 46.4% and 6.5% of our revenue in the United States, Europe and Rest of World, respectively (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 20 - Business Segment and Geographical Information </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in the consolidated financial statements).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The ICON Strategy</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have achieved strong growth since our foundation in 1990, as a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations.  We focus our innovation on those factors that are critical to our clients - reducing time to market, reducing cost and increasing quality. Our global team has extensive experience in a broad range of therapeutic areas. ICON has been recognized as one of the world's leading Contract Research Organizations (''CROs") through a number of high-profile industry awards.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As our market has evolved, biopharmaceutical companies are tackling productivity challenges, increasing budget constraints and greater demands to demonstrate product value; all of which are placing increased pressure on their revenues and levels of profitability. However, these trends have generally been positive for CROs, as increased outsourcing has been adopted by these companies as they seek to create greater efficiencies in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">One consequence of the drive to accelerate time to market will be increased emphasis on making existing drug development phases more seamless, through the use of techniques such as adaptive trial designs to filter the most promising compounds and test these in parallel in several therapeutic indications or with other drug combinations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory and reimbursement pressures will increase the emphasis on late stage (post marketing) research, while increasing requirements to demonstrate the economic value of new treatments. As a result, outcomes and comparative effectiveness research will most likely be required in order to secure on-going product reimbursement. Furthermore, we believe </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn should create further growth opportunities for both biopharma companies and their outsource development partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect that continued outsourcing will be a core strategy of clients in the near term as they respond to the increased pressures on their revenues and profitability. Larger clients were the first to form strategic partnerships with global CROs in an effort to reduce the number of outsource partners with whom they engage and to reduce inefficiencies in their current drug development models. More recently we have seen the increasing adoption of this partner model with mid-tier pharmaceutical and biotechnology firms as they also seek to drive development efficiencies. As outsourcing penetration increases, we believe clients may seek a greater level of integration of service offerings from CROs, although some will continue to purchase services on a stand-alone basis. Creating greater connectivity and &#8220;seamlessness&#8221; between our services and the sharing of &#8220;real-time&#8221; clinical, operational and &#8220;real world&#8221; data with clients will therefore become increasingly important for CROs. ICON will seek to benefit from this increased outsourcing by clients to grow our business by increasing market share with our existing client base and adding new clients within the Phase I-IV outsourced development services market; the aim being to ensure we will be considered for all major Phase I-IV projects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Delivery of our mission and strategy is focused on our four strategic pillars, being (i) Patient Access &amp; Engagement (ii) Career Development &amp; Employer of choice (iii) Enduring Customer Partnerships and (iv) Healthcare Intelligence &amp; Applied Innovation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><img src="iclr-20211231_g3.jpg" alt="iclr-20211231_g3.jpg" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient Access &amp; Engagement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a focused patient, site and data strategy, which is helping us to improve site identification, study placement and patient recruitment and retention. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accellacare is ICON's global clinical research network offering customers a wide range of stand-alone and integrated solutions at the site or in patients' homes as part of decentralized trials. Our patient centric approach accelerates study start-up and increases patient recruitment and retention for pharmaceutical, biotechnology and medical device industries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Accellacare Site Network encompasses more than 150 sites across 8 countries and incorporates PMG Research in the US and MeDiNova Research in EMEA. Accellacare offers a quality focused clinical research infrastructure delivering value and benefits to sponsors. Accellacare supports customers with faster start-up - site selected to site initiation visit is on average 30% faster and it achieves an average of 40% more patients per site when compared to other sites.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accellacare In-Home Services takes study visits directly to patients where they live, work, study or play in all phases and therapeutic areas of clinical trials. By bringing trial visits directly to patients, we ease the burden of participating in clinical research to increase patient recruitment, retention and diversity. Accellacare In-Home Services has experience in more than 400 clinical trials, tailoring our services to fit each study's specific requirements across more than 55 countries. This cohesive approach is leading to higher patient recruitment and retention rates. Accellacare is also achieving faster study start-up for its customers through efficiencies gained in central process management including budget and contracting, which can otherwise be a source of delay. This combined with a finely tuned feasibility approach allows the network to identify and recruit more patients to studies, in a wide range of therapeutic areas, in a shorter time frame. Accellacare is an important part of the integrated patient, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">site and data strategy, helping us to improve patient recruitment and retention. Through Accellacare we are committed to delivering on the promise of patient centricity in clinical research. It is also providing investigators with innovative treatments for their patients with a quality-focused clinical research infrastructure supported by experienced professionals globally.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In 2021, Accellacare entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities. Agreements with Asclepes Research and Olympian Clinical Research in the U.S., Curiositas ad Sanum and Intermed in Germany, Quironsalud in Spain, and KO-MED in Poland. Through these new partnerships, Accellacare is also enhancing its capability in the central nervous system (CNS) and immune-inflammation therapeutic areas.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expansion of the Accellacare Site Network increases access and engagement with investigative sites and its patients, with the goal of faster recruitment and reducing the overall time and cost associated with drug development for customers. Accellacare now has access to more than 9 million patients.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finding and engaging suitable patients to conduct clinical trials is one of the biggest issues facing the drug development industry today. Less than 1% of the US population participates in clinical trials and the performance of investigative sites that do take part in research is uneven, hard to predict and many trials do not meet the initial recruitment goals. The current market challenge in patient enrollment creates an opportunity for ICON to differentiate its service offering and we are working to reduce patient recruitment times through enhanced site and investigator selection based on key performance metrics and through use of our proprietary Firecrest technology which is used to train and support sites during the development process. Our Accellacare and Oncacare site network alliances enhances our ability to enroll patients onto the clinical studies we perform. We have also developed strategic alliances with investigator site groups and healthcare systems in all major global research markets. In partnership with others we are pioneering patient recruitment solutions that leverage cognitive computing to transform clinical trial matching and allow a data-driven approach to deliver the right patients for trials. One Search is our intuitive, integrated workflow and interrogation tool that enables access to multiple data sources and provides the visualization and tools necessary for optimum&#160;site identification&#160;based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Career Development &amp; Employer of choice</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">People have long been central to our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people&#8217;s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge. Programs include tailored CRA academies and a range of project management curricula, therapeutic-focused programs, and people leader development programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Enduring Customer Partnerships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to focus on expanding and deepening our partnerships with existing customers, while also developing new customer relationships. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Strategic client relationships will increasingly manifest themselves in many different forms. Many of these relationships will require innovative forms of collaboration across ICON service areas and departments and will therefore require increased flexibility to offer services on both a standalone functional basis and as part of a fully integrated service solution. To support this objective, we continue to evolve our collaboration and delivery models, invest in technology that will enable closer data integration across our service areas and enhance our project and program management capabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To meet the evolving needs of both our existing and new clients we continue to enhance our capabilities through both organic service development and targeted acquisitions.   </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year, we continued to enhance our scientific and therapeutic expertise to support our customers in specific areas including oncology, orphan and rare diseases, CNS, dermatology, infectious disease and women's health. During 2021 and 2020, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON mobilized its vaccine resources to address the COVID-19 global threat, including its ability to conduct home-based trials to minimize infect</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ion. In addition, the Company is currently providing clinical monitoring and safety oversight on numerous COVID-19 trials for both the private and government sectors. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON mobilized a large global team of therapeutic and operational specialists to partner on the implementation of Pfizer&#8216;s and BioNTech&#8217;s strategic plan and framework for the monitoring of the trial, which included a high level of remote clinical monitoring and source data verification in addition to on-site monitoring, safeguarding data quality and integrity in the evolving pandemic environment. The team combined the benefits of full service and functional service provider clinical operating models to increase efficiency and ensure rapid study start-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON worked with 153 sites in the US, Europe, South Africa and Latin America to ensure the recruitment of more than 44,000 trial participants over a four month period in late 2020. ICON provided site training, document management and operational support for patient Informed Consent Form review, coordinated eConsent in most countries, and assisted with clinical supply management services. Achieving the unprecedented trial timelines, while maintaining high standards of quality, undertaken in response to the pandemic required collaboration and strong communication between the ICON and companies&#8217; project teams.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to target growth in under-penetrated CRO market segments. Penetration within medical device companies has lagged that of bio-pharma firms but is beginning to accelerate. EU regulatory reform enacted in 2017 is a further catalyst to growth in this segment as it included stricter requirements to perform clinical evaluations and post-sale surveillance. In early 2020, the Group acquired MedPass which has further enhanced our value offering in this area.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also invested significantly in our site and patient network (Accellacare), and consider our expertise and offering in this area as one of our strategic pillars effective from 2021.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Intelligence &amp; Applied Innovation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Innovation at ICON is focused on the factors that are critical to our clients. We develop integrated technologies to significantly enhance the efficiency and productivity of clients&#8217; drug and device development programs, providing true transparency across all areas of a study.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is focused on applying innovation that can help our customers improve their development outcomes. We are focusing this innovation in three critical areas: improving clinical trial design and execution; faster and more predictable patient recruitment; and evolving clinical trials to be more patient centric which includes data collection and analysis directly from patient&#8217;s digital devices. Our approach to developing solutions to these challenges incorporates partnering with best in class technology providers but is also supported by a suite of differentiated ICON proprietary technologies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have continued to invest in building our capabilities in the gathering, analysis and application of real world patient data within both the clinical trial and post-trial observational study environments. Alongside expanding internal capabilities, we continue to develop innovative partnerships with providers of real world data including TriNetX. During 2018, we signed an agreement with Intel to deploy the Intel&#174; Pharma Analytics Platform for use in clinical trials. The Intel platform is an artificial intelligence solution that enables remote monitoring and continuous capture of clinical data from study subjects using sensors and wearable devices and can apply machine learning techniques to objectively measure symptoms and quantify the impact of new therapies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Firecrest is ICON&#8217;s proprietary comprehensive site performance management system, is a web-based solution which enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to investigative sites. It allows site behavior to be tracked to ensure training is understood, procedures are being followed and that timelines and study parameters are met. It can significantly reduce the number of data queries originated from investigator sites. Firecrest is now integrated into the ICON Safety Reporting Solution and provides a new Site Question Management Tool. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has also developed a patient engagement platform to support improved patient experience &amp; enrollment in clinical trials. The web based patient engagement platform, provides patients with study specific information and connectivity with the nearest investigative site. The solution supplements patient recruitment outreach by sites and increases visibility of potential study participants for sponsors and sites. An easy to navigate, user friendly interface guides the patient to new and ongoing studies in their particular indication and a pre-qualification questionnaire helps to determine if the study is a right fit for them. If the patient decides to register interest, they are given the option to select their nearest investigative site. This establishes connection with the site and the patient can then choose to contact the site or ask to be contacted for pre-screening.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The completion of the Merger has significantly expanded ICON's data driven strategy with the addition of Symphony Health. Symphony Health is a trusted partner and leading enabler of integrated health data liquidity and analytics, delivered as a cloud-based solution. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We positively impact patients&#8217; lives by understanding their journeys and how they can benefit from drugs currently in development and on the market. We do this by developing a holistic, global data environment across pharmaceutical/ biotech companies (development to commercial) that gives insights into patients, and how best to serve them.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Alongside the application of these technology solutions we are also focused on innovation through the redesign and where appropriate the automation of current clinical trial processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operational Excellence, Quality and Delivery</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quality is the foundation of our success. The quality of our work is vital to our mission of bringing better medications to patients around the world. We are committed to maintaining, supporting, checking and improving our quality systems to meet or exceed the quality standards demanded by our clients, patients and regulatory authorities. We focus our innovation on the factors that are critical to our clients &#8211; reducing time to market, reducing cost and increasing quality &#8211; and our global team of experts has extensive experience in a broad range of therapeutic areas.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quality project execution underpins all that we do and we have an ongoing focus on developing our people and&#160;processes to continue to&#160;enhance our service delivery. We also deploy supporting technologies which we believe will enable faster and deeper insights into the quality of trial data.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on operational excellence across our support functions and we operate a global business support infrastructure across functions including finance, information technology, facilities, human resources and legal. This enables us to enhance the service levels across these support areas whilst driving down the costs of the service provision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Capabilities and Service Offerings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is a global provider of outsourced drug and device development and commercialization services to pharmaceutical, biotechnology, medical device, government, and public, consumer health organizations. These solutions span the Clinical Development lifecycle from compound selection to Phase I-IV clinical studies and post approval outcome research and market access consulting solutions.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><img src="iclr-20211231_g4.jpg" alt="iclr-20211231_g4.jpg" style="height:192px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer a broad range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit&#160;local trials or large global programs. Specific clinical development services offered to biopharmaceutical and medical device companies include:</span></div><div><img src="iclr-20211231_g5.jpg" alt="iclr-20211231_g5.jpg" style="height:819px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Industry Overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry provides independent product development solutions and services for the pharmaceutical, biotechnology and medical device industries. Companies in these industries outsource services to CROs in order to manage the drug and device development process more efficiently and to bring both patent-protected bio-similars and medical devices to market faster to enhance patient well-being and maximize their return on investment. The CRO industry has evolved since the 1970s from a small number of companies that provided limited clinical development services to a larger number of CROs that offer a range of services that encompass the entire research and development process, including pre-clinical development, clinical trials management, clinical data management, study design, bio statistical analyses, post market surveillance, regulatory affairs, central laboratory and market access services. CROs are required to provide services in accordance with good clinical and laboratory practices, as governed by the applicable regulatory authorities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is highly fragmented, consisting of several hundred small, limited-service providers, medium sized CROs and a small number of large CROs with global operations. Although there are few barriers to entry for small, specialist service providers, we believe there are significant barriers to becoming a CRO with global capabilities and expertise. These barriers include the infrastructure and experience necessary to serve the global demands of clients (sponsors), the ability to recruit sites and patients globally, the simultaneous management of complex clinical trials, the ability to offer customers a variety of delivery models, broad therapeutic expertise and the development and maintenance of the complex information technology systems required to integrate these capabilities. In recent years, the CRO industry has experienced consolidation, resulting in the emergence of a select group of CROs that have the capital, technical resources, integrated global capabilities, data and expertise to manage the development programs of pharmaceutical, biotechnology and medical device companies. We believe that large and medium-sized pharmaceutical companies are selecting a limited number of CRO service providers with which they deal rather than utilizing many, in order to form strategic partnerships with global CROs in an effort to drive incremental development efficiencies and leverage the scientific and medical expertise. We believe that this trend will continue to concentrate the market share among the larger CROs with a track record of quality, speed, flexibility, responsiveness, global capabilities and access to patients and overall development experience and expertise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Drug Development Overview </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> Ethical Pharmaceuticals and Biologics</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Before a new drug or biologic may be marketed, it must undergo extensive testing and regulatory review in order to determine that it is safe and effective. The following discussion primarily relates to the FDA approval process for such products. Similar procedures must be followed for product development with other global regulatory agencies. The stages of this development process are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Preclinical Research</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#8220;In vitro&#8221; (test tube) and animal studies must be conducted in accordance with applicable regulations to establish the relative toxicity of the drug over a wide range of doses and to detect any potential to cause birth defects, affect vital organs, cause mutations or cancer. Many of these tests must be performed before a new investigational therapy can progress into human studies. If results warrant continuing development of the drug or biologic, the sponsor or owner of the asset will file for an Investigational New Drug Application, or ("IND"), which must be approved by the FDA before starting the proposed clinical trials.  However, preclinical studies will continue to be conducted in parallel with the clinical trials, some of which can take up to 3 years to complete. Preclinical research is not commonly provided by ICON as a service to its customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Clinical Trials (approximately 3.5 to 7 years)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Exploratory Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase I</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> (approximately 6 months to 1 year)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> consists of basic safety and tolerability testing in small numbers of human subjects, initially in healthy volunteers, and includes studies which may show the drug is having an effect on the body, if it is safe, how it is affected by other drugs, where it goes in the body, how long it remains active and how it is broken down by and eliminated from the body. After single and multiple dose studies have been conducted, the asset can progress into Phase II, however, Phase I studies will continue to be done to help support the development of the asset in new populations such as children or the elderly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase II</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> (approximately 2 to 3 years</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) includes basic efficacy and dose-range testing in a limited patient population (usually) 100 to 200 patients to help provide preliminary safety and evidence that the drug is likely to be effective in the target disease. If the Phase II results are satisfactory the sponsor may decide to proceed to Phase III studies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Confirmatory Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase III </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">(2 years or greater)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">consists of efficacy and safety studies in several hundred to a few thousand patients at multiple investigational sites (hospitals and clinics), often in multiple geographies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FDA approval, through submission of an IND, is necessary for all clinical trials, regardless of the phase of development. In addition, parallel independent committee approval is also required.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">NDA or BLA Preparation and Submission.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Upon completion of Phase III trials, the sponsor assembles the statistically analyzed data from all phases of development into a single large submission along with the Chemistry, Manufacturing and Controls (CMC) and preclinical data and the proposed labeling into the New Drug Application (NDA), or Biologics License Application (BLA) and submits them for assessment and approval by the relevant division of the FDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Expanded Access Programs (EAPs).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Sometimes a study drug may continue to be provided to subjects after completion of a clinical trial, also called compassionate use. EAPs refer to the regulated use of a study drug outside of a clinical trial by patients with serious or life-threatening conditions where there is no alternative therapy available. In this context the FDA may allow the sponsor to make the study drug available to a larger number of patients for treatment use. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">FDA Review and Approval of NDA or BLA (1 to 1.5 years).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Data from all phases of development is scrutinized to confirm that the applicant company has complied with all applicable regulations and that the benefit to risk ratio for the drug or biologic is positive for the specific use (or &#8220;indication&#8221;) under study. The FDA may refuse to accept the NDA or BLA if the application has administrative or content criteria which do not meet FDA standards. The FDA may also deny approval of the drug or biologic product if applicable regulatory requirements are not satisfied, if the drug has not adequately shown to be effective or if there are safety concerns. Often a company will be required to conduct specific studies after the approval of a drug. These are called post approval commitments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Post-Market Surveillance, Phase IV Studies and Health Outcomes.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Once approved by the FDA, the FDA requires the drug or biologic license holder to collect and periodically report to the FDA additional safety (and perhaps efficacy) data on the drug or biologic for as long as the license holder markets it (post-market surveillance, including pharmacovigilance). If the product is marketed outside the U.S., these reports must include data from all countries in which the drug is sold. Additional studies (Phase III and Phase IV) may be undertaken after initial approval to find new uses for the drug, to test new dosage formulations, or to confirm selected non-clinical benefits, e.g., increased cost-effectiveness or improved quality of life. Additionally, the FDA and other regulatory agencies are requiring license holders of drugs or biologics to prepare risk management plans which are aimed at assessing areas of product risk and actively managing such risks throughout the product lifecycle.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Key Trends Affecting the CRO Industry</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CROs derive substantially all of their revenue from the research and development expenditures of pharmaceutical, biotechnology and medical device companies. We believe that the following trends create further growth opportunities for global CROs, although there is no assurance that growth will materialize.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Continued Innovation and Development of Enabling Technologies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Innovation Driving New Drug Development Activity </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New technologies together with improved understanding of disease pathology (driven by scientific advances such as the mapping of the human genome) have increased the number of new drug candidates being investigated in early development. This has greatly broadened the number of biological mechanisms being targeted, which increasingly include rare/orphan diseases that currently have no effective treatments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These developments should lead to increased activity in both Preclinical and Phase I development and in turn lead to more treatments in Phase II-III clinical trials. As the number of trials that need to be performed increases and these trials become focused in indications where finding suitable patients is increasingly challenging, we believe that drug developers will increasingly rely on CROs to manage these trials to leverage their global expertise and to continue to focus their own competences on drug discovery and sales and marketing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Decentralized and hybrid trials</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Decentralized and hybrid trials have existed for quite some time but the coronavirus pandemic accelerated the demand when pharma was challenged to move to remote models to protect patient safety and ensure data integrity for COVID-19 vaccine trials and other ongoing trials. The pandemic has provided an opportunity to move many technologies and remote patient care solutions from pilot phase to supporting patients and research. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As an industry, we have an opportunity to make decentralized and hybrid the standard moving forward. The ways the industry have been conducting clinical research in a traditional site-based approach need to flex so we can implement these tools, techniques and processes in everyday research to bring about a more patient-centric approach. Each new element needs to be evaluated to assess the impact for the individual patients and study sites. Recent experiences in the industry have shown:</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Using fewer countries and fewer sites can reduce costs, decrease timelines for start-up and minimize the risk of disruption during and post pandemic. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Hybrid studies, utilizing digital health, in-home health, and telehealth, can reduce the number and frequency of onsite patient visits and therefore reduce patient burden.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Home-based patient visits and direct-to-patient contacts can increase patient satisfaction, compliance and retention, providing greater trial resilience. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Harmonizing data from disparate data sources will provide real-time access and consistent data visibility, helping to improve safety monitoring and enabling the visualization of data trends. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory easement has resulted in a number of positive changes to clinical trial procedures, enabling studies to continue and in some case progress at a faster pace, and improvements to the process of CTA and IND approvals despite the restrictions imposed by the current COVID-19 pandemic. However, the regulatory authorities have been clear that regulatory easement will be discontinued once the pandemic recedes so it remains to be seen how many of these improvements will endure and become standard practice in the longer term. It is hoped that we can hold on to some of the improvements for the benefit of the patient and healthcare advancement. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the day, we are trying to increase the speed at which drugs can meet approval guidelines and help treatable populations. By using decentralized tools, technologies and processes, we will reduce the burden on patients, increase satisfaction and provide them with the same standard of care during a virtual or home visit that they would receive in a clinic and fulfilling the promise of clinical research as a care option. While reduced costs may not be seen in the early phase of adoption (in fact investment may be required initially) choosing the right solution for the specific study characteristics has the potential to increase patient recruitment and retention which can result in reduced overall research costs and quicker time to market. To find the best clinical trial design to suit their needs, sponsors will need to take patient centricity into consideration from the outset and at every step along the way. Because what benefits the patient will ultimately benefit the sponsor in outcomes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">New Technology Enabling More Efficient Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Technology innovation is playing an increasingly important role in helping to support more efficient drug development. Leveraging differentiated technology solutions and data collaborations drives better execution in clinical trials. The larger CROs have been at the forefront of this innovation developing technology solutions that support the integration of trial data across multiple systems, data repositories that enable sponsors to get real time clinical insights on their drugs performance and tools that support better trial designs and operation. See further details on our new technologies and innovations in the section on information systems on page 46.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The emergence of modern healthcare technologies ("mHealth")  that build on the global prevalence of mobile and digital technologies also have an influence on drug development. It is now possible to capture health data using mobile devices and wearables. This enables sponsors to gather new clinical and &#8220;real-world&#8221; patient insights and will also be used to enhance patient engagement and adherence throughout the development process. As these devices mature it will also be possible to complete more &#8220;virtual trials&#8221; based on remote monitoring of patients in their home environment which may drive further efficiencies in the trial process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Social media is also becoming an important platform for life sciences companies to strengthen patient engagement programs and collaborate with other stakeholders in the healthcare system. Many sufferers of specific diseases are forming patient groups and actively collaborating using social media. These groups represent an important potential source of patients for new clinical studies but can also provide valuable insights into effectiveness and safety of new treatments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the influence of technology on drug development grows, it broadens the potential number of partners that CROs will work with in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Expanded Use of New Patient Data Sources  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical companies are looking to access a variety of new healthcare data sources containing medical and prescribing records to help improve development programs and to get better evidence of the value their treatments are bringing to patients once they are launched in the market. The larger global CROs have significant data management experience which can be leveraged to support these efforts and have invested in analytics capabilities to help deliver better insights for customers during the product lifecycle. Global CROs are also forging collaborations to access specific data sets that can provide further patient insights to support better matching of patients to the clinical trial process. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Improving Productivity and Operating Efficiencies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Continuing Focus on Productivity within Research and Development Programs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical and biotechnology companies continue to seek ways to improve the productivity of their development efforts and increasingly see the use of CROs as a strategic component of these efforts. They are leveraging the expertise with CROs to help identify the most promising drug candidates in early development and discontinue developing those that have safety issues, limited efficacy or that will have significant reimbursement challenges. These companies are also initiating programs to drive more efficiency in their development programs. One example of this has been the efforts to achieve a more seamless transition across development phases, particularly Phase I-III. In parallel, regulatory initiatives such as the 21</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Century Cures Act and the emergence of clinical trial techniques such as adaptive trial design, risk based clinical trial monitoring, decentralized and hybrid trials are enhancing development, allowing effective treatments to get to patients quicker at reduced development costs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost Containment Pressures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Over the past several years, drug companies have sought more efficient ways of conducting business due to margin pressures stemming from patent expirations, greater acceptance of generic drugs, pricing pressures caused by the impact of managed care, purchasing alliances and regulatory consideration of the economic benefit of new drugs. Consequently, drug companies are centralizing research and development, streamlining their internal structures and outsourcing certain functions to CROs, thereby converting previously fixed costs to variable costs. Larger companies (and more recently medium sized companies) are actively entering strategic partnerships with a limited number of CROs in an effort to drive increased efficiencies. The CRO industry and in particular large CROs with global capabilities, considerable scientific knowledge and expertise are often able to perform the needed services with greater focus and at a lower cost than the client could perform internally, although CRO companies themselves are facing increased cost containment pressures as drug companies seek to further reduce their cost base.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Global trends influencing the CRO industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pressure to Accelerate Time to Markets and Globalization of the Marketplace</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reducing product development time maximizes the client&#8217;s potential period of patent exclusivity, which in turn maximizes potential economic returns. We believe that clients are increasingly using CROs that have the appropriate expertise and innovation to improve the speed of product development to assist them in improving economic returns. In addition, applying for regulatory approval in multiple markets and for multiple indications simultaneously, rather than sequentially, reduces product development time and thereby maximizes economic returns. We believe that CROs with global capabilities, considerable knowledge and experience in a broad range of therapeutic areas are key resources to support a global regulatory approval strategy. Alongside this, the increasing need to access pools of new patients is leading to the conduct of clinical trials in new &#8220;emerging regions&#8221; such as Eastern Europe, Latin America, Asia-Pacific and South America. We believe that having access to both traditional and emerging clinical research markets gives global CROs a competitive advantage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Growth within the Biotechnology Sector</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of the drugs being developed is continuing to change. Biotechnology is enabling the development of targeted drugs with diagnostic tests to determine whether a drug will be effective given a patient&#8217;s genomic profile. An increasing proportion of research and development expenditure is being spent on the development of highly technical drugs to treat very specific therapeutic areas in areas of unmet medical need. Much of this discovery expertise is found in biotechnology firms. We believe that it is to these organizations that the large pharmaceutical companies will look for an increasing proportion of their new drug pipelines. Whether it is through licensing agreements, joint ventures or equity investment, we believe we may see the emergence of more strategic relationships between small discovery firms and the larger pharmaceutical groups. As the majority of these biotechnology companies do not have a clinical development infrastructure, we believe that the services offered by CROs will continue to be in demand from such companies providing they have the necessary funding.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Increasing Number of Large Long-Term Studies and an Increasing Requirement to Show the Economic Value of New Treatments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that to establish competitive claims and demonstrate product value, to obtain reimbursement authorization from bodies such as the National Institute for Health and Clinical Excellence in the UK, and to encourage drug prescription by physicians in some large and competitive categories, more clients need to conduct outcome studies to demonstrate, for example, that mortality rates are reduced by certain drugs. To verify such outcomes, very large patient numbers are required and they must be monitored over long time periods. We believe that as these types of studies increase there will be a commensurate increase in demand for the services of CROs who have the ability to quickly assemble large patient populations, globally if necessary, and manage this complex process throughout its duration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The rising costs of healthcare in most developed countries also means there is an increasing pressure to show that new medical treatments are more cost effective and deliver better patient outcomes than existing treatment regimes. This also means that sponsors need to increasingly generate outcomes data both as part of the product approval submissions and as part of post-approval research programs. This is creating opportunities for CROs who can offer support in developing and interpreting this data.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">A Focus on Long-term Product Safety</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The clinical trial approval process can only detect major and common adverse side effects of drugs; less common but no less serious side effects may only become apparent after many years of use. As a result, there is an increase in the number of drugs given &#8220;conditional approvals&#8221; where further &#8216;post-approval&#8217; studies are being mandated. In addition, prudent sponsors undertake similar studies to detect early warning signs of any potential problems with their products. Such studies may take the form of prospective long-term safety studies, simpler observational studies or registries where patients meeting specific criteria for disease or drug use are followed for long periods to detect any safety issues. CROs are well positioned to perform these studies on behalf of sponsors.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Increasing Regulatory Demands</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory agencies are requiring more data to support new drug approvals and are seeking more evidence that new drugs are safer and more effective than existing products. As a result, the complexity of clinical trials, the number of procedures required to be conducted in these trials and the size of regulatory submissions are driving the demand for services provided by CROs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Environmental, Social and Governance ('ESG')</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our mission is to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We help our customers deliver life-changing medicines by being innovative in our solutions, collaborative in how we work as teams, accountable for the results we achieve and committed to doing the right thing for our customers and the patients they serve. We are advancing clinical research while offering customers broader and deeper experience, scale, and focus, complemented by continuity of delivery and speed to market. Our business model is described in the sections preceding this. The completion of our Acquisition of PRA Health Sciences in July 2021 marked the birth of the new ICON and the start of work to unify two global leaders in healthcare intelligence and clinical research. The new ICON remains committed to responsible and sustainable business practices. We believe that business should not only operate in compliance with applicable laws, rules, and regulations, but that our behaviors should also address underlying societal concerns.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our core values underpin our mission and drive a culture and mind-set of ownership at ICON. "Own It @ ICON" is a statement of values that has remained at the very heart of ICON&#8217;s culture, encouraging our people to seize the opportunity and bring flexibility, innovation, and determination to every situation. We believe our culture of ownership personifies who we are as a company &#8212; it also helps us apply our expertise, collaborate to get things done, and succeed at our mission.  ICON is redefining the company values to take the best of both ICON and PRA values. The Board approved the new values in December 2021 with a roll out plan during 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The ICON values during 2021 were:</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Accountability &amp; delivery:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We take pride in what we do.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Collaboration:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We are one team.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Partnership:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We partner with our customers.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Integrity: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do the right thing.&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The refined ICON values being rolled out in 2022 are:</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Integrity: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We always do the right thing.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Collaboration:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We are better together working as one team.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Agility:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We are passionate about providing innovative solutions for customers.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Inclusion:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We value diversity and care about the success of our people.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><img src="iclr-20211231_g6.jpg" alt="iclr-20211231_g6.jpg" style="height:381px;margin-bottom:5pt;vertical-align:text-bottom;width:542px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our values underpin how we work together to deliver on our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. These values and our Code of Ethical Conduct, which underpins these values, form the core of what we do and how we do it. It applies to all officers, directors, employees, consultants and agents globally. All employees and temporary workers are mandated to complete global ethics training.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON established an Environmental, Social, and Governance Committee ('ESG Committee') in 2019, which brought together all of our existing initiatives and efforts under one umbrella to ensure consistency, enhance monitoring, reveal areas for development and facilitate reporting to the Board. The ESG Committee is chaired by the Chief Administrative Officer and General Counsel (CAO), who is responsible for reporting to the ICON executive leadership team and Board on ESG matters. In February 2022, the Board delegated</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> oversight responsibilities of the Company's strategies, activities and risks in respect to ESG matters to the</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Nominating and Governance Committee. Accordingly, the CAO will report to the Nominating and Governance Committee on ESG matters going forward whilst also providing periodic updates to the executive leadership team.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The ESG Committee is focused on developing our strategy and initiatives relating to the environment, social matters, health and safety, community engagement, corporate governance, sustainability and other public policy matters relevant to the Company. The ESG Committee is a cross-functional management committee of the Company including representation from facilities, corporate communications, finance, legal, investor relations, procurement, enterprise risk and resilience, commercial, marketing and human resources departments. The composition of the ESG Committee was revised following the Acquisition of PRA to include representatives that have joined from PRA. The Committee assists and supports executive management and the Board of the Company in:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">determining and setting the strategy relating to ESG matters;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">developing, implementing and monitoring initiatives and policies based on that strategy; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">communicating our strategies and initiatives and their results.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We are committed to building and developing our ESG strategies and reporting. In 2020 we published our first annual ESG Report covering 2019 and in 2021 we published our ESG Report covering 2020, which provided an overview of both ICON and PRA's actions and results during 2020. It also summarizes our current policies, priorities and commitments in respect to ESG matters. We also launched our ESG page in 2020 on the ICON website and have an internal ESG page on our MyICON portal to engage with our employees and provide information and updates relating to ESG matters and our commitment to sustainability. The ESG page is available at https://www.iconplc.com/about/esg/.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The global landscape in respect to regulatory and legislative requirements relating to ESG reporting and disclosure requirements is rapidly evolving and we are monitoring potential requirements so that we are in a position to adhere to any additional requirements in due course.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In 2021, as a testament to our commitment to managing ICON responsibly and sustainably, we became a participant in the United Nations Global Compact (UNGC), a set of Ten Principles covering the areas of human rights, labor, environment,</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and anti-corruption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Building a sustainable future &#8211; our commitment to the United Nations Sustainable Development Goals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a global company, we maintain an ethical and sustainable presence in hundreds of locations worldwide. At its core, ICON&#8217;s mission is to improve health and lives. We are also committed to contributing to the 2030 United Nations Sustainable Development Goals (SDGs), and are proud that our work contributes to their advancement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our research, our work with customers and patients and our on-the-ground efforts to meet the diverse needs across our communities align with the SDGs. These efforts, however, focus on a subset of themes where we have the greatest opportunity to effect change and further details are set out in our ESG Report.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Environmental Management </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is committed to delivering excellence in care to our communities. To improve our overall sustainability, this commitment means tracking and improving our environmental performance across all business activities. We achieve this by pursuing sustainability strategies that recognize the impact of our operations as a CRO on the environment, addressing greenhouse gas (GHG) emissions, energy use, waste generation and procurement-related activities. Our employees, directors, officers, contractors, and temporary workers are expected to support our sustainability objectives.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON Green is our program for managing environmental sustainability initiatives, in accordance with our Global Environmental Management Policy and Environmental Management Plan. The implementation of the ICON Green program is led by our facilities team, reporting to our Chief Administrative Officer and General Counsel (CAO). The CAO is responsible for reporting on the program to the ICON executive leadership team and Nominating and Governance Committee and the Board.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON set environmental goals around the use of renewable energy and carbon emissions in 2019 and we are working towards achieving these goals which are as follows: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">100% renewable electricity by 2025</span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">20% reduction in kilowatt hours (kWh) of electricity by 2030</span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">Net zero carbon emissions on Scope 1 &amp; 2 by 2030</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have programs in place to manage and minimize climate impacts of business activities. To continue to improve processes and reduce our environmental impact, we track, calculate, and report our GHG footprint. We follow the GHG Protocol Corporate Standard, which is the global corporate accounting and reporting standard for calculating carbon emissions. We work with Carbon Trust to verify emissions data. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In line with carbon reduction targets, ICON&#8217;s Scope 1 and 2 GHG emissions, relative to revenue and the number of employees, have fallen year on year since 2016. Since 2020, following the pandemic-related closure of many of our facilities and a reduction in business travel, GHG emissions across our operations declined significantly. As the recovery continues, and as we resume more normal operations we will reflect on opportunities to continue to reduce our carbon emissions across our combined organization to develop and improve our environmental program.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">CDP (formerly the Carbon Disclosure Project) provides a globally recognized system that enables companies to measure and manage their environmental impacts. ICON continues to be committed to improving its current scoring of a C. Legacy PRA&#8217;s CDP improved from a D score to a C from 2019. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on reducing energy use across our global operations. For example, reducing energy use and shifting to renewable energy are components of our specific environmental goals. Waste reduction is embedded into our environmental policies and practices and is one of the objectives of ICON&#8217;s Environmental Management Policy. As we continue to combine the ICON and legacy PRA organizations, we will seek new opportunities to reduce waste by increasing recycling volumes, reducing consumption of primary materials, and decreasing use of disposable products in our offices and facilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority of our sites are leased and we work closely with our landlords and leasing agents to implement measures to ensure we operate in an environmentally sustainable manner. The Acquisition of PRA has expanded our global real estate footprint and our real estate group is working with other business leaders to understand the sustainability implications and opportunities of this new footprint, and find ways to continue to advance our collective sustainability goals. During 2021, we initiated a project to integrate offices and reduce our footprint. When selecting new locations for offices and planning building modifications, experts from our real estate team factor in environmental considerations. In addition, we have implemented a series of measures globally to reduce the local footprint of our offices, such as installing energy-efficient LED lighting, using motion detectors to reduce energy use, purchasing recycled office supplies, and reducing paper consumption by promoting paperless office processes, or where printing is necessary, enabling double-sided output. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our office design has efficiency in mind, utilizing space to provide the maximum number of desks and functional provisions while still providing comfortable, safe spaces for our employees. Our strategies include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Perimeter glazing of meeting rooms, offices, and other spaces which allow in natural light.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Recycling areas built into business centers and kitchen/ canteens which reduce waste sent to landfills.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Planted green spaces which contribute to internal air quality, temperature, and humidity.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Building materials and vendors which we select for low environmental impact.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also require our suppliers to abide by our Global Supplier Code of Conduct which includes a commitment to comply with applicable environmental laws and regulations, our expectations around waste management and sustainable use of resources.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Community Engagement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to making a positive impact on the communities in which we work and live and we have aligned our community efforts to a broader vision for social impact, including by aligning priorities with our organizational goals of diversity, inclusion, and belonging.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our community engagement activities are focused on two core areas:</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">supporting education &amp; building closer ties between industry &amp; academia; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">improving the welfare of people in the communities in which we live.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Supporting education and building closer ties between industry and academia </span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A core area of community support includes building ties between industry and academia to inspire the next generation of leaders in business and science.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%;padding-left:14.85pt">Benefactor through the Centuries of Trinity College Dublin.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> ICON has been honored by Trinity College Dublin as a Benefactor Through the Centuries. This award recognizes our enduring support for Trinity, including:</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.81pt">The creation of the ICON-McKeon Research Fellowship in Motor Neuron Disease ('MND') in honor of Mr. Declan McKeon, former Board member, acting Chairman, Lead Independent Director and Chair of the ICON Audit committee. The ICON-McKeon Research Fellow in MND will carry out research in the areas of machine-learning and artificial intelligence to derive insights from multimodal clinical, imaging neuro-electric signaling, in the context of the neurodegenerative disease of ALS. </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.81pt">Partnership with Trinity Centre for People with Intellectual Disabilities ('TCPID') - In 2019, we entered into a partnership with the TCPID. The TCPID situated within the School of Education, Trinity College Dublin, aims to promote the inclusion of people with intellectual disabilities in education and society. The Centre provides people who have intellectual disabilities with the opportunity to participate in a higher education program designed to enhance their capacity to fully participate in society as independent adults. The 2-year education program includes work placements and internships to enable students to experience and participate in the work environment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Partnership with Junior Achievement to inspire schoolchildren.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ICON supports our people who take time out of their working day to deliver Junior Achievement educational programs. Junior Achievement encourages young people to remain in education and teaches them the skills they need to succeed in a changing world. Our volunteers teach primary and secondary level students valuable business, STEM and entrepreneurship skills that will stand them in good stead as they progress through education and beyond.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">The PRA Veteran Leadership Training Program (VLTP), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The VLTP has been recruiting United States military veterans from all branches to join the Company in an operational capacity since 2016. Veterans are placed in roles across the organization to help translate leadership skills learned during military service and apply them in civilian life and as members of the PRA team. Members of the VLTP also have hands-on learning and mentoring opportunities that will help ease the transition to corporate life and that connect them with team-based support system. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Improving the welfare of people in the communities in which we live</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Through volunteering, donations and other charitable initiatives, our employees across the world are making a positive difference to their communities. We support causes that are important to our employees and have a number of programs that support the welfare of people in our local communities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In July 2021, ICON contributed $0.2 million to support the purchase of 38,000 COVID-19 vaccines through the UNICEF COVID-19 vaccination program, one to represent each employee in the new ICON - and became a founding member of UNICEF&#8217;s Corporate Vaccine Alliance in Ireland. The alliance supported UNICEF&#8217;s ambitious goal to deliver over two billion COVID-19 vaccines by the end of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:105%">Since 2012, ICON&#8217;s annual employee-nominated charity donation program has supported over 70 charities. These organizations focus on a range of critical issues, from relieving poverty and homelessness, to improving child welfare through education, to enhancing the lives of patients who are living with a variety of diseases, including cancer, blindness, Alzheimer&#8217;s disease, autism, and neuromuscular diseases. Usually, ICON donates $10,000 to each of 10 charities around the world, selected from a list of staff nominations. In 2021, in lieu of formal holiday events, we expanded our program and donated $10,000 each to 20 organizations around the world, instead of our normal practice of supporting 10 charities. The organizations were chosen to align with our ESG goals.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:105%">Under the PRA Cares initiative, PRA employees from around the world have supported community charity programs. For more than five years, from donation drives to programming community events, PRA people have donated time, money, and support to inspire kindness and empower action. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Talent and People </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the core of our strategy is our people.&#160;Within ICON we have highly qualified and experienced teams, the majority of whom have third level educational qualifications. The need to develop and retain this expertise and talent within the organization is fundamental in enabling us to be the global CRO partner of choice for our customers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">At the core of our strategy is our people </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">People have long been central to our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader. We call it: the potential of together.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The training and development of our staff is a key focus for us</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people&#8217;s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge. Programs include tailored CRA academies and a range of project management curricula, therapeutic-focused programs, and people leader development programs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our People Leader development program focuses on providing our People Leaders with the relevant skills to effectively manage themselves, their team and their business, including psychometrics to raise their awareness of their behavioral preferences and the preference of others.  ICON also invested in Harvard Manage Mentor, an online learning platform, providing People Leaders with access to learning that can be accessed at any time with topics ranging from Change Management, Diversity &amp; Inclusion, Retaining Employees and Developing Employees.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide our people with a personalized and flexible learning experience, delivered through a combination of in-person and technology-driven programs that suit their learning styles and can flex to suit their schedules. Through our industry leading CareerHub, ICON employees are encouraged to broaden their scientific, technical, leadership, and business knowledge. By tapping into development programs and partnerships with leading academic institutions, team members can use the hub to develop competencies that advance their careers. We also collaborate with University College Dublin to deliver customized leadership development programs for global employees.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2021, the PRA Academy was maintained for legacy PRA employees, which served as an umbrella for various training programs, including the Clinical Research Associate (CRA) Bridge Program, Specialty Bridge, Oncology University, and the CRA Internship Program. Additionally, in 2020, two development programs &#8212; PD STRIDES, which focused on Project Managers in Product Delivery, and Leadership Essentials and Development (LEAD), a comprehensive training program for all PRA Functional Managers &#8212; moved from the pilot phase to full implementation. In addition to formal training, PRA also launched LinkedIn Learning globally, which provided unlimited access to more than 16,000 expert-led courses and video tutorials covering professional skills, business software and tools, project management, information technology, creative topics, and much more.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">As an organization we are keen to hear directly from our employees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We recognize that, to attract and retain the best talent, it is essential that we listen to and respond to our people&#8217;s needs and we actively seek to understand our employees&#8217; perspectives and amplify their voices. This begins with a focus on diversity, inclusion and belonging, and extends to every aspect of our work, from recruitment and onboarding, to training, engagement, enablement, and reward.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We pursue best-in-class approaches to building employee engagement and these include, among others:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Comprehensive global employee surveys, which measure how people feel about their work and whether they feel they have the tools to do their jobs well. Feedback from these studies informs detailed action plans at the group, function, and team level.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Pulse check surveys, which are smaller-scale studies designed to measure employee sentiment on specific topics and initiatives.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Stay interviews to help managers understand why staff stay and to uncover what might put them at risk to depart.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Skip-level meetings to develop trust and rapport between senior leaders and employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our listening strategy also informs our efforts to reduce turnover, which we monitor closely through analytics. Qualitative information is collected through formal exit interviews and, where we believe they&#8217;ll make an impact, we intervene via retention plans and related efforts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Employee well-being </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the heart of our well-being ethos is a commitment to support our employees&#8217; ability to lead happy, healthy lives. We aim to ensure that all employees worldwide have equal and direct access to locally relevant information and resources to support</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">them and their families across a broad range of needs. These include, but aren&#8217;t limited to, the physical, social, psychological, and environmental dimensions of well-being.&#160;&#160;&#160;&#160;Our Global Employee Assistance Program ensures that all employees, and their families, have access to a range of different resources and experts to help them better manage their working life and personal life.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health and safety</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The welfare and safety of our employees, customers, and clinical trial patients remains our highest priority. We take guidance from global and regional health authorities and governments to protect the safety and welfare of employees, as well as abide by government directives. Our priority objectives are the safety of our staff, clinical trial patients, protecting the environment, maintaining business continuity, and ensuring ongoing protection of our data.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to providing a safe working environment for our people. We achieve this goal by working in ways that protect the safety, health, and welfare of all our employees, clinical trial patients, and visitors. We work to identify, mitigate, and monitor existing and emerging health or environmental risks that may be associated with our business activities. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In response to the pandemic, both PRA and ICON deployed a range of measures to protect employee safety, to ensure the continuity of customers&#8217; research programs, and to protect patient welfare. These were, and remain, our top priorities for all decisions we make relating to COVID-19. With pandemic conditions changing around the world during 2020 and   2021, the Company's COVID Pandemic Task Force worked through the Business Continuity (BC) office, Site Head network, and with other critical stakeholders to communicate and reopen offices as conditions permitted in accordance with recommendations from the CDC, WHO, and local governments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fostering diversity, inclusion and belonging</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diversity, inclusion and belonging are fundamental to our culture and values. Our rich diversity makes us more innovative and more creative, which helps us better serve our patients, our customers and our communities. We recognize the critical importance of diversity in clinical trials and also affirm that diversity of thought in an inclusive workplace is vital to innovative ideas, spur more fruitful collaboration and nurture a vibrant culture. We are committed to being a workplace where all employees feel included with a deep sense of belonging. To achieve this, we acknowledge and celebrate our differences in gender, ethnicity, culture and abilities. As a values-driven organization, respect for diverse points is foundational to how we interact with each other, as well as with customers, patients, and suppliers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We established a Diversity, Inclusion &amp; Belonging Steering Committee in 2019 which was updated in 2021, following the Acquisition, to comprise of leaders from both the legacy ICON and PRA organizations to guide us in our journey to become a more inclusive workplace where all employees feel they can be themselves and deliver their best work. We believe in a workplace culture that embraces diverse perspectives and empowers our team members to grow &#8212; at work, at home and in their communities. The key areas of focus for our diversity, inclusion, and belonging agenda include talent management, country-level inclusion policies, rewards, training, and communications.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The new ICON brings together two diverse organizations, made great by the talented and ambitious people whose varied skills, perspectives, and backgrounds will continue to be vital to our success. As a global operation, we deliberately structure teams to be international, so that we can support the delivery of our customers&#8217; clinical development programs across multiple geographies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has Diversity, Inclusion &amp; Belonging advocates from the global employee population to better understand local needs, build local presence and awareness, and to give a voice to every corner of the world. These Diversity, Inclusion &amp; Belonging Advocates play a key role in supporting the Diversity, Inclusion &amp; Belonging Steering Committee, aligning activities across the organization which led to the creation of community groups which are broadly aligned with groups that were already in place in PRA:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">NOW@ICON</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Networking Organization for Women at ICON is committed to inspiring and connecting current and potential leaders through an inclusive environment of targeted initiatives and supportive mentorship.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">SPACE</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Supporting Parents and Carers Everywhere to create a workplace where stepping out of careers due to personal commitments for a period is wholly accepted and not career limiting, and where stepping back into their career is an organic and positive process.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">PRIDE</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Supporting LGBTQ+ colleagues and allies, ensuring that no matter where employees are in the world, our offices are a safe space where they are welcomed, respected, and valued.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">DAWN</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: The Disability Awareness Network is a community group striving to develop and foster a mindset towards creating an inclusive workplace and working environment where everyone is treated equally with respect and dignity, irrespective of any visible or hidden disabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">EmbRACE</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Supporting all race and ethnic backgrounds in creating an inclusive workplace culture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ICON is focused on building an inclusive culture where employees feel supported by a fair system supporting pay equity.  We have a long track record of developing talent and filling vacancies through internal hires. Using best-in-class analysis, we conduct regular reviews of salary ranges to ensure fair pay, irrespective of gender, race, or ethnicity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We monitor and seek to maintain pay equity for our employees and, as such, strive to structure our pay principles to ensure that individual differences are not a factor in how we deliver rewards. We have made significant investments in organization design structures, tools, and communications which underpin our pay principles. This information is hosted through core technology, giving managers direct access to resources to support and inform pay-related decisions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As we are integrating the ICON and PRA legacy organizations, we are performing reviews to identify and close any pay equity gaps and we will continue to expand pay equity analytics and provide actionable guidance to leaders and managers. To support enterprise planning, we will continue to track company-wide metrics and report on progress to the Board.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are also committed to ensuring fair employment practices. For every jurisdiction in which we operate, we act in compliance with relevant laws relating to labor rights and labor relations as well as market competitive benefits. We believe in fair and equal treatment for all our people, without regard to gender, race, ethnicity, sexual orientation, marital status, physical or mental disability, age, pregnancy, veteran status, nationality, religion, or any other legally-protected status. We do not tolerate our employees being subjected to physical, sexual, racial, psychological, verbal, or any other form of harassment. We encourage our employees to report any issues of harassment or discrimination. We prohibit retaliation against any employee who rejects, protests, or complains about unlawful discrimination or harassment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Human rights</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is committed to human rights and the adoption and pursuit of compliance with the United Nations Guiding Principles on Human Rights and we maintain policies and practices to uphold human rights globally and within our communities around the world. Our business model and our policies, including our Global Code of Ethical Conduct and Global Supplier Code of Conduct, are intended to fully comply with applicable human rights legislation in the countries where we operate. Indeed, our zero-tolerance policy on forced labor, slavery, and human trafficking is defined clearly in these policies, which are available to employees, suppliers, customers, and the public.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are completely opposed to forced labor, slavery, and human trafficking. We will not knowingly support or conduct business with any organization involved in such activities. We do not employ anyone below the minimum employment age in the jurisdictions in which we operate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Supplier Code of Conduct incorporates the Pharmaceutical Supply Chain Initiative (PSCI) principles for Responsible Supply Chain Management, including for labor. Before doing business with any supplier, we require suppliers to certify that they will comply with the ICON Global Supplier Code of Conduct or to their own materially equivalent internal code, which includes human rights. We perform pre-engagement due diligence on all of our suppliers, including in relation to labor issues, which we support through periodic re-screening. We hold our suppliers accountable for meeting their contractual obligations. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ethics and Compliance</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's core values (as detailed on page 36) are infused in everything we do. Meeting these values requires us all to work to the highest ethical standards and demonstrate a commitment to honesty, transparency and quality. Our focus on acting ethically is reflected in our policies and codes of conduct, including our Global Code of Ethical Conduct. This Code addresses the core values expected of our people in our internal interactions with each other as well as in external dealings with patients, customers, healthcare professionals, regulators, investors, vendors and other third parties.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Ethics and Compliance Program is foundational to our culture and will continue to define expectations and guide behavior across ICON.  The Legal Compliance and Ethics Team has oversight of day-to-day management of the program. The team is independent of the business and reports to the Chief Administrative Officer and General Counsel (CAO). The CAO is responsible to report on the program to our executive leadership team and the Board. The program supports all functional areas globally and is dedicated to the implementation of standardized global policies, procedures, training, guidance, communications, monitoring, investigations, issue management, assessing compliance-related risk and mitigations, and reporting to ensure the overall compliance program is effectively functioning. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has incorporated a third-party system for employees and third parties to report ethics and compliance questions, as well as concerns, and to track reports through follow-up and resolution. These tools also provide visibility into our risks while highlighting opportunities to address them. ICON&#8217;s combined compliance and ethics programs will continue to grow and evolve in response to changes in our business and in the global business climate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All employees are required to complete mandatory training in key areas which support our values and our ways of working. The training incorporates the key principles of our policies and codes and includes interactive scenarios where applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2021 we introduced the Speak Up Policy, ICON&#8217;s open door policy which replaces the former Ethics Line Charter. The Speak Up Policy promotes a culture that encourages compliance, openness, and accountability without retaliation. The Speak Up Policy aims to support our culture and values and seeks to encourage the prompt reporting or surfacing of concerns or violations. Reported ethics concerns and other ethics and compliance-related data are reported to the Board as appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Anti-bribery and Corruption</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON is guided by the foundational principle that we do not tolerate bribery or any other form of corruption or fraud. Our anti-bribery/ anti-corruption (ABAC) program is a key element of our Ethics and Compliance Program. ICON and all ICON directors, employees, consultants, agents and all third parties acting on ICON's behalf must act in compliance with international laws and regulations relating to bribery, corruption, and illicit payments, including the US Foreign Corrupt Practices Act and the UK Bribery Act 2010.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON has the ISO 37001:2016 certification for its Anti-Bribery Management System having established, implemented, maintained, reviewed and improved an Anti-Bribery Management System that can prevent, detect and mitigate the risk of bribery. Our program is designed to ensure our compliance with anti-corruption laws, including due diligence, training, policies, procedures, and internal controls.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Bribery and corruption remains a business risk as we conduct our business across the globe and enter into partnerships and collaborations. There is no certainty that all employees and third party business partners (including our vendors, suppliers, agents, contractors, and other partners) will comply with anti-bribery laws. When working with third parties, we are committed to working with only those who embrace high standards of ethical behavior consistent with our own. Bribery and corruption risks are a focus of our third-party diligence and management process. We hold our suppliers accountable for meeting their contractual obligations with ICON, including commitments that are made with regard to our Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business with ICON. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's internal audit teams conduct ABAC Program audits. Internal Audit focuses on testing for compliance and design effectiveness of the overall ABAC Program. Internal Audit incorporates an assessment of ABAC measures in all audits, as appropriate. In this approach, bribery and corruption risks are incorporated into the risk assessment and scoping process of each audit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Information Security and Privacy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We understand that data privacy and information security are fundamental to business and key to retaining customers, building investor trust, protecting patients, and complying with global and regional regulations. We recognize and respect that our customers, employees, patients, and all those who do business with us expect that we will protect their personal information in accordance with our legal obligations and the promises we make. Our cybersecurity strategy and program protect our systems and data against changing threats. The cybersecurity program has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. Our cybersecurity program is independently assessed on a regular basis. We have embedded security in our processes to maintain the security of our data and our customers&#8217; data. We understand that cyber threats move at machine speed and accordingly we have invested in cybersecurity automation to detect and respond to vulnerabilities and threats rapidly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our processes and range of information security policies are certified to ISO27001 and are independently audited twice annually. We also have the Cyber Essentials certification. During an acquisition process, we conduct security and privacy due diligence and risk assessments, implement policies, deliver employee training, and securely integrate IT systems.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Data Protection Policy regulates the processing of personal data in accordance with the applicable data protection laws of the countries where we operate, including Europe&#8217;s General Data Protection Regulation (GDPR) framework.  COVID-19 raised new privacy and data issues, for example, verifying remotely sourced data became a new priority that will likely endure beyond the pandemic. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our people and partners play a critical role in safeguarding data. ICON has training in place for all employees and contingent workers on information security and privacy practices, so that they understand their responsibilities with respect to data security and privacy.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sustainable procurement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains policies and practices to support responsible, sustainable and ethical business practices and is committed to working with only those suppliers who embrace high standards of behavior.  We manage our suppliers through our Global Procurement department. The onboarding of new suppliers is completed through a centrally managed due diligence process</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Environmental sustainability, bribery, and corruption risks are a focus of our collective third-party diligence and management process. We require our suppliers to abide by our Global Supplier Code of Conduct.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON performs pre-engagement due diligence on all of our suppliers, this includes screening of sanctions lists, debarment, and adverse media. Suppliers are periodically re-screened to ensure any potential new findings are captured and addressed. As part of this process, suppliers are subject to a risk assessment, with suppliers deemed higher risk subject to enhanced due diligence which may include periodic training, auditing, and assessments. We hold our suppliers accountable for meeting their contractual obligations, including commitments relating to our Global Supplier Code of Conduct and regulatory compliance. Contract noncompliance can result in termination of the business relationship and exclusion from future business our company.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our marketing strategy is focused on building a differentiated brand position for ICON and supporting our business development efforts to develop and build relationships with pharmaceutical, biotechnology, medical device, and government and public health organizations. Our marketing activities are coordinated centrally to ensure a consistent and differentiated market positioning for ICON and to ensure all marketing efforts align to the overall strategic objectives of the business. Our business development teams are located throughout the Americas, Europe and Asia Pacific regions. Business development activities are carried out by account executives with assigned territories and global account directors supporting our large accounts. Specialized business development teams focus on growing each of our business areas. Collectively, our business development team, senior executives and project team leaders share responsibility for the maintenance of key client relationships. Our aim is to develop deeper relationships within our client base in order to gain repeat business and enable us new opportunities to penetrate into other therapeutic indications and adjacent service lines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is fragmented, consisting of many small, niche service providers, a declining number of medium-sized providers and a smaller number of large CROs, including ICON, that are differentiated by the scale of their&#160;global operations, breadth of service portfolios and supporting technology infrastructure. The need to conduct complex research and access patients on a global basis is driving market share to these global CROs. When competing for large development programs, ICON competes primarily with IQVIA, PAREXEL, Pharmaceutical Product Development ('PPD'), the Covance Drug Development business of LabCorp and Syneos Health. In some specific markets, for example biotech and mid-tier pharma, ICON may also compete against mid-tier CROs. Competition also exists for acquisition candidates in addition to competition for customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CROs generally compete on the basis of previous product experience, the ability to recruit patients on a global basis, the depth of therapeutic and scientific expertise, the strength of project teams, price and increasingly on the ability to apply new innovation that can drive significant time and cost savings throughout the development process. An evolving area of competition is the need to provide services that can help generate the evidence of the economic value of new treatments that payers and regulators require. This requires access to new data sources which includes information to support the identification of suitable investigator sites and patient populations as well as data on the value delivered by new products following marketing approval. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we compete favorably in all these areas and we continue to invest in our capabilities to ensure that we remain competitive in the future.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Customers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, revenue was earned from a wide range of clients.&#160;During the year ended December&#160;31, 2021, 31.6% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.0% of revenue for the year (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 17 - Disaggregation of revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in the consolidated financial statements).&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, 39.1% of our revenues were derived from our top five customers, with one customers individually contributing more than 10% of our revenues during the period (12.1%).&#160;No other customer contributed more than 10% of our revenues during this period.  &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2019, 37.6% of our revenues were derived from our top five customers, with two customer individually contributing more than 10% of our revenues during the period (The largest contributing 12.5% and the second largest contributing 10.2%). No other customer contributed more than 10% of our revenues during this period. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The loss of, or a significant decrease in business from one or more of these key customers could have a material adverse impact on our results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unsatisfied Performance Obligation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation consists of contracted revenue yet to be earned from projects awarded by clients. At December&#160;31, 2021 we had contracted unsatisfied performance obligations of $13.3 billion (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 18 - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in the consolidated financial statements).&#160;We believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize this unsatisfied performance obligation as revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Information Systems</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Having access to accurate and timely information is critical in the management, delivery and quality of all aspects of drug development. ICON utilizes an extensive range of both on premise and cloud based applications that support its services including clinical trial design and planning, site and patient identification and recruitment, site start-up, patient consent, site payments, content management, clinical data analysis and real world evidence generation, customer relationship management (CRM), performance management, compliance and safety reporting and master data management. These solutions are to allow healthcare companies to manage, optimize and execute their clinical and commercial strategies in an orchestrated manner while addressing their regulatory obligations.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has developed an informatics strategy built around key platforms including ICONIK and Health Cloud, web-based information platforms that enable the management, reporting, analysis and visualization of all data relating to drug development. ICONIK and Health Cloud collects, manage and standardize study data from multiple sources, including Electronic Data Capture (EDC), patient engagement, EMR/EHR, mobile health, Telehealth, Wearables, central laboratories, Symphony Health and Imaging platforms to provide a single view of study information. ICONIK and Health Cloud enable ICON to deliver services such as Risk Based Monitoring (RBM) which uses near-real time clinical data to drive monitoring visit schedules, enabling better decision making and the successful implementation of clinical trial strategies that significantly improve efficiency in clinical trials thereby reducing overall cost and time to market whilst better protecting patient safety.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to managing clinical data, ICONIK and Health Cloud collect operational data, such as project management, clinical trials management system (CTMS) and metrics information to drive trial efficiency and transparency. Investigator data, such as payments, site details and performance, can also be incorporated. ICONIK and Health Cloud &#8211; PredictivvTM can be accessed via a portal that allows clients access to study-related information via a secure web-based environment. Data analysis from ICONIK and Health Cloud Informatics Hubs and CDRP allows us to enhance the design and delivery of our projects, through stronger engagement with investigators and patients. Data management and collection is a key business process for Symphony Health through its Integrated Dataverse (IDV&#174;) platform. Integrated Dataverse (IDV&#174;) is a comprehensive and longitudinal source of healthcare data in the industry, bringing together our vast claims resources &#8211; medical, hospital, and prescription &#8211; with our rich point-of-sale prescription data, non-retail invoice data, and demographic data.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Firecrest, our site management and training technology, is another important component of our informatics strategy. Firecrest provides an on-line web-based portal to access visit by visit study guides which drive site performance and quality. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON also utilizes a range of enterprise applications that enable the delivery of our business services in a global environment. The focus is to provide ease of access and capture of study information for our staff and clients globally. Our current information systems are built on open standards and leading commercial business applications from vendors including Microsoft, Amazon, Oracle, Dell, SAS, Veeva, Dassault, Salesforce and BOX. IT expenditure is authorized by strict IT governance policies requiring senior level approval of all strategic IT expenditure based on defined business strategy and measurable business benefits. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In Clinical Operations, we have deployed a suite of software applications that assist in the management and tracking of our clinical trial activities. These software applications are both internally developed and commercially available applications from external vendors. These include a clinical trial management application that tracks all relevant data in a trial and automates all management and reporting processes. In our Data Management function, we have both leading clinical data management solutions including EDC and Clinical Data Warehouse solutions from external vendors as well as our proprietary EDC capability NEXTrials Prism eClinical. This allows us to guarantee the integrity of client data and provide consolidated information across client studies.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Within Clinical Operations ICON also provides its Connected Health Services enabling the delivery of Decentralised and Hybrid Clinical Trial services, maximizing patient recruitment and retention and at the same time expanding access to diverse and remote patient populations. We develop strategic, flexible approaches that leverage clinical informatics, state-of-the-art technologies, and our global reach to maximize safety and efficiency and make data-driven decisions for every study.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In our clinical trials management area Firecrest Clinical provides a comprehensive site performance management system that improves compliance, consistency and efficient execution of activities at investigative sites. The web-based solution enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to sites. Site behavior can then be tracked to ensure training is understood, procedures are being followed, timelines are met and study parameters are maintained. As well as meeting day to day operational requirements, these systems are feeder systems into the ICONIK and Health Cloud platforms.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide interactive response technology (IXR) to enable centralized patient randomization, drug inventory management, patient diary collection, providing our clients with a fully flexible multi-channel data retrieval solution which can be utilized via telephone, internet browser or a mobile device. In our central laboratory business, we utilize a comprehensive suite of software, including a laboratory information management system (LIMS), a kit / sample management system and a web interface system to allow clients to review results online. Our Laboratory also utilizes IMRA, a web based laboratory review application that allows global access to the latest laboratory data on a study - it facilitates detailed analysis of any trends, signals, alerts or patient-specific data on a real-time basis. ICON provides imaging services through the use of its internally developed MIRA </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">platform and also utilizes Medidata&#8217;s Rave Commercial Imaging for collecting, managing and processing data to support its imaging capabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its Pharmacovigilance Services using Oracle&#8217;s ARGUS safety database, the system is FDA regulation 21 CFR Part 11 compliant and generates all the standard regulatory required reports as well the periodic reports required to support operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON supports Population Pharmacokinetics and Pharmacokinetic Pharmacodynamic modeling through the use of its proprietary software NONMEM&#174;. NONMEM&#174; is a nonlinear mixed effects modeling tool that can be used to fit models to many different types of data. Statistical analysis with NONMEM&#174; using the appropriate model helps pharmaceutical companies determine appropriate dosing strategies for their products, and increase their understanding of drug mechanisms and interactions. NONMEM&#174; can also be accompanied with PDx-Pop proprietary software. PDx-Pop software is a graphical interface for NONMEM&#174; which has its own automation methodology which expedites the iterative process of population pharmacokinetic modeling and analysis. ICON also utilizes PREDPP - a powerful package of subroutines handling population PK data as well as general linear and nonlinear models, which can free the user from coding standard kinetic-type equations while simultaneously allowing complicated patient-type data to be easily analyzed and NM-TRAN - a preprocessor allowing control and other needed inputs to be specified in a user-friendly manner. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's configurable Real World Data &#8220;Evidence&#8221; platform is a fit-for-purpose solution to support and enhance observational research. The platform gathers disparate real world data assets into a common data model, provides analytics to support multiple audiences across the product lifecycle, and serves as a central repository and analytic platform for all Real World Data assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s Integrated Dataverse (IDV&#174;), one of the largest integrated repositories of healthcare data consisting of 280 million patient lives, 1.8 million Prescribers and 16 thousand health plans provides powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market. We transform data into decisions and give deeper insight into the relationships that sponsor brands have with the market by allowing a holistic view of the impacts of payer, prescriber, and patient behavior. Our proprietary Tokenisation technology Synoma&#174; simplifies the anonymization, exchange and connection of industry data sources to provide an integrated view of a patient&#8217;s data.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s global finance operations utilize Oracle&#8217;s eBusiness suite, with the integrated Excel4Apps reporting tool, to serve the organization&#8217;s financial and project accounting requirements. Lawson ERP software and OneStream reporting software is also used by finance operations. Workday and Infor&#174; Global Human Resources ("GHR") is used to fulfill our HR people management requirements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s strategy of using technology to enhance our global processes is evident from our deployment of platforms like ICONIK and Health Cloud, Metrics Stream and Veeva EDMS/QMS, our global SOP Document Management system, our Web-based training delivery solution, iLearn and Cornerstone, workflow and automation platforms such as ServiceNow, Sailpoint for identity management and governance and Pega and ARGUS for pharmacovigilance. The Electronic Trial Master File is delivered via ICON&#8217;s proprietary software ICOMaster or the Wingspan and PhlexGlobal software platforms. Our business development and contracting teams use Salesforce CRM.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our IT systems are operated from two data center hubs in Europe - Dublin, Ireland, Groningen, Netherlands; four in North America - Philadelphia, Pennsylvania, Lenexa, Kansas, Charlottesville, Virginia, Dallas, Texas and one in Asia located in Singapore. These hubs reside within purpose-built data center facility locations. Other offices are linked to these hubs through a network managed by Verizon, a tier one global telecommunications provider. This network provides global connectivity for our applications and allows collaboration and communication using tools like Microsoft Teams, Cisco Jabber, WebEx, Sharepoint and Box. Mobile staff can also access all systems via secure remote access facilities. A global corporate intranet portal provides access to all authorized data and applications for our internal staff as well as providing an internal platform for company-wide communication. IT systems are protected with robust information security controls which are independently audited biannually as part of maintaining ICON&#8217;s ISO27001:2013 certification. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON enables its patient site and data strategy through the services delivered via Accellacare, and through our partnerships with Oncacare and Veradigm Allscripts, where we work with biopharmaceutical companies and other life science providers (e.g. medical devices companies) to develop and deploy bespoke stakeholder engagement solutions. ICON&#8217;s patient engagement services enable site staff to engage directly with patients to help improve their disease and medication understanding through interventional and non-interventional support.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its Phase I clinical development services in state of the art facilities in the Netherlands and North America as well as an Innovative Patient Pharmacology model in Central and Eastern Europe. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is the leading provider of Functional Service Provision (FSP) globally. Our team of operational, functional and therapeutic specialists offer a range of FSP models. We offer FSP solutions across all major functions from clinical monitoring and project management through data management, statistical programming and beyond. Our teams leverage either Sponsor or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s IT Infrastructure and extensive experience managing the migration of systems can support system upgrades as part of the ramp-up phase.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides molecular diagnostic laboratory capabilities that enables the development and commercialization of precision medicines in oncology. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other key innovations and new technologies include;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">FLEX ADVANTAGE, our interactive response technology platform (accessible through the web and web-enabled mobile devices) for managing patient randomization, investigator sites and clinical suppliers.  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">PubsHub brings speed and efficiency to medical teams by delivering easy-to-use, web-based solutions that bridge process gaps for system harmonization across companies. ICON utilizes PubsHub to automate medical and scientific communications and publications management.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The ICON Patient Engagement Platform features an easy to navigate, user friendly website enabling patients to explore new and ongoing studies available, opt-in and connect with their nearest clinical research site.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">One Search, an intuitive, integrated workflow and interrogation tool from ICON, enables access to multiple data sources and provides the visualization and tools necessary for optimum site identification based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">ADDPLAN for simulation and design of exploratory/pilot and confirmatory/pivotal adaptive clinical trials (ADDPLAN&#174; DF (Dose Finder), ADDPLAN&#174; Base, ADDPLAN&#174; MC (Multiple Comparison) and ADDPLAN&#174; PE (Population Enrichment)).</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">AptivAdvantage which is an integrated platform comprising EDC, randomization and drug supply management specifically created for execution of adaptive clinical trials and used to deliver risk-based monitoring; and Aptiv Insite which is a novel approach to risk-based monitoring, using Verification by Statistical Sampling (VSS) to manage data quality and site related risks.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Sample Inventory Management System (SIMS) is an interactive reporting module in ICOLabs for use by sponsors and study teams. It offers near real time, high level traceability of all patient samples in a clinical trial as they move from accessioning through disposition. SIMS provides detailed sample inventory reports and summaries of sample status and location with drill down capabilities. It helps locate samples more rapidly, particularly at critical study junctures.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Unified Platform - Virtual/Hybrid Trials. Utilizing a combination of ICON developed capabilities in conjunction with commercially available software, ICON brings trials directly to patients, thus allowing diverse and difficult to recruit patient populations to be accessed.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">APECS - for Investigator Payments ensures timely and accurate payments to sites for the work performed in the care and management of patients as they participate within clinical trials.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The PredictivvTM platform is a fully integrated solution for designing, planning, managing and optimizing the execution of global clinical studies. Designed around a unified Sales Force platform that harmonizes data, processes, and people across every aspect of a clinical study, PredictivvTM enables unprecedented adaptive intelligence and decision support for the ever-increasing complexities of the clinical development process.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">EXACT&#8482; allows users quickly to construct re-usable programs for data extraction, data transformation, statistical reporting and electronic publishing, in a visual environment with limited code writing. The EXACT&#8482; system is used to simplify and automate the production of multiple Clinical Data Interchange Standards Consortium (CDISC) guidelines as well as tables, figures and listings in trial reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Contractual Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are generally awarded projects based upon our responses to requests for proposals received from companies in the pharmaceutical, biotechnology and medical device industries, or work orders executed under our strategic partnership agreements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues on long term contracts are recognized based on an assessment of progress towards completion. Payment terms usually provide either for payments based on the delivery of certain identified milestones, units delivered or monthly payments, according to a contracted payment schedule over the life of the contract. Where clients request changes in the scope of a trial or in the services to be provided by us, a change order or amendment is issued which may result either in an increase or decrease in the contract value. We also contract on a "fee-for-service" or "time and materials" basis.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contract periods may range from several weeks to several years depending on the nature of the work to be performed. In most cases, an upfront portion of the contract fee is paid at the time the study or trial is started. The balance of the contract fee is generally payable in installments over the study or trial duration and may be based on the completion of certain performance targets or "milestones", on units delivered, or on a fixed monthly payment schedule. For instance, installment payments may be based on patient enrollment dates or delivery of the database. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The progress towards completion for clinical service contracts is measured based on total project costs (direct fees are therefore inclusive of third party costs). Reimbursable costs include payments to investigators, travel and accommodation costs and various other expenses incurred over the course of the clinical trial which are fully reimbursable by the client. Reimbursable expenses are included within direct costs. Reimbursable expenses are included within the contract and are invoiced on a monthly basis based on actual expenses incurred. Expenses incurred are determined by reference to activity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred, we usually negotiate currency fluctuation clauses in our contracts which allow for price adjustments if changes in the relative value of those currencies exceed predetermined tolerances.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Most of our contracts are terminable immediately by the client with justifiable cause or with 30 to 90 days&#8217; notice without cause. In the event of termination, we are usually entitled to all sums owed for work performed and expenses incurred through the notice of termination and certain costs associated with termination of the study. Termination or delay in the performance of a contract occurs for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client's decision to de-emphasize a particular trial, inadequate patient enrollment or investigator recruitment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Management </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Chief Executive Officer and other members of the executive management team are responsible for day-to-day risk management of the Company and our Board oversees management's activities through both the full Board and its committees. Our Chief Executive Officer and other members of the executive management team are members of ICON&#8217;s Quality and Risk Forum, which reviews risk. Our executive management team regularly report to the Board and its Committees to ensure effective and efficient oversight of our activities and to assist in proper risk management and the ongoing evaluation of management controls. The Board oversees general business and market risk management, our Audit Committee oversees risk management with respect to financial statements, accounting and financial controls and our Compensation and Organization Committee oversees risk management with respect to our compensation plans, policies and procedures and our Nominating and Governance Committee oversees risks relating to ESG matters. Internal audit reports functionally and administratively to our Chief Financial Officer and directly to the Audit Committee. With respect to non-financial risk management, including cybersecurity, legal compliance, privacy and enterprise risk, the Board and its Committees receive updates from the appropriate executives on the primary risks facing the Company and the measures the Company is taking to mitigate such risks. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government Regulation  </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The clinical investigation of new drugs is highly regulated by government agencies. The standard for the conduct of clinical research and development studies is Good Clinical Practice (&#8220;GCP&#8221;), which stipulates procedures designed to ensure the quality and integrity of data obtained from clinical testing and to protect the rights and safety of clinical subjects. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FDA and other prominent regulators have promulgated regulations and guidelines that pertain to applications to initiate trials of products, the approval and conduct of studies, report and record retention, informed consent, applications for the approval of drugs and post-marketing requirements. Pursuant to these regulations and guidelines, service providers that assume the obligations of a drug sponsor are required to comply with applicable regulations and are subject to regulatory action for failure to comply with such regulations and guidelines. In the United States and Europe, the trend has been in the direction of increased regulation and enforcement by the applicable regulatory authority. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In providing services in the United States, we are obligated to comply with FDA requirements governing such activities. These include ensuring that the study is approved by an appropriate Independent Review Board (&#8220;IRB&#8221;) and Ethics Committee, obtaining patient informed consents, verifying qualifications of investigators, reporting patients&#8217; adverse reactions to drugs and maintaining thorough and accurate records. We must maintain critical documents for each study for specified periods, and such documents may be reviewed by the study sponsor and the FDA.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The services we provide outside the United States are ultimately subject to similar regulation by the relevant regulatory authority. In addition, our activities in Europe are affected by the European Medicines Agency.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We must retain records for each study for specified periods for inspection by the client and by the applicable regulatory authority during audits. If we fail to comply with applicable regulations and guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines, debarment, termination or suspension of ongoing research, the disqualification of data or litigation by clients, any of which could also result in a material adverse effect.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Potential Liability and Insurance &#160;</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of our business exposes us to potential liability including, but not limited to, potential liability for (i) breach of contract or negligence claims by our customers; and, (ii) third party (such as patients) claims in respect of our performance of services.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, although we do not believe we are legally responsible for acts of third party investigators (physicians running trials), we could be subject to claims arising as a result of the actions of these investigators.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We try to reduce this potential liability by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.85pt">Seeking contractual indemnification from customers in relation to certain activities. However, the terms and scope of indemnification varies from customer to customer and project to project and the performance of these indemnities is not secured. As a result, we bear the risk that indemnification may not be relevant or sufficient or that the indemnifying party may not have the financial ability to fulfill its indemnification obligations. This indemnification does not protect us against our own acts or omissions such as our negligence or where our performance does not reach the required contractual, industry or regulatory standard.</span></div><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.85pt">Maintaining worldwide professional liability insurance. While we maintain the types and amounts of insurance we view as customary in the industries and countries in which we operate, there is no guarantee that we will continue to be able to maintain such insurance coverage on terms acceptable to us, if at all, or that the relevant policy will respond and provide cover when we want it to.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We could be materially adversely affected if ICON is required to pay damages or bear the costs of defending or settling any claim outside the scope of or in excess of a contractual indemnification provision, an indemnifying party does not fulfill its indemnification obligations, the claim is in excess of the level of our insurance coverage or the relevant circumstances are not covered by our insurance policies.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Organizational Structure </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Details of the Company&#8217;s significant subsidiaries or entities under the Company's control at December&#160;31, 2021 are as follows:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.A.</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research PTY Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medpass International Pty Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Pty Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Austria GmbH </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Austria GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP-Logistics Bel, FLLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belarus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Belgium N.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Belgium B.V. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Bermuda,&#160;Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bermuda</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON Pesquisas Cl&#237;nicas LTDA.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Ltda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS do Brasil Servi&#231;os de Pesquisas LTDA.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS China Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Virgin Islands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research EOOD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Bulgaria EOOD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Canada) Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3065613 Nova Scotia Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates ULC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Services de Recherche Pharmaceutique Srl</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oxford Outcomes LTD.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Life Sciences Canada Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Chile Limitada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Chile SpA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRS (Beijing) Clinical Research Co., Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Beijing No.2) Co., Ltd </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Beijing) Co., Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences China, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Colombia Ltda.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Costa Rica, LTDA.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ispitivanja ICON d.o.o                                           <br/>ICON Research Ltd. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates d.o.o. za klinicka ispitivanja</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research s.r.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates CZ, s.r.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Nordic Countries A/S</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Denmark ApS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Egypt (Limited Liability Company)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Estonia O&#220;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estonia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Finland Oy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Finland Oy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International France S.A.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.A.R.L. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Research Trust * </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi SAS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Sarl</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services France S.A.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP Logistics Georgia LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Georgia LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Averion Europe GmbH </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Germany GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Greece A.E.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Greece</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Guatemala, S.A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guatemala</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Hong Kong Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences (Hong Kong) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Klinikai Kutat&#243; Korl&#225;tolt Felel&#337;ss&#233;g&#369; T&#225;rsas&#225;g (ICON Clinical Research Limited Liability Company)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Magyarorsz&#225;g Kutat&#225;s-Fejleszt&#233;si Korl&#225;tolt Felel&#337;ss&#233;g&#369; T&#225;rsas&#225;g<br/></span><span style="font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Pharmaceutical Research Associates Hungary Research and Development Ltd.)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Iceland ehf.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Iceland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research India Private Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates India Private Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Resourcing Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON (LR) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Global Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical International Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Property Development (Ireland) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Property Holdings (Ireland) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Holdings Clinical Research International Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Five Unlimited Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Four Unlimited Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Operational Financing Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Operational Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services (Outsourcing Ireland) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Global Treasury Unlimited Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Clinical Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Israel LTD.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Israel Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Italy S.r.l.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Development Center KK</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences KK</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Japan K.K.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jersey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Kenya Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kenya</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Latvia SIA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latvia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UAB RPS Lithuania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lithuania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Luxembourg S.&#224; r.l.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON CRO Malaysia SDN. BHD.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Malaysia Sdn. Bhd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research M&#233;xico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">M&#233;xico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Mexico S. de R.L. de C. V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">M&#233;xico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research M&#233;xico, S. de R.L. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">M&#233;xico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Servicios, S. de R.L. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">M&#233;xico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Insourcing B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International B.V. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Contracting Solutions Holdings B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Group B.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Holdings B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Metaholdings B.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Operations B.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services Netherlands B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (New Zealand) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates New Zealand Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Norway AS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Panama Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Panama</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Per&#250; S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per&#250;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Per&#250; S.A.C.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per&#250;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Services Philippines, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Philippines,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Poland Sp. z o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symphony Clinical Research Sp zoo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Sp. z o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Portugal, Unipessoal, Lda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Puerto Rico,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.R.L. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Romania S.R.L.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Rus) LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joint Stock Company IMP Logistics </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research d.o.o. Beograd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates doo Belgrade</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Pte) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Life Sciences Singapore Pte. Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Singapore Pte. Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Slovakia, s.r.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates SK s.r.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Pharmaceutical S A (Proprietary) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare South Africa (PTY) LTD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Korea Yuhan Hoesa/ ICON Clinical Research Korea Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Korea Yuhan Hoesa/ Mapi Korea LLC (In Voluntary Liquidation)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Korea Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Espa&#241;a, S.L. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Espa&#241;a, S.A.U.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS ReSearch Ib&#233;rica, S.L.U.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Spain S.L.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare Espa&#241;a S.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Sweden AB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Sweden AB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Switzerland GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Switzerland) GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Switzerland AG</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Taiwan Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Taiwan,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Thailand) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research (Thailand) Co.,&#160;Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Ankara Klinik Arastirma Dis Ticaret Anonim Sirketi</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pra Turkey Sa&#287;lik Ara&#351;tirma Ve Geli&#351;tirme Limited &#350;irketi </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Ukraine LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP-Logistics Ukraine, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Ukraine, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aptiv Solutions (UK) Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON (LR) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 2 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 3 Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 4 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 5 Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Development Solutions Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments (UK) Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Improving Treatments Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medeval Group Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeDiNova Lakeside Clinical Research Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeDiNova Merc (UK) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VSK (Kenilworth) Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP Logistics UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates (UK) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates Russia Limited (in Voluntary Liquidation) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sterling Synergy Systems Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Holdings (U.K.) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 6 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Global S.A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uruguay</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Latin America S.A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uruguay</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Early Phase Services, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ClinStar LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nextrials, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates CIS, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Eastern Europe, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRN North America, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research, LP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addplan, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beacon Bioscience, Inc </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">C4 MedSolutions, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHC Group, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRN Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Pharmaceutical Strategies Group, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Investments, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Laboratory Services, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Tennessee, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON US Holdings Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MMMM Consulting, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MMMM Group, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MolecularMD Corp.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PriceSpective LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PubsHub LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care Innovations, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care Innovations, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI NewCo,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI Worldwide, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International Medical Technical Consultants, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Parallel 6, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Early Development Research, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Holdings,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Receivables, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Roy RPS Holdings LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Global Holdings,&#160;LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Parent Holding LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Source Healthcare Analytics, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunset Hills, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symphony Health Solutions Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Christie Clinic, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Resource Network, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Global, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Managed Care Strategic Solutions, L.L.C. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI International, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Charlotte, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Hickory, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Raleigh, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Rocky Mount, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Salisbury, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Wilmington, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Winston-Salem, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare US Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complete Healthcare Communications LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complete Publication Solutions, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Charleston, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Bristol, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lifetree Clinical Research, LC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Government and Public Health Solutions, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*Mapi Research Trust is an association, its members are ICON Subsidiary entities. </span></td></tr></table></div><div id="i6df4b473ec484136b91516d30b1a0b24_31"></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.    Description of Property</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our principal executive offices are located in South County Business Park, Leopardstown, Dublin, Republic of Ireland, where we own an office facility of approximately 15,000 square meters. We lease all other properties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We maintain sixty-seven offices in Europe; twelve of our offices are in the UK, seven each in Germany and The Netherlands, five in Spain, three in each of France, Italy, Hungary, Poland and Russia, two in each of Ireland, Israel, Romania, Sweden, Switzerland and Turkey and one in each of Belarus, Belgium, Bulgaria, the Czech Republic, Georgia, Latvia, Serbia, Slovakia and the Ukraine. We maintain forty-one offices in North America; thirty-seven in the United States, two in Canada and two in Mexico. We have twenty-one offices in Asia; six in China (including one in Hong Kong), five in India, two in each of Japan, Singapore, South Korea and Taiwan and one in each of The Philippines and Thailand. We have two offices in Australia and one in New Zealand. We have nine offices in South America; three in Brazil, two in Argentina and one in each of Colombia, Chile, Peru and Guatemala. We maintain one office in South Africa.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4A. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 5. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Operating and Financial Review and Prospects.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with our consolidated financial statements, accompanying notes and other financial information, appearing in Item 18. The consolidated financial statements have been prepared in accordance with U.S. GAAP. The information included in the discussion and analysis below provides details on the information for the years ended December&#160;31, 2021 and December&#160;31, 2020. Information related to the year ended December&#160;31, 2019 has not been included. It can be found in the Company's filing of the form 20-F for the year ended December&#160;31, 2020.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a CRO, providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated &#8220;full-service&#8221; solution. At December&#160;31, 2021, we employed approximately 38,330 employees, in 142 locations in 53 countries. During the year ended December&#160;31, 2021 we derived approximately 47.1%, 46.4% and 6.5% of our revenue in the United States, Europe, and the rest of the world, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue consists of fees earned under contracts with third-party clients. In most cases, a portion of the contract fee is paid at the time the study or trial is started, with the balance of the contract fee generally payable in installments over the study or trial duration, based on the delivery of certain performance targets or milestones. Revenue from long term contracts is recognized on a proportional performance method based on the relationship between cost incurred and the total estimated costs of the trial or on a fee-for-service basis according to the particular circumstances of the contract. As is customary in the CRO industry, we contract with third party investigators in connection with clinical trials. Investigator costs and certain other third party costs are included in our assessment of progress towards completion and costs incurred in measuring revenue. Where these costs are reimbursed by clients, they are included in the total contract value recognized over time, based on our assessment of progress towards completion. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the nature of our business involves the management of projects, the majority of which have a duration of one to four years, the commencement or completion of projects in a fiscal year can have a material impact on revenues earned with the relevant clients in such years. In addition, as we typically work with some, but not all divisions of a client, fluctuations in the number and status of available projects within such divisions can also have a material impact on revenues earned from such clients from year to year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Termination or delay in the performance of an individual contract may occur for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client&#8217;s decision to de-emphasize a particular trial or inadequate patient enrollment or investigator recruitment. In the event of termination the Company is usually entitled to all sums owed for work performed through the notice of termination and certain costs associated with the termination of the study. In addition, contracts generally contain provisions for renegotiation in the event of changes in the scope, nature, duration, or volume of services of the contract.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation comprises our assessment of contracted revenue yet to be earned from projects awarded by clients. At December&#160;31, 2021 we had unsatisfied performance obligations of approximately $13.3 billion.&#160;We believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results, due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize the unsatisfied performance obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON announced the completion of the Acquisition of PRA. The combined Group retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organizations. The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development. The operating results of the Group for the year ended December&#160;31, 2021 are materially impacted by the completion of the Merger and result in large variances when comparing to the year ended December&#160;31, 2020. Where applicable, management have included commentary on specific one-time charges related to the Merger in order to provide an understanding of the normal operations of the Group. The management's discussion and analysis below includes the results of PRA from July 1, 2021 to December 31, 2021. The results of PRA prior to July 1, 2021 are not reflected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we are domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be materially affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to translation exposures, we are also subject to transaction exposures because the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred.&#160;Our operations in the United States are not materially exposed to such currency differences as the majority of our revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts are usually priced in a single currency, most often U.S. dollars or euros, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging, due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our currency exposures.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As we conduct operations on a global basis, our effective tax rate has depended and will depend on the geographic distribution of our revenue and earnings among locations with varying tax rates. Our results therefore may be affected by changes in the tax rates of the various jurisdictions. In particular, as the geographic mix of our results of operations among various tax jurisdictions changes, our effective tax rate may vary significantly from period to period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;Operating Results</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Assessment of COVID-19 impact on operating results</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the period since December 31, 2020, the Company has continued to experience a return to positive growth in revenue and net income as a result of the ongoing recovery from the global COVID-19 pandemic. At this point in time, there still remains some degree of uncertainty relating to the long-term effect of COVID-19 on our business and when it will be possible for business activity to return to normal operating levels. Although the impact of the global COVID-19 pandemic on our business is reducing, the emergence of COVID-19 variants of concern continue to create restrictions on our ability to ensure laboratory samples are collected and analyzed on time, our ability to monitor our clinical trials, the ability of patients or service providers to travel, and our ability to travel, as a result of the outbreak.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has continued to successfully mobilize its vaccine resources to address the COVID-19 global threat, including its ability to conduct home-based trials to minimize infection. In addition, the Company is currently providing clinical monitoring and safety oversight on numerous COVID-19 trials for both the private and government sectors. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provided clinical trial services to the Pfizer and BioNTech SE investigational COVID-19 vaccine program. ICON worked with Pfizer and 153 sites in the US, Europe and Latin America to ensure over 44,000 patients were recruited within four months for phase 3 of the trial, in late 2020, in one of the largest and most expeditious clinical trials ever performed. Trial capabilities were key to enabling agility and speed in the global study, which included a high level of remote clinical monitoring and source data verification, in addition to on-site monitoring, safeguarding data quality and integrity in the evolving pandemic environment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Revenue for the year ended December&#160;31, 2021 increased by $2,683.5 million, or 95.9%, to $5,480.8 million, compared to $2,797.3 million for the year ended December&#160;31, 2020. Revenue increased by 94.5% in constant currency terms (Constant currency revenue growth reflects growth in revenue had foreign exchange rates that existed in 2020 remained constant). The increase in revenues in the year ended December&#160;31, 2021 reflected the completion of the Merger and the continued recovery from the impact of the COVID-19 global pandemic. The Company has earned revenue from clinical trials associated with COVID-19, which include the Pfizer BioNTech COVID-19 vaccine program described above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, certain financial data as a percentage of revenue and the percentage change in these items compared to the prior comparable period. The trends illustrated in the following table may not be indicative of future results.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage Increase/(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;N/M =  Not Meaningful</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Year ended December&#160;31, 2021 compared to year ended December&#160;31, 2020</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,797,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,683,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue for the year ended December&#160;31, 2021 increased by $2,683.5 million, or 95.9%, to $5,480.8 million, compared to $2,797.3 million for the year ended December&#160;31, 2020. Revenue increased by 94.5% in constant currency terms. The increase in revenues in the year ended December&#160;31, 2021 is due to the Merger and the impact of the continued recovery from the COVID-19 global pandemic has had on operations including: our ability to ensure laboratory samples are collected and analyzed on time, our ability to perform on-site monitoring of clinical trials, the ability of patients or service providers to travel, and our ability to travel. The Company has earned revenue from clinical trials associated with COVID-19, most notably with the Pfizer BioNTech COVID-19 vaccine program.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues from our top five customers amounted to $1,733.1 million in the year ended December&#160;31, 2021 compared to $1,092.8 million in the year ended December&#160;31, 2020 or 31.6% and 39.1% respectively. The largest of these customers related to a strategic partnership with a large global pharmaceutical company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue in Ireland increased by $184.6 million in the year ended December&#160;31, 2021, to $1,365.9 million, compared to $1,181.3 million for the year ended December&#160;31, 2020.&#160;Revenue in Ireland during the year ended December&#160;31, 2021 increased by 15.6% compared to an overall increase in Group revenue of 95.9%.&#160;Revenue in Ireland is principally a function of our global contracting model (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 20 - Business segment and geographical information </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">n the consolidated financial statements). Entities acquired as part of the Merger are currently being integrated into the global contracting model and this process remains ongoing at December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue in the Rest of Europe increased by $758.6 million or 182.0%, to $1,175.5 million, compared to $416.9 million for the year ended December&#160;31, 2020. Revenue in the U.S. increased by $1,655.4 million or 178.9%, to $2,581.0 million, compared to $925.6 million for the year ended December&#160;31, 2020. Revenue in our Rest of World (&#8216;Other&#8217;) region increased by $84.8 million or 31.0%, to $358.4 million, compared to $273.5 million for the year ended December&#160;31, 2020. Revenue has increased across all regions principally reflecting the Merger completion and continued recovery from the COVID-19 global pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:50.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,972,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,979,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,992,729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs for the year increased by $1,992.7 million, or 100.6%, to $3,972.6 million, compared to $1,979.9 million for the year ended December&#160;31, 2020. Direct costs consist primarily of investigator and other reimbursable costs, compensation, associated fringe benefits and routine share based compensation expense for project-related employees and other direct project driven costs. The increase in direct costs during the year arose due to an increase in headcount and an increase in personnel related expenditure of $1,217.2 million, as a result of the Merger, combined with an increase in other direct project related costs of $22.3 million, an increase in laboratory costs of $17.2 million, an increase in third party investigator and other reimbursable costs of $734.4 million and an increase in travel related costs of $1.6 million.&#160; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:51.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.760%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">585,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">242,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the year increased by $242.9 million, or 70.9%, to $585.3 million, compared to $342.4 million for the year ended December&#160;31, 2020. Selling, general and administrative expenses comprise primarily of compensation, related fringe benefits and routine share based compensation expense for non-project-related employees, recruitment expenditures, professional service costs, advertising costs and all costs related to facilities and information systems. As a percentage of revenue, selling, general and administrative expenses decreased to 10.7% of revenue, compared to 12.2% of  revenue for the year ended December&#160;31, 2020. During the year, the increase in selling, general and administrative expenses relates to an increase in general overhead costs of $9.0 million, an increase of $58.3 million in facilities related costs, an increase of $188.1 million in personnel related expenditure and an increase of $8.2 million in marketing fees. These increases were partly offset by a decrease of $20.1 million due to foreign exchange movements and other immaterial decreases.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share based compensation expense recognized during the years ended December&#160;31, 2021 and December&#160;31, 2020 were $133.8 million and $26.3 million respectively (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 11 - Equity Incentive Schemes and Stock Compensation Charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to the consolidated financial statements). Share based compensation expenses are part of personnel related expenditure in direct costs and selling, general and administrative expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:51.041%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation expense for the year increased by $28.6 million or 61.0%, to $75.5 million, compared to $46.9 million for the year ended December&#160;31, 2020. The depreciation charge reflects investments in facilities, information systems and equipment supporting the Company&#8217;s continued growth. The depreciation charge, from a value perspective, has increased mainly due to the additional office footprint acquired through the Merger.&#160;As a percentage of revenue, the depreciation expense decreased to 1.4% of revenues, compared to 1.7% for the year ended December&#160;31, 2020.&#160; Amortization expense for the year increased by $220.3 million or 1,145.2%, to $239.5 million, compared to $19.2 million for the year ended December&#160;31, 2020. The amortization expense represents the amortization of intangible assets acquired in business combinations. The increase in amortization expense for the year reflects the amortization of newly acquired intangibles arising on the Merger.&#160;As a percentage of revenue, the amortization expense increased to 4.4%, compared to  0.7% of revenue for the year ended December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, transaction and integration-related expenses associated with the Merger</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:51.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(759)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">N/M = Not Meaningful</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company incurred $229.4 million for restructuring, transaction and integration-related expenses associated with the Merger. The charge includes transaction and integration costs of $198.3 million associated with investment banking, advisory costs, retention agreements with employees, accelerated share compensation charges and ongoing integration activities. The transaction and integration related credit of $0.8 million incurred in the year ended December&#160;31, 2020 related to the release of contingent consideration net of expenses incurred as part of ICON's recent acquisitions prior to the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has also undertaken a restructuring program following the announcement of the Merger to review its global office footprint, optimize its locations to best fit the requirements of the Company and reorganize its workforce to drive future growth. This program has resulted in a charge of $31.1 million in the year ended December&#160;31, 2021. In the year ended December&#160;31, 2020, a restructuring charge of $18.1 million was recognized under a restructuring plan adopted following a review of operations. The restructuring plan reflected resource rationalization across the business to improve resource utilization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect to incur additional expenses associated with the Merger; however, the timing and the amount of these expenses depends on various factors such as, but not limited to, the execution of integration activities and the aggregate amount of synergies we achieve from these activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income from operations</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,971)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations decreased by $13.0 million, or 3.3%, to $378.5 million, compared to $391.5 million for the year ended December&#160;31, 2020. As a percentage of revenue, income from operations decreased to 6.9% of revenues compared to 14.0% of revenues for year ended December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Reconciliation to adjusted income from operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations, excluding restructuring, transaction and integration related expenses ("adjusted income from operations") reflects income from operations with restructuring charges and transaction and integration related expenses added back. The most comparable GAAP measure is income from operations. The amounts added back to income from operations are presented directly from the consolidated statement of operations and in the notes to the financial statements.  Management believes adjusted income from operations provides stakeholders more insight into underlying business performance. Adjusted income from operations increased by $199.1 million, or 48.7%, to $607.9 million, compared to $408.8 million for the year ended December&#160;31, 2020. As a percentage of revenue, income from operations decreased to 11.1% of revenues compared to 14.6% of revenues for year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted income from operations in Ireland decreased by $133.5 million or 45.2% to $161.9 million, compared to $295.4 million for the year ended December&#160;31, 2020. The decrease in the year ended December&#160;31, 2021 is mainly a result of the amortization charged on the intangible assets acquired in the Merger. Income from operations in Ireland and other geographic regions are reflective of the Company&#8217;s global transfer pricing model and the centralization of intragroup financing activities in Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the Rest of Europe region, adjusted income from operations increased by $148.0 million, to $183.4 million, compared to $35.4 million for the year ended December&#160;31, 2020.&#160;The increase is due to the additional activity in the region as a result of the Merger. As a percentage of  revenues, income from operations, excluding restructuring and transaction related items, in the Rest of Europe region increased to 15.6% compared to 8.5% for the year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the U.S. region, Adjusted income from operations increased by $175.1 million, to $232.0 million, compared to $56.9 million for the year ended December&#160;31, 2020. The increase is due to the additional activity in the region as a result of the Merger. As a percentage of revenues, income from operations, excluding restructuring and transaction related items, in the U.S. region increased to 9.0% compared to 6.1% for the year ended December&#160;31, 2020. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In other regions, Adjusted income from operations increased by $9.5 million, to $30.6 million, compared to $21.1 million for the year ended December&#160;31, 2020. The increase is due to the additional activity in the region as a result of the Merger. As a percentage of  revenues, income from operations, excluding restructuring and transaction related items, in the other regions increased to 8.5% , compared to 7.7% for the year ended December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest income and expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:37.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.367%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,150)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182,423)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(169,404)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,301.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense increased to $182.4 million compared to $13.0 million for the year ended December&#160;31, 2020 due to the draw down of debt facilities associated with the Merger and costs related to the extinguishment of previous debt facilities&#160;(see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 24 - Non-current bank credit lines and loan facilities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">to the consolidated financial statements). No amounts were drawn down on the revolving credit facilities during the year ended December&#160;31, 2021 or the year ended December&#160;31, 2020. Interest income for the year ended December&#160;31, 2021 decreased to $0.6 million, compared to $2.7 million for the year ended December&#160;31, 2020. This reflects reduced returns on cash and cash equivalents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,541)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for income taxes for the year decreased to $41.3 million compared to $47.9 million for the year ended December&#160;31, 2020.&#160;The Company&#8217;s effective tax rate for the year ended December&#160;31, 2021 was 21.0%&#160;compared to 12.6% for the year ended December&#160;31, 2020. The Company&#8217;s effective tax rate remains principally a function of the distribution of pre-tax profits amongst the territories in which it operates and the tax treatment of costs related to the Merger.</span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B. &#160;&#160;&#160;&#160;Liquidity and Capital Resources</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is generally not capital intensive. The Group&#8217;s principal operating cash needs are payment of salaries, office rents, travel expenditures and payments to investigators. Investing activities primarily reflect capital expenditures for facilities and information systems enhancements, the purchase and sale of short term investments and acquisitions. Financing activities primarily reflect the servicing of the Company's external debt.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our clinical research and development contracts are generally fixed price with some variable components and range in duration from a few weeks to several years. Revenue from contracts is generally recognized as income on the basis of the relationship between costs incurred and the total estimated contract costs. The cash flow from contracts typically consists of a small down payment at the time the contract is entered into, with the balance paid in installments over the contract duration, in some cases on the achievement of certain milestones. Therefore, cash receipts do not correspond to costs incurred and revenue recognized on contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash and cash equivalents and borrowings (net)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,  2020</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Drawn down/</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(repaid)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash inflow/</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(outflow)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other non-cash adjustments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of exchange rates</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,  2021</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">dollars in thousands</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">840,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">752,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,712</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">842,034&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80,382)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,727)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">753,925</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance <br/>December 31,  2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Drawn down/<br/>(repaid)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash inflow/<br/>(outflow)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other non-cash adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of exchange rates</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance <br/>December 31,  2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">dollars in thousands</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(363,992)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities &amp; Senior Secured Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,015,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(589,986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,436,312</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,477&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,651,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(589,986)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,436,312</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash and cash equivalents and borrowings </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">493,557</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5,651,008)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">509,604</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(26,813)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7,727)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4,682,387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents and available for sale investments at December&#160;31, 2021 amounted to $753.9 million compared with cash and available for sale investments of $842.0 million at December&#160;31, 2020.&#160;The Company&#8217;s cash and short term investment balances at December&#160;31, 2021 comprised cash and cash equivalents $752.2 million and short-term investments $1.7 million. The Company&#8217;s cash and short term investment balances at December&#160;31, 2020 comprised cash and cash equivalents $840.3 million and short-term investments $1.7 million.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay in full (i) PRA&#8217;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the transaction. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026.  No amounts have been drawn under the revolving loan facility as at December&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, the Company, issued $500 million in aggregate principal amount of 2.875% senior secured notes in a private offering. The senior secured notes will mature on July 15, 2026 and will bear interest at a rate of 2.875%. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 27, 2021, the Company repaid $13.8&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.4&#160;million. On December 29, 2021, the Company repaid $500.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.8&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has contractual liabilities for lease arrangements of $227.7&#160;million which will be predominantly settled over the next five year period through cash payments.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company also has tax related liabilities of $217.0 million which are predominantly long term in nature with $112.0 million expected to be settled in the next five year period. The balance of $105.0 million is expected to be settled beyond that five year period.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 8, 2020, ICON Investments Five Unlimited Company issued new senior notes ("2020 Senior Notes") for aggregate gross proceeds of $350.0 million in a private placement which was guaranteed by ICON plc. The 2020 Senior Notes were issued in two tranches; Series A Notes of $275.0 million maturing on December 8, 2023 and Series B Notes of $75.0 million maturing on December 8, 2025. Interest payable on the 2020 Senior Notes was fixed at 2.32% and 2.43% for Series A Notes and Series B Notes respectively. Due to the conditions attached to the additional borrowings to fund the PRA Merger, the 2020 Senior Notes were repaid in full on July 1, 2021 inclusive of early repayment charges. The total repayment on July 1, 2021 was $364.0 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into an interest rate hedge in respect of the planned issuance of the 2020 Senior Notes in June 2020. The interest rate hedge matured in July 2020 when the interest rates on the 2020 Senior Notes was fixed. The interest rate hedge was effective in accordance with ASC 815 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Derivatives and Hedging'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. There was a cash outflow on maturity in July 2020 of $0.9 million, representing the realized loss on the interest rate hedge. The unamortized portion of this loss has been released in the period in line with the commitment to early settle the 2020 Senior Notes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 15, 2015, ICON Investments Five Unlimited Company issued Senior Notes for aggregate gross proceeds of $350.0 million in a private placement. Interest payable was fixed at 3.64%, and was payable semi-annually on the Senior Notes on each June 15 and December 15, commencing June 15, 2016. The Senior Notes were guaranteed by ICON plc and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">matured on December 15, 2020 at which time they were repaid in full.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash from operating activities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by operating activities was $829.1 million for the year ended December&#160;31, 2021 compared with net cash provided by operating activities of $568.0 million for the year ended December&#160;31, 2020. The dollar value of working capital balances and the related number of days&#8217; revenue outstanding (i.e. revenue outstanding as a percentage of revenue for the period, multiplied by the number of days in the period) can vary over a study or trial duration. The number of days&#8217; revenue outstanding at December&#160;31, 2021 was&#160;31 days compared to 57 days at December&#160;31, 2020. This reflects the timing of cash collections and individual contractual terms. Contract fees are generally payable in installments based on the achievement of certain performance targets or &#8220;milestones&#8221; (e.g. target patient enrollment rates, clinical testing sites initiated or case report forms completed), such milestones being specific to the terms of each individual contract, while revenues on contracts are recognized as contractual obligations are performed.&#160;Billed and unbilled revenue also includes amounts recoverable from customers in respect of reimbursable costs. Amounts recorded as accrued to investigators and others in respect of reimbursable expenses were $323.6 million at December&#160;31, 2021 and $138.2&#160;million at December&#160;31, 2020 (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 8 - Other liabilities </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in the consolidated financial statements). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Contractual terms with our customers require ICON to receive and discharge payment to third parties prior to billing the customer for these items. During the year, unearned revenue increased to $1,324.0 million from $660.9 million at December&#160;31, 2020 (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">note 18 - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">in the consolidated financial statements). These fluctuations are primarily due to the balance acquired as part of the Merger but are also due to timing of payments and invoicing related to the Group's clinical trial management contracts. These advance billings and the completion of the Merger have resulted in the significant increase in unearned revenue at December&#160;31, 2021. During the year, cash from other net assets increased to a $108.3 million inflow from a $2.2 million outflow at December&#160;31, 2020. These fluctuations are primarily due to the balance acquired as part of the Merger and increases in tax related liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash generated from operations, and days&#8217; revenue outstanding may be positively or negatively impacted by, amongst others, the scheduling of contractual milestones over a study or trial duration, the achievement of a particular milestone during the period, the timing of receipt of invoices from third parties for reimbursable costs and the timing of cash receipts from customers.&#160;A decrease in the number of days&#8217; revenue outstanding during a period will result in cash inflows to the Company while an increase in days revenue outstanding will lead to cash outflows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash used in investing activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities was $6,024.2 million for the year ended December&#160;31, 2021 compared to net cash used in investing activities of $46.6 million for the year ended December&#160;31, 2020. Net cash used in investing activities the year ended December&#160;31, 2021 was largely attributable to the cash element of the Merger consideration of $5,914.5 million (net of cash acquired). During the year, capital expenditure of  $93.8 million was made mainly related to investment in facilities and IT infrastructure. Further cash outflow of $2.5 million was made in respect of the Company's investment in Oncacare, a loan of $10.0 million was provided to Oncacare and $3.6 million in relation to investments in long-term equity. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2020, net cash used in investing activities of $46.6 million was largely attributable to cash outflows on the acquisitions of MedPass of $47.6 million on January 22, 2020, cash outflows of $0.3 million in relation to the working capital adjustment on the acquisition of Symphony which was acquired on September 24, 2019, cash outflows of $0.5 million in relation to the contingent consideration paid for Symphony in the period and a cash inflow of $0.5 million in relation to the working capital adjustment for MeDiNova which was acquired on May 23, 2019. These amounts were offset in part by cash acquired of $10.2 million. A cash outflow of $2.5 million was made in respect of the Company's investment in Oncacare. During the year, capital expenditure of $40.9 million was made mainly related to the investment in facilities and IT infrastructure. In addition, $47.9 million was generated by the sale of short term investments and $3.2 million cash was paid in relation to investments in long-term equity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash used in financing activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by financing activities amounted to $5,114.7 million for the year ended December&#160;31, 2021 compared with net cash outflow from financing activities of $208.3 million for the year ended December&#160;31, 2020. The Company drew down external financing of $6,015 million to fund the completion of the Merger. This was offset by debt discount and certain debt issue costs of $109.9 million. As part of the external financing, the Company paid financing professional fees of $30.3 million and made payments of principal on the external debt of $513.8 million. The Company also repaid the 2020 Senior Notes on 1 July 2021, including early repayment charges, totaling $364.0 million. During the year ended December&#160;31, 2021, $118.6 million was received by the Company from the exercise of share options. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2020, cash outflows in respect of financing activities includes consideration paid by the Company for share buybacks pursuant to the Company&#8217;s share repurchase program totaling $175.0 million in the year ended December&#160;31, 2020 (see note 13 - Share Capital in the consolidated financial statements). In December 2020, $350.0 million was received in respect of the issue of the 2020 Senior Notes and $350.0 million was paid in respect of the repayment of the 2015 Senior Notes. Finance costs in respect of the issue of the 2020 Senior Notes were $1.6 million and there was a cash outflow of $0.9 million in respect of the loss on settlement of the interest rate hedge on the 2020 Senior Notes. There were cash outflows of $43.9 million in relation to the purchase of the remaining share capital in MeDiNova. In addition, $13.2 million was received by the Company from the exercise of share options.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:174%">Net cash outflow</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of these cash flows, cash and cash equivalents decreased by $88.1 million for the year ended December&#160;31, 2021 compared to an increase of $320.0 million for the year ended December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C. &#160;&#160;&#160;&#160;Research and development, patents and licenses</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plays a critical role in new drug development by undertaking activities in each of the different stages of the drug development process. Clinical trials result in an advancement in the field of medical science as they establish the safety and efficacy of new drugs, thus resolving scientific uncertainty. As one of a number of world leaders in clinical research and commercialization, ICON is a trusted partner for pharmaceutical and medical device companies in helping them to accelerate the development of drugs and devices that save lives and improve the quality of life. ICON's role in ensuring that the trial design is scientifically valid is a crucial part of the design and involves scientists, medical doctors and biostatisticians. ICON works with the sponsors in designing the conduct of the clinical research trial. ICON's role of conducting clinical trials is an integral part of the research and development process leading ultimately to a decision as to whether or not each drug is safe for human consumption, has the desired effect on targeted diseases and the best means of delivering that drug to the patient. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D. &#160;&#160;&#160;&#160;Trend information</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other than as disclosed elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, or commitments or events since December&#160;31, 2021 that are reasonably likely to have a material adverse effect on our revenues, income, profitability, liquidity or capital resources, or that would cause the reported financial information in this annual report to be not necessarily indicative of future operating results or financial conditions. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E. &#160;&#160;&#160;&#160;Critical Accounting Policies and Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Significant accounting policies are summarized in Note 1 to the consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We base our estimates and judgments on historical experience and on the other factors that we believe are reasonable under current circumstances. Actual results may differ from these estimates if these assumptions prove to be incorrect or if conditions develop other than as assumed for the purposes of such estimates. The following is a discussion of the accounting policies used by us, which we believe are critical in that they require estimates and judgments by management. The application of these critical accounting policies and estimates is discussed with the Audit Committee of the Board of Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Significant management judgments and estimates must be made and used in connection with the recognition of revenue in any accounting period. Material differences in the amount of revenue in any given period may result if these judgments or estimates prove to be incorrect or if management&#8217;s estimates change on the basis of development of the business or market conditions. To date there have been no material differences arising from these judgments and estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We earn revenues by providing a number of different services to our clients. These services, which are integral elements of the clinical development process, include clinical trials management, contract staffing, consulting and laboratory services. Contracts range in duration from a number of months to several years. The criteria for revenue recognition is based on five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Clinical trial services are a single performance obligation satisfied over time i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. We have concluded that ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research project. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. An assessment of the realizable contract value is judgmental in nature. The realizable value assessment is updated at each reporting period, having regard to (i) contract terms and (ii) customer experience.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized on a percentage completion basis as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured therefore based on an input measure being total project costs (inclusive of third party costs) at each reporting period. Measurement of the progress towards completion involves judgment and estimation.  Assessment of completion requires an evaluation of labor and related time cost incurred at the reporting date and third party costs incurred at the reporting date. The assessment of third party costs incurred (principally investigator costs) requires a review of activity performed and recorded by the third party services providers. The timing of payments to third parties in respect of cost incurred reflect invoicing by third parties. The timing difference between the activity performed and receipt of invoices from third parties may result in significant accrued amounts at reporting periods.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assessment of progress towards completion also requires an up to date evaluation of the forecast costs to complete in respect of these projects. Given the long-term nature of the clinical trials, and the complex nature of those trials, the forecast costs to complete (being internal direct costs and costs that will be incurred by third parties (principally investigators)) is judgmental.  Forecast time (and related costs) is determined by reference to (i) contract terms and (ii) past experience. Forecast third party costs to complete are determined by project by reference to (i) contract terms and (ii) past experience. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data services to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. The calculation of the fair value of certain non-monetary terms involves management judgement and estimation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets acquired in a business combination</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Significant management judgments and estimates must be made and used in connection with the recognition of intangible assets associated with a business combination. The cost of a business combination is measured as the aggregate of the fair values at the date of exchange of assets given, liabilities incurred or assumed and equity instruments issued in exchange for control. The assets, liabilities and contingent liabilities of businesses acquired are generally measured at their fair values at the date of acquisition. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Measurement of intangible assets involves the use of estimates for determining the fair value at the acquisition date.  The determination of the fair values of assets and liabilities, as well as of the useful lives of the assets is based on management&#8217;s judgment. The valuation of intangible assets required management to develop discounted cash flow models which required the use of reasonable and supportable inputs such as customer attrition data, discount rates developed from various weighted average cost of capital assumptions, growth rates, margin forecasting and assessment of useful lives. Management utilized external valuation experts, where necessary, to ensure the valuation process was sufficiently detailed and robust to develop reliable valuations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of New Accounting Pronouncements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of new accounting pronouncements adopted during fiscal year ended December&#160;31, 2021 (or previously)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers'. The amendments in this ASU require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. For public business entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption of the amendments is permitted, including adoption in an interim period. An entity that early adopts in an interim period should apply the amendments (1) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (2) prospectively to all business combinations that occur on or after the date of initial application. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has taken then option to early adopt the amendments in this ASU for year ended December&#160;31, 2021 and apply the amendments to interim periods from the beginning of the fiscal year. The Company has applied the amendments of this ASU to the Merger with PRA, completed on July 1, 2021. The application of these amendments has resulted in a $16.0 million increase in goodwill and corresponding $16.0 million increase to unearned revenue compared to the initial accounting for the Merger. Since July 1, 2021, the Company had amortized $4.0 million of the unearned revenue adjustment through the revenue line in the Consolidated Statement of Comprehensive Income. This amortization has been reversed in December 2021 resulting in a net nil impact on revenue for the year ended December&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other accounting pronouncements</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 &#8216;Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8217; which removes the separation models in ASC 470 &#8216;Debt&#8217; for convertible debt with cash conversion features and convertible instruments with beneficial conversion features. The ASU also removes from ASC 815 &#8216;Derivatives and Hedge Accounting&#8217; certain conditions for equity classification for contracts on an entity&#8217;s own equity. The ASU is effective for the Company for the year ended December&#160;31, 2021. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01, 'Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)'. ASU 2020-01 states any equity security transitioning from the alternative method of accounting under Topic 321 to the equity method, or vice versa, due to an observable transaction will be re-measured immediately before the transition. In addition, the ASU clarifies the accounting for certain non-derivative forward contracts or purchased call options to acquire equity securities stating such instruments will be measured using the fair value principles of Topic 321 before settlement or exercise. The ASU is effective for the Company for the year ended December&#160;31, 2021, and has been applied on a prospective basis. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12 'Simplifying the Accounting for Income Taxes (Topic 740)'. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The Company adopted the amendments in this ASU on a prospective basis, except where the required method of adoption is retrospective or modified retrospective. ASU 2019-12 is effective for the Company for the year ended December&#160;31, 2021. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of new accounting pronouncements which will be adopted during fiscal year ended December 31, 2022</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No other new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inflation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that the effects of inflation generally do not have a material adverse impact on our operations or financial conditions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 6. Directors, Senior Management and Employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Directors and Senior Management</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table and accompanying biographies set forth certain information concerning each of ICON plc&#8217;s Directors, officers and other key employees as of March&#160;1, 2022.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Age</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray (5)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair and Director </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler (1)(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan (1)(6)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy (2)(3)(5)(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lead Independent Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Professor Hugh Brady (3)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy (2)(4) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Professor William Hall (2)(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague (3)(4)(5)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill (5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mary Pendergast (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Colin Shannon </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diarmaid Cunningham </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Administrative Officer, General Counsel &amp; Company Secretary</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Named Executive Officer of the Company.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Compensation and Organization Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Audit Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Nominating and Governance Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Integration Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Execution Committee.</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ciaran Murray</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Ciaran Murray graduated with a Bachelor of Commerce degree from University College Dublin in 1982. Mr. Murray subsequently qualified as a chartered accountant with PwC.&#160;Following qualification, Mr. Murray gained extensive global experience working as an executive in the fast moving consumer goods and technology sectors in Ireland, Italy, the UK and the US.&#160;Mr. Murray has been the Chair of ICON plc since March 2017 and an outside director since the May 2018. Mr. Murray served as Chief Executive Officer from October 2011 until March 2017 and was Chief Financial Officer from joining ICON plc in 2005 until his appointment as Chief Executive Officer in 2011.&#160;During his time with ICON plc, Mr. Murray was recognized for his leadership of ICON and the CRO industry.&#160; Mr. Murray served as Chairman of the Association of Clinical Research Organizations (ACRO) which represents the CRO industry globally. In addition, Mr. Murray was named as a leader in CRO Innovation by PharmaVOICE100, a listing of the most influential people in the bio pharma industry.&#160;University College Dublin awarded Mr. Murray an honorary degree of Doctor of Laws in 2013 for his support of third level research and innovation in Ireland. In 2018, the Royal Dublin Society awarded Mr. Murray the RDS Gold Medal for Enterprise for making an exceptional impact on Irish industry and commerce. Mr. Murray is also a member of the advisory Board of UCD Smurfit Business School. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Steve Cutler </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017, having previously served as Chief Operating Officer from January 2014. Dr. Cutler served as Group President of Clinical Research Services since November 2011 until his appointment as Chief Operating Officer.&#160;Dr. Cutler was appointed to the Board of ICON plc in November 2015. Prior to joining the Company, Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer.&#160;Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe, as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. Dr. Cutler holds a B.Sc. and a Ph.D. from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Brendan Brennan</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Brendan Brennan has served as Chief Financial Officer since February 2012. Mr. Brennan has developed his career over the last  22 years from experience in various industries. Mr. Brennan joined ICON in 2006 and he has served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. Prior to this he developed his broad financial experience in Cement Roadstone Holdings, a major Irish building materials organization. Mr. Brennan also spent a number of years in public accounting with PwC. Mr. Brennan is a Fellow of the Institute of Chartered Accountants in Ireland and holds a bachelor&#8217;s degree in Accounting and Finance from Dublin City University. Over his years in the CRO industry, Mr. Brennan has been involved in many industry organizations and developments including ACRO (Association of Clinical Research Organizations) where he was the founding Chairman of the industry CFO round table group, a group formed to aid CROs dealing with the various industry challenges. Mr. Brennan held the position of Chairman&#160;of the round table from its foundation in 2017 to December 31, 2019.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">R&#243;n&#225;n Murphy</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy has served as an outside Director of the Company since October 2016.&#160;He was appointed as Lead Independent Director in January 2019. Mr. Murphy is the former Senior Partner of PwC Ireland. He was elected Senior Partner in 2007 and was re-elected for a further four year term in 2011. Following completion of the maximum two terms, Mr. Murphy retired from the firm in 2015. Mr. Murphy was also a member of the PwC EMEA Leadership Board for a five year period from 2010 to 2015. Mr. Murphy joined PwC in 1980 and was admitted to the Partnership in 1992. Mr. Murphy is presently Chairman of Greencoat Renewables PLC and a non-executive Director of Davy Stockbrokers. Mr. Murphy currently serves as a council member of the ESRI and as Chair of Business in the Community Ireland. He is also a founding Board Member of the British Irish Chamber of Commerce. Mr. Murphy completed a Bachelor of Commerce and Masters in Business Studies at University College Dublin before qualifying as a chartered accountant in 1982.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Professor Hugh Brady</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Professor Hugh Brady has served as an outside Director of the Company since April 2014. Professor Brady is a physician-scientist. He is currently President and Vice-Chancellor of the University of Bristol in the UK - a member of the UK's Russell Group of elite research-intensive universities. He is President Designate of Imperial College London, where he will serve from August 1, 2022, and President Emeritus of University College Dublin (UCD), where he served as President from 2004-2013. A nephrologist by training, Professor Brady served as Professor of Medicine and Therapeutics and Head of Department at UCD. Prior to that, he built a successful career as a physician and biomedical research scientist in the US - spending almost a decade at Harvard University where he was Associate Professor of Medicine, Director of the Renal Division of the Brockton/West Roxbury VA Medical Center and Consultant Physician at the Brigham and Women&#8217;s Hospital, Boston. He has an international reputation in the pathogenesis of diabetic kidney disease and renal inflammation. Professor Brady has held many national and international leadership roles, including Chairman of the Irish Health Research Board and Chairman of the Universitas 21 Network of global research universities. He is also a non-executive Director of Kerry Group plc.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. John Climax</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. John Climax, one of the Company&#8217;s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009 and as Chief Executive Officer from June 1990 to October 2002.&#160;Since January 2010 he has held a position as an outside Director of the Company.&#160;Dr. Climax has over 30 years of experience in the clinical research industry. Dr. Climax received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his Ph.D. in pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations, and holds adjunct professorship at the Royal College of Surgeons of Ireland and an honorary professorship at the National University of Singapore. He is currently Executive Chairman of DS Biopharma and CEO of Afimmune, both of which are private companies.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Joan Garahy&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Joan Garahy was appointed as an outside Director of ICON plc in November 2017. Ms. Garahy is a Non-Executive Director of Irish Residential Properties REIT plc, IPB Insurance CLG and two private wealth management companies. Ms. Garahy&#8217;s previous executive roles include founder and CEO of ClearView Investment &amp; Pensions Limited, a financial advisory company, Managing Director of HBCL Investment &amp; Pensions Ltd, Director of Investments at HC Financial Services Group, Head  of Research at the Irish National Pension Reserve Fund,  Head of Research at Hibernian Investment Managers and her equity analyst roles with Goodbody Stockbrokers and NCB Group. Ms. Garahy was also previously Senior Independent non-executive Director of Kerry Group plc and a non executive director at Galway University Foundation and she is currently a member of the board of The Irish Chamber Orchestra. Ms. Garahy is a Qualified Financial Advisor, she holds a Bachelor of Science degree from University College Galway, a Master of Science from University College Dublin and a Diploma in Accounting &amp; Finance from ACCA.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Professor William Hall</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Professor William Hall has served as an outside Director of ICON plc since February 2013. He is a renowned expert in infectious diseases and virology. He currently serves as Distinguished Professor at Hokkaido University in Japan and is Professor Emeritus of Medical Microbiology and the Centre for Research in Infectious Diseases at University College Dublin&#8217;s (UCD) School of Medicine and Medical Science. Professor Hall also has served as Consultant to the Minister of Health and Children in the Republic of Ireland, providing input on a range of topics including influenza pandemic preparedness, SARS, and bioterrorism. Prior to his tenure at UCD, Professor Hall was Professor and Head of the Laboratory of Medical Virology, Senior Physician and Director of the Clinical Research Centre at the Rockefeller University in New York. He previously served as an Assistant and Associate Professor of Medicine at Cornell University and is also a co-founder of the Global Virus Network.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Eugene McCague</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Eugene McCague was appointed as an outside Director of the Company in October 2017. Mr. McCague was a corporate partner of Arthur Cox, one of Ireland&#8217;s premier law firms, from 1988 until June 2017. During his time with Arthur Cox, Mr. McCague served as both managing partner and chairman of Arthur Cox and also advised a wide range of public and private companies on mainstream corporate work, mergers and acquisitions, corporate restructurings and corporate governance. In addition to his distinguished legal career, Mr. McCague also has extensive board experience with commercial, government and educational organizations. Mr. McCague currently serves on the board of the Irish branch of AON Insurance and he also serves as chairman of Ibec, Ireland&#8217;s leading business representative association. Mr. McCague&#8217;s previous board roles include the Health Service Executive, the Irish state body which administers public health service in Ireland, chairman of the governing body of the Dublin Institute of Technology, chairman of the Dublin Institute of Technology Foundation and chairman of the governing authority of University College Dublin and director of Fly Leasing Limited. Mr. McCague was also president of the Dublin Chamber of Commerce in 2006. Mr. McCague holds a Bachelor of Civil Law degree and a diploma in European Law from University College Dublin.&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Julie O&#8217;Neill</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Julie O&#8217;Neill has served as an outside Director of ICON plc since July 2019. Ms. O&#8217;Neill was formerly Executive Vice President, Global Operations of Alexion Pharmaceuticals, Inc., where she was responsible for global manufacturing operations and expanding and improving supply chain and quality operations in the US, Europe, and Asia. Before joining Alexion, Ms. O&#8217;Neill was Vice President of Operations and General Manager for Ireland at Gilead Sciences and earlier in her career, Ms. O'Neill held leadership positions in operations, manufacturing and quality functions at Burnil Pharmacies and Helsinn Birex Pharmaceuticals. Ms. O&#8217;Neill serves as a Board Member of DBV Technologies, Hookipa Pharma Inc.,ILC Dover, Achilles Therapeutics plc and Angus Chemical Company. She is also on the board of Ireland&#8217;s National Institute for Bioprocessing Research and Training. Ms. O&#8217;Neill holds a Bachelor of Science in Pharmacy from Trinity College Dublin, a Masters of Business Administration from University College Dublin and is a Chartered Director of The Institute of Directors in Ireland. Ms. O'Neill is also a member of the Strategy Committee of the State Claims Agency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mary Pendergast </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Mary Pendergast has served as a non-executive director of ICON plc since February 2014. Ms. Pendergast is an expert in the regulatory aspects of drug development and is President of Pendergast Consulting, a consulting firm that advises biopharmaceutical companies, patient groups, professional and advocacy organizations, governments and academic and financial institutions. Prior to founding her own firm, Ms. Pendergast was Executive Vice President of Government Affairs at Elan Corporation plc from 1998 to 2003. Ms. Pendergast also spent more than 18 years at the US Food and Drug Administration (FDA), serving as Deputy Commissioner and Senior Advisor to the FDA Commissioner and Associate Chief Counsel for Enforcement.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Colin Shannon</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Colin Shannon previously served as PRA's President and Chief Executive Officer and was a director of the Company since 2010. He was also the Chairman of the Board of Directors at PRA Health Sciences. Mr. Shannon joined PRA in 2007, serving first as President and Chief Operating Officer. Prior to joining PRA Health Sciences, he was Executive Vice President, Global Clinical Operations at Pharmaceutical Product Development, Inc. (now known as Pharmaceutical Product Development LLC) or PPD. During his 12 year tenure with PPD, he held various leadership roles, including Chief Operating Officer for its European division and Chief Financial and Administration Officer for Europe and the Pacific Rim. Prior to joining PPD, Mr. Shannon had more than 15 years of experience in a variety of financial and accounting positions in the utility and multimedia industries. Mr. Shannon earned his M.B.A. from London's City University and is a fellow member of the Chartered Association of Certified Accountants.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Linda Grais </span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais was previously a member of the PRA Health Sciences board since October 2015. Dr. Grais served as a member of the board of directors of Ocera Therapeutics, Inc. from January 2008 through December 2017 and as President and Chief Executive Officer of Ocera Therapeutics, Inc. from June 2012 to December 2017. Prior to her employment by Ocera, Dr. Grais served as a managing member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company focusing on new treatments for cancer. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich &amp; Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. She currently serves on the boards of directors of Zosana Pharma Company and Arca Biopharma, Inc. and sits on the compensation and audit committees of Arca Biopharma, Inc. Dr. Grais received a B.A. from Yale University, an M.D. from Yale Medical School and a J.D. from Stanford Law School.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diarmaid Cunningham&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Diarmaid Cunningham is Chief Administrative Officer, General Counsel and Company Secretary. Mr. Cunningham joined the Company as General Counsel in November 2009.  From 2009 until 2013, Mr. Cunningham was based in the Company&#8217;s global headquarters in Dublin.  In 2013, Mr. Cunningham was seconded to the Company&#8217;s US headquarters in Pennsylvania and that secondment ended in 2018 when Mr. Cunningham returned to Dublin. In July 2016, Mr. Cunningham&#8217;s role expanded to include Chief Administrative Officer in addition to General Counsel. This expansion of his role means Mr. Cunningham has responsibility to the Company&#8217;s Quality Assurance, Client Contracts Services, Facilities and Procurement groups in addition to his responsibility for the Company&#8217;s Legal group. Mr. Cunningham graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997, qualified as a lawyer in 2001 and completed the Stanford Executive Program at Stanford University in California in 2015.  Mr. Cunningham served as Secretary to the Board of the Association of Clinical Research Organizations (ACRO) in 2013, 2014, 2020 and 2021. ACRO represents the CRO industry globally to key stakeholders including pharmaceutical, biotech and medical device companies, regulators, legislators and patient groups. Prior to joining the Company, Mr. Cunningham spent 10 years with A&amp;L Goodbody, one of Ireland's premier corporate law firms. In January 2021, Mr. Cunningham was appointed as a non-executive director of the Irish charity The Jack &amp; Jill Foundation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Compensation Discussion &amp; Analysis </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Remuneration policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Compensation and Organization Committee seeks to achieve the following goals with the Company&#8217;s executive compensation programs: to attract, motivate and retain key executives and to reward executives for value creation. The Committee seeks to foster a performance-oriented environment by ensuring that a significant portion of each executive&#8217;s cash and equity compensation is based on the achievement of performance targets that are important to the Company, its shareholders and other stakeholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s executive compensation program has three main elements: base salary, a bonus plan and equity incentives in the form of share related awards granted under the Company&#8217;s equity incentive plans. All elements of key executives&#8217; compensation are determined by the Compensation and Organization Committee based on the achievement of the Group&#8217;s and individual performance objectives. Base salary, bonus awards and Directors&#8217; fees were determined by the Compensation and Organization Committee in U.S. dollars or euro.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outside Directors&#8217; remuneration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outside Directors are remunerated by way of Directors&#8217; fees and are also eligible for participation in the share equity incentive schemes. Up to July 1, 2021 each outside Director (excluding the Board Chairman) was paid an annual retainer of $65,000 and additional fees for Board Committee service. With effect from July 1, 2021, the annual retainer was increased to $90,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Murray&#8217;s Executive Chairman term expired on May 12, 2018 and he transitioned to the outside Director role of  Chair. Up to July 1, 2021, the arrangements with the Chair of the Board provided for payment of &#8364;300,000 (translated at average rate for the year: $356,244) annually. With effect from July 1, 2021, the Chair fee was increased to &#8364;330,000 (translated at average rate for the year: $392,244) annually.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy was appointed as Lead Independent Director with effect from January 1, 2019 and receives an additional annual fee of $25,000 for this role.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outside Directors are not eligible for performance related bonuses and no pension contributions are made on their behalf. The Compensation and Organization Committee sets outside Directors' remuneration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Executive Directors&#8217; and Key Executive Officers&#8217; remuneration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash compensation is divided into a base salary portion and a bonus incentive portion. The Committee targets total cash compensation with regard to healthcare/biopharmaceutical companies of similar market capitalization and peer CRO companies, adjusted upward or downward based on individual performance and experience and level of responsibility. The Compensation and Organization Committee believes that the higher the executive&#8217;s level of responsibility within the Company, the greater the percentage of the executive&#8217;s compensation that should be tied to the Company&#8217;s performance. Target bonus incentive for executive officers range between 60% and 200% with actual pay outs for 2021 ranging from 60% to 200%, of salary, based on Group and individual performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A total bonus of $3.2 million was awarded to the following individuals; Dr. Steve Cutler Chief Executive Officer ($2.3 million) and Mr. Brendan Brennan Chief Financial Officer ($0.9 million) to reflect their contribution to the performance of the Company during 2021.&#160;These amounts were approved by the Compensation and Organization Committee and will be paid during the year ended December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s executives are eligible to receive equity incentives, including stock options, Restricted Share Units and Performance Share Units, granted under the Company&#8217;s equity incentive plans. If executives receive equity incentive grants, they are normally approved annually at the first scheduled meeting of the Committee in the fiscal year. The grant date and value is determined by the Committee and the number of units granted is determined based on the closing price of the Company's shares on the day of grant. Newly hired executives may receive sign-on grants. In addition, the Committee may, at its discretion, issue additional equity incentive awards to executives if the Committee determines such awards are necessary to ensure appropriate incentives are in place. The equity awards granted to each participant are determined primarily by the Committee at the start of each year based on peer groups and advice from independent compensation consultants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All executive officers are eligible to participate in applicable pension plans. The Company&#8217;s contributions are generally a fixed percentage of their annual compensation, supplementing contributions by the executive. The Company has the discretion to make additional contributions if deemed appropriate by the Committee. The Company&#8217;s contributions are determined at the peer group median of comparable Irish companies and peer CRO companies. Contributions to this plan are recorded as an expense in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Third party Agreements and Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has not identified any arrangements or agreements relating to compensation or other payments provided by a third party to ICON&#8217;s directors or director nominees in connection with their candidacy or board service as required to be disclosed pursuant to NASDAQ Rule&#160;5250(b)(3).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Executive Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December 31, 2021</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:18.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name &amp; principal<br/>position</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">contribution</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s Fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">compensation</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler<br/>Chief Executive Officer </span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan,<br/>Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,973&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,753</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,214</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">197</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,230</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,300</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,574</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December 31, 2020</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name &amp; principal<br/>position</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary *</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">contribution</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s Fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">compensation</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler<br/>Chief Executive Officer </span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,664&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan,<br/>Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,280&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,734</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,046</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">241</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,081</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,819</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,944</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">*Note: CEO salary is part of a bi-weekly payroll process. The 2020 payroll included an additional pay period compared to 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Director Compensation</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December 31, 2021</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:19.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.199%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company<br/>pension&#160; contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">compensation</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy </span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hugh Brady</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">John Climax</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William Hall</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary Pendergast</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colin Shannon </span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Linda Grais </span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,146</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">121</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,331</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,598</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,011</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,326</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,935</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December 31, 2020</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:19.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.199%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary *</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company<br/>pension&#160; contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">compensation</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,167&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,664&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hugh Brady</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">John Climax</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William Hall</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary Pendergast</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,172</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">824</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,167</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,666</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,062</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,895</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">*Note: CEO salary is part of a bi-weekly payroll process. The 2020 payroll included an additional pay period compared to 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of Compensation Agreements</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Employment Contracts, Termination of Employment and Change in Control Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does not have any termination or change of control agreements with its named executive officers other than as set out below and in the agreements relating to their equity incentives which provide for accelerated vesting on change of control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; and Executive Officers&#8217; service agreements and letters of engagement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Ciaran Murray</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Ciaran Murray has served as Chair of the Board of Directors since May 2018 having served as Executive Chairman of the Board of Directors from March 2017 until May 2018. Mr. Murray served as Chief Executive Officer of the Company from October 2011 until March 2017. Mr. Murray has served as a Director of the Company since September 2011. He previously served as Chief Financial Officer of the Company from October 2005 until October 2011. Mr. Murray entered into an agreement with the Company in respect of his role as Executive Chairman which was effective from March 2017. Mr. Murray&#8217;s Executive Chairman term expired on May 1</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2, 20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18 and he transitioned to Chair.  Up to July 1, 2021, the arrangements with the Chair of the Board provided for the payment to him of fees of $356,244 (&#8364;300,000) per annum in respect of his position as Chair. With effect from July 1, 2021, the Chair fee was increased to &#8364;330,000 (translated at average rate for the year: $392,244) annually. His prev</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ious service agreement as Executive Chairman included termination pr</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ovisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions which still apply. As Chief Financial Officer, Chief Executive and Executive Chairman, Mr. Murray was granted and held ordinary share options, Restricted Share Units and Performance Share Units.  The vesting of the ordinary share options and Restricted Share Units which were unvested on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018 were accelerated and the outstanding ordinary share options and Restricted Share Units vested on that date. The unvested Performance Share Units with vesting dates between May 12, 2018 and March 2019 were forfeited on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018. He was previously granted and held at March&#160;1, 2022 58,646 ordinary share options at exercise prices ranging from $71.95 to $125.74 per share and 865 Restricted Share Units, which vest in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Steve Cutler</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Dr. Steve Cutler has served as Chief Executive Officer since March 2017 having served as Chief Operating Officer of the Company from January 2014 until March 2017. Prior to his appointment as Chief Operating Officer he served as Group President Clinical Research Services since November 2011. He has served as an Executive Director of the Company since November 2015. The Chief Executive Officer service agreement with Dr. Cutler is terminable on 12 months&#8217; notice by either party. Under the terms of this agreement Dr. Cutler is entitled to receive an annual salary of $1,146,127 and a bonus to be agreed by the Compensation and Organization Committee.  He is also entitled to receive a pension contribution, a car allowance of $12,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at March&#160;1, 2022 173,016 ordinary share options at exercise prices ranging from $71.95 to $174.96 per share, 18,857 Restricted Share Units which vest on various dates between March 2022 and March 2024 and 34,082 (up to a maximum of 68,164) Performance Share Units which vest between March 2022 and March 2024 subject to the fulfillment of certain performance conditions. His Chief Executive Officer service agreement requires him to devote his full time and attention to his duties for the Company excepting certain outside director positions authorized by the Company. The agreement with Dr. Cutler includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions. Dr. Cutler has a separate agreement with the Company in respect to his role as a director of ICON plc. Under the terms of this agreement he is entitled to receive an annual fee of $44,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Brendan Brennan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Brendan Brennan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">has served as Chief Financial Officer since February 2012 having previously served as acting Chief Financial Officer since October 2011.&#160;Prior to this appointment, he served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. The service agreement with Mr. Brennan is terminable on 12 months&#8217; notice by either party. Under the terms of this agreement Mr. Brennan is entitled to receive an annual </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">sala</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ry of $607,035 (&#8364;510,922)  and a bonus to be agreed by the Compensation and Organization Committee.  He is also entitled to receive a pension contribution, a car allowance of &#8364;20,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at March&#160;1, 2022 64,215 ordinary share options at exercise prices ranging from $71.95 to $174.96 per share, 4,261 Restricted Share Units, which vest on various dates between March 2022 and March 2024, and 7,600 (up to a maximum of 15,200) Performance Share Units which vest between March 2022 and March 2024 subject to the fulfillment of certain performance conditions. His service agreement requires him to devote his full time and attention to his duties for the Company excepting certain outside Director positions authorized by the Board. The agreement with Mr. Brennan includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy has served as Lead Independent Director from January 2019 having served as an outside Director of the Company since October 2016. The current arrangements with Mr. Murphy provide for the payment to him of Directors fees of $160,000 per annum. He was previously granted and held at March&#160;1, 2022 9,622 ordinary share options at an exercise prices ranging from $90.03 to $125.74 and 865 Restricted Share Units, which vest in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Professor Hugh Brady</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Professor Hugh Brady has served as an outside Director of the Company since April 2014. The current arrangements with Professor Brady provide for the payment to him of Directors fees of $102,500 per annum. He was previously granted and held at March&#160;1, 2022 5,192 ordinary share options at exercise prices ranging from $65.60 to $90.03 and 865 Restricted Share Units, which vest in May 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. John Climax</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. John Climax, one of the Company&#8217;s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009. He also served as Chief Executive Officer of the Company from June 1990 to October 2002 and is currently an outside Director of the Company. The current arrangements with Dr. Climax provide for the payment to him of Directors fees of $90,000 per annum. He was previously granted and held at March&#160;1, 2022 43,255 ordinary share options at exercise prices ranging from $40.83 to $125.74 per share and 865 Restricted Share Units, which vest in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ms. Joan Garahy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Joan Garahy has served as an outside Director of the Company since November 2017. The current arrangements with Ms. Garahy provide for the payment to her of Directors fees of $122,500 per annum. She was previously granted and held at March&#160;1, 2022 5,005 ordinary share options at an exercise price of $125.74 and 865 Restricted Share Units, which vest in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Professor William Hall</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Professor William Hall has served as an outside Director of the Company since February 2013. The current arrangements with Professor Hall provide for the payment to him of Directors fees of $115,000 per annum. He was previously granted and held at March&#160;1, 2022 1,541 ordinary share options at exercise price of $90.03 and 865 Restricted Share Units, which vest in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Eugene McCague</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Eugene McCague</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">has served as an outside Director of the Company since October 2017. The current arrangements with Mr. McCague provide for the payment to him of Directors fees of $135,000 per annum. He was previously granted and held at March&#160;1, 2022 5,005 ordinary share options at an exercise price of $125.74 and 865 Restricted Share Units, which vest in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ms. Julie O'Neill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Julie O'Neill was appointed an outside Director of the Company in July 2019. The current arrangements with Ms. O'Neill provide for the payment to her of Directors fees of $102,500 per annum. She was previously granted and held at March&#160;1, 2022 865 Restricted Share Units, which vest in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ms. Mary Pendergast</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Mary Pendergast has served as an outside Director of the Company since February 2014. The current arrangements with Ms. Pendergast provide for the payment to her of Directors fees of $102,500 per annum. She was previously granted and held at March&#160;1, 2022 43,255 ordinary share options at exercise prices ranging from $40.83 to $125.74 and 865 Restricted Share Units, which vest in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Colin Shannon </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Colin Shannon has served as an outside Director of the Company since July 2021 having served as PRA Health Sciences, Inc. President and Chief Executive Officer and was a director of from 2010 to July 2021. He was also the Chairman of the Board of Directors at PRA Health Sciences. The current arrangements with Mr. Shannon provide for the payment to him of Directors fees of $90,000 per annum. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Linda Grais</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais has served as an outside Director of the Company since July 2021 having served as a member of the PRA Health Sciences, Inc. board since October 2015. The current arrangements with Dr. Grais provide for the payment to her of Director fees of $90,000 per annum. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Board Practices</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board of Directors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The business of the Company is managed by the Directors who may exercise all the powers of the Company which are not required by the Companies Act 2014 of Ireland or by the Constitution of the Company to be exercised by the Company in general meeting.  A meeting of Directors, at which a quorum is present, may exercise all powers exercisable by the Directors. The Directors may delegate (with power to sub-delegate) to any Director holding any executive office and to any Committee consisting of one or more Directors, together with such other persons as may be appointed to such Committee by the Directors, provided that a majority of the members of each Committee appointed by the Directors shall at all times consist of Directors and that no resolution of any such Committee shall be effective unless two of the members of the Committee present at the meeting at which it was passed are Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board comprises one executive and eleven outside Directors at the date of this report.&#160;The outside Directors bring independent judgment to bear on issues of strategy, performance, resources, key appointments and standards.&#160;The Company considers all of its outside Directors to be of complementary skills, experience and knowledge and each outside Director has specific skills, experience and knowledge that are valuable to the Company. The Board members between them have strong financial, pharmaceutical, CRO, scientific, medical and other skills and knowledge which are harnessed to address the challenges facing the Group. The Board meets regularly throughout the year and all Directors have full and timely access to the information necessary for them to discharge their duties.  The Directors have access to the advice and services of the Company Secretary and may seek external independent professional advice where required. The Board considers its current size (12 Directors) to be adequate but continues to look for suitable qualified potential candidates to join the Board.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As set out below, certain other matters are delegated to Board Committees and all Board Committees report to the Board. The Company maintains what it considers an appropriate level of insurance cover in respect of legal action against its Directors. The Board, through the Nominating and Governance Committee, engages in succession planning for the Board and in so doing considers the strength and depth of the Board and the levels of knowledge, skills and experience of the Directors necessary for the Company to achieve its objectives. The Board meets at least four times each year. During the year ended December&#160;31, 2021 the Board held nine board meetings.  During 2021, in response to the global pandemic, those meetings were held both virtually and in-person depending on government guidelines at the time of the meetings. All Directors allocated sufficient time to the Company during the year ended December&#160;31, 2021 to effectively discharge their responsibilities to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; retirement and re-election</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company&#8217;s Constitution provides that, unless otherwise determined by the Company at a general meeting, the number of Directors shall not be more than 15 nor less than 3. At each annual general meeting, one third of the Directors who are subject to retirement by rotation, rounded down to the next whole number if it is a fractional number, shall retire from office</span><span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Directors to retire shall be those who have been longest in office, but as between persons who became or were last re-appointed on the same day, those to retire shall be determined, unless otherwise agreed, by lot. Any additional Director appointed by the Company shall hold office until the next annual general meeting and will be subject to re-election at that meeting. Accordingly, at the annual general meeting of the Company to be held in 2022, it is anticipated that 4 Directors will retire in accordance with the Constitution and offer themselves for re-election. The Board of Directors adopted a Non-Executive Director Policy for Service on April 24, 2018, the Policy was amended on April 21, 2020 which provides that, subject to individual waiver by the Board, an outside Director of ICON plc shall serve on the Board of the Directors for an initial term which expires at the fourth annual general meeting after their appointment. Each outside director may serve a further term of 3 years, subject to the Board&#8217;s approval. After the second 3 year term the Board may request that the outside Director serve up to 3 further terms of 1 year each. After a third 1 year term the Board may request that the outside director serve for further 1 year terms in the event that the Board has particular requirement or desire for the outside director&#8217;s skill, knowledge or experience. For an outside Director who previously served as an executive of the Company, the initial 3 year term referred to in this policy is deemed to commence on the date that he/she is determined to be independent as per the NASDAQ Rules. This policy does not apply to Dr. John Climax as he is a founder of the Company.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Lead Independent Director </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors adopted a Lead Independent Director Charter on February 14, 2017 which provides that in circumstances where the Chairman of the Board is not independent, the independent members of the Board of Directors shall appoint, from among their number, a Lead Independent Director. The Lead Independent Director shall generally assist in optimizing the effectiveness and independence of the Board of Directors by performing such duties as described in the charter, on behalf of the Board of Directors, including coordinating the meetings of the other non-employee and independent directors, and such other duties as determined from time to time by the Board of Directors and/or its independent members. Mr. R&#243;n&#225;n Murphy was appointed as Lead Independent Director with effect from January 1, 2019. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board Committees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Board has delegated some of its responsibilities to Board Committees. There are currently five Committees. These are the Audit Committee, the Compensation and Organization Committee, the Nominating and Governance Committee, Integration Committee and the Execution Committee. Each Committee has been charged with specific responsibilities and each has written terms of reference that are reviewed periodically. Minutes of Committee meetings are available to all members of the Board. The Company Secretary is available to act as secretary to each of the Board Committees if required. Appropriate key executives are regularly invited to attend meetings of the Board Committe</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">es. The Audit Committee, Compensation and Organization Committee and Nominating and Governance Committee each completed a self-evaluation of the performance of the Committee during the year ended December&#160;31, 2021 or in respect to th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">e year ended December 31, 2021 and each </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Committee was satisfied with their performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee meets a minimum of four times a year. It reviews the quarterly and annual financial statements, the effectiveness of the system of internal control and recommends the appointment and removal of the external auditors. It monitors the adequacy of internal accounting practices and addresses all issues raised and recommendations made by the external auditors.  The Audit Committee pre-approves all audit and non-audit services provided to the Company by its external auditors on a quarterly basis. The Audit Committee, on a case by case basis, may approve additional services not covered by the quarterly pre-approval, as the need for such services arises. The Audit Committee reviews all services which are provided by the external auditor to review the independence and objectivity of the external auditor, taking into consideration relevant professional and regulatory requirements. The Chief Financial Officer, the Head of Internal Audit, the General Counsel and the external auditors normally attend all meetings of the Audit Committee and have direct access to the Committee Chairperson at all times. The Audit Committee is currently comprised of three independent Directors: R&#243;n&#225;n Murphy (Chairperson), Professor Hugh Brady and Eugene McCague. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Organization Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Compensation and Organization Committee is responsible for senior executive remuneration. The Committee aims to ensure that remuneration packages are competitive so that individuals are appropriately rewarded relative to their responsibility, experience and value to the Company.  Annual bonuses for the executive Directors and senior executive management are determined by the Committee based on the achievement of the Company&#8217;s objectives. The Committee also oversees succession planning for the Company&#8217;s senior management. The Compensation and Organization Committee is currently comprised of the following independent Directors:  Joan Garahy (Chairperson), Professor William Hall, Mary Pendergast and R&#243;n&#225;n Murphy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Nominating and Governance Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Nominating and Governance Committee is responsible for Board succession, oversight of the Board and committee composition and performance and oversight of the Company's corporate governance and business ethics initiatives and strategies and activities in respect to environmental, social and governance (ESG) matters.  The Committee reviews the membership of the Board of the Company and Board Committees on an ongoing basis. As part of this, it regularly evaluates the balance of skills, knowledge and experience on the Board and then, based on this evaluation, identifies and, if appropriate, recommends individuals to join the Board of the Company. The Committee uses external search consultants as needed to assist it in identifying potential new outside Directors. Once potential suitable candidates are identified either by the external search consultants or by members of the Nominating and Governance Committee, the Committee then discusses and considers the skills, knowledge and experience of the potential candidate. The Committee will assess if the Board of the Company requires and would benefit from the potential candidate&#8217;s skills, knowledge and experience and, if it decides the potential candidate is suitable, the Committee would recommend to the Board of the Company that the potential candidate be appointed. The Board of the Company then decides whether or not to appoint the candidate. The Committee considers diversity of the Board members when making recommendations to the Board of the Company. The Committee Charter was updated in February 2022 to include specific responsibilities in respect to the oversight of the Company's strategic plans, objectives and risks relating to ESG matters.  The Nominating and Governance Committee currently comprises the following independent Directors: Eugene McCague (Chairperson), Professor William Hall and Joan Garahy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Integration Committee </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Integration Committee was set up in April 2021 to assist the Board with its oversight responsibilities in relation to the integration of PRA Health Sciences into the ICON Group. The Integration Committee will meet a minimum of four times a year. It is responsible for the reviewing and assessing the integration plan and providing oversight of the integration team including reviewing the progress of the integration and recommending to the Board for approval any changes to the plans, documents, policies and procedures of the integration team. The Committee is also responsible for meeting the external advisors for the integration. The Integration Committee currently comprises the following independent Directors: Ciaran Murray (Chairperson), R&#243;n&#225;n Murphy, Eugene McCague and Julie O'Neill. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Execution Committee</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The primary function of the Execution Committee is to exercise the powers and authority of the Board in intervals between meetings of the Board within the limits set out in the Charter of the Execution Committee. The Execution Committee exercises business judgment to act in what the Committee members reasonably believe to be in the best interest of the Company and its shareholders. All powers exercised by the Execution Committee are ratified at board meetings. This Committee convenes as often as it determines to be necessary or appropriate. The Execution Committee is currently comprised of the following Directors and Officers: Steve Cutler (Chairperson), R&#243;n&#225;n Murphy and Brendan Brennan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Attendance at Board and Committee meetings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Attendance at Board and Committee meetings by the Directors who held office during 2021 are set out as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Directors&#8217; Attendance Table</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation<br/>and<br/>Organization</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating<br/>and<br/>Governance</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Integration (3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director</span></td><td colspan="15" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of meetings attended / number of meetings eligible to attend as a Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/9</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/9</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/9</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/6</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prof. Hugh Brady (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/9</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/9</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/9</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/6</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prof. William Hall (1) </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/9</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/6</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/9</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/9</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary Pendergast (1) </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9/9</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/6</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colin Shannon</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais (1)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%;padding-left:7.02pt">Independent Director as defined under NASDAQ Rule 5605(a)(2). Ciaran Murray is an independent director in accordance with NASDAQ Rule 5605(a)(2) since May 2021.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%;padding-left:7.02pt">All decisions by the Execution Committee were made by written resolution and therefore no meetings were held.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%;padding-left:7.02pt">The Integration Committee was set up in April 2021 and held 3 meetings from that period to year end, it will hold a minimum of 4 meetings in a full year.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%;padding-left:9.01pt">Employees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 we employed approximately 38,330, 15,730 and 14,650 people respectively. Our employees are not unionized and we believe we have a satisfactory relationship with our employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Share Ownership</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Shares</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as of March&#160;1, 2022 regarding beneficial ownership of our ordinary shares by all of our current Directors and executive officers. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of<br/>Shares (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of total<br/>Shares</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Ciaran Murray</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,274&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professor Hugh Brady</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">508,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professor William Hall&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Julie O'Neill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Mary Pendergast&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Colin Shannon </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As used in these tables, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e. the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as of March&#160;1, 2022 regarding beneficial ownership of Restricted Share Units (&#8220;RSUs&#8221;) and Performance Share Units (&#8220;PSUs&#8221;) which have been issued to our current Directors and executive officers.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of<br/>RSUs </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vesting Date</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vesting Date</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Ciaran Murray</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,526</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">781</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professor Hugh Brady</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professor William Hall</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Julie O'Neill</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Mary Pendergast</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:7.02pt">Of the issued PSUs, performance conditions will determine how many vest. If performance targets are exceeded, additional PSUs will be issued and will vest in accordance with the terms of the relevant PSU award. The PSUs vest based on service and specified EPS targets over the periods 2019 &#8211; 2021, 2020 &#8211; 2022 and 2021 &#8211; 2023. Depending on the actual amount of EPS from 2019 to 2023, up to a maximum of 41,682 additional PSUs may also be granted to Dr. Steve Cutler and Mr. Brendan Brennan.</span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as of March&#160;1, 2022 regarding options to acquire ordinary shares of the Company by all of our current Directors and executive officers.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise price</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiration Date</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Ciaran Murray</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$71.95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$71.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$83.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$115.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$140.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2028</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$174.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2029</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$71.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$83.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$115.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$140.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2028</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$174.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2029</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professor Hugh Brady</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$65.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 20, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$40.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 23, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$68.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 18, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$65.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 20, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professor William Hall</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="background-color:#ffffff;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Mary Pendergast</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$40.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 23, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$68.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 18, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$65.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 20, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The title of securities covered by all of the above options are </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">non-qualified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2018, the Board approved the appointment of Mr. Murray as Chair of the Board of Directors with effect from May 12, 2018. Mr. Murray ceased to be an employee of the Company as of this date. Mr. Murray was granted and held ordinary share options, Restricted Share Units and Performance Share Units as Chief Financial Officer, Chief Executive Officer and Executive Chairman. The vesting of the ordinary share options and Restricted Share Units which were unvested on Mr. Murray ceasing to be an ICON plc employee (May 12, 2018) were accelerated and the outstanding ordinary share options and Restricted Share Units vested on that date. The unvested Performance Share Units with vesting dates between May 12, 2018 and March 2019 were forfeited on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018.     </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or Non-Executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to Non-Executive Directors during 2020 and 2021 vest over twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the &#8220;2013 RSU Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan.&#160;On May 11, 2015, the 2013 RSU Plan was amended and restated in order to increase the number of ordinary shares that can be issued under the RSU Plan by 2.5 million shares.&#160;Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the &#8220;2008 Employee Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the &#8220;2008 Consultants Plan&#8221;), pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may grant options to any consultant, adviser or Non-Executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the &#8220;2008 Option Plans&#8221;) were amended and restated in order to increase the number of options&#160;that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan under which a limit of 1.0 million shares applies.&#160;Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans will be a nonqualified stock option, or NSO and not an incentive stock option as described in Section 422&#160;of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans will be evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price will be specified in each Stock Option Agreement, however, option prices will not be less than 100% of the fair market value of an ordinary share on the date the option is granted.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 17, 2003 the Company adopted the Share Option Plan 2003 (the &#8220;2003 Share Option Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Board could grant options to officers and other employees of the Company or its subsidiaries for the purchase of ordinary shares.&#160; An aggregate of 6.0 million ordinary shares were reserved under the 2003 Share Option Plan; and, in no event could the number of ordinary shares issued pursuant to options awarded under this plan exceed 10% of the outstanding shares, as defined in the 2003 Share Option Plan, at the time of the grant, unless the Board expressly determined otherwise. Further, the maximum number of ordinary shares with respect to which options could be granted under the 2003 Share Option Plan during any calendar year to any employee was 0.4 million ordinary shares.&#160;The 2003 Share Option Plan expired on January 17, 2013. No new options may be granted under this plan.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share option awards are granted with an exercise price equal to the market price of the Company&#8217;s shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. Share options granted to Non-Executive Directors during 2018 vest over 12 months and expire eight years from the date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Legacy PRA Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the legacy PRA equity incentive plans, which still have equity outstanding but have been</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Pursuant to the Merger Agreement, effective on July 1, 2021, each outstanding stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2020 Stock Incentive Plan (&#8220;the 2020 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2,500,000 shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The PRA Health Sciences, Inc. 2018 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2,000,000 shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The PRA Health Sciences, Inc. 2014 Omnibus Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021 (the &#8220;2014 Plan&#8221;). On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The 2013 Stock Incentive Plan for Key Employees of PRA Health Sciences and its Subsidiaries was amended and restated and assumed by the Registrant effective as of July 1, 2021 (the &#8220;2013 Plan&#8221;). On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_40"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 7. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Major Shareholders and Related Party Transactions.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Major Shareholders</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information regarding beneficial ownership of ICON's ordinary shares as of March&#160;1, 2022&#160;(i) by each person that beneficially owns more than 5% of the outstanding ordinary shares, based upon information known to us and publicly available information; and (ii) by all of our current Directors, officers and other key employees as a group. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law. None of the persons listed below have voting rights that differ from any other person listed below.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:37.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.888%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 (4)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 (5)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or Identity of Group</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WCM Investment Management (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,179,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,976,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,643,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MFS Investment Management (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,785,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,073,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,489,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wellington Management Company, LLP (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,154,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,989,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,800,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Directors, officers and other key employees as a group&#160;(3)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,129,726&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,152,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,278,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As used in this table, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e., the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Neither the Company nor any of its officers, Directors or affiliates holds any voting power in this entity.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes 430,451 ordinary shares issuable upon the exercise of stock options granted by the Company, 33,568 RSUs awarded by the Company to Directors, officers and other key employees and 92,866 PSUs awarded by the Company to Directors, officers and other key employees. Of the PSUs, performance conditions determine how many of them will vest and, if performance targets are exceeded, additional PSUs will be issued and vest in accordance with the terms of the relevant PSU award, the figure included is the maximum amount of PSUs that may be issued.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Amounts shown above are stated as of February 24, 2021.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Amounts shown above are stated as of February 27, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc, is not directly or indirectly, owned or controlled by another corporation or by any government. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Related Party Transactions</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $30,000 (December&#160;31, 2020: $321,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December&#160;31, 2021 (December&#160;31, 2020: $41,000).&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $551,000 (December&#160;31, 2020: $9,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $197,000 was recorded as due from Afimmune Limited at December&#160;31, 2021 (December&#160;31, 2020: $Nil).&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $465,000 during the year ended December&#160;31, 2021. $264,000 was recorded as due from Oncacare at December&#160;31, 2021.&#160;During the year ended December&#160;31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The full amount of this loan remains outstanding at December&#160;31, 2021 along with accrued interest of $23,000.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.    Interests of experts and counsel</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_43"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 8. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Financial Information.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Consolidated Statements and Other Financial Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 18.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have not paid cash dividends on our ordinary shares and do not currently intend to pay cash dividends on our ordinary shares in the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Significant Changes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no significant changes to our business that we believe could reasonably be expected to have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 9. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; The Offer and Listing.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Offer and listing details</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.&#160;ICON plc&#8217;s American Depositary Receipt ("ADR") program was terminated on January 31, 2013 and ICON plc&#8217;s ordinary shares began directly trading on NASDAQ on February 4, 2013.&#160;Prior to that date, ICON plc&#8217;s American Depositary Shares ("ADSs") were traded on NASDAQ and ICON plc&#8217;s Depository for the ADSs was The Bank of New York Mellon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Plan of distribution</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Markets</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NASDAQ.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Selling shareholders</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Dilution </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Expenses of the issue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> Additional Information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Share Capital</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Memorandum and articles of association </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Constitution </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We hereby incorporate by reference our Constitution, as amended, located under the heading &#8220;Constitution of the Company&#8221; in Exhibit 3.1.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of certain provisions of the current Constitution of the Company. This summary does not purport to be complete and is qualified in its entirety by reference to the complete text of the Constitution of the Company, which are included as an exhibit to this annual report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Objects</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is incorporated under the name ICON&#160;plc, and is registered in Ireland under registered number&#160;145835. The Company's objects, which are detailed in the Constitution of the Company, are broad and include, but are not limited to the carrying on the business of an investment holding company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to certain exceptions, Directors may not vote on matters in which they have a material interest. Any Director who holds any executive office, serves on any Committee or otherwise performs services, which, in the opinion of the Directors, are outside the scope of the ordinary duties of a Director, may be paid such extra remuneration as the Directors may determine. The Directors may exercise all the powers of the Company to borrow money. These powers may be amended by special resolution of the shareholders. The Directors are not required to retire at any particular age. One-third of the Directors retire and offer themselves for re-election at each Annual General Meeting ("AGM") of the Company. The Directors to retire by rotation are those who have been longest in office since their last appointment or reappointment. As between persons who became or were appointed Directors on the same date, those to retire are determined by agreement between them or, otherwise, by lot. All of the shareholders entitled to attend and vote at the AGM may vote on the re-election of Directors. There is no requirement for Directors to hold shares set out in the Constitution.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Rights, Preferences and Dividends Attaching to Shares </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has only one class of shares, Ordinary Shares with a par value of &#8364;0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Action Necessary to Change the Rights of Shareholders </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Annual and General Meetings</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15&#160;months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (&#8220;EGM&#8221;) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21&#160;clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days&#8217; notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Limitations on the Right to Own Shares </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no limitations on the right to own shares in the Constitution of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Share Ownership </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Provisions of the Constitution</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no provisions in the Constitution of the Company:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i) delaying or prohibiting a change in the control of the Company, but which operate only with respect to a merger, acquisition or corporate restructuring;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii) discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares; or</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iii) governing changes in capital, in each case, where such provisions are more stringent than those required by law.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Material Contracts</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of each contract (not being a contract entered into in the ordinary course of business) that has been entered into: (a) within the two years immediately preceding the date of this Form 20-F which are, or may be, material to us; or (b) at any time which contain obligations or entitlements which is, or may be, material to us as at the date of this Form 20-F:</span></div><div style="text-align:justify;text-indent:28.8pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Agreement and Plan of Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 24, 2021, we entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with PRA Health Sciences, Inc. (&#8220;PRA&#8221;), ICON US Holdings Inc., a Delaware corporation and subsidiary of ICON (&#8220;US HoldCo&#8221;), and Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON and US HoldCo (&#8220;Merger Subsidiary&#8221;). Upon the terms and subject to the conditions of the Merger Agreement, Merger Subsidiary will merge with and into PRA (the &#8220;Merger&#8221;), with PRA surviving as a subsidiary of ICON and US HoldCo (the &#8220;Surviving Corporation&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the &#8220;Closing Date&#8221;), Pursuant to the terms and subject to the conditions of the Merger Agreement, Merger Sub was merged with and into PRA, with PRA surviving as a subsidiary of ICON and US HoldCo.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of the Merger, each share of PRA common stock issued and outstanding immediately prior to the completion of the Merger (other than shares held by any shareholder who properly demands and perfects his, her or its appraisal rights with respect to such shares and treasury shares held by PRA) was cancelled and converted into the right to receive: (i) from ICON, 0.4125 of one ICON ordinary share and (ii) from US Holdco and the surviving corporation $80.00 in cash, without interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Equity awards of PRA that are outstanding prior to the effective time of the Merger were generally treated as follows (subject to the terms and conditions set forth in the Merger Agreement):</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Each outstanding PRA stock option and restricted stock unit was assumed by ICON on the same terms and conditions (including vesting conditions) and converted to a stock option or restricted stock unit based on ICON ordinary shares with the number of ICON ordinary shares and exercise price in the case of stock options determined at a conversion ratio as set forth under the Merger Agreement; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Each outstanding share of PRA restricted stock was vested at the Closing and was cancelled and converted into the right to receive the per share merger consideration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The foregoing description of the Merger and the Merger Agreement, and the related transactions contemplated thereby, does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Merger Agreement which is attached as Exhibit 2.1 to ICON&#8217;s Current Report on Form 6-K filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 24, 2021 and incorporated herein by reference herein.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="text-align:justify;text-indent:28.8pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA&#8217;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026.</span></div><div style="text-align:justify;text-indent:28.8pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is LIBOR plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i412657424e8a46e09c66a2345306a17a_D20210101-20211231" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxMzQzNQ_4c9d5fa3-39ee-434c-9d07-88f258aabb3c">2.50</ix:nonFraction>%, in each case, with a step down of 0.25% if the first lien net leverage ratio is equal to or less than <ix:nonFraction unitRef="number" contextRef="ib6f10a8ae3df4827be9831c930c77331_I20211231" decimals="2" name="iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxMzU0Mg_bf81259e-f340-4523-90f8-c922d214a250">4.00</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ie2fff4332a1d4c0698311a5bd0290b3c_I20211231" decimals="2" name="iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxMzU0OQ_a2a4c6ad-3e7b-41ac-bb34-1c8bc5ba9fa3">1.00</ix:nonFraction>. The senior secured term loan facility is subject to a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="i7acc5e38562846649f0134d3bdc33705_D20210101-20211231" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxMzYyMw_4615bc1e-39bf-4d0b-af5d-ce80766b5e85">0.50</ix:nonFraction>%. </span></div><div style="text-align:justify;text-indent:28.8pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the credit agreement) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes (see below), subject to other permitted liens.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. In addition, the Revolving Credit Facility contains a financial covenant that requires ICON to maintain a Total Net Leverage Ratio (as defined in the Credit Agreement) of 5.75:1.00 prior to June 30, 2023 and 4.50:1.00 on and after June 30, 2023, subject to a step-down of 0.50:1.00 following a Material Acquisition (as defined in the Credit Agreement), which will be tested at the end of any fiscal quarter only if amounts are drawn under the Revolving Credit Facility (excluding cash collateralized and backstopped letters of credit) in excess of 30% of the Revolving Commitments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities provide that, upon the occurrence of certain events of default, the obligations thereunder may be accelerated. Such events of default will include payment defaults to the lenders thereunder, material inaccuracies of representations and warranties, covenant defaults, cross-defaults to other material indebtedness, voluntary and involuntary bankruptcy proceedings, material money judgments, material pension-plan events, change of control and other customary events of default.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 27, 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTQ2OA_4e97f4d0-4354-48f1-9b92-7b177fa613ce">13.8</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTU1NA_dc177634-8b5c-4a58-949e-5c25d84412ba">40.4</ix:nonFraction>&#160;million. On November&#160;10, 2021, the Company achieved a net leverage ratio of less than <ix:nonFraction unitRef="number" contextRef="ifdac2dc9cabd4d0d9b3df33a7ae8822e_I20211231" decimals="0" name="iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTYyMg_d988fb6d-3c8b-49a6-aaaa-1fc1c71665b9">4</ix:nonFraction> times and the margin applicable to the senior secured term loan was reduced by <ix:nonFraction unitRef="number" contextRef="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231" decimals="4" sign="-" name="iclr:DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTcwNA_aeb50050-ebbd-4166-86b4-e94a7c938557">0.25</ix:nonFraction>% with the overall rate reducing from <ix:nonFraction unitRef="number" contextRef="i19229e729ec74c57a20161ea7ce568f9_D20210701-20211109" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTc0NA_e6fbd43d-e269-4aab-bc75-3d09d7579e1b">3.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTc1MQ_de264374-829d-493c-ad8a-b74bbd62fc73">2.75</ix:nonFraction>%. On December 29, 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTc5Nw_03040b24-64d4-467b-830a-8c6ee609e2c0">500.0</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTg4Mw_6245d4ad-c16e-46cf-b677-4adb487a2239">40.8</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December&#160;31, 2021, <ix:nonFraction unitRef="usd" contextRef="ie8f0b47b5969447b80a94a01cfae1776_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTg5Nw_68b68790-3cbc-49e7-b0fc-187a35910da3">no</ix:nonFraction> amounts have been drawn under the revolving loan facility with the exception of $<ix:nonFraction unitRef="usd" contextRef="i7cb2372376cf46b9a240ab10ece87d9c_I20211231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTk4MQ_20737a0d-7682-4607-beb6-9dcaf228e39c">4.1</ix:nonFraction>&#160;million letters of credit given to landlords to guarantee lease arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, Indigo Merger Sub, Inc. (which was merged with and into PRA Health Sciences, Inc.) (the &#8220;Issuer&#8221;), a wholly-owned subsidiary of the Company, issued $500.0 million in aggregate principal amount of 2.875% senior secured notes due July 2026 (the &#8220;Senior Secured Notes&#8221;) in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. The Issuer will pay interest on the Senior Secured Notes on January 15 and July 15 of each year. Interest on the Senior Secured Notes will accrue at a rate of 2.875% per annum.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The proceeds from the Offering and borrowings made under the Senior Secured Credit Facilities, together with cash on hand, were used to (i) fund the cash consideration payable by ICON for the Merger, (ii) repay existing indebtedness of ICON and PRA and (iii) pay fees and expenses related to the Merger, the Offering and the Senior Secured Credit Facilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Notes are guaranteed on a senior secured basis by ICON and its direct and indirect subsidiaries that guarantee the Senior Secured Credit Facilities. The Senior Secured Notes are secured by a lien on substantially all of ICON&#8217;s, the Issuer&#8217;s and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Notes have a first-priority lien on such assets, which rank pari passu with the liens securing the Senior Secured Credit Facilities, subject to other permitted liens.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At any time prior to July 15, 2023, the Issuer may redeem all or part of the Senior Secured Notes at a redemption price equal to 100% of the principal amount of the Notes plus an applicable make whole premium and accrued and unpaid interest to, but not including the redemption date. At any time prior to July 15, 2023, the Issuer may redeem up to 40% of the aggregate principal amount of the Senior Secured Notes at a redemption price of 102.875% of the principal amount plus accrued and unpaid interest to, but not including, the date of redemption. In addition, at any time and from time to time prior to July 15, 2023, the Issuer may redeem up to 10% per annum of the aggregate principal amount of the Senior Secured Notes at a redemption price of 103.000% of the aggregate principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Indenture contains contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. The Indenture contains customary events of default and remedies.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Exchange Controls and Other Limitations Affecting Security Holders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Irish exchange control regulations ceased to apply from and after December 31, 1992. Except as indicated below, there are no restrictions on non-residents of Ireland dealing in domestic securities, which includes shares or depository receipts of Irish companies. Except as indicated below, dividends and redemption proceeds also continue to be freely transferable to non-resident holders of such securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Financial Transfers Act, 1992 gives power to the Minister for Finance of Ireland to make provision for the restriction of financial transfers between Ireland and other countries and persons. Financial transfers are broadly defined, and include all transfers which would be movements of capital or payments within the meaning of the treaties governing the European Communities. The acquisition or disposal of shares issued by an Irish incorporated company and associated payments may fall within this definition. In addition, dividends or payments on redemption or purchase of shares and payments on a liquidation of an Irish incorporated company would fall within this definition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Financial Transfers Act, 1992 prohibits financial transfers involving a number of persons, entities and bodies, which is subject to amendment on an ongoing, regular basis and currently includes, but is not limited to: certain persons and activities in Belarus, Bosnia &amp; Herzegovina, Burundi, Sudan, South Sudan, the Central African Republic, Libya, Lebanon, Mali, the Democratic People's Republic of Korea, Myanmar/Burma, Tunisia, Zimbabwe, Venezuela, certain persons, entities and bodies in Syrian Arab Republic, the Republic of Guinea-Bissau, Nicaragua, Democratic Republic of Congo, Iran, Ukraine, associated with the Taliban in Afghanistan; associated with ISIL (Da&#8217;esh) and Al-Qaeda; associated with Turkey&#8217;s unauthorized drilling activities in the Eastern Mediterranean and certain known terrorists and terrorist groups and countries that harbor certain terrorist groups, without the prior permission of the Central Bank of Ireland.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no restrictions under the Company&#8217;s Constitution or under Irish Law that limit the right of non-residents or foreign owners to hold the Company&#8217;s ordinary shares or vote at general meetings of the Company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Taxation </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The following discussion is based on existing Irish tax law, Irish court decisions and the practice of the Revenue Commissioners of Ireland, and the convention between the United States and Ireland for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with respect to income and capital gains (the "Treaty"). This discussion does not purport to deal with the tax consequences of owning the ordinary shares for all categories of investors, some of which may be subject to special rules. Prospective purchasers of ordinary shares are advised to consult their own tax advisors concerning the overall tax consequences arising in their own particular situations under Irish law. Each prospective investor should understand that future legislative, administrative and judicial changes could modify the tax consequences described below, possibly with retroactive effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As used herein, the term "U.S. Holder" means a beneficial owner of ordinary shares that (i) owns the ordinary shares as capital assets; (ii) is a U.S. citizen or resident, a U.S. corporation, an estate the income of which is subject to U.S. federal income taxation regardless of its source or a trust that meets the following two tests: (A) a U.S. court is able to exercise primary supervision over the administration of the trust, and (B) one or more U.S. persons have the authority to control all substantial decisions of the trust; and for the purpose of the discussion under Irish Taxation of U.S. Holders (A) is not a resident of, or ordinarily resident in, Ireland for the purposes of Irish tax; and (B) is not engaged in trade or business in Ireland through a permanent establishment.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">AS USED HEREIN, REFERENCES TO THE ORDINARY SHARES SHALL INCLUDE SHARES HELD IN THE ACCOUNTS OF PARTICIPANTS THROUGH THE DEPOSITARY TRUST COMPANY (&#8220;THE DTC&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Irish Taxation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish corporation tax on income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ICON is a public limited company incorporated and resident for tax purposes in Ireland by virtue of its place of central management and control being in Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Companies which are resident in the Republic of Ireland are subject to Irish corporation tax on their total profits (wherever arising and, generally, whether or not remitted to the Republic of Ireland). The question of residence, by virtue of management and control, is essentially one of fact. It is the present intention of the Company's management to continue to manage and control the Company from the Republic of Ireland, so that the Company will continue to be resident in the Republic of Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The standard rate of Irish corporation tax on trading income (with certain exceptions) is currently 12.5%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A research and development tax credit is available in Ireland where an Irish resident company incurs qualifying expenditure on research and development activities. Qualifying expenditure incurred in a particular account period results in a tax credit of 25% of that expenditure.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Corporation tax is charged at the rate of 25% on a company's non-trading income and certain types of trading income not eligible for the lower rate of 12.5% referred to above.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Capital gains arising to an Irish resident company are liable to tax at 33%. However, a capital gains tax exemption is available in Ireland for qualifying Irish resident companies in respect of disposals of certain qualifying shareholdings.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The exemption from capital gains tax on the disposal of shares by an Irish resident company will apply where certain conditions are met. These conditions principally are:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:13.8pt">The company claiming the exemption must hold (directly or indirectly) at least 5% of the ordinary share capital of the company in which the interest is being disposed of, throughout a continuous period of at least 12 months, in the two year period prior to disposal;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:13.8pt">The shares being disposed of must be in a company, which at the date of disposal, is resident in a Member State of the European Communities or in a country with which Ireland has signed or made specific arrangements to sign a double tax agreement (together a &#8220;Relevant Territory&#8221;);</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares must be in a company which is primarily a trading company or the company making the disposal together with its &#8220;5% plus subsidiaries&#8221; should be primarily a trading group; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares must not derive the greater part of their value from land or mineral rights in the State.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish withholding tax on dividends</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Unless specifically exempted, all dividends paid by the Company, will be subject to Irish withholding tax. The current rate for dividend withholding tax is 25%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">An individual shareholder who is neither resident nor ordinarily resident for tax purposes in Ireland, but is resident in a country with which Ireland has a double tax treaty, or in a member state of the European Communities, other than Ireland (together, a Relevant Territory), will be exempt from withholding tax provided he or she makes the requisite declaration.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident corporate shareholders will be exempt from withholding tax. Where the shareholding held by the recipient company, in the company paying the dividend is not 51% or greater a declaration must be made in order to avail of the exemption.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Non-Irish resident corporate shareholders will be exempt from withholding tax on the production of the appropriate certificates and declarations where they:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are resident in a Relevant Territory and are not controlled (directly or indirectly) by Irish residents;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are ultimately controlled (directly or indirectly) by residents of a Relevant Territory; or</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">have the principal class of their shares, or shares of a 75% parent, substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories; or</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are wholly owned by two or more companies, each of whose principal class of shares is substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">U.S. holders of ordinary shares should note, however, that detailed documentation requirements may need to be complied with. Special arrangements are available in the case of an interest in shares held in Irish companies through a depositary or in accounts of participants through the DTC. In certain cases, the depositary or the DTC can receive and pass on a dividend from an Irish company without deducting withholding tax, provided the depositary or the DTC is a qualifying intermediary, and provided the person beneficially entitled to the distribution would meet the same conditions outlined above for the withholding tax exemption to apply and has provided the qualifying intermediary with the appropriate declarations. The depositary or the DTC shall be regarded as a qualifying intermediary provided the following conditions are met:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC is resident in a Relevant Territory; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC have entered into a qualifying intermediary agreement with the Irish tax authorities; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC have been authorized by the Irish Revenue Commissioners as a qualifying intermediary and such authorization has not expired or been revoked.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish income tax on dividends</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident or ordinarily resident shareholders will generally be liable to Irish income tax on dividend income at their marginal rate of income tax. This income may also be liable to Pay Related Social Insurance (&#8220;PRSI&#8221;) of up to 4% and the Universal Social Charge (&#8220;USC&#8221;) of up to 11% (up to 15% in total).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under certain circumstances, non-Irish resident shareholders will be subject to Irish income tax on dividend income. Where withholding tax of 25% has been deducted, this will fully satisfy the non-Irish resident shareholder&#8217;s tax liability. No PRSI or USC should apply in these circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">However, a non-Irish resident shareholder will not have an Irish income tax liability on dividends from the Company if the holder is neither resident nor ordinarily resident in the Republic of Ireland and the holder is:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">an individual resident in the U.S. or in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation that is ultimately controlled by person(s) resident in the U.S. or in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation whose principal class of shares (or its 75% or greater parent&#8217;s principal class of shares) is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation resident in another EU member state or in a Relevant Territory, which is not controlled directly or indirectly by Irish residents; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation that is wholly owned by two or more corporations each of whose principal class of shares is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">U.S. Holders who do not qualify for the above income tax exemption may be able to obtain treaty benefits under the double tax treaty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish domicile levy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certain non-Irish resident individuals that are domiciled in Ireland will be subject to an annual levy of &#8364;200,000 if the market value of their Irish-located property on 31 December exceeds &#8364;5,000,000, their worldwide annual income exceeds &#8364;1,000,000 and their liability to Irish Income Tax in that year is less than &#8364;200,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish capital gains tax on disposal of shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident or ordinarily resident shareholders will be liable to capital gains tax at 33% on gains arising from the disposal or part disposal of their shareholding.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A person who is not resident or ordinarily resident in Ireland, who has not been an Irish resident within the past five years and who does not carry on a trade in Ireland through a branch or agency will not be subject to Irish capital gains tax on the disposal of ordinary shares or shares held in accounts of participants through the DTC, so long as the shares do not derive the greater part of their value from Irish land or mineral rights</span><span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There are provisions to subject a person who disposes of an interest in a company while temporarily being non-Irish resident, to Irish capital gains tax. This treatment will apply to Irish domiciled individuals:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who cease to be Irish resident;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who beneficially own the relevant assets when they cease to be resident;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">if there are not more than 5 years of assessment between the last year of Irish tax residence prior to becoming temporarily non-resident and the tax year that he/she resumes Irish tax residency;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who dispose of the relevant assets during this temporary non-residence; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the interest disposed of represents 5% or greater of the issued share capital of the company or is worth at least &#8364;500,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In these circumstances the person will be deemed, for Irish capital gains tax purposes, to have sold and immediately reacquired the interest in the company on the date of his or her departure and will be subject to tax at 33% of the taxable gain.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish capital acquisitions tax</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish capital acquisitions tax (referred to as CAT) applies to gifts and inheritances. Subject to certain tax-free thresholds, gifts and inheritances are liable to tax at 33%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Where a gift or inheritance is taken under a disposition made after December 1, 1999 it will be within the charge to CAT:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">to the extent that the property of which the gift or inheritance consists is situated in the Republic of Ireland at the date of the gift or inheritance;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">where the person making the gift or inheritance is or was resident or ordinarily resident in the Republic of Ireland at the date of the disposition under which the gift or inheritance is taken;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">in the case of a gift taken under a discretionary trust where the person from whom the gift is taken was resident or ordinarily resident in the Republic of Ireland at the date he/she made the settlement, or at the date of the gift or, if he/she is dead at the date of the gift, at the date of his/her death; or</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">where the person receiving the gift or inheritance is resident or ordinarily resident in the Republic of Ireland at the date of the gift or inheritance. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">For these purposes a non-Irish domiciled individual will not be regarded as resident or ordinarily resident in the Republic of Ireland on a particular date unless they are resident or ordinarily resident in the Republic of Ireland on that date and have been resident for the 5 consecutive tax years immediately preceding the year of assessment in which the date falls.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The person who receives the gift or inheritance (&#8220;the beneficiary&#8221;) is primarily liable for CAT. In the case of an inheritance, where a beneficiary and personal representative of the deceased are both non-residents, a solicitor must be appointed to be responsible for paying inheritance tax. Taxable gifts or inheritances received by an individual since December 5, 1991 from donors in the same threshold class are aggregated and only the excess over a specified tax-free threshold is taxed. The tax-free threshold is dependent on the relationship between the donor and the donees and the aggregation since December 5, 1991 of all previous gifts and inheritances, within the same tax threshold.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The tax-free threshold amounts that apply are:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;16,250 in the case of persons who are not related to one another;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;32,500 in the case of gifts or inheritances received from inter alia a brother or sister or from a brother or sister of a parent or from a grandparent; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;335,000 in the case of gifts and inheritances received from a parent (or from a grandparent by a minor child of a deceased child) and specified inheritances received by a parent from a child for gifts or inheritances taken on or after October 9, 2019. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Gifts and inheritances passing between spouses are exempt from CAT.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A gift or inheritance of the Company&#8217;s ordinary shares or American Depositary Shares (ADSs) will be within the charge to Irish capital acquisitions tax, notwithstanding that the person from whom or by whom the gift or inheritance is received is domiciled or resident outside Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Estate Tax Convention between Ireland and the United States generally provides for Irish capital acquisitions tax paid on inheritances in Ireland to be credited against U.S. Federal Estate tax payable in the United States and for tax paid in the United States to be credited against tax payable in Ireland, based on priority rules set forth in the Estate Tax Convention. The Estate Tax Convention does not apply to Irish capital acquisitions tax paid on gifts.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish stamp duty </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish stamp duty, which is a tax on certain documents, is payable on all transfers of ordinary shares (other than between spouses) whenever a document of transfer is executed. Where the transfer is attributable to a sale, stamp duty will be charged at a rate of 1%, rounded to the nearest euro. The stamp duty is calculated on the amount or value of the consideration (i.e. purchase price) or, if the transfer is by way of a gift (subject to certain exceptions) or for consideration less than the market value, on the market value of the shares. Where the consideration for the sale is expressed in a currency other than euro, the duty will be charged on the euro equivalent calculated at the rate of exchange prevailing on the date of the transfer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transfers through the DTC of book entry interests in shares are not subject to Irish stamp duty.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A transfer of ordinary shares by a shareholder to a depositary or custodian for deposit and a transfer of ordinary shares from the depositary or the custodian for the purposes of the withdrawal of the underlying ordinary shares in accordance with the terms of a deposit agreement will be subject to stamp duty at the 1% rate if the transfer relates to a sale, a contemplated sale, a gift or any other change in the beneficial ownership of such ordinary shares. However, transfers of ordinary shares into or out of the DTC are not subject to Irish stamp duty where no change in beneficial ownership of the shares has occurred and provided a contract for sale in respect of the transferring shares is not in place.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The person accountable for payment of stamp duty is normally the transferee or, in the case of a transfer by way of gift, or for a consideration less than the market value, all parties to the transfer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transfers of ordinary shares between associated companies (broadly, companies within a 90% group relationship and subject to the satisfaction of certain conditions) are exempt from stamp duty in the Republic of Ireland. In the case of transfers of ordinary shares where no beneficial interest passes (e.g. a transfer of shares from a beneficial owner to his nominee), no stamp duty arises.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">No stamp duty shall arise on the transfer of ordinary shares where the consideration for the transfer does not exceed &#8364;1,000, provided the instrument contains a statement certifying that the transaction does not form part of a larger transaction or a series of larger transactions, in respect of which the amount of the total consideration attributable to the shares would exceed &#8364;1,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Dividends and paying agents</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">G.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:8.5pt">Statement by experts</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">H.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Documents on Display</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;) and file reports and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC at http://www.sec.gov.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We &#8220;incorporate by reference&#8221; information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this report and more recent information automatically updates and supersedes more dated information contained or incorporated by reference in this report. Our SEC file number for Exchange Act reports is 333-08704.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a foreign private issuer, we are exempt from certain rules under the Exchange Act, including prescribing the furnishing and content of proxy statements to shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We will provide without charge to each person, including any beneficial owner, on the written or oral request of such person, a copy of any or all documents referred to above which have been or may be incorporated by reference in this report (not including exhibits to such incorporated information that are not specifically incorporated by reference into such information). Requests for such copies should be directed to us at the following address: ICON plc, South County Business Park, Leopardstown, Dublin 18, Ireland, D18 X5R3 Attention: Corporate Governance, email: corporate.governance@iconplc.com.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">I.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:13pt">Subsidiary Information</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exemptions From Corporate Governance Listing Requirements Under the NASDAQ Marketplace Rules</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NASDAQ may provide exemptions from certain NASDAQ corporate governance standards to a foreign private issuer if, among other reasons those standards are contrary to a law, rule or regulation of a public authority exercising jurisdiction over such issuer or contrary to generally accepted business practices in the issuer&#8217;s home country of domicile, provided, that, the foreign private issuer properly notifies NASDAQ and makes the required disclosure except to the extent that such exemptions would be contrary to United States federal securities laws.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-right:2.25pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The exemptions that the Company relies on, and the practices the Company adheres to, are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">The Company is exempt from provisions set forth in NASDAQ Rule 5620(c), which requires each issuer (other than limited partnerships) to provide for a quorum in its by-laws for any meeting of the holders of common stock, which shall in no case be less than 33.33% of the outstanding shares of the issuer&#8217;s common voting stock. The Company&#8217;s Constitution requires that only 3 members be present, in person or by proxy, at a shareholder meeting to constitute a quorum. This quorum requirement is in accordance with Irish law and generally accepted business practices in Ireland.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">The Company is exempt from provisions set forth in NASDAQ Rule 5635(c) which requires (other than for certain specified exceptions) shareholder approval prior to the establishment or material amendment of a stock option or purchase plan or other equity compensation arrangement made or materially amended, pursuant to which stock may be acquired by officers, Directors, employees or consultants. Irish law does not require shareholder approval with respect to equity compensation arrangements. Accordingly, the 2019 Consultants and Directors Restricted Share Unit Plan, the 2013 Employees Restricted Share Unit Plan and the amendments to the Employee Share Option Plan 2008 and Consultants Share Option Plan 2008 were adopted by the Board of Directors without shareholder approval.</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">The Company is exempt from provisions set forth in NASDAQ Rule 5605(b)(2), which requires independent Directors to hold regularly scheduled meetings at which only independent Directors are present.  Irish law does not require independent Directors to hold regularly scheduled meetings at which only independent Directors are present. The Company holds regularly scheduled meetings which all of the Directors may attend and the Lead Independent Director may call meetings of the independent Directors and non-employee Directors of the Board, as appropriate, in accordance with the Lead Independent Director Charter.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:4.5pt"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Quantitative and Qualitative Disclosures about Market Risk.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The principal market risks (i.e. risk of loss arising from adverse changes in market rates and prices) to which we are exposed include foreign currency risk and interest rate risk.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to a number of foreign currency risks given the global nature of our operations. The principal foreign currency risks to which the business is subject to includes both foreign currency translation risk and foreign currency transaction risk.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are also subject to foreign currency transaction exposures as the currency in which our contracts are priced can be different from the currencies in which costs relating to those contracts are incurred. Our operations in the United States are not materially exposed to such currency differences as the majority of revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts may be priced in a single currency, most often U.S. dollars, or euro, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our foreign currency exposures and enter into forward currency contracts to manage our exposure. We had no open foreign currency contracts at December&#160;31, 2021.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following significant exchange rates applied during the year:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Rate</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Euro:USD</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.1886</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.1370</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pound Sterling:USD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.3788</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.3532</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to interest rate risk in respect of our cash and cash equivalents and available for sale investments. Our treasury function actively manages our available cash resources and invests significant cash balances to ensure optimum returns for the Company. Financial instruments are classified either as cash and cash equivalents or available for sale investments depending upon the maturity of the related investment. Funds may be invested in the form of floating rate notes and medium term minimum &#8220;A-&#8221; rated corporate securities. We may be subject to interest rate risk in respect of interest rate changes on amounts invested. Interest rate risk is managed by monitoring the composition of the Company&#8217;s investment portfolio on an ongoing basis having regard to current market interest rates and future trends.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a Senior Secured Term Loan Facility of $5,515 million. Borrowings under the Senior Secured Term Loan facility amortize in quarterly installments equal to 1.00% per annum of the original principal amount ($5,515 million), and the remaining balance is due for repayment by July 2028. The interest rate margin applicable to the borrowings under the Senior Secured Term Loan Facility will be, at the option of the applicable borrower (as defined in the credit agreement), either (1) the base rate ( as described in the credit agreement) plus an applicable margin of 1.50% or (2) LIBOR plus an applicable margin of 2.50%, in each case , with a step down of 0.25% if the first lien net leverage ratio is equal to or less than 4.00 to 1.00. The senior secured facility is subject to a LIBOR floor of 0.50%</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As at the December&#160;31, 2021 the outstanding principal amount of the Senior Secured Term Loan Facility was $5,001 million. The applicable interest rate for the next quarterly interest period is expected to be 2.75%, comprising of the lower margin of 2.25% and the LIBOR floor of 0.50%. The interest rate is fixed on this debt on a calendar quarter basis and is subject to external market conditions. As at December&#160;31, 2021 no hedges had been entered into to fix the interest on this debt beyond the quarterly term.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Senior Secured Facilities, on July 1, 2021, the Company issued $500 million in aggregate principal senior notes due in 2026 in a private (&#8220;the Offering &#8220;). The Senior Secured Notes will mature in July 2026 and pay a fixed semi annual coupon to investors of 2.875% per annum. This debt is not subject to movements in interest rate conditions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We regularly evaluate our debt arrangements, as well as market conditions, and we will explore the opportunity to modify our existing arrangements or pursue additional financing arrangements that may result in the issuance of new debt securities by us or our affiliates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The sensitivity analysis below represents the hypothetical change in the net interest payable of a 1% movement in market interest rates.&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest for the year ended December 31, 2021 (in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest<br/>Change 1% increase in<br/>market interest rate<br/>(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest<br/>Change 1% decrease in<br/>market interest rate<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9,772&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($182,423)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($206,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($150,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($181,849)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($196,626)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($150,177)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14% of the interest costs fixed due to high yield bond issuance. $88.6&#160;million financing fees have been allocated to interest cost which are not impacted by a change in interest rate. </span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_55"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Description of Securities Other than Equity Securities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_58"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part II</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Defaults, Dividend Arrearages and Delinquencies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 14.  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Material Modifications to the Rights of Security Holders and Use of Proceeds.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 15.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Disclosure controls and procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer (CEO) and the Chief Financial Officer (CFO), of the effectiveness of our disclosure controls and procedures as at December&#160;31, 2021. Based on that evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Following the completion of the Merger on July 1, 2021, Management has continued to progress the integration of PRA into the established internal control framework of the Company. As of December&#160;31, 2021, Management have not yet formally completed its evaluation of the internal control framework of PRA and management have elected to exclude the acquired business from its assessment of internal control over financial reporting as of December&#160;31, 2021. Management expect to have completed its evaluation by June 30, 2022. PRA represented 10% of total assets as of December&#160;31, 2021 and 38% of revenue for the year then ended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Management's Annual Report on Internal Accounting Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made to page 102 of this Form 20-F.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Attestation Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made to page 103 of this Form 20-F.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Changes in Internal Controls over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no changes in our internal controls over financial reporting during the period covered by this Form 20-F that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reserved.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16A. Audit Committee Financial Expert</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy acts as the Audit Committee financial expert serving on our Audit Committee and Board of Directors. The Board has determined that Mr. Murphy is independent. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16B. Code of Ethical Conduct </span></div><div style="text-align:justify;text-indent:-40.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Our Global Code of Ethical Conduct applies to all officers, directors, employees, consultants and agents globally of ICON plc, its subsidiaries and branches. There are no waivers from the provisions of the Code of Ethical Conduct that are required to be disclosed. This Code of Ethical Conduct is available on our website a</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">t: </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline">https://investor.iconplc.com/corporate-governance/governance-documents</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> .</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16C. Principal Accountant Fees and Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our principal accountants for the years ended December&#160;31, 2021 and December&#160;31, 2020 were KPMG, Dublin, Ireland (Audit firm ID: <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF83OS9mcmFnOjExZTNjYTNhODM0MDQ4OWQ5MmYwMGFmOTAyOTllMjMzL3RleHRyZWdpb246MTFlM2NhM2E4MzQwNDg5ZDkyZjAwYWY5MDI5OWUyMzNfMjE5OTAyMzI1NjkyMw_5af24a7c-3b42-45c1-bae2-ae09ae75142e">1116</ix:nonNumeric>). The table below summarizes the fees for professional services rendered by KPMG for the audit of our annual financial statements for the years ended December&#160;31, 2021 and December&#160;31, 2020 and fees billed for other services rendered by KPMG.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 month period ended December 31, 2021 (in thousands)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 month period ended December 31, 2020 (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit fees (1)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit related fees (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax fees (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9,085&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Audit fees include annual audit fees for the Company and its subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Audit related fees principally consist of fees for financial due diligence services, fees for the audit of employee benefit plans and fees for pension reviews. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Tax fees are fees for tax compliance and tax consultation services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee pre-approves all audit and non-audit services provided to the Company by its auditors.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16D. Exemptions from the Listing Standards for Audit Committees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_85"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No ordinary shares were redeemed by the Company during the year ended December&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2020, 1,235,218 ordinary shares were redeemed by the Company for a total consideration of $175.0 million. All ordinary shares that are redeemed under the buyback program were canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number<br/>of Shares Purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number<br/>of Shares Purchased</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Price<br/>Paid for Shares Purchased </span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February  02/1/20 &#8211; 02/29/20</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$160.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$14,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March  03/1/20 &#8211; 03/31/20</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,143,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$140.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,143,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$160,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,235,218&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$141.68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,235,218&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$175,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 8, 2019, the Company commenced a share buyback program of up to 1.0 million shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of&#160;$141.6 million. &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.762%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number<br/>of Shares Purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number<br/>of Shares Purchased as<br/>Part of a<br/>Publicly Announced<br/>Plan</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Price<br/>Paid for Shares Purchased as<br/>Part of a<br/>Publicly Announced<br/>Plan</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 1/1 /19&#8211; 1/31/19</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$124.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 4/1/19 &#8211; 4/30/19</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$129.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 5/1/19 &#8211; 5/31/19</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$136.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$32,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 8/1/19 &#8211; 8/31/19</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$152.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 9/1/19 &#8211; 9/30/19</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$151.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$75,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$141.57&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$141,573&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, 35,100 ordinary shares were redeemed for a total consideration of $5.3 million. All ordinary shares that were redeemed under the buyback programs were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number<br/>of Shares Purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number<br/>of Shares Purchased</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Price<br/>Paid for Shares Purchased </span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10/1/19 &#8211; 10/31/19</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$152.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$152.66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,358&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the repurchase programs, a broker purchased the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The programs are designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information, applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker were irrevocable and the trading decisions in respect of the repurchase programs were made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the programs. In addition, acquisitions under the programs may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the programs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16F. Changes in Registrant's Certifying Accountant</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_91"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16G. Corporate Governance</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 10 "Exemptions from Corporate Governance Listing Requirements under the NASDAQ Marketplace Rules".</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16H. Mine Safety Disclosure</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part III</span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 17. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See item 18.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_103"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Financial Statements.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made to pages 102 to 158 of this Form 20-F.</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_106"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 19. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated Financial Statements of ICON plc and subsidiaries</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibits of ICON plc and subsidiaries</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reports of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated Balance Sheets as at December&#160;31, 2021 and December&#160;31, 2020 </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated Statements of Operations for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated Statements of Comprehensive Income for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated Statements of Shareholders' Equity and Comprehensive Income for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibits of ICON plc and subsidiaries</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121006002/nc10020781x8_ex2-1.htm">2.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of February 24, 2021, by and among ICON plc, ICON US Holdings Inc., Indigo Merger Sub, Inc and PRA Health Sciences, Inc. (incorporated by reference to exhibit 2.1 to the Form 6K (file No. 333-08704) filed on February 24, 2021.</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit22-2021.htm">2.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of Securities Registered Under Section 12 of the Exchange Act.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-1.htm">2.3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Credit Agreement, dated as of July 1, 2021, by and among ICON Luxembourg, S.&#192; R.L., ICON Clinical Investments, LLC, Indigo Merger Sub, Inc. (which, after giving effect to the Merger on the Closing Date was succeeded by PRA Health Sciences, Inc.), ICON Public Limited Company, the other borrowers party thereto from time to time, the subsidiary guarantors party thereto from time to time, lenders party thereto Citibank, N.A., as administrative agent, and Citibank, N.A., London Branch, as collateral agent (incorporated by reference to exhibit 99.1 to the Form 6K (File No. 333-08704) filed on July 1, 2021).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-2.htm">2.4</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indenture, dated as of July 1, 2021, by and among Indigo Merger Sub, Inc., PRA Health Sciences, Inc., the guarantors party thereto and Citibank, N.A., London Branch as trustee, notes collateral agent, paying agent, transfer agent and registrar (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 1, 2021).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1060955/000115752316006157/a51386268ex99_2.htm">3.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of the Constitution of the Company (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 25, 2016).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit121-2021.htm">12.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 302 certifications.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit122-2021.htm">12.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 906 certifications.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_28">21.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">List of Subsidiaries (incorporated by reference to Item 4 of Form 20-F filed herewith).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-2021.htm">23.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consent of KPMG, Independent Registered Public Accounting Firm.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interactive Data Files (XBRL &#8211; Related Documents).</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* &#160; Filed herewith</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's internal control over financial reporting is a process designed by, or under the supervision of, the Company's executive and financial officers and effected by the Company's board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorization of management and Directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of the inherent limitation due to, for example, the potential for human error or circumvention of control, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Following the completion of the Merger on July 1, 2021, Management has continued to progress the integration of PRA into the established internal control framework of the Company. As of December&#160;31, 2021, Management have not yet formally completed its evaluation of the internal control framework of PRA and management have elected to exclude the acquired business from its assessment of internal control over financial reporting as of December&#160;31, 2021. Management expect to have completed its evaluation by June 30, 2022. PRA represented 10% of total assets as of December&#160;31, 2021 and 38% of revenue for the year then ended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company's </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">internal control over financial reporting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">as of December&#160;31, 2021. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework 2013</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Based upon the assessment performed, we determined that, as of December&#160;31, 2021 the Company's internal control over financial reporting was effective.</span><span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes in the Company's internal control over financial reporting during 2021 that have materially affected, or are reasonably likely to affect materially, the Group's internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">KPMG, an independent registered public accounting firm, has audited the consolidated financial statements of ICON plc and subsidiaries as of and for the year ended December&#160;31, 2021, included herein, and has issued an audit report on the effectiveness of our internal control over financial reporting, which is included below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Opinion on the Consolidated Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of ICON, plc and subsidiaries (&#8220;the Company&#8221;) as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income, shareholders equity and comprehensive income, and cash flows for each of the years in the three&#8209;year period ended December 31, 2021, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the three&#8209;year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the Company&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated March&#160;1, 2022 expressed an unqualified opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Critical Audit Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Valuation of customer relationship intangible asset acquired in a business combination</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As discussed in Note 6 to the consolidated financial statements, the Company completed its merger (the &#8220;Merger&#8221;) with PRA Health Sciences, Inc. ("PRA") on July 1, 2021. The Company estimated the preliminary fair value of the customer relationship intangible asset to be $3,915.0 million as of the date of the Acquisition.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We identified the evaluation of the preliminary fair value of the customer relationship intangible asset acquired as a critical audit matter. It required subjective auditor judgement to assess the forecasts of the acquiree&#8217;s cash flows, which include forecasted revenue growth, operating income margins and the customer attrition rate, as well as the discount rate based on an analysis of the acquiree&#8217;s weighted average cost of capital. In addition, specialized skills and knowledge were needed to test the significant assumptions listed above and used in the discounted cash flow model.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter:</span></div><div style="padding-left:36pt;text-indent:14.2pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We evaluated the design and tested the operating effectiveness of certain internal controls related to the business combinations process, including controls over the valuation of the customer relationship intangible asset. This included controls related to the significant assumptions used in the development of the discounted cash flow model, including forecasted revenue growth, operating income margins, customer attrition rate and the discount rate. We also tested management's controls over the completeness and accuracy of the data used in the fair value estimate.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Basis for Opinion (continued)</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Critical Audit Matter (continued)</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We assessed the reasonableness of the Company&#8217;s estimate forecasted revenue growth and operating income margins by comparing forecasted revenue growth and operating income margins to the acquiree&#8217;s historical results and publicly available industry data. To assess the Company&#8217;s customer attrition rates, we compared them to historic customer attrition rates of the acquiree.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also involved a valuation professional with specialized skills and knowledge who assisted in:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- evaluating the discount rate by comparing it against discount rates that were independently developed using publicly available market data of comparable entities</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- assessing the fair value of the customer relationship intangible asset acquired using (1) the Company&#8217;s forecasted cash flows and (2) our independently developed discount rates.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Revenue recognition for clinical trial service contracts</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As discussed in Note 17 to the consolidated financial statements, the Company recognized revenue of US$5,480.8 million for the year ended 31 December 2021, a significant portion of which relates to clinical trial service revenue. As discussed in Note 2 to the consolidated financial statements, clinical trial service revenue is recognized over time, using an input measure, being total project costs (inclusive of third party costs) incurred to date relative to total forecast project costs, to measure progress towards satisfying the Company&#8217;s performance obligation. The transaction price is based on the contract or latest change order value, adjusted to reflect the estimated realizable contract value.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We identified the evaluation of revenue recognition for clinical trial service revenue as a critical audit matter. Complex and subjective auditor judgment was required to evaluate the Company&#8217;s estimate of total forecast project costs and the estimated realizable contract values.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We evaluated the design and tested the operating effectiveness of certain internal controls related to the revenue process, including controls over total forecast project costs and estimated realizable contract values.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We tested the total forecast project costs and the realizable contract values for a selection of clinical trial service contracts, by evaluating:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- Direct costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the direct costs by agreeing to source data</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- Third-party costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the third-party costs incurred by agreeing to invoices received</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- Findings from interviews with operational personnel of the Company to assess progress to date, the estimate of remaining costs to be incurred and factors impacting the amount of time and costs to complete the selected contracts, including an understanding of the nature and complexity of the work to be performed</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- Correspondence of amendments to the scope or contract value, if any, between the Company and the customer for the selected contracts as part of our evaluation of contract progress</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- Changes to estimated costs and project margins, including the amount and timing of the changes and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- The reasonableness of the Company&#8217;s adjustments from total contract value to arrive at realizable contract value. We confirmed total contract value with customers and compared the assumptions used to derive the adjustments from total contract value to realizable contract value to underlying records.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also evaluated the Company&#8217;s methods, assumptions and data used to accurately estimate total forecast project costs and realizable contract values, by comparing historical estimates developed at contract inception to actual results for a selection of contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(signed) <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTUvZnJhZzozMDNmNmE2YjZiNzI0M2I2ODU5YWQwZWM1OTZjYjE3Zi90ZXh0cmVnaW9uOjMwM2Y2YTZiNmI3MjQzYjY4NTlhZDBlYzU5NmNiMTdmXzIxOTkwMjMyNjY2NjY_2c92eaf3-abc7-487c-b3c1-9b907cc5b8e7">KPMG</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 1990.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTUvZnJhZzozMDNmNmE2YjZiNzI0M2I2ODU5YWQwZWM1OTZjYjE3Zi90ZXh0cmVnaW9uOjMwM2Y2YTZiNmI3MjQzYjY4NTlhZDBlYzU5NmNiMTdmXzIxOTkwMjMyNjY2Njc_67be6c76-ae57-4ceb-9558-853384460566">Dublin, Ireland</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March&#160;1, 2022</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Opinion on Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have audited ICON plc and subsidiaries&#8217; (&#8220;the Company&#8221;) internal control over financial reporting as of December&#160;31, 2021, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">December&#160;31, 2021, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the consolidated balance sheets of the Company as of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">December&#160;31, 2021 and 2020, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity and comprehensive income, and cash flows for each of the years in the three-year period ended December&#160;31, 2021, and the related notes (collectively, the &#8220;consolidated financial statements&#8221;), and our report dated March&#160;1, 2022 expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc acquired PRA Health Sciences, Inc. (&#8220;PRA&#8221;) during 2021, and management excluded from its assessment of the effectiveness of the Company&#8217;s internal control over financial reporting as of December 31, 2021, PRA&#8217;s internal control over financial reporting associated with 10% of total assets and 38% of total revenues included in the consolidated financial statements of the Company as of and for the year ended December 31, 2021. Our audit of internal control over financial reporting of the Company also excluded an evaluation of the internal control over financial reporting of PRA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(signed) KPMG</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dublin, Ireland</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March&#160;1, 2022</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:64.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.055%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.496%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="6" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMtMS0xLTEtMzYyNDg_0ae1a5ea-4bb3-4a90-9893-20aab8e69662">752,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMtMi0xLTEtMzYyNDg_aee5d0ea-fcee-4931-828a-61625c8b173b">840,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (Note 3a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQtMS0xLTEtMzYyNDg_092a8a3a-6a65-49d4-8ba9-41f145d47298">1,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQtMi0xLTEtMzYyNDg_61a76701-4587-404c-9e86-b2ff37945a5a">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net (Note 18)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzUtMS0xLTEtMzYyNDg_0ef43c3a-4515-4a3c-ba93-b376e34361cb">1,342,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzUtMi0xLTEtMzYyNDg_17572d12-2c85-4344-8b61-fa1f00e9f090">715,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled revenue (Note 18)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzYtMS0xLTEtMzYyNDg_769536b9-4a5b-4432-8d17-4d3b01d7107d">623,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzYtMi0xLTEtMzYyNDg_123da609-332b-44f0-8f0c-b3086df20991">428,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:NontradeReceivablesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzctMS0xLTEtMzYyNDg_02b74c5f-3401-4ab0-b44c-5cbf397ca6be">56,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:NontradeReceivablesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzctMi0xLTEtMzYyNDg_71875f3b-8aea-4e2c-8343-621cc989bfd2">35,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzgtMS0xLTEtMzYyNDg_3a52b51a-5653-4bef-a00c-babd9519d56a">114,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzgtMi0xLTEtMzYyNDg_34d807ba-4aaa-462e-b605-842fc656ef29">53,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes receivable (Note 14)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzktMS0xLTEtMzYyNDg_f29de971-28bf-4675-87cb-18003b19e592">50,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzktMi0xLTEtMzYyNDg_09762fa0-f06a-47d9-b87a-30345d557c5a">28,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEwLTEtMS0xLTM2MjQ4_f14166c9-bc4a-4a63-aae6-ad3904a0ac7f">2,941,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEwLTItMS0xLTM2MjQ4_6863f4be-55b4-4f2c-ab9b-2980925a3f0d">2,102,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net (Note 7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEyLTEtMS0xLTM2MjQ4_d8e7d134-625c-4a8b-86eb-65b9af17e6c7">336,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEyLTItMS0xLTM2MjQ4_d41d55ea-2eb2-4107-990e-b359d4cc36b4">174,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill (Note 4) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEzLTEtMS0xLTM2MjQ4_a862c8c9-b3e2-4daf-a428-76df83471701">9,037,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEzLTItMS0xLTM2MjQ4_57ec6b93-0938-42e0-b859-f8c61e38c9da">936,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets (Note 5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE0LTEtMS0xLTYxNzI3_7a852abe-c5a5-459f-bb4e-0da7f7f55faa">4,710,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE0LTItMS0xLTYxNzI3_76c6bb9b-f61a-4839-b7a8-661d021f4f37">66,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use assets (Note 23)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE0LTEtMS0xLTM2MjQ4_e3515871-313d-4411-92bb-d49b3c2938ff">198,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE0LTItMS0xLTM2MjQ4_e6220b0a-e824-4e63-8e06-946bf979026a">84,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE1LTEtMS0xLTM2MjQ4_b552c89a-6705-4c50-93ea-3205dc0db0ee">70,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE1LTItMS0xLTM2MjQ4_ceb5df3d-4269-43cc-b2e5-7c575d3ff813">20,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current income taxes receivable (Note 14)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE2LTEtMS0xLTM2MjQ4_abac4edc-e9ca-47ed-8111-a3c84ff05b85">18,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE2LTItMS0xLTM2MjQ4_3465a30a-d019-4873-9113-4ab5acb4f740">17,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax asset (Note 14)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE3LTEtMS0xLTM2MjQ4_4bf2c602-fb38-4e81-9440-2b47edf66dea">48,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE3LTItMS0xLTM2MjQ4_e5af5c18-7cf4-4e42-b024-999ddbf5746a">12,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method investments (Note 3c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE4LTEtMS0xLTM2MjQ4_e69e29fa-8d04-47f9-aedd-fb2283bd47ae">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE4LTItMS0xLTM2MjQ4_d171af92-2677-48dc-b3cd-e278d5e217cc">4,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity-long term (Note 3b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE5LTEtMS0xLTM2MjQ4_603db20a-7871-4cf8-9139-c42661c3ae8c">22,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE5LTItMS0xLTM2MjQ4_1562b99b-0333-4047-90eb-606487b0801c">15,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzIxLTEtMS0xLTM2MjQ4_752496c8-fb6e-4417-81f2-d17c0fcaa3a1">17,387,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzIxLTItMS0xLTM2MjQ4_cb294eae-ff97-4e09-95fd-4a78925a9071">3,435,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI0LTEtMS0xLTM2MjQ4_9242c90b-ead5-4a61-b4de-62900bb9b7ed">90,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI0LTItMS0xLTM2MjQ4_3c97c0dc-d866-4b0c-aa49-9dc2d754b91a">51,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (Note 18)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI1LTEtMS0xLTM2MjQ4_c04c5bda-b86e-433b-b360-0cc3d6d69398">1,323,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI1LTItMS0xLTM2MjQ4_fc0efe1f-0aa8-4da2-acca-8e699a35a161">660,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities (Note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI2LTEtMS0xLTM2MjQ4_0ad61c77-6ef6-4632-a81b-b418c1cda74e">949,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI2LTItMS0xLTM2MjQ4_c6b449b7-c8db-46be-8ab8-6572b059cecd">399,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes payable (Note 14)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI3LTEtMS0xLTM2MjQ4_9a6e7f48-d448-4cc8-b982-057ca7e6279f">59,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI3LTItMS0xLTM2MjQ4_9f4131db-9c9e-4bfa-aad4-6eef6e6fc9df">12,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current bank credit lines and loan facilities (Note 24)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI4LTEtMS0xLTM2MjQ4_91113a5a-19de-4a49-b92f-a8053e29303b">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI4LTItMS0xLTM2MjQ4_2fe55496-d7f5-4f7e-8e9c-20768ae2624d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI5LTEtMS0xLTM2MjQ4_812f126f-49f1-4068-af2b-2d0244e9086a">2,478,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI5LTItMS0xLTM2MjQ4_d7a42403-b116-4c50-b37b-35d9b21a7b36">1,123,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current bank credit lines and loan facilities (Note 24)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMxLTEtMS0xLTM2MjQ4_6a956329-c1ad-4330-8901-d212f8447374">5,381,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMxLTItMS0xLTM2MjQ4_ad2db86b-f7a1-4fe8-93fe-e5ba3a11bfdf">348,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current operating lease liabilities (Note 23)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMyLTEtMS0xLTM2MjQ4_76515a1f-9ac9-4a72-9240-e467d1887814">159,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMyLTItMS0xLTM2MjQ4_db1ac003-5966-415b-b7d8-c3667963ecc5">60,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMzLTEtMS0xLTM2MjQ4_01ceccb2-ea8a-4fee-b0a1-dee00d83996d">41,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMzLTItMS0xLTM2MjQ4_e50c235b-689a-4e9a-b72d-dd716d7af23d">26,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current government grants </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:CapitalGovernmentGrantsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM0LTEtMS0xLTM2MjQ4_a30f4935-f1b2-47ec-bf5a-65632cbd36e6">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:CapitalGovernmentGrantsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM0LTItMS0xLTM2MjQ4_5a014360-1e25-4c51-89b1-07dfb34374ab">838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current income taxes payable (Note 14)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM1LTEtMS0xLTM2MjQ4_3f392eac-dff9-4815-9e1e-5c53c57a4007">172,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM1LTItMS0xLTM2MjQ4_71e27f93-7788-478a-a242-e2b9b1131bdd">14,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability (Note 14)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM2LTEtMS0xLTM2MjQ4_8ed259cf-5299-4dc9-b1e4-fb3072684ed7">1,085,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM2LTItMS0xLTM2MjQ4_9fbbb577-a75b-4fdb-bf0b-637cf27fc84a">10,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies&#160;(Note 16)&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM3LTEtMS0xLTM2MjQ4_296debce-668d-4ab0-af61-68e65cb931a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM3LTItMS0xLTM2MjQ4_8eae87c3-bd6c-4ed0-968c-e427d9a60598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total&#160;Liabilities&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM4LTEtMS0xLTM2MjQ4_b87b0fac-5427-4a95-a925-3584145b0578">9,320,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM4LTItMS0xLTM2MjQ4_4b1f314f-d453-45cf-a797-295c5a51332e">1,585,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders' Equity:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares par value <ix:nonFraction unitRef="eurPerShare" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQwLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246OTQwYjFkMGM2ZTA4NGQ2YjhiY2I0OTEwZDlkMDM5MzlfMzE_65d96420-9326-4edb-8a55-0cc59c60a654"><ix:nonFraction unitRef="eurPerShare" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQwLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246OTQwYjFkMGM2ZTA4NGQ2YjhiY2I0OTEwZDlkMDM5MzlfMzE_876554a4-1a0d-44da-81e0-64a3e94edf64">6</ix:nonFraction></ix:nonFraction> euro cents per share;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQwLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246OTQwYjFkMGM2ZTA4NGQ2YjhiY2I0OTEwZDlkMDM5MzlfNTY_819b2761-0e8e-46c8-ad63-4a829d386fbd"><ix:nonFraction unitRef="shares" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQwLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246OTQwYjFkMGM2ZTA4NGQ2YjhiY2I0OTEwZDlkMDM5MzlfNTY_f78e2535-a889-49e8-9e97-f29a37daaea8">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized, (Note 13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246M2JiM2NkYTRhYzE3NGYwOGE2N2MzYjM5YmE5YjkxMTBfNA_d441f569-592b-474c-9d4d-d9f74119c285"><ix:nonFraction unitRef="shares" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246M2JiM2NkYTRhYzE3NGYwOGE2N2MzYjM5YmE5YjkxMTBfNA_d4f450ec-e3fb-4b7f-909b-fbb845eb5901">81,554,683</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2021 and<br/><ix:nonFraction unitRef="shares" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246M2JiM2NkYTRhYzE3NGYwOGE2N2MzYjM5YmE5YjkxMTBfNjI_cbe15b1c-308c-4111-9653-3ae6dacb79ca"><ix:nonFraction unitRef="shares" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246M2JiM2NkYTRhYzE3NGYwOGE2N2MzYjM5YmE5YjkxMTBfNjI_e80b6aa4-97d7-42f7-952b-20f5deabb28d">52,788,093</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2020.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTEtMS0xLTM2MjQ4_97d787a4-a40b-4196-b661-fe3a82c4162b">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTItMS0xLTM2MjQ4_45a3a62f-b90e-4ec7-82e6-80b9b4c902ee">4,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQyLTEtMS0xLTM2MjQ4_263e7821-5a56-42da-835a-070e2148678f">6,733,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQyLTItMS0xLTM2MjQ4_579e8f8f-248d-4b76-b758-f958f3c8d7f2">617,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other undenominated capital (Note 13 (a))</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:OtherUndenominatedCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQzLTEtMS0xLTM2MjQ4_25e2a37e-b718-44fd-9db6-81324968ecb7">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:OtherUndenominatedCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQzLTItMS0xLTM2MjQ4_ded16c14-bb69-46d3-bdd3-768213314f48">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (Note 22)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ0LTEtMS0xLTM2MjQ4_04545224-57dc-45a5-b6ce-f6b5624bd93b">90,937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ0LTItMS0xLTM2MjQ4_ba7c2241-b531-47cf-b374-ca8549aeb6dd">35,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ1LTEtMS0xLTM2MjQ4_e5d50fb2-0480-4f01-b11e-4ee52f99273b">1,416,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ1LTItMS0xLTM2MjQ4_afe5f1f4-6cba-442f-b01e-911962e55ef5">1,262,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ2LTEtMS0xLTM2MjQ4_035a3efe-1176-43af-9fe3-3153e075c5d0">8,066,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ2LTItMS0xLTM2MjQ4_70bf581f-ed38-488f-8248-bc523e37ae3a">1,850,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ5LTEtMS0xLTM2MjQ4_b367b29f-fef4-47de-8771-811858717417">17,387,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ5LTItMS0xLTM2MjQ4_41d1903f-3995-4639-83cc-a81183c63498">3,435,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzYtMS0xLTEtMzYyNDg_7a2c7ebd-e50f-4560-b9e0-e7bdac828d4a">5,480,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzYtMi0xLTEtMzYyNDg_1677b326-9919-4971-8033-bc763410ca3e">2,797,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzYtMy0xLTEtMzYyNDg_55996e85-c606-4181-b640-f7938ff06240">2,805,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs (excluding depreciation and amortization) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEwLTEtMS0xLTM2MjQ4_6d568cfa-e9e9-4510-81fb-ea1fb31a16b5">3,972,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEwLTItMS0xLTM2MjQ4_e10fab7a-f33e-405a-b2e8-a1834e2f63af">1,979,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEwLTMtMS0xLTM2MjQ4_65e0ceea-91b5-4efb-9a53-fb79cd2048ab">1,974,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzExLTEtMS0xLTM2MjQ4_552e8627-2836-4b0c-aab0-96737f645281">585,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzExLTItMS0xLTM2MjQ4_76fb2540-3464-4a44-ad96-37a54d95f522">342,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzExLTMtMS0xLTM2MjQ4_5c67a942-8a24-45d9-abef-ebec661c278a">332,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEyLTEtMS0xLTM2MjQ4_1308801e-811c-4e85-8bf4-e60911ae775b">314,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEyLTItMS0xLTM2MjQ4_ac49e85b-6dc2-4ae3-8fc2-9ce306e330f0">66,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEyLTMtMS0xLTM2MjQ4_128993a5-f4da-4cff-8157-bc7ed2708bf6">61,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTEtMS0xLTQxODY5_e53909c9-bca9-4b53-864a-29db9b2653d3">198,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTItMS0xLTQxODY5_fe8e6288-a9b5-44fb-99da-94c64100e038">759</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTMtMS0xLTQxODY5_0c2e0a80-fdfc-4ab1-a7b0-30ee603e4096">4,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring (Note 15)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTEtMS0xLTM2MjQ4_13b1a532-7f36-4b9a-8764-bf722e9e4b5d">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTItMS0xLTM2MjQ4_95f4ecb0-fa01-4a43-8db7-743e0b575fad">18,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTMtMS0xLTM2MjQ4_37debfd8-2d19-4b54-9291-79a03f95fe22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE0LTEtMS0xLTM2MjQ4_c953dfa2-6eaa-4eb9-a515-48a321f404d4">5,102,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE0LTItMS0xLTM2MjQ4_0da7149b-cf9b-4172-8ae6-86df7b6740a7">2,405,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE0LTMtMS0xLTM2MjQ4_bb5fd3b1-d20f-49a6-96b8-bab0e79291b5">2,372,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE2LTEtMS0xLTM2MjQ4_a85e88d7-8f0e-4b36-84cf-5a91df23fe08">378,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE2LTItMS0xLTM2MjQ4_67969542-7a25-4e18-a9ca-223750d49b0d">391,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE2LTMtMS0xLTM2MjQ4_0310d1ab-f4d6-499c-90bb-67373ec1f6cc">433,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE3LTEtMS0xLTM2MjQ4_a02777d6-b3af-4bf9-810d-3e5aa893488b">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE3LTItMS0xLTM2MjQ4_54d9c16f-42a6-404c-94cd-36743333736d">2,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE3LTMtMS0xLTM2MjQ4_46458df2-5e84-4640-bd85-fce92f61aca9">6,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (Note 24)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE4LTEtMS0xLTM2MjQ4_48b61847-3fca-43bb-9e02-ae745a32a9c0">182,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE4LTItMS0xLTM2MjQ4_4b71a155-f5dd-49df-be0e-69b1d7a57ae4">13,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE4LTMtMS0xLTM2MjQ4_122473b8-f2ff-4126-aa7e-40e6863a3c78">13,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIwLTEtMS0xLTM2MjQ4_ca7d6da1-595d-4b3c-9fa2-43c33c1c9d50">196,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIwLTItMS0xLTM2MjQ4_ab869176-0b91-4305-afae-a88087b1ab42">381,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIwLTMtMS0xLTM2MjQ4_4f171f6e-e306-40f3-85d1-1760c174e604">426,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense (Note 14)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIxLTEtMS0xLTM2MjQ4_cbdad50f-2541-4a6d-b75d-b4cbe5700050">41,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIxLTItMS0xLTM2MjQ4_e72834d5-d7c7-4b1d-9c48-9d6fe29bfd1e">47,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIxLTMtMS0xLTM2MjQ4_5969e262-ec8a-497b-88a1-70ef4984a9d8">51,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before share of earnings from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIzLTEtMS0xLTM2MjQ4_7f813b2d-ebca-47c4-807a-48c3bcb7a5cc">155,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIzLTItMS0xLTM2MjQ4_39c36607-3cce-477f-92da-e59141501138">333,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIzLTMtMS0xLTM2MjQ4_132ae423-85e2-4116-a9e0-681bccab5593">375,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI0LTEtMS0xLTM2MjQ4_27c8126a-da2c-429b-8f41-eeea81541256">2,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI0LTItMS0xLTM2MjQ4_83c21625-eb23-4fa9-9ea7-544457097810">366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI0LTMtMS0xLTM2MjQ4_5744e42e-a844-4cb4-9811-9c0cab704a8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI2LTEtMS0xLTM2MjQ4_128c3eef-571d-4921-9701-7489812e6f3a">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI2LTItMS0xLTM2MjQ4_47cacb30-5293-45a9-b586-9a4f718c9ce5">332,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI2LTMtMS0xLTM2MjQ4_ec347aae-f5a2-4847-a708-00ed52069ca5">375,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI3LTEtMS0xLTM2MjQ4_5d896dc4-6f8b-4873-80e3-50e9a0740d4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI3LTItMS0xLTM2MjQ4_a42dacf3-4ad4-442c-8edf-b83e96345b0f">633</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI3LTMtMS0xLTM2MjQ4_15868ff6-e700-4cd1-b877-8209980ffc2c">1,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI4LTEtMS0xLTM2MjQ4_63cfbd98-ef12-458e-9b51-f0fb2ee510b2">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI4LTItMS0xLTM2MjQ4_04b8633d-57c4-4ba9-8aa1-f9d106d713a3">332,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI4LTMtMS0xLTM2MjQ4_1247ac87-8d26-4019-9795-72b41f85a9aa">373,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per Ordinary Share attributable to the Group (Note 27):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMyLTEtMS0xLTM2MjQ4_1eba59bc-4ae0-422d-b395-7bcb760b342f">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMyLTItMS0xLTM2MjQ4_108f2223-9d61-4a08-9df1-d2699c2774b2">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMyLTMtMS0xLTM2MjQ4_0f27168d-ba45-4e3a-8531-3c9ecf5939da">6.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMzLTEtMS0xLTM2MjQ4_3544084e-5bf0-43ee-9a63-988a3882fb49">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMzLTItMS0xLTM2MjQ4_af3a474e-67d1-47e2-bb30-f7bb916252d3">6.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMzLTMtMS0xLTM2MjQ4_65e07872-9721-455d-afc1-91ecca2fe8ad">6.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic (Note 2 (w))</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM2LTEtMS0xLTM2MjQ4_c7eb21f6-a710-448c-9747-aed1b2481182">67,110,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM2LTItMS0xLTM2MjQ4_2c72b890-9ef4-4b82-b8af-743fd94e702e">52,859,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM2LTMtMS0xLTM2MjQ4_c94794f6-7f97-4434-a55b-d57cabd97a15">53,859,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted (Note 2 (w))</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM3LTEtMS0xLTM2MjQ4_829aae10-8226-41dc-a1e4-c73f00e2a725">68,068,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM3LTItMS0xLTM2MjQ4_7e95d890-1cf4-43ed-9be3-def373a5bce3">53,283,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM3LTMtMS0xLTM2MjQ4_23ba4a7f-07a8-4627-aaa3-f14f49da3140">54,333,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">107</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzMtMS0xLTEtMzYyNDg_128c3eef-571d-4921-9701-7489812e6f3a">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzMtMi0xLTEtMzYyNDg_8bfd6a38-0ae5-4d0e-96e7-08ea8631dc68">332,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzMtMy0xLTEtMzYyNDg_0055555f-83f9-4a62-978c-232c2ce859b7">375,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzUtMS0xLTEtMzYyNDg_7e7084bb-f5d1-437b-a17c-ce4fdda0ac6d">60,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzUtMi0xLTEtMzYyNDg_9dbc0a1e-947c-49e7-8587-f21d60b800dd">48,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzUtMy0xLTEtMzYyNDg_c4f50ba5-b858-42a6-a92e-e108a7b86087">1,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact of long-term funding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzYtMS0xLTEtMzYyNDg_4259ab57-73a1-44ad-bddd-5a1555a6dfa6">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzYtMi0xLTEtMzYyNDg_f2bcbb24-5dd1-49a1-b722-46bb7623cce8">1,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzYtMy0xLTEtMzYyNDg_7b9489d6-b44e-4e4f-853d-9807927c05a9">2,710</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized capital (loss)/gain - investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzctMS0xLTEtMzYyNDg_fed95ab9-6069-44e4-8b65-3cb4e5f4e16c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzctMi0xLTEtMzYyNDg_51ca3b53-afb8-43a9-a44a-650af86c3d6f">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzctMy0xLTEtMzYyNDg_402308a7-79a7-48ac-b0c3-ac8163be027f">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss) on defined benefit pension plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzgtMS0xLTEtMzYyNDg_94e6c84f-61d2-4401-a356-d264cd61cef2">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzgtMi0xLTEtMzYyNDg_5c204a9b-9e7e-4724-84bd-82d2e98a3bc0">4,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzgtMy0xLTEtMzYyNDg_964d8bbd-4460-48be-b7f8-69b3f3acc2b5">2,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzktMS0xLTEtMzYyNDg_646f1bcb-d39e-430a-a4af-9d3ccd21f079">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzktMi0xLTEtMzYyNDg_0eb928d7-98ea-4533-b16b-5c1a3d1c755f">910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzktMy0xLTEtMzYyNDg_ea138d26-d772-4bad-ac90-42413f3f2641">923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEwLTEtMS0xLTM2MjQ4_cfeb2c54-9a53-4060-a19e-676f108b1490">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEwLTItMS0xLTM2MjQ4_4a742b48-7f30-4b49-928b-a9327496e3a3">905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEwLTMtMS0xLTM2MjQ4_a1e4869d-51b0-4df4-96f5-94a79867f17b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEyLTEtMS0xLTM2MjQ4_a81bfbd7-72cf-463c-b9e1-94fb16a2a7ae">97,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEyLTItMS0xLTM2MjQ4_e0a5c844-3b4b-4c6d-832d-1c237b022fc5">373,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEyLTMtMS0xLTM2MjQ4_78254037-e0c0-4024-964a-28a30c3c3f81">369,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less net income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEzLTEtMS0xLTM2MjQ4_05387a2b-f0b7-4eba-85da-abad67a7bdbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEzLTItMS0xLTM2MjQ4_ce3b6b72-6117-4222-8323-c115d104cc79">633</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEzLTMtMS0xLTM2MjQ4_d1285d22-f89c-4ce7-b230-21ce321d9f82">1,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income attributable to the Group</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzE0LTEtMS0xLTM2MjQ4_92072ebc-7dba-4f42-b373-7765688c5044">97,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzE0LTItMS0xLTM2MjQ4_208b0af9-7224-4b17-a4cf-d3154001aa95">372,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzE0LTMtMS0xLTM2MjQ4_7d9a1494-c0b0-4627-b10f-77c3f046df77">367,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">108</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interest</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at January 1, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82b500db472f497aa1b840c473c52982_I20181231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTEtMS0xLTM2MjQ4_73271088-329c-4ba1-bb1b-bb9025c409df">53,971,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b500db472f497aa1b840c473c52982_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTItMS0xLTM2MjQ4_4433bbeb-b17a-47d4-a45a-84c5cfc118c4">4,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61027c17b46042b1b491d04374d1f997_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTMtMS0xLTM2MjQ4_c31e0258-7843-41e7-bfde-0516e7166b89">529,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cd379f284664447a1d6537e6eb39f2e_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTQtMS0xLTM2MjQ4_a92a2cf9-d530-453a-8852-c7f0acf092e8">983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90ad54f2c49046fdacfa10fdbb3eb49a_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTUtMS0xLTM2MjQ4_cbb9af43-6534-4add-8db9-5c7e252f261f">69,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib573afa6334547daa0d3c19f31f8dbef_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTYtMS0xLTM2MjQ4_21628dd8-dbd3-48c8-93af-23977b789927">888,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e24d855ba14a97a64dd8c818215580_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTctMS0xLTM2MjQ4_fb31b8b8-6f56-4063-8d6d-b12213568193">1,354,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0c29cae9c2c47cdbf7580c35f3f4e38_I20181231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTgtMS0xLTM2MjQ4_54f5e165-adf9-4e8a-a882-9bf8b9eb3f0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive Income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI3LTYtMS0xLTM2MjQ4_5a5a980a-2dfe-4f1c-b6ec-230afbe9b05f">373,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI3LTctMS0xLTM2MjQ4_6c276494-b8d4-4d8f-b73a-9d3c025dcb4d">373,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1855db4bb0b4dbb98b316a593a03fa6_D20190101-20191231" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI3LTgtMS0xLTM2MjQ4_ab1c77d7-069a-4845-a338-c64557944d6c">1,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI4LTUtMS0xLTM2MjQ4_0886b741-eeb3-498a-9998-e825acba3443">1,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI4LTctMS0xLTM2MjQ4_6632a3a5-0790-4fbe-87ed-19b24a090825">1,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact of long-term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231" decimals="-3" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI5LTUtMS0xLTM2MjQ4_ae72943b-2097-4220-a650-b80a8a5e7a80">2,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI5LTctMS0xLTM2MjQ4_959dde07-882d-46bf-8ac1-bacf1f6a20b7">2,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized capital gain - investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMwLTUtMS0xLTM2MjQ4_0a269133-3509-45ae-93ad-442c5b418c8c">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMwLTctMS0xLTM2MjQ4_2cbfc87e-5c59-43d6-aafc-82f085395e8f">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss on defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMxLTUtMS0xLTM2MjQ4_c571356a-a650-4d05-bea8-511d470630de">2,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMxLTctMS0xLTM2MjQ4_ce9d9b2f-888a-4125-83c4-fc6ce00f94a3">2,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMyLTUtMS0xLTM2MjQ4_ddaece84-3212-45ac-a832-9773da1f7a43">923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMyLTctMS0xLTM2MjQ4_6e0b09ed-74f4-4b51-a879-3d6f3976c7f6">923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM0LTctMS0xLTM2MjQ4_6ed9bf2c-6cab-4e22-b76f-be90f9c7642a">367,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM1LTEtMS0xLTM2MjQ4_7b61c0d3-926f-483b-8ffb-2b148a9629b8">329,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM1LTItMS0xLTM2MjQ4_a6ff4a95-b6ca-4f08-a9e6-9e620cd8af0d">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa0833c316264e0ea3f2e1469249cc7b_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM1LTMtMS0xLTM2MjQ4_e02b5908-d037-4415-844e-0c59424e5d4b">21,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM1LTctMS0xLTM2MjQ4_85674716-ebad-4f22-b533-41d2a36896b0">21,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM2LTEtMS0xLTM2MjQ4_7ec8cc7a-1f14-4fda-b4a9-cb0ced9f61ad">355,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM2LTItMS0xLTM2MjQ4_05f5cec7-9c09-4f94-a9f5-6f60a3d73ba1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM2LTctMS0xLTM2MjQ4_6de58050-f000-48d5-87be-142af60b022f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa0833c316264e0ea3f2e1469249cc7b_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM3LTMtMS0xLTM2MjQ4_3843ccad-4ca9-41b6-8d56-83a225cf7a11">26,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM3LTctMS0xLTM2MjQ4_205f599e-4514-4a40-9d2f-d70c8d249348">26,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa0833c316264e0ea3f2e1469249cc7b_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM4LTMtMS0xLTM2MjQ4_1ad99d92-c55d-412f-918e-adc233138d26">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM4LTctMS0xLTM2MjQ4_9d00b51c-ac35-4a45-a3cf-1993f29f3904">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTEtMS0xLTM2MjQ4_444bc5ac-806b-4e52-825d-126eac4544e4">1,035,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTItMS0xLTM2MjQ4_ae7bc840-e23a-417a-9595-0a128d1799cc">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f8d018bbf94621ae5409b6eda9be54_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTQtMS0xLTM2MjQ4_67ac1795-85cb-4542-b7a1-b8aee1461740">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTYtMS0xLTM2MjQ4_49bdacf2-b231-4ea2-89ad-4b08c4612715">146,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTctMS0xLTM2MjQ4_a8e0d067-56e6-4b01-9a24-9c730bad0a64">146,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQwLTYtMS0xLTM2MjQ4_1f23b167-28a2-475a-923c-a5109fdf5456">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQwLTctMS0xLTM2MjQ4_9fa41fec-bb78-4a7e-8586-2bb1e79e8ada">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of redeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1855db4bb0b4dbb98b316a593a03fa6_D20190101-20191231" decimals="-3" name="iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQxLTgtMS0xLTM2MjQ4_37bae16a-aff8-461c-ad40-1299daa6964c">32,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231" decimals="-3" name="iclr:RedeemableNoncontrollingInterestAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQyLTYtMS0xLTM2MjQ4_a0c86861-4994-405c-92a2-6203a14df269">5,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="iclr:RedeemableNoncontrollingInterestAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQyLTctMS0xLTM2MjQ4_65faa3af-5a61-4fdb-96a7-a1d7a9162693">5,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1855db4bb0b4dbb98b316a593a03fa6_D20190101-20191231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQyLTgtMS0xLTM2MjQ4_54d66df7-02c5-4bdc-a06c-5fb0415f7379">5,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i68a8df88a51a4914b34c331af346e762_I20191231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTEtMS0xLTM2MjQ4_52f8e91e-afc3-4328-acdc-5c2e091d788d">53,622,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a8df88a51a4914b34c331af346e762_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTItMS0xLTM2MjQ4_52ac2123-4421-494e-8f49-a73dc57f1e03">4,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9c424a36dd4a109577161d2940b41b_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTMtMS0xLTM2MjQ4_1a3140b2-c381-4902-97c9-c41088b9b7ef">577,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e62c0f5e8c74f1aa308fbbfc8707376_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTQtMS0xLTM2MjQ4_10110c35-da0c-496c-9d28-e16c5d369aa6">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6d50f7cd15643d798684811166d0ba9_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTUtMS0xLTM2MjQ4_773c005d-06c4-46fd-88d8-4554c715bd3b">75,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750b3a109f9044d3af3bdc0259dc0293_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTYtMS0xLTM2MjQ4_7f9c3007-021f-4321-b42e-e730c2429f50">1,110,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTctMS0xLTM2MjQ4_a402df5a-d126-4442-9c6d-17b81c9b394a">1,618,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94be34191abe4629b7ebef1ad29ea857_I20191231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTgtMS0xLTM2MjQ4_fa3f036d-f947-47c0-9094-0890d442c3fa">39,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.279%"><tr><td style="width:1.0%"></td><td style="width:29.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.371%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interest</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i68a8df88a51a4914b34c331af346e762_I20191231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctMS0xLTEtMzYyNDg_33667cfe-7fb0-411e-8150-2820206fec99">53,622,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68a8df88a51a4914b34c331af346e762_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctMi0xLTEtMzYyNDg_e9ea9d85-c3a6-44ca-ba3b-ac59eac30cdd">4,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c9c424a36dd4a109577161d2940b41b_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctMy0xLTEtMzYyNDg_dc919e29-bf40-4600-9050-3470f37c9094">577,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e62c0f5e8c74f1aa308fbbfc8707376_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctNC0xLTEtMzYyNDg_6ddd5999-b1fe-486c-84b0-5aa1e6b54a0c">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6d50f7cd15643d798684811166d0ba9_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctNS0xLTEtMzYyNDg_1b532770-0ac0-4967-b5fd-cb7b1d190ca2">75,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750b3a109f9044d3af3bdc0259dc0293_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctNi0xLTEtMzYyNDg_130d5894-fe22-4528-95ba-3f2d669387b2">1,110,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctNy0xLTEtMzYyNDg_a24b1808-3664-4b7b-8571-7cf335f0934e">1,618,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94be34191abe4629b7ebef1ad29ea857_I20191231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctOC0xLTEtMzYyNDg_b58a8d81-2a22-4745-90bd-429c1ed2dd0d">39,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzktNi0xLTEtMzYyNDg_acf1ccb1-b412-4619-80c3-567dd7a5739f">332,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzktNy0xLTEtMzYyNDg_ac2a0960-c8c2-4b46-897a-53ea067ec6c5">332,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0962b68ff61246e5a9f5b9e8d38e3989_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzktOC0xLTEtMzYyNDg_80ba1fbe-51cf-4508-a8cd-f64996f32205">633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzEwLTUtMS0xLTM2MjQ4_1206e32c-fd72-4c81-86c9-38fac7b4a77f">48,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzEwLTctMS0xLTM2MjQ4_da4d52c0-fe71-42ae-817f-6264702e763d">48,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact of long-term funding </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzExLTUtMS0xLTM2MjQ4_4116f192-bf00-4af0-a421-a5a10f53c403">1,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzExLTctMS0xLTM2MjQ4_b4bfee4b-3f32-4542-8a9a-f1a1d2e7a3d3">1,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized capital loss - investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzEzLTUtMS0xLTM2MjQ4_f23d069b-3ca8-4b5d-98ed-34e5d9b381a5">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzEzLTctMS0xLTM2MjQ4_1acceed8-c36c-401a-8a82-92351bbe16a8">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss on defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE0LTUtMS0xLTM2MjQ4_cd4ae131-4321-4300-b7a0-ceeb6378d9b2">4,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE0LTctMS0xLTM2MjQ4_9b3fdb94-0400-4971-8543-c6cac2351ce5">4,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE1LTUtMS0xLTM2MjQ4_fe748d3a-452e-4067-ad07-41f14dfb7e41">910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE1LTctMS0xLTM2MjQ4_5517ff9e-aaef-4697-9b55-67be41fedb15">910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE2LTUtMS0xLTM2MjQ4_729e23f2-f045-418c-b14a-a71afab5df61">905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE2LTctMS0xLTM2MjQ4_9a1bac8a-c261-4533-b502-686f1af8ff44">905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE4LTctMS0xLTM2MjQ4_5959010d-140b-4518-a081-7a6cebbc01de">372,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIwLTEtMS0xLTM2MjQ4_04453c52-520a-48cb-aa83-5ce1f0b930cf">193,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIwLTItMS0xLTM2MjQ4_18855576-bd61-4f1c-bb14-62b26e6d87c2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ce1847176642a7a8d12c476ee2b2d1_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIwLTMtMS0xLTM2MjQ4_e74e1630-09cf-4fbb-8b9a-a2f922e2a971">13,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIwLTctMS0xLTM2MjQ4_59ce2128-257a-459c-bc12-4b19d33152d3">13,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIxLTEtMS0xLTM2MjQ4_63ada338-4800-442c-bd01-bbf96f2b73af">207,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIxLTItMS0xLTM2MjQ4_b0c4e09a-0686-4160-804e-f9cdf8ab1d3b">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIxLTctMS0xLTM2MjQ4_a01f1626-93a5-4315-a558-ef1898a3914f">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ce1847176642a7a8d12c476ee2b2d1_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIyLTMtMS0xLTM2MjQ4_1f8d88fc-7a79-43d2-8d84-0f19c99db6d5">25,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIyLTctMS0xLTM2MjQ4_bf3a9c03-2aa7-401a-b2da-3008976970b4">25,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90ce1847176642a7a8d12c476ee2b2d1_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIzLTMtMS0xLTM2MjQ4_8422cc47-bc60-4a0f-b950-d2ed19b45dea">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIzLTctMS0xLTM2MjQ4_be382ddc-dd15-4613-be5d-9fc25c4912fb">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTEtMS0xLTM2MjQ4_ad8b53dd-49f3-4300-9503-3653aa0a11fc">1,235,218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTItMS0xLTM2MjQ4_9bb5fe4b-c94c-4d0c-a7d7-d3258d0d18ff">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0b7e51cfbd494db946ce79e9bb7c29_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTQtMS0xLTM2MjQ4_a75a16b3-cc23-4970-9045-6792cc924c35">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTYtMS0xLTM2MjQ4_94efc3fb-369c-4bbe-8ce4-40ae8536e4f6">175,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTctMS0xLTM2MjQ4_be65803b-0bbc-4244-acf2-44239621c805">175,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI1LTYtMS0xLTM2MjQ4_8aa89681-8bf3-4b87-8c7c-253844fe7625">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI1LTctMS0xLTM2MjQ4_621b49b1-926e-4a03-afd2-2773f37d8516">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231" decimals="-3" sign="-" name="iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI2LTYtMS0xLTM2MjQ4_76cfa8ab-891a-4a7e-a521-063918ff5e86">4,522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI2LTctMS0xLTM2MjQ4_e1ce2994-a53e-44fd-bf4f-f8de6e845886">4,522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0962b68ff61246e5a9f5b9e8d38e3989_D20200101-20201231" decimals="-3" name="iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI2LTgtMS0xLTM2MjQ4_43394604-51a3-4854-a3e0-2b081d1780d7">4,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of call option on noncontrolling interest shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0962b68ff61246e5a9f5b9e8d38e3989_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI3LTgtMS0xLTM2MjQ4_1fa2250c-f16f-4a54-b8e5-5ca4758d0516">44,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a3c3f480da466f979b83dd7f24aaa6_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTEtMS0xLTM2MjQ4_8dff6dc2-0713-46f6-9062-eb691e05ebbe">52,788,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a3c3f480da466f979b83dd7f24aaa6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTItMS0xLTM2MjQ4_debaacfe-2bcf-46ab-8013-a45cd516ddee">4,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f26675e42484470a39567b27487f173_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTMtMS0xLTM2MjQ4_12b9b272-a321-48ac-904f-a345240768e2">617,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17db85087b8349beb2ce7a3c58760e87_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTQtMS0xLTM2MjQ4_13cda993-bc27-48f8-a636-001dc75f3eb3">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if485c36ee8d54bf0a345ece247288e1c_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTUtMS0xLTM2MjQ4_ead7af4a-a27a-4183-9dee-01b50aa909d3">35,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2f810ef5f14db3a7c717dc50d0207d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTYtMS0xLTM2MjQ4_a0dd4834-b480-4aa0-b1d9-80c59f47b96f">1,262,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTctMS0xLTM2MjQ4_3ab3828d-17f5-4881-a26f-4d11ad7fc5b1">1,850,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6be1e93cc2e4a22825aee8e63f813bd_I20201231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTgtMS0xLTM2MjQ4_ea4514ec-e820-497d-8ce9-3cad89171911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.056%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Group</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a3c3f480da466f979b83dd7f24aaa6_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctMS0xLTEtNDE5ODk_c0911bae-ed2b-477b-b5c2-b5dee618125e">52,788,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a3c3f480da466f979b83dd7f24aaa6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctMi0xLTEtNDE5ODk_71dc7e3a-4dc7-4382-b305-58a190d48359">4,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f26675e42484470a39567b27487f173_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctMy0xLTEtNDE5ODk_85858af7-bb28-4071-8270-af9533645e20">617,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17db85087b8349beb2ce7a3c58760e87_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctNC0xLTEtNDE5ODk_45c6acc0-5794-47ff-ac76-94859b4c03e8">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if485c36ee8d54bf0a345ece247288e1c_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctNS0xLTEtNDE5ODk_5040e1ba-fa12-4dde-ae2b-123d644fa7e0">35,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2f810ef5f14db3a7c717dc50d0207d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctNi0xLTEtNDE5ODk_bde55093-076f-40e9-91ac-40ffb97a5803">1,262,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctNy0xLTEtNDE5ODk_f6e6f4d7-4065-4632-98b6-9957c9378c07">1,850,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a8bfe01d1774f4e96679362547f99f0_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzktNi0xLTEtNDIxMjU_29ee85dd-6e1f-4f80-90eb-27bde1e28839">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzktNy0xLTEtNDIxMjU_1618a999-b629-4fd3-98f8-86a729c6960a">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzEwLTUtMS0xLTQyMTI1_7750534a-a6b0-4430-9c69-eb58524832e6">60,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzEwLTctMS0xLTQyMTI1_0e6d79a4-60bd-43e7-acd0-4ed6e316b3ce">60,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact of long-term funding </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzExLTUtMS0xLTQyMTI1_4a63af06-152b-48d5-978f-f077773fe477">525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzExLTctMS0xLTQyMTI1_e46d3564-4875-41a9-9c0b-6d8af8372bc0">525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE0LTUtMS0xLTQyMTI1_17a2b20c-c634-4d00-96b6-ddace8cdb8bf">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE0LTctMS0xLTQyMTI1_eb01dbe4-49e9-4b8f-844d-988310a77e03">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE1LTUtMS0xLTQyMTI1_be7f180e-5823-4d7a-8913-0e25dd2ce279">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE1LTctMS0xLTQyMTI1_2b9b813a-0438-42ed-bbde-6af314913791">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE2LTUtMS0xLTQyMTI1_187ec990-f835-4ce3-879b-85e6071a719e">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE2LTctMS0xLTQyMTI1_6f062662-6a02-4789-94d9-8104a7c7b461">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE4LTctMS0xLTQyMTMz_8c117ae8-4d4d-470a-9633-d443dc2c9d3b">97,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIwLTEtMS0xLTQyMTUx_622d7f94-8096-430b-8bb0-9546d0ff3b54">1,065,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIwLTItMS0xLTQyMTUx_e7aca88d-4fdd-49f6-a1d0-2fc05b3d1b8d">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIwLTMtMS0xLTQyMTUx_94a2cfcc-9ad8-401d-9353-731be7931594">118,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIwLTctMS0xLTQyMTUx_c79d99de-cbf4-4417-a482-133074a35486">118,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIxLTEtMS0xLTQyMTUx_4fa56c28-f840-4ba3-9a71-12b04b416b0c">328,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIxLTItMS0xLTQyMTUx_e266db60-a189-4410-aba2-e6274a85e908">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIxLTctMS0xLTQyMTUx_3c835bc8-dc59-49f5-839d-5a9450aa8d80">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIyLTMtMS0xLTQyMTUx_712b91e6-8347-478f-ac88-6c6a9067412c">133,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIyLTctMS0xLTQyMTUx_3b613aa2-fe1b-4b7e-9f57-ce2e80071c48">133,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIzLTMtMS0xLTQyMTUx_b6af9701-0a77-4d88-80f3-a55a11ec9d50">853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIzLTctMS0xLTQyMTUx_5e70926c-9a30-40b8-b700-0c2057c705cb">853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of shares associated with a business combination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI0LTEtMS0xLTQyMTUx_16771fa9-834b-43f7-87d1-ce3b849c5930">27,372,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI0LTItMS0xLTQyMTUx_4d65e9a7-7a70-4660-9d94-6459136b6471">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI0LTMtMS0xLTQyMTUx_28873f2e-e7fc-4c5e-a6de-acb558de4cb7">5,656,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI0LTctMS0xLTQyMTUx_038e187f-75f4-4959-be74-e35627545444">5,658,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI1LTMtMS0xLTQyMTUx_034175e3-4ec0-4acd-8114-587dd04e8fff">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI1LTctMS0xLTQyMTUx_c9cf6b99-569d-4580-976b-d06d89e9dd23">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica03b62926534e1c96e97c487693f9b2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTEtMS0xLTQxOTg4_03ed2196-ac0a-49e8-8aad-d780c15ad44a">81,554,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica03b62926534e1c96e97c487693f9b2_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTItMS0xLTQxOTg4_03807c85-37b3-4a30-b711-3f5af1fea660">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbb11854a164b7bb15d92889e4c2bb4_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTMtMS0xLTQxOTg4_8d6f59ea-76b6-4077-b48d-411b9249bf06">6,733,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd6e0d8b7e5144638aef2b48835ca0f3_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTQtMS0xLTQxOTg4_857f2cf1-b726-4dcf-a7f9-ab2df5955399">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5839a28afffc48f8a9ce6fc8cd0b1215_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTUtMS0xLTQxOTg4_892ef9f4-dd7c-4c50-af52-3e224a811b7e">90,937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7670eea39a0649e3b66786e7d2cf4f1c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTYtMS0xLTQxOTg4_3dd370de-0aa0-451e-9188-4a7fb72ed4b7">1,416,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTctMS0xLTQxOTg4_3cf6b105-d157-423b-b5b0-3d5d0bc52ab5">8,066,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">111</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_130"></div><hr style="page-break-after:always"/><div style="min-height:21.6pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMtMS0xLTEtMzYyNDg_c887a750-f8ae-4ca0-85f7-1b0e5c898603">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMtMi0xLTEtMzYyNDg_e0183486-a8d0-4c59-9697-83da81f06eda">332,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMtMy0xLTEtMzYyNDg_976dce0f-bb61-4455-8bf4-923f14937e9c">375,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzYtMS0xLTEtMzYyNDg_767005ef-d688-46ac-bd55-c991d43dfa9d">314,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzYtMi0xLTEtMzYyNDg_c21900df-6e51-4ad2-8b7b-b66d76e92a57">66,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzYtMy0xLTEtMzYyNDg_12435389-0cdd-400d-b089-e9e20ec8fea4">61,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Impairment of long lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzctMS0xLTEtMzYyNDg_ffd94fb6-c4e2-491d-b18c-bc239455910e">20,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzctMi0xLTEtMzYyNDg_cb1e2716-274b-40f7-9cd9-5c367f130fa7">5,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzctMy0xLTEtMzYyNDg_37176d86-6496-4d4a-87ca-838ca6b22549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Reduction in carrying value of operating right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzgtMS0xLTEtMzYyNDg_18332793-106a-4d15-912f-bf4b8c50aeb1">45,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzgtMi0xLTEtMzYyNDg_360c5d6f-4634-412e-9401-94fd4c1cdf71">28,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzgtMy0xLTEtMzYyNDg_761e1a29-0efe-45e5-a5d5-b37c31e90cfb">30,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE2LTEtMS0xLTM2MjQ4_91826338-4977-46a8-b81e-d394dc178de2">2,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE2LTItMS0xLTM2MjQ4_ecf131ee-77f0-432f-a775-6bf6ff86f62d">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE2LTMtMS0xLTM2MjQ4_5c42276c-5d04-47b0-b75a-97a0d9b1f3b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Charge/(credit) on interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE3LTEtMS0xLTM2MjQ4_f0cd7e58-ac02-42f0-8c0a-17e65f897103">891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE3LTItMS0xLTM2MjQ4_7499fb61-a100-454c-84d6-23cbf1999be3">910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE3LTMtMS0xLTM2MjQ4_60ff6e4a-ab50-4062-a090-2db27809169e">923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Amortization of financing costs and debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE4LTEtMS0xLTM2MjQ4_d17eec7b-0509-43d9-aa0c-9e7858032a71">12,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE4LTItMS0xLTM2MjQ4_bbcb8531-06c7-495b-a9c6-d72b40d10bc5">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE4LTMtMS0xLTM2MjQ4_49375343-ad3e-4645-a8f6-d437d1ed910c">540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE5LTEtMS0xLTM2MjQ4_8ae5e49f-9f94-4c5a-ac2d-931a8d315291">133,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE5LTItMS0xLTM2MjQ4_7a7b1b5e-b44f-4a36-bbaa-05630b7b6b29">26,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE5LTMtMS0xLTM2MjQ4_2eabc0c7-9ae1-4e97-8f1c-7444d865189a">26,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzEzLTEtMS0xLTUyMTcx_41b566cf-23e8-4b70-8b87-c2b0d6d7708d">73,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzEzLTItMS0xLTUyMTcx_bca9a000-4363-4d09-bfd7-f07b27c3891a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzEzLTMtMS0xLTUyMTcx_e3914ec7-9d69-45f6-adc1-b51c5869f30c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIwLTEtMS0xLTM2MjQ4_57a9f8d4-b3e9-4017-8f1b-40bce5470de7">60,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIwLTItMS0xLTM2MjQ4_45862641-50f9-48d1-bd8c-16c74d86e731">927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIwLTMtMS0xLTM2MjQ4_5ba2c0d1-ba45-4d05-a8c5-dabcbc987dd9">1,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Unrealized foreign exchange (gain)/loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE1LTEtMS0xLTUyMTgx_1540d195-7b7f-4125-9bcc-9f7d18206c03">6,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE1LTItMS0xLTUyMTgx_e0ac4bd9-081b-4f8d-a573-2fdfab65d3f5">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE1LTMtMS0xLTUyMTgx_1e021499-f3d5-4350-9dd7-9c36ceb432f6">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE0LTEtMS0xLTUxMTcw_41992e74-16eb-4456-93cd-9a6cf334ce5a">3,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE0LTItMS0xLTUxMTcw_2e129b9a-f9ad-4b93-83d8-e63db8d3c98e">6,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE0LTMtMS0xLTUxMTcw_c273e83c-89bd-4243-85ab-6b55a37b749e">2,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIyLTEtMS0xLTM2MjQ4_06aed684-4f7c-41b1-973a-aae9a2a4ea21">113,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIyLTItMS0xLTM2MjQ4_5f4979db-a1c9-4547-82ec-5418f1556205">175,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIyLTMtMS0xLTM2MjQ4_a1980c4d-0c60-4e9b-b70b-c2082bd59229">101,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIzLTEtMS0xLTM2MjQ4_f964e10b-e3c7-47fd-a91d-7f61bfce6b39">17,656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIzLTItMS0xLTM2MjQ4_82d75da3-f14c-4804-af6f-39e0a90f326d">5,748</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIzLTMtMS0xLTM2MjQ4_cf15929b-b44d-4f55-8cd4-21cf90a52d50">55,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI3LTEtMS0xLTM2MjQ4_f7f5b360-4e25-4bcd-a130-46964121877e">69,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI3LTItMS0xLTM2MjQ4_d6b35307-ff60-4a03-a2cb-87e4cbe00653">291,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI3LTMtMS0xLTM2MjQ4_fc15d517-9981-441c-80a6-f42b46cfb458">86,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other net assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI4LTEtMS0xLTM2MjQ4_512937f5-7076-4ae4-ac69-548e38d902ba">108,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI4LTItMS0xLTM2MjQ4_a1f7772f-32ec-4d07-b14e-ed634f8905f9">2,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI4LTMtMS0xLTM2MjQ4_c98e8412-152c-41d5-b29d-7f1cd9fb2e85">11,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMzLTEtMS0xLTM2MjQ4_3c30e955-5bcc-4e45-8afa-4fe1c981d255">829,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMzLTItMS0xLTM2MjQ4_4289511f-cd1c-406e-93bc-b0222c70d629">568,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMzLTMtMS0xLTM2MjQ4_238b3575-90cf-4a9e-b2e1-48a5e2d74b67">412,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM1LTEtMS0xLTM2MjQ4_84ff00e1-fb4a-405a-ae08-85e47054cd6a">93,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM1LTItMS0xLTM2MjQ4_4189a269-d91c-4a05-bf8c-db4b31503b12">40,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM1LTMtMS0xLTM2MjQ4_0b3567b2-ae87-45cb-9b48-4c42ad94b3aa">38,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of subsidiary undertakings (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM2LTEtMS0xLTM2MjQ4_eee15f3f-ca34-4204-ade8-2a1253afbfa5">5,914,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM2LTItMS0xLTM2MjQ4_a7047fe3-821b-497b-8fdb-0b1d928ae618">47,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM2LTMtMS0xLTM2MjQ4_f9ecb903-f780-46e2-94a6-293fae410e12">131,272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Investment in equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM3LTEtMS0xLTM2MjQ4_5b4fd2da-8968-44ad-bdb8-68b1581c972b">2,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM3LTItMS0xLTM2MjQ4_fd2fd418-130c-464d-bdbf-a5e2560a2532">2,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM3LTMtMS0xLTM2MjQ4_90c1b9f9-5583-429b-a4c7-d9e62d3f395c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loan to equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM4LTEtMS0xLTM2MjQ4_31ebcc51-1b03-4ae2-b768-ed25fcdfa1e8">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM4LTItMS0xLTM2MjQ4_fcf05af3-8820-4353-8a1b-a1dbe5a55410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM4LTMtMS0xLTM2MjQ4_a64ceb56-5d8a-4202-a2e4-24fd83195bff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Sale of available for sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM5LTEtMS0xLTM2MjQ4_8805caac-68f1-407f-ba28-be1fb12181c6">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM5LTItMS0xLTM2MjQ4_2a367d4f-c338-4926-83e8-af30ae69230e">47,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM5LTMtMS0xLTM2MjQ4_4c5757f9-54bc-49be-b330-9d3498b280b5">21,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of available for sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQwLTEtMS0xLTM2MjQ4_2439d89c-6cf9-46a5-b0fd-73a30ce60100">480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQwLTItMS0xLTM2MjQ4_33a6aa27-9cd1-4640-8427-a1b13ca439c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQwLTMtMS0xLTM2MjQ4_7fe9cb4d-199c-471d-9293-af96fbb581e8">9,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of investments in equity - long term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQxLTEtMS0xLTM2MjQ4_23a303a3-8edc-48e0-949d-6bb3569573bf">3,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQxLTItMS0xLTM2MjQ4_f04b9246-c10e-4712-9040-05c31487a181">3,212</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQxLTMtMS0xLTM2MjQ4_b667d836-aadb-42e2-be99-eb73abb29e28">3,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQyLTEtMS0xLTM2MjQ4_7f5cd34f-7d77-4bd7-90eb-11f5bea3b390">6,024,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQyLTItMS0xLTM2MjQ4_752da563-c73c-432c-a1d0-a6557768b5af">46,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQyLTMtMS0xLTM2MjQ4_dfc4a5ca-493e-4045-a3eb-53d46ff54fa2">162,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ0LTEtMS0xLTM2MjQ4_1c15313d-6c94-486c-b51a-025979aabce5">30,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ0LTItMS0xLTM2MjQ4_af1d685d-e9fe-4c3b-83cf-f206dbff9532">1,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ0LTMtMS0xLTM2MjQ4_65cc921e-f1ce-460d-b28d-d7b0bb507e99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Drawdown of credit lines and facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ1LTEtMS0xLTM2MjQ4_bb3398ce-654d-4c8a-97fa-1cf338872261">5,905,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ1LTItMS0xLTM2MjQ4_1b6afa83-fd13-48e0-b1c4-a793cbd740a7">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ1LTMtMS0xLTM2MjQ4_574f189e-38be-4fb9-b7e1-5277ae4287e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Repayment of credit lines and facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ2LTEtMS0xLTM2MjQ4_e954d510-c763-40b2-8b2f-3eaf64aa2b09">877,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ2LTItMS0xLTM2MjQ4_1ce1cfd7-29b2-4419-967e-a05f64165b49">350,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ2LTMtMS0xLTM2MjQ4_2bc2fd9f-6b16-4c36-961c-4a089d3b410b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ3LTEtMS0xLTM2MjQ4_facbe4cb-6396-4929-be43-fafeee8a6e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ3LTItMS0xLTM2MjQ4_b6034294-138d-4d68-9a34-ca80011801cd">43,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ3LTMtMS0xLTM2MjQ4_f5b27b1d-dfd0-4ed8-bd0f-ef250105da60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from the exercise of equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ4LTEtMS0xLTM2MjQ4_515a240d-c047-457c-80d0-3a417397a321">118,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ4LTItMS0xLTM2MjQ4_20e5ef88-054d-4676-95af-2661f44c980c">13,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ4LTMtMS0xLTM2MjQ4_e0abc193-6364-4657-9974-d5792333dad2">21,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ5LTEtMS0xLTM2MjQ4_0beb118f-b8ae-4777-95c5-73681b978015">853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ5LTItMS0xLTM2MjQ4_35529819-a935-481b-95ca-c51d5f723109">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ5LTMtMS0xLTM2MjQ4_b79a2bbf-5da1-45ec-9223-890ca6be60be">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUxLTEtMS0xLTM2MjQ4_c2dd3487-b3e6-4b50-9b28-c0ce70c23e79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUxLTItMS0xLTM2MjQ4_a4f7fdac-d949-48cc-8f6f-c53003b0d8d5">175,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUxLTMtMS0xLTM2MjQ4_460864ae-3b5a-4d3a-b9d2-5a10787927f1">146,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUyLTEtMS0xLTM2MjQ4_de6766af-1163-4369-8f89-981dfbc53428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUyLTItMS0xLTM2MjQ4_9b6cca19-9b44-44af-b1d5-e02fc4e40247">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUyLTMtMS0xLTM2MjQ4_225bc7bf-75f4-467c-aca0-a7d64d1f4f00">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Settlement of interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU0LTEtMS0xLTM2MjQ4_936f7d74-dd14-4b30-8d3b-88b895185397">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU0LTItMS0xLTM2MjQ4_d9505087-aaba-48b6-a5aa-424fabbc64e3">905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU0LTMtMS0xLTM2MjQ4_6ab082e0-c001-40d6-8db0-7d50fb45f3d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU1LTEtMS0xLTM2MjQ4_5c5b836a-98ef-460f-a0f0-86b3a017adcc">5,114,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU1LTItMS0xLTM2MjQ4_a759bfcd-6f30-486f-afb7-8fa76fb7fc9b">208,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU1LTMtMS0xLTM2MjQ4_9e16f7c7-20bb-4fd5-8f14-641bb9ae65bf">125,406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Effect of exchange rate movements on cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU2LTEtMS0xLTM2MjQ4_3db7508d-ef68-42c8-a656-5123947acbc8">7,727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU2LTItMS0xLTM2MjQ4_181a4a1a-c255-4458-ad2a-011014ceeffb">6,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU2LTMtMS0xLTM2MjQ4_dbdd8f5d-50b5-4fe3-b19a-9954bf7d006b">650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Net (decrease)/increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU3LTEtMS0xLTM2MjQ4_94f02218-ef94-419a-99f7-7e7bbb4753cf">88,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU3LTItMS0xLTM2MjQ4_271b1f50-e03b-4b5c-8d01-537547792dc6">319,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU3LTMtMS0xLTM2MjQ4_e06c9b50-0d08-42b0-ae4a-f6f3f18c1f6d">124,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU4LTEtMS0xLTM2MjQ4_7fb336eb-73ba-4e33-9b52-163287f1e2ae">840,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU4LTItMS0xLTM2MjQ4_b0ce09dd-29eb-454b-994e-23eeca7590f0">520,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e24d855ba14a97a64dd8c818215580_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU4LTMtMS0xLTM2MjQ4_ba07e387-3235-4c72-9449-0cd63be4dce2">395,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU5LTEtMS0xLTM2MjQ4_eccc27c0-77e6-4612-8830-507b171115f7">752,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU5LTItMS0xLTM2MjQ4_eeba804d-e4a0-4874-b72c-1f0efbdf619c">840,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU5LTMtMS0xLTM2MjQ4_08025f13-9f12-4169-8695-faa869dccd35">520,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statement</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_136"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzE3MjA_5d52c6b2-f3d0-4bc7-bbe8-49b94212f82f" continuedAt="i1133b01a08b24b5d81c88ad486b5277e" escape="true">Description of business </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1133b01a08b24b5d81c88ad486b5277e"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2021 we had approximately <ix:nonFraction unitRef="employee" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="0" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3Xzk3Mw_ff449fdc-1ae9-4a48-b016-7cd051e0ec07">38,330</ix:nonFraction> employees, in <ix:nonFraction unitRef="location" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="INF" name="iclr:NumberOfLocations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3Xzk5MA_ce41e8e4-d996-4e2b-8c7a-49e6a5b515d2">142</ix:nonFraction> locations in <ix:nonFraction unitRef="country" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzEwMDY_cd4c1a3f-c783-4424-aa22-58abcf1a37c9">53</ix:nonFraction> countries. During the year ended December&#160;31, 2021, we derived approximately <ix:nonFraction unitRef="number" contextRef="iccd478baae434af395e71d177b28bd2e_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzEwNzE_76a30cb1-facd-46b8-8596-987080f37909">47.1</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i50822bc1a62345aca0219ef6e28bf127_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzEwNzU_d727428b-d899-43d5-9fbc-cd52a89fd0ab">46.4</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="iad57efdbfd9c4bd3a89a3bbc5b80f396_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzEwODI_bad24c20-6e11-4ccc-bdf6-08e7654b4ccb">6.5</ix:nonFraction>% of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div></ix:continuation><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_139"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDM3_763e8f54-d3f3-4eda-b299-36965bdacd93" continuedAt="i7f511e2319c540ea8a1610790f05e095" escape="true">Significant accounting policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7f511e2319c540ea8a1610790f05e095" continuedAt="i9130dd0715214fdeb01367b5d31af104"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDE4_ae9610f9-fe8f-4856-a1c5-7160c71a6178" continuedAt="i1b0da6c53deb4b6f88ff9948ed42b715" escape="true">Basis of consolidation</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i1b0da6c53deb4b6f88ff9948ed42b715">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</ix:continuation></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDEx_892f0efe-219f-4059-839f-61782487eb4d" continuedAt="ibb50b686af0e427aab749bfa34e970f9" escape="true">Use of estimates</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ibb50b686af0e427aab749bfa34e970f9">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.</ix:continuation></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDQ3_7a997313-9024-4112-aac0-88c2af1b6727" continuedAt="i5e78ad84a1e2497fbf30e3963a88b256" escape="true">Revenue recognition</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i5e78ad84a1e2497fbf30e3963a88b256" continuedAt="i4d68ce735f884379950da37d01a2f320"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i9130dd0715214fdeb01367b5d31af104" continuedAt="ic06e6d75f1524236bc4bc51eb50024d0"><ix:continuation id="i4d68ce735f884379950da37d01a2f320"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDI4_92974f15-59d9-40a1-809f-b17a6c8dd664" continuedAt="id53f61e6664f4de796bbef40b94f023a" escape="true">Pass-through/ Reimbursable expenses</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="id53f61e6664f4de796bbef40b94f023a" continuedAt="i5c239ec98e7c432884bc85d613b0c1ee"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pass through/ Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(e) Direct costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic06e6d75f1524236bc4bc51eb50024d0" continuedAt="i755b3641f5ad4048965e56ccc156412f"><ix:continuation id="i5c239ec98e7c432884bc85d613b0c1ee"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(e) &#160; Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time i.e. the full-service obligation is in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Investigator payment costs are recorded and reported reflecting investigator activity over the life of the contract. Investigator payments are made based on predetermined contractual arrangements. Timing of payments may differ from the recording and reporting of the expense which is based on activity.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(f) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDU5_f66616d6-1386-4e41-8591-615d2b8f5c66" continuedAt="ie5d71e4beb9a4d10a98d55f3787358ca" escape="true">Advertising costs</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ie5d71e4beb9a4d10a98d55f3787358ca">All costs associated with advertising and promotion are expensed as incurred.</ix:continuation> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(g) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzk4_84f673b9-6b18-4f1e-ab98-214fab0b3ea3" continuedAt="i439035d18b084ea69c07bf8ae3a94fbd" escape="true">Foreign currencies and translation of subsidiaries</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i439035d18b084ea69c07bf8ae3a94fbd" continuedAt="i53a15eb7620140fb8f141c5fa0a77277">ICON plc's financial statements are prepared in United States dollars. Transactions in currencies other than the functional currency of the individual entities within the ICON Group are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the individual entities within the ICON Group are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income.</ix:continuation> <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:ForeignCurrencyDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzk5_f5042e72-61bd-4eaf-9dc3-b7e2303e3438" continuedAt="i5a2e0fe7e41d49df8e5beee522eec8f4" escape="true">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 were as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div><ix:continuation id="i5a2e0fe7e41d49df8e5beee522eec8f4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTo5YWRjN2NlNjFiZTU0YjE2YTFhZDEzZWY1NTNhYWI5Yy90YWJsZXJhbmdlOjlhZGM3Y2U2MWJlNTRiMTZhMWFkMTNlZjU1M2FhYjljXzMtMS0xLTEtMzYyNDg_650367f1-215e-45ce-a0c9-5e3208946cb9">14,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTo5YWRjN2NlNjFiZTU0YjE2YTFhZDEzZWY1NTNhYWI5Yy90YWJsZXJhbmdlOjlhZGM3Y2U2MWJlNTRiMTZhMWFkMTNlZjU1M2FhYjljXzMtMi0xLTEtMzYyNDg_74aaeed9-0056-46ea-800d-4ee966bcd001">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTo5YWRjN2NlNjFiZTU0YjE2YTFhZDEzZWY1NTNhYWI5Yy90YWJsZXJhbmdlOjlhZGM3Y2U2MWJlNTRiMTZhMWFkMTNlZjU1M2FhYjljXzMtMy0xLTEtMzYyNDg_7549a526-aca4-416b-b483-053f02616da2">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i53a15eb7620140fb8f141c5fa0a77277">The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. Foreign currency transaction gains and losses are reported in other comprehensive income ("currency impact of long term funding") rather than through income where the foreign currency transaction is 'long-term investment' in nature i.e. settlement is not planned or anticipated in the foreseeable future.</ix:continuation>  </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i755b3641f5ad4048965e56ccc156412f" continuedAt="i5f7e07f6a0fd40ab8992ae8672b85b0f"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(h) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzcy_f4deeecc-d971-4f76-9a49-323c7827cd75" continuedAt="i1875a641095f4a7b9121d095bf3801a1" escape="true">Disclosure of fair value of financial instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1875a641095f4a7b9121d095bf3801a1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDE2_bdb7ee8b-67a5-42ab-bfb4-6665ab9ee91a" continuedAt="ie820ddded9de4fa18097a032fd878b7e" escape="true">Business combinations</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie820ddded9de4fa18097a032fd878b7e" continuedAt="i1cada566202b4b9ebf67ccb16b65eb4b"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair values at the date of exchange of assets given, liabilities incurred or assumed and equity instruments issued in exchange for control. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5f7e07f6a0fd40ab8992ae8672b85b0f" continuedAt="i12ac902368a74e04b9bd1a49472a3d3c"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(j) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDI0_82342197-ad02-41b4-a90c-b66e4baf1612" continuedAt="if742d9cb682542019233686748988ce5" escape="true">Goodwill and Impairment</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="if742d9cb682542019233686748988ce5">Goodwill represents the excess of the cost of acquired entities over the net amounts assigned to assets acquired and liabilities assumed. Goodwill primarily comprises acquired workforce in place which does not qualify for recognition as an asset apart from goodwill. Goodwill is stated net of any provision for impairment. The Company tests goodwill annually for any impairments or whenever events occur which may indicate impairment. An impairment charge would be recognized for any amount by which the carrying amount exceeds the reporting unit's fair value up to the amount of existing goodwill. The Company performs a qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzEzNTYz_64cf21a2-317d-47d3-9f86-5dcfa00f71c5"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzEzNTYz_a2926e0e-a351-4523-afed-8930dec70186"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzEzNTYz_cf1d387f-5133-490c-847b-a1b3c58b7741">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment was recognized as a result of the impairment testing carried out for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(k) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDUx_97530add-7b2a-4b83-bbb5-2760937c160d" continuedAt="ie147edac181847dbaf34907f5a429137" escape="true">Intangible assets</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ie147edac181847dbaf34907f5a429137">Intangible assets are amortized on a straight line basis over their estimated useful life.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(l) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzU3_bc4fa5a5-8a38-472d-8c7c-349ff84db71b" continuedAt="i1e7edf1a1fa34b65a558921e7d974bd9" escape="true">Cash and cash equivalents</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i1e7edf1a1fa34b65a558921e7d974bd9">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</ix:continuation></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(m) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDE0_52652300-2949-4627-a854-162cea6d7e64" continuedAt="i8598df2f575c4461b68a52d8bfe3e44c" escape="true">Investments in debt, equity and other</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8598df2f575c4461b68a52d8bfe3e44c"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale in accordance with the terms of ASC 320 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Investments - Debt and Equity Securities'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Realized gains and losses are determined using specific identification. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2020 and December&#160;31, 2021 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(n)   <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzc2_dbf61845-f8f8-4cec-afae-85e1ec837be9" continuedAt="i6755763167c642d0bed51082e794b792" escape="true">Accounts receivable, net and unbilled revenue&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><ix:continuation id="i6755763167c642d0bed51082e794b792" continuedAt="i4f3f0f9aaae245d8babda64a082e0713"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div></ix:continuation></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i12ac902368a74e04b9bd1a49472a3d3c" continuedAt="i61aa17ecb9a1464b903f77f727a01efb"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i4f3f0f9aaae245d8babda64a082e0713" continuedAt="ia964e039ddfb485ea38ab0a9c5185a1d">Accounts receivable factoring</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="ia964e039ddfb485ea38ab0a9c5185a1d" continuedAt="i21d7b924688744cb9065f39d03e0ac6d"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Transfers and Servicing'</span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i21d7b924688744cb9065f39d03e0ac6d"> (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. The associated finance costs are presented as interest expense.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(o) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzYx_fc368864-9849-410b-aee9-cdc9b0bed679" continuedAt="ice6684e8d5c84ab2ad8df29ae7478bea" escape="true">Inventory</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ice6684e8d5c84ab2ad8df29ae7478bea">Inventory is valued at the lower of cost and net realizable value and after provisions for obsolescence. The cost of inventories comprises the purchase price and attributable costs, less trade discounts.</ix:continuation> At December&#160;31, 2021 the carrying value of inventory, included within prepayments and other current assets on the Consolidated Balance Sheet, was $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzE4MTM3_1857aaee-4261-42ee-ba3c-29a89e1597f7">5.8</ix:nonFraction> million (2020: $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzE4MTQ1_cc8dc847-754c-428f-8992-5930a9c902f8">4.8</ix:nonFraction> million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(p) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzQ2_bf662893-e6d4-4dcf-a7eb-0a9f53d1233c" continuedAt="i1f582ea59204494b9dfdd888f42d2549" escape="true">Property, plant and equipment</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1f582ea59204494b9dfdd888f42d2549" continuedAt="iec77c4279aec40fdbfa25c1a991fb6bf"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzUw_352e2bac-0066-4ac8-ac29-112a1ba9b7b9" continuedAt="i6947eda5a4df43e9a8f741a7c83a9ff9" escape="true">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i6947eda5a4df43e9a8f741a7c83a9ff9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2a7dd4344dd34202b588af91a6812de7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzEtMS0xLTEtMzYyNDg_0af6a7a0-b6ad-4bba-b4e3-c828d38a7c1a">40</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2987d6914a1d4cc68e8c95d19b068254_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzItMS0xLTEtMzYyNDgvdGV4dHJlZ2lvbjo5ZGY3YmIwYTFmNmU0MDA5OGYxOTEzMzkxYjk0MDBjZl80_9e212f85-ce4e-4d02-a482-0d1eb0567e84">2</ix:nonNumeric>-<ix:nonNumeric contextRef="i57ebfffca8f94564b236e3cf355daa0a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzItMS0xLTEtMzYyNDgvdGV4dHJlZ2lvbjo5ZGY3YmIwYTFmNmU0MDA5OGYxOTEzMzkxYjk0MDBjZl83_6e723416-bdfe-44ac-a8f8-97b073624a96">8</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8f2e7237f254495a965fa61e435b32cc_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzMtMS0xLTEtMzYyNDg_845011f5-2354-42f5-ba27-29f304284cff">8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98447e8a7c144589ae3d680ab7ea1f11_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzQtMS0xLTEtMzYyNDg_ea711cfb-02c5-491d-a1c9-751804bcb344">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2e9789e124d454fb74080cfc1ea1d70_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzUtMS0xLTEtMzYyNDg_21527f3b-234f-488d-814d-15d39061f9de">5</ix:nonNumeric></span></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="iec77c4279aec40fdbfa25c1a991fb6bf">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.</ix:continuation> </span></div><div style="margin-top:4pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(q) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDAy_e5a8ba52-b0ed-45b0-b514-30b9b7087f6e" continuedAt="i19f44fb2b59e4e789f2513148c553a29" escape="true">Leases</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i19f44fb2b59e4e789f2513148c553a29" continuedAt="if78a79af4a404444b90499c8bc48862e"><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company adopted ASC 842 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Leases' (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 842), with a date of initial application of January 1, 2019. The lease accounting policy applied in preparation of the results for the year ended December&#160;31, 2020 and December&#160;31, 2021 therefore reflect application of ASC 842. The Company adopted the standard using the cumulative-effect adjustment approach. Under this transition method, the Company applied the ASC 842 as at the date of initial application (i.e. January 1, 2019), without restatement of comparative period amounts. The cumulative effect of applying the standard is recorded as an adjustment to the opening consolidated balance sheet as at the date of initial application.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 842 requires lessees to recognize the rights and obligations resulting from virtually all leases on the Consolidated Balance Sheet as right-of-use (ROU) assets with corresponding lease liabilities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The most significant impact of application of the standard for the Company related to the recognition of right-of-use assets and lease liabilities on the Consolidated Balance Sheet for operating leases for certain property, vehicles and equipment. Prior to application of ASC 842, costs in respect of operating leases were charged to the Consolidated Statements of Operations on a straight-line basis over the lease term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to certain practical expedients available as part of adopting ASC 842, ICON did not reassess whether existing or expired supplier contracts are or contain leases, the classification of existing or expired leases, or whether unamortized initial direct costs meet the new definition of initial direct costs under ASC 842. Additionally, the Company elected to use hindsight in determining the lease term and in assessing impairment of ROU assets, if any. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2021 and December&#160;31, 2020, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i61aa17ecb9a1464b903f77f727a01efb" continuedAt="ie3e087ce678c4dd7b16b28ea47f65bee"><ix:continuation id="if78a79af4a404444b90499c8bc48862e"><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Although subleases are accounted for separately from the lease they relate to, subleases are accounted for in the same way as other leases.</span></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(r) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDI5_c87c990d-67ae-45b3-ba04-663014fe7d0b" continuedAt="ic757f86d3e9641648eafe9b450f6bfed" escape="true">Income taxes</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ic757f86d3e9641648eafe9b450f6bfed">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#8220;global intangible low-taxed income&#8221;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</ix:continuation></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(s) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:GovernmentGrantsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDU2_dd60d033-e6eb-49a5-9f55-6f969a138806" continuedAt="ia837860527e94ec49ee295d3ad97b9db" escape="true">Government grants</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia837860527e94ec49ee295d3ad97b9db"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(t) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:ResearchandDevelopmentCreditsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzcz_14fb93c6-36c8-4088-b5bb-5e19a266951c" continuedAt="i03b8c99bb1c14580986a1fcdd299d4c0" escape="true">Research and development credits</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i03b8c99bb1c14580986a1fcdd299d4c0">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits are generally recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</ix:continuation></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie3e087ce678c4dd7b16b28ea47f65bee" continuedAt="i3c177fdc58cb418fa2e457d29b48fcab"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(u) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzc4_732db34a-5d91-4bcb-a460-a129885f48e1" continuedAt="ib1aa7b5ed0174acbbed6cca1132ba87e" escape="true">Pension costs</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib1aa7b5ed0174acbbed6cca1132ba87e"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Pension'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These plans are presented in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(v) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzQ4_42115973-137a-49a5-9ac6-bdbe91063503" continuedAt="ie9bf58c4d4c74fd19e534b4fa898e6f7" escape="true">Redeemable noncontrolling interests and equity</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="ie9bf58c4d4c74fd19e534b4fa898e6f7" continuedAt="i3d2a326a6e004a8d8817021d7b50d768"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Distinguishing Liabilities from Equity'. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 9, 2020, ICON exercised its option to call the remaining shares and took <ix:nonFraction unitRef="number" contextRef="i34a011f87a9d4997aa40aa4d09a4fc8d_I20200309" decimals="INF" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzI3MTU0_85a6a283-349f-4dcb-aeb8-9e5ff859a1af">100</ix:nonFraction>% ownership of MeDiNova. </span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i3d2a326a6e004a8d8817021d7b50d768">Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(w)   <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzk0_de883bf1-f99d-424b-9ffe-ca197b54843a" continuedAt="i70056210d0544392ac0ba511d27520d0" escape="true">Net income per ordinary share</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="i70056210d0544392ac0ba511d27520d0"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 27 - Net income per ordinary share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(x) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzYy_2884847f-dd7c-4802-b99a-6271d897f616" continuedAt="iac393d0662ae4bc0a0e896de7b204dae" escape="true">Share-based compensation</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="iac393d0662ae4bc0a0e896de7b204dae" continuedAt="iba8d2d71b5a140be8065f67edb03f18c"><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Compensation &#8211; Stock Compensation'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i3c177fdc58cb418fa2e457d29b48fcab" continuedAt="ib90f28d9f8e54882890d99658836be0d"><ix:continuation id="iba8d2d71b5a140be8065f67edb03f18c"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(y) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDI1_549f64bd-a49a-4971-9d31-e11542d9db07" continuedAt="ifcd77c2bffb84239ac0a754d95849d4a" escape="true">Impairment of long-lived assets</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ifcd77c2bffb84239ac0a754d95849d4a">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(z) &#160; <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzkz_76de7011-fc7a-4dc7-b352-c593d2b6673e" continuedAt="id011c333827e47b69fa5bc757f70d537" escape="true">Derivative financial instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id011c333827e47b69fa5bc757f70d537"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We enter into transactions in the normal course of business using various financial instruments in order to hedge against exposure to fluctuating exchange and interest rates. We use derivative financial instruments to reduce exposure to fluctuations in interest rates. A derivative is a financial instrument or other contract whose value changes in response to some underlying variable, which has an initial net investment smaller than would be required for other instruments that have a similar response to the variable and that will be settled at a future date. We do not enter into derivative financial instruments for trading or speculative purposes. We did not hold any interest rate swap contracts or forward currency contracts at December&#160;31, 2021 or December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use derivative financial instruments to reduce exposure to fluctuations in foreign exchange rates. During the years ended December&#160;31, 2019 and December&#160;31, 2020, we entered into forward currency contracts in respect of identified exposure arising from euro payments. All contracts expired during the year in which the contract was entered into. No forward currency contracts were entered into during the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(aa) <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzIxOTkwMjMzMTAyNjI_b78f8aae-46e7-4816-abb9-b37350cf05ab" continuedAt="ibe807e52f746467bb9468be1c0a755f3" escape="true">Debt issuance costs</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ibe807e52f746467bb9468be1c0a755f3">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ab)<ix:continuation id="i1cada566202b4b9ebf67ccb16b65eb4b" continuedAt="ia8a5ee159e0541e6a03dde8413ccadfc"> Transaction and integration-related expenses</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:continuation id="ia8a5ee159e0541e6a03dde8413ccadfc">Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</ix:continuation></span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ib90f28d9f8e54882890d99658836be0d"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(ac) <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzEzMTk0MTM5NjA5NTc3_edf6066a-44ae-4fed-8590-3270b035b83f" continuedAt="ic4500d153af34076a330f69a4b3f5d46" escape="true">Restructuring</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:continuation id="ic4500d153af34076a330f69a4b3f5d46">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ad) &#160;<ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzU4_ae222efe-b337-4d8e-9f53-86864cfbac43" continuedAt="i95073375277f47d38fd6e0ddb77eaec0" escape="true">Reclassifications</ix:nonNumeric></span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i95073375277f47d38fd6e0ddb77eaec0">Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#8217;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the years ended December 31, 2020 and December 31, 2019 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#8217;s presentation.</ix:continuation></span></div></ix:continuation><div id="i6df4b473ec484136b91516d30b1a0b24_142"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE2OTA_da7a7eb8-522c-4eb1-9245-a6239da70ed3" continuedAt="i1c19d391eb0c4d478a8037026be393b7" escape="true">Investments</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1c19d391eb0c4d478a8037026be393b7" continuedAt="ic3d49a5480b341ad8f2ce7d6cbd57ccd"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(a) &#160;&#160;&#160;&#160;Available for sale investments</span></div><div style="margin-top:5pt"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE2OTI_05481d99-07d3-4f1a-bb16-f98f8f2cac4c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzItMS0xLTEtMzYyNDg_30414e56-465c-4a5f-9414-d2058f5adaa2">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzItMi0xLTEtMzYyNDg_8a09c594-02fb-4b2d-910d-2cd771aafd4c">49,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzQtMS0xLTEtNDUwNjg_2fbf93fe-23b4-4733-8930-d6bc4d012c00">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzQtMi0xLTEtNDUwNjg_1de2854b-7169-476a-b276-cfe73344e1fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzQtMS0xLTEtMzYyNDg_3002c541-a290-48bb-b6ec-4bddd3e67dd1">497</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzQtMi0xLTEtMzYyNDg_6146f07b-2ce4-4f22-90bf-1bf0e788cd43">47,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gain on sale of short term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzYtMS0xLTEtMzYyNDg_c6407b54-8cfc-4e49-bffc-de854eaa7c24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzYtMi0xLTEtMzYyNDg_430cc213-b7d1-4dba-a16d-405db37992c7">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized capital loss &#8211; investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzctMS0xLTEtMzYyNDg_a2ddbdff-df3c-4ae2-8069-901d57a1776a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzctMi0xLTEtMzYyNDg_a86c7ae1-4d4b-4f29-b54b-c3a952f878b4">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Available for sale investments at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzgtMS0xLTEtMzYyNDg_7dc06407-b2df-4f92-b2d0-0bbc7dadcfa8">1,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzgtMi0xLTEtMzYyNDg_7faa0535-75cc-4044-9916-c6ad4aa7e995">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. Short term investments at December&#160;31, 2021 have an average mat</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">urity of <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzIxOTkwMjMyNTc0MTg_dd08cd59-dceb-4402-999a-d02c856a1648">2.7</ix:nonNumeric> years co</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">mpared to <ix:nonNumeric contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" name="iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzM3NA_61e2c136-368d-4f34-8349-c18a3dd2fb82">3.4</ix:nonNumeric> years at December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE2ODg_91175537-b821-4af9-a8ca-f28a5fa468c9" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our available for sale short term investments by major security type as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity by period</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost<br/>Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1<br/>year</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1 to 5<br/>years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzUtMS0xLTEtMzYyNDg_706d1a18-9fc4-47d2-840e-03da5d176b4a">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzUtMy0xLTEtMzYyNDg_8da6af95-2396-4dd0-a2c6-90fb807799ec">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzUtNC0xLTEtMzYyNDg_9f2c3ae2-a575-42c5-8c1a-ef03c26d4246">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzUtNS0xLTEtMzYyNDg_f867fa6c-291e-4f7e-b3e5-8ee831956e04">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ($ in millions)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzYtMS0xLTEtMzYyNDg_75db7691-1bbd-4fe9-bec0-e0c88c5cff21">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzYtMy0xLTEtMzYyNDg_dd5f927a-c341-4924-b326-d6b4733b6afc">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzYtNC0xLTEtMzYyNDg_426baa54-cd31-426b-aa61-c0c1982ed36b">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzYtNS0xLTEtMzYyNDg_1436fc91-f225-4cfa-9da2-e2689946d6a1">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:continuation id="ic3d49a5480b341ad8f2ce7d6cbd57ccd" continuedAt="id3ee31e2b96448cda8af8c61e4df4da5">(b)&#160;&#160;&#160;&#160;Investments in equity - long term</ix:continuation></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="id3ee31e2b96448cda8af8c61e4df4da5" continuedAt="i1812cb60f72e45d6b28235c8dce4b8ee"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. Capital totaling $<ix:nonFraction unitRef="usd" contextRef="i34fdb5db483e4be88aed63d7fba68086_D20180101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzEwMDg_6344e6cf-9dbf-479c-855a-434218669d7c">16.9</ix:nonFraction> million had been advanced under the terms of the subscription agreements at December&#160;31, 2021 (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="ic87e1dcfa6f645709ebb66f6f1e00a7d_D20180101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzEwODc_61f6a837-8447-4a38-82dd-a1e278ffb400">13.3</ix:nonFraction> million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'. There was an increase in fair value of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE0NDc_8b877ce6-8ebc-4fdc-92bc-67ad5c066ff0">3.2</ix:nonFraction> million (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE0ODE_835f6090-2d6c-4606-a0af-77514c95df98">2.5</ix:nonFraction> million) recognized in net income during the year bringing the carrying value of the subscriptions to $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE1Nzg_1e270284-484d-48d0-8e7c-577d24930fc2">22.6</ix:nonFraction> million at December&#160;31, 2021 (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE1OTI_fc69e375-a63c-45db-83fc-691e37f0db13">15.8</ix:nonFraction> million).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i1812cb60f72e45d6b28235c8dce4b8ee" continuedAt="i07fd953176e549b8a91da99ffb0c5860">December&#160;31, 2021, the Company had committed to future investments of $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="iclr:CommitmentToAcquireLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE2NDkyNjc0NDE4NTUz_85e31fb4-41fa-49f7-9b03-f370adc117f1">17.4</ix:nonFraction> million in respect of these funds.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_145"></div><ix:continuation id="i07fd953176e549b8a91da99ffb0c5860"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160; Equity method investments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has invested $<ix:nonFraction unitRef="usd" contextRef="i79b2e8fe7b204f0c9abe56bd2cd862ae_I20200724" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEwOTk1MTE2Mjg5NTE_540a0e34-bd0d-4f1c-8419-995ca3c955fa">4.9</ix:nonFraction> million to obtain a <ix:nonFraction unitRef="number" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3Xzc3_bb54b333-55e9-4995-8cf5-286efafbef2d">49</ix:nonFraction>% interest in the voting share capital of Oncacare. The Company&#8217;s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations. See additional details in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 2 - Significant accounting policies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor has the right to sell the <ix:nonFraction unitRef="number" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="2" name="iclr:EquityMethodInvestmentMajorityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzYxMw_770c50aa-5f45-426f-9d83-a73157f62d41">51</ix:nonFraction>% majority voting share capital exclusively to the Company in an <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEwOTk1MTE2Mjc5Mzkz_3876afe6-3db0-4cc2-9950-e47bc05a4602">eighteen month</ix:nonNumeric> period, commencing January 1, 2023 and ICON also has the right to acquire the <ix:nonFraction unitRef="number" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="2" name="iclr:EquityMethodInvestmentMajorityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3Xzc3Mg_770c50aa-5f45-426f-9d83-a73157f62d41">51</ix:nonFraction>% majority voting share capital from August 1, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzExNjI_279e47e7-6ad0-4f61-8ba6-b22c3c6cfeb7" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our equity method investments at December&#160;31, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ownership Percentage</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90YWJsZToxMzhlNTEwZTJjYjM0M2JlODJhODU3MTkyMGM0ZTJlYy90YWJsZXJhbmdlOjEzOGU1MTBlMmNiMzQzYmU4MmE4NTcxOTIwYzRlMmVjXzQtMS0xLTEtMzYyNDg_a2e0a09d-1ab3-491a-8ce7-625cd6215df8">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90YWJsZToxMzhlNTEwZTJjYjM0M2JlODJhODU3MTkyMGM0ZTJlYy90YWJsZXJhbmdlOjEzOGU1MTBlMmNiMzQzYmU4MmE4NTcxOTIwYzRlMmVjXzQtMi0xLTEtMzYyNDg_c241ee5e-7f8e-4d96-b052-71a0e8c90b53">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90YWJsZToxMzhlNTEwZTJjYjM0M2JlODJhODU3MTkyMGM0ZTJlYy90YWJsZXJhbmdlOjEzOGU1MTBlMmNiMzQzYmU4MmE4NTcxOTIwYzRlMmVjXzQtMy0xLTEtMzYyNDg_0f3a767e-7f46-49d8-8863-f3a60e9d4043">4,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEwNjI_faa29d64-ceeb-4901-9394-3975505d6c57">2.2</ix:nonFraction>&#160;million representing its pro rata share of the losses in Oncacare since December&#160;31, 2020. From the date of initial investment to year ended December&#160;31, 2020, the Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEyMDk0NjI3OTA3Mzgw_64bb842c-2c93-4bed-bcbe-474e54751e59">0.4</ix:nonFraction>&#160;million. During the year ended December&#160;31, 2021, the Company provided a loan of $<ix:nonFraction unitRef="usd" contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231" decimals="-6" name="us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzI3NDg3NzkwNzEwNDc_5000bb67-b3c4-4b01-a473-68b0ef798d19">10</ix:nonFraction>&#160;million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at <ix:nonFraction unitRef="number" contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231" decimals="3" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEzMTk0MTM5NTM1MzUw_5a4231ef-e97f-4a32-8d69-2fdf4559ad32">1.6</ix:nonFraction>% and the loan is repayable on June 30, 2025. Oncacare continues to perform in line with expectations.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_151"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90ZXh0cmVnaW9uOmEyZTc4MjY3ZmQyNTQ4MDNhMTdhYTI5ZjZjNTJmMzk3XzEwODU5_a14f6aa2-30ae-4818-824c-e00a8604402e" continuedAt="i5b5b55df8bed44b6b669869dcc6dd158" escape="true">Goodwill</ix:nonNumeric></span></div><ix:continuation id="i5b5b55df8bed44b6b669869dcc6dd158"><div style="margin-top:5pt"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90ZXh0cmVnaW9uOmEyZTc4MjY3ZmQyNTQ4MDNhMTdhYTI5ZjZjNTJmMzk3XzEwODY1_a5d09a72-851f-4345-a8f2-d86b5e366e77" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzItMS0xLTEtMzYyNDg_af26083b-6373-4ea0-b31c-99658203bfae">936,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzItMi0xLTEtMzYyNDg_8a3a0c29-32cf-446b-a05d-10fe5e2487c3">883,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzMtMS0xLTEtMzYyNDg_204de165-abc0-4aa4-b780-4e7c3671366c">8,120,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzMtMi0xLTEtMzYyNDg_27384fdd-29db-411d-8672-17ecb607a0fe">27,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzQtMS0xLTEtMzYyNDg_3f69f660-0960-421e-a5c7-bb1345be0ee2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzQtMi0xLTEtMzYyNDg_92f170ce-99d1-4ce4-b73f-7a45386d8e7c">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzUtMS0xLTEtMzYyNDg_d14e280b-bb26-480f-97ae-f81cecac1065">18,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzUtMi0xLTEtMzYyNDg_041236c4-f85f-464e-9568-42c76aa8e42b">25,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzYtMS0xLTEtMzYyNDg_0a7afb56-c3d8-40bb-b60d-21f37f7d6b6d">9,037,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzYtMi0xLTEtMzYyNDg_786832d8-d524-46e9-b0c3-8e0f55aa7177">936,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has made a number of strategic acquisitions since inception to enhance its capabilities and experience in certain areas of the clinical development process. Goodwill arising on acquisition represents the excess of the cost of acquired entities over the net amounts assigned to assets acquired and liabilities assumed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company tests goodwill annually for impairment or whenever events occur which may indicate impairment. The results of the Company's goodwill impairment testing assessed at September 30, 2021 during the year ended December&#160;31, 2021 provided no evidence of impairment and indicated the existence of sufficient headroom such that a reasonably possible change to the key assumptions used would be unlikely to result in an impairment of the related goodwill.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90ZXh0cmVnaW9uOmEyZTc4MjY3ZmQyNTQ4MDNhMTdhYTI5ZjZjNTJmMzk3XzEwODY3_64cbbaa8-ac9d-4c99-8b69-b2a5afacbfab" continuedAt="i2bc7aee814974ffc957af331a7dca5c9" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzg5NjU_74f8fa6d-f23a-4a56-8b56-ef8acf9bd99c" continuedAt="i53efcd580fd54b54ae51d8f6abbfcfe9" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i53efcd580fd54b54ae51d8f6abbfcfe9"><div style="margin-top:5pt"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzg5NjY_40218e06-f601-4036-bc0a-f3f2fc8827c8" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d3fa59c20354798b3fe32fbe88700c6_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzItMS0xLTEtMzYyNDg_5a552991-3cb2-4d5a-a165-b7024ff96c55">4,056,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27d114693994c1bbb27bce87b357b48_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzItMi0xLTEtMzYyNDg_66b9df81-de60-48bb-8dcb-05244efc4c3d">144,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727c1622461843c1a81f8f6fb66f40aa_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzMtMS0xLTEtMzYyNDg_d551341f-3f26-4d36-be3b-c79a819dbcfa">528,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i391000958f6f4ad4b03f663ad0a01ee6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzMtMi0xLTEtMzYyNDg_f9d92cc5-3b30-4300-a6fd-e5dc7be53374">39,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ca96102037f405a834d371c8285ea8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzQtMS0xLTEtMzYyNDg_797ec232-b679-496a-9e6f-e2de70b33b15">204,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a2e822e6e146128cc9a04440ccd362_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzQtMi0xLTEtMzYyNDg_7f553f9b-b7f3-4d1f-b0bb-ac229ee34eb9">2,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a9a1d8583f64d51af91b99d7a6b4135_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzUtMS0xLTEtMzYyNDg_8a4b03eb-7033-46ca-9abf-080cc0b08075">170,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86eec55be971443da0d8c545532a4f94_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzUtMi0xLTEtMzYyNDg_7642f8f9-6177-43a7-b959-7b9f04652d60">2,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbf4b780c904be2bf1341d2e01a6247_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzYtMS0xLTEtMzYyNDg_8456770b-55b9-438b-923e-35a3b8866f49">121,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dd17c1d14eb4336b8de511f325caec7_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzYtMi0xLTEtMzYyNDg_52744d38-5c3d-4ab0-84cd-a44b2310d7b3">11,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzEwLTEtMS0xLTM2MjQ4_e5eadc00-04a0-4a75-b515-00223be968bd">5,081,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzEwLTItMS0xLTM2MjQ4_58d5aa4e-7e68-4fe9-a58b-cee45de05534">200,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzExLTEtMS0xLTM2MjQ4_bc2b33bc-8815-4106-b2aa-1a26511f3705">370,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzExLTItMS0xLTM2MjQ4_2f0f7567-8700-4b7c-8a53-0fb2640f80ef">133,551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzEzLTEtMS0xLTM2MjQ4_50be8bcb-03db-44ff-8ad5-f5f452bb09fe">4,710,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzEzLTItMS0xLTM2MjQ4_843b0eec-9f3f-47d8-a37e-5fdbcba2de52">66,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $<ix:nonFraction unitRef="usd" contextRef="ib2760f7ce2844eeb9454a223b0d6bdd9_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5MzE_c15f0b24-44ee-44be-8e13-b2fc06adb8df">3,915.0</ix:nonFraction>&#160;million, Order backlog of $<ix:nonFraction unitRef="usd" contextRef="i0c3d250f7b48429daff67944653a547e_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5NDM_e7c480b8-3d03-4f00-b5e4-090fb986f404">490.0</ix:nonFraction>&#160;million, Trade names of $<ix:nonFraction unitRef="usd" contextRef="i9fdaf7dd9b454d2b8940cc6620aa6239_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5NTU_afc478c5-8296-4c9d-8b6f-91ab65207362">202.0</ix:nonFraction>&#160;million, Patient database of $<ix:nonFraction unitRef="usd" contextRef="i20ad6864825548d6963d2ca543226afa_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5Njg_181b7ac9-b433-46ed-87ee-6700c2e065e0">168.0</ix:nonFraction>&#160;million and Technology assets of $<ix:nonFraction unitRef="usd" contextRef="i34c5cbb5923847049004e8c7917d853b_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5ODk_e9b5ddcb-ba9e-42f8-a0cb-2a638a8d6c19">111.0</ix:nonFraction>&#160;million. These assets will be amortized over their expected useful lives of between <ix:nonNumeric contextRef="i653318d9e6234778be8ddf6cd1ffc904_D20210701-20210701" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzIxOTkwMjMyODE4MTc_05866679-8392-49cf-996b-ea947b621e8a">3</ix:nonNumeric> and <ix:nonNumeric contextRef="iea4c19eacf6342068eda7cdb8712f339_D20210701-20210701" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzIxOTkwMjMyODE4MTk_1ac1101b-76fd-4243-99da-82c76b41bc92">23</ix:nonNumeric> years. The valuation and useful lives of these assets remains provisional at December&#160;31, 2021. In total, $<ix:nonFraction unitRef="usd" contextRef="i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDU4Njk_0a46adae-ffdb-4c76-bb42-e30663ae71fd">223.5</ix:nonFraction>&#160;million has been amortized in the period since the date of acquisition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 22, 2020 a subsidiary of the Company, ICON Investments Limited acquired <ix:nonFraction unitRef="number" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzExNg_422d1bf6-0d6e-4a02-8220-0a5beb0eb14d">100</ix:nonFraction>% of the equity share capital of the MedPass Group. MedPass is the leading European medical device CRO, regulatory and reimbursement consultancy, that specializes in medical device development and market access. The acquisition of MedPass further enhances ICON&#8217;s Medical Device and Diagnostic Research services, through the addition of new regulatory and clinical capabilities in Europe. On acquisition, certain customer relationships and order backlog identified, which were valued at $<ix:nonFraction unitRef="usd" contextRef="i7de8b4b9115b4c429dc042e5ecb81b66_I20200122" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzU4MQ_738a697a-0a13-4e76-bdd9-4141c147dc38">11.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic7fa7bd0b2d84f9bb5d970eebb2b2cc0_I20200122" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzU4OA_d4d2bae4-7cc3-4302-9452-f22b61c29a40">2.9</ix:nonFraction>&#160;million respectively, were recognized and are being amortized over approximately <ix:nonNumeric contextRef="i586effbcf5d3481cb59812fdb908734f_D20200122-20200122" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzY3OA_7ad78cc3-918b-48af-8822-4bf359ad4733">13</ix:nonNumeric> years and <ix:nonNumeric contextRef="ibdff042d535e43268017baca8988f1a5_D20200122-20200122" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzY4NQ_41c80633-428e-430a-bce7-86012813f53b">3</ix:nonNumeric> years, the estimated period of benefit. In total, $<ix:nonFraction unitRef="usd" contextRef="ibd05d6e491a44874be7f139b3e968b8d_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDU4MzE_de46c8d8-174d-4b7c-a146-7cb5c0f8ae2c">2.0</ix:nonFraction>&#160;million has been amortized in the period to December&#160;31, 2021 relating to the acquisition. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzg5NTg_db896293-cc5b-4f1c-81d8-53706fa04401" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2022 to December 31, 2026 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzItMS0xLTEtMzYyNDg_47b452d1-4c75-4efd-990b-70e64c443671">456,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzMtMS0xLTEtMzYyNDg_1bc59918-e331-49c8-8dd1-6096ac1317ee">454,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzQtMS0xLTEtMzYyNDg_ca1fd802-2268-4532-82ad-4eb6d26aedd1">338,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzUtMS0xLTEtMzYyNDg_37ba14c9-a0de-439a-92fc-67cca1c3c5ea">222,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzYtMS0xLTEtMzYyNDg_a0087344-2cad-420b-aad3-9fdf003ffe8f">208,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzctMS0xLTEtMzYyNDg_4726ec7e-7e1e-4e61-8e74-4cddd2dbe6da">1,680,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_1923"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8yMTk5MDIzMjcxODY3_0e839103-5244-4b85-89f7-fb9675e2f8cd" continuedAt="iba59bc3ed12a4cceba9027a31eff5be2" escape="true">Business combinations</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="iba59bc3ed12a4cceba9027a31eff5be2" continuedAt="ia9788a9bf4a543e7bddf26cfac3a9769"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Health Sciences, Inc. - Merger Completion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences Group ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately <ix:nonFraction unitRef="employee" contextRef="ic93da52af8c448b795d98224ecc5b70b_I20210701" decimals="-3" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8yMTk5MDIzMjczMDI4_f67970d1-56f8-45da-a8d4-43b6fcdd5831">38,000</ix:nonFraction> (as at the Merger date) employees across the globe, creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia9788a9bf4a543e7bddf26cfac3a9769" continuedAt="i6468f6ad311a49ed99aa1479e1c9d9ea"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $<ix:nonFraction unitRef="usdPerShare" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="INF" name="iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1Mjgw_372a76e0-e134-4d9b-94d9-6b8da205b354">80</ix:nonFraction> in cash and <ix:nonFraction unitRef="shares" contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701" decimals="4" name="iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1Mjky_572edba4-7183-4f1d-a32a-2a51af1879bb">0.4125</ix:nonFraction> shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the year ended December&#160;31, 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzA5_7d091025-cb95-4742-b7ec-b1a8c870f051">198.3</ix:nonFraction> million of Merger-related expenses which were accounted for separately from the business combination and expensed as incurred within the &#8220;Transaction and integration related&#8221; line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in the $<ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjQ2NzI5_7d091025-cb95-4742-b7ec-b1a8c870f051">198.3</ix:nonFraction> million of transaction and integration costs are acquisition related costs (as defined by ASC 805) of $<ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjQ3MDcy_9c3c57b1-61fb-40c5-8089-3daa09e57249">57.1</ix:nonFraction>&#160;million. These costs include finders fees; advisory, legal, accounting, valuation, and other professional or consulting fees.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company also incurred approximately $<ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-5" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjQ2MTA3_9553d913-0fde-4665-9f78-5534b2b2a2f3">86.7</ix:nonFraction> million of Merger-related financing fees which are included in the &#8220;Interest expense&#8221; line item in the Consolidated Statement of Operations for the year ended December&#160;31, 2021. The Company deferred $<ix:nonFraction unitRef="usd" contextRef="i1ec6866f5ee348deb48316da2665156b_I20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjQ0MzMw_bdfe0c3e-5755-4400-805d-ddc31c5631b7">76.2</ix:nonFraction>&#160;million of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The purchase accounting associated with the PRA Merger remains ongoing and the Company continues to review the acquisition balance sheet. The Company expects to conclude the purchase accounting exercise by June 30, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8yMTk5MDIzMjcxODY5_58a5cd3d-52fd-4374-b25d-6df72119d095" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF8xLTEtMS0xLTM3ODU3_a8e3b6f8-8a11-4853-836c-382c8339fb27">5,308,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF8yLTEtMS0xLTM3ODU3_a523b998-40d3-43c0-a4c9-ea892157be24">5,658,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF8zLTEtMS0xLTM3ODU3_2b02452b-d565-4bca-abec-8d7e0128348c">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF80LTEtMS0xLTM3ODU3_d54cb4b8-6558-42b8-9f34-878f622f82ef">865,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF81LTEtMS0xLTM3ODU3_2d8d7109-96db-49c8-be80-422222ff6721">12,041,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $<ix:nonFraction unitRef="usd" contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701" decimals="-5" name="iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzM4_7b0073d5-6981-4c51-8876-6487135b602b">401.6</ix:nonFraction>&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i6468f6ad311a49ed99aa1479e1c9d9ea" continuedAt="i70ff6f01b907455bb71ceed8c0d29d6d"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8yMTk5MDIzMjcxODcw_e8e5e49c-53c0-4989-a99a-a0bc22a0c66d" continuedAt="i0a292e9c01a94eda917a36b2747dcb1d" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the preliminary allocation of the consideration transferred based on management&#8217;s estimates of Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:84.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8zLTEtMS0xLTM3ODU3_8d2de5a7-44ba-4a7c-83b1-db4cc33327b3">259,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV80LTEtMS0xLTM3ODU3_9b863d51-f82c-4828-827a-42ba373cd028">934,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV81LTEtMS0xLTM3ODU3_868adc1d-1885-4f40-89e7-ca0135b48322">125,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV82LTEtMS0xLTM3ODU3_7a2bb5b3-1bc1-48ca-814b-4ffa5be35dcd">156,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV83LTEtMS0xLTM3ODU3_ba7c7b51-fdf5-4406-81e3-858f2f6c6d59">177,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV84LTEtMS0xLTM3ODU3_46f600a3-80ff-45e1-a942-8b79d7551b0b">8,120,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV85LTEtMS0xLTM3ODU3_cce450c6-5c46-4094-a6ae-0c832617982d">4,886,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMC0xLTEtMS02MTI5Mg_e1cf49b9-ee4b-4644-8150-c94beaa6a0d4">28,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMC0xLTEtMS0zNzg1Nw_46d6ad0f-836a-486c-bd1d-5bafd510e3c2">35,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMS0xLTEtMS0zNzg1Nw_bc8d6f15-1f73-41dc-875f-376950869d73">50,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMi0xLTEtMS0zNzg1Nw_e1e0d535-500d-41b6-b08a-98da2f104e95">380,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMy0xLTEtMS0zNzg1Nw_178d7a88-06af-46ed-83d2-1f3d1d8bafd6">36,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xNC0xLTEtMS0zNzg1Nw_e432cbfb-96b8-498c-90b5-e6471de48667">739,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xNi0xLTEtMS0zNzg1Nw_05fd24a8-6780-4e7a-a1eb-41c201bb39f5">144,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xNy0xLTEtMS0zNzg1Nw_71dfc75f-490b-4074-8e18-4b21a777e48c">1,126,952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xOC0xLTEtMS0zNzg1Nw_5dbfe0ba-d575-4e60-b4fd-c157ea22838f">203,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8yMC0xLTEtMS0zNzg1Nw_856eadab-258d-495a-bf0c-c5149aca6fef">12,041,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. <ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="INF" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzU4_4b80a466-3d64-4782-ba09-1414f1bf9d73">None</ix:nonFraction> of the goodwill recognized is expected to be deductible for income tax purposes.</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjI5NDA4OQ_cccc938e-1ef6-424e-9c75-c0fd10e20739" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the preliminary estimates of the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2760f7ce2844eeb9454a223b0d6bdd9_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8xLTEtMS0xLTM3ODU3_0b8b6812-e2e6-46c5-b9a7-d74644f607b4">3,915,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i08c50c20b0824778afb5ac1731634e8a_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8xLTItMS0xLTQxNDQ1_3a723fe6-e3ca-4950-85ad-28e412f53ba6">23</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c3d250f7b48429daff67944653a547e_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8yLTEtMS0xLTM3ODU3_71ce1789-1627-4d9e-990f-9ae953c7eb42">490,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i42dfcdcf3ee74f698b4cc05d9992198b_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8yLTItMS0xLTQxNDQ1_8fa7b234-7dae-41b4-b4e9-09eb069fd833">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdaf7dd9b454d2b8940cc6620aa6239_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8zLTEtMS0xLTM3ODU3_16c8680a-5571-4b89-97ec-3cbee3d396e5">202,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5baf4cdf019f4d0082973e733aaf95ff_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8zLTItMS0xLTQxNDQ1_5b96ffc8-0839-4b38-9f11-152f788b6b7d">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ad6864825548d6963d2ca543226afa_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV80LTEtMS0xLTM3ODU3_b2a748f9-7d34-4a47-9f47-973a82552a93">168,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1704b22ade43460f8a75f94af7619d42_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV80LTItMS0xLTQxNDQ1_72417e6a-e068-46b0-a408-2371989066ef">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c5cbb5923847049004e8c7917d853b_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV81LTEtMS0xLTM3ODU3_a8ec0426-afc4-40a6-9415-293fd38038b6">111,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b46d27d792a425aa8aa8c08a233f77e_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV81LTItMS0xLTQxNDQ1_c61b83e4-3d28-46f7-9886-d59d07f08d75">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV82LTEtMS0xLTM3ODU3_bab1bd4d-6871-4062-86c6-57e90c509ad8">4,886,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since July 1, 2021, PRA has earned revenue of $<ix:nonFraction unitRef="usd" contextRef="i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzYx_56a889df-f756-454c-8117-bcc262113e23">2,053.4</ix:nonFraction> million and pre-tax net income of $<ix:nonFraction unitRef="usd" contextRef="i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231" decimals="-5" name="iclr:BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzY5_24ae4c64-2f78-44ee-81fc-2331786a0a9b">169.9</ix:nonFraction> million in the six months ended December 31, 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><ix:continuation id="i70ff6f01b907455bb71ceed8c0d29d6d" continuedAt="ib0ed1c6a88a84495ac7df13d7ef2fcb4"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unaudited Supplemental Pro Forma Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following pro forma financial information was derived from the historical financial statements of the Company and PRA and presents the combined results of operations as if the Merger had occurred on January 1, 2020. The pro forma financial information is presented for comparative purposes only and is not necessarily indicative of the results that would have actually occurred had the Merger been completed on January 1, 2020. In addition, the pro forma financial information does not give effect to any anticipated cost savings, operating efficiencies or other synergies that may result from the Merger, or any estimated costs that have been or will be incurred by the Company to integrate the assets and operations of PRA. <ix:continuation id="i2bc7aee814974ffc957af331a7dca5c9" continuedAt="ib7d6a76e6ec34acaa89e52b652602d98">Consequently, actual future results of the Company will differ from the pro forma financial information presented below:</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="ib7d6a76e6ec34acaa89e52b652602d98" continuedAt="i6badf59ec4594792bd4782bd8416d75d"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.030%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6YjFhYWJhN2QyODA3NGI0YWJhNGQwYWRlYmI3MzJkY2IvdGFibGVyYW5nZTpiMWFhYmE3ZDI4MDc0YjRhYmE0ZDBhZGViYjczMmRjYl80LTEtMS0xLTM3ODU3_6b50cd7d-f8ff-401b-9771-15120655cfa6">7,462,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b4e53fcd7342a8bab594419987a4b2_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6YjFhYWJhN2QyODA3NGI0YWJhNGQwYWRlYmI3MzJkY2IvdGFibGVyYW5nZTpiMWFhYmE3ZDI4MDc0YjRhYmE0ZDBhZGViYjczMmRjYl80LTItMS0xLTM3ODU3_7d81393c-3c63-4908-b30f-f4abefdf99b1">5,980,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income/(loss)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6YjFhYWJhN2QyODA3NGI0YWJhNGQwYWRlYmI3MzJkY2IvdGFibGVyYW5nZTpiMWFhYmE3ZDI4MDc0YjRhYmE0ZDBhZGViYjczMmRjYl81LTEtMS0xLTM3ODU3_862f613e-36c7-4b13-baff-77b859931b5c">340,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54b4e53fcd7342a8bab594419987a4b2_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6YjFhYWJhN2QyODA3NGI0YWJhNGQwYWRlYmI3MzJkY2IvdGFibGVyYW5nZTpiMWFhYmE3ZDI4MDc0YjRhYmE0ZDBhZGViYjczMmRjYl81LTItMS0xLTM3ODU3_54e402a5-dcd1-447d-b74c-b6ab64c08587">149,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The pro forma adjustments primarily relate to the amortization of acquired intangible assets, interest expense and amortization of deferred financing costs related to the new financing arrangements. In addition, the pro forma net income for the year ended December 31, 2021 was adjusted to exclude certain Merger-related nonrecurring adjustments; these adjustments were included in the year ended December 31, 2020 giving effect to the Merger as if it had occurred on January 1, 2020. The nonrecurring Merger-related adjustments include transaction costs, share-based compensation expense related to the acceleration of share-based compensation awards and replacement share-based awards, and financing fees. The Merger-related adjustments were tax effected using the rates applicable to the jurisdictions where they arose.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions &#8211; MedPass Group ("MedPass")</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 22, 2020 a subsidiary of the Company, ICON Investments Limited acquired <ix:nonFraction unitRef="number" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1NDY3_9f0b22fb-74b4-41ca-9dc9-2b561dfcf1df">100</ix:nonFraction>% of the equity share capital of the MedPass Group. MedPass is the leading European medical device CRO, regulatory and reimbursement consultancy, that specializes in medical device development and market access. The acquisition of MedPass further enhances ICON&#8217;s Medical Device and Diagnostic Research services, through the addition of new regulatory and clinical capabilities in Europe. The integration of MedPass&#8217;s services brings noted expertise in complex class 3 medical devices, interventional cardiology and structural heart devices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounting for the acquisition of MedPass was finalized in the period ended December 31, 2020. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The acquisition of MedPass has been accounted for as a business combination in accordance with ASC 805 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company has made an assessment of the fair value of assets acquired and liabilities assumed as at that date. <ix:continuation id="i0a292e9c01a94eda917a36b2747dcb1d" continuedAt="ia93f0c6ae32e45fb82843ea4ef05c3c8">The following table summarizes the Company&#8217;s fair values of the assets acquired and liabilities assumed:</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ib0ed1c6a88a84495ac7df13d7ef2fcb4"><ix:continuation id="ia93f0c6ae32e45fb82843ea4ef05c3c8"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:84.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 22,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash &amp; cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8zLTEtMS0xLTM3ODU3_c97feed3-1619-46b1-858e-e148a1fcdde7">10,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF80LTEtMS0xLTM3ODU3_e43475fe-d295-4ef5-9195-ef4313582667">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF81LTEtMS0xLTM3ODU3_5f522d46-be71-4f95-8c1f-b0914da06a1b">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF82LTEtMS0xLTM3ODU3_d6414e92-567b-43ac-aeeb-2be6d597efc4">27,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de8b4b9115b4c429dc042e5ecb81b66_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF83LTEtMS0xLTM3ODU3_4b848ac0-d7f8-4b1c-bb23-c22a08509c32">11,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7fa7bd0b2d84f9bb5d970eebb2b2cc0_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF84LTEtMS0xLTM3ODU3_ad3b59f8-1250-46d7-abab-8c71215dfdf3">2,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF85LTEtMS0xLTM3ODU3_7dce69c4-27a8-4867-ad7c-c2a765a07649">3,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xMi0xLTEtMS0zNzg1Nw_04f9d643-6630-4196-a1f6-3fc145b9579c">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xMy0xLTEtMS0zNzg1Nw_97d08f73-101c-47f2-9cdb-db4a7e2e8a19">368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xNC0xLTEtMS0zNzg1Nw_a36a223b-67de-41e1-9bed-e4cca959db70">989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xNS0xLTEtMS0zNzg1Nw_69383d75-e745-4b62-aa42-3b3c7262e220">2,202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xNi0xLTEtMS0zNzg1Nw_d8de1815-ece0-417d-ac30-061ca4e7aeb3">219</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xNy0xLTEtMS0zNzg1Nw_0d0c2957-5483-433b-b238-9c7d88c4adb3">320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xOC0xLTEtMS0zNzg1Nw_66d44c9f-f0f8-497b-8995-7e0f0404ce9c">4,090</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yMC0xLTEtMS0zNzg1Nw_680abd31-94a1-4c6c-9cd8-707dc3176798">47,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash outflows</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ea2f6a48cb4ba19857680cfba954e9_D20200122-20200122" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yMi0xLTEtMS0zNzg1Nw_a207aa26-d845-44b0-a249-aecdf620cf74">46,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital adjustment paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ea2f6a48cb4ba19857680cfba954e9_D20200122-20200122" decimals="-3" name="iclr:BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yMy0xLTEtMS0zNzg1Nw_454d18c6-4c4c-45a7-b985-3b9e5f5ab391">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yNC0xLTEtMS0zNzg1Nw_193bdc48-f417-4d70-9db2-b9597bbf6dba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total consideration</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ea2f6a48cb4ba19857680cfba954e9_D20200122-20200122" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yNi0xLTEtMS0zNzg1Nw_7eb6412e-fb5c-4c17-8239-4737c64b6041">47,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Goodwill represents the acquisition of an established workforce that specializes in medical device development and market access. <ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="INF" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84Nzk2MDkzMDI4NjM1_0b5e66fa-ae40-410f-8cb6-527bea24c9cb">None</ix:nonFraction> of the goodwill recognized is expected to be deductible for income tax purposes. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The fair value of the contingent consideration was estimated at the date of acquisition as $<ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1NDc2_d3dbe106-32df-4e0a-ac54-f1b536c2c631">Nil</ix:nonFraction>. Depending on performance of MedPass for the 12 month period ended December 31, 2020, the total consideration could have increased by a maximum of $<ix:nonFraction unitRef="usd" contextRef="i502149ae91374acc8a5f8e388394c164_I20200122" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1NDkx_27bb7701-5578-4d8b-a34b-abd3d252fd3a">6.7</ix:nonFraction>&#160;million in contingent consideration. In January 2021, the contingent consideration was finalized and a value of $<ix:nonFraction unitRef="usd" contextRef="i00c03d2629a049ada2da2d86c94ddd58_I20210131" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1NTA4_162ece96-8f8f-4c64-9611-a1dbe98b653d">Nil</ix:nonFraction> was payable.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In finalizing the acquisition of MedPass in the 12 month period from acquisition, fair value adjustments were made which resulted in an increase in accounts receivable ($<ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-5" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4ODU0_04bbbdcb-2327-422b-94fe-e4512f0a970c">0.2</ix:nonFraction> million) and unearned revenue ($<ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-5" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4ODgx_3b492f16-3678-4414-b603-2c5a7544e6ed">0.8</ix:nonFraction>&#160;million) and a decrease in operating right of use assets ($<ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-5" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4OTM1_ee50cf10-1cd8-4cc1-ae5a-f0efd9546b65">0.8</ix:nonFraction> million), other liabilities ($<ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-5" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4OTYw_e0438840-cb13-4357-b2e4-9836fdc0950d">0.8</ix:nonFraction>&#160;million), current lease liabilities ($<ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-5" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4OTkz_f28719d5-8250-4b26-8377-8ebc7184e4c5">0.1</ix:nonFraction> million), non-current lease liabilities ($<ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-5" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM5MDMw_3dee4db4-a228-43ab-ad65-71ffc8bd0c77">0.7</ix:nonFraction> million) and non-current deferred tax liability ($<ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-5" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM5MDc1_a4eaa168-07b8-4f2b-a168-c4d8fbef393c">0.6</ix:nonFraction> million). Customer relationship and order backlog assets were also finalized.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since January 22, 2020, MedPass earned revenue of $<ix:nonFraction unitRef="usd" contextRef="ia31f39dce85e49bda0b0796d89773f47_D20200123-20201231" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM5MjA3_7688af1b-49d7-41e2-a5bc-05635282759b">13.2</ix:nonFraction> million and net income of $<ix:nonFraction unitRef="usd" contextRef="ia31f39dce85e49bda0b0796d89773f47_D20200123-20201231" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM5MjI5_81eac5c0-d1aa-400c-94d8-fef24675e86c">2.5</ix:nonFraction>&#160;million in the year ended December 31, 2020. <ix:continuation id="i6badf59ec4594792bd4782bd8416d75d" continuedAt="i282978c9b8cb45b9857a3a555f66583e">The proforma effect of the MedPass acquisition if completed on January 1, 2019 would have resulted in revenue and net income for the fiscal years ended December 31, 2020 and December 31, 2019 as follows:  </ix:continuation></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i282978c9b8cb45b9857a3a555f66583e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZGI1ZGM1Nzg4NTkyNGJjODhjN2RlZmUyMzAxMzE2ZGEvdGFibGVyYW5nZTpkYjVkYzU3ODg1OTI0YmM4OGM3ZGVmZTIzMDEzMTZkYV8zLTItMS0xLTQxMTAx_f6520679-7084-4153-a5ad-c159adf808d4">2,798,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1001c2ebac745e5abfbd3e906c6f1d0_D20190101-20191231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZGI1ZGM1Nzg4NTkyNGJjODhjN2RlZmUyMzAxMzE2ZGEvdGFibGVyYW5nZTpkYjVkYzU3ODg1OTI0YmM4OGM3ZGVmZTIzMDEzMTZkYV8zLTMtMS0xLTQxMTAx_e7650ebc-3091-4208-b745-398ba09331a6">2,820,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZGI1ZGM1Nzg4NTkyNGJjODhjN2RlZmUyMzAxMzE2ZGEvdGFibGVyYW5nZTpkYjVkYzU3ODg1OTI0YmM4OGM3ZGVmZTIzMDEzMTZkYV80LTItMS0xLTQxMTAx_72b3a2e0-a987-4287-8f99-35467286317d">332,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1001c2ebac745e5abfbd3e906c6f1d0_D20190101-20191231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZGI1ZGM1Nzg4NTkyNGJjODhjN2RlZmUyMzAxMzE2ZGEvdGFibGVyYW5nZTpkYjVkYzU3ODg1OTI0YmM4OGM3ZGVmZTIzMDEzMTZkYV80LTMtMS0xLTQxMTAx_de7256a8-5409-4514-bfa1-cebf00c323b5">377,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> 7. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90ZXh0cmVnaW9uOmIzOTlhZmZkYWQ2MTQ2OGU5YmJmMDY3MTI5OGUzMWQyXzQ5_db6f38d8-560e-4700-9cd0-e0e1730e527a" continuedAt="i3df3a23df0e5419eb9f75dd4bced0b3e" escape="true">Property, Plant and Equipment, net</ix:nonNumeric></span></div><ix:continuation id="i3df3a23df0e5419eb9f75dd4bced0b3e"><div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90ZXh0cmVnaW9uOmIzOTlhZmZkYWQ2MTQ2OGU5YmJmMDY3MTI5OGUzMWQyXzUy_41ff5303-db1b-4727-9024-7777e9b0ecc2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzMtMS0xLTEtMzYyNDg_57aa0634-5827-4ab3-8f4d-f7bf9d3dcfe7">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzMtMi0xLTEtMzYyNDg_402e06c2-ec43-4f96-9ea7-1666c4f56709">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzQtMS0xLTEtMzYyNDg_c236efcc-88df-4485-9d58-c70675bb039e">82,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzQtMi0xLTEtMzYyNDg_6f415464-e64c-437d-9783-2f17a502309c">90,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzUtMS0xLTEtMzYyNDg_909cc8a6-96b6-4e17-ac15-64a3b3b04844">506,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzUtMi0xLTEtMzYyNDg_d025e8be-0a9b-44e1-9e7c-291887da2118">440,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzYtMS0xLTEtMzYyNDg_557414de-144f-47af-bd45-e458c361e15b">107,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzYtMi0xLTEtMzYyNDg_167bbcc7-f800-4fa2-bf3c-ba14a6623394">91,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzctMS0xLTEtMzYyNDg_d45c3394-ab23-4e23-8d47-9fc4b118c019">29,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzctMi0xLTEtMzYyNDg_5ddc56b6-262c-4270-bd77-aa7e6f546309">44,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzgtMS0xLTEtMzYyNDg_6f53a597-56bb-49a5-ab09-b5ef9ae76547">70,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzgtMi0xLTEtMzYyNDg_3c89b3c3-ea73-422c-ac3f-0cef64e4431e">32,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:VehiclesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzktMS0xLTEtMzYyNDg_52e9a32d-8967-44c0-9eba-8c5b4dc289e6">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:VehiclesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzktMi0xLTEtMzYyNDg_fae0ca4f-199d-4aed-accd-57c0b4ae15ea">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzExLTEtMS0xLTM2MjQ4_5e11a4b3-78d0-42fc-a347-f0466fd11df6">798,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzExLTItMS0xLTM2MjQ4_8257c799-86ac-440f-80ae-f0dca8e6ddd4">703,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzEyLTEtMS0xLTM2MjQ4_06fa4140-8385-4f4f-8539-1f6a6d9bfc10">462,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzEyLTItMS0xLTM2MjQ4_3e62c321-1627-4156-98a8-6d72ac070557">529,371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzE0LTEtMS0xLTM2MjQ4_226fc2b8-da2b-4f98-a4eb-a2773bdf5f7e">336,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzE0LTItMS0xLTM2MjQ4_62078c3a-cfde-4aeb-a95e-1e1a79ae8cb9">174,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2021 and the year ended December&#160;31, 2020, certain fully depreciated assets were written off as they were no longer used in the Company.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_160"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90ZXh0cmVnaW9uOjlkYjZmZjU1OTlhZTRjYzI4NzYxYjQ1M2E0ZDYyNTJlXzI3NDg3NzkwNzAwMDY_4a9655c7-92da-4ff2-b0de-0ba1c803a323" continuedAt="i029ff220755043459161329085adb37b" escape="true">Other Liabilities</ix:nonNumeric></span></div><ix:continuation id="i029ff220755043459161329085adb37b"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:OtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90ZXh0cmVnaW9uOjlkYjZmZjU1OTlhZTRjYzI4NzYxYjQ1M2E0ZDYyNTJlXzEyMDk0NjI3OTA2MTAz_196da644-0974-47fb-a142-f2b97a6b6cda" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzItMS0xLTEtMzYyNDg_d0f9925e-7b0a-42ce-9bfd-0ab39dbe09e3">459,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzItMi0xLTEtMzYyNDg_89bc0adf-c6eb-42b9-a501-17a02102f123">188,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzMtMS0xLTEtMzYyNDg_5feea2ad-0d60-44d6-b314-5e2c4626078f">413,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzMtMi0xLTEtMzYyNDg_615f0f6b-8a70-4605-af14-40a46ecd30c4">161,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (note 23)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzQtMS0xLTEtMzYyNDg_5f69ce9b-216f-4d6d-a783-09f1f3330de3">49,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzQtMi0xLTEtMzYyNDg_09f1eec6-2c9c-4321-b545-fbd916376e8a">24,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AccruedUtilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzUtMS0xLTEtMzYyNDg_b82562c7-53f7-4d40-ae87-932976e9b9bb">12,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AccruedUtilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzUtMi0xLTEtMzYyNDg_7eda55c6-fd0f-4b3e-958f-eab99367ef18">9,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzYtMS0xLTEtMzYyNDg_a40f02cd-9533-4a5e-9bff-db8135cf43be">7,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzYtMi0xLTEtMzYyNDg_42fdb50b-874f-496e-bcf3-22ea68be1de1">8,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities (note 15)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:RestructuringReserveandOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzctMS0xLTEtMzYyNDg_2bd90b33-68ef-4e50-9749-f7a4da80a520">7,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:RestructuringReserveandOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzctMi0xLTEtMzYyNDg_4ea7de47-85bd-495d-8de1-adfb313c2205">7,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:CapitalGovernmentGrantsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzgtMS0xLTEtMzYyNDg_87c6a4d9-f820-4a19-880a-a33e5a10173e">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:CapitalGovernmentGrantsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzgtMi0xLTEtMzYyNDg_eef75b92-e8bd-417b-b691-63b4fb5b1d01">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzktMS0xLTEtMzYyNDg_12b70f64-721f-4813-925a-40f2bc5ef46e">949,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzktMi0xLTEtMzYyNDg_23066ba7-a601-47a7-b2f7-2dd51744bdc8">399,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90ZXh0cmVnaW9uOjlkYjZmZjU1OTlhZTRjYzI4NzYxYjQ1M2E0ZDYyNTJlXzEwOTk1MTE2MjgxOTY_12507025-6d4b-4234-87ed-14dd1ea90477">323.6</ix:nonFraction>&#160;million at December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90ZXh0cmVnaW9uOjlkYjZmZjU1OTlhZTRjYzI4NzYxYjQ1M2E0ZDYyNTJlXzEwOTk1MTE2MjgyMTI_d68872d8-f548-4fe8-bc30-dbdc4e841c65">138.2</ix:nonFraction>&#160;million at December&#160;31, 2020.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_163"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90ZXh0cmVnaW9uOjQxODhjZTY0MTU4MDRkNWY4N2ZjOThiMDA0MTAyOGUwXzQ3_515e8d6b-448c-4074-9cfc-315cd950c969" continuedAt="if44b030ed210419aa1d9fbf7c943b4e5" escape="true">Non-Current Other Liabilities</ix:nonNumeric></span></div><div><ix:continuation id="if44b030ed210419aa1d9fbf7c943b4e5"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90ZXh0cmVnaW9uOjQxODhjZTY0MTU4MDRkNWY4N2ZjOThiMDA0MTAyOGUwXzQy_33f0020d-36cc-4f8a-b013-ac65c352ad51" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 10)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzMtMS0xLTEtNDQxNTk_20300024-b3e7-4f88-85f3-a5c91546826b">16,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzMtMi0xLTEtNDQxNTk_790b5b9e-4af7-458c-a265-9a12910189f5">10,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzMtMS0xLTEtMzYyNDg_29a8d832-c3ae-4c43-8ac3-f4aceba6aed3">25,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzMtMi0xLTEtMzYyNDg_0de9961a-0f53-462b-a4aa-c8f7f6d92626">15,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzQtMS0xLTEtMzYyNDg_7c059534-63cd-4b45-a5ae-f157be1402aa">41,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzQtMi0xLTEtMzYyNDg_ed5d1832-9224-4a26-bc6d-4af12bf29dc5">26,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2MzU_7605130f-9b13-4718-aa93-758b817ce5b5" continuedAt="if6feea374969425e8f2da316b56cb767" escape="true">Employee Benefits</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if6feea374969425e8f2da316b56cb767" continuedAt="i36de5ac0aacb4851a7c70f514774a516"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defined contribution or profit sharing style plans ("the Plans") are offered globally in a number of countries. In some cases, these plans are required by local laws or regulations. Certain Company employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. Contributions to the plan are recorded as an expense in the selling, general and administrative line in the Consolidated Statement of Operations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of <ix:nonFraction unitRef="number" contextRef="icf72293147ed4ca08c6367f48b6a674e_D20210101-20211231" decimals="3" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzE2NDkyNjc0NDM0ODc5_d1ff7140-98aa-4cda-b027-a4728c381dd5">4.5</ix:nonFraction>% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 were $<ix:nonFraction unitRef="usd" contextRef="icf72293147ed4ca08c6367f48b6a674e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzEzMTI_66ee92b0-f24d-407c-b977-d26d6c46ca00">23.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i11b91c2328484f58921510f5691f05a1_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzEzMTY_9ca17df3-d2c9-44d3-ba50-db5dfd9b6031">17.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i27d941fab37b403093cfa434f63692f7_D20190101-20191231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzEzMjM_902abb27-8be1-4fe9-946a-087892937d11">16.5</ix:nonFraction> million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company maintains various retirement plans across the Group, many of which are required by local employment laws. In addition to the specific defined benefit schemes shown separately below, the Company maintains several other retirement plans with a total net obligation associated with these schemes of $<ix:nonFraction unitRef="usd" contextRef="i2b89aca039eb4e798c4afcd95f0f1b09_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzIxOTkwMjMyODU5Nzc_8dfcc1a9-ee08-4321-b722-f79625be4192">8.0</ix:nonFraction>&#160;million. This balance has been recorded in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON Development Solutions Limited pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> 'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The plan has been closed to new entrants with effect from July 1, 2003.</span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2NzQ_c416ef16-c56b-4375-ac3a-13954666bd16" continuedAt="i6c957ffac5ab4fb6b4373dd048c38885" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzItMS0xLTEtMzYyNDg_ae131773-e58d-4b58-bf09-271e87f858b0">41,813</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzItMi0xLTEtMzYyNDg_e4b1b93b-7f3d-47a4-9016-5d37744067d0">43,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzMtMS0xLTEtMzYyNDg_1edfe815-8576-4168-b402-f2e20047e68c">36,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzMtMi0xLTEtMzYyNDg_c6a5a580-9467-4e63-bd21-0831749b6fcc">34,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzQtMS0xLTEtMzYyNDg_960d7805-6d52-45c0-ae8b-820a2ce7f197">5,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzQtMi0xLTEtMzYyNDg_f4745d2d-85ba-4a0f-8553-3a667080c32f">9,376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzUtMS0xLTEtMzYyNDg_900f1c91-cd7d-4c4f-89de-6f9557d70157">5,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzUtMi0xLTEtMzYyNDg_8d133d93-edb1-4a8b-a806-3d2f9727a6de">9,376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzItMS0xLTEtMzYyNDg_5098c3f8-5ae6-494f-88fc-890d3afaa516">43,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic55595e1f75246f1aadac4c6ddd9900e_I20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzItMi0xLTEtMzYyNDg_a621f0cb-e594-4764-b1c5-6a11b3525e9d">37,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzMtMS0xLTEtMzYyNDg_3468aac5-ca60-4f77-bed5-60cf0caf8ec8">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzMtMi0xLTEtMzYyNDg_5e76462c-0e5f-4c02-8573-0d66d72ef86c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzQtMS0xLTEtMzYyNDg_bfd2fc86-b4fe-4edc-bf58-fc2bde4baaaf">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzQtMi0xLTEtMzYyNDg_65525011-0c7a-4b30-81f8-e6bd443d02ca">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzUtMS0xLTEtMzYyNDg_e2d4b803-dec1-4b4e-bc23-4087399f9f21">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzUtMi0xLTEtMzYyNDg_7f8afc7c-5ae9-42f8-b578-148608394412">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzctMS0xLTEtMzYyNDg_4f1774b1-adf9-4ee4-8d30-a4fbbe9a6b1b">489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzctMi0xLTEtMzYyNDg_58bbe8fe-3bed-4077-a140-2176ff3d9a2f">724</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzgtMS0xLTEtMzYyNDg_735e2e49-7950-4a54-8c76-6a00269b6d2f">2,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzgtMi0xLTEtMzYyNDg_9dcfe2f0-b1bd-453b-9283-16765dcaecc3">5,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzktMS0xLTEtMzYyNDg_7b219394-6b5e-4554-ad84-873e76f169ce">411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzktMi0xLTEtMzYyNDg_682094cf-0cf8-406e-aff8-a9f8212b1293">1,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzEwLTEtMS0xLTM2MjQ4_c9d855e4-6d23-4dea-8b29-c7c3896a9b62">41,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzEwLTItMS0xLTM2MjQ4_75f324ca-0c8f-426d-bed9-dde7c13f5d71">43,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i36de5ac0aacb4851a7c70f514774a516" continuedAt="i425e2d381bc041fa80173c0fc1385573"><div><ix:continuation id="i6c957ffac5ab4fb6b4373dd048c38885" continuedAt="i350bc7edcc8f4feb94f2ec171cee5205"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzItMS0xLTEtMzYyNDg_b84e3a8e-c7fa-4b89-a912-399997d0a9fe">34,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic55595e1f75246f1aadac4c6ddd9900e_I20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzItMi0xLTEtMzYyNDg_4b775926-b11d-48b6-8796-3213dffd1f18">32,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzMtMS0xLTEtMzYyNDg_8b6b40a6-bb74-4e3a-8d5b-84e9719314c1">2,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzMtMi0xLTEtMzYyNDg_bc6589ff-401e-4f6b-8744-7f0187654d58">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzQtMS0xLTEtMzYyNDg_7cf88e93-a1f1-4678-930f-2bcdcf45fc1b">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzQtMi0xLTEtMzYyNDg_96fd1a7c-b365-4d4d-a498-37d2b803d5a3">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzUtMS0xLTEtMzYyNDg_d06b09c9-7e76-4387-af60-d25ae6693763">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzUtMi0xLTEtMzYyNDg_36b62f6a-ef85-40da-baa0-9e93067175b1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzYtMS0xLTEtMzYyNDg_c7f5a1ea-e31c-43c0-8ed5-46e399a32a50">489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzYtMi0xLTEtMzYyNDg_bfe50c20-3eac-44e7-9f3a-83c4ce76bab6">724</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzctMS0xLTEtMzYyNDg_964ab63f-6602-456c-93a4-acb379c946f7">386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzctMi0xLTEtMzYyNDg_50bb107c-9b94-4a1b-b0fb-18789b911b2f">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzgtMS0xLTEtMzYyNDg_c8cb385a-15ef-40e8-b47f-6b15ec5b1f7b">36,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzgtMi0xLTEtMzYyNDg_f63d2921-ce7f-4282-9688-a3ea6f1ebc05">34,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2Mzc_9abedcc1-1f8f-4598-98a7-24e451bbea8b" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzItMS0xLTEtMzYyNDg_68eaa6e1-28fa-4f03-bc97-749b42930a94">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzItMi0xLTEtMzYyNDg_02311fe7-802f-4990-8b7d-760c109b8069">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzItMy0xLTEtMzYyNDg_bb8437b8-057b-4dab-8f97-b61c866ea4ff">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzMtMS0xLTEtMzYyNDg_f64b7bda-85d3-4771-9ae3-16fd9edd5af4">665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzMtMi0xLTEtMzYyNDg_03e724c4-6424-4b91-a8b9-2e1dc8a15e9e">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzMtMy0xLTEtMzYyNDg_3bd7823c-8bc6-4228-831f-ea6921ec4b42">867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzQtMS0xLTEtMzYyNDg_2b2c0a85-14c9-4a7c-80d3-c4d08cbd8690">1,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzQtMi0xLTEtMzYyNDg_36d2de9b-bff2-4555-b4bd-ed91f50d85fd">1,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzQtMy0xLTEtMzYyNDg_200b379d-5d40-4869-b703-5f855643e2b6">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzUtMS0xLTEtMzYyNDg_9f2b8ebe-61f4-414a-823b-679f680344c0">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzUtMi0xLTEtMzYyNDg_91720149-69d7-4331-b3d6-524cb8124884">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzUtMy0xLTEtMzYyNDg_7b16a1cb-3871-4820-9fe8-f932f0b4e2b6">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzctMS0xLTEtMzYyNDg_7f743aa6-c3c1-4944-a959-ffa4cfc37ea4">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzctMi0xLTEtMzYyNDg_9fef6115-729b-4b6c-8e87-ba7d7c5d5477">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzctMy0xLTEtMzYyNDg_8f15685e-30de-41b4-8867-02a5e459bfdc">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2NDc_159e71d9-1740-4486-8ffd-71f3ff82d2a9" continuedAt="ia7bfc9f224ed47ba864717bd3d39b465" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzEtMS0xLTEtMzYyNDg_57248b3e-752b-46f0-baf5-e39f1947ffaa">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzEtMi0xLTEtMzYyNDg_b000d3a8-0833-4458-830d-8944a7c5997b">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzEtMy0xLTEtMzYyNDg_d57e5942-fc5d-4284-8149-0b0a9b28bda4">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzItMS0xLTEtMzYyNDg_0aa08a3c-73f7-4640-a8c4-8052b4ced899">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzItMi0xLTEtMzYyNDg_07568e7a-b7f0-428e-be12-7fdfb38cb2a6">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzItMy0xLTEtMzYyNDg_5f32ee84-3992-459f-a1d6-49cabe48fef8">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzMtMS0xLTEtMzYyNDg_469ab44b-6692-4261-9e77-ff4560ed7f3b">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzMtMi0xLTEtMzYyNDg_4306d6d1-5aa5-46e9-8e0f-358be2cbeb0a">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzMtMy0xLTEtMzYyNDg_2aa55040-263e-4fd3-955d-f0eb55b26e78">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2MTk_0efb29d2-e7a5-4533-9bf8-dbc0c429e9ab" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzItMS0xLTEtMzYyNDg_6c801d84-d602-4d6e-a545-e79dd5a66748">2,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" sign="-" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzItMi0xLTEtMzYyNDg_38ec61e7-daf3-431d-9ce2-f6773470cb9b">5,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" sign="-" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzItMy0xLTEtMzYyNDg_7483fe63-c62d-4241-a14c-121995557169">4,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain &#8211; plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzMtMS0xLTEtMzYyNDg_26e15845-5ae8-4277-9957-3e9405c13bf8">1,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzMtMi0xLTEtMzYyNDg_a4132b2d-6fb6-435f-b0d2-f461ee7c3476">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzMtMy0xLTEtMzYyNDg_f07c40d7-bc30-4c3c-bcf4-5299101a6a09">2,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss recognized in net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzQtMS0xLTEtMzYyNDg_ecfa4fcd-6838-4e8e-b011-2fcc957b8f4a">625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzQtMi0xLTEtMzYyNDg_73ebf4fc-4f20-43e7-97b5-321e5619db7f">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzQtMy0xLTEtMzYyNDg_dd99602d-e3a3-43e3-acc6-73982523fd1c">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzUtMS0xLTEtMzYyNDg_1b0f8b88-d6c4-4b49-afcd-873942a93fe9">3,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzUtMi0xLTEtMzYyNDg_f30ad0a5-dce6-45d8-b33d-80b9fd5c2e2f">4,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzUtMy0xLTEtMzYyNDg_f8ca6148-1224-419a-97b7-219050360763">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $<ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzI3MTA_876c0c10-c184-4b0f-8c60-0b50d049ad0a">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzI3MTc_167aa00d-4f6a-4d15-b443-79c00512364f">Nil</ix:nonFraction> respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i425e2d381bc041fa80173c0fc1385573" continuedAt="ic72d5da1236447aba7e610683a89b17e"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit Obligation</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ia7bfc9f224ed47ba864717bd3d39b465"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphNjA3OTk4NTRiYzU0M2YzYWZiZmQ0OWM2YTJjZGFjOC90YWJsZXJhbmdlOmE2MDc5OTg1NGJjNTQzZjNhZmJmZDQ5YzZhMmNkYWM4XzEtMS0xLTEtMzYyNDg_1642602a-7b03-43e2-b64e-f0ed06b2b8f7">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphNjA3OTk4NTRiYzU0M2YzYWZiZmQ0OWM2YTJjZGFjOC90YWJsZXJhbmdlOmE2MDc5OTg1NGJjNTQzZjNhZmJmZDQ5YzZhMmNkYWM4XzEtMi0xLTEtMzYyNDg_f11117ca-5aad-41ee-b794-bd61a3882a4b">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphNjA3OTk4NTRiYzU0M2YzYWZiZmQ0OWM2YTJjZGFjOC90YWJsZXJhbmdlOmE2MDc5OTg1NGJjNTQzZjNhZmJmZDQ5YzZhMmNkYWM4XzItMS0xLTEtMzYyNDg_9aab379d-f6b5-45d0-9631-51a81ee59d17">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphNjA3OTk4NTRiYzU0M2YzYWZiZmQ0OWM2YTJjZGFjOC90YWJsZXJhbmdlOmE2MDc5OTg1NGJjNTQzZjNhZmJmZDQ5YzZhMmNkYWM4XzItMi0xLTEtMzYyNDg_e47bced1-fb9f-4c04-97f5-f50994e58fda">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a <ix:nonNumeric contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" name="iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzIxOTkwMjMyNzg5MzY_b53a5ed3-2412-4181-9471-25d7df7cb699">26</ix:nonNumeric> year duration, gives the same result as a full AA corporate bond yield curve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Actuarial gains on the benefit obligation during 2021 resulted from changes in the assumptions compared to those adopted at December 2020. Changes in the assumptions reflect the changes in market conditions from December 2020 to December 2021 and the actuarial gain is primarily due to the change in the discount rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets of the scheme are held on an investment platform with Mobius which invests in a number of investment funds with Legal &amp; General, Stone Harbor, Ninety-One and Barings.&#160;The overall investment strategy is that approximately <ix:nonFraction unitRef="number" contextRef="iee612b419754414e8828f427b68f7002_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzM2NzE_3e1b6019-8e21-48a7-aed0-58e3354c63fc">20</ix:nonFraction>% of investments are in senior secured loans, <ix:nonFraction unitRef="number" contextRef="ia159cefdf37f4364a9843092cf3a2325_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzM3MTg_478855b2-ddba-49c6-8f6f-c9186b4ab51d">18</ix:nonFraction>% in corporate bonds, <ix:nonFraction unitRef="number" contextRef="i27a855a3bed8480bab49ff8e8735587d_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzEwOTk1MTE2Mjg4MTI5_d174c1b6-5dda-4432-8e2e-8cbd157601ad">19</ix:nonFraction>% in high yield bonds and multi-asset credit fund and <ix:nonFraction unitRef="number" contextRef="i49cd9b5fb069425c885e4e858a9cd7db_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzM3OTA_d53537b4-c636-4545-b058-97712c8fe059">24</ix:nonFraction>% in world equities respectively. There is no self-investment in employer related assets. The expected long-term rate of return on assets at December&#160;31, 2021 of <ix:nonFraction unitRef="number" contextRef="i9c04b88d67624c00974b95408ed71c3c_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzM5Mzg_e06614f7-e8ac-4d32-b4db-d7f407644af6">3.8</ix:nonFraction>% was calculated as the value of the fund after application of a market value reduction factor. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2MjU_2bad8bb8-d6e3-43d3-be0c-2dc7d2104807" continuedAt="i5cb4a494e5c44e5e9830d268851c0e9c" escape="true">The expected long term rates of return on different asset classes are as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i5cb4a494e5c44e5e9830d268851c0e9c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected long-term return per annum</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including <ix:nonFraction unitRef="number" contextRef="ib9509a32705e43b195f8a5dee756c081_I20211231" decimals="INF" name="iclr:DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzEtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjozYzNkZDA1YTkzYjI0MmRmOThkMGMxM2Q0ZWMzZGI1Y18zMQ_abe687e4-c8b0-4368-8684-37058dc15df8">50</ix:nonFraction>% high yield bonds)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iece79a92c4da478a8144d377620226a2_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzEtMS0xLTEtMzYyNDg_36f231a2-7b4a-4a28-b959-ee82b52fa57e">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d7dd97703d84c88a35a15329488f10f_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzEtMi0xLTEtNjE5MjQ_f0e23c89-bd04-4830-b99a-79be648f72ec">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2722f8b4561c498cb1416e166b7ad02c_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzItMS0xLTEtMzYyNDg_fa160e83-6084-4dfc-b171-3eb7ca5f499f">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63bf8a993c2147649f1d3f6fb9bebb7c_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzItMi0xLTEtNjE5MjQ_f453008c-5032-4231-a9de-ee08853e0472">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic522ae4b5b4b4ec5b45ddca4c8a8a60f_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzMtMS0xLTEtMzYyNDg_e0809cee-50c0-4489-b21a-67df6fe4267b">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e1ef306fa1d450b985b7cfbaf9ce6f2_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzMtMi0xLTEtNjE5MjQ_3fde2398-238e-4f44-9504-8e2a4ce12cf2">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The long-term expected rate of return on cash is determined by reference to traditional corporate bond rates at the latest Balance Sheet date. The long-term expected returns on traditional corporate and government bonds are determined by reference to corporate bond yields and gilt yields respectively at the Balance Sheet date. The long-term expected returns on equities are based on the rate of return on government bonds with an allowance for out-performance. The long-term expected return on high yield bonds, secured loans and multi asset credit is based on the return on traditional corporate bonds with an allowance for out-performance. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2MzI_64614ee9-9014-43d9-8253-e10a2cd0ddd4" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The underlying asset split of the fund is shown below.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including <ix:nonFraction unitRef="number" contextRef="ib9509a32705e43b195f8a5dee756c081_I20211231" decimals="INF" name="iclr:DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzEtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjozYzUzNzllYmU3MjI0NDJkODVkOTQwNjRjZGZiYjllYV8zMQ_abe687e4-c8b0-4368-8684-37058dc15df8">50</ix:nonFraction>% high yield bonds)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia159cefdf37f4364a9843092cf3a2325_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzEtMS0xLTEtMzYyNDg_0c2d6cc5-eb82-4c3e-acc0-1f5a974ff35c">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4eef861e44254199911aaf8a9ce379f4_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzEtMi0xLTEtMzYyNDg_d71a4191-139e-4bc4-bb32-9666f9efaeb5">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49cd9b5fb069425c885e4e858a9cd7db_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzItMS0xLTEtMzYyNDg_479a4574-4fc1-4190-be93-2b220a297fe6">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40941b5fcb9547c4aec232ca49dbee5a_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzItMi0xLTEtMzYyNDg_d4ee230e-b71c-4e3b-9198-d3ee13c47848">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee612b419754414e8828f427b68f7002_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzMtMS0xLTEtMzYyNDg_48bcdd49-9cfd-4883-89f2-a0130f65a06a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37cabf6d514a484e8c75d7747a3e6cee_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzMtMi0xLTEtMzYyNDg_7b7d7627-1ba7-46d6-959d-764928d99338">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9509a32705e43b195f8a5dee756c081_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzYtMS0xLTEtMzYyNDg_d85e92c0-05b8-4006-928c-829484049e7b">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21d1d31dbff94254ae22cf50de458c51_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzYtMi0xLTEtMzYyNDg_efc6827e-39c0-452d-a67f-9888241d4963">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Applying the above expected long term rates of return to the asset distribution at December&#160;31, 2021, gives rise to an expected overall rate of return of scheme assets of approximately <ix:nonFraction unitRef="number" contextRef="i9c04b88d67624c00974b95408ed71c3c_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzUwMDE_e06614f7-e8ac-4d32-b4db-d7f407644af6">3.8</ix:nonFraction>% per annum.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic72d5da1236447aba7e610683a89b17e" continuedAt="i8a81a601ad284554ad2f73c08d5d780f"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Asset Fair Value Measurements</span></div><div style="margin-top:5pt"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2Njc_b2e7c1cd-e19d-49cf-a782-b509efcb14c2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>Level 1</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib955eed4b9ce4d00a2bd4e2ce7b5a191_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzMtMS0xLTEtMzYyNDg_e6261d36-0c19-48e5-8982-077ae4a075df">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf105ea7475a47ae9ce9c72b2859f1b6_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzMtMi0xLTEtMzYyNDg_30de57a7-ad7e-4b19-bbd9-796b19f95b11">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Income Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">L&amp;G Life GPBF All World Equity Index Fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9487d796fcc149dbb3f7bcd120e40e56_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzUtMS0xLTEtMzYyNDg_b2f34527-ee17-4ec0-a8ff-1f05fd428283">8,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id748b57582fe44e5b3492d06beea0921_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzUtMi0xLTEtMzYyNDg_3b554b40-367e-4486-a422-e3fdec973ad9">7,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">L&amp;G Life DC Active Corporate Bond</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77d9586a1ce944dd8bc0eb9cfc5adc1b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzYtMS0xLTEtMzYyNDg_fb0a5ee3-bd14-4218-a6bf-5d633eaca431">6,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie033646e348048399b773047abffe484_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzYtMi0xLTEtMzYyNDg_d9af3fd2-1c03-458e-aedb-324dc089696c">6,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stone Harbor High Yield Bond Fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64cfe0b0c94c43f6b451b69b6c85fb20_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzctMS0xLTEtMzYyNDg_b4814198-537c-4467-9e0e-414e6e69d648">6,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1216803a75bf46db999c06ae0853a289_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzctMi0xLTEtMzYyNDg_82453d3f-2846-43ab-ad4d-cd3be1e38ad4">6,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ninety One Global Total Return Credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i517f5d381f324edebe16b610b9162167_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzgtMS0xLTEtMzYyNDg_9972edc4-6b8d-446b-a277-672d1ebf491f">3,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dda409457ee4051a9ab0dd254b58fe5_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzgtMi0xLTEtMzYyNDg_4ddb6a95-f39b-4a3c-ace7-7d1ec014811e">3,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stone Harbor Multi Asset Credit Portfolio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7054f2015f4b71993232abe485627d_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzEwLTEtMS0xLTM2MjQ4_d53a0b27-ee11-4564-a102-0970c84aab84">3,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac9953fae724a3596870ee57bc6901a_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzEwLTItMS0xLTM2MjQ4_e20542b4-5b30-4731-96e0-16222c1de979">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Barings European Loan Fund Buy &amp; Hold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8195e9a7884d23b49443cc99b9ce4b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzExLTEtMS0xLTM2MjQ4_35af977c-5837-4f9a-90e2-f5b36efa96d4">7,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id45f53eaf45c4c91b83e80ae121a0eda_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzExLTItMS0xLTM2MjQ4_8142eee1-fa03-4a8a-8329-920dbdeefaeb">6,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6eb058c3c334fa9bc0c1e5cd98974fa_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzEyLTEtMS0xLTM2MjQ4_a71baf8f-70e0-4550-8108-4de54f320107">36,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b64280f32c462596b287ec2de84d69_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzEyLTItMS0xLTM2MjQ4_3eab716e-0199-4c75-b22a-3d535ce85cd4">34,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to contribute $<ix:nonFraction unitRef="usd" contextRef="i216dac94d38a475db23d353853c31110_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzUxMDM_b6a4c5d8-d38f-4617-98bf-d41713210e5f">0.1</ix:nonFraction> million to the pension fund in the year ending December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2Mzg_575c99e4-7981-4f2e-aeb7-d006263f94e0" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzEtMS0xLTEtMzYyNDg_d70d4cee-b1ec-459d-89ce-b3248bbe0a96">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzItMS0xLTEtMzYyNDg_e23ed646-4f64-49b1-aac3-bcf9c6cd52ea">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzMtMS0xLTEtMzYyNDg_ce9e7b5e-6009-4a61-974e-2e4f4584cdb6">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzQtMS0xLTEtMzYyNDg_4e55faec-3d88-4990-8eda-677c46a8a038">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzUtMS0xLTEtMzYyNDg_f5eba913-dc65-41ac-a520-a9ae814a1729">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2027 - 2031</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzYtMS0xLTEtMzYyNDg_fd37cc0d-77e5-4a0c-8b5d-d884e4fcc297">3,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected cash flows are estimated figures based on the members expected to retire over the next <ix:nonNumeric contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231" name="iclr:ExpectedRetirementPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzUzNzQ_2578dd9b-3037-45d3-8d86-dc8730cfd724">10</ix:nonNumeric> years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8a81a601ad284554ad2f73c08d5d780f" continuedAt="i12204f2183ba4e9d9076df70f6c2e4a5"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aptiv Solutions pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 7, 2014 the Company acquired <ix:nonFraction unitRef="number" contextRef="id0c8fd01370246349a9908b32d1373e7_I20140507" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzU5MjY_33396be8-0bf2-49ea-a14d-bb354f717ca7">100</ix:nonFraction>% of the common stock of Aptiv Solutions ("Aptiv"). The acquisition of Aptiv was accounted for as a business combination in accordance with ASC 805 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Business Combinations'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021 and December&#160;31, 2020 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i350bc7edcc8f4feb94f2ec171cee5205" continuedAt="ic3c8a5d882f245b08f7292bd35337210"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzItMS0xLTEtMzYyNDg_1def5095-c64b-4983-826a-8c5645a4a5f9">7,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87320a0e379947f09f57eb63148701a9_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzItMi0xLTEtMzYyNDg_318c7f0a-b8d8-42de-b84b-27c4116ce6b8">8,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzMtMS0xLTEtMzYyNDg_39c8381b-3253-403a-8744-e4908a408d2d">6,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87320a0e379947f09f57eb63148701a9_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzMtMi0xLTEtMzYyNDg_92869ff3-1c20-4a6e-94ba-3c823e9c1454">7,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzQtMS0xLTEtMzYyNDg_69469b2c-1d5b-4982-b7fe-fe59922b5347">679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87320a0e379947f09f57eb63148701a9_I20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzQtMi0xLTEtMzYyNDg_05506413-5147-45f5-97cb-b0d76a07a266">1,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzUtMS0xLTEtMzYyNDg_ac7d4f52-9852-46f8-a519-ca82d66a21e7">679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87320a0e379947f09f57eb63148701a9_I20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzUtMi0xLTEtMzYyNDg_ada0dd19-1cf4-4e74-b2df-2a9fefeb2de8">1,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87320a0e379947f09f57eb63148701a9_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzItMS0xLTEtMzYyNDg_31f6f13f-ad66-4ce9-b545-5ddf3f171b2b">8,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536575760ce54ae2893373d1d02dc0d6_I20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzItMi0xLTEtMzYyNDg_9c9f8186-a720-4dfd-9d59-80eeb5494fec">7,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzMtMS0xLTEtMzYyNDg_746c8119-ea6c-4eb9-b2e6-581b509b7ca1">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzMtMi0xLTEtMzYyNDg_ba3a8163-3fd1-4f19-9425-99a56a672c76">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzQtMS0xLTEtMzYyNDg_82ac8ba7-7ea0-402b-a7b3-e65415f6e9f6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzQtMi0xLTEtMzYyNDg_1d90c8b8-0272-4e13-8748-cd4062af4e56">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzUtMS0xLTEtMzYyNDg_f44c53bc-fcc5-48b4-93c2-c618d9927c09">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzUtMi0xLTEtMzYyNDg_7e0ad531-3bbc-4e8b-8007-14cc875e25c7">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzYtMS0xLTEtMzYyNDg_5eceba5f-eaaf-4a0b-8048-f0c5c6dea432">483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzYtMi0xLTEtMzYyNDg_f9e313fc-9b22-47d8-92e2-dccf32833935">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzctMS0xLTEtMzYyNDg_03cae1e1-13d7-4116-80c6-f3f3719c31f9">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzctMi0xLTEtMzYyNDg_0392b20c-28af-42a1-9881-084ace9b8569">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanOtherChanges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzgtMS0xLTEtMzYyNDg_d85be970-7819-4b3b-801c-bf6170f23c8b">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanOtherChanges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzgtMi0xLTEtMzYyNDg_a995b56d-3674-4e46-b5ef-11a6ea3d9dad">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/ loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzktMS0xLTEtMzYyNDg_f09a679e-991b-4836-a62a-0eb12ed38678">484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzktMi0xLTEtMzYyNDg_9fa721cc-ed24-4ac9-89a9-ac01257c8fa2">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzEwLTEtMS0xLTM2MjQ4_cbf417de-5acc-42f4-88a1-4c00d897fdf2">261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzEwLTItMS0xLTM2MjQ4_d6c022cb-e0f7-4670-a35a-564714e90e59">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzExLTEtMS0xLTM2MjQ4_ea1c716f-901f-48a7-ad87-deea51f1d612">7,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87320a0e379947f09f57eb63148701a9_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzExLTItMS0xLTM2MjQ4_a5a0560e-3fbd-4082-afd1-be24e2b2d596">8,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87320a0e379947f09f57eb63148701a9_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzMtMS0xLTEtMzYyNDg_549f0170-7a07-4515-a4a7-c91b5383b090">7,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536575760ce54ae2893373d1d02dc0d6_I20191231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzMtMi0xLTEtMzYyNDg_a2758e9c-008c-42f6-9c0f-2ebb14906f19">6,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzQtMS0xLTEtMzYyNDg_d2ad17bf-0375-499c-98ea-60ee38fe2570">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzQtMi0xLTEtMzYyNDg_213c645b-bcb9-4e81-9e00-a6084be855b3">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzUtMS0xLTEtMzYyNDg_e9187675-38cc-4454-b581-1168d9b8fbe5">238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzUtMi0xLTEtMzYyNDg_35e21bac-0b0c-4bed-a46b-141e9147c97d">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="iclr:DefinedBenefitPlanSchemeContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzYtMS0xLTEtMzYyNDg_597e8571-73ac-46c4-a038-29a9710f8493">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="iclr:DefinedBenefitPlanSchemeContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzYtMi0xLTEtMzYyNDg_ce0199d8-39ad-4cfe-b511-2ad78b683141">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzctMS0xLTEtMzYyNDg_15398ed8-5697-4a1c-913e-8e850e7285c1">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzctMi0xLTEtMzYyNDg_7a416b7f-623d-4709-b47f-4b8f1e3ebfbc">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzgtMS0xLTEtMzYyNDg_fbd3d246-7bdf-4144-b6c6-c41d90ec088e">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzgtMi0xLTEtMzYyNDg_533953db-bf54-4b38-91a6-560beda03505">245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzktMS0xLTEtMzYyNDg_6520e2b0-aabb-4b04-9642-8d36da73d110">483</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzktMi0xLTEtMzYyNDg_afab7200-294a-46ad-9ff5-b0461d35eef7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzEwLTEtMS0xLTM2MjQ4_c4c7d44f-c2a3-48f8-8541-23e4734a4e9c">230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzEwLTItMS0xLTM2MjQ4_c4a5b274-a29c-4759-b530-0d343344fb51">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzExLTEtMS0xLTM2MjQ4_6df965ba-c1b9-4a86-8d2b-835313495930">6,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87320a0e379947f09f57eb63148701a9_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzExLTItMS0xLTM2MjQ4_719c12c0-ecf6-4303-8d22-7b851a908e7e">7,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i12204f2183ba4e9d9076df70f6c2e4a5"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRA Switzerland AG pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021 consist of units held in independently administered funds. <ix:continuation id="ic3c8a5d882f245b08f7292bd35337210" continuedAt="ia487e950efd24981a2f1477c872e1e33">The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </ix:continuation></span><ix:continuation id="ia487e950efd24981a2f1477c872e1e33" continuedAt="ie7998e2f04ef422289e323f4f81ea888"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie7998e2f04ef422289e323f4f81ea888"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkMTk2YmVmNWNhMTI0MTkzYmFhOTgxNDNmYTljMmI1YS90YWJsZXJhbmdlOmQxOTZiZWY1Y2ExMjQxOTNiYWE5ODE0M2ZhOWMyYjVhXzItMS0xLTEtNDYxMzc_82437cff-d10a-4a75-94f3-5a42c73d5f47">4,990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkMTk2YmVmNWNhMTI0MTkzYmFhOTgxNDNmYTljMmI1YS90YWJsZXJhbmdlOmQxOTZiZWY1Y2ExMjQxOTNiYWE5ODE0M2ZhOWMyYjVhXzMtMS0xLTEtNDYxMzc_6a95dcbb-8caf-4d52-9c83-ba241301c7a5">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkMTk2YmVmNWNhMTI0MTkzYmFhOTgxNDNmYTljMmI1YS90YWJsZXJhbmdlOmQxOTZiZWY1Y2ExMjQxOTNiYWE5ODE0M2ZhOWMyYjVhXzQtMS0xLTEtNDYxNDU_c670aa3f-f263-4c96-96c2-ee59897c17b4">1,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkMTk2YmVmNWNhMTI0MTkzYmFhOTgxNDNmYTljMmI1YS90YWJsZXJhbmdlOmQxOTZiZWY1Y2ExMjQxOTNiYWE5ODE0M2ZhOWMyYjVhXzUtMS0xLTEtNDYxNTE_9573d7d3-0fd9-4360-a8ac-f92741fea671">1,973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation as at July 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68dd1b4a3d3641879b1d63d1751d2f6a_I20210630" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzItMS0xLTEtNDYyMTU_3039c141-f093-4b72-af4c-9f4de53e5f0e">4,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzMtMS0xLTEtNDYyMTU_b6f68f5c-c055-4bb1-adad-33c33f3f00e4">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzQtMS0xLTEtNDYyMTU_348454f3-ab11-4a41-a462-0157ccf0991a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzUtMS0xLTEtNDYyMTU_35d89df2-eccc-4794-9608-76e2a2a8332e">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzgtMS0xLTEtNDYyMTU_9ffe2d6e-471e-43e5-b0ed-8b854e9d5ef5">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzktMS0xLTEtNDYyMTU_e33a93f1-c97e-4aa0-9b9b-7de2f6f3bc34">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzEwLTEtMS0xLTQ2MjE1_a5825ceb-b561-4f49-b2f1-35eaddc4a06e">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzExLTEtMS0xLTQ2MjE5_50a1b37f-e2de-44f7-a782-6b617b9b10d2">4,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at as at July 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03867c06634a4d5ab2189dd7fe751c3d_I20210630" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzMtMS0xLTEtNDYwOTQ_f07b340a-37bb-4250-a864-4b831eef73b7">2,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzQtMS0xLTEtNDYwOTQ_37b3bbef-93c9-4122-962a-6288a912ff62">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzYtMS0xLTEtNDYwOTQ_60d6f5af-93f5-4a0b-9e1d-3b487c4a37a6">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzctMS0xLTEtNDYwOTQ_c6ec70f2-a0cd-4595-be88-03aef6e24cfc">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzgtMS0xLTEtNDYwOTQ_02348716-66cf-4d84-be5e-8724aca45b6c">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzEwLTEtMS0xLTQ2MDk0_69049b17-192a-41cc-9671-151507c2e58b">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00041bfad6e143b8a90b3fb840be4f61_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzExLTEtMS0xLTQ2MTA3_b4a1a615-8578-498f-9dec-64fc48c348bb">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3ODA_b51e98d2-5145-47f7-93d8-47e40a26e5cc" continuedAt="i2a2757440e7a41c99e90ba81572fda1e" escape="true">Equity Incentive Schemes and Stock Compensation Charges</ix:nonNumeric></span></div><ix:continuation id="i2a2757440e7a41c99e90ba81572fda1e" continuedAt="if7c883d9a17847a4ae05dd63e34258a2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from <ix:nonFraction unitRef="shares" contextRef="i52e1bbc1869b4151944d394318356ae3_I20170213" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwNDE_f9fcc277-6576-46a6-9ba9-68a299b482e6">0.4</ix:nonFraction> million to <ix:nonFraction unitRef="shares" contextRef="i82ba7a6e4424420f8f44f4aaed17b2c2_I20170214" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwNDc_d4e783e2-0e32-44a4-9628-72f561adb70d">1.0</ix:nonFraction> million and to extend the date for options to be granted under the 2008 Option Plans.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An aggregate of <ix:nonFraction unitRef="shares" contextRef="id13244e709104dbb91bd8e7035149dd0_I20170214" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzExNDc_cdba0fcf-5245-488b-b094-c338999ba3b9">6.0</ix:nonFraction> million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of <ix:nonFraction unitRef="shares" contextRef="i9238ad4bc0c9411fa4d50e26b14d2e1f_D20170214-20170214" decimals="-5" name="iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEzNDc_3d7f316f-98a0-4c9f-a487-32e11f210154">1.0</ix:nonFraction> million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be <ix:nonFraction unitRef="shares" contextRef="i4f3c204e0dce42b98babf937edce3e3e_D20170214-20170214" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzE1NDU_5fb5cf45-68ce-46e4-9ac1-f6fefd34783a">0.4</ix:nonFraction> million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans will be an employee stock option, or NSO, as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans will be evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price will be specified in each Stock Option Agreement, however option prices will not be less than <ix:nonFraction unitRef="number" contextRef="ia2ef196657454b409ef6b9ff50ada92e_D20170214-20170214" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxMTQ_6554767d-b305-499e-8272-eea4ceecd557">100</ix:nonFraction>% of the fair market value of an ordinary share on the date the option is granted.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 17, 2003 the Company adopted the Share Option Plan 2003 (the "2003 Share Option Plan") pursuant to which the Compensation and Organization Committee of the Board could grant options to officers and other employees of the Company or its subsidiaries for the purchase of ordinary shares. An aggregate of <ix:nonFraction unitRef="shares" contextRef="i35ae564697d142d9bd558468bc6260be_I20030117" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzI1MTI_e810a213-e1c3-4f1e-9206-1f22be02bb20">6.0</ix:nonFraction> million ordinary shares were reserved under the 2003 Share Option Plan; and in no event could the number of ordinary shares issued pursuant to options awarded under this plan exceed <ix:nonFraction unitRef="number" contextRef="i00bc75888c8147eba2c8e5dde8818f99_D20030117-20030117" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzI2ODk_eb2f3f03-7f33-4589-ad89-e6ac0b91da6e">10</ix:nonFraction>% of the outstanding shares, as defined in the 2003 Share Option Plan, at the time of the grant, unless the Board expressly determined otherwise. Further, the maximum number of ordinary shares with respect to which options could be granted under the 2003 Share Option Plan during any calendar year to any employee was <ix:nonFraction unitRef="shares" contextRef="i00bc75888c8147eba2c8e5dde8818f99_D20030117-20030117" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzMwMDg_cbb570f5-4960-44b8-a37e-7ec7d164062d">0.4</ix:nonFraction> million ordinary shares. The 2003 Share Option Plan expired on January 17, 2013. No new options may be granted under this plan.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Prior to 2018, share options typically vest over a period of <ix:nonNumeric contextRef="i6e4e19cbbee143049fbca064c93a8efc_D19970101-20171231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzMzMTY_b33f7d1d-b990-45ba-ba79-6e618b3ee658">five years</ix:nonNumeric> from date of grant and expire <ix:nonNumeric contextRef="i6e4e19cbbee143049fbca064c93a8efc_D19970101-20171231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzMzNDk_62f44530-7d89-4262-9769-2d39dbb4bbb2">eight years</ix:nonNumeric> from date of grant. Share options granted to non-executive directors from 2018 vest over <ix:nonNumeric contextRef="i718ff08202614127a3831397cc22d119_D20190101-20191231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM0NDM_a6f8fc34-b75d-44b3-bae1-27809cfc3bf7">12</ix:nonNumeric> months and expire <ix:nonNumeric contextRef="i718ff08202614127a3831397cc22d119_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM0NTc_6189d98f-b3b8-4512-a37a-4b8cd11e81c8">eight years</ix:nonNumeric> from the date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Legacy PRA  Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the legacy PRA equity incentive plans, which still have equity outstanding but have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Pursuant to the Merger Agreement, effective on July 1, 2021, each outstanding stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan was amended and restated and assumed by the Registrant effective as of July 1, 2021. The 2020 Stock Incentive Plan (&#8220;the 2020 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="i8d541f61a07d4ac29868fce496e97445_I20200518" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxOTkwMjMyODQ5NDU_d2c8de27-cfc7-4733-a65f-4beed8a263e5">2,500,000</ix:nonFraction> shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The PRA Health Sciences, Inc. 2018 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="ief51d6a7563d4bc8ab4a279609f4a22d_I20180531" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxOTkwMjMyODQ5Nzg_93025f4d-52cf-43cd-ade5-253b23b4896c">2,000,000</ix:nonFraction> shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The PRA Health Sciences, Inc. 2014 Omnibus Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021 (the &#8220;2014 Plan&#8221;). On November 23, 2014, the PRA Health Sciences, Inc. Board of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if7c883d9a17847a4ae05dd63e34258a2" continuedAt="if81f621f871449a9b9795ed0c901d9ce"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The 2013 Stock Incentive Plan for Key Employees of PRA Health Sciences and its Subsidiaries was amended and restated and assumed by the Registrant effective as of July 1, 2021 (the &#8220;2013 Plan&#8221;). On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was <ix:nonFraction unitRef="number" contextRef="ic851a23a9692444896ff76991dcb6a7c_I20130923" decimals="3" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxOTkwMjMyODQ5NTY_5375ab65-137b-4773-a941-d48d969ffc98">12.5</ix:nonFraction>% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="ic851a23a9692444896ff76991dcb6a7c_I20130923" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxOTkwMjMyODQ5ODk_f37224b3-9903-427f-ad69-0ab02f7721b3">2,052,909</ix:nonFraction> shares of common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3OTQ_1e016177-7951-42d5-ab1a-a8908a26fe37" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbca4abf2817496684bb2ab04067235b_I20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEtMS0xLTEtMzYyNDg_5f576153-572f-4e49-b0a0-41b43f997a76">920,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbca4abf2817496684bb2ab04067235b_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEtMy0xLTEtMzYyNDg_f66d68b2-31fa-4fba-b0cb-414f2afc7741">74.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzItMS0xLTEtMzYyNDg_893a136b-186c-489b-80e1-4b1204eda4a1">97,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzItMy0xLTEtMzYyNDg_364eeb34-f2c7-403f-8ff4-6f717b7d468b">140.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzMtMS0xLTEtMzYyNDg_33058866-2875-4c58-8bfc-153f579bfe67">329,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzMtMy0xLTEtMzYyNDg_4816c53a-532c-4f63-85cb-966dd05512e0">65.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzQtMS0xLTEtMzYyNDg_edcf4fe4-626b-46b0-bdce-c61b06b942ab">31,881</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzQtMy0xLTEtMzYyNDg_727a0ad1-f610-4441-bb7c-bd3ad028fa06">88.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7ea21c26dac40328506c0cba3319723_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzUtMS0xLTEtMzYyNDg_04e1636c-7a85-4815-bfb0-cf583221eb55">656,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7ea21c26dac40328506c0cba3319723_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzUtMy0xLTEtMzYyNDg_51ee4bf1-b1c9-4122-941a-328f4071abd1">87.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzYtMS0xLTEtMzYyNDg_a9977e0d-1a61-45c3-9f43-7449ba88fd40">107,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzYtMy0xLTEtMzYyNDg_271efc84-cc14-49bd-90e6-68f647397c34">159.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzctMS0xLTEtMzYyNDg_a270f785-2c15-48a3-9773-a3b026ea17d0">193,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzctMy0xLTEtMzYyNDg_4ada7b09-32b9-4f7e-8415-2a87b532a7db">68.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzgtMS0xLTEtMzYyNDg_48af46e7-81a2-4434-888f-e4fa86ad79c9">16,681</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzgtMy0xLTEtMzYyNDg_4f47f0c2-d792-41d2-b145-0b23c4a7232c">92.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i953fc3f9f5114324bcd9a4293c83b977_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzktMS0xLTEtMzYyNDg_d9449117-898d-4345-88e8-5c71665d867c">553,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i953fc3f9f5114324bcd9a4293c83b977_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzktMy0xLTEtMzYyNDg_0f19a509-7789-4222-800f-ae2aec1148cd">108.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" decimals="INF" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEwLTEtMS0xLTQ1NDc4_59e76a24-f2ab-4b3f-af54-d2ced20b4c19">2,177,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEwLTMtMS0xLTQ1NDg1_06462842-1142-4e33-9e00-df6318dba2ff">108.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEwLTEtMS0xLTM2MjQ4_391b019d-7e41-44f6-8b00-53603b4b4119">100,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEwLTMtMS0xLTM2MjQ4_5b908a81-14f6-4889-8ef0-5b88006b94ce">177.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzExLTEtMS0xLTM2MjQ4_c10cb1f0-a295-4e88-807f-b061ec32da90">1,065,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzExLTMtMS0xLTM2MjQ4_b7dec31c-432a-463e-8ea4-b94795e9cce0">111.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEyLTEtMS0xLTM2MjQ4_5877c10d-eebb-44b7-b1b0-77b118665bfd">70,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEyLTMtMS0xLTM2MjQ4_1aa957a0-aa56-4b56-bb50-7a37f0d74be8">128.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib049563e613d4855a95f4886886e70d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEzLTEtMS0xLTM2MjQ4_ae58f409-69ce-48ff-8208-81fe3f24e3fb">1,695,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib049563e613d4855a95f4886886e70d4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEzLTMtMS0xLTM2MjQ4_9cf4c2aa-6d6d-42aa-ac1e-4651eb67d4d4">104.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib049563e613d4855a95f4886886e70d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzE0LTEtMS0xLTM2MjQ4_6763cd60-c36a-4972-ac58-d993c977b9a9">989,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib049563e613d4855a95f4886886e70d4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzE0LTMtMS0xLTM2MjQ4_0f0b3324-8b8c-4d66-9948-267306d51aed">91.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2021, was <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM3MjA_3a148b44-2b41-4c44-b8ff-85de91d13cae">5.39</ix:nonNumeric> years and <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM3Mjc_43d49586-347e-43c3-b07f-273a0b122c36">4.55</ix:nonNumeric> years respectively (2020: <ix:nonNumeric contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM3NDg_1a9eec0a-4885-4073-9ca3-b1d989ec1f37">4.86</ix:nonNumeric> years and <ix:nonNumeric contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM3NTU_df72a692-64df-4e19-94ad-e7a729e2b208">3.60</ix:nonNumeric> years respectively).</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" xsi:nil="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3OTg_249d25da-73d1-4e9f-9b54-dff32b0bb2c9" escape="true"></ix:nonNumeric>Outstanding and exercisable share options:</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3ODY_bc01b009-140e-4159-a75b-3b1fcfbc8567" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.448%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a89202c30764a8e9ad0c13560be2ae0_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjoyNWE3MzQ3ZGNmZDQ0ZmEzOWM3MmE2YmY0OTZhNmVlMV8xMjA5NDYyNzkwNTU1MA_867c60f6-830f-4ee8-b790-f770a96d645e">14.80</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i0a89202c30764a8e9ad0c13560be2ae0_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjoyNWE3MzQ3ZGNmZDQ0ZmEzOWM3MmE2YmY0OTZhNmVlMV8yMTk5MDIzMjU1NTcy_8e526fcd-256c-4dfe-926c-656fdcd2f12e">97.30</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcc6762b3d2c402e97ea3771e8aeb750_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtMS0xLTEtMzYyNDg_217193e5-a522-4933-8f9e-84552ca8f002">638,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i22c88a1dd7ca45d48c661d231dd100b2_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtMi0xLTEtMzYyNDg_ab29762f-d972-46d1-b9d3-bb670fc864ba">3.45</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcc6762b3d2c402e97ea3771e8aeb750_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtNS0xLTEtMzYyNDg_c3832c51-9eb1-4cdf-b3b1-b96b76990a18">605,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6de01c93a2fb457e98a862dc99d4abdd_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjozM2ZkYThkNTQyYTk0M2M1YWZhNThhZDQ3MzllZDBhZl8yMTk5MDIzMjU1NTY4_2ad2eac8-ff80-4475-b450-f18caeb80aca">103.81</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i6de01c93a2fb457e98a862dc99d4abdd_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjozM2ZkYThkNTQyYTk0M2M1YWZhNThhZDQ3MzllZDBhZl8yMTk5MDIzMjU1NTc0_f88f77e3-fd73-4973-831e-9cbaad1629d9">124.00</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7eb517873331422d82ddeb24ae81abab_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtMS0xLTEtMzYyNDg_e6fb948b-86a4-49bc-ac91-263521b7d2e8">320,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f9f44ae168e404abf9f671dd8805b74_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtMi0xLTEtMzYyNDg_7fba8f03-88db-4de5-964b-e6233aafd980">6.49</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7eb517873331422d82ddeb24ae81abab_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtNS0xLTEtMzYyNDg_027f30c2-57f4-4406-b83c-c347b511143c">130,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8a3088705f84bc0ba8f033ac2ceb1b4_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjoyNWE5NGQ3MDQxMjc0YTM0YTNlZDU5ZTIwZjQyODY2NV8xMjA5NDYyNzkwNTU1Mg_021f4de6-3aad-4b97-90d1-09ecb88c6282">125.74</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="ib8a3088705f84bc0ba8f033ac2ceb1b4_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjoyNWE5NGQ3MDQxMjc0YTM0YTNlZDU5ZTIwZjQyODY2NV8yMTk5MDIzMjU1NTc0_74a7efc3-4e36-4dcd-9736-6df2f53a2c64">147.26</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbcd9f1bcda345dca2a0d46fb1c81d47_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtMS0xLTEtMzYyNDg_f5333a11-afed-4f77-8a03-ad69764862dd">540,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i671a1d31e3054ac49e3a79c6e68909c4_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtMi0xLTEtMzYyNDg_54c74a48-9979-4713-9490-2913b7087877">6.56</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbcd9f1bcda345dca2a0d46fb1c81d47_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtNS0xLTEtMzYyNDg_a7f60715-3487-4212-8e2c-2ef4b557e965">235,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d77c5373ca24c15b6733894571c4107_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjo0YzJiNGQ1NjdmYWY0MjQ3YTk4YjEyMGZkMTM5ZDMyY18xMjA5NDYyNzkwNTU1Mg_f9abc912-8b1e-41b1-95e1-8371d0ac4577">159.33</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i8d77c5373ca24c15b6733894571c4107_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjo0YzJiNGQ1NjdmYWY0MjQ3YTk4YjEyMGZkMTM5ZDMyY18yMTk5MDIzMjU1NTc4_7232790c-d811-4dd1-ba62-f206afa7e20f">231.08</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7a8bb4ad4a743548875aefa396266a4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtMS0xLTEtMzYyNDg_f14b5e5f-cfc6-47fe-bda7-d21a6ad9cc1d">196,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i08fa3aedb11a4eae933e80b642a4260d_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtMi0xLTEtMzYyNDg_89a0da1b-a646-4b06-a903-1b41529b7235">6.68</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7a8bb4ad4a743548875aefa396266a4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtNS0xLTEtMzYyNDg_1defcd6d-ac94-4b5a-9b0e-0e2bd783b96a">17,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjphYmY1YTYwN2U1MTQ0YWJhYmQwZWU0YWY3ODhiYjc1YV8yMTk5MDIzMjU1NTc1_5d675925-5625-45f7-8f11-18936c4cf5e5">14.80</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjphYmY1YTYwN2U1MTQ0YWJhYmQwZWU0YWY3ODhiYjc1YV8yMTk5MDIzMjU1NTg0_2e0ff810-bc5d-4401-bd50-9c19c19b1ca4">231.08</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib049563e613d4855a95f4886886e70d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMS0xLTEtMzYyNDg_6fcdc5f4-3829-4a0a-8d24-37f6ab9d4620">1,695,460</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMi0xLTEtMzYyNDg_977a204f-ea49-464f-a089-ccc9713d882a">5.39</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib049563e613d4855a95f4886886e70d4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMy0xLTEtMzYyNDg_9cf4c2aa-6d6d-42aa-ac1e-4651eb67d4d4">104.79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib049563e613d4855a95f4886886e70d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctNS0xLTEtMzYyNDg_e7152e2f-d055-4656-afb2-6965bceac92f">989,419</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib049563e613d4855a95f4886886e70d4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctNi0xLTEtMzYyNDg_0f0b3324-8b8c-4d66-9948-267306d51aed">91.70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if81f621f871449a9b9795ed0c901d9ce" continuedAt="i6e947a0e3ab04afe9db8a8daebc5fd72"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding include both vested and unvested options as at December&#160;31, 2021. Options exercisable represent options which have vested at December&#160;31, 2021. From the date of grant, substantially all options vest over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzQ2NDQ_8b84bb10-99f4-411b-a818-270432b50926">five</span> to <ix:nonNumeric contextRef="i7db9820d8aa244e2852525ef7396441a_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwOTk1MTE2MzA3MjMw_4d690d79-1296-49b1-9bcb-ff0d300c4cb7">eight year</ix:nonNumeric> period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 was calculated using the Black-Scholes option pricing model. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3ODc_4fa3f8e5-d6cc-4743-9c07-c9042f95cb70" continuedAt="i091fe3cc6f154a1b996ff65fd9388872" escape="true">The weighted average fair values and assumptions were as follows:</ix:nonNumeric></span></div><ix:continuation id="i091fe3cc6f154a1b996ff65fd9388872"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzItMS0xLTEtMzYyNDg_747d5e4e-ba69-43b1-815d-4600b95e1584">49.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzItMi0xLTEtMzYyNDg_82d057de-fbd9-42ba-bc15-017dc3cc34c6">42.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzItMy0xLTEtMzYyNDg_1a578098-6293-4b8e-8ab1-d3f9cc53c38a">43.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzUtMS0xLTEtMzYyNDg_b8995133-1fe4-44aa-a208-100fec10f217">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzUtMi0xLTEtMzYyNDg_18f65bfc-e9dc-4aac-abbc-51078047f5cf">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzUtMy0xLTEtMzYyNDg_72266808-332c-494f-9c04-22097b17b61e">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzYtMS0xLTEtMzYyNDg_6f5d8aa1-2d7f-4589-9a5a-6afcd432782c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzYtMi0xLTEtMzYyNDg_ba2a2e3e-d5a7-43d2-b527-09d3fd42c151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzYtMy0xLTEtMzYyNDg_d1de1b28-c446-4ef8-9669-eaf71cf9275c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzctMS0xLTEtMzYyNDg_28e16823-df08-454d-993a-f23ae0084746">0.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzctMi0xLTEtMzYyNDg_86957329-d6ea-4739-b2b1-89c6541d369d">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzctMy0xLTEtMzYyNDg_1ce03ada-d214-4085-ab89-70d9c04ba345">2.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzgtMS0xLTEtMzYyNDg_b683c2a4-6119-4c7b-8e2b-1cb36ca49563">5.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzgtMi0xLTEtMzYyNDg_000048e9-90ef-41b6-8f2c-3f6d4c89fa88">5.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzgtMy0xLTEtMzYyNDg_2d274236-6105-4d99-81cb-78d5b2716d32">5.0</ix:nonNumeric> years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzEtMS0xLTEtNDU1ODA_c0523906-1278-4bef-908e-5dfcf565232a">107.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzMtMS0xLTEtNDU1ODA_2cef8112-8923-4099-8969-dcd629039f5b">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzQtMS0xLTEtNDU1ODA_243153d1-a0a5-4012-9dd7-86692fa74886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzUtMS0xLTEtNDU1ODA_bbe43812-ae42-4cc7-baa1-3f857a406f9c">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzYtMS0xLTEtNDU1ODA_e170c87d-862d-4ad9-b94a-b4895d291df7">3.5</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by <ix:nonFraction unitRef="shares" contextRef="i46b83645e00244b685127e098dab3ac7_D20150511-20150511" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzYwNTg_75c6da66-5b4d-4b29-9870-d41d7c5bab83">2.5</ix:nonFraction> million shares. Accordingly, an aggregate of <ix:nonFraction unitRef="shares" contextRef="i092c95b988b148d88d0639ad4cfc0a58_I20150511" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzYwOTg_54a32d13-f31b-4724-83be-b87e8ab511ac">4.1</ix:nonFraction> million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. <ix:nonFraction unitRef="shares" contextRef="i454968911a6a4e2aa2a973ab9436c62a_I20190516" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzY3NDk_29a92bc6-94a9-4c62-a694-4f0a9315ddeb">250,000</ix:nonFraction> ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over <ix:nonNumeric contextRef="i13e925d1823c400d84b4408ce6181505_D20190101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzY5NzA_03307477-5f6c-4d0b-a02a-273b9be454d8">twelve months</ix:nonNumeric>. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i6e947a0e3ab04afe9db8a8daebc5fd72"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3NzU_b103a535-8399-4897-b097-2bd482f77e4d" continuedAt="i53c33dafc18543409f2cf6c03e7b0cbe" escape="true">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2021:</ix:nonNumeric></span></div><ix:continuation id="i53c33dafc18543409f2cf6c03e7b0cbe"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4af659507f244f3be56ce1d3a1e11dd_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzEtMS0xLTEtMzYyNDg_6efd4d23-63f2-4974-a2c5-8a498bc122c8">159,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4af659507f244f3be56ce1d3a1e11dd_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzEtMi0xLTEtMzYyNDg_2d828bab-b045-448c-978b-21d3ba279558">137.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idfcb074b2ed840d0889e5704a9ace54e_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzEtNC0xLTEtMzYyNDg_0a96d207-6ede-42c5-b9f2-dc38ca93c4af">341,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idfcb074b2ed840d0889e5704a9ace54e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzEtNS0xLTEtMzYyNDg_9874072f-6a3d-4c63-87ea-cde93671a1f4">145.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combination*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="INF" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtMS0xLTEtNDk4NjE_2af6dbba-1ca9-426b-acc4-46ed23dc1ce0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtMi0xLTEtNDk4NjE_8e0d37c5-dd69-4df7-bbea-637d3ab3de84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="INF" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtNC0xLTEtNDYzNTA_c336be86-53a6-4276-8948-96d39a9fb921">589,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtNS0xLTEtNDYzNTA_544cc4f8-5748-4135-aac6-3dcb44d2eb41">206.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtMS0xLTEtMzYyNDg_6d3e1776-6682-4393-ae1c-4f549660362d">55,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtMi0xLTEtMzYyNDg_758d41a3-afd3-431a-9586-520659650037">177.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtNC0xLTEtMzYyNDg_f9756040-064d-41dc-88a5-43f2db7f7f13">171,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtNS0xLTEtMzYyNDg_463825e0-4dd7-473c-9aaf-1b5dd6dcf7c5">214.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested **</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzQtMS0xLTEtMzYyNDg_ecb760da-4aa2-4f71-a50d-bbb1e0ead31a">44,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzQtMi0xLTEtMzYyNDg_11bec073-059e-489f-8cd4-9658ad0a8435">115.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzQtNC0xLTEtMzYyNDg_2288f34e-192a-4f2c-b3c6-a34c5d28186a">446,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzQtNS0xLTEtMzYyNDg_f93803e4-aaa2-45a8-b966-149e6823a8f2">186.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzUtMS0xLTEtMzYyNDg_40e3fb0d-111a-43ea-bf90-9c96fb4a7521">16,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzUtMi0xLTEtMzYyNDg_e6437d3e-1ace-4587-9256-bed44810708a">141.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzUtNC0xLTEtMzYyNDg_319fd785-662d-4174-9d76-aad1495bfb0e">83,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzUtNS0xLTEtMzYyNDg_7c54b3af-4493-497d-bf17-0ace46351b59">188.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id023f7897c634581b20db0f0c13adc57_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzctMS0xLTEtMzYyNDg_d11a83bf-f4d0-4c01-a75e-6692347d973a">154,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id023f7897c634581b20db0f0c13adc57_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzctMi0xLTEtMzYyNDg_13903c25-1bd8-4ef6-aafa-5e9b02e09284">160.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id13136d269d54783b5556de26f903c56_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzctNC0xLTEtMzYyNDg_beac734e-3de0-4b76-9058-64c37c3f345a">572,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id13136d269d54783b5556de26f903c56_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzctNS0xLTEtMzYyNDg_f51a9cad-c36a-4ea2-b7f3-4430eeb12ca3">191.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents restricted stock units issued as replacement awards in connection with the Merger.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Includes <ix:nonFraction unitRef="shares" contextRef="i21ce434056744af495320d8e2505e585_D20210701-20210701" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEzMTk0MTM5NTY3OTY4_868cc105-41cc-4ce5-b726-69c46f094ba4">161,389</ix:nonFraction> RSU's which vested on the date of the Merger.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December&#160;31, 2021 totaled $<ix:nonFraction unitRef="usd" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcxOTY_e66e44a9-c0ca-43c1-a38a-356e0b498392">83.5</ix:nonFraction> million (2020: $<ix:nonFraction unitRef="usd" contextRef="ia5199d2dbdbd4fe9afdad9bb0b6011c8_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyMDQ_6484504a-b601-437c-8d95-878649543d42">14.3</ix:nonFraction> million). The share price range for the year was $<ix:nonFraction unitRef="usdPerShare" contextRef="i289f65e4064e4e14973a986310115295_I20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyNDY_f1b84534-52d7-4415-b32a-daf9827f7d93">115.11</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i1cf76ea842904bb687cb878a30fd91b0_I20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyNTE_93856341-d4a9-44e9-8253-2bf71b954b35">206.71</ix:nonFraction> (2020: $<ix:nonFraction unitRef="usdPerShare" contextRef="ib87cf475a42848d990b63ce6c940842c_I20201231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyNTk_c0ee621a-7419-4352-98c4-b813e5fa754d">83.47</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="ia0e29a847bcb402b8b35bd56be034dca_I20201231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyNjQ_d5751957-29c9-4eb9-b62d-5df69bffe2b1">156.21</ix:nonFraction>).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December&#160;31, 2021 totaled $<ix:nonFraction unitRef="usd" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczMzE_4d411f0d-9a2e-449c-b30f-4fb079a97c2f">5.1</ix:nonFraction> million (2020: $<ix:nonFraction unitRef="usd" contextRef="ib014ca4b61704308b759eb2b4e4cbe13_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczMzk_bb67dff3-6900-4a35-9ae8-5ca5efcd6090">5.3</ix:nonFraction> million). The share price range for the year was $<ix:nonFraction unitRef="usdPerShare" contextRef="i73e2c7ebf97b43da88211b323320aa76_I20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczODM_90f4335e-f2f7-4093-a3f7-5ecde7a47078">115.11</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i1846e9d35064408781a6a5388df65c41_I20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczODg_6015400f-ee0e-4110-bd69-4410004869f5">125.74</ix:nonFraction> (2020: $<ix:nonFraction unitRef="usdPerShare" contextRef="i54544aae1c2043709f665f7d1cc9eebf_I20201231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczOTY_f225900d-8019-47b1-9c95-b6aae2c18703">83.47</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i302f632b409e431a99d19fa4a3ec38d9_I20201231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzc0MDE_3d9d1c31-dc87-48fc-af11-ef27901bf4d2">90.03</ix:nonFraction>).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period 2019 &#8211; 2021, 2020 &#8211; 2022 and 2021 &#8211; 2023. Depending on the actual amount of EPS from 2019 to 2023, up to an additional <ix:nonFraction unitRef="shares" contextRef="i6eb358d140d045a48a95a6f2a26b3d5d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwOTk1MTE2NDc3MDc_261bb19a-3180-4c2d-b818-ddb71679ea6d">71,890</ix:nonFraction> PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-cash stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December&#160;31, 2021 is stated after charging $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwOTk1MTE2NDc5NjU_7c2e2cdc-bb43-44e2-a6e2-ad3a7f46f33f">133.8</ix:nonFraction> million in respect of non-cash stock compensation expense. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3ODg_42569849-1931-44e8-917a-05c2dcb12b16" continuedAt="i0a160ab7ba31421ab1f0ab6bb47a9e0a" escape="true">Non-cash stock compensation expense has been allocated as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i0a160ab7ba31421ab1f0ab6bb47a9e0a"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8aedbfe82f84258b4f5fb8ae5be9756_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzMtMS0xLTEtMzYyNDg_4ecaa933-fadf-46ba-bece-5ca3d3d802ba">18,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3104d5908eb42a781a65f9e3b34447b_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzMtMi0xLTEtMzYyNDg_2cd876b6-4d1a-40e6-9c9b-41d168f272bf">8,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a4ebf926a04a1399759e8c4dd65228_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzMtMy0xLTEtMzYyNDg_6601bdf0-f1b3-4048-8c50-d72ca27d9f34">14,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c3ba2a7a9949e4b4296e482b3406d4_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzQtMS0xLTEtMzYyNDg_08141759-5c2e-4bd6-9a73-7eecefbef960">41,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia28188c5a298446189940f3d7538dc9f_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzQtMi0xLTEtMzYyNDg_5fe4ff46-2e88-4990-8b92-aeebecb6dc47">17,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e7f286996a495b9fbebdd313a6affa_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzQtMy0xLTEtMzYyNDg_58a54fc0-8812-49d4-ac33-107ac887497f">12,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c449fefc2cd4b4399d71b4faba625e0_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMS0xLTEtNDY0ODU_b4a774c8-04f4-490a-838c-24b2526fb9d5">73,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b5db980b4e4123a417be9e69e6a306_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMi0xLTEtNDk4NjQ_fd39d6bf-6dfd-4f30-b27c-0651c25262c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da48aa526a04e8c802268f3ee3f55f5_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMy0xLTEtNDk4NjQ_07c26a57-3f84-48a0-bc5a-4036a7200f98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMS0xLTEtMzYyNDg_a58799bb-074a-46e5-9c88-93efbb106ed5">133,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMi0xLTEtMzYyNDg_2b5db54a-af6a-4a1a-8502-9780074ac267">26,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMy0xLTEtMzYyNDg_1446f200-7cc0-4106-b24e-99a0a515b7a7">26,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzgxMTQ_690c4337-c64e-4288-b4e7-9818cfb6dc0a">22.7</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzgyNzA_1ea1f15b-6b51-4091-b990-5ef2a0c0c8fb">23.9</ix:nonFraction> million. The income tax expense for the year ended December&#160;31, 2020 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzgzNTY_8bcda93a-edc9-4230-8ba8-22d8d03f50f0">6.9</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2020 was $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg1MTI_748782c6-fd16-42e5-b065-7a0ff7f350b5">2.5</ix:nonFraction> million. The income tax expense for the year ended December&#160;31, 2019 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg1OTg_dcabb8c7-4e6a-4d2c-9ebf-0f1409f91065">8.2</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2019 was $<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3NjU_ca414dca-e862-4c85-b9bb-5747100edbe1">1.9</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_172"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzE4MTQxOTQxODY2NDM0_7b211642-ea09-4b15-acb4-e0f17be08b2f" continuedAt="i984dd35e6f474c368b7f85a5ae92cfbb" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i984dd35e6f474c368b7f85a5ae92cfbb"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 &#8212; Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 &#8212; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Recurring Fair Value Measurements </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in investments in equity-long term having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2021 and December&#160;31, 2020 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 and December&#160;31, 2020 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzI0NDQ_8b877ce6-8ebc-4fdc-92bc-67ad5c066ff0">3.2</ix:nonFraction> million (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzI0NTQ_835f6090-2d6c-4606-a0af-77514c95df98">2.5</ix:nonFraction> million) recognized in net income during the year bringing the carrying value of the subscriptions to $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzI1NTI_1e270284-484d-48d0-8e7c-577d24930fc2">22.6</ix:nonFraction> million at December&#160;31, 2021 (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzI1Njk_fc69e375-a63c-45db-83fc-691e37f0db13">15.8</ix:nonFraction> million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2021, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $<ix:nonFraction unitRef="usd" contextRef="ie59648bd657b4adbaa014e0c1010eef4_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzU5MDk_67a9e0e0-33b7-4167-ab49-de4b8265b0ad">13,748.8</ix:nonFraction> million and are identified as Level 3 assets. These assets are comprised of goodwill of $<ix:nonFraction unitRef="usd" contextRef="ie59648bd657b4adbaa014e0c1010eef4_I20211231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzU5MTc_3945dfda-1fb5-4d6e-a59b-91d96751279c">9,037.9</ix:nonFraction> million and identifiable intangible assets, net of $<ix:nonFraction unitRef="usd" contextRef="ie59648bd657b4adbaa014e0c1010eef4_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzU5MjU_7fb27e04-f61e-458c-bce5-4076b5af659e">4,710.8</ix:nonFraction> million. Refer to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 24 - Non-current bank credit lines and loan facilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information regarding the fair value of long-term debt balances.</span></div></ix:continuation><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_175"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzUxMDA_64cd4e0a-a176-4159-85d8-43a80bfe196c" continuedAt="icf03db5a80d248f6a585653aca34a11e" escape="true">Share Capital</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icf03db5a80d248f6a585653aca34a11e" continuedAt="ibadfd3fd26044f46a7f991fcba0cf026"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Holders of ordinary shares will be entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares will be repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have <ix:nonFraction unitRef="vote" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="INF" name="iclr:NumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyMDk0NjI3OTIzMDUy_55b60308-77ac-4b46-aee3-fa672da3faae">one</ix:nonFraction> vote, for each ordinary share held with no individual having more than <ix:nonFraction unitRef="vote" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="INF" name="iclr:NumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyMDk0NjI3OTIzMDYy_0ca133f9-35d3-4491-a2e8-410b92fec553">one</ix:nonFraction> vote. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued <ix:nonFraction unitRef="shares" contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2MzU5MDE_0377f49e-2b79-44c4-952b-700d8f37df3c">27,372,427</ix:nonFraction> shares of the Company&#8217;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzc4Nw_aae8ad32-e3f2-4973-91bb-cd46a907f331">1,065,529</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzg1OA_1958f897-b279-45f7-8e92-50e9f39052ca">111.29</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzg5Mw_3ef711e8-9ba1-4885-b27d-a96af6c0b6e1">118.6</ix:nonFraction> million. During the year ended December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzkyMw_c693dcbc-abaa-46ce-a487-7695963083ed">446,404</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzk4NQ_070e0753-12db-45dc-af9f-b151faae9c24">44,132</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTg_9b79d1fa-b58a-4b0a-a801-11bc13436a90">193,417</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzExNjk_84cb1fcb-7f8e-4428-9db4-73ba98fb7758">68.19</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyMDQ_e027de7a-d048-47e6-88ea-069cf4623a54">13.2</ix:nonFraction> million. During the year ended December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="ia5199d2dbdbd4fe9afdad9bb0b6011c8_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyMzQ_560b3a2d-3590-45bc-8085-95de9fa67efc">144,172</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="ib014ca4b61704308b759eb2b4e4cbe13_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyOTY_68db9da5-8c0c-41c7-99d9-fd9fd8c0c7fe">63,516</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ibadfd3fd26044f46a7f991fcba0cf026"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2019, <ix:nonFraction unitRef="shares" contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE0MDk_37e6ef04-94e0-4a9e-93ec-4f9acb1235a0">329,870</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE0ODA_249763c3-0987-4cbf-8bfe-e9f0d86faccb">65.54</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE1MTU_a80872b9-6570-4e74-b8db-c1c64ea87ca8">21.6</ix:nonFraction> million. During the year ended December&#160;31, 2019, <ix:nonFraction unitRef="shares" contextRef="i10a8b70f27484636b98e9821a55c5304_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE1NDU_fa286365-2e0c-4d55-827c-1b76350cb8c5">237,119</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="i00c3280bc64040eb92d3e3380fb6b522_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE2MDc_d734a1fc-d6c3-4f61-93dd-bd2a858e01d1">118,611</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no share buybacks in the year ended December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to <ix:nonFraction unitRef="number" contextRef="if98fe533fad34c48891d45c338b523fb_D20160722-20160722" decimals="INF" name="iclr:StockRepurchaseProgramAuthorizedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzI1MTE_8d27351f-0307-47d3-8ca5-e6079c2f6869">10</ix:nonFraction>% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020 and July 20, 2021.&#160;On October 3, 2016, the Company commenced a share buyback program of up to $<ix:nonFraction unitRef="usd" contextRef="i64c25c9fbdc24c8e8f96527346976256_I20161003" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzI3NTY_0beecf2e-a8e0-41a2-bcea-da4ddc289aab">400</ix:nonFraction> million. The share buyback program was completed during the year ended December 31, 2018 with a total of <ix:nonFraction unitRef="shares" contextRef="iebd957ddedf34e7eb4e6d9840ebd08ab_D20180101-20181231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MDkw_9db3f2ee-9fb4-4424-b2cb-fc3f9c2986b6">4,026,576</ix:nonFraction> ordinary shares redeemed for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="iebd957ddedf34e7eb4e6d9840ebd08ab_D20180101-20181231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTAx_3340b63b-0246-465e-b15f-49d8bf83a268">372.1</ix:nonFraction>&#160;million. On January 8, 2019, the Company commenced a further share buyback program of up to <ix:nonFraction unitRef="shares" contextRef="i0bc02d64aa5f4b4d8b36a740dd3bc014_I20190108" decimals="INF" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTE3_26a518d3-b2b3-448c-ae0e-458da1afcd94">1.0</ix:nonFraction>&#160;million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="ia044a3b1cbe441bc85cbe89198164aad_D20190101-20191231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTMw_7d36122d-8d65-4861-92a5-2a7833515251">141.6</ix:nonFraction>&#160;million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, <ix:nonFraction unitRef="shares" contextRef="i53e8433bda4546de9704023960c6b72f_D20191231-20191231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTQ2_5c3ea27a-739f-48b5-a213-5a1951d2ff1e">35,100</ix:nonFraction> ordinary shares were redeemed by the Company for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="i53e8433bda4546de9704023960c6b72f_D20191231-20191231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTU0_ee2c7733-8160-4adc-a025-9b17d8df92b3">5.3</ix:nonFraction>&#160;million. During the year ended December 31, 2020, <ix:nonFraction unitRef="shares" contextRef="id3d7547a1a224157af8991715ce82080_D20200101-20201231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTY4_9bffa382-f47d-444e-9455-32092fefbab1">1,235,218</ix:nonFraction> ordinary shares were redeemed by the Company under this buyback program for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="id3d7547a1a224157af8991715ce82080_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTc5_15d81a82-327c-4830-b61a-47a967cf519e">175.0</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_178"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NTc_735b6055-4aae-4946-9610-6445ace808bf" continuedAt="i0f341bfaca204698beea3a1a1889b463" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0f341bfaca204698beea3a1a1889b463" continuedAt="i24e36259602b4a3190f19013347f45ef"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:IncomeBeforeIncomeTaxTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4MzU_7837f12b-723a-47bc-962f-841b71536c89" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzMtMS0xLTEtMzYyNDg_c5c35c09-441f-4a0f-86c1-da8fb0d5e504">231,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzMtMi0xLTEtMzYyNDg_3c7151a8-075e-4613-a446-9e2891294da5">280,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzMtMy0xLTEtMzYyNDg_c6e80c1b-2591-44db-a50b-f66a9cf3979e">323,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzQtMS0xLTEtMzYyNDg_d0a5bc03-9d5d-471a-9015-4a70741943f2">278,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzQtMi0xLTEtMzYyNDg_1ec70091-6c00-40a4-9a71-a69915452b49">41,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzQtMy0xLTEtMzYyNDg_d93c32de-7a11-4c63-bb25-d600d233aecf">21,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b675ea0523544f39cc9dc1c1d30c495_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzUtMS0xLTEtMzYyNDg_2fbcaf3c-7a8b-45e7-b915-3acba79b0016">243,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc9dba39f11143b7a99700fa9154586e_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzUtMi0xLTEtMzYyNDg_dd074ff0-1b16-47cc-ab9b-a602e78202a0">58,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aabd4a6d84543e59b0b347ddb8394d7_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzUtMy0xLTEtMzYyNDg_0830a6b5-4aad-477d-a3d2-143a146e4505">82,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzYtMS0xLTEtMzYyNDg_6b48f98f-f412-4080-8a55-90eee3cfbef4">196,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzYtMi0xLTEtMzYyNDg_d3ba0f36-fea4-43c3-b51c-bfa66d47a98e">381,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzYtMy0xLTEtMzYyNDg_07afac91-23b7-49a5-a366-85e8643414fd">426,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i24e36259602b4a3190f19013347f45ef" continuedAt="iae0fe6cd71784855ae27f37325bf7222"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NTM_396d616d-4e36-452d-81d6-e411549e462f" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzUtMS0xLTEtMzYyNDg_0e5f784c-ed69-4a14-b968-892ab694b9af">18,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzUtMi0xLTEtMzYyNDg_81f07fa5-9975-42ac-9352-a91e5380cf9d">28,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzUtMy0xLTEtMzYyNDg_4263a75c-9d0b-4298-b71e-07f82b7c1942">35,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzYtMS0xLTEtMzYyNDg_81497290-19a2-4d6c-822d-20f729fd9b3f">35,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzYtMi0xLTEtMzYyNDg_8aad226e-bd8b-4d46-8da0-53826f87f19a">3,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzYtMy0xLTEtMzYyNDg_eaa5d65d-51a0-44ca-8ba7-1db3dfad6768">5,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b675ea0523544f39cc9dc1c1d30c495_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzctMS0xLTEtMzYyNDg_7f9be069-b363-4e92-a057-758a4cf2f89d">48,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc9dba39f11143b7a99700fa9154586e_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzctMi0xLTEtMzYyNDg_5abba59e-14d4-44b9-a563-38785f40ab2f">14,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aabd4a6d84543e59b0b347ddb8394d7_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzctMy0xLTEtMzYyNDg_4eea3ab5-d1c2-4eed-9bc8-5bac8754d279">11,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzgtMS0xLTEtMzYyNDg_4899cbc3-a2bf-44b2-a5ee-82a5885d12ad">101,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzgtMi0xLTEtMzYyNDg_ac056aa3-b2f6-4001-93b0-4b20aa8a4eaa">46,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzgtMy0xLTEtMzYyNDg_d0c4f34b-4cb6-4c99-bf8d-50833c15e26e">52,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzExLTEtMS0xLTM2MjQ4_f995a56a-b828-4435-bced-eae5de3f09d3">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzExLTItMS0xLTM2MjQ4_fece122d-ead8-4591-bc86-e8341b48bce9">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzExLTMtMS0xLTM2MjQ4_a36868a5-5aae-4cb0-bacf-ca2c018b1a8d">2,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEyLTEtMS0xLTM2MjQ4_ca6affdc-af4d-4eba-9539-42ba6ca9904c">52,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEyLTItMS0xLTM2MjQ4_e5ea67d9-5d64-4956-abbb-6a74744cefad">4,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEyLTMtMS0xLTM2MjQ4_9171c768-3b50-480d-94e0-2a7d502c1399">3,502</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b675ea0523544f39cc9dc1c1d30c495_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEzLTEtMS0xLTM2MjQ4_02912249-ddc3-4007-8e5e-6ba3d17cc4e4">8,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc9dba39f11143b7a99700fa9154586e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEzLTItMS0xLTM2MjQ4_0b784b59-b3b7-411c-a7e2-7731f0f5fc6b">5,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aabd4a6d84543e59b0b347ddb8394d7_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEzLTMtMS0xLTM2MjQ4_cd324021-4c74-49c0-ac24-b8e902752ca5">868</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE0LTEtMS0xLTM2MjQ4_129193f6-50c3-4845-ad0c-506136296397">60,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE0LTItMS0xLTM2MjQ4_08a05fee-5671-46cc-bc4a-00f1956b63f6">927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE0LTMtMS0xLTM2MjQ4_079c7597-ffae-4fa0-8a2c-b82a1cbe9686">1,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE2LTEtMS0xLTM2MjQ4_09d08b56-a572-49f5-89ac-d29e92f11b4a">41,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE2LTItMS0xLTM2MjQ4_23bff1af-f0ec-4288-a7e6-d97e5f5ee4f4">47,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE2LTMtMS0xLTM2MjQ4_13d35868-8e91-4a50-b194-248ef7ea8984">51,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIwLTEtMS0xLTM2MjQ4_5071dc51-d307-44cf-bc22-bd98ea5795ca">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIwLTItMS0xLTM2MjQ4_ed423173-5dc6-4501-bb18-ca2f811209e1">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIwLTMtMS0xLTM2MjQ4_be6d9187-8cb5-426d-98a8-30bbc6e88e95">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIzLTEtMS0xLTM2MjQ4_080ba941-8ee6-4155-b747-dcdff78f8783">41,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIzLTItMS0xLTM2MjQ4_773b02d0-e240-4280-877b-fc95de07fcd7">47,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIzLTMtMS0xLTM2MjQ4_5a08348a-460b-4799-b9cd-3197e0aeee52">51,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory income tax rate is 12.5%. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NTA_89e6bfef-3ef2-497f-a20c-5887cbaecb6d" continuedAt="iecfe5c260c43453580b4ec1a9d2d4eea" escape="true">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div><ix:continuation id="iecfe5c260c43453580b4ec1a9d2d4eea"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzMtMS0xLTEtMzYyNDg_c7734cb8-1a73-4088-8f6d-b641ab963ba1">24,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzMtMi0xLTEtMzYyNDg_af8d605f-53df-4660-bd1d-50f373d42dcd">47,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzMtMy0xLTEtMzYyNDg_e51267ac-0c8b-4399-8267-ce6a413961e9">53,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzQtMS0xLTEtMzYyNDg_5d3ebf5d-5b0d-4d09-8553-d9294c01351d">20,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzQtMi0xLTEtMzYyNDg_51468266-ec22-49d2-be61-24fce426f26f">7,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzQtMy0xLTEtMzYyNDg_d6c97d41-1628-4795-97b3-2b389083400d">7,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzUtMS0xLTEtMzYyNDg_dac662a0-0106-437d-b901-22323b09f565">3,120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzUtMi0xLTEtMzYyNDg_d86a4424-ffc9-45e1-94ff-9e7da60eb579">1,243</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzUtMy0xLTEtMzYyNDg_b4064f62-41e6-4fd3-8caa-1c9d9a3f7c3d">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzYtMS0xLTEtMzYyNDg_b6d37989-c05c-46e4-a03e-306749c9dc2a">3,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzYtMi0xLTEtMzYyNDg_9f20b1e2-1d27-404e-a912-c32b373d8a34">3,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzYtMy0xLTEtMzYyNDg_ee79deb7-6ae7-45ed-9c8f-cac64ea71366">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzctMS0xLTEtMzYyNDg_9d7dcd3e-237f-456b-a08c-f5fabb76e2a6">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzctMi0xLTEtMzYyNDg_cdb27d3e-ad92-424b-9002-30b8214d625d">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzctMy0xLTEtMzYyNDg_34bfb424-2362-4322-aebc-177b447ffa19">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzgtMS0xLTEtMzYyNDg_df010ddc-151a-4781-8881-562dbfeed68f">5,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzgtMi0xLTEtMzYyNDg_c4e273d1-4d03-4509-af7b-0c7efb8a0040">1,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzgtMy0xLTEtMzYyNDg_3f497115-c767-41c9-ba13-a0f73f041e48">1,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzktMS0xLTEtMzYyNDg_2bd945fa-6306-4efd-9660-3a7d3807c8ed">9,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzktMi0xLTEtMzYyNDg_48a8473a-fe48-4c83-9c9b-7bb68d7a82a2">5,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzktMy0xLTEtMzYyNDg_dbd4f620-16b6-4619-a153-519a0ae89e02">7,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzExLTEtMS0xLTM2MjQ4_8e7a0605-298c-45b9-a077-d34a7bc681a2">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzExLTItMS0xLTM2MjQ4_3859fd33-35d4-4a17-82d3-e1e225af3b00">3,343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzExLTMtMS0xLTM2MjQ4_49c228e6-1a55-4989-882f-2dbb72673009">397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzEyLTEtMS0xLTM2MjQ4_a50da586-8d3e-455f-8633-4aa5a55235b8">41,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzEyLTItMS0xLTM2MjQ4_e9d80bda-a732-4a44-942e-f6e140b444b8">47,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzEyLTMtMS0xLTM2MjQ4_e5c9e6d7-4ddf-4dc6-b6e9-ca95e0f3d17a">51,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iae0fe6cd71784855ae27f37325bf7222" continuedAt="i8854d9558068453fb4c6d850fd9eb2fe"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NTU_51485398-a0ba-4285-8338-3075022824cb" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzMtMS0xLTEtMzYyNDg_2830ae1e-72ac-4f97-b3a3-d7d63db00003">19,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzMtMi0xLTEtMzYyNDg_f456aef0-be2c-42a1-a4ce-037648207875">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzQtMS0xLTEtMzYyNDg_47ed33f5-0c18-420c-a7ec-2f4644a9638b">33,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzQtMi0xLTEtMzYyNDg_ad7f6013-6025-4851-af2b-f46220a8e4fb">9,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzUtMS0xLTEtMzYyNDg_71b34ccf-8057-443a-95b5-030318121bf8">33,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzUtMi0xLTEtMzYyNDg_b22d7abe-5813-47cd-90dd-b9e5ccda12aa">31,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzYtMS0xLTEtMzYyNDg_197da601-bc12-4fc5-a673-90c6e0bdec50">1,201,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzYtMi0xLTEtMzYyNDg_f63b00b9-46db-47ed-8819-75125cb348ff">13,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzctMS0xLTEtMzYyNDg_c33d734b-6704-4502-b70c-3a74d0263bbb">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzctMi0xLTEtMzYyNDg_c8caa976-2e5b-4e82-8e4c-f0fadb5b2190">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzgtMS0xLTEtMzYyNDg_3bf55f03-9bbb-45d3-8a59-17b2109168b7">1,289,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzgtMi0xLTEtMzYyNDg_70576892-e689-4b27-9982-925d17625dff">56,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzExLTEtMS0xLTM2MjQ4_a4ee9901-16d3-456b-b50c-0402cd1e4e79">86,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzExLTItMS0xLTM2MjQ4_4527b80a-1c49-49da-8255-a78a80a1f712">42,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzEyLTEtMS0xLTM2MjQ4_f6f0c2da-c9ab-4249-88d9-597ea77f64b5">5,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzEyLTItMS0xLTM2MjQ4_b9d82fc2-ff9e-4eb9-ad16-2bde59b0e211">6,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzEzLTEtMS0xLTM2MjQ4_cae887a7-2f7d-4d4c-ad51-3914e18c1fe1">36,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzEzLTItMS0xLTM2MjQ4_4b8f7036-24f0-4863-a7a4-01730113f0e7">9,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE0LTEtMS0xLTUzNDQ2_25d4139c-48cc-419f-8f9c-0dd979adf64d">4,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE0LTItMS0xLTUzNDQ2_482e82b1-f077-4e33-8696-e6834c8ae549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE0LTEtMS0xLTM2MjQ4_8a71bac3-60a3-411c-a52d-2774cf25f461">69,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE0LTItMS0xLTM2MjQ4_dd7bb491-6225-4609-acff-f66b4bd7082f">24,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE1LTEtMS0xLTM2MjQ4_61b333ed-c7ca-4e4e-812f-7e49ceb46148">25,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE1LTItMS0xLTM2MjQ4_8d0fa302-b283-442e-9815-14cdff5657e5">3,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE2LTEtMS0xLTM2MjQ4_478031f7-437b-4255-8fab-c732ea293a91">3,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE2LTItMS0xLTM2MjQ4_b0db8b02-1906-4c8a-a52e-88fb4bd54425">3,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:DeferredTaxAssetContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE3LTEtMS0xLTM2MjQ4_3f2e46d8-da05-4a41-a438-05c440db71ac">64,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:DeferredTaxAssetContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE3LTItMS0xLTM2MjQ4_abb6e06c-5a65-4c62-b576-8b7c0184cfb8">2,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE4LTEtMS0xLTM2MjQ4_98fad342-cba8-4e6f-8284-9af803a718f3">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE4LTItMS0xLTM2MjQ4_54f68961-6207-4cbc-bcf4-f84e6c289933">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE5LTEtMS0xLTM2MjQ4_600581bb-589f-4c90-ba7f-07bda8d66d9d">297,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE5LTItMS0xLTM2MjQ4_14c2b8ec-4ea3-40e1-b5f6-e0c42ae2842a">91,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIwLTEtMS0xLTM2MjQ4_b467790f-958b-4407-b232-67637a76464d">45,495</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIwLTItMS0xLTM2MjQ4_b87c93f7-6932-466f-b43d-98be801af1f6">32,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIxLTEtMS0xLTM2MjQ4_5e664aeb-1f31-4a10-a873-ac1c5e1b8839">251,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIxLTItMS0xLTM2MjQ4_b926468a-4d1e-4518-8d8c-bfc82ae9e14e">59,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax asset/(liability)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIyLTEtMS0xLTM2MjQ4_9bf7817a-ddbc-47b9-9523-d8a511aabcc0">1,037,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIyLTItMS0xLTM2MjQ4_3e63f834-84d0-49ee-9bc0-2b1d165b8e2f">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $<ix:nonFraction unitRef="usd" contextRef="icd1b1b778ce1423d993f536ec42792a4_I20211231" decimals="-5" name="iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzkyOQ_d74bb9d1-266a-4a2e-8a15-d7e1f6592426">14.0</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i8b603335e3c141be945379a94b120638_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEwNDQ_f7af84da-5d5e-4358-bf3c-553ca4ff8742">10.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if1def15985c34968963f6b9121b38e63_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEwNTE_24fa8940-8886-46e5-b32c-56fe18446ef6">297.0</ix:nonFraction> million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $<ix:nonFraction unitRef="usd" contextRef="i8b603335e3c141be945379a94b120638_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzExOTM_f7af84da-5d5e-4358-bf3c-553ca4ff8742">10.3</ix:nonFraction> million U.S. federal NOLs, approximately $<ix:nonFraction unitRef="usd" contextRef="i844861916668498588f0491ce84b368e_I20211231" decimals="-5" name="iclr:OperatingLossCarryforwardsUSFederal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEyMjk_3037bb34-93a7-4a3e-931e-ab1c186f9d8c">5.0</ix:nonFraction> million is available for offset against future U.S. federal taxable income in 2022. The subsidiaries' ability to use the  remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $<ix:nonFraction unitRef="usd" contextRef="i8b603335e3c141be945379a94b120638_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzE1ODE_043ebecc-b75a-4cad-bb9e-55ba84c5a38a">10.3</ix:nonFraction> million are limited by Section 382 as follows: $<ix:nonFraction unitRef="usd" contextRef="ia7ad5c604007471b856dd9490f6f5c80_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzE2MjM_e443259a-c1d8-477b-8a86-be6c993e9a8a">10.2</ix:nonFraction> million for the years 2022 - 2035 and $<ix:nonFraction unitRef="usd" contextRef="i5bf376e140f446a785d5f08cdd6bfebc_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzE2NTM_7a3bdbce-9fe3-44c3-a578-8aba3dac6349">0.1</ix:nonFraction> million in 2036 - 2040. As at December&#160;31, 2021, U.S subsidiaries also had disallowed interest carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i8b603335e3c141be945379a94b120638_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEwOTk1MTE2NTQ1NTc_867e3596-e1a0-4cad-9f86-ed8c60b5ddb5">145.7</ix:nonFraction>&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $<ix:nonFraction unitRef="usd" contextRef="i983be088cf6b46e6ac433beda8d697ec_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzIyMjU_1f6e4ad8-c223-4f9d-806d-6a08a8621179">42.3</ix:nonFraction> million. At December&#160;31, 2021 those subsidiaries also had additional operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="iecd57dd26a63495fb590d21da1ee1dd2_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzIzMDY_9a3af0d0-87bf-441a-9ffe-d86ccdff29f5">19.9</ix:nonFraction> million which are due to expire between 2022 and 2028 and operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ie7a5026822b54a889031ee7975200e68_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzIzOTE_5170682b-4c36-4a7e-933a-77d564327271">19.9</ix:nonFraction> million which are due to expire between 2029 and 2038. In addition, at December&#160;31, 2021 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $<ix:nonFraction unitRef="usd" contextRef="i441eef7611ae4627900c2aa94e200087_I20211231" decimals="-5" name="iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzI2NTI_f8bbaa40-628a-4d80-a673-1988827a39c8">5.3</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8854d9558068453fb4c6d850fd9eb2fe" continuedAt="i1a7fe88a6a2c447f99d28dee21f2e5c5"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NDM_c9367ed3-898c-4371-b235-a457f721fc1e" continuedAt="i62169ffcdaf14b1ebb78789c3e76e626" escape="true">The expected expiry dates of these US losses are as follows:&#160;</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i62169ffcdaf14b1ebb78789c3e76e626"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2035</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ad5c604007471b856dd9490f6f5c80_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzItMS0xLTEtMzYyNDg_f247a4eb-ab99-4d5d-9e4b-d27d4cccbd5c">10,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c96a63b4834593b815f76192244271_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzItMi0xLTEtMzYyNDg_04b5ca2a-b462-470d-b6b5-a0324ea665d1">227,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2036-2040</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf376e140f446a785d5f08cdd6bfebc_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzMtMS0xLTEtMzYyNDg_1e26a441-d471-4c77-b79d-29a6a9a1e192">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4899bcc705b74b12bfb11fcc895a643d_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzMtMi0xLTEtMzYyNDg_d098ea73-8633-4f5a-98bd-c6c4d004322b">25,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b603335e3c141be945379a94b120638_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzQtMS0xLTEtMzYyNDg_7f173b20-3992-426e-a729-93163ae2279c">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1def15985c34968963f6b9121b38e63_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzQtMi0xLTEtMzYyNDg_96ccaaab-8c08-44ee-893b-df60e922f4de">44,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b603335e3c141be945379a94b120638_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzYtMS0xLTEtMzYyNDg_1d8b2afa-5dc5-4f31-b8f9-dbb080a27837">10,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1def15985c34968963f6b9121b38e63_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzYtMi0xLTEtMzYyNDg_ce832440-dabe-497e-99de-08a7f25c1f12">296,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i844861916668498588f0491ce84b368e_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzI4MTA_62f65a92-2112-43db-9962-bdeb6aea3cd2">0.8</ix:nonFraction> million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December&#160;31, 2021 was approximately $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMwMzg_475c94e0-9bb4-4ccb-acf2-f063ce354a01">45.5</ix:nonFraction> million. The valuation allowance for deferred tax assets as of December&#160;31, 2020 and December&#160;31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMxMTA_00753b7f-c9a2-470a-8f69-02175dc994f9">32.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMxMTc_f8c1dda9-4165-49a4-8969-d80c88923358">27.7</ix:nonFraction> million respectively. The net change in the total valuation allowance was an increase of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMyMDE_e664c6c2-4033-4660-930e-5e3ea3675517">12.8</ix:nonFraction> million during 2021 and an increase of $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMyMzM_23cc198e-b95e-490d-a7fb-438b6c24411f">5.1</ix:nonFraction> million during 2020. Of the total increase of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMyNzI_e664c6c2-4033-4660-930e-5e3ea3675517">12.8</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEwOTk1MTE2NTQ3NTI_03f4d3ee-9fe9-43b2-a8a6-7b3f2591d4dc">9.3</ix:nonFraction> million was in respect of acquired entity, $<ix:nonFraction unitRef="usd" contextRef="i9da9a786e8de49f39d28567667a24931_D20210101-20211231" decimals="INF" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMyODI_67904eee-f4ac-4276-80fe-ae19f05049d9">4.4</ix:nonFraction> million was recognized within income tax expense and a decrease of $<ix:nonFraction unitRef="usd" contextRef="i5533029580bc4f90b5489c2ed50c777c_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMzMzA_9e527d92-28aa-4130-bf65-1c807b840cfc">0.9</ix:nonFraction> million was recognized in Other Comprehensive Income. Of the total increase of $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzM0MDQ_23cc198e-b95e-490d-a7fb-438b6c24411f">5.1</ix:nonFraction> million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i58e5f687cc39462f8d659f4d701f5ac0_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzM0MTU_f790240d-c4ec-426c-92fd-cfd610cce6a8">3.6</ix:nonFraction> million resulted in a current year income tax expense, and $<ix:nonFraction unitRef="usd" contextRef="i896d44f274c24721bd6b58ccbd470666_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzM0Njk_9ca1d0af-b678-4dc3-a6f0-fd9839255bfd">1.5</ix:nonFraction> million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December&#160;31, 2021 and December&#160;31, 2020 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recognized a deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzQ1NjA_afe5580d-1752-4573-b08e-7f0f4a1f1c9c">0.8</ix:nonFraction> million (2020: $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzQ1Njg_ea8f7e65-9b4c-4528-86e1-3907742a3147">0.9</ix:nonFraction> million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#8217;s tax treaty network and the EU parent subsidiary directive.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4Mzk_78108a8b-6b98-4f3a-ab4f-b4f042789417" escape="true"><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzItMS0xLTEtMzYyNDg_9a4298f7-ad2a-43a0-957f-7586e6cc691d">19,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzItMi0xLTEtMzYyNDg_5eb1d8ae-738d-4ea5-90a6-5a67c463fb68">20,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e24d855ba14a97a64dd8c818215580_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzItMy0xLTEtMzYyNDg_c2c7670a-d6ad-47ad-bebf-7cc8336225a7">21,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMS0xLTEtNTM0NTM_1c416707-4ffb-4318-8d52-72c81681014a">170,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMi0xLTEtNTM0NTM_66e114e0-36ea-4aca-b83e-60f4235a46c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMy0xLTEtNTM0NjM_803fdf72-2f99-4cdc-91c1-3c2f3ca346f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMS0xLTEtMzYyNDg_d2ae1d94-9e68-4a19-9ccb-b9f597a30f05">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMi0xLTEtMzYyNDg_f1a5ead1-3160-477d-99ab-64d1dab4e610">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMy0xLTEtMzYyNDg_581e26ba-70e8-4bfe-a4c7-ae58c1312e1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzQtMS0xLTEtMzYyNDg_34917c83-380a-4319-bedc-11e53820b226">1,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzQtMi0xLTEtMzYyNDg_cece85f4-296e-494c-af48-38ff1f61e782">1,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzQtMy0xLTEtMzYyNDg_ea9375d5-aa29-498a-8f14-a24313e09e3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzUtMS0xLTEtMzYyNDg_d909df72-fc08-47e8-8ce3-474724b11dbd">18,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzUtMi0xLTEtMzYyNDg_70a53313-61bc-4d0d-994f-6a515d20c72c">2,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzUtMy0xLTEtMzYyNDg_e47202e7-8307-4f3f-83f9-910219895ff5">1,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzYtMS0xLTEtMzYyNDg_ee4eb465-df13-41f8-a573-859716bccd53">844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzYtMi0xLTEtMzYyNDg_6fff2dc5-a1c4-4e3a-94b5-2ba8e6c4de2d">369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzYtMy0xLTEtMzYyNDg_9fbe015d-2d4b-41d1-8af7-d96c36fc27b6">347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzctMS0xLTEtMzYyNDg_f06bdd04-e934-44d9-b303-fe6c0cfc3ce3">3,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzctMi0xLTEtMzYyNDg_eccc153d-aa6b-4450-a161-a40726f6424f">2,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzctMy0xLTEtMzYyNDg_5bff28a0-9826-49e9-a722-cde27855c5f7">2,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzgtMS0xLTEtMzYyNDg_648934e0-5c91-4619-9cf5-0eb60ee4cdfc">202,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzgtMi0xLTEtMzYyNDg_3a4fcfa9-a869-4026-9403-c589ff7c0bf1">19,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzgtMy0xLTEtMzYyNDg_40f670ed-d82a-4828-97b6-b1232ba6d4ea">20,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzU2NDQ_68ee2dfc-8fbd-41e5-bf25-931190808bf9">38.8</ix:nonFraction> million could potentially expire during 2022. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1a7fe88a6a2c447f99d28dee21f2e5c5"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December&#160;31, 2021 were potential benefits of $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzU3ODA_8cfb4fb4-e02d-4cfa-8878-76588aa8d70f">202.1</ix:nonFraction> million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2020 and December&#160;31, 2019 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYwNjU_6334d045-02fb-425d-9bec-7133b720b86c">19.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYwNzI_8f59304a-85ce-4c6b-9d2c-469ff3e0f8e2">20.2</ix:nonFraction> million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December&#160;31, 2021 amounted to a net charge of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYxNzk_35b441c8-8b4c-42e1-aa02-ea9fcd462aa2">1.9</ix:nonFraction> million (2020: ($<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYxODc_a38d8002-16a8-490f-823b-7d9eba804018">0.6</ix:nonFraction> million), 2019: <ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYyMTA_0df3acea-d514-4afe-a1bf-cbc910d237b3">Nil</ix:nonFraction>) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2021 and December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYzMjA_f4543833-5e4d-489b-bd44-cf763b7b5d1b">15.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYzMjc_5a757c9f-5dd1-4563-b308-4868bbdf4917">0.5</ix:nonFraction> million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020 and December&#160;31, 2021. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020 and December&#160;31, 2021. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i6df4b473ec484136b91516d30b1a0b24_181"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE0MDY_f7bdd610-2eb1-4edb-97ef-5b20422631fa" continuedAt="ib3b0b4a5fc1f4afb8fb5a7e9c591856f" escape="true">Restructuring charges</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib3b0b4a5fc1f4afb8fb5a7e9c591856f"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A restructuring charge of $<ix:nonFraction unitRef="usd" contextRef="iae97c86e7991410685e37fea162dced3_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzIxOTkwMjMyNjYxODg_8708d642-7992-4243-85b0-af5cde6d57b3">31.1</ix:nonFraction>&#160;million was recognized during the year ended December&#160;31, 2021 under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $<ix:nonFraction unitRef="usd" contextRef="ia73c34c13a8742aa9e45adff138292ef_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzI2Mzg4Mjc5MDczNzMw_2235fb73-1360-4d50-8ac1-9f0dbc416e6b">4.8</ix:nonFraction>&#160;million relating to workforce reductions, an impairment of ROU assets and associated unavoidable costs totaling $<ix:nonFraction unitRef="usd" contextRef="iae97c86e7991410685e37fea162dced3_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE1MzkzMTYyODAwMzI5_27e23d06-85fd-4de5-93bf-ab4483157c7a">21.9</ix:nonFraction>&#160;million and fixed asset impairment of $<ix:nonFraction unitRef="usd" contextRef="iae97c86e7991410685e37fea162dced3_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2MzY0NjY_4871355c-a202-406f-964d-82c5e89b57a5">4.4</ix:nonFraction>&#160;million.</span></div><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE0MDk_e44879ab-d0a1-490b-bd5a-d8da8cccb233" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzMtMS0xLTEtMzYyNDg_45dc1f03-6121-4a1b-bc4b-884687c5e60d">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzMtMi0xLTEtMzYyNDg_bd56a70d-e6a1-44b4-b77a-9f7abaa4a515">18,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzMtMy0xLTEtMzYyNDg_87968755-a4b2-459c-9dda-5b7a8dff9475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzQtMS0xLTEtMzYyNDg_23b19524-ba51-4aa1-8b73-6578241e80ef">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzQtMi0xLTEtMzYyNDg_ee7df673-2f7d-4f49-b444-2914f6080b64">18,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzQtMy0xLTEtMzYyNDg_55d2fd4a-36e7-4fdf-bd83-079340446ef3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021, a total liability of $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2Mjg1ODE4_70079421-223b-448f-91d8-cf95423b3a9e">28.4</ix:nonFraction> million was on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $<ix:nonFraction unitRef="usd" contextRef="ie267803461c24ea8b3916fbd1ae6771c_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2Mzg4MTU_05822a0b-2290-4890-b025-047435b99c23">23.2</ix:nonFraction> million from lease and lease related liabilities of which $<ix:nonFraction unitRef="usd" contextRef="i8dc5a2134f884432820063e1b886264a_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2Mzg4MjI_efa3b510-e80e-4f00-8581-3f7c8d866298">10.4</ix:nonFraction>&#160;million is included within other liabilities and $<ix:nonFraction unitRef="usd" contextRef="id23f0621c3b244fd89bd3711026df87b_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2Mzg4MzE_b14eaaae-6bf0-4fee-9022-3e355a180c40">12.8</ix:nonFraction> million is included within non-current operating lease liabilities. The remaining provision of $<ix:nonFraction unitRef="usd" contextRef="i04f1dd5a84134d2894c1da8788efa67c_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE1MzkzMTYyNzk0NDQx_63723ba5-1d3c-4fde-b451-0f5aa0309f24">5.2</ix:nonFraction>&#160;million relates to workforce reduction and is included within other liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" xsi:nil="true" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE0MTQ_a10ed1f9-d6d8-4b15-9e47-50439aaa7afc" escape="true"></ix:nonNumeric><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE0MDA_de2c4a17-6d5e-4341-972e-e3e750dcd875" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzQtMS0xLTEtNDcwMzg_72a437b4-82b4-4082-802e-2d7da052138e">10,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzQtMi0xLTEtNDcwMzg_cd264c21-a1ed-48c7-ba80-dcb033ef667b">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e24d855ba14a97a64dd8c818215580_I20181231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzQtMy0xLTEtNDcwMzg_2a8b9a52-af1c-4e39-8f27-00953b87a13e">6,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzUtMS0xLTEtNDcwMzg_61592d2f-7354-42e3-9b86-d2de48a8c58d">26,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzUtMi0xLTEtNDcwMzg_cf0d24e4-b005-4590-984a-7330a8a99edf">18,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzUtMy0xLTEtNDcwMzg_fd778dfd-d444-4a15-84bb-8d0dcddb4345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzYtMS0xLTEtNDcwMzg_0677217d-1826-4e6f-9fb1-981863f12b5f">9,069</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzYtMi0xLTEtNDcwMzg_cac9acda-6287-4541-a985-c549f411494e">8,978</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzYtMy0xLTEtNDcwMzg_dbceff4e-ec90-42d0-bce5-4dd35dffaa64">4,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzctMS0xLTEtNDcwNDU_75952c77-0262-4c59-bf4e-d2d7d8c106fc">28,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzctMi0xLTEtNDcwNDU_58f2b86c-b624-45d2-b0a1-4a74f1912c0f">10,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzctMy0xLTEtNDcwNDU_07ed51f3-8ab2-44bb-8471-1072656d2c17">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_184"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODQvZnJhZzo5MDQzNTcwODQwZGU0YjI1OTY3ZmY1NDZhNGEyYzkyOS90ZXh0cmVnaW9uOjkwNDM1NzA4NDBkZTRiMjU5NjdmZjU0NmE0YTJjOTI5XzE4OTk_8e7f100e-e098-4355-b605-04eccd1c1bab" continuedAt="i5e81b603171d40cab93dabcb60ac0cd8" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5e81b603171d40cab93dabcb60ac0cd8" continuedAt="i7a2ba03e915b490089a95888363fcd9b"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7a2ba03e915b490089a95888363fcd9b"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next <ix:nonNumeric contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODQvZnJhZzo5MDQzNTcwODQwZGU0YjI1OTY3ZmY1NDZhNGEyYzkyOS90ZXh0cmVnaW9uOjkwNDM1NzA4NDBkZTRiMjU5NjdmZjU0NmE0YTJjOTI5XzE2MTM_c2181052-781b-45c8-8da5-f89c4de514e1">twelve years</ix:nonNumeric>. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 23 - Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2021 and December&#160;31, 2020 and future minimum rental commitments as of December&#160;31, 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_187"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90ZXh0cmVnaW9uOjkwZjQ1N2QyYWQ5NTRjZDliYjM4NGY3YzNhNjE4MGNkXzIzNA_753afc7e-66b6-46bd-9463-2b228a78c737" continuedAt="i506d2b740dd44fa9b8ae83e8852ce870" escape="true">Disaggregation of Revenue</ix:nonNumeric></span></div><ix:continuation id="i506d2b740dd44fa9b8ae83e8852ce870" continuedAt="iad31d8c1429749c4b374d3f111b60812"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90ZXh0cmVnaW9uOjkwZjQ1N2QyYWQ5NTRjZDliYjM4NGY3YzNhNjE4MGNkXzIzNg_ca904744-fa1b-4446-bc59-c61bae57637c" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9faa218b12a4b3cbf68ef2876caf309_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzMtMS0xLTEtMzYyNDg_5a88d0b1-a12f-46df-b05f-4a2aa9587977">441,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b459699c0644968482717272d94004_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzMtMi0xLTEtMzYyNDg_887a3d42-8b96-4a5c-9c28-1db230b15d3f">337,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia579ed66ea164732848f24e059ca35c5_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzMtMy0xLTEtMzYyNDg_372fa5ac-2580-4bf4-9565-b977fe2db5e4">350,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie82ad39f10bb41e4a084c8444e8989e2_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzQtMS0xLTEtMzYyNDg_d28fea6b-1b2d-456b-a555-3b221216cee2">1,291,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0fe21c6d5f44e195d836fd2b3861df_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzQtMi0xLTEtMzYyNDg_1c87e032-2065-4573-ba0c-61efa813d8f9">754,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0595a59077864be3995b98eb22ddb2b8_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzQtMy0xLTEtMzYyNDg_85fce5e0-170a-4775-954d-301ad55b85fb">704,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf29ed6c91d7496d942630ab211f4988_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzUtMS0xLTEtMzYyNDg_ab1c0a76-10a6-483d-adc9-ac0751de93b5">752,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i485faa3e5fc04aacbcde0602daee7a53_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzUtMi0xLTEtMzYyNDg_99b05ef7-ac2e-4070-a1cd-5a32a608fece">350,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b863197bb30417a90a009a4abea9561_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzUtMy0xLTEtMzYyNDg_089452a0-c358-4e54-b08d-433948687cb4">347,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2bfed171104f319e9a84bb08cd25c7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzYtMS0xLTEtMzYyNDg_57d52bdc-c29a-440d-8814-c03f513b3334">1,077,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice57c280ae3940bca26f984dc95288ba_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzYtMi0xLTEtMzYyNDg_4241910e-a0d9-4a83-a426-41376f2ddc57">501,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28103989f8142d59279653ff6548119_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzYtMy0xLTEtMzYyNDg_7f09b521-ecc0-4229-b5ae-4473dbb2d5f4">529,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45550d1365114ceeb217ab47d70cb97c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzctMS0xLTEtMzYyNDg_cde7e362-74f5-40c4-9b74-03fda3de34c2">1,918,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if73f3bd5251f468199c2f39f63ce992f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzctMi0xLTEtMzYyNDg_69bcd5df-78d6-4f67-9df1-f8c28b8a20d8">851,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb97c73d747941d58453e74f92d14e13_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzctMy0xLTEtMzYyNDg_139907cc-aaa1-480d-aa9f-99d5806ecc10">873,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzgtMS0xLTEtMzYyNDg_6a6f424a-3ff7-44f8-90b7-a98a2b96da9e">5,480,826</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzgtMi0xLTEtMzYyNDg_da56b7b7-1e90-4dbc-8036-fa7b1a630010">2,797,288</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzgtMy0xLTEtMzYyNDg_44beeff9-1cfd-400c-a117-3b363d91588e">2,805,839</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="iad31d8c1429749c4b374d3f111b60812" continuedAt="i2287b29617f448a5aeed7ce567474916">Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_190"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18. <ix:continuation id="i2287b29617f448a5aeed7ce567474916" continuedAt="i388b843d35cc486e84aa971129957937">Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="i388b843d35cc486e84aa971129957937" continuedAt="iee7d24aff69e49c597f7be14d0797bb3"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzMyNTI_db5d3371-a15b-4c67-927a-051c75c8414f" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzItMS0xLTEtMzYyNDg_41062c42-517f-4ec8-b888-ab081c19f26e">1,349,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzItMy0xLTEtMzYyNDg_b953a424-4bf2-445f-aa7b-e8ec290da691">722,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 19)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzMtMS0xLTEtNTE3MjY_a900c36b-4e52-4daa-acfe-9aeba8322792">7,081</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzMtMy0xLTEtNTE3MzU_8b15cfac-fd61-4ea9-a8dc-2a3eed1f4802">7,149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:ContractsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzMtMS0xLTEtMzYyNDg_912b24b3-e448-4928-8aff-bdfdacd50e63">1,342,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:ContractsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzMtMy0xLTEtMzYyNDg_9e5a4a3d-353a-4e86-b7e9-2b64a2ad0030">715,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzUtMS0xLTEtMzYyNDg_769536b9-4a5b-4432-8d17-4d3b01d7107d">623,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzUtMy0xLTEtNDM1MTM_123da609-332b-44f0-8f0c-b3086df20991">428,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:ContractsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzctMS0xLTEtMzYyNDg_36db84b4-9d5f-4be0-b204-c88e1aa4cfa9">1,965,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:ContractsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzctMy0xLTEtMzYyNDg_c4b317ca-3280-490c-846f-a2bc3a1712e6">1,143,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzItMS0xLTEtMzYyNDg_35d91a08-7964-46b1-bedd-a696b86806e8">623,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzItMy0xLTEtMzYyNDg_0600b449-dd18-4d6c-b6be-9663efe55f9d">428,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzItNS0xLTEtMzYyNDg_ffcbdd76-a1ca-40d9-9b87-b13e716dad8f">194,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="3" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzItNy0xLTEtMzYyNDg_a4cb4626-691b-41d8-9d0c-c0a4d6ab6a8b">45.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzMtMS0xLTEtMzYyNDg_6a6350b5-e8e3-4a64-9ba9-d8426ea902e1">1,323,961</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzMtMy0xLTEtMzYyNDg_b8bc3964-475f-41ce-bb02-62cec6a2f16e">660,883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzMtNS0xLTEtMzYyNDg_77bf5642-1e0a-469b-a108-ca04b3c392db">663,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="3" name="iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzMtNy0xLTEtMzYyNDg_12dd4cfe-e751-4df6-ab72-8efe76c38617">100.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" sign="-" name="iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzQtMS0xLTEtMzYyNDg_4dd74bd0-ca59-44a4-83e4-30c01aaf0fba">700,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" sign="-" name="iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzQtMy0xLTEtMzYyNDg_60a78a79-9642-403f-87a2-dab0ba89d615">232,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzQtNS0xLTEtMzYyNDg_d4dfb342-69bc-4875-8bad-4f419d96c932">468,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="3" sign="-" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzQtNy0xLTEtMzYyNDg_c4115f4c-a31d-4ea4-947c-979c78d3e707">201.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivables when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iee7d24aff69e49c597f7be14d0797bb3" continuedAt="icdc2e471c6da4777bd3e09d96d3ac095"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2021 and December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzEwOTk1MTE2MzEyNTA_12507025-6d4b-4234-87ed-14dd1ea90477">323.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzEwOTk1MTE2MzEyODI_d68872d8-f548-4fe8-bc30-dbdc4e841c65">138.2</ix:nonFraction>&#160;million (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 8 - Other liabilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2021 increased by $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzIwMjI_c88ef5e3-f426-48c1-a55a-ec7aaa5ff0f7">194.4</ix:nonFraction> million as compared to December&#160;31, 2020. Unearned revenue increased by $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzIwNjc_1ca88b97-501a-43f1-b408-59d3375646b4">663.1</ix:nonFraction> million over the same period resulting in a increase of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" sign="-" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzIxMTI_3b0cf5ad-101e-4697-ba6b-153741878910">468.6</ix:nonFraction> million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2020 and December&#160;31, 2021. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contract when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Group's receivables and unbilled services was  $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzI4NDc_65c83a1b-2c2d-4e80-88e7-d4b4b7e32cb5">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzI4NTQ_7b65171e-3d19-4b03-afb7-390cdfb0d970">2.9</ix:nonFraction>&#160;million for the twelve months ended December&#160;31, 2021 and 2020, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="icdc2e471c6da4777bd3e09d96d3ac095">As of December&#160;31, 2021 approximately $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzI5MzU_a3e40685-1b56-4a02-a63a-9acbb9e91ea7">13.3</ix:nonFraction> billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately <ix:nonFraction unitRef="number" contextRef="ieb24ee78b3b34864be5c6ac9dba168fd_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzMxMDE_d625ca99-e6f2-46f1-98b6-8e1e8947839e">48</ix:nonFraction>% of the unrealized performance obligation over the next <ix:nonNumeric contextRef="ieb24ee78b3b34864be5c6ac9dba168fd_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzMxNTk_b0d6f721-dccc-4cac-bb6c-35b369265929">twelve months</ix:nonNumeric>, with the remainder recognized thereafter over the duration of the customer contracts.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_193"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:AllowanceForDoubtfulAccountsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90ZXh0cmVnaW9uOmRmMGQ0ODY4ZjExNTQ5YWQ5MDJjMWFiYjA4ZjkxZGMyXzIxMw_c4e61c96-c5d1-484e-99cf-287c28516581" continuedAt="if0bfa6a58f6441028d4c0b2b8955dca8" escape="true">Provision for Credit Losses</ix:nonNumeric></span></div><ix:continuation id="if0bfa6a58f6441028d4c0b2b8955dca8"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:AllowanceForDoubtfulAccountsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90ZXh0cmVnaW9uOmRmMGQ0ODY4ZjExNTQ5YWQ5MDJjMWFiYjA4ZjkxZGMyXzIwOA_1cdf88bd-1070-413f-bc94-be4a66d0d180" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2021 and December&#160;31, 2020 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzItMS0xLTEtMzYyNDg_83237d60-0c45-4aa2-9cfb-4d9a428c39c1">7,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2834e916024d02918294df579c7494_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzItMi0xLTEtMzYyNDg_e814c736-92cb-4a08-b7ef-b92c9df370d4">7,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzMtMS0xLTEtMzYyNDg_69676835-d379-4451-8417-5d10ecd60fe5">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzMtMi0xLTEtMzYyNDg_2ed8756d-7eec-438d-b08a-97cbd7583860">2,561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:AccountsReceivableCreditLossExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzQtMS0xLTEtMzYyNDg_833af661-56e6-4d59-88a0-6362a75debd9">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:AccountsReceivableCreditLossExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzQtMi0xLTEtMzYyNDg_ededeb9a-68d3-4eec-800b-2324a05b1d71">2,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts released during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:AccountsReceivableCreditLossReversal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzUtMS0xLTEtMzYyNDg_49a15c5d-c7a4-4a33-affa-a1e46fbcc129">544</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:AccountsReceivableCreditLossReversal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzUtMi0xLTEtMzYyNDg_ad2b72ee-0e05-480b-96ae-f976a1463e6e">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" sign="-" name="iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzYtMS0xLTEtMzYyNDg_e98f9f27-40e5-4079-84c6-5ca8552bd423">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzYtMi0xLTEtMzYyNDg_02be0d70-1020-487d-aeb5-f96072601d68">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzctMS0xLTEtMzYyNDg_72be83a6-e0e6-4869-aa0b-e6358a742e21">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzctMi0xLTEtMzYyNDg_ae1fb8dd-2050-402f-bcd9-abafcf4c9e10">7,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i6df4b473ec484136b91516d30b1a0b24_196"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">20. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzUzMjA_180a7406-2146-48fe-b04c-c7d48e773931" continuedAt="ic9e85e547d5043339e49533e6ffdf77d" escape="true">Business Segment and Geographical Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic9e85e547d5043339e49533e6ffdf77d" continuedAt="i4f62a1af4edd48228dc53e5030dc1585"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#8216;CODM&#8217;) in accordance with ASC 280 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Segment Reporting'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates as <ix:nonFraction unitRef="segment" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEyNjg_c85eed66-44ac-495c-9f6b-0246c2c0e5c9">one</ix:nonFraction> business segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. </span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4f62a1af4edd48228dc53e5030dc1585" continuedAt="i6643a0144371413f918672e095e1fac9"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#8217;s transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland (Ireland Segment) acts as the Group entrepreneur under the Company&#8217;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#8217;s global network. ICON Ireland enters into the majority of the Company&#8217;s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland. The </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">integration of entities acquired through the Merger into the global transfer pricing model remains ongoing and these entities were not substantially part of the Group's cost plus arrangement in the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's areas of operation outside of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland include th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e United States, United Kingdom, Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Hungary, Italy, Latvia, Poland, Portugal, Romania, Russia, Serbia, Spain, Sweden, The Netherlands, Turkey, Ukraine, Canada, Argentina, Brazil, Chile, Colombia, Mexico, Peru, China (including Hong Kong), India, Israel, Japan, Singapore, South Korea, The Philippines, Taiwan, Thailand, Australia, New Zealand, South Africa, Belarus, Bermuda, British Virgin Islands, Costa Rica, Croatia, Denmark, Egypt, Estonia, Finland, Georgia, Greece, Guatemala, Iceland, Jersey, Kenya, Lithuania, Luxembourg, Malaysia, Norway, Panama, Puerto Rico, Slovakia, Switzerland and Uruguay.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reportable segment and geographic information at December&#160;31, 2021 and December&#160;31, 2020 and for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzUzMTY_353b99ad-6801-4e40-b980-92a55c908d5b" continuedAt="i146c5e66e7e645a7849652091ace732c" escape="true">The distribution of revenue by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div><ix:continuation id="i146c5e66e7e645a7849652091ace732c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzQtMS0xLTEtMzYyNDg_20ef6187-c06b-4f53-a8c4-cb82ba948fa4">1,365,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzQtMi0xLTEtMzYyNDg_ea70656f-1e22-45d6-8081-67e18359d5b4">1,181,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzQtMy0xLTEtMzYyNDg_7c996328-2592-4540-aa6e-b2cb9219c170">1,252,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7560d016044c24b3bdac4149860edf_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzUtMS0xLTEtMzYyNDg_31f5d782-0ad1-49da-aada-f062143df8e9">1,175,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedf131d1b8644060b1d2530e00834656_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzUtMi0xLTEtMzYyNDg_80e7ca9c-2d5f-471d-9f6c-4d40fc5d9bfd">416,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f149fe5aaf499d867e3e597050ca23_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzUtMy0xLTEtMzYyNDg_dc7dd54f-255f-4f53-810d-bc0f8723aa32">388,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzYtMS0xLTEtMzYyNDg_e7fda06b-9993-412d-8cae-00eeb61b405b">2,581,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzYtMi0xLTEtMzYyNDg_a73f3af6-621b-4389-9abb-975a983427b9">925,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzYtMy0xLTEtMzYyNDg_bf226acc-0a8c-4d09-915a-b33898e3e474">892,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6939b2d79b084dc0a660f3b73a074210_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzctMS0xLTEtMzYyNDg_e24de07a-d088-4df0-9319-aa8bf15e9eea">358,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ddd5c933e7b4f74b37135036f3084df_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzctMi0xLTEtMzYyNDg_65aced16-a9b3-4eb0-86f9-dfaafb209c8e">273,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i555b937d50554bbdb3d03c3c137d6aa2_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzctMy0xLTEtMzYyNDg_af1d14e3-8cc8-4166-b687-fdfe91c33f12">271,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzgtMS0xLTEtMzYyNDg_b03961ba-5a98-4b0d-b456-50c800d4813a">5,480,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzgtMi0xLTEtMzYyNDg_37d8fac1-c350-4fc1-8215-7e61b457c646">2,797,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzgtMy0xLTEtMzYyNDg_b022205d-9275-44f9-92f7-fb5ae8181977">2,805,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:OperatingIncomeByGeographyTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzUzMTc_128bb1e0-d42b-4683-8d1b-545060494a70" continuedAt="i94dff31fcfc94a95acdd3d7c35f7b527" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i6643a0144371413f918672e095e1fac9"><ix:continuation id="i94dff31fcfc94a95acdd3d7c35f7b527"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) The distribution of income from operations, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">excluding restructuring, transaction and integration related expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzMtMS0xLTEtMzYyNDg_580b043a-21af-48d8-9580-190c7ab34b66">161,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzMtMi0xLTEtMzYyNDg_b61ad059-a764-4043-9241-f53d1b87ba79">295,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzMtMy0xLTEtMzYyNDg_7a5810a3-8aac-49aa-a75c-4552a1ecc860">314,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7560d016044c24b3bdac4149860edf_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzQtMS0xLTEtMzYyNDg_d34d3aa6-d3e5-4422-8e34-7932899144c5">183,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedf131d1b8644060b1d2530e00834656_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzQtMi0xLTEtMzYyNDg_b29977aa-7ccd-4845-a5d7-48a5eed7f65c">35,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f149fe5aaf499d867e3e597050ca23_D20190101-20191231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzQtMy0xLTEtMzYyNDg_7577cfdb-9dee-4017-948f-fcd0e87a536f">37,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzUtMS0xLTEtMzYyNDg_af60fcbe-b91b-4337-ab84-79dc9107a14c">231,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzUtMi0xLTEtMzYyNDg_138830f8-a130-4e7e-b3ac-cbfe41f5afe5">56,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzUtMy0xLTEtMzYyNDg_c164471d-8b2e-4bca-83f2-ed3e89e23e93">60,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6939b2d79b084dc0a660f3b73a074210_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzYtMS0xLTEtMzYyNDg_b87e6e6f-0b12-4be5-82aa-44fe1599c77e">30,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ddd5c933e7b4f74b37135036f3084df_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzYtMi0xLTEtMzYyNDg_01e86f1a-e364-4093-bc09-c51122aa42fb">21,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i555b937d50554bbdb3d03c3c137d6aa2_D20190101-20191231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzYtMy0xLTEtMzYyNDg_a6e0379a-2aba-4b7b-bf19-970b8fc83cbe">20,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzctMS0xLTEtMzYyNDg_cfb5acce-54c3-4269-a0c9-2f4e0bd8168e">607,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzctMi0xLTEtMzYyNDg_fd81baa7-c7e8-457d-8e82-9222ec90d1f7">408,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzctMy0xLTEtMzYyNDg_57b1f8ab-897d-4012-bdf9-bcad4207989f">433,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. These assets have been provisionally allocated to Ireland.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations, excluding restructuring, transaction and integration related expenses of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="iclr:IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEwOTk1MTE2NTAzNDg_524a70cb-e206-4168-85c9-03d95bec00e7">607.9</ix:nonFraction> million was earned during the year ended December&#160;31, 2021 having added back restructuring expenses of $<ix:nonFraction unitRef="usd" contextRef="iae97c86e7991410685e37fea162dced3_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEwOTk1MTE2NTAxMTY_8708d642-7992-4243-85b0-af5cde6d57b3">31.1</ix:nonFraction>&#160;million (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 Restructuring charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and transaction and integration related expenses of $<ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEwOTk1MTE2NTAyMzk_7d091025-cb95-4742-b7ec-b1a8c870f051">198.3</ix:nonFraction> million (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 6 Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) to income from operations of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEwOTk1MTE2NTAzMzA_0a33e5a9-9244-421b-b5f3-8ebc28701563">378.5</ix:nonFraction> million as presented in the Consolidated Statement of Operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzUyOTc_1676d38d-7cc2-4956-8dcf-f24b99c787db" continuedAt="i09254e395fc4490da5254256fbeaea4c" escape="true">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i09254e395fc4490da5254256fbeaea4c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639f5002243748caaade65a18fa1abd4_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzItMS0xLTEtMzYyNDg_095a04a2-777a-44fd-8678-0195a1031e6c">118,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibadbd19679bc427dba0f5f5ae0f7fd8e_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzItMi0xLTEtNDM4NDY_f2ac65ca-be88-4ff6-b04b-35f581440ed5">118,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57430deb2fc84136b5fd0563c9976335_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzMtMS0xLTEtMzYyNDg_94ebd2cf-fa06-4f61-95d8-514b63cfc9ca">121,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9169f6af6160491cb03265cd3846ea11_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzMtMi0xLTEtNDM4NDY_3c5f866e-041f-4cd9-96fc-aab917f8cd9f">36,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844861916668498588f0491ce84b368e_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzQtMS0xLTEtMzYyNDg_11bf78d7-e5b0-4462-86ab-1324efaef611">239,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84dbafe769b9418dae1e4cb9de53c5e6_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzQtMi0xLTEtNDM4NDY_48430bae-2bba-4638-b156-81bd5983e4bd">65,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a66c15d3893461486dcf165a1add471_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzUtMS0xLTEtMzYyNDg_3659ec7e-e215-4897-ad34-8aea7ae9232a">55,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e8457bcc7054ec4a4014e91fdf31028_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzUtMi0xLTEtNDM4NDY_4b4820a1-f040-4a75-9717-61ab4dd9940a">38,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzYtMS0xLTEtMzYyNDg_08ce0ec7-7a82-476e-8fc2-3ac932186ad6">534,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzYtMi0xLTEtNDM4OTM_e730c4ce-3b9c-40e8-ad31-1cf3e6d71e53">258,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i6df4b473ec484136b91516d30b1a0b24_199"></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">21. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90ZXh0cmVnaW9uOjFiMWIxNTU2ODUyZTRhOGY4NTE3NGMyMGY1OTRiMDE0XzY1_c147d58f-2fc4-4589-b026-5062f060e0ea" continuedAt="i9cc4a66f36d44f80bb6ec6167197cfad" escape="true">Supplemental Disclosure of Cash Flow Information</ix:nonNumeric></span></div><div><ix:continuation id="i9cc4a66f36d44f80bb6ec6167197cfad"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90ZXh0cmVnaW9uOjFiMWIxNTU2ODUyZTRhOGY4NTE3NGMyMGY1OTRiMDE0XzYy_02d9f8e2-6be4-460e-b6a0-2923768a2dac" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzMtMS0xLTEtMzYyNDg_119b8523-0251-4b44-8e48-c9e9439c01d6">106,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzMtMi0xLTEtMzYyNDg_b97c2358-8926-417e-a05f-0beed0162017">13,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzMtMy0xLTEtMzYyNDg_0bbbbdec-b78b-4448-b8f7-b0094b82c07d">13,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzQtMS0xLTEtMzYyNDg_ac53d390-4f7f-4582-93b6-5baf5dcd3a90">55,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzQtMi0xLTEtMzYyNDg_76e20607-c136-452c-9dc5-93dde3b75796">27,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzQtMy0xLTEtMzYyNDg_b1c6a86c-bb12-41e1-8a17-25b930b49364">29,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">149</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90ZXh0cmVnaW9uOjk2MjBkYWI0YzUyZjQyOTRhMjQ3NTM4N2ZhMjI4MzBkXzUz_5b39722a-293d-4774-b155-6c716bb68717" continuedAt="i506c3fd133534dd8a259a6d5a5c968d3" escape="true">Accumulated Other Comprehensive Income</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i506c3fd133534dd8a259a6d5a5c968d3"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90ZXh0cmVnaW9uOjk2MjBkYWI0YzUyZjQyOTRhMjQ3NTM4N2ZhMjI4MzBkXzU1_6207ffc6-93f8-4be2-9c9e-64c469c84c74" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzMtMS0xLTEtMzYyNDg_4ae0f300-351b-4949-b863-b691e0b97c62">75,986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzMtMi0xLTEtMzYyNDg_ae9a6aa1-9cb9-4497-bbed-4bb2065aa677">15,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" sign="-" name="iclr:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzQtMS0xLTEtMzYyNDg_52638d33-1a72-442f-a43d-aafefd28f76b">9,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" sign="-" name="iclr:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzQtMi0xLTEtMzYyNDg_51457d0b-1ef0-4fca-8a01-71dc5eee85a4">9,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss on defined benefit pension plan (note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzUtMS0xLTEtMzYyNDg_a629401a-e4d4-4053-b317-8bc94f52dc45">5,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzUtMi0xLTEtMzYyNDg_d9e8b22d-670b-4fe4-8b41-9887b6d69c3b">9,364</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gain on interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75873ccb8a5c422b9bf776cba332d63d_I20211231" decimals="-3" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzctMS0xLTEtMzYyNDg_88f9b824-aad6-4164-9627-867fb4a33479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38942652cf84800b863e3e7022c6277_I20201231" decimals="-3" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzctMi0xLTEtMzYyNDg_d2403708-e9e2-44e3-9810-1611c06d5847">4,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of gain on interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75873ccb8a5c422b9bf776cba332d63d_I20211231" decimals="-3" name="iclr:AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzgtMS0xLTEtMzYyNDg_bbf1a564-2c2b-4e0b-85a7-fb644acb3c20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie38942652cf84800b863e3e7022c6277_I20201231" decimals="-3" name="iclr:AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzgtMi0xLTEtMzYyNDg_0aff8cf2-ba91-44e1-b718-680af184e108">4,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzktMS0xLTEtMzYyNDg_85c1617e-8c7a-4f47-a505-10cc1c30298d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzktMi0xLTEtMzYyNDg_e102ba48-dce9-420c-a63d-bfcc897ff2d2">905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of loss on interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzExLTEtMS0xLTM2MjQ4_7aae4f04-4c38-4645-87d8-bd1639df7cb3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzExLTItMS0xLTM2MjQ4_cc195544-dea5-4463-b8b8-b111ccdcaa42">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzEyLTEtMS0xLTM2MjQ4_6fee589e-b900-49d8-9f95-f06253ab30a0">90,937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzEyLTItMS0xLTM2MjQ4_cfc4845b-e619-4940-a403-90cca0cf2fe7">35,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:5pt"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_205"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">23. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODk_4b2a6938-a0e1-4aaa-8ac1-daafe1bbe5fa" continuedAt="i06de80365dff4cd9bdc3c137d75fb0e8" escape="true">Operating leases</ix:nonNumeric></span></div><ix:continuation id="i06de80365dff4cd9bdc3c137d75fb0e8" continuedAt="i77e6f8f8f41b46eba20c7d57ab8e9382"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2OTA_4003a9a9-c237-4e9d-9e86-bf210f44f727" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzQtMS0xLTEtMzYyNDg_a10b892a-8232-4a26-985e-d5c3a7fd66da">51,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzQtMi0xLTEtMzYyNDg_4ee96532-634c-4cbc-a4fb-3d8cc74c1064">31,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzUtMS0xLTEtMzYyNDg_27274e38-ff97-4564-b37a-245f2051bb60">1,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzUtMi0xLTEtMzYyNDg_fccb8038-fc7a-4e50-9d83-492a44903ae6">940</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzYtMS0xLTEtMzYyNDg_07e48bf3-c9ec-433e-998a-9adcc08f75bd">49,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzYtMi0xLTEtMzYyNDg_7363772f-889c-4e2a-a457-db10a153b073">30,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzExNA_537944ee-08f2-4cfe-b94b-849ed619c010">49.9</ix:nonFraction> million incurred in the year ended December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="if5c3ba2a7a9949e4b4296e482b3406d4_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE0MA_cc92361d-1742-4ca8-aab4-c18be56cb8c9">47.5</ix:nonFraction> million is recorded within selling, general and administration costs and $<ix:nonFraction unitRef="usd" contextRef="id8aedbfe82f84258b4f5fb8ae5be9756_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzIwOA_dcf6a4af-4f5a-462a-b484-e82445cf1c88">2.4</ix:nonFraction> million is recorded within direct costs. Of the total cost of $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzI2NQ_c0eed4ae-674c-412b-bb1e-d85eb64a9435">30.1</ix:nonFraction>&#160;million incurred in the year ended December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="ia28188c5a298446189940f3d7538dc9f_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzI5MQ_1cca5ff5-12a3-4fbb-9983-1eb5af62f275">27.6</ix:nonFraction> million is recorded within selling, general and administration costs and $<ix:nonFraction unitRef="usd" contextRef="ic3104d5908eb42a781a65f9e3b34447b_D20200101-20201231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzM1OQ_96a12db9-dd08-47f8-b91b-103838c26d87">2.5</ix:nonFraction> million is recorded within direct costs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and December&#160;31, 2020, the Group did <ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="INF" name="us-gaap:VariableLeaseCost" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2OTE_9b0ae7bd-a5e4-411f-aad1-9be2b5adb991"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="INF" name="us-gaap:VariableLeaseCost" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzQ0NA_07592614-c09e-4407-86e5-19153ae0a265">no</ix:nonFraction></ix:nonFraction>t incur any costs related to variable lease payments.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December&#160;31, 2021 and December&#160;31, 2020 totaled $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzgxMw_b3f680f6-4545-4c96-82ef-e04ff74af598">10.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzgyMA_b7de676a-11da-4f7f-823c-b62a679dbeda">12.1</ix:nonFraction> million, respectively. During the year ended December&#160;31, 2021,  office consolidations resulted in the recognition of an impairment of ROU assets. The right-of-use assets related to these offices have been impaired and a charge of $<ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEwOTk1MTE2MzA0MDA_f1f17faf-c947-4ad8-ab41-2bce0f5acd74">15.4</ix:nonFraction> million was recorded (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 - Restructuring charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">). An impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEwOTk1MTE2Mjk3MjU_35fe85aa-eb90-403a-8630-63d2d51bc033">5.4</ix:nonFraction> million was recognized during the year ended December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2021 were <ix:nonNumeric contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEyNzg_ea4cfda4-f9b0-4d7b-85a9-9fc3478af5d8">6.91</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEyODU_43c010c8-5aa0-41fa-8e52-7e0fcf836e7c">2.51</ix:nonFraction>%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2020 were <ix:nonNumeric contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEzOTE_5304ebe4-d240-4dce-8e13-aa4a75629687">4.45</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEzOTg_63832733-6536-4ff0-bfa0-29f0c740a078">2.53</ix:nonFraction>%, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i77e6f8f8f41b46eba20c7d57ab8e9382"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODc_37765990-a8e1-4c87-a33c-2abd48cfa84b" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2021 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzMtMS0xLTEtMzYyNDg_0a4c33b1-19c4-42db-8ea3-836495ca64de">54,292</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzQtMS0xLTEtMzYyNDg_fd6dbffb-7726-47f8-a31c-4623c1186b57">45,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzUtMS0xLTEtMzYyNDg_69889cb3-311e-4443-8d02-1a249bbaf29e">29,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzYtMS0xLTEtMzYyNDg_3b07b3f4-ff32-4d2b-a227-af48671cd2eb">20,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzctMS0xLTEtMzYyNDg_7afd4ba9-e78d-4612-b71c-2520208c0137">17,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzgtMS0xLTEtMzYyNDg_387336c5-3d7b-48f6-a940-bf6b0c2c86ad">59,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzktMS0xLTEtMzYyNDg_c8fc885f-6b1d-455c-b330-7c4822f25306">227,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzEwLTEtMS0xLTM2MjQ4_6705616c-d182-4e38-a9a0-e29ddc09e3c5">18,266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzExLTEtMS0xLTM2MjQ4_93709fa7-31c3-48c7-b4b4-391efde51fb9">209,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="i7e95612f074040ca8329b4a89d847966_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzIxOTkwMjMyNTgxNjM_4e4f6989-566d-482b-af9f-ec1d36724284">49.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3c03db364d544bbd8c5f621de598194c_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2MTQ_dbeed5b0-d37a-4172-8a6b-6799b8bb3d4a">24.3</ix:nonFraction> million have been included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7b15ff89-21bb-47d6-8b93-387dc069fe0d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7ee1e415-4195-48f3-aa9c-3b52eaebf0fd">other liabilities</span></span> as at December&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_208"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzM0NTY_796f17d7-e5fd-4634-877a-bcb5165ab111" continuedAt="ie9f63f48cceb4dc290a712760772d25e" escape="true">Non-current bank credit lines and loan facilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie9f63f48cceb4dc290a712760772d25e" continuedAt="i382123b6c91445f2b06e1d3d1d0a9c60"><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyNzYwNzA_00dee637-e16f-4d4c-beb6-5211c2c5e109" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ee2cf622d234c2aa3264bc99d1d99f6_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzQtMS0xLTEtNDAxNzc_5398cc11-926b-491d-9280-15e4b2d9c3f5">2.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee2cf622d234c2aa3264bc99d1d99f6_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzQtMi0xLTEtNDAxNzc_7b4e8056-3bcd-47cb-9b45-afff27a94537">5,001,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0acaa265f49241d68f4649867f4f00a1_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzQtMy0xLTEtNDAxNzc_333ca487-93cf-4416-a7fe-c1aff9cb2e71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i452b01c0112d4ccd9b653f71e8f9dcbb_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzYtMS0xLTEtNDAxNzc_adb3396d-94fd-40a0-a7d6-6f3301926b0f">2.875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452b01c0112d4ccd9b653f71e8f9dcbb_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzYtMi0xLTEtNDAxNzc_ce55c552-45a5-4a47-b4e8-0031fa9f7224">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa28345cbd8749e8a4e0f211a8ca39ca_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzYtMy0xLTEtNDAxNzc_23a08795-4430-4a4a-89c7-d91777cb4393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020 Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Series A notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c04ffd49dae4f0992771a4e20c9df7b_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzgtMi0xLTEtNDAxNzc_b064da60-7352-45b7-88a1-9437592c1f36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21502e982c90437c9bfab920645d67a9_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzgtMy0xLTEtNDAxNzc_e9d81e82-e9c7-4fea-96d4-2a7c287f6ca3">275,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Series B notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a8f70dc107f44d0b434efabb00c6480_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzktMi0xLTEtNDAxNzc_205ab1e1-e918-4e76-9e21-8449900b765e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6231795e2c4c7b85a8443de30f290a_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzktMy0xLTEtNDAxNzc_504094b3-e88e-4958-99f8-6a0458da5a95">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzExLTItMS0xLTQwMTc3_e3b51c03-9668-4467-b1f3-bac4e50ae4ad">5,501,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzExLTMtMS0xLTQwMTc3_c133b315-4c44-4957-8968-3aa8258164ba">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:LongTermDebtCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzEzLTItMS0xLTQwMTc3_a26eec70-fd9d-485b-bb97-54d2e7bb1086">55,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:LongTermDebtCurrentMaturitiesGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzEzLTMtMS0xLTQwMTc3_2e2b3355-905e-43b9-b8fe-dacca2a6345e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:LongTermDebtExcludingCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE0LTItMS0xLTQwMTc3_0c9414c9-adf7-45f5-88a4-1474666b9d48">5,446,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="iclr:LongTermDebtExcludingCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE0LTMtMS0xLTQwMTc3_c3d3e585-a2f6-46ed-a30a-6559116cc60c">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE1LTItMS0xLTQwMTc3_b3f78ffc-99a6-4bf0-afb8-c7ab12dff6b8">64,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE1LTMtMS0xLTQwMTc3_b04b4182-fce1-40ba-8c1d-d7451359c684">1,523</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE2LTItMS0xLTQwMTc3_e669ec93-b8d5-4d9d-9bbc-1764caf8fb1e">5,381,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE2LTMtMS0xLTQwMTc3_15bda1d5-a982-44c6-bb71-04540686796e">348,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company paid a $<ix:nonFraction unitRef="usd" contextRef="ieb0064f5e15c4dab8c532e6ad71f7603_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE1OTQyOTE4NjI1OTA5_7fea364d-a1bb-45d6-aaa4-e55e80f1f522">27.6</ix:nonFraction> million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2021,  December&#160;31, 2020 and December&#160;31, 2019 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the year ended December&#160;31, 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NTU0MTI_b65d6e80-0465-4c14-abfb-72cbf1ef8381">86.7</ix:nonFraction> million transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyODM5Njk_a0ab506b-100b-4ff4-9873-53f23e10b104" continuedAt="i3ba560412ad54530a4e7ccb3c02dc687" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i382123b6c91445f2b06e1d3d1d0a9c60" continuedAt="ic7bf97868655456392766f0c713c22b7"><div><ix:continuation id="i3ba560412ad54530a4e7ccb3c02dc687"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzItMS0xLTEtNTY2MDg_fd384c01-a8a5-4059-aeaa-fcc522a22d28">93,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzItMi0xLTEtNTY2MDg_79682265-14ae-41d3-918c-442d0852580e">13,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzItMy0xLTEtNTY2MTk_ebafc52e-2223-4df8-9f92-2ca51672059c">13,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzMtMS0xLTEtNTY2MDg_7fad7581-a6a4-4724-9480-b71f7e9ac029">12,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzMtMi0xLTEtNTY2MDg_49bffb54-74f1-443c-859f-7c2b90a24eeb">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzMtMy0xLTEtNTY2MTk_26ea0010-44fd-4d4a-b717-3b65a8849234">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzQtMS0xLTEtNTY2MDg_003a9f76-94cb-4131-85f4-6bfddf220af2">75,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzQtMi0xLTEtNTY2MDg_d4a7dc94-cc62-4347-bd2c-3a55f61e60b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzQtMy0xLTEtNTY2MTk_f14af4d2-f4e3-4ba2-80fd-4eb5192f47ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs/(credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="iclr:InterestExpenseCreditOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzUtMS0xLTEtNTY2MDg_5eb8e957-2e39-49cb-9afc-c4bce3b18a27">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" sign="-" name="iclr:InterestExpenseCreditOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzUtMi0xLTEtNTY2MDg_e9b4ffc2-4042-4442-b591-e8b343f0b7df">910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" sign="-" name="iclr:InterestExpenseCreditOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzUtMy0xLTEtNTY2MTk_08eea5bc-7d8c-4d8a-a92a-c99e5c438436">923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzYtMS0xLTEtNTY2MDg_c7bab059-20fe-46a3-909e-441509963704">182,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzYtMi0xLTEtNTY2MDg_6b868668-27b5-4cc5-b471-67d3bd1c6e24">13,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzYtMy0xLTEtNTY2MTk_2eadad39-add8-44ed-97e1-a985b848f2cd">13,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyNzYwNzE_fa7685cb-058a-4cc2-8a42-24f35065bfe4" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzEtNC0xLTEtNDAxNzc_bc6b6732-330c-4756-a597-22ffe24ff443">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzItNC0xLTEtNDAxNzc_dc49a1b4-5d5c-453e-b7b6-7fd19365b94a">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzMtNC0xLTEtNDAxNzc_90afd248-2749-498e-9af8-07d221f1a2fa">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzQtNC0xLTEtNDAxNzc_b1121475-17ad-4b8c-8368-51405fce84ba">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="iclr:LongTermDebtMaturityYearFiveAndThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzUtNC0xLTEtNDAxNzc_4caf1676-faa4-466c-9a21-58441a5a5557">5,280,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzYtNC0xLTEtNDAxNzc_c35c835b-8b12-4404-b752-d132993abac4">5,501,213</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $<ix:nonFraction unitRef="usd" contextRef="i82f9f7da96f842ad91fb773f1d6c7517_I20210701" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDY5NDY_fd59e292-88b2-44b6-9416-faf6cf19fe99">5,515</ix:nonFraction>&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i86b692f1ce7e413c834c8a2488e2c0ac_I20210701" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDY5NjI_d637553e-8346-4dc0-87e2-4ed2841f3b86">300</ix:nonFraction>&#160;million. The proceeds of the senior secured term loan facility were used to repay in full (i) PRA&#8217;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the transaction. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="i82f9f7da96f842ad91fb773f1d6c7517_I20210701" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyODI1MTY_ce794da7-8b6a-4987-9a60-51f2a2322767">1.00</ix:nonFraction>% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is LIBOR plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i412657424e8a46e09c66a2345306a17a_D20210101-20211231" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1ODE_4c9d5fa3-39ee-434c-9d07-88f258aabb3c">2.50</ix:nonFraction>%, in each case, with a step down of <ix:nonFraction unitRef="number" contextRef="i412657424e8a46e09c66a2345306a17a_D20210101-20211231" decimals="4" name="iclr:DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyODI1MjM_1b5ba939-eb1b-4580-a13b-bb41dabb54eb">0.25</ix:nonFraction>% if the first lien net leverage ratio is equal to or less than <ix:nonFraction unitRef="number" contextRef="ib6f10a8ae3df4827be9831c930c77331_I20211231" decimals="2" name="iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1ODg_bf81259e-f340-4523-90f8-c922d214a250">4.00</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ie2fff4332a1d4c0698311a5bd0290b3c_I20211231" decimals="2" name="iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1OTQ_a2a4c6ad-3e7b-41ac-bb34-1c8bc5ba9fa3">1.00</ix:nonFraction>. The senior secured term loan facility is subject to a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="i7acc5e38562846649f0134d3bdc33705_D20210101-20211231" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg2MDA_4615bc1e-39bf-4d0b-af5d-ce80766b5e85">0.50</ix:nonFraction>%. On November 10, 2021, the Company achieved a net leverage ratio of less than <ix:nonFraction unitRef="number" contextRef="ifdac2dc9cabd4d0d9b3df33a7ae8822e_I20211231" decimals="0" name="iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1Nzk_d988fb6d-3c8b-49a6-aaaa-1fc1c71665b9">4</ix:nonFraction> times and the margin applicable to the senior secured term loan was reduced by <ix:nonFraction unitRef="number" contextRef="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231" decimals="4" sign="-" name="iclr:DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1NjA_aeb50050-ebbd-4166-86b4-e94a7c938557">0.25</ix:nonFraction>% with the overall rate reducing from <ix:nonFraction unitRef="number" contextRef="i19229e729ec74c57a20161ea7ce568f9_D20210701-20211109" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1Njc_e6fbd43d-e269-4aab-bc75-3d09d7579e1b">3.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1NzM_de264374-829d-493c-ad8a-b74bbd62fc73">2.75</ix:nonFraction>%. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="ib0abb09c8d394db38d57f51554da92af_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwMjI_f646e6a6-247b-4533-9aa4-d53cef94bece">1.00</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ib58d47ddfc2141cabb5fab1f21a38d72_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwMjk_4f774598-d7fb-415c-a615-bc8a1afabb71">0.60</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="id5a30f909b8e4e1fba6812998b6bf24d_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwMzY_929cfa78-bf39-4fef-92f2-725eeb9733a5">0.25</ix:nonFraction>% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) LIBOR (or an alternative reference rate) plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="if83f4a5e20174093b9f01e04ee9c1d6d_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwNDM_1dd67775-ee91-4a80-8108-c0d34aa051eb">2.00</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="if05006669b12476d9fce3bf96834b1c1_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwNTA_81bae241-1db7-44ee-927b-4e7dbbc4a5c2">1.60</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="ic3fdf86501a24ebcbc7842721c5fffa2_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwNTc_6a5c0a81-9046-48e9-b6cb-d0f4300e681f">1.25</ix:nonFraction>% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders of under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December&#160;31, 2021, <ix:nonFraction unitRef="usd" contextRef="ie8f0b47b5969447b80a94a01cfae1776_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2MzM5ODM_68b68790-3cbc-49e7-b0fc-187a35910da3">no</ix:nonFraction> amounts have been drawn under the revolving loan facility with the exception of $<ix:nonFraction unitRef="usd" contextRef="i7cb2372376cf46b9a240ab10ece87d9c_I20211231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2Mjk4NzM4_20737a0d-7682-4607-beb6-9dcaf228e39c">4.1</ix:nonFraction>&#160;million letters of credit given to landlords to guarantee lease arrangements.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic7bf97868655456392766f0c713c22b7"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to monitor the phasing out of LIBOR. We have engaged with our lenders on the implications of the change and will continue to discuss with them as replacement rates for LIBOR become more prevalent in the syndicated lending market. The Company is therefore subject to interest rate volatility in respect of the senior secured term loan facility, any future draw down on the Revolving Credit Facility or in respect of any future issuances of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the credit agreement) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes (see below), subject to other permitted liens. Our long-term debt arrangements contain customary restrictive covenants and, as of December&#160;31, 2021, we were in compliance with our restrictive covenants in all material respects.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 27, 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc0ODI_4e97f4d0-4354-48f1-9b92-7b177fa613ce">13.8</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDg0NDc_dc177634-8b5c-4a58-949e-5c25d84412ba">40.4</ix:nonFraction>&#160;million. On December 29, 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc1MDE_03040b24-64d4-467b-830a-8c6ee609e2c0">500.0</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDg0NTU_6245d4ad-c16e-46cf-b677-4adb487a2239">40.8</ix:nonFraction>&#160;million. These repayments resulted in an additional charge associated with previously capitalized fees of $<ix:nonFraction unitRef="usd" contextRef="i3a42a3fb378b499bba8795f930f41618_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEyMDk0NjI3OTI4ODc3_ce792621-d277-4dec-8367-383668188c40">5.6</ix:nonFraction>&#160;million. The Company is permitted to make prepayments on the senior secured term loan without penalty.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $<ix:nonFraction unitRef="usd" contextRef="if5dd5a8e35954342aeb8de12c5800669_I20210701" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5NjY_71ae2a19-f4ef-4f50-aa3e-c821cea32349">500</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if5dd5a8e35954342aeb8de12c5800669_I20210701" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5NTg_a63c6228-c9ad-4542-bc89-5850862eaaa1">2.875</ix:nonFraction>% senior secured notes due 2026 in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. The proceeds from the Offering and borrowings made under the Senior Secured Credit Facilities, together with cash on hand, were used to (i) fund the cash consideration payable by ICON for the Merger, (ii) repay existing indebtedness of ICON and PRA and (iii) pay fees and expenses related to the Merger, the Offering and the Senior Secured Credit Facilities. The Senior Secured Notes are guaranteed on a senior secured basis by ICON and its direct and indirect subsidiaries</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">that guarantee the Senior Secured Credit Facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">2020 Senior Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 8, 2020, the Company issued new senior notes, (the "2020 Senior Notes") for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i4f5d4c306fa444b4bdb0bf1fe82e8279_D20201208-20201208" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5ODA_30eb2192-fd86-427e-ae76-c5e31a31dce2">350.0</ix:nonFraction>&#160;million in the private placement market. The 2020 Senior Notes were issued in <ix:nonFraction unitRef="tranche" contextRef="if4a6b701f2454838a6d52713b838fb03_D20201208-20201208" decimals="INF" name="iclr:IssueOfSeniorNotesNumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5OTU_0b41030e-fa6c-44f8-a405-5103a8eb2034">two</ix:nonFraction> tranches; Series A Notes of $<ix:nonFraction unitRef="usd" contextRef="i52b4c03037324b8685b2023af8543025_I20201208" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5OTc_dd209dbf-8d8a-4314-bdd2-3897824c5f19">275.0</ix:nonFraction>&#160;million at a  fixed interest rate of <ix:nonFraction unitRef="number" contextRef="i52b4c03037324b8685b2023af8543025_I20201208" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwMTI_0035465f-9e44-4810-a0b6-614834ce355d">2.32</ix:nonFraction>% and Series B Notes of $<ix:nonFraction unitRef="usd" contextRef="icc237be9542b46be97a5052ea2194da9_I20201208" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwMzI_a3c623fe-b51c-4116-a9a0-b2d60338d8bb">75.0</ix:nonFraction>&#160;million at a fixed interest rate of <ix:nonFraction unitRef="number" contextRef="icc237be9542b46be97a5052ea2194da9_I20201208" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwNDc_f78ada2e-bc7c-4092-b1ea-6097994a87fb">2.43</ix:nonFraction>%. The effective interest rate was adjusted by the impact of an interest rate cash flow hedge which was entered into in advance of the rate fixing date. This cash flow hedge was deemed to be fully effective in accordance with ASC 815 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Derivatives and Hedging'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The realized loss related to this derivative was recorded within other comprehensive income and amortized over the life of the 2020 Senior Notes. The effective rate on the 2020 Senior Notes was fixed at <ix:nonFraction unitRef="number" contextRef="i61d39490d9d341c6a04dd22b7c2e3548_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwNTQ_45a59cad-f3b5-4fba-89c1-9cbe479d3408">2.41</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Merger, the Company was required to repay the 2020 Senior Notes prior to entering into the Senior Secured Credit Facilities and the Senior Secured Notes. In June 2021, ICON committed to entering into the Senior Secured Credit Facilities and the Senior Secured Notes and therefore committed to replacing the 2020 Senior Notes. The 2020 Senior Notes have been repaid and long term financing consisting of the Senior Secured Credit Facilities and the Senior Secured Notes have been drawn. The 2020 Senior Notes were repaid on July 1, 2021 inclusive of early repayment charges. The total repayment on July 1, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i7c29619485354cb987ceeeec9f4fd1ad_D20210701-20210701" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwNjE_732dba79-1077-43ee-b15e-a8afcb91ed9b">364.0</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was $<ix:nonFraction unitRef="usd" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDg3NDI_afad51a8-09b8-46f6-8933-f8694dd8d29e">5,507.2</ix:nonFraction>&#160;million at December&#160;31, 2021. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">153</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_211"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">25. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:NewAndRecentAccountingPronouncementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0Xzk5MTc_190fb9bc-14a4-466a-bf72-85412b06e775" continuedAt="idf0bb42299aa4fd8ad0f566e43173bca" escape="true">Impact of New Accounting Pronouncements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="idf0bb42299aa4fd8ad0f566e43173bca"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of new accounting pronouncements adopted during fiscal year ended December&#160;31, 2021 (or previously)</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business combinations</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The amendments in this ASU require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. For public business entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption of the amendments is permitted, including adoption in an interim period. An entity that early adopts in an interim period should apply the amendments (1) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (2) prospectively to all business combinations that occur on or after the date of initial application. </span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has taken the option to early adopt the amendments in this ASU for year ended December&#160;31, 2021 and apply the amendments to interim periods from the beginning of the fiscal year. The Company has applied the amendments of this ASU to the Merger with PRA, completed on July 1, 2021. The application of these amendments has resulted in a $<ix:nonFraction unitRef="usd" contextRef="i071a74bae9594a1c88d29e82ccf0ce67_I20210701" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0XzI3NDg3NzkxMDAzOTQ_f53c7f1f-f449-4d3f-a024-c4b97d701c7c">16.0</ix:nonFraction>&#160;million increase in goodwill and corresponding $<ix:nonFraction unitRef="usd" contextRef="i071a74bae9594a1c88d29e82ccf0ce67_I20210701" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0XzI3NDg3NzkxMDA0MDk_254f73d4-03ff-46a7-b5a8-6d07c6d49f07">16.0</ix:nonFraction>&#160;million increase to unearned revenue compared to the Company's Balance Sheet at September 30, 2021. Since July 1, 2021, the Company had amortized $<ix:nonFraction unitRef="usd" contextRef="i1e15468a473f4c8da1405b2a6d723f2a_D20210701-20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0XzI3NDg3NzkxMDA0MjQ_2efea23f-433f-43df-813c-82c8fd49f838">4.0</ix:nonFraction>&#160;million of the unearned revenue adjustment through the revenue line in the Consolidated Statement of Comprehensive Income. This amortization has been reversed in December 2021 resulting in a net <ix:nonFraction unitRef="usd" contextRef="i1e15468a473f4c8da1405b2a6d723f2a_D20210701-20211231" decimals="0" name="iclr:IncreaseDecreaseRevenueFromContractsWithCustomers" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0XzI3NDg3NzkxMDA0Mzg_7a9f1b69-0cdc-4446-b0a5-21ad3e015eef">nil</ix:nonFraction> impact on revenue for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other accounting pronouncements adopted during fiscal year ended December&#160;31, 2021</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">'Simplifying the Accounting for Income Taxes (Topic 740)'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The Company adopted the amendments in this ASU on a prospective basis, except where the required method of adoption is retrospective or modified retrospective. ASU 2019-12 is effective for the Company for the year ended December&#160;31, 2021. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">'. ASU 2020-01 states any equity security transitioning from the alternative method of accounting under Topic 321 to the equity method, or vice versa, due to an observable transaction will be re-measured immediately before the transition. In addition, the ASU clarifies the accounting for certain non-derivative forward contracts or purchased call options to acquire equity securities stating such instruments will be measured using the fair value principles of Topic 321 before settlement or exercise. The ASU is effective for the Company for the year ended December&#160;31, 2021, and has been applied on a prospective basis. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8216;Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which removes the separation models in ASC 470 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8216;Debt&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for convertible debt with cash conversion features and convertible instruments with beneficial conversion features. The ASU also removes from ASC 815 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8216;Derivatives and Hedge Accounting&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> certain conditions for equity classification for contracts on an entity&#8217;s own equity. The ASU is effective for the Company for the year ended December&#160;31, 2021. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Impact of new accounting pronouncements which will be adopted during fiscal year ended December 31, 2022</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No other new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#8217;s consolidated financial statements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_214"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">26. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzExMjM_6f91d677-5bfe-4e28-9fbe-43172c8957b6" continuedAt="ibdfec75ab2134b7a8e920ae80d80aa33" escape="true">Related Parties </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibdfec75ab2134b7a8e920ae80d80aa33" continuedAt="icf5c1f3f7ead42eab9be295812f337f9"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $<ix:nonFraction unitRef="usd" contextRef="id3368954c9a64c52b38aa3707ffc38a7_D20210101-20211231" decimals="0" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzc1_bab37963-1c46-4590-91e8-af7ce9f77849">30,000</ix:nonFraction> (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="i968ed30311b94d908cfbb9557550531c_D20200101-20201231" decimals="0" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzgz_6d89bebd-dc96-4d47-9a38-e2d68234f96f">321,000</ix:nonFraction>) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $<ix:nonFraction unitRef="usd" contextRef="ia4794a4624e34b81aaa3d969dd0bc3b2_I20211231" decimals="0" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzI2NQ_f88cf5ce-079c-484c-8a6d-3b12287d55c3">12,000</ix:nonFraction> was recorded as due from DS Biopharma Limited at December&#160;31, 2021 (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="ie76f68691f174c19a8058971dbcc477c_I20201231" decimals="0" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzMyNQ_85dc583b-4d2e-40d2-8545-3d68046e235b">41,000</ix:nonFraction>).&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $<ix:nonFraction unitRef="usd" contextRef="i0813a3b3dd0749b2b2e5f5ef20260483_D20210101-20211231" decimals="0" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzEzOTE_8e6fbd6e-88d7-4669-897c-784e60eb3851">551,000</ix:nonFraction> (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="i24a1e9760cab4726b37a107bc29fd4cb_D20200101-20201231" decimals="0" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzEzOTU_4eb5b847-6949-495a-8407-c537acc54c16">9,000</ix:nonFraction>) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $<ix:nonFraction unitRef="usd" contextRef="id23d592eefe04b35928d0cc687d6a2ff_I20211231" decimals="0" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzEzOTk_e4695538-733d-41dc-902a-cd86bc52c78a">197,000</ix:nonFraction> was recorded as due from Afimmune Limited at December&#160;31, 2021 (December&#160;31, 2020: $<ix:nonFraction unitRef="usd" contextRef="i05316c63db6641378950248cee4a1582_I20201231" decimals="0" name="us-gaap:DueFromRelatedParties" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MjgzNDUy_59ef9a59-acdf-42b5-bed1-094c90cd880f">nil</ix:nonFraction>).&#160;</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="icf5c1f3f7ead42eab9be295812f337f9"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $<ix:nonFraction unitRef="usd" contextRef="i509ce783c2ea4a39bdebdb581d6ed480_I20211231" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzY1Mg_713e4b8b-e162-4e3b-9be0-234957eba0f8">4.9</ix:nonFraction> million to obtain a <ix:nonFraction unitRef="number" contextRef="i509ce783c2ea4a39bdebdb581d6ed480_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzY2Nw_7a325f57-eed7-468f-96f8-55ef86cc914c">49</ix:nonFraction>% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $<ix:nonFraction unitRef="usd" contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231" decimals="0" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzMzMzI_9853e251-7edf-41b3-9f3c-43febb6d9152">465,000</ix:nonFraction> during the year ended December&#160;31, 2021. $<ix:nonFraction unitRef="usd" contextRef="i9315b0dbc9034bb8aee3c7fc387583e3_I20211231" decimals="0" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzMzNDM_03bab295-f67d-44ca-88fc-bf4242210519">264,000</ix:nonFraction> was recorded as due from Oncacare at December&#160;31, 2021.&#160;During the year ended December&#160;31, 2021, the Company provided a loan of $<ix:nonFraction unitRef="usd" contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231" decimals="-6" name="us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzMzNTc_e3440cdd-1391-4350-ae3f-abc6f90a888d">10</ix:nonFraction> million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at <ix:nonFraction unitRef="number" contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231" decimals="3" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEzMTk0MTM5NTM5MTMz_efff4a41-8d89-484d-8a7f-4d1c43426da3">1.6</ix:nonFraction>% and the loan is repayable on June 30, 2025. The full amount of this loan remains outstanding at December&#160;31, 2021 along with accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i9315b0dbc9034bb8aee3c7fc387583e3_I20211231" decimals="0" name="iclr:InterestReceivableRelatedPartyLoans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzMzNjg_47f67620-6a54-4f22-83cb-c4f44f5c13ee">23,000</ix:nonFraction>.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor in Oncacare has the right to sell the <ix:nonFraction unitRef="number" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="2" name="iclr:EquityMethodInvestmentMajorityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzkwNw_770c50aa-5f45-426f-9d83-a73157f62d41">51</ix:nonFraction>% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the <ix:nonFraction unitRef="number" contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231" decimals="2" name="iclr:EquityMethodInvestmentMajorityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwNjY_770c50aa-5f45-426f-9d83-a73157f62d41">51</ix:nonFraction>% majority voting share capital from August 1, 2025.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i6df4b473ec484136b91516d30b1a0b24_217"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">27. <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90ZXh0cmVnaW9uOjkyY2E3MzU1NGI1OTQxNDQ4YjI0YTFjNWI4Y2JhYzYzXzEyNTA_557a7071-9f04-4f3a-8321-9664df30bd24" continuedAt="i48a02cfb66b94cda9a6593e5cc02dd4c" escape="true">Net income per ordinary share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i48a02cfb66b94cda9a6593e5cc02dd4c"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted net income per ordinary share attributable to the Group for the years ended December&#160;31, 2020 and December&#160;31, 2019 include the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the year ended December 31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90ZXh0cmVnaW9uOjkyY2E3MzU1NGI1OTQxNDQ4YjI0YTFjNWI4Y2JhYzYzXzEyNTE_f6b8a789-aec2-4327-9c7e-e39928ef0f6c" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzEtMS0xLTEtMzYyNDg_c7eb21f6-a710-448c-9747-aed1b2481182">67,110,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzEtMi0xLTEtMzYyNDg_9abdbd24-ee2a-4e12-8a5a-5c3547aad4f2">52,859,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzEtMy0xLTEtMzYyNDg_d218de40-b04d-43ba-aab3-bc1272274b6d">53,859,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzItMS0xLTEtMzYyNDg_9ebd6706-0c88-4ecf-82fa-4267962f63a0">958,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzItMi0xLTEtMzYyNDg_cd676465-d4d2-495d-afe7-eaef9c45a615">423,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzItMy0xLTEtMzYyNDg_ccef9010-2078-491d-a90f-6f40f1d7a248">473,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzMtMS0xLTEtMzYyNDg_829aae10-8226-41dc-a1e4-c73f00e2a725">68,068,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzMtMi0xLTEtMzYyNDg_cc054119-115d-45de-9e88-cc0849abe29e">53,283,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzMtMy0xLTEtMzYyNDg_da6380a5-3dff-4c30-a2d7-9d84b68dbc0e">54,333,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90ZXh0cmVnaW9uOjkyY2E3MzU1NGI1OTQxNDQ4YjI0YTFjNWI4Y2JhYzYzXzEyNTI_3ad1b9f5-0078-460d-9fd0-62f61f8e6524" escape="true"><div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzItMS0xLTEtMzYyNDg_63cfbd98-ef12-458e-9b51-f0fb2ee510b2">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzItMi0xLTEtMzYyNDg_04b8633d-57c4-4ba9-8aa1-f9d106d713a3">332,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzItMy0xLTEtMzYyNDg_1247ac87-8d26-4019-9795-72b41f85a9aa">373,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzMtMS0xLTEtMzYyNDg_8be2bb1e-5c75-433d-b04b-f84fd7c913ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzMtMi0xLTEtMzYyNDg_5668ecb8-86c8-4459-bfc7-925689dfd3a5">4,522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzMtMy0xLTEtMzYyNDg_07e997df-6dba-4316-9ff3-fa86ac11d715">5,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group (including NCI redemption adjustment)</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzQtMS0xLTEtMzYyNDg_8241e1bb-975c-4628-99dd-d535d6cadb95">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzQtMi0xLTEtMzYyNDg_a32173be-ec8b-465d-b4b5-b0688677e15e">327,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzQtMy0xLTEtMzYyNDg_f40e2abe-22f9-4261-be42-4da945777af7">368,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzgtMS0xLTEtMzYyNDg_79f38bf1-03d7-46ce-b5da-c23f0976cd8c">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzgtMi0xLTEtMzYyNDg_d2f43893-83fd-4237-80f6-72a1f57e946b">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzgtMy0xLTEtMzYyNDg_7c6cf6f9-e13b-4362-bdc6-26f51bdb2cbc">6.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzktMS0xLTEtMzYyNDg_9736b798-d73d-4b7c-a461-b6720a1db16f">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzktMi0xLTEtMzYyNDg_d157abba-d3d6-4d3d-bcf2-184837c10241">6.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzktMy0xLTEtMzYyNDg_566106a3-4155-4cc4-9aa5-a71c12adca1f">6.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">155</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_220"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">28.  <ix:nonNumeric contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMjAvZnJhZzo5OTRkZWExOTIzMTQ0NDU2ODVlOThhOWQ2MDliYjc2Zi90ZXh0cmVnaW9uOjk5NGRlYTE5MjMxNDQ0NTY4NWU5OGE5ZDYwOWJiNzZmXzE2MzM_21302a9d-eae6-4ace-9f06-b53938d4221e" continuedAt="i886b053219c346e485eb2b2f4c429263" escape="true">Subsequent Events</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i886b053219c346e485eb2b2f4c429263"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">T</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">he Company has evaluated subsequent events from the Balance Sheet date th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">rough March&#160;1, 2022, the d</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ate at which the consolidated financial statements were available to be </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">issued.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On February&#160;18, 2022, the Company's Board of Directors authorized a new buyback program of up to $<ix:nonFraction unitRef="usd" contextRef="i9ccacdd571674f36bbf5930a33df99f2_I20220218" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMjAvZnJhZzo5OTRkZWExOTIzMTQ0NDU2ODVlOThhOWQ2MDliYjc2Zi90ZXh0cmVnaW9uOjk5NGRlYTE5MjMxNDQ0NTY4NWU5OGE5ZDYwOWJiNzZmXzE2NDkyNjc0NDUyODQ_39b6cb12-0543-455f-a4e9-5b1eec4849e5">100</ix:nonFraction>&#160;million of the outstanding ordinary shares of the Company. All ordinary shares that are redeemed under the buyback program will be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time. At March&#160;1, 2022, the Company has repurchased $<ix:nonFraction unitRef="usd" contextRef="idf645606cd69465ab48f7e54e02bf243_D20220101-20220301" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMjAvZnJhZzo5OTRkZWExOTIzMTQ0NDU2ODVlOThhOWQ2MDliYjc2Zi90ZXh0cmVnaW9uOjk5NGRlYTE5MjMxNDQ0NTY4NWU5OGE5ZDYwOWJiNzZmXzIxOTkwMjMyNjU5Mzk_65e2facb-5913-413c-b675-0f6923fc62c1">80.9</ix:nonFraction> million of ordinary shares of the Company since December&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has determined that there are no other items to disclose.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">156</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_229"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121006002/nc10020781x8_ex2-1.htm">2.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of February 24, 2021, by and among ICON plc, ICON US Holdings Inc., Indigo Merger Sub, Inc and PRA Health Sciences, Inc. (incorporated by reference to exhibit 2.1 to the Form 6K (file No. 333-08704) filed on February 24, 2021.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit22-2021.htm">2.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of Securities Registered Under Section 12 of the Exchange Act.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-1.htm">2.3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Credit Agreement, dated as of July 1, 2021, by and among ICON Luxembourg, S.&#192; R.L., ICON Clinical Investments, LLC, Indigo Merger Sub, Inc. (which, after giving effect to the Merger on the Closing Date was succeeded by PRA Health Sciences, Inc.), ICON Public Limited Company, the other borrowers party thereto from time to time, the subsidiary guarantors party thereto from time to time, lenders party thereto Citibank, N.A., as administrative agent, and Citibank, N.A., London Branch, as collateral agent (incorporated by reference to exhibit 99.1 to the Form 6K (File No. 333-08704) filed on July 1, 2021).</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-2.htm">2.4</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indenture, dated as of July 1, 2021, by and among Indigo Merger Sub, Inc., PRA Health Sciences, Inc., the guarantors party thereto and Citibank, N.A., London Branch as trustee, notes collateral agent, paying agent, transfer agent and registrar (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 1, 2021).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1060955/000115752316006157/a51386268ex99_2.htm">3.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of the Constitution of the Company (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 25, 2016).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit121-2021.htm">12.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 302 certifications.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit122-2021.htm">12.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 906 certifications.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6df4b473ec484136b91516d30b1a0b24_28">21.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">List of Subsidiaries (incorporated by reference to Item 4 of Form 20-F filed herewith).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-2021.htm">23.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consent of KPMG, Independent Registered Public Accounting Firm.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interactive Data Files (XBRL &#8211; Related Documents).</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* &#160; Filed herewith</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157</span></div></div></div><div id="i6df4b473ec484136b91516d30b1a0b24_226"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;Brendan Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date March&#160;1, 2022 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>2
<FILENAME>exhibit22-2021.htm
<DESCRIPTION>EX-2.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i992b7ada6e2548c2a2aa0d57640ca159_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 2.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Description of Securities  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">    Registered Under Section 12 of the Exchange Act </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2021 ICON plc (&#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) had the following series of securities registered pursuant to Section 12(b) of the Exchange Act&#58; </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading symbol</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares, nominal value &#8364;0.06 per share</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICLR</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NASDAQ Global Select Market<br></font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Ordinary Shares </font></div><div style="padding-left:180pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.General</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.1. Limitations or qualifications </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.2. Other rights </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.3. Type and class of securities </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each ICON plc share has nominal value of &#8364;0.06 per share. The respective number of shares that have been issued as of December&#160;31, 2021 is given in the Consolidated Balance Sheet of the annual report on Form 20-F for the fiscal year ended December&#160;31, 2021. All ICON shares have equal voting rights and carry equal entitlements to dividends. No participation certificates, non-voting equity securities or profit-sharing certificates have been issued. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.4. Pre-emptive rights</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.B Memorandum and articles of association</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> 10.B.1 Shareholder Rights, Preferences and Dividends Attaching to Shares </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has only one class of shares, Ordinary Shares with a par value of &#8364;0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.2. Action Necessary to Change the Rights of Shareholders </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.3  Annual and General Meetings</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15&#160;months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (&#8220;EGM&#8221;) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21&#160;clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days&#8217; notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.4 Limitations on the Right to Own Shares </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no limitations on the right to own shares in the Constitution of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.5 Disclosure of Share Ownership </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>3
<FILENAME>exhibit121-2021.htm
<DESCRIPTION>EX-12.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i96d68fa0f592428798961f66ed619a6e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 12.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section 302 of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Brendan Brennan, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 20-F of ICON plc (&#34;the registrant&#34;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dated&#58; March&#160;1, 2022 </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Brendan Brennan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section 302 of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Steve Cutler, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 20-F of ICON plc (&#34;the registrant&#34;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dated&#58; March&#160;1, 2022 </font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Steve Cutler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>4
<FILENAME>exhibit122-2021.htm
<DESCRIPTION>EX-12.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6c9f8a421a5449778d6d198af5f6d31d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 12.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification Pursuant to 18 U.S.C. Section 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Annual Report of ICON plc (the &#34;Company&#34;) on Form 20-F for the year ending December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), I, Brendan Brennan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;&#160;March&#160;1, 2022 </font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Brendan Brennan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification Pursuant to 18 U.S.C. Section 1350,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Annual Report of ICON plc (the &#34;Company&#34;) on Form 20-F for the year ending December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), I, Steve Cutler, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;&#160;March&#160;1, 2022 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Steve Cutler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>exhibit231-2021.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id860d6e79e204969b4896ab03088174f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 23.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We consent to the incorporation by reference in the registration statement(s) (No. 333-231527, 333-204153, 333-190068, 333-152802, 333-257578 and 333-254891) each on Form S-8 of ICON plc of our reports dated March&#160;1, 2022 with respect to the consolidated financial statements of ICON plc and the effectiveness of internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#47;s&#47; KPMG</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dublin, Ireland</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March&#160;1, 2022 </font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>iclr-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e141d476-ae09-4ec9-a80f-baeacfb8f81a,g:a196524c-1dde-4a8b-8796-f0fa7ce72378-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iclr="http://www.iconplc.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.iconplc.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.iconplc.com/role/Cover">
        <link:definition>000010001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.iconplc.com/role/AuditInformation">
        <link:definition>000020002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>100010003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>100030005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME">
        <link:definition>100050007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>100060008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Descriptionofbusiness" roleURI="http://www.iconplc.com/role/Descriptionofbusiness">
        <link:definition>210011001 - Disclosure - Description of business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofbusinessDetails" roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails">
        <link:definition>240024001 - Disclosure - Description of business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Significantaccountingpolicies" roleURI="http://www.iconplc.com/role/Significantaccountingpolicies">
        <link:definition>210031002 - Disclosure - Significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantaccountingpoliciesPolicies" roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies">
        <link:definition>220042001 - Disclosure - Significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantaccountingpoliciesTables" roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesTables">
        <link:definition>230053001 - Disclosure - Significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantaccountingpoliciesNarrativeDetails" roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails">
        <link:definition>240064002 - Disclosure - Significant accounting policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails">
        <link:definition>240074003 - Disclosure - Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails" roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails">
        <link:definition>240084004 - Disclosure - Significant accounting policies - Estimated Useful Lives of Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.iconplc.com/role/Investments">
        <link:definition>210091003 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.iconplc.com/role/InvestmentsTables">
        <link:definition>230103002 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAvailableForSaleInvestmentsDetails" roleURI="http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails">
        <link:definition>240114005 - Disclosure - Investments - Available For Sale Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails">
        <link:definition>240124006 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails" roleURI="http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails">
        <link:definition>240134007 - Disclosure - Investments - Available For Sale Short Term Investments by Major Security Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsEquityMethodInvestmentsDetails" roleURI="http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails">
        <link:definition>240144008 - Disclosure - Investments - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.iconplc.com/role/Goodwill">
        <link:definition>210151004 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.iconplc.com/role/GoodwillTables">
        <link:definition>230163003 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofGoodwillDetails" roleURI="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails">
        <link:definition>240174009 - Disclosure - Goodwill - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.iconplc.com/role/IntangibleAssets">
        <link:definition>210181005 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.iconplc.com/role/IntangibleAssetsTables">
        <link:definition>230193004 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsSummaryofIntangibleAssetsDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails">
        <link:definition>240204010 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>240214011 - Disclosure - Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails">
        <link:definition>240224012 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Businesscombinations" roleURI="http://www.iconplc.com/role/Businesscombinations">
        <link:definition>210231006 - Disclosure - Business combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsTables" roleURI="http://www.iconplc.com/role/BusinesscombinationsTables">
        <link:definition>230243005 - Disclosure - Business combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsNarrativePRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails">
        <link:definition>240254013 - Disclosure - Business combinations - Narrative, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails">
        <link:definition>240264014 - Disclosure - Business combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails">
        <link:definition>240274015 - Disclosure - Business combinations - Schedule of Acquisitions, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails">
        <link:definition>240284016 - Disclosure - Business combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails">
        <link:definition>240294017 - Disclosure - Business combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails">
        <link:definition>240304018 - Disclosure - Business combinations - Narrative, MedPass Group Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails">
        <link:definition>240314019 - Disclosure - Business combinations - Schedule of Acquisitions, MedPass Group Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails">
        <link:definition>240324020 - Disclosure - Business combinations - Schedule of Pro-Forma Information, MedPass Group Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnet" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnet">
        <link:definition>210331007 - Disclosure - Property, Plant and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetTables" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables">
        <link:definition>230343006 - Disclosure - Property, Plant and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetDetails" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails">
        <link:definition>240354021 - Disclosure - Property, Plant and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilities" roleURI="http://www.iconplc.com/role/OtherLiabilities">
        <link:definition>210361008 - Disclosure - Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesTables" roleURI="http://www.iconplc.com/role/OtherLiabilitiesTables">
        <link:definition>230373007 - Disclosure - Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesDetails" roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails">
        <link:definition>240384022 - Disclosure - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCurrentOtherLiabilities" roleURI="http://www.iconplc.com/role/NonCurrentOtherLiabilities">
        <link:definition>210391009 - Disclosure - Non-Current Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCurrentOtherLiabilitiesTables" roleURI="http://www.iconplc.com/role/NonCurrentOtherLiabilitiesTables">
        <link:definition>230403008 - Disclosure - Non-Current Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonCurrentOtherLiabilitiesDetails" roleURI="http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails">
        <link:definition>240414023 - Disclosure - Non-Current Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefits" roleURI="http://www.iconplc.com/role/EmployeeBenefits">
        <link:definition>210421010 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsTables" roleURI="http://www.iconplc.com/role/EmployeeBenefitsTables">
        <link:definition>230433009 - Disclosure - Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNarrativeDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails">
        <link:definition>240444024 - Disclosure - Employee Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsFundedStatusDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails">
        <link:definition>240454025 - Disclosure - Employee Benefits - Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangeinBenefitObligationsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails">
        <link:definition>240464026 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangeinPlanAssetsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails">
        <link:definition>240474027 - Disclosure - Employee Benefits - Change in Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>240484028 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails">
        <link:definition>240494029 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails">
        <link:definition>240504030 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails">
        <link:definition>240514031 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails">
        <link:definition>240524032 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAnnualBenefitPaymentsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails">
        <link:definition>240534033 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationCharges" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges">
        <link:definition>210541011 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesTables" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables">
        <link:definition>230553010 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails">
        <link:definition>240564034 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails">
        <link:definition>240574035 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails">
        <link:definition>240584036 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails">
        <link:definition>240594037 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails">
        <link:definition>240604038 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails">
        <link:definition>240614039 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareCapital" roleURI="http://www.iconplc.com/role/ShareCapital">
        <link:definition>210621012 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareCapitalDetails" roleURI="http://www.iconplc.com/role/ShareCapitalDetails">
        <link:definition>240634040 - Disclosure - Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.iconplc.com/role/IncomeTaxes">
        <link:definition>210641013 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.iconplc.com/role/IncomeTaxesTables">
        <link:definition>230653011 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails">
        <link:definition>240664041 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails">
        <link:definition>240674042 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails">
        <link:definition>240684043 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240694044 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240704045 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesExpectedExpiryDatesofNOLsDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails">
        <link:definition>240714046 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails">
        <link:definition>240724047 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuringcharges" roleURI="http://www.iconplc.com/role/Restructuringcharges">
        <link:definition>210731014 - Disclosure - Restructuring charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesTables" roleURI="http://www.iconplc.com/role/RestructuringchargesTables">
        <link:definition>230743012 - Disclosure - Restructuring charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesNarrativeDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails">
        <link:definition>240754048 - Disclosure - Restructuring charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesSummaryofRestructuringChargesDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails">
        <link:definition>240764049 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesRestructuringProvisionDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails">
        <link:definition>240774050 - Disclosure - Restructuring charges - Restructuring Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.iconplc.com/role/CommitmentsandContingencies">
        <link:definition>210781015 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>240794051 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenue" roleURI="http://www.iconplc.com/role/DisaggregationofRevenue">
        <link:definition>210801016 - Disclosure - Disaggregation of Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenueTables" roleURI="http://www.iconplc.com/role/DisaggregationofRevenueTables">
        <link:definition>230813013 - Disclosure - Disaggregation of Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenueDetails" roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails">
        <link:definition>240824052 - Disclosure - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities" roleURI="http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities">
        <link:definition>210831017 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables">
        <link:definition>230843014 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails">
        <link:definition>240854053 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Summary of Contract Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails">
        <link:definition>240864054 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1">
        <link:definition>240864054 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionforCreditLosses" roleURI="http://www.iconplc.com/role/ProvisionforCreditLosses">
        <link:definition>210871018 - Disclosure - Provision for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionforCreditLossesTables" roleURI="http://www.iconplc.com/role/ProvisionforCreditLossesTables">
        <link:definition>230883015 - Disclosure - Provision for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProvisionforCreditLossesDetails" roleURI="http://www.iconplc.com/role/ProvisionforCreditLossesDetails">
        <link:definition>240894055 - Disclosure - Provision for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformation" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation">
        <link:definition>210901019 - Disclosure - Business Segment and Geographical Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationTables" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables">
        <link:definition>230913016 - Disclosure - Business Segment and Geographical Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationNarrativeDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails">
        <link:definition>240924056 - Disclosure - Business Segment and Geographical Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails">
        <link:definition>240934057 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails">
        <link:definition>240944058 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails">
        <link:definition>240954059 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformation" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation">
        <link:definition>210961020 - Disclosure - Supplemental Disclosure of Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformationTables" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables">
        <link:definition>230973017 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformationDetails" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails">
        <link:definition>240984060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncome" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome">
        <link:definition>210991021 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables">
        <link:definition>231003018 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>241014061 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.iconplc.com/role/OperatingLeases">
        <link:definition>211021022 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.iconplc.com/role/OperatingLeasesTables">
        <link:definition>231033019 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesLeaseCostsDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails">
        <link:definition>241044062 - Disclosure - Operating Leases - Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesNarrativeDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails">
        <link:definition>241054063 - Disclosure - Operating Leases Operating Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails">
        <link:definition>241064064 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1">
        <link:definition>241064064 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Noncurrentbankcreditlinesandloanfacilities" roleURI="http://www.iconplc.com/role/Noncurrentbankcreditlinesandloanfacilities">
        <link:definition>211071023 - Disclosure - Non-current bank credit lines and loan facilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentbankcreditlinesandloanfacilitiesTables" roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables">
        <link:definition>231083020 - Disclosure - Non-current bank credit lines and loan facilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails" roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails">
        <link:definition>241094065 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails" roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails">
        <link:definition>241104066 - Disclosure - Non-current bank credit lines and loan facilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails" roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails">
        <link:definition>241114067 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Finance Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails" roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails">
        <link:definition>241124068 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.iconplc.com/role/FairValue">
        <link:definition>211131024 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueDetails" roleURI="http://www.iconplc.com/role/FairvalueDetails">
        <link:definition>241144069 - Disclosure - Fair value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ImpactofNewAccountingPronouncements" roleURI="http://www.iconplc.com/role/ImpactofNewAccountingPronouncements">
        <link:definition>211151025 - Disclosure - Impact of New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ImpactofNewAccountingPronouncementsDetails" roleURI="http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails">
        <link:definition>241164070 - Disclosure - Impact of New Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedParties" roleURI="http://www.iconplc.com/role/RelatedParties">
        <link:definition>211171026 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartiesDetails" roleURI="http://www.iconplc.com/role/RelatedPartiesDetails">
        <link:definition>241184071 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShare" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShare">
        <link:definition>211191027 - Disclosure - Net Income Per Ordinary Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareTables" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables">
        <link:definition>231203021 - Disclosure - Net Income Per Ordinary Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails">
        <link:definition>241214072 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails">
        <link:definition>241224073 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.iconplc.com/role/SubsequentEvents">
        <link:definition>211231028 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.iconplc.com/role/SubsequentEventsDetails">
        <link:definition>241244074 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iclr_ResearchandDevelopmentCreditsPolicyTextBlock" abstract="false" name="ResearchandDevelopmentCreditsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_NumberOfLocations" abstract="false" name="NumberOfLocations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_RestOfEuropeAndOtherCountriesMember" abstract="true" name="RestOfEuropeAndOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OperatingIncomeByGeographyTableTextBlock" abstract="false" name="OperatingIncomeByGeographyTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_CommitmentToAcquireLongTermInvestments" abstract="false" name="CommitmentToAcquireLongTermInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VariableRateComponentTwoMember" abstract="true" name="VariableRateComponentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_TransactionAndIntegrationExpenseMember" abstract="true" name="TransactionAndIntegrationExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfNonCashStockCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_InterestExpenseCreditOther" abstract="false" name="InterestExpenseCreditOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" abstract="false" name="DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherUndenominatedCapital" abstract="false" name="OtherUndenominatedCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxYear20362040Member" abstract="true" name="TaxYear20362040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_GovernmentGrantsPolicyTextBlock" abstract="false" name="GovernmentGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_AwardDateAllYearsExcluding2018Member" abstract="true" name="AwardDateAllYearsExcluding2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OtherCustomersMember" abstract="true" name="OtherCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ContractsReceivableNet" abstract="false" name="ContractsReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VariableRateComponentAxis" abstract="true" name="VariableRateComponentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iclr_OperatingLossCarryforwardsUSFederal" abstract="false" name="OperatingLossCarryforwardsUSFederal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_MedpassGroupLimitedMember" abstract="true" name="MedpassGroupLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ContractsReceivableGross" abstract="false" name="ContractsReceivableGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" abstract="true" name="ICONDevelopmentSolutionsLimitedPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_StockRepurchaseProgramAuthorizedPercentage" abstract="false" name="StockRepurchaseProgramAuthorizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_NonexecutiveDirectorMember" abstract="true" name="NonexecutiveDirectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AfimmuneLimitedMember" abstract="true" name="AfimmuneLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AccountingStandardsUpdate202108Member" abstract="true" name="AccountingStandardsUpdate202108Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AllowanceForDoubtfulAccountsTextBlock" abstract="false" name="AllowanceForDoubtfulAccountsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_DSBiopharmaLimitedMember" abstract="true" name="DSBiopharmaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" abstract="false" name="IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_InterestReceivableRelatedPartyLoans" abstract="false" name="InterestReceivableRelatedPartyLoans" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_LeaseLiabilityMember" abstract="true" name="LeaseLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_A2021RestructuringPlanMember" abstract="true" name="A2021RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" abstract="false" name="AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" abstract="false" name="AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" abstract="false" name="RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AptivSolutionsMember" abstract="true" name="AptivSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_The2020LegacyPRAPlanMember" abstract="true" name="The2020LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_StoneHarborHighYieldBondFundMember" abstract="true" name="StoneHarborHighYieldBondFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" abstract="true" name="CompensationRelatedCostsShareBasedPaymentsDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ForeignCurrencyDisclosureTableTextBlock" abstract="false" name="ForeignCurrencyDisclosureTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_PaymentsForShareRepurchaseCosts" abstract="false" name="PaymentsForShareRepurchaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ReconciliationOfProvisionOfIncomeTaxesTable" abstract="true" name="ReconciliationOfProvisionOfIncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio" abstract="false" name="DebtInstrumentCovenantFirstLienNetLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" abstract="false" name="IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_OtherUndenominatedCapitalMember" abstract="true" name="OtherUndenominatedCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_SeniorBNotesMember" abstract="true" name="SeniorBNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" abstract="false" name="AdjustmentToRetainedEarningShareRepurchaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_NumberOfVotes" abstract="false" name="NumberOfVotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" abstract="true" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_EmployeeStockPlanTwentyZeroEightPlanMember" abstract="true" name="EmployeeStockPlanTwentyZeroEightPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" abstract="false" name="AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" abstract="false" name="ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" abstract="false" name="ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" abstract="false" name="BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" abstract="false" name="StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherRetirementPlansMember" abstract="true" name="OtherRetirementPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_RestructuringReserveUtilizations" abstract="false" name="RestructuringReserveUtilizations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_SeniorNotes2020Member" abstract="true" name="SeniorNotes2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" abstract="false" name="ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_The2018LegacyPRAPlanMember" abstract="true" name="The2018LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" abstract="false" name="BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PerformanceShareUnitMember" abstract="true" name="PerformanceShareUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" abstract="false" name="LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AccountsReceivableCreditLossReversal" abstract="false" name="AccountsReceivableCreditLossReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxYear2022to2035Member" abstract="true" name="TaxYear2022to2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AllowanceForDoubtfulAccountsTableTextBlock" abstract="false" name="AllowanceForDoubtfulAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" abstract="false" name="ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_BuybackProgramMember" abstract="true" name="BuybackProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_CapitalGovernmentGrantsNoncurrent" abstract="false" name="CapitalGovernmentGrantsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PerformanceBasedGrantsMember" abstract="true" name="PerformanceBasedGrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_CapitalGovernmentGrantsCurrent" abstract="false" name="CapitalGovernmentGrantsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherGeographicLocationsMember" abstract="true" name="OtherGeographicLocationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_LongTermDebtMaturityYearFiveAndThereafter" abstract="false" name="LongTermDebtMaturityYearFiveAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Range4Member" abstract="true" name="Range4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_SeniorANotesMember" abstract="true" name="SeniorANotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Clients610Member" abstract="true" name="Clients610Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" abstract="false" name="BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward" abstract="true" name="ReconciliationOfDebtSecuritiesAvailableForSaleRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_SeniorSecuredNotesMember" abstract="true" name="SeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" abstract="true" name="ReconciliationOfProvisionOfIncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" abstract="false" name="EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_ConsultantsStockPlan2008PlanMember" abstract="true" name="ConsultantsStockPlan2008PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" abstract="false" name="DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RestrictedStockUnitsTwentyThirteenMember" abstract="true" name="RestrictedStockUnitsTwentyThirteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" abstract="false" name="BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock" abstract="false" name="NewAndRecentAccountingPronouncementsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_StockOptionAndAwardPlansMember" abstract="true" name="StockOptionAndAwardPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredRevolvingLoanFacilityMember" abstract="true" name="SeniorSecuredRevolvingLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue" abstract="false" name="RedeemableNoncontrollingInterestAccretionToRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Range1Member" abstract="true" name="Range1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" abstract="false" name="DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_IncreaseDecreaseRevenueFromContractsWithCustomers" abstract="false" name="IncreaseDecreaseRevenueFromContractsWithCustomers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ExpectedRetirementPeriod" abstract="false" name="ExpectedRetirementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_BaringsEuropeanLoanFundBuyAndHoldMember" abstract="true" name="BaringsEuropeanLoanFundBuyAndHoldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OptionPlans2008Member" abstract="true" name="OptionPlans2008Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OncacareMember" abstract="true" name="OncacareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_LAndGLifeDCActiveCorporateBondMember" abstract="true" name="LAndGLifeDCActiveCorporateBondMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_Range2Member" abstract="true" name="Range2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_Range3Member" abstract="true" name="Range3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanSchemeContributions" abstract="false" name="DefinedBenefitPlanSchemeContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" abstract="true" name="ConsultantsRestrictedStockUnitsTwentyNineteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_IssueOfSeniorNotesNumberOfTranches" abstract="false" name="IssueOfSeniorNotesNumberOfTranches" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" abstract="false" name="IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_StoneHarborMultiAssetCreditPortfolioMember" abstract="true" name="StoneHarborMultiAssetCreditPortfolioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_Clients1125Member" abstract="true" name="Clients1125Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_LongTermDebtCurrentMaturitiesGross" abstract="false" name="LongTermDebtCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TransactionAndOneTimeFinancingCosts" abstract="false" name="TransactionAndOneTimeFinancingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_HighYieldBondsMember" abstract="true" name="HighYieldBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" abstract="false" name="OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iclr_VariableRateComponentDomain" abstract="true" name="VariableRateComponentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DeferredTaxAssetContractWithCustomerLiability" abstract="false" name="DeferredTaxAssetContractWithCustomerLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VehiclesGross" abstract="false" name="VehiclesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncomeBeforeIncomeTaxTableTextBlock" abstract="false" name="IncomeBeforeIncomeTaxTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_LongTermDebtExcludingCurrentMaturitiesGross" abstract="false" name="LongTermDebtExcludingCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" abstract="false" name="IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" abstract="false" name="DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncomeTaxBenefitMember" abstract="true" name="IncomeTaxBenefitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" abstract="false" name="ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_RestOfEuropeMember" abstract="true" name="RestOfEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ComputerEquipmentAndCapitalizedSoftwareMember" abstract="true" name="ComputerEquipmentAndCapitalizedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_PRAHealthSciencesIncMember" abstract="true" name="PRAHealthSciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" abstract="false" name="IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_NinetyOneGlobalTotalReturnCreditMember" abstract="true" name="NinetyOneGlobalTotalReturnCreditMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_MeDiNovaResearchMember" abstract="true" name="MeDiNovaResearchMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember" abstract="true" name="LAndGLifeGPBFAllWorldEquityIndexFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" abstract="false" name="OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" abstract="false" name="BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Clients25Member" abstract="true" name="Clients25Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" abstract="false" name="DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" abstract="true" name="SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" abstract="false" name="OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RestructuringReserveandOtherLiabilitiesCurrent" abstract="false" name="RestructuringReserveandOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" abstract="false" name="IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxYear2022To2028Member" abstract="true" name="TaxYear2022To2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxYear2029To2038Member" abstract="true" name="TaxYear2029To2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_EmployeeStockPlanTwentyZeroThreePlanMember" abstract="true" name="EmployeeStockPlanTwentyZeroThreePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AccountsReceivableCreditLossExpense" abstract="false" name="AccountsReceivableCreditLossExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VariableRateComponentOneMember" abstract="true" name="VariableRateComponentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_TopClientMember" abstract="true" name="TopClientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" abstract="true" name="CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" abstract="true" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_EquityMethodInvestmentMajorityOwnershipPercentage" abstract="false" name="EquityMethodInvestmentMajorityOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_A2013LegacyPRAPlanMember" abstract="true" name="A2013LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_TermDepositsMember" abstract="true" name="TermDepositsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" abstract="false" name="AdvancePaymentsNettedAgainstUnbilledContractsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AptivSolutionsPensionPlanMember" abstract="true" name="AptivSolutionsPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" abstract="false" name="ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PRASwitzerlandAGPensionPlanMember" abstract="true" name="PRASwitzerlandAGPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AwardDate2018Member" abstract="true" name="AwardDate2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>iclr-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e141d476-ae09-4ec9-a80f-baeacfb8f81a,g:a196524c-1dde-4a8b-8796-f0fa7ce72378-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e81084da-a07d-42bc-8cfd-0ac61a2cf378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d28fd039-b0f2-4c66-9ae1-b465b92d2ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e81084da-a07d-42bc-8cfd-0ac61a2cf378" xlink:to="loc_us-gaap_CommonStockValue_d28fd039-b0f2-4c66-9ae1-b465b92d2ea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_36aa1ccc-0d01-416e-953c-7172962299a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e81084da-a07d-42bc-8cfd-0ac61a2cf378" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_36aa1ccc-0d01-416e-953c-7172962299a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital_cb3f251d-281a-403b-ae4d-4c01464adc43" xlink:href="iclr-20211231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e81084da-a07d-42bc-8cfd-0ac61a2cf378" xlink:to="loc_iclr_OtherUndenominatedCapital_cb3f251d-281a-403b-ae4d-4c01464adc43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf71e7c8-600a-45ec-84dd-1edb7051a505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e81084da-a07d-42bc-8cfd-0ac61a2cf378" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf71e7c8-600a-45ec-84dd-1edb7051a505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_566762a0-8d58-42e0-9710-a61f4479ee41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e81084da-a07d-42bc-8cfd-0ac61a2cf378" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_566762a0-8d58-42e0-9710-a61f4479ee41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ebec5e67-4dc8-46de-a26e-7ea0c132b62e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_df935cbe-0da3-4936-a085-fe4759602562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ebec5e67-4dc8-46de-a26e-7ea0c132b62e" xlink:to="loc_us-gaap_Liabilities_df935cbe-0da3-4936-a085-fe4759602562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1a1b1f3b-42d4-47c8-ab36-16328095aa60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ebec5e67-4dc8-46de-a26e-7ea0c132b62e" xlink:to="loc_us-gaap_StockholdersEquity_1a1b1f3b-42d4-47c8-ab36-16328095aa60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a020e5b9-d0f0-4b06-8c50-42d399c0a749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_91a6ebb4-d307-42f9-a538-384fd18beefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a020e5b9-d0f0-4b06-8c50-42d399c0a749" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_91a6ebb4-d307-42f9-a538-384fd18beefd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4e30d670-8f41-414d-a337-5438374f9519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a020e5b9-d0f0-4b06-8c50-42d399c0a749" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4e30d670-8f41-414d-a337-5438374f9519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a631ed4b-63b8-4639-bc28-4f8e90df9bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a020e5b9-d0f0-4b06-8c50-42d399c0a749" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a631ed4b-63b8-4639-bc28-4f8e90df9bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_33cf5bb9-0232-4d77-b66d-968cf54cb484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a020e5b9-d0f0-4b06-8c50-42d399c0a749" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_33cf5bb9-0232-4d77-b66d-968cf54cb484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_7cdfd801-570d-48f4-ace3-298fe03c0cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a020e5b9-d0f0-4b06-8c50-42d399c0a749" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_7cdfd801-570d-48f4-ace3-298fe03c0cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b231a5a-5582-4b60-b811-1e26d26bc85b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a020e5b9-d0f0-4b06-8c50-42d399c0a749" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b231a5a-5582-4b60-b811-1e26d26bc85b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_a4ef8c40-21ab-458d-9e16-63b593529e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a020e5b9-d0f0-4b06-8c50-42d399c0a749" xlink:to="loc_us-gaap_IncomeTaxesReceivable_a4ef8c40-21ab-458d-9e16-63b593529e5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d55d9b14-9ffc-40aa-9c82-34b2bcee120e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_859cfaa3-1371-4e7f-9713-c5a3747a8e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d55d9b14-9ffc-40aa-9c82-34b2bcee120e" xlink:to="loc_us-gaap_AccountsPayableCurrent_859cfaa3-1371-4e7f-9713-c5a3747a8e8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c85c6d64-670f-482f-b38b-097a55b7e4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d55d9b14-9ffc-40aa-9c82-34b2bcee120e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c85c6d64-670f-482f-b38b-097a55b7e4d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0d6bce5d-f90d-4bbe-bf79-2a6038f9fca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d55d9b14-9ffc-40aa-9c82-34b2bcee120e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0d6bce5d-f90d-4bbe-bf79-2a6038f9fca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_aa049410-72a6-4aaf-9199-c5e61e08681e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d55d9b14-9ffc-40aa-9c82-34b2bcee120e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_aa049410-72a6-4aaf-9199-c5e61e08681e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_51b662a2-1d10-4523-8db7-80320595de44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d55d9b14-9ffc-40aa-9c82-34b2bcee120e" xlink:to="loc_us-gaap_LinesOfCreditCurrent_51b662a2-1d10-4523-8db7-80320595de44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d7c0a6ac-6615-4cf9-a113-f0a893baef9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:to="loc_us-gaap_LiabilitiesCurrent_d7c0a6ac-6615-4cf9-a113-f0a893baef9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_64889f86-6810-4529-aa21-213a3ed1c9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:to="loc_us-gaap_LongTermLineOfCredit_64889f86-6810-4529-aa21-213a3ed1c9c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e0d78560-9089-474e-ad39-74d06cfc0def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e0d78560-9089-474e-ad39-74d06cfc0def" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0df3b3f8-95f0-4e91-92b2-1e38a631cf28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0df3b3f8-95f0-4e91-92b2-1e38a631cf28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsNoncurrent_3deb13de-25fe-4761-842d-2a835e8af7dd" xlink:href="iclr-20211231.xsd#iclr_CapitalGovernmentGrantsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:to="loc_iclr_CapitalGovernmentGrantsNoncurrent_3deb13de-25fe-4761-842d-2a835e8af7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a64ce947-dbde-4707-b8c5-17eb82bb098a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a64ce947-dbde-4707-b8c5-17eb82bb098a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fbf9afe1-2049-4e84-af62-8015c4908bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fbf9afe1-2049-4e84-af62-8015c4908bc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ce04f77f-3417-4d00-96cb-49e59ecb9dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_da07b105-2bc6-4701-8901-b6a569c6cbde" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ce04f77f-3417-4d00-96cb-49e59ecb9dd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5cb07f56-de7a-4d05-81e0-60814f4357af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5cb07f56-de7a-4d05-81e0-60814f4357af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9abe3ab0-2d98-4c0a-89dd-1bb89a74a888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9abe3ab0-2d98-4c0a-89dd-1bb89a74a888" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7c3056a0-bdc0-4365-aa9e-42444486e080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_EquityMethodInvestments_7c3056a0-bdc0-4365-aa9e-42444486e080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_b23c9975-1935-489a-819d-9e8d7a491a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_b23c9975-1935-489a-819d-9e8d7a491a38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7c007bb2-d756-4199-932b-09db5c7a84f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7c007bb2-d756-4199-932b-09db5c7a84f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0e6daf0c-acd1-417a-adc7-3036212a1abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0e6daf0c-acd1-417a-adc7-3036212a1abd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_6e027b8b-be33-4f75-8a49-5f9ba5de1919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_OtherLongTermInvestments_6e027b8b-be33-4f75-8a49-5f9ba5de1919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_133e45d0-b613-4d3d-bb30-3f92a32c5985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_AssetsCurrent_133e45d0-b613-4d3d-bb30-3f92a32c5985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_84157594-ed40-4c34-9cb4-db1e3666c4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_84157594-ed40-4c34-9cb4-db1e3666c4c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6a353cd4-8faa-4417-9541-78f3e3c22137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_30d35088-2ad1-44e6-a3ee-a2d5247719f5" xlink:to="loc_us-gaap_Goodwill_6a353cd4-8faa-4417-9541-78f3e3c22137" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_8ff3043a-df84-4ab4-ab10-28b66a291fb2" xlink:href="iclr-20211231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_01c42b76-3875-454b-a0c2-f8800f5ff499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_8ff3043a-df84-4ab4-ab10-28b66a291fb2" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_01c42b76-3875-454b-a0c2-f8800f5ff499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_793e00fb-1cb7-4ee2-ae8b-414d93f9b8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_8ff3043a-df84-4ab4-ab10-28b66a291fb2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_793e00fb-1cb7-4ee2-ae8b-414d93f9b8f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ee8e2f0a-60c9-403e-a842-ffaf59360053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_13817648-d190-4a90-9501-48a2ba741f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ee8e2f0a-60c9-403e-a842-ffaf59360053" xlink:to="loc_us-gaap_CostsAndExpenses_13817648-d190-4a90-9501-48a2ba741f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a1c0527-02fa-4f7f-8884-646007bfa510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ee8e2f0a-60c9-403e-a842-ffaf59360053" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2a1c0527-02fa-4f7f-8884-646007bfa510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_56794d32-aade-44f3-80d4-52c01cdfc65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ac15b4b1-36bd-48bd-b57a-8edf47b98ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_56794d32-aade-44f3-80d4-52c01cdfc65b" xlink:to="loc_us-gaap_ProfitLoss_ac15b4b1-36bd-48bd-b57a-8edf47b98ac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_7e39d3fa-1963-433f-ad74-5d52a585a68a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_56794d32-aade-44f3-80d4-52c01cdfc65b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_7e39d3fa-1963-433f-ad74-5d52a585a68a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8d59f12c-bc0a-466b-b800-d4923ebd951a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_6b8ac840-6ce4-4cf3-a6f6-c853c04cef23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d59f12c-bc0a-466b-b800-d4923ebd951a" xlink:to="loc_us-gaap_RestructuringCosts_6b8ac840-6ce4-4cf3-a6f6-c853c04cef23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_13e92589-0be8-4065-a095-8b9c6b01a4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d59f12c-bc0a-466b-b800-d4923ebd951a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_13e92589-0be8-4065-a095-8b9c6b01a4b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_b4baa788-1e5a-4f9c-9739-af2918803c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d59f12c-bc0a-466b-b800-d4923ebd951a" xlink:to="loc_us-gaap_DepreciationAndAmortization_b4baa788-1e5a-4f9c-9739-af2918803c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_26e2630a-4f69-486e-9401-e0703edf5262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d59f12c-bc0a-466b-b800-d4923ebd951a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_26e2630a-4f69-486e-9401-e0703edf5262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1f9d5678-8bcb-4b64-a551-ad30585c8291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8d59f12c-bc0a-466b-b800-d4923ebd951a" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1f9d5678-8bcb-4b64-a551-ad30585c8291" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_722dcc67-f6e3-44f2-a2dd-2b5a1b0135d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f46dc908-7ede-4816-b03e-d450badf765c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_722dcc67-f6e3-44f2-a2dd-2b5a1b0135d7" xlink:to="loc_us-gaap_OperatingIncomeLoss_f46dc908-7ede-4816-b03e-d450badf765c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_70ea7d78-443c-465e-8ada-a52a5c00ed84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_722dcc67-f6e3-44f2-a2dd-2b5a1b0135d7" xlink:to="loc_us-gaap_InvestmentIncomeInterest_70ea7d78-443c-465e-8ada-a52a5c00ed84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e649e722-e8d0-4f56-8c61-297058a2e689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_722dcc67-f6e3-44f2-a2dd-2b5a1b0135d7" xlink:to="loc_us-gaap_InterestExpense_e649e722-e8d0-4f56-8c61-297058a2e689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_552782e0-f42a-44f6-9c1b-ed4da8006f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ae461e5-4528-4bcd-a49d-8bcaffd04688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_552782e0-f42a-44f6-9c1b-ed4da8006f2d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ae461e5-4528-4bcd-a49d-8bcaffd04688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_2edd3b1f-d09a-46b9-9eac-88d3b054650b" xlink:href="iclr-20211231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_552782e0-f42a-44f6-9c1b-ed4da8006f2d" xlink:to="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_2edd3b1f-d09a-46b9-9eac-88d3b054650b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_40dcdc60-4b3c-43c5-8f34-484dd9ba8d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_403e3241-1149-478b-b617-42888da30faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_40dcdc60-4b3c-43c5-8f34-484dd9ba8d76" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_403e3241-1149-478b-b617-42888da30faf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_742a8c1f-7f67-4978-bb10-01898a2cef8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_40dcdc60-4b3c-43c5-8f34-484dd9ba8d76" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_742a8c1f-7f67-4978-bb10-01898a2cef8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b975fe10-78c1-488c-9ed7-ec2da1a82fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5c0a96d1-6aa1-4f09-8c84-4b30569b45c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b975fe10-78c1-488c-9ed7-ec2da1a82fb8" xlink:to="loc_us-gaap_ProfitLoss_5c0a96d1-6aa1-4f09-8c84-4b30569b45c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_0a2ad127-8531-4385-922d-b38e34b1e1c6" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b975fe10-78c1-488c-9ed7-ec2da1a82fb8" xlink:to="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_0a2ad127-8531-4385-922d-b38e34b1e1c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_fdc98635-4387-4a84-bae8-f5a834971115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b975fe10-78c1-488c-9ed7-ec2da1a82fb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_fdc98635-4387-4a84-bae8-f5a834971115" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_fd530125-0ef5-475a-809f-475355f01bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b975fe10-78c1-488c-9ed7-ec2da1a82fb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_fd530125-0ef5-475a-809f-475355f01bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_381c3f54-ef54-433e-a24d-83eb5f21574a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b975fe10-78c1-488c-9ed7-ec2da1a82fb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_381c3f54-ef54-433e-a24d-83eb5f21574a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ae30253a-5647-453f-8816-5df1b15d395e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b975fe10-78c1-488c-9ed7-ec2da1a82fb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ae30253a-5647-453f-8816-5df1b15d395e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c2bfe07-85bb-484c-8b24-29df62e61d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b975fe10-78c1-488c-9ed7-ec2da1a82fb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c2bfe07-85bb-484c-8b24-29df62e61d54" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e032025f-3ca4-4279-9f6c-bfb52534bf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_39b9225b-aeef-42ae-b3b1-2a8636990d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e032025f-3ca4-4279-9f6c-bfb52534bf8c" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_39b9225b-aeef-42ae-b3b1-2a8636990d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_933e5439-752b-4e16-9211-b443c48078b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e032025f-3ca4-4279-9f6c-bfb52534bf8c" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_933e5439-752b-4e16-9211-b443c48078b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_3bd856e7-b877-4375-b763-6cd2b7764f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e032025f-3ca4-4279-9f6c-bfb52534bf8c" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_3bd856e7-b877-4375-b763-6cd2b7764f4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ab637904-6d81-42f3-933e-dc10f64392d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e032025f-3ca4-4279-9f6c-bfb52534bf8c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ab637904-6d81-42f3-933e-dc10f64392d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6f6d9779-57ff-488e-b92b-09e37d11c820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e032025f-3ca4-4279-9f6c-bfb52534bf8c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6f6d9779-57ff-488e-b92b-09e37d11c820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cb71e668-206f-4505-83c0-5b107cbda3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e032025f-3ca4-4279-9f6c-bfb52534bf8c" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cb71e668-206f-4505-83c0-5b107cbda3e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3d94572f-34ea-4212-884f-4c62dd9d6db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e032025f-3ca4-4279-9f6c-bfb52534bf8c" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3d94572f-34ea-4212-884f-4c62dd9d6db6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_39a95237-d2f1-41a7-8e27-0d9129024331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_39a95237-d2f1-41a7-8e27-0d9129024331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4ac5e757-69e2-41b0-a64d-3a66f8471618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4ac5e757-69e2-41b0-a64d-3a66f8471618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2a6efea6-8c8a-4911-a81f-614a8416a7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2a6efea6-8c8a-4911-a81f-614a8416a7ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_287b221b-f4bb-4548-8011-54f007279631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_287b221b-f4bb-4548-8011-54f007279631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_76938503-5f82-4dc8-a908-d20d96e64a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_76938503-5f82-4dc8-a908-d20d96e64a93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a1862320-c120-41c0-8f19-1f5746c52eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a1862320-c120-41c0-8f19-1f5746c52eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dcf149f2-9130-421d-aeec-fa14a418476b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_ProfitLoss_dcf149f2-9130-421d-aeec-fa14a418476b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ba8ad8dc-c04e-40bf-b42a-10e426399c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_ShareBasedCompensation_ba8ad8dc-c04e-40bf-b42a-10e426399c4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_e695076a-4709-4baa-8ad5-d5d6378c80f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_e695076a-4709-4baa-8ad5-d5d6378c80f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_86981048-c879-4f0b-be58-d4469eeede80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_86981048-c879-4f0b-be58-d4469eeede80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_06c76608-f033-433c-a6eb-5221de0e930a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_06c76608-f033-433c-a6eb-5221de0e930a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_78c036fd-05f5-433b-90c9-0d75f4a8733e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_78c036fd-05f5-433b-90c9-0d75f4a8733e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_eb1ef96b-9645-404f-9c89-b8501bf55bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_eb1ef96b-9645-404f-9c89-b8501bf55bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9bd35184-4101-4897-a28f-c6017a76965c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9bd35184-4101-4897-a28f-c6017a76965c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_7e58f3b5-2ad2-4ff5-900d-a564c9759e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_7e58f3b5-2ad2-4ff5-900d-a564c9759e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_db803eee-fa1a-4b7e-82a0-59f4cee28821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_39615303-1dd2-4876-b51a-d5d1c0a96f29" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_db803eee-fa1a-4b7e-82a0-59f4cee28821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a89a9a63-ef3a-42ed-9861-ae9b2cea695f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_61d87bd6-f8a6-4d7f-a877-be5d256bb001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a89a9a63-ef3a-42ed-9861-ae9b2cea695f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_61d87bd6-f8a6-4d7f-a877-be5d256bb001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c6ee4ef-2d62-4927-89ed-313b857cecde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a89a9a63-ef3a-42ed-9861-ae9b2cea695f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7c6ee4ef-2d62-4927-89ed-313b857cecde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_891df36a-6076-4b6c-9c6a-0e59d4b1ad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a89a9a63-ef3a-42ed-9861-ae9b2cea695f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_891df36a-6076-4b6c-9c6a-0e59d4b1ad8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4631d6ee-1d59-46b3-98bc-b667d34e3bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a89a9a63-ef3a-42ed-9861-ae9b2cea695f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4631d6ee-1d59-46b3-98bc-b667d34e3bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b77a5069-f483-40cc-bb43-1e8697c91f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b77a5069-f483-40cc-bb43-1e8697c91f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_e56d37a1-c2c6-4352-958c-9f7d5fa3ed29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_e56d37a1-c2c6-4352-958c-9f7d5fa3ed29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_29d9670b-0350-4360-95b0-07eb18f0b172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_29d9670b-0350-4360-95b0-07eb18f0b172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_caeffea4-37e3-4187-8d2f-3f08c41afe37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_caeffea4-37e3-4187-8d2f-3f08c41afe37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_af96826f-4fc9-4b8b-9e90-9d446e3f8f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_af96826f-4fc9-4b8b-9e90-9d446e3f8f39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ff681f4a-21da-4d83-9fb3-413ca7651ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ff681f4a-21da-4d83-9fb3-413ca7651ff1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_162f3665-9f8f-4df7-badd-bd5257090aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_162f3665-9f8f-4df7-badd-bd5257090aa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts_65362146-563a-43a9-b00c-4195560c548d" xlink:href="iclr-20211231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_iclr_PaymentsForShareRepurchaseCosts_65362146-563a-43a9-b00c-4195560c548d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_a33553fb-4600-42b7-b090-6f356a96bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca9cc3e0-63c6-4b27-bc90-9dfa09b33e2e" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_a33553fb-4600-42b7-b090-6f356a96bbe0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4a551749-bfd1-4166-92aa-eebbf1352586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c3ccb024-e515-4c1c-8a50-7eab51388970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4a551749-bfd1-4166-92aa-eebbf1352586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c3ccb024-e515-4c1c-8a50-7eab51388970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_752d058c-1764-4fa4-8e26-2b989feb288b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4a551749-bfd1-4166-92aa-eebbf1352586" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_752d058c-1764-4fa4-8e26-2b989feb288b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_b2a577d3-01b4-4982-9277-91c68874575e" xlink:href="iclr-20211231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_15257f8b-018e-4152-998e-bd9cd4d3312a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_b2a577d3-01b4-4982-9277-91c68874575e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_15257f8b-018e-4152-998e-bd9cd4d3312a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_384345a1-c89e-4c69-93cc-2f3c5d6d0350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_b2a577d3-01b4-4982-9277-91c68874575e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_384345a1-c89e-4c69-93cc-2f3c5d6d0350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d0a8a515-77e5-469e-9bd8-61896cb0c4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_b2a577d3-01b4-4982-9277-91c68874575e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d0a8a515-77e5-469e-9bd8-61896cb0c4bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_57665e8f-4d7a-423a-80e9-9614f6377abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_b2a577d3-01b4-4982-9277-91c68874575e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_57665e8f-4d7a-423a-80e9-9614f6377abf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5c48d326-de8a-4bfd-a031-1c4deb317dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_b2a577d3-01b4-4982-9277-91c68874575e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5c48d326-de8a-4bfd-a031-1c4deb317dc2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c6255876-7f0e-4cb8-b348-57cf9f5cddb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_53d461b0-981a-49f5-b96a-88fa645faf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c6255876-7f0e-4cb8-b348-57cf9f5cddb3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_53d461b0-981a-49f5-b96a-88fa645faf5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c8e84fd8-772c-4472-a673-9105c37ba43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c6255876-7f0e-4cb8-b348-57cf9f5cddb3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c8e84fd8-772c-4472-a673-9105c37ba43f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d137ab38-37fd-47bb-97ef-6b9309435ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c6255876-7f0e-4cb8-b348-57cf9f5cddb3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d137ab38-37fd-47bb-97ef-6b9309435ae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f4db95d7-80d9-49fe-96bb-c4d806f837c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c6255876-7f0e-4cb8-b348-57cf9f5cddb3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f4db95d7-80d9-49fe-96bb-c4d806f837c2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d81b696c-ed29-48d6-ae05-8d7abedde31c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d81b696c-ed29-48d6-ae05-8d7abedde31c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_a885caa9-cb29-41c4-b3f8-17ed1712a116" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_a885caa9-cb29-41c4-b3f8-17ed1712a116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_1992ad76-50c0-4e8b-bd63-f4cc97e8b46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_1992ad76-50c0-4e8b-bd63-f4cc97e8b46b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fecdcda1-57c6-40fa-aa69-993e6f3a1cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fecdcda1-57c6-40fa-aa69-993e6f3a1cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_64f0282a-5f5d-4b54-a141-a751e5dee39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_Goodwill_64f0282a-5f5d-4b54-a141-a751e5dee39a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cc91ece5-2943-4f9f-bfd1-ad1f61316f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cc91ece5-2943-4f9f-bfd1-ad1f61316f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_7fc1beae-81fa-4376-a179-54c8e6de7189" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_7fc1beae-81fa-4376-a179-54c8e6de7189" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d1159114-5d0d-4abe-9d9e-06520b688100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d1159114-5d0d-4abe-9d9e-06520b688100" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a3436665-2eb7-46d1-a3e5-21eb4221ffb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a3436665-2eb7-46d1-a3e5-21eb4221ffb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_67e5bb36-c3b7-450e-b378-f496c3a5a6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_67e5bb36-c3b7-450e-b378-f496c3a5a6bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_426612d6-344c-4cf7-918b-16042c586a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_426612d6-344c-4cf7-918b-16042c586a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_8685d237-426c-4cf4-9ad8-f3c139d23c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_8685d237-426c-4cf4-9ad8-f3c139d23c0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_71967ecd-c8e8-4c7d-a4d7-bff1ca51d130" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_71967ecd-c8e8-4c7d-a4d7-bff1ca51d130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2be0d586-876e-42ba-9fd3-71fa9f75ca20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2be0d586-876e-42ba-9fd3-71fa9f75ca20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3cfeea13-d3eb-4fba-bc5b-5a9bf4e36d39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3cfeea13-d3eb-4fba-bc5b-5a9bf4e36d39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_9a27fead-41ee-4f7f-8592-ebeaaeae22f9" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_602f462f-aac9-42b0-b3fd-d86e6948d09c" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_9a27fead-41ee-4f7f-8592-ebeaaeae22f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#PropertyPlantandEquipmentnetDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_d951023b-a410-47da-b347-eed95d4b5039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_d925b278-08a6-4e1e-aa12-419530ce7d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d951023b-a410-47da-b347-eed95d4b5039" xlink:to="loc_us-gaap_Land_d925b278-08a6-4e1e-aa12-419530ce7d47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_95c7fa76-0688-4ce5-9c4e-4b2f9b7ae67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d951023b-a410-47da-b347-eed95d4b5039" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_95c7fa76-0688-4ce5-9c4e-4b2f9b7ae67e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_e29b5ebc-1887-4964-a070-458353a2a6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d951023b-a410-47da-b347-eed95d4b5039" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_e29b5ebc-1887-4964-a070-458353a2a6b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_51aa438f-2b86-4e8b-9f3c-2983ceb4215f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d951023b-a410-47da-b347-eed95d4b5039" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_51aa438f-2b86-4e8b-9f3c-2983ceb4215f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_a0ff8a82-a1a9-4074-ab3e-4b9b26115546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d951023b-a410-47da-b347-eed95d4b5039" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_a0ff8a82-a1a9-4074-ab3e-4b9b26115546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_e3e741bd-1a9e-4622-981a-3a77c5d689e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d951023b-a410-47da-b347-eed95d4b5039" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_e3e741bd-1a9e-4622-981a-3a77c5d689e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross_23375815-c3ce-4f93-ac7b-6c597a72ff20" xlink:href="iclr-20211231.xsd#iclr_VehiclesGross"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_d951023b-a410-47da-b347-eed95d4b5039" xlink:to="loc_iclr_VehiclesGross_23375815-c3ce-4f93-ac7b-6c597a72ff20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_07cd2938-ac28-4dfa-8b1e-72c04fe06bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2a6201cd-396a-4957-a48d-2f046c3966e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_07cd2938-ac28-4dfa-8b1e-72c04fe06bfe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2a6201cd-396a-4957-a48d-2f046c3966e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_92603667-52d2-48c0-91c3-82fe2b01a210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_07cd2938-ac28-4dfa-8b1e-72c04fe06bfe" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_92603667-52d2-48c0-91c3-82fe2b01a210" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#OtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1c009c34-0d37-410d-8bbe-2ecd17516e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_9ee0848b-0370-4f96-8d3c-77bffc8c2a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1c009c34-0d37-410d-8bbe-2ecd17516e01" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_9ee0848b-0370-4f96-8d3c-77bffc8c2a2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6b45b4e9-50d6-4972-9dba-601885a1c784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1c009c34-0d37-410d-8bbe-2ecd17516e01" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6b45b4e9-50d6-4972-9dba-601885a1c784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_50b75526-e1d4-434d-8b42-4b7e2591653b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1c009c34-0d37-410d-8bbe-2ecd17516e01" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_50b75526-e1d4-434d-8b42-4b7e2591653b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_396b5c83-d533-4239-b7ae-df45d8d33805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1c009c34-0d37-410d-8bbe-2ecd17516e01" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_396b5c83-d533-4239-b7ae-df45d8d33805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cf00841e-5333-414a-bc90-8f4be1eccd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1c009c34-0d37-410d-8bbe-2ecd17516e01" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cf00841e-5333-414a-bc90-8f4be1eccd7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_8fcf63d2-17c0-409b-a491-b7d4d2e24057" xlink:href="iclr-20211231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1c009c34-0d37-410d-8bbe-2ecd17516e01" xlink:to="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_8fcf63d2-17c0-409b-a491-b7d4d2e24057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent_39eb0f9d-1263-4ad6-b723-bc1fd6a6ccd7" xlink:href="iclr-20211231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1c009c34-0d37-410d-8bbe-2ecd17516e01" xlink:to="loc_iclr_CapitalGovernmentGrantsCurrent_39eb0f9d-1263-4ad6-b723-bc1fd6a6ccd7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NonCurrentOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bf231ff7-2b7f-4651-889f-9951e3b07860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_e611c626-56f0-4a0e-ad85-225dafa0e610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_bf231ff7-2b7f-4651-889f-9951e3b07860" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_e611c626-56f0-4a0e-ad85-225dafa0e610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_967d4eb2-93c8-499e-b6df-425238e09cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_bf231ff7-2b7f-4651-889f-9951e3b07860" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_967d4eb2-93c8-499e-b6df-425238e09cf3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d3dac263-877e-4953-890b-045a12f03ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_44548ed0-0562-4cfe-ae6e-9d39ee09a346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d3dac263-877e-4953-890b-045a12f03ecb" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_44548ed0-0562-4cfe-ae6e-9d39ee09a346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3b7b884a-8be7-4945-9498-4c0ce86315de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d3dac263-877e-4953-890b-045a12f03ecb" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3b7b884a-8be7-4945-9498-4c0ce86315de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1f695a9d-ce49-4332-8db4-1006a9da5eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_01b773ad-dd0c-4c8a-a62d-63239abdbb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1f695a9d-ce49-4332-8db4-1006a9da5eb2" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_01b773ad-dd0c-4c8a-a62d-63239abdbb7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_41b72927-bb80-4d44-941e-b4b36a0db56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1f695a9d-ce49-4332-8db4-1006a9da5eb2" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_41b72927-bb80-4d44-941e-b4b36a0db56c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_99ea4e54-eceb-4432-a0bb-11f51c2b2e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1f695a9d-ce49-4332-8db4-1006a9da5eb2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_99ea4e54-eceb-4432-a0bb-11f51c2b2e2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_16bdc671-2a78-4644-b267-495b4e80653a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1f695a9d-ce49-4332-8db4-1006a9da5eb2" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_16bdc671-2a78-4644-b267-495b4e80653a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_a2d6f5da-27ae-4948-960b-efa9a4e5f750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_6012003f-2601-4ab9-a1f7-20f15c095fe7" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_a2d6f5da-27ae-4948-960b-efa9a4e5f750" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_6012003f-2601-4ab9-a1f7-20f15c095fe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_59e5d84c-069e-4e76-a0f7-55e9d5f89cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_a2d6f5da-27ae-4948-960b-efa9a4e5f750" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_59e5d84c-069e-4e76-a0f7-55e9d5f89cfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_9ded2592-8dba-4770-967e-c71b81e365d0" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_a2d6f5da-27ae-4948-960b-efa9a4e5f750" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_9ded2592-8dba-4770-967e-c71b81e365d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_14d816d4-c97d-43da-9b95-ca23147abf20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_66515209-ae87-431f-a356-93b51309207f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_14d816d4-c97d-43da-9b95-ca23147abf20" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_66515209-ae87-431f-a356-93b51309207f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_475a0063-9094-4d96-a2ee-fe5ef6ab7566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_14d816d4-c97d-43da-9b95-ca23147abf20" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_475a0063-9094-4d96-a2ee-fe5ef6ab7566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_02f46732-0f3b-472e-b97a-6c7a5acb58a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f5ea3cfd-2c63-4cc2-964d-3dcd23847657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_02f46732-0f3b-472e-b97a-6c7a5acb58a6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f5ea3cfd-2c63-4cc2-964d-3dcd23847657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2f84506b-fc0b-4b59-b389-c300f0629d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_02f46732-0f3b-472e-b97a-6c7a5acb58a6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2f84506b-fc0b-4b59-b389-c300f0629d2c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_25901ca8-978b-4bcb-b41e-e0a14626a08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_25901ca8-978b-4bcb-b41e-e0a14626a08d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_80adf8e7-6c66-47f9-842e-071bb8b48520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_80adf8e7-6c66-47f9-842e-071bb8b48520" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_fa1a74e5-4185-475f-b828-e16466934868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_fa1a74e5-4185-475f-b828-e16466934868" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fb8eff74-b3b8-4045-aed5-23cef94cb8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fb8eff74-b3b8-4045-aed5-23cef94cb8ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_08b456df-a663-4995-9577-c1eebcd7eaae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_08b456df-a663-4995-9577-c1eebcd7eaae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_9cbc51e7-5d20-4da7-9d7b-b1eb545a6c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_9cbc51e7-5d20-4da7-9d7b-b1eb545a6c2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_60764836-6724-41e1-bfb6-6ecd2375315c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_60764836-6724-41e1-bfb6-6ecd2375315c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c9885d84-a4a6-4917-a571-613b20849642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_927d9ae6-9042-46cb-b1d7-460e9c36cbcd" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c9885d84-a4a6-4917-a571-613b20849642" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_eb6eca42-dd18-4023-b750-556279a7b764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_0ba5ccfd-a4fe-487d-b103-9a8dc42c765c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_eb6eca42-dd18-4023-b750-556279a7b764" xlink:to="loc_us-gaap_DeferredTaxLiabilities_0ba5ccfd-a4fe-487d-b103-9a8dc42c765c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ffb6a9a6-c662-4b63-95f6-31f0f4b37b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_eb6eca42-dd18-4023-b750-556279a7b764" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_ffb6a9a6-c662-4b63-95f6-31f0f4b37b75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_df66dfec-14a7-42ef-aa9b-741f92c6c5fd" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_df66dfec-14a7-42ef-aa9b-741f92c6c5fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_36d571b8-7345-4d22-92d8-9ddb8b05125d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_36d571b8-7345-4d22-92d8-9ddb8b05125d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_4741bf86-53c8-45b3-9111-abcdf433e2a1" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_4741bf86-53c8-45b3-9111-abcdf433e2a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_8806a406-36bc-4c30-960c-e97f1d326555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_8806a406-36bc-4c30-960c-e97f1d326555" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_57c53ee8-f8b7-4e44-b3fc-4bb39288db86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_57c53ee8-f8b7-4e44-b3fc-4bb39288db86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_c64c1226-f6d6-456e-a729-62729f759903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_c64c1226-f6d6-456e-a729-62729f759903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_7a5a10eb-0a78-4737-a0c0-fb7f915ae8ae" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_7a5a10eb-0a78-4737-a0c0-fb7f915ae8ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_4b2cea12-0e09-491d-904b-85d4636b0ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_4b2cea12-0e09-491d-904b-85d4636b0ab8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_3f0095cf-bc55-49c1-ac79-377270bd4388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0ee56d36-cb0d-4bb5-9bf4-87199c010350" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_3f0095cf-bc55-49c1-ac79-377270bd4388" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_8bc32110-bbcd-49d7-8799-dab1415852f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a0ba5a22-78cf-4ddb-928a-dd40d2ebcb68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_8bc32110-bbcd-49d7-8799-dab1415852f1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a0ba5a22-78cf-4ddb-928a-dd40d2ebcb68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_a9c8c3ac-44e4-4dea-9837-ce7518c460cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_8bc32110-bbcd-49d7-8799-dab1415852f1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_a9c8c3ac-44e4-4dea-9837-ce7518c460cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e93d9066-f1af-4396-b97b-c1785fd96c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_4d19a516-e8ed-40d2-a592-c9768451d7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e93d9066-f1af-4396-b97b-c1785fd96c5e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_4d19a516-e8ed-40d2-a592-c9768451d7ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_3f49ca77-0f57-4c27-bc5f-d36ce7d5ae20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e93d9066-f1af-4396-b97b-c1785fd96c5e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_3f49ca77-0f57-4c27-bc5f-d36ce7d5ae20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2522a670-d698-4a87-9a43-d8afc41231d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e93d9066-f1af-4396-b97b-c1785fd96c5e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2522a670-d698-4a87-9a43-d8afc41231d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_3f6335a8-790a-4f61-94a8-6090379d9bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e93d9066-f1af-4396-b97b-c1785fd96c5e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_3f6335a8-790a-4f61-94a8-6090379d9bc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_47143950-5a4b-4607-b645-5c5e430d7b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_e93d9066-f1af-4396-b97b-c1785fd96c5e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_47143950-5a4b-4607-b645-5c5e430d7b5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_2efbf692-b8a1-4a51-8353-5fae3a0f7ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_941391c0-4e58-471e-9e57-99136751ea83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_2efbf692-b8a1-4a51-8353-5fae3a0f7ecb" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_941391c0-4e58-471e-9e57-99136751ea83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_85f1f063-aa3f-46ad-93c9-7dd8b3dbf693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_2efbf692-b8a1-4a51-8353-5fae3a0f7ecb" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_85f1f063-aa3f-46ad-93c9-7dd8b3dbf693" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1c55ad8c-c047-4ccd-b562-8e1f911a27a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_2f63a7ce-6e31-4dee-9a84-57425e5ba8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1c55ad8c-c047-4ccd-b562-8e1f911a27a3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_2f63a7ce-6e31-4dee-9a84-57425e5ba8e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_be9d8b57-39aa-48e8-bc99-a05d06693e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1c55ad8c-c047-4ccd-b562-8e1f911a27a3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_be9d8b57-39aa-48e8-bc99-a05d06693e55" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_c74745c6-7734-4e38-91fb-c9a6e45b1fd5" xlink:href="iclr-20211231.xsd#iclr_ContractsReceivableGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_83eee347-2c9d-4f37-9a6d-0aae3832702b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BilledContractReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableGross_c74745c6-7734-4e38-91fb-c9a6e45b1fd5" xlink:to="loc_us-gaap_BilledContractReceivables_83eee347-2c9d-4f37-9a6d-0aae3832702b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_94f2fccc-6ac4-43af-942e-0fa94172fb74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableGross_c74745c6-7734-4e38-91fb-c9a6e45b1fd5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_94f2fccc-6ac4-43af-942e-0fa94172fb74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet_7c774e58-be90-4587-980f-3697302804c4" xlink:href="iclr-20211231.xsd#iclr_ContractsReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_99132bce-e7b8-4859-abcd-0a1a92851482" xlink:href="iclr-20211231.xsd#iclr_ContractsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableNet_7c774e58-be90-4587-980f-3697302804c4" xlink:to="loc_iclr_ContractsReceivableGross_99132bce-e7b8-4859-abcd-0a1a92851482" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_5f404efb-36d5-49ea-b747-fa3c1be0fbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableNet_7c774e58-be90-4587-980f-3697302804c4" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_5f404efb-36d5-49ea-b747-fa3c1be0fbcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_05a7af98-8aea-427c-8f49-3972a3432cc0" xlink:href="iclr-20211231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_32705108-18e6-4e80-8c57-a7be2e6ab304" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_05a7af98-8aea-427c-8f49-3972a3432cc0" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_32705108-18e6-4e80-8c57-a7be2e6ab304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_e5fdd96d-2ddd-4b66-87c6-a536a63f919d" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_05a7af98-8aea-427c-8f49-3972a3432cc0" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_e5fdd96d-2ddd-4b66-87c6-a536a63f919d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_595a3b46-3ca6-4338-b69d-7c75bc43981c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_4689ae9e-0e3e-4a65-a2d4-e3a2b837dc6e" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_595a3b46-3ca6-4338-b69d-7c75bc43981c" xlink:to="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_4689ae9e-0e3e-4a65-a2d4-e3a2b837dc6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_6704b0ae-198d-4ce9-897c-0b95e8a44326" xlink:href="iclr-20211231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_595a3b46-3ca6-4338-b69d-7c75bc43981c" xlink:to="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_6704b0ae-198d-4ce9-897c-0b95e8a44326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_ba7d6cae-5271-40f0-a5c6-6c37db4d1e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_595a3b46-3ca6-4338-b69d-7c75bc43981c" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_ba7d6cae-5271-40f0-a5c6-6c37db4d1e88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_2d2cbf6b-da8b-4c92-9bc2-ba237cf99d35" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_595a3b46-3ca6-4338-b69d-7c75bc43981c" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_2d2cbf6b-da8b-4c92-9bc2-ba237cf99d35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_0352938b-e77f-46ff-959f-976df3c4695b" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_595a3b46-3ca6-4338-b69d-7c75bc43981c" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_0352938b-e77f-46ff-959f-976df3c4695b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_7f1442f8-6dbf-4daf-a9ae-2d9fe5ec20b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_595a3b46-3ca6-4338-b69d-7c75bc43981c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_7f1442f8-6dbf-4daf-a9ae-2d9fe5ec20b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_252f171d-30c7-40d0-98df-86330da635ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_595a3b46-3ca6-4338-b69d-7c75bc43981c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_252f171d-30c7-40d0-98df-86330da635ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_f539e85b-b14b-4507-9086-0830a6e68827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_48dd74ac-0fbd-462f-af3c-d7316dfc7bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f539e85b-b14b-4507-9086-0830a6e68827" xlink:to="loc_us-gaap_SubleaseIncome_48dd74ac-0fbd-462f-af3c-d7316dfc7bc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_905dd8dd-0986-49fe-99d8-21f272efc5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f539e85b-b14b-4507-9086-0830a6e68827" xlink:to="loc_us-gaap_OperatingLeaseCost_905dd8dd-0986-49fe-99d8-21f272efc5ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ef5c0e89-391e-4a2c-a7e8-a71516d39009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cada9e4f-2662-49d1-a260-d3bcce33a24c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ef5c0e89-391e-4a2c-a7e8-a71516d39009" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cada9e4f-2662-49d1-a260-d3bcce33a24c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3d1b8241-2ab2-4814-b83b-eacbd7aa2aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ef5c0e89-391e-4a2c-a7e8-a71516d39009" xlink:to="loc_us-gaap_OperatingLeaseLiability_3d1b8241-2ab2-4814-b83b-eacbd7aa2aab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e62dd510-3d23-4ce7-b867-d88707322189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6a26d35c-1f1b-4215-9329-a96c51f2350d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e62dd510-3d23-4ce7-b867-d88707322189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6a26d35c-1f1b-4215-9329-a96c51f2350d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fec032d6-d764-4f61-92fc-8d0fe696f4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e62dd510-3d23-4ce7-b867-d88707322189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fec032d6-d764-4f61-92fc-8d0fe696f4bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_75a90003-a5d1-4395-a261-d1b5e5819715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e62dd510-3d23-4ce7-b867-d88707322189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_75a90003-a5d1-4395-a261-d1b5e5819715" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_edbccc80-013f-476c-a9d0-bc31ebf7bf82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e62dd510-3d23-4ce7-b867-d88707322189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_edbccc80-013f-476c-a9d0-bc31ebf7bf82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8c76f99c-3609-42b3-b6f4-74d02181610d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e62dd510-3d23-4ce7-b867-d88707322189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8c76f99c-3609-42b3-b6f4-74d02181610d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b81eb368-51de-4f28-a186-60dd09990da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e62dd510-3d23-4ce7-b867-d88707322189" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b81eb368-51de-4f28-a186-60dd09990da3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_56756f83-843a-429c-bac8-6253a7d007e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_d0923f2e-5681-478b-9fb4-4200bceb7d3e" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_56756f83-843a-429c-bac8-6253a7d007e6" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_d0923f2e-5681-478b-9fb4-4200bceb7d3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9cd54b12-aa89-4909-ac38-eff2272a41e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_56756f83-843a-429c-bac8-6253a7d007e6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9cd54b12-aa89-4909-ac38-eff2272a41e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e8b4d100-4270-470c-b9f1-952e7d8de820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_52c90d43-0119-4036-84a2-e12f746142d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e8b4d100-4270-470c-b9f1-952e7d8de820" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_52c90d43-0119-4036-84a2-e12f746142d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8fb19386-1678-415a-be45-e96100181d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e8b4d100-4270-470c-b9f1-952e7d8de820" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8fb19386-1678-415a-be45-e96100181d23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f2b71cb0-b19c-4fb2-9496-bc4c24ea17b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e8b4d100-4270-470c-b9f1-952e7d8de820" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f2b71cb0-b19c-4fb2-9496-bc4c24ea17b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_c474f5d1-38e6-4907-b4f0-5c4b473bf31c" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e8b4d100-4270-470c-b9f1-952e7d8de820" xlink:to="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_c474f5d1-38e6-4907-b4f0-5c4b473bf31c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a686b0fe-7f8c-4e66-9cc5-6cfd59920e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e8b4d100-4270-470c-b9f1-952e7d8de820" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a686b0fe-7f8c-4e66-9cc5-6cfd59920e3b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6551d435-7cc0-4af3-830c-b771552ef9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2b1a03a1-941c-4784-b27d-75e0baa7671f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6551d435-7cc0-4af3-830c-b771552ef9cd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2b1a03a1-941c-4784-b27d-75e0baa7671f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ad968893-a72b-4075-a23a-d010cc3071c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6551d435-7cc0-4af3-830c-b771552ef9cd" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ad968893-a72b-4075-a23a-d010cc3071c8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7c7115c-4df7-4e47-838c-b50c231e0794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_abd2feef-fed9-441d-ba7f-05e2b17adbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7c7115c-4df7-4e47-838c-b50c231e0794" xlink:to="loc_us-gaap_NetIncomeLoss_abd2feef-fed9-441d-ba7f-05e2b17adbe4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_14c077d0-d191-4341-8492-a1609addd2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7c7115c-4df7-4e47-838c-b50c231e0794" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_14c077d0-d191-4341-8492-a1609addd2d4" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>iclr-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e141d476-ae09-4ec9-a80f-baeacfb8f81a,g:a196524c-1dde-4a8b-8796-f0fa7ce72378-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/Cover" xlink:type="simple" xlink:href="iclr-20211231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/Cover" xlink:type="extended" id="i46740e84926a4e2ab047c65bbe946662_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5b0cc050-0218-4a3f-a5a6-c917e96a7c9e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentType_5b0cc050-0218-4a3f-a5a6-c917e96a7c9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_a8c2f21e-31ce-4d18-8235-ea5530877978" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentRegistrationStatement_a8c2f21e-31ce-4d18-8235-ea5530877978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_a85fc749-3c46-4707-ae8f-7a43362c37a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentAnnualReport_a85fc749-3c46-4707-ae8f-7a43362c37a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ba815163-9346-4824-a4cf-0fc45e5f5b04" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentPeriodEndDate_ba815163-9346-4824-a4cf-0fc45e5f5b04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4e8279b4-b819-4b1b-be8b-7ed19c03e1d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_CurrentFiscalYearEndDate_4e8279b4-b819-4b1b-be8b-7ed19c03e1d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8f2664d2-ee26-4197-b0bc-17e70331eb3b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentTransitionReport_8f2664d2-ee26-4197-b0bc-17e70331eb3b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_3768b7de-ba37-4077-baa9-b115e576c7a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentShellCompanyReport_3768b7de-ba37-4077-baa9-b115e576c7a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_398ae245-3c10-4844-a912-61262ce63a61" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityFileNumber_398ae245-3c10-4844-a912-61262ce63a61" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6d6779a7-0b75-4741-a1b2-a519fa5a5e6a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityRegistrantName_6d6779a7-0b75-4741-a1b2-a519fa5a5e6a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_603e4c7d-d615-45e8-9898-5041bdd15860" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_603e4c7d-d615-45e8-9898-5041bdd15860" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_788e44e1-16cd-4573-855a-12383a6a10b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressAddressLine1_788e44e1-16cd-4573-855a-12383a6a10b9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_e0a992fe-0b3e-41d6-8b91-e96af9312ab4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressAddressLine2_e0a992fe-0b3e-41d6-8b91-e96af9312ab4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4ac58253-e167-4fd1-91b0-6ed958d2b5d2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressCityOrTown_4ac58253-e167-4fd1-91b0-6ed958d2b5d2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_07ff2094-1aab-4188-ae90-52e1069873ad" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressPostalZipCode_07ff2094-1aab-4188-ae90-52e1069873ad" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_f786dc73-2cbe-46ef-a083-b5c48d5f235a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressCountry_f786dc73-2cbe-46ef-a083-b5c48d5f235a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_405b431c-99e6-45ed-ba26-f2ba9994c6ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_ContactPersonnelName_405b431c-99e6-45ed-ba26-f2ba9994c6ac" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_c21f9fdb-f96c-4c07-8d71-4c339de4d78d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_ContactPersonnelEmailAddress_c21f9fdb-f96c-4c07-8d71-4c339de4d78d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_72fb9290-5152-4790-b438-d100dab22cd6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_CountryRegion_72fb9290-5152-4790-b438-d100dab22cd6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7acd125c-fef4-4a5b-aa2d-aa4702565c6b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_CityAreaCode_7acd125c-fef4-4a5b-aa2d-aa4702565c6b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ef4f926e-58bd-4050-83e4-2039b2cfb72c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_LocalPhoneNumber_ef4f926e-58bd-4050-83e4-2039b2cfb72c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ef40539a-04cc-4b9a-b8a3-29743037f18a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_Security12bTitle_ef40539a-04cc-4b9a-b8a3-29743037f18a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9616c03e-44d9-4be1-88b3-bcd4d5da2a13" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_TradingSymbol_9616c03e-44d9-4be1-88b3-bcd4d5da2a13" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_427d1231-a14b-42b3-a1a3-1cea2646c511" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_SecurityExchangeName_427d1231-a14b-42b3-a1a3-1cea2646c511" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_931cba2c-aa89-49fc-813f-f264278096f1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_931cba2c-aa89-49fc-813f-f264278096f1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_96c0767e-3452-41f1-b8eb-15dbe5eac639" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_96c0767e-3452-41f1-b8eb-15dbe5eac639" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_1d00af7f-1f7a-4233-ad58-be852439b3f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityVoluntaryFilers_1d00af7f-1f7a-4233-ad58-be852439b3f7" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_49078e55-d133-419f-b644-f22b75b812c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityCurrentReportingStatus_49078e55-d133-419f-b644-f22b75b812c4" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7a2696bb-cb65-4ca6-8974-5051439278f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityInteractiveDataCurrent_7a2696bb-cb65-4ca6-8974-5051439278f5" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_299d2a5b-7415-4700-91ef-1a388ca1d3cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityFilerCategory_299d2a5b-7415-4700-91ef-1a388ca1d3cb" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ef1d34d9-e97e-401d-8410-973cf22fc079" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityEmergingGrowthCompany_ef1d34d9-e97e-401d-8410-973cf22fc079" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_1d824a4e-ad7e-4b74-a9fb-a573443066a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_IcfrAuditorAttestationFlag_1d824a4e-ad7e-4b74-a9fb-a573443066a7" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_328579fe-f4f9-4446-af47-f7777e9bff3f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentAccountingStandard_328579fe-f4f9-4446-af47-f7777e9bff3f" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9ac295ed-736f-4904-be04-0ffb20e4bce3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityShellCompany_9ac295ed-736f-4904-be04-0ffb20e4bce3" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_91bb6863-0450-470b-8cd7-9c68fb1d39d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_AmendmentFlag_91bb6863-0450-470b-8cd7-9c68fb1d39d9" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2e4d3c02-efc1-458c-b387-9cb383f16f08" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentFiscalYearFocus_2e4d3c02-efc1-458c-b387-9cb383f16f08" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e030a720-1b8f-4bcc-9a9d-62f7a25fbbdd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e030a720-1b8f-4bcc-9a9d-62f7a25fbbdd" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0af5d319-fdc4-4026-a257-98dfa0fa7db3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityCentralIndexKey_0af5d319-fdc4-4026-a257-98dfa0fa7db3" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_671dd477-2418-46e2-933a-fde83c823085" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentInformationTable_671dd477-2418-46e2-933a-fde83c823085" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_713e6f2d-85e6-41e3-a00d-8918dc21e227" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_671dd477-2418-46e2-933a-fde83c823085" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_713e6f2d-85e6-41e3-a00d-8918dc21e227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_713e6f2d-85e6-41e3-a00d-8918dc21e227_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_713e6f2d-85e6-41e3-a00d-8918dc21e227" xlink:to="loc_dei_AddressTypeDomain_713e6f2d-85e6-41e3-a00d-8918dc21e227_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_71f28ab2-aab6-49f6-8e82-e80facd63240" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_713e6f2d-85e6-41e3-a00d-8918dc21e227" xlink:to="loc_dei_AddressTypeDomain_71f28ab2-aab6-49f6-8e82-e80facd63240" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_6d2d51a8-3cbf-4c05-b7fe-e6d67372c8a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_71f28ab2-aab6-49f6-8e82-e80facd63240" xlink:to="loc_dei_BusinessContactMember_6d2d51a8-3cbf-4c05-b7fe-e6d67372c8a1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="extended" id="iffbe2ff300104ff983a17a8afb44b565_CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f79ddbaa-12b3-42ca-9242-11bdef2f4bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f79ddbaa-12b3-42ca-9242-11bdef2f4bd0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_29b327d2-b5ca-4af0-8618-9f29dc3f9c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_CommonStockSharesIssued_29b327d2-b5ca-4af0-8618-9f29dc3f9c0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2819df30-1484-46b4-9057-566eb39aeb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockholdersEquity_2819df30-1484-46b4-9057-566eb39aeb13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_92cc3aca-b866-43f4-a6b1-8b17a59d812f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_NetIncomeLoss_92cc3aca-b866-43f4-a6b1-8b17a59d812f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6312ebfe-2c19-4227-86aa-a1dd3541be33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6312ebfe-2c19-4227-86aa-a1dd3541be33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_fcc4571c-b3fe-4868-9d30-7c91127642ca" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_fcc4571c-b3fe-4868-9d30-7c91127642ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5297f7b6-9526-4a7c-99e5-6b08cedb7d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5297f7b6-9526-4a7c-99e5-6b08cedb7d76" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_41080f82-3133-4a2d-8a16-10467da1ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_41080f82-3133-4a2d-8a16-10467da1ae95" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_00c78396-3e9c-419b-9bf0-032ee557a1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_00c78396-3e9c-419b-9bf0-032ee557a1a5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0328e4ea-a1a5-493d-b8ea-89e23448b622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0328e4ea-a1a5-493d-b8ea-89e23448b622" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_57db4089-f785-42d6-94bc-7e03543b63ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_57db4089-f785-42d6-94bc-7e03543b63ed" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bdd8b3c1-0739-4517-8f8c-1f14c582d7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bdd8b3c1-0739-4517-8f8c-1f14c582d7a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3382e17f-be31-47a4-a8f2-6c4b7e93e80e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3382e17f-be31-47a4-a8f2-6c4b7e93e80e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5435f5e4-e75a-42e0-9bd2-630d5e5c23f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5435f5e4-e75a-42e0-9bd2-630d5e5c23f3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1865a520-cd3b-4f43-a64e-34b091449a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1865a520-cd3b-4f43-a64e-34b091449a94" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ebc8da9f-34be-458a-93a0-929cb52d1957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ebc8da9f-34be-458a-93a0-929cb52d1957" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_fda2c6d3-5c1c-4029-ba54-0eb958662e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_fda2c6d3-5c1c-4029-ba54-0eb958662e93" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f54e9b8f-d4b9-4a14-8eeb-0b72e6015bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f54e9b8f-d4b9-4a14-8eeb-0b72e6015bd0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_067bdeb8-7b8f-4eff-89a1-59b030d11290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_067bdeb8-7b8f-4eff-89a1-59b030d11290" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_d8b06824-baab-4779-adea-0d8e93c76256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_d8b06824-baab-4779-adea-0d8e93c76256" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3a0433d4-8594-482c-a24d-017b5c1acc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3a0433d4-8594-482c-a24d-017b5c1acc2a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f5d5a682-cbbe-41fa-8aab-7c33faf281fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f5d5a682-cbbe-41fa-8aab-7c33faf281fd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_8072814b-4177-448e-b9ad-4a4666f36b25" xlink:href="iclr-20211231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_8072814b-4177-448e-b9ad-4a4666f36b25" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue_cb06e7de-4b25-4282-8350-7f22534f38dc" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue_cb06e7de-4b25-4282-8350-7f22534f38dc" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a22faa95-ed47-49d5-b890-94d67ad2eca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fa657473-bca0-4628-9464-0159768c0330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f79ddbaa-12b3-42ca-9242-11bdef2f4bd0" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e9e9d100-2a47-466c-82af-7179bd54d697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e9e9d100-2a47-466c-82af-7179bd54d697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_6e4bffac-8c96-48dc-b8a9-4f75dfa70b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_6e4bffac-8c96-48dc-b8a9-4f75dfa70b07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_9d086b08-dab4-472f-ba19-28034be34e93" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_9d086b08-dab4-472f-ba19-28034be34e93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_3e641ed9-46a0-437d-83e5-2e599d336460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_3e641ed9-46a0-437d-83e5-2e599d336460" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59485455-722f-4bf6-b1c9-1ad1b467a888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2c2abe2e-c4c4-4b80-8f83-1ad833ddf740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f79ddbaa-12b3-42ca-9242-11bdef2f4bd0" xlink:to="loc_us-gaap_StatementTable_2c2abe2e-c4c4-4b80-8f83-1ad833ddf740" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6f32ec7a-a797-447f-a147-fe5b711de14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2c2abe2e-c4c4-4b80-8f83-1ad833ddf740" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6f32ec7a-a797-447f-a147-fe5b711de14c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6f32ec7a-a797-447f-a147-fe5b711de14c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f32ec7a-a797-447f-a147-fe5b711de14c" xlink:to="loc_us-gaap_EquityComponentDomain_6f32ec7a-a797-447f-a147-fe5b711de14c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f32ec7a-a797-447f-a147-fe5b711de14c" xlink:to="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b097869a-f9fe-4a26-8173-21d784a115d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_us-gaap_CommonStockMember_b097869a-f9fe-4a26-8173-21d784a115d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_01a3015c-575c-4a67-a979-14ce423ee386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_01a3015c-575c-4a67-a979-14ce423ee386" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember_4dae5087-fedf-4adc-9a63-7795020e0664" xlink:href="iclr-20211231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_iclr_OtherUndenominatedCapitalMember_4dae5087-fedf-4adc-9a63-7795020e0664" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_49bf75cd-57dc-43de-8c09-20dcf6eda096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_49bf75cd-57dc-43de-8c09-20dcf6eda096" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9deca998-10a6-41f4-ba6e-27747d0ae691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_us-gaap_RetainedEarningsMember_9deca998-10a6-41f4-ba6e-27747d0ae691" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestMember_8bfe444c-fc49-48de-b988-0ac6e4854115" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_iclr_RedeemableNoncontrollingInterestMember_8bfe444c-fc49-48de-b988-0ac6e4854115" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#DescriptionofbusinessDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="extended" id="i344cd125c7884e61a191aca092ddb4cb_DescriptionofbusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_d8e855b5-8bfb-4522-b932-a991b8ae0efd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_dei_EntityNumberOfEmployees_d8e855b5-8bfb-4522-b932-a991b8ae0efd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations_24c22435-d4c3-46e9-a115-6be175a9a785" xlink:href="iclr-20211231.xsd#iclr_NumberOfLocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_iclr_NumberOfLocations_24c22435-d4c3-46e9-a115-6be175a9a785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_5651df06-05c7-48c3-b353-6bc61a8925d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_5651df06-05c7-48c3-b353-6bc61a8925d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_cc067ae3-4d4b-411b-bed0-053d9b91d87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_cc067ae3-4d4b-411b-bed0-053d9b91d87e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d03beb71-b824-4a83-94a8-0ea13339a078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d03beb71-b824-4a83-94a8-0ea13339a078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d03beb71-b824-4a83-94a8-0ea13339a078_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d03beb71-b824-4a83-94a8-0ea13339a078" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d03beb71-b824-4a83-94a8-0ea13339a078_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ce1ee798-ad31-4f40-a2b1-68a0f8507f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d03beb71-b824-4a83-94a8-0ea13339a078" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ce1ee798-ad31-4f40-a2b1-68a0f8507f38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_0915046e-2926-4e09-8988-36a1b8d5b280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ce1ee798-ad31-4f40-a2b1-68a0f8507f38" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_0915046e-2926-4e09-8988-36a1b8d5b280" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_52393636-0ec2-4eea-8e29-5d88da662fae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:to="loc_srt_StatementGeographicalAxis_52393636-0ec2-4eea-8e29-5d88da662fae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_52393636-0ec2-4eea-8e29-5d88da662fae_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_52393636-0ec2-4eea-8e29-5d88da662fae" xlink:to="loc_srt_SegmentGeographicalDomain_52393636-0ec2-4eea-8e29-5d88da662fae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_52393636-0ec2-4eea-8e29-5d88da662fae" xlink:to="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6c50a238-95fb-4c9e-9acc-acd1810c51c9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:to="loc_country_US_6c50a238-95fb-4c9e-9acc-acd1810c51c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_fd9bdffc-bb15-4b2f-80c5-c47c298662b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:to="loc_srt_EuropeMember_fd9bdffc-bb15-4b2f-80c5-c47c298662b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember_402a4331-0e80-4db0-8737-bcee8b15cc9c" xlink:href="iclr-20211231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:to="loc_iclr_OtherGeographicLocationsMember_402a4331-0e80-4db0-8737-bcee8b15cc9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_57cc8711-852f-408a-9b85-6e7f3d9ae96b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_57cc8711-852f-408a-9b85-6e7f3d9ae96b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_57cc8711-852f-408a-9b85-6e7f3d9ae96b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_57cc8711-852f-408a-9b85-6e7f3d9ae96b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_57cc8711-852f-408a-9b85-6e7f3d9ae96b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11e4f82f-2c0f-4c7a-9706-77ade7e790d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_57cc8711-852f-408a-9b85-6e7f3d9ae96b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11e4f82f-2c0f-4c7a-9706-77ade7e790d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_a9a5e3dd-27b3-4248-bf25-3c36cf49a364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11e4f82f-2c0f-4c7a-9706-77ade7e790d3" xlink:to="loc_us-gaap_SalesRevenueNetMember_a9a5e3dd-27b3-4248-bf25-3c36cf49a364" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#SignificantaccountingpoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails" xlink:type="extended" id="i448cbe8c9521439b82b0322b576a2ec8_SignificantaccountingpoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_6b9ae45c-d0af-4ba3-bd97-47f672119af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_6b9ae45c-d0af-4ba3-bd97-47f672119af3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_57257a8b-6c24-4475-8d97-aff76cd41f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:to="loc_us-gaap_InventoryNet_57257a8b-6c24-4475-8d97-aff76cd41f67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_bee5a7e1-2cea-40c4-b8a6-fafdbf946c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_bee5a7e1-2cea-40c4-b8a6-fafdbf946c84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8dcf05b0-418d-4544-bdde-5597ba59e6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8dcf05b0-418d-4544-bdde-5597ba59e6aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fdeae475-c88f-4fb1-aecb-91006e92dedf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8dcf05b0-418d-4544-bdde-5597ba59e6aa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fdeae475-c88f-4fb1-aecb-91006e92dedf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fdeae475-c88f-4fb1-aecb-91006e92dedf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fdeae475-c88f-4fb1-aecb-91006e92dedf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fdeae475-c88f-4fb1-aecb-91006e92dedf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff4faece-4b56-4ab8-9385-0b3a3a181efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fdeae475-c88f-4fb1-aecb-91006e92dedf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff4faece-4b56-4ab8-9385-0b3a3a181efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MeDiNovaResearchMember_240e3140-e910-49cc-8011-0486ad16fc61" xlink:href="iclr-20211231.xsd#iclr_MeDiNovaResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff4faece-4b56-4ab8-9385-0b3a3a181efd" xlink:to="loc_iclr_MeDiNovaResearchMember_240e3140-e910-49cc-8011-0486ad16fc61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails" xlink:type="extended" id="ic2e60009d5a5439dad330fb8d9fdc359_SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ec85b32-2272-4b0c-be09-12d8134247be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f3959b1b-99be-42d9-9348-b9221ed616b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ec85b32-2272-4b0c-be09-12d8134247be" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f3959b1b-99be-42d9-9348-b9221ed616b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ec85b32-2272-4b0c-be09-12d8134247be" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_6b9e9a05-8ac6-4ee4-9ac1-9a515598489e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_us-gaap_BuildingMember_6b9e9a05-8ac6-4ee4-9ac1-9a515598489e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_c637b1cd-13f7-4714-9470-ba7f6272e259" xlink:href="iclr-20211231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_c637b1cd-13f7-4714-9470-ba7f6272e259" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ed18a8e4-b1b5-4129-bf9a-51c51c8a3b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ed18a8e4-b1b5-4129-bf9a-51c51c8a3b22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_c1f5a205-2ae6-4bbd-94d5-9164c8def31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_us-gaap_EquipmentMember_c1f5a205-2ae6-4bbd-94d5-9164c8def31d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_355c099b-d14d-48cb-9004-c5a2cf684c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_us-gaap_VehiclesMember_355c099b-d14d-48cb-9004-c5a2cf684c28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:to="loc_srt_RangeAxis_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2" xlink:to="loc_srt_RangeMember_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_659f98ed-0e6c-4174-ac57-7ac3d97e22e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2" xlink:to="loc_srt_RangeMember_659f98ed-0e6c-4174-ac57-7ac3d97e22e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6bd0d12d-0171-4b33-af77-2b635770e059" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_659f98ed-0e6c-4174-ac57-7ac3d97e22e7" xlink:to="loc_srt_MinimumMember_6bd0d12d-0171-4b33-af77-2b635770e059" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4d86dc80-7376-454e-bfdc-da329e634c3b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_659f98ed-0e6c-4174-ac57-7ac3d97e22e7" xlink:to="loc_srt_MaximumMember_4d86dc80-7376-454e-bfdc-da329e634c3b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="i60170864b76247049bc4014d1496ab02_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_01b679a8-7da6-49e5-8157-5a790efb7590" xlink:href="iclr-20211231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_01b679a8-7da6-49e5-8157-5a790efb7590" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_ac075432-8d27-4cd3-89d8-4243931632f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_ac075432-8d27-4cd3-89d8-4243931632f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_034777a2-3ec5-4bde-83e5-cf9bbc259c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_034777a2-3ec5-4bde-83e5-cf9bbc259c24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3b8cfc64-d8fe-4721-9972-b878877c2c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3b8cfc64-d8fe-4721-9972-b878877c2c4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments_a8f2d5b0-9a10-41c8-b4b5-ce26d367ba60" xlink:href="iclr-20211231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_iclr_CommitmentToAcquireLongTermInvestments_a8f2d5b0-9a10-41c8-b4b5-ce26d367ba60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_db4e696a-780b-46c8-ae76-e5ef9f171da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_EquityMethodInvestments_db4e696a-780b-46c8-ae76-e5ef9f171da2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0a29ce61-0a69-4723-966a-fa038ac8f298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0a29ce61-0a69-4723-966a-fa038ac8f298" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_8467eafb-dd69-4cab-8b92-a22967cdb0f6" xlink:href="iclr-20211231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_8467eafb-dd69-4cab-8b92-a22967cdb0f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b8047077-a3f0-44d8-b131-213bc92245ea" xlink:href="iclr-20211231.xsd#iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b8047077-a3f0-44d8-b131-213bc92245ea" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dedc6167-1bef-4c6c-b204-77aced67afb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dedc6167-1bef-4c6c-b204-77aced67afb2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_996e4835-5646-4811-ad96-c4bf5352a18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_996e4835-5646-4811-ad96-c4bf5352a18e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_3fc8afc0-ed63-49ec-a51e-03af3a9f7778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_3fc8afc0-ed63-49ec-a51e-03af3a9f7778" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bbe38a6d-8eaa-4dcc-8d93-b0747cc61ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bbe38a6d-8eaa-4dcc-8d93-b0747cc61ff7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bbe38a6d-8eaa-4dcc-8d93-b0747cc61ff7" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d6c76a7d-ba19-47d5-836e-4cdf2f7fab54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d6c76a7d-ba19-47d5-836e-4cdf2f7fab54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_906c6cb7-955f-4432-bea5-7a1a73a6a91f" xlink:href="iclr-20211231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d6c76a7d-ba19-47d5-836e-4cdf2f7fab54" xlink:to="loc_iclr_OncacareMember_906c6cb7-955f-4432-bea5-7a1a73a6a91f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails" xlink:type="extended" id="i2bb703a2fffe4c349b34950f66d61fa1_InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2a67b614-a681-4864-825e-6637fe1048dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2a67b614-a681-4864-825e-6637fe1048dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_72e96850-35c1-4f8a-b969-0cd90438ce20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_72e96850-35c1-4f8a-b969-0cd90438ce20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_69675350-f537-4b28-9099-b8395fe0e761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_69675350-f537-4b28-9099-b8395fe0e761" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_086c14ab-9020-4cb1-8f0f-acdf2d0f45d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_086c14ab-9020-4cb1-8f0f-acdf2d0f45d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_494f6a7a-9143-4b62-93b1-908fe0cb34b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_494f6a7a-9143-4b62-93b1-908fe0cb34b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c2563fae-2d70-46f0-b31e-a8408b068296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_494f6a7a-9143-4b62-93b1-908fe0cb34b5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c2563fae-2d70-46f0-b31e-a8408b068296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c2563fae-2d70-46f0-b31e-a8408b068296_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c2563fae-2d70-46f0-b31e-a8408b068296" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c2563fae-2d70-46f0-b31e-a8408b068296_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0b6a8e0-e044-48e1-b869-d3a87b27b365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c2563fae-2d70-46f0-b31e-a8408b068296" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0b6a8e0-e044-48e1-b869-d3a87b27b365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermDepositsMember_4b4d98a1-a87f-4a3f-a8ee-788d0e4df7e6" xlink:href="iclr-20211231.xsd#iclr_TermDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0b6a8e0-e044-48e1-b869-d3a87b27b365" xlink:to="loc_iclr_TermDepositsMember_4b4d98a1-a87f-4a3f-a8ee-788d0e4df7e6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended" id="i74a01bdf9dca4b1485fff19ffc720a2f_IntangibleAssetsSummaryofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_78d67eaf-e3e0-4fbf-9573-3fb744f1b282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_78d67eaf-e3e0-4fbf-9573-3fb744f1b282" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_de86b3bc-d7f0-4189-9d31-ba1de1f3fa46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_de86b3bc-d7f0-4189-9d31-ba1de1f3fa46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ea9a5f61-766a-4823-9578-023117b5a8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ea9a5f61-766a-4823-9578-023117b5a8a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_711c3279-5675-4178-ad6f-7e83d327cda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_711c3279-5675-4178-ad6f-7e83d327cda5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bf6c0a83-093e-403c-a8a7-50fc97c19180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_711c3279-5675-4178-ad6f-7e83d327cda5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bf6c0a83-093e-403c-a8a7-50fc97c19180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf6c0a83-093e-403c-a8a7-50fc97c19180_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bf6c0a83-093e-403c-a8a7-50fc97c19180" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf6c0a83-093e-403c-a8a7-50fc97c19180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bf6c0a83-093e-403c-a8a7-50fc97c19180" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_556923be-c532-4898-886b-1de4eff5533d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_CustomerRelationshipsMember_556923be-c532-4898-886b-1de4eff5533d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_21fed44e-475a-4050-b60b-2cf989d5a0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_21fed44e-475a-4050-b60b-2cf989d5a0a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ad0bc0cc-5e68-4cbe-851c-b855ca59a07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_TradeNamesMember_ad0bc0cc-5e68-4cbe-851c-b855ca59a07d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_cc882de7-884a-4949-a610-10b38a822dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_DatabasesMember_cc882de7-884a-4949-a610-10b38a822dc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f45681bb-4b54-4a5a-9da4-737dd2985c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f45681bb-4b54-4a5a-9da4-737dd2985c94" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended" id="i0cc5786283d34265bd97952547d647be_IntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ef20c3d8-acf4-4991-b628-388c8265d7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ef20c3d8-acf4-4991-b628-388c8265d7d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6ca34707-7a7b-4a8e-a4c7-e7198c4e71ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6ca34707-7a7b-4a8e-a4c7-e7198c4e71ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9a709bac-da1b-4c58-8138-ab4166509070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9a709bac-da1b-4c58-8138-ab4166509070" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_64cc3df3-611f-4a58-a216-5371bdedd782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_64cc3df3-611f-4a58-a216-5371bdedd782" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e19d31fc-1a6c-4870-9e65-44d22cbc292d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e19d31fc-1a6c-4870-9e65-44d22cbc292d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e19d31fc-1a6c-4870-9e65-44d22cbc292d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e19d31fc-1a6c-4870-9e65-44d22cbc292d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e19d31fc-1a6c-4870-9e65-44d22cbc292d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53203016-8fa6-4e7a-a869-53ab7ea41d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e19d31fc-1a6c-4870-9e65-44d22cbc292d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53203016-8fa6-4e7a-a869-53ab7ea41d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_8096ff42-62af-4241-8c1e-1b60d64f2b55" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53203016-8fa6-4e7a-a869-53ab7ea41d95" xlink:to="loc_iclr_PRAHealthSciencesIncMember_8096ff42-62af-4241-8c1e-1b60d64f2b55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember_411b0520-221b-4e80-a640-bae00badfd58" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53203016-8fa6-4e7a-a869-53ab7ea41d95" xlink:to="loc_iclr_MedpassGroupLimitedMember_411b0520-221b-4e80-a640-bae00badfd58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ea78864-b6fc-4bbe-ae95-50b2ce830afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ea78864-b6fc-4bbe-ae95-50b2ce830afa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ea78864-b6fc-4bbe-ae95-50b2ce830afa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ea78864-b6fc-4bbe-ae95-50b2ce830afa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ea78864-b6fc-4bbe-ae95-50b2ce830afa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ea78864-b6fc-4bbe-ae95-50b2ce830afa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2d7fc7bc-0651-414c-9fff-d9a26b9cb408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2d7fc7bc-0651-414c-9fff-d9a26b9cb408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_998ab98f-5739-4ec7-b07b-1d7d68b1f94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_998ab98f-5739-4ec7-b07b-1d7d68b1f94d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a465a660-15fa-4ad3-b3d2-95bb26fd7074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_TradeNamesMember_a465a660-15fa-4ad3-b3d2-95bb26fd7074" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_97706b51-dae7-4ccf-ac8d-10b6f469a4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_DatabasesMember_97706b51-dae7-4ccf-ac8d-10b6f469a4c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_640e4b1a-a251-43a4-b1bf-252cba02f7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_640e4b1a-a251-43a4-b1bf-252cba02f7dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_08db1676-e831-4679-b9f5-de44f79d3a9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:to="loc_srt_RangeAxis_08db1676-e831-4679-b9f5-de44f79d3a9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_08db1676-e831-4679-b9f5-de44f79d3a9d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_08db1676-e831-4679-b9f5-de44f79d3a9d" xlink:to="loc_srt_RangeMember_08db1676-e831-4679-b9f5-de44f79d3a9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_098a27f3-701a-4f9a-9f05-925efd6ed0d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_08db1676-e831-4679-b9f5-de44f79d3a9d" xlink:to="loc_srt_RangeMember_098a27f3-701a-4f9a-9f05-925efd6ed0d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_73a59527-43c1-47d6-8764-8297e6f711ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_098a27f3-701a-4f9a-9f05-925efd6ed0d7" xlink:to="loc_srt_MinimumMember_73a59527-43c1-47d6-8764-8297e6f711ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_32d2d5ca-c2da-4863-8434-52bfccb6909d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_098a27f3-701a-4f9a-9f05-925efd6ed0d7" xlink:to="loc_srt_MaximumMember_32d2d5ca-c2da-4863-8434-52bfccb6909d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsNarrativePRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails" xlink:type="extended" id="ie0cc94662195415cbd2574fd6e34d38d_BusinesscombinationsNarrativePRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_228e3629-0fc2-46f1-837d-4be5ec260179" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_dei_EntityNumberOfEmployees_228e3629-0fc2-46f1-837d-4be5ec260179" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_67dd07aa-59cf-4121-ae7e-338a2bcfe2a3" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_67dd07aa-59cf-4121-ae7e-338a2bcfe2a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_5ee1702e-64f2-4fe4-b215-d9572f44a952" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_5ee1702e-64f2-4fe4-b215-d9572f44a952" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fe40abe2-4cca-45ba-b45f-ef996dc1584c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fe40abe2-4cca-45ba-b45f-ef996dc1584c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_29cd9144-6905-4da0-8f4f-1d02d25665db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_29cd9144-6905-4da0-8f4f-1d02d25665db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9c27ef57-a58d-4070-a12d-f7893525f7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_InterestExpense_9c27ef57-a58d-4070-a12d-f7893525f7f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_accf99b4-6c52-4697-be68-32b5ca86b486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_accf99b4-6c52-4697-be68-32b5ca86b486" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_5b7af423-f0c3-49d2-8832-b589e1588265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_5b7af423-f0c3-49d2-8832-b589e1588265" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual_a909130f-62fc-4bb9-9ecf-c53505a1db4c" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual_a909130f-62fc-4bb9-9ecf-c53505a1db4c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_2bc53d40-832b-414b-bb40-f7f1f79d3b79" xlink:href="iclr-20211231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_2bc53d40-832b-414b-bb40-f7f1f79d3b79" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_908c1006-f6ef-4a28-903d-dc45dc7726dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_908c1006-f6ef-4a28-903d-dc45dc7726dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0f0cfa75-23b6-4846-a842-e1809e3da56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_908c1006-f6ef-4a28-903d-dc45dc7726dd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0f0cfa75-23b6-4846-a842-e1809e3da56c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f0cfa75-23b6-4846-a842-e1809e3da56c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f0cfa75-23b6-4846-a842-e1809e3da56c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f0cfa75-23b6-4846-a842-e1809e3da56c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4afdf00-0551-4c89-9607-f8b3cb50c187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f0cfa75-23b6-4846-a842-e1809e3da56c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4afdf00-0551-4c89-9607-f8b3cb50c187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_cddaa2a8-3563-49a8-a269-708eb99b0493" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4afdf00-0551-4c89-9607-f8b3cb50c187" xlink:to="loc_iclr_PRAHealthSciencesIncMember_cddaa2a8-3563-49a8-a269-708eb99b0493" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended" id="i5fcc89f6785545f2832791fb3305d596_BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9eac9072-29a0-45a4-aad8-61c58e80138d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9eac9072-29a0-45a4-aad8-61c58e80138d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_acdcfa18-3998-4fa3-be68-9373dc5b7388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_acdcfa18-3998-4fa3-be68-9373dc5b7388" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_afd93d58-9c32-4f84-a9f4-bc98a2e52906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_afd93d58-9c32-4f84-a9f4-bc98a2e52906" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_01b39f0d-6204-4d4a-83a4-b470a50eb1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_01b39f0d-6204-4d4a-83a4-b470a50eb1ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3d6a16ce-867d-42ae-b263-571c65a6dc89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3d6a16ce-867d-42ae-b263-571c65a6dc89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_f34575c0-9ecf-4c4b-8e31-3fb40aa0f91c" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_f34575c0-9ecf-4c4b-8e31-3fb40aa0f91c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93c62576-1a0b-445f-b64a-3a7c49916bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93c62576-1a0b-445f-b64a-3a7c49916bb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_be0cd952-cfb6-4a4c-9fd5-74d5935d637f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93c62576-1a0b-445f-b64a-3a7c49916bb2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_be0cd952-cfb6-4a4c-9fd5-74d5935d637f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be0cd952-cfb6-4a4c-9fd5-74d5935d637f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be0cd952-cfb6-4a4c-9fd5-74d5935d637f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_be0cd952-cfb6-4a4c-9fd5-74d5935d637f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fb3c026-a30b-44ab-bd58-5c20a2def684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be0cd952-cfb6-4a4c-9fd5-74d5935d637f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fb3c026-a30b-44ab-bd58-5c20a2def684" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_25518024-4f60-4f09-84b5-bc8cb509b48c" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fb3c026-a30b-44ab-bd58-5c20a2def684" xlink:to="loc_iclr_PRAHealthSciencesIncMember_25518024-4f60-4f09-84b5-bc8cb509b48c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended" id="ia289d219900045499ff38bc0dd8b8bdf_BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ba16ee24-1bfe-4778-8180-6cf5f8f1d18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ba16ee24-1bfe-4778-8180-6cf5f8f1d18e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_465491fe-9aa5-4a14-be28-34aed3d81d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_465491fe-9aa5-4a14-be28-34aed3d81d14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_eee07fb4-75f7-4bb9-9f4b-fddfd3c8f813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_eee07fb4-75f7-4bb9-9f4b-fddfd3c8f813" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e897bdd6-5791-4359-9bb4-1192b939dac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e897bdd6-5791-4359-9bb4-1192b939dac3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_ea10577b-150b-497e-8c06-868caad5d5cd" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_ea10577b-150b-497e-8c06-868caad5d5cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c069c62c-6760-46d9-a992-91b98b9b2d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_Goodwill_c069c62c-6760-46d9-a992-91b98b9b2d66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2e55bc01-54ac-42bc-aa63-ff0b5dcf6ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2e55bc01-54ac-42bc-aa63-ff0b5dcf6ef0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e41c0c5c-e973-4bc1-af2c-375af99619b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e41c0c5c-e973-4bc1-af2c-375af99619b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f40f01e2-b8f9-4da2-ab20-7787811193f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f40f01e2-b8f9-4da2-ab20-7787811193f6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a5731e9b-c502-42a3-88f5-020a6bf3d180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a5731e9b-c502-42a3-88f5-020a6bf3d180" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_8fd86fc7-d092-4863-adb1-d581653533a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_8fd86fc7-d092-4863-adb1-d581653533a3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_8e90529b-1480-4465-884c-ef833daffb1b" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_8e90529b-1480-4465-884c-ef833daffb1b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_8f11d881-4aa5-4103-adba-3264e0f962c5" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_8f11d881-4aa5-4103-adba-3264e0f962c5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_a14528c7-dca7-49dc-9580-0fd0280e4119" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_a14528c7-dca7-49dc-9580-0fd0280e4119" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0444f6f6-19be-4699-9a9d-52636ff2afc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0444f6f6-19be-4699-9a9d-52636ff2afc0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_096e183d-9c2b-4db2-921b-2a21cc79320c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_096e183d-9c2b-4db2-921b-2a21cc79320c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_bbdba907-7ce4-4621-b0be-14a28ffcd777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_bbdba907-7ce4-4621-b0be-14a28ffcd777" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2bbac4e6-a041-4497-8274-d395d967f016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2bbac4e6-a041-4497-8274-d395d967f016" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_88631924-f421-4a49-9712-6e8a7c438c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_88631924-f421-4a49-9712-6e8a7c438c08" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2262b55c-c76b-4471-8884-47c91b0725c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_88631924-f421-4a49-9712-6e8a7c438c08" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2262b55c-c76b-4471-8884-47c91b0725c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2262b55c-c76b-4471-8884-47c91b0725c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2262b55c-c76b-4471-8884-47c91b0725c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2262b55c-c76b-4471-8884-47c91b0725c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4601519-6a10-4cc9-9ccc-517c9cc24e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2262b55c-c76b-4471-8884-47c91b0725c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4601519-6a10-4cc9-9ccc-517c9cc24e7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_4bbfe7f6-ea02-4e91-9223-53bdfe7960b0" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4601519-6a10-4cc9-9ccc-517c9cc24e7c" xlink:to="loc_iclr_PRAHealthSciencesIncMember_4bbfe7f6-ea02-4e91-9223-53bdfe7960b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="extended" id="if8c7515bf74a457792d6d1d82abffd86_BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d36b3910-bb01-4e1c-b8d3-dae45f31d099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_41cf105a-a7a8-4613-bb29-39b33c469f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d36b3910-bb01-4e1c-b8d3-dae45f31d099" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_41cf105a-a7a8-4613-bb29-39b33c469f81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0be27567-7640-4cba-af51-9faeb6241817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d36b3910-bb01-4e1c-b8d3-dae45f31d099" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0be27567-7640-4cba-af51-9faeb6241817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d36b3910-bb01-4e1c-b8d3-dae45f31d099" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bd9297a5-23a6-4859-b7b6-9634292017a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bd9297a5-23a6-4859-b7b6-9634292017a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bd9297a5-23a6-4859-b7b6-9634292017a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd9297a5-23a6-4859-b7b6-9634292017a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bd9297a5-23a6-4859-b7b6-9634292017a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed802be7-3b04-4df5-ae51-4aa166cd8344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd9297a5-23a6-4859-b7b6-9634292017a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed802be7-3b04-4df5-ae51-4aa166cd8344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_a2f4ad46-20b9-42d8-8306-9d0106a1561e" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed802be7-3b04-4df5-ae51-4aa166cd8344" xlink:to="loc_iclr_PRAHealthSciencesIncMember_a2f4ad46-20b9-42d8-8306-9d0106a1561e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ee7b4f7c-98ba-4e14-ba9b-64498e8aa77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ee7b4f7c-98ba-4e14-ba9b-64498e8aa77b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_3fb6af56-4436-4708-a735-ea0a2596c580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_3fb6af56-4436-4708-a735-ea0a2596c580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_92118354-468b-47d5-8c15-1a4b5e4fcb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_TradeNamesMember_92118354-468b-47d5-8c15-1a4b5e4fcb9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_3e8ff900-ffaa-4b97-bbe7-07d4fd2d5320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_DatabasesMember_3e8ff900-ffaa-4b97-bbe7-07d4fd2d5320" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_9141322c-f935-4990-8558-ad4fce7c5fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_9141322c-f935-4990-8558-ad4fce7c5fdc" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="extended" id="i7621a63fe1e543348bb46a5a40e24bac_BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_80c18041-4905-4784-870b-44b713e61395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_b78f9343-fa3a-46c8-a0ff-fa5742fa4aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_80c18041-4905-4784-870b-44b713e61395" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_b78f9343-fa3a-46c8-a0ff-fa5742fa4aad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f7b58412-f4c1-427b-a096-ed258455711c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_80c18041-4905-4784-870b-44b713e61395" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f7b58412-f4c1-427b-a096-ed258455711c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb506d8b-cc56-4019-a32b-49dcab1db96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_80c18041-4905-4784-870b-44b713e61395" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb506d8b-cc56-4019-a32b-49dcab1db96e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb506d8b-cc56-4019-a32b-49dcab1db96e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a882123-b3b2-45b2-9cf6-2995e465e50d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a882123-b3b2-45b2-9cf6-2995e465e50d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_3f38cd46-5f2e-4342-80c7-9a3a76c75a2a" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a882123-b3b2-45b2-9cf6-2995e465e50d" xlink:to="loc_iclr_PRAHealthSciencesIncMember_3f38cd46-5f2e-4342-80c7-9a3a76c75a2a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails" xlink:type="extended" id="i13bedc9393fc40ab8729d84f0846f04b_BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_268e4aaf-1f62-42a5-9e3c-3aa37cc531cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_268e4aaf-1f62-42a5-9e3c-3aa37cc531cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables_2319eca6-5756-4c41-b192-796f25437652" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables_2319eca6-5756-4c41-b192-796f25437652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue_698e41d5-f597-44da-ab87-63e9875bb073" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue_698e41d5-f597-44da-ab87-63e9875bb073" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets_af7bf7aa-095f-4271-988a-499d603f1a06" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets_af7bf7aa-095f-4271-988a-499d603f1a06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4028c884-fc8b-4c79-b63f-06c5da7cdd8f" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4028c884-fc8b-4c79-b63f-06c5da7cdd8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities_dec487e3-4284-416d-b27c-b1eeddbd37b1" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities_dec487e3-4284-416d-b27c-b1eeddbd37b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities_24514bdb-d030-4a7d-9ef6-0d84d84e43bf" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities_24514bdb-d030-4a7d-9ef6-0d84d84e43bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability_3b7175c0-4387-4d65-91a2-9c0aa20d1ffb" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability_3b7175c0-4387-4d65-91a2-9c0aa20d1ffb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_d0d2d47a-1682-4105-8628-3f466a0b90a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_d0d2d47a-1682-4105-8628-3f466a0b90a8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_10303fb6-0b8e-433c-8130-73abdc981081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_10303fb6-0b8e-433c-8130-73abdc981081" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c97d96de-b45b-464e-ad4b-e02ba2fc4203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c97d96de-b45b-464e-ad4b-e02ba2fc4203" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_547151cf-60a2-462d-b4d9-716a7d025dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c97d96de-b45b-464e-ad4b-e02ba2fc4203" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_547151cf-60a2-462d-b4d9-716a7d025dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_547151cf-60a2-462d-b4d9-716a7d025dd0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_547151cf-60a2-462d-b4d9-716a7d025dd0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_547151cf-60a2-462d-b4d9-716a7d025dd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ae8991b-4acf-45bd-8c7e-1d11406706ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_547151cf-60a2-462d-b4d9-716a7d025dd0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ae8991b-4acf-45bd-8c7e-1d11406706ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember_cf959184-276e-41a8-af9d-bc66cba9ec1a" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ae8991b-4acf-45bd-8c7e-1d11406706ae" xlink:to="loc_iclr_MedpassGroupLimitedMember_cf959184-276e-41a8-af9d-bc66cba9ec1a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails" xlink:type="extended" id="i6a8d62ddf13c4bbc95a95412be7a7949_BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b502e4d9-3069-4fde-84e7-7f7f46e9a5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b502e4d9-3069-4fde-84e7-7f7f46e9a5e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_61b46693-e1d9-43d8-8345-55d9816c113b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_61b46693-e1d9-43d8-8345-55d9816c113b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_66737245-9870-483a-9f0d-fd438eec2a50" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_66737245-9870-483a-9f0d-fd438eec2a50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d849c45e-032c-4e8b-8a97-64671b30e3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_Goodwill_d849c45e-032c-4e8b-8a97-64671b30e3f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1a676dae-4579-480c-ad98-5f236df2dc96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1a676dae-4579-480c-ad98-5f236df2dc96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e703a54d-b644-485a-a42b-cca601a066ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e703a54d-b644-485a-a42b-cca601a066ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_329c77e2-e6b1-4640-8b0b-bdcbbaeb764a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_329c77e2-e6b1-4640-8b0b-bdcbbaeb764a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_71e64a53-070f-46c8-a89a-bb8e44e0a55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_71e64a53-070f-46c8-a89a-bb8e44e0a55e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_ccb72c73-fc73-4863-be93-3240825824b9" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_ccb72c73-fc73-4863-be93-3240825824b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_b370e26d-be19-4258-a361-4419140d6eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_b370e26d-be19-4258-a361-4419140d6eac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_26b77698-362c-4e55-be2d-c2b1216a1d16" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_26b77698-362c-4e55-be2d-c2b1216a1d16" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_7229512b-73b6-48c3-9d32-dca0aafe54d3" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_7229512b-73b6-48c3-9d32-dca0aafe54d3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4e8c59a5-579d-4be9-b35c-37b8e3a614ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4e8c59a5-579d-4be9-b35c-37b8e3a614ca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9641a136-0c6c-4f83-9530-fe9044c290de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9641a136-0c6c-4f83-9530-fe9044c290de" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_60e1234f-5102-47f6-97df-e91b931223bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_60e1234f-5102-47f6-97df-e91b931223bc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments_8964f283-eb3b-4c0d-a10a-421ce0a617f7" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments_8964f283-eb3b-4c0d-a10a-421ce0a617f7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_87e9e5ba-c4d6-4344-9b16-526f9f80f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_87e9e5ba-c4d6-4344-9b16-526f9f80f4da" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_06b98fce-77f6-4b06-844b-55791c2dd113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_06b98fce-77f6-4b06-844b-55791c2dd113" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_109709b2-c49d-4a69-affd-79c00ba3d496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_109709b2-c49d-4a69-affd-79c00ba3d496" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_c5905b95-b0f3-4f73-825f-c2d723d8d6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_c5905b95-b0f3-4f73-825f-c2d723d8d6bd" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14d8e4ee-5f19-4710-a7aa-34e8839afae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14d8e4ee-5f19-4710-a7aa-34e8839afae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14d8e4ee-5f19-4710-a7aa-34e8839afae7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14d8e4ee-5f19-4710-a7aa-34e8839afae7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_14d8e4ee-5f19-4710-a7aa-34e8839afae7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efdc8568-79c8-40a7-aef6-93f20d04409b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14d8e4ee-5f19-4710-a7aa-34e8839afae7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efdc8568-79c8-40a7-aef6-93f20d04409b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember_8dd3680d-0cc8-45e5-838a-e11c602b9094" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efdc8568-79c8-40a7-aef6-93f20d04409b" xlink:to="loc_iclr_MedpassGroupLimitedMember_8dd3680d-0cc8-45e5-838a-e11c602b9094" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b556b770-9336-4600-9180-77c117924a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b556b770-9336-4600-9180-77c117924a7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b556b770-9336-4600-9180-77c117924a7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b556b770-9336-4600-9180-77c117924a7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b556b770-9336-4600-9180-77c117924a7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38588fd8-821a-4ac0-853b-43236425c77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b556b770-9336-4600-9180-77c117924a7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38588fd8-821a-4ac0-853b-43236425c77b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_83703873-071e-4fb2-92dc-07827a4ecb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38588fd8-821a-4ac0-853b-43236425c77b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_83703873-071e-4fb2-92dc-07827a4ecb4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_2f609f2f-0041-4fc9-884a-ab0b6bdff850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38588fd8-821a-4ac0-853b-43236425c77b" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_2f609f2f-0041-4fc9-884a-ab0b6bdff850" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails" xlink:type="extended" id="i7b89bbf766344e028e9eaf5a40c4f131_BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b3c4eb45-87a4-4513-ba41-bd9266a08049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_bb9ca3a2-157d-48d2-849a-c0ad9c517595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3c4eb45-87a4-4513-ba41-bd9266a08049" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_bb9ca3a2-157d-48d2-849a-c0ad9c517595" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_56855dd8-fe6d-4da4-ac64-eb9c05f3d494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3c4eb45-87a4-4513-ba41-bd9266a08049" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_56855dd8-fe6d-4da4-ac64-eb9c05f3d494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_563cde77-1309-48db-b81e-23e2deef8b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3c4eb45-87a4-4513-ba41-bd9266a08049" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_563cde77-1309-48db-b81e-23e2deef8b93" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_867d3d3c-026c-4eea-a334-e16f8670e884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_563cde77-1309-48db-b81e-23e2deef8b93" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_867d3d3c-026c-4eea-a334-e16f8670e884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_867d3d3c-026c-4eea-a334-e16f8670e884_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_867d3d3c-026c-4eea-a334-e16f8670e884" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_867d3d3c-026c-4eea-a334-e16f8670e884_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c60def2b-2cbc-4526-af76-e9916b2b5724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_867d3d3c-026c-4eea-a334-e16f8670e884" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c60def2b-2cbc-4526-af76-e9916b2b5724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember_a0a1c7d7-7940-48e1-9542-29c0a16d2461" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c60def2b-2cbc-4526-af76-e9916b2b5724" xlink:to="loc_iclr_MedpassGroupLimitedMember_a0a1c7d7-7940-48e1-9542-29c0a16d2461" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended" id="i3289e9884b2646a9b1b52c48d91c725b_EmployeeBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9a3c7a25-7e47-4bd9-85b9-876c316040a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9a3c7a25-7e47-4bd9-85b9-876c316040a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_db40baf6-bf17-4795-9a4d-57142bd0dbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_db40baf6-bf17-4795-9a4d-57142bd0dbd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_52ed2698-3f5a-4de6-94e0-4fb32ed210b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_52ed2698-3f5a-4de6-94e0-4fb32ed210b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_fc525cf0-b1a7-41d2-8172-8f16cd840069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_fc525cf0-b1a7-41d2-8172-8f16cd840069" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_26c99a65-3e47-411a-89ef-b473e544af6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_26c99a65-3e47-411a-89ef-b473e544af6a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_2fbb0e3f-88b2-4604-ac79-0bc429d7a3bb" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_2fbb0e3f-88b2-4604-ac79-0bc429d7a3bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_62b24467-e5b1-4ef1-afa2-85bc93771093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_62b24467-e5b1-4ef1-afa2-85bc93771093" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_089d2543-d286-4701-8152-02a5fe677c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_089d2543-d286-4701-8152-02a5fe677c83" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4e31ef75-f7e7-4b59-877f-952ad6c5728c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4e31ef75-f7e7-4b59-877f-952ad6c5728c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod_5eb1d401-03e7-4d32-a1a1-bb8ffeba8048" xlink:href="iclr-20211231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_iclr_ExpectedRetirementPeriod_5eb1d401-03e7-4d32-a1a1-bb8ffeba8048" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_e0ffe56c-c92d-47a5-96b4-5c253462d7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_e0ffe56c-c92d-47a5-96b4-5c253462d7ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_583aac41-a86c-4bc5-aad9-d6477587a4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_583aac41-a86c-4bc5-aad9-d6477587a4a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_583aac41-a86c-4bc5-aad9-d6477587a4a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_583aac41-a86c-4bc5-aad9-d6477587a4a8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_583aac41-a86c-4bc5-aad9-d6477587a4a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca999cdd-674b-45fe-aca6-f8837b61cdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_583aac41-a86c-4bc5-aad9-d6477587a4a8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca999cdd-674b-45fe-aca6-f8837b61cdb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca999cdd-674b-45fe-aca6-f8837b61cdb2" xlink:to="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_62c74ec6-2d87-4edc-ad84-49e2caca3044" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:to="loc_country_US_62c74ec6-2d87-4edc-ad84-49e2caca3044" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_4a0aac0f-6942-48a1-8b69-3eee9a90b170" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:to="loc_country_GB_4a0aac0f-6942-48a1-8b69-3eee9a90b170" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_5e965077-26ee-4937-adb5-d83557da30a9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:to="loc_country_CH_5e965077-26ee-4937-adb5-d83557da30a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_a35e880e-79ee-4896-9536-15eb89701fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_RetirementPlanNameAxis_a35e880e-79ee-4896-9536-15eb89701fb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_a35e880e-79ee-4896-9536-15eb89701fb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_a35e880e-79ee-4896-9536-15eb89701fb7" xlink:to="loc_us-gaap_RetirementPlanNameDomain_a35e880e-79ee-4896-9536-15eb89701fb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_a35e880e-79ee-4896-9536-15eb89701fb7" xlink:to="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember_80bfb5e9-cb9e-4ca5-ae50-44f6016bfe22" xlink:href="iclr-20211231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:to="loc_iclr_OtherRetirementPlansMember_80bfb5e9-cb9e-4ca5-ae50-44f6016bfe22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_492e3a11-168a-486c-a57e-01791d310860" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_492e3a11-168a-486c-a57e-01791d310860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_b0443d92-775e-45b0-b2f5-1e944140b93a" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_b0443d92-775e-45b0-b2f5-1e944140b93a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9646777e-7fe8-46fd-87dc-03ea45f81121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9646777e-7fe8-46fd-87dc-03ea45f81121" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_9646777e-7fe8-46fd-87dc-03ea45f81121_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9646777e-7fe8-46fd-87dc-03ea45f81121" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_9646777e-7fe8-46fd-87dc-03ea45f81121_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9646777e-7fe8-46fd-87dc-03ea45f81121" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_4a4ccbb8-6489-4460-8d50-0e723b11a70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:to="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_4a4ccbb8-6489-4460-8d50-0e723b11a70d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d3b4473c-6210-498e-a997-0114afea2821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d3b4473c-6210-498e-a997-0114afea2821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_HighYieldBondsMember_72e1a7c5-a27e-405b-bbbd-3839b65d8e77" xlink:href="iclr-20211231.xsd#iclr_HighYieldBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:to="loc_iclr_HighYieldBondsMember_72e1a7c5-a27e-405b-bbbd-3839b65d8e77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e6bc20c9-de53-4e85-b28d-464d389976bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e6bc20c9-de53-4e85-b28d-464d389976bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5fc51a97-dfdc-4435-8810-f40dd97d2f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5fc51a97-dfdc-4435-8810-f40dd97d2f05" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5fc51a97-dfdc-4435-8810-f40dd97d2f05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5fc51a97-dfdc-4435-8810-f40dd97d2f05" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5fc51a97-dfdc-4435-8810-f40dd97d2f05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_999297f0-bffa-40c1-a124-64060401de83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5fc51a97-dfdc-4435-8810-f40dd97d2f05" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_999297f0-bffa-40c1-a124-64060401de83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember_dc41908d-314d-45fa-9b3c-2b9419aa4e92" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_999297f0-bffa-40c1-a124-64060401de83" xlink:to="loc_iclr_AptivSolutionsMember_dc41908d-314d-45fa-9b3c-2b9419aa4e92" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended" id="if7b808a40b6544a1ae960be46fe01130_EmployeeBenefitsFundedStatusDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_09910e38-d795-4308-bbee-8423cca0a90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_09910e38-d795-4308-bbee-8423cca0a90c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_80eaffcb-854e-403a-a157-dcd1f8a3ffd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_80eaffcb-854e-403a-a157-dcd1f8a3ffd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8502cd13-5d44-4647-9bf0-117767d3de30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8502cd13-5d44-4647-9bf0-117767d3de30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_048dad94-b83f-4c6d-9fcc-c69e828b234b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_048dad94-b83f-4c6d-9fcc-c69e828b234b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_cdb64ddd-8abe-4b0f-905f-4a14b9747e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_cdb64ddd-8abe-4b0f-905f-4a14b9747e50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_cdb64ddd-8abe-4b0f-905f-4a14b9747e50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_cdb64ddd-8abe-4b0f-905f-4a14b9747e50" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_cdb64ddd-8abe-4b0f-905f-4a14b9747e50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce5b5fda-3109-4f65-a765-e9b5a0bbf79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_cdb64ddd-8abe-4b0f-905f-4a14b9747e50" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce5b5fda-3109-4f65-a765-e9b5a0bbf79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5f0aeb54-8dc4-4117-a7a1-ec84b35284eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce5b5fda-3109-4f65-a765-e9b5a0bbf79d" xlink:to="loc_us-gaap_ForeignPlanMember_5f0aeb54-8dc4-4117-a7a1-ec84b35284eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_19ca4e47-724c-4535-a514-99dae3605db3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5f0aeb54-8dc4-4117-a7a1-ec84b35284eb" xlink:to="loc_country_GB_19ca4e47-724c-4535-a514-99dae3605db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_914862d9-a098-4584-953e-6ff0ef0b0c91" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5f0aeb54-8dc4-4117-a7a1-ec84b35284eb" xlink:to="loc_country_CH_914862d9-a098-4584-953e-6ff0ef0b0c91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_581abc8f-c259-415e-8a47-4102d6cbc896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:to="loc_us-gaap_RetirementPlanNameAxis_581abc8f-c259-415e-8a47-4102d6cbc896" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_581abc8f-c259-415e-8a47-4102d6cbc896_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_581abc8f-c259-415e-8a47-4102d6cbc896" xlink:to="loc_us-gaap_RetirementPlanNameDomain_581abc8f-c259-415e-8a47-4102d6cbc896_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_581abc8f-c259-415e-8a47-4102d6cbc896" xlink:to="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_5ecf7122-4eaa-44c3-8896-ca435fa3d6da" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_5ecf7122-4eaa-44c3-8896-ca435fa3d6da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_446709f4-c382-4138-ad42-46058ff6b22c" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_446709f4-c382-4138-ad42-46058ff6b22c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_d973f14a-6cb2-4fce-a67d-f168c428b5a2" xlink:href="iclr-20211231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_d973f14a-6cb2-4fce-a67d-f168c428b5a2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsChangeinBenefitObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="extended" id="ia83f9e8f2bc2477aa3c6969358bf4d13_EmployeeBenefitsChangeinBenefitObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_179676b4-6fd2-47a9-a526-1763857390d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_179676b4-6fd2-47a9-a526-1763857390d0" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0085676b-5331-41f1-be5a-d5e520b780a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0085676b-5331-41f1-be5a-d5e520b780a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_00cc7d2e-2892-4f2a-9e90-8dde8b1d1166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_00cc7d2e-2892-4f2a-9e90-8dde8b1d1166" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_ad23de1d-4478-4c75-a3b7-29aef54364c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_ad23de1d-4478-4c75-a3b7-29aef54364c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_83c29e47-82a1-4ec1-ba6e-a3c93f982f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_83c29e47-82a1-4ec1-ba6e-a3c93f982f9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_677ef52f-d997-4f9d-b97b-d02c57b4a0be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_677ef52f-d997-4f9d-b97b-d02c57b4a0be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_255a53f2-c437-4b57-9893-ead2ad71493c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_255a53f2-c437-4b57-9893-ead2ad71493c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_51bc2370-aeb6-441c-9b95-204153d35c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_51bc2370-aeb6-441c-9b95-204153d35c46" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherChanges_d0e66b7f-6122-461d-86d5-9a6994a35ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherChanges_d0e66b7f-6122-461d-86d5-9a6994a35ba2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f0ce360a-f909-4b12-9ec3-4c2f12cf9658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f0ce360a-f909-4b12-9ec3-4c2f12cf9658" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_bd79ed77-c769-4cae-be83-357b3c01f406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_bd79ed77-c769-4cae-be83-357b3c01f406" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_655fa9c3-0e3f-4dfc-9025-7bb3ddbf8cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_179676b4-6fd2-47a9-a526-1763857390d0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_4cb3d3a8-7810-4beb-ac61-756b3c0fce13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_4cb3d3a8-7810-4beb-ac61-756b3c0fce13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4cb3d3a8-7810-4beb-ac61-756b3c0fce13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_4cb3d3a8-7810-4beb-ac61-756b3c0fce13" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4cb3d3a8-7810-4beb-ac61-756b3c0fce13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a7ee8ab-aba5-4929-ae01-274ee208f8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_4cb3d3a8-7810-4beb-ac61-756b3c0fce13" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a7ee8ab-aba5-4929-ae01-274ee208f8f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_efaad376-7f65-474c-84fb-5a8c7e737ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a7ee8ab-aba5-4929-ae01-274ee208f8f2" xlink:to="loc_us-gaap_ForeignPlanMember_efaad376-7f65-474c-84fb-5a8c7e737ac7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_5da3c5e2-69d0-4806-b4ac-3b39affda054" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_efaad376-7f65-474c-84fb-5a8c7e737ac7" xlink:to="loc_country_GB_5da3c5e2-69d0-4806-b4ac-3b39affda054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_c7baff6d-0374-4026-8710-2a534927a6bd" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_efaad376-7f65-474c-84fb-5a8c7e737ac7" xlink:to="loc_country_CH_c7baff6d-0374-4026-8710-2a534927a6bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_3ce4919c-fe1f-47c4-89f0-ab36b3f69547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:to="loc_us-gaap_RetirementPlanNameAxis_3ce4919c-fe1f-47c4-89f0-ab36b3f69547" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_3ce4919c-fe1f-47c4-89f0-ab36b3f69547_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_3ce4919c-fe1f-47c4-89f0-ab36b3f69547" xlink:to="loc_us-gaap_RetirementPlanNameDomain_3ce4919c-fe1f-47c4-89f0-ab36b3f69547_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_3ce4919c-fe1f-47c4-89f0-ab36b3f69547" xlink:to="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_6a762c7f-399c-4e1f-a811-77abb2a330e5" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_6a762c7f-399c-4e1f-a811-77abb2a330e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_5dcfef6b-9ec3-4313-89e4-660b7d30b4f6" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_5dcfef6b-9ec3-4313-89e4-660b7d30b4f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_82d782b8-a769-4e4b-8e2d-5c63dd35583e" xlink:href="iclr-20211231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_82d782b8-a769-4e4b-8e2d-5c63dd35583e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsChangeinPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="extended" id="i231c4a52e902410eaccee44e8b2480fb_EmployeeBenefitsChangeinPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d2c13637-0970-4e6a-96c2-7fdba83bd6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d2c13637-0970-4e6a-96c2-7fdba83bd6cd" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0043d89f-0d59-4215-8214-f26b02e2b542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0043d89f-0d59-4215-8214-f26b02e2b542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e31e825c-f0f1-4016-82e8-f6519ba07258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e31e825c-f0f1-4016-82e8-f6519ba07258" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_2a3c8085-87f2-4d1a-a409-a1e8e9de247e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_2a3c8085-87f2-4d1a-a409-a1e8e9de247e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_959442e2-070b-49a6-a916-e1e50186ab00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_959442e2-070b-49a6-a916-e1e50186ab00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions_01c8628b-ac8b-4870-8182-3b1ff99dbcce" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_iclr_DefinedBenefitPlanSchemeContributions_01c8628b-ac8b-4870-8182-3b1ff99dbcce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_f28fb0bc-251b-4fdc-95ce-e0410970ec40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_f28fb0bc-251b-4fdc-95ce-e0410970ec40" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c786b007-4da6-4bd0-bb71-c77eb01dca6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c786b007-4da6-4bd0-bb71-c77eb01dca6a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_b507191a-9746-456a-8790-fa0cf20b63dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_b507191a-9746-456a-8790-fa0cf20b63dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_c207ad95-1885-486d-b896-2f5845ac631c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_c207ad95-1885-486d-b896-2f5845ac631c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_1e70f7eb-573c-49e2-a4fa-20f1265af643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_1e70f7eb-573c-49e2-a4fa-20f1265af643" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cf6dd498-c459-4f77-847b-8fdbeff174fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d2c13637-0970-4e6a-96c2-7fdba83bd6cd" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_00f69008-4446-4a77-93f3-2e615dc597b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_00f69008-4446-4a77-93f3-2e615dc597b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_00f69008-4446-4a77-93f3-2e615dc597b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_00f69008-4446-4a77-93f3-2e615dc597b4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_00f69008-4446-4a77-93f3-2e615dc597b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c5cf67b5-2e0f-413e-99e8-7e7213d56110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_00f69008-4446-4a77-93f3-2e615dc597b4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c5cf67b5-2e0f-413e-99e8-7e7213d56110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_2a897f65-f937-48cf-b913-769718b7d124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c5cf67b5-2e0f-413e-99e8-7e7213d56110" xlink:to="loc_us-gaap_ForeignPlanMember_2a897f65-f937-48cf-b913-769718b7d124" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_daf06edb-11b0-4e74-9c93-1649ab086a82" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_2a897f65-f937-48cf-b913-769718b7d124" xlink:to="loc_country_GB_daf06edb-11b0-4e74-9c93-1649ab086a82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_3923cf78-c5af-4dd9-9c29-22d97696a4b9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_2a897f65-f937-48cf-b913-769718b7d124" xlink:to="loc_country_CH_3923cf78-c5af-4dd9-9c29-22d97696a4b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_da9a8ade-91ff-4423-8b82-84473d3d4cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:to="loc_us-gaap_RetirementPlanNameAxis_da9a8ade-91ff-4423-8b82-84473d3d4cf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_da9a8ade-91ff-4423-8b82-84473d3d4cf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_da9a8ade-91ff-4423-8b82-84473d3d4cf5" xlink:to="loc_us-gaap_RetirementPlanNameDomain_da9a8ade-91ff-4423-8b82-84473d3d4cf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_da9a8ade-91ff-4423-8b82-84473d3d4cf5" xlink:to="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_2762432e-f745-4d79-9d23-0444b2f8740c" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_2762432e-f745-4d79-9d23-0444b2f8740c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_6d3b70c6-77f0-4d38-bb84-25f69b6d110d" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_6d3b70c6-77f0-4d38-bb84-25f69b6d110d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_296327fb-fd35-497d-ae17-942ef9447ce1" xlink:href="iclr-20211231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_296327fb-fd35-497d-ae17-942ef9447ce1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended" id="idd44f8c4dcfe4eef892e728051c6f634_EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_7419ffb4-037e-456e-acf4-ee0a421f53f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_7419ffb4-037e-456e-acf4-ee0a421f53f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a50155dc-ba6c-4f06-915b-d6965882498a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a50155dc-ba6c-4f06-915b-d6965882498a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d5d52a96-2447-4a29-9a1d-eea774d5294c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d5d52a96-2447-4a29-9a1d-eea774d5294c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d88f9185-d9c3-4777-bb2a-7b48a6816920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d88f9185-d9c3-4777-bb2a-7b48a6816920" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_26a0d526-ab22-43f3-8c75-be3126b005e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_26a0d526-ab22-43f3-8c75-be3126b005e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_d1b1d3ea-31b5-4cb4-929f-6656d3404c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_d1b1d3ea-31b5-4cb4-929f-6656d3404c50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d1b1d3ea-31b5-4cb4-929f-6656d3404c50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d1b1d3ea-31b5-4cb4-929f-6656d3404c50" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d1b1d3ea-31b5-4cb4-929f-6656d3404c50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_eddd0644-e849-45c5-8f3c-bd38431531d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d1b1d3ea-31b5-4cb4-929f-6656d3404c50" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_eddd0644-e849-45c5-8f3c-bd38431531d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_033d43d4-2822-45cb-b58c-a0ce57342106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_eddd0644-e849-45c5-8f3c-bd38431531d1" xlink:to="loc_us-gaap_ForeignPlanMember_033d43d4-2822-45cb-b58c-a0ce57342106" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_dc46f4fb-8160-45fa-80f4-9c2a8097dfa7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_033d43d4-2822-45cb-b58c-a0ce57342106" xlink:to="loc_country_GB_dc46f4fb-8160-45fa-80f4-9c2a8097dfa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_b23d9677-93d1-4a54-98a7-5c9f5966329f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_033d43d4-2822-45cb-b58c-a0ce57342106" xlink:to="loc_country_CH_b23d9677-93d1-4a54-98a7-5c9f5966329f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_5bb0d0b8-fc79-4bcf-9334-1396a34fa04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27" xlink:to="loc_us-gaap_RetirementPlanNameDomain_5bb0d0b8-fc79-4bcf-9334-1396a34fa04c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_3d370bdc-1c80-4b6a-844e-906442d5aeef" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_5bb0d0b8-fc79-4bcf-9334-1396a34fa04c" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_3d370bdc-1c80-4b6a-844e-906442d5aeef" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended" id="if27750f2c7ed4aea8fd4d304df900e1e_EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_7ce520a9-0170-41f0-afb5-73a84282c8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_7ce520a9-0170-41f0-afb5-73a84282c8a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_32191da1-87f4-4722-82de-811a99349232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_32191da1-87f4-4722-82de-811a99349232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_011a71d7-4898-4a60-a8f7-b60a4d0d7d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_011a71d7-4898-4a60-a8f7-b60a4d0d7d72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_f9359c0f-f169-404a-9650-7bf6ce884f63" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_f9359c0f-f169-404a-9650-7bf6ce884f63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_32f774d1-4ad3-4335-a907-db74a0ee2110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_32f774d1-4ad3-4335-a907-db74a0ee2110" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_0e9927ad-0d8a-46bf-9267-5f39b1caabef" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_0e9927ad-0d8a-46bf-9267-5f39b1caabef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_9e5704dc-d052-41c6-a5b9-9f95a33def35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_9e5704dc-d052-41c6-a5b9-9f95a33def35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9acd140a-4768-4df8-b476-e5e1ca5c80ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9acd140a-4768-4df8-b476-e5e1ca5c80ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9acd140a-4768-4df8-b476-e5e1ca5c80ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9acd140a-4768-4df8-b476-e5e1ca5c80ce" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9acd140a-4768-4df8-b476-e5e1ca5c80ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6cdc3625-21cc-41fc-82a6-09576cd843f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9acd140a-4768-4df8-b476-e5e1ca5c80ce" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6cdc3625-21cc-41fc-82a6-09576cd843f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b729a014-d3e8-4600-a80f-2ad49dada12c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6cdc3625-21cc-41fc-82a6-09576cd843f8" xlink:to="loc_us-gaap_ForeignPlanMember_b729a014-d3e8-4600-a80f-2ad49dada12c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_ca24e4bf-207a-43f6-a4c5-f983c7eea5f7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_b729a014-d3e8-4600-a80f-2ad49dada12c" xlink:to="loc_country_GB_ca24e4bf-207a-43f6-a4c5-f983c7eea5f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_4d5da15a-f98e-4f2b-a1e8-e230cc13bffc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_b729a014-d3e8-4600-a80f-2ad49dada12c" xlink:to="loc_country_CH_4d5da15a-f98e-4f2b-a1e8-e230cc13bffc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:to="loc_us-gaap_RetirementPlanNameAxis_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_326e88b4-1be5-4da4-ba36-1bece4d88c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_326e88b4-1be5-4da4-ba36-1bece4d88c69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_44e159a7-d0e6-4b83-bda9-2803acd1dbd0" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_326e88b4-1be5-4da4-ba36-1bece4d88c69" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_44e159a7-d0e6-4b83-bda9-2803acd1dbd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="extended" id="i2b0c42e21b6c47bf8d582ce3bd56c841_EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c31d486e-4423-4a9a-a087-86bc28466c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1ee32ee5-7084-4bc1-a0f1-efdbcf4613aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c31d486e-4423-4a9a-a087-86bc28466c8f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1ee32ee5-7084-4bc1-a0f1-efdbcf4613aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_07a01ed5-6c88-46f3-909d-6b1499c46a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c31d486e-4423-4a9a-a087-86bc28466c8f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_07a01ed5-6c88-46f3-909d-6b1499c46a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c31d486e-4423-4a9a-a087-86bc28466c8f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a864d36-0c1c-46c0-8d1e-15e928fe0b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a864d36-0c1c-46c0-8d1e-15e928fe0b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_e40447db-ae64-4019-8616-a1b15992da48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a864d36-0c1c-46c0-8d1e-15e928fe0b79" xlink:to="loc_us-gaap_ForeignPlanMember_e40447db-ae64-4019-8616-a1b15992da48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_812e4724-1b06-4f26-8c52-288a13df51c4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_e40447db-ae64-4019-8616-a1b15992da48" xlink:to="loc_country_GB_812e4724-1b06-4f26-8c52-288a13df51c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_21ced01e-a2de-473e-ad21-cad3d4f5a543" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_e40447db-ae64-4019-8616-a1b15992da48" xlink:to="loc_country_CH_21ced01e-a2de-473e-ad21-cad3d4f5a543" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d64fc927-cd2d-418c-b7f2-a8809e3a193a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d64fc927-cd2d-418c-b7f2-a8809e3a193a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d64fc927-cd2d-418c-b7f2-a8809e3a193a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d64fc927-cd2d-418c-b7f2-a8809e3a193a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d64fc927-cd2d-418c-b7f2-a8809e3a193a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_658526c8-7638-4850-aa74-91e64462507c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d64fc927-cd2d-418c-b7f2-a8809e3a193a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_658526c8-7638-4850-aa74-91e64462507c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_8b458405-8169-4a79-9125-887dc3309549" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_658526c8-7638-4850-aa74-91e64462507c" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_8b458405-8169-4a79-9125-887dc3309549" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="extended" id="iec89d5f3f8fb403d993116e7c6164dde_EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_16747a71-b976-41bd-a488-38a257439f65" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:to="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_16747a71-b976-41bd-a488-38a257439f65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d42519c7-b1f0-4586-8aab-aa8dd907e0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d42519c7-b1f0-4586-8aab-aa8dd907e0ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_fa281c6a-3f97-4015-9819-30a27dd5bd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_fa281c6a-3f97-4015-9819-30a27dd5bd8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_1567b934-2aaa-40aa-ae6f-7731c780bec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_1567b934-2aaa-40aa-ae6f-7731c780bec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_1567b934-2aaa-40aa-ae6f-7731c780bec8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1567b934-2aaa-40aa-ae6f-7731c780bec8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_1567b934-2aaa-40aa-ae6f-7731c780bec8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3f060dd3-93d1-4cab-9fe7-2b14dacd0e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1567b934-2aaa-40aa-ae6f-7731c780bec8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3f060dd3-93d1-4cab-9fe7-2b14dacd0e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5db0c54d-a8e3-43a2-adbe-1e574720c3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_3f060dd3-93d1-4cab-9fe7-2b14dacd0e24" xlink:to="loc_us-gaap_ForeignPlanMember_5db0c54d-a8e3-43a2-adbe-1e574720c3b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_72450bf5-9b98-4764-adeb-70e276a01471" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5db0c54d-a8e3-43a2-adbe-1e574720c3b0" xlink:to="loc_country_GB_72450bf5-9b98-4764-adeb-70e276a01471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dfffb3db-2481-4d0e-b7b6-c15c1fdc4a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dfffb3db-2481-4d0e-b7b6-c15c1fdc4a67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_d236b892-43bf-4084-bcf5-5b38cee833fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_d236b892-43bf-4084-bcf5-5b38cee833fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_898796fd-6cc7-4ef0-92d7-7368b7be3533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:to="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_898796fd-6cc7-4ef0-92d7-7368b7be3533" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_b7267244-9c0f-4d00-8afa-a530c96df2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:to="loc_us-gaap_RetirementPlanNameAxis_b7267244-9c0f-4d00-8afa-a530c96df2a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_b7267244-9c0f-4d00-8afa-a530c96df2a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b7267244-9c0f-4d00-8afa-a530c96df2a4" xlink:to="loc_us-gaap_RetirementPlanNameDomain_b7267244-9c0f-4d00-8afa-a530c96df2a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_300baf8f-d96f-45c9-9fce-2658a475b870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b7267244-9c0f-4d00-8afa-a530c96df2a4" xlink:to="loc_us-gaap_RetirementPlanNameDomain_300baf8f-d96f-45c9-9fce-2658a475b870" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_3b930aba-3c5b-4b99-a752-32252ab6569f" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_300baf8f-d96f-45c9-9fce-2658a475b870" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_3b930aba-3c5b-4b99-a752-32252ab6569f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="extended" id="i48f5b6080c194eeb8a86b42fef6ffa0a_EmployeeBenefitsPlanAssetFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5ed7aec1-cea7-4f0a-89ef-dd682b082a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c83a9a10-1a68-472d-b2d9-afa245ba2b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5ed7aec1-cea7-4f0a-89ef-dd682b082a43" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c83a9a10-1a68-472d-b2d9-afa245ba2b7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_7cc575a2-6331-4568-a08a-e57703e21134" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5ed7aec1-cea7-4f0a-89ef-dd682b082a43" xlink:to="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_7cc575a2-6331-4568-a08a-e57703e21134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5ed7aec1-cea7-4f0a-89ef-dd682b082a43" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cb833189-217f-444a-9b62-27a47caa54a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cb833189-217f-444a-9b62-27a47caa54a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cb833189-217f-444a-9b62-27a47caa54a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cb833189-217f-444a-9b62-27a47caa54a6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cb833189-217f-444a-9b62-27a47caa54a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fcb757c-72bc-4f8a-8eb6-06638824d0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cb833189-217f-444a-9b62-27a47caa54a6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fcb757c-72bc-4f8a-8eb6-06638824d0d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_eed78bab-4d0e-42e2-b906-81ae581bf5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fcb757c-72bc-4f8a-8eb6-06638824d0d7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_eed78bab-4d0e-42e2-b906-81ae581bf5fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1158a486-1aa3-4a3d-b5ee-37f788dcc015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1158a486-1aa3-4a3d-b5ee-37f788dcc015" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_1158a486-1aa3-4a3d-b5ee-37f788dcc015_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1158a486-1aa3-4a3d-b5ee-37f788dcc015" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_1158a486-1aa3-4a3d-b5ee-37f788dcc015_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1158a486-1aa3-4a3d-b5ee-37f788dcc015" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember_55868277-5b96-4408-aa42-22499a641d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_us-gaap_DefinedBenefitPlanCashMember_55868277-5b96-4408-aa42-22499a641d3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember_ea4b4373-03a8-48cd-a9cf-4911b5206e4c" xlink:href="iclr-20211231.xsd#iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember_ea4b4373-03a8-48cd-a9cf-4911b5206e4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LAndGLifeDCActiveCorporateBondMember_6d269c32-43b1-453e-b477-cf2635873c5f" xlink:href="iclr-20211231.xsd#iclr_LAndGLifeDCActiveCorporateBondMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_LAndGLifeDCActiveCorporateBondMember_6d269c32-43b1-453e-b477-cf2635873c5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StoneHarborHighYieldBondFundMember_9a6c9c1f-98fa-47d6-b344-e6f555a0042d" xlink:href="iclr-20211231.xsd#iclr_StoneHarborHighYieldBondFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_StoneHarborHighYieldBondFundMember_9a6c9c1f-98fa-47d6-b344-e6f555a0042d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NinetyOneGlobalTotalReturnCreditMember_ce6cf277-045d-4516-92fe-82e01c893094" xlink:href="iclr-20211231.xsd#iclr_NinetyOneGlobalTotalReturnCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_NinetyOneGlobalTotalReturnCreditMember_ce6cf277-045d-4516-92fe-82e01c893094" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StoneHarborMultiAssetCreditPortfolioMember_20302033-e497-486b-9d46-3603baa559bb" xlink:href="iclr-20211231.xsd#iclr_StoneHarborMultiAssetCreditPortfolioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_StoneHarborMultiAssetCreditPortfolioMember_20302033-e497-486b-9d46-3603baa559bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BaringsEuropeanLoanFundBuyAndHoldMember_bc56848d-11fc-4076-aa38-c3e63a9d4920" xlink:href="iclr-20211231.xsd#iclr_BaringsEuropeanLoanFundBuyAndHoldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_BaringsEuropeanLoanFundBuyAndHoldMember_bc56848d-11fc-4076-aa38-c3e63a9d4920" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_645c8224-f0eb-4657-b684-d55f60bbdaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:to="loc_us-gaap_RetirementPlanNameAxis_645c8224-f0eb-4657-b684-d55f60bbdaa7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_645c8224-f0eb-4657-b684-d55f60bbdaa7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_645c8224-f0eb-4657-b684-d55f60bbdaa7" xlink:to="loc_us-gaap_RetirementPlanNameDomain_645c8224-f0eb-4657-b684-d55f60bbdaa7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_e1b673ae-77a3-4f89-bea7-b2b5f2381ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_645c8224-f0eb-4657-b684-d55f60bbdaa7" xlink:to="loc_us-gaap_RetirementPlanNameDomain_e1b673ae-77a3-4f89-bea7-b2b5f2381ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_f556ec98-4277-4207-a481-5d1f8d89076c" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_e1b673ae-77a3-4f89-bea7-b2b5f2381ece" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_f556ec98-4277-4207-a481-5d1f8d89076c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsAnnualBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="extended" id="i78b2aebc075747158b1cb0bc828f9b9d_EmployeeBenefitsAnnualBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_27dc3be6-befb-4c0b-9001-28586057e027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_27dc3be6-befb-4c0b-9001-28586057e027" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_58145d01-9a06-43a2-baab-b9670f65eebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_58145d01-9a06-43a2-baab-b9670f65eebd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_4ba28c5b-3ac7-49dc-9ce1-8258f603a3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_4ba28c5b-3ac7-49dc-9ce1-8258f603a3f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7e3dbfe1-e897-4ac1-b8f7-dbcdcc7c43b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7e3dbfe1-e897-4ac1-b8f7-dbcdcc7c43b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_aedffdc9-9156-41a8-be37-9945eb72edf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_aedffdc9-9156-41a8-be37-9945eb72edf3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_ce5f5d68-bf0d-4d55-8e86-c5282a80c91f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_ce5f5d68-bf0d-4d55-8e86-c5282a80c91f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6dfc5a20-3248-4251-81a9-8c13718a5381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6dfc5a20-3248-4251-81a9-8c13718a5381" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6dfc5a20-3248-4251-81a9-8c13718a5381_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6dfc5a20-3248-4251-81a9-8c13718a5381" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6dfc5a20-3248-4251-81a9-8c13718a5381_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6e64242f-b4bc-4b58-a995-2a4c94aeddad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6dfc5a20-3248-4251-81a9-8c13718a5381" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6e64242f-b4bc-4b58-a995-2a4c94aeddad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1c3ec20f-6e9a-4eb0-941f-10d851735862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6e64242f-b4bc-4b58-a995-2a4c94aeddad" xlink:to="loc_us-gaap_ForeignPlanMember_1c3ec20f-6e9a-4eb0-941f-10d851735862" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_294cb106-718a-495f-9127-e1f919172768" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_1c3ec20f-6e9a-4eb0-941f-10d851735862" xlink:to="loc_country_GB_294cb106-718a-495f-9127-e1f919172768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_5244c4f5-285c-4aec-9d89-19f7950b8ea7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_1c3ec20f-6e9a-4eb0-941f-10d851735862" xlink:to="loc_country_CH_5244c4f5-285c-4aec-9d89-19f7950b8ea7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2d38e17d-5aee-424b-993e-2965eabb07fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:to="loc_us-gaap_PlanNameAxis_2d38e17d-5aee-424b-993e-2965eabb07fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2d38e17d-5aee-424b-993e-2965eabb07fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_2d38e17d-5aee-424b-993e-2965eabb07fd" xlink:to="loc_us-gaap_PlanNameDomain_2d38e17d-5aee-424b-993e-2965eabb07fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9b038e41-100c-49e6-ad79-5813146b3b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_2d38e17d-5aee-424b-993e-2965eabb07fd" xlink:to="loc_us-gaap_PlanNameDomain_9b038e41-100c-49e6-ad79-5813146b3b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_fc9da55b-b868-462e-9121-f53435466a00" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9b038e41-100c-49e6-ad79-5813146b3b5d" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_fc9da55b-b868-462e-9121-f53435466a00" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="extended" id="i38b381d659bd46698028365be8a3b170_EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:href="iclr-20211231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c45f8e63-68fb-4c26-b626-618d0e565785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c45f8e63-68fb-4c26-b626-618d0e565785" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_cf3ce8e5-8947-4cd4-8fa9-d0875fb10b22" xlink:href="iclr-20211231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_cf3ce8e5-8947-4cd4-8fa9-d0875fb10b22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1d06d554-b560-4d3d-bf4c-7a368e707569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1d06d554-b560-4d3d-bf4c-7a368e707569" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5d7339a5-c2a1-4bf0-b34c-f65aa48673c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5d7339a5-c2a1-4bf0-b34c-f65aa48673c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_cb077f20-9255-4ed8-82ac-5d161a3fa143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_cb077f20-9255-4ed8-82ac-5d161a3fa143" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a2d8add-9ed7-476a-8461-904fd2deb919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a2d8add-9ed7-476a-8461-904fd2deb919" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_78e06422-bb10-463a-a781-e5fb3fd24e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_78e06422-bb10-463a-a781-e5fb3fd24e50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_82f68d38-cb52-4f9b-a1f5-f34317f9bfe6" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_82f68d38-cb52-4f9b-a1f5-f34317f9bfe6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4fa2be42-9030-4ad0-962a-b7198ac59658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4fa2be42-9030-4ad0-962a-b7198ac59658" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_38d8e686-6d42-4b23-bfbd-c69fa7fff529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_38d8e686-6d42-4b23-bfbd-c69fa7fff529" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_16ce410b-21d0-4edd-a007-403fa1a27f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_16ce410b-21d0-4edd-a007-403fa1a27f3b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7b6ce88a-e718-4376-a780-50a790a65ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7b6ce88a-e718-4376-a780-50a790a65ee4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_d813dbd5-9392-4572-a64e-e1c5672c7d04" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_d813dbd5-9392-4572-a64e-e1c5672c7d04" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5e89b440-943b-40a2-8bc8-70f1d6fd16a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5e89b440-943b-40a2-8bc8-70f1d6fd16a1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a7cd7919-cd44-4986-ac4f-8fa64a2658ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensation_a7cd7919-cd44-4986-ac4f-8fa64a2658ad" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_23a32870-d6a1-4b9e-89a8-65d45bf98490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_23a32870-d6a1-4b9e-89a8-65d45bf98490" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d07b33e4-a13f-4685-9547-6a3c4463e1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d07b33e4-a13f-4685-9547-6a3c4463e1e1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:href="iclr-20211231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f01c7be2-2876-46cc-9270-014840934c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_us-gaap_AwardTypeAxis_f01c7be2-2876-46cc-9270-014840934c92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f01c7be2-2876-46cc-9270-014840934c92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f01c7be2-2876-46cc-9270-014840934c92" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f01c7be2-2876-46cc-9270-014840934c92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f01c7be2-2876-46cc-9270-014840934c92" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember_d8f749e5-6fda-4d80-8f24-ee9e324d72e7" xlink:href="iclr-20211231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_ConsultantsStockPlan2008PlanMember_d8f749e5-6fda-4d80-8f24-ee9e324d72e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_335bdb48-75d6-4423-9bec-056b6be3ded9" xlink:href="iclr-20211231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_335bdb48-75d6-4423-9bec-056b6be3ded9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member_fc58bd2f-8dc5-4f6e-8cac-ae48c7429466" xlink:href="iclr-20211231.xsd#iclr_OptionPlans2008Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_OptionPlans2008Member_fc58bd2f-8dc5-4f6e-8cac-ae48c7429466" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroThreePlanMember_088b0ff8-273a-4e06-a06f-7f64490c136d" xlink:href="iclr-20211231.xsd#iclr_EmployeeStockPlanTwentyZeroThreePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroThreePlanMember_088b0ff8-273a-4e06-a06f-7f64490c136d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f8f07be1-0a67-4451-97b2-bfdb9f206a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f8f07be1-0a67-4451-97b2-bfdb9f206a3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_19adab04-dabf-4463-a779-3263b1660023" xlink:href="iclr-20211231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_19adab04-dabf-4463-a779-3263b1660023" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_c5f204b0-c750-4139-8b4d-782665fc931f" xlink:href="iclr-20211231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_c5f204b0-c750-4139-8b4d-782665fc931f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c63fa4ee-4ce0-4c4b-8417-ff7a14fc20d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c63fa4ee-4ce0-4c4b-8417-ff7a14fc20d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_148ab804-3981-4568-9a6d-48e9b971d4c5" xlink:href="iclr-20211231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_PerformanceShareUnitMember_148ab804-3981-4568-9a6d-48e9b971d4c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember_404cd73b-82a9-4b22-9ad1-19ef2a166bb9" xlink:href="iclr-20211231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_PerformanceBasedGrantsMember_404cd73b-82a9-4b22-9ad1-19ef2a166bb9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_0af9b452-27e8-408c-9dd2-560bba1edec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_us-gaap_AwardDateAxis_0af9b452-27e8-408c-9dd2-560bba1edec4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_0af9b452-27e8-408c-9dd2-560bba1edec4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_0af9b452-27e8-408c-9dd2-560bba1edec4" xlink:to="loc_us-gaap_AwardDateDomain_0af9b452-27e8-408c-9dd2-560bba1edec4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_e49b8f7e-77e2-4d48-b5dc-27c7b5affb59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_0af9b452-27e8-408c-9dd2-560bba1edec4" xlink:to="loc_us-gaap_AwardDateDomain_e49b8f7e-77e2-4d48-b5dc-27c7b5affb59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member_89a87de4-70da-400f-95a4-8e95f1bafefa" xlink:href="iclr-20211231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_e49b8f7e-77e2-4d48-b5dc-27c7b5affb59" xlink:to="loc_iclr_AwardDateAllYearsExcluding2018Member_89a87de4-70da-400f-95a4-8e95f1bafefa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDate2018Member_93610e1c-c502-4632-ba6c-165c268a11af" xlink:href="iclr-20211231.xsd#iclr_AwardDate2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_e49b8f7e-77e2-4d48-b5dc-27c7b5affb59" xlink:to="loc_iclr_AwardDate2018Member_93610e1c-c502-4632-ba6c-165c268a11af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_dei_LegalEntityAxis_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e" xlink:to="loc_dei_EntityDomain_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_875c2ade-82e4-4967-98fa-8bf1d7760c27" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e" xlink:to="loc_dei_EntityDomain_875c2ade-82e4-4967-98fa-8bf1d7760c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_74c4e58e-fbd8-41b4-b272-a78400c89f2f" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_875c2ade-82e4-4967-98fa-8bf1d7760c27" xlink:to="loc_iclr_PRAHealthSciencesIncMember_74c4e58e-fbd8-41b4-b272-a78400c89f2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_srt_RangeAxis_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6" xlink:to="loc_srt_RangeMember_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_24355fd8-5afc-4201-a82b-8819144f9912" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6" xlink:to="loc_srt_RangeMember_24355fd8-5afc-4201-a82b-8819144f9912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d08b1bed-9fb3-46a4-99c5-2221d51ef7ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_24355fd8-5afc-4201-a82b-8819144f9912" xlink:to="loc_srt_MinimumMember_d08b1bed-9fb3-46a4-99c5-2221d51ef7ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0e392388-c95e-4d7e-aa2a-abd01a174177" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_24355fd8-5afc-4201-a82b-8819144f9912" xlink:to="loc_srt_MaximumMember_0e392388-c95e-4d7e-aa2a-abd01a174177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_9f523bf6-87f1-4b9e-98fe-3186af5647ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_srt_TitleOfIndividualAxis_9f523bf6-87f1-4b9e-98fe-3186af5647ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9f523bf6-87f1-4b9e-98fe-3186af5647ea_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_9f523bf6-87f1-4b9e-98fe-3186af5647ea" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9f523bf6-87f1-4b9e-98fe-3186af5647ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f11702e9-ed03-4104-b91e-cb309bcf7a06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_9f523bf6-87f1-4b9e-98fe-3186af5647ea" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f11702e9-ed03-4104-b91e-cb309bcf7a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember_e1b9ea4a-f326-4050-ac17-866e1fee539a" xlink:href="iclr-20211231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f11702e9-ed03-4104-b91e-cb309bcf7a06" xlink:to="loc_iclr_NonexecutiveDirectorMember_e1b9ea4a-f326-4050-ac17-866e1fee539a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_us-gaap_PlanNameAxis_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e" xlink:to="loc_us-gaap_PlanNameDomain_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e" xlink:to="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember_2ddc235a-cbd5-4ffb-9269-832895f822e1" xlink:href="iclr-20211231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:to="loc_iclr_The2020LegacyPRAPlanMember_2ddc235a-cbd5-4ffb-9269-832895f822e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember_68e01796-da98-4951-8cfb-7cc2bcd1b42b" xlink:href="iclr-20211231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:to="loc_iclr_The2018LegacyPRAPlanMember_68e01796-da98-4951-8cfb-7cc2bcd1b42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2013LegacyPRAPlanMember_6d978ce2-7ee2-4509-a70c-fc1981af6b4e" xlink:href="iclr-20211231.xsd#iclr_A2013LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:to="loc_iclr_A2013LegacyPRAPlanMember_6d978ce2-7ee2-4509-a70c-fc1981af6b4e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="extended" id="i9af9a85414114bb988d54a1f4e179bf9_EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_380453b1-091f-4576-8e7f-e6c635404c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_380453b1-091f-4576-8e7f-e6c635404c4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_a3cb590f-b9d0-4064-992d-639b332bfdb2" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_a3cb590f-b9d0-4064-992d-639b332bfdb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_cfc27302-e866-42bd-b291-156a3928ffe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_cfc27302-e866-42bd-b291-156a3928ffe2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e97661c-9065-4125-ba70-4f112d7c8ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e97661c-9065-4125-ba70-4f112d7c8ee9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ab6c829b-90fd-472e-8a6b-696f530350b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ab6c829b-90fd-472e-8a6b-696f530350b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_de7fd376-ebb9-4830-966c-7adcb1cf5fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_94c7d389-8533-44b5-83f8-859a5d0cc831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_94c7d389-8533-44b5-83f8-859a5d0cc831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79c51321-8e55-498d-8254-c6c67641e4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79c51321-8e55-498d-8254-c6c67641e4bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_987d67fd-ac80-4c15-8e53-219861515453" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_987d67fd-ac80-4c15-8e53-219861515453" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7772d13c-c80a-46d1-b3cb-021952e60d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7772d13c-c80a-46d1-b3cb-021952e60d0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_312b7ca1-5a53-4f2c-b383-74fcee22fc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_312b7ca1-5a53-4f2c-b383-74fcee22fc1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_911aa29c-5497-4aee-b4a8-19d595232c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_911aa29c-5497-4aee-b4a8-19d595232c21" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fb7fd09f-c4fe-41e7-9342-d29b7fe75a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_f40bc291-9733-4727-ac4b-c18606bdba0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_f40bc291-9733-4727-ac4b-c18606bdba0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51b1abde-6b8e-40c2-914e-794d0b5b0383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51b1abde-6b8e-40c2-914e-794d0b5b0383" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9306667e-5408-417f-8977-c95400f8b1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51b1abde-6b8e-40c2-914e-794d0b5b0383" xlink:to="loc_us-gaap_AwardTypeAxis_9306667e-5408-417f-8977-c95400f8b1e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9306667e-5408-417f-8977-c95400f8b1e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9306667e-5408-417f-8977-c95400f8b1e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9306667e-5408-417f-8977-c95400f8b1e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8bad141-bf0e-48ac-b0a3-056b95a24d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9306667e-5408-417f-8977-c95400f8b1e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8bad141-bf0e-48ac-b0a3-056b95a24d74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_69387d92-8376-4e96-88b8-99a3f135a56d" xlink:href="iclr-20211231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8bad141-bf0e-48ac-b0a3-056b95a24d74" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_69387d92-8376-4e96-88b8-99a3f135a56d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="extended" id="id1a07a5d230a4749b8d3c9c497b08d42_EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f1afceab-caf8-4761-b597-49f802ea3d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f1afceab-caf8-4761-b597-49f802ea3d20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_2e46f229-17d4-4591-9e49-6aa808a5b137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_2e46f229-17d4-4591-9e49-6aa808a5b137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_24ec654e-cec2-4583-9e83-2d5833b3a654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_24ec654e-cec2-4583-9e83-2d5833b3a654" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_542c260d-696c-4ee6-aca1-624134530d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_542c260d-696c-4ee6-aca1-624134530d5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13793bcf-23d2-4370-bac7-4c6a25b54b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13793bcf-23d2-4370-bac7-4c6a25b54b35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_69146082-2888-49fa-b865-70b04f353128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_69146082-2888-49fa-b865-70b04f353128" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_9d8b252d-064c-4c74-9080-9ada6d2f5024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_9d8b252d-064c-4c74-9080-9ada6d2f5024" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c1576301-0a6c-4c02-a771-d4b58d87f646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:to="loc_us-gaap_AwardTypeAxis_c1576301-0a6c-4c02-a771-d4b58d87f646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1576301-0a6c-4c02-a771-d4b58d87f646_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c1576301-0a6c-4c02-a771-d4b58d87f646" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1576301-0a6c-4c02-a771-d4b58d87f646_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e60c4500-095d-469b-b10e-50c0a89a95fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c1576301-0a6c-4c02-a771-d4b58d87f646" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e60c4500-095d-469b-b10e-50c0a89a95fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_2796f5a4-ea9c-4a8e-b502-0c81c9e04f8d" xlink:href="iclr-20211231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e60c4500-095d-469b-b10e-50c0a89a95fa" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_2796f5a4-ea9c-4a8e-b502-0c81c9e04f8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f3bca583-8a28-46d8-a1f9-9208a33293ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f3bca583-8a28-46d8-a1f9-9208a33293ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f3bca583-8a28-46d8-a1f9-9208a33293ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f3bca583-8a28-46d8-a1f9-9208a33293ef" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f3bca583-8a28-46d8-a1f9-9208a33293ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f3bca583-8a28-46d8-a1f9-9208a33293ef" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member_ba751d33-0de0-4cac-bd83-ce0ecf3eaacd" xlink:href="iclr-20211231.xsd#iclr_Range1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:to="loc_iclr_Range1Member_ba751d33-0de0-4cac-bd83-ce0ecf3eaacd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member_0a09a51f-0f6c-4862-923d-3b4ac0b4b37e" xlink:href="iclr-20211231.xsd#iclr_Range2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:to="loc_iclr_Range2Member_0a09a51f-0f6c-4862-923d-3b4ac0b4b37e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member_c62e5413-f97e-420f-8535-805a836f0641" xlink:href="iclr-20211231.xsd#iclr_Range3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:to="loc_iclr_Range3Member_c62e5413-f97e-420f-8535-805a836f0641" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member_3ccb1ad6-9728-433e-9ec0-b55c06940a78" xlink:href="iclr-20211231.xsd#iclr_Range4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:to="loc_iclr_Range4Member_3ccb1ad6-9728-433e-9ec0-b55c06940a78" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="extended" id="i1fdba5b4176c4f9dbb98948a33b3dd1b_EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_462a79c7-8025-4619-a9d1-a55ab21a5088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3b65784-1c44-4032-94d9-be4875bd1232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_462a79c7-8025-4619-a9d1-a55ab21a5088" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3b65784-1c44-4032-94d9-be4875bd1232" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_462a79c7-8025-4619-a9d1-a55ab21a5088" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6515fdcb-cb77-486a-8c3d-b6e212c6617a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6515fdcb-cb77-486a-8c3d-b6e212c6617a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31561450-bc83-46bf-94fb-61f9b33304fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31561450-bc83-46bf-94fb-61f9b33304fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5624b8bb-78ae-4823-b44c-37ba8f05769f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5624b8bb-78ae-4823-b44c-37ba8f05769f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_92a4ec40-00d6-42cd-b491-8bda31a9972e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_92a4ec40-00d6-42cd-b491-8bda31a9972e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839c693b-618d-439c-b9d8-d8cb14a1ed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_462a79c7-8025-4619-a9d1-a55ab21a5088" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839c693b-618d-439c-b9d8-d8cb14a1ed9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bb63480f-be4d-4faf-b17d-079da9a72843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839c693b-618d-439c-b9d8-d8cb14a1ed9d" xlink:to="loc_us-gaap_AwardTypeAxis_bb63480f-be4d-4faf-b17d-079da9a72843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb63480f-be4d-4faf-b17d-079da9a72843_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bb63480f-be4d-4faf-b17d-079da9a72843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bb63480f-be4d-4faf-b17d-079da9a72843_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5fbcc56-d59b-4222-b87b-6b2eb15ab3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bb63480f-be4d-4faf-b17d-079da9a72843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5fbcc56-d59b-4222-b87b-6b2eb15ab3b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e32c5b79-f11e-4ffc-97ae-6e595d82ffbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5fbcc56-d59b-4222-b87b-6b2eb15ab3b5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e32c5b79-f11e-4ffc-97ae-6e595d82ffbf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="extended" id="i7f91e7fb3c694759b040e27507f76a70_EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d75859ce-0cf3-4c94-b8dc-c1067b55cb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d75859ce-0cf3-4c94-b8dc-c1067b55cb0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8295a9a0-7af7-41ff-8acf-b53837c89581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8295a9a0-7af7-41ff-8acf-b53837c89581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_f2afc779-7b76-4cee-9541-27b5b721de9a" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_f2afc779-7b76-4cee-9541-27b5b721de9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cf471478-f315-4125-bc8c-117f4bde84ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cf471478-f315-4125-bc8c-117f4bde84ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0f9fe06f-149f-44e8-8b68-35b03a1ebc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0f9fe06f-149f-44e8-8b68-35b03a1ebc85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2df7bf66-1349-42ac-bbb9-5f12a2dd6ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2df7bf66-1349-42ac-bbb9-5f12a2dd6ef1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dd7bf316-d130-487a-b7fa-608cbe2d6aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d75859ce-0cf3-4c94-b8dc-c1067b55cb0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e82d228d-a8fb-4175-9a2f-236ecd1dca3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e82d228d-a8fb-4175-9a2f-236ecd1dca3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_aecbe10e-08a7-4a98-9ff5-ac299314fe49" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_aecbe10e-08a7-4a98-9ff5-ac299314fe49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_86cdfcce-7d9a-4221-8c34-e8ed48ed2085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_86cdfcce-7d9a-4221-8c34-e8ed48ed2085" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_891f38df-7fc9-4330-904d-a4433092c5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_891f38df-7fc9-4330-904d-a4433092c5cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_573fa74e-47ec-43bf-b50d-3eb65c8f79f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_573fa74e-47ec-43bf-b50d-3eb65c8f79f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8bbac6b3-9333-4a37-8ce8-8c66cca5cf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed5da16c-0a75-4d9e-b636-b0915ce010cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d75859ce-0cf3-4c94-b8dc-c1067b55cb0c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed5da16c-0a75-4d9e-b636-b0915ce010cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_215f002f-7c01-411a-ad5f-141ee3954ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed5da16c-0a75-4d9e-b636-b0915ce010cb" xlink:to="loc_us-gaap_AwardTypeAxis_215f002f-7c01-411a-ad5f-141ee3954ce9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_215f002f-7c01-411a-ad5f-141ee3954ce9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_215f002f-7c01-411a-ad5f-141ee3954ce9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_215f002f-7c01-411a-ad5f-141ee3954ce9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3869a23e-0813-4819-88b5-b9cb333a9e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_215f002f-7c01-411a-ad5f-141ee3954ce9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3869a23e-0813-4819-88b5-b9cb333a9e56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_f64362b6-a651-4322-880d-2b6395e5a63b" xlink:href="iclr-20211231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3869a23e-0813-4819-88b5-b9cb333a9e56" xlink:to="loc_iclr_PerformanceShareUnitMember_f64362b6-a651-4322-880d-2b6395e5a63b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ffff41c0-3ad8-4e75-aff8-b7c09ba72bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3869a23e-0813-4819-88b5-b9cb333a9e56" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ffff41c0-3ad8-4e75-aff8-b7c09ba72bdb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="extended" id="i230b7bda8cd24e91837a607af20060ea_EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b7ae2c-4023-4bcc-9a9d-be9d215e5ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_81c66f09-4274-4af7-976a-7f547c57ab7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b7ae2c-4023-4bcc-9a9d-be9d215e5ff1" xlink:to="loc_us-gaap_ShareBasedCompensation_81c66f09-4274-4af7-976a-7f547c57ab7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a09209c-fef7-4e9c-a23b-0d248b9b4c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b7ae2c-4023-4bcc-9a9d-be9d215e5ff1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a09209c-fef7-4e9c-a23b-0d248b9b4c11" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a09209c-fef7-4e9c-a23b-0d248b9b4c11" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6e1bc4da-16db-4ef8-b992-82c786db2c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:to="loc_us-gaap_CostOfSalesMember_6e1bc4da-16db-4ef8-b992-82c786db2c48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0b9c8751-cdc7-401d-b570-cd8a3ed0f20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0b9c8751-cdc7-401d-b570-cd8a3ed0f20f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember_f6ae58de-d95f-4f5f-868d-51d06de79be9" xlink:href="iclr-20211231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:to="loc_iclr_TransactionAndIntegrationExpenseMember_f6ae58de-d95f-4f5f-868d-51d06de79be9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#ShareCapitalDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="extended" id="i8ef14ea96cf94901a1739500994d43d7_ShareCapitalDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes_3cabfcb8-9761-478d-ad30-82615a496e53" xlink:href="iclr-20211231.xsd#iclr_NumberOfVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_iclr_NumberOfVotes_3cabfcb8-9761-478d-ad30-82615a496e53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8498927b-38d0-4a3b-a840-73d7c632dcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8498927b-38d0-4a3b-a840-73d7c632dcfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1620cfb7-ce67-4aaf-a1aa-eee21bbfeffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1620cfb7-ce67-4aaf-a1aa-eee21bbfeffa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d23dc9bf-e638-4120-a650-5377582b848a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d23dc9bf-e638-4120-a650-5377582b848a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_acb2f5a7-1173-411b-b004-65a2fd22be92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_acb2f5a7-1173-411b-b004-65a2fd22be92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3b331642-9119-4750-8ca4-a4127c87de36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3b331642-9119-4750-8ca4-a4127c87de36" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_81471060-889b-409e-b291-6d2fe12c7bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_81471060-889b-409e-b291-6d2fe12c7bd0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_0044edaf-aea4-4edf-8d4e-0ae48a49e708" xlink:href="iclr-20211231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_0044edaf-aea4-4edf-8d4e-0ae48a49e708" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_48c6a32f-ce04-4f2f-b4bf-afd75fab99d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_48c6a32f-ce04-4f2f-b4bf-afd75fab99d3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_04c2d87c-feb0-4f74-aeaf-e8567154d2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_04c2d87c-feb0-4f74-aeaf-e8567154d2d7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_26d214bd-1b3c-45ac-afd5-319768312271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_26d214bd-1b3c-45ac-afd5-319768312271" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_6c2402a1-3e3a-40bb-aeb6-211afd5d48d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_6c2402a1-3e3a-40bb-aeb6-211afd5d48d1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8bab64cb-3002-42e1-9b62-6a0180196905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8bab64cb-3002-42e1-9b62-6a0180196905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8bab64cb-3002-42e1-9b62-6a0180196905_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8bab64cb-3002-42e1-9b62-6a0180196905" xlink:to="loc_us-gaap_EquityComponentDomain_8bab64cb-3002-42e1-9b62-6a0180196905_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ce0fcbd0-f4f1-4752-a0e7-c3852c25f2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8bab64cb-3002-42e1-9b62-6a0180196905" xlink:to="loc_us-gaap_EquityComponentDomain_ce0fcbd0-f4f1-4752-a0e7-c3852c25f2c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_930e2103-3d60-42a0-a6e3-34689e8c975d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ce0fcbd0-f4f1-4752-a0e7-c3852c25f2c7" xlink:to="loc_us-gaap_CommonStockMember_930e2103-3d60-42a0-a6e3-34689e8c975d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_29dbc014-a86d-450e-a6f9-a8d713a83455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_us-gaap_AwardTypeAxis_29dbc014-a86d-450e-a6f9-a8d713a83455" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29dbc014-a86d-450e-a6f9-a8d713a83455_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_29dbc014-a86d-450e-a6f9-a8d713a83455" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29dbc014-a86d-450e-a6f9-a8d713a83455_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_29dbc014-a86d-450e-a6f9-a8d713a83455" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4cd6e968-a429-47ef-9b44-414aece103ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4cd6e968-a429-47ef-9b44-414aece103ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_40e8a482-1154-42be-a78f-3ffb56fdc7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_40e8a482-1154-42be-a78f-3ffb56fdc7f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_e4521dba-fce9-42fd-947f-1f27f9c3f1fd" xlink:href="iclr-20211231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:to="loc_iclr_PerformanceShareUnitMember_e4521dba-fce9-42fd-947f-1f27f9c3f1fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_srt_RangeAxis_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1" xlink:to="loc_srt_RangeMember_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c59cdd5-5a90-4992-ac19-4865f3ea55a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1" xlink:to="loc_srt_RangeMember_3c59cdd5-5a90-4992-ac19-4865f3ea55a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e616d47-cb02-4aeb-9b92-8a4159d05217" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3c59cdd5-5a90-4992-ac19-4865f3ea55a3" xlink:to="loc_srt_MaximumMember_9e616d47-cb02-4aeb-9b92-8a4159d05217" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f6952d21-01a8-43ee-9955-82c85375fed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f6952d21-01a8-43ee-9955-82c85375fed7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f6952d21-01a8-43ee-9955-82c85375fed7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f6952d21-01a8-43ee-9955-82c85375fed7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f6952d21-01a8-43ee-9955-82c85375fed7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5c7181dd-ffd5-41a5-9f42-36740655f468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f6952d21-01a8-43ee-9955-82c85375fed7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5c7181dd-ffd5-41a5-9f42-36740655f468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_4f0cb25e-3f1f-43b6-9264-717b6c08e04f" xlink:href="iclr-20211231.xsd#iclr_BuybackProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5c7181dd-ffd5-41a5-9f42-36740655f468" xlink:to="loc_iclr_BuybackProgramMember_4f0cb25e-3f1f-43b6-9264-717b6c08e04f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="extended" id="i2451a339776e4b309a8b2e288fe184ce_IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_71c37797-0c33-44f2-a1f1-8f3422488e1c" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a62702fa-eda0-4ef0-9b04-4c90d50c5fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_71c37797-0c33-44f2-a1f1-8f3422488e1c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a62702fa-eda0-4ef0-9b04-4c90d50c5fa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_6edb4f08-7ec5-45ce-afb9-8c3d88a5fbef" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_71c37797-0c33-44f2-a1f1-8f3422488e1c" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_6edb4f08-7ec5-45ce-afb9-8c3d88a5fbef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1514d104-f942-4861-8ca3-8fd6709bc735" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_6edb4f08-7ec5-45ce-afb9-8c3d88a5fbef" xlink:to="loc_srt_StatementGeographicalAxis_1514d104-f942-4861-8ca3-8fd6709bc735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1514d104-f942-4861-8ca3-8fd6709bc735_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1514d104-f942-4861-8ca3-8fd6709bc735" xlink:to="loc_srt_SegmentGeographicalDomain_1514d104-f942-4861-8ca3-8fd6709bc735_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1514d104-f942-4861-8ca3-8fd6709bc735" xlink:to="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_ac131d7a-68ab-4a35-924e-f7340d74ce1f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:to="loc_country_IE_ac131d7a-68ab-4a35-924e-f7340d74ce1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6b8da3ac-7e2b-4eea-9a2d-70a2e0074585" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:to="loc_country_US_6b8da3ac-7e2b-4eea-9a2d-70a2e0074585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_07e5d0fa-fbaf-4566-96bd-02d426ed44ee" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_07e5d0fa-fbaf-4566-96bd-02d426ed44ee" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended" id="i5a0c15e3903646c298cca8d07fe002aa_IncomeTaxesComponentsofProvisionforIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:href="iclr-20211231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_97d65f8a-b9cc-471f-bd12-9a95c8a8c25e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_97d65f8a-b9cc-471f-bd12-9a95c8a8c25e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_51abc0be-1f62-4ab0-a05d-b90b16877db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_97d65f8a-b9cc-471f-bd12-9a95c8a8c25e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_51abc0be-1f62-4ab0-a05d-b90b16877db4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_4b351f25-3f2c-4b0c-a857-6286cf56fd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_4b351f25-3f2c-4b0c-a857-6286cf56fd3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e1bc701f-272b-4280-815a-ef313c04cd25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_4b351f25-3f2c-4b0c-a857-6286cf56fd3e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e1bc701f-272b-4280-815a-ef313c04cd25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f09ff226-e52a-48e4-86a4-703118699005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f09ff226-e52a-48e4-86a4-703118699005" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract_2986bc59-4b9a-420a-a2da-d1499276ee32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:to="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract_2986bc59-4b9a-420a-a2da-d1499276ee32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_bbc3f1ec-8844-449b-b7d2-64aacc122cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract_2986bc59-4b9a-420a-a2da-d1499276ee32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_bbc3f1ec-8844-449b-b7d2-64aacc122cda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_34288689-d6fe-48ea-af9d-1efa9892f46e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_34288689-d6fe-48ea-af9d-1efa9892f46e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_f7e74641-f824-4286-835e-0526defd02d7" xlink:href="iclr-20211231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_f7e74641-f824-4286-835e-0526defd02d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_973594bb-7c50-4a30-a13c-3e94bf0fdb9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_f7e74641-f824-4286-835e-0526defd02d7" xlink:to="loc_srt_StatementGeographicalAxis_973594bb-7c50-4a30-a13c-3e94bf0fdb9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_973594bb-7c50-4a30-a13c-3e94bf0fdb9a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_973594bb-7c50-4a30-a13c-3e94bf0fdb9a" xlink:to="loc_srt_SegmentGeographicalDomain_973594bb-7c50-4a30-a13c-3e94bf0fdb9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_973594bb-7c50-4a30-a13c-3e94bf0fdb9a" xlink:to="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_c17b47c0-28ed-460d-b5e7-1c58369a44bf" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:to="loc_country_IE_c17b47c0-28ed-460d-b5e7-1c58369a44bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a529e870-457a-47b9-9740-176e923b7641" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:to="loc_country_US_a529e870-457a-47b9-9740-176e923b7641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_d4f1d40e-af8d-44d9-ab90-ca74a18dafdb" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_d4f1d40e-af8d-44d9-ab90-ca74a18dafdb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ia2fee3898207481d89dc1d57de82329b_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_cf43e1bf-dae3-47e4-92b1-f55765dea83e" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_cf43e1bf-dae3-47e4-92b1-f55765dea83e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9a3701f0-fa48-40cd-a4c3-3945e65c64da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9a3701f0-fa48-40cd-a4c3-3945e65c64da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal_2e293457-7162-4df3-88a0-98daf6500680" xlink:href="iclr-20211231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_iclr_OperatingLossCarryforwardsUSFederal_2e293457-7162-4df3-88a0-98daf6500680" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_11f85a33-5d5e-45f9-b9c6-2671031bce10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_11f85a33-5d5e-45f9-b9c6-2671031bce10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_3db68401-f3e7-4f9d-b3a0-52bc52a43234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_3db68401-f3e7-4f9d-b3a0-52bc52a43234" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_12d086d8-bc89-4611-a19b-7cdb3791625b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_12d086d8-bc89-4611-a19b-7cdb3791625b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5b614132-a9d7-4961-9dd5-ebb0f27305d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5b614132-a9d7-4961-9dd5-ebb0f27305d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_dc0e994e-aa07-41d4-92eb-2a10aa31ce13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_dc0e994e-aa07-41d4-92eb-2a10aa31ce13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_648d3d4b-a964-45f0-9a66-9a4b890db1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_648d3d4b-a964-45f0-9a66-9a4b890db1e6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1d335ceb-2df3-4f96-9053-821221cc14d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1d335ceb-2df3-4f96-9053-821221cc14d7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_4baaaa76-ee30-412f-ae35-3b09f4c2d6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_4baaaa76-ee30-412f-ae35-3b09f4c2d6f7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_774ed01d-781c-419b-9bcf-95f3b5a67601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_774ed01d-781c-419b-9bcf-95f3b5a67601" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_580cc4b3-cd10-44da-b735-06c3b2963a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_580cc4b3-cd10-44da-b735-06c3b2963a7d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d4cc66ec-bab9-4c41-af39-d4176ee66139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d4cc66ec-bab9-4c41-af39-d4176ee66139" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_cffe1374-15ba-4016-aaca-0e92cd89a692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_cffe1374-15ba-4016-aaca-0e92cd89a692" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_eafeadb6-d901-44ec-99b3-36113709d901" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_srt_StatementGeographicalAxis_eafeadb6-d901-44ec-99b3-36113709d901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_eafeadb6-d901-44ec-99b3-36113709d901_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_eafeadb6-d901-44ec-99b3-36113709d901" xlink:to="loc_srt_SegmentGeographicalDomain_eafeadb6-d901-44ec-99b3-36113709d901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_eafeadb6-d901-44ec-99b3-36113709d901" xlink:to="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_2f1eb772-34ba-4e3e-81ed-3fce5c9fca54" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:to="loc_country_IE_2f1eb772-34ba-4e3e-81ed-3fce5c9fca54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_51466191-7733-44ae-9438-50fdfc926c69" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:to="loc_country_US_51466191-7733-44ae-9438-50fdfc926c69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_8206f299-ac43-4a1b-b8db-431796680ed1" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:to="loc_iclr_OtherCountriesMember_8206f299-ac43-4a1b-b8db-431796680ed1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_42953620-cd8c-4a5f-a355-0c2e3d7778ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_42953620-cd8c-4a5f-a355-0c2e3d7778ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_0c176507-2a2f-4217-84a3-ae0239a8e9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_42953620-cd8c-4a5f-a355-0c2e3d7778ad" xlink:to="loc_us-gaap_ForeignCountryMember_0c176507-2a2f-4217-84a3-ae0239a8e9bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3d57e98b-5706-4e05-83f9-0dd1e0211ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_42953620-cd8c-4a5f-a355-0c2e3d7778ad" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3d57e98b-5706-4e05-83f9-0dd1e0211ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8fea87b1-97b8-4950-8074-da24bbb2a7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8fea87b1-97b8-4950-8074-da24bbb2a7a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_173efbd3-0e22-4855-bbd7-56254e9b38a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8fea87b1-97b8-4950-8074-da24bbb2a7a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_173efbd3-0e22-4855-bbd7-56254e9b38a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_3e8d3d1b-aa94-4631-b27a-293cb61a50a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_TaxPeriodAxis_3e8d3d1b-aa94-4631-b27a-293cb61a50a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_3e8d3d1b-aa94-4631-b27a-293cb61a50a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_3e8d3d1b-aa94-4631-b27a-293cb61a50a2" xlink:to="loc_us-gaap_TaxPeriodDomain_3e8d3d1b-aa94-4631-b27a-293cb61a50a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_3e8d3d1b-aa94-4631-b27a-293cb61a50a2" xlink:to="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022to2035Member_4bffa3bd-2fef-492f-a130-cf05ff08ac1a" xlink:href="iclr-20211231.xsd#iclr_TaxYear2022to2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:to="loc_iclr_TaxYear2022to2035Member_4bffa3bd-2fef-492f-a130-cf05ff08ac1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20362040Member_b67d96a4-fec8-49db-96a7-6e452cc781bb" xlink:href="iclr-20211231.xsd#iclr_TaxYear20362040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:to="loc_iclr_TaxYear20362040Member_b67d96a4-fec8-49db-96a7-6e452cc781bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022To2028Member_872adbb7-0b3f-410c-86d9-febf196a5cfa" xlink:href="iclr-20211231.xsd#iclr_TaxYear2022To2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:to="loc_iclr_TaxYear2022To2028Member_872adbb7-0b3f-410c-86d9-febf196a5cfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2029To2038Member_34f32737-b827-4320-bdb5-ffebcb027299" xlink:href="iclr-20211231.xsd#iclr_TaxYear2029To2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:to="loc_iclr_TaxYear2029To2038Member_34f32737-b827-4320-bdb5-ffebcb027299" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a26ea303-da4e-4658-982e-0af1b7314523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a26ea303-da4e-4658-982e-0af1b7314523" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a26ea303-da4e-4658-982e-0af1b7314523_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a26ea303-da4e-4658-982e-0af1b7314523" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a26ea303-da4e-4658-982e-0af1b7314523_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c464e1ab-a786-47fe-85ca-e9a96093ca03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a26ea303-da4e-4658-982e-0af1b7314523" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c464e1ab-a786-47fe-85ca-e9a96093ca03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember_2e1b380a-90f0-4ed9-8979-c58afc16eb00" xlink:href="iclr-20211231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c464e1ab-a786-47fe-85ca-e9a96093ca03" xlink:to="loc_iclr_IncomeTaxBenefitMember_2e1b380a-90f0-4ed9-8979-c58afc16eb00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_de87fa5f-e452-493c-879b-88984fcdbe89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_de87fa5f-e452-493c-879b-88984fcdbe89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_de87fa5f-e452-493c-879b-88984fcdbe89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_de87fa5f-e452-493c-879b-88984fcdbe89" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_de87fa5f-e452-493c-879b-88984fcdbe89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_0925963c-a4d3-4cf5-9363-cf5193918403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_de87fa5f-e452-493c-879b-88984fcdbe89" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_0925963c-a4d3-4cf5-9363-cf5193918403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_81fde330-c6ba-4ecf-8847-c65e240875b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_0925963c-a4d3-4cf5-9363-cf5193918403" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_81fde330-c6ba-4ecf-8847-c65e240875b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a6522125-fddb-4730-b6ad-5259b2d4ec23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a6522125-fddb-4730-b6ad-5259b2d4ec23" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6522125-fddb-4730-b6ad-5259b2d4ec23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6522125-fddb-4730-b6ad-5259b2d4ec23" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6522125-fddb-4730-b6ad-5259b2d4ec23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec7b7d78-e5fb-49de-be61-8c1a44cb64f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6522125-fddb-4730-b6ad-5259b2d4ec23" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec7b7d78-e5fb-49de-be61-8c1a44cb64f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_09b65086-b8f5-4353-8881-db3cd4ff3c73" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec7b7d78-e5fb-49de-be61-8c1a44cb64f6" xlink:to="loc_iclr_PRAHealthSciencesIncMember_09b65086-b8f5-4353-8881-db3cd4ff3c73" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended" id="ic233eecf6cb54794995799037a1ef45f_IncomeTaxesExpectedExpiryDatesofNOLsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_11e1fda8-a8e7-4992-a278-c08ddd7ee8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_11e1fda8-a8e7-4992-a278-c08ddd7ee8da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_e3cce967-e3a6-45fc-a80e-4f02031b7c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_e3cce967-e3a6-45fc-a80e-4f02031b7c4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_03f0066a-d262-4d7e-9371-2191e477f52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_03f0066a-d262-4d7e-9371-2191e477f52c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_94662560-1267-4413-8a80-abfe615e9790" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_srt_StatementGeographicalAxis_94662560-1267-4413-8a80-abfe615e9790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_94662560-1267-4413-8a80-abfe615e9790_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_94662560-1267-4413-8a80-abfe615e9790" xlink:to="loc_srt_SegmentGeographicalDomain_94662560-1267-4413-8a80-abfe615e9790_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d8a273a1-cb0c-4a52-ae27-2eccf8f5e81d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_94662560-1267-4413-8a80-abfe615e9790" xlink:to="loc_srt_SegmentGeographicalDomain_d8a273a1-cb0c-4a52-ae27-2eccf8f5e81d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1c820383-1740-4a6d-9521-7c1441fed347" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d8a273a1-cb0c-4a52-ae27-2eccf8f5e81d" xlink:to="loc_country_US_1c820383-1740-4a6d-9521-7c1441fed347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_2b720641-2fab-4b14-ba10-f7b7899c3999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_2b720641-2fab-4b14-ba10-f7b7899c3999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_8c906271-9cb7-437e-b94a-9ff570b8b44e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_2b720641-2fab-4b14-ba10-f7b7899c3999" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_8c906271-9cb7-437e-b94a-9ff570b8b44e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_58bde70b-0165-4bba-875a-27f12213e9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_58bde70b-0165-4bba-875a-27f12213e9ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_58bde70b-0165-4bba-875a-27f12213e9ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_58bde70b-0165-4bba-875a-27f12213e9ba" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_58bde70b-0165-4bba-875a-27f12213e9ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_7191fbd8-a3f6-4ade-9342-14d4bf1d8ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_58bde70b-0165-4bba-875a-27f12213e9ba" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_7191fbd8-a3f6-4ade-9342-14d4bf1d8ff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_49d99bf7-7c93-4926-9f1c-187c5f66dceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_7191fbd8-a3f6-4ade-9342-14d4bf1d8ff7" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_49d99bf7-7c93-4926-9f1c-187c5f66dceb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_30049257-4a1c-41ca-8af7-3c38b9759fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_us-gaap_TaxPeriodAxis_30049257-4a1c-41ca-8af7-3c38b9759fc9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_30049257-4a1c-41ca-8af7-3c38b9759fc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_30049257-4a1c-41ca-8af7-3c38b9759fc9" xlink:to="loc_us-gaap_TaxPeriodDomain_30049257-4a1c-41ca-8af7-3c38b9759fc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_34f932d2-fca0-47a6-b7e4-3681256f4ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_30049257-4a1c-41ca-8af7-3c38b9759fc9" xlink:to="loc_us-gaap_TaxPeriodDomain_34f932d2-fca0-47a6-b7e4-3681256f4ec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022to2035Member_df071b16-4cd0-4077-a1a8-057ff60945ef" xlink:href="iclr-20211231.xsd#iclr_TaxYear2022to2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_34f932d2-fca0-47a6-b7e4-3681256f4ec9" xlink:to="loc_iclr_TaxYear2022to2035Member_df071b16-4cd0-4077-a1a8-057ff60945ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20362040Member_930cbe31-4c54-4202-8519-85f651aaa45d" xlink:href="iclr-20211231.xsd#iclr_TaxYear20362040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_34f932d2-fca0-47a6-b7e4-3681256f4ec9" xlink:to="loc_iclr_TaxYear20362040Member_930cbe31-4c54-4202-8519-85f651aaa45d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#RestructuringchargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="extended" id="i17b85aa4cfbd456caa73ba46501eda8c_RestructuringchargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_8e71a712-330f-47a2-9889-b5015ce34f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_RestructuringCosts_8e71a712-330f-47a2-9889-b5015ce34f03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_633ecfd1-c75a-4175-96b1-0321d79f510e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_633ecfd1-c75a-4175-96b1-0321d79f510e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a5bf48b9-0b06-4744-b1a6-f462a2aef286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a5bf48b9-0b06-4744-b1a6-f462a2aef286" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7844ec22-786c-4065-87ca-b54bc71fb038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_RestructuringReserve_7844ec22-786c-4065-87ca-b54bc71fb038" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_96f111be-5f0e-4a35-9c4f-52fdd2dc1f94" xlink:href="iclr-20211231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_96f111be-5f0e-4a35-9c4f-52fdd2dc1f94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_c52c1bc4-5c2d-4130-8b75-5b857cf4371a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_c52c1bc4-5c2d-4130-8b75-5b857cf4371a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c52c1bc4-5c2d-4130-8b75-5b857cf4371a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c52c1bc4-5c2d-4130-8b75-5b857cf4371a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c52c1bc4-5c2d-4130-8b75-5b857cf4371a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_00865fb7-8289-471d-9b48-37f45fd7eae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c52c1bc4-5c2d-4130-8b75-5b857cf4371a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_00865fb7-8289-471d-9b48-37f45fd7eae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_ea2f7c3c-461a-430c-9597-08d996dc3480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_00865fb7-8289-471d-9b48-37f45fd7eae7" xlink:to="loc_us-gaap_EmployeeSeveranceMember_ea2f7c3c-461a-430c-9597-08d996dc3480" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember_7b3ba5f6-1029-405a-b25e-322c3fe4a304" xlink:href="iclr-20211231.xsd#iclr_LeaseLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_00865fb7-8289-471d-9b48-37f45fd7eae7" xlink:to="loc_iclr_LeaseLiabilityMember_7b3ba5f6-1029-405a-b25e-322c3fe4a304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_bff38a16-43b7-4a8f-a5e3-49e86c6f7137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_RestructuringPlanAxis_bff38a16-43b7-4a8f-a5e3-49e86c6f7137" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bff38a16-43b7-4a8f-a5e3-49e86c6f7137_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_bff38a16-43b7-4a8f-a5e3-49e86c6f7137" xlink:to="loc_us-gaap_RestructuringPlanDomain_bff38a16-43b7-4a8f-a5e3-49e86c6f7137_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_f6826d8f-0054-4665-b764-46297c44dd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_bff38a16-43b7-4a8f-a5e3-49e86c6f7137" xlink:to="loc_us-gaap_RestructuringPlanDomain_f6826d8f-0054-4665-b764-46297c44dd5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember_d1ceb95b-3b8e-479f-b96f-01cd57dfcf5e" xlink:href="iclr-20211231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_f6826d8f-0054-4665-b764-46297c44dd5d" xlink:to="loc_iclr_A2021RestructuringPlanMember_d1ceb95b-3b8e-479f-b96f-01cd57dfcf5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1d70e178-e145-49a2-b244-cf74c09cf7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1d70e178-e145-49a2-b244-cf74c09cf7d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1d70e178-e145-49a2-b244-cf74c09cf7d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1d70e178-e145-49a2-b244-cf74c09cf7d4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1d70e178-e145-49a2-b244-cf74c09cf7d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a38dcdf8-81d9-40cd-a690-b662c02aeced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1d70e178-e145-49a2-b244-cf74c09cf7d4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a38dcdf8-81d9-40cd-a690-b662c02aeced" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_d2f0567d-943e-43fc-863b-a72a67f72511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a38dcdf8-81d9-40cd-a690-b662c02aeced" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_d2f0567d-943e-43fc-863b-a72a67f72511" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_a3b675ff-bcb8-439d-bf6b-ef52257aac4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a38dcdf8-81d9-40cd-a690-b662c02aeced" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_a3b675ff-bcb8-439d-bf6b-ef52257aac4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_04234f33-81ae-4403-9056-bfac4c64238c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_04234f33-81ae-4403-9056-bfac4c64238c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04234f33-81ae-4403-9056-bfac4c64238c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_04234f33-81ae-4403-9056-bfac4c64238c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_04234f33-81ae-4403-9056-bfac4c64238c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0eabdd01-5d40-42f8-a5e4-99d2a4890e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_04234f33-81ae-4403-9056-bfac4c64238c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0eabdd01-5d40-42f8-a5e4-99d2a4890e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_32c0750a-b311-4f80-87ff-fc288e5a3f3d" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0eabdd01-5d40-42f8-a5e4-99d2a4890e1e" xlink:to="loc_iclr_PRAHealthSciencesIncMember_32c0750a-b311-4f80-87ff-fc288e5a3f3d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#DisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="extended" id="ie1397788d6904d13a859614f5559e73f_DisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_17f5f86d-f4d9-43f8-827f-26f7ce093866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1b51d9c7-a74e-4d40-9cb7-56f65df5eb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_17f5f86d-f4d9-43f8-827f-26f7ce093866" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1b51d9c7-a74e-4d40-9cb7-56f65df5eb54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_34ef2fd4-c4e5-4acb-9610-fdbf87dd42d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_17f5f86d-f4d9-43f8-827f-26f7ce093866" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_34ef2fd4-c4e5-4acb-9610-fdbf87dd42d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_17568a89-e1d3-4219-921c-5505d98989e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ef2fd4-c4e5-4acb-9610-fdbf87dd42d3" xlink:to="loc_srt_MajorCustomersAxis_17568a89-e1d3-4219-921c-5505d98989e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_17568a89-e1d3-4219-921c-5505d98989e0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_17568a89-e1d3-4219-921c-5505d98989e0" xlink:to="loc_srt_NameOfMajorCustomerDomain_17568a89-e1d3-4219-921c-5505d98989e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_17568a89-e1d3-4219-921c-5505d98989e0" xlink:to="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember_c29215c4-3b0a-41f2-986e-029b6eda28be" xlink:href="iclr-20211231.xsd#iclr_TopClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_TopClientMember_c29215c4-3b0a-41f2-986e-029b6eda28be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member_46ad258f-24b5-4030-82ca-545fa0f88a01" xlink:href="iclr-20211231.xsd#iclr_Clients25Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_Clients25Member_46ad258f-24b5-4030-82ca-545fa0f88a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member_f6818516-8a59-4053-8693-a72940c1cf32" xlink:href="iclr-20211231.xsd#iclr_Clients610Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_Clients610Member_f6818516-8a59-4053-8693-a72940c1cf32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member_463dddde-5803-443b-b4df-ffa5226c8c38" xlink:href="iclr-20211231.xsd#iclr_Clients1125Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_Clients1125Member_463dddde-5803-443b-b4df-ffa5226c8c38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember_b5476e02-c0c3-493e-a553-0768bb2ef8ea" xlink:href="iclr-20211231.xsd#iclr_OtherCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_OtherCustomersMember_b5476e02-c0c3-493e-a553-0768bb2ef8ea" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" xlink:type="extended" id="iba5f45162e4e44f397bf09d0fc0208e2_AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_29f96407-c699-4a5a-a382-82dd5798f055" xlink:href="iclr-20211231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_29f96407-c699-4a5a-a382-82dd5798f055" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_2e7a6ceb-bd5e-44b4-a8f6-c746aa395bc4" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_2e7a6ceb-bd5e-44b4-a8f6-c746aa395bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_245c37da-9d55-47ba-b400-62b3685f49a6" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_245c37da-9d55-47ba-b400-62b3685f49a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_4502bb07-4f0d-4964-9976-45ad3947613c" xlink:href="iclr-20211231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_4502bb07-4f0d-4964-9976-45ad3947613c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_6c5d74bc-fa33-4227-86c0-f86ba792d66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_6c5d74bc-fa33-4227-86c0-f86ba792d66f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_53c46c14-f348-4cfd-8a1f-e11b34b0ea10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_53c46c14-f348-4cfd-8a1f-e11b34b0ea10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_cc180bd1-40c8-4148-a95b-11620fcf95c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_cc180bd1-40c8-4148-a95b-11620fcf95c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6f7c8a6d-4c8a-4221-a17b-1c13f0474b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6f7c8a6d-4c8a-4221-a17b-1c13f0474b3d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_998cd3c2-530b-4361-acbc-869f676f9f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_998cd3c2-530b-4361-acbc-869f676f9f61" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1" xlink:type="extended" id="i4844508a2ec24fc89c7a44dfce069dc6_AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_29f96407-c699-4a5a-a382-82dd5798f055" xlink:href="iclr-20211231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_29f96407-c699-4a5a-a382-82dd5798f055" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_2e7a6ceb-bd5e-44b4-a8f6-c746aa395bc4" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_2e7a6ceb-bd5e-44b4-a8f6-c746aa395bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_245c37da-9d55-47ba-b400-62b3685f49a6" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_245c37da-9d55-47ba-b400-62b3685f49a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_4502bb07-4f0d-4964-9976-45ad3947613c" xlink:href="iclr-20211231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_4502bb07-4f0d-4964-9976-45ad3947613c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_6c5d74bc-fa33-4227-86c0-f86ba792d66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_6c5d74bc-fa33-4227-86c0-f86ba792d66f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_53c46c14-f348-4cfd-8a1f-e11b34b0ea10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_53c46c14-f348-4cfd-8a1f-e11b34b0ea10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_cc180bd1-40c8-4148-a95b-11620fcf95c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_cc180bd1-40c8-4148-a95b-11620fcf95c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6f7c8a6d-4c8a-4221-a17b-1c13f0474b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6f7c8a6d-4c8a-4221-a17b-1c13f0474b3d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="extended" id="i934fea11f6094037ad58de1af37c6ea8_BusinessSegmentandGeographicalInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8d173fa7-e00e-4ff4-a2b4-1e3ab696259c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8d173fa7-e00e-4ff4-a2b4-1e3ab696259c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts_865ea523-bc6e-4887-8f1f-1253e5c52a3d" xlink:href="iclr-20211231.xsd#iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts_865ea523-bc6e-4887-8f1f-1253e5c52a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_e956dcc5-a08a-4a77-9249-352077cb5275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_RestructuringCosts_e956dcc5-a08a-4a77-9249-352077cb5275" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_5ea6dc89-694b-431d-9305-d198daaa8493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_5ea6dc89-694b-431d-9305-d198daaa8493" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1cfd3269-a548-4422-8369-3d1fb2b62fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_OperatingIncomeLoss_1cfd3269-a548-4422-8369-3d1fb2b62fb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:to="loc_us-gaap_RestructuringPlanAxis_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f" xlink:to="loc_us-gaap_RestructuringPlanDomain_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0caa152c-face-4ef5-a0d8-c9f2523a42a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f" xlink:to="loc_us-gaap_RestructuringPlanDomain_0caa152c-face-4ef5-a0d8-c9f2523a42a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember_316a4c77-f626-4994-85f4-d28c1492a477" xlink:href="iclr-20211231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0caa152c-face-4ef5-a0d8-c9f2523a42a7" xlink:to="loc_iclr_A2021RestructuringPlanMember_316a4c77-f626-4994-85f4-d28c1492a477" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34dbb599-2000-4a9e-be6c-033979e75fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34dbb599-2000-4a9e-be6c-033979e75fff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34dbb599-2000-4a9e-be6c-033979e75fff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34dbb599-2000-4a9e-be6c-033979e75fff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34dbb599-2000-4a9e-be6c-033979e75fff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc53de3f-19ed-4710-a3b6-88222037000b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34dbb599-2000-4a9e-be6c-033979e75fff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc53de3f-19ed-4710-a3b6-88222037000b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_6c9283c0-f43c-450b-87c4-4d5b348b7782" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc53de3f-19ed-4710-a3b6-88222037000b" xlink:to="loc_iclr_PRAHealthSciencesIncMember_6c9283c0-f43c-450b-87c4-4d5b348b7782" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="extended" id="i6d5b27a7e4fb4463b054cbbc89ead172_BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6bfa8a48-fafb-497a-917a-a2d7e3eacdd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34def085-09a4-4da2-9342-c39a1a8ddd37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6bfa8a48-fafb-497a-917a-a2d7e3eacdd3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34def085-09a4-4da2-9342-c39a1a8ddd37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fcdc4114-95f6-47a2-bad0-54c824e9f813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6bfa8a48-fafb-497a-917a-a2d7e3eacdd3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fcdc4114-95f6-47a2-bad0-54c824e9f813" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9ba31d16-334c-4b21-b722-bd6a918130f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fcdc4114-95f6-47a2-bad0-54c824e9f813" xlink:to="loc_srt_StatementGeographicalAxis_9ba31d16-334c-4b21-b722-bd6a918130f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9ba31d16-334c-4b21-b722-bd6a918130f4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9ba31d16-334c-4b21-b722-bd6a918130f4" xlink:to="loc_srt_SegmentGeographicalDomain_9ba31d16-334c-4b21-b722-bd6a918130f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9ba31d16-334c-4b21-b722-bd6a918130f4" xlink:to="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_0d54669b-65d2-4228-88b0-9e065bfda032" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:to="loc_country_IE_0d54669b-65d2-4228-88b0-9e065bfda032" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_c5fade99-cbaa-4638-980d-95d448b47257" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:to="loc_iclr_RestOfEuropeMember_c5fade99-cbaa-4638-980d-95d448b47257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b2a5e490-b202-4d01-864a-d1fed6708e77" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:to="loc_country_US_b2a5e490-b202-4d01-864a-d1fed6708e77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_22c56737-0d0d-4382-a2cc-6126326eb6a1" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:to="loc_iclr_OtherCountriesMember_22c56737-0d0d-4382-a2cc-6126326eb6a1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="extended" id="i5d59e64ceb4f4d00bf641fd04c4e78cd_BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ad2e1174-4d50-47dd-a4d9-0994cfdce887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_36b22d25-c499-4a3b-9e92-51a9dc72a7ac" xlink:href="iclr-20211231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e1174-4d50-47dd-a4d9-0994cfdce887" xlink:to="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_36b22d25-c499-4a3b-9e92-51a9dc72a7ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f791d190-2d44-448d-8a2a-bf1720a8efde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e1174-4d50-47dd-a4d9-0994cfdce887" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f791d190-2d44-448d-8a2a-bf1720a8efde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b1d9ef6a-3073-4547-b579-93d748f19474" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f791d190-2d44-448d-8a2a-bf1720a8efde" xlink:to="loc_srt_StatementGeographicalAxis_b1d9ef6a-3073-4547-b579-93d748f19474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b1d9ef6a-3073-4547-b579-93d748f19474_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b1d9ef6a-3073-4547-b579-93d748f19474" xlink:to="loc_srt_SegmentGeographicalDomain_b1d9ef6a-3073-4547-b579-93d748f19474_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b1d9ef6a-3073-4547-b579-93d748f19474" xlink:to="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_389edd49-3148-4589-ab1c-83aa7f04718b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:to="loc_country_IE_389edd49-3148-4589-ab1c-83aa7f04718b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_dcfb56b8-07b3-43b5-9344-4dce80a6bd10" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:to="loc_iclr_RestOfEuropeMember_dcfb56b8-07b3-43b5-9344-4dce80a6bd10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a3b900fb-5e2a-4e91-8f86-409ec0ab3952" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:to="loc_country_US_a3b900fb-5e2a-4e91-8f86-409ec0ab3952" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_142fa8d0-ddd2-440d-a795-c80c6df658a1" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:to="loc_iclr_OtherCountriesMember_142fa8d0-ddd2-440d-a795-c80c6df658a1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="extended" id="i068353aeff00490d95d525033073f1e7_BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_278b4c7a-2d2f-4f30-a887-814d6b531ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_d89567b3-6225-4e16-8032-0058993a11d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_278b4c7a-2d2f-4f30-a887-814d6b531ce7" xlink:to="loc_us-gaap_NoncurrentAssets_d89567b3-6225-4e16-8032-0058993a11d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a23ef652-50ae-4f16-b1a0-24991ff84b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_278b4c7a-2d2f-4f30-a887-814d6b531ce7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a23ef652-50ae-4f16-b1a0-24991ff84b31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8fd14c0e-4553-450d-ac0d-60845b0a22ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a23ef652-50ae-4f16-b1a0-24991ff84b31" xlink:to="loc_srt_StatementGeographicalAxis_8fd14c0e-4553-450d-ac0d-60845b0a22ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8fd14c0e-4553-450d-ac0d-60845b0a22ce_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8fd14c0e-4553-450d-ac0d-60845b0a22ce" xlink:to="loc_srt_SegmentGeographicalDomain_8fd14c0e-4553-450d-ac0d-60845b0a22ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8fd14c0e-4553-450d-ac0d-60845b0a22ce" xlink:to="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_8ebb2399-cbfa-4b10-aa49-e3da31c40f92" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:to="loc_country_IE_8ebb2399-cbfa-4b10-aa49-e3da31c40f92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_3e0b01e5-f2ae-469b-9b46-33400aba5afc" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:to="loc_iclr_RestOfEuropeMember_3e0b01e5-f2ae-469b-9b46-33400aba5afc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dd2a6f8e-3555-4895-93a5-cbb0331ad839" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:to="loc_country_US_dd2a6f8e-3555-4895-93a5-cbb0331ad839" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_78d244ff-16df-45f8-a6b4-f8e8e39975cc" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:to="loc_iclr_OtherCountriesMember_78d244ff-16df-45f8-a6b4-f8e8e39975cc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="i11150d63e2e94cbfb84b6dcda1e094e6_AccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1e4d4922-39e0-4698-901b-d3c572665f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1e4d4922-39e0-4698-901b-d3c572665f20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_462db7a1-3857-4bbe-b6ee-294c978ec1bd" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_462db7a1-3857-4bbe-b6ee-294c978ec1bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e9f491d3-8f7b-4e01-b4fa-6ce3eda371ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e9f491d3-8f7b-4e01-b4fa-6ce3eda371ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_69af2baa-9ea3-4641-8487-a07e82b91953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_69af2baa-9ea3-4641-8487-a07e82b91953" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_e6fe8eb5-8c54-4715-b565-bac7272976fe" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_e6fe8eb5-8c54-4715-b565-bac7272976fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_fa74e961-4f32-4f92-9941-ab8e7c961f0c" xlink:href="iclr-20211231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_fa74e961-4f32-4f92-9941-ab8e7c961f0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_effc27e6-f805-4aa9-9ae7-0e11fbebfe90" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_effc27e6-f805-4aa9-9ae7-0e11fbebfe90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_82f04895-4715-45eb-8d1e-ae94e47f0b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_82f04895-4715-45eb-8d1e-ae94e47f0b30" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f91d0431-15b4-42e5-8877-2f76dc073410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f91d0431-15b4-42e5-8877-2f76dc073410" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f91d0431-15b4-42e5-8877-2f76dc073410" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_63d46ee3-9b59-4838-b195-a6515a76da9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_63d46ee3-9b59-4838-b195-a6515a76da9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_04a6cc5a-7a8d-4d64-988b-74abe697c21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_63d46ee3-9b59-4838-b195-a6515a76da9c" xlink:to="loc_us-gaap_InterestRateContractMember_04a6cc5a-7a8d-4d64-988b-74abe697c21e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesOperatingLeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="extended" id="i91530f8d132745fab039b2c2c67a930f_OperatingLeasesOperatingLeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_103b6fbb-10ca-4903-a9b0-17cd45797169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_LeaseCost_103b6fbb-10ca-4903-a9b0-17cd45797169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_a269f952-7f23-4cca-890e-6a24ebc95bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_VariableLeaseCost_a269f952-7f23-4cca-890e-6a24ebc95bc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8a9a318a-c1ab-4afd-9dab-61c3a074aa47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8a9a318a-c1ab-4afd-9dab-61c3a074aa47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_0d4148af-f9c1-4116-bdf7-c02c3fbb10a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_0d4148af-f9c1-4116-bdf7-c02c3fbb10a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_26c3c7a6-e121-4991-aec2-2205b90e41b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_26c3c7a6-e121-4991-aec2-2205b90e41b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fc8c2597-40a4-4726-b85d-ee1bccd221e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fc8c2597-40a4-4726-b85d-ee1bccd221e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_68991803-04d4-45cb-a645-7d1baa61eb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_68991803-04d4-45cb-a645-7d1baa61eb48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_29b9427b-c08c-46ac-a30a-e018afbddfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_29b9427b-c08c-46ac-a30a-e018afbddfc9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_afdf2020-3eea-433a-9500-a0dcdc6e4992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_afdf2020-3eea-433a-9500-a0dcdc6e4992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_afdf2020-3eea-433a-9500-a0dcdc6e4992_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_afdf2020-3eea-433a-9500-a0dcdc6e4992" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_afdf2020-3eea-433a-9500-a0dcdc6e4992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2415b499-33fd-432d-a965-beba23658dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_afdf2020-3eea-433a-9500-a0dcdc6e4992" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2415b499-33fd-432d-a965-beba23658dbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3a53e4a4-2b38-44b9-a0b2-cc4aa4f15b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2415b499-33fd-432d-a965-beba23658dbb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3a53e4a4-2b38-44b9-a0b2-cc4aa4f15b3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_824960ca-964c-43c4-8fd5-b3ce46891ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2415b499-33fd-432d-a965-beba23658dbb" xlink:to="loc_us-gaap_CostOfSalesMember_824960ca-964c-43c4-8fd5-b3ce46891ca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_787dc55f-f597-4fc7-b25e-cbf26d534ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_787dc55f-f597-4fc7-b25e-cbf26d534ef4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_787dc55f-f597-4fc7-b25e-cbf26d534ef4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_787dc55f-f597-4fc7-b25e-cbf26d534ef4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_787dc55f-f597-4fc7-b25e-cbf26d534ef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5b12e2e0-bffe-487f-8388-3fd8da75cd76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_787dc55f-f597-4fc7-b25e-cbf26d534ef4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5b12e2e0-bffe-487f-8388-3fd8da75cd76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_316a2523-53a0-4c28-862a-9f0b1a3eb1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5b12e2e0-bffe-487f-8388-3fd8da75cd76" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_316a2523-53a0-4c28-862a-9f0b1a3eb1bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails" xlink:type="extended" id="if86f8ffd31d34398badc9e243ab7f6bb_NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_af8fa9d6-ba67-4e72-b3e7-ed3d668a6609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_af8fa9d6-ba67-4e72-b3e7-ed3d668a6609" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_856f4d18-9205-4806-8eae-4b6e9e9dc0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_856f4d18-9205-4806-8eae-4b6e9e9dc0e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_759618e3-c61d-4871-85a4-0a3ce13876e0" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_759618e3-c61d-4871-85a4-0a3ce13876e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_b36fbdad-50c6-470b-9ad7-ae3c44473965" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_b36fbdad-50c6-470b-9ad7-ae3c44473965" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_42c28922-4fc6-43f7-a4c0-b9ebfe2cd1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_42c28922-4fc6-43f7-a4c0-b9ebfe2cd1a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e06e0fc3-0de5-40b1-9682-dc3ccbe550cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e06e0fc3-0de5-40b1-9682-dc3ccbe550cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4e4607c9-40bd-4329-96b1-64de54cad9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:to="loc_us-gaap_SecuredDebtMember_4e4607c9-40bd-4329-96b1-64de54cad9d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_db21605e-078f-4ec4-825b-25b342a8aa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_db21605e-078f-4ec4-825b-25b342a8aa3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0b10f726-1980-42b7-81a0-b3e8541f1429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:to="loc_us-gaap_SeniorNotesMember_0b10f726-1980-42b7-81a0-b3e8541f1429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4b53337e-e6ee-4743-be52-9d35eaf3f456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:to="loc_us-gaap_DebtInstrumentAxis_4b53337e-e6ee-4743-be52-9d35eaf3f456" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4b53337e-e6ee-4743-be52-9d35eaf3f456_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4b53337e-e6ee-4743-be52-9d35eaf3f456" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4b53337e-e6ee-4743-be52-9d35eaf3f456_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4b53337e-e6ee-4743-be52-9d35eaf3f456" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_44a048e2-d2e2-4abe-aef3-27c94ea8c65c" xlink:href="iclr-20211231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:to="loc_iclr_TermLoanFacilityMember_44a048e2-d2e2-4abe-aef3-27c94ea8c65c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorANotesMember_39855a04-c6ed-441b-904c-1c91637791df" xlink:href="iclr-20211231.xsd#iclr_SeniorANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:to="loc_iclr_SeniorANotesMember_39855a04-c6ed-441b-904c-1c91637791df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorBNotesMember_ada6ae49-e866-41f7-a572-5179d2756a5d" xlink:href="iclr-20211231.xsd#iclr_SeniorBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:to="loc_iclr_SeniorBNotesMember_ada6ae49-e866-41f7-a572-5179d2756a5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_dfa70097-1549-407c-9926-41a774047096" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:to="loc_iclr_SeniorSecuredNotesMember_dfa70097-1549-407c-9926-41a774047096" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails" xlink:type="extended" id="i4da49a20ee5044b78be6dbb37dc279b3_NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5ac38099-fd6d-49d3-a05b-d7c8cb8e7a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5ac38099-fd6d-49d3-a05b-d7c8cb8e7a1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5ca3d6a1-cd2c-4b42-9e08-7092a8e4807a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_InterestExpense_5ca3d6a1-cd2c-4b42-9e08-7092a8e4807a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4fbeb34b-0699-4ed5-9587-e9a2680e87a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4fbeb34b-0699-4ed5-9587-e9a2680e87a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_02eef8d8-ff99-4f65-aeb5-09ae7cbfbbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_02eef8d8-ff99-4f65-aeb5-09ae7cbfbbe5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5e05738-450a-4947-a117-c227fd20fb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5e05738-450a-4947-a117-c227fd20fb3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c08daaaf-a421-4583-b858-12402056e1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c08daaaf-a421-4583-b858-12402056e1a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage_226b00af-76d7-48b8-990e-b951dc0bcc12" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage_226b00af-76d7-48b8-990e-b951dc0bcc12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio_8bfdaacb-9a68-4384-809c-8bc16cfc8df9" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio_8bfdaacb-9a68-4384-809c-8bc16cfc8df9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate_09781c5e-65e0-4911-91e8-0308a67e56fb" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate_09781c5e-65e0-4911-91e8-0308a67e56fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a708e046-0a49-4146-bbba-08ff96d4778a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_LineOfCredit_a708e046-0a49-4146-bbba-08ff96d4778a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c7d006db-a00b-419c-8b9e-9dea7948ecb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c7d006db-a00b-419c-8b9e-9dea7948ecb1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_80b64712-c871-40a1-a19a-28ac849459aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_80b64712-c871-40a1-a19a-28ac849459aa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f536d4fb-54cd-45e7-88d9-0de3df936468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_InterestPaidNet_f536d4fb-54cd-45e7-88d9-0de3df936468" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_a85788da-03a0-4e1b-83e6-c5b1cbcf1301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_a85788da-03a0-4e1b-83e6-c5b1cbcf1301" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_15b18093-51c5-405b-9a54-5ce7db2dd743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_15b18093-51c5-405b-9a54-5ce7db2dd743" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IssueOfSeniorNotesNumberOfTranches_effb9e23-d24d-4c28-b1e8-a84524082406" xlink:href="iclr-20211231.xsd#iclr_IssueOfSeniorNotesNumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_iclr_IssueOfSeniorNotesNumberOfTranches_effb9e23-d24d-4c28-b1e8-a84524082406" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_37a17ea6-74da-4a32-8a75-d2cb711d3351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_37a17ea6-74da-4a32-8a75-d2cb711d3351" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_aef78467-7e06-44be-9b36-d045612b1aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_RepaymentsOfDebt_aef78467-7e06-44be-9b36-d045612b1aab" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_083a2987-58e5-4af7-a244-46f8c5f60ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_LongTermDebtFairValue_083a2987-58e5-4af7-a244-46f8c5f60ded" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e8a09fce-9348-45c8-a4c4-e3089b79a6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e8a09fce-9348-45c8-a4c4-e3089b79a6da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e8a09fce-9348-45c8-a4c4-e3089b79a6da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e8a09fce-9348-45c8-a4c4-e3089b79a6da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e8a09fce-9348-45c8-a4c4-e3089b79a6da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e8a09fce-9348-45c8-a4c4-e3089b79a6da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_353d4180-8b6f-4403-b2db-d7bef800e8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_SecuredDebtMember_353d4180-8b6f-4403-b2db-d7bef800e8da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d13ae572-f2c6-4c3c-8bdd-d62e250115b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_LineOfCreditMember_d13ae572-f2c6-4c3c-8bdd-d62e250115b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_9658f595-634d-4fcb-8edd-062e8902270a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_LetterOfCreditMember_9658f595-634d-4fcb-8edd-062e8902270a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_814ba4ce-e35b-4deb-9240-d2df6c3b2048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_814ba4ce-e35b-4deb-9240-d2df6c3b2048" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2c7f37ea-d5bb-46f8-93e4-eeceaac58114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_SeniorNotesMember_2c7f37ea-d5bb-46f8-93e4-eeceaac58114" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_DebtInstrumentAxis_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_5bbb3b58-b65d-4771-af55-bcdeee82c03a" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_5bbb3b58-b65d-4771-af55-bcdeee82c03a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_991e42b0-12ef-4bee-8b68-6ec376ebdb61" xlink:href="iclr-20211231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_TermLoanFacilityMember_991e42b0-12ef-4bee-8b68-6ec376ebdb61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_3630b999-19ac-43fe-8e76-086475418d8a" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_3630b999-19ac-43fe-8e76-086475418d8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_f3467378-f724-4600-bdec-ddeb42224549" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorSecuredNotesMember_f3467378-f724-4600-bdec-ddeb42224549" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorNotes2020Member_104c8319-f924-481f-a653-ced3d60ac919" xlink:href="iclr-20211231.xsd#iclr_SeniorNotes2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorNotes2020Member_104c8319-f924-481f-a653-ced3d60ac919" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorANotesMember_8199671b-6eef-4a42-bd7d-5890f2d2f68d" xlink:href="iclr-20211231.xsd#iclr_SeniorANotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorANotesMember_8199671b-6eef-4a42-bd7d-5890f2d2f68d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorBNotesMember_55b7c14d-a993-47f4-889f-286e21798ae0" xlink:href="iclr-20211231.xsd#iclr_SeniorBNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorBNotesMember_55b7c14d-a993-47f4-889f-286e21798ae0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f0cffa91-8333-4705-83eb-6150a94097e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_CreditFacilityAxis_f0cffa91-8333-4705-83eb-6150a94097e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f0cffa91-8333-4705-83eb-6150a94097e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f0cffa91-8333-4705-83eb-6150a94097e4" xlink:to="loc_us-gaap_CreditFacilityDomain_f0cffa91-8333-4705-83eb-6150a94097e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3ff57f3f-e96e-4549-a6f9-62d30342fa74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f0cffa91-8333-4705-83eb-6150a94097e4" xlink:to="loc_us-gaap_CreditFacilityDomain_3ff57f3f-e96e-4549-a6f9-62d30342fa74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_818c2d7a-0319-49a5-a040-33c79d9f8d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3ff57f3f-e96e-4549-a6f9-62d30342fa74" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_818c2d7a-0319-49a5-a040-33c79d9f8d03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis_788fda0f-4e2a-4416-bbf1-f5933ad94002" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_iclr_VariableRateComponentAxis_788fda0f-4e2a-4416-bbf1-f5933ad94002" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_788fda0f-4e2a-4416-bbf1-f5933ad94002_default" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iclr_VariableRateComponentAxis_788fda0f-4e2a-4416-bbf1-f5933ad94002" xlink:to="loc_iclr_VariableRateComponentDomain_788fda0f-4e2a-4416-bbf1-f5933ad94002_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_375fcc8d-e810-42cd-bb8a-e71aa7d400f1" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iclr_VariableRateComponentAxis_788fda0f-4e2a-4416-bbf1-f5933ad94002" xlink:to="loc_iclr_VariableRateComponentDomain_375fcc8d-e810-42cd-bb8a-e71aa7d400f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember_7f5ea0ce-6f44-4a37-b74f-686430f5c771" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_VariableRateComponentDomain_375fcc8d-e810-42cd-bb8a-e71aa7d400f1" xlink:to="loc_iclr_VariableRateComponentOneMember_7f5ea0ce-6f44-4a37-b74f-686430f5c771" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember_60019700-267a-4896-b91c-f82324718ca4" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_VariableRateComponentDomain_375fcc8d-e810-42cd-bb8a-e71aa7d400f1" xlink:to="loc_iclr_VariableRateComponentTwoMember_60019700-267a-4896-b91c-f82324718ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_VariableRateAxis_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a" xlink:to="loc_us-gaap_VariableRateDomain_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e6b28bf5-498e-4405-aaab-4f45f734ff9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a" xlink:to="loc_us-gaap_VariableRateDomain_e6b28bf5-498e-4405-aaab-4f45f734ff9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c9b213bb-f9a9-4c6c-8c43-6b4f98216ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e6b28bf5-498e-4405-aaab-4f45f734ff9f" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c9b213bb-f9a9-4c6c-8c43-6b4f98216ae7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_01715ed7-4e45-4b0b-b44b-1e418479e441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e6b28bf5-498e-4405-aaab-4f45f734ff9f" xlink:to="loc_us-gaap_BaseRateMember_01715ed7-4e45-4b0b-b44b-1e418479e441" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_srt_RangeAxis_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40" xlink:to="loc_srt_RangeMember_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3460a660-3092-4745-bd8a-acd54c1cd598" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40" xlink:to="loc_srt_RangeMember_3460a660-3092-4745-bd8a-acd54c1cd598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_82603ff7-ea69-4060-b6d0-36c43a707eb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3460a660-3092-4745-bd8a-acd54c1cd598" xlink:to="loc_srt_MaximumMember_82603ff7-ea69-4060-b6d0-36c43a707eb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b0410d76-8748-4499-a6d5-be144b223be6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3460a660-3092-4745-bd8a-acd54c1cd598" xlink:to="loc_srt_MinimumMember_b0410d76-8748-4499-a6d5-be144b223be6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e64a983a-cdf4-44af-a869-84185afb8d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e64a983a-cdf4-44af-a869-84185afb8d21" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e64a983a-cdf4-44af-a869-84185afb8d21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e64a983a-cdf4-44af-a869-84185afb8d21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e64a983a-cdf4-44af-a869-84185afb8d21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227ac2e8-e7a4-473c-9359-d63534b0fdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e64a983a-cdf4-44af-a869-84185afb8d21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227ac2e8-e7a4-473c-9359-d63534b0fdd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_91613663-3074-4434-ab43-16d8fa20d6e9" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227ac2e8-e7a4-473c-9359-d63534b0fdd7" xlink:to="loc_iclr_PRAHealthSciencesIncMember_91613663-3074-4434-ab43-16d8fa20d6e9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairvalueDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#FairvalueDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/FairvalueDetails" xlink:type="extended" id="if622d428342a4a14902947429eee1fbd_FairvalueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0996263d-e39b-4d74-89c7-6cae2e5bfd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0996263d-e39b-4d74-89c7-6cae2e5bfd23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_24e1e308-3610-4e5d-aaac-a96aecd86ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_24e1e308-3610-4e5d-aaac-a96aecd86ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d4c0df37-b45f-4211-8b0b-cb722ba158d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d4c0df37-b45f-4211-8b0b-cb722ba158d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_d8c29b05-6fa2-4017-bbc5-8ac87d836520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_d8c29b05-6fa2-4017-bbc5-8ac87d836520" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_719e77a0-23d6-4d98-a248-680499555234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_719e77a0-23d6-4d98-a248-680499555234" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_18e0885c-260a-4f36-b82e-987b241d0bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_18e0885c-260a-4f36-b82e-987b241d0bde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9c9ddd46-11ab-48ab-a342-4b8a3daae33a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_18e0885c-260a-4f36-b82e-987b241d0bde" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9c9ddd46-11ab-48ab-a342-4b8a3daae33a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9c9ddd46-11ab-48ab-a342-4b8a3daae33a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9c9ddd46-11ab-48ab-a342-4b8a3daae33a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9c9ddd46-11ab-48ab-a342-4b8a3daae33a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_10ed7b38-1e06-422f-a564-9e298c3562ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9c9ddd46-11ab-48ab-a342-4b8a3daae33a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_10ed7b38-1e06-422f-a564-9e298c3562ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_7713758b-5535-41da-b211-4e3c6d5b7c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_10ed7b38-1e06-422f-a564-9e298c3562ec" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_7713758b-5535-41da-b211-4e3c6d5b7c94" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#ImpactofNewAccountingPronouncementsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails" xlink:type="extended" id="ifc1e00fdd0244efeb9cd45b8b12c8f81_ImpactofNewAccountingPronouncementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7efaea1d-cc01-4fad-8778-0f13931cb7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_us-gaap_Goodwill_7efaea1d-cc01-4fad-8778-0f13931cb7eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_69703d5e-55fa-4aa8-8372-6f4d3940dc90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_us-gaap_ContractWithCustomerLiability_69703d5e-55fa-4aa8-8372-6f4d3940dc90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1f3889b3-de04-4227-aecd-db7831e58cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1f3889b3-de04-4227-aecd-db7831e58cd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers_635ab7b3-1a97-4f91-81ec-99bfc1271aeb" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseRevenueFromContractsWithCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers_635ab7b3-1a97-4f91-81ec-99bfc1271aeb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3565ebdb-d41d-4e66-9312-f659b35f1306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3565ebdb-d41d-4e66-9312-f659b35f1306" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5e1c2a1c-45bd-44dc-995a-1398c2c85248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3565ebdb-d41d-4e66-9312-f659b35f1306" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5e1c2a1c-45bd-44dc-995a-1398c2c85248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5e1c2a1c-45bd-44dc-995a-1398c2c85248_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5e1c2a1c-45bd-44dc-995a-1398c2c85248" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5e1c2a1c-45bd-44dc-995a-1398c2c85248_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_30b42111-2b58-474c-8e12-a9d2e96df472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5e1c2a1c-45bd-44dc-995a-1398c2c85248" xlink:to="loc_us-gaap_TypeOfAdoptionMember_30b42111-2b58-474c-8e12-a9d2e96df472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountingStandardsUpdate202108Member_dbe45a58-fc3c-449a-8017-641e23059751" xlink:href="iclr-20211231.xsd#iclr_AccountingStandardsUpdate202108Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_30b42111-2b58-474c-8e12-a9d2e96df472" xlink:to="loc_iclr_AccountingStandardsUpdate202108Member_dbe45a58-fc3c-449a-8017-641e23059751" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#RelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="extended" id="ifefd7e609c47487891d203ab55bc4b83_RelatedPartiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_09a5ad00-47b1-4fa5-9ea3-64d9f18ea24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_RevenueFromRelatedParties_09a5ad00-47b1-4fa5-9ea3-64d9f18ea24a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties_32f0d275-aaad-43a9-af5f-a13d953ed63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_DueFromRelatedParties_32f0d275-aaad-43a9-af5f-a13d953ed63a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_e58e3537-15dc-4f25-80c6-01bbb8ee2879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_e58e3537-15dc-4f25-80c6-01bbb8ee2879" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_7dc4572e-cbd0-4794-95ed-2c930f7a552f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_7dc4572e-cbd0-4794-95ed-2c930f7a552f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0f8ba22c-d65d-4824-98ef-12ee56494708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0f8ba22c-d65d-4824-98ef-12ee56494708" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_a92c8a1e-3b46-4b2d-bc18-bb9078365181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_a92c8a1e-3b46-4b2d-bc18-bb9078365181" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_7c630cb5-67f5-482f-906a-4cd893707d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_7c630cb5-67f5-482f-906a-4cd893707d93" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestReceivableRelatedPartyLoans_46d0d666-da67-4040-8da0-57604c312cd1" xlink:href="iclr-20211231.xsd#iclr_InterestReceivableRelatedPartyLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_iclr_InterestReceivableRelatedPartyLoans_46d0d666-da67-4040-8da0-57604c312cd1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_878cb494-1092-47ba-9c6b-fd921f5edd8d" xlink:href="iclr-20211231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_878cb494-1092-47ba-9c6b-fd921f5edd8d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_a7610941-d5ff-4dd6-a72e-ad26471fda8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_a7610941-d5ff-4dd6-a72e-ad26471fda8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a7610941-d5ff-4dd6-a72e-ad26471fda8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a7610941-d5ff-4dd6-a72e-ad26471fda8e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a7610941-d5ff-4dd6-a72e-ad26471fda8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a7610941-d5ff-4dd6-a72e-ad26471fda8e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DSBiopharmaLimitedMember_418f33f5-b33e-43b4-aa23-cc221db0d8f0" xlink:href="iclr-20211231.xsd#iclr_DSBiopharmaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:to="loc_iclr_DSBiopharmaLimitedMember_418f33f5-b33e-43b4-aa23-cc221db0d8f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember_09b62cc2-8b1c-4ea6-b897-865f7489d642" xlink:href="iclr-20211231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:to="loc_iclr_AfimmuneLimitedMember_09b62cc2-8b1c-4ea6-b897-865f7489d642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_94494403-5045-4bd1-ba7b-9070ce3cf68c" xlink:href="iclr-20211231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:to="loc_iclr_OncacareMember_94494403-5045-4bd1-ba7b-9070ce3cf68c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7c2311b0-9191-44b4-8eac-f7982d371198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7c2311b0-9191-44b4-8eac-f7982d371198" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_7c2311b0-9191-44b4-8eac-f7982d371198_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7c2311b0-9191-44b4-8eac-f7982d371198" xlink:to="loc_us-gaap_RelatedPartyDomain_7c2311b0-9191-44b4-8eac-f7982d371198_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c55ca080-a8ab-4f49-9725-2f24b430a958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7c2311b0-9191-44b4-8eac-f7982d371198" xlink:to="loc_us-gaap_RelatedPartyDomain_c55ca080-a8ab-4f49-9725-2f24b430a958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember_164be0b0-e73f-4e03-b165-ce93cc928ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c55ca080-a8ab-4f49-9725-2f24b430a958" xlink:to="loc_us-gaap_SubsidiaryOfCommonParentMember_164be0b0-e73f-4e03-b165-ce93cc928ddf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f2148156-af5f-4894-bdfd-1c6ee06e3259" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f2148156-af5f-4894-bdfd-1c6ee06e3259" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f2148156-af5f-4894-bdfd-1c6ee06e3259_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f2148156-af5f-4894-bdfd-1c6ee06e3259" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f2148156-af5f-4894-bdfd-1c6ee06e3259_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_45ada2b3-4c21-4a25-b3a7-00aa41798e12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f2148156-af5f-4894-bdfd-1c6ee06e3259" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_45ada2b3-4c21-4a25-b3a7-00aa41798e12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_6256a646-47c5-4c77-954c-9cdd25813d75" xlink:href="iclr-20211231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_45ada2b3-4c21-4a25-b3a7-00aa41798e12" xlink:to="loc_iclr_OncacareMember_6256a646-47c5-4c77-954c-9cdd25813d75" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="extended" id="i81be2d09b7a74720a93bc89ab343f381_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_187f9769-41aa-4a0c-8515-c26c6528f540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f0c7f041-e9c4-4cdd-906b-d2e78e7a66cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_187f9769-41aa-4a0c-8515-c26c6528f540" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f0c7f041-e9c4-4cdd-906b-d2e78e7a66cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6350509b-b075-4fdd-93c2-8e50afd95bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_187f9769-41aa-4a0c-8515-c26c6528f540" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6350509b-b075-4fdd-93c2-8e50afd95bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_187f9769-41aa-4a0c-8515-c26c6528f540" xlink:to="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1d71eae8-52e0-4ae9-830f-b207b81421bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1d71eae8-52e0-4ae9-830f-b207b81421bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1d71eae8-52e0-4ae9-830f-b207b81421bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1d71eae8-52e0-4ae9-830f-b207b81421bb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1d71eae8-52e0-4ae9-830f-b207b81421bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d4a67005-83c8-41ff-a419-078e06bf0fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1d71eae8-52e0-4ae9-830f-b207b81421bb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d4a67005-83c8-41ff-a419-078e06bf0fc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c375c92b-156b-4859-8176-7f915659c6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d4a67005-83c8-41ff-a419-078e06bf0fc7" xlink:to="loc_us-gaap_SubsequentEventMember_c375c92b-156b-4859-8176-7f915659c6f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f2f3df26-86fd-4210-8ac9-4c12aa11fb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f2f3df26-86fd-4210-8ac9-4c12aa11fb55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f2f3df26-86fd-4210-8ac9-4c12aa11fb55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f2f3df26-86fd-4210-8ac9-4c12aa11fb55" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f2f3df26-86fd-4210-8ac9-4c12aa11fb55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1470c73c-7b7c-43cd-87b2-b7036f9af79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f2f3df26-86fd-4210-8ac9-4c12aa11fb55" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1470c73c-7b7c-43cd-87b2-b7036f9af79e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_be4bdbf0-1e1d-4e41-bfbf-83b6df954429" xlink:href="iclr-20211231.xsd#iclr_BuybackProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1470c73c-7b7c-43cd-87b2-b7036f9af79e" xlink:to="loc_iclr_BuybackProgramMember_be4bdbf0-1e1d-4e41-bfbf-83b6df954429" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>iclr-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e141d476-ae09-4ec9-a80f-baeacfb8f81a,g:a196524c-1dde-4a8b-8796-f0fa7ce72378-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_srt_NameOfMajorCustomerDomain_1a1de2bc-a7df-4c6d-81a6-fdbe5f34cba8_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_3a035a16-496b-4aa0-bcdb-e90b51ced118_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_539d7317-1d5f-4661-9fd3-26e19b2434fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain)/loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36524236-69e3-4623-8aee-2afaa26b2280_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_e7663404-975f-4bcb-9f9e-7a4afc895fc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1c7a491b-35ca-4643-999c-11cbd30a3e92_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments (Note 3a)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_18cf266e-9546-4474-b4d5-38674e2e051e_periodStartLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments at start of year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_8a630da6-a0a6-4612-bc2e-1e77e0da1dc1_periodEndLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Available for sale investments at end of year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_497aaa6c-7673-4afd-9e3b-53cdebf9bc68_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_e15a2d56-91c3-4358-8f4c-37f3ea9e0a0a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_99498a0b-79eb-4802-8275-506e5432b6fc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d861a472-27e1-4390-b89d-5f225d07492f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_41122858-879b-4dd4-a32d-dc5ed7f13787_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_83a0ecfb-4ed6-49b4-b463-52d188476aeb_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of long-term investments in equity</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8fe2c3ad-1533-4bd6-b783-a95393b2baba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_cc1842e3-b030-44d6-a238-d8f76f56b8e0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contracts with Customers, Asset and Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_d95c71b5-5c77-4f0a-8157-cc39e90acc10_negatedNetLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_6277f8a1-9928-448c-a9d9-af57bd420e26_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e022f82c-f482-4816-83b5-14ec69a2822d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StoneHarborHighYieldBondFundMember_71209d55-a10f-45cc-a30a-7879fce28963_terseLabel_en-US" xlink:label="lab_iclr_StoneHarborHighYieldBondFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stone Harbor High Yield Bond Fund</link:label>
    <link:label id="lab_iclr_StoneHarborHighYieldBondFundMember_label_en-US" xlink:label="lab_iclr_StoneHarborHighYieldBondFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stone Harbor High Yield Bond Fund [Member]</link:label>
    <link:label id="lab_iclr_StoneHarborHighYieldBondFundMember_documentation_en-US" xlink:label="lab_iclr_StoneHarborHighYieldBondFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stone Harbor High Yield Bond Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StoneHarborHighYieldBondFundMember" xlink:href="iclr-20211231.xsd#iclr_StoneHarborHighYieldBondFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StoneHarborHighYieldBondFundMember" xlink:to="lab_iclr_StoneHarborHighYieldBondFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f1a833f8-d4e7-4010-99f1-271b73a9f1a7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_beda961d-5cba-4386-b894-399ed5e9917b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currencies and Translation of Subsidiaries</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_d23c2000-c1be-4afb-8f45-a815a24b9fbf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2029To2038Member_cc7e3fd3-28d2-4428-90ab-de0b545386d2_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2029To2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029 to 2038</link:label>
    <link:label id="lab_iclr_TaxYear2029To2038Member_label_en-US" xlink:label="lab_iclr_TaxYear2029To2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029 to 2038 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2029To2038Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2029To2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2027 to 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2029To2038Member" xlink:href="iclr-20211231.xsd#iclr_TaxYear2029To2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2029To2038Member" xlink:to="lab_iclr_TaxYear2029To2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4d28ec1b-5eda-41af-ab84-4ddbe1fdeb11_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c1bc20c4-a649-4b10-8b67-edff7c054605_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_b3a5ac5d-1641-4742-a0e8-b7430b90442f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c71c9a43-c7e2-4590-ae63-914e495d98ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units to be granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c257242e-2eb4-472b-b188-6658b8e04338_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease)/increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_dbdae5e4-9088-4139-b74e-7eed83fc2940_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_d7147dd4-f328-4d08-9757-52a298de6f34_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Contract With Customer, Liability</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Contract With Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:to="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3f2968d6-a008-4786-8ddb-41f9e27141b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b5d6a6ba-b942-4251-b10b-09cc1258ad52_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_bc85fa00-a9d5-40ea-b953-4c432d75eee6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior period acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_2af92c97-e827-4641-b6d7-0ed7b170ad0a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Range Exercise Price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4fd8e826-4caa-4515-ad63-feab7e814fed_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a9a4e04e-71ef-4b51-aac7-cf651d954616_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c1a6df9c-667b-45f4-b5bd-d835953c6951_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_d665d9b1-907a-43b3-b70a-7fc5134266f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_38f13788-8a0b-4aea-83ac-f627c9b68582_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_79e18b78-f123-4839-bf6b-383f44c95536_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_c4a62377-6358-4be9-832c-421c2ba24d89_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Overall net deferred tax asset/(liability)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_791cafce-44eb-423a-94ad-312ecded96cb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (in percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_90422ac0-3a5b-4de8-b259-834cd4acaa39_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability, revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_2361955e-91a1-48af-9acd-6d229b9ff3f7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_7febf290-096a-4545-b857-c47d0f0622dc_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets recognized</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_38155195-22a8-4c5e-a2fd-ba6902be3a12_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_2f35f797-98f5-4a02-bb7b-654332eb981e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_c2cb1ce9-ea7f-47a7-98d7-62626a248eb7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative minimum tax credit carry forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOfCommonParentMember_8ec478f1-be01-4f19-be49-cba290abf9a8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOfCommonParentMember_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary of Common Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOfCommonParentMember" xlink:to="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_da80ccd8-3e4a-4e34-b1ff-138759fe8181_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9c7b2fc-f66c-484d-b872-ee266417411d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e390a39b-e494-46a0-9583-adc488805b4c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_279cd981-8065-4419-88fc-9ce9dc536b92_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gain on sale of short term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_02705e33-a78e-4e08-9d86-919ab3502b23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost and Fair Value of Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_acc02890-3202-4eb6-9313-0c941ef1582a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_30261a40-5956-48ea-bef4-d6b8753324bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_fa7fa059-759f-44cf-a79c-8c101af41d79_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TermDepositsMember_35c62725-414b-4939-82b5-733a71642297_terseLabel_en-US" xlink:label="lab_iclr_TermDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term deposits</link:label>
    <link:label id="lab_iclr_TermDepositsMember_label_en-US" xlink:label="lab_iclr_TermDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Deposits [Member]</link:label>
    <link:label id="lab_iclr_TermDepositsMember_documentation_en-US" xlink:label="lab_iclr_TermDepositsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermDepositsMember" xlink:href="iclr-20211231.xsd#iclr_TermDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TermDepositsMember" xlink:to="lab_iclr_TermDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_6228c6db-d81b-4afb-b6d5-b202423e22c9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_ba560785-5089-44af-bc33-b63e6eab471e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_25f08fd6-f786-4d89-aa81-87303e9d45f5_terseLabel_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments Resulting From Foreign Currency Translations</link:label>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_label_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Disclosure [Table Text Block]</link:label>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:href="iclr-20211231.xsd#iclr_ForeignCurrencyDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:to="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_61307bc0-842c-47fd-814b-74706ae23316_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_75323720-2359-4f48-991e-a88579fc3951_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_75fbb4bb-b6e6-475a-92d4-cafec224248e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorANotesMember_2dc0855a-0734-4634-8205-5e6e466c6206_terseLabel_en-US" xlink:label="lab_iclr_SeniorANotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A notes</link:label>
    <link:label id="lab_iclr_SeniorANotesMember_label_en-US" xlink:label="lab_iclr_SeniorANotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorANotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorANotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorANotesMember" xlink:href="iclr-20211231.xsd#iclr_SeniorANotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorANotesMember" xlink:to="lab_iclr_SeniorANotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorSubordinatedNotesMember_eb642428-59ac-4c0c-a8b0-91b2fbefb6c9_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:label id="lab_us-gaap_SeniorSubordinatedNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Subordinated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorSubordinatedNotesMember" xlink:to="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_59f48ea1-6a65-489e-a68a-ab6bbc9724ff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_bce8b256-59ef-4915-81a9-0d4e800fbc9b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_7dbf558c-5ff6-49db-9391-6d5a4d1a5cae_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_255a0b4d-08ae-4503-9c18-cb51c23a3e39_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_146dd50c-1398-42a8-a620-38f971c08bb4_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_164cfe51-743a-43fa-a8a5-b0d46448bf62_terseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency impact on long term funding</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Currency Impact on Long Term Funding, Net of Tax</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Currency Impact on Long Term Funding, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" xlink:to="lab_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments_8b585dc1-c9ab-4788-ae8d-cc1b1c1ef1d0_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital adjustment paid</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Working Capital Adjustments</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Working Capital Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_42018a1a-725e-48d0-b10c-2b3e527ab3b4_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party Costs (Reimbursable expenses)</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c91148c4-13e4-4b5b-8cd0-fe46041b82f4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_0b5f2b9a-13ea-47c6-9ba1-2bc5be21c399_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_3805c0a2-13ed-4164-b771-d5eebb0bcd04_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_d851b2ce-29d5-4ee9-9614-24bd77a262a4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_92064c71-d8c1-4d45-a0be-38572e564a73_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_3eb90319-ea01-4f7d-b773-05c90587d8de_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_7e8a0ec8-5a47-4eb4-80cf-96b74c933fab_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from sub-leases</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9393d738-ad34-4251-8d3b-9a7bf9a02148_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3e1983ab-a753-452a-9661-73e946f5b385_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at ending of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_eda3cbeb-a48d-4215-9f1e-377d44676aa6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_9536c802-1550-41ae-b9bc-e20f36793984_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on drawn facilities</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_f10d6f92-9e58-47b2-bd22-6781c4b40448_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_c7a1d7c1-65d5-42c3-8e8d-0a40ab718862_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_73edae0e-f9bb-4be8-b78c-fe4e522870a3_terseLabel_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts provided during the year</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_label_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_documentation_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossExpense" xlink:href="iclr-20211231.xsd#iclr_AccountsReceivableCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccountsReceivableCreditLossExpense" xlink:to="lab_iclr_AccountsReceivableCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_d0d8e9a9-fedd-4c63-b14a-21de5894adb7_terseLabel_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_label_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_documentation_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:href="iclr-20211231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:to="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_bc197a0c-48e2-40cd-9811-23696af6ed39_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension obligations, net (note 10)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_f8e1acab-92ff-4213-9bac-bb665264b4ae_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Overall net deferred tax asset/(liability)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_0efe0917-156d-443e-ab12-9c6deb0c2d3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_df88f94f-c22c-4328-83b8-3b6be8cf408a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ca1af9e2-c81e-4cda-9b17-b143f57fa4fe_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_c31695d6-8d3d-4e3e-96b5-b3c5c511b0e2_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_f30dda3a-6df7-4ca1-b415-819a8e3376a9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_ed7f2d16-883f-46c6-9c5c-fa251142a4f3_negatedLabel_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase costs</link:label>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_label_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Share Repurchase Costs</link:label>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_documentation_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Share Repurchase Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts" xlink:href="iclr-20211231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PaymentsForShareRepurchaseCosts" xlink:to="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_2d1d8a59-a52a-42e7-b364-2a22f20842a3_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_cafa3178-9470-4f1d-8749-b547b737e9d4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_8b512744-bc7f-4613-b309-b646fed4be6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d02a8a08-31a7-40a1-9ea7-fc6f2ae39f67_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_13326486-89bd-44ed-baff-99bbcd9ffaef_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ace0383f-fafa-4ae8-a0ca-6ec757018b3f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_bbc8e55a-de0d-4764-ad2b-e5d07288c75a_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1640c8bc-7f46-42f5-a6af-59e87301def1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_6adbf116-f2be-47c3-be05-b2339c8bb4f1_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_label_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Effects Allocated Directly to Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:to="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractsReceivableNet_921a2295-f388-4c57-997b-0dee7e1b0bb9_totalLabel_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and unbilled revenue, net</link:label>
    <link:label id="lab_iclr_ContractsReceivableNet_label_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Net</link:label>
    <link:label id="lab_iclr_ContractsReceivableNet_documentation_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet" xlink:href="iclr-20211231.xsd#iclr_ContractsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractsReceivableNet" xlink:to="lab_iclr_ContractsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e8215c37-83c9-43c1-a0cd-149859a325d9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_5341b739-b8c1-4afd-aeb7-0813b5cfaf90_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized tax benefits net of potential benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_MedpassGroupLimitedMember_c7ecbf8c-8cad-47c5-bded-7ddb655099b4_terseLabel_en-US" xlink:label="lab_iclr_MedpassGroupLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medpass Group Limited</link:label>
    <link:label id="lab_iclr_MedpassGroupLimitedMember_label_en-US" xlink:label="lab_iclr_MedpassGroupLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medpass Group Limited [Member]</link:label>
    <link:label id="lab_iclr_MedpassGroupLimitedMember_documentation_en-US" xlink:label="lab_iclr_MedpassGroupLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medpass Group Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_MedpassGroupLimitedMember" xlink:to="lab_iclr_MedpassGroupLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_b9e701ea-ab9d-4c38-9bb2-53d0fc420c3a_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_label_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_documentation_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:to="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_b145314a-6a26-42f2-9464-fbc15b95f709_negatedLabel_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss recognized in net periodic benefit cost</link:label>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_label_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</link:label>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_documentation_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:to="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_b91c146e-e594-4eff-a2b2-6f50c71f5223_terseLabel_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_label_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital [Member]</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_documentation_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember" xlink:href="iclr-20211231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherUndenominatedCapitalMember" xlink:to="lab_iclr_OtherUndenominatedCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_c964fa20-5ac3-45f4-aba5-2dc9121bad10_negatedLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_8ecccc4b-3dbe-4915-a336-f500096b35d4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Other Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_9d9edb2f-cbb5-4f0a-8804-118e5a629b8f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_27165096-992a-4fe4-b148-01b83a7ff089_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_670061be-838a-4f89-879a-9f94b42d6bdb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_4b8d11c0-ef61-4701-bd2d-8efaa5b25053_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_f7346ed0-1d8c-4f4f-a61f-320739e4fb8e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of share options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_b65af4bd-10d0-4f04-8109-9191c32f3325_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency impact on long term funding</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_b4480d25-e3fd-4f91-9907-1d39654a1b6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable (Note 14)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_d55ce322-d585-4fe2-8f4f-b48401187c7d_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashMember_0873c5ce-738a-4a13-a566-ec00a89b551f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_a1363084-e6cf-4dc2-9c3f-a5f5cb51cad1_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through business combination (in shares)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LAndGLifeDCActiveCorporateBondMember_5efaefbf-d2fa-426b-9e41-5f8b735964c8_terseLabel_en-US" xlink:label="lab_iclr_LAndGLifeDCActiveCorporateBondMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">L&amp;G Life DC Active Corporate Bond</link:label>
    <link:label id="lab_iclr_LAndGLifeDCActiveCorporateBondMember_label_en-US" xlink:label="lab_iclr_LAndGLifeDCActiveCorporateBondMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">L And G Life DC Active Corporate Bond [Member]</link:label>
    <link:label id="lab_iclr_LAndGLifeDCActiveCorporateBondMember_documentation_en-US" xlink:label="lab_iclr_LAndGLifeDCActiveCorporateBondMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">L And G Life DC Active Corporate Bond [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LAndGLifeDCActiveCorporateBondMember" xlink:href="iclr-20211231.xsd#iclr_LAndGLifeDCActiveCorporateBondMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LAndGLifeDCActiveCorporateBondMember" xlink:to="lab_iclr_LAndGLifeDCActiveCorporateBondMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_6256e0fa-70bd-4ac9-b434-fc15eb34bb77_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_e42d1457-57db-4960-804d-90570d6d36a7_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_21357ba5-b26f-40c3-9e72-35c3bba2d908_negatedTerseLabel_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on interest rate hedge</link:label>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_label_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, after Tax</link:label>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_documentation_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:href="iclr-20211231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:to="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d5864d2c-ca79-4add-9669-731f950869df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less net income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_08b2c60c-608e-4782-a624-49abcad32bbc_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at start of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_8e534d48-65ec-42b3-9ec1-4afd191b995f_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Unrecognized tax benefits at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_5fae0fb2-410e-47ed-8702-93cddcc725a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_d329bce9-0c9a-466b-851e-788afe4401b4_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_02021324-bfaa-4f4c-b35b-ce4fdc8bbec0_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Expiry Dates of NOL's</link:label>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0a3b34fc-174a-43a1-81d8-b6bf3335df00_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_20a7b1f9-4cb4-4afd-b431-6dca2ffcc16b_terseLabel_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan granted tp related party</link:label>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_label_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Related Parties, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:to="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_1c4ce5fb-3aa8-4818-8929-fab3fd9a7f43_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_de5d4b1a-7b6c-4a5b-b43c-cf15ab8a7ddd_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening provision</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_195f2d53-88d4-4515-9142-cef4d5263ad5_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending provision</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_d7ef6ff3-ec4b-4eb4-98a6-7c1ef7041952_terseLabel_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_label_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan [Member]</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_documentation_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:href="iclr-20211231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:to="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_6111f43a-ff15-402d-9805-df72e616427b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset (Note 14)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_a0affd66-0aaf-436b-bfec-3545dcdfdd36_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_52dccefe-c371-4646-a741-9f13794bd02a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of shares associated with a business combination</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_61cbf2c6-f161-4386-a96b-341a21b91efe_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_517d2641-f3c4-4345-a5e4-771bbe12da73_terseLabel_en-US" xlink:label="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-Controlling Interests and Equity</link:label>
    <link:label id="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_label_en-US" xlink:label="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy [Policy Text Block]</link:label>
    <link:label id="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:href="iclr-20211231.xsd#iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:to="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_0f2c55db-150f-4ef7-b90d-f797e130ec06_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_b0597151-db69-48be-9f9f-6e3b1c6cc609_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTextBlock_ceb9f70a-a981-45fc-93bb-ae3aaac9bc28_terseLabel_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Credit Losses</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTextBlock_label_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts [Text Block]</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTextBlock_documentation_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:href="iclr-20211231.xsd#iclr_AllowanceForDoubtfulAccountsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:to="lab_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_dcf0b15e-e7b7-4286-b625-c64459ef5d11_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_0044a388-49fb-41dc-80de-b86fb6f053d2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_328056cb-119c-4a91-91d2-7c8416d17dd0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_4e010a8f-2bff-498b-8fe3-ecc661341a6e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2e3fecf6-bc20-4064-860a-45f26bc9e92c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contractual term of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities_6e2208f2-9d7a-4040-b961-a982d09e43d9_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating current lease liabilities fair value adjustment</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Lease Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range4Member_9bf0d5fe-bdd6-46c3-894e-fe95140b7393_terseLabel_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4</link:label>
    <link:label id="lab_iclr_Range4Member_label_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4 [Member]</link:label>
    <link:label id="lab_iclr_Range4Member_documentation_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member" xlink:href="iclr-20211231.xsd#iclr_Range4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range4Member" xlink:to="lab_iclr_Range4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_d4d4e350-e630-42f9-8156-9adb7f0113a8_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_60a70ba9-918d-4381-8618-57f4d5a4d3d4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_0699adee-e150-4532-b089-cef9393c9191_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a322fd87-f1c2-4419-ac4f-c4dfb71a8279_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_079ab9c5-abe0-4144-b593-8980239238dc_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_53a1ea58-76d5-4d7d-b2c6-65c49306c43e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_1b8f22e5-de98-4e2a-8fde-0ce338fbbb27_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1d16ea72-6868-4df8-bec6-668ee8c1c304_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value 6 euro cents per share; 100,000,000 shares authorized, (Note 12), 52,788,093 shares issued and outstanding at December 31, 2020 and 53,622,206 shares issued and outstanding at December 31, 2019.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_225b1f78-9177-4052-92f8-cfd0bd86af12_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6be636c-d6cd-4116-9d61-027c81d84572_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_8bfa3d1d-41c3-49fd-b20d-fbb35e34d51a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3ba8ada1-e99f-4dd5-82cf-825a0b9dc934_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_4377c29e-33e5-44a9-b21b-3939fc0b8c01_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LeaseLiabilityMember_772dc433-d620-4a55-bce7-78508e046bad_terseLabel_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability</link:label>
    <link:label id="lab_iclr_LeaseLiabilityMember_label_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability [Member]</link:label>
    <link:label id="lab_iclr_LeaseLiabilityMember_documentation_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember" xlink:href="iclr-20211231.xsd#iclr_LeaseLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LeaseLiabilityMember" xlink:to="lab_iclr_LeaseLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_c687c9c4-ebee-423a-86c9-c0e038457507_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_613b8719-a58a-4501-bb53-51ea338b9c8f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Weighted Average Fair Values and Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_7df3706c-ac94-4e82-8eb6-1efaf0dd6bb1_terseLabel_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net balance</link:label>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_label_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_documentation_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:href="iclr-20211231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:to="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_a4f5199d-b760-4848-8783-4994039cef68_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland subsidiaries additional tax credit carryforward for income tax</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:to="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_fd28d9bf-0c1a-4d3e-98d5-c28685751d40_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_72ad2b00-f0a9-4db1-bfb8-bb19aebdbdc3_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_a8c476c2-1b4c-4c8b-a76c-e1b9aeca37a9_terseLabel_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan</link:label>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_label_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan [Member]</link:label>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_documentation_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember" xlink:href="iclr-20211231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_A2021RestructuringPlanMember" xlink:to="lab_iclr_A2021RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_dde50b16-ee3a-410a-916e-63f0c18adba0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Net Revenue by Geographical Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_50d5f5d1-a621-4d01-a14d-6234a596bc90_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0db5ebd6-2e14-471c-b0ac-841b0be13485_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and unbilled revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_2f46d003-79ca-48d2-b184-137a60148508_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income/(loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_1724f1d6-ebd8-4c8e-9ffc-c3f84190d91c_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_4b5e369e-1e9e-4271-b699-a59f442315b2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_2b7159bb-437e-4593-9069-97677c05f303_terseLabel_en-US" xlink:label="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period majority voting share capital can be sold to the company</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_label_en-US" xlink:label="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_documentation_en-US" xlink:label="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:href="iclr-20211231.xsd#iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:to="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1c2962f4-b4b4-4bac-a02c-14d855b17f58_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_9289da4f-3928-466d-8f35-aa9f9a0a4f71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_d1616da0-c7db-4156-bb1a-9a28da7c3046_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue earned from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_fd248de7-8865-4dad-8b55-01e3635cda35_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_36365430-a75b-4311-aa59-183c71adddc0_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f4b3a2ca-64c0-4d13-b846-65ac429d74ce_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_1ecfc210-13fd-4f2a-982e-859d620fd83a_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, potentially expire in 2021</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_34493b78-45f8-4cc1-85f6-3602cdbceb4b_terseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss [Text Block]</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of the components of accumulated other comprehensive income (loss).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:to="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_e3164dd8-ed04-4499-ab0f-87eded0cdfd8_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share</link:label>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Adjusted Earnings Per Share, Basic And Diluted [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_def69b10-c446-4917-a428-28bb6642d7b8_terseLabel_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_label_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Capitalized Software [Member]</link:label>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_documentation_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Capitalized Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:href="iclr-20211231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:to="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_a0337e71-3d2b-44d4-89bc-6a18e672eacd_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_6ee2fcac-6d72-4205-bda4-302b0ec39405_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain &#8211; plan assets</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_145ebe11-d8b9-4e53-af80-6db1d7c69d00_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issue costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_4dbf647f-bd66-40a7-b792-06e24026a945_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_cd6abbad-70fd-4fe9-848c-361b9bbcb7a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_f02a1c8d-ca53-46b1-ae20-974b437b91ea_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_d61223a9-4606-47c0-ab92-677273d8f636_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-U.S subsidiaries operating loss carryforwards for income tax</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b4968396-118c-43f8-9406-6f9a1d4f5ea0_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_9e534cbe-cd13-4a98-a87c-0759ff49ca27_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_88ac4dcd-f947-420e-9863-9811144ad073_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3a019bfd-3edb-42c5-9524-016c8cc48965_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment and Geographical Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VehiclesGross_d46ac1da-95d2-44f2-81ce-cdb469d1688a_terseLabel_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Motor vehicles</link:label>
    <link:label id="lab_iclr_VehiclesGross_label_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles, Gross</link:label>
    <link:label id="lab_iclr_VehiclesGross_documentation_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross" xlink:href="iclr-20211231.xsd#iclr_VehiclesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VehiclesGross" xlink:to="lab_iclr_VehiclesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NumberOfVotes_ae513098-0c68-44d2-ae68-9e4ec8960296_terseLabel_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes</link:label>
    <link:label id="lab_iclr_NumberOfVotes_label_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes</link:label>
    <link:label id="lab_iclr_NumberOfVotes_documentation_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes" xlink:href="iclr-20211231.xsd#iclr_NumberOfVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NumberOfVotes" xlink:to="lab_iclr_NumberOfVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherChanges_ce9d03e4-af79-4df8-8ea1-d83a1d5ca471_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred balances</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherChanges_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanOtherChanges" xlink:to="lab_us-gaap_DefinedBenefitPlanOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1bd6a8d1-a3b6-4a61-ad06-5e1fd3f9a679_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_aff38341-11b6-478a-a92e-07823a478a65_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_5a77e295-ae19-4efe-bb8d-24174b6a51d6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1 to 5 years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_aae03454-2157-4912-bc4e-011afc853227_terseLabel_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions pension plan</link:label>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_label_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AptivSolutionsPensionPlanMember" xlink:to="lab_iclr_AptivSolutionsPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e7a90ba-b768-4d37-accc-3fb93abb38a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_291ddb50-b400-43d1-b24f-e2a06715f9a7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3886fabc-fb4e-4cf5-80cd-028a7f20c0bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan to equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_3d4d4a36-c06f-4de3-9a87-75636c9c2e14_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_8fefbf01-a635-4ea8-ba36-81f70f3b41dd_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_066a59b2-8e0d-4cdb-b85c-cb53794b5396_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan period</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:to="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9e73c44a-6127-4c4b-9997-838c27155e3f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_55ebc85a-5e8a-4014-86b2-5f78f7d4b158_terseLabel_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember" xlink:href="iclr-20211231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_The2018LegacyPRAPlanMember" xlink:to="lab_iclr_The2018LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_f0dea24f-b4be-414f-9e0d-9ca6f407940a_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_6593d321-f103-4789-a1f5-baebedf596b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_7aa0bfda-ede4-478b-93bb-77f22cf36e29_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Years 2027 - 2031</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_26d64d1e-5045-4afb-9455-b9dc3977f752_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillFairValueDisclosure" xlink:to="lab_us-gaap_GoodwillFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c8ae9e9d-2c2d-4082-839c-59ebfa20b85e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_f828de47-4145-4c2a-b02c-ed78fa762a6f_terseLabel_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments average maturity period</link:label>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_label_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Available For Sale Investments Average Remaining Maturity Period</link:label>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_documentation_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Available For Sale Investments Average Remaining Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:href="iclr-20211231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:to="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_10bb1cb3-a322-43bc-9c41-7002e51a7a73_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue of acquiree since acquisition date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_2a12080e-74ed-4006-9389-ca724cd6f087_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue (Note 18)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_efcf78f3-540b-45c8-bfd5-6f75056c2b26_netLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled services (unbilled revenue)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_a8c04dc3-1eeb-4b7f-bc9e-adc066fe1558_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drawdown of credit lines and facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_b433805c-1ff5-4685-a7dc-7f7abb457956_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_37061461-f58b-4bd4-84ec-54219480c0ad_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt at fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_aa1f2f34-f17e-4127-8a38-67d380a772a1_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4b496d6e-967b-4129-aeb0-70ec2466c135_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares redeemed (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_e0367e35-ca62-4c2f-84da-3bd732fcf071_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_40d46e22-1699-4b06-861c-62c6fe9e052e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d935d8e4-4341-4c00-b4f2-4f1d89f3a814_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8af772b7-58ff-4cb0-bf05-8fbd9baaac58_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_8319139d-3007-43d2-9160-2316d5b192f9_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_6802b090-d8c8-4834-ba5e-037b2ab143f7_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue_eeafd216-0a38-426b-82b5-250b767515f0_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue adjustment</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6ac70b16-8704-4407-8b21-a3333f8b98b2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_f191ef7e-a6c2-4f98-8f55-286278d8e374_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current income taxes receivable (Note 14)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:to="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_0459a554-1d77-40e1-9c93-7bfd0aea23e4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_4d09dbf2-d9a1-4181-8ad6-271f372a4d81_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_139ef9d7-c142-4c92-b214-4aac1d6f6052_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_22dd4328-1301-4f58-9866-4d3ddf0e2aac_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5cd4fc8b-883e-4e5c-9f90-52f9f796ebec_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_62cb3db2-0783-4a98-8689-70c373c61897_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_3af991db-25f9-4895-8632-2143d5a15b53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_f997e8c1-f529-4973-9423-76881a9e52fd_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_label_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:href="iclr-20211231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:to="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_34a3fbe1-92db-4cef-bd03-787946c8ad8e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_fc7e1fdb-7b24-475e-801c-06682180f819_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_c2ee04f3-3e0e-4909-9165-ad536124ee13_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of senior debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_ac40119d-d3a1-4769-ab3f-b422aaf8f33f_terseLabel_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest adjustment to redemption amount</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Increase From Business Combination</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_documentation_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Increase From Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_8a48715c-efb7-4517-9178-7a0edd15600d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_bef1d15a-b75d-4860-ac27-14e3d9388dd5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_fe961aa6-5aa0-4e0a-af97-5e4390c13c9f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1273134e-523c-457b-aa12-d2bf225dc2d3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_c190a1cc-604f-41f1-8b95-f7bbd090f289_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_f330db17-d6e2-4271-b573-1b8eda704322_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StoneHarborMultiAssetCreditPortfolioMember_03f43846-6fc1-41fc-807e-d9d0fd3984fc_terseLabel_en-US" xlink:label="lab_iclr_StoneHarborMultiAssetCreditPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stone Harbor Multi Asset Credit Portfolio</link:label>
    <link:label id="lab_iclr_StoneHarborMultiAssetCreditPortfolioMember_label_en-US" xlink:label="lab_iclr_StoneHarborMultiAssetCreditPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stone Harbor Multi Asset Credit Portfolio [Member]</link:label>
    <link:label id="lab_iclr_StoneHarborMultiAssetCreditPortfolioMember_documentation_en-US" xlink:label="lab_iclr_StoneHarborMultiAssetCreditPortfolioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stone Harbor Multi Asset Credit Portfolio [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StoneHarborMultiAssetCreditPortfolioMember" xlink:href="iclr-20211231.xsd#iclr_StoneHarborMultiAssetCreditPortfolioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StoneHarborMultiAssetCreditPortfolioMember" xlink:to="lab_iclr_StoneHarborMultiAssetCreditPortfolioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_d666e31a-a14c-4f4e-adf0-4e3e49a37c0b_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_c351d12e-7ee3-4cda-9b0d-de6702c8e08e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liabilities (Note 23)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_72309a92-a93c-4b80-9a87-80fbe2cfc2bb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_a06aa4f7-d932-4cd9-a5df-6f1710005e3b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_e537ac01-47e9-4796-a240-61d4d67d5532_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_0253ef7e-c2b2-48c6-91b6-2123c538dfb5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_35a56449-36f7-48e0-acc5-2422d18585d6_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_960943cf-7011-42d3-b3d5-b280d0213fbb_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss on defined benefit pension plan (note 10)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_bb4fd5c5-7e0e-4a55-9a24-3ae4d944a79e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit related to stock compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OncacareMember_ebca6289-0554-46e6-af34-7de78702236f_terseLabel_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare</link:label>
    <link:label id="lab_iclr_OncacareMember_label_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare [Member]</link:label>
    <link:label id="lab_iclr_OncacareMember_documentation_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember" xlink:href="iclr-20211231.xsd#iclr_OncacareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OncacareMember" xlink:to="lab_iclr_OncacareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fcac33df-3857-450d-a619-aeacb7296a86_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_c39919f8-ee61-42ba-bb8f-14cf29c2eac1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cancelable operating leases for facilities expiration period</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8631f0a1-2d92-47ad-8bdf-3731b2b6390d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_e12c03d6-230b-4b66-b5b9-d65a0ade4b89_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BilledContractReceivables_073383e2-7aa8-48ed-b085-8e4d64cbc6c4_terseLabel_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed services (accounts receivable)</link:label>
    <link:label id="lab_us-gaap_BilledContractReceivables_label_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BilledContractReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BilledContractReceivables" xlink:to="lab_us-gaap_BilledContractReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_4989c4ea-49e8-41c4-be95-3c9e55f297c8_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Total deferred tax liabilities recognized</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_23136f81-2b41-4e93-a06b-f1a8a4f503ae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients1125Member_562db781-0874-4056-879e-f43756fe4def_terseLabel_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25</link:label>
    <link:label id="lab_iclr_Clients1125Member_label_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25 [Member]</link:label>
    <link:label id="lab_iclr_Clients1125Member_documentation_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member" xlink:href="iclr-20211231.xsd#iclr_Clients1125Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients1125Member" xlink:to="lab_iclr_Clients1125Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a14db01b-ff42-45b0-8e23-7c43fe1e9dd1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_5c233e5e-3b73-4fee-b3e5-73976b412d95_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_37543b30-62e1-48d9-9557-ef0bf7a85947_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_f527c48a-3a67-4038-907c-f3937b85da58_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments (Note 3c)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_14dd7873-003b-4062-97b6-9d10f871d829_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d6c2fe84-14b3-48e0-a121-3950e66a4770_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractsReceivableGross_6453b7d6-c839-48bf-af63-a97e24668715_totalLabel_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable (net)</link:label>
    <link:label id="lab_iclr_ContractsReceivableGross_label_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Gross</link:label>
    <link:label id="lab_iclr_ContractsReceivableGross_documentation_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross" xlink:href="iclr-20211231.xsd#iclr_ContractsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractsReceivableGross" xlink:to="lab_iclr_ContractsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_71cb2bb9-0259-4588-af06-af83375cf495_negatedLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_aa6c08b0-27de-4308-b27e-9ab6e2c66149_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_ae3af5dd-fe3f-4a9f-87c5-0ad6aa645710_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which company operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_254930e9-85a5-48c7-ab1b-efe41c22f6b7_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and unbilled revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1376e57c-3ed9-48ad-9557-52c1ad8e04ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_a30a95ae-ed27-4b08-9f33-e98d517f3098_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants' contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_8444c7b4-fe0b-44be-b5e6-75128cd8d706_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_d5dd43a3-4aec-48f9-a5d1-953673692c5f_terseLabel_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due to third parties for reimbursable expenses</link:label>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_label_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</link:label>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_documentation_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:href="iclr-20211231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:to="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_19b11310-8a3d-4234-9d54-bce4329d160f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (Note 14)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8874790a-5cdf-4055-9b4e-0f6cafd1e71e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense allocated to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_5b4c8c5b-c7de-4ab5-88d9-6e70888ad2b5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_bfba00a1-e6ea-4835-9171-0e97f008dba2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net (Note 18)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AfimmuneLimitedMember_ef9655a6-757a-44f3-b297-98b4c5fe04d5_terseLabel_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited</link:label>
    <link:label id="lab_iclr_AfimmuneLimitedMember_label_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited [Member]</link:label>
    <link:label id="lab_iclr_AfimmuneLimitedMember_documentation_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember" xlink:href="iclr-20211231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AfimmuneLimitedMember" xlink:to="lab_iclr_AfimmuneLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_deafffce-05b7-41e8-ad9b-4b5177380161_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_660d3ebd-2099-4b96-b2d9-f54e98af8197_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c44dc915-d92e-4818-8038-1686c03a50e7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_58759ad8-721c-405d-a5b7-6f9b836626d3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_874c4480-38be-49a9-9196-8c9ca37b0ab0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Information Concerning Outstanding and Exercisable Share Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_58a25897-33fe-49c1-846c-f20a9a5603cf_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5299a53a-ab5c-4165-b188-74440d288b58_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c7f82bdd-ed84-4a39-bc87-65ebeb6c82f7_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_876aef38-8990-4462-8417-86ccb93ffdd7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_940c4e30-3da7-4f06-8981-2b118c3aff9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_17537128-73c0-49de-8b9b-3f66ca1738e0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_2699dcdd-f983-45b5-9a18-2818d8662e78_terseLabel_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award date, prior to 2018</link:label>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_label_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date, All Years Excluding 2018 [Member]</link:label>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_documentation_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date, Prior to 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member" xlink:href="iclr-20211231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AwardDateAllYearsExcluding2018Member" xlink:to="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_9612e0ff-25fc-4bb0-8125-6e7e09097734_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, aggregate cost</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_b7a0f1f3-42de-4871-8698-5cba5b66a3db_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_23ab66a5-7617-45b3-b52f-add8e3a06148_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_1d4794b9-c6bf-4fff-bbfe-7bc1ab0ea207_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c06781ad-ddcf-493a-8254-d2e63a5b6aa6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_d7deb68b-8505-4f26-8f2f-08c65b1d6c81_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_7b2ff5a4-16c5-4164-8978-52e7e810436a_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured revolving loan facility</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Loan Facility [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:to="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e6f61758-f14c-44ba-b09d-365170aa22f8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_5d372826-7379-4ce8-8a1a-ab9ca685557e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_a4a635af-12ed-4cfb-8d1c-e1a12959f05e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_ab971049-e696-49d7-a4f5-1f9f68b1dd03_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of ordinary shares issued to acquiree stockholders</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_46fdd97c-93b8-4c77-97fb-a91c9cd3a73e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a3ce92d4-d4cd-4780-a63c-282559de2a3f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_72573a98-e1c3-4e74-bdb4-8efc24f0aeb9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on interest rate hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f700d2f8-5ba9-4d54-b79c-c7cf5a60c068_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of shares associated with a business combination (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_4e7a735f-7fba-49e0-8a0d-f7b35281a17c_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_label_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_documentation_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_1e51c4fb-e2e3-4bc7-8f3f-0b07bd2dd9c1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_30d670bd-e4a3-48f5-98f0-33924be8f383_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_4e7e90cf-7d84-4d1f-97a7-a0adcb86ff71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Plan Asset Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_7da291a2-44cc-42c8-b579-f8566785bb59_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_aae755cd-d600-4a9b-a424-d55641382d92_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccountsReceivableCreditLossReversal_908aee25-7b0f-43aa-b8bf-3a903d5bdec7_negatedLabel_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossReversal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts released during the year</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossReversal_label_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Reversal</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossReversal_documentation_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Reversal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossReversal" xlink:href="iclr-20211231.xsd#iclr_AccountsReceivableCreditLossReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccountsReceivableCreditLossReversal" xlink:to="lab_iclr_AccountsReceivableCreditLossReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_5b03e4a6-8891-4b15-8299-91e54fa95320_terseLabel_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financing Cost</link:label>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_label_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Financing Cost [Table Text Block]</link:label>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_documentation_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Financing Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:href="iclr-20211231.xsd#iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:to="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_70c83e03-7025-460a-bd60-bb54f46d90b0_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_e2e87b70-f7cd-42d3-83d4-f01800ca705f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research &amp; development tax incentives</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_9cd959dc-9e64-4d3a-b4c9-cd0b5608f504_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_63bbc100-2e2f-4934-a872-05cd5e167e80_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_98fb8cd2-a8b1-4914-a8d4-83385bc73646_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_04f534e2-a98f-4cd1-86a0-dc2bedc94351_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4980f85f-57ad-48e4-8c25-1beb3c79ff63_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_cf120981-1205-4abd-b3c7-6985028b799e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_39980bc7-ab13-4a92-b30b-b412fee02814_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b78b9054-adde-4d5b-853e-973a97752e23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_f16dd076-d118-4acc-92d0-3bc5d66414d5_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, number of shares issued (in shares)</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Shares Issued To Shareholders, Per Share Held</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_41a259df-389b-4c93-8109-ebdf37ba983b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_08cd4a85-09cb-43d0-8001-4e42a874ffeb_terseLabel_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Components of Income Before Provision for Income Taxes</link:label>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_label_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Income Tax [Table Text Block]</link:label>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_documentation_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Income Tax, Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:href="iclr-20211231.xsd#iclr_IncomeBeforeIncomeTaxTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:to="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_cb9ec9a9-8bd7-41f2-a036-47c872aca765_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_609d61ae-57c5-42ce-a71c-97485f5a0df0_terseLabel_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal net operating loss carry forwards currently available for offset</link:label>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_label_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, US Federal</link:label>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_documentation_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, US Federal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal" xlink:href="iclr-20211231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingLossCarryforwardsUSFederal" xlink:to="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_91d02a15-1430-420e-87ef-a528912285d4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit)/expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_2a0e2e40-18fd-4a04-9ed3-29a000bca873_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_dc2bedae-962e-481a-8d27-f0584d5210cb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_a887e29f-cabe-4761-b358-c0d7ce5ee540_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable - weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_6cb7eee0-0d5e-4040-8661-494994b8505d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity-long term (Note 3b)</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e48c78d4-0f17-43fc-aaed-da67b60cd85f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to the Group (including NCI redemption adjustment)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_96fc372a-4a54-445f-a3eb-172a24522468_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_75323d99-d6a6-448e-909f-9a6e6d78daf9_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_BusinessContactMember_9fac9363-0c8c-4be4-8839-7c30988c1766_terseLabel_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Contact</link:label>
    <link:label id="lab_dei_BusinessContactMember_label_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Contact [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual_09761243-fe3a-47fc-bbad-13dcdc3a2c2c_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax net income of acquiree since acquisition date</link:label>
    <link:label id="lab_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings Or Loss Before Tax Of Acquiree Since Acquisition Date, Actual</link:label>
    <link:label id="lab_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings Or Loss Before Tax Of Acquiree Since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_72991877-8f13-48a0-b8f9-d090207c7b62_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NinetyOneGlobalTotalReturnCreditMember_be218229-9895-488a-a144-33a1717dcfb0_terseLabel_en-US" xlink:label="lab_iclr_NinetyOneGlobalTotalReturnCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ninety One Global Total Return Credit</link:label>
    <link:label id="lab_iclr_NinetyOneGlobalTotalReturnCreditMember_label_en-US" xlink:label="lab_iclr_NinetyOneGlobalTotalReturnCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ninety One Global Total Return Credit [Member]</link:label>
    <link:label id="lab_iclr_NinetyOneGlobalTotalReturnCreditMember_documentation_en-US" xlink:label="lab_iclr_NinetyOneGlobalTotalReturnCreditMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ninety One Global Total Return Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NinetyOneGlobalTotalReturnCreditMember" xlink:href="iclr-20211231.xsd#iclr_NinetyOneGlobalTotalReturnCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NinetyOneGlobalTotalReturnCreditMember" xlink:to="lab_iclr_NinetyOneGlobalTotalReturnCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_8e4e1090-1c83-46c1-a2f2-1cb3cc37e221_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_c31bba06-36fc-4295-89ed-4df3f514c543_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf9b87c4-a777-4183-9c7b-0477ea83aead_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_cf0b825a-0e12-45c2-8c77-11e738b40ac6_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving loan facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_433f5b02-9c7f-4d91-a2ef-f51b75448d91_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, undistributed foreign earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_42e53624-2545-4371-9fcc-86322efbb1aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_3ba3bed7-379c-46f2-8b11-c81c84161ecb_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_2f216ea8-9994-4eb4-ada0-c0047c6227c4_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_label_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress" xlink:to="lab_dei_ContactPersonnelEmailAddress" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_5178d62b-3d90-4e4f-b833-a97e5178f4c3_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High yield percentage of corporate bond investment</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Corporate Bonds Target Allocation, High Yield Percentage</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Corporate Bonds Target Allocation, High Yield Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" xlink:to="lab_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_8d2fec23-64d4-468a-85c8-714435e1e94c_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_0ea8fca9-a740-495a-88b8-67710e19fbda_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State NOL's</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5ad466f4-6eb2-47cc-a1b2-7d641d65bf04_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in carrying value of operating right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_277c676a-9708-4ec2-9b2d-fbdb8ad444a8_terseLabel_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG pension plan</link:label>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_label_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember" xlink:href="iclr-20211231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PRASwitzerlandAGPensionPlanMember" xlink:to="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_cba0f53f-d70c-47ec-9a88-77c135b5fd3b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_79868c90-af52-4c5c-b2b7-ca13de607ada_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign and other income taxed at higher rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DatabasesMember_cdfb06f6-9fb2-45aa-80ae-faa6fa6845c7_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient database</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_label_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DatabasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember" xlink:to="lab_us-gaap_DatabasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_9b3ca82f-99b1-4ffd-93db-65bf7c1ebd42_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Debt, Equity and Other</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_5908df90-7139-4bfe-9d2a-acd6c3e97cb2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c4523dbf-f330-45bc-b7ce-9b6f5f93d244_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7f43d929-a2c3-4f5d-900d-7e44c8bf7927_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c3f6d962-f02b-46cb-a1c7-1e70cc94b9e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_2826609a-2fb4-4d5b-a395-232aa348729a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_23efa60e-b03e-423f-9a18-82e2d6f43bb7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and penalties recognized as an expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_844d5750-48b4-482d-89b8-2d67e4da1d27_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_1c6826bc-1460-4eed-bec8-3833b5ed7027_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_39304f9c-9a56-4a3f-abcd-99e0f66111dc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_cdbd6f5d-8e97-4da8-83b7-8b35f73698e6_terseLabel_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units 2019</link:label>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_label_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units Twenty Nineteen [Member]</link:label>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_documentation_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units Twenty Nineteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:href="iclr-20211231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:to="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_ba872193-4fe0-4111-b268-31491184011c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional provision in the year</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_2a9f8905-aca5-4980-95d6-acd7d2ba43c9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PerformanceShareUnitMember_414dc388-e4d5-4317-9122-6015b780ca82_terseLabel_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit (PSUs)</link:label>
    <link:label id="lab_iclr_PerformanceShareUnitMember_label_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit [Member]</link:label>
    <link:label id="lab_iclr_PerformanceShareUnitMember_documentation_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember" xlink:href="iclr-20211231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PerformanceShareUnitMember" xlink:to="lab_iclr_PerformanceShareUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2dad0ba7-08ca-43d1-9751-0864cb34e181_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_c1c16ed4-4031-4306-8c10-4943b8c54af0_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Country</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_3efac57b-5397-48e5-b641-b148a6134c1c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_d11f7bcf-7006-4fd2-8766-8533b54e2b71_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_c261a570-823b-4182-b67b-ffefd37b208a_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and Integration-related Expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dbb876c3-1a86-4207-aee7-f3119d9f39ef_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_d2c5e415-3a0d-47e4-9060-1069e243b377_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_aabd8d2b-d62f-4a55-9a52-1f3970735ac2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_26b1d3f4-2f43-43f2-85b1-76c35f66a406_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_c3081087-840b-4200-babb-75ae66172338_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_1b7505c7-0657-47ae-a859-3a7ced5b6330_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_c283a719-83c7-4a8b-90a9-9d41f76f80a5_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_7f1a8fa9-234d-4524-ad80-33e215c04769_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-cash Stock Compensation Expense</link:label>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non Cash Stock Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non Cash Stock Compensation Expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:to="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3a5ec4ef-a450-40a5-9db1-aa1c687fcbba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Granted Under Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_6e4cedaf-7460-464b-acd6-689ce45fc5e0_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_a03db08f-15d3-4785-a9af-b4d407e311e2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8faa636c-4fd2-4896-b067-6a70f9bebdc7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1aaf5186-5102-480c-90a1-61666cc7304a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of ordinary shares which have been reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestExpenseCreditOther_b3927425-c16a-4f06-8c19-bd5fb2c68bd0_terseLabel_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing costs/(credits)</link:label>
    <link:label id="lab_iclr_InterestExpenseCreditOther_label_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense (Credit), Other</link:label>
    <link:label id="lab_iclr_InterestExpenseCreditOther_documentation_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense (Credit), Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther" xlink:href="iclr-20211231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestExpenseCreditOther" xlink:to="lab_iclr_InterestExpenseCreditOther" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestOfEuropeMember_2e05980b-3161-4ced-b9be-874f42b4dc05_terseLabel_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of Europe</link:label>
    <link:label id="lab_iclr_RestOfEuropeMember_label_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe [Member]</link:label>
    <link:label id="lab_iclr_RestOfEuropeMember_documentation_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestOfEuropeMember" xlink:to="lab_iclr_RestOfEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d1cb757e-8494-426c-86af-90c03ea5f1fd_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net (Note 7)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5e64bba2-e8fa-452a-82b5-82fffea531f2_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment (net)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_d6adbd83-adf2-48d4-b4ed-a4eaaa86ea88_terseLabel_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring liabilities (note 15)</link:label>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve and Other Liabilities, Current</link:label>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve and Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:href="iclr-20211231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:to="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_6bb263b6-3b16-4406-a0ca-beaeaf405d13_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit facility and senior secured notes</link:label>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility And Senior Secured Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility And Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:to="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_3986991a-fb6e-4578-b256-9e9df5c923fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3e93807a-bcde-48f1-a37c-7333cf33ea9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Intangible Asset Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ee14a30a-a68f-407a-9f57-0e99596bbe54_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per Ordinary Share attributable to the Group (Note 27):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_54af5722-66c7-4bca-a44d-590b974a9052_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_a591cf83-facd-4f3b-a4f4-fa338977689a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses (note 19)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_8b7f74ca-afd4-4939-adab-ba591f07374e_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_2ee873cb-7300-4f09-89db-aae16c954c6f_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Closing provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_f78fa9b6-d58f-4590-bf27-32af09818c6e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation (in percent)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ddedab46-a3d2-47d1-9f14-3317f3ab2236_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5a9245f9-393a-46e7-a06b-f4852c38839e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e38e9b3c-1061-4f4e-b3b1-fe464cee794b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_e12dc014-c190-4bb2-aeac-a44c87ecf821_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_30efacb5-1d9b-4e12-9103-fc7016acbaa5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BaringsEuropeanLoanFundBuyAndHoldMember_23fcfd0d-740c-44d8-854b-12808c1e3b79_terseLabel_en-US" xlink:label="lab_iclr_BaringsEuropeanLoanFundBuyAndHoldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barings European Loan Fund Buy &amp; Hold</link:label>
    <link:label id="lab_iclr_BaringsEuropeanLoanFundBuyAndHoldMember_label_en-US" xlink:label="lab_iclr_BaringsEuropeanLoanFundBuyAndHoldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barings European Loan Fund Buy And Hold [Member]</link:label>
    <link:label id="lab_iclr_BaringsEuropeanLoanFundBuyAndHoldMember_documentation_en-US" xlink:label="lab_iclr_BaringsEuropeanLoanFundBuyAndHoldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barings European Loan Fund Buy And Hold [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BaringsEuropeanLoanFundBuyAndHoldMember" xlink:href="iclr-20211231.xsd#iclr_BaringsEuropeanLoanFundBuyAndHoldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BaringsEuropeanLoanFundBuyAndHoldMember" xlink:to="lab_iclr_BaringsEuropeanLoanFundBuyAndHoldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_02c3dbcd-00e5-48f9-8339-b955cd7427aa_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6b76e7f8-2315-4525-ad03-af4189b2e171_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e019add8-41e4-4238-81be-d92087d14cb0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b5a96fa4-df9c-4525-9c2c-395a57b91716_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9aec4901-950f-4dc4-bcd7-25ed023bb4d1_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6bff6a52-9106-4a30-af94-1b73e79676da_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Fair value of plan assets at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_5f249e87-3c69-45b6-a741-09b20f2244f1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution to pension fund in the year ending December 31, 2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_e5e4987a-5497-409d-9f16-41b830322859_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_8f7915b4-f23e-48b7-9a5f-9ee8b4a4d126_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of financing costs and debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_2c32567f-b34f-4a7a-9008-187abe2ca22d_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_30cce2de-e1ea-4537-a128-081aa722d814_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_218d1d51-fe2d-48b8-bf11-b42ced2731c7_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_e3d27126-a03a-4e36-858d-aa6015657c6c_terseLabel_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_label_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_documentation_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:href="iclr-20211231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:to="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_b8921e01-d6ab-47d4-8fba-0fd976eec367_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_208a8d51-9cd6-4734-979a-edb90818901a_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_e75ca318-7af0-4851-8669-1e45e57d4f1c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_b0fb0bb6-ae0d-46b6-86f9-cbca8d1a1733_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_628b01e5-4f5e-4eca-ad26-7cdcec0a69a5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_cdcfd8db-221f-4d0e-ae78-470026bfb6da_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_0ed9bbcb-88f6-4197-af1a-4f2397fb7ee6_negatedTerseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unearned revenue (payments on account)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_4e636dd5-817d-420d-bc67-d714de821fc9_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unearned revenue (payments on account)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contracts With Customers, Liability, Current</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contracts With Customers, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:to="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_86b0d658-820a-49f2-8a16-64f6c608bcfe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherRetirementPlansMember_95c2ba61-a994-44ea-870f-17e5061e99d9_terseLabel_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other retirement plans</link:label>
    <link:label id="lab_iclr_OtherRetirementPlansMember_label_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Retirement Plans [Member]</link:label>
    <link:label id="lab_iclr_OtherRetirementPlansMember_documentation_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Retirement Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember" xlink:href="iclr-20211231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherRetirementPlansMember" xlink:to="lab_iclr_OtherRetirementPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0c14c89f-b575-4c46-bc73-ea524c3a90bb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_aa07b1c5-7f82-42fd-897b-f4c9f3e640f7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d9777565-0a6a-4592-b931-43f7e8bb0558_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock_58c49e4a-84b0-4e10-9f5d-7efeef17f6c8_terseLabel_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Credit Losses</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock_label_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts [Table Text Block]</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock_documentation_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts, Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:href="iclr-20211231.xsd#iclr_AllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:to="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c979aa93-e290-4e96-9a12-4518f81a6c38_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_6c22740f-4f87-4a64-8007-0c33f9638549_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_7c17857d-9e95-4c35-a84b-2d0a3e082e11_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_313b303d-f395-4942-b53a-47850b2e0dc6_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, share price (in USD per share)</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_cb2774e5-b910-4dde-9a93-daa864382347_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_76a146cb-61e7-41df-b8ce-9b48887911e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transactions for Company's Share Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4e6e1185-f501-4296-8d36-624abfc52578_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_28988d76-cebf-43e5-9b70-1ceacdd32f6e_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_label_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:href="iclr-20211231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:to="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_cf6ab4ad-ac22-46f2-8c7a-6e4e5984cdcf_terseLabel_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember" xlink:href="iclr-20211231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_The2020LegacyPRAPlanMember" xlink:to="lab_iclr_The2020LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_0ed18ddd-3615-46dc-9ca2-ba8561f8fd15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio_cc414931-72f4-45c3-abb6-f22e31254cf6_terseLabel_en-US" xlink:label="lab_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First lien net leverage ratio</link:label>
    <link:label id="lab_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio_label_en-US" xlink:label="lab_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, First Lien Net Leverage Ratio</link:label>
    <link:label id="lab_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio_documentation_en-US" xlink:label="lab_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, First Lien Net Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio" xlink:to="lab_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract_a60a5a23-68d8-4589-944f-7b18fd9e5949_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense was allocated to the following components of other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract" xlink:to="lab_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_5795a595-b874-4ac6-8c11-36376c32fc79_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_fe77c2a8-bfc9-44b0-8e6b-198262dd1dd7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_3ab991bd-1bd1-49c1-8baf-297acd86a4bb_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_1ce940b5-e5cd-40f6-baac-c4e1cad021f1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7a0de51f-0342-4805-9e9e-e3781d2de612_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7dca2e07-8c99-487d-a4cf-fd58c930d170_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_0123d337-18d1-4fec-a451-a46dcd960517_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_1ad68506-da09-4d63-aedc-335238fddc94_terseLabel_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan</link:label>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_label_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan [Member]</link:label>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_documentation_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember" xlink:href="iclr-20211231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ConsultantsStockPlan2008PlanMember" xlink:to="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_3031822d-d519-4009-b94c-728c5b3759d5_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eff18e68-91ec-4f1e-a931-ef70576b56aa_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and asset write offs</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorNotes2020Member_a10bbcf6-9707-4dbe-8b1b-d67ac919eb4c_terseLabel_en-US" xlink:label="lab_iclr_SeniorNotes2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020</link:label>
    <link:label id="lab_iclr_SeniorNotes2020Member_label_en-US" xlink:label="lab_iclr_SeniorNotes2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 [Member]</link:label>
    <link:label id="lab_iclr_SeniorNotes2020Member_documentation_en-US" xlink:label="lab_iclr_SeniorNotes2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorNotes2020Member" xlink:href="iclr-20211231.xsd#iclr_SeniorNotes2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorNotes2020Member" xlink:to="lab_iclr_SeniorNotes2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_0067c255-6860-4d3f-a354-2d993c8e3afe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_97cb79a8-997c-498d-a682-2ef85156c495_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_5c346648-4671-4401-96e1-d888d9632044_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8bf47882-81ae-49e8-9e96-94154a171eea_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2d50e5c6-f5bd-4908-ad2a-ab979ea5dc84_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_9dead5c4-31b3-485e-9304-4bf13a193548_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DSBiopharmaLimitedMember_16be696a-649f-4242-9037-ba1b0d969742_terseLabel_en-US" xlink:label="lab_iclr_DSBiopharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Biopharma Limited</link:label>
    <link:label id="lab_iclr_DSBiopharmaLimitedMember_label_en-US" xlink:label="lab_iclr_DSBiopharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Biopharma Limited [Member]</link:label>
    <link:label id="lab_iclr_DSBiopharmaLimitedMember_documentation_en-US" xlink:label="lab_iclr_DSBiopharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Biopharma Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DSBiopharmaLimitedMember" xlink:href="iclr-20211231.xsd#iclr_DSBiopharmaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DSBiopharmaLimitedMember" xlink:to="lab_iclr_DSBiopharmaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AptivSolutionsMember_bc1953d4-752a-48f2-aa75-b3e946d0db3a_terseLabel_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions</link:label>
    <link:label id="lab_iclr_AptivSolutionsMember_label_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions [Member]</link:label>
    <link:label id="lab_iclr_AptivSolutionsMember_documentation_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AptivSolutionsMember" xlink:to="lab_iclr_AptivSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_a422558c-fe34-4d1f-ac7b-31db1dae6a6c_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of call option on noncontrolling interest shares</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0e542235-d039-46b6-bd06-3564d7472c30_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_bb50ee6a-909f-4ea8-ae56-66fb811c7934_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of award as percentage of shares outstanding (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_6e99845a-0a39-49d7-ac84-ff84b4aa0a9e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Underlying Asset Split of Fund</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_824d4ab3-ace9-4169-b33c-c3f4adec6f7f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_f1f323c2-d59b-4657-bfa8-ac070262c9b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less debt issuance costs and debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_7491c339-31b5-4f4d-ac93-0e7ca07e9f9e_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentDomain_8b8c058a-f17b-40bf-882a-17824a77c11e_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:label id="lab_iclr_VariableRateComponentDomain_label_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:label id="lab_iclr_VariableRateComponentDomain_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentDomain" xlink:to="lab_iclr_VariableRateComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_df46ccd9-2cd1-4703-abc8-c7934b6f0874_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_0e9c7c82-472e-4326-ac50-f410e214155d_terseLabel_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration related *</link:label>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_label_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And Integration Expense [Member]</link:label>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_documentation_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And Integration Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember" xlink:href="iclr-20211231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TransactionAndIntegrationExpenseMember" xlink:to="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_2560d233-28ff-4952-bd2e-a502cb54d144_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_c49f40b2-366b-4ebf-bb96-b86666e3366f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_fe186ecc-516c-49a0-b7e6-de94686969be_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2022to2035Member_3be5a500-efd9-4241-b5de-fd4b0bdd563e_verboseLabel_en-US" xlink:label="lab_iclr_TaxYear2022to2035Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2022 to 2035</link:label>
    <link:label id="lab_iclr_TaxYear2022to2035Member_165f8d06-a743-49c1-878f-a2dabbe6a22e_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2022to2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022-2035</link:label>
    <link:label id="lab_iclr_TaxYear2022to2035Member_label_en-US" xlink:label="lab_iclr_TaxYear2022to2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2022 to 2035 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2022to2035Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2022to2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2022 to 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022to2035Member" xlink:href="iclr-20211231.xsd#iclr_TaxYear2022to2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2022to2035Member" xlink:to="lab_iclr_TaxYear2022to2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b9befaad-2416-4996-a65b-3b0e81f7c898_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_6a3ed49d-c3f8-4c1f-b1e0-32e0cccd16c4_terseLabel_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_label_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_documentation_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:href="iclr-20211231.xsd#iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:to="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_ea1aff72-389e-49d4-a65b-7f2d20d184d3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_67716acb-970a-491f-b2e6-e7654d6a9734_terseLabel_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive director</link:label>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_label_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive Director [Member]</link:label>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_documentation_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember" xlink:href="iclr-20211231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NonexecutiveDirectorMember" xlink:to="lab_iclr_NonexecutiveDirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_def01092-dc2d-4939-a230-9e714082d9d0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets (Note 5)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_e4593bf6-f5d6-4d84-9b1d-18cf794689ca_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Net book value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_af9f6ec8-4aaf-4ccb-9ff8-84c0a22256ee_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Note 4)</link:label>
    <link:label id="lab_us-gaap_Goodwill_6afdd18c-41f2-484d-b326-c6fcb2733b18_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_dfe6c03a-380a-456f-8d20-65c11b0b3bbd_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_02a67334-48d7-4e45-8e3b-fadd187d214e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_dc7f47b6-5fbe-417d-b15c-b0dd795ba045_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_4263a0cf-dddb-4c03-8b4f-638015cd2372_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6f33f248-3ab3-41a6-8ac6-b7aa932d175a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_5646ee52-18ee-4655-b6d5-40b09efb1de4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_8c7b7e9a-8648-40e3-9891-c1bd6c886877_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4e8b95aa-88e5-4175-b663-afe96f944981_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_7e26c894-e09f-4171-9702-6357a0202f70_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participant's contributions percentage of annual compensation (in percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccountingStandardsUpdate202108Member_66a4d38d-abba-438a-9599-76f7118d0943_terseLabel_en-US" xlink:label="lab_iclr_AccountingStandardsUpdate202108Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2021-08</link:label>
    <link:label id="lab_iclr_AccountingStandardsUpdate202108Member_label_en-US" xlink:label="lab_iclr_AccountingStandardsUpdate202108Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2021-08 [Member]</link:label>
    <link:label id="lab_iclr_AccountingStandardsUpdate202108Member_documentation_en-US" xlink:label="lab_iclr_AccountingStandardsUpdate202108Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2021-08</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountingStandardsUpdate202108Member" xlink:href="iclr-20211231.xsd#iclr_AccountingStandardsUpdate202108Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccountingStandardsUpdate202108Member" xlink:to="lab_iclr_AccountingStandardsUpdate202108Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_92048286-1fdb-4434-82d4-35f38ac60e24_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss and tax credits carryforwards</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:to="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_cc58c6f1-8292-4bfb-a621-6ea775cb76ec_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit)/expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8506f9b3-0434-4e9e-8af1-60b12ce080e3_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_674aa42c-8181-4860-be44-56a7b16f83e3_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_0fcd14c5-67ce-4949-ae05-f72538d421c6_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unbilled receivables (in percent)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:to="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_9821e83c-bd5b-4208-b577-25ff6e0b244d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_247fb8ee-2cbe-4b03-b8a1-6b497fd12313_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration related (Note 6)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_4c91a5a6-45b7-413c-adc1-c1d41bd06cef_terseLabel_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs Based on Service and EPS Targets</link:label>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_label_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Grants [Member]</link:label>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_documentation_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Grants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember" xlink:href="iclr-20211231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PerformanceBasedGrantsMember" xlink:to="lab_iclr_PerformanceBasedGrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_85e46374-9a5a-4569-b687-a05c8e113388_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5344c041-6909-428b-980e-e6b5ddbb3ba1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to the Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2956d48e-190b-43d8-ae50-1ed1fa2149a4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_d038b5ae-f346-41b9-b5d2-2450bda174a5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to the Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_007e98e2-7ee1-48fe-8dfa-b275bd6d4b52_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Net and Unbilled Revenue</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_373dc5fb-54f8-4d6f-8f5c-58727e996b5c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating right-of-use assets (Note 23)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_c68cfe13-5d7f-4567-8470-97e9ae27663d_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Costs</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3765d803-0bef-44e5-847c-f6f48c2abed2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6d1a5c8e-bd07-4b52-9c0d-9a3b521790d2_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_61b5c816-5a87-474b-be6f-ca8f0b3f8082_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3b74945a-ea63-4f56-aaed-5781ef94b9d0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personnel related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_807d1514-3f1b-493c-89ad-b0d51b5e6999_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4a243beb-6d3a-43bd-b581-7e01ed3921c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7c0d37f3-bd98-4346-bfe7-f6f2a03fcbec_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_423be6ea-a6ec-42cc-be60-54720fc1b603_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range2Member_2309fe1f-286e-46ef-a21a-40712390698d_terseLabel_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2</link:label>
    <link:label id="lab_iclr_Range2Member_label_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2 [Member]</link:label>
    <link:label id="lab_iclr_Range2Member_documentation_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member" xlink:href="iclr-20211231.xsd#iclr_Range2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range2Member" xlink:to="lab_iclr_Range2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_3ac6f673-ea24-4d15-9089-6606eb63ced5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b8e22a31-51ba-47dc-ab6c-e906bd7b18cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_f8b27e7f-4aed-4a7e-b9eb-7e43eea7183d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9a25cf46-9983-46f7-8c83-1a38a9d76a44_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_68ebfc97-5544-431d-877d-0e029734bdf9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentAxis_7f2625bd-a4f4-4a20-b1bc-404b837eb633_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Axis]</link:label>
    <link:label id="lab_iclr_VariableRateComponentAxis_label_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Axis]</link:label>
    <link:label id="lab_iclr_VariableRateComponentAxis_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentAxis" xlink:to="lab_iclr_VariableRateComponentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_6f352e70-7716-429a-96d4-f4a0d4509746_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_24c43d90-04d6-4fd9-bf21-b0e6a4c5e84a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_998192f8-61b8-4cd0-ad36-41d05ef885f5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_613b1d17-b500-45be-8114-606df6eee453_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_58756935-b263-4672-b03f-99dddf851a83_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_e81f9853-dd11-444f-a266-c4f974d80937_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_b0687f71-4188-474c-abf8-c0d4d2489d43_negatedLabel_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase costs</link:label>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_label_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Retained Earning Share Repurchase costs</link:label>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_documentation_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Retained Earning Share Repurchase costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:href="iclr-20211231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:to="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_98c71ebe-dd06-4869-93dc-50c47418ef05_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ff32973f-a973-4092-8264-f2043e0ba9b2_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1ccc7129-63b0-486e-b671-6f4d84d64550_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_bea3133c-97a6-4d7d-82bd-0bf8392b2009_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_bb25df1b-297e-442e-ba5a-bcbb8025e0a7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f01d6bc9-ad23-4e5e-b26b-39409471eaef_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_4d2b1d50-85f8-4a0d-9bb0-f2ea77ffa83d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses incurred from related party transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_96fc102d-306d-4f72-a3e4-b6fa8c07b688_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Short Term Investments by Major Security Type</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroThreePlanMember_72a164dc-b811-4fef-8c82-49a7e650134b_terseLabel_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2003 Plan</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroThreePlanMember_label_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2003 Plan [Member]</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroThreePlanMember_documentation_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroThreePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2003 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroThreePlanMember" xlink:href="iclr-20211231.xsd#iclr_EmployeeStockPlanTwentyZeroThreePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EmployeeStockPlanTwentyZeroThreePlanMember" xlink:to="lab_iclr_EmployeeStockPlanTwentyZeroThreePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_5608e8d1-da61-4514-98a2-71dc4b062a03_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_3cf20659-7e89-403a-b8db-7c42486cde8b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge/(credit) on interest rate hedge</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_07d88115-41ff-461a-9c4a-f7bf3f24aee6_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b68dd6fc-9264-4094-941c-9035c24b6d15_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_f36e78e9-840a-46d0-a267-00ee45c2bb54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_f5b0428c-e89e-401d-902f-18190c7c20ad_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheme contributions</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Scheme Contributions</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Scheme Contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanSchemeContributions" xlink:to="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_cdb02348-58b9-469f-aefb-823b650e46af_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs related to variable lease payments</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_b7844c41-3ed5-453f-a4e8-8dd56856d63b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain/(loss) on defined benefit pension plan</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_a6208ecd-5ca2-4767-bf26-39bb31d78463_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss) on defined benefit pension plan</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_22f8cb7b-5229-4f3d-96fc-58f46eb4516f_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building &#160;</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_33c2332c-f05d-41f2-bb17-8442b2d90d34_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income of acquiree since acquisition date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1bdf5f69-a39c-4ea4-9fd6-ef73e968457f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_602ca761-fc1d-4279-a5a0-186aa08e1066_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock units vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_5b3e6015-bc29-497e-9014-7e4173a7f376_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_f1843090-3264-438a-9743-86305c7c214e_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3ac8f7c2-e3d4-4b77-8d40-b00fceed6d17_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized capital (loss)/gain - investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TermLoanFacilityMember_56b15674-cbf7-4d18-9df2-f82b6323b2a6_terseLabel_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_iclr_TermLoanFacilityMember_label_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_iclr_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember" xlink:href="iclr-20211231.xsd#iclr_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TermLoanFacilityMember" xlink:to="lab_iclr_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_75f0faa9-0805-4825-a826-b93a616e946b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_b8763964-cee6-4916-bebd-8c71d2721d4e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_af3b64c2-be33-4609-8086-69b398f9eaf3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_ff009d3e-12d2-4770-9e9c-106e8b1dac2e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_fe1f3308-68c2-4188-be1e-5ff03a8a4aca_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_dc0ec42f-14a9-4c64-a422-198092f39b90_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9bd6b23c-802c-4dd4-b8ce-60b434bc57dd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8e8b327e-9f21-46b8-b70a-085ad2547c58_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_b39f3b25-4f60-41ad-86da-c4db2a05e2d5_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (Note 15)</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_6704ec27-1733-478d-8b92-49b2494ae08b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_963167e7-9ced-439d-abb2-144b6db047f9_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of company revenue (in percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_03d1eebb-011f-499b-bd31-14cf863f5a27_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_41b68321-52d7-4358-a65f-563e57c79f56_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_8d10b54a-c804-4f2f-8087-50b0d893cf8f_negatedTerseLabel_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion of long-term debt</link:label>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_label_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities, Gross</link:label>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtCurrentMaturitiesGross" xlink:to="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b274e165-e589-4a21-86fd-15b7a5471333_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4b903de4-1986-43fc-a333-e5632387040f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_61823582-cd59-4457-a1a1-4a602f12c63f_terseLabel_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Income from Operations by Geographical Area</link:label>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_label_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income by Geography [Table Text Block]</link:label>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_documentation_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income by Geography.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:href="iclr-20211231.xsd#iclr_OperatingIncomeByGeographyTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:to="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_869f9b6c-6263-4276-b9d2-b20a50089d6b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_e2e6daa8-d211-4a17-a6dc-6d5a55f1cf45_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names &amp; brands</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_f8289f75-4075-4879-99a3-3e0d4dcb305c_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_03762b39-8e99-47d4-ac42-15f4c5f6c295_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_c291eb9e-b61a-4b7e-8fa8-94e6500c68ca_terseLabel_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations, excluding restructuring and other items</link:label>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_label_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</link:label>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_documentation_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:href="iclr-20211231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:to="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_72c151dc-e730-4f91-b838-bed01fa04ed4_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_51ed5cac-0909-4643-84d3-11916493798c_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_48111a57-891f-4f98-9913-d7176c30bbd6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_04634f3a-ba08-4c41-b940-7bce767c595f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities_eabd690d-124f-4603-b998-4764ffb6d764_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating non-current lease liabilities fair value adjustment</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Lease Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_7a478117-4d7f-465c-9efa-42e7ccc97396_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredNotesMember" xlink:to="lab_iclr_SeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_551242ba-dcbf-42ce-9e94-9d2a44e20544_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General trade and overhead liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate_042f174f-3145-4a45-ab64-2bbb175f53c4_negatedTerseLabel_en-US" xlink:label="lab_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in basis spread on variable rate</link:label>
    <link:label id="lab_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase (Decrease) Basis Spread on Variable Rate</link:label>
    <link:label id="lab_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate_documentation_en-US" xlink:label="lab_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase (Decrease) Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" xlink:to="lab_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c29c4513-ab1f-46e9-8f7e-9710945d222f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6a3b5568-0630-4721-b13c-4cf08c58affa_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_843ef557-8ded-4778-87a0-bb9dd67df5f5_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_bad5ad68-df08-4d6b-9c64-0d05b1b64b53_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares redeemed, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_04b7f7fa-58c5-465e-832d-c251e91a8e23_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_7a94b655-e8bf-40e9-8852-5fb2e046b0a8_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Long-lived Assets, Net, by Geographical Area</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ad2b27d8-6e53-45a7-bb0e-c041ebb0c966_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_01e7202e-3dc5-4af0-ba9d-977c501dda61_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Proforma Information per Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_2d0247f7-9744-4474-ac0c-b0ade0d536e1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination acquisition percentage (in percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_55831d20-ba6e-4275-91b8-26318f724815_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75982525-f04f-4e60-a19e-2a0fc7fc5a44_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4dd4ee80-1363-48b4-aa8b-3349cbefc52b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of investments (in percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bac9c948-88a0-4ba8-88d8-5fa5aa575d8f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_7afe114e-2691-4e41-b804-df5fe5c87ca6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_1e3585cc-66e1-4442-b685-ea413e6e4ff0_terseLabel_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</link:label>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:to="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_570fc5ba-36e0-4c06-847d-b8ae5afceb74_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_MeDiNovaResearchMember_2990cb33-b07a-48aa-8ea8-ebec167daee0_terseLabel_en-US" xlink:label="lab_iclr_MeDiNovaResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeDiNova</link:label>
    <link:label id="lab_iclr_MeDiNovaResearchMember_label_en-US" xlink:label="lab_iclr_MeDiNovaResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeDiNova Research [Member]</link:label>
    <link:label id="lab_iclr_MeDiNovaResearchMember_documentation_en-US" xlink:label="lab_iclr_MeDiNovaResearchMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeDiNova Research [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MeDiNovaResearchMember" xlink:href="iclr-20211231.xsd#iclr_MeDiNovaResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_MeDiNovaResearchMember" xlink:to="lab_iclr_MeDiNovaResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_13364236-197e-4d6b-94a9-5d9f26682800_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_cfa2242a-5cde-4686-af77-1201bc7ac3ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_fab5e679-1a14-4fbb-8bf3-edb80217c99d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedParties_c8046745-c3b4-471e-aa0f-baf6172f922c_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due from related parties</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedParties" xlink:to="lab_us-gaap_DueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_df83c373-bf93-439e-9d85-d7aaac619512_terseLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in advance payments netted against unbilled contracts receivable (in percent)</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_label_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_documentation_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:href="iclr-20211231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:to="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_8addbe57-658b-4a3b-aa24-2ee21af164db_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_baa55c88-9547-4e34-af21-88e03e670282_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding number of shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fbb7238a-b78a-4410-b06f-9e8fdee162c1_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f68d872a-887c-4f66-82f0-8725c3956d9f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a3c9ec59-3599-4fb6-ae9e-8fe9d2ba8282_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_6ee8e255-315f-4c46-89b0-af8d3eca93d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non Vested Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_13832c38-e929-4474-95ac-b4b6c7b2d563_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_09df9c58-d933-4d62-bf99-1f31c8a6922c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares which have been reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CapitalGovernmentGrantsNoncurrent_e890b72c-89d6-45a4-b014-7e07f80bdc85_verboseLabel_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current government grants</link:label>
    <link:label id="lab_iclr_CapitalGovernmentGrantsNoncurrent_label_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Government Grants Noncurrent</link:label>
    <link:label id="lab_iclr_CapitalGovernmentGrantsNoncurrent_documentation_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent capital government grants, which are amortized and recognized in earnings over the grant period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsNoncurrent" xlink:href="iclr-20211231.xsd#iclr_CapitalGovernmentGrantsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CapitalGovernmentGrantsNoncurrent" xlink:to="lab_iclr_CapitalGovernmentGrantsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_701f1a98-49cb-40a6-a7b7-a6bdeb14a7cc_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_fb9adc1a-e55f-4f36-a923-ec20741b506e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_010b2d33-6482-4336-af72-a46073e24477_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_5bc71d63-d1c0-4d47-b86b-5762b10e01a9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability_41b713a0-ca88-4874-b17c-53533e30073c_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating non-current deferred tax liability fair value adjustment</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liability</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_30ac6e8b-e431-4cf6-8128-dfa155ef7d6d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_15036455-77ef-4e2c-bcd1-a9e6a54bbcad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange (gain)/loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f7008871-0736-4d26-9911-02c253d4e588_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_a2406d03-bfcf-4ed0-ab68-24b1f7dcb002_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party, loan interest rate</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionRate" xlink:to="lab_us-gaap_RelatedPartyTransactionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AuditInformationAbstract_label_en-US" xlink:label="lab_iclr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_iclr_AuditInformationAbstract_documentation_en-US" xlink:label="lab_iclr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AuditInformationAbstract" xlink:href="iclr-20211231.xsd#iclr_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AuditInformationAbstract" xlink:to="lab_iclr_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_7ef29352-5649-480d-b6ad-dca3f0ee7ae1_terseLabel_en-US" xlink:label="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Majority investor, ownership percentage</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_label_en-US" xlink:label="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Majority Ownership Percentage</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_documentation_en-US" xlink:label="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Majority Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:href="iclr-20211231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:to="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_987691ca-c888-4237-bb62-810c832b7bc4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1535cf90-caf7-4998-8249-9a214c415300_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9cc5b8b5-754c-48bd-a786-c0044c833ae1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_271d5423-40f1-427c-9d60-6d21d0cc79da_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NumberOfLocations_099174ac-ac5e-4fd4-a285-bbedc48c65f8_terseLabel_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of locations in which company operates</link:label>
    <link:label id="lab_iclr_NumberOfLocations_label_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Locations</link:label>
    <link:label id="lab_iclr_NumberOfLocations_documentation_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Locations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations" xlink:href="iclr-20211231.xsd#iclr_NumberOfLocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NumberOfLocations" xlink:to="lab_iclr_NumberOfLocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_f7f34cbf-d6a4-44bc-9728-776f8050fbfc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_60fa34bf-4923-4ecb-bb8d-b7db40e0c39a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue (Note 18)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_212894ff-c4f6-450a-8755-5342067fa486_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue (payments on account)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_301baa00-b3e6-48bf-a413-0cf81e371609_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_19517d5f-8f6d-4c7f-abbc-e8cccafce891_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_bbdf8c02-3acf-436a-815a-f5a8919d5081_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise price of option per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_40295faa-4caa-4e09-ba30-4d22bb9cf2af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock_9d410a6f-83dd-415c-8ae1-4e5cc4742118_terseLabel_en-US" xlink:label="lab_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expected Long Term Rates of Return on Different Asset Classes</link:label>
    <link:label id="lab_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock_label_en-US" xlink:label="lab_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Long Term Rate of Return on Plan Assets [Table Text Block]</link:label>
    <link:label id="lab_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock_documentation_en-US" xlink:label="lab_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Long Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" xlink:href="iclr-20211231.xsd#iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" xlink:to="lab_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_d5585abe-213d-4ae7-82d8-7ce49a417d80_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_942b0b10-869f-4ecf-a321-d558ba26941e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash tax benefit related to stock options exercised</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients610Member_6c76af29-690f-4a60-8046-29968f23bda3_terseLabel_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10</link:label>
    <link:label id="lab_iclr_Clients610Member_label_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10 [Member]</link:label>
    <link:label id="lab_iclr_Clients610Member_documentation_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member" xlink:href="iclr-20211231.xsd#iclr_Clients610Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients610Member" xlink:to="lab_iclr_Clients610Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_c8b65c6b-0e69-4b2f-9050-3879dd7254f0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_ae080662-3d80-4af7-80ff-0a42248762f9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per ordinary share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_a14ee6cb-0adb-4150-bf31-45eb55baab0b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long lived assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_c349bea6-7192-49de-a4b8-4ba18f089b89_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_a2891675-e5e2-4b9c-8f69-59e0fab5bfac_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [member]</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets_e0968c65-66f6-4734-b387-fa1729f44648_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating right-to-use assets fair value adjustment</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Right-To-Use Assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Right-To-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_87c49135-72f4-47b4-b8e8-22d0e936805f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_cd3d9488-c665-4c24-9997-e3feea6e7a6c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_391e3c7f-066d-4679-83da-ba961eb59c89_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_fddc0e4c-19d0-4edd-af78-696871a28774_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b33212b9-4be5-4c87-8e5e-226f372a2cfe_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c8d589b0-7824-4115-898a-0802821e8a3e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate movements on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_13fc1c07-993e-49ef-8cc5-3b1484e62a04_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ef340164-5991-42b8-b0b6-c5a93907491a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c34a9169-6838-463f-bb18-7337754df695_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_9d7e1623-133b-4f82-af61-236068cc2135_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Debt Securities, Available-For-Sale [Roll Forward]</link:label>
    <link:label id="lab_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_label_en-US" xlink:label="lab_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Debt Securities, Available-For-Sale [Roll Forward]</link:label>
    <link:label id="lab_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Debt Securities, Available-For-Sale [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward" xlink:href="iclr-20211231.xsd#iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward" xlink:to="lab_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_a2a95644-9982-43bc-b8b4-12e8ab78038c_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_ff257681-4cbb-44c0-8893-44756f216685_terseLabel_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grants</link:label>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_label_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grants [Policy Text Block]</link:label>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grants, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentGrantsPolicyTextBlock" xlink:href="iclr-20211231.xsd#iclr_GovernmentGrantsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_GovernmentGrantsPolicyTextBlock" xlink:to="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_HighYieldBondsMember_cdc0bb6b-f42f-455f-98ef-6b367b5e7a62_terseLabel_en-US" xlink:label="lab_iclr_HighYieldBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High yield bonds</link:label>
    <link:label id="lab_iclr_HighYieldBondsMember_label_en-US" xlink:label="lab_iclr_HighYieldBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High Yield Bonds [Member]</link:label>
    <link:label id="lab_iclr_HighYieldBondsMember_documentation_en-US" xlink:label="lab_iclr_HighYieldBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High Yield Bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_HighYieldBondsMember" xlink:href="iclr-20211231.xsd#iclr_HighYieldBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_HighYieldBondsMember" xlink:to="lab_iclr_HighYieldBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_9adbfd9d-7832-435e-b692-dc55a3ad2b5e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of share capital acquired (in percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_4aaa794a-0c13-4b06-a9b2-f5625fb6d8f7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of share capital acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_32f2b148-e8a1-4f41-be61-a935bc8fe6a7_totalLabel_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before share of earnings from equity method investments</link:label>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_label_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</link:label>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_documentation_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:href="iclr-20211231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:to="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_9c9fffdd-98ca-443a-8092-4d7ae57e73e0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_1cc3db1f-dec4-4480-a328-996781b07d5f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_367037c5-6a89-4894-a79c-f372bbdcf333_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net prior service cost for defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_41c87de0-5e27-4d7e-8a22-2cd17541a096_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Components of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_ef23ed31-1d6e-4ed4-a86f-e1b044575617_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_36802dbe-ccbd-4d16-8106-e2c33dfd9d1a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_9c95022a-48ac-4896-a45d-7442f5c334d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bf85cb3c-d031-47a4-8438-ea9cdf91802e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Schemes and Stock Compensation Charges</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_61f0fc50-a7de-4298-a056-2a6169a0f31e_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_d47e3e56-491f-431b-a846-69b66a74d63b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_0ce81e9c-f7bf-40e1-ad85-56c08f731e6c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issue costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_686c713d-b202-4834-bafc-0c63e8c41733_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of replacement share-based awards issued to acquiree employees</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_69708e5d-d20b-43fd-a883-f641801271fe_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember_a5e795bb-de6e-420c-905a-0ea1c501910c_terseLabel_en-US" xlink:label="lab_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">L&amp;G Life GPBF All World Equity Index Fund</link:label>
    <link:label id="lab_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember_label_en-US" xlink:label="lab_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">L And G Life GPBF All World Equity Index Fund [Member]</link:label>
    <link:label id="lab_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember_documentation_en-US" xlink:label="lab_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">L And G Life GPBF All World Equity Index Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember" xlink:href="iclr-20211231.xsd#iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember" xlink:to="lab_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_536c0e81-9c21-40a4-a593-b2de39a499fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Amounts (credited)/charged</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_403d3000-58f1-4d70-9614-74d160c72167_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_05ae2123-edb0-4b5a-a921-0ce07ef6a719_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year acquisitions (note 6)</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_709dc851-a3a7-4ba3-a4e3-dd43e0f945e9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies&#160;(Note 16)&#160;</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_dfccee2e-9d01-4f87-be01-817d88c3eb4e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_e3dbe88d-e3e6-4580-b669-0a513a280fe3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Loans and Multi Asset Credit</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities, Securitized Loans and Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eff7d28f-7835-4674-a03d-630545d1e67f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (Note 22)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_08bc4bd9-98d4-45cd-ba7f-351339a99989_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c43aef84-c172-4359-914c-97d54b3dfb66_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_06546a9b-f174-4fe1-a2fd-2f838a85cba5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_e7ddf231-750e-44bf-be04-cb1c8162449b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current income taxes payable (Note 14)</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1274972d-a7d0-4e40-a193-98795b7e3c80_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate changes</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_ecc1def7-5e48-423d-ad4f-962806ce6c22_terseLabel_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized percentage (in percent)</link:label>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_label_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program Authorized Percentage</link:label>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_documentation_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program Authorized Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:href="iclr-20211231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:to="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_3ddd5956-9c70-4b56-93da-8745f78b4df0_terseLabel_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nontrade Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NontradeReceivablesCurrent" xlink:to="lab_us-gaap_NontradeReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_9cb19d51-e7fa-403a-a2ef-816292c76606_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8de70c65-801f-4d33-9132-91c1eab5b4e0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_4da73fb7-0602-42b0-88f5-3a09eb0a7e6a_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_0f98204c-b66a-45d4-9628-c6de085ae0d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility related liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Utilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedUtilitiesCurrent" xlink:to="lab_us-gaap_AccruedUtilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2022To2028Member_2e572ad8-9911-43ea-beb5-ff92d73b0880_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2022To2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2022 to 2028</link:label>
    <link:label id="lab_iclr_TaxYear2022To2028Member_label_en-US" xlink:label="lab_iclr_TaxYear2022To2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2022 to 2028 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2022To2028Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2022To2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2020 to 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022To2028Member" xlink:href="iclr-20211231.xsd#iclr_TaxYear2022To2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2022To2028Member" xlink:to="lab_iclr_TaxYear2022To2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1cfb99a2-0a48-4498-b80a-e68dbf29f763_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e21efea0-fa79-4fa9-abfb-2fc22669ac61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_20eed284-fb4f-43af-b8ad-5fb173768156_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_54e5f1c1-2e60-49ba-b664-e3a8b31e1f73_terseLabel_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_label_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities, Gross</link:label>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:to="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_23715379-d627-4b8d-868c-b4fb5c5ebf76_terseLabel_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to acquire future long-term investments</link:label>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_label_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Acquire Long-Term Investments</link:label>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_documentation_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments" xlink:href="iclr-20211231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CommitmentToAcquireLongTermInvestments" xlink:to="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_31d31217-b74e-435c-bdb1-ae04cc32a681_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_f9c32534-cd7e-41d6-a2e7-dc1155e791f8_terseLabel_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units 2013</link:label>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_label_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Twenty Thirteen [Member]</link:label>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_documentation_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Twenty Thirteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:href="iclr-20211231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:to="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_d6faab30-f1e3-4e5c-a5c9-d783f50d902a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_a7be0fe8-9f1e-479f-8018-bf332c545ee1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a04d1c63-00dc-4e03-a7d1-a1095e1c3689_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expense:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_48c48c73-698b-453a-a5d5-18fdd5edae56_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_89e01524-39e4-402e-a0bd-074b428178d5_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_47412b22-7f69-491e-b1d4-b2071b265d98_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_d20bd094-dcce-48a3-81e7-35a0a74e71da_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8400b502-5a9a-45a3-962e-bf0d939fe4d5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_308da166-fd1c-4f8c-848f-bd77d16d5237_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_92ff3dfe-ceab-4132-b51f-96899655cad3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments in equity - long term</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_098209e4-5999-4655-85e4-8fb5cd7be71d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments in equity - long term</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IssueOfSeniorNotesNumberOfTranches_5c40dd3c-6337-4417-85bc-6c9f1a96786a_terseLabel_en-US" xlink:label="lab_iclr_IssueOfSeniorNotesNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of senior notes, number of tranches</link:label>
    <link:label id="lab_iclr_IssueOfSeniorNotesNumberOfTranches_label_en-US" xlink:label="lab_iclr_IssueOfSeniorNotesNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue Of Senior Notes, Number Of Tranches</link:label>
    <link:label id="lab_iclr_IssueOfSeniorNotesNumberOfTranches_documentation_en-US" xlink:label="lab_iclr_IssueOfSeniorNotesNumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue Of Senior Notes, Number Of Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IssueOfSeniorNotesNumberOfTranches" xlink:href="iclr-20211231.xsd#iclr_IssueOfSeniorNotesNumberOfTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IssueOfSeniorNotesNumberOfTranches" xlink:to="lab_iclr_IssueOfSeniorNotesNumberOfTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_37e5b9b3-5d34-4214-8029-1e6e47d5b558_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (note 23)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c9af30d9-4d99-4b22-9eda-b8ecf57d65c6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_777b41ec-6b96-4d38-bb9d-ed9b0a991d04_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_5ba31b29-84ad-4116-9315-97e191b2f818_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyAbstract" xlink:to="lab_us-gaap_ForeignCurrencyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_e4667dab-a9b2-402f-a5e5-ae2524784575_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest adjustment to redemption amount</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_c720ac15-d00b-4337-a5a9-2f68f763d04f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range3Member_8c811fdb-7606-41c8-9de6-9e5b82656a7d_terseLabel_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3</link:label>
    <link:label id="lab_iclr_Range3Member_label_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3 [Member]</link:label>
    <link:label id="lab_iclr_Range3Member_documentation_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member" xlink:href="iclr-20211231.xsd#iclr_Range3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range3Member" xlink:to="lab_iclr_Range3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_1ef10636-3989-41b4-a9b4-744eb5db4be8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_aa729d6e-ccf8-4f78-abe9-4643c53bc105_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation costs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2e84f73c-7fd4-4d4d-af1e-9eae26044463_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_bcedaa75-a189-4609-899b-9f37dce51714_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_a7602489-a647-4caf-ac98-59a854a7bf57_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_71d407be-7933-4530-ba1e-7be4fb2d7f80_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate component two</link:label>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_label_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component Two [Member]</link:label>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentTwoMember" xlink:to="lab_iclr_VariableRateComponentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtRestructuringCosts_9c0e43c9-9d35-4431-8e7a-cad6a140ade2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:to="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_176a9caa-072a-4ebc-8661-3fcdbc6c53ff_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_9eb16ba4-4df5-47ff-8272-0b872f161159_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of available for sale investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_dadee88a-d66e-4978-8fa2-4676facdeacb_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients25Member_501ed27b-fc9d-4dfb-a786-66c2cd19fbda_terseLabel_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5</link:label>
    <link:label id="lab_iclr_Clients25Member_label_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5 [Member]</link:label>
    <link:label id="lab_iclr_Clients25Member_documentation_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member" xlink:href="iclr-20211231.xsd#iclr_Clients25Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients25Member" xlink:to="lab_iclr_Clients25Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_51bdb607-1e2e-46ff-be82-02ce8e7b0e2a_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Useful Lives of Assets</link:label>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Useful Lives For Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:to="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherUndenominatedCapital_c893321c-b0fe-4655-8433-ec60e3dd6ad2_terseLabel_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital (Note 13 (a))</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapital_label_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapital_documentation_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital" xlink:href="iclr-20211231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherUndenominatedCapital" xlink:to="lab_iclr_OtherUndenominatedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b94bb197-26cd-4faf-a28d-4d3cde57ba6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of change in tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fa21f354-0e3b-4ec2-ae57-fdde7b835599_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_514fdbd8-528a-4513-9cf6-d65c2ef99906_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate changes</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_23970dac-9fd3-42c6-b83d-5f0475e7e97a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_c2c42792-4e96-48af-b38f-973ebe9f93ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities (Note 8)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_d61324c1-9633-470e-a859-c0ba54924ffd_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_5dc6f4d0-16c3-49ea-b2c5-bdc0c8174abf_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unbilled receivables</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:to="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_28556bdb-11c2-459e-b1d8-aeeae1686822_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_ad9b142a-a3e1-401a-9de8-0540efa55a02_terseLabel_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_label_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe And Other Countries [Member]</link:label>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_documentation_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe And Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestOfEuropeAndOtherCountriesMember" xlink:to="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_0c2b7916-ca8a-43f3-ab03-03c9ec799c7e_terseLabel_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited pension plan</link:label>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_label_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:to="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock_467bc6ca-95f1-423f-8148-4a695b49eaec_terseLabel_en-US" xlink:label="lab_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of New Accounting Pronouncements</link:label>
    <link:label id="lab_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock_label_en-US" xlink:label="lab_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New And Recent Accounting Pronouncements Disclosure [Text Block]</link:label>
    <link:label id="lab_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock_documentation_en-US" xlink:label="lab_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New And Recent Accounting Pronouncements Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock" xlink:href="iclr-20211231.xsd#iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock" xlink:to="lab_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_45d95c1c-144a-487f-a0cb-5181d4b8f09a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total&#160;Liabilities&#160;</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_2c724747-acfb-4edb-ae87-6733784aed80_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_31593c8e-8f21-4d50-a04f-5a2c54d0ebe0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7fae50f3-08e8-4b66-8b4f-439aaab4b3ae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_83fc61f3-9b06-411d-8170-f576fae70c91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_e6db12fc-8d62-447c-a5dd-ce9f2b09d20e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts_b0802563-dba8-4556-a1b0-99a80756159b_terseLabel_en-US" xlink:label="lab_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations, excluding restructuring, transaction and integration costs</link:label>
    <link:label id="lab_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts_label_en-US" xlink:label="lab_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) From Operations, Excluding Restructuring, Transaction And Integration Costs</link:label>
    <link:label id="lab_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts_documentation_en-US" xlink:label="lab_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) From Operations, Excluding Restructuring, Transaction And Integration Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" xlink:href="iclr-20211231.xsd#iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" xlink:to="lab_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_2f33687a-5790-4dc8-b7ba-bcd260d7062d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal net operating loss carry forwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_04a9fd5d-1b01-46e6-82a7-a05ed58f2e06_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_837e825e-6597-4f32-bde9-fe67f1da5489_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_54855f69-acf0-4164-b186-6c85fcc11089_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range1Member_0aeed9c9-f78a-4b21-b87e-c0abed49a846_terseLabel_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1</link:label>
    <link:label id="lab_iclr_Range1Member_label_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1 [Member]</link:label>
    <link:label id="lab_iclr_Range1Member_documentation_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member" xlink:href="iclr-20211231.xsd#iclr_Range1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range1Member" xlink:to="lab_iclr_Range1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_1f1dd8c8-e517-4241-83b8-fc0c63d8bb66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assumptions Used in Calculating Pension Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6821a984-e3c2-4b61-aff8-cea893db0dc3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_de36efb7-705e-4762-a9c2-a62c058ec9df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_e70dfadc-4645-4ef6-a103-36dc5daf04d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Benefit Payments which Reflect Expected Future Service</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_81d6787e-7aac-4816-9868-296e33444970_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_eedbf3a1-b44f-41c0-a29b-0b88fe3aaf20_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price of equity instruments other than options, vested in period (in USD per share)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_4c02ec3c-84a8-4dd8-96e4-4c7300983bc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_b675a429-522b-420b-8540-1291ce9a234a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_dfe4ca6e-f5e9-4cb4-b46d-cef4fdbe4798_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_5e0ecaab-1758-4805-b694-d1b6f95c3ad4_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense (Note 24)</link:label>
    <link:label id="lab_us-gaap_InterestExpense_c3bcf01d-66b2-4888-9ffe-e01a9045a7d6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financing costs</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_88253400-8f4e-4610-b85d-a72a67385c64_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to acquired tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09137cdf-327e-4cd4-a551-ec634e1eee15_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit)/expense:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_153ec888-3bdd-4585-b659-d8b4e147f988_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">44561</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_484350fe-bf75-4851-a3eb-f7fb2d26060c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b786b8d4-df6c-4508-a4b9-ad32f5fb9fe1_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_dfb95df9-0d60-4575-b21c-77b40e84a4b3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_6f38bda0-58f2-4d7e-8c80-71c634ca21af_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e36edf50-4474-4a41-98b7-465670b755c1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c0a9c7d6-76c5-49f8-a86e-2b2135ab8ed9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_406cb8b0-754e-465b-9394-bbdcd3be04eb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_a794b38b-3fa7-41ae-9d6a-1f3a68ea03c2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestMember_814ed0a1-dc10-485e-9b29-3a387ee5d424_terseLabel_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestMember" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RedeemableNoncontrollingInterestMember" xlink:to="lab_iclr_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5a23bd3d-d327-43cb-a285-d43c28584c94_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filler Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9d3c5349-9ef0-4cae-873c-6cd3352231e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_4055a6df-4ba9-48e5-b03b-470adbab7518_terseLabel_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Order backlog</link:label>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_label_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Order or Production Backlog [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrderOrProductionBacklogMember" xlink:to="lab_us-gaap_OrderOrProductionBacklogMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_559b0688-d1b7-49f3-a5df-fd1fd46006fd_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding shares authorized</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityNumberOfEmployees_e919803d-0ca1-4d1f-9e7d-759a287f46eb_terseLabel_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees</link:label>
    <link:label id="lab_dei_EntityNumberOfEmployees_label_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Number of Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityNumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityNumberOfEmployees" xlink:to="lab_dei_EntityNumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_2f2cfad4-65dc-4ed1-ac9d-da5036a4925e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of credit lines and facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_1aac43e1-8f29-430e-966b-24723541bae9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of equity compensation</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_0ff6dcb1-7cb9-4ef9-a1e0-39d36ae2ebb7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total proceeds from exercise of stock options by employees</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08df473d-d84b-47da-9880-fb8448253caf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_633766b4-5171-4574-970c-68f6c390a7ec_negatedLabel_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization</link:label>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_label_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve Utilizations</link:label>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_documentation_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve Utilizations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveUtilizations" xlink:href="iclr-20211231.xsd#iclr_RestructuringReserveUtilizations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestructuringReserveUtilizations" xlink:to="lab_iclr_RestructuringReserveUtilizations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fc4aa493-2018-46a2-ba4d-788e7f3ba3a3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9b6c8eee-9c9c-417c-ae73-f50587b7580d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_bd890b37-9c5d-4df2-89a7-dd70f0811feb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_bc73e841-af89-412d-b1b6-d17490172c54_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_3ed1c114-6df4-424b-b678-71581eff08ab_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_408bc756-5335-452f-801f-709658fbe870_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_b3b6871e-7b2a-4a31-9536-3f51dcd163a4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0b3d3b31-21af-4445-819b-55fd469f0479_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_423a3661-44db-4a33-825d-030f61f47a43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/expired (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_466da0f9-511a-446d-843e-1e1e3bb98b82_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorBNotesMember_5ab8b7df-b3bb-4950-a0c1-309e7e6de4b3_terseLabel_en-US" xlink:label="lab_iclr_SeniorBNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B notes</link:label>
    <link:label id="lab_iclr_SeniorBNotesMember_label_en-US" xlink:label="lab_iclr_SeniorBNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorBNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorBNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorBNotesMember" xlink:href="iclr-20211231.xsd#iclr_SeniorBNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorBNotesMember" xlink:to="lab_iclr_SeniorBNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_fe9af1d6-e85f-4714-aa85-03d57618fd52_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in the total valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_ed2f3e04-b576-49f3-9cef-d6b610b1eb1e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Total</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_0ac63ee1-4166-42da-9fa5-fa16307d0174_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_713542bb-1446-4368-bdbb-ea6510400eff_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred balances</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_d5fd1a0a-7d51-4a41-ab1b-13d0a3e25683_terseLabel_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc</link:label>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_label_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc [Member]</link:label>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_documentation_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PRAHealthSciencesIncMember" xlink:to="lab_iclr_PRAHealthSciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c02b3921-3e60-45d6-840c-b38d12a715dd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of restricted share units / performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ec190bcc-94d0-4d77-b6d7-391d409c1eee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_4591f92f-a4e0-4ff8-9fc6-b8d2c11a1a42_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Motor vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_200f1f95-1d1b-4988-8382-59de9bd45a62_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_82f5b58a-a629-4892-810e-c921f818fb89_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other net assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_5b38b545-c02b-487e-9696-4009d3f6bff0_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current bank credit lines and loan facilities (Note 24)</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_3c6ae150-b709-495e-b5b7-d0935a7e1031_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c417728e-798b-4076-b0f0-5c56ecb7b7c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4a52c114-fa42-4774-99cd-ffef92dbc39b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of restricted share units / performance share units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2fc4ab24-eeab-4d6f-9275-6e361d248fc8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherCountriesMember_aae473b3-ca2e-4145-99f7-3449dc7afafd_terseLabel_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_OtherCountriesMember_label_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_iclr_OtherCountriesMember_documentation_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherCountriesMember" xlink:to="lab_iclr_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_0702ecdc-bde4-4dbf-9664-8e093049f8e5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, range of outcomes, maximum value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_3c30ab75-a758-4f7e-93eb-18dac36229a9_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_d04e2067-b33b-4394-9030-bd7b3cbc41c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_38f6fb49-d6a9-42ae-b4d3-a8c2f800baa8_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_90882ea8-b216-421a-8907-b31eb62263b0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of option price for fair value of ordinary share (in percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d7454b7c-59ef-442f-b2f0-f9d31554c2b2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9cf69303-070e-4831-92fd-341a88b32f6d_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_ec9b7742-ec88-4f37-afc2-973151ac0587_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_2d1dc5c6-42f3-4043-a9ad-70dac802e56c_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_2a80a411-1d91-421f-b960-751d6fe89746_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current bank credit lines and loan facilities (Note 24)</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_af58538c-8232-42ae-9b27-6f6f5e76da9d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentOneMember_f9fbdf44-4f8f-4686-ad94-1387107ea80b_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate component one</link:label>
    <link:label id="lab_iclr_VariableRateComponentOneMember_label_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component One [Member]</link:label>
    <link:label id="lab_iclr_VariableRateComponentOneMember_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentOneMember" xlink:to="lab_iclr_VariableRateComponentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_225d5f8b-4979-490a-906c-c7e926e11d10_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b0008dfb-b76b-49ce-bdde-9b40824a5036_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_1d009d01-b04e-46b6-8f25-0559c1d718b9_totalLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in advance payments netted against unbilled contracts receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_73dd8359-71fb-4eac-99c6-32deca629808_terseLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in advance payments netted against unbilled contracts receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_label_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_documentation_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:href="iclr-20211231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:to="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_178a8c08-197f-453c-9a23-fc3cc59d5577_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_1650233a-e398-411e-975f-498dc19dfa8a_verboseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_59b2245c-4e46-4fbb-8d51-8b4e47d35077_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating right of use assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_63206613-3823-43c4-90c0-fa92148a4796_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_96f27a0d-cb7a-496b-908e-f044dbb49448_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to settle debt obligations that existed prior to acquisition date</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_68f71bf1-9cfd-49b8-92ed-1398b33d1a70_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_1017c20a-13a5-42a7-a16e-ea9e1eeee8da_negatedTerseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of gain on interest rate hedge</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Amortization Of Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Amortization Of Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" xlink:to="lab_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_99f86c9c-b5c9-474f-8bd1-3bf5db9a5170_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_4732e124-d4a5-4115-a740-be69228b3cc3_terseLabel_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_label_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five And Thereafter</link:label>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_documentation_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five And Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:to="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage_1b8ffe18-76bb-4417-b56f-77b918877944_terseLabel_en-US" xlink:label="lab_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate, step down percentage (in percent)</link:label>
    <link:label id="lab_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage_label_en-US" xlink:label="lab_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread On Variable Rate, Step Down Percentage</link:label>
    <link:label id="lab_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage_documentation_en-US" xlink:label="lab_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread On Variable Rate, Step Down Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" xlink:to="lab_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_46093106-7b52-4bed-92e0-5c69639f8239_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_ede72b6c-9816-4437-a4f1-ae8839d80a8a_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_830255cc-b169-4a45-b914-613a91f0af69_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_0e795dd9-80c9-42e6-b89f-34b795ec9f7a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_0d70b8a7-11c2-42e6-a80c-00260dcf11bf_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables_bdada408-5cb3-41ed-9a70-66c9afbc1121_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable adjustment</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Receivables</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_bcf7f545-979c-41b1-b1fe-e7600be01ed4_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through business combination (USD per share)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:to="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_ffb0cfbc-ea52-47b6-9743-adf10a8a7dc3_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant accounting policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7a57a442-958f-430f-b61f-0cbaaa1c2104_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0a55492-72e1-4616-aeec-f2cf590d9f7b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_971aa7bc-8d28-40a0-b296-db548b5a8e0f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carry forward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_da09858a-6c90-4f65-b15d-54d0563ba9fa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_37ef99e1-6fff-4925-bdbd-6e04861dd94d_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_8569b7aa-db46-41c3-986f-8c66e536cdda_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_2ff8a521-7759-46be-b383-93f00ea7428d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_503f4f33-5675-4b90-b7ab-3caaf5a01a3c_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities adjustment</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_4738145c-d2e3-4fc2-ac0d-9798ae6713a5_terseLabel_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency impact of long-term funding</link:label>
    <link:label id="lab_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_label_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction And Translation Adjustment, Net Of Tax, Long-Term Funding</link:label>
    <link:label id="lab_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_documentation_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment that results from the process of translating the impact of long-term funding into the functional currency of the reporting entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" xlink:to="lab_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ad198760-d6b2-444d-b487-caf87c194944_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ecd05b10-a843-43e6-8e82-8de74892739e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_3e02ea47-083e-4e68-9031-e113944de1b5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a8ab6920-2aeb-4764-b69e-f335592d690e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive share options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_2f66a203-acbb-4bab-8965-06af602648ae_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_dcbec0bd-bb76-42ab-bdc4-e82502c2fc6a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_3cf1c4e6-9e54-400e-95c0-c5158cb4dc89_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes (net of refunds)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_988b00d3-160f-492c-90e7-3e205e363c96_terseLabel_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Award Plans</link:label>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_label_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Award Plans [Member]</link:label>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_documentation_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Award Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember" xlink:href="iclr-20211231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockOptionAndAwardPlansMember" xlink:to="lab_iclr_StockOptionAndAwardPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestReceivableRelatedPartyLoans_58a10f82-ce7e-41cd-bc8a-cb39b70bf63d_terseLabel_en-US" xlink:label="lab_iclr_InterestReceivableRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable, related party loans</link:label>
    <link:label id="lab_iclr_InterestReceivableRelatedPartyLoans_label_en-US" xlink:label="lab_iclr_InterestReceivableRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Related Party Loans</link:label>
    <link:label id="lab_iclr_InterestReceivableRelatedPartyLoans_documentation_en-US" xlink:label="lab_iclr_InterestReceivableRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Related Party Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestReceivableRelatedPartyLoans" xlink:href="iclr-20211231.xsd#iclr_InterestReceivableRelatedPartyLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestReceivableRelatedPartyLoans" xlink:to="lab_iclr_InterestReceivableRelatedPartyLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_4a78a078-6017-442b-8dc5-a36bf03ee98f_terseLabel_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement period used as a basis to estimate expected cash flows</link:label>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_label_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Retirement period</link:label>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_documentation_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Retirement period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod" xlink:href="iclr-20211231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ExpectedRetirementPeriod" xlink:to="lab_iclr_ExpectedRetirementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5e7ed9bc-ae4c-4dd4-a74e-e1981ede60f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_cbb53d8d-133e-40ad-a911-d89ad7533adb_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to the Group</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_296d9073-df2f-46c4-ad12-b0ef4162d60e_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to the Group</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_f57b080b-31e7-4e1b-93c9-4c8acddc3417_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce reductions</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_33af49a8-2456-4c8d-8872-6efe0088f1c7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_704f3785-f283-4e18-9f50-4f016c7a8189_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a8617e81-a79c-497e-8e5d-c9010416ef36_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income &#160;</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_f9ea075f-16eb-4110-905a-58bd24909942_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Replacement share-based awards issued to acquiree employees</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers_a8bc1d79-4306-447c-aee5-20d091aca8eb_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in revenue from contracts with customers</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Revenue From Contracts With Customers</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Revenue From Contracts With Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseRevenueFromContractsWithCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers" xlink:to="lab_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_f8cafe4f-2c9b-49b5-b7ff-33d309f6c404_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c31e96f5-87aa-4c14-9d3e-2b934442e6b1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability (Note 14)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_3bfe1a05-9a23-4063-b252-a9b16f730de7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3629a9fc-ad5e-415d-9b0e-bd47304f8eee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b28eb438-269c-441e-bf75-f921233178fa_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_11426d88-5737-490d-9683-cca73802301c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_431d3d0d-706a-484e-bb29-41737680fa87_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bonds (including 50% high yield bonds)</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_538a976d-fbe8-41b0-82fa-d446ba3bf16f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue_b83570e2-735b-4856-bdf7-61e3fa86bb23_negatedTerseLabel_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of call option on noncontrolling interest shares</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue_label_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Accretion To Redemption Value</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue_documentation_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Accretion To Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue" xlink:to="lab_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_590ca4e9-e9ae-4feb-8bb9-86f4c7e25e1a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_681e5ce6-0267-4c73-9f7a-297120cc13bc_terseLabel_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_label_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit [Member]</link:label>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_documentation_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember" xlink:href="iclr-20211231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeTaxBenefitMember" xlink:to="lab_iclr_IncomeTaxBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_e6d0756d-7011-4cba-aa73-3dd424f9934b_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7cbb3da7-2173-4b66-b8be-47df74910f3d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_daf8d56f-8930-484c-8ee3-f32fb9ea37d4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_951d9e2f-21f1-461b-8b4f-1ff2cda91235_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a8f00cf7-8b4e-4012-989c-593af4e0cee4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_791f4568-b6c4-4976-9f87-e019fb93685b_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_2db12662-29e6-4e1b-b092-cf0f62af1489_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AwardDate2018Member_cac5fae4-cbcf-45b6-b1e2-aad3fe1e922b_terseLabel_en-US" xlink:label="lab_iclr_AwardDate2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award date, 2018 and thereafter</link:label>
    <link:label id="lab_iclr_AwardDate2018Member_label_en-US" xlink:label="lab_iclr_AwardDate2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date, 2018 [Member]</link:label>
    <link:label id="lab_iclr_AwardDate2018Member_documentation_en-US" xlink:label="lab_iclr_AwardDate2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date, 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDate2018Member" xlink:href="iclr-20211231.xsd#iclr_AwardDate2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AwardDate2018Member" xlink:to="lab_iclr_AwardDate2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_439f7398-89a1-4a4f-9b46-07072752efc8_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct costs (excluding depreciation and amortization)</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_cacb5a2b-bf68-48b7-94c3-87554981d534_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_1a859268-ff3f-4028-9ec1-22816fae0bb4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e7cff133-b56d-48b8-85a6-fef647bea1a2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4c58a0a1-fea1-4fb0-a9ff-e4be565197c9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_b961ff28-a715-4f11-92e9-6904c1712edc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_31bbd16b-7da9-406e-8762-cfcc22f9b6b7_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_3a7e05da-a1db-448a-b779-4b01e221ddda_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_ba6c9505-d817-43ba-be6f-92d8dbd67e43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Range Exercise Price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_bcbdacb0-fc91-4e19-a4ec-fb47176d058e_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_6b06d080-63c4-4cb5-aeeb-7e23c9c196ed_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherCustomersMember_a2ab4549-5bc0-4b12-93a5-210bb6b24ddb_terseLabel_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_OtherCustomersMember_label_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:label id="lab_iclr_OtherCustomersMember_documentation_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember" xlink:href="iclr-20211231.xsd#iclr_OtherCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherCustomersMember" xlink:to="lab_iclr_OtherCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_ed3c41b0-f445-43f9-b90c-381aa9df1de1_negatedLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain)/loss - benefit obligation</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:to="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_30e2ded3-1c4f-44cb-9d07-c13bd8ce3e11_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_6f103fdf-a164-47c2-8a0d-8666ecbc992e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_86fe617c-d52b-47bd-ac59-c48d4d883972_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_74404962-33ab-412c-90db-66300c76caac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (Note 9)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_dee0bdf6-1adc-487f-9a6b-21e797e07367_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (Note 9)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_b5e0ce9f-4a71-40eb-a825-e4a760e65430_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_9b65b8e5-06fd-47b3-85e5-f382beb08770_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_e20ded64-5223-4b53-828f-d3f1f2af74b6_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_be76f694-1270-4496-bb66-4f38f96c4714_terseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of loss on interest rate hedge</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:to="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_b557e963-5a67-49f7-86b0-e1aaebe606e3_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6ae36e13-c07a-4d04-95dc-5e50d0786b09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_bf32e00a-da37-4eb7-a63f-c05b310cccea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_87d7d8a7-6faa-47ed-8b46-99f490aab388_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_8a6f85d7-7c2a-4f9e-a7ea-9562131f43e0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_a2752173-f0a8-49c3-9488-20a8ea3ff461_terseLabel_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term government grants</link:label>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_label_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Government Grants Current</link:label>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_documentation_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Government Grants Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent" xlink:href="iclr-20211231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CapitalGovernmentGrantsCurrent" xlink:to="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_ac11cd6b-b1fc-4f5b-a089-1abc8a177d67_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU and PSU Activity</link:label>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:to="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_87870fc9-d63e-46c8-aee2-8dfbd3388641_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_56f51ba9-0e84-4eec-9bd3-042bde42165a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_ea61ff53-59ac-4f96-a17c-5b4f8bcc0870_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gain on interest rate hedge</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_2e883c6e-7bbc-4972-a1c1-3c3d2c3592ed_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment &#160;</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_d9dfeedb-e89f-4fcf-9a88-44abe2e35991_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_5d030ec8-aa8e-4b6a-8f6e-d5ce523194fe_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of available for sale investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_a8ceb804-b921-4f9a-ac3d-2545df4f9648_negatedLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and maturities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d8bc6f9e-b04a-4bfe-b1b7-6b02aed5545b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants' contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TopClientMember_b174fc09-6ef4-4f9d-a24d-bce2e302bcc4_terseLabel_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top client</link:label>
    <link:label id="lab_iclr_TopClientMember_label_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Client [Member]</link:label>
    <link:label id="lab_iclr_TopClientMember_documentation_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Client [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember" xlink:href="iclr-20211231.xsd#iclr_TopClientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TopClientMember" xlink:to="lab_iclr_TopClientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_37b97b1e-1e49-431c-9635-513857c954c0_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_5e1aaf68-f9b3-4e0c-b56a-3fb4df9ddeb1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_ba8f6a00-1fd1-4115-9f99-3ceefc6d1dd1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan obligations and accrued interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_72fab32d-53a2-4976-8028-b944d74404d3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_85c2d12b-2456-4fd5-8903-4335bcda24bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_2815d1f2-01e9-4d14-9c56-b79d87f5d7ba_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_31414a19-4289-4dc5-9685-208b93cca9ae_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_767ef9c5-d9af-4221-a24f-4fad06878ce3_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b65a96fd-32f8-400d-abd4-b172c54f364d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e074d4de-0cbe-4bc9-917c-91042a6e8153_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3b7cea46-41da-4152-ae69-ca65624fafd3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (in EUR per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_92d95ea3-26af-4976-a2cd-f7f8d0560ef8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4ae9abd4-6c89-4c52-b8f4-fdc620049579_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_6845510a-89d3-428a-a0a8-1e544827dff2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_958e4c77-f0c1-4b81-b85b-842a3c1a7a40_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_5169ee55-f93d-4122-8d9c-578097edfbbf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_22b6855d-68f5-48be-8994-dc50d5167d34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_d0166fe4-8614-4aa5-a799-7cfff12b56da_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_942332a4-acb6-4d9a-ba7e-4d5ac9369ca3_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal NOL's</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_67c29193-a9f7-47db-ace3-5e6ca027874d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of share options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_16e70b33-d8d6-4967-8ca9-d4eb4a346a71_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_21822104-3c49-4f4c-b520-ba3d0ef62f1b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by employees (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_38fcec22-ea0b-4067-a95a-f47d40d64749_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BuybackProgramMember_17d37d80-0430-4f0a-b651-aa8927fd67e9_terseLabel_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback program</link:label>
    <link:label id="lab_iclr_BuybackProgramMember_label_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback Program [Member]</link:label>
    <link:label id="lab_iclr_BuybackProgramMember_documentation_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember" xlink:href="iclr-20211231.xsd#iclr_BuybackProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BuybackProgramMember" xlink:to="lab_iclr_BuybackProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_9efcdd36-21a4-48c5-9fff-8715178f630c_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts used during the year</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2f1381e5-ff46-4e2b-9a25-18eced872631_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Capital</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ebd9bb44-5335-4827-8528-c0e44280ff68_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5572bffa-784e-4676-b4e4-fdd73442ffce_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_73009a8e-28ad-4a8f-b4e9-72c747bd315d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_c216078a-d514-4ad8-a6d2-392183cae1c6_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_b0910050-5754-4953-a1c4-fabd01e4ec94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_87387c23-a172-4031-b499-29f1f7628bd3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_329ef713-443d-4368-9cb3-374ae493c35e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_dace7433-aac0-44a9-8118-3349050aa0d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_59d46e96-cc71-43f2-9fb0-34c798eff0be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a9b405a9-a087-4881-9ccf-94271176926f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_f480061e-07f0-41bc-a959-dc3c60bd7636_terseLabel_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit of shares issued or to be issued pursuant to options granted (in shares)</link:label>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_label_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted</link:label>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_documentation_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit of Shares Issued or To Be Issued Pursuant to Options Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:href="iclr-20211231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:to="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_3a1be106-19db-4901-b8c5-21ad282ad30f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of subsidiary undertakings (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_ad28ab29-abae-49e2-97c7-df2f8da0549c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_547eb460-a6ad-4017-adc9-0944d76050e4_terseLabel_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_label_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Locations [Member]</link:label>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_documentation_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Locations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember" xlink:href="iclr-20211231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherGeographicLocationsMember" xlink:to="lab_iclr_OtherGeographicLocationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_090894e9-db36-419a-9f97-89b5adc33296_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_89c4c76b-403e-4949-b9c8-528ed654871e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange movement</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_6509e22c-4447-432f-9b42-19ebf8982ae4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_057e11fc-b9c3-43a7-b74b-6b1d6797c1f1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e7544494-7625-4c76-980a-444a43e2789e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b43331bb-6e9c-45c9-88b7-9ea474969b23_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_64828cac-256c-42b9-becd-d3677d1b9b0c_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_cbcfbff2-4463-49e5-9833-75b043791ff7_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_4c62c7a6-b03e-47f7-b7c1-f37c0d719154_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unearned revenue (payments on account) (in percent)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:to="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_394ab675-7141-4fa4-bdb4-87dc3c4d6304_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_A2013LegacyPRAPlanMember_5853aeb6-9d95-48b2-85d6-afef0ffa3372_terseLabel_en-US" xlink:label="lab_iclr_A2013LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_A2013LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_A2013LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_A2013LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_A2013LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Legacy PRA Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2013LegacyPRAPlanMember" xlink:href="iclr-20211231.xsd#iclr_A2013LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_A2013LegacyPRAPlanMember" xlink:to="lab_iclr_A2013LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_d80d63a9-2c23-4863-b236-9a83692701e4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (note 9)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_6abfe180-822e-430c-b178-2ac17d85606c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear20362040Member_0489514b-3d9a-4d9e-8315-9adb2e1bdf69_verboseLabel_en-US" xlink:label="lab_iclr_TaxYear20362040Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2036-2040</link:label>
    <link:label id="lab_iclr_TaxYear20362040Member_4449344b-6e11-490e-b85e-972865c608be_terseLabel_en-US" xlink:label="lab_iclr_TaxYear20362040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2036-2040</link:label>
    <link:label id="lab_iclr_TaxYear20362040Member_label_en-US" xlink:label="lab_iclr_TaxYear20362040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2036-2040 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear20362040Member_documentation_en-US" xlink:label="lab_iclr_TaxYear20362040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20362040Member" xlink:href="iclr-20211231.xsd#iclr_TaxYear20362040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear20362040Member" xlink:to="lab_iclr_TaxYear20362040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_031d740a-c4f2-4681-801a-724bed7a317e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_e24d0864-7e9e-44bb-853b-7957f30fdead_terseLabel_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Credits</link:label>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_label_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Credits [Policy Text Block]</link:label>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Credits [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:href="iclr-20211231.xsd#iclr_ResearchandDevelopmentCreditsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:to="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_b177796c-978a-4924-a822-1cd6ad79b0c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_860f1529-b836-4f62-8f8b-d6cebe85388a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct costs</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_5f9f3532-6fdf-43c1-868c-4776413603d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable (Note 14)</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_14d41862-4651-4741-9d1a-4c63cd4d5b0c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_d16f08ac-4386-4c37-bd1b-b18626cacedb_totalLabel_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite lived intangible assets, amortization expense, net, total</link:label>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_label_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, Net</link:label>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_documentation_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:href="iclr-20211231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:to="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_2c9a5ece-cb2d-482e-8777-ea6d9f02e5b7_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_12dbf9fe-4396-442f-a519-d1353babb9ec_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 1 year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_316f286b-85c7-471b-81a8-72ed54946348_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_5a953665-3d0b-44c6-92b4-97da8b306a7d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount paid</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OptionPlans2008Member_e0a6eb8c-2050-437e-b552-393ec32c7681_terseLabel_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008</link:label>
    <link:label id="lab_iclr_OptionPlans2008Member_label_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008 [Member]</link:label>
    <link:label id="lab_iclr_OptionPlans2008Member_documentation_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member" xlink:href="iclr-20211231.xsd#iclr_OptionPlans2008Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OptionPlans2008Member" xlink:to="lab_iclr_OptionPlans2008Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_fd13c264-9b6c-409c-b161-0d860169d066_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current bank credit lines and loan facilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_d6531d0a-500d-4eea-89c0-d58ad17d4a46_terseLabel_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and one time financing costs</link:label>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_label_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And One Time Financing Costs</link:label>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_documentation_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And One Time Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts" xlink:href="iclr-20211231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TransactionAndOneTimeFinancingCosts" xlink:to="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>iclr-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e141d476-ae09-4ec9-a80f-baeacfb8f81a,g:a196524c-1dde-4a8b-8796-f0fa7ce72378-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iconplc.com/role/Cover" xlink:type="simple" xlink:href="iclr-20211231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_510212f2-64ba-4e77-9971-8bb0c2dd9c87" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_671dd477-2418-46e2-933a-fde83c823085" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_510212f2-64ba-4e77-9971-8bb0c2dd9c87" xlink:to="loc_dei_DocumentInformationTable_671dd477-2418-46e2-933a-fde83c823085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_713e6f2d-85e6-41e3-a00d-8918dc21e227" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_671dd477-2418-46e2-933a-fde83c823085" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_713e6f2d-85e6-41e3-a00d-8918dc21e227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_71f28ab2-aab6-49f6-8e82-e80facd63240" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_713e6f2d-85e6-41e3-a00d-8918dc21e227" xlink:to="loc_dei_AddressTypeDomain_71f28ab2-aab6-49f6-8e82-e80facd63240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_6d2d51a8-3cbf-4c05-b7fe-e6d67372c8a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_71f28ab2-aab6-49f6-8e82-e80facd63240" xlink:to="loc_dei_BusinessContactMember_6d2d51a8-3cbf-4c05-b7fe-e6d67372c8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_671dd477-2418-46e2-933a-fde83c823085" xlink:to="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5b0cc050-0218-4a3f-a5a6-c917e96a7c9e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentType_5b0cc050-0218-4a3f-a5a6-c917e96a7c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_a8c2f21e-31ce-4d18-8235-ea5530877978" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentRegistrationStatement_a8c2f21e-31ce-4d18-8235-ea5530877978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_a85fc749-3c46-4707-ae8f-7a43362c37a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentAnnualReport_a85fc749-3c46-4707-ae8f-7a43362c37a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ba815163-9346-4824-a4cf-0fc45e5f5b04" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentPeriodEndDate_ba815163-9346-4824-a4cf-0fc45e5f5b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4e8279b4-b819-4b1b-be8b-7ed19c03e1d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_CurrentFiscalYearEndDate_4e8279b4-b819-4b1b-be8b-7ed19c03e1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8f2664d2-ee26-4197-b0bc-17e70331eb3b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentTransitionReport_8f2664d2-ee26-4197-b0bc-17e70331eb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_3768b7de-ba37-4077-baa9-b115e576c7a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentShellCompanyReport_3768b7de-ba37-4077-baa9-b115e576c7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_398ae245-3c10-4844-a912-61262ce63a61" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityFileNumber_398ae245-3c10-4844-a912-61262ce63a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6d6779a7-0b75-4741-a1b2-a519fa5a5e6a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityRegistrantName_6d6779a7-0b75-4741-a1b2-a519fa5a5e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_603e4c7d-d615-45e8-9898-5041bdd15860" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_603e4c7d-d615-45e8-9898-5041bdd15860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_788e44e1-16cd-4573-855a-12383a6a10b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressAddressLine1_788e44e1-16cd-4573-855a-12383a6a10b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_e0a992fe-0b3e-41d6-8b91-e96af9312ab4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressAddressLine2_e0a992fe-0b3e-41d6-8b91-e96af9312ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4ac58253-e167-4fd1-91b0-6ed958d2b5d2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressCityOrTown_4ac58253-e167-4fd1-91b0-6ed958d2b5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_07ff2094-1aab-4188-ae90-52e1069873ad" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressPostalZipCode_07ff2094-1aab-4188-ae90-52e1069873ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_f786dc73-2cbe-46ef-a083-b5c48d5f235a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityAddressCountry_f786dc73-2cbe-46ef-a083-b5c48d5f235a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_405b431c-99e6-45ed-ba26-f2ba9994c6ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_ContactPersonnelName_405b431c-99e6-45ed-ba26-f2ba9994c6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_c21f9fdb-f96c-4c07-8d71-4c339de4d78d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_ContactPersonnelEmailAddress_c21f9fdb-f96c-4c07-8d71-4c339de4d78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_72fb9290-5152-4790-b438-d100dab22cd6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_CountryRegion_72fb9290-5152-4790-b438-d100dab22cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7acd125c-fef4-4a5b-aa2d-aa4702565c6b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_CityAreaCode_7acd125c-fef4-4a5b-aa2d-aa4702565c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ef4f926e-58bd-4050-83e4-2039b2cfb72c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_LocalPhoneNumber_ef4f926e-58bd-4050-83e4-2039b2cfb72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ef40539a-04cc-4b9a-b8a3-29743037f18a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_Security12bTitle_ef40539a-04cc-4b9a-b8a3-29743037f18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9616c03e-44d9-4be1-88b3-bcd4d5da2a13" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_TradingSymbol_9616c03e-44d9-4be1-88b3-bcd4d5da2a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_427d1231-a14b-42b3-a1a3-1cea2646c511" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_SecurityExchangeName_427d1231-a14b-42b3-a1a3-1cea2646c511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_931cba2c-aa89-49fc-813f-f264278096f1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_931cba2c-aa89-49fc-813f-f264278096f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_96c0767e-3452-41f1-b8eb-15dbe5eac639" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_96c0767e-3452-41f1-b8eb-15dbe5eac639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_1d00af7f-1f7a-4233-ad58-be852439b3f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityVoluntaryFilers_1d00af7f-1f7a-4233-ad58-be852439b3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_49078e55-d133-419f-b644-f22b75b812c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityCurrentReportingStatus_49078e55-d133-419f-b644-f22b75b812c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7a2696bb-cb65-4ca6-8974-5051439278f5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityInteractiveDataCurrent_7a2696bb-cb65-4ca6-8974-5051439278f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_299d2a5b-7415-4700-91ef-1a388ca1d3cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityFilerCategory_299d2a5b-7415-4700-91ef-1a388ca1d3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ef1d34d9-e97e-401d-8410-973cf22fc079" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityEmergingGrowthCompany_ef1d34d9-e97e-401d-8410-973cf22fc079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_1d824a4e-ad7e-4b74-a9fb-a573443066a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_IcfrAuditorAttestationFlag_1d824a4e-ad7e-4b74-a9fb-a573443066a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_328579fe-f4f9-4446-af47-f7777e9bff3f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentAccountingStandard_328579fe-f4f9-4446-af47-f7777e9bff3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9ac295ed-736f-4904-be04-0ffb20e4bce3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityShellCompany_9ac295ed-736f-4904-be04-0ffb20e4bce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_91bb6863-0450-470b-8cd7-9c68fb1d39d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_AmendmentFlag_91bb6863-0450-470b-8cd7-9c68fb1d39d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2e4d3c02-efc1-458c-b387-9cb383f16f08" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentFiscalYearFocus_2e4d3c02-efc1-458c-b387-9cb383f16f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e030a720-1b8f-4bcc-9a9d-62f7a25fbbdd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e030a720-1b8f-4bcc-9a9d-62f7a25fbbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0af5d319-fdc4-4026-a257-98dfa0fa7db3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4bd9929f-5630-4f34-aa45-48aebf1de2f5" xlink:to="loc_dei_EntityCentralIndexKey_0af5d319-fdc4-4026-a257-98dfa0fa7db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AuditInformation" xlink:type="simple" xlink:href="iclr-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AuditInformationAbstract_ad50f7ba-4983-478c-8cef-95798cc8d6b7" xlink:href="iclr-20211231.xsd#iclr_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_09a5a755-9b35-4d98-9a01-c1e1f6e96491" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_ad50f7ba-4983-478c-8cef-95798cc8d6b7" xlink:to="loc_dei_AuditorFirmId_09a5a755-9b35-4d98-9a01-c1e1f6e96491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_1ad61904-62b9-4ea4-9243-2b24f6afa5ee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_ad50f7ba-4983-478c-8cef-95798cc8d6b7" xlink:to="loc_dei_AuditorName_1ad61904-62b9-4ea4-9243-2b24f6afa5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_b381226a-d6f4-4d28-9eee-8dd26793177f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_ad50f7ba-4983-478c-8cef-95798cc8d6b7" xlink:to="loc_dei_AuditorLocation_b381226a-d6f4-4d28-9eee-8dd26793177f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a13645e3-4625-4f94-8592-a4a94f191cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_31355115-9b8f-4fbb-9813-493fdcec5ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a13645e3-4625-4f94-8592-a4a94f191cbd" xlink:to="loc_us-gaap_AssetsAbstract_31355115-9b8f-4fbb-9813-493fdcec5ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31355115-9b8f-4fbb-9813-493fdcec5ba0" xlink:to="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_efb28323-ba0a-40d2-9cfb-480b275970da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_efb28323-ba0a-40d2-9cfb-480b275970da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_90819eba-3094-456b-a89b-125c1b9bc20c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_90819eba-3094-456b-a89b-125c1b9bc20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_52746506-b5e7-47f9-b57d-de779854573d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_52746506-b5e7-47f9-b57d-de779854573d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_4939a81d-5a7f-4c5e-8196-62ab28ea8c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_4939a81d-5a7f-4c5e-8196-62ab28ea8c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_e45a13be-1464-41f0-910d-4ed363026bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_e45a13be-1464-41f0-910d-4ed363026bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cb045dbb-9611-49e2-a836-9dfdf99ef6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cb045dbb-9611-49e2-a836-9dfdf99ef6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_692b7cf0-0d4f-4e05-ab16-fc20db45a5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:to="loc_us-gaap_IncomeTaxesReceivable_692b7cf0-0d4f-4e05-ab16-fc20db45a5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_30ce20ab-536d-4327-99fa-978d483b5e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_82a91dbb-1c20-45f7-a02c-8630402a4086" xlink:to="loc_us-gaap_AssetsCurrent_30ce20ab-536d-4327-99fa-978d483b5e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31355115-9b8f-4fbb-9813-493fdcec5ba0" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2da8e2ef-db51-40ae-938f-c8aae909f1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2da8e2ef-db51-40ae-938f-c8aae909f1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2dee7d71-252f-4647-ac57-8ceb653409af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_Goodwill_2dee7d71-252f-4647-ac57-8ceb653409af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9321f69d-4381-4fe1-afd9-449f65533408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9321f69d-4381-4fe1-afd9-449f65533408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4113263c-1b8e-4b71-91ca-63702674bc13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4113263c-1b8e-4b71-91ca-63702674bc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5f236e26-d418-482b-b37f-cf307fec1fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5f236e26-d418-482b-b37f-cf307fec1fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_1df1284a-2914-48d6-80f3-1a9634583748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_1df1284a-2914-48d6-80f3-1a9634583748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_603292fa-eebd-4875-9a1f-a6405f030a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_603292fa-eebd-4875-9a1f-a6405f030a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_88d355cb-fea5-4888-901f-8f95dfc0d6df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_EquityMethodInvestments_88d355cb-fea5-4888-901f-8f95dfc0d6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_876d26f8-e893-43f5-84a0-9621a9ff038c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_cc7f837b-901d-45a1-b5ff-29aea9c7d226" xlink:to="loc_us-gaap_OtherLongTermInvestments_876d26f8-e893-43f5-84a0-9621a9ff038c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_03365d2e-a544-4570-a851-87391e6a24b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31355115-9b8f-4fbb-9813-493fdcec5ba0" xlink:to="loc_us-gaap_Assets_03365d2e-a544-4570-a851-87391e6a24b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_df050c2f-3f37-4ca6-bb9d-2384a4d1168f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a13645e3-4625-4f94-8592-a4a94f191cbd" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_df050c2f-3f37-4ca6-bb9d-2384a4d1168f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c2859930-24f6-47dd-a493-e753bcd34ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_df050c2f-3f37-4ca6-bb9d-2384a4d1168f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c2859930-24f6-47dd-a493-e753bcd34ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7b69a93a-2ce7-4a47-b027-966c61e5acfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c2859930-24f6-47dd-a493-e753bcd34ae7" xlink:to="loc_us-gaap_AccountsPayableCurrent_7b69a93a-2ce7-4a47-b027-966c61e5acfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_888105c7-4215-46a7-b8e5-8e6a0af7907a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c2859930-24f6-47dd-a493-e753bcd34ae7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_888105c7-4215-46a7-b8e5-8e6a0af7907a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e26451a1-3425-4e26-bf61-f3de4b07c97e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c2859930-24f6-47dd-a493-e753bcd34ae7" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e26451a1-3425-4e26-bf61-f3de4b07c97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_7eb3a571-0bf0-4f6b-bcbc-4a05d431f631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c2859930-24f6-47dd-a493-e753bcd34ae7" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_7eb3a571-0bf0-4f6b-bcbc-4a05d431f631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_dd6e7dca-bc57-4aee-962e-f71d5c954e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c2859930-24f6-47dd-a493-e753bcd34ae7" xlink:to="loc_us-gaap_LinesOfCreditCurrent_dd6e7dca-bc57-4aee-962e-f71d5c954e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2da534fc-1dbd-42ee-b2eb-755f124ad21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c2859930-24f6-47dd-a493-e753bcd34ae7" xlink:to="loc_us-gaap_LiabilitiesCurrent_2da534fc-1dbd-42ee-b2eb-755f124ad21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_df050c2f-3f37-4ca6-bb9d-2384a4d1168f" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_6fb2d172-1b9c-4117-90f3-ac826cf9c543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:to="loc_us-gaap_LongTermLineOfCredit_6fb2d172-1b9c-4117-90f3-ac826cf9c543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7bdf70fe-b415-41d8-aa35-3acd1ff9b859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7bdf70fe-b415-41d8-aa35-3acd1ff9b859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_86282c6f-ee08-4ccf-b9c0-30e974f9a993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_86282c6f-ee08-4ccf-b9c0-30e974f9a993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsNoncurrent_dc580547-6a50-482d-8816-43d4fe9d303c" xlink:href="iclr-20211231.xsd#iclr_CapitalGovernmentGrantsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:to="loc_iclr_CapitalGovernmentGrantsNoncurrent_dc580547-6a50-482d-8816-43d4fe9d303c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_185e95d3-e758-412f-a83f-1a5585af895e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_185e95d3-e758-412f-a83f-1a5585af895e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_42b548b4-69ce-41d8-a890-6c4d409aaf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_42b548b4-69ce-41d8-a890-6c4d409aaf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_02f54d0a-21f6-4aa7-8b28-97314bd6aaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_34022106-4f92-4ec9-bd03-002cfe4be516" xlink:to="loc_us-gaap_CommitmentsAndContingencies_02f54d0a-21f6-4aa7-8b28-97314bd6aaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_871e0281-e4b8-4ca2-bddf-9ad091ae2045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_df050c2f-3f37-4ca6-bb9d-2384a4d1168f" xlink:to="loc_us-gaap_Liabilities_871e0281-e4b8-4ca2-bddf-9ad091ae2045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_070a0125-c622-487e-a976-8b2a162a1aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_df050c2f-3f37-4ca6-bb9d-2384a4d1168f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_070a0125-c622-487e-a976-8b2a162a1aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6cafedb9-fb1f-41c1-aded-451ae06d1de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_070a0125-c622-487e-a976-8b2a162a1aa3" xlink:to="loc_us-gaap_CommonStockValue_6cafedb9-fb1f-41c1-aded-451ae06d1de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fd38a986-7f6f-43f4-bf38-f0cb864f89b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_070a0125-c622-487e-a976-8b2a162a1aa3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fd38a986-7f6f-43f4-bf38-f0cb864f89b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital_7979f98b-d86e-43e4-be56-bc48a57114c1" xlink:href="iclr-20211231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_070a0125-c622-487e-a976-8b2a162a1aa3" xlink:to="loc_iclr_OtherUndenominatedCapital_7979f98b-d86e-43e4-be56-bc48a57114c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_719f56a3-ee02-404e-a037-999560c8a66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_070a0125-c622-487e-a976-8b2a162a1aa3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_719f56a3-ee02-404e-a037-999560c8a66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ed499233-69a8-46ee-9fdb-2a4d72aefb22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_070a0125-c622-487e-a976-8b2a162a1aa3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ed499233-69a8-46ee-9fdb-2a4d72aefb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3c57d857-869a-4968-8ca6-2923ed4953e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_070a0125-c622-487e-a976-8b2a162a1aa3" xlink:to="loc_us-gaap_StockholdersEquity_3c57d857-869a-4968-8ca6-2923ed4953e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_44c1a996-8d2d-43c5-b381-47602f47c04a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_df050c2f-3f37-4ca6-bb9d-2384a4d1168f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_44c1a996-8d2d-43c5-b381-47602f47c04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c9b1fd30-57be-4721-b372-6447b769e9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3cadd2e9-8c03-4c5f-b597-4d11a5e12a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9b1fd30-57be-4721-b372-6447b769e9a0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3cadd2e9-8c03-4c5f-b597-4d11a5e12a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7fe71395-f00f-4166-a8ba-f5722cf2721e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9b1fd30-57be-4721-b372-6447b769e9a0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7fe71395-f00f-4166-a8ba-f5722cf2721e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3065c5d2-b5c5-41c3-8991-50a47e109c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9b1fd30-57be-4721-b372-6447b769e9a0" xlink:to="loc_us-gaap_CommonStockSharesIssued_3065c5d2-b5c5-41c3-8991-50a47e109c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_de5c1990-7309-4346-91b3-5835b9a764b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9b1fd30-57be-4721-b372-6447b769e9a0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_de5c1990-7309-4346-91b3-5835b9a764b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_cc44d0b8-1e05-4d7d-b21a-6f7edfcc9482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_RevenuesAbstract_cc44d0b8-1e05-4d7d-b21a-6f7edfcc9482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1683d9b5-8e80-4b62-8c32-0d908c73a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_cc44d0b8-1e05-4d7d-b21a-6f7edfcc9482" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1683d9b5-8e80-4b62-8c32-0d908c73a3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_8f2a1b0a-f597-4e85-a6e0-ec162065d89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_8f2a1b0a-f597-4e85-a6e0-ec162065d89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0bd6c366-40b5-4cff-8b9e-535264a200e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8f2a1b0a-f597-4e85-a6e0-ec162065d89a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0bd6c366-40b5-4cff-8b9e-535264a200e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4068c96a-5171-4a18-8a47-e9cf93c2b805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8f2a1b0a-f597-4e85-a6e0-ec162065d89a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4068c96a-5171-4a18-8a47-e9cf93c2b805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d5c60b0e-9312-4e4c-b9c5-ca493f505e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8f2a1b0a-f597-4e85-a6e0-ec162065d89a" xlink:to="loc_us-gaap_DepreciationAndAmortization_d5c60b0e-9312-4e4c-b9c5-ca493f505e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_aecc2b76-1966-4b64-94a1-82081f8878e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8f2a1b0a-f597-4e85-a6e0-ec162065d89a" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_aecc2b76-1966-4b64-94a1-82081f8878e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_fe9f59a5-4d42-4e52-a36c-88f64813e394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8f2a1b0a-f597-4e85-a6e0-ec162065d89a" xlink:to="loc_us-gaap_RestructuringCosts_fe9f59a5-4d42-4e52-a36c-88f64813e394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_b4a09490-defa-43d6-828d-30a5adbe4f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_8f2a1b0a-f597-4e85-a6e0-ec162065d89a" xlink:to="loc_us-gaap_CostsAndExpenses_b4a09490-defa-43d6-828d-30a5adbe4f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e28fb280-cc20-43d2-86fc-3263048f6818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_OperatingIncomeLoss_e28fb280-cc20-43d2-86fc-3263048f6818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_eeb3d040-42c9-4a6c-8dda-066378e4865d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_InvestmentIncomeInterest_eeb3d040-42c9-4a6c-8dda-066378e4865d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_db5aa303-7b71-40c5-b2dd-7a8e682d1bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_InterestExpense_db5aa303-7b71-40c5-b2dd-7a8e682d1bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_3d1099b9-de04-40cb-b44b-fedc40d4fe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_3d1099b9-de04-40cb-b44b-fedc40d4fe6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_11f4db5a-5e6f-41be-9ec5-fba3c1d68fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_11f4db5a-5e6f-41be-9ec5-fba3c1d68fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_f9a858c4-a2b2-4518-a828-0c7b3600e8f3" xlink:href="iclr-20211231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_f9a858c4-a2b2-4518-a828-0c7b3600e8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_83911ef3-5a41-4a2d-8d2c-ed721fa1c2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_83911ef3-5a41-4a2d-8d2c-ed721fa1c2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89adbaf9-242c-4edd-8542-c1ae37adddbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_ProfitLoss_89adbaf9-242c-4edd-8542-c1ae37adddbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c766987e-d795-41e8-8968-e488c2da15ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_c766987e-d795-41e8-8968-e488c2da15ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0fcf4dbc-1de2-46c6-b709-1c8e7df89cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_NetIncomeLoss_0fcf4dbc-1de2-46c6-b709-1c8e7df89cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8f82049b-0e2b-4010-ba90-8af2d19f7e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8f82049b-0e2b-4010-ba90-8af2d19f7e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_47ae4b5a-4c6b-4126-9693-aa79bb34ba52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f82049b-0e2b-4010-ba90-8af2d19f7e7f" xlink:to="loc_us-gaap_EarningsPerShareBasic_47ae4b5a-4c6b-4126-9693-aa79bb34ba52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_236e2f2a-abb6-46a0-ad94-64891c9ef792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f82049b-0e2b-4010-ba90-8af2d19f7e7f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_236e2f2a-abb6-46a0-ad94-64891c9ef792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_108190fa-bc97-4efd-ac74-62f6662f0ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_eac85cc5-261d-40ec-b12f-0c38e689d8a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_108190fa-bc97-4efd-ac74-62f6662f0ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df624c9d-e89c-4e39-9df0-115fec11e441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_108190fa-bc97-4efd-ac74-62f6662f0ba3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df624c9d-e89c-4e39-9df0-115fec11e441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5115f04d-18be-4b36-95ac-04d29f542250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_108190fa-bc97-4efd-ac74-62f6662f0ba3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5115f04d-18be-4b36-95ac-04d29f542250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d957f904-ec96-4593-8bdc-755032fd3b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_62064fa0-d387-4a45-8921-ad705aa468f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d957f904-ec96-4593-8bdc-755032fd3b77" xlink:to="loc_us-gaap_ProfitLoss_62064fa0-d387-4a45-8921-ad705aa468f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_30f86a0e-683a-4a77-86ff-cb42c0917efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d957f904-ec96-4593-8bdc-755032fd3b77" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_30f86a0e-683a-4a77-86ff-cb42c0917efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_390628a8-e1e9-4164-a638-31f0f6334602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_30f86a0e-683a-4a77-86ff-cb42c0917efb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_390628a8-e1e9-4164-a638-31f0f6334602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_4187f398-76b9-4af7-9b72-628234d6aa2e" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_30f86a0e-683a-4a77-86ff-cb42c0917efb" xlink:to="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_4187f398-76b9-4af7-9b72-628234d6aa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4dfce6dc-329a-4adc-b02d-0179135c92dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_30f86a0e-683a-4a77-86ff-cb42c0917efb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4dfce6dc-329a-4adc-b02d-0179135c92dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_50f60d2b-1fe8-4412-b262-6bb2a5a3fd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_30f86a0e-683a-4a77-86ff-cb42c0917efb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_50f60d2b-1fe8-4412-b262-6bb2a5a3fd8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9ee5f5e9-5708-4261-9e79-2b95473e7a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_30f86a0e-683a-4a77-86ff-cb42c0917efb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9ee5f5e9-5708-4261-9e79-2b95473e7a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0fa0a473-a2b3-4b33-8859-268eaa8fa88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_30f86a0e-683a-4a77-86ff-cb42c0917efb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0fa0a473-a2b3-4b33-8859-268eaa8fa88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_57189d83-ff78-49f1-bfb3-26bd0fda6f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d957f904-ec96-4593-8bdc-755032fd3b77" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_57189d83-ff78-49f1-bfb3-26bd0fda6f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a4b14c31-e62f-48b8-b522-d114901f7026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d957f904-ec96-4593-8bdc-755032fd3b77" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a4b14c31-e62f-48b8-b522-d114901f7026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_401cb6ee-681f-4ff6-bb73-fb44c6fe1d90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d957f904-ec96-4593-8bdc-755032fd3b77" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_401cb6ee-681f-4ff6-bb73-fb44c6fe1d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_810205fe-8760-4783-9ef8-a389e7f2704b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2c2abe2e-c4c4-4b80-8f83-1ad833ddf740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_810205fe-8760-4783-9ef8-a389e7f2704b" xlink:to="loc_us-gaap_StatementTable_2c2abe2e-c4c4-4b80-8f83-1ad833ddf740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6f32ec7a-a797-447f-a147-fe5b711de14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2c2abe2e-c4c4-4b80-8f83-1ad833ddf740" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6f32ec7a-a797-447f-a147-fe5b711de14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f32ec7a-a797-447f-a147-fe5b711de14c" xlink:to="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b097869a-f9fe-4a26-8173-21d784a115d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_us-gaap_CommonStockMember_b097869a-f9fe-4a26-8173-21d784a115d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_01a3015c-575c-4a67-a979-14ce423ee386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_01a3015c-575c-4a67-a979-14ce423ee386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember_4dae5087-fedf-4adc-9a63-7795020e0664" xlink:href="iclr-20211231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_iclr_OtherUndenominatedCapitalMember_4dae5087-fedf-4adc-9a63-7795020e0664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_49bf75cd-57dc-43de-8c09-20dcf6eda096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_49bf75cd-57dc-43de-8c09-20dcf6eda096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9deca998-10a6-41f4-ba6e-27747d0ae691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_us-gaap_RetainedEarningsMember_9deca998-10a6-41f4-ba6e-27747d0ae691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestMember_8bfe444c-fc49-48de-b988-0ac6e4854115" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e33b2fac-61e4-4544-bac5-e31adbd2de78" xlink:to="loc_iclr_RedeemableNoncontrollingInterestMember_8bfe444c-fc49-48de-b988-0ac6e4854115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f79ddbaa-12b3-42ca-9242-11bdef2f4bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2c2abe2e-c4c4-4b80-8f83-1ad833ddf740" xlink:to="loc_us-gaap_StatementLineItems_f79ddbaa-12b3-42ca-9242-11bdef2f4bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f79ddbaa-12b3-42ca-9242-11bdef2f4bd0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_29b327d2-b5ca-4af0-8618-9f29dc3f9c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_CommonStockSharesIssued_29b327d2-b5ca-4af0-8618-9f29dc3f9c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2819df30-1484-46b4-9057-566eb39aeb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockholdersEquity_2819df30-1484-46b4-9057-566eb39aeb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_92cc3aca-b866-43f4-a6b1-8b17a59d812f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_NetIncomeLoss_92cc3aca-b866-43f4-a6b1-8b17a59d812f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6312ebfe-2c19-4227-86aa-a1dd3541be33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6312ebfe-2c19-4227-86aa-a1dd3541be33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_fcc4571c-b3fe-4868-9d30-7c91127642ca" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding_fcc4571c-b3fe-4868-9d30-7c91127642ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5297f7b6-9526-4a7c-99e5-6b08cedb7d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5297f7b6-9526-4a7c-99e5-6b08cedb7d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_41080f82-3133-4a2d-8a16-10467da1ae95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_41080f82-3133-4a2d-8a16-10467da1ae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_00c78396-3e9c-419b-9bf0-032ee557a1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_00c78396-3e9c-419b-9bf0-032ee557a1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0328e4ea-a1a5-493d-b8ea-89e23448b622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0328e4ea-a1a5-493d-b8ea-89e23448b622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_57db4089-f785-42d6-94bc-7e03543b63ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_57db4089-f785-42d6-94bc-7e03543b63ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bdd8b3c1-0739-4517-8f8c-1f14c582d7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bdd8b3c1-0739-4517-8f8c-1f14c582d7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3382e17f-be31-47a4-a8f2-6c4b7e93e80e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3382e17f-be31-47a4-a8f2-6c4b7e93e80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5435f5e4-e75a-42e0-9bd2-630d5e5c23f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5435f5e4-e75a-42e0-9bd2-630d5e5c23f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1865a520-cd3b-4f43-a64e-34b091449a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1865a520-cd3b-4f43-a64e-34b091449a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ebc8da9f-34be-458a-93a0-929cb52d1957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ebc8da9f-34be-458a-93a0-929cb52d1957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_fda2c6d3-5c1c-4029-ba54-0eb958662e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_fda2c6d3-5c1c-4029-ba54-0eb958662e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f54e9b8f-d4b9-4a14-8eeb-0b72e6015bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f54e9b8f-d4b9-4a14-8eeb-0b72e6015bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_067bdeb8-7b8f-4eff-89a1-59b030d11290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_067bdeb8-7b8f-4eff-89a1-59b030d11290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_d8b06824-baab-4779-adea-0d8e93c76256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_d8b06824-baab-4779-adea-0d8e93c76256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3a0433d4-8594-482c-a24d-017b5c1acc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3a0433d4-8594-482c-a24d-017b5c1acc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f5d5a682-cbbe-41fa-8aab-7c33faf281fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_f5d5a682-cbbe-41fa-8aab-7c33faf281fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_8072814b-4177-448e-b9ad-4a4666f36b25" xlink:href="iclr-20211231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_8072814b-4177-448e-b9ad-4a4666f36b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue_cb06e7de-4b25-4282-8350-7f22534f38dc" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue_cb06e7de-4b25-4282-8350-7f22534f38dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a22faa95-ed47-49d5-b890-94d67ad2eca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_CommonStockSharesIssued_a22faa95-ed47-49d5-b890-94d67ad2eca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fa657473-bca0-4628-9464-0159768c0330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46bedde-cb6b-468b-b863-a3dacc3bbb0a" xlink:to="loc_us-gaap_StockholdersEquity_fa657473-bca0-4628-9464-0159768c0330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f79ddbaa-12b3-42ca-9242-11bdef2f4bd0" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e9e9d100-2a47-466c-82af-7179bd54d697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e9e9d100-2a47-466c-82af-7179bd54d697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_6e4bffac-8c96-48dc-b8a9-4f75dfa70b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_6e4bffac-8c96-48dc-b8a9-4f75dfa70b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_9d086b08-dab4-472f-ba19-28034be34e93" xlink:href="iclr-20211231.xsd#iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_9d086b08-dab4-472f-ba19-28034be34e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_3e641ed9-46a0-437d-83e5-2e599d336460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_3e641ed9-46a0-437d-83e5-2e599d336460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59485455-722f-4bf6-b1c9-1ad1b467a888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_12d9d3a4-680e-482b-8e51-6f1683a0277d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_59485455-722f-4bf6-b1c9-1ad1b467a888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iclr-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9b2b1cd4-41a4-4757-a777-4a482bebeb61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_55014b21-3751-4963-8221-7e7581c8aa3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9b2b1cd4-41a4-4757-a777-4a482bebeb61" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_55014b21-3751-4963-8221-7e7581c8aa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_55869481-799e-4574-8f8e-cc7a57a5792e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_55014b21-3751-4963-8221-7e7581c8aa3b" xlink:to="loc_us-gaap_ProfitLoss_55869481-799e-4574-8f8e-cc7a57a5792e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_55014b21-3751-4963-8221-7e7581c8aa3b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_37f4c363-ff59-4eda-894d-e89c27a6f5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_37f4c363-ff59-4eda-894d-e89c27a6f5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_37a7584d-9e6d-439f-997b-64b4d10ceb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_37a7584d-9e6d-439f-997b-64b4d10ceb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_4c0b0471-a680-4601-bbfb-003234371687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_4c0b0471-a680-4601-bbfb-003234371687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_58e47239-a460-4bc4-b8d8-dddd5eb6a134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_58e47239-a460-4bc4-b8d8-dddd5eb6a134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_da591459-244a-4f83-aea5-724f783f946d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_da591459-244a-4f83-aea5-724f783f946d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9f36f904-ebf9-4662-ae00-cf82ee3ea531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9f36f904-ebf9-4662-ae00-cf82ee3ea531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bcb85d8c-e980-4d41-9329-d4c33e485aff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_ShareBasedCompensation_bcb85d8c-e980-4d41-9329-d4c33e485aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1ba2bcfe-679f-4596-a9ce-29312393b555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1ba2bcfe-679f-4596-a9ce-29312393b555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2394ac03-1557-46bd-9949-52791df2570b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2394ac03-1557-46bd-9949-52791df2570b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2f12d156-bc76-42c9-95a8-c5aab7ffdf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_23accc04-2899-44ac-9acb-1d2f80612233" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2f12d156-bc76-42c9-95a8-c5aab7ffdf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_8fe23ec6-9754-41fb-995e-1d4733a307d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_55014b21-3751-4963-8221-7e7581c8aa3b" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_8fe23ec6-9754-41fb-995e-1d4733a307d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65225c14-583a-46ac-85ad-53a41ea92c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_55014b21-3751-4963-8221-7e7581c8aa3b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65225c14-583a-46ac-85ad-53a41ea92c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ec399a61-5486-4c85-918d-68d3c474ebe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65225c14-583a-46ac-85ad-53a41ea92c86" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ec399a61-5486-4c85-918d-68d3c474ebe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_8f1427b7-e549-49ad-af8f-6411c44d5e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65225c14-583a-46ac-85ad-53a41ea92c86" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_8f1427b7-e549-49ad-af8f-6411c44d5e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e8311b48-e1b5-4fd1-b516-5fa9708b13ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65225c14-583a-46ac-85ad-53a41ea92c86" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e8311b48-e1b5-4fd1-b516-5fa9708b13ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_164fdd08-0087-4483-99af-92e4f5366f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_65225c14-583a-46ac-85ad-53a41ea92c86" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_164fdd08-0087-4483-99af-92e4f5366f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97cc8f7b-c06e-4c00-870f-ecdac8db89ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_55014b21-3751-4963-8221-7e7581c8aa3b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97cc8f7b-c06e-4c00-870f-ecdac8db89ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9b2b1cd4-41a4-4757-a777-4a482bebeb61" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9a3d76e7-3bd4-4efc-99c4-388008a63964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9a3d76e7-3bd4-4efc-99c4-388008a63964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_eb1be1e5-b15d-40b5-9714-8265a39b9b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_eb1be1e5-b15d-40b5-9714-8265a39b9b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ca788aff-772c-4a93-9ebc-84f89c7b240c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_ca788aff-772c-4a93-9ebc-84f89c7b240c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_274822d4-62c0-45a2-a45f-86d59e23c5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_274822d4-62c0-45a2-a45f-86d59e23c5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_7a385aeb-f6ce-477d-827a-94a4ab0298b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_7a385aeb-f6ce-477d-827a-94a4ab0298b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d37200d4-3d39-4585-8c09-b4ace4c5933f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d37200d4-3d39-4585-8c09-b4ace4c5933f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_c25a2899-f71c-4c7e-9c31-7b76a62cd870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_c25a2899-f71c-4c7e-9c31-7b76a62cd870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b7a1fdb-933c-4151-91b1-ae9596fee9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c60480d-cf54-4465-862e-2227490aebe0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b7a1fdb-933c-4151-91b1-ae9596fee9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9b2b1cd4-41a4-4757-a777-4a482bebeb61" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_cb218f87-5946-40b0-8f9b-1949a1de29f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_cb218f87-5946-40b0-8f9b-1949a1de29f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_631144c5-2a08-40f2-b975-e690d35bcfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_631144c5-2a08-40f2-b975-e690d35bcfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_e5c66704-f4ad-49ff-b8c1-73ef56812b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_e5c66704-f4ad-49ff-b8c1-73ef56812b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_15daff09-6eeb-46d6-a361-0aa827de1d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_15daff09-6eeb-46d6-a361-0aa827de1d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6a260e4d-d08f-4cd1-b335-1775266aeed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6a260e4d-d08f-4cd1-b335-1775266aeed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_9d29df5b-b139-4c37-a5af-1cee69c4448a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_9d29df5b-b139-4c37-a5af-1cee69c4448a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_97d44341-5703-4acf-97f2-49be6c57b8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_97d44341-5703-4acf-97f2-49be6c57b8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts_b062ee3f-68ed-43a9-aec5-b0a2e02bb2cb" xlink:href="iclr-20211231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_iclr_PaymentsForShareRepurchaseCosts_b062ee3f-68ed-43a9-aec5-b0a2e02bb2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_072b89d8-8194-41b7-9cb0-73dc14dc1dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_072b89d8-8194-41b7-9cb0-73dc14dc1dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e8740af-79d8-4371-b205-03b1388b80d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b21566c2-3a56-432c-9617-bc84c6716a75" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e8740af-79d8-4371-b205-03b1388b80d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0f0a8723-1955-4083-a620-fe66cb24ed30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9b2b1cd4-41a4-4757-a777-4a482bebeb61" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0f0a8723-1955-4083-a620-fe66cb24ed30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf234b2e-de69-4049-a485-7123e6be828f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9b2b1cd4-41a4-4757-a777-4a482bebeb61" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf234b2e-de69-4049-a485-7123e6be828f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf234dcc-372c-4517-977c-86fbc59ac84a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9b2b1cd4-41a4-4757-a777-4a482bebeb61" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf234dcc-372c-4517-977c-86fbc59ac84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_62f4f8ed-08b4-47ff-b08c-5535295ac7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9b2b1cd4-41a4-4757-a777-4a482bebeb61" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_62f4f8ed-08b4-47ff-b08c-5535295ac7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Descriptionofbusiness" xlink:type="simple" xlink:href="iclr-20211231.xsd#Descriptionofbusiness"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Descriptionofbusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f313b140-5bf0-4fc2-b431-27115b7b4ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_229d3e46-ea38-451c-808f-f082c2964662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f313b140-5bf0-4fc2-b431-27115b7b4ddf" xlink:to="loc_us-gaap_NatureOfOperations_229d3e46-ea38-451c-808f-f082c2964662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#DescriptionofbusinessDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ac6b330a-60ed-4357-97e1-98d4d443837b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ac6b330a-60ed-4357-97e1-98d4d443837b" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d03beb71-b824-4a83-94a8-0ea13339a078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d03beb71-b824-4a83-94a8-0ea13339a078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ce1ee798-ad31-4f40-a2b1-68a0f8507f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d03beb71-b824-4a83-94a8-0ea13339a078" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ce1ee798-ad31-4f40-a2b1-68a0f8507f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_0915046e-2926-4e09-8988-36a1b8d5b280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ce1ee798-ad31-4f40-a2b1-68a0f8507f38" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_0915046e-2926-4e09-8988-36a1b8d5b280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_52393636-0ec2-4eea-8e29-5d88da662fae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:to="loc_srt_StatementGeographicalAxis_52393636-0ec2-4eea-8e29-5d88da662fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_52393636-0ec2-4eea-8e29-5d88da662fae" xlink:to="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6c50a238-95fb-4c9e-9acc-acd1810c51c9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:to="loc_country_US_6c50a238-95fb-4c9e-9acc-acd1810c51c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_fd9bdffc-bb15-4b2f-80c5-c47c298662b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:to="loc_srt_EuropeMember_fd9bdffc-bb15-4b2f-80c5-c47c298662b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember_402a4331-0e80-4db0-8737-bcee8b15cc9c" xlink:href="iclr-20211231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6fc9b19d-7696-4d9a-8c7c-6e4b5757ac25" xlink:to="loc_iclr_OtherGeographicLocationsMember_402a4331-0e80-4db0-8737-bcee8b15cc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_57cc8711-852f-408a-9b85-6e7f3d9ae96b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_57cc8711-852f-408a-9b85-6e7f3d9ae96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11e4f82f-2c0f-4c7a-9706-77ade7e790d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_57cc8711-852f-408a-9b85-6e7f3d9ae96b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11e4f82f-2c0f-4c7a-9706-77ade7e790d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_a9a5e3dd-27b3-4248-bf25-3c36cf49a364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_11e4f82f-2c0f-4c7a-9706-77ade7e790d3" xlink:to="loc_us-gaap_SalesRevenueNetMember_a9a5e3dd-27b3-4248-bf25-3c36cf49a364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_da7da903-6ab0-4192-906f-7810f1b8c64d" xlink:to="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_d8e855b5-8bfb-4522-b932-a991b8ae0efd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_dei_EntityNumberOfEmployees_d8e855b5-8bfb-4522-b932-a991b8ae0efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations_24c22435-d4c3-46e9-a115-6be175a9a785" xlink:href="iclr-20211231.xsd#iclr_NumberOfLocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_iclr_NumberOfLocations_24c22435-d4c3-46e9-a115-6be175a9a785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_5651df06-05c7-48c3-b353-6bc61a8925d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_5651df06-05c7-48c3-b353-6bc61a8925d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_cc067ae3-4d4b-411b-bed0-053d9b91d87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f7c3d103-1302-481f-9d74-7124dd6d9761" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_cc067ae3-4d4b-411b-bed0-053d9b91d87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Significantaccountingpolicies" xlink:type="simple" xlink:href="iclr-20211231.xsd#Significantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Significantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aea38de6-14aa-48dd-9752-22539d473318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_343fb42a-7fea-422c-b9be-4460d3447e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aea38de6-14aa-48dd-9752-22539d473318" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_343fb42a-7fea-422c-b9be-4460d3447e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="iclr-20211231.xsd#SignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_fd121908-18e5-4e27-bee5-586b8877cca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_fd121908-18e5-4e27-bee5-586b8877cca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c9d8c2ad-90d1-4c6b-9d74-9dc1def19699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_UseOfEstimates_c9d8c2ad-90d1-4c6b-9d74-9dc1def19699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_443c4f32-f734-45f6-9914-fe57c4f00d11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_443c4f32-f734-45f6-9914-fe57c4f00d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_4bbfd5b5-99b7-422c-af53-27a47199b9db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_4bbfd5b5-99b7-422c-af53-27a47199b9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_17185862-74cf-4b88-aef2-20c30d6a4366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_17185862-74cf-4b88-aef2-20c30d6a4366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_00dd2db3-9698-4361-855f-93666bbcc873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_00dd2db3-9698-4361-855f-93666bbcc873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4b3a0808-53eb-4180-8ca8-f70369e5c2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_4b3a0808-53eb-4180-8ca8-f70369e5c2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_4f7691a5-ece4-4414-a5d5-141218f5d49b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_4f7691a5-ece4-4414-a5d5-141218f5d49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_74cb7ee8-a0eb-4144-a9ba-d907301ba48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_74cb7ee8-a0eb-4144-a9ba-d907301ba48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_66b669cd-22da-4e3f-a39b-de6a2eaa0e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_66b669cd-22da-4e3f-a39b-de6a2eaa0e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f791ecbc-7ea4-4eb6-84e7-e8f2f4bfa502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f791ecbc-7ea4-4eb6-84e7-e8f2f4bfa502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_a394c476-d51d-488d-8071-4615ca618643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_a394c476-d51d-488d-8071-4615ca618643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_8555249f-fee1-4be5-a30d-1eb165eefc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_8555249f-fee1-4be5-a30d-1eb165eefc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_554849ce-c9e2-4ba4-bec8-e3cedf0aa402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_554849ce-c9e2-4ba4-bec8-e3cedf0aa402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_78c063c1-24db-4728-be14-76cc34d57f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_78c063c1-24db-4728-be14-76cc34d57f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_fb26d06a-8dac-4572-ba4d-a32e2b0ef70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_fb26d06a-8dac-4572-ba4d-a32e2b0ef70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_69c29fe6-4f86-4ea0-b895-1b3ba271dfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_69c29fe6-4f86-4ea0-b895-1b3ba271dfe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentGrantsPolicyTextBlock_1e2e0841-70f1-490c-aa0d-10120c94fcaa" xlink:href="iclr-20211231.xsd#iclr_GovernmentGrantsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_iclr_GovernmentGrantsPolicyTextBlock_1e2e0841-70f1-490c-aa0d-10120c94fcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_3055614c-afbd-4abc-bfe4-b481a0926313" xlink:href="iclr-20211231.xsd#iclr_ResearchandDevelopmentCreditsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_3055614c-afbd-4abc-bfe4-b481a0926313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_ed026b13-3171-46a9-96cb-80284249e2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_ed026b13-3171-46a9-96cb-80284249e2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_c64d4f14-b19f-4dce-8706-03964933ec4b" xlink:href="iclr-20211231.xsd#iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_c64d4f14-b19f-4dce-8706-03964933ec4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_07021294-668b-4fd6-8caa-9f1ca0685310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_07021294-668b-4fd6-8caa-9f1ca0685310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f9b48c65-25a4-4eb3-8b01-fd1f7f564821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f9b48c65-25a4-4eb3-8b01-fd1f7f564821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_4a6870db-3379-4c8c-b72e-215f6d9c9e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_4a6870db-3379-4c8c-b72e-215f6d9c9e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_519665b4-c1ee-40fe-a0bc-0ce341e323dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_519665b4-c1ee-40fe-a0bc-0ce341e323dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_66744506-6fe3-42e5-bccb-5d28aff17666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_DebtPolicyTextBlock_66744506-6fe3-42e5-bccb-5d28aff17666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_e60ab4a0-a5d3-4754-a766-a6e6b4b17b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_e60ab4a0-a5d3-4754-a766-a6e6b4b17b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_456e6777-5e90-4821-beed-b66e44acdaec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_456e6777-5e90-4821-beed-b66e44acdaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_8142b2f5-1bca-4247-bc8c-e0835a817424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2e5608ab-f337-4848-9b54-ce6a467d3d3c" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_8142b2f5-1bca-4247-bc8c-e0835a817424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#SignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6b2fd4d4-633c-49f9-b5f3-6c081546f73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ForeignCurrencyDisclosureTableTextBlock_56200fe3-ca8f-442a-b949-0e7e7df3d0e3" xlink:href="iclr-20211231.xsd#iclr_ForeignCurrencyDisclosureTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6b2fd4d4-633c-49f9-b5f3-6c081546f73c" xlink:to="loc_iclr_ForeignCurrencyDisclosureTableTextBlock_56200fe3-ca8f-442a-b949-0e7e7df3d0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_4d801345-85f6-44ef-b35f-4a5b093db9e6" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6b2fd4d4-633c-49f9-b5f3-6c081546f73c" xlink:to="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_4d801345-85f6-44ef-b35f-4a5b093db9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#SignificantaccountingpoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bb139ef3-cbf1-4a90-8ed4-c93ef671e65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8dcf05b0-418d-4544-bdde-5597ba59e6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bb139ef3-cbf1-4a90-8ed4-c93ef671e65d" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8dcf05b0-418d-4544-bdde-5597ba59e6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fdeae475-c88f-4fb1-aecb-91006e92dedf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8dcf05b0-418d-4544-bdde-5597ba59e6aa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fdeae475-c88f-4fb1-aecb-91006e92dedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff4faece-4b56-4ab8-9385-0b3a3a181efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fdeae475-c88f-4fb1-aecb-91006e92dedf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff4faece-4b56-4ab8-9385-0b3a3a181efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MeDiNovaResearchMember_240e3140-e910-49cc-8011-0486ad16fc61" xlink:href="iclr-20211231.xsd#iclr_MeDiNovaResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ff4faece-4b56-4ab8-9385-0b3a3a181efd" xlink:to="loc_iclr_MeDiNovaResearchMember_240e3140-e910-49cc-8011-0486ad16fc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8dcf05b0-418d-4544-bdde-5597ba59e6aa" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_6b9ae45c-d0af-4ba3-bd97-47f672119af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_6b9ae45c-d0af-4ba3-bd97-47f672119af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_57257a8b-6c24-4475-8d97-aff76cd41f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:to="loc_us-gaap_InventoryNet_57257a8b-6c24-4475-8d97-aff76cd41f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_bee5a7e1-2cea-40c4-b8a6-fafdbf946c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ca21f24a-24fa-4cc7-84bb-2d34621db7a6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_bee5a7e1-2cea-40c4-b8a6-fafdbf946c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_92e00de2-79a8-4c21-9d23-17a456e142b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract_2dd0e189-56df-47a1-8672-ddabd63c72ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92e00de2-79a8-4c21-9d23-17a456e142b8" xlink:to="loc_us-gaap_ForeignCurrencyAbstract_2dd0e189-56df-47a1-8672-ddabd63c72ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_b072cd68-219c-4a2f-a64d-1f2ab94c4210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyAbstract_2dd0e189-56df-47a1-8672-ddabd63c72ab" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_b072cd68-219c-4a2f-a64d-1f2ab94c4210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ecb38493-2bd7-4ea3-a58d-2ffdeed06a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7fdbf209-e357-4edd-9074-f0245eb4bf62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ecb38493-2bd7-4ea3-a58d-2ffdeed06a05" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7fdbf209-e357-4edd-9074-f0245eb4bf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7fdbf209-e357-4edd-9074-f0245eb4bf62" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9fbc0b82-509f-4d93-99d3-ee2b8e4b0b3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_6b9e9a05-8ac6-4ee4-9ac1-9a515598489e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_us-gaap_BuildingMember_6b9e9a05-8ac6-4ee4-9ac1-9a515598489e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_c637b1cd-13f7-4714-9470-ba7f6272e259" xlink:href="iclr-20211231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_c637b1cd-13f7-4714-9470-ba7f6272e259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ed18a8e4-b1b5-4129-bf9a-51c51c8a3b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ed18a8e4-b1b5-4129-bf9a-51c51c8a3b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_c1f5a205-2ae6-4bbd-94d5-9164c8def31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_us-gaap_EquipmentMember_c1f5a205-2ae6-4bbd-94d5-9164c8def31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_355c099b-d14d-48cb-9004-c5a2cf684c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_78d0953e-6b73-44f4-9c73-e4a42ccdd4af" xlink:to="loc_us-gaap_VehiclesMember_355c099b-d14d-48cb-9004-c5a2cf684c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:to="loc_srt_RangeAxis_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_659f98ed-0e6c-4174-ac57-7ac3d97e22e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_06b87f5a-fe0b-477f-811d-0ea9cd6e4df2" xlink:to="loc_srt_RangeMember_659f98ed-0e6c-4174-ac57-7ac3d97e22e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6bd0d12d-0171-4b33-af77-2b635770e059" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_659f98ed-0e6c-4174-ac57-7ac3d97e22e7" xlink:to="loc_srt_MinimumMember_6bd0d12d-0171-4b33-af77-2b635770e059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4d86dc80-7376-454e-bfdc-da329e634c3b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_659f98ed-0e6c-4174-ac57-7ac3d97e22e7" xlink:to="loc_srt_MaximumMember_4d86dc80-7376-454e-bfdc-da329e634c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ec85b32-2272-4b0c-be09-12d8134247be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6654ede-7728-4042-ae83-7ebe237771b5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ec85b32-2272-4b0c-be09-12d8134247be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f3959b1b-99be-42d9-9348-b9221ed616b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1ec85b32-2272-4b0c-be09-12d8134247be" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f3959b1b-99be-42d9-9348-b9221ed616b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Investments" xlink:type="simple" xlink:href="iclr-20211231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b3f6fdf9-df4e-4b56-bc47-a9ecf344686d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_b1bec24b-c6cc-48d1-875f-cae147feead5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b3f6fdf9-df4e-4b56-bc47-a9ecf344686d" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_b1bec24b-c6cc-48d1-875f-cae147feead5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d59c66fd-a86b-4f7c-95aa-bcd3e6a83457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_a9abb3bb-b28a-4610-8d08-a0cbaf424a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d59c66fd-a86b-4f7c-95aa-bcd3e6a83457" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_a9abb3bb-b28a-4610-8d08-a0cbaf424a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_acacfbc3-04c6-468c-a169-fbf470e4fae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d59c66fd-a86b-4f7c-95aa-bcd3e6a83457" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_acacfbc3-04c6-468c-a169-fbf470e4fae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_f62d0e74-eb26-4bc4-a3fe-81575b05d789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d59c66fd-a86b-4f7c-95aa-bcd3e6a83457" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_f62d0e74-eb26-4bc4-a3fe-81575b05d789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#InvestmentsAvailableForSaleInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_32b4d61c-010b-489e-83f5-4d5154f0d67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_4a6c29ab-83c9-46ea-9b61-56f7b15ac7d8" xlink:href="iclr-20211231.xsd#iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_32b4d61c-010b-489e-83f5-4d5154f0d67c" xlink:to="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_4a6c29ab-83c9-46ea-9b61-56f7b15ac7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_74355292-bc41-4ad3-a122-1854b0e6a28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_4a6c29ab-83c9-46ea-9b61-56f7b15ac7d8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_74355292-bc41-4ad3-a122-1854b0e6a28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8c2705f2-ea9e-4de0-b08e-d82ce45d09b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_4a6c29ab-83c9-46ea-9b61-56f7b15ac7d8" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8c2705f2-ea9e-4de0-b08e-d82ce45d09b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3eb8e23e-7c47-4905-8a9b-6c7d6189dbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_4a6c29ab-83c9-46ea-9b61-56f7b15ac7d8" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3eb8e23e-7c47-4905-8a9b-6c7d6189dbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_68eadbf7-add4-4d70-9f28-c0e9667056e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_4a6c29ab-83c9-46ea-9b61-56f7b15ac7d8" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_68eadbf7-add4-4d70-9f28-c0e9667056e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4c4c4bdd-c3c4-419f-b446-0fcd4949762f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_4a6c29ab-83c9-46ea-9b61-56f7b15ac7d8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4c4c4bdd-c3c4-419f-b446-0fcd4949762f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a931be4f-16c1-4e93-828b-66491fd22120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward_4a6c29ab-83c9-46ea-9b61-56f7b15ac7d8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a931be4f-16c1-4e93-828b-66491fd22120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d296b0bc-8519-4800-aeec-5d8b0a1ca63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bbe38a6d-8eaa-4dcc-8d93-b0747cc61ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d296b0bc-8519-4800-aeec-5d8b0a1ca63b" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bbe38a6d-8eaa-4dcc-8d93-b0747cc61ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bbe38a6d-8eaa-4dcc-8d93-b0747cc61ff7" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d6c76a7d-ba19-47d5-836e-4cdf2f7fab54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1fb4f11e-6b61-4adc-ac13-df79a9e56ae2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d6c76a7d-ba19-47d5-836e-4cdf2f7fab54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_906c6cb7-955f-4432-bea5-7a1a73a6a91f" xlink:href="iclr-20211231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d6c76a7d-ba19-47d5-836e-4cdf2f7fab54" xlink:to="loc_iclr_OncacareMember_906c6cb7-955f-4432-bea5-7a1a73a6a91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bbe38a6d-8eaa-4dcc-8d93-b0747cc61ff7" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_01b679a8-7da6-49e5-8157-5a790efb7590" xlink:href="iclr-20211231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_01b679a8-7da6-49e5-8157-5a790efb7590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_ac075432-8d27-4cd3-89d8-4243931632f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_ac075432-8d27-4cd3-89d8-4243931632f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_034777a2-3ec5-4bde-83e5-cf9bbc259c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_034777a2-3ec5-4bde-83e5-cf9bbc259c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3b8cfc64-d8fe-4721-9972-b878877c2c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3b8cfc64-d8fe-4721-9972-b878877c2c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments_a8f2d5b0-9a10-41c8-b4b5-ce26d367ba60" xlink:href="iclr-20211231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_iclr_CommitmentToAcquireLongTermInvestments_a8f2d5b0-9a10-41c8-b4b5-ce26d367ba60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_db4e696a-780b-46c8-ae76-e5ef9f171da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_EquityMethodInvestments_db4e696a-780b-46c8-ae76-e5ef9f171da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0a29ce61-0a69-4723-966a-fa038ac8f298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0a29ce61-0a69-4723-966a-fa038ac8f298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_8467eafb-dd69-4cab-8b92-a22967cdb0f6" xlink:href="iclr-20211231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_8467eafb-dd69-4cab-8b92-a22967cdb0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b8047077-a3f0-44d8-b131-213bc92245ea" xlink:href="iclr-20211231.xsd#iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b8047077-a3f0-44d8-b131-213bc92245ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dedc6167-1bef-4c6c-b204-77aced67afb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dedc6167-1bef-4c6c-b204-77aced67afb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_996e4835-5646-4811-ad96-c4bf5352a18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_996e4835-5646-4811-ad96-c4bf5352a18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_3fc8afc0-ed63-49ec-a51e-03af3a9f7778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4594f19e-5e77-4b7a-a12d-8ea7bc0c7b99" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_3fc8afc0-ed63-49ec-a51e-03af3a9f7778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ab6c0b4d-1157-47b2-b3de-21f822e38997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_494f6a7a-9143-4b62-93b1-908fe0cb34b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ab6c0b4d-1157-47b2-b3de-21f822e38997" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_494f6a7a-9143-4b62-93b1-908fe0cb34b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c2563fae-2d70-46f0-b31e-a8408b068296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_494f6a7a-9143-4b62-93b1-908fe0cb34b5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c2563fae-2d70-46f0-b31e-a8408b068296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0b6a8e0-e044-48e1-b869-d3a87b27b365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c2563fae-2d70-46f0-b31e-a8408b068296" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0b6a8e0-e044-48e1-b869-d3a87b27b365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermDepositsMember_4b4d98a1-a87f-4a3f-a8ee-788d0e4df7e6" xlink:href="iclr-20211231.xsd#iclr_TermDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b0b6a8e0-e044-48e1-b869-d3a87b27b365" xlink:to="loc_iclr_TermDepositsMember_4b4d98a1-a87f-4a3f-a8ee-788d0e4df7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_494f6a7a-9143-4b62-93b1-908fe0cb34b5" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2a67b614-a681-4864-825e-6637fe1048dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2a67b614-a681-4864-825e-6637fe1048dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_72e96850-35c1-4f8a-b969-0cd90438ce20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_72e96850-35c1-4f8a-b969-0cd90438ce20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_69675350-f537-4b28-9099-b8395fe0e761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_69675350-f537-4b28-9099-b8395fe0e761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_086c14ab-9020-4cb1-8f0f-acdf2d0f45d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_95e96b20-37dd-4883-9dfe-62386f8780dc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_086c14ab-9020-4cb1-8f0f-acdf2d0f45d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#InvestmentsEquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a7380f95-8ec8-4d7d-a2ca-d2a0f7a89982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5f9bfc34-9240-42be-a796-4d614f90cb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a7380f95-8ec8-4d7d-a2ca-d2a0f7a89982" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5f9bfc34-9240-42be-a796-4d614f90cb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d83cbd3c-2df6-4886-976b-509fd7275eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a7380f95-8ec8-4d7d-a2ca-d2a0f7a89982" xlink:to="loc_us-gaap_EquityMethodInvestments_d83cbd3c-2df6-4886-976b-509fd7275eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Goodwill" xlink:type="simple" xlink:href="iclr-20211231.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe9fc885-dedd-42e2-b757-62165557c690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_ce42be64-7014-438a-ace2-ae4b0b280688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe9fc885-dedd-42e2-b757-62165557c690" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_ce42be64-7014-438a-ace2-ae4b0b280688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_30b97e43-4fb6-4325-b0ad-784c3ba10d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_7d177e4c-4313-4b1c-b85d-cd5f945afed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_30b97e43-4fb6-4325-b0ad-784c3ba10d0b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_7d177e4c-4313-4b1c-b85d-cd5f945afed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#GoodwillScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ae925c1c-b9b9-4ffa-9442-866e08812c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_1a8aba3c-6cb0-47ce-9f08-ec8ce302043d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ae925c1c-b9b9-4ffa-9442-866e08812c6c" xlink:to="loc_us-gaap_GoodwillRollForward_1a8aba3c-6cb0-47ce-9f08-ec8ce302043d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aa2a50c6-a06e-4cec-9031-bcc31fc06d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1a8aba3c-6cb0-47ce-9f08-ec8ce302043d" xlink:to="loc_us-gaap_Goodwill_aa2a50c6-a06e-4cec-9031-bcc31fc06d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0a9e4728-56c2-47d5-9e96-550e3e059c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1a8aba3c-6cb0-47ce-9f08-ec8ce302043d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0a9e4728-56c2-47d5-9e96-550e3e059c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d3c4d1d2-9517-4c50-92c5-d021ce545606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1a8aba3c-6cb0-47ce-9f08-ec8ce302043d" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d3c4d1d2-9517-4c50-92c5-d021ce545606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9d485915-6f76-429b-a73e-e2a4b85e99a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1a8aba3c-6cb0-47ce-9f08-ec8ce302043d" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9d485915-6f76-429b-a73e-e2a4b85e99a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dbc70c8a-5686-45d3-b3c8-ffc332462783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1a8aba3c-6cb0-47ce-9f08-ec8ce302043d" xlink:to="loc_us-gaap_Goodwill_dbc70c8a-5686-45d3-b3c8-ffc332462783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssets" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c8c96f5-7242-4f93-9e6a-bf6808810de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_cc84363c-3723-497b-a48e-f52cc6b8c226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1c8c96f5-7242-4f93-9e6a-bf6808810de0" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_cc84363c-3723-497b-a48e-f52cc6b8c226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2f0ee150-0634-491c-ae87-7bf30733e069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_29adf194-1e4c-4cd9-aeb8-a3fe57750c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2f0ee150-0634-491c-ae87-7bf30733e069" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_29adf194-1e4c-4cd9-aeb8-a3fe57750c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5cfe12d2-b13e-441c-82b9-2a680e77eee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2f0ee150-0634-491c-ae87-7bf30733e069" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5cfe12d2-b13e-441c-82b9-2a680e77eee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8f0aea74-ac64-4b71-8b03-7119347001b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_711c3279-5675-4178-ad6f-7e83d327cda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8f0aea74-ac64-4b71-8b03-7119347001b0" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_711c3279-5675-4178-ad6f-7e83d327cda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bf6c0a83-093e-403c-a8a7-50fc97c19180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_711c3279-5675-4178-ad6f-7e83d327cda5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bf6c0a83-093e-403c-a8a7-50fc97c19180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bf6c0a83-093e-403c-a8a7-50fc97c19180" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_556923be-c532-4898-886b-1de4eff5533d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_CustomerRelationshipsMember_556923be-c532-4898-886b-1de4eff5533d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_21fed44e-475a-4050-b60b-2cf989d5a0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_21fed44e-475a-4050-b60b-2cf989d5a0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ad0bc0cc-5e68-4cbe-851c-b855ca59a07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_TradeNamesMember_ad0bc0cc-5e68-4cbe-851c-b855ca59a07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_cc882de7-884a-4949-a610-10b38a822dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_DatabasesMember_cc882de7-884a-4949-a610-10b38a822dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f45681bb-4b54-4a5a-9da4-737dd2985c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ac2195b8-0f21-4af5-9516-ba995878c846" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f45681bb-4b54-4a5a-9da4-737dd2985c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_711c3279-5675-4178-ad6f-7e83d327cda5" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_78d67eaf-e3e0-4fbf-9573-3fb744f1b282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_78d67eaf-e3e0-4fbf-9573-3fb744f1b282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_de86b3bc-d7f0-4189-9d31-ba1de1f3fa46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_de86b3bc-d7f0-4189-9d31-ba1de1f3fa46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ea9a5f61-766a-4823-9578-023117b5a8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_28fba519-0e52-4207-81ec-6c6d27b72a2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ea9a5f61-766a-4823-9578-023117b5a8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8c4be0a0-5bd0-48ef-aad3-ecdbc5ed6ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8c4be0a0-5bd0-48ef-aad3-ecdbc5ed6ce6" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e19d31fc-1a6c-4870-9e65-44d22cbc292d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e19d31fc-1a6c-4870-9e65-44d22cbc292d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53203016-8fa6-4e7a-a869-53ab7ea41d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e19d31fc-1a6c-4870-9e65-44d22cbc292d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53203016-8fa6-4e7a-a869-53ab7ea41d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_8096ff42-62af-4241-8c1e-1b60d64f2b55" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53203016-8fa6-4e7a-a869-53ab7ea41d95" xlink:to="loc_iclr_PRAHealthSciencesIncMember_8096ff42-62af-4241-8c1e-1b60d64f2b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember_411b0520-221b-4e80-a640-bae00badfd58" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53203016-8fa6-4e7a-a869-53ab7ea41d95" xlink:to="loc_iclr_MedpassGroupLimitedMember_411b0520-221b-4e80-a640-bae00badfd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ea78864-b6fc-4bbe-ae95-50b2ce830afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ea78864-b6fc-4bbe-ae95-50b2ce830afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ea78864-b6fc-4bbe-ae95-50b2ce830afa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2d7fc7bc-0651-414c-9fff-d9a26b9cb408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2d7fc7bc-0651-414c-9fff-d9a26b9cb408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_998ab98f-5739-4ec7-b07b-1d7d68b1f94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_998ab98f-5739-4ec7-b07b-1d7d68b1f94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a465a660-15fa-4ad3-b3d2-95bb26fd7074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_TradeNamesMember_a465a660-15fa-4ad3-b3d2-95bb26fd7074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_97706b51-dae7-4ccf-ac8d-10b6f469a4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_DatabasesMember_97706b51-dae7-4ccf-ac8d-10b6f469a4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_640e4b1a-a251-43a4-b1bf-252cba02f7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a2b54d45-b4bc-41e1-938f-bca1d821df0c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_640e4b1a-a251-43a4-b1bf-252cba02f7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_08db1676-e831-4679-b9f5-de44f79d3a9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:to="loc_srt_RangeAxis_08db1676-e831-4679-b9f5-de44f79d3a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_098a27f3-701a-4f9a-9f05-925efd6ed0d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_08db1676-e831-4679-b9f5-de44f79d3a9d" xlink:to="loc_srt_RangeMember_098a27f3-701a-4f9a-9f05-925efd6ed0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_73a59527-43c1-47d6-8764-8297e6f711ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_098a27f3-701a-4f9a-9f05-925efd6ed0d7" xlink:to="loc_srt_MinimumMember_73a59527-43c1-47d6-8764-8297e6f711ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_32d2d5ca-c2da-4863-8434-52bfccb6909d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_098a27f3-701a-4f9a-9f05-925efd6ed0d7" xlink:to="loc_srt_MaximumMember_32d2d5ca-c2da-4863-8434-52bfccb6909d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_9df358c7-07b0-4595-b9eb-3bb3dd44a77c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ef20c3d8-acf4-4991-b628-388c8265d7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ef20c3d8-acf4-4991-b628-388c8265d7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6ca34707-7a7b-4a8e-a4c7-e7198c4e71ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6ca34707-7a7b-4a8e-a4c7-e7198c4e71ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9a709bac-da1b-4c58-8138-ab4166509070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9a709bac-da1b-4c58-8138-ab4166509070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_64cc3df3-611f-4a58-a216-5371bdedd782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ddc74b5-2a96-420d-a661-f65bffcf9335" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_64cc3df3-611f-4a58-a216-5371bdedd782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba60f558-80cc-4b92-9986-063986adfc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8b2e4b87-3855-4b22-b491-1a180dcc0abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba60f558-80cc-4b92-9986-063986adfc43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8b2e4b87-3855-4b22-b491-1a180dcc0abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_aa9b5818-d396-4baf-b1c2-f1110fe50320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba60f558-80cc-4b92-9986-063986adfc43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_aa9b5818-d396-4baf-b1c2-f1110fe50320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4c0a377c-8333-4d03-a5ea-f59c6ab5e466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba60f558-80cc-4b92-9986-063986adfc43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4c0a377c-8333-4d03-a5ea-f59c6ab5e466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dadd150a-eb19-4d5b-96f4-1bb6c6f17e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba60f558-80cc-4b92-9986-063986adfc43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dadd150a-eb19-4d5b-96f4-1bb6c6f17e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9957216f-df8a-42e8-83ac-f2b691eedb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba60f558-80cc-4b92-9986-063986adfc43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9957216f-df8a-42e8-83ac-f2b691eedb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9b30ade5-ca2a-49df-a9ef-1e178f8857a9" xlink:href="iclr-20211231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba60f558-80cc-4b92-9986-063986adfc43" xlink:to="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9b30ade5-ca2a-49df-a9ef-1e178f8857a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Businesscombinations" xlink:type="simple" xlink:href="iclr-20211231.xsd#Businesscombinations"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Businesscombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e4dd2b0f-1878-4553-ba1e-a2aed011a439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_d418af16-550c-49a1-ad09-6a065bb2dc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e4dd2b0f-1878-4553-ba1e-a2aed011a439" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_d418af16-550c-49a1-ad09-6a065bb2dc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_299f1ecc-7654-4f37-b4ca-a146daef0452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3320292e-b860-49d9-99e9-ff897d4eb66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_299f1ecc-7654-4f37-b4ca-a146daef0452" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3320292e-b860-49d9-99e9-ff897d4eb66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_cbf34cd6-0049-462b-b20f-00ed9dbd3199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_299f1ecc-7654-4f37-b4ca-a146daef0452" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_cbf34cd6-0049-462b-b20f-00ed9dbd3199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_6fb0c193-12b7-4143-acb9-aa2b21769780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_299f1ecc-7654-4f37-b4ca-a146daef0452" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_6fb0c193-12b7-4143-acb9-aa2b21769780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9c425fce-8ba7-4fd3-912a-d34864bf2bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_299f1ecc-7654-4f37-b4ca-a146daef0452" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_9c425fce-8ba7-4fd3-912a-d34864bf2bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsNarrativePRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9dabe67f-2cbf-42e6-a336-d83557c6bd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_908c1006-f6ef-4a28-903d-dc45dc7726dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9dabe67f-2cbf-42e6-a336-d83557c6bd7c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_908c1006-f6ef-4a28-903d-dc45dc7726dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0f0cfa75-23b6-4846-a842-e1809e3da56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_908c1006-f6ef-4a28-903d-dc45dc7726dd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0f0cfa75-23b6-4846-a842-e1809e3da56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4afdf00-0551-4c89-9607-f8b3cb50c187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f0cfa75-23b6-4846-a842-e1809e3da56c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4afdf00-0551-4c89-9607-f8b3cb50c187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_cddaa2a8-3563-49a8-a269-708eb99b0493" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4afdf00-0551-4c89-9607-f8b3cb50c187" xlink:to="loc_iclr_PRAHealthSciencesIncMember_cddaa2a8-3563-49a8-a269-708eb99b0493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_908c1006-f6ef-4a28-903d-dc45dc7726dd" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_228e3629-0fc2-46f1-837d-4be5ec260179" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_dei_EntityNumberOfEmployees_228e3629-0fc2-46f1-837d-4be5ec260179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_67dd07aa-59cf-4121-ae7e-338a2bcfe2a3" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_67dd07aa-59cf-4121-ae7e-338a2bcfe2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_5ee1702e-64f2-4fe4-b215-d9572f44a952" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_5ee1702e-64f2-4fe4-b215-d9572f44a952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fe40abe2-4cca-45ba-b45f-ef996dc1584c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fe40abe2-4cca-45ba-b45f-ef996dc1584c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_29cd9144-6905-4da0-8f4f-1d02d25665db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_29cd9144-6905-4da0-8f4f-1d02d25665db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9c27ef57-a58d-4070-a12d-f7893525f7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_InterestExpense_9c27ef57-a58d-4070-a12d-f7893525f7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_accf99b4-6c52-4697-be68-32b5ca86b486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_accf99b4-6c52-4697-be68-32b5ca86b486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_5b7af423-f0c3-49d2-8832-b589e1588265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_5b7af423-f0c3-49d2-8832-b589e1588265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual_a909130f-62fc-4bb9-9ecf-c53505a1db4c" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual_a909130f-62fc-4bb9-9ecf-c53505a1db4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_2bc53d40-832b-414b-bb40-f7f1f79d3b79" xlink:href="iclr-20211231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_13a4a12e-7791-45b6-a73f-130536550a97" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_2bc53d40-832b-414b-bb40-f7f1f79d3b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7553e539-5eef-4487-be6a-7327096a085b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93c62576-1a0b-445f-b64a-3a7c49916bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7553e539-5eef-4487-be6a-7327096a085b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93c62576-1a0b-445f-b64a-3a7c49916bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_be0cd952-cfb6-4a4c-9fd5-74d5935d637f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93c62576-1a0b-445f-b64a-3a7c49916bb2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_be0cd952-cfb6-4a4c-9fd5-74d5935d637f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fb3c026-a30b-44ab-bd58-5c20a2def684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_be0cd952-cfb6-4a4c-9fd5-74d5935d637f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fb3c026-a30b-44ab-bd58-5c20a2def684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_25518024-4f60-4f09-84b5-bc8cb509b48c" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fb3c026-a30b-44ab-bd58-5c20a2def684" xlink:to="loc_iclr_PRAHealthSciencesIncMember_25518024-4f60-4f09-84b5-bc8cb509b48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93c62576-1a0b-445f-b64a-3a7c49916bb2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9eac9072-29a0-45a4-aad8-61c58e80138d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9eac9072-29a0-45a4-aad8-61c58e80138d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_acdcfa18-3998-4fa3-be68-9373dc5b7388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_acdcfa18-3998-4fa3-be68-9373dc5b7388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_afd93d58-9c32-4f84-a9f4-bc98a2e52906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_afd93d58-9c32-4f84-a9f4-bc98a2e52906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_01b39f0d-6204-4d4a-83a4-b470a50eb1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_01b39f0d-6204-4d4a-83a4-b470a50eb1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3d6a16ce-867d-42ae-b263-571c65a6dc89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3d6a16ce-867d-42ae-b263-571c65a6dc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_f34575c0-9ecf-4c4b-8e31-3fb40aa0f91c" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_198f527d-52b2-4abe-8575-68bf23f46c9d" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_f34575c0-9ecf-4c4b-8e31-3fb40aa0f91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a67b0dd4-ffae-49e5-a817-013be15c79ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_88631924-f421-4a49-9712-6e8a7c438c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a67b0dd4-ffae-49e5-a817-013be15c79ed" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_88631924-f421-4a49-9712-6e8a7c438c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2262b55c-c76b-4471-8884-47c91b0725c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_88631924-f421-4a49-9712-6e8a7c438c08" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2262b55c-c76b-4471-8884-47c91b0725c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4601519-6a10-4cc9-9ccc-517c9cc24e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2262b55c-c76b-4471-8884-47c91b0725c8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4601519-6a10-4cc9-9ccc-517c9cc24e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_4bbfe7f6-ea02-4e91-9223-53bdfe7960b0" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a4601519-6a10-4cc9-9ccc-517c9cc24e7c" xlink:to="loc_iclr_PRAHealthSciencesIncMember_4bbfe7f6-ea02-4e91-9223-53bdfe7960b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_88631924-f421-4a49-9712-6e8a7c438c08" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ba16ee24-1bfe-4778-8180-6cf5f8f1d18e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ba16ee24-1bfe-4778-8180-6cf5f8f1d18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_465491fe-9aa5-4a14-be28-34aed3d81d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_465491fe-9aa5-4a14-be28-34aed3d81d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_eee07fb4-75f7-4bb9-9f4b-fddfd3c8f813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_eee07fb4-75f7-4bb9-9f4b-fddfd3c8f813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e897bdd6-5791-4359-9bb4-1192b939dac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e897bdd6-5791-4359-9bb4-1192b939dac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_ea10577b-150b-497e-8c06-868caad5d5cd" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_ea10577b-150b-497e-8c06-868caad5d5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c069c62c-6760-46d9-a992-91b98b9b2d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_Goodwill_c069c62c-6760-46d9-a992-91b98b9b2d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2e55bc01-54ac-42bc-aa63-ff0b5dcf6ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2e55bc01-54ac-42bc-aa63-ff0b5dcf6ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e41c0c5c-e973-4bc1-af2c-375af99619b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e41c0c5c-e973-4bc1-af2c-375af99619b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f40f01e2-b8f9-4da2-ab20-7787811193f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f40f01e2-b8f9-4da2-ab20-7787811193f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a5731e9b-c502-42a3-88f5-020a6bf3d180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a5731e9b-c502-42a3-88f5-020a6bf3d180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_8fd86fc7-d092-4863-adb1-d581653533a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_8fd86fc7-d092-4863-adb1-d581653533a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_8e90529b-1480-4465-884c-ef833daffb1b" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_8e90529b-1480-4465-884c-ef833daffb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_8f11d881-4aa5-4103-adba-3264e0f962c5" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_8f11d881-4aa5-4103-adba-3264e0f962c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_a14528c7-dca7-49dc-9580-0fd0280e4119" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_a14528c7-dca7-49dc-9580-0fd0280e4119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0444f6f6-19be-4699-9a9d-52636ff2afc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0444f6f6-19be-4699-9a9d-52636ff2afc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_096e183d-9c2b-4db2-921b-2a21cc79320c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_096e183d-9c2b-4db2-921b-2a21cc79320c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_bbdba907-7ce4-4621-b0be-14a28ffcd777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_bbdba907-7ce4-4621-b0be-14a28ffcd777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2bbac4e6-a041-4497-8274-d395d967f016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29862e60-7764-41d2-9d27-f392c80b9a3f" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2bbac4e6-a041-4497-8274-d395d967f016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_2bd9a407-bcaa-4c07-beb8-2fef6d0a31d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2bd9a407-bcaa-4c07-beb8-2fef6d0a31d2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bd9297a5-23a6-4859-b7b6-9634292017a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bd9297a5-23a6-4859-b7b6-9634292017a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed802be7-3b04-4df5-ae51-4aa166cd8344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd9297a5-23a6-4859-b7b6-9634292017a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed802be7-3b04-4df5-ae51-4aa166cd8344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_a2f4ad46-20b9-42d8-8306-9d0106a1561e" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed802be7-3b04-4df5-ae51-4aa166cd8344" xlink:to="loc_iclr_PRAHealthSciencesIncMember_a2f4ad46-20b9-42d8-8306-9d0106a1561e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7badaa7a-0cc2-4183-b4dd-cf1a1ab02eeb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ee7b4f7c-98ba-4e14-ba9b-64498e8aa77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ee7b4f7c-98ba-4e14-ba9b-64498e8aa77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_3fb6af56-4436-4708-a735-ea0a2596c580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_3fb6af56-4436-4708-a735-ea0a2596c580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_92118354-468b-47d5-8c15-1a4b5e4fcb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_TradeNamesMember_92118354-468b-47d5-8c15-1a4b5e4fcb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_3e8ff900-ffaa-4b97-bbe7-07d4fd2d5320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_DatabasesMember_3e8ff900-ffaa-4b97-bbe7-07d4fd2d5320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_9141322c-f935-4990-8558-ad4fce7c5fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_318aa6f2-ad04-4b91-be55-ad74d61a0679" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_9141322c-f935-4990-8558-ad4fce7c5fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d36b3910-bb01-4e1c-b8d3-dae45f31d099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a7544d6b-3735-40c3-a8a1-c9e62fc90906" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d36b3910-bb01-4e1c-b8d3-dae45f31d099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_41cf105a-a7a8-4613-bb29-39b33c469f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d36b3910-bb01-4e1c-b8d3-dae45f31d099" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_41cf105a-a7a8-4613-bb29-39b33c469f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0be27567-7640-4cba-af51-9faeb6241817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d36b3910-bb01-4e1c-b8d3-dae45f31d099" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0be27567-7640-4cba-af51-9faeb6241817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7e23991f-508d-4751-8c04-649b85c5641c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb506d8b-cc56-4019-a32b-49dcab1db96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7e23991f-508d-4751-8c04-649b85c5641c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb506d8b-cc56-4019-a32b-49dcab1db96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb506d8b-cc56-4019-a32b-49dcab1db96e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a882123-b3b2-45b2-9cf6-2995e465e50d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1b986eb-08a1-41ef-aa0e-72fc7d7cb100" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a882123-b3b2-45b2-9cf6-2995e465e50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_3f38cd46-5f2e-4342-80c7-9a3a76c75a2a" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6a882123-b3b2-45b2-9cf6-2995e465e50d" xlink:to="loc_iclr_PRAHealthSciencesIncMember_3f38cd46-5f2e-4342-80c7-9a3a76c75a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_80c18041-4905-4784-870b-44b713e61395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cb506d8b-cc56-4019-a32b-49dcab1db96e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_80c18041-4905-4784-870b-44b713e61395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_b78f9343-fa3a-46c8-a0ff-fa5742fa4aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_80c18041-4905-4784-870b-44b713e61395" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_b78f9343-fa3a-46c8-a0ff-fa5742fa4aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f7b58412-f4c1-427b-a096-ed258455711c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_80c18041-4905-4784-870b-44b713e61395" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_f7b58412-f4c1-427b-a096-ed258455711c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a20b6c16-87ee-455b-a6f2-48d60fd48451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c97d96de-b45b-464e-ad4b-e02ba2fc4203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a20b6c16-87ee-455b-a6f2-48d60fd48451" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c97d96de-b45b-464e-ad4b-e02ba2fc4203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_547151cf-60a2-462d-b4d9-716a7d025dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c97d96de-b45b-464e-ad4b-e02ba2fc4203" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_547151cf-60a2-462d-b4d9-716a7d025dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ae8991b-4acf-45bd-8c7e-1d11406706ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_547151cf-60a2-462d-b4d9-716a7d025dd0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ae8991b-4acf-45bd-8c7e-1d11406706ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember_cf959184-276e-41a8-af9d-bc66cba9ec1a" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ae8991b-4acf-45bd-8c7e-1d11406706ae" xlink:to="loc_iclr_MedpassGroupLimitedMember_cf959184-276e-41a8-af9d-bc66cba9ec1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c97d96de-b45b-464e-ad4b-e02ba2fc4203" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_268e4aaf-1f62-42a5-9e3c-3aa37cc531cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_268e4aaf-1f62-42a5-9e3c-3aa37cc531cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables_2319eca6-5756-4c41-b192-796f25437652" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables_2319eca6-5756-4c41-b192-796f25437652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue_698e41d5-f597-44da-ab87-63e9875bb073" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue_698e41d5-f597-44da-ab87-63e9875bb073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets_af7bf7aa-095f-4271-988a-499d603f1a06" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets_af7bf7aa-095f-4271-988a-499d603f1a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4028c884-fc8b-4c79-b63f-06c5da7cdd8f" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_4028c884-fc8b-4c79-b63f-06c5da7cdd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities_dec487e3-4284-416d-b27c-b1eeddbd37b1" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities_dec487e3-4284-416d-b27c-b1eeddbd37b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities_24514bdb-d030-4a7d-9ef6-0d84d84e43bf" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities_24514bdb-d030-4a7d-9ef6-0d84d84e43bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability_3b7175c0-4387-4d65-91a2-9c0aa20d1ffb" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability_3b7175c0-4387-4d65-91a2-9c0aa20d1ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_d0d2d47a-1682-4105-8628-3f466a0b90a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_d0d2d47a-1682-4105-8628-3f466a0b90a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_10303fb6-0b8e-433c-8130-73abdc981081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9a75dfa0-91f9-40de-9a4c-4b1b566b1e12" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_10303fb6-0b8e-433c-8130-73abdc981081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_bf0c956d-6d74-40b7-9eff-ee2d63847252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bf0c956d-6d74-40b7-9eff-ee2d63847252" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_14d8e4ee-5f19-4710-a7aa-34e8839afae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_14d8e4ee-5f19-4710-a7aa-34e8839afae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efdc8568-79c8-40a7-aef6-93f20d04409b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_14d8e4ee-5f19-4710-a7aa-34e8839afae7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efdc8568-79c8-40a7-aef6-93f20d04409b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember_8dd3680d-0cc8-45e5-838a-e11c602b9094" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efdc8568-79c8-40a7-aef6-93f20d04409b" xlink:to="loc_iclr_MedpassGroupLimitedMember_8dd3680d-0cc8-45e5-838a-e11c602b9094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b556b770-9336-4600-9180-77c117924a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b556b770-9336-4600-9180-77c117924a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38588fd8-821a-4ac0-853b-43236425c77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b556b770-9336-4600-9180-77c117924a7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38588fd8-821a-4ac0-853b-43236425c77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_83703873-071e-4fb2-92dc-07827a4ecb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38588fd8-821a-4ac0-853b-43236425c77b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_83703873-071e-4fb2-92dc-07827a4ecb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_2f609f2f-0041-4fc9-884a-ab0b6bdff850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38588fd8-821a-4ac0-853b-43236425c77b" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_2f609f2f-0041-4fc9-884a-ab0b6bdff850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2d857a5e-1732-4b94-92ff-73291d260a2f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b502e4d9-3069-4fde-84e7-7f7f46e9a5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b502e4d9-3069-4fde-84e7-7f7f46e9a5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_61b46693-e1d9-43d8-8345-55d9816c113b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_61b46693-e1d9-43d8-8345-55d9816c113b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_66737245-9870-483a-9f0d-fd438eec2a50" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_66737245-9870-483a-9f0d-fd438eec2a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d849c45e-032c-4e8b-8a97-64671b30e3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_Goodwill_d849c45e-032c-4e8b-8a97-64671b30e3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1a676dae-4579-480c-ad98-5f236df2dc96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1a676dae-4579-480c-ad98-5f236df2dc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e703a54d-b644-485a-a42b-cca601a066ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e703a54d-b644-485a-a42b-cca601a066ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_329c77e2-e6b1-4640-8b0b-bdcbbaeb764a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_329c77e2-e6b1-4640-8b0b-bdcbbaeb764a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_71e64a53-070f-46c8-a89a-bb8e44e0a55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_71e64a53-070f-46c8-a89a-bb8e44e0a55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_ccb72c73-fc73-4863-be93-3240825824b9" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_ccb72c73-fc73-4863-be93-3240825824b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_b370e26d-be19-4258-a361-4419140d6eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_b370e26d-be19-4258-a361-4419140d6eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_26b77698-362c-4e55-be2d-c2b1216a1d16" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_26b77698-362c-4e55-be2d-c2b1216a1d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_7229512b-73b6-48c3-9d32-dca0aafe54d3" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_7229512b-73b6-48c3-9d32-dca0aafe54d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4e8c59a5-579d-4be9-b35c-37b8e3a614ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4e8c59a5-579d-4be9-b35c-37b8e3a614ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9641a136-0c6c-4f83-9530-fe9044c290de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9641a136-0c6c-4f83-9530-fe9044c290de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_60e1234f-5102-47f6-97df-e91b931223bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_60e1234f-5102-47f6-97df-e91b931223bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments_8964f283-eb3b-4c0d-a10a-421ce0a617f7" xlink:href="iclr-20211231.xsd#iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments_8964f283-eb3b-4c0d-a10a-421ce0a617f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_87e9e5ba-c4d6-4344-9b16-526f9f80f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_87e9e5ba-c4d6-4344-9b16-526f9f80f4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_06b98fce-77f6-4b06-844b-55791c2dd113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_06b98fce-77f6-4b06-844b-55791c2dd113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_109709b2-c49d-4a69-affd-79c00ba3d496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_109709b2-c49d-4a69-affd-79c00ba3d496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_c5905b95-b0f3-4f73-825f-c2d723d8d6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b21f6406-a990-4982-9ca2-a2b1ddddf123" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_c5905b95-b0f3-4f73-825f-c2d723d8d6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_acdede92-c966-474e-9eee-1e82334844ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_563cde77-1309-48db-b81e-23e2deef8b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_acdede92-c966-474e-9eee-1e82334844ad" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_563cde77-1309-48db-b81e-23e2deef8b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_867d3d3c-026c-4eea-a334-e16f8670e884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_563cde77-1309-48db-b81e-23e2deef8b93" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_867d3d3c-026c-4eea-a334-e16f8670e884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c60def2b-2cbc-4526-af76-e9916b2b5724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_867d3d3c-026c-4eea-a334-e16f8670e884" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c60def2b-2cbc-4526-af76-e9916b2b5724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MedpassGroupLimitedMember_a0a1c7d7-7940-48e1-9542-29c0a16d2461" xlink:href="iclr-20211231.xsd#iclr_MedpassGroupLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c60def2b-2cbc-4526-af76-e9916b2b5724" xlink:to="loc_iclr_MedpassGroupLimitedMember_a0a1c7d7-7940-48e1-9542-29c0a16d2461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b3c4eb45-87a4-4513-ba41-bd9266a08049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_563cde77-1309-48db-b81e-23e2deef8b93" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b3c4eb45-87a4-4513-ba41-bd9266a08049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_bb9ca3a2-157d-48d2-849a-c0ad9c517595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3c4eb45-87a4-4513-ba41-bd9266a08049" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_bb9ca3a2-157d-48d2-849a-c0ad9c517595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_56855dd8-fe6d-4da4-ac64-eb9c05f3d494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b3c4eb45-87a4-4513-ba41-bd9266a08049" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_56855dd8-fe6d-4da4-ac64-eb9c05f3d494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnet" xlink:type="simple" xlink:href="iclr-20211231.xsd#PropertyPlantandEquipmentnet"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_28f0c67b-acb8-4465-829c-a3f9ea029af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c6ec96f9-bcbf-424e-a2cb-4508f805362d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_28f0c67b-acb8-4465-829c-a3f9ea029af7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c6ec96f9-bcbf-424e-a2cb-4508f805362d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#PropertyPlantandEquipmentnetTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_577d6cd3-348c-4800-ae09-f475e0134d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fe37c331-8d33-457d-ad8c-447d0e0864e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_577d6cd3-348c-4800-ae09-f475e0134d99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fe37c331-8d33-457d-ad8c-447d0e0864e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#PropertyPlantandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_1d506fc5-c230-484c-88c3-6c94e1948c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_Land_1d506fc5-c230-484c-88c3-6c94e1948c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_fd096e80-ed26-4f45-a1b8-9e87775adfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_fd096e80-ed26-4f45-a1b8-9e87775adfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_ab577de9-947e-43a8-9e15-d02175ef82e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_ab577de9-947e-43a8-9e15-d02175ef82e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_0339ae58-5f6c-469d-9520-511f319484d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_0339ae58-5f6c-469d-9520-511f319484d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_f90efccb-d0a9-4751-afa5-b35d6f01990b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_f90efccb-d0a9-4751-afa5-b35d6f01990b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_ff40eb8f-c7f1-4f89-92fc-1a857b513be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_ff40eb8f-c7f1-4f89-92fc-1a857b513be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross_af7b6135-d1cf-489a-b64e-bac89a282006" xlink:href="iclr-20211231.xsd#iclr_VehiclesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_iclr_VehiclesGross_af7b6135-d1cf-489a-b64e-bac89a282006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f38544bc-c1bf-4bbc-a742-3be3b3e716cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f38544bc-c1bf-4bbc-a742-3be3b3e716cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7be5a232-34f4-4aff-89be-68581573d48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7be5a232-34f4-4aff-89be-68581573d48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6bc99e7f-36ca-4a8a-a151-385179f95c97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cdfac926-81ff-4a27-8f1f-8a32f804e200" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6bc99e7f-36ca-4a8a-a151-385179f95c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilities" xlink:type="simple" xlink:href="iclr-20211231.xsd#OtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd55fdd5-1743-4db5-982c-922373d02e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_ec337b9c-3380-4f22-8d25-7a60fcf0e467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_dd55fdd5-1743-4db5-982c-922373d02e3d" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_ec337b9c-3380-4f22-8d25-7a60fcf0e467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#OtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_18dd53d0-ce8f-4314-8145-3c3b5bef49fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_fa992de9-3018-4b36-b5c8-7838891b32c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_18dd53d0-ce8f-4314-8145-3c3b5bef49fd" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_fa992de9-3018-4b36-b5c8-7838891b32c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#OtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_b8b4ca6e-b06d-423f-acbf-e120b7a71879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_b8b4ca6e-b06d-423f-acbf-e120b7a71879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9d41d0c9-b844-435c-aec0-39b4a85b29b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9d41d0c9-b844-435c-aec0-39b4a85b29b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8680feef-3728-4a53-9a26-22f85bd0dea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8680feef-3728-4a53-9a26-22f85bd0dea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_3f1b0804-9509-4cc2-be74-369cba60c09b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_3f1b0804-9509-4cc2-be74-369cba60c09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_22e6935b-6090-4c69-bcee-9e77f5ecb37e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_22e6935b-6090-4c69-bcee-9e77f5ecb37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_c94bb073-83c4-4c81-9c21-5e21d5625d07" xlink:href="iclr-20211231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_c94bb073-83c4-4c81-9c21-5e21d5625d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent_1e5a15d0-7f73-43be-9ded-1949084c61ad" xlink:href="iclr-20211231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_iclr_CapitalGovernmentGrantsCurrent_1e5a15d0-7f73-43be-9ded-1949084c61ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d0c32c24-12b1-43f2-86a7-bacc5edda813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d0c32c24-12b1-43f2-86a7-bacc5edda813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_d90fbefc-2b5f-4801-ab78-75ce76ac1a1f" xlink:href="iclr-20211231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_72a9ec8b-4e86-4ff0-b138-038cc33944ca" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_d90fbefc-2b5f-4801-ab78-75ce76ac1a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NonCurrentOtherLiabilities" xlink:type="simple" xlink:href="iclr-20211231.xsd#NonCurrentOtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NonCurrentOtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_098e6a18-c6a9-4fdd-8dc4-fbad0396279d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_db1ab1a6-4f8f-4905-86f3-29cdd1abc26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_098e6a18-c6a9-4fdd-8dc4-fbad0396279d" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_db1ab1a6-4f8f-4905-86f3-29cdd1abc26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NonCurrentOtherLiabilitiesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#NonCurrentOtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NonCurrentOtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_3a22672b-a7f3-430d-b714-b1e2bd97f8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_a0505e16-2196-4eab-a9de-02c7d168867d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_3a22672b-a7f3-430d-b714-b1e2bd97f8f9" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_a0505e16-2196-4eab-a9de-02c7d168867d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NonCurrentOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_f76a1135-24d9-426b-835a-8b1b53f253c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_4241c437-8f9d-4dce-a94c-dfd0dddd9553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f76a1135-24d9-426b-835a-8b1b53f253c1" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_4241c437-8f9d-4dce-a94c-dfd0dddd9553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_abf85667-a0f8-4b0c-86ea-282e2ff71a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f76a1135-24d9-426b-835a-8b1b53f253c1" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_abf85667-a0f8-4b0c-86ea-282e2ff71a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7e6b61dd-4aaf-499a-9dfd-9f0a9ac6526e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f76a1135-24d9-426b-835a-8b1b53f253c1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7e6b61dd-4aaf-499a-9dfd-9f0a9ac6526e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefits"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_617dd6fa-2b85-4624-9230-8e5f37e79ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_17d88fe7-e2fb-4fe1-b707-3cd956991a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_617dd6fa-2b85-4624-9230-8e5f37e79ede" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_17d88fe7-e2fb-4fe1-b707-3cd956991a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_d5ae9eb7-09f4-4dda-be34-21ca143ca803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:to="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_d5ae9eb7-09f4-4dda-be34-21ca143ca803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_3e62e41c-4a1f-449f-aac8-880054275fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_3e62e41c-4a1f-449f-aac8-880054275fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b30689fd-624b-41bd-a13d-c968c56c62a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b30689fd-624b-41bd-a13d-c968c56c62a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_38a9cd84-e07e-480a-9243-c0e54365bddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_38a9cd84-e07e-480a-9243-c0e54365bddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock_01c35b95-6997-49bf-9aed-9ce72d9f83b1" xlink:href="iclr-20211231.xsd#iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:to="loc_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock_01c35b95-6997-49bf-9aed-9ce72d9f83b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_349439b3-e7af-4a97-9898-4926ceacdcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:to="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_349439b3-e7af-4a97-9898-4926ceacdcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_005d00b8-8e0f-4d56-8441-c41803a21695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_005d00b8-8e0f-4d56-8441-c41803a21695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_b82b3ec6-4ab7-4a13-a99a-2541ae423bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7a0bf5d0-33f2-415e-9e93-d8b0da631c40" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_b82b3ec6-4ab7-4a13-a99a-2541ae423bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a174751c-9547-4bda-9622-12ab105853f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a174751c-9547-4bda-9622-12ab105853f0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_583aac41-a86c-4bc5-aad9-d6477587a4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_583aac41-a86c-4bc5-aad9-d6477587a4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca999cdd-674b-45fe-aca6-f8837b61cdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_583aac41-a86c-4bc5-aad9-d6477587a4a8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca999cdd-674b-45fe-aca6-f8837b61cdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca999cdd-674b-45fe-aca6-f8837b61cdb2" xlink:to="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_62c74ec6-2d87-4edc-ad84-49e2caca3044" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:to="loc_country_US_62c74ec6-2d87-4edc-ad84-49e2caca3044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_4a0aac0f-6942-48a1-8b69-3eee9a90b170" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:to="loc_country_GB_4a0aac0f-6942-48a1-8b69-3eee9a90b170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_5e965077-26ee-4937-adb5-d83557da30a9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_b35ef169-b571-4537-8131-7a6817cc0bca" xlink:to="loc_country_CH_5e965077-26ee-4937-adb5-d83557da30a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_a35e880e-79ee-4896-9536-15eb89701fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_RetirementPlanNameAxis_a35e880e-79ee-4896-9536-15eb89701fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_a35e880e-79ee-4896-9536-15eb89701fb7" xlink:to="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember_80bfb5e9-cb9e-4ca5-ae50-44f6016bfe22" xlink:href="iclr-20211231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:to="loc_iclr_OtherRetirementPlansMember_80bfb5e9-cb9e-4ca5-ae50-44f6016bfe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_492e3a11-168a-486c-a57e-01791d310860" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_492e3a11-168a-486c-a57e-01791d310860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_b0443d92-775e-45b0-b2f5-1e944140b93a" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_1a60c155-b944-4433-b29f-f5153b157492" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_b0443d92-775e-45b0-b2f5-1e944140b93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9646777e-7fe8-46fd-87dc-03ea45f81121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9646777e-7fe8-46fd-87dc-03ea45f81121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_9646777e-7fe8-46fd-87dc-03ea45f81121" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_4a4ccbb8-6489-4460-8d50-0e723b11a70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:to="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_4a4ccbb8-6489-4460-8d50-0e723b11a70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d3b4473c-6210-498e-a997-0114afea2821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d3b4473c-6210-498e-a997-0114afea2821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_HighYieldBondsMember_72e1a7c5-a27e-405b-bbbd-3839b65d8e77" xlink:href="iclr-20211231.xsd#iclr_HighYieldBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:to="loc_iclr_HighYieldBondsMember_72e1a7c5-a27e-405b-bbbd-3839b65d8e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e6bc20c9-de53-4e85-b28d-464d389976bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d04bef1d-0cd6-4685-88e1-c737de8ebb39" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e6bc20c9-de53-4e85-b28d-464d389976bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5fc51a97-dfdc-4435-8810-f40dd97d2f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5fc51a97-dfdc-4435-8810-f40dd97d2f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_999297f0-bffa-40c1-a124-64060401de83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5fc51a97-dfdc-4435-8810-f40dd97d2f05" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_999297f0-bffa-40c1-a124-64060401de83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember_dc41908d-314d-45fa-9b3c-2b9419aa4e92" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_999297f0-bffa-40c1-a124-64060401de83" xlink:to="loc_iclr_AptivSolutionsMember_dc41908d-314d-45fa-9b3c-2b9419aa4e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d9f7d6a7-fe3f-42d6-9c2f-297e00c62d3c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9a3c7a25-7e47-4bd9-85b9-876c316040a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_9a3c7a25-7e47-4bd9-85b9-876c316040a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_db40baf6-bf17-4795-9a4d-57142bd0dbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_db40baf6-bf17-4795-9a4d-57142bd0dbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_52ed2698-3f5a-4de6-94e0-4fb32ed210b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_52ed2698-3f5a-4de6-94e0-4fb32ed210b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_fc525cf0-b1a7-41d2-8172-8f16cd840069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_fc525cf0-b1a7-41d2-8172-8f16cd840069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_26c99a65-3e47-411a-89ef-b473e544af6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_26c99a65-3e47-411a-89ef-b473e544af6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_2fbb0e3f-88b2-4604-ac79-0bc429d7a3bb" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_2fbb0e3f-88b2-4604-ac79-0bc429d7a3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_62b24467-e5b1-4ef1-afa2-85bc93771093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_62b24467-e5b1-4ef1-afa2-85bc93771093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_089d2543-d286-4701-8152-02a5fe677c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_089d2543-d286-4701-8152-02a5fe677c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4e31ef75-f7e7-4b59-877f-952ad6c5728c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4e31ef75-f7e7-4b59-877f-952ad6c5728c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod_5eb1d401-03e7-4d32-a1a1-bb8ffeba8048" xlink:href="iclr-20211231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_iclr_ExpectedRetirementPeriod_5eb1d401-03e7-4d32-a1a1-bb8ffeba8048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_e0ffe56c-c92d-47a5-96b4-5c253462d7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b40e5333-c02f-41f5-8b6e-90f3d13e5a04" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_e0ffe56c-c92d-47a5-96b4-5c253462d7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_964c5e15-25fd-4cca-8aa8-f0d333f824ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_964c5e15-25fd-4cca-8aa8-f0d333f824ad" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_cdb64ddd-8abe-4b0f-905f-4a14b9747e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_cdb64ddd-8abe-4b0f-905f-4a14b9747e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce5b5fda-3109-4f65-a765-e9b5a0bbf79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_cdb64ddd-8abe-4b0f-905f-4a14b9747e50" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce5b5fda-3109-4f65-a765-e9b5a0bbf79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5f0aeb54-8dc4-4117-a7a1-ec84b35284eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_ce5b5fda-3109-4f65-a765-e9b5a0bbf79d" xlink:to="loc_us-gaap_ForeignPlanMember_5f0aeb54-8dc4-4117-a7a1-ec84b35284eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_19ca4e47-724c-4535-a514-99dae3605db3" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5f0aeb54-8dc4-4117-a7a1-ec84b35284eb" xlink:to="loc_country_GB_19ca4e47-724c-4535-a514-99dae3605db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_914862d9-a098-4584-953e-6ff0ef0b0c91" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5f0aeb54-8dc4-4117-a7a1-ec84b35284eb" xlink:to="loc_country_CH_914862d9-a098-4584-953e-6ff0ef0b0c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_581abc8f-c259-415e-8a47-4102d6cbc896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:to="loc_us-gaap_RetirementPlanNameAxis_581abc8f-c259-415e-8a47-4102d6cbc896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_581abc8f-c259-415e-8a47-4102d6cbc896" xlink:to="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_5ecf7122-4eaa-44c3-8896-ca435fa3d6da" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_5ecf7122-4eaa-44c3-8896-ca435fa3d6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_446709f4-c382-4138-ad42-46058ff6b22c" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_446709f4-c382-4138-ad42-46058ff6b22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_d973f14a-6cb2-4fce-a67d-f168c428b5a2" xlink:href="iclr-20211231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_3ac2ee7f-108e-4f80-b925-c676767852fd" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_d973f14a-6cb2-4fce-a67d-f168c428b5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36df239c-a1cb-4b57-a4c3-96402ab57db7" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_09910e38-d795-4308-bbee-8423cca0a90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_09910e38-d795-4308-bbee-8423cca0a90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_80eaffcb-854e-403a-a157-dcd1f8a3ffd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_80eaffcb-854e-403a-a157-dcd1f8a3ffd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8502cd13-5d44-4647-9bf0-117767d3de30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8502cd13-5d44-4647-9bf0-117767d3de30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_048dad94-b83f-4c6d-9fcc-c69e828b234b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_15374cc2-0416-48d3-8e80-3074c631ea8e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_048dad94-b83f-4c6d-9fcc-c69e828b234b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsChangeinBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6052ee3b-3358-46ba-af73-73601f0c1254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6052ee3b-3358-46ba-af73-73601f0c1254" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_4cb3d3a8-7810-4beb-ac61-756b3c0fce13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_4cb3d3a8-7810-4beb-ac61-756b3c0fce13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a7ee8ab-aba5-4929-ae01-274ee208f8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_4cb3d3a8-7810-4beb-ac61-756b3c0fce13" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a7ee8ab-aba5-4929-ae01-274ee208f8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_efaad376-7f65-474c-84fb-5a8c7e737ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_5a7ee8ab-aba5-4929-ae01-274ee208f8f2" xlink:to="loc_us-gaap_ForeignPlanMember_efaad376-7f65-474c-84fb-5a8c7e737ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_5da3c5e2-69d0-4806-b4ac-3b39affda054" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_efaad376-7f65-474c-84fb-5a8c7e737ac7" xlink:to="loc_country_GB_5da3c5e2-69d0-4806-b4ac-3b39affda054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_c7baff6d-0374-4026-8710-2a534927a6bd" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_efaad376-7f65-474c-84fb-5a8c7e737ac7" xlink:to="loc_country_CH_c7baff6d-0374-4026-8710-2a534927a6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_3ce4919c-fe1f-47c4-89f0-ab36b3f69547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:to="loc_us-gaap_RetirementPlanNameAxis_3ce4919c-fe1f-47c4-89f0-ab36b3f69547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_3ce4919c-fe1f-47c4-89f0-ab36b3f69547" xlink:to="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_6a762c7f-399c-4e1f-a811-77abb2a330e5" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_6a762c7f-399c-4e1f-a811-77abb2a330e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_5dcfef6b-9ec3-4313-89e4-660b7d30b4f6" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_5dcfef6b-9ec3-4313-89e4-660b7d30b4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_82d782b8-a769-4e4b-8e2d-5c63dd35583e" xlink:href="iclr-20211231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_8567b49e-427d-41a1-9515-ff76c2b8fb16" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_82d782b8-a769-4e4b-8e2d-5c63dd35583e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_179676b4-6fd2-47a9-a526-1763857390d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a694cf4-9b13-41e4-80a9-fecfe5116ef4" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_179676b4-6fd2-47a9-a526-1763857390d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_179676b4-6fd2-47a9-a526-1763857390d0" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0085676b-5331-41f1-be5a-d5e520b780a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0085676b-5331-41f1-be5a-d5e520b780a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_00cc7d2e-2892-4f2a-9e90-8dde8b1d1166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_00cc7d2e-2892-4f2a-9e90-8dde8b1d1166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_ad23de1d-4478-4c75-a3b7-29aef54364c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_ad23de1d-4478-4c75-a3b7-29aef54364c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_83c29e47-82a1-4ec1-ba6e-a3c93f982f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_83c29e47-82a1-4ec1-ba6e-a3c93f982f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_677ef52f-d997-4f9d-b97b-d02c57b4a0be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_677ef52f-d997-4f9d-b97b-d02c57b4a0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_255a53f2-c437-4b57-9893-ead2ad71493c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_255a53f2-c437-4b57-9893-ead2ad71493c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_51bc2370-aeb6-441c-9b95-204153d35c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_51bc2370-aeb6-441c-9b95-204153d35c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherChanges_d0e66b7f-6122-461d-86d5-9a6994a35ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanOtherChanges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherChanges_d0e66b7f-6122-461d-86d5-9a6994a35ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f0ce360a-f909-4b12-9ec3-4c2f12cf9658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f0ce360a-f909-4b12-9ec3-4c2f12cf9658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_bd79ed77-c769-4cae-be83-357b3c01f406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_bd79ed77-c769-4cae-be83-357b3c01f406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_655fa9c3-0e3f-4dfc-9025-7bb3ddbf8cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_34579916-71e2-4a99-8cdb-0d897b803474" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_655fa9c3-0e3f-4dfc-9025-7bb3ddbf8cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsChangeinPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_88dae7c3-62fb-48b2-8c54-1a66b533269d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_88dae7c3-62fb-48b2-8c54-1a66b533269d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_00f69008-4446-4a77-93f3-2e615dc597b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_00f69008-4446-4a77-93f3-2e615dc597b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c5cf67b5-2e0f-413e-99e8-7e7213d56110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_00f69008-4446-4a77-93f3-2e615dc597b4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c5cf67b5-2e0f-413e-99e8-7e7213d56110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_2a897f65-f937-48cf-b913-769718b7d124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c5cf67b5-2e0f-413e-99e8-7e7213d56110" xlink:to="loc_us-gaap_ForeignPlanMember_2a897f65-f937-48cf-b913-769718b7d124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_daf06edb-11b0-4e74-9c93-1649ab086a82" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_2a897f65-f937-48cf-b913-769718b7d124" xlink:to="loc_country_GB_daf06edb-11b0-4e74-9c93-1649ab086a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_3923cf78-c5af-4dd9-9c29-22d97696a4b9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_2a897f65-f937-48cf-b913-769718b7d124" xlink:to="loc_country_CH_3923cf78-c5af-4dd9-9c29-22d97696a4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_da9a8ade-91ff-4423-8b82-84473d3d4cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:to="loc_us-gaap_RetirementPlanNameAxis_da9a8ade-91ff-4423-8b82-84473d3d4cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_da9a8ade-91ff-4423-8b82-84473d3d4cf5" xlink:to="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_2762432e-f745-4d79-9d23-0444b2f8740c" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_2762432e-f745-4d79-9d23-0444b2f8740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_6d3b70c6-77f0-4d38-bb84-25f69b6d110d" xlink:href="iclr-20211231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_6d3b70c6-77f0-4d38-bb84-25f69b6d110d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_296327fb-fd35-497d-ae17-942ef9447ce1" xlink:href="iclr-20211231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_6a4bf314-276d-4fac-a535-95f96f055b90" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_296327fb-fd35-497d-ae17-942ef9447ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d2c13637-0970-4e6a-96c2-7fdba83bd6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_547316a2-e366-48b9-895e-11144cce00cf" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d2c13637-0970-4e6a-96c2-7fdba83bd6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d2c13637-0970-4e6a-96c2-7fdba83bd6cd" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0043d89f-0d59-4215-8214-f26b02e2b542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0043d89f-0d59-4215-8214-f26b02e2b542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e31e825c-f0f1-4016-82e8-f6519ba07258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e31e825c-f0f1-4016-82e8-f6519ba07258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_2a3c8085-87f2-4d1a-a409-a1e8e9de247e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_2a3c8085-87f2-4d1a-a409-a1e8e9de247e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_959442e2-070b-49a6-a916-e1e50186ab00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_959442e2-070b-49a6-a916-e1e50186ab00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions_01c8628b-ac8b-4870-8182-3b1ff99dbcce" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_iclr_DefinedBenefitPlanSchemeContributions_01c8628b-ac8b-4870-8182-3b1ff99dbcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_f28fb0bc-251b-4fdc-95ce-e0410970ec40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_f28fb0bc-251b-4fdc-95ce-e0410970ec40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c786b007-4da6-4bd0-bb71-c77eb01dca6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c786b007-4da6-4bd0-bb71-c77eb01dca6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_b507191a-9746-456a-8790-fa0cf20b63dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_b507191a-9746-456a-8790-fa0cf20b63dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_c207ad95-1885-486d-b896-2f5845ac631c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_c207ad95-1885-486d-b896-2f5845ac631c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_1e70f7eb-573c-49e2-a4fa-20f1265af643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_1e70f7eb-573c-49e2-a4fa-20f1265af643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cf6dd498-c459-4f77-847b-8fdbeff174fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_81c4aaad-af30-48da-a9d9-db6fb5bc4149" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cf6dd498-c459-4f77-847b-8fdbeff174fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0e663f61-b235-4672-a829-fd38f4827c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0e663f61-b235-4672-a829-fd38f4827c1e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_d1b1d3ea-31b5-4cb4-929f-6656d3404c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_d1b1d3ea-31b5-4cb4-929f-6656d3404c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_eddd0644-e849-45c5-8f3c-bd38431531d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d1b1d3ea-31b5-4cb4-929f-6656d3404c50" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_eddd0644-e849-45c5-8f3c-bd38431531d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_033d43d4-2822-45cb-b58c-a0ce57342106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_eddd0644-e849-45c5-8f3c-bd38431531d1" xlink:to="loc_us-gaap_ForeignPlanMember_033d43d4-2822-45cb-b58c-a0ce57342106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_dc46f4fb-8160-45fa-80f4-9c2a8097dfa7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_033d43d4-2822-45cb-b58c-a0ce57342106" xlink:to="loc_country_GB_dc46f4fb-8160-45fa-80f4-9c2a8097dfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_b23d9677-93d1-4a54-98a7-5c9f5966329f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_033d43d4-2822-45cb-b58c-a0ce57342106" xlink:to="loc_country_CH_b23d9677-93d1-4a54-98a7-5c9f5966329f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_5bb0d0b8-fc79-4bcf-9334-1396a34fa04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d7a615f2-d615-46d7-bd8d-d2d0c1ae6a27" xlink:to="loc_us-gaap_RetirementPlanNameDomain_5bb0d0b8-fc79-4bcf-9334-1396a34fa04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_3d370bdc-1c80-4b6a-844e-906442d5aeef" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_5bb0d0b8-fc79-4bcf-9334-1396a34fa04c" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_3d370bdc-1c80-4b6a-844e-906442d5aeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3abf14e0-c9d7-41cf-9520-0db1993d47a7" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_7419ffb4-037e-456e-acf4-ee0a421f53f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_7419ffb4-037e-456e-acf4-ee0a421f53f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a50155dc-ba6c-4f06-915b-d6965882498a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a50155dc-ba6c-4f06-915b-d6965882498a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d5d52a96-2447-4a29-9a1d-eea774d5294c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d5d52a96-2447-4a29-9a1d-eea774d5294c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d88f9185-d9c3-4777-bb2a-7b48a6816920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_d88f9185-d9c3-4777-bb2a-7b48a6816920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_26a0d526-ab22-43f3-8c75-be3126b005e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ea13de00-435d-41aa-a937-693b0729f981" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_26a0d526-ab22-43f3-8c75-be3126b005e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66ec730a-45de-44ce-a85e-630c67c7ab91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_66ec730a-45de-44ce-a85e-630c67c7ab91" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9acd140a-4768-4df8-b476-e5e1ca5c80ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9acd140a-4768-4df8-b476-e5e1ca5c80ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6cdc3625-21cc-41fc-82a6-09576cd843f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9acd140a-4768-4df8-b476-e5e1ca5c80ce" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6cdc3625-21cc-41fc-82a6-09576cd843f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b729a014-d3e8-4600-a80f-2ad49dada12c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6cdc3625-21cc-41fc-82a6-09576cd843f8" xlink:to="loc_us-gaap_ForeignPlanMember_b729a014-d3e8-4600-a80f-2ad49dada12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_ca24e4bf-207a-43f6-a4c5-f983c7eea5f7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_b729a014-d3e8-4600-a80f-2ad49dada12c" xlink:to="loc_country_GB_ca24e4bf-207a-43f6-a4c5-f983c7eea5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_4d5da15a-f98e-4f2b-a1e8-e230cc13bffc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_b729a014-d3e8-4600-a80f-2ad49dada12c" xlink:to="loc_country_CH_4d5da15a-f98e-4f2b-a1e8-e230cc13bffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:to="loc_us-gaap_RetirementPlanNameAxis_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_326e88b4-1be5-4da4-ba36-1bece4d88c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_a4c84ed2-ede8-4ff9-bf64-7d31b968afb0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_326e88b4-1be5-4da4-ba36-1bece4d88c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_44e159a7-d0e6-4b83-bda9-2803acd1dbd0" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_326e88b4-1be5-4da4-ba36-1bece4d88c69" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_44e159a7-d0e6-4b83-bda9-2803acd1dbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d6de8551-d0a2-41f5-a3c5-c4574325b4b9" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_7ce520a9-0170-41f0-afb5-73a84282c8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_7ce520a9-0170-41f0-afb5-73a84282c8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_32191da1-87f4-4722-82de-811a99349232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_32191da1-87f4-4722-82de-811a99349232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_011a71d7-4898-4a60-a8f7-b60a4d0d7d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_011a71d7-4898-4a60-a8f7-b60a4d0d7d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0b7054d5-04e8-44da-b5c7-7391593d61eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_f9359c0f-f169-404a-9650-7bf6ce884f63" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_f9359c0f-f169-404a-9650-7bf6ce884f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_32f774d1-4ad3-4335-a907-db74a0ee2110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_32f774d1-4ad3-4335-a907-db74a0ee2110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_0e9927ad-0d8a-46bf-9267-5f39b1caabef" xlink:href="iclr-20211231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_0e9927ad-0d8a-46bf-9267-5f39b1caabef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_9e5704dc-d052-41c6-a5b9-9f95a33def35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_67b96ace-e38e-4382-8972-5ad4880c1526" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_9e5704dc-d052-41c6-a5b9-9f95a33def35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5f2dc2f3-d087-4164-9d46-aca24af358f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5f2dc2f3-d087-4164-9d46-aca24af358f4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a864d36-0c1c-46c0-8d1e-15e928fe0b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_47ba6d09-3ca1-451d-aa8c-58d8b6adf3e0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a864d36-0c1c-46c0-8d1e-15e928fe0b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_e40447db-ae64-4019-8616-a1b15992da48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8a864d36-0c1c-46c0-8d1e-15e928fe0b79" xlink:to="loc_us-gaap_ForeignPlanMember_e40447db-ae64-4019-8616-a1b15992da48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_812e4724-1b06-4f26-8c52-288a13df51c4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_e40447db-ae64-4019-8616-a1b15992da48" xlink:to="loc_country_GB_812e4724-1b06-4f26-8c52-288a13df51c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_21ced01e-a2de-473e-ad21-cad3d4f5a543" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_e40447db-ae64-4019-8616-a1b15992da48" xlink:to="loc_country_CH_21ced01e-a2de-473e-ad21-cad3d4f5a543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d64fc927-cd2d-418c-b7f2-a8809e3a193a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d64fc927-cd2d-418c-b7f2-a8809e3a193a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_658526c8-7638-4850-aa74-91e64462507c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d64fc927-cd2d-418c-b7f2-a8809e3a193a" xlink:to="loc_us-gaap_RetirementPlanNameDomain_658526c8-7638-4850-aa74-91e64462507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_8b458405-8169-4a79-9125-887dc3309549" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_658526c8-7638-4850-aa74-91e64462507c" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_8b458405-8169-4a79-9125-887dc3309549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c31d486e-4423-4a9a-a087-86bc28466c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1b1f229-74ec-4656-81b7-f4e68c125fb4" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c31d486e-4423-4a9a-a087-86bc28466c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1ee32ee5-7084-4bc1-a0f1-efdbcf4613aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c31d486e-4423-4a9a-a087-86bc28466c8f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1ee32ee5-7084-4bc1-a0f1-efdbcf4613aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_07a01ed5-6c88-46f3-909d-6b1499c46a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c31d486e-4423-4a9a-a087-86bc28466c8f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_07a01ed5-6c88-46f3-909d-6b1499c46a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0788cf85-ce04-43a8-b48a-d6dc24741779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0788cf85-ce04-43a8-b48a-d6dc24741779" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_1567b934-2aaa-40aa-ae6f-7731c780bec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_1567b934-2aaa-40aa-ae6f-7731c780bec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3f060dd3-93d1-4cab-9fe7-2b14dacd0e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1567b934-2aaa-40aa-ae6f-7731c780bec8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3f060dd3-93d1-4cab-9fe7-2b14dacd0e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5db0c54d-a8e3-43a2-adbe-1e574720c3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_3f060dd3-93d1-4cab-9fe7-2b14dacd0e24" xlink:to="loc_us-gaap_ForeignPlanMember_5db0c54d-a8e3-43a2-adbe-1e574720c3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_72450bf5-9b98-4764-adeb-70e276a01471" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5db0c54d-a8e3-43a2-adbe-1e574720c3b0" xlink:to="loc_country_GB_72450bf5-9b98-4764-adeb-70e276a01471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_e13e9368-a8a3-4297-b4a3-51ddcb38f5a3" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dfffb3db-2481-4d0e-b7b6-c15c1fdc4a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dfffb3db-2481-4d0e-b7b6-c15c1fdc4a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_d236b892-43bf-4084-bcf5-5b38cee833fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_d236b892-43bf-4084-bcf5-5b38cee833fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_898796fd-6cc7-4ef0-92d7-7368b7be3533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_29323668-1e77-4631-886f-4e1992695b05" xlink:to="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_898796fd-6cc7-4ef0-92d7-7368b7be3533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_b7267244-9c0f-4d00-8afa-a530c96df2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:to="loc_us-gaap_RetirementPlanNameAxis_b7267244-9c0f-4d00-8afa-a530c96df2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_300baf8f-d96f-45c9-9fce-2658a475b870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b7267244-9c0f-4d00-8afa-a530c96df2a4" xlink:to="loc_us-gaap_RetirementPlanNameDomain_300baf8f-d96f-45c9-9fce-2658a475b870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_3b930aba-3c5b-4b99-a752-32252ab6569f" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_300baf8f-d96f-45c9-9fce-2658a475b870" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_3b930aba-3c5b-4b99-a752-32252ab6569f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_730c9868-ba7e-49ca-bcab-4b7441d234ad" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_16747a71-b976-41bd-a488-38a257439f65" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:to="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_16747a71-b976-41bd-a488-38a257439f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d42519c7-b1f0-4586-8aab-aa8dd907e0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d42519c7-b1f0-4586-8aab-aa8dd907e0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_fa281c6a-3f97-4015-9819-30a27dd5bd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_459c4258-7b8d-4302-b8bb-5e25805e7840" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_fa281c6a-3f97-4015-9819-30a27dd5bd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e3925aa6-56ca-4482-8745-549d9068b9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e3925aa6-56ca-4482-8745-549d9068b9a5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cb833189-217f-444a-9b62-27a47caa54a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cb833189-217f-444a-9b62-27a47caa54a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fcb757c-72bc-4f8a-8eb6-06638824d0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cb833189-217f-444a-9b62-27a47caa54a6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fcb757c-72bc-4f8a-8eb6-06638824d0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_eed78bab-4d0e-42e2-b906-81ae581bf5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fcb757c-72bc-4f8a-8eb6-06638824d0d7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_eed78bab-4d0e-42e2-b906-81ae581bf5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1158a486-1aa3-4a3d-b5ee-37f788dcc015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1158a486-1aa3-4a3d-b5ee-37f788dcc015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1158a486-1aa3-4a3d-b5ee-37f788dcc015" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashMember_55868277-5b96-4408-aa42-22499a641d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_us-gaap_DefinedBenefitPlanCashMember_55868277-5b96-4408-aa42-22499a641d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember_ea4b4373-03a8-48cd-a9cf-4911b5206e4c" xlink:href="iclr-20211231.xsd#iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember_ea4b4373-03a8-48cd-a9cf-4911b5206e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LAndGLifeDCActiveCorporateBondMember_6d269c32-43b1-453e-b477-cf2635873c5f" xlink:href="iclr-20211231.xsd#iclr_LAndGLifeDCActiveCorporateBondMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_LAndGLifeDCActiveCorporateBondMember_6d269c32-43b1-453e-b477-cf2635873c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StoneHarborHighYieldBondFundMember_9a6c9c1f-98fa-47d6-b344-e6f555a0042d" xlink:href="iclr-20211231.xsd#iclr_StoneHarborHighYieldBondFundMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_StoneHarborHighYieldBondFundMember_9a6c9c1f-98fa-47d6-b344-e6f555a0042d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NinetyOneGlobalTotalReturnCreditMember_ce6cf277-045d-4516-92fe-82e01c893094" xlink:href="iclr-20211231.xsd#iclr_NinetyOneGlobalTotalReturnCreditMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_NinetyOneGlobalTotalReturnCreditMember_ce6cf277-045d-4516-92fe-82e01c893094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StoneHarborMultiAssetCreditPortfolioMember_20302033-e497-486b-9d46-3603baa559bb" xlink:href="iclr-20211231.xsd#iclr_StoneHarborMultiAssetCreditPortfolioMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_StoneHarborMultiAssetCreditPortfolioMember_20302033-e497-486b-9d46-3603baa559bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BaringsEuropeanLoanFundBuyAndHoldMember_bc56848d-11fc-4076-aa38-c3e63a9d4920" xlink:href="iclr-20211231.xsd#iclr_BaringsEuropeanLoanFundBuyAndHoldMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d76ecf48-5412-4df9-b30f-ce2c8baf3466" xlink:to="loc_iclr_BaringsEuropeanLoanFundBuyAndHoldMember_bc56848d-11fc-4076-aa38-c3e63a9d4920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_645c8224-f0eb-4657-b684-d55f60bbdaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:to="loc_us-gaap_RetirementPlanNameAxis_645c8224-f0eb-4657-b684-d55f60bbdaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_e1b673ae-77a3-4f89-bea7-b2b5f2381ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_645c8224-f0eb-4657-b684-d55f60bbdaa7" xlink:to="loc_us-gaap_RetirementPlanNameDomain_e1b673ae-77a3-4f89-bea7-b2b5f2381ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_f556ec98-4277-4207-a481-5d1f8d89076c" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_e1b673ae-77a3-4f89-bea7-b2b5f2381ece" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_f556ec98-4277-4207-a481-5d1f8d89076c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5ed7aec1-cea7-4f0a-89ef-dd682b082a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6ced0559-d7a7-4e0f-9b88-9888d538563b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5ed7aec1-cea7-4f0a-89ef-dd682b082a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c83a9a10-1a68-472d-b2d9-afa245ba2b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5ed7aec1-cea7-4f0a-89ef-dd682b082a43" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c83a9a10-1a68-472d-b2d9-afa245ba2b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_7cc575a2-6331-4568-a08a-e57703e21134" xlink:href="iclr-20211231.xsd#iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5ed7aec1-cea7-4f0a-89ef-dd682b082a43" xlink:to="loc_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage_7cc575a2-6331-4568-a08a-e57703e21134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EmployeeBenefitsAnnualBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_934ecbe1-4670-48e0-851c-a0b9ef48b0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_934ecbe1-4670-48e0-851c-a0b9ef48b0d2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6dfc5a20-3248-4251-81a9-8c13718a5381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6dfc5a20-3248-4251-81a9-8c13718a5381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6e64242f-b4bc-4b58-a995-2a4c94aeddad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6dfc5a20-3248-4251-81a9-8c13718a5381" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6e64242f-b4bc-4b58-a995-2a4c94aeddad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1c3ec20f-6e9a-4eb0-941f-10d851735862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_6e64242f-b4bc-4b58-a995-2a4c94aeddad" xlink:to="loc_us-gaap_ForeignPlanMember_1c3ec20f-6e9a-4eb0-941f-10d851735862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_294cb106-718a-495f-9127-e1f919172768" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_1c3ec20f-6e9a-4eb0-941f-10d851735862" xlink:to="loc_country_GB_294cb106-718a-495f-9127-e1f919172768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_5244c4f5-285c-4aec-9d89-19f7950b8ea7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_1c3ec20f-6e9a-4eb0-941f-10d851735862" xlink:to="loc_country_CH_5244c4f5-285c-4aec-9d89-19f7950b8ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2d38e17d-5aee-424b-993e-2965eabb07fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:to="loc_us-gaap_PlanNameAxis_2d38e17d-5aee-424b-993e-2965eabb07fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9b038e41-100c-49e6-ad79-5813146b3b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2d38e17d-5aee-424b-993e-2965eabb07fd" xlink:to="loc_us-gaap_PlanNameDomain_9b038e41-100c-49e6-ad79-5813146b3b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_fc9da55b-b868-462e-9121-f53435466a00" xlink:href="iclr-20211231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9b038e41-100c-49e6-ad79-5813146b3b5d" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_fc9da55b-b868-462e-9121-f53435466a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_129ea23f-eb2a-4113-b39c-e83e17784505" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_27dc3be6-befb-4c0b-9001-28586057e027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_27dc3be6-befb-4c0b-9001-28586057e027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_58145d01-9a06-43a2-baab-b9670f65eebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_58145d01-9a06-43a2-baab-b9670f65eebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_4ba28c5b-3ac7-49dc-9ce1-8258f603a3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_4ba28c5b-3ac7-49dc-9ce1-8258f603a3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7e3dbfe1-e897-4ac1-b8f7-dbcdcc7c43b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7e3dbfe1-e897-4ac1-b8f7-dbcdcc7c43b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_aedffdc9-9156-41a8-be37-9945eb72edf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_aedffdc9-9156-41a8-be37-9945eb72edf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_ce5f5d68-bf0d-4d55-8e86-c5282a80c91f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_3dc5ef08-3010-41d5-91db-0c2eb1923fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_ce5f5d68-bf0d-4d55-8e86-c5282a80c91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationCharges"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_904bb37c-3a96-4a80-be26-2adeaa67d4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3767cf7d-c111-44d3-b52a-78de2a353e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_904bb37c-3a96-4a80-be26-2adeaa67d4e0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3767cf7d-c111-44d3-b52a-78de2a353e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57d84db2-db74-49c2-a440-a29024519f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0787de92-1a3f-46f6-8114-aba81186ed75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57d84db2-db74-49c2-a440-a29024519f29" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0787de92-1a3f-46f6-8114-aba81186ed75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_1dc0d30f-bc20-4f4a-bb3d-77731a529cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57d84db2-db74-49c2-a440-a29024519f29" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_1dc0d30f-bc20-4f4a-bb3d-77731a529cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_380c58d6-a8da-4c53-90b3-0c52f411e7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57d84db2-db74-49c2-a440-a29024519f29" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_380c58d6-a8da-4c53-90b3-0c52f411e7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_327013bb-542b-4b48-bd43-962745bb33c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57d84db2-db74-49c2-a440-a29024519f29" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_327013bb-542b-4b48-bd43-962745bb33c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_4661d625-ac62-4625-8eb7-d4756b570701" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57d84db2-db74-49c2-a440-a29024519f29" xlink:to="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_4661d625-ac62-4625-8eb7-d4756b570701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_d14eeca4-1f2d-44b2-93ad-0754fc9f6c33" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_57d84db2-db74-49c2-a440-a29024519f29" xlink:to="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_d14eeca4-1f2d-44b2-93ad-0754fc9f6c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_43c62645-c3a6-4d55-a4f5-fcdcd2573e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:href="iclr-20211231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_43c62645-c3a6-4d55-a4f5-fcdcd2573e59" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f01c7be2-2876-46cc-9270-014840934c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_us-gaap_AwardTypeAxis_f01c7be2-2876-46cc-9270-014840934c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f01c7be2-2876-46cc-9270-014840934c92" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember_d8f749e5-6fda-4d80-8f24-ee9e324d72e7" xlink:href="iclr-20211231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_ConsultantsStockPlan2008PlanMember_d8f749e5-6fda-4d80-8f24-ee9e324d72e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_335bdb48-75d6-4423-9bec-056b6be3ded9" xlink:href="iclr-20211231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_335bdb48-75d6-4423-9bec-056b6be3ded9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member_fc58bd2f-8dc5-4f6e-8cac-ae48c7429466" xlink:href="iclr-20211231.xsd#iclr_OptionPlans2008Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_OptionPlans2008Member_fc58bd2f-8dc5-4f6e-8cac-ae48c7429466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroThreePlanMember_088b0ff8-273a-4e06-a06f-7f64490c136d" xlink:href="iclr-20211231.xsd#iclr_EmployeeStockPlanTwentyZeroThreePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroThreePlanMember_088b0ff8-273a-4e06-a06f-7f64490c136d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f8f07be1-0a67-4451-97b2-bfdb9f206a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f8f07be1-0a67-4451-97b2-bfdb9f206a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_19adab04-dabf-4463-a779-3263b1660023" xlink:href="iclr-20211231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_19adab04-dabf-4463-a779-3263b1660023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_c5f204b0-c750-4139-8b4d-782665fc931f" xlink:href="iclr-20211231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_c5f204b0-c750-4139-8b4d-782665fc931f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c63fa4ee-4ce0-4c4b-8417-ff7a14fc20d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c63fa4ee-4ce0-4c4b-8417-ff7a14fc20d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_148ab804-3981-4568-9a6d-48e9b971d4c5" xlink:href="iclr-20211231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_PerformanceShareUnitMember_148ab804-3981-4568-9a6d-48e9b971d4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember_404cd73b-82a9-4b22-9ad1-19ef2a166bb9" xlink:href="iclr-20211231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7abdaaeb-6b5e-4c0e-aba0-ef67ef197556" xlink:to="loc_iclr_PerformanceBasedGrantsMember_404cd73b-82a9-4b22-9ad1-19ef2a166bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_0af9b452-27e8-408c-9dd2-560bba1edec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_us-gaap_AwardDateAxis_0af9b452-27e8-408c-9dd2-560bba1edec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_e49b8f7e-77e2-4d48-b5dc-27c7b5affb59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_0af9b452-27e8-408c-9dd2-560bba1edec4" xlink:to="loc_us-gaap_AwardDateDomain_e49b8f7e-77e2-4d48-b5dc-27c7b5affb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member_89a87de4-70da-400f-95a4-8e95f1bafefa" xlink:href="iclr-20211231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_e49b8f7e-77e2-4d48-b5dc-27c7b5affb59" xlink:to="loc_iclr_AwardDateAllYearsExcluding2018Member_89a87de4-70da-400f-95a4-8e95f1bafefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDate2018Member_93610e1c-c502-4632-ba6c-165c268a11af" xlink:href="iclr-20211231.xsd#iclr_AwardDate2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_e49b8f7e-77e2-4d48-b5dc-27c7b5affb59" xlink:to="loc_iclr_AwardDate2018Member_93610e1c-c502-4632-ba6c-165c268a11af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_dei_LegalEntityAxis_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_875c2ade-82e4-4967-98fa-8bf1d7760c27" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5dab6fbe-9c14-4c4c-8deb-6cfbb7980a0e" xlink:to="loc_dei_EntityDomain_875c2ade-82e4-4967-98fa-8bf1d7760c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_74c4e58e-fbd8-41b4-b272-a78400c89f2f" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_875c2ade-82e4-4967-98fa-8bf1d7760c27" xlink:to="loc_iclr_PRAHealthSciencesIncMember_74c4e58e-fbd8-41b4-b272-a78400c89f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_srt_RangeAxis_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_24355fd8-5afc-4201-a82b-8819144f9912" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cd81e8bb-3412-45d4-9cf2-4bfbfef446c6" xlink:to="loc_srt_RangeMember_24355fd8-5afc-4201-a82b-8819144f9912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d08b1bed-9fb3-46a4-99c5-2221d51ef7ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_24355fd8-5afc-4201-a82b-8819144f9912" xlink:to="loc_srt_MinimumMember_d08b1bed-9fb3-46a4-99c5-2221d51ef7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0e392388-c95e-4d7e-aa2a-abd01a174177" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_24355fd8-5afc-4201-a82b-8819144f9912" xlink:to="loc_srt_MaximumMember_0e392388-c95e-4d7e-aa2a-abd01a174177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_9f523bf6-87f1-4b9e-98fe-3186af5647ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_srt_TitleOfIndividualAxis_9f523bf6-87f1-4b9e-98fe-3186af5647ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f11702e9-ed03-4104-b91e-cb309bcf7a06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_9f523bf6-87f1-4b9e-98fe-3186af5647ea" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f11702e9-ed03-4104-b91e-cb309bcf7a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember_e1b9ea4a-f326-4050-ac17-866e1fee539a" xlink:href="iclr-20211231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f11702e9-ed03-4104-b91e-cb309bcf7a06" xlink:to="loc_iclr_NonexecutiveDirectorMember_e1b9ea4a-f326-4050-ac17-866e1fee539a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_us-gaap_PlanNameAxis_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2e4c2978-ccd1-490f-b6e7-0732c2b59c6e" xlink:to="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember_2ddc235a-cbd5-4ffb-9269-832895f822e1" xlink:href="iclr-20211231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:to="loc_iclr_The2020LegacyPRAPlanMember_2ddc235a-cbd5-4ffb-9269-832895f822e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember_68e01796-da98-4951-8cfb-7cc2bcd1b42b" xlink:href="iclr-20211231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:to="loc_iclr_The2018LegacyPRAPlanMember_68e01796-da98-4951-8cfb-7cc2bcd1b42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2013LegacyPRAPlanMember_6d978ce2-7ee2-4509-a70c-fc1981af6b4e" xlink:href="iclr-20211231.xsd#iclr_A2013LegacyPRAPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dea6e79d-1d76-4f3e-b240-c30befdf90e3" xlink:to="loc_iclr_A2013LegacyPRAPlanMember_6d978ce2-7ee2-4509-a70c-fc1981af6b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:href="iclr-20211231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_fa69d466-a334-4a58-83d8-c44b739572cd" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c45f8e63-68fb-4c26-b626-618d0e565785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c45f8e63-68fb-4c26-b626-618d0e565785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_cf3ce8e5-8947-4cd4-8fa9-d0875fb10b22" xlink:href="iclr-20211231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_cf3ce8e5-8947-4cd4-8fa9-d0875fb10b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1d06d554-b560-4d3d-bf4c-7a368e707569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1d06d554-b560-4d3d-bf4c-7a368e707569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5d7339a5-c2a1-4bf0-b34c-f65aa48673c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_5d7339a5-c2a1-4bf0-b34c-f65aa48673c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_cb077f20-9255-4ed8-82ac-5d161a3fa143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_cb077f20-9255-4ed8-82ac-5d161a3fa143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a2d8add-9ed7-476a-8461-904fd2deb919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a2d8add-9ed7-476a-8461-904fd2deb919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_78e06422-bb10-463a-a781-e5fb3fd24e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_78e06422-bb10-463a-a781-e5fb3fd24e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_82f68d38-cb52-4f9b-a1f5-f34317f9bfe6" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_82f68d38-cb52-4f9b-a1f5-f34317f9bfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4fa2be42-9030-4ad0-962a-b7198ac59658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4fa2be42-9030-4ad0-962a-b7198ac59658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_38d8e686-6d42-4b23-bfbd-c69fa7fff529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_38d8e686-6d42-4b23-bfbd-c69fa7fff529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_16ce410b-21d0-4edd-a007-403fa1a27f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_16ce410b-21d0-4edd-a007-403fa1a27f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7b6ce88a-e718-4376-a780-50a790a65ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7b6ce88a-e718-4376-a780-50a790a65ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_d813dbd5-9392-4572-a64e-e1c5672c7d04" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_d813dbd5-9392-4572-a64e-e1c5672c7d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5e89b440-943b-40a2-8bc8-70f1d6fd16a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5e89b440-943b-40a2-8bc8-70f1d6fd16a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a7cd7919-cd44-4986-ac4f-8fa64a2658ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_ShareBasedCompensation_a7cd7919-cd44-4986-ac4f-8fa64a2658ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_23a32870-d6a1-4b9e-89a8-65d45bf98490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_23a32870-d6a1-4b9e-89a8-65d45bf98490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d07b33e4-a13f-4685-9547-6a3c4463e1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_b2a4de1c-b202-435c-8eab-1d7bb3149260" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_d07b33e4-a13f-4685-9547-6a3c4463e1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9402af68-3c57-43e6-8ae2-87d8a5f54438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51b1abde-6b8e-40c2-914e-794d0b5b0383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9402af68-3c57-43e6-8ae2-87d8a5f54438" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51b1abde-6b8e-40c2-914e-794d0b5b0383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9306667e-5408-417f-8977-c95400f8b1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51b1abde-6b8e-40c2-914e-794d0b5b0383" xlink:to="loc_us-gaap_AwardTypeAxis_9306667e-5408-417f-8977-c95400f8b1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8bad141-bf0e-48ac-b0a3-056b95a24d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9306667e-5408-417f-8977-c95400f8b1e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8bad141-bf0e-48ac-b0a3-056b95a24d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_69387d92-8376-4e96-88b8-99a3f135a56d" xlink:href="iclr-20211231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c8bad141-bf0e-48ac-b0a3-056b95a24d74" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_69387d92-8376-4e96-88b8-99a3f135a56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51b1abde-6b8e-40c2-914e-794d0b5b0383" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_380453b1-091f-4576-8e7f-e6c635404c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_380453b1-091f-4576-8e7f-e6c635404c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_a3cb590f-b9d0-4064-992d-639b332bfdb2" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_a3cb590f-b9d0-4064-992d-639b332bfdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_cfc27302-e866-42bd-b291-156a3928ffe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_cfc27302-e866-42bd-b291-156a3928ffe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e97661c-9065-4125-ba70-4f112d7c8ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e97661c-9065-4125-ba70-4f112d7c8ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ab6c829b-90fd-472e-8a6b-696f530350b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ab6c829b-90fd-472e-8a6b-696f530350b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_de7fd376-ebb9-4830-966c-7adcb1cf5fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_89f7a83f-e92c-4910-9570-a3be76f8507b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_de7fd376-ebb9-4830-966c-7adcb1cf5fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_94c7d389-8533-44b5-83f8-859a5d0cc831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_94c7d389-8533-44b5-83f8-859a5d0cc831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79c51321-8e55-498d-8254-c6c67641e4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79c51321-8e55-498d-8254-c6c67641e4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_987d67fd-ac80-4c15-8e53-219861515453" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_987d67fd-ac80-4c15-8e53-219861515453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7772d13c-c80a-46d1-b3cb-021952e60d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7772d13c-c80a-46d1-b3cb-021952e60d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_312b7ca1-5a53-4f2c-b383-74fcee22fc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_312b7ca1-5a53-4f2c-b383-74fcee22fc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_911aa29c-5497-4aee-b4a8-19d595232c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_911aa29c-5497-4aee-b4a8-19d595232c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fb7fd09f-c4fe-41e7-9342-d29b7fe75a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_3e831bf7-3d0b-4793-9405-e453a65d51de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fb7fd09f-c4fe-41e7-9342-d29b7fe75a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_f40bc291-9733-4727-ac4b-c18606bdba0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_427aa97c-aef9-4987-9ce3-fd3e62725acd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_f40bc291-9733-4727-ac4b-c18606bdba0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d5f15261-0757-4867-9897-c7195042d06f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_227dc155-a4b8-444a-b418-ee82e4998561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d5f15261-0757-4867-9897-c7195042d06f" xlink:to="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_227dc155-a4b8-444a-b418-ee82e4998561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_227dc155-a4b8-444a-b418-ee82e4998561" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c1576301-0a6c-4c02-a771-d4b58d87f646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:to="loc_us-gaap_AwardTypeAxis_c1576301-0a6c-4c02-a771-d4b58d87f646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e60c4500-095d-469b-b10e-50c0a89a95fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c1576301-0a6c-4c02-a771-d4b58d87f646" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e60c4500-095d-469b-b10e-50c0a89a95fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_2796f5a4-ea9c-4a8e-b502-0c81c9e04f8d" xlink:href="iclr-20211231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e60c4500-095d-469b-b10e-50c0a89a95fa" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_2796f5a4-ea9c-4a8e-b502-0c81c9e04f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f3bca583-8a28-46d8-a1f9-9208a33293ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f3bca583-8a28-46d8-a1f9-9208a33293ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f3bca583-8a28-46d8-a1f9-9208a33293ef" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member_ba751d33-0de0-4cac-bd83-ce0ecf3eaacd" xlink:href="iclr-20211231.xsd#iclr_Range1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:to="loc_iclr_Range1Member_ba751d33-0de0-4cac-bd83-ce0ecf3eaacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member_0a09a51f-0f6c-4862-923d-3b4ac0b4b37e" xlink:href="iclr-20211231.xsd#iclr_Range2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:to="loc_iclr_Range2Member_0a09a51f-0f6c-4862-923d-3b4ac0b4b37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member_c62e5413-f97e-420f-8535-805a836f0641" xlink:href="iclr-20211231.xsd#iclr_Range3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:to="loc_iclr_Range3Member_c62e5413-f97e-420f-8535-805a836f0641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member_3ccb1ad6-9728-433e-9ec0-b55c06940a78" xlink:href="iclr-20211231.xsd#iclr_Range4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_77bd2413-0759-49f3-9065-a615929230c8" xlink:to="loc_iclr_Range4Member_3ccb1ad6-9728-433e-9ec0-b55c06940a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9ec75c17-05e7-435a-a082-383795eba8cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f1afceab-caf8-4761-b597-49f802ea3d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f1afceab-caf8-4761-b597-49f802ea3d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_2e46f229-17d4-4591-9e49-6aa808a5b137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_2e46f229-17d4-4591-9e49-6aa808a5b137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_24ec654e-cec2-4583-9e83-2d5833b3a654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_24ec654e-cec2-4583-9e83-2d5833b3a654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_542c260d-696c-4ee6-aca1-624134530d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_542c260d-696c-4ee6-aca1-624134530d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13793bcf-23d2-4370-bac7-4c6a25b54b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13793bcf-23d2-4370-bac7-4c6a25b54b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_69146082-2888-49fa-b865-70b04f353128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_69146082-2888-49fa-b865-70b04f353128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_9d8b252d-064c-4c74-9080-9ada6d2f5024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3ec3ed5e-abee-4212-a1e2-d80ffef32ee6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_9d8b252d-064c-4c74-9080-9ada6d2f5024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1df46087-a96e-403d-9af2-b8db18e222a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839c693b-618d-439c-b9d8-d8cb14a1ed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1df46087-a96e-403d-9af2-b8db18e222a4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839c693b-618d-439c-b9d8-d8cb14a1ed9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bb63480f-be4d-4faf-b17d-079da9a72843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839c693b-618d-439c-b9d8-d8cb14a1ed9d" xlink:to="loc_us-gaap_AwardTypeAxis_bb63480f-be4d-4faf-b17d-079da9a72843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5fbcc56-d59b-4222-b87b-6b2eb15ab3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bb63480f-be4d-4faf-b17d-079da9a72843" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5fbcc56-d59b-4222-b87b-6b2eb15ab3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e32c5b79-f11e-4ffc-97ae-6e595d82ffbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5fbcc56-d59b-4222-b87b-6b2eb15ab3b5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e32c5b79-f11e-4ffc-97ae-6e595d82ffbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_462a79c7-8025-4619-a9d1-a55ab21a5088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_839c693b-618d-439c-b9d8-d8cb14a1ed9d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_462a79c7-8025-4619-a9d1-a55ab21a5088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3b65784-1c44-4032-94d9-be4875bd1232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_462a79c7-8025-4619-a9d1-a55ab21a5088" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3b65784-1c44-4032-94d9-be4875bd1232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_462a79c7-8025-4619-a9d1-a55ab21a5088" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6515fdcb-cb77-486a-8c3d-b6e212c6617a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6515fdcb-cb77-486a-8c3d-b6e212c6617a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31561450-bc83-46bf-94fb-61f9b33304fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31561450-bc83-46bf-94fb-61f9b33304fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5624b8bb-78ae-4823-b44c-37ba8f05769f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5624b8bb-78ae-4823-b44c-37ba8f05769f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_92a4ec40-00d6-42cd-b491-8bda31a9972e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_56735f10-a337-4cf6-9ae9-642f18a24af5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_92a4ec40-00d6-42cd-b491-8bda31a9972e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ceb1cace-4013-43a9-9aa2-484078e20b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed5da16c-0a75-4d9e-b636-b0915ce010cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ceb1cace-4013-43a9-9aa2-484078e20b19" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed5da16c-0a75-4d9e-b636-b0915ce010cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_215f002f-7c01-411a-ad5f-141ee3954ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed5da16c-0a75-4d9e-b636-b0915ce010cb" xlink:to="loc_us-gaap_AwardTypeAxis_215f002f-7c01-411a-ad5f-141ee3954ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3869a23e-0813-4819-88b5-b9cb333a9e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_215f002f-7c01-411a-ad5f-141ee3954ce9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3869a23e-0813-4819-88b5-b9cb333a9e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_f64362b6-a651-4322-880d-2b6395e5a63b" xlink:href="iclr-20211231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3869a23e-0813-4819-88b5-b9cb333a9e56" xlink:to="loc_iclr_PerformanceShareUnitMember_f64362b6-a651-4322-880d-2b6395e5a63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ffff41c0-3ad8-4e75-aff8-b7c09ba72bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3869a23e-0813-4819-88b5-b9cb333a9e56" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ffff41c0-3ad8-4e75-aff8-b7c09ba72bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d75859ce-0cf3-4c94-b8dc-c1067b55cb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed5da16c-0a75-4d9e-b636-b0915ce010cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d75859ce-0cf3-4c94-b8dc-c1067b55cb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d75859ce-0cf3-4c94-b8dc-c1067b55cb0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8295a9a0-7af7-41ff-8acf-b53837c89581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8295a9a0-7af7-41ff-8acf-b53837c89581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_f2afc779-7b76-4cee-9541-27b5b721de9a" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_f2afc779-7b76-4cee-9541-27b5b721de9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cf471478-f315-4125-bc8c-117f4bde84ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cf471478-f315-4125-bc8c-117f4bde84ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0f9fe06f-149f-44e8-8b68-35b03a1ebc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0f9fe06f-149f-44e8-8b68-35b03a1ebc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2df7bf66-1349-42ac-bbb9-5f12a2dd6ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2df7bf66-1349-42ac-bbb9-5f12a2dd6ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dd7bf316-d130-487a-b7fa-608cbe2d6aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7b21c0b8-7cbe-49ab-8191-102d90a0d53b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dd7bf316-d130-487a-b7fa-608cbe2d6aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d75859ce-0cf3-4c94-b8dc-c1067b55cb0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e82d228d-a8fb-4175-9a2f-236ecd1dca3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e82d228d-a8fb-4175-9a2f-236ecd1dca3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_aecbe10e-08a7-4a98-9ff5-ac299314fe49" xlink:href="iclr-20211231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_aecbe10e-08a7-4a98-9ff5-ac299314fe49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_86cdfcce-7d9a-4221-8c34-e8ed48ed2085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_86cdfcce-7d9a-4221-8c34-e8ed48ed2085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_891f38df-7fc9-4330-904d-a4433092c5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_891f38df-7fc9-4330-904d-a4433092c5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_573fa74e-47ec-43bf-b50d-3eb65c8f79f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_573fa74e-47ec-43bf-b50d-3eb65c8f79f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8bbac6b3-9333-4a37-8ce8-8c66cca5cf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a93c478c-c6b0-4cff-b329-91a40b2526a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8bbac6b3-9333-4a37-8ce8-8c66cca5cf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_16b7bfaf-252d-4e7b-a6f7-e04c8bb7c719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a09209c-fef7-4e9c-a23b-0d248b9b4c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_16b7bfaf-252d-4e7b-a6f7-e04c8bb7c719" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a09209c-fef7-4e9c-a23b-0d248b9b4c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a09209c-fef7-4e9c-a23b-0d248b9b4c11" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fa7ad2d-cba6-408b-b4c4-dfd59bbb06ce" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6e1bc4da-16db-4ef8-b992-82c786db2c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:to="loc_us-gaap_CostOfSalesMember_6e1bc4da-16db-4ef8-b992-82c786db2c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0b9c8751-cdc7-401d-b570-cd8a3ed0f20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0b9c8751-cdc7-401d-b570-cd8a3ed0f20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember_f6ae58de-d95f-4f5f-868d-51d06de79be9" xlink:href="iclr-20211231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_504ae7ba-46fe-4a81-ad16-1efd9e2fa38b" xlink:to="loc_iclr_TransactionAndIntegrationExpenseMember_f6ae58de-d95f-4f5f-868d-51d06de79be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b7ae2c-4023-4bcc-9a9d-be9d215e5ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a09209c-fef7-4e9c-a23b-0d248b9b4c11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b7ae2c-4023-4bcc-9a9d-be9d215e5ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_81c66f09-4274-4af7-976a-7f547c57ab7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a8b7ae2c-4023-4bcc-9a9d-be9d215e5ff1" xlink:to="loc_us-gaap_ShareBasedCompensation_81c66f09-4274-4af7-976a-7f547c57ab7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapital" xlink:type="simple" xlink:href="iclr-20211231.xsd#ShareCapital"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ShareCapital" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_076e994f-e75b-44e0-93e0-b31bd9141807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f0add676-e23b-4c11-b5ed-0f2d631825aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_076e994f-e75b-44e0-93e0-b31bd9141807" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f0add676-e23b-4c11-b5ed-0f2d631825aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#ShareCapitalDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_989a8146-af45-4cc9-a2e4-9848272b3dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_989a8146-af45-4cc9-a2e4-9848272b3dc4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8bab64cb-3002-42e1-9b62-6a0180196905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8bab64cb-3002-42e1-9b62-6a0180196905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ce0fcbd0-f4f1-4752-a0e7-c3852c25f2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8bab64cb-3002-42e1-9b62-6a0180196905" xlink:to="loc_us-gaap_EquityComponentDomain_ce0fcbd0-f4f1-4752-a0e7-c3852c25f2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_930e2103-3d60-42a0-a6e3-34689e8c975d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ce0fcbd0-f4f1-4752-a0e7-c3852c25f2c7" xlink:to="loc_us-gaap_CommonStockMember_930e2103-3d60-42a0-a6e3-34689e8c975d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_29dbc014-a86d-450e-a6f9-a8d713a83455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_us-gaap_AwardTypeAxis_29dbc014-a86d-450e-a6f9-a8d713a83455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_29dbc014-a86d-450e-a6f9-a8d713a83455" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4cd6e968-a429-47ef-9b44-414aece103ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4cd6e968-a429-47ef-9b44-414aece103ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_40e8a482-1154-42be-a78f-3ffb56fdc7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_40e8a482-1154-42be-a78f-3ffb56fdc7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_e4521dba-fce9-42fd-947f-1f27f9c3f1fd" xlink:href="iclr-20211231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77218520-c437-4764-a374-c519b2d91639" xlink:to="loc_iclr_PerformanceShareUnitMember_e4521dba-fce9-42fd-947f-1f27f9c3f1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_srt_RangeAxis_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c59cdd5-5a90-4992-ac19-4865f3ea55a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a85bbd7d-8983-4f13-8fda-efc9b3a2fcf1" xlink:to="loc_srt_RangeMember_3c59cdd5-5a90-4992-ac19-4865f3ea55a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e616d47-cb02-4aeb-9b92-8a4159d05217" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3c59cdd5-5a90-4992-ac19-4865f3ea55a3" xlink:to="loc_srt_MaximumMember_9e616d47-cb02-4aeb-9b92-8a4159d05217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f6952d21-01a8-43ee-9955-82c85375fed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f6952d21-01a8-43ee-9955-82c85375fed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5c7181dd-ffd5-41a5-9f42-36740655f468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f6952d21-01a8-43ee-9955-82c85375fed7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5c7181dd-ffd5-41a5-9f42-36740655f468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_4f0cb25e-3f1f-43b6-9264-717b6c08e04f" xlink:href="iclr-20211231.xsd#iclr_BuybackProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5c7181dd-ffd5-41a5-9f42-36740655f468" xlink:to="loc_iclr_BuybackProgramMember_4f0cb25e-3f1f-43b6-9264-717b6c08e04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_c0a9e1ba-2f84-4f29-b5a4-dc4caad241eb" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes_3cabfcb8-9761-478d-ad30-82615a496e53" xlink:href="iclr-20211231.xsd#iclr_NumberOfVotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_iclr_NumberOfVotes_3cabfcb8-9761-478d-ad30-82615a496e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8498927b-38d0-4a3b-a840-73d7c632dcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8498927b-38d0-4a3b-a840-73d7c632dcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1620cfb7-ce67-4aaf-a1aa-eee21bbfeffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1620cfb7-ce67-4aaf-a1aa-eee21bbfeffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d23dc9bf-e638-4120-a650-5377582b848a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d23dc9bf-e638-4120-a650-5377582b848a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_acb2f5a7-1173-411b-b004-65a2fd22be92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_acb2f5a7-1173-411b-b004-65a2fd22be92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3b331642-9119-4750-8ca4-a4127c87de36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3b331642-9119-4750-8ca4-a4127c87de36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_81471060-889b-409e-b291-6d2fe12c7bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_81471060-889b-409e-b291-6d2fe12c7bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_0044edaf-aea4-4edf-8d4e-0ae48a49e708" xlink:href="iclr-20211231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_0044edaf-aea4-4edf-8d4e-0ae48a49e708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_48c6a32f-ce04-4f2f-b4bf-afd75fab99d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_48c6a32f-ce04-4f2f-b4bf-afd75fab99d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_04c2d87c-feb0-4f74-aeaf-e8567154d2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_04c2d87c-feb0-4f74-aeaf-e8567154d2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_26d214bd-1b3c-45ac-afd5-319768312271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_26d214bd-1b3c-45ac-afd5-319768312271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_6c2402a1-3e3a-40bb-aeb6-211afd5d48d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_42b8b1ca-1866-4212-9eb3-6ade1da4b9fe" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_6c2402a1-3e3a-40bb-aeb6-211afd5d48d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_277f0c23-ff80-4b8b-acde-87c7782b8a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_17971feb-109d-481c-b1fa-a71b1bde3069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_277f0c23-ff80-4b8b-acde-87c7782b8a4a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_17971feb-109d-481c-b1fa-a71b1bde3069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_72a92b30-31fb-4825-b5b3-3986d9a039f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock_55219f87-e757-41c5-98b0-8db86d004160" xlink:href="iclr-20211231.xsd#iclr_IncomeBeforeIncomeTaxTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72a92b30-31fb-4825-b5b3-3986d9a039f1" xlink:to="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock_55219f87-e757-41c5-98b0-8db86d004160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0b63e2e6-6d00-471f-bca2-dcab3053198d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72a92b30-31fb-4825-b5b3-3986d9a039f1" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0b63e2e6-6d00-471f-bca2-dcab3053198d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f651e5f4-5408-4e5b-a8bd-f5a4b13a5084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72a92b30-31fb-4825-b5b3-3986d9a039f1" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f651e5f4-5408-4e5b-a8bd-f5a4b13a5084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_937a8fac-aa55-4ee6-a426-5e430e612293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72a92b30-31fb-4825-b5b3-3986d9a039f1" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_937a8fac-aa55-4ee6-a426-5e430e612293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_579bb95a-ae50-405d-86c4-43a7fdfb128c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72a92b30-31fb-4825-b5b3-3986d9a039f1" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_579bb95a-ae50-405d-86c4-43a7fdfb128c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_f0ddff7b-d6fa-4744-b65b-1b7db4a8499f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_72a92b30-31fb-4825-b5b3-3986d9a039f1" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_f0ddff7b-d6fa-4744-b65b-1b7db4a8499f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a4ef2c63-bb61-4eef-809e-3b360e182e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_6edb4f08-7ec5-45ce-afb9-8c3d88a5fbef" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a4ef2c63-bb61-4eef-809e-3b360e182e24" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_6edb4f08-7ec5-45ce-afb9-8c3d88a5fbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1514d104-f942-4861-8ca3-8fd6709bc735" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_6edb4f08-7ec5-45ce-afb9-8c3d88a5fbef" xlink:to="loc_srt_StatementGeographicalAxis_1514d104-f942-4861-8ca3-8fd6709bc735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1514d104-f942-4861-8ca3-8fd6709bc735" xlink:to="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_ac131d7a-68ab-4a35-924e-f7340d74ce1f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:to="loc_country_IE_ac131d7a-68ab-4a35-924e-f7340d74ce1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6b8da3ac-7e2b-4eea-9a2d-70a2e0074585" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:to="loc_country_US_6b8da3ac-7e2b-4eea-9a2d-70a2e0074585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_07e5d0fa-fbaf-4566-96bd-02d426ed44ee" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2b4a72f2-8a74-4655-af10-ceb3aefd80c8" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_07e5d0fa-fbaf-4566-96bd-02d426ed44ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_71c37797-0c33-44f2-a1f1-8f3422488e1c" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_6edb4f08-7ec5-45ce-afb9-8c3d88a5fbef" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_71c37797-0c33-44f2-a1f1-8f3422488e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a62702fa-eda0-4ef0-9b04-4c90d50c5fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_71c37797-0c33-44f2-a1f1-8f3422488e1c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a62702fa-eda0-4ef0-9b04-4c90d50c5fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c53f141c-895d-4d10-99e2-43dd27948923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_f7e74641-f824-4286-835e-0526defd02d7" xlink:href="iclr-20211231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c53f141c-895d-4d10-99e2-43dd27948923" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_f7e74641-f824-4286-835e-0526defd02d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_973594bb-7c50-4a30-a13c-3e94bf0fdb9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_f7e74641-f824-4286-835e-0526defd02d7" xlink:to="loc_srt_StatementGeographicalAxis_973594bb-7c50-4a30-a13c-3e94bf0fdb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_973594bb-7c50-4a30-a13c-3e94bf0fdb9a" xlink:to="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_c17b47c0-28ed-460d-b5e7-1c58369a44bf" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:to="loc_country_IE_c17b47c0-28ed-460d-b5e7-1c58369a44bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a529e870-457a-47b9-9740-176e923b7641" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:to="loc_country_US_a529e870-457a-47b9-9740-176e923b7641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_d4f1d40e-af8d-44d9-ab90-ca74a18dafdb" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4af77b30-3ab0-487e-8294-b3af80ce8ce6" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_d4f1d40e-af8d-44d9-ab90-ca74a18dafdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:href="iclr-20211231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_f7e74641-f824-4286-835e-0526defd02d7" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_97d65f8a-b9cc-471f-bd12-9a95c8a8c25e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_97d65f8a-b9cc-471f-bd12-9a95c8a8c25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_51abc0be-1f62-4ab0-a05d-b90b16877db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_97d65f8a-b9cc-471f-bd12-9a95c8a8c25e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_51abc0be-1f62-4ab0-a05d-b90b16877db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_4b351f25-3f2c-4b0c-a857-6286cf56fd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_4b351f25-3f2c-4b0c-a857-6286cf56fd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e1bc701f-272b-4280-815a-ef313c04cd25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_4b351f25-3f2c-4b0c-a857-6286cf56fd3e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e1bc701f-272b-4280-815a-ef313c04cd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f09ff226-e52a-48e4-86a4-703118699005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_c67b40bb-2b78-403c-8d70-1fda6a87949b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f09ff226-e52a-48e4-86a4-703118699005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract_2986bc59-4b9a-420a-a2da-d1499276ee32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:to="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract_2986bc59-4b9a-420a-a2da-d1499276ee32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_bbc3f1ec-8844-449b-b7d2-64aacc122cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract_2986bc59-4b9a-420a-a2da-d1499276ee32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_bbc3f1ec-8844-449b-b7d2-64aacc122cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_34288689-d6fe-48ea-af9d-1efa9892f46e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_45b8cc9e-3e7a-48e4-8f0b-337a897da42d" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_34288689-d6fe-48ea-af9d-1efa9892f46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_81f31b85-b4cd-412e-8ba6-309088b441a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_81f31b85-b4cd-412e-8ba6-309088b441a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c2c43ca2-0808-47a4-b773-3cde78f6dee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c2c43ca2-0808-47a4-b773-3cde78f6dee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_07d14e83-cb8a-48ab-8c2e-13697da5a050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_07d14e83-cb8a-48ab-8c2e-13697da5a050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_96e6b060-2bed-4014-b8c8-9e1b0daf2f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_96e6b060-2bed-4014-b8c8-9e1b0daf2f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a9fcd0d8-865b-4d89-a789-89d1fdb86793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a9fcd0d8-865b-4d89-a789-89d1fdb86793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7489d7e9-fa5a-4110-a428-a6ef0ed30a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7489d7e9-fa5a-4110-a428-a6ef0ed30a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_e3d307d2-9d42-41fe-8aa3-ddb4c175dc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_e3d307d2-9d42-41fe-8aa3-ddb4c175dc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_03ed1fd9-57fd-477b-8c4b-81f61320854d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_03ed1fd9-57fd-477b-8c4b-81f61320854d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0aea5192-7ec8-4308-9bb8-a4acfdcf0657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_86407bc0-9528-4089-9dab-9c109c9f3847" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0aea5192-7ec8-4308-9bb8-a4acfdcf0657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ea8ba4d9-8f02-411b-a9e6-e6ab0a833ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_75f9b2d1-fc41-4a84-8b00-1ee7a47300d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ea8ba4d9-8f02-411b-a9e6-e6ab0a833ac0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_75f9b2d1-fc41-4a84-8b00-1ee7a47300d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fa823ba0-12f0-492c-9527-a6227aeb5789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_75f9b2d1-fc41-4a84-8b00-1ee7a47300d0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fa823ba0-12f0-492c-9527-a6227aeb5789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9da3b921-7853-4990-918e-7e682f27347f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_75f9b2d1-fc41-4a84-8b00-1ee7a47300d0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9da3b921-7853-4990-918e-7e682f27347f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_9ace4ea4-1c78-4b62-b4c1-82dca21b2ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_75f9b2d1-fc41-4a84-8b00-1ee7a47300d0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_9ace4ea4-1c78-4b62-b4c1-82dca21b2ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_4f5e27d4-8145-4ce4-b33c-6240b432e2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_75f9b2d1-fc41-4a84-8b00-1ee7a47300d0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_4f5e27d4-8145-4ce4-b33c-6240b432e2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_ae3d24e9-5929-4100-8419-0b0351591ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_75f9b2d1-fc41-4a84-8b00-1ee7a47300d0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_ae3d24e9-5929-4100-8419-0b0351591ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a5eff20f-dab0-41d6-8ea7-e2255f8ff027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_75f9b2d1-fc41-4a84-8b00-1ee7a47300d0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a5eff20f-dab0-41d6-8ea7-e2255f8ff027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ea8ba4d9-8f02-411b-a9e6-e6ab0a833ac0" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_862d4cee-9767-4aae-b90b-ca103ab3edd4" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_862d4cee-9767-4aae-b90b-ca103ab3edd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_38756c6d-bb3f-44a3-aa04-373daa87fc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_38756c6d-bb3f-44a3-aa04-373daa87fc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_d836cd35-7822-4c3c-9b6f-f1d620d9802f" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_d836cd35-7822-4c3c-9b6f-f1d620d9802f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_6d9bac67-ebb4-425c-81cb-69b4b6d71701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_6d9bac67-ebb4-425c-81cb-69b4b6d71701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_34e09afc-dfd2-4f1c-8c7a-9b8743e55cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_34e09afc-dfd2-4f1c-8c7a-9b8743e55cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_9c65552b-6413-48b4-8e5a-742e0ff5ed89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_9c65552b-6413-48b4-8e5a-742e0ff5ed89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_52be0395-928c-41fb-93c9-aa5240362293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_52be0395-928c-41fb-93c9-aa5240362293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_9ef2279b-93e6-4108-86e8-1f19757e11b0" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_9ef2279b-93e6-4108-86e8-1f19757e11b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_b513172b-3eda-4914-bf43-4ce21d31dd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_b513172b-3eda-4914-bf43-4ce21d31dd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b6f9b430-f24a-429b-a4c5-77a919458a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_b6f9b430-f24a-429b-a4c5-77a919458a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_21404f72-3d63-46e7-a030-983f19e9152d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_21404f72-3d63-46e7-a030-983f19e9152d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_6e01e749-f69d-45bf-a6cd-464a349bdcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_6e01e749-f69d-45bf-a6cd-464a349bdcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_37346ba3-0526-4897-a2c9-ca50417277d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxLiabilities_37346ba3-0526-4897-a2c9-ca50417277d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_fe9bf359-36da-4d24-89a2-37ab0c664e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_164935bb-296e-4a1d-828f-28f9d4e790ef" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_fe9bf359-36da-4d24-89a2-37ab0c664e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_13b3b09e-88d1-4743-a497-644251880c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_13b3b09e-88d1-4743-a497-644251880c80" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_eafeadb6-d901-44ec-99b3-36113709d901" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_srt_StatementGeographicalAxis_eafeadb6-d901-44ec-99b3-36113709d901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_eafeadb6-d901-44ec-99b3-36113709d901" xlink:to="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_2f1eb772-34ba-4e3e-81ed-3fce5c9fca54" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:to="loc_country_IE_2f1eb772-34ba-4e3e-81ed-3fce5c9fca54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_51466191-7733-44ae-9438-50fdfc926c69" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:to="loc_country_US_51466191-7733-44ae-9438-50fdfc926c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_8206f299-ac43-4a1b-b8db-431796680ed1" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4b6feb18-bc5d-4fc1-8551-063afe383f11" xlink:to="loc_iclr_OtherCountriesMember_8206f299-ac43-4a1b-b8db-431796680ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_42953620-cd8c-4a5f-a355-0c2e3d7778ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1cd53a76-b5c8-4bfc-ba88-b156b81ebe35" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_42953620-cd8c-4a5f-a355-0c2e3d7778ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_0c176507-2a2f-4217-84a3-ae0239a8e9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_42953620-cd8c-4a5f-a355-0c2e3d7778ad" xlink:to="loc_us-gaap_ForeignCountryMember_0c176507-2a2f-4217-84a3-ae0239a8e9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3d57e98b-5706-4e05-83f9-0dd1e0211ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_42953620-cd8c-4a5f-a355-0c2e3d7778ad" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3d57e98b-5706-4e05-83f9-0dd1e0211ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8fea87b1-97b8-4950-8074-da24bbb2a7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_ebefe0fe-e9ee-4432-adad-5503e0dd2fd4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8fea87b1-97b8-4950-8074-da24bbb2a7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_173efbd3-0e22-4855-bbd7-56254e9b38a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8fea87b1-97b8-4950-8074-da24bbb2a7a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_173efbd3-0e22-4855-bbd7-56254e9b38a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_3e8d3d1b-aa94-4631-b27a-293cb61a50a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_TaxPeriodAxis_3e8d3d1b-aa94-4631-b27a-293cb61a50a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_3e8d3d1b-aa94-4631-b27a-293cb61a50a2" xlink:to="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022to2035Member_4bffa3bd-2fef-492f-a130-cf05ff08ac1a" xlink:href="iclr-20211231.xsd#iclr_TaxYear2022to2035Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:to="loc_iclr_TaxYear2022to2035Member_4bffa3bd-2fef-492f-a130-cf05ff08ac1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20362040Member_b67d96a4-fec8-49db-96a7-6e452cc781bb" xlink:href="iclr-20211231.xsd#iclr_TaxYear20362040Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:to="loc_iclr_TaxYear20362040Member_b67d96a4-fec8-49db-96a7-6e452cc781bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022To2028Member_872adbb7-0b3f-410c-86d9-febf196a5cfa" xlink:href="iclr-20211231.xsd#iclr_TaxYear2022To2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:to="loc_iclr_TaxYear2022To2028Member_872adbb7-0b3f-410c-86d9-febf196a5cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2029To2038Member_34f32737-b827-4320-bdb5-ffebcb027299" xlink:href="iclr-20211231.xsd#iclr_TaxYear2029To2038Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_46dcd2f0-4bcb-4598-b88c-7567a7c82be5" xlink:to="loc_iclr_TaxYear2029To2038Member_34f32737-b827-4320-bdb5-ffebcb027299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a26ea303-da4e-4658-982e-0af1b7314523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a26ea303-da4e-4658-982e-0af1b7314523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c464e1ab-a786-47fe-85ca-e9a96093ca03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a26ea303-da4e-4658-982e-0af1b7314523" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c464e1ab-a786-47fe-85ca-e9a96093ca03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember_2e1b380a-90f0-4ed9-8979-c58afc16eb00" xlink:href="iclr-20211231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c464e1ab-a786-47fe-85ca-e9a96093ca03" xlink:to="loc_iclr_IncomeTaxBenefitMember_2e1b380a-90f0-4ed9-8979-c58afc16eb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_de87fa5f-e452-493c-879b-88984fcdbe89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_de87fa5f-e452-493c-879b-88984fcdbe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_0925963c-a4d3-4cf5-9363-cf5193918403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_de87fa5f-e452-493c-879b-88984fcdbe89" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_0925963c-a4d3-4cf5-9363-cf5193918403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_81fde330-c6ba-4ecf-8847-c65e240875b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_0925963c-a4d3-4cf5-9363-cf5193918403" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_81fde330-c6ba-4ecf-8847-c65e240875b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a6522125-fddb-4730-b6ad-5259b2d4ec23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a6522125-fddb-4730-b6ad-5259b2d4ec23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec7b7d78-e5fb-49de-be61-8c1a44cb64f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6522125-fddb-4730-b6ad-5259b2d4ec23" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec7b7d78-e5fb-49de-be61-8c1a44cb64f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_09b65086-b8f5-4353-8881-db3cd4ff3c73" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ec7b7d78-e5fb-49de-be61-8c1a44cb64f6" xlink:to="loc_iclr_PRAHealthSciencesIncMember_09b65086-b8f5-4353-8881-db3cd4ff3c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_f0c8888f-c884-43e0-b49d-fd47d300ecf7" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_cf43e1bf-dae3-47e4-92b1-f55765dea83e" xlink:href="iclr-20211231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_cf43e1bf-dae3-47e4-92b1-f55765dea83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9a3701f0-fa48-40cd-a4c3-3945e65c64da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9a3701f0-fa48-40cd-a4c3-3945e65c64da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal_2e293457-7162-4df3-88a0-98daf6500680" xlink:href="iclr-20211231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_iclr_OperatingLossCarryforwardsUSFederal_2e293457-7162-4df3-88a0-98daf6500680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_11f85a33-5d5e-45f9-b9c6-2671031bce10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_11f85a33-5d5e-45f9-b9c6-2671031bce10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_3db68401-f3e7-4f9d-b3a0-52bc52a43234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_3db68401-f3e7-4f9d-b3a0-52bc52a43234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_12d086d8-bc89-4611-a19b-7cdb3791625b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_12d086d8-bc89-4611-a19b-7cdb3791625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5b614132-a9d7-4961-9dd5-ebb0f27305d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5b614132-a9d7-4961-9dd5-ebb0f27305d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_dc0e994e-aa07-41d4-92eb-2a10aa31ce13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_dc0e994e-aa07-41d4-92eb-2a10aa31ce13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_648d3d4b-a964-45f0-9a66-9a4b890db1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_648d3d4b-a964-45f0-9a66-9a4b890db1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1d335ceb-2df3-4f96-9053-821221cc14d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1d335ceb-2df3-4f96-9053-821221cc14d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_4baaaa76-ee30-412f-ae35-3b09f4c2d6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_4baaaa76-ee30-412f-ae35-3b09f4c2d6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_774ed01d-781c-419b-9bcf-95f3b5a67601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_774ed01d-781c-419b-9bcf-95f3b5a67601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_580cc4b3-cd10-44da-b735-06c3b2963a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_580cc4b3-cd10-44da-b735-06c3b2963a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d4cc66ec-bab9-4c41-af39-d4176ee66139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d4cc66ec-bab9-4c41-af39-d4176ee66139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_cffe1374-15ba-4016-aaca-0e92cd89a692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a33fb041-c21a-4cc3-a127-b5756337fd6d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_cffe1374-15ba-4016-aaca-0e92cd89a692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_31896f83-9d6e-44a0-afbe-fd4ba753f7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31896f83-9d6e-44a0-afbe-fd4ba753f7ed" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_94662560-1267-4413-8a80-abfe615e9790" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_srt_StatementGeographicalAxis_94662560-1267-4413-8a80-abfe615e9790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d8a273a1-cb0c-4a52-ae27-2eccf8f5e81d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_94662560-1267-4413-8a80-abfe615e9790" xlink:to="loc_srt_SegmentGeographicalDomain_d8a273a1-cb0c-4a52-ae27-2eccf8f5e81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1c820383-1740-4a6d-9521-7c1441fed347" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d8a273a1-cb0c-4a52-ae27-2eccf8f5e81d" xlink:to="loc_country_US_1c820383-1740-4a6d-9521-7c1441fed347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_2b720641-2fab-4b14-ba10-f7b7899c3999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1c20dc02-9e3c-4fdb-bf6f-4278ae533df9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_2b720641-2fab-4b14-ba10-f7b7899c3999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_8c906271-9cb7-437e-b94a-9ff570b8b44e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_2b720641-2fab-4b14-ba10-f7b7899c3999" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_8c906271-9cb7-437e-b94a-9ff570b8b44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_58bde70b-0165-4bba-875a-27f12213e9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_58bde70b-0165-4bba-875a-27f12213e9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_7191fbd8-a3f6-4ade-9342-14d4bf1d8ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_58bde70b-0165-4bba-875a-27f12213e9ba" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_7191fbd8-a3f6-4ade-9342-14d4bf1d8ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_49d99bf7-7c93-4926-9f1c-187c5f66dceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_7191fbd8-a3f6-4ade-9342-14d4bf1d8ff7" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_49d99bf7-7c93-4926-9f1c-187c5f66dceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_30049257-4a1c-41ca-8af7-3c38b9759fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_us-gaap_TaxPeriodAxis_30049257-4a1c-41ca-8af7-3c38b9759fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_34f932d2-fca0-47a6-b7e4-3681256f4ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_30049257-4a1c-41ca-8af7-3c38b9759fc9" xlink:to="loc_us-gaap_TaxPeriodDomain_34f932d2-fca0-47a6-b7e4-3681256f4ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022to2035Member_df071b16-4cd0-4077-a1a8-057ff60945ef" xlink:href="iclr-20211231.xsd#iclr_TaxYear2022to2035Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_34f932d2-fca0-47a6-b7e4-3681256f4ec9" xlink:to="loc_iclr_TaxYear2022to2035Member_df071b16-4cd0-4077-a1a8-057ff60945ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20362040Member_930cbe31-4c54-4202-8519-85f651aaa45d" xlink:href="iclr-20211231.xsd#iclr_TaxYear20362040Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_34f932d2-fca0-47a6-b7e4-3681256f4ec9" xlink:to="loc_iclr_TaxYear20362040Member_930cbe31-4c54-4202-8519-85f651aaa45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_12ac1d92-3d60-41b1-8970-0b5e4f684df6" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_11e1fda8-a8e7-4992-a278-c08ddd7ee8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_11e1fda8-a8e7-4992-a278-c08ddd7ee8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_e3cce967-e3a6-45fc-a80e-4f02031b7c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_e3cce967-e3a6-45fc-a80e-4f02031b7c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_03f0066a-d262-4d7e-9371-2191e477f52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_70105e61-25fd-4d5b-953f-c5f3a1375e3c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_03f0066a-d262-4d7e-9371-2191e477f52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d25d2927-fc1f-411e-b36f-676f719a7225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d25d2927-fc1f-411e-b36f-676f719a7225" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8bbcabc4-8862-420a-8c2b-4a5cacb45904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8bbcabc4-8862-420a-8c2b-4a5cacb45904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_9adbc2d0-5df0-470b-af77-95ac595f7647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_9adbc2d0-5df0-470b-af77-95ac595f7647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_485f6a29-00a5-41e8-b12f-fed232e8c8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_485f6a29-00a5-41e8-b12f-fed232e8c8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_462278fd-faad-4cc8-be6f-d4d598de1884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_462278fd-faad-4cc8-be6f-d4d598de1884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b10ecef0-144b-42e4-b869-7bd252a801e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b10ecef0-144b-42e4-b869-7bd252a801e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_5dff38e6-440a-4711-9b02-9a71f3d98065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_5dff38e6-440a-4711-9b02-9a71f3d98065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ea576f1f-ec21-4f6d-ad45-0c7a5533adf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ea576f1f-ec21-4f6d-ad45-0c7a5533adf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_95051c66-7f1a-4fd2-b9b7-96212e2e540a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_dffd1ead-783d-4845-b43f-995915100f8a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_95051c66-7f1a-4fd2-b9b7-96212e2e540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Restructuringcharges" xlink:type="simple" xlink:href="iclr-20211231.xsd#Restructuringcharges"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Restructuringcharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8c8c6b95-c8ff-4ddd-803b-a94e278c4e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5379024d-c01b-4ead-ac86-22deea20fcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8c8c6b95-c8ff-4ddd-803b-a94e278c4e9c" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5379024d-c01b-4ead-ac86-22deea20fcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#RestructuringchargesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e81ab47d-8985-4ce6-8dec-bda5d73b7769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_33d8a399-b921-4723-b798-eba258b8dcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e81ab47d-8985-4ce6-8dec-bda5d73b7769" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_33d8a399-b921-4723-b798-eba258b8dcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_e38ae5e6-e762-460d-be5b-ff3b3a826bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e81ab47d-8985-4ce6-8dec-bda5d73b7769" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_e38ae5e6-e762-460d-be5b-ff3b3a826bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#RestructuringchargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ac211748-0a87-4027-9e57-14ba510ba789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ac211748-0a87-4027-9e57-14ba510ba789" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_c52c1bc4-5c2d-4130-8b75-5b857cf4371a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_c52c1bc4-5c2d-4130-8b75-5b857cf4371a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_00865fb7-8289-471d-9b48-37f45fd7eae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c52c1bc4-5c2d-4130-8b75-5b857cf4371a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_00865fb7-8289-471d-9b48-37f45fd7eae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_ea2f7c3c-461a-430c-9597-08d996dc3480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_00865fb7-8289-471d-9b48-37f45fd7eae7" xlink:to="loc_us-gaap_EmployeeSeveranceMember_ea2f7c3c-461a-430c-9597-08d996dc3480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember_7b3ba5f6-1029-405a-b25e-322c3fe4a304" xlink:href="iclr-20211231.xsd#iclr_LeaseLiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_00865fb7-8289-471d-9b48-37f45fd7eae7" xlink:to="loc_iclr_LeaseLiabilityMember_7b3ba5f6-1029-405a-b25e-322c3fe4a304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_bff38a16-43b7-4a8f-a5e3-49e86c6f7137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_RestructuringPlanAxis_bff38a16-43b7-4a8f-a5e3-49e86c6f7137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_f6826d8f-0054-4665-b764-46297c44dd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_bff38a16-43b7-4a8f-a5e3-49e86c6f7137" xlink:to="loc_us-gaap_RestructuringPlanDomain_f6826d8f-0054-4665-b764-46297c44dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember_d1ceb95b-3b8e-479f-b96f-01cd57dfcf5e" xlink:href="iclr-20211231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_f6826d8f-0054-4665-b764-46297c44dd5d" xlink:to="loc_iclr_A2021RestructuringPlanMember_d1ceb95b-3b8e-479f-b96f-01cd57dfcf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1d70e178-e145-49a2-b244-cf74c09cf7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1d70e178-e145-49a2-b244-cf74c09cf7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a38dcdf8-81d9-40cd-a690-b662c02aeced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1d70e178-e145-49a2-b244-cf74c09cf7d4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a38dcdf8-81d9-40cd-a690-b662c02aeced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_d2f0567d-943e-43fc-863b-a72a67f72511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a38dcdf8-81d9-40cd-a690-b662c02aeced" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_d2f0567d-943e-43fc-863b-a72a67f72511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_a3b675ff-bcb8-439d-bf6b-ef52257aac4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a38dcdf8-81d9-40cd-a690-b662c02aeced" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_a3b675ff-bcb8-439d-bf6b-ef52257aac4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_04234f33-81ae-4403-9056-bfac4c64238c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_04234f33-81ae-4403-9056-bfac4c64238c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0eabdd01-5d40-42f8-a5e4-99d2a4890e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_04234f33-81ae-4403-9056-bfac4c64238c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0eabdd01-5d40-42f8-a5e4-99d2a4890e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_32c0750a-b311-4f80-87ff-fc288e5a3f3d" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0eabdd01-5d40-42f8-a5e4-99d2a4890e1e" xlink:to="loc_iclr_PRAHealthSciencesIncMember_32c0750a-b311-4f80-87ff-fc288e5a3f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_77dbec93-ba90-44f7-a365-9131622002da" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_8e71a712-330f-47a2-9889-b5015ce34f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_RestructuringCosts_8e71a712-330f-47a2-9889-b5015ce34f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_633ecfd1-c75a-4175-96b1-0321d79f510e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_633ecfd1-c75a-4175-96b1-0321d79f510e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a5bf48b9-0b06-4744-b1a6-f462a2aef286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a5bf48b9-0b06-4744-b1a6-f462a2aef286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7844ec22-786c-4065-87ca-b54bc71fb038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_us-gaap_RestructuringReserve_7844ec22-786c-4065-87ca-b54bc71fb038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_96f111be-5f0e-4a35-9c4f-52fdd2dc1f94" xlink:href="iclr-20211231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e0ebe25e-c851-4d68-b656-a580a748e416" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_96f111be-5f0e-4a35-9c4f-52fdd2dc1f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#RestructuringchargesSummaryofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c8e7d50c-259b-464f-89dd-b2daffee760f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_834ad9f1-1a0f-4ff3-b285-8ca531f3f0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c8e7d50c-259b-464f-89dd-b2daffee760f" xlink:to="loc_us-gaap_RestructuringCosts_834ad9f1-1a0f-4ff3-b285-8ca531f3f0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#RestructuringchargesRestructuringProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_74167552-0768-4b72-90f6-d64291978158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_823397c4-6684-4a85-9770-403d0e351bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_74167552-0768-4b72-90f6-d64291978158" xlink:to="loc_us-gaap_RestructuringReserveRollForward_823397c4-6684-4a85-9770-403d0e351bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_94108cc5-4991-4dda-b289-02ce84a9fef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_823397c4-6684-4a85-9770-403d0e351bff" xlink:to="loc_us-gaap_RestructuringReserve_94108cc5-4991-4dda-b289-02ce84a9fef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3783a3eb-0886-48b9-855f-7ba736e2ec12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_823397c4-6684-4a85-9770-403d0e351bff" xlink:to="loc_us-gaap_RestructuringCharges_3783a3eb-0886-48b9-855f-7ba736e2ec12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveUtilizations_b4a68853-9746-4679-a572-51e9dbd0d5bb" xlink:href="iclr-20211231.xsd#iclr_RestructuringReserveUtilizations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_823397c4-6684-4a85-9770-403d0e351bff" xlink:to="loc_iclr_RestructuringReserveUtilizations_b4a68853-9746-4679-a572-51e9dbd0d5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_059ed886-9c92-45aa-9446-d1c17c03e49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_823397c4-6684-4a85-9770-403d0e351bff" xlink:to="loc_us-gaap_RestructuringReserve_059ed886-9c92-45aa-9446-d1c17c03e49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="iclr-20211231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_17c15e1b-5992-4521-a660-4a50fef05703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0ed59416-d2f8-4c0f-9c24-44ccfab7cc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_17c15e1b-5992-4521-a660-4a50fef05703" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0ed59416-d2f8-4c0f-9c24-44ccfab7cc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f6af63a-3e06-4f4f-833a-bc0f8106ec3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b75c7345-3557-42d8-946e-7c55d2530715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f6af63a-3e06-4f4f-833a-bc0f8106ec3b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b75c7345-3557-42d8-946e-7c55d2530715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenue" xlink:type="simple" xlink:href="iclr-20211231.xsd#DisaggregationofRevenue"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b249bb8-0661-4448-82e0-b76446da399a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8af56df7-40ed-4fa1-97bd-b02ba8de3e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b249bb8-0661-4448-82e0-b76446da399a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8af56df7-40ed-4fa1-97bd-b02ba8de3e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#DisaggregationofRevenueTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54f7bed4-1aa6-4c39-b5be-61cf038441b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_64c25f19-82c8-4303-a0cf-5b7a03270f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54f7bed4-1aa6-4c39-b5be-61cf038441b7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_64c25f19-82c8-4303-a0cf-5b7a03270f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#DisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_05f7791a-e1a8-4dc2-9624-8037e650a261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_34ef2fd4-c4e5-4acb-9610-fdbf87dd42d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_05f7791a-e1a8-4dc2-9624-8037e650a261" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_34ef2fd4-c4e5-4acb-9610-fdbf87dd42d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_17568a89-e1d3-4219-921c-5505d98989e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ef2fd4-c4e5-4acb-9610-fdbf87dd42d3" xlink:to="loc_srt_MajorCustomersAxis_17568a89-e1d3-4219-921c-5505d98989e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_17568a89-e1d3-4219-921c-5505d98989e0" xlink:to="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember_c29215c4-3b0a-41f2-986e-029b6eda28be" xlink:href="iclr-20211231.xsd#iclr_TopClientMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_TopClientMember_c29215c4-3b0a-41f2-986e-029b6eda28be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member_46ad258f-24b5-4030-82ca-545fa0f88a01" xlink:href="iclr-20211231.xsd#iclr_Clients25Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_Clients25Member_46ad258f-24b5-4030-82ca-545fa0f88a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member_f6818516-8a59-4053-8693-a72940c1cf32" xlink:href="iclr-20211231.xsd#iclr_Clients610Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_Clients610Member_f6818516-8a59-4053-8693-a72940c1cf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member_463dddde-5803-443b-b4df-ffa5226c8c38" xlink:href="iclr-20211231.xsd#iclr_Clients1125Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_Clients1125Member_463dddde-5803-443b-b4df-ffa5226c8c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember_b5476e02-c0c3-493e-a553-0768bb2ef8ea" xlink:href="iclr-20211231.xsd#iclr_OtherCustomersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4460e831-23b0-4d14-bb8a-a0b89e1c3a4d" xlink:to="loc_iclr_OtherCustomersMember_b5476e02-c0c3-493e-a553-0768bb2ef8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_17f5f86d-f4d9-43f8-827f-26f7ce093866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ef2fd4-c4e5-4acb-9610-fdbf87dd42d3" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_17f5f86d-f4d9-43f8-827f-26f7ce093866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1b51d9c7-a74e-4d40-9cb7-56f65df5eb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_17f5f86d-f4d9-43f8-827f-26f7ce093866" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1b51d9c7-a74e-4d40-9cb7-56f65df5eb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities" xlink:type="simple" xlink:href="iclr-20211231.xsd#Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7aff2486-29c6-45b6-b5b5-dd5f886cc55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4e139f1e-9aa4-4246-8cb5-8de1f5f29181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7aff2486-29c6-45b6-b5b5-dd5f886cc55e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4e139f1e-9aa4-4246-8cb5-8de1f5f29181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_60989524-2b96-4e54-a816-a93d24c7a639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_14b9daf4-9b1b-4676-82c7-42bf07efefc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_60989524-2b96-4e54-a816-a93d24c7a639" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_14b9daf4-9b1b-4676-82c7-42bf07efefc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_6700905f-ea13-46d4-ad28-fd8187a88b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BilledContractReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_us-gaap_BilledContractReceivables_6700905f-ea13-46d4-ad28-fd8187a88b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_9da2d5fd-5aad-48bf-b863-2516d070a616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_9da2d5fd-5aad-48bf-b863-2516d070a616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_802cd567-9b96-4fb9-957c-0610432761a3" xlink:href="iclr-20211231.xsd#iclr_ContractsReceivableGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_ContractsReceivableGross_802cd567-9b96-4fb9-957c-0610432761a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_1ce02866-c0fb-4ce3-afba-c056995048c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_1ce02866-c0fb-4ce3-afba-c056995048c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet_4f1d90ca-a397-41a3-aa69-dd209fa482bd" xlink:href="iclr-20211231.xsd#iclr_ContractsReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_ContractsReceivableNet_4f1d90ca-a397-41a3-aa69-dd209fa482bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_73987f33-a8d8-4aec-bd0d-f6ced6cc2a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_73987f33-a8d8-4aec-bd0d-f6ced6cc2a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_01195e0f-be11-4877-be3f-dd29edd3225d" xlink:href="iclr-20211231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_01195e0f-be11-4877-be3f-dd29edd3225d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_aafffc34-8365-4b7e-b98a-f9b618f3575e" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_aafffc34-8365-4b7e-b98a-f9b618f3575e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_79fa289e-27ca-472b-a86a-6b74f6f0b5f7" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_79fa289e-27ca-472b-a86a-6b74f6f0b5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_12da9944-ac27-40a9-87cb-2a7d8357cff5" xlink:href="iclr-20211231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_12da9944-ac27-40a9-87cb-2a7d8357cff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_70f98d42-1e71-4ffd-8eb5-2fc86ab4d824" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_70f98d42-1e71-4ffd-8eb5-2fc86ab4d824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_9776b7fb-a81b-48a0-aa63-48c59dfce191" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_9776b7fb-a81b-48a0-aa63-48c59dfce191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_42cd858a-c60f-4ae3-bc19-4a2fc3b08dfb" xlink:href="iclr-20211231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ec901de4-25e9-457a-9546-bb2983045b7b" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_42cd858a-c60f-4ae3-bc19-4a2fc3b08dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c9d83295-6b2e-4138-a637-813b3196d64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c9d83295-6b2e-4138-a637-813b3196d64d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_998cd3c2-530b-4361-acbc-869f676f9f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_998cd3c2-530b-4361-acbc-869f676f9f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d8a4560e-9e66-4e8b-8b49-0d35620c303b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_29f96407-c699-4a5a-a382-82dd5798f055" xlink:href="iclr-20211231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_29f96407-c699-4a5a-a382-82dd5798f055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_2e7a6ceb-bd5e-44b4-a8f6-c746aa395bc4" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_2e7a6ceb-bd5e-44b4-a8f6-c746aa395bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_245c37da-9d55-47ba-b400-62b3685f49a6" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_245c37da-9d55-47ba-b400-62b3685f49a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_4502bb07-4f0d-4964-9976-45ad3947613c" xlink:href="iclr-20211231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_4502bb07-4f0d-4964-9976-45ad3947613c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_6c5d74bc-fa33-4227-86c0-f86ba792d66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_6c5d74bc-fa33-4227-86c0-f86ba792d66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_53c46c14-f348-4cfd-8a1f-e11b34b0ea10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_53c46c14-f348-4cfd-8a1f-e11b34b0ea10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_cc180bd1-40c8-4148-a95b-11620fcf95c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_cc180bd1-40c8-4148-a95b-11620fcf95c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6f7c8a6d-4c8a-4221-a17b-1c13f0474b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e95e4432-996e-41b1-9da0-f53c09ef2e66" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6f7c8a6d-4c8a-4221-a17b-1c13f0474b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/ProvisionforCreditLosses" xlink:type="simple" xlink:href="iclr-20211231.xsd#ProvisionforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ProvisionforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_9ae2cc0d-2408-4374-84be-1fb6f3507dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsTextBlock_3125823c-c61b-4b4f-a96e-093f6d8f222e" xlink:href="iclr-20211231.xsd#iclr_AllowanceForDoubtfulAccountsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_9ae2cc0d-2408-4374-84be-1fb6f3507dc0" xlink:to="loc_iclr_AllowanceForDoubtfulAccountsTextBlock_3125823c-c61b-4b4f-a96e-093f6d8f222e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ProvisionforCreditLossesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#ProvisionforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ProvisionforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_74924c24-935d-4736-8659-668754f59bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsTableTextBlock_874b894c-0dc6-4d60-a62f-dbde9eadcd1c" xlink:href="iclr-20211231.xsd#iclr_AllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_74924c24-935d-4736-8659-668754f59bd8" xlink:to="loc_iclr_AllowanceForDoubtfulAccountsTableTextBlock_874b894c-0dc6-4d60-a62f-dbde9eadcd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ProvisionforCreditLossesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#ProvisionforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ProvisionforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_5cf8290d-b324-4195-959e-8ea2fc7aa547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6fcaa4e9-e088-4110-80d3-53dd6f881173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_5cf8290d-b324-4195-959e-8ea2fc7aa547" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6fcaa4e9-e088-4110-80d3-53dd6f881173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b0fcbf32-ce2a-47e7-a6fe-3226c4e07583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6fcaa4e9-e088-4110-80d3-53dd6f881173" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b0fcbf32-ce2a-47e7-a6fe-3226c4e07583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_d7397d5e-fff0-4d7d-bc23-98b99725994f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6fcaa4e9-e088-4110-80d3-53dd6f881173" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_d7397d5e-fff0-4d7d-bc23-98b99725994f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossExpense_c166a371-0427-4d26-a2bf-f44759ce07aa" xlink:href="iclr-20211231.xsd#iclr_AccountsReceivableCreditLossExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6fcaa4e9-e088-4110-80d3-53dd6f881173" xlink:to="loc_iclr_AccountsReceivableCreditLossExpense_c166a371-0427-4d26-a2bf-f44759ce07aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossReversal_93bc8f53-0214-42e2-966f-08cf28ddf4b7" xlink:href="iclr-20211231.xsd#iclr_AccountsReceivableCreditLossReversal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6fcaa4e9-e088-4110-80d3-53dd6f881173" xlink:to="loc_iclr_AccountsReceivableCreditLossReversal_93bc8f53-0214-42e2-966f-08cf28ddf4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_a15e8995-6aac-42e8-a320-d70a6d1b8028" xlink:href="iclr-20211231.xsd#iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6fcaa4e9-e088-4110-80d3-53dd6f881173" xlink:to="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_a15e8995-6aac-42e8-a320-d70a6d1b8028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_dce03212-4395-41c5-bcbf-c18a3b6bd916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6fcaa4e9-e088-4110-80d3-53dd6f881173" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_dce03212-4395-41c5-bcbf-c18a3b6bd916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_39cae274-d449-4c2c-9804-435c5b86f3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_78143890-73d4-4b8e-9f98-13b374c3c71a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_39cae274-d449-4c2c-9804-435c5b86f3f7" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_78143890-73d4-4b8e-9f98-13b374c3c71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_68afbf34-1349-4dcd-8473-fedcf2d2755b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_8d88a1f6-5f07-4def-9885-dfd87a166af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_68afbf34-1349-4dcd-8473-fedcf2d2755b" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_8d88a1f6-5f07-4def-9885-dfd87a166af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeByGeographyTableTextBlock_64f6e8b4-1d5a-4727-83ad-e8ecaa407d00" xlink:href="iclr-20211231.xsd#iclr_OperatingIncomeByGeographyTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_68afbf34-1349-4dcd-8473-fedcf2d2755b" xlink:to="loc_iclr_OperatingIncomeByGeographyTableTextBlock_64f6e8b4-1d5a-4727-83ad-e8ecaa407d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_f55a5aaf-7b75-4a5d-814b-c7c61909e302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_68afbf34-1349-4dcd-8473-fedcf2d2755b" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_f55a5aaf-7b75-4a5d-814b-c7c61909e302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_17d91936-6bdd-4929-8419-f57ee4fa276c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_17d91936-6bdd-4929-8419-f57ee4fa276c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:to="loc_us-gaap_RestructuringPlanAxis_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0caa152c-face-4ef5-a0d8-c9f2523a42a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_8e0a6d83-a11d-4e6f-a98f-f6e7c5ee776f" xlink:to="loc_us-gaap_RestructuringPlanDomain_0caa152c-face-4ef5-a0d8-c9f2523a42a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember_316a4c77-f626-4994-85f4-d28c1492a477" xlink:href="iclr-20211231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0caa152c-face-4ef5-a0d8-c9f2523a42a7" xlink:to="loc_iclr_A2021RestructuringPlanMember_316a4c77-f626-4994-85f4-d28c1492a477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34dbb599-2000-4a9e-be6c-033979e75fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34dbb599-2000-4a9e-be6c-033979e75fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc53de3f-19ed-4710-a3b6-88222037000b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34dbb599-2000-4a9e-be6c-033979e75fff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc53de3f-19ed-4710-a3b6-88222037000b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_6c9283c0-f43c-450b-87c4-4d5b348b7782" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cc53de3f-19ed-4710-a3b6-88222037000b" xlink:to="loc_iclr_PRAHealthSciencesIncMember_6c9283c0-f43c-450b-87c4-4d5b348b7782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_72645d27-af7f-49b9-9a00-f1266917801c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8d173fa7-e00e-4ff4-a2b4-1e3ab696259c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8d173fa7-e00e-4ff4-a2b4-1e3ab696259c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts_865ea523-bc6e-4887-8f1f-1253e5c52a3d" xlink:href="iclr-20211231.xsd#iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts_865ea523-bc6e-4887-8f1f-1253e5c52a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_e956dcc5-a08a-4a77-9249-352077cb5275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_RestructuringCosts_e956dcc5-a08a-4a77-9249-352077cb5275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_5ea6dc89-694b-431d-9305-d198daaa8493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_5ea6dc89-694b-431d-9305-d198daaa8493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1cfd3269-a548-4422-8369-3d1fb2b62fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a06c29c-f01d-4626-a9a6-25626ed5cf4e" xlink:to="loc_us-gaap_OperatingIncomeLoss_1cfd3269-a548-4422-8369-3d1fb2b62fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7dec9fd7-3c53-4dc9-b510-832116f1979a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fcdc4114-95f6-47a2-bad0-54c824e9f813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7dec9fd7-3c53-4dc9-b510-832116f1979a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fcdc4114-95f6-47a2-bad0-54c824e9f813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9ba31d16-334c-4b21-b722-bd6a918130f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fcdc4114-95f6-47a2-bad0-54c824e9f813" xlink:to="loc_srt_StatementGeographicalAxis_9ba31d16-334c-4b21-b722-bd6a918130f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9ba31d16-334c-4b21-b722-bd6a918130f4" xlink:to="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_0d54669b-65d2-4228-88b0-9e065bfda032" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:to="loc_country_IE_0d54669b-65d2-4228-88b0-9e065bfda032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_c5fade99-cbaa-4638-980d-95d448b47257" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:to="loc_iclr_RestOfEuropeMember_c5fade99-cbaa-4638-980d-95d448b47257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b2a5e490-b202-4d01-864a-d1fed6708e77" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:to="loc_country_US_b2a5e490-b202-4d01-864a-d1fed6708e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_22c56737-0d0d-4382-a2cc-6126326eb6a1" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3c51e7c3-6915-455d-940d-c8b87995d5fc" xlink:to="loc_iclr_OtherCountriesMember_22c56737-0d0d-4382-a2cc-6126326eb6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6bfa8a48-fafb-497a-917a-a2d7e3eacdd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fcdc4114-95f6-47a2-bad0-54c824e9f813" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6bfa8a48-fafb-497a-917a-a2d7e3eacdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34def085-09a4-4da2-9342-c39a1a8ddd37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6bfa8a48-fafb-497a-917a-a2d7e3eacdd3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34def085-09a4-4da2-9342-c39a1a8ddd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1c378bec-e4e9-48c2-9346-61aceba69a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f791d190-2d44-448d-8a2a-bf1720a8efde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1c378bec-e4e9-48c2-9346-61aceba69a73" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f791d190-2d44-448d-8a2a-bf1720a8efde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b1d9ef6a-3073-4547-b579-93d748f19474" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f791d190-2d44-448d-8a2a-bf1720a8efde" xlink:to="loc_srt_StatementGeographicalAxis_b1d9ef6a-3073-4547-b579-93d748f19474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b1d9ef6a-3073-4547-b579-93d748f19474" xlink:to="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_389edd49-3148-4589-ab1c-83aa7f04718b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:to="loc_country_IE_389edd49-3148-4589-ab1c-83aa7f04718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_dcfb56b8-07b3-43b5-9344-4dce80a6bd10" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:to="loc_iclr_RestOfEuropeMember_dcfb56b8-07b3-43b5-9344-4dce80a6bd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a3b900fb-5e2a-4e91-8f86-409ec0ab3952" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:to="loc_country_US_a3b900fb-5e2a-4e91-8f86-409ec0ab3952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_142fa8d0-ddd2-440d-a795-c80c6df658a1" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b7e70007-5d22-4261-9e27-20b038389808" xlink:to="loc_iclr_OtherCountriesMember_142fa8d0-ddd2-440d-a795-c80c6df658a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ad2e1174-4d50-47dd-a4d9-0994cfdce887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f791d190-2d44-448d-8a2a-bf1720a8efde" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ad2e1174-4d50-47dd-a4d9-0994cfdce887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_36b22d25-c499-4a3b-9e92-51a9dc72a7ac" xlink:href="iclr-20211231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e1174-4d50-47dd-a4d9-0994cfdce887" xlink:to="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_36b22d25-c499-4a3b-9e92-51a9dc72a7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b30a9b3f-fab5-4efe-8ae3-96eb7bc2a8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a23ef652-50ae-4f16-b1a0-24991ff84b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b30a9b3f-fab5-4efe-8ae3-96eb7bc2a8a2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a23ef652-50ae-4f16-b1a0-24991ff84b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8fd14c0e-4553-450d-ac0d-60845b0a22ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a23ef652-50ae-4f16-b1a0-24991ff84b31" xlink:to="loc_srt_StatementGeographicalAxis_8fd14c0e-4553-450d-ac0d-60845b0a22ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8fd14c0e-4553-450d-ac0d-60845b0a22ce" xlink:to="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_8ebb2399-cbfa-4b10-aa49-e3da31c40f92" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:to="loc_country_IE_8ebb2399-cbfa-4b10-aa49-e3da31c40f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_3e0b01e5-f2ae-469b-9b46-33400aba5afc" xlink:href="iclr-20211231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:to="loc_iclr_RestOfEuropeMember_3e0b01e5-f2ae-469b-9b46-33400aba5afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dd2a6f8e-3555-4895-93a5-cbb0331ad839" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:to="loc_country_US_dd2a6f8e-3555-4895-93a5-cbb0331ad839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_78d244ff-16df-45f8-a6b4-f8e8e39975cc" xlink:href="iclr-20211231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3813b5a9-717d-496a-9406-1a1748b18c99" xlink:to="loc_iclr_OtherCountriesMember_78d244ff-16df-45f8-a6b4-f8e8e39975cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_278b4c7a-2d2f-4f30-a887-814d6b531ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a23ef652-50ae-4f16-b1a0-24991ff84b31" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_278b4c7a-2d2f-4f30-a887-814d6b531ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_d89567b3-6225-4e16-8032-0058993a11d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_278b4c7a-2d2f-4f30-a887-814d6b531ce7" xlink:to="loc_us-gaap_NoncurrentAssets_d89567b3-6225-4e16-8032-0058993a11d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" xlink:type="simple" xlink:href="iclr-20211231.xsd#SupplementalDisclosureofCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_6636f449-3f78-48ee-833d-4cf0c3f07900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_e248e8bb-d17d-4e85-b31d-cdf5aa42eb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_6636f449-3f78-48ee-833d-4cf0c3f07900" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_e248e8bb-d17d-4e85-b31d-cdf5aa42eb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#SupplementalDisclosureofCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_637e2418-50eb-40f4-92b4-6aec4adb7f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_5fa34a0a-af6a-4b3d-9c13-437f6d7f47e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_637e2418-50eb-40f4-92b4-6aec4adb7f13" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_5fa34a0a-af6a-4b3d-9c13-437f6d7f47e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#SupplementalDisclosureofCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_9a418739-fd06-42e6-a047-f4314fda9146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_ba1c28a1-c98b-4d6b-b49a-97d15c6276ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9a418739-fd06-42e6-a047-f4314fda9146" xlink:to="loc_us-gaap_InterestPaidNet_ba1c28a1-c98b-4d6b-b49a-97d15c6276ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_836c4580-5a1a-4e71-a666-ec12b6149255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9a418739-fd06-42e6-a047-f4314fda9146" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_836c4580-5a1a-4e71-a666-ec12b6149255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_3d3a51ad-4b71-4019-b098-5c0c269586fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_3e1e6112-4900-4d28-9cf1-31d0fdf52fed" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_3d3a51ad-4b71-4019-b098-5c0c269586fd" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_3e1e6112-4900-4d28-9cf1-31d0fdf52fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_5b6f0365-b781-4647-8a6f-8484b1aab4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_21ee4e79-742e-4b7a-ba48-d362077995da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_5b6f0365-b781-4647-8a6f-8484b1aab4ab" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_21ee4e79-742e-4b7a-ba48-d362077995da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_d4fb8716-85e7-4d85-8427-6efbd9bca439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f91d0431-15b4-42e5-8877-2f76dc073410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_d4fb8716-85e7-4d85-8427-6efbd9bca439" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f91d0431-15b4-42e5-8877-2f76dc073410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f91d0431-15b4-42e5-8877-2f76dc073410" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_63d46ee3-9b59-4838-b195-a6515a76da9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5e1a7acb-4b74-435c-a5f2-f02c42e9b1de" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_63d46ee3-9b59-4838-b195-a6515a76da9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_04a6cc5a-7a8d-4d64-988b-74abe697c21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_63d46ee3-9b59-4838-b195-a6515a76da9c" xlink:to="loc_us-gaap_InterestRateContractMember_04a6cc5a-7a8d-4d64-988b-74abe697c21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f91d0431-15b4-42e5-8877-2f76dc073410" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1e4d4922-39e0-4698-901b-d3c572665f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1e4d4922-39e0-4698-901b-d3c572665f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_462db7a1-3857-4bbe-b6ee-294c978ec1bd" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax_462db7a1-3857-4bbe-b6ee-294c978ec1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e9f491d3-8f7b-4e01-b4fa-6ce3eda371ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e9f491d3-8f7b-4e01-b4fa-6ce3eda371ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_69af2baa-9ea3-4641-8487-a07e82b91953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_69af2baa-9ea3-4641-8487-a07e82b91953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_e6fe8eb5-8c54-4715-b565-bac7272976fe" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax_e6fe8eb5-8c54-4715-b565-bac7272976fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_fa74e961-4f32-4f92-9941-ab8e7c961f0c" xlink:href="iclr-20211231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_fa74e961-4f32-4f92-9941-ab8e7c961f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_effc27e6-f805-4aa9-9ae7-0e11fbebfe90" xlink:href="iclr-20211231.xsd#iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_effc27e6-f805-4aa9-9ae7-0e11fbebfe90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_82f04895-4715-45eb-8d1e-ae94e47f0b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_64d67a18-424a-40b6-baf7-7acd245ae516" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_82f04895-4715-45eb-8d1e-ae94e47f0b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeases" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9380efaa-ed40-435f-9543-d9e51e7bf61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_431662c6-f968-43c4-b724-b0a2d3063ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9380efaa-ed40-435f-9543-d9e51e7bf61b" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_431662c6-f968-43c4-b724-b0a2d3063ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6e4a03fa-0107-4fc4-bcef-c7f79a2c8dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_960b0f36-7730-4b51-8d9a-4a157c1054d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6e4a03fa-0107-4fc4-bcef-c7f79a2c8dcf" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_960b0f36-7730-4b51-8d9a-4a157c1054d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_89a7b87e-92a8-4e29-8c20-4f9ed3a60ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6e4a03fa-0107-4fc4-bcef-c7f79a2c8dcf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_89a7b87e-92a8-4e29-8c20-4f9ed3a60ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f0d9e6b1-d37f-4595-b06b-d344c18bd0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_958cf0e9-1b29-475b-90e9-314b1ea10663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0d9e6b1-d37f-4595-b06b-d344c18bd0b2" xlink:to="loc_us-gaap_OperatingLeaseCost_958cf0e9-1b29-475b-90e9-314b1ea10663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_295040ac-1a54-4eff-a002-a88987408b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0d9e6b1-d37f-4595-b06b-d344c18bd0b2" xlink:to="loc_us-gaap_SubleaseIncome_295040ac-1a54-4eff-a002-a88987408b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9c4c4237-c827-4983-9e31-2980d9702e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f0d9e6b1-d37f-4595-b06b-d344c18bd0b2" xlink:to="loc_us-gaap_LeaseCost_9c4c4237-c827-4983-9e31-2980d9702e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesOperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2fff5672-7b18-4db9-b939-3fe8d8a5084c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2fff5672-7b18-4db9-b939-3fe8d8a5084c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_afdf2020-3eea-433a-9500-a0dcdc6e4992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_afdf2020-3eea-433a-9500-a0dcdc6e4992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2415b499-33fd-432d-a965-beba23658dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_afdf2020-3eea-433a-9500-a0dcdc6e4992" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2415b499-33fd-432d-a965-beba23658dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3a53e4a4-2b38-44b9-a0b2-cc4aa4f15b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2415b499-33fd-432d-a965-beba23658dbb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3a53e4a4-2b38-44b9-a0b2-cc4aa4f15b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_824960ca-964c-43c4-8fd5-b3ce46891ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2415b499-33fd-432d-a965-beba23658dbb" xlink:to="loc_us-gaap_CostOfSalesMember_824960ca-964c-43c4-8fd5-b3ce46891ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_787dc55f-f597-4fc7-b25e-cbf26d534ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_787dc55f-f597-4fc7-b25e-cbf26d534ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5b12e2e0-bffe-487f-8388-3fd8da75cd76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_787dc55f-f597-4fc7-b25e-cbf26d534ef4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5b12e2e0-bffe-487f-8388-3fd8da75cd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_316a2523-53a0-4c28-862a-9f0b1a3eb1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5b12e2e0-bffe-487f-8388-3fd8da75cd76" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_316a2523-53a0-4c28-862a-9f0b1a3eb1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7f65d05b-759f-4e69-9504-b7472494a29c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_103b6fbb-10ca-4903-a9b0-17cd45797169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_LeaseCost_103b6fbb-10ca-4903-a9b0-17cd45797169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_a269f952-7f23-4cca-890e-6a24ebc95bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_VariableLeaseCost_a269f952-7f23-4cca-890e-6a24ebc95bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8a9a318a-c1ab-4afd-9dab-61c3a074aa47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8a9a318a-c1ab-4afd-9dab-61c3a074aa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_0d4148af-f9c1-4116-bdf7-c02c3fbb10a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_0d4148af-f9c1-4116-bdf7-c02c3fbb10a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_26c3c7a6-e121-4991-aec2-2205b90e41b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_26c3c7a6-e121-4991-aec2-2205b90e41b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fc8c2597-40a4-4726-b85d-ee1bccd221e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fc8c2597-40a4-4726-b85d-ee1bccd221e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_68991803-04d4-45cb-a645-7d1baa61eb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_68991803-04d4-45cb-a645-7d1baa61eb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_29b9427b-c08c-46ac-a30a-e018afbddfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_343d9c0d-1217-4940-b5ef-ce7df4a2f486" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_29b9427b-c08c-46ac-a30a-e018afbddfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_465f3326-a69a-47c9-8a1e-a4d4b999073d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_465f3326-a69a-47c9-8a1e-a4d4b999073d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7caa3ed7-3790-4142-af8f-f2122f51ea70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7caa3ed7-3790-4142-af8f-f2122f51ea70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2c026678-f513-4059-8327-81a38b020330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2c026678-f513-4059-8327-81a38b020330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c1487249-73b2-4986-b0ef-8c73c5461c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c1487249-73b2-4986-b0ef-8c73c5461c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_be113be8-ade8-42e3-bded-43ff89332b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_be113be8-ade8-42e3-bded-43ff89332b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8f29b1cd-64e7-4e75-81f7-45cb1fb005d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8f29b1cd-64e7-4e75-81f7-45cb1fb005d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_397de03f-91c9-4b76-9347-a782983e60d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_397de03f-91c9-4b76-9347-a782983e60d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_762b6e08-1713-446b-a292-4ad103365af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_762b6e08-1713-446b-a292-4ad103365af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_05f0f68a-62b9-40e3-b17d-adf7492aa81c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8f1fff6-ee0f-4d26-976a-ce2db7831e2c" xlink:to="loc_us-gaap_OperatingLeaseLiability_05f0f68a-62b9-40e3-b17d-adf7492aa81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="iclr-20211231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/Noncurrentbankcreditlinesandloanfacilities" xlink:type="simple" xlink:href="iclr-20211231.xsd#Noncurrentbankcreditlinesandloanfacilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Noncurrentbankcreditlinesandloanfacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_15698770-5830-4f87-ad2a-dd398423de2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_3e8284cd-7b5f-4cf1-86c7-a55d61ddca42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15698770-5830-4f87-ad2a-dd398423de2c" xlink:to="loc_us-gaap_LongTermDebtTextBlock_3e8284cd-7b5f-4cf1-86c7-a55d61ddca42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_49ec4f52-d607-47b2-8148-a0d5a40436d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9cf2de82-a968-4837-a3dc-e4b3ff1b8ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49ec4f52-d607-47b2-8148-a0d5a40436d1" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9cf2de82-a968-4837-a3dc-e4b3ff1b8ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_e44f254c-ae64-488c-870f-71ec5db7a47c" xlink:href="iclr-20211231.xsd#iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49ec4f52-d607-47b2-8148-a0d5a40436d1" xlink:to="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_e44f254c-ae64-488c-870f-71ec5db7a47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_32aa5159-01c6-4565-88c0-90fa68830ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49ec4f52-d607-47b2-8148-a0d5a40436d1" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_32aa5159-01c6-4565-88c0-90fa68830ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6e893c30-6bde-4b98-add3-66ad65835e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6e893c30-6bde-4b98-add3-66ad65835e57" xlink:to="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c46f97b1-c2dc-4739-af9a-ff1e8f13e3aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4e4607c9-40bd-4329-96b1-64de54cad9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:to="loc_us-gaap_SecuredDebtMember_4e4607c9-40bd-4329-96b1-64de54cad9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_db21605e-078f-4ec4-825b-25b342a8aa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_db21605e-078f-4ec4-825b-25b342a8aa3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0b10f726-1980-42b7-81a0-b3e8541f1429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c26040fa-804d-4507-92dc-86f322b594f3" xlink:to="loc_us-gaap_SeniorNotesMember_0b10f726-1980-42b7-81a0-b3e8541f1429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4b53337e-e6ee-4743-be52-9d35eaf3f456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:to="loc_us-gaap_DebtInstrumentAxis_4b53337e-e6ee-4743-be52-9d35eaf3f456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4b53337e-e6ee-4743-be52-9d35eaf3f456" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_44a048e2-d2e2-4abe-aef3-27c94ea8c65c" xlink:href="iclr-20211231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:to="loc_iclr_TermLoanFacilityMember_44a048e2-d2e2-4abe-aef3-27c94ea8c65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorANotesMember_39855a04-c6ed-441b-904c-1c91637791df" xlink:href="iclr-20211231.xsd#iclr_SeniorANotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:to="loc_iclr_SeniorANotesMember_39855a04-c6ed-441b-904c-1c91637791df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorBNotesMember_ada6ae49-e866-41f7-a572-5179d2756a5d" xlink:href="iclr-20211231.xsd#iclr_SeniorBNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:to="loc_iclr_SeniorBNotesMember_ada6ae49-e866-41f7-a572-5179d2756a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_dfa70097-1549-407c-9926-41a774047096" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9a75d4b0-b6c8-4d2d-9943-9cb463cf0de6" xlink:to="loc_iclr_SeniorSecuredNotesMember_dfa70097-1549-407c-9926-41a774047096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eb216a20-52ef-4916-b246-1d72d2ae0e7d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_af8fa9d6-ba67-4e72-b3e7-ed3d668a6609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_af8fa9d6-ba67-4e72-b3e7-ed3d668a6609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_856f4d18-9205-4806-8eae-4b6e9e9dc0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_856f4d18-9205-4806-8eae-4b6e9e9dc0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_759618e3-c61d-4871-85a4-0a3ce13876e0" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_759618e3-c61d-4871-85a4-0a3ce13876e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_b36fbdad-50c6-470b-9ad7-ae3c44473965" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_b36fbdad-50c6-470b-9ad7-ae3c44473965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_42c28922-4fc6-43f7-a4c0-b9ebfe2cd1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_42c28922-4fc6-43f7-a4c0-b9ebfe2cd1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e06e0fc3-0de5-40b1-9682-dc3ccbe550cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5cff42d1-cabc-472e-9751-69e31869f619" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e06e0fc3-0de5-40b1-9682-dc3ccbe550cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6cbef152-0f77-4d25-98dd-5d619bc8818c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6cbef152-0f77-4d25-98dd-5d619bc8818c" xlink:to="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e8a09fce-9348-45c8-a4c4-e3089b79a6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e8a09fce-9348-45c8-a4c4-e3089b79a6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e8a09fce-9348-45c8-a4c4-e3089b79a6da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_353d4180-8b6f-4403-b2db-d7bef800e8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_SecuredDebtMember_353d4180-8b6f-4403-b2db-d7bef800e8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d13ae572-f2c6-4c3c-8bdd-d62e250115b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_LineOfCreditMember_d13ae572-f2c6-4c3c-8bdd-d62e250115b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_9658f595-634d-4fcb-8edd-062e8902270a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_LetterOfCreditMember_9658f595-634d-4fcb-8edd-062e8902270a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_814ba4ce-e35b-4deb-9240-d2df6c3b2048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_814ba4ce-e35b-4deb-9240-d2df6c3b2048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2c7f37ea-d5bb-46f8-93e4-eeceaac58114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_aeb340d8-3f90-467d-90f3-e318bcb590ca" xlink:to="loc_us-gaap_SeniorNotesMember_2c7f37ea-d5bb-46f8-93e4-eeceaac58114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_DebtInstrumentAxis_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2c7d1c5f-4a3a-4f1e-acbf-a05883b94a1e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_5bbb3b58-b65d-4771-af55-bcdeee82c03a" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_5bbb3b58-b65d-4771-af55-bcdeee82c03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_991e42b0-12ef-4bee-8b68-6ec376ebdb61" xlink:href="iclr-20211231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_TermLoanFacilityMember_991e42b0-12ef-4bee-8b68-6ec376ebdb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_3630b999-19ac-43fe-8e76-086475418d8a" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_3630b999-19ac-43fe-8e76-086475418d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_f3467378-f724-4600-bdec-ddeb42224549" xlink:href="iclr-20211231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorSecuredNotesMember_f3467378-f724-4600-bdec-ddeb42224549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorNotes2020Member_104c8319-f924-481f-a653-ced3d60ac919" xlink:href="iclr-20211231.xsd#iclr_SeniorNotes2020Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorNotes2020Member_104c8319-f924-481f-a653-ced3d60ac919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorANotesMember_8199671b-6eef-4a42-bd7d-5890f2d2f68d" xlink:href="iclr-20211231.xsd#iclr_SeniorANotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorANotesMember_8199671b-6eef-4a42-bd7d-5890f2d2f68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorBNotesMember_55b7c14d-a993-47f4-889f-286e21798ae0" xlink:href="iclr-20211231.xsd#iclr_SeniorBNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0c7eef9-5451-4abb-a905-0a83bdd8ef73" xlink:to="loc_iclr_SeniorBNotesMember_55b7c14d-a993-47f4-889f-286e21798ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f0cffa91-8333-4705-83eb-6150a94097e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_CreditFacilityAxis_f0cffa91-8333-4705-83eb-6150a94097e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3ff57f3f-e96e-4549-a6f9-62d30342fa74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f0cffa91-8333-4705-83eb-6150a94097e4" xlink:to="loc_us-gaap_CreditFacilityDomain_3ff57f3f-e96e-4549-a6f9-62d30342fa74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_818c2d7a-0319-49a5-a040-33c79d9f8d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3ff57f3f-e96e-4549-a6f9-62d30342fa74" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_818c2d7a-0319-49a5-a040-33c79d9f8d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis_788fda0f-4e2a-4416-bbf1-f5933ad94002" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_iclr_VariableRateComponentAxis_788fda0f-4e2a-4416-bbf1-f5933ad94002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_375fcc8d-e810-42cd-bb8a-e71aa7d400f1" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentAxis_788fda0f-4e2a-4416-bbf1-f5933ad94002" xlink:to="loc_iclr_VariableRateComponentDomain_375fcc8d-e810-42cd-bb8a-e71aa7d400f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember_7f5ea0ce-6f44-4a37-b74f-686430f5c771" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentDomain_375fcc8d-e810-42cd-bb8a-e71aa7d400f1" xlink:to="loc_iclr_VariableRateComponentOneMember_7f5ea0ce-6f44-4a37-b74f-686430f5c771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember_60019700-267a-4896-b91c-f82324718ca4" xlink:href="iclr-20211231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentDomain_375fcc8d-e810-42cd-bb8a-e71aa7d400f1" xlink:to="loc_iclr_VariableRateComponentTwoMember_60019700-267a-4896-b91c-f82324718ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_VariableRateAxis_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e6b28bf5-498e-4405-aaab-4f45f734ff9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d5ebbc9e-bf83-4a12-a709-6cc039a9ce0a" xlink:to="loc_us-gaap_VariableRateDomain_e6b28bf5-498e-4405-aaab-4f45f734ff9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c9b213bb-f9a9-4c6c-8c43-6b4f98216ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e6b28bf5-498e-4405-aaab-4f45f734ff9f" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c9b213bb-f9a9-4c6c-8c43-6b4f98216ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_01715ed7-4e45-4b0b-b44b-1e418479e441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e6b28bf5-498e-4405-aaab-4f45f734ff9f" xlink:to="loc_us-gaap_BaseRateMember_01715ed7-4e45-4b0b-b44b-1e418479e441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_srt_RangeAxis_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3460a660-3092-4745-bd8a-acd54c1cd598" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9af2e9ab-a19d-45a1-9a59-64ac8fc12e40" xlink:to="loc_srt_RangeMember_3460a660-3092-4745-bd8a-acd54c1cd598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_82603ff7-ea69-4060-b6d0-36c43a707eb0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3460a660-3092-4745-bd8a-acd54c1cd598" xlink:to="loc_srt_MaximumMember_82603ff7-ea69-4060-b6d0-36c43a707eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b0410d76-8748-4499-a6d5-be144b223be6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3460a660-3092-4745-bd8a-acd54c1cd598" xlink:to="loc_srt_MinimumMember_b0410d76-8748-4499-a6d5-be144b223be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e64a983a-cdf4-44af-a869-84185afb8d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e64a983a-cdf4-44af-a869-84185afb8d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227ac2e8-e7a4-473c-9359-d63534b0fdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e64a983a-cdf4-44af-a869-84185afb8d21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227ac2e8-e7a4-473c-9359-d63534b0fdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_91613663-3074-4434-ab43-16d8fa20d6e9" xlink:href="iclr-20211231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_227ac2e8-e7a4-473c-9359-d63534b0fdd7" xlink:to="loc_iclr_PRAHealthSciencesIncMember_91613663-3074-4434-ab43-16d8fa20d6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5dee5fa7-95e6-4560-9d9a-5e687a09832a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5ac38099-fd6d-49d3-a05b-d7c8cb8e7a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5ac38099-fd6d-49d3-a05b-d7c8cb8e7a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5ca3d6a1-cd2c-4b42-9e08-7092a8e4807a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_InterestExpense_5ca3d6a1-cd2c-4b42-9e08-7092a8e4807a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4fbeb34b-0699-4ed5-9587-e9a2680e87a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4fbeb34b-0699-4ed5-9587-e9a2680e87a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_02eef8d8-ff99-4f65-aeb5-09ae7cbfbbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_02eef8d8-ff99-4f65-aeb5-09ae7cbfbbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5e05738-450a-4947-a117-c227fd20fb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e5e05738-450a-4947-a117-c227fd20fb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c08daaaf-a421-4583-b858-12402056e1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c08daaaf-a421-4583-b858-12402056e1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage_226b00af-76d7-48b8-990e-b951dc0bcc12" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage_226b00af-76d7-48b8-990e-b951dc0bcc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio_8bfdaacb-9a68-4384-809c-8bc16cfc8df9" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio_8bfdaacb-9a68-4384-809c-8bc16cfc8df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate_09781c5e-65e0-4911-91e8-0308a67e56fb" xlink:href="iclr-20211231.xsd#iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate_09781c5e-65e0-4911-91e8-0308a67e56fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a708e046-0a49-4146-bbba-08ff96d4778a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_LineOfCredit_a708e046-0a49-4146-bbba-08ff96d4778a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c7d006db-a00b-419c-8b9e-9dea7948ecb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c7d006db-a00b-419c-8b9e-9dea7948ecb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_80b64712-c871-40a1-a19a-28ac849459aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_80b64712-c871-40a1-a19a-28ac849459aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f536d4fb-54cd-45e7-88d9-0de3df936468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_InterestPaidNet_f536d4fb-54cd-45e7-88d9-0de3df936468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_a85788da-03a0-4e1b-83e6-c5b1cbcf1301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_a85788da-03a0-4e1b-83e6-c5b1cbcf1301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_15b18093-51c5-405b-9a54-5ce7db2dd743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_15b18093-51c5-405b-9a54-5ce7db2dd743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IssueOfSeniorNotesNumberOfTranches_effb9e23-d24d-4c28-b1e8-a84524082406" xlink:href="iclr-20211231.xsd#iclr_IssueOfSeniorNotesNumberOfTranches"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_iclr_IssueOfSeniorNotesNumberOfTranches_effb9e23-d24d-4c28-b1e8-a84524082406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_37a17ea6-74da-4a32-8a75-d2cb711d3351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_37a17ea6-74da-4a32-8a75-d2cb711d3351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_aef78467-7e06-44be-9b36-d045612b1aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_RepaymentsOfDebt_aef78467-7e06-44be-9b36-d045612b1aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_083a2987-58e5-4af7-a244-46f8c5f60ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ccebfde2-a21f-4363-90e0-43d08e907f76" xlink:to="loc_us-gaap_LongTermDebtFairValue_083a2987-58e5-4af7-a244-46f8c5f60ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_108ef678-d7b6-46da-8fe4-a8e859e7eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_732b7bf0-9741-48d7-8821-50a76a7852c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_108ef678-d7b6-46da-8fe4-a8e859e7eaba" xlink:to="loc_us-gaap_InterestExpenseDebt_732b7bf0-9741-48d7-8821-50a76a7852c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_dbb96275-d8de-4ce0-99f2-aac457512022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_108ef678-d7b6-46da-8fe4-a8e859e7eaba" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_dbb96275-d8de-4ce0-99f2-aac457512022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_863b3c96-ca2d-405e-9b3b-755682bbe885" xlink:href="iclr-20211231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_108ef678-d7b6-46da-8fe4-a8e859e7eaba" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_863b3c96-ca2d-405e-9b3b-755682bbe885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther_6ed90157-63f5-41b3-aaf5-0035a2517b69" xlink:href="iclr-20211231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_108ef678-d7b6-46da-8fe4-a8e859e7eaba" xlink:to="loc_iclr_InterestExpenseCreditOther_6ed90157-63f5-41b3-aaf5-0035a2517b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9d29456d-ce97-4427-bf03-a682c466d9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_108ef678-d7b6-46da-8fe4-a8e859e7eaba" xlink:to="loc_us-gaap_InterestExpense_9d29456d-ce97-4427-bf03-a682c466d9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_624bb8ff-46b8-4ab0-9823-9f4e760567ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_845ad57f-5c12-462e-84a2-d543a6a666a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_624bb8ff-46b8-4ab0-9823-9f4e760567ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_845ad57f-5c12-462e-84a2-d543a6a666a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_45aa40bf-f2d5-46ee-848e-6f800d3a6c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_624bb8ff-46b8-4ab0-9823-9f4e760567ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_45aa40bf-f2d5-46ee-848e-6f800d3a6c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5d823a79-02ca-4738-9fe0-04984ba70d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_624bb8ff-46b8-4ab0-9823-9f4e760567ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5d823a79-02ca-4738-9fe0-04984ba70d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2df50c49-7573-4a37-9d19-b944de19bc80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_624bb8ff-46b8-4ab0-9823-9f4e760567ff" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2df50c49-7573-4a37-9d19-b944de19bc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_cf4d8910-68e4-45de-9b3c-0ba2d5591b2d" xlink:href="iclr-20211231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_624bb8ff-46b8-4ab0-9823-9f4e760567ff" xlink:to="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_cf4d8910-68e4-45de-9b3c-0ba2d5591b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c579e508-9ee4-4792-b14b-73fea646e1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_624bb8ff-46b8-4ab0-9823-9f4e760567ff" xlink:to="loc_us-gaap_LongTermDebt_c579e508-9ee4-4792-b14b-73fea646e1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValue" xlink:type="simple" xlink:href="iclr-20211231.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_14b267c5-e54e-4dae-b26a-8eae4ee3b0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_632838d1-3bb5-4184-b000-44bfbaef4000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_14b267c5-e54e-4dae-b26a-8eae4ee3b0f0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_632838d1-3bb5-4184-b000-44bfbaef4000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairvalueDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#FairvalueDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairvalueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4e900392-8bbb-4e7d-a474-9f74b6773ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_18e0885c-260a-4f36-b82e-987b241d0bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e900392-8bbb-4e7d-a474-9f74b6773ccd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_18e0885c-260a-4f36-b82e-987b241d0bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9c9ddd46-11ab-48ab-a342-4b8a3daae33a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_18e0885c-260a-4f36-b82e-987b241d0bde" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9c9ddd46-11ab-48ab-a342-4b8a3daae33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_10ed7b38-1e06-422f-a564-9e298c3562ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9c9ddd46-11ab-48ab-a342-4b8a3daae33a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_10ed7b38-1e06-422f-a564-9e298c3562ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_7713758b-5535-41da-b211-4e3c6d5b7c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_10ed7b38-1e06-422f-a564-9e298c3562ec" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_7713758b-5535-41da-b211-4e3c6d5b7c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_18e0885c-260a-4f36-b82e-987b241d0bde" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0996263d-e39b-4d74-89c7-6cae2e5bfd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0996263d-e39b-4d74-89c7-6cae2e5bfd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_24e1e308-3610-4e5d-aaac-a96aecd86ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_24e1e308-3610-4e5d-aaac-a96aecd86ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d4c0df37-b45f-4211-8b0b-cb722ba158d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d4c0df37-b45f-4211-8b0b-cb722ba158d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_d8c29b05-6fa2-4017-bbc5-8ac87d836520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_d8c29b05-6fa2-4017-bbc5-8ac87d836520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_719e77a0-23d6-4d98-a248-680499555234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2d7dce7e-72b4-4c9b-a188-c7c5b2d39d2b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_719e77a0-23d6-4d98-a248-680499555234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ImpactofNewAccountingPronouncements" xlink:type="simple" xlink:href="iclr-20211231.xsd#ImpactofNewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ImpactofNewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_321e21fa-b1f5-4973-9e26-fb2a76be42c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock_070aba57-a59b-4590-a327-5243c8f02429" xlink:href="iclr-20211231.xsd#iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_321e21fa-b1f5-4973-9e26-fb2a76be42c3" xlink:to="loc_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock_070aba57-a59b-4590-a327-5243c8f02429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#ImpactofNewAccountingPronouncementsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_f860c097-1c78-4073-b463-ec52b45d7e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3565ebdb-d41d-4e66-9312-f659b35f1306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_f860c097-1c78-4073-b463-ec52b45d7e3c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3565ebdb-d41d-4e66-9312-f659b35f1306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5e1c2a1c-45bd-44dc-995a-1398c2c85248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3565ebdb-d41d-4e66-9312-f659b35f1306" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5e1c2a1c-45bd-44dc-995a-1398c2c85248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_30b42111-2b58-474c-8e12-a9d2e96df472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5e1c2a1c-45bd-44dc-995a-1398c2c85248" xlink:to="loc_us-gaap_TypeOfAdoptionMember_30b42111-2b58-474c-8e12-a9d2e96df472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountingStandardsUpdate202108Member_dbe45a58-fc3c-449a-8017-641e23059751" xlink:href="iclr-20211231.xsd#iclr_AccountingStandardsUpdate202108Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_30b42111-2b58-474c-8e12-a9d2e96df472" xlink:to="loc_iclr_AccountingStandardsUpdate202108Member_dbe45a58-fc3c-449a-8017-641e23059751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3565ebdb-d41d-4e66-9312-f659b35f1306" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7efaea1d-cc01-4fad-8778-0f13931cb7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_us-gaap_Goodwill_7efaea1d-cc01-4fad-8778-0f13931cb7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_69703d5e-55fa-4aa8-8372-6f4d3940dc90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_us-gaap_ContractWithCustomerLiability_69703d5e-55fa-4aa8-8372-6f4d3940dc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1f3889b3-de04-4227-aecd-db7831e58cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1f3889b3-de04-4227-aecd-db7831e58cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers_635ab7b3-1a97-4f91-81ec-99bfc1271aeb" xlink:href="iclr-20211231.xsd#iclr_IncreaseDecreaseRevenueFromContractsWithCustomers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_05e0c4c1-c43f-40ad-8f00-c6b99926783e" xlink:to="loc_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers_635ab7b3-1a97-4f91-81ec-99bfc1271aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedParties" xlink:type="simple" xlink:href="iclr-20211231.xsd#RelatedParties"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_7b3fb738-0bb3-4b6a-8309-3ea2585448e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_7f537612-56d9-4044-872d-88b3bfb3879d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_7b3fb738-0bb3-4b6a-8309-3ea2585448e3" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_7f537612-56d9-4044-872d-88b3bfb3879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#RelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a5598102-093b-4def-908f-d505ddca5e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a5598102-093b-4def-908f-d505ddca5e69" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_a7610941-d5ff-4dd6-a72e-ad26471fda8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_a7610941-d5ff-4dd6-a72e-ad26471fda8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a7610941-d5ff-4dd6-a72e-ad26471fda8e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DSBiopharmaLimitedMember_418f33f5-b33e-43b4-aa23-cc221db0d8f0" xlink:href="iclr-20211231.xsd#iclr_DSBiopharmaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:to="loc_iclr_DSBiopharmaLimitedMember_418f33f5-b33e-43b4-aa23-cc221db0d8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember_09b62cc2-8b1c-4ea6-b897-865f7489d642" xlink:href="iclr-20211231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:to="loc_iclr_AfimmuneLimitedMember_09b62cc2-8b1c-4ea6-b897-865f7489d642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_94494403-5045-4bd1-ba7b-9070ce3cf68c" xlink:href="iclr-20211231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_3501013d-e4df-4655-8fbc-ab1e1ad97e1a" xlink:to="loc_iclr_OncacareMember_94494403-5045-4bd1-ba7b-9070ce3cf68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7c2311b0-9191-44b4-8eac-f7982d371198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7c2311b0-9191-44b4-8eac-f7982d371198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c55ca080-a8ab-4f49-9725-2f24b430a958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7c2311b0-9191-44b4-8eac-f7982d371198" xlink:to="loc_us-gaap_RelatedPartyDomain_c55ca080-a8ab-4f49-9725-2f24b430a958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember_164be0b0-e73f-4e03-b165-ce93cc928ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c55ca080-a8ab-4f49-9725-2f24b430a958" xlink:to="loc_us-gaap_SubsidiaryOfCommonParentMember_164be0b0-e73f-4e03-b165-ce93cc928ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f2148156-af5f-4894-bdfd-1c6ee06e3259" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f2148156-af5f-4894-bdfd-1c6ee06e3259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_45ada2b3-4c21-4a25-b3a7-00aa41798e12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f2148156-af5f-4894-bdfd-1c6ee06e3259" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_45ada2b3-4c21-4a25-b3a7-00aa41798e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_6256a646-47c5-4c77-954c-9cdd25813d75" xlink:href="iclr-20211231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_45ada2b3-4c21-4a25-b3a7-00aa41798e12" xlink:to="loc_iclr_OncacareMember_6256a646-47c5-4c77-954c-9cdd25813d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7db1deb2-a9b3-4116-b413-7f244f5e586b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_09a5ad00-47b1-4fa5-9ea3-64d9f18ea24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_RevenueFromRelatedParties_09a5ad00-47b1-4fa5-9ea3-64d9f18ea24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties_32f0d275-aaad-43a9-af5f-a13d953ed63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_DueFromRelatedParties_32f0d275-aaad-43a9-af5f-a13d953ed63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_e58e3537-15dc-4f25-80c6-01bbb8ee2879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_e58e3537-15dc-4f25-80c6-01bbb8ee2879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_7dc4572e-cbd0-4794-95ed-2c930f7a552f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_7dc4572e-cbd0-4794-95ed-2c930f7a552f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0f8ba22c-d65d-4824-98ef-12ee56494708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0f8ba22c-d65d-4824-98ef-12ee56494708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_a92c8a1e-3b46-4b2d-bc18-bb9078365181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_a92c8a1e-3b46-4b2d-bc18-bb9078365181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_7c630cb5-67f5-482f-906a-4cd893707d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_7c630cb5-67f5-482f-906a-4cd893707d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestReceivableRelatedPartyLoans_46d0d666-da67-4040-8da0-57604c312cd1" xlink:href="iclr-20211231.xsd#iclr_InterestReceivableRelatedPartyLoans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_iclr_InterestReceivableRelatedPartyLoans_46d0d666-da67-4040-8da0-57604c312cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_878cb494-1092-47ba-9c6b-fd921f5edd8d" xlink:href="iclr-20211231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10d2cd4e-587d-46ca-975d-90dc8abf11ee" xlink:to="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_878cb494-1092-47ba-9c6b-fd921f5edd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShare" xlink:type="simple" xlink:href="iclr-20211231.xsd#NetIncomePerOrdinaryShare"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_43814d94-196e-4120-8284-b88b6b9f7421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_bf503a29-4a49-417e-9d3d-83321484879a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_43814d94-196e-4120-8284-b88b6b9f7421" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_bf503a29-4a49-417e-9d3d-83321484879a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" xlink:type="simple" xlink:href="iclr-20211231.xsd#NetIncomePerOrdinaryShareTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_441aed3e-1922-495e-9bbe-b05c31e8a1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9180a924-41a0-4531-811c-04508cbda000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_441aed3e-1922-495e-9bbe-b05c31e8a1a9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9180a924-41a0-4531-811c-04508cbda000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_b5b9045e-0993-4efe-aa5b-c68e65fca576" xlink:href="iclr-20211231.xsd#iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_441aed3e-1922-495e-9bbe-b05c31e8a1a9" xlink:to="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_b5b9045e-0993-4efe-aa5b-c68e65fca576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d6e130a0-a867-4b56-96fe-5a71dd9df974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67f668e7-58fd-45e9-ae69-b5d9ba32eca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d6e130a0-a867-4b56-96fe-5a71dd9df974" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67f668e7-58fd-45e9-ae69-b5d9ba32eca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_aa9e5c41-50fb-4606-883a-7750fd92e5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d6e130a0-a867-4b56-96fe-5a71dd9df974" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_aa9e5c41-50fb-4606-883a-7750fd92e5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47b360e6-2513-4582-b82c-40000cb4ea82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d6e130a0-a867-4b56-96fe-5a71dd9df974" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47b360e6-2513-4582-b82c-40000cb4ea82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_70a4b1cc-8e17-44ba-8f03-e24b92d105cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2bcc01b0-29d9-4656-96a5-ae1c2787c34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70a4b1cc-8e17-44ba-8f03-e24b92d105cf" xlink:to="loc_us-gaap_NetIncomeLoss_2bcc01b0-29d9-4656-96a5-ae1c2787c34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_350250cc-86ce-45ab-8219-59a6ef931cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70a4b1cc-8e17-44ba-8f03-e24b92d105cf" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_350250cc-86ce-45ab-8219-59a6ef931cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ddf4a2a1-9310-4082-8849-9ca5e30d3c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70a4b1cc-8e17-44ba-8f03-e24b92d105cf" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ddf4a2a1-9310-4082-8849-9ca5e30d3c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_c0935e61-91f5-4fcf-aadb-83d8411f65b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70a4b1cc-8e17-44ba-8f03-e24b92d105cf" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_c0935e61-91f5-4fcf-aadb-83d8411f65b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_535674a9-8d7f-415e-970c-36a6100525ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_c0935e61-91f5-4fcf-aadb-83d8411f65b2" xlink:to="loc_us-gaap_EarningsPerShareBasic_535674a9-8d7f-415e-970c-36a6100525ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5ab107b9-23f4-4d03-817d-52d0e7a62b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_c0935e61-91f5-4fcf-aadb-83d8411f65b2" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5ab107b9-23f4-4d03-817d-52d0e7a62b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEvents" xlink:type="simple" xlink:href="iclr-20211231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_285c9c93-6bc0-448e-9686-6e567bf2faa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_93ee11e6-c9e3-4aa6-9479-ff2e768b5766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_285c9c93-6bc0-448e-9686-6e567bf2faa3" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_93ee11e6-c9e3-4aa6-9479-ff2e768b5766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="iclr-20211231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_2d9b3709-ec56-4a33-adcf-151eca8c3334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_2d9b3709-ec56-4a33-adcf-151eca8c3334" xlink:to="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1d71eae8-52e0-4ae9-830f-b207b81421bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1d71eae8-52e0-4ae9-830f-b207b81421bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d4a67005-83c8-41ff-a419-078e06bf0fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1d71eae8-52e0-4ae9-830f-b207b81421bb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d4a67005-83c8-41ff-a419-078e06bf0fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c375c92b-156b-4859-8176-7f915659c6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d4a67005-83c8-41ff-a419-078e06bf0fc7" xlink:to="loc_us-gaap_SubsequentEventMember_c375c92b-156b-4859-8176-7f915659c6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f2f3df26-86fd-4210-8ac9-4c12aa11fb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f2f3df26-86fd-4210-8ac9-4c12aa11fb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1470c73c-7b7c-43cd-87b2-b7036f9af79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f2f3df26-86fd-4210-8ac9-4c12aa11fb55" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1470c73c-7b7c-43cd-87b2-b7036f9af79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_be4bdbf0-1e1d-4e41-bfbf-83b6df954429" xlink:href="iclr-20211231.xsd#iclr_BuybackProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1470c73c-7b7c-43cd-87b2-b7036f9af79e" xlink:to="loc_iclr_BuybackProgramMember_be4bdbf0-1e1d-4e41-bfbf-83b6df954429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_187f9769-41aa-4a0c-8515-c26c6528f540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5b769548-61dd-4e21-9d0e-fec2942ce5e4" xlink:to="loc_us-gaap_SubsequentEventLineItems_187f9769-41aa-4a0c-8515-c26c6528f540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f0c7f041-e9c4-4cdd-906b-d2e78e7a66cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_187f9769-41aa-4a0c-8515-c26c6528f540" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f0c7f041-e9c4-4cdd-906b-d2e78e7a66cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6350509b-b075-4fdd-93c2-8e50afd95bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_187f9769-41aa-4a0c-8515-c26c6528f540" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_6350509b-b075-4fdd-93c2-8e50afd95bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>iclr-20211231_g1.jpg
<TEXT>
begin 644 iclr-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)Y<FYE+"!%
M86UO;FX   60 P "    %   $*:0!  "    %   $+J2D0 "     S8Q  "2
MD@ "     S8Q  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M:+\_S/0Z*2EK,[PHHHS0 4444 %%%% !1110 4444 %%%% !1110 449HS0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH XGQ7X6NX;X^(_"N(M4B&980/EN5[@CU_G7#)XBDM?$J:I
MX4TJ]ANG4MJ=@8OW9QR2,?CVKV^F^6H8D* 6ZG'6M8U+*S/-K8%3ES4Y<O7Y
M^1YSKWQ+BNM)M[?P[%--?:A$1'Y1'F02#L5K4\%>"AI1;5M9(N=7N3YCR.O,
M1(Y ]_>MVU\*Z+9:JVI6NG0Q7;$GS%7D9ZX]*UZ3DK6B53PTY5/:5W=K;M_P
MX4445F>@%&*** #%&*** "DQ2T4 )BEQ110 8K%U?PKIVM:WIFJ7HD-SI;E[
M?:^ ">N1WZ5M44TVA-)JS$Q2XHHI#$Q2XHHH 3%&*6B@ Q1BBB@ Q1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 457O;VVT^U:XOIXX(5^\\C8 KEI/BEX5CN/*^W,XS]
M]8B5'XTU%O8QJ5J=-VG)([&BJ.EZUI^M6_G:7=Q7,8ZE#R/J.U7J6QI&2DKQ
M84444%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU-==X:\>:+HGPRM=6N;S4[N*:X>*$79\RYF?<?E !Y_PINFT*->,CTNBN/\
M#_Q'TO6[^>PN;2^TB\@B,[0:C 8B8QU8>U9D?QET![F)GLM3BTR:;R8]4DM2
MMNS9Q]X]JGEEV+]K#N>AYHK \;W,MM\/]=N;65HI8].G>.2-L%2(R001WKSS
MP9\6[/3?!^D)KUOJ\RL!%-JDD#-")">A<]::@VKH)58QE9GL5%<W;^-;"Z\<
MR^%XHIC<QVRW/G<>6RD C'.>_I7'^*_B%I6J^&]5 DU>P72]22UEELV5)&;<
M1P<_=XI*+8Y5(I7/5**\QT[6KF/XX:I;W.H3#38-)2;RI)#Y:< EL=,^]8OC
MOXM6VJ^ =3'A^#6+,L\:6NIB!HXI&$JE@KCH2H;KCTJO9N]B/;Q2;9[117E/
MAWQ);1>,0+J^U:>ZA\/QW4MNT@-N1L0E@"<[^>ON:M1?'#0Y+"WOVTG5TL99
M/+>[-M^ZC;.,%LX)[\4<DN@U6AU9Z917'^(_B1I?A_5+;3([6^U34+B(3+;6
M$)D=4/0D?ATJ?P?X]T[QI<:A#IMO=0FP<))]H3823GMU'3O4\KM<M5(-\J>I
MU-%%%26%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)"DE71AAHV'52/45HU#.J,E)<T=@HHHH*"BBB@ HHHH **** "BBB@ HHHH
M***S-=URVT'3S<W.69CMBA3EI7/10*:5R924(\TMC2I:\VCU+Q:NO0+;W44^
MH70,EQICK^YM(OX<L.0W\ZUKFS\::L#;OJ6F::J'<S61=Y-V/E!S@ >M5R6Z
MG)'%J2=HL[.BL#PUK\FI>;8:G']GU:S %Q%V;T=?8UOU+5F=5.<:D>:(4444
MBPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JLFFV<U
M]'>RVL3W,0(CF9 64>QJU10)I/<****!A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>>^,]&N=
M BU/Q%H]Y@W2;+N"?!W \#8W52">G0UZ%6;KVCQ:[H\UA,[1A\%70\HP.0?S
M%5&5F<V)I>UIM+?IZG(?#^WO]2L;"[FNH(M/LXO+CM;0D>9)T9I??VIGB'3=
M5\)PW3Z!<M%I%ZW^D @NUCD_,Z#TQ^59#7VI>%=>\[[+,-3=@ES!#$3#J*?\
M]$Q]UQWKH-3\82^($ATKP@IENKN(/+.P^6U4D@[N#\V1C!]:U:?-?H>7"=/V
M/LY-J:^_^O(Z?P[IVGZ9H=O!I#![<KO$N[<92>2Q/<FM2LSP]HT>@:';Z=#*
MTJP@Y=NY))/'89/2M.L7N>S25H)-6"BBBD:!1110 4444 %%%% !1110 444
M4 %<WXG\./J-Q!JMA>&UU"P4F(R -$1U(93T^HYKI*9-$D\+Q2#*.I5AZ@TT
M[,SJ4XU(\K/(_!;ZGXDGOH8[N"R2XO&N;N2-B+AT)X13_=XQFNS\0Z-J-C?-
MX@\+D&]";;BT<G9=*!Q_P(=C7)ZQI5WX2FB_>R)':Y.FZDD98H,Y\B8#JI[&
MMO\ X62ITB)!IT_]N2GRUTXJ0V_ .?7:1WQ6\KMWB>+1<(4W3K-J2Z_Y?UJ:
M'@*&UN--EU4SFZU*[;_3)7&&1A_RSQV ]*ZVN<\(:#=:5#=7FJ3>;?W[B28*
M %3T''4CUKHZQEN>KA8N-))JS"BBBI.D**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>7L&GV<MU>2
M+%#$NYW8X %6*\]\9W4L7B"%O$-O-_PCUNH>/RAF.6;^'S?09Z545=G/B*WL
MH<W]?,U+;XC:.TH345GTT2+O@>YC(69/48IUS\1=&BN(UMQ/=0D_OKB*([(!
MG&6)[5SW@_5[;4M8BO/*_M/5KX'SMH^33X <!>>G]:V;OQ.=$GO-/\66B>5(
M&-K+#&2ERA_Y9X_O=L5HXI.UC@AB*LJ?,YJW>WY]#L8I4FB62)@Z. 593D$>
MM/KF/ NF7NEZ"R7@:&.65I;>U9MQMHV.0A/^<5T]9-6=CTZ4G."DU:X4444C
M0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M75XXH7E!C(+.%4L0O/)P#7D-S:C3=/N-)U*R34-86^@Q?/.AD524(7LQ('&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXE#7$I\N('IGU_"M'I[J/9KS]G; 87=[ON_\C*\=>,5T>W.GZ>X:]D&&8?\
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M[^TI(+15N2!TC,HP2HI^X"=<]%HI!2UB=84444 %%%% !1110 4444 %%%%
M!1110 5S^N^*X=(O([*VM9M0O64R-!;X)C0=6;/3^M:VIF[72[DZ8J/=^6?)
M60X4MCC->0RZQ!8*FDZF\^GWU_*3K5U.O[PJ!D*I'\)S@8K2$;G!C,0Z5DM+
M]3OH/B-X?GM1*DTY8CF,0.6!].!5G0?%L&M74EK+:SV%R%\R.*Y7:TL9Z,O^
M%4K.YU*;P>EQX=TV.R$+_P"C6TR\S0C_ -!)[5E7FI)XVU'38-&MY(+ZRD$M
MS<R*5:SP<&/W)P1BGRIF7UBI'E;=WVMOZ'H=% Z45D>H%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M006NJVH_?09X8=G0]U/J*PM0NXF^)%M'X8C9KX'&IM'Q'Y?'WP1R<'@BIH?
MVA733/HNJ3I>P$()X[CS&A'/R8].3Q71>'?#EGX<L/(M-SR.=TT[\O*WJ35W
MBM4<L88BHE"I96Z_UU->BCI4-M=V][%YMI-'-'DKNC8,,CJ,BLCTR:BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGW%^@I]+F2DW5<?06BBBD:A1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVW:T6Y%N"LD!QA&7VP.?:I[GX=W+Q:7>6_B"[_MO3FD9;^<>;Y@?[RE3_#Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"F4%21GU.1C/TJ9:Q?4N"Y:D;JVAS7QFNKSQC\0#H6CJ9AI%I)-(H[L%WO\
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M)7/B?Q%H#+$'L8#.MVQ8 JKQE00._)KAM(^%WB.TT6/[>J3WT>KVA4^8.+6
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M]3R?3]8E\'7DC,@M#%M74-,9L*XZ">#/7/<5U_B'Q?IPT&(62IJ4VHIMMK8
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M>(K23Q+K5C!9WIB@BL+#[0H7W('%=O'X[G_M*6RT_1;W5+:PG6SN[^)E!$O
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MCMPR_>3N[VTO^GJ.HHHK,[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[>#[7%_9UQ)<6\B7!#JTAR_/<&B\-Q<E6UKE+2/'&KZL%U*'1(CH;SR1"87
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MN'+.STU,+P;J=Y;_ !*.D0W.O2:;/IC7(37"QD\Q9 NY-W(7!KHOA=_R)?\
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MW@X(W5WR>,O#TFGS7R:M;_9H75))"2-A;[N01GGM0GC+P_+="VCU2%IBNX(
M?[N['3KCG'6CFEV#V<.DCR\:1JAT22SN-(U@6\5Z\UO$+9V0JT:X!C#[@-VX
M]?E)YK0M-'UR+Q+HMS<Z7J1N0+7S/,E:1(% &_$H; QSE6!W?C79:5\0]#O_
M  [;:O=W*V,=P[H(Y<D@J2#T'(QSGIS5ZZ\9^';.YBM[G5K=))421!DG*/\
M=;(XP?7I3YI=B53A_,>:Z?H>K7VNDWFFZE9)>P7*7DKHX1)>'C)8N=P!7AL
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M '6JY/,Y_K4N7F<++KJCT"BH;2X2[LX;B,,%E0. PP0",\U-69W)W5T%%%%
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M\:D(PC'WE_6OD=XI!4%>G:G4@   '0=*6L3V@HHHH **** "N8T#_D>?%/\
MUUMO_1(KIZYC0/\ D>?%/_76V_\ 1(JELS"I\4?7]#IZ***DW"BBB@ HHHH
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MSCE\X[VD>3RUCW,3S\J@ #V%:E%#DVK%JG&+N@HHHJ2PHHHH **** "BBB@
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M=U^?3[O3[:YD:.PM[R,QO'&S;W^0_=!;'Y4_<:N+]ZI)-GJ HHHK$ZPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .9C_P"2J3?]@A?_ $;735S,
M?_)5)O\ L$+_ .C:Z:JD<]#:7JPHHHJ3H"BBB@ HHHH **** "BBB@ HHHH
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M75Q%=V\2*P#GYV*],#H!VQGFM;2/B=I&K:E:6R6M];PW[E+.[GAVQ3L.P/\
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M %3:+XRM-7U)K)[:XLI&!>W^TIL^T)_>7_"GRR,EB:+:2EN='1114G0%%%%
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MCL &^4@A^%&,UF:Q\-]?O1XO"26\K:P+86\COM+%  Q8 87IVKN_^$X\-?\
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M3US&C?\ )0_$G_7&T_E)73U4C"C\+]7^84445)N%%%% !1110!R\O_)4;?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445Q7BSXDV/A3Q5I>B7%LTS7V#+,)-HMU9MJDC
M!SDY].E-)O8F4E%791^*_A^\\0MX:@M+.:YACU6-KHPYS'%D!F)'3CO63?\
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M14'2%%%% &7XF_Y%35?^O27_ -!-)X8_Y%/2O^O.+_T$4OB;_D5-5_Z])?\
MT$TGAC_D4]*_Z\XO_015?9.?_E_\OU-6BBBI.@**** "BBB@ HHHH ****
M]*\FT7XCW.CVU])K$=YJC3:_)I]M'" 608RJ@<9Z8KUFO.H?A=)%<VTO]JH?
M)U_^V,>1U'_//[WZ_I5QMU,:BFVN4L1_%73TTO59]1TR^LKS3)HX)+"15,CO
M)GRPN#CG!_*N;N_'>J3^*-<^V1:IH]K:Z$)S9ML$D<GF??4\@Y!'/UKH=5^&
M']JW_B"Z;5##)JD]K<6[)#DVTD.[!.3\V=_M5>X^&6JZC>:I>ZOXBCNKG4-,
M^P%EL]BQX?<" &Z<=/4GFK7(C*2K-V)[_P")::'IUL?['U+4(H["*YN+HLB!
M590>K$;VQR0M=OI>H0ZMI-IJ-IN,%Y D\>X8.UE##/X&O.-1^$-S?23[=:A9
M)[&*U_TBR\UH2D83,9+?*#C)'N>:] \/Z8VB^&]-TMY1,;&UBM_,"[=^Q N<
M<XSBIERVT-*3J7]XT:***S-PHHHH *;)_JF^AIU(1D8- '@F@ZCJEMH7ABPT
MK4IK!=1UZ\AG>( DKN]Q47B2XU.^\-:K;:KK5U.FC^((K:.1RH+(Q4Y;CJN.
M/J:]NC\.Z1"+<1:=;K]FE::'"#]V[=6'N:)?#ND30W4,VFV[Q7<GF3HT8(D;
M^\?>MO:*^QR.A*UKGD?B?Q9XBC\5:AING7US';:=90O:R)=6\(F)4'S',I&\
M9X^7TK6T74?%'B7QS:V=SJ\FFPKI%M>7,-OL<.Y8YVMR,-CMV->AW?AC0[U8
M/MFE6DPME"Q>9$#L4= /:HM/O_#EWKDS:9<64NHK&(I#$P+[%/"\=@:.=6T0
M>R:E[TCR23Q)XF@\.W7B$:_=,UMK[6:VS*OEM'YF,'C-+XJ\<:Q%?:K>Z3JM
MV([+4DME#M%'$,,%9!%R[]_FX%>OKH.B3Z>8$L+62TEE^T%54%7<G._W/O67
MJEIX(CU&Z;5H=+6[.PSF55W\L-N?<G%"FNPI4I)?$>:ZI)-I7CCQY=P:O<07
M<6G12PJ77]Z2A.,$<A>U:-KX@U+5]>_L_4_$LFA6UKI$%Q"Z;$-T[H"SDL,$
M \8%>DOHGA_6Y!?O8V=X[(8O/*!B5^Z5S^8J6]\,:)J,<$=]I5K<+;KMB$D0
M.P>@]J.=#]C+HSROP_XB\2^*]2\-V4^L7%BMW:W9FF@109Q&^%<9'!([U6M?
M&FMRZ19Z;<:M>2W@U:ZM-\ BC>>.+&-TCD*O7TYKV5-)L([FWN([.%);:,Q0
MNJ &-#U4>@XJI-X3T&XMS!/I%I)$96F*-$"-[=6^II<Z[![&=MSQB/7-1UN#
MPW_:MR;E[7QA##'(S!SM#C W 8;ZU[_65%X8T2%8Q#I=J@BG%P@6, +(.CCT
M-:M3*2EL:TH."U9SOCG_ )%6;_KK%_Z&M="GW%^@KGO'/_(JS?\ 76+_ -#6
MNA3[B_04GL*/\:7HA:***DW"BBB@ HHHH **** "L7Q?:SWO@W5K:TB:6:6U
M=4C09+$C@"MJLWQ!K=OX;T&[U>]CED@M(_,=80"Q'L"0/UIK<4K6U/&;;X<:
MRFM:';QVDT>DZE;6TVK1E>(YH1]T^F<#\2:BM_!?B.VT33KIM-O6BLM4NI);
M&*)&D*OC9(J/\K=*]SLM0@OK""[C.Q)HUD"N0" PR,\]:L!U+$!@2.HS6OM)
M'*L-"VC/#H_!NLV%CI.K_P!AWM]:P:I)=SZ1,T1DVL,!@@ 4<\[><57O/"^N
M7FB>(VMO#5U9?;=7M;B"T$8SL').%XX[^E>\"1"Q4,I;N,T&5!G+KQUYZ4O:
M,KZO'N>/R:#JNGZAK6FW7@[^W)]2U$7-OJ+E?*"$C&Y\AE*X/ K(\7>'O$EW
M<>)[:/PY=N]U(IMI;.&,Q2H ,,SL=V[V%>TZ9JRZE'.S6ES9^5,T(%RJJ9,?
MQ+@G(/:KXD0KN# J.^>*/:-,7L(N.YP'@/2-1L/&WB6[OK2:&"Z2T\F21<"0
MK" V/H>*]!IJR(WW6!XSP:=6;=W<WA%15D%%%%(LYC1O^2A^)/\ KC:?RDKI
MZYC1O^2A^)/^N-I_*2NGJI&%'X7ZO\PHHHJ3<**** "BBB@#EY/^2I6__8-?
M_P!#%=16!)87)\?PWXB/V9;%HC)G@,6!Q6_52Z'-033G?O\ H@HHHJ3I"BBB
M@ HHHH *YC0/^1Y\4_\ 76V_]$BNGKF- _Y'GQ3_ -=;;_T2*I;,PJ?%'U_0
MZ>BBBI-Q#7$:'\0&U'2-?N+VWCBN=*FD5(E)_>IDA&Y]2I'U%=Q7"I\-E%Y8
M3-J) @N))+I$BP+J,R^:B'GC:W?ODU<>7J95.>ZY2WHWCVSE\-:??:^ZV=W=
M1&22&&)Y!& Q4D[0=JY'4\4>)O'^FZ/IMT;"9+J\A\L!!%(T>7*X#.HV@[3G
M!.>E9LWPR<Q0>1J,0E6U:TE:6!F5D,CN"H#C!'F,.<@^E27/P[O%TN_TK2]7
MA@TZ_F2>5);7>ZN-F=K!@,'8#TXJK0,[U;6L:D/C?2+:.=;^]BWPW,\02UMY
MG\M(W*_, I(QC!;[N>AQ5V7Q?HD5]':->YEE**A6%VCR_P!P%P-H)R, GG-8
M5KX"O],U#4+[2=8BAGU"2X,IEM2X5))6D&WYAAEW$9.0?2HKSX>:A<7"NNM1
M.L=S!<1O/;,TF8BI"G#A<';V4'FBT.X*56VQL/XDN1\/;K7UAB^T0V\LJQG.
MPE"P /?'%00^)=3TN^LXO%*V*6]]"\D5S:EP(RB[BK*V>JY((/8U<?PR[>!;
MGP^MTH>:"6(3F/A2Y8YVY[9]:S+SP3?ZXBKXAU6&58+9X;9+2V,:HS  NV78
ML<#'4#DU*Y2I<_0V+;QAHEU(D<5VXD>58522WDC;<P)7(900#@X)X/K59?&N
MDM?76=0@%I;1G>3%('WK(8S@D88;AM&W))Z5F0^ )UT^^634(4O9UB$$T,#!
M83&Q96PSL3R3QD"B;X=!X[<07XB>VM88XG\G.9HY?-\QAGD%LY'OUIV@+FJ]
MC:_X3/0_LWG?:I?O^7Y7V67S=V,X\O;OZ<]*UK&]M]1LX[NRE6:"4;D=>XKE
M-1\%ZEJDT=[>ZK;R7T<C%1]F980A4#;M#ANP.=U:GAW2[[16&GO)'+8Q0*5=
M8]A:4LQ;N>.1_B:34;:%1E._O(WZ***@V"N=L/\ D?\ 5O\ KU@_FU=%7.V'
M_(_ZM_UZP?S:J6S,*OQ1]?T.BHHHJ3<***PO&NH76E^"=6O;#/VF&V=HR.QQ
MU_#K32N[";LKFR)X3*8A*AD'5-PS^5(US F[=-&NT@-EQP3TS7D5EX0\,VW@
M#2O$UUK,^G:E)'%<2ZPLI:0R-@E2,\C)QCVK,U_48['5_&5P]G;WZMJE@HCN
M5)7F-?FP"#FM.1'/[9I:H]UJ">.VO(Y;681S*R[9(C@\'U%>87_Q!\5PVOB/
M4+&STDZ?H-UY4@E\P22KA>!@X! /4_E4$OC[^R=8\3:C:Z3:_:6AT\1-\P:5
MYE.T2-G&%SV I<DANM!Z'6/\.-,1A-8W5Y;W47_'M+YQ;R.<X4'M[5I>&_#%
MEX7LW(E,UQ)S/=2G!?G]!STK G\4^*M#L-3;Q#::,TEO;K-;S077EQL20-KJ
MQW#'J.M<EK'CK4];T#Q+HNIK9RJFDBZCN+6*2,<M@KA^3]:JTWNS!0P].7-&
M-F>R/>VL>!)<PKD9&Z0#(]:<;F!81*9HQ&>CEQ@_C7@HM=-N_&FCIJWA^[UV
M(>%[,K!:QJ[(<?>(9EX_&LN_MC>?"*YMXBT$,OB(106;L2UHI) 0^A'I1[/S
M-/K#UT/H^2>&*,/+*B(>C,P /XT\$$ @Y!Z$5\R>*M6O?$?@?3] =V\WP]!-
M-J)/8QMY48^O/Y&OH[0_^1>T[_KUC_\ 014RARHTIUO:.R+U%%%9FX5R\W_)
M5+;_ +!;_P#HP5U%<O-_R52V_P"P6_\ Z,%4C"OM'U1U%%%%2;A1110 445Y
M]J7C37+%M1F$%F;6'4UTVW B=W+,1^\;!Z 9X R3CD4U%LB4U'<[_P M,L=B
MY;[QQU^M-\F((4$:;3U7:,&O/D\:>(KHO!;PV4,MO#=RRR7%O(HD$(B*E4W9
M7/F8()XQGZA\=:U9V<<M[!8RO>:?%=VXC#HL)DD5,.23D#<"2,=*KD9G[:!Z
M"8(BP8QH6'0[1D4GV>$DDQ1Y/4[1S7G'B#Q#X@CU2UTG[99)/'?V;&ZMXG".
MDC$;&7?QR.F>1Z5HV7C;4;GQ1':_8U-E)?RV1 @=639N&_>3M;)7[H&0#G-/
ME=@]K"]CN7C21<2*K#.<,,T>6@ &Q<+TXZ5P_B3Q5KFF76L26"6!M=+^S_)-
M&Y>4RD _,& &,^AI[>)M<2Z.E.=.%^=1^R"Z,;B%5\@39*[LD\[0-PS2Y6/V
ML;G9B"%<;8D&.F%'%*L4:,61%5FZD#&:X"3QEKT]JILTTU)8;2\FN&='='-O
M($^3##AO?./>H+S7=4O_ !!I3Z?+!9+<I92R;U=]WF)*VT_,!@8].:.1B]K'
MH>BF")F+-$A8]25&33A&BXVHHP,# Z"O/)?'NK1:;'JYALC97%W-:16@#>?&
M5WA78[L'E,D8& >M03^+M<M=+M=7NX+ WDVBR7D21B0(F9(0%/S<_?SGM_,Y
M&'MH'I*11Q9\M%3/7:,4^N(D\3ZY;W<NE3_V?]N^WPVJ7(C<1*'A:7)4MDD!
M2.HR2.E;'A'6+S6-/O'U'[,9K:^FM=UL"$8(< C)-)Q:U+C4BW9&_1114F@4
M444 %%%% !1110 4444 %%%% !1110 4444 <S'_ ,E4F_[!"_\ HVNFKF8_
M^2J3?]@A?_1M=-52.>AM+U84445)T!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%<]JOB*Y753I.A6:W=ZJ;YGD;;%;@]"Q]?85G+KWB.TCDNITTO5K:'_ %R:
M<S"2+U."3GZ<52BSFEB81=M3LJ*K:??V^IZ?#>6;B2&9=R,*LU)T)IJZ"BBB
M@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!\S;]W/KC Q3+G1-,O8Y4N[&"99I!)('0'<X  8^^ !GVJ_6/H.ISZE-J:W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I#2T4 >>16EU>Z5XOL[+/]I/>'*[MK,F!@9]P"
M*=X?TY!XHLKO2]#N-&M;:T>.]:>/RQ,2!M&/XL$$[JU?$]K-I&H1>)]-1F>
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M&<DG@<5Y&?"6LZ-H,LVK16]K-_PD?VVWMKZ[CVW2D#"EP<;OJ!3T\/ZIXO\
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M27W>OI^IWJD,H93D$9%+2  # Z"EK$]D**** "BBB@ KF- _Y'GQ3_UUMO\
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MU!;3P_"UI=;+?Q>C!3;L@CCW#G;_  K^@KZ$J)1Y3:E4<[MA1114&QE^)O\
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MB_05SWCG_D59O^NL7_H:UT*?<7Z"J>QA'^-+T0M%%%2;A1110 4444 %%%%
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MB@ HHHH **** "BBB@!#T-<WX'_Y ]W_ -A"X_\ 1AKI#T-<WX'_ .0/=_\
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M1110 4444 %%%% !1110 4444 (>AKF_ _\ R![O_L(7'_HPUTAZ&N;\#_\
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M&Z;X<N[B[MI;N[O;H 2W=]<&:5P.@R>U:2FFK&$*,E--G04449K$[ HHS10
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MU7_KTE_]!-)X8_Y%/2O^O.+_ -!%5]DY_P#E_P#+]35HHHJ3H"BBB@ HHHH
M**** "BBB@ HHHH @OO^0?<?]<V_E6)X#_Y$?3?^N9_]"-;=]_R#[C_KFW\J
MQ/ ?_(CZ;_US/_H1J_LG++_>8^C_ #1T5%%%0=04444 %%%% !1110 4444
M%%%% !7+Z]_R/?A?_>N?_15=17+Z]_R/?A?_ 'KG_P!%54=SGQ'P+U7YG444
M45)T!1110 4444 <[XY_Y%6;_KK%_P"AK70I]Q?H*Y[QS_R*LW_76+_T-:Z%
M/N+]!5/8PC_&EZ(6BBBI-PHHHH ***3- "T49HH **** "BBB@!#T-<WX'_Y
M ]W_ -A"X_\ 1AKI#T-<WX'_ .0/=_\ 80N/_1AJU\+.:?\ &A\SI:***@Z0
MHHHH ***3- '.:1!*GCSQ#*\;+')#:A'*G#8#YP>^*Z2DH!IMD0CR*PM%%%(
ML**** "BBB@#EY?^2I6__8-?_P!#%=17+R_\E2M_^P:__H8KJ*N70Y</O/\
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M61:Z;/#XJO\ 4'V^3<011I@\Y7.<C\:I;,QJ)N4;=S7HHHJ38**** "BBB@
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MB@ HHHH **** "BBB@ HHHH **** .9C_P"2J3?]@A?_ $;735S,?_)5)O\
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M?_80N/\ T8:Z0]#7-^!_^0/=_P#80N/_ $8:M?"SFG_&A\SI:***@Z0HHHH
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MV^'B0.;K3M7O8K\+Y:W$C[\1XQL([BO/M7\?(-+\ ^([J25UB,PN8XB<NZ*
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M>AM+U84445)T!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 @I:Y[1+B:7Q=XBBDE9HX9(!&A/"9B!./3FNAIM
M6(ISYU<****184444 %%%% !7.^'O^1D\1_]?4?_ **6NBKG?#W_ ",GB/\
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MAJU\+.:?\:'S.EHHHJ#I"BN*\=^,=7\.ZMHVFZ%I]M>W.J2/&HN'*@$#/45
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M&+=K)NZ04445!V!1110 4444 <O%_P E6G_[!"_^C:ZBN7B_Y*M/_P!@A?\
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MUI%>16DMU"ES*"T<+2 .X'4A>IQ4] !12$@=2!4-O>VMV\R6MS#.T#^7*(Y
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MNKVLDZ6EW:!)6BV7<7EL=IQN _NGL:B3YG<WA%07*:%%)FEJ300]#7-^!_\
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M6NI>&E:*"S7;>7V"HG!&?*Q_%CCKTKOA6<E8[L/4=2+OK;KW"BBBI.D****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YF/\ Y*I-_P!@A?\
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M,%+8Z8' /6KL<:1(%C544=%48 I2G=6L.%'EE>XIZ&N;\#_\@>[_ .PA<?\
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MO]=72X3.)'=XXIFCQ'*R_>53GKP>H[&IY64JL&[7.CHHHJ34Y>7_ )*E;_\
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M 5R\W_)5+;_L%O\ ^C!745R\W_)5+;_L%O\ ^C!5(PK[1]4=11114FX4444
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M9+747\U[$@>7&_=E[COQ[^U=-64G=G333C&S"BBBI- HHHH YG0/^1T\3_\
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MYC6?^2A>'?\ KE=?^@K51W,*_P *]4=/1114FX4444 %%%% '->-O^/+3?\
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MP:HUQJK22"[U)+R:2=DWA8HP$!" #);L.@%>C4II)Z%4G)J\C+\3?\BIJO\
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MGE X;=OZXVXW=.>E'-*UK J<+WYCD_B%::G=ZM+]ALKAVCM5-M*B22?/DDA
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M$*O"Q+072%X9U(P0X'/'4&N4D^'%RZ172R62727$DHM83+#;J'55(4H0P/R
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M@A2&%%CC0!551@ >E4Y+H<\*%5VC4E=+[_F244E&:S.\6BBB@ HHHH YF/\
MY*I-_P!@A?\ T;735S,?_)5)O^P0O_HVNFJI'/0VEZL****DZ HHHH ****
M"BBB@ HHHH **** .;^(#RIX#U4P9#>3@[?[I(S^E8'B&WL4OM)&I07,WAQ;
M3$0M0Y42<;2VSGITKO[B".YMY()T62*12CHPR&!&"#7*^'9GT#5Y/#-](6A"
MF73Y7/WHNZ9]5_E6D7H>?B*=YJ^S_K\3 FADC^&XDN5F1H]01],%QGS57S1L
M'//0G\*],7[HSZ5R%FG_  EWB8ZA)\VDZ9(5M%[33#@R>X'05V%*3+PL;7:V
MV];=0HHHJ#M"BBB@ JCI^JV^I2WD=ONW6<Y@DW#'S  \>W(J]7,>$/\ C_\
M$?\ V%7_ /1:4TM#*<VIQBNIT]%%%(U"BBB@ HHHH YG0/\ D=/$_P#UTM__
M $4*Z:N9T#_D=/$__72W_P#10KIJN6YSX?X/F_S"BBBH.@**** "BBB@ KG?
M#W_(R>(_^OJ/_P!%+715SOA[_D9/$?\ U]1_^BEJELS&I\</7]&=%117%?%7
M7;C1O!,L6G2M%J&H2+:6Q1L,&<XR#V..])*[L:2DHQNSM:*\H\'^,+SPYX(\
M06^MO<:MJ'ARX9& <O),C-\K9.3MYSGL*=<?$E]8\':W+<V2*EK:+.)-.U$$
MG+ ;=PPR-SZ>M7[-W,?;PM<]5I#TKS36OB=/X>M5*Z9"UM;VD,K-=7ZK+,&4
M']VO+.1W)Q71^+=2>7X7ZCJ5E));O)8&:-E8JR9&1R.AJ>5Z%^UB[VZ$%WX(
M\_Q&UQ'=;-)N)1<W5CCY9)EZ'Z'J?7%=>!Q7@OAK6#<7OA/_ (1?6=<U#4Y?
M*.KQ7$LTD*KL'F'Y^.N<$5V*_%:6/Q%96-YI4,,-[?BRC47J-<(2VT,\8^Z,
MGUK24),YZ,J4+M*U_F>E45P-K\0M3U*[>XTGPU/>:-'>&T:ZCF'F$@X+B/\
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MUF_735CE7RKO>$*,>, GUZ8KR?0]<F\.W=^/#ET(-!D\4P6Z-P8Q$S?O I/
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M=/7,>#_^/_Q'_P!A5_\ T6E4MF<]3^)#Y_D=/1114G0%%%% !1110!S.@?\
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M,2WWE3(S!?+<D\GYE;C'&?K56F9J5%FMJ/@*&_\ $BZN;^1'2[CNT7RD8JR
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M'UP3SWQ7H$NG64^\SVD$GF$%]\8.XCIGUIIAT^SGMOW,,4C9B@P@!Z$E1Z<
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MFT2-M>CU [ L675 O+2D;=Y/LO ^IK5HHJ31)+8****!A1110 4444 %%%%
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M_P#O7/\ Z*KJ*Y?7O^1[\+_[US_Z*JH[G/B/@7JOS.HHHHJ3H"BBB@ HHHH
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MO_V#7_\ 0Q745<NARX?>?^+]$%%%%0=04444 %%%% !7,:!_R//BG_KK;?\
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M]$%%%%2=(4444 %%%% !1110 4444 <SX>_Y&_Q+_P!=H?\ T6*Z:N9\/?\
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MO_8-/_H==+7-'_DI:_\ 8-/_ *'72U4NAST/M>O^04445)T!1110 5R^O?\
M(]^%_P#>N?\ T5745R^O?\CWX7_WKG_T551W.?$? O5?F=11114G0%%%% !1
M110!SOCG_D59O^NL7_H:UT*?<7Z"N>\<_P#(JS?]=8O_ $-:Z%/N+]!5/8PC
M_&EZ(6BBBI-PHHHH ***JZGJ-OI.FS7UZQ6"%=SD+D@9QTH$VDKLM44B,'0,
MO(89%+0,**** "BBB@!#T-<WX'_Y ]W_ -A"X_\ 1AKI#T-<WX'_ .0/=_\
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MKF-&_P"2A^)/^N-I_*2NGJI&%'X7ZO\ ,****DW"BBB@ HHHH Y>7_DJ5O\
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M /12U2V9C4^.'K^C.BHHHJ38**** "BBB@#F[_\ Y*-I'_7G<?S6NDKF[_\
MY*-I'_7G<?S6NDJI=#FH?%4_Q?H@HHHJ3I"BBB@ HHHH **** "BBB@#F?#W
M_(W^)?\ KM#_ .BQ735S/A[_ )&_Q+_UVA_]%BNFJI;G/AOX?S?YL****DZ
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MA?\ T;745R\7_)5I_P#L$+_Z-KJ*J1ST-I>K"BBBI.@**** "BBB@ KEYO\
MDJEM_P!@M_\ T8*ZBN7F_P"2J6W_ &"W_P#1@JD85]H^J.HHHHJ3<**** "B
MBB@ HHHH **** "N;\)?\?&O?]A27^2UTE<WX2_X^->_["DO\EJELS"?\2'S
M.DHHHJ3<**** "BBB@ HHHH **** "BBB@ HHHH YGP-_P @R_\ ^PE<_P#H
MPUTU<SX&_P"09?\ _82N?_1AKIJJ6YSX;^#'T"BBBI.@**** "BBB@#F8_\
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MSX><N3YO\SL_^$RL_P#GA-^E'_"96?\ SPF_2N,HK'^TL1W.CG9V?_"96?\
MSPF_2C_A,K/_ )X3?I7&44?VEB.X<[.S_P"$RL_^>$WZ4?\ "96?_/";]*XR
MBC^TL1W#G9V?_"96?_/";]*P]$\4VL.NZ[*T,I$UPC #''[L#^E9%9NF_P#(
M3U/_ *[+_P"@"MJ>85W&3[+]3&I-\\/7]&>B_P#"96?_ #PF_2C_ (3*S_YX
M3?I7&45C_:5?N;<[.S_X3*S_ .>$WZ4?\)E9_P#/";]*XRBC^TL1W#G9V?\
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M_P AG5/]]/\ T&M2MZ^85XSLNR_(PP\WR?-_FSL_^$RL_P#GA-^E'_"96?\
MSPF_2N,HK#^TL1W-^=G9_P#"96?_ #PF_2C_ (3*S_YX3?I7&44?VEB.X<[.
MS_X3*S_YX3?I7/ZIXGMI?&VAW AE"PQW (.,G(7_  K,K*O?^1DTW_<E_D*V
MHYA7E)I]F85YOE7JCTC_ (3*S_YX3?I1_P )E9_\\)OTKC**Q_M+$=S?G9V?
M_"96?_/";]*/^$RL_P#GA-^E<911_:6([ASL[/\ X3*S_P">$WZ4?\)E9_\
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ME9_\\)OTKC**/[2Q'<.=G9_\)E9_\\)OTKG]&\3VL'B_Q#.T4I6=X"H&.,1
M5F5EZ?\ \C!JW^]%_P"@"MJ>85W&3?1&%2;YH>IZ/_PF5G_SPF_2C_A,K/\
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M <[-3PCXHM;33[U'AE):_G<8QT+DUO\ _"96?_/";]*\WT#_ (];G_KZE_\
M0C6K6^(S"O&JXIG/AIOV,3L_^$RL_P#GA-^E'_"96?\ SPF_2N,HK#^TL1W.
MCG9V?_"96?\ SPF_2C_A,K/_ )X3?I7&44?VEB.X<[.S_P"$RL_^>$WZ4?\
M"96?_/";]*XRBC^TL1W#G9IQ^*+8?$2:[\F78=-6/'&<^9FN@_X3*S_YX3?I
M7FZ?\C=)_P!>8_\ 0ZUJVK9A7BU;LC"A-VEZL[+_ (3*S_YX3?I1_P )E9_\
M\)OTKC**Q_M+$=S?G9V?_"96?_/";]*/^$RL_P#GA-^E<911_:6([ASL[/\
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M **** "L[2HWCEOS(I4/=,RY'48'-:-'%:1DXQ<>Y$H7DI=@HHS16984444
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M#')>VUN-\BJ""Y/7ZCUK L=1GTYW:WV9==K;USQ4G]KW(G66-88V"E2$C #
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M HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
IBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>iclr-20211231_g2.jpg
<TEXT>
begin 644 iclr-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *3!2H# 2(  A$! Q$!_\0
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M _Z!V@_^ \O_ ,<KYPHH_L3+?^?"#_6;./\ H)D?1_\ PWA\0/\ H':#_P"
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M $#1/H/_ (;<\=_\^&B?^ \O_P <H_X;<\=_\^&B?^ \O_QROGRBCV4.P_\
M5G)O^@:/W'T'_P -N>._^?#1/_ >7_XY1_PVYX[_ .?#1/\ P'E_^.5\^44>
MRAV#_5G)O^@:/W'T'_PVYX[_ .?#1/\ P'E_^.4?\-N>._\ GPT3_P !Y?\
MXY7SY11[*'8/]6<F_P"@:/W'T'_PVYX[_P"?#1/_  'E_P#CE'_#;GCO_GPT
M3_P'E_\ CE?/E%'LH=@_U9R;_H&C]Q]!_P##;GCO_GPT3_P'E_\ CE'_  VY
MX[_Y\-$_\!Y?_CE?/E%'LH=@_P!6<F_Z!H_<?0?_  VYX[_Y\-$_\!Y?_CE'
M_#;GCO\ Y\-$_P# >7_XY7SY11[*'8/]6<F_Z!H_<?0?_#;GCO\ Y\-$_P#
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M=2,@@^A%>=4INF]3\*S[(,3D-=0J^]"7PR[_ .3\BQ11161\N%%%% !1110
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MPO@]4D;RV'_?+FL*\%4IM'N9'C)8',*56+TND_1Z,_6NBBBOF3^F1&8*I).
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MRN_P.0HI%_>?=^;_ '>:<J,X)568#K@9Q3-Q**[SX3_":Y^*TFNK:ZC#I_\
M95G]L8RQE_,'/RC!&#Q67K7@VRTKP3H>O0^)-.U"[U$XETBW8&XL^"<R#<2.
M@[#J*GF5['#]>P_MWA^;WTTFK/1M-KI;5)G+T4;3MW8.W^]CC\Z!EF  R3T
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MA0, C Q76_"GXC:IIO[.OQ(NH8-/W^'[MX;-6M%*,NY3^]'\9^8\GVKAK/\
M:ZTGPWXLNM?\-_#73=,O]0#'4)Y+MFEG8G/#!0$&[D@#DXKA_A?^T'=?#G3_
M !'I=QX>T_Q#HNN3&>XL;XD*&/49P01C'!'85=? 8K%\U2='_GW9-K7E;YNM
MMF9X;-<#@.2E2Q%_XUY*,K+G2Y=TF[-?)_>>A^,M/M]<_9)\"7KVUK;W^I>(
MF6:ZBA5#\\UUGD#H../85UOQ5^*5S\ ?B#X8\!>%=(L(?#<5M;F\MY+57>^\
MQRK;F/.<#KUR3G/2O O%7QNG\2_"O3? R:-;Z?9V&HR:A%<02G(W/*PC"XP
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MC<#D>F2>IKT7QA;0:I9_!7Q!<WNG:[K<GB.WMYM;T^$1I<KN?=C@9&4'X@D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#B*/\ 6K,>Z^X/]1LG_EE_X$> _P##!?CW_H+^'_\ O_-_\:H_X8+\>_\
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MK5F/=?<'^HV3_P LO_ CP'_A@OQ[_P!!?P__ -_YO_C5'_#!?CW_ *"_A_\
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M'_A@OQ[_ -!?P_\ ]_YO_C5'_#!?CW_H+^'_ /O_ #?_ !JO?O\ AM;X6?\
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M_07\/_\ ?^;_ .-4?\,%^/?^@OX?_P"_\W_QJO?O^&UOA9_T$M3_ /!1<_\
MQ%'_  VM\+/^@EJ?_@HN?_B*/]:LQ[K[@_U&R?\ EE_X$> _\,%^/?\ H+^'
M_P#O_-_\:H_X8+\>_P#07\/_ /?^;_XU7OW_  VM\+/^@EJ?_@HN?_B*/^&U
MOA9_T$M3_P#!1<__ !%'^M68]U]P?ZC9/_++_P "/ ?^&"_'O_07\/\ _?\
MF_\ C5'_  P7X]_Z"_A__O\ S?\ QJO?O^&UOA9_T$M3_P#!1<__ !%'_#:W
MPL_Z"6I_^"BY_P#B*/\ 6K,>Z^X/]1LG_EE_X$> _P##!?CW_H+^'_\ O_-_
M\:H_X8+\>_\ 07\/_P#?^;_XU7OW_#:WPL_Z"6I_^"BY_P#B*/\ AM;X6?\
M02U/_P %%S_\11_K5F/=?<'^HV3_ ,LO_ CP'_A@OQ[_ -!?P_\ ]_YO_C5'
M_#!?CW_H+^'_ /O_ #?_ !JO?O\ AM;X6?\ 02U/_P %%S_\11_PVM\+/^@E
MJ?\ X*+G_P"(H_UJS'NON#_4;)_Y9?\ @1X$G[!7CPL VL>'U7N1-,?_ &E7
M7>%_^"?[><K^(_%8,0/,&EV^"?\ @;]/^^:]/_X;6^%G_02U/_P47/\ \11_
MPVM\+/\ H):G_P""BY_^(K.IQ-F5164TO1(WH\%Y-2ES.FY>LG^ECT+X<?!W
MPG\*;,P^'=*CMIG7;+>2?O+B7_><\X]A@>U=K7A'_#:WPL_Z"6I_^"BY_P#B
M*/\ AM;X6?\ 02U/_P %%S_\17S56M.M-U*LFV^K/LJ-"EAZ:I48J,5LDK(]
MWHKPC_AM;X6?]!+4_P#P47/_ ,11_P -K?"S_H):G_X*+G_XBLC<]WHKPC_A
MM;X6?]!+4_\ P47/_P 11_PVM\+/^@EJ?_@HN?\ XB@#W>N+^)7P=\(_%K3Q
M:^)M'AO60$172_)/#_N2#D?3I[5YY_PVM\+/^@EJ?_@HN?\ XBC_ (;6^%G_
M $$M3_\ !1<__$4U)Q=TS*K2IUX.G5BI1?1ZH\B\7?\ !.E6G>3PQXN\N(GY
M;?5;?<5_[:)C/_?-<5)_P3T^(*N0FM>'77LQGG!_+RJ^DO\ AM;X6?\ 02U/
M_P %%S_\11_PVM\+/^@EJ?\ X*+G_P"(KK6,JKJ?)5>$<IJ2YE3<?1L^:_\
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M_$4?\-K?"S_H):G_ ."BY_\ B*/KM7N'^IN5?RR_\"/FO_AWK\0_^@QX<_\
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MCPY_X$3_ /QFOI3_ (;6^%G_ $$M3_\ !1<__$4?\-K?"S_H):G_ ."BY_\
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MK\0_^@QX<_\  B?_ .,T?\.]?B'_ -!CPY_X$3__ !FOI3_AM;X6?]!+4_\
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M.?YH_P#@)XK_ ,,/^./^@KH/_?\ F_\ C5'_  P_XX_Z"N@_]_YO_C5>U?\
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M_P!!70?^_P#-_P#&J/\ AA_QQ_T%=!_[_P W_P :KVK_ (;6^%G_ $$M3_\
M!1<__$4?\-K?"S_H):G_ ."BY_\ B*/K$P_U[SG^:/\ X">*_P###_CC_H*Z
M#_W_ )O_ (U1_P ,/^./^@KH/_?^;_XU7M7_  VM\+/^@EJ?_@HN?_B*/^&U
MOA9_T$M3_P#!1<__ !%'UB8?Z]YS_-'_ ,!/%?\ AA_QQ_T%=!_[_P W_P :
MH_X8?\<?]!70?^_\W_QJO:O^&UOA9_T$M3_\%%S_ /$4?\-K?"S_ *"6I_\
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M1_PVM\+/^@EJ?_@HN?\ XBCZQ,/]>\Y_FC_X">*_\,/^./\ H*Z#_P!_YO\
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M_AM;X6?]!+4__!1<_P#Q%'_#:WPL_P"@EJ?_ (*+G_XBCZQ,/]>\Y_FC_P"
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M^@EJ?_@HN?\ XB@#W>BO"/\ AM;X6?\ 02U/_P %%S_\11_PVM\+/^@EJ?\
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M .>:_P#?(H\B/_GFO_?(J2B@"/R(_P#GFO\ WR*/(C_YYK_WR*DHH C\B/\
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MH7D1_P#/-?\ OD4>1'_SS7_OD5'J&H6VDZ?<WMY,MO:6T33332'"HB@EF/L
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH]=N0,  9/4G- 'SSXBF\-Z[IWC/4I_&/CGXE>+H?M$UMJGAR"YM].T]E0L
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M-NO$5Q!IECH0G@ANKAY+*SD\NV)E$;-M !9B>G!/K3E_9,\<>(M+T/PEXO\
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MEJERUP]I,JRX=&/3F/\ )CG. :].^*7[-[^-M+\%WFB^('T#QCX1BCCL-86
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MP=^SWXGO/B[IOQ$^(GBFQUW6-)MFMK"VTJQ^S1+D.-[DG+'#MQZGK@8KWVF
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MOXH/]8LM_P"?GX2_R/>Z*\$_X:<N?^A?B_\  L__ !%'_#3ES_T+\7_@6?\
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MO_ L_P#Q%'_#3ES_ -"_%_X%G_XBC^SL3_+^*#_6++?^?GX2_P CWNBO!/\
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M+\7_ (%G_P"(H_L[$_R_B@_UBRW_ )^?A+_(][HKP3_AIRY_Z%^+_P "S_\
M$4?\-.7/_0OQ?^!9_P#B*/[.Q/\ +^*#_6++?^?GX2_R/>Z*\$_X:<N?^A?B
M_P# L_\ Q%'_  TY<_\ 0OQ?^!9_^(H_L[$_R_B@_P!8LM_Y^?A+_(][HKP3
M_AIRY_Z%^+_P+/\ \11_PTY<_P#0OQ?^!9_^(H_L[$_R_B@_UBRW_GY^$O\
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M //LO_??_P!:CZ[0_F_!A[&?8Z*BN=_X2M_^?9?^^_\ ZU'_  E;_P#/LO\
MWW_]:CZ[0_F_!A[&?8Z*BN=_X2M_^?9?^^__ *U'_"5O_P ^R_\ ??\ ]:CZ
M[0_F_!A[&?8Z*BN=_P"$K?\ Y]E_[[_^M1_PE;_\^R_]]_\ UJ/KM#^;\&'L
M9]CHJ*YW_A*W_P"?9?\ OO\ ^M1_PE;_ //LO_??_P!:CZ[0_F_!A[&?8Z*B
MN=_X2M_^?9?^^_\ ZU'_  E;_P#/LO\ WW_]:CZ[0_F_!A[&?8Z*BN=_X2M_
M^?9?^^__ *U'_"5O_P ^R_\ ??\ ]:CZ[0_F_!A[&?8Z*BN=_P"$K?\ Y]E_
M[[_^M1_PE;_\^R_]]_\ UJ/KM#^;\&'L9]CHJ*YW_A*W_P"?9?\ OO\ ^M1_
MPE;_ //LO_??_P!:CZ[0_F_!A[&?8Z*BN=_X2M_^?9?^^_\ ZU'_  E;_P#/
MLO\ WW_]:CZ[0_F_!A[&?8Z*BN=_X2M_^?9?^^__ *U'_"5O_P ^R_\ ??\
M]:CZ[0_F_!A[&?8Z*BN=_P"$K?\ Y]E_[[_^M1_PE;_\^R_]]_\ UJ/KM#^;
M\&'L9]CHJ*YW_A*W_P"?9?\ OO\ ^M1_PE;_ //LO_??_P!:CZ[0_F_!A[&?
M8Z*BN=_X2M_^?9?^^_\ ZU'_  E;_P#/LO\ WW_]:CZ[0_F_!A[&?8Z*BN=_
MX2M_^?9?^^__ *U'_"5O_P ^R_\ ??\ ]:CZ[0_F_!A[&?8Z*BN=_P"$K?\
MY]E_[[_^M1_PE;_\^R_]]_\ UJ/KM#^;\&'L9]CHJ*YW_A*W_P"?9?\ OO\
M^M1_PE;_ //LO_??_P!:CZ[0_F_!A[&?8Z*BN=_X2M_^?9?^^_\ ZU'_  E;
M_P#/LO\ WW_]:CZ[0_F_!A[&?8Z*BN=_X2M_^?9?^^__ *U'_"5O_P ^R_\
M??\ ]:CZ[0_F_!A[&?8Z*BN=_P"$K?\ Y]E_[[_^M1_PE;_\^R_]]_\ UJ/K
MM#^;\&'L9]CHJ*YW_A*W_P"?9?\ OO\ ^M1_PE;_ //LO_??_P!:CZ[0_F_!
MA[&?8Z*BN=_X2M_^?9?^^_\ ZU'_  E;_P#/LO\ WW_]:CZ[0_F_!A[&?8Z*
MBN=_X2M_^?9?^^__ *U'_"5O_P ^R_\ ??\ ]:CZ[0_F_!A[&?8Z*BN=_P"$
MK?\ Y]E_[[_^M1_PE;_\^R_]]_\ UJ/KM#^;\&'L9]CHJ*YW_A*W_P"?9?\
MOO\ ^M1_PE;_ //LO_??_P!:CZ[0_F_!A[&?8Z*BN=_X2M_^?9?^^_\ ZU'_
M  E;_P#/LO\ WW_]:CZ[0_F_!A[&?8Z*BN=_X2M_^?9?^^__ *U'_"5O_P ^
MR_\ ??\ ]:CZ[0_F_!A[&?8Z*BN=_P"$K?\ Y]E_[[_^M1_PE;_\^R_]]_\
MUJ/KM#^;\&'L9]CHJ*YW_A*W_P"?9?\ OO\ ^M1_PE;_ //LO_??_P!:CZ[0
M_F_!A[&?8Z*BN=_X2M_^?9?^^_\ ZU'_  E;_P#/LO\ WW_]:CZ[0_F_!A[&
M?8Z*BN=_X2M_^?9?^^__ *U30^*8F.)863W4YIK&4']H7L9]C<HJ"UO8+Q=T
M,BOZCN/PJ>NM-25T9:K<****8CB_C5_R1[QQ_P!@2\_]$/7BGPI_Y)=X._[
MUG_Z(2O:_C5_R1[QQ_V!+S_T0]>*?"G_ ))=X._[ UG_ .B$I,#I/V5_^0I\
M8?\ L>+_ /\ 9:][KP3]E?\ Y"GQA_['B_\ _9:][I@1S31VT,DTKK'%&I9W
M8X"@#))-?-7Q2^,EWXJN)=.TB5[71E.TNN5>Y]R>R^W?OZ5V7[1'C1["PMO#
MUK)MDNU\VY*GGRP<!?Q(/_?/O7S]7TN6X./+[>:]/\S\YXBS:?.\%0=DOB??
MR_S^X****^@/@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=M.L%C;^T!J"D"8X;<%W*<MUY'J.:]$\?#2GC\*S#3M=OK9;9#8OH\@$:'C
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M^'G_ &>E97Q'T#4=$\22RW]T-2%\/M,.H(!MN$/1N. >G%13BJ==Q2LFOO\
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M38=)O3;>5>:=&2V2VW!6,]EQS7HWP)^.6I>(K+QEI_CN2QL=3\)3%+W4(<)
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M4(-)=VO75,7M'OV/MWQ?\0O#W@.33$U[4DTY]3N/LMH'C=O-DX^4;0<?>'7
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M=I'<:<;W[)"D=NK)YXOA*"YV_>W??)/]T^E4Z$;Z];+3T%SNQ])>+_BUX1\
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M01FL6BDX1<>5K0<:U6,_:1DU+O?7[S4U[Q1JWBB9)-5U":^9/N"1OE7/7 '
MK2M_B;XIM=-%A%KETML%V!<@L%] V-P_.N9HI>S@THN*LO(I8FO&3FIN[W=W
M=^I>M=>U&RL;NR@O9HK2[_U\*M\LO^]ZU7L[R?3[J*YM9GM[B)M\<L9PRD=P
M:AHJ^5:Z;F7/+37;;R+U_KNHZIJ*W]W>S7-ZNTK<2-EQM^[S[5)-XEU6XU=-
M5DU&X?4DQMNC(?,&.!S6;12Y8]A^UJ7OS/>^_7OZG0:[X_\ $/B:S6UU+59[
MJV!!\HX53CID*!G\:71/B%XC\.V1M-.U>XMK;M%PRKG^[N!Q^%<]14>RI\O+
MRJWH:_6J_/[3VCYN]W?[S0M_$&IVNK'5(K^X342Q8W0D.\D]<GO5_7O'OB#Q
M1;+;ZIJDUU;J<^4<*I(Z$A0,_C6!15>S@VI65T0J]51<%-V>ZN[/U"BBBK,0
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH O:!:QWVO:;;3'$4US'&^?[I< UV/QDL]6N?
M'FHS36%TMI&5AMF\EO+\M5 &TXQC.?SK@%8JP(.".0176:;\6/%NEQA(=<N&
M0=!/ME_5@37-4A/G52%G96U/1H5J/L94*UU=IW5GLGHTVN_<YR+2[V9ML=G<
M2-Z)$Q/\J]#\0:?>K\%=*.JVTUK=66I-#;"X0HYA92< 'MG^594_QJ\97"X.
MLL@_Z9P1K_[+7-:SXFU;Q$RG4]2N;[8<JLTA95/J!T%0XU:DHN22L[[M_HC:
M-7"T(5%2<I.2MJDET?=]C-HHH52S  $DG  ')KL/(-?PCX?E\5>)-/TN($_:
M)0'('W4'+'\ #7V=%&L,:1H-J* JCT KR_X(_#1_"E@VK:E%LU6[3"Q,.8(^
MN#_M'C/I@#UKU.OD,QQ"K5.6.T3];X>R^6#PSJ5%:4]?1=/\PHHHKR3ZHPO%
M%J6BBG ^Z=K?0]/\^]<Y7>30I<0O&XRC#!%<9J%A)I]P8W&5ZJW8BO!QU%QE
M[1;,[J$[KE96HHHKRCJ.$\6? OP#XYU-M1USPM87M^QR]SM:-W/JQ0C=^.:U
MH?AKX4M_"K^&8_#VGIX?D(,FG" >4Y!!!8=SD Y// KI:*OGE9*XN5=C$U#P
M3X?U;P[!H-[HMC=Z+ B1Q6$T*M%&JC"A5/3 X&*R-9^#?@CQ!X=LM"O_  QI
M\VDV6?LML(]@@R<G85(*Y)YP:[*BA2DMF%D8'@WP#X>^'NFM8>'-(MM(M7;>
MZ6ZG+MTRS$DL?J:M^)/#&D^,-(FTO6].M]4T^;!>WN4W*2.A'H1ZCFM2BES.
M_-?4+*UC@M%^ OP\\/Z;>:?9>$-,6TO %N$FB,QD .0"SDG&0#C/:NOT/0]/
M\,Z7;Z;I-G%I]A;C$-M -J1C.< =ADU>HIN4I;L$DMC$\->"= \&_;/["T>S
MTG[9)YMQ]DC">:_/S-ZGD_G5[6M%L/$6EW.FZI9PW^GW*>7-;SJ&1U]"*NT4
MKN]P\CSC3?V<_AGI=O/!!X+TMHYR#()XS,3@Y&"Y) SV%='XB^&_A7Q<EFNM
M^'M.U46:".W^U0*YB4=%4GD#CI72457M)MW;%RKL8UGX,T+3_$=UX@MM(M(-
M;NHA#/J"1@32( H"LW<81?\ OD5RTG[/OPXF\0?VT_@_33J._P W?Y9"%\YW
M&/.S.?\ 9KT*BDIR6S'9=C&OO!NA:GX@L-=N])M+C6;!=EI?21@RP+SPK=A\
MS?F:+CP;H5UXFMO$4VDVLNO6T7DPZBT8,T:88;0W889OS-;-%+F?<+(YYOAY
MX7;Q0GB0Z!I_]OH=RZD(%$^2-I.X=\'&:U=8T:P\0:;/I^IV4&H6,Z[9;>YC
M#HX]P:N44<S[A9'GFA?L]_#CPWJR:GIWA#3X;V-_,21E:38W8JK$@'Z"NB\9
M_#_PY\1-/2R\2:/:ZO;QL6C%PIW1D]2K AES[&NAHI\\F[MZARK:QR_AGX8>
M%/!NAW>CZ-H-G8:;>*4N8(TSYZD%2'8DEA@D<GO3I/AGX4F\(GPLWA^Q'ATD
MM_9JQ8B#%BVX =#DDY'-=-11S2O>X61P.D_ /X=Z':PP6?@_2T2&<7*-)$9'
M$HZ-N8ELCMSQ6[XD^'OACQE>6]YKN@:?JUW;X\F>Z@5W3!R,-UZ\UT-%'/)N
M[8<JVL8VC^#="\/ZEJ>H:;I%I8WVJ/YE]<0QA7N6R3ESWY9OS-<O;_L^_#FU
M\0#6HO!^F)J(?S0_EG8'SG<(\[ <_P"S7H-%"G);,.5=C'U+P=H>L:]I^MWV
MDVMWJ^G\6=[+&#+!R3\A[=327?@[0[_Q)9^(;G2;6?7+./RK?4'C!FB0[OE5
MNP^9OS-;-%+F?<+(\[O?V>?AOJ.NMK%QX.TV2_9_,9MC!&;.<F,'83GVKT*.
M-8XU1%"(H"JJC  '0 4ZBG*4I;L$DM@HHHJ!A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'D_[52EOV??&04$G[-&>/^NJ5QEQJ7P2\1:=K;:CXTL4N/$>
MFV=GJ*QWX7:(%7;LX^5LCGKTKZ'N+>&\MY(+B))X)%*/%(H964]00>"*YW_A
M6/@[_H4]#_\ !=#_ /$UTPJ*,>5W^7R_R,Y1;=SPGP#\6/ FB_'GQ]?OXHTV
M#1KC3M.M[.ZDG&R7RX]K*I[D8YKE/%GB+P5X\^/FN7K>/+#1]*C@TJZAU%9,
MQW#P2;FA!R.<'\,5]0_\*Q\'?]"GH?\ X+H?_B:/^%8^#O\ H4]#_P#!=#_\
M36JK03YDGM;H1R2:L?-S3>&[K]H/P;=^'O%]MXI;5O%%YJLMO;-N^Q*UL%"=
M3Q\IYXZ5];UBZ7X)\.Z'=BZTW0=,T^Z *B:ULXXW /4;E -=AH6E&[F$T@Q"
MAXS_ !'_  J-<1*,(%?PTVS<T:U-II\2$89OF;ZFKU%%?2PBH145T/-;YG<X
MOXU?\D>\<?\ 8$O/_1#UXI\*?^27>#O^P-9_^B$KVOXU?\D>\<?]@2\_]$/7
MBGPI_P"27>#O^P-9_P#HA*IB.D_97_Y"GQA_['B__P#9:][KP3]E?_D*?&'_
M +'B_P#_ &6O>Z8!7,^-OA_I/CNQ$-_$5GC'[JZBP)(_H>X]CQ7345<)RIR4
MHNS,JM*G7@Z=6-T^A\N^*/@3XET&1WLX5UBU'22VXDQ[H><_3-<-=:)J-C(4
MN-/NH'_NR0,I_45]MTE>S3S:I%6G&_X'QM?A7#SE>C-Q\M_\F?#WV&Z_Y]IO
M^_;?X4?8;K_GVF_[]M_A7W#16W]KO^3\?^ <O^J4?^?_ /Y+_P $^'OL-U_S
M[3?]^V_PH^PW7_/M-_W[;_"ON&BC^UW_ "?C_P  /]4H_P#/_P#\E_X)\/?8
M;K_GVF_[]M_A1]ANO^?:;_OVW^%?<-%']KO^3\?^ '^J4?\ G_\ ^2_\$^'O
ML-U_S[3?]^V_PH^PW7_/M-_W[;_"ON&BC^UW_)^/_ #_ %2C_P __P#R7_@G
MP]]ANO\ GVF_[]M_A1]ANO\ GVF_[]M_A7W#11_:[_D_'_@!_JE'_G__ .2_
M\$^'OL-U_P ^TW_?MO\ "C[#=?\ /M-_W[;_  K[AHH_M=_R?C_P _U2C_S_
M /\ R7_@GP]]ANO^?:;_ +]M_A1]ANO^?:;_ +]M_A7W#11_:[_D_'_@!_JE
M'_G_ /\ DO\ P3X>^PW7_/M-_P!^V_PH^PW7_/M-_P!^V_PK[AHH_M=_R?C_
M , /]4H_\_\ _P E_P""?#WV&Z_Y]IO^_;?X4?8;K_GVF_[]M_A7W#11_:[_
M )/Q_P" '^J4?^?_ /Y+_P $^'OL-U_S[3?]^V_PH^PW7_/M-_W[;_"ON&BC
M^UW_ "?C_P  /]4H_P#/_P#\E_X)\/?8;K_GVF_[]M_A1]ANO^?:;_OVW^%?
M<-%']KO^3\?^ '^J4?\ G_\ ^2_\$^'OL-U_S[3?]^V_PH^PW7_/M-_W[;_"
MON&BC^UW_)^/_ #_ %2C_P __P#R7_@GP]]ANO\ GVF_[]M_A1]ANO\ GVF_
M[]M_A7W#11_:[_D_'_@!_JE'_G__ .2_\$^'OL-U_P ^TW_?MO\ "C[#=?\
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M[;_"ON&BC^UW_)^/_ #_ %2C_P __P#R7_@GP]]ANO\ GVF_[]M_A1]ANO\
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ME_X)\/?8;K_GVF_[]M_A1]ANO^?:;_OVW^%?<-%']KO^3\?^ '^J4?\ G_\
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MUORH\MO[K?E7?T4?V=_?_#_@A]8\C@/+;^ZWY4>6W]UORKOZ*/[._O\ X?\
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M[K?E7?T4?V=_?_#_ ((?6/(X#RV_NM^5'EM_=;\J[^BC^SO[_P"'_!#ZQY'
M>6W]UORH\MO[K?E7?T4?V=_?_#_@A]8\C@/+;^ZWY4>6W]UORKOZ*/[._O\
MX?\ !#ZQY' >6W]UORH\MO[K?E7?T4?V=_?_  _X(?6/(X#RV_NM^5'EM_=;
M\J[^BC^SO[_X?\$/K'D<!Y;?W6_*CRV_NM^5=_11_9W]_P##_@A]8\C@/+;^
MZWY4>6W]UORKOZ*/[._O_A_P0^L>1P'EM_=;\J/+;^ZWY5W]%']G?W_P_P""
M'UCR. \M_P"ZWY5/#I]S<'"0.??&!^==Q252RY=9"^L/HC L/#.&#W3 _P#3
M-?ZFMY46-0J@*HX '2G45Z%*C"BK01SRG*>X4445N0<7\:O^2/>./^P)>?\
MHAZ\4^%/_)+O!W_8&L__ $0E>U_&K_DCWCC_ + EY_Z(>O%/A3_R2[P=_P!@
M:S_]$)28'2?LK_\ (4^,/_8\7_\ [+7O=>"?LK_\A3XP_P#8\7__ ++7O=,
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M,7_DI-_\11_PU+\,_P#H8O\ R4F_^(K\_P"BBX'Z ?\ #4OPS_Z&+_R4F_\
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M9_\ 0Q?^2DW_ ,11_P -2_#/_H8O_)2;_P"(K\_Z*+@?H!_PU+\,_P#H8O\
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M8GPE_P"AH_\ )*X_^(K\SZ*/[&P_\S_#_(/J%+NS],/^&Q/A+_T-'_DE<?\
MQ%'_  V)\)?^AH_\DKC_ .(K\SZ*/[&P_P#,_P /\@^H4N[/TP_X;$^$O_0T
M?^25Q_\ $4?\-B?"7_H:/_)*X_\ B*_,^BC^QL/_ #/\/\@^H4N[/TP_X;$^
M$O\ T-'_ ))7'_Q%'_#8GPE_Z&C_ ,DKC_XBOS/HH_L;#_S/\/\ (/J%+NS]
M,/\ AL3X2_\ 0T?^25Q_\11_PV)\)?\ H:/_ "2N/_B*_,^BC^QL/_,_P_R#
MZA2[L_3#_AL3X2_]#1_Y)7'_ ,11_P -B?"7_H:/_)*X_P#B*_,^BC^QL/\
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M1_PV)\)?^AH_\DKC_P"(K\SZ*/[&P_\ ,_P_R#ZA2[L_3#_AL3X2_P#0T?\
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MH-'&K?V;>?V5O\O[?]G?R-^<;?,QMSGMFE=+<"C1113 **** "BBB@ HHHH
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M)-RTU^%6ZV9\\5WGP8^*E[\)?&UKJL+.^GR$17]J#Q+"3SQ_>7J#^'<UU_Q
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M\=:S#%_PE&@WPM);Z.,(9D,JQL"!V(D1L= 0<8S4OCRW^%_[4<FF^*CXYM?
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M_L"7G_HAZ\4^%/\ R2[P=_V!K/\ ]$)7M?QJ_P"2/>./^P)>?^B'KQ3X4_\
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M['<?\^\W_?L_X5^J'DI_<7\J/)3^XOY46 _*_P"QW'_/O-_W[/\ A1]CN/\
MGWF_[]G_  K]4/)3^XOY4>2G]Q?RHL!^5_V.X_Y]YO\ OV?\*/L=Q_S[S?\
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MQ'T-?7OP]^&VA?#'0UTS0[3R4.&FG<[I9V_O.W<^W0=A7444 %%%%, HHHH
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M?W?Q/QP^PW7_ #[3?]^V_P */L-U_P ^TW_?MO\ "OV/\F/_ )YK^0H\F/\
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MD*/)C_YYK^0H_MO_ *=_C_P _M#^[^)^.'V&Z_Y]IO\ OVW^%'V&Z_Y]IO\
MOVW^%?L?Y,?_ #S7\A1Y,?\ SS7\A1_;?_3O\?\ @!_:']W\3\</L-U_S[3?
M]^V_PH^PW7_/M-_W[;_"OV/\F/\ YYK^0H\F/_GFOY"C^V_^G?X_\ /[0_N_
MB?CA]ANO^?:;_OVW^%'V&Z_Y]IO^_;?X5^Q_DQ_\\U_(4>3'_P \U_(4?VW_
M -._Q_X ?VA_=_$_'#[#=?\ /M-_W[;_  H^PW7_ #[3?]^V_P *_8_R8_\
MGFOY"CR8_P#GFOY"C^V_^G?X_P# #^T/[OXGXX?8;K_GVF_[]M_A1]ANO^?:
M;_OVW^%?L?Y,?_/-?R%'DQ_\\U_(4?VW_P!._P ?^ ']H?W?Q/QP^PW7_/M-
M_P!^V_PH^PW7_/M-_P!^V_PK]C_)C_YYK^0H\F/_ )YK^0H_MO\ Z=_C_P
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M '98'_OQN.5;Z?CFNKHH ^=K?P'\:O@Z!#X0U^Q^(OAN/B+2O$KF&^A7LJ7
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M;^('_@N7_P"*H_X:@U;_ *(W\0/_  7+_P#%5[U10!X+_P -0:M_T1OX@?\
M@N7_ .*H_P"&H-6_Z(W\0/\ P7+_ /%5[U10!X+_ ,-0:M_T1OX@?^"Y?_BJ
M/^&H-6_Z(W\0/_!<O_Q5>]44 >"_\-0:M_T1OX@?^"Y?_BJ/^&H-6_Z(W\0/
M_!<O_P 57O5% '@O_#4&K?\ 1&_B!_X+E_\ BJ/^&H-6_P"B-_$#_P %R_\
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M '@O_#4&K?\ 1&_B!_X+E_\ BJ/^&H-6_P"B-_$#_P %R_\ Q5>]44 >"_\
M#4&K?]$;^('_ (+E_P#BJ/\ AJ#5O^B-_$#_ ,%R_P#Q5>]44 >"_P##4&K?
M]$;^('_@N7_XJC_AJ#5O^B-_$#_P7+_\57O5% '@O_#4&K?]$;^('_@N7_XJ
MC_AJ#5O^B-_$#_P7+_\ %5[U10!X+_PU!JW_ $1OX@?^"Y?_ (JC_AJ#5O\
MHC?Q _\ !<O_ ,57O5% '@O_  U!JW_1&_B!_P""Y?\ XJC_ (:@U;_HC?Q
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M"Y?_ (JC_AJ#5O\ HC?Q _\ !<O_ ,57O5% '@O_  U!JW_1&_B!_P""Y?\
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M#6;_ .*KSNBCE78/J]'^1?<CT3_AHSXJ_P#11_%'_@UF_P#BJ/\ AHSXJ_\
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MHSXJ_P#11_%'_@UF_P#BJ\[HHY5V#ZO1_D7W(]$_X:,^*O\ T4?Q1_X-9O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#[6_8MN=/^+'P!^*/P3>_@T_7]55K_3/.;:)B43IZ[7B0D#G:V>QKU/\
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M59X)#M7N=H) [XKXSL?&7B#2]8N-7LM=U.SU:YW>??V][)'/+N(+;I P9LD
MG)["KO@[XE^+?A[<7,_ACQ+JOA^6Z&)VT^[>+S<=-V#R>3R?6DJ36S[$1RJ=
M**Y)JZY6KKK%M_=J?7/Q2\!ZW\._^":VDZ-XCT^33-5_M];B2RG&)(EDFE90
MZ]FVD'!Y&:[[]HKP/K6M?$C]FKQE8Z>;KPUIYTJVN-2C="D3R7-OY8QG)W9X
M(!%?G_J_CKQ+X@M9[75/$6K:C:SSFZEM[N^EECDF)R9"K,06_P!K&:2'QUXE
MM]-M].B\1:O%I]O(LL%HE_*(8G4[E94#84J0""!D'I3]F][]_P 399?5NI<Z
MO>3>FGO*SZ]#],=/O(;G]K_]H/P]9W$=KXKUCPO9QZ1(SA&+K9@,%/J&>)OH
MN>U>+_LP^ _$GP1^!/QWU'XBZ5=^'-"N]*^QQ6>J)Y9N;GRYDRBG[V3(BAAU
M)XSBOC"7Q;KL^OIKLNM:C+K:,KKJ4EW(UR&484B4G=D 8'/2M7QC\5O&GQ"M
MX(/$_BO6-?@MSNBAU"\>5$/J%)QGWZTO9.UK]OP,UEE2,?9J2Y6H7TU]VVWK
M;Y'TU^T_/*O[$7[/-MYC>1) &DCS\KLMO\I([XR?SKW#6;KQ@T?[*-UX-N=(
M_P"$G/AVX*+K\SI!=I]CM/,B+*K-N*Y(QW&:_-V^\2ZQJFF66FWNK7UYIUD,
M6MG<7+R0V_&/W:$E4X] *EN/&.OW2Z8)]=U.8:7C[ )+R1A9XQCR<M^[^ZOW
M<=!Z4_9Z6]3666N4(QYEHYO;^:_^9]_ZWX)T3XH_#7XOZUJ7P^UWX(>)]*MY
MI]0OK2\EAT_5Y0LC$%?D296((/R?\M00V37YT+]T<8KLO%7QE\>^.M*33/$7
MC+7-;TY2"+2^OY)(LCH2I."1[UQU7"+CN=>"PT\,I*<KWV6KMIW>O^04445J
M>D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 >N_LJ_!NW^.7QGTGP]J+M'H<*/J&INIVG[
M/%@LH/;<Q5<]@Q/:NR^/7[1GB+XZ^(HOAUX$M3I?@%+E--T?P[I<0C%[M<+&
MTF.N2 P7[J\$Y.37/_LB_&CP_P#!'XE:CJ?BBWO9]#U+2+C3)VT] \T>\JP8
M D9^[CKQG-?3?['^@_LXZI\;-/E\ ?\ "7S^)["UGNK9?$ C^S@!0C,-HSO
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUI\-?^AF\5?]_K;_ .,UZ'_PW3\//^?37/\ P$C_ /CE'_#=/P\_Y]-<_P#
M2/\ ^.4>RQ79A_KUA?\ H.7WGGG_  ZT^&O_ $,WBK_O];?_ !FC_AUI\-?^
MAF\5?]_K;_XS7H?_  W3\//^?37/_ 2/_P".4?\ #=/P\_Y]-<_\!(__ (Y1
M[+%=F'^O6%_Z#E]YYY_PZT^&O_0S>*O^_P!;?_&:/^'6GPU_Z&;Q5_W^MO\
MXS7H?_#=/P\_Y]-<_P# 2/\ ^.4?\-T_#S_GTUS_ ,!(_P#XY1[+%=F'^O6%
M_P"@Y?>>>?\ #K3X:_\ 0S>*O^_UM_\ &:/^'6GPU_Z&;Q5_W^MO_C->A_\
M#=/P\_Y]-<_\!(__ (Y1_P -T_#S_GTUS_P$C_\ CE'LL5V8?Z]87_H.7WGG
MG_#K3X:_]#-XJ_[_ %M_\9H_X=:?#7_H9O%7_?ZV_P#C->A_\-T_#S_GTUS_
M ,!(_P#XY1_PW3\//^?37/\ P$C_ /CE'LL5V8?Z]87_ *#E]YYY_P .M/AK
M_P!#-XJ_[_6W_P 9H_X=:?#7_H9O%7_?ZV_^,UZ'_P -T_#S_GTUS_P$C_\
MCE'_  W3\//^?37/_ 2/_P".4>RQ79A_KUA?^@Y?>>>?\.M/AK_T,WBK_O\
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M\.M/AK_T,WBK_O\ 6W_QFC_AUI\-?^AF\5?]_K;_ .,UZ'_PW3\//^?37/\
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MZ'_PW3\//^?37/\ P$C_ /CE'_#=/P\_Y]-<_P# 2/\ ^.4>RQ79A_KUA?\
MH.7WGGG_  ZT^&O_ $,WBK_O];?_ !FC_AUI\-?^AF\5?]_K;_XS7H?_  W3
M\//^?37/_ 2/_P".4?\ #=/P\_Y]-<_\!(__ (Y1[+%=F'^O6%_Z#E]YYY_P
MZT^&O_0S>*O^_P!;?_&:/^'6GPU_Z&;Q5_W^MO\ XS7H?_#=/P\_Y]-<_P#
M2/\ ^.4?\-T_#S_GTUS_ ,!(_P#XY1[+%=F'^O6%_P"@Y?>>>?\ #K3X:_\
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MY]-<_P# 2/\ ^.4?\-T_#S_GTUS_ ,!(_P#XY1[+%=F'^O6%_P"@Y?>>>?\
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M?^AF\5?]_K;_ .,UZ'_PW3\//^?37/\ P$C_ /CE'_#=/P\_Y]-<_P# 2/\
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MBK_O];?_ !FC_AUI\-?^AF\5?]_K;_XS7H?_  W3\//^?37/_ 2/_P".4?\
M#=/P\_Y]-<_\!(__ (Y1[+%=F'^O6%_Z#E]YYY_PZT^&O_0S>*O^_P!;?_&:
M/^'6GPU_Z&;Q5_W^MO\ XS7H?_#=/P\_Y]-<_P# 2/\ ^.4?\-T_#S_GTUS_
M ,!(_P#XY1[+%=F'^O6%_P"@Y?>>>?\ #K3X:_\ 0S>*O^_UM_\ &:/^'6GP
MU_Z&;Q5_W^MO_C->A_\ #=/P\_Y]-<_\!(__ (Y1_P -T_#S_GTUS_P$C_\
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M#S_GTUS_ ,!(_P#XY1[+%=F'^O6%_P"@Y?>>>?\ #K3X:_\ 0S>*O^_UM_\
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MO_0S>*O^_P!;?_&:/^'6GPU_Z&;Q5_W^MO\ XS7H?_#=/P\_Y]-<_P# 2/\
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M<%+E2^)K=O\ E3Z6Z^>GJZ21I9&=V9W8Y9F.23ZDTVBBO=/QL**** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4HKH?S#6JRKU959[R;;^>H44451B%%%% !1110 4444 %%%% !1110 4444
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M5I'#N,U._5O[TCDQ&>QK8.6&4&FX0C>_\DI2O\[GZ+:ES\;M=)ZGP.A)]?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?V>_#&B3>-]1U:X2_P!/T?6_['L[6^U5--0C:'+R3%3SA@  !D@T_K4.J?\
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MX4[N^A\18.,XX]:2OH[7%T&\_9S^'%C)H31376M26@F6\8F.02!9I.GS!P&
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M+-Y>T>7R1MP2",UYS^S:LFF>$OB5X@T:!;GQAI>F1MIH\L220HS$2RHI!RP
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MY8 C"C .#FL_K'*^6:U\OF_+L=KR-5H*MAJEH.]^=<K5I1CLN;=R7XKH?/\
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MGX _%/5[\LEAJ7V/3K7S,_O[D2ESCU*@Y)KQBN\^)WQ8NOB$EAIUKI]OX?\
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M\TR,&1BQ&1@@< @<4_\ X5)XX_Z$_7?_  72_P#Q-'_"I/''_0GZ[_X+I?\
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MC'S,$R6QQN)R.>>:QO\ A4GCC_H3]=_\%TO_ ,31_P *D\<?]"?KO_@NE_\
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M 8<'ONSFH_\ A4GCC_H3]=_\%TO_ ,31_P *D\<?]"?KO_@NE_\ B:7[GR_
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M/];)?\^?_)O^ 'M_(^P?[0M?^?F'_OL4?VA:_P#/S#_WV*^/J*/];)?\^?\
MR;_@![?R/L'^T+7_ )^8?^^Q1_:%K_S\P_\ ?8KX^HH_ULE_SY_\F_X >W\C
M[!_M"U_Y^8?^^Q1_:%K_ ,_,/_?8KX^HH_ULE_SY_P#)O^ 'M_(^P?[0M?\
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M_P#/S#_WV*^/J*/];)?\^?\ R;_@![?R/L'^T+7_ )^8?^^Q1_:%K_S\P_\
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M[[%']H6O_/S#_P!]BOCZBC_6R7_/G_R;_@![?R/L'^T+7_GYA_[[%']H6O\
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MEK[D=%_G\SSZDN:04445X!D%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5U
M/A+X=ZGXMMY+N)X;+3XSAKJZ;:F1U ]?Y5RU>J>/&:S^$_A2WM"5LY@K3;>C
M-MW8/XEC^%>K@:%*HJE6LKQ@KV6E]4EKV[EQ2=V^AS7BCX8ZEX:TT:BMQ;ZE
MIV<-<6K9"Y..1Z9[BN/R*Z;P_=^)%\-ZO;Z6CR:05)O%V*RJ-IR<GIP.WI78
MZQ>6GPQT#08K32;*^O+Z'[1<W%Y'O+# .T>G7]*Z'A:.(3KT[TX))N^NM[>[
MW7Y:CY4]5HCRFDR*]J_X1'2%^)'A^>&QA&GZK9R7#6<B!D5@F>%/'<?B*7PK
MJFF:UXPU3PNWA_3XM-3SE1EB_>95L$D^_/3&.*VCDTN?DJ5$FY<JT;N[)KY-
M,?L^C9XID>M+7L/@RQL/^$9GMM%;26\1QW<BRKJBAF9 [ !>_(V]/>FV>AV\
M_P 6;&WOO#L.G)+;2-):MME@E8*?G4 8Q[>U1'*)RA3DI_&TMG97\^ZZIV\K
MA[/8\@K<O?"-Y8^%;+Q!))";*ZD,:(K'S 1NZC&/X3WKK/AWH]C??%+4[.YL
MX)[6,W.R&2,,@Q( , \<"M+Q%<KIOPIT"<6\-PD&IR,+>9<QL \WRD>E+#Y=
M&5"I6J/1*5O6+BK_ (@H:-LX#4/!VI:5>:9;WB1V[:CM,#-("N"0,DCH.157
MQ!H<OAS59;"::"XDC"DR6[;D.1G@X'K7KOQ$U**XU#P?82Z;921WIA9I&BRT
M:[TRB^BD'!'I3]/\-:.WQ3\0V<FF6K64-A&Z6_DKL4D)DJ,<'D\UVU<GINHZ
M5&7VHJ[Z7BWV\MRG3ULCPW-&:]?\)ZGI_CS0?$%A/H=A9Q6=L9+9K>/#IPV,
MGJ2,#GOS574+JT^'O@;P^]OI5E?W6J1^=<37<>_(V@[1Z?> _"N#^S(^S5?V
MJ]G:][/ORVMZD<FE[Z'E=;'A;PO>>+M4^QVAC0JADDEE.$C0=6/YUUGQ?TW3
M[%?#TNG6,-A'<6AD9(D"DYVD9/<C/4U+\(;0Z3_:'B6]NDM-'MXS;S!EW>=G
M'R@>QV_7.*5/+U''K"U7=+=K32UV]=D"C[W*SF?$G@F?P_I]KJ,5[;:IIMPQ
MC2ZM6)4,,_*0?H?RKG*]I\;>%WU3PW;1:*]G8^%+6W:_6;<S>8_/RGOG!./K
M7BRJ6( &6/ %9YGA%A*RC%632]'WMUM?9L)QY6=3X7^'&K>+M+N;^R,*PPL4
MQ*Q#.P&2%P#[?G7+<C@C!]*^B-+TG6/"ECX3T[3;)IK>-S)J4BLH^\,'J1G!
M8G_@(KF+/X>V?_"W+^"[A$FGK$VH1PD?*^X@8QW 8GCV%>K7R1J%*---3;2E
M?:[5[KR6J?F6Z>BL><>$?"5YXSU"6SL9(8Y8XC,3,Q P"!V!YY%8S+M8CN#B
MO;_ACXSA\3>*KZ/^R+.Q9+=S!+:Q[&$>Y?D;U['\*Y2RT>T\2_"V[>ULX1K&
MFW7S2QQ@22(6XR1R>&/_ 'S7)++:4Z$)8>?,WSOKKRVT2[V;)Y%;1G'^&?#L
MWBC4OL4%Q;VS^69/,NG*I@8XS@\\UF3)Y,CHQ!*L5)'0X.*]SL?#NB0^.=*\
M/MIEG.+32VDN2\"L9)24 +<<G )_X%7/?#J'2I-.UN&W;38_$GVEA;C4D!01
M@C 4'_@73VJY919QI.24KR3?HD[)=];;ZC]GT/*Z3(Z9YKUC7?";:QXQ\.V6
MHZ)'I,EP2+FXLW'DW(5=QV@#Y3P>O/-7K76]+U/QY/X1DT#3UTG?):HR18E#
M*I.[=]0??IS6*RE\[C.I;WE%73U;5]NFZU_,7L^[/&J3->O^&] T?0?#OB^3
M4M/AU,:7>LB-(HWL%"[5W8R 3C/U-5O#=U8?$BW\16<ND6-EJ#6PEM#!$ 4V
MC& <9Z[?S-)94_<@ZB4YIV5GTOUVW5D+V>VIY56QX6\*7_B_43:6"KN5=\DD
MAPD:^I-=/KFF6?ASX7Z2DMI"=8U.0S&9XQYB1@YP#U'&W\S5;X8>)O\ A&;K
M4)+C3[B]TRXB$=R]O&6,0&>3[8)[BL*>$IT\53I8F6C2;MTNKV?X7["45S),
MDO\ X27\.GW%WI^I6&L"W!,T=G)EUQU^O?BN$SW[5[)HOAG1=3%W+X%\17&G
MW[19>TD_B7T(89QGOS1X<\+RZ#X)L[^QT[3[W6KUR9)-290L2 GY5#$<\#IZ
MFO3JY2JTHNC'EC9MM/G3LTO=MK?75.Q;IWV/'**]IO?"VE2>-?"MU]DLD:^\
MQ+ZPA99(A((R<@#C&<_D*Y[Q=XHTG2?$#Z/::!916%G?K)-(R M+@_.N,8V\
MD >PKBJY7]7C*=:HDD[+1ZZ)_+1ZWV)<+;L\WK8N/#,]OX:MM:-S;-!/)Y2P
M*Y,RG+#)7'3Y3W[BO5#X&TRU^(UYJ$MI = BT_[<(O+'E<C;C'3L6_*N<US3
M+&\^%>E:C!8VUM>WFHLIECB56"L\N%R!T'''L*U>4RHQJ.H[M*5O^W6E?YWT
M'[.U[GFN1ZTM>N^*-8TWX:ZGI^AVVB65W:K"DEY+<1!Y)=Q(.">_!-'@W0-&
MU:X\0:_INFK+#!M6RL;\JL:2%<DMDXQDC&>V:C^R;UOJ\:B<UNK/2RN[=^WJ
M'L];7/(<YZ<T9'3/->N>,M$CU+P/<:AJ5KIFG:Y9N"O]GR)MFC) P0#UY/Y>
M];]K96EU9Z<?#%CHFK:2(<7-G(%%R[8Y.X]#TZUI')9RJ.'/T36CN[Z?#OI;
M7?YA[-W/!:*O:] +76KZ);22P59F M9#EHN?ND]\51KY^4>23B^AD%%%%0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%% Y(!.!ZT %%>U)H-C#XBM?#*>%X;C1I;=6;5MA,K93/F"
M3H,'C'_ZJ\KT?0?[;\3P:1;S*!-<&)9CR-H)^;WX&:]7$9?4P[C%.[;Y>NZM
MWW6N^Q;BT9-%=UK'A#09]&U:YT*\O)+C2'5;E+Q %D!;;N3 XY!X-<+7)B,/
M/#R2G9WVL[KM^:)::"BBBN41ZY\%_B!)#<Q^'K^4M#)_QZ2,?N-_SS^A[>_'
M>O;*^.H9I+::.:)BDL;!T8=00<@U]-Z7\0M,O-+LYYI@DLL*.Z^C%02/SK]+
MX=S/GHO#UY?#LWV[?([*,]+,^8Y)&FD>1CEF8L3[DYIM!!4D'@C@T5^:G&%%
M%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "NX\+?$2#3]";0M<TT:MI.
M=T:[L/'SG _'W!&:X>BNG#XBIA9\])^7=-=FGN-2<=CO/$'Q$L&\.RZ'X<TH
MZ38SG,[NV7D'<=3UQUR>.*6V\>Z-JVAZ=8>)=)FOI-/&V">VDVEEX&UAD=@/
MRK@J*Z_[2Q#DY-IJUK67+;>UK6W*YV=\?BHTGCBSUR2QQ:6<+006:/C:I4CK
MCKSZ=JS?#7CA- \:W>O-9M,D[3$0!P"-[9ZX[5R=%2\PQ+DIN6JES;+?3_):
M;"YF=K9^+M"OM*:PUO1I'V7#SQ75BRI-AF)VL3UZXS]*N7OQ7:;QAI6K06)2
MSTZ(P1V[R9=T888EO7I^5>?452S+$QBE%I6MK97]W57?6P^=GJ%G\4/#NB:]
M/JNF>'IQ<W6XSR2SX/)R0HY R>37-ZYXXCUCP79Z$+-HFM[E[@SF0$'<SG&,
M?[?Z5R=%.IF6)J1<&TD[Z));V;Z=;('-O0[_ %#XF6>K6>C&ZT7.I::T)CNE
MFP-J,I8!<?Q!??&:EM_BQ%!XRU77/[-D9;VU6W$/FC*8"C.<<]*\[HI_VIB^
M92YM4T]ENDTNFNC#GD=/X)\9)X1BU9'M&NOMUOY *N%V=>>G/6NTT9M6NO &
MEI/H%IXJM8VQ:^7*?,@(S@2+CH.G7IC->259L]4O=.#"TO+BU#?>\F5DS]<&
MGA<PE02ISNXI-*UNKOU33^?R",K:,]"^.%\)M0T6VD:/[9;VF;B./[J,V./T
M/X8K%\'>-[31]'O=%UC3VU'2+IA(4C;:Z-QR/R'<=*X^21I79W9G=CDLQR2?
M<TE35S"I/%RQ4-&^F^EK6??3<'-\W,CTW_A:VCV^ER:';^'6.@M$R>4T^)2Q
M.=V>?K]:X31-0M=+UZUO9;=[FUMYA*("P#-@Y4$XQUQGBLVBLJV.KUY0E-KW
M=M$K>6VWD)R;W.F\5>/M2\1:Y<WT-U=6$,F EO'<, @  [$#/?\ &NB/QB;[
M9HE]_9[&]LHC;W,C2C%Q&0-PZ<'(##\:\WHJXYEBH3E-3UD[OU3O^8^>6]ST
M[2OB9X<\,ZG<7FD>'KA)+H'SFEG *Y.=J#D 9_I7/?#_ ,>'P1J-Y.UJ;NWN
M4VM"'"_,#D'H?4_G7)44WF6)YX3BTG"[5DE:^_3J'.]#M=%^)!T[QW?>([BT
M:X^TJZ"!9,%02NT9QV"@57T/Q5I":9?:;K6DF[MKB8SI<6Y59XB3G 8]1_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWL!SSW[XI+ 86I/W9]WHUT4G\K62N]'>XN6+ZGF?_"*ZP-0DL#IMP+V.,S-
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M6VIQNI>&=6T>UCN;[3KFTMY.%DEC('T]C]:F;P7KR6OVEM(NDM_*,QD:/ "
M9+?E7<^(?&NE-9ZB+*>TNSJ%S'+]GBM95D8!PV9&=MH;M\HK=N(XVU7QAJ)O
M;H&YTF0M97$#Q^1\@P&+?+GTQZFMXY9AIS:A4NEV:_O=>NRT6NOD/D5]SR)/
M#>J27-E;K8RF>]C\VVCP,RI@G(]L UHWWA%K?P[HE]!YT][J$TL)M53."C8
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M0^%]76_EL3IUPMY%&9GA9,,$'5L=Q27_ (9U72[>2>[L)K>&-UC=I%QM9AD
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MI\ M9!]G:59HUZ%<=#UZ^M+I_B+P]#J'B"RLA)HVG7]JMO!=[6=E93DLP!R
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MK8S^>/WO_(/82/F2BOIO_A4_A/\ Z \?_?R3_P"*H_X5/X3_ .@/'_W\D_\
MBJ/]5L9_/'[W_D'L)'S)17TW_P *G\)_] >/_OY)_P#%4?\ "I_"?_0'C_[^
M2?\ Q5'^JV,_GC][_P @]A(^9**^F_\ A4_A/_H#Q_\ ?R3_ .*H_P"%3^$_
M^@/'_P!_)/\ XJC_ %6QG\\?O?\ D'L)'S)17TW_ ,*G\)_] >/_ +^2?_%4
M?\*G\)_] >/_ +^2?_%4?ZK8S^>/WO\ R#V$CYDHKZ;_ .%3^$_^@/'_ -_)
M/_BJ/^%3^$_^@/'_ -_)/_BJ/]5L9_/'[W_D'L)'S)17TW_PJ?PG_P! >/\
M[^2?_%4?\*G\)_\ 0'C_ ._DG_Q5'^JV,_GC][_R#V$CYDHKZ;_X5/X3_P"@
M/'_W\D_^*H_X5/X3_P"@/'_W\D_^*H_U6QG\\?O?^0>PD?,E%?3?_"I_"?\
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M4?\ "I_"?_0'C_[^2?\ Q5'^JV,_GC][_P @]A(^9**^F_\ A4_A/_H#Q_\
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MD?-NGZI>:3<>?974UI-C'F0N5./3BFWM_<ZE<-<7=Q+<SMUDF<LQ_$U]*?\
M"I_"?_0'C_[^2?\ Q5'_  J?PG_T!X_^_DG_ ,55_P"K..Y>3VD;=KO_ "#V
M,NY\R45]-_\ "I_"?_0'C_[^2?\ Q5'_  J?PG_T!X_^_DG_ ,54?ZK8S^>/
MWO\ R#V$CYDHKZ;_ .%3^$_^@/'_ -_)/_BJ/^%3^$_^@/'_ -_)/_BJ/]5L
M9_/'[W_D'L)'S)17TW_PJ?PG_P! >/\ [^2?_%4?\*G\)_\ 0'C_ ._DG_Q5
M'^JV,_GC][_R#V$CYDHKZ;_X5/X3_P"@/'_W\D_^*H_X5/X3_P"@/'_W\D_^
M*H_U6QG\\?O?^0>PD?,E%?3?_"I_"?\ T!X_^_DG_P 51_PJ?PG_ - >/_OY
M)_\ %4?ZK8S^>/WO_(/82/F2BOIO_A4_A/\ Z \?_?R3_P"*H_X5/X3_ .@/
M'_W\D_\ BJ/]5L9_/'[W_D'L)'S)17TW_P *G\)_] >/_OY)_P#%4?\ "I_"
M?_0'C_[^2?\ Q5'^JV,_GC][_P @]A(^9**^F_\ A4_A/_H#Q_\ ?R3_ .*H
M_P"%3^$_^@/'_P!_)/\ XJC_ %6QG\\?O?\ D'L)'S)17TW_ ,*G\)_] >/_
M +^2?_%4?\*G\)_] >/_ +^2?_%4?ZK8S^>/WO\ R#V$CYDHKZ;_ .%3^$_^
M@/'_ -_)/_BJ/^%3^$_^@/'_ -_)/_BJ/]5L9_/'[W_D'L)'S)17TW_PJ?PG
M_P! >/\ [^2?_%4?\*G\)_\ 0'C_ ._DG_Q5'^JV,_GC][_R#V$CYDHKZ;_X
M5/X3_P"@/'_W\D_^*H_X5/X3_P"@/'_W\D_^*H_U6QG\\?O?^0>PD?,E%?3?
M_"I_"?\ T!X_^_DG_P 51_PJ?PG_ - >/_OY)_\ %4?ZK8S^>/WO_(/82/F2
MBOIO_A4_A/\ Z \?_?R3_P"*H_X5/X3_ .@/'_W\D_\ BJ/]5L9_/'[W_D'L
M)'S)17TW_P *G\)_] >/_OY)_P#%4?\ "I_"?_0'C_[^2?\ Q5'^JV,_GC][
M_P @]A(^9**^F_\ A4_A/_H#Q_\ ?R3_ .*H_P"%3^$_^@/'_P!_)/\ XJC_
M %6QG\\?O?\ D'L)'S)17TW_ ,*G\)_] >/_ +^2?_%4?\*G\)_] >/_ +^2
M?_%4?ZK8S^>/WO\ R#V$CYDHKZ;_ .%3^$_^@/'_ -_)/_BJ/^%3^$_^@/'_
M -_)/_BJ/]5L9_/'[W_D'L)'S)17TW_PJ?PG_P! >/\ [^2?_%4?\*G\)_\
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MX:[O_P#H6[;_ ,"F_P#B:^?:*K^R,#_S[_%_YD_VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
MB:/^&N[_ /Z%NV_\"F_^)KY]HH_LC _\^_Q?^8?VQCO^?GX+_(^@O^&N[_\
MZ%NV_P# IO\ XFC_ (:[O_\ H6[;_P "F_\ B:^?:*/[(P/_ #[_ !?^8?VQ
MCO\ GY^"_P CZ"_X:[O_ /H6[;_P*;_XFC_AKN__ .A;MO\ P*;_ .)KY]HH
M_LC _P#/O\7_ )A_;&._Y^?@O\CZ"_X:[O\ _H6[;_P*;_XFC_AKN_\ ^A;M
MO_ IO_B:^?:*/[(P/_/O\7_F']L8[_GY^"_R/H+_ (:[O_\ H6[;_P "F_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&SM..M+2J=K D;@#T]: /K"
MZMO$.O>!O#<OPOUFQL[*UMP)[-=@=GP.&)4X(.<@XR3G->;_ !(T_7OB9X[\
M/:)?>&O[ \0O&8IKMI \=P@ )D!48PN&/!/4"KLW@OPOXLBTW6? GBBQ\(7
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MM4%2<G)],U@L11DVE-77FO3\]#H>'K12;@[/R?K^6IB4445N<X4444 %%%%
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M-.ZYJ>BO9=KN^GY?U8]=T3PY9Z=X3U/4?#?AZ#Q7J*ZX]D8;R#[0UO:C.SY
M>"W'SU>T=8_#.C_%C=H=I:BWCM"=*:?[3!&^\G:6!&0"<[?P->)66I7>FNSV
M=U/:.PVLUO*R$CT.#TI([^ZAAGBCN9DBN,>=&LC!9<'(W#/S<^M;2P4Y7YIW
M3:[WT:?>W333K]^,<;"*7+"S2?:VJ:[7ZZZ]/N[WXQ:=80?\(KJ5EI]OIKZK
MI$=U<0VB;(O,).2J]J\[J>XOKF\6%;BXFG6%/+B660L(U_NKGH/85!7?0INE
M34&[V//KU%5J.:5KA1116Y@%%%% !7IO[/\ =0P^+M1@$T=MJ=WID]OITTC!
M=MP0-N#V) ->94JL58$'!'((K"O2]O2E3O:YT8>K["K&I:]CW+1_ >HZ;\*_
M%HU>'7M)OH[=YKB.XGC^S7C*V050@L<<98$<D<U=\->$;$Q^"+*S\*V>M:%J
MUEYVJZQ+"S/%(<[QYH/[K9@<=Z\-FUS4KC/G:C>2YC,1\RX=LH>J\G[O XZ<
M5%#JE[;VLEM%>7$5M)]^&.5E1OJH.#7FRP5:2E>>K=^MMK=[Z;H]*.-HQ<;0
MT2MK:^]^UM=F>W^ _!_ASQ9I4,@BM6@\+ZO.U[<&-0UW8A7=&<_Q<J%Y[9J]
MX-\/^']4\,:?KD.C6]]-JVH3_;((]):\\E-YVP*$91!A<'=CO7@-MJ%U913Q
MV]U-;QSKLE2*1E$B^C 'D>QI;/5+S3UD6TO+BU608=8960./?!YHJ8&I+FM4
M>^GXW_%W^2"GCZ<>6]-;:_A;\%;YL]CL;+P]X:\,>/M1BT*UU9--UB**QCU%
M=QC!XVL0<E02<C.#@9JQH_\ 9-EX;^&\[^&]'NI]<U"X@NI+BV#'RS,!A>>P
M;@G. O%>(QWUS':R6J7$J6TC!GA60A'(Z$KG!(]Z>-3O!';(+NX"6S;H%\UL
M1,3DE!GY3GTJY8&4MY]?/^6W?OJ1''1C:T.GE_-?MVT/;-0TO1O!GASQ5=0:
M#IM_)9^*?L5O]NA\P1Q$#Y>N2,9X)QSFM3Q%X=\/MXB^(7AR'P[IMM::7I#:
MC;7$,1%PLVQ6SO)^[EONCC KP&;5KZXCECEO;F6.67SI%>9F#R?WR">6]SS2
MMK6HR3SS-J%TTUPGES2&=BTB]-K'.6'L:S^H5+W=37Y_W?/R?WFGU^G:RIZ?
M+^]Y>:^X^@O"W@CPU'X;\,K_ &2NK6>HV/G7MQ'I;SR-(0=V+D.%@V'L1VKG
M])AT;0_!_@6:/0M,U234=9N+*6YOK<.[P^?M'0\MC&"<XQQUKQN'5+VVM9+6
M*\N(K:3[\$<S*C?50<&D_M*[$,$(NYQ#;OYD,?FMMB;.=RC/RG/<4U@:EWS5
M&TW?\'_FON^Y?7Z=ERTTFE;_ -)_R?W_ '^_:) ?#[?%W1=%TFUNDLV5[:U:
MU$[."WW".2Z@=!VKSSX#V!NOB%!=)+(L^G6\M[%;P8\RZ9%_U*YXRP)_#-<1
M'K6HPWDMW'J%U'=RY\RX6=A(^>N6SD_C56"XEM9DFAD>&5#E9(V*LI]01TK6
M.#E&G4AS:S2U^5G]_P"IE+&1E4ISY=(-Z?.Z^[]#W'XU>&3<>!])UV.SN-%L
MX-L4.@_9MILVD9FE:5L_Q,!M.!G(XK'^#W]G?\*[^(G]K?:AIWD6WG?8MOG8
MWM]W=QG..M>82:YJ4PN1)J-W(+D 3[YW/FXZ;\GYL>]0PWUS;V\\$5Q-%!.
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M8ZY'$5D+A5*/Y^<2;B3\M0:#9Z-;W'POTV7PWI-TNN6)%[//;YD;W!!X;/\
M%UKPF35+V:S2TDO+B2U3[L#2L8U^BYP*<NL7ZR6KK?7*O:C%NPF;,(]$.?E_
M"E]0J<O*Y_GV:OOO?5C_ +0I\W,J?Y=T[;;6T1[?X \+Z6+"\M1X?6:9M;FL
MX]1N=/\ [0A:-6*B%@K;X>WSX]\UXYXOTO\ L7Q5JU@%A06]U)'MMG+QKACP
MI/) ]^:J6NM:A8M,UM?W5NTQ)E,,[(9,]=V#S^-4^3R3DUUT,/.E4E.4KI_U
M_7Z''7Q$*M.,(QLU_7]?J%%%%=YP!1110![#=>&=6\3? ;PE%I.FW.I21:C<
MNZ6T9<JN6&3CWJ/X=^"[K3=$UV\U#0X'O+6ZBM3'=Z>]]<1$@-M6W! P01\[
M&O,[/Q)J^G6X@M-5OK6!3D107+HHSUX!Q3%U[4UFGF74KQ9K@8FD%P^Z4>C'
M/S?C7E_5:O+*FI*S;?GJ[V/56*H\T:CB[I)>6BL>^7WA'P[HGC_QT&T&UN+&
MS\/K?I92)A5DP"=O4IG'8\9.*YGP];Q:QX#UCQ-I7A+3=7UV?5$MGTZ.U:6*
MTM_+&"D0.1N/\7;/M7E#:WJ+M*[:A=LTL7DR,T[DO'_<//*^QXK=\(>-K?PS
M97EI<Z/'J$=R03-'=26LZX_A\Q#DH>ZFL'@ZL*?Q<S]W[E:_5;[[FZQE*=3X
M5&/O?*^W1[;;'M=UX%\/CQQKK'2;6"[L=%M)[;2X[,W*!VW"1_)4@RE< =>^
M3FO+OC1H^EZ7JVDO86+Z=<7-F)+JW-J;9"^<!UB+$H&Y^4^E<YXJ\<:AXH\2
M-K)/]GSK&D,*6;,@AC4855.<].]85S=37D[S7$TEQ,_+22N69OJ3R:O"X2K3
ME&I4GTV^7]/U,\5C*56,J=.'7?YW_P"!Z'N6K7GAC3_AW\,[KQ -6>6"WEEM
MDTQHU5L2*2'+<CD+T]Z=I_CH>)/"OQ6\32:9;R+--8NEE<C?'@-M7>!C=C )
M[$UX=-?7-S#!#-<330P K%')(66,'J%!. /I217US#;36\=Q+';S8\V%7(23
M'(W#H<>]/^SX\NKN[W^7-S60?VC+FT6EK?/EY;L][F\%:=J'B_3-0L]$TU$F
M\,IJUQ:-"[PK*206C@3EST^3@5<;P;HTOC3X:33:-;QMJ:7(O()+ 6R3;%)4
MM 20IYSCZ5\_KK>HQSP3KJ%VLT">7%(L[AHT_NJ<Y ]AQ3O[>U/S(9/[2O/-
MA+-$_P!H?=&6^\5.>">^.M9/ 5O^?G1K[TU^J^XU6/H_\^^J?3HT_P!&OF>L
M^'+W1=87Q[=_\(KI,4&C:=BTMC$6!*RMAW8G)8\9((R!CI72Z19:#JNO> K6
M;PKHRKXFTZ26^:.W*[61"08AG"<CJ.37SS#J%U;K.L5S-$MP-LP20@2C.<-@
M_,,^M2QZSJ$4ELZ7]TCVJE(&6=@85/4(<_*/I6E3 .3?+.WS?\MN_?4BGF$8
MI<T+_)?S7[=M#VCX;^#[>'0["YET>ROHKW5WM3*^GM?S-&K[2K<A(%X/S9SW
MKS'XF:3:Z#\0-?T^QB$%I;W;)%$#D(O7 ]N:Q+?6-0M(I(H+^Z@BD;>\<<[*
MK-ZD \FH;FZFO;AY[B:2XGD.7EE8LS'U)/)KHHX>I3K2J2E=/H<U;$4ZE&-*
M,+-=?D14445Z!YP4444 %%%% 'LOP#\1-X3\/^-=849^QQVDC#U7S3N'_?)-
M>HZ98V/@6^O]!TV2.1=:AU#67*#[L.P"%?IRWY5\GPWUS;PS0PW$L4,X"RQH
MY59 .0& /(^M3KK6HK,LHU"Z$JQ>0L@G?<(^FP'/W?;I7AXC+77J2GS6YOT2
M2^YW9[N'S)4*<*?+?E_5MO[UH>[?#WP;H'_"%>%;@:4FLG4@_P#:##2WO'+!
ML>6)%<"WP.Y'/6L32?#5E8^#=6OO#GAZ'Q5?_P!N/8M'>0F=[>U&=GRJ>">!
MO']*\@M=4O;&&6&VO+BWBE&)(X9617^H!YI+34+JP\P6MS-;"1=K^3(R;U]#
M@\BM?J57FD_:7N[_ (WMO_5OD9?7:7+%>SM96_!*_P#7?YGT)\0]+M+WQ#\2
MYKFRADGM-!LW@,BAS"VT\J3T/&,BLVZ\*QV4.D:?H_@NQUW0;K2!=3ZO,?+<
MR%27?[3TCVD?=KQ&36M1E:<OJ%TYG01REIV/F(.BMSR!V!IBZG>1V;6:WEPM
MHQRUNLK",_5<XJ(X"I"*BI[6[]DNC7:Z+GCZ<Y.7)O?MW;ZI][,]T^%O@VU;
M1/"K7FBV-[;ZM-)YLHT]KV21 Q'SRDA8 /;)XK#\1:?#I/PB\6V5LNRWM_%A
MBC7.<*JD ?E7E=KK6HV4 @M]0NK>$.)!'%.Z*&'1L XS[U'+JE[/#+#)>7$D
M,LGG21O*Q5Y/[Y!/+>YYJU@ZGM7.4[JZ=O1W_P" 9O&T_9*G&&MFK^JM_P $
M]2\!Z/J&N_ WQ;9Z9:3WMVVIVY6&W4LY "DX ]JZ>'P_%)X9^''A;QK(8+R;
M4I9/L\\F)8[;:VU&.<J&;:OX^U>%Z?KFI:3&Z6.HW=DCG<RVT[QACZD*1DU6
MNKR>^G::YGEN)FZR3.78_B>:<\'.<Y/FLF[K35/EM_P0AC80A%<EVDD]=&N:
M_P#P#W+XB:3HNAZ VIOH,=O>:?JD:V^-':SAEC#?-"X=SYPV@G<!_.HOB9X7
MT+PAX=U/4K2SM)%\37MNVE_NU/V>WV+)(4_NY9MO'8BO%KS5+S41&+N\N+H1
MC">?*S[1Z#)XI+C4+NZA@BGNIYHK<;88Y)&98QZ*"?E' Z>E*G@9QY;U+V>O
MGLU^*_%CJ8ZG+FM3M=:>6Z?X/\$>_:WX/TBW^('CY]/T*SO]1TRRMI=-T;R<
MQ,65?,?REQNV]<>]4?#?@ZPUCQC&^N^&;31+\:*][%I4.9$N9@<!S; AE.,G
MRL\XKQ)M7OWOOMK7MRU[_P _)F8R],?>SGI[U&VH74EY]K:YF:ZSN^T-(QDS
MZ[LYS4K U5'E]IK9*^M]DN^W7YE/'4G+F]GU;MI;=OM>_3Y'I'QFT?2[&ST"
MZM=/;3M2N$D%RHL#8QRJ"-KK"S$IU(]Z[[X,::MCX'T,+83:U_:FH2W*7*QA
MX-'N(@5CD<<'G@G) Q^OSQ>7USJ$YFNKB:ZF(P9)I"['\2<T^WU2]L[>:"WO
M+B"";B2**5E5_P#> .#^-74P4ZF'5!SV>_W_ )?I;8BGC84\0Z_)HUM]WY_K
M?<Z+XH>&Y/"OC:_L9;B:\ERLSW4T7E^<[C<S*.ZY)P?:O1_&OA'Q-XATGX:3
M^'K"\G>'1X%^TVX(6)_E(+-V]:\4NM0NK_ROM-S-<^4@CC\Z0OL4=%&3P/85
M<C\3ZS%:K;)J^H);JNQ85NI @7T SC'M6L\/5DJ;4ES1[K1Z6V,H8BE&51.+
MY9=GJM;[GN?CR+2=<UKXI7(AM;VYL-(M5-QL#;)QD.RGL> #CTJ_X=^'^GM;
MV^DZCH-BT$FBFZ:6WT]Y/WA3(D-XQ'S?[*@BOG&&^N;6.>.&XFBCG7;,D<A4
M2#KA@.H^M6(?$&JV\4446IWL<<0(C1+EPJ C!"@'CCTKD>7U%#DA4M:WX)+]
M#K684W/GG3O>_P"+;_4]G\%^&+=/#?@)M/\ "MGXBBU:Y;^U[RX@,K0;9 -N
MX']V N3SP<>]1W]CI/A_2?BAJ*:%IMW-INMQQ6<=S;AHX5+[< #'R\_=Z5PW
MA/XF0^&=+M;9]!@O)K2?[1%.MU+ '8'*^<B'$N"!C/I7,:MXCU'6;S4;BXNI
M/^)A.;BYBC8K&[DYR5S@X[9Z4HX2M*K+F=HW^_WK]^VG0)8NC&E'D5W;MM[M
MNW?7J>Y7?@O0Y/%]Y=VFAVES?-X:AU6ST55(@EN&R&P@/S   [1US6;)X7T^
MXO/ -]JOA2.VUC4)YUO-"LP+?SXD!V2>6[ *<XXR-W2O%Y-5O9;B&=[VX>>%
M0D4K3,7C4= ISD >@IEQJ%U>7/VF>YFGN,@^=)(S/QT^8G-:1P-56_>=//LU
MWVZ][]3.6.I._P"[Z^7=/MOT[6/>]9TFWTJ_\*:_::7IMO'_ &W'9[;C26L9
MP&;&UHB2K[>HD'0@4:UIJZM\1_B:=5T>V7[-HUQ+:,]H$W88;9@2/F;DC?[5
MX/?:M?:FZ/>7MS>/'PC7$S2%?ID\5))KVIRR/(^I7CR21>0[-<.2T?\ <)SR
MOMTI1P$U9\^MK?BF6\P@[I0TO?\ !H]HL?"Z6ND^$[?1?!ECXGTW4M.^T7^H
M7 *MYV#O7S\XAV8J;X;^%]-U/POI-LOAV$W=Y/<(U[>6'VVWN0&("^=&VZ#:
M!C) SC->&0ZG>6]K):Q7EQ%:R??@25E1OJH.#3K75K^QMY8+:^N;:"7_ %D<
M,S(K_4 X-5+!5)1<5/6^^OGOK;KVZ>EHACJ49*3AI;;3RVTOT[]?6_4_#NU^
MP_&#0K;]V?)U=(_W3;DXDQP>XXZUZQHLV@_\+'\=IHHU./Q.;:^ -^Z-:,P;
MY]JIAOIFOG>WN);6:.:"1X9HR&22-BK*1T((Z&I8=4O;>\>[BO+B.[?.ZX25
MA(V>N6!R<]ZUQ&#=>3ES6TM^-]?(RP^,5"*CRW]Z_P"%M/,]]\!>#?#_ /PA
M_A:8:2FLKJ:.VH.-+>[D+9P8Q*' @V^X[9JG\/\ PSHTNF306^A?:3-K$MM#
MJ=YIPOXI(@<+$^Q]T.!CY\8[YKP^VU2]LX)8;>\N((9>)(XI657^H!P:+'5K
M[3%D6SO;FT608=;>9HPP]\'FL)8&K+G_ 'F[_P _Z^7I;>..I1Y/W>RM^7^7
MX^M_<O"'@72-/TOQ)<FRM-0UBUUEK)H8[!]3CMX1T"1!@<,<C>>F,5#;^"]+
MA\9>,KC2]'MVLM.@@86U]:O=26TD@^81VRD[^>S'Y:\1L]2N]-E:6TNY[25A
M@O!*R,1Z$@TMKJE[83O/:WEQ;3N"&EAE9&;/7)!R:IX*KS2?M-_^!_E^/K>5
MC:-HKV6W_!_S_#TM]$/X)T"#XI:0DNB6XMKOPW)>7-FUL(E,P!RPCR1&WL#P
M:XSP;]B\4:/XJ\06'A;3;O6K&.WCLM%B@:2)(B</+Y6<R-CJ?4>]>7C7=361
M)!J-X)(XS$C_ &A]RH>J@YX4^G2J]G>7&GS+-:W$MK,O DAD*,/Q%$<#-1:<
M[NR77H[OKUV"6.IN2<865V^G5673IN>]^%+4Z/XD\62W?ANUT2=_"DEQ/I<4
MVZ-F)4Y*CF/=W3.1^-</\2K.PO/ 7@CQ#;Z99Z7?:BES'<I81>7$_EN%4[>Q
MQG\ZX!-4O8Y)Y$O+A9+A2DSK*P:53U#'/S#V-1RWUS-;PV\EQ+);PY\J%W)2
M//)VCH,^U:4\'*%15.;MWVLU;=]=?D9U,9&=)T^7OVWNG?1+I=?,AHHHKU#R
M@HHHH **** "BBB@ HHHH **** "K6EZK>:)?PWNGW,MG=PG='-"VUE-5:*3
M2:LQIN+NCU5?C]=:E"B>(_#&B>))5&!<7, 24_4@$?D!4&I?'W6?[/DL= TS
M3?"EM(,.=,A"RD?[W;Z@9KS&BN%8##)WY/ET^[;\#O>/Q+5N?Y]?OW_$=)(\
MTC22,SR,2S,QR23U)/<TVBBN\X HHJ>PL+G5+R&TLX)+JZF;9'#$I9G/H *3
M:2NP2;=D:/A'PQ=>,O$FGZ-9J3+=2A"V/N)U9C[ 9-??&GZ7;:7I]M9P1*L%
MO$L,8P.%4 #]!7FOP-^#J_#K37O]1"2:_=IB0J<BW3KY:GN?4^WM7JM?G.<8
MY8NJH4W[L?Q9^DY-@'A*3G47O2_!!67XB\,Z7XMTU[#5[**^M6YV2#E3ZJ>H
M/N*U**\",G%J479GORBI)QDKH^<_%7[):O*\OAW6/*0\BUU!20/8.O/YC\:X
M2X_9G\=PN0EG9W _O1W:@?\ CV*^QZS[KQ#I5C)Y=SJ5G;R?W)9T4_D37NTL
M[QE-<K:EZK_*QX%;(\%4?-9Q]'_G<^0_^&;?'W_0+M__  ,C_P :/^&;?'W_
M $"[?_P,C_QKZV_X2[0O^@UI_P#X%1_XT?\ "7:%_P!!K3__  *C_P :Z/[>
MQG\L?N?^9S_V#@OYG]Z_R/DG_AFWQ]_T"[?_ ,#(_P#&C_AFWQ]_T"[?_P #
M(_\ &OK;_A+M"_Z#6G_^!4?^-'_"7:%_T&M/_P# J/\ QH_M[&?RQ^Y_YA_8
M."_F?WK_ "/DG_AFWQ]_T"[?_P #(_\ &C_AFWQ]_P! NW_\#(_\:^MO^$NT
M+_H-:?\ ^!4?^-'_  EVA?\ 0:T__P "H_\ &C^WL9_+'[G_ )A_8."_F?WK
M_(^2?^&;?'W_ $"[?_P,C_QH_P"&;?'W_0+M_P#P,C_QKZV_X2[0O^@UI_\
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ML?N?^8?V#@OYG]Z_R/DG_AFWQ]_T"[?_ ,#(_P#&C_AFWQ]_T"[?_P #(_\
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MPEVA?]!K3_\ P*C_ ,:/[>QG\L?N?^8?V#@OYG]Z_P CY)_X9M\??] NW_\
M R/_ !H_X9M\??\ 0+M__ R/_&OK;_A+M"_Z#6G_ /@5'_C1_P )=H7_ $&M
M/_\  J/_ !H_M[&?RQ^Y_P"8?V#@OYG]Z_R/DG_AFWQ]_P! NW_\#(_\:/\
MAFWQ]_T"[?\ \#(_\:^MO^$NT+_H-:?_ .!4?^-'_"7:%_T&M/\ _ J/_&C^
MWL9_+'[G_F']@X+^9_>O\CY)_P"&;?'W_0+M_P#P,C_QH_X9M\??] NW_P#
MR/\ QKZV_P"$NT+_ *#6G_\ @5'_ (T?\)=H7_0:T_\ \"H_\:/[>QG\L?N?
M^8?V#@OYG]Z_R/DG_AFWQ]_T"[?_ ,#(_P#&C_AFWQ]_T"[?_P #(_\ &OK;
M_A+M"_Z#6G_^!4?^-'_"7:%_T&M/_P# J/\ QH_M[&?RQ^Y_YA_8."_F?WK_
M "/DG_AFWQ]_T"[?_P #(_\ &C_AFWQ]_P! NW_\#(_\:^MO^$NT+_H-:?\
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MC_QKZV_X2[0O^@UI_P#X%1_XT?\ "7:%_P!!K3__  *C_P :/[>QG\L?N?\
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M !H_X9M\??\ 0+M__ R/_&OK;_A+M"_Z#6G_ /@5'_C1_P )=H7_ $&M/_\
M J/_ !H_M[&?RQ^Y_P"8?V#@OYG]Z_R/DG_AFWQ]_P! NW_\#(_\:/\ AFWQ
M]_T"[?\ \#(_\:^MO^$NT+_H-:?_ .!4?^-'_"7:%_T&M/\ _ J/_&C^WL9_
M+'[G_F']@X+^9_>O\CY)_P"&;?'W_0+M_P#P,C_QH_X9M\??] NW_P# R/\
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MZ#6G_P#@5'_C1_PEVA?]!K3_ /P*C_QH_M[&?RQ^Y_YA_8."_F?WK_(^2?\
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M'_"7:%_T&M/_ / J/_&C^WL9_+'[G_F']@X+^9_>O\CY)_X9M\??] NW_P#
MR/\ QH_X9M\??] NW_\  R/_ !KZV_X2[0O^@UI__@5'_C1_PEVA?]!K3_\
MP*C_ ,:/[>QG\L?N?^8?V#@OYG]Z_P CY)_X9M\??] NW_\  R/_ !H_X9M\
M??\ 0+M__ R/_&OK;_A+M"_Z#6G_ /@5'_C1_P )=H7_ $&M/_\  J/_ !H_
MM[&?RQ^Y_P"8?V#@OYG]Z_R/DG_AFWQ]_P! NW_\#(_\:/\ AFWQ]_T"[?\
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M:%_T&M/_ / J/_&C^WL9_+'[G_F']@X+^9_>O\CY)_X9M\??] NW_P# R/\
MQH_X9M\??] NW_\  R/_ !KZV_X2[0O^@UI__@5'_C1_PEVA?]!K3_\ P*C_
M ,:/[>QG\L?N?^8?V#@OYG]Z_P CY)_X9M\??] NW_\  R/_ !H_X9M\??\
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M_P #(_\ &C_AFWQ]_P! NW_\#(_\:^MO^$NT+_H-:?\ ^!4?^-'_  EVA?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@O/$^LZCIT6GW>KZA=6$6/+M9KJ1XDQTPA.!^5&G^)M9TFRFL['5[^RLYO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#VYNIZV7Y;6S!R5+H9__  4%_9RN/B-X7@\=^'[5KC7M#A*7EO"N7N;,$L2
M.K1DDX[J6]!7YEU^^M?$7[47_!/V/Q=?7GBKX:BWL=4F8RW6@R$1P3N>2\+=
M(V/=3\I[%>_DX+&*"]E4VZ,^QSS)9UY/%897?5=_-'YST5M^+O!.O^ =6DTS
MQ'H][HE_&<&&]A:,GW!/##W&16)7OIIJZ/SJ490?+)684444R0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\,8_!7_H0-/_ ._LW_Q=%%'MJO\ ,_O#ZEA?^?4?N7^0?\,8_!7_ *$#3_\
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M%_Y]1^Y?Y!_PQC\%?^A T_\ [^S?_%T?\,8_!7_H0-/_ ._LW_Q=%%'MJO\
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M T__ +^S?_%T?\,8_!7_ *$#3_\ O[-_\7111[:K_,_O#ZEA?^?4?N7^0?\
M#&/P5_Z$#3_^_LW_ ,71_P ,8_!7_H0-/_[^S?\ Q=%%'MJO\S^\/J6%_P"?
M4?N7^0?\,8_!7_H0-/\ ^_LW_P 71_PQC\%?^A T_P#[^S?_ !=%%'MJO\S^
M\/J6%_Y]1^Y?Y!_PQC\%?^A T_\ [^S?_%T?\,8_!7_H0-/_ ._LW_Q=%%'M
MJO\ ,_O#ZEA?^?4?N7^0?\,8_!7_ *$#3_\ O[-_\71_PQC\%?\ H0-/_P"_
MLW_Q=%%'MJO\S^\/J6%_Y]1^Y?Y!_P ,8_!7_H0-/_[^S?\ Q='_  QC\%?^
MA T__O[-_P#%T44>VJ_S/[P^I87_ )]1^Y?Y!_PQC\%?^A T_P#[^S?_ !='
M_#&/P5_Z$#3_ /O[-_\ %T44>VJ_S/[P^I87_GU'[E_D'_#&/P5_Z$#3_P#O
M[-_\71_PQC\%?^A T_\ [^S?_%T44>VJ_P S^\/J6%_Y]1^Y?Y!_PQC\%?\
MH0-/_P"_LW_Q='_#&/P5_P"A T__ +^S?_%T44>VJ_S/[P^I87_GU'[E_D'_
M  QC\%?^A T__O[-_P#%T?\ #&/P5_Z$#3_^_LW_ ,7111[:K_,_O#ZEA?\
MGU'[E_D'_#&/P5_Z$#3_ /O[-_\ %T?\,8_!7_H0-/\ ^_LW_P 7111[:K_,
M_O#ZEA?^?4?N7^0?\,8_!7_H0-/_ ._LW_Q='_#&/P5_Z$#3_P#O[-_\7111
M[:K_ #/[P^I87_GU'[E_D'_#&/P5_P"A T__ +^S?_%T?\,8_!7_ *$#3_\
MO[-_\7111[:K_,_O#ZEA?^?4?N7^0?\ #&/P5_Z$#3_^_LW_ ,71_P ,8_!7
M_H0-/_[^S?\ Q=%%'MJO\S^\/J6%_P"?4?N7^0?\,8_!7_H0-/\ ^_LW_P 7
M1_PQC\%?^A T_P#[^S?_ !=%%'MJO\S^\/J6%_Y]1^Y?Y!_PQC\%?^A T_\
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M5_Z$#3_^_LW_ ,7111[:K_,_O#ZEA?\ GU'[E_D'_#&/P5_Z$#3_ /O[-_\
M%T?\,8_!7_H0-/\ ^_LW_P 7111[:K_,_O#ZEA?^?4?N7^0?\,8_!7_H0-/_
M ._LW_Q='_#&/P5_Z$#3_P#O[-_\7111[:K_ #/[P^I87_GU'[E_D'_#&/P5
M_P"A T__ +^S?_%T?\,8_!7_ *$#3_\ O[-_\7111[:K_,_O#ZEA?^?4?N7^
M0?\ #&/P5_Z$#3_^_LW_ ,71_P ,8_!7_H0-/_[^S?\ Q=%%'MJO\S^\/J6%
M_P"?4?N7^0?\,8_!7_H0-/\ ^_LW_P 71_PQC\%?^A T_P#[^S?_ !=%%'MJ
MO\S^\/J6%_Y]1^Y?Y!_PQC\%?^A T_\ [^S?_%T?\,8_!7_H0-/_ ._LW_Q=
M%%'MJO\ ,_O#ZEA?^?4?N7^0?\,8_!7_ *$#3_\ O[-_\71_PQC\%?\ H0-/
M_P"_LW_Q=%%'MJO\S^\/J6%_Y]1^Y?Y!_P ,8_!7_H0-/_[^S?\ Q='_  QC
M\%?^A T__O[-_P#%T44>VJ_S/[P^I87_ )]1^Y?Y!_PQC\%?^A T_P#[^S?_
M !=2P?L:_!>%MP^'^FL?]MI6'Y%Z**/;5?YG]X_J6%_Y]1^Y'?\ A'X6^#_
I*@>'/#&DZ(>GF65FD;GZL!D_B:ZFBBLFW)W9U1C&"Y8JR"BBBD4?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>iclr-20211231_g3.jpg
<TEXT>
begin 644 iclr-20211231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)Y<FYE+"!%
M86UO;FX   60 P "    %   $*:0!  "    %   $+J2D0 "     S$T  "2
MD@ "     S$T  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M5/\ P-D_QK(HHL@]K4_F?WFO_P )9XC_ .@_JG_@;)_C1_PEGB/_ *#^J?\
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M (&R?XT?\)9XC_Z#^J?^!LG^-9%%%D'M:G\S^\U_^$L\1_\ 0?U3_P #9/\
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MLG^-9%%%D'M:G\S^\U_^$L\1_P#0?U3_ ,#9/\:/^$L\1_\ 0?U3_P #9/\
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M7N+&]FN;)H(F=O+L9+APRD#:47D=>IZ8]ZSK'3;[4Y6CTVRN+N15W,EO$TA
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M***R/8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *9//%;0M-<RI%$@RSR,%4?4FGUR7Q2_Y)KJG_;'_P!')32N[&=6?LZ<
MI]DV:W_"6>'/^@_I?_@;'_C1_P )9X<_Z#^E_P#@;'_C7,>'OAQX4OO#&EW=
MUI7F3W%G#+(_VB4;F9 2<!L#DUH_\*M\'?\ 0'_\FIO_ (NJ]TYHRQ<DFE'[
MW_D:W_"6>'/^@_I?_@;'_C1_PEGAS_H/Z7_X&Q_XUD_\*M\'?] ?_P FIO\
MXNC_ (5;X._Z _\ Y-3?_%TO='?%]H_>_P#(UO\ A+/#G_0?TO\ \#8_\:X3
MXNZYI.I>$;6'3M3L[N5;Y'*07".P7RY!G /3D?G72_\ "K?!W_0'_P#)J;_X
MNN,^*'@S0/#OABWN]&L/LT[WBQ,_G2/E2CG&&8CJ!51Y;G+BWB?82YE&UN[_
M ,CRFBBBND^5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=R\CITQ1HAQ]K5>C;W_+_(@3Q[XFCLA:IJL@C6/RPWEIY@7IC?C=^M<[6@=
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MQB66!E0YZ<D8JM#%RJRU;?\ 6OYE_4O&GB#5[%[._P!19X)""Z)$D>_']XJ
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MF_\ ^$7UD>&S<?:O^$@G^V_9<^9LYVYV\[<_KFKVA0ZG -2/B*ZN)M7;2(3
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MF6+.T/CY@,]LUXC^SDBG5O%[D?,LD !] 6FS_(5[K0""N2^*7_)-=4_[8_\
MHY*ZVN2^*7_)-=4_[8_^CDJH[HPQ7\"?H_R-;PG_ ,B7HG_8/@_]%K6O61X3
M_P"1+T3_ +!\'_HM:UZ3W-*7\./H@HHHI&@5B>+_  ^/$WA>ZTT,%E8!X7;H
MKKR/P/3Z&MNBA:$S@IQ<9;,^4;ZQN=-O9;2^A>"XB;:\;C!!JO7U)J_AW2-=
M4#5]/ANBHPK.N&4>S#D?G6)_PJ[P<?\ F#_^3,W_ ,76ZJKJ?.3R>KS>Y)6\
MSYVHKZ)_X5;X._Z _P#Y-3?_ !='_"K?!W_0'_\ )J;_ .+I^U1']D5^Z_'_
M "/G:BOHG_A5O@[_ * __DU-_P#%T?\ "K?!W_0'_P#)J;_XNCVJ#^R*_=?C
M_D?.U%?1/_"K?!W_ $!__)J;_P"+H_X5;X._Z __ )-3?_%T>U0?V17[K\?\
MCYVHKZ)_X5;X._Z _P#Y-3?_ !='_"K?!W_0'_\ )J;_ .+H]J@_LBOW7X_Y
M'SM17T3_ ,*M\'?] ?\ \FIO_BZ/^%6^#O\ H#_^34W_ ,71[5!_9%?NOQ_R
M/G:BOHG_ (5;X._Z _\ Y-3?_%T?\*M\'?\ 0'_\FIO_ (NCVJ#^R*_=?C_D
M?.U%?1/_  JWP=_T!_\ R:F_^+H_X5;X._Z _P#Y-3?_ !='M4']D5^Z_'_(
M^=J*^B?^%6^#O^@/_P"34W_Q='_"K?!W_0'_ /)J;_XNCVJ#^R*_=?C_ )'S
MM17T3_PJWP=_T!__ ":F_P#BZ/\ A5O@[_H#_P#DU-_\71[5!_9%?NOQ_P C
MYVHKZ)_X5;X._P"@/_Y-3?\ Q='_  JWP=_T!_\ R:F_^+H]J@_LBOW7X_Y'
MSM17T3_PJWP=_P! ?_R:F_\ BZ/^%6^#O^@/_P"34W_Q='M4']D5^Z_'_(^=
MJ*^B?^%6^#O^@/\ ^34W_P 71_PJWP=_T!__ ":F_P#BZ/:H/[(K]U^/^1\[
M45]$_P#"K?!W_0'_ /)J;_XNC_A5O@[_ * __DU-_P#%T>U0?V17[K\?\CYV
MHKZ)_P"%6^#O^@/_ .34W_Q='_"K?!W_ $!__)J;_P"+H]J@_LBOW7X_Y'SM
M17T3_P *M\'?] ?_ ,FIO_BZ/^%6^#O^@/\ ^34W_P 71[5!_9%?NOQ_R/G:
MBOHG_A5O@[_H#_\ DU-_\71_PJWP=_T!_P#R:F_^+H]J@_LBOW7X_P"1\[45
M]$_\*M\'?] ?_P FIO\ XNC_ (5;X._Z _\ Y-3?_%T>U0?V17[K\?\ (^=J
M*^B?^%6^#O\ H#_^34W_ ,71_P *M\'?] ?_ ,FIO_BZ/:H/[(K]U^/^1\[4
M5]$_\*M\'?\ 0'_\FIO_ (NC_A5O@[_H#_\ DU-_\71[5!_9%?NOQ_R/G:BO
MHG_A5O@[_H#_ /DU-_\ %T?\*M\'?] ?_P FIO\ XNCVJ#^R*_=?C_D?.U%?
M1/\ PJWP=_T!_P#R:F_^+H_X5;X._P"@/_Y-3?\ Q='M4']D5^Z_'_(^=J*^
MB?\ A5O@[_H#_P#DU-_\71_PJWP=_P! ?_R:F_\ BZ/:H/[(K]U^/^1\[45]
M$_\ "K?!W_0'_P#)J;_XNC_A5O@[_H#_ /DU-_\ %T>U0?V17[K\?\CYVHKZ
M)_X5;X._Z __ )-3?_%T?\*M\'?] ?\ \FIO_BZ/:H/[(K]U^/\ D?.U%?1/
M_"K?!W_0'_\ )J;_ .+H_P"%6^#O^@/_ .34W_Q='M4']D5^Z_'_ "/G:BOH
MG_A5O@[_ * __DU-_P#%T?\ "K?!W_0'_P#)J;_XNCVJ#^R*_=?C_D?.U%?1
M/_"K?!W_ $!__)J;_P"+H_X5;X._Z __ )-3?_%T>U0?V17[K\?\CYVHKZ)_
MX5;X._Z _P#Y-3?_ !='_"K?!W_0'_\ )J;_ .+H]J@_LBOW7X_Y'SM17T3_
M ,*M\'?] ?\ \FIO_BZ/^%6^#O\ H#_^34W_ ,71[5!_9%?NOQ_R/G:BOHG_
M (5;X._Z _\ Y-3?_%T?\*M\'?\ 0'_\FIO_ (NCVJ#^R*_=?C_D?.U%?1/_
M  JWP=_T!_\ R:F_^+H_X5;X._Z _P#Y-3?_ !='M4']D5^Z_'_(^=J*^B?^
M%6^#O^@/_P"34W_Q='_"K?!W_0'_ /)J;_XNCVJ#^R*_=?C_ )'SM17T3_PJ
MWP=_T!__ ":F_P#BZ/\ A5O@[_H#_P#DU-_\71[5!_9%?NOQ_P CYVHKZ)_X
M5;X._P"@/_Y-3?\ Q='_  JWP=_T!_\ R:F_^+H]J@_LBOW7X_Y'SM17T3_P
MJWP=_P! ?_R:F_\ BZ/^%6^#O^@/_P"34W_Q='M4']D5^Z_'_(^=J*^B?^%6
M^#O^@/\ ^34W_P 71_PJWP=_T!__ ":F_P#BZ/:H/[(K]U^/^1\[45]$_P#"
MK?!W_0'_ /)J;_XNC_A5O@[_ * __DU-_P#%T>U0?V17[K\?\CYVHKZ)_P"%
M6^#O^@/_ .34W_Q='_"K?!W_ $!__)J;_P"+H]J@_LBOW7X_Y'SM17T3_P *
MM\'?] ?_ ,FIO_BZ/^%6^#O^@/\ ^34W_P 71[5!_9%?NOQ_R/G:BOHG_A5O
M@[_H#_\ DU-_\71_PJWP=_T!_P#R:F_^+H]J@_LBOW7X_P"1\[45]$_\*M\'
M?] ?_P FIO\ XNC_ (5;X._Z _\ Y-3?_%T>U0?V17[K\?\ (^=J*^B?^%6^
M#O\ H#_^34W_ ,71_P *M\'?] ?_ ,FIO_BZ/:H/[(K]U^/^1\[45]$_\*M\
M'?\ 0'_\FIO_ (NC_A5O@[_H#_\ DU-_\71[5!_9%?NOQ_R/G:BOHG_A5O@[
M_H#_ /DU-_\ %T?\*M\'?] ?_P FIO\ XNCVJ#^R*_=?C_D?.U%?1/\ PJWP
M=_T!_P#R:F_^+H_X5;X._P"@/_Y-3?\ Q='M4']D5^Z_'_(^=J*^B?\ A5O@
M[_H#_P#DU-_\71_PJWP=_P! ?_R:F_\ BZ/:H/[(K]U^/^1\[45]$_\ "K?!
MW_0'_P#)J;_XNC_A5O@[_H#_ /DU-_\ %T>U0?V17[K\?\CYVHKZ)_X5;X._
MZ __ )-3?_%T?\*M\'?] ?\ \FIO_BZ/:H/[(K]U^/\ D?.U%?1/_"K?!W_0
M'_\ )J;_ .+H_P"%6^#O^@/_ .34W_Q='M4']D5^Z_'_ "/G:BOHG_A5O@[_
M * __DU-_P#%T?\ "K?!W_0'_P#)J;_XNCVJ#^R*_=?C_D?.U%?1/_"K?!W_
M $!__)J;_P"+H_X5;X._Z __ )-3?_%T>U0?V17[K\?\CYVHKZ)_X5;X._Z
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M/_Y-3?\ Q='_  JWP=_T!_\ R:F_^+H]J@_LBOW7X_Y'SM17T3_PJWP=_P!
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MK:!(+:)(8HU"I'&H55 [ #H*?10!R>H?"[P7JFLOJM_H%O+=R-O=][JKMZE
MP4GZCFK^B>"O#WAO5;W4M$TY;2ZOB3<,DCD-EMW"DE5&3T %;M% &%X<\%Z!
MX2DO)/#UA]D:^*M<'SI)-Y7=C[[''WFZ8ZUNT44 %<E\4O\ DFNJ?]L?_1R5
MUM<E\4O^2:ZI_P!L?_1R54=T<^*_@3]'^1K>$_\ D2]$_P"P?!_Z+6M>LCPG
M_P B7HG_ &#X/_1:UKTGN:4OX<?1!1112- HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNMKDOBE_R375/^V/_HY*J.Z,,5_ GZ/\C6\)_P#(EZ)_V#X/_1:UKUD>$_\
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M]^H__CE'_"ZO#G_/EJG_ 'ZC_P#CE>&T4>SB']JXGNON/<O^%U>'/^?+5/\
MOU'_ /'*/^%U>'/^?+5/^_4?_P <KPVBCV<0_M7$]U]Q[E_PNKPY_P ^6J?]
M^H__ (Y1_P +J\.?\^6J?]^H_P#XY7AM%'LXA_:N)[K[CW+_ (75X<_Y\M4_
M[]1__'*/^%U>'/\ GRU3_OU'_P#'*\-HH]G$/[5Q/=?<>Y?\+J\.?\^6J?\
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MY1_PNKPY_P ^6J?]^H__ (Y7AM%'LXA_:N)[K[CW+_A=7AS_ )\M4_[]1_\
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M\^6J?]^H_P#XY7AM%'LXA_:N)[K[CW+_ (75X<_Y\M4_[]1__'*/^%U>'/\
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M*K!%5E9"#U Z@<&J2^,["+Q!H/VK7Y=1@M9WFN;@62P1(2I5=J*@<GGG.?\
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MI],4:WT*C*BX152UDEZ_%^5A+WPAIESH^H7.B0ZU;3:?'YS+J<(59XP<,5(
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MTE9A1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#KOA;_ ,E*TO\
M[;?^B7KZ(KYW^%O_ "4K2_\ MM_Z)>OHBN>KN?49/_ ?K^B"BBBLCV HHHH
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M/_Q='_"K?&/_ $!__)J'_P"+HYEW#ZK7_D?W,Y&BNN_X5;XQ_P"@/_Y-0_\
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M /DU#_\ %T<R[A]5K_R/[F<C177?\*M\8_\ 0'_\FH?_ (NC_A5OC'_H#_\
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M/_Q='_"K?&/_ $!__)J'_P"+HYEW#ZK7_D?W,Y&BNN_X5;XQ_P"@/_Y-0_\
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M/_0'_P#)J'_XNC_A5OC'_H#_ /DU#_\ %T<R[A]5K_R/[F<C177?\*M\8_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1W6-&>1@JJ,LS'
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M_.IPE3DX35F@HHHH("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:"(;A]UU9XC<GJR_PM^F/PKJ:XVK.Q^58BA/#U94I[H****1@%%%% !1110
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MH9DEC.UT8,I]"*^AK2<75E!<+TFC5Q^(S7SM7NOA"<W'@_3';DB )_WS\O\
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M:*?[-:)!))",1LX))V_[/.!7.T4N76YST\%&%?VU_EZ_U_G<****H[PHHHH
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MUSPQ9W6MV%GI$\<)-HLDV8=JI&!DRDYY)]/UK$O- M1I4U_H^J+J$5LRB=3
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MHG_/KJ'_ '[3_P"+H_X6GHG_ #ZZA_W[3_XNNUHK&\>Q\;[? _\ /E_^!_\
MVIQ7_"T]$_Y]=0_[]I_\71_PM/1/^?74/^_:?_%UVM%%X]@]O@?^?+_\#_\
MM3BO^%IZ)_SZZA_W[3_XNC_A:>B?\^NH?]^T_P#BZ[6BB\>P>WP/_/E_^!__
M &IQ7_"T]$_Y]=0_[]I_\71_PM/1/^?74/\ OVG_ ,77:T47CV#V^!_Y\O\
M\#_^U.*_X6GHG_/KJ'_?M/\ XNC_ (6GHG_/KJ'_ '[3_P"+KM:*+Q[![? _
M\^7_ .!__:GFWB3X@Z7J_AV[L+2WO$EF4!6D10H^8$YPQ["O.J]R\:)YG@W4
M@.T6[\B#_2O#:VIVMH?8Y#4HSP\O91Y5?O?HO)!1116I]"%.1&DD5(U+NQPJ
MJ,DGT%-KH/!*3#Q/!=I&K0VH:2=W<*L:8(+$GTSFDW97,:]7V5*53LC'NK&[
ML65;VUFMF89431E"1[9J*.-YI4BA1I)'8*J*,EB>@ [FNR\6QW"Z396%J;K4
M[9 ]X-0<%]R'MD9P!D9SW]*YSP[_ ,C1I7_7Y#_Z&*2=U<YJ&*=3#NJUJK_A
M^7H'_".ZW_T!]0_\!7_PK/DC>*1HY49'0E65A@J1U!%=GJEC>MK%XR>++&%3
M.Y$37TBE!N/RD!>,=,5FZ?I&FS:#=ZOJ]Q=-Y%V(F%N03*".Q8=<G.3V'3-)
M2,Z6-O#GGKMLGN_4YRBNQD\/^'(+[3X9;G4F_M1(Y+=5" Q*_ WG'/.>GI5:
M#P_I5OIM_=ZM<W(%E?&U"P;09< \#/0YYSZ \4^9%K,*35[/[M];?F8KW.H:
MP;6TQ)=-;Q^7!'''E@HYQ@#)]:HUW6@Z5:6?BK1+_2YI9+.^CN"@G #HR1L&
M!QP>3UK%MM*TBTT.UU'7)KMC>LX@AM-H(53@LQ;W[4N9$0QE-2Y8QTTLDM;M
MRNK>7*_Q.?HKJW\*VAN;J"VN99FDL!?:>< >8G.588^]@'ICIGVJ#3O"Z7]G
MI*&9X[S4IY"@.-J0H.6(ZYR#CG'%/F1K]?H<O-?^K-_DG]S.;HKK;GPUI\]A
M?2:4FJ0S6<9FS?1!4F1?O;2 ,''.#_\ JIZQI>C:7IEI\]])?W5G%<J,IY2%
MAR#QGU_2CF3"&.I3:C%.[TM8YZBBBJ.X**** .Y\&>-=/\.Z+)9WT-U([3M(
MIA12,%5'=ASD&N@_X6GHG_/KJ'_?M/\ XNI?ABFSPDQ/\=R[#\E']*["N:3C
MS;'YWF-?!K%U%.DV[[\UOPL<5_PM/1/^?74/^_:?_%T?\+3T3_GUU#_OVG_Q
M==K14WCV.'V^!_Y\O_P/_P"U.*_X6GHG_/KJ'_?M/_BZ/^%IZ)_SZZA_W[3_
M .+KM:*+Q[![? _\^7_X'_\ :G%?\+3T3_GUU#_OVG_Q='_"T]$_Y]=0_P"_
M:?\ Q==K11>/8/;X'_GR_P#P/_[4XK_A:>B?\^NH?]^T_P#BZ/\ A:>B?\^N
MH?\ ?M/_ (NNUHHO'L'M\#_SY?\ X'_]J<5_PM/1/^?74/\ OVG_ ,71_P +
M3T3_ )]=0_[]I_\ %UVM%%X]@]O@?^?+_P# _P#[4^=)7\R9W_O,33*L7R>5
MJ%Q&>"LK+^1-5ZZC]0BTXIH****905T?@26.+Q=;"0A6D22.-C_"Q4@?X?C7
M.4JL48,I*L#D$'D&DU=6,,12]M2E3O:Z:+2:;=OJ@TX0,+LR>7Y9'(:M^"R?
M3?#/BJSEDCD>"2U1FB;*Y#MG!_2J1\9^(##Y?]HO]W9O\M-^/]_&[]:HZ;K6
MHZ1-++I]RT32C$F5#!_J&!!J=6<M2GBJL;2Y5:SM=ZM23WMIMV9U%F_V33/"
M$TUE+=JCW;^2D>YB-PPP'?'WOPJ35M0N;S0IK[3]:BU)+&>*;=-:^7/;'=A=
MIZ$9]NU<S<>)M8N;FVN)KYS+:LS0N%4%"V,]!TX''2C4?$NK:K;?9[Z\+PEM
MQ18U0,?4[0,_C2Y7<Y%@*KJ1G*V[;Z[R;MK'L[737G='<:A=SR^+-9D;%Q+I
MEB);*)U#"-F1"S 8Y(ZUS\E_=:_X*U*ZUG$\MG-%]FN60*V6.&3(ZC&#CW^E
M9#^)]9DNK>X:^836RE8Y%100#C@X'S=!US4>IZ_J>L1I'J%T98XSN5%144'U
MPH S[T*+0J&7U*?(FHZ<NNMU;>VGVNNV[W/06U6YF^(>H:1-Y;Z>(&+6[1J5
M<^6&R>,DY-<_'?S>(O"CG695D,6HPHDFU5,:MD,!@=*YX>(-3&KR:I]I_P!,
ME4J\OEKR"-O3&.@]*K)?W,>GRV*28MI7$CIM'+#H<]>]"A8*66.FHVLFE#5=
MU\3VZ_CU/2Y[JUA\1MI4FJ1FR7]T='33I'^7;T!"G)_BR*PKO4KC1?!%@-)F
M,>Z[N(A*4&\IN/'(XSQGZ"L-/%^O):BW747"!-@;8N\#TWXW?K6=)J-U-IT-
MA)+FV@9GC3:/E)Z\XS24":.5SBX^TLTFKKO9-7^%:Z];^;*M%%%:GOA1110
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ME<J2.H['M0I-D4LRJ5;*,5=VMY7?7^O(Y_2/#M[J>O1Z7)%+:RD%I#)$V8E
MZD?D/Q%9L]O-:SM#=0R0RK]Z.12K#Z@UZ+8SR/XG\)322LTLU@5E<MS(-K$
MGOSZUYW=?:?M3_;O-\_/S^=G=T[YYZ4XMMG3A,34K56I6M9:>=Y)_E^1#111
M5GIA7T#HMM]CT&QM\8,5NBGZA1FO$/#]A_:?B*QM",K),N\?[(Y;] :]\K"J
M]D?&<355>G27F_T7ZA1116!\:%%%% !1110 4444 %%%% %35K;[9HU[;8R9
MH'0#ZJ17SY7T=7@OB2P_LSQ+?VH&U4F)0?[)Y7]"*WI/='V/#-97J4GY/]'^
MAET445N?:!6SH&L6^G1WMIJ$,DME?1".7R2!(A!R&&>/PK&HI-7,JM*-6#A+
M8[!?$^D6WA^;0[2+47LYD8F:611(KG! "C@+D<C/.37-Z5=)8ZS97<P8QV]Q
M'*P4<D*P)Q[\53HI**1C3PE.E&48W][?_,Z6\G\)WM]/=.^LJT\C2,!%%@$G
M/][WJN^K6$7AF]TJT6Y;S;M9HGE51\@&/FP>OTJE8:'J.I6LUS9V^^"#_62,
MZH!QG&6(R<=A6?19&<*%)ODYV^6VE]K:HWKG7+:;5-"N524)IUO!%*"!EBC$
MG;STYXSBMJ"XTR]\*:Q=:C'<?99M5\Q#%M\Q"PR#@\=#@\]S7'6=I/?WD5K:
M)YDTK;47(&3]3Q2RR75LLMA)+(B+(?,A#_+O'&2!P3[TG%$5,'3E:$)6:L]]
M;7N=+;>*-/L]8TK[-;W"Z;IL<JH&P97:12&8\XZD<9_PJE;:KI%WH=KIVN0W
M:FR9S!-:;22K')5@WOWKGZM1Z==3:=-?QQ9MH&5)'W#Y2>G&<T^5%O!T(6=V
MGIK?6]W^+YGZW.BM=6FU+QEID^C64BPV0CMXH\;R(@2"6/N&.3VS2:GXA33O
M'4=UI\:O;:8!;0QY(!105;GWRW/TKF[:\NK)F:SN9K=G7:QBD*EAZ'':H*7*
MKDK T^>[7N\O+;UWO_75G6WOB73VT^[CMKK7;J2X0HB7EV1'&#U/RM\W'8\>
MM8^NZG#J;:>8%D7[+8Q6S[P!EE!R1@]*RJ*:BD:TL'2I-2C>X44451V!114M
MM ]U=16\0R\KA%'N3@4";25V>U>![;[+X,T]2,%T,A]]S$C]"*WZBMK=+6TA
MMXAA(45%'L!@5+7$W=W/R'$5/:UIU.[;^]A1112,0HHHH **** "BBB@ HHH
MH \*\6VWV7Q=J4>,9G9P/][YOZUC5V_Q1L/(U^WO%&%N8<$^K*<']"M<179%
MWBC]7R^JJV$IS\E^&C"BBBJ.XZ2/3="M/#NG7^J_VB\MZ91BV= J[&Q_$ON*
M@U?1K*/1[/5=&DN'MKB1H6BN /,1Q_N\$$5IR7EA:>"-!_M#2UO]S7.S=.\>
MS#C/W>N>/RJ"RU2[U_7-+T[3%@TN&"0M;HB[UC;&2YW9W-P<9_\ KUGKN>'"
MI6NZNMDYW;:Y;)RTMJ^W3IUZX5QI&I6D'GW6GW4,7_/22!E7\R*=%HNJ3(KP
MZ;>2*P#*R0,00>AZ=Z[N")_[+U\R3:S<?Z%+ODOH_+A+=?E4DG/7Z#\*P/$V
MHWMO::%!;W4T47]EPOLC<J"Q)YX_W1^5"DV71QU6M/V<4KW\^U]MS.UCPS?Z
M5JTMDL$]R(U#B5(&PZX&2/8%L9K/N]/O;#;]NM)[;?\ =\Z)DW?3(KT*]FO+
M?QIXDG#S((]*D:W<YP,"/E?Q].]8^GW1O?"E@^K3M/$NO1*[3ONPFS+#)[=:
M%)V(H8^LZ<932>D;]]5<Y=]+U"*T%U+8W*6Y (F:%@A!Z?-C%$6EZA/;^?#8
MW,D.TMYB0L5P#@G.,8R#7I1;'B:\\Z+7[E6$BRP21QBV:/!Z%F VXZ'K^M<E
MJEW<P>!O#T,$\D4<JW(D5'*A_P!YCGUZGKZT*395',*E9QBDKMK[FI/_ -M^
M=S".E:B+3[4;"Z%OMW>=Y+;,>N[&,5HR^'99-!TJ\TVWNKJ>[69IDC0N$V/M
M& !D?C79K]LU+4FBE35M'U!X"CD8FL\;/?@ CTZ'WKFK_4;VQ\$^'5L[J:W#
M?:&;RG*Y(EXSCZFCF;(AC:U:4(QLG?Y6<9/=:/;2S^XQ;.RC:._%Y;7QE@B)
M401\1L#UDST6F1Z-J<L?F1:==NFT/N6!B-I&0<XZ$=Z[K4/^0]XP]].0G_OV
ME07G]O\ VKPR-,^U"V^Q6Q'DYV;L#=NQQTQU[4<S".83EJK*Z3U>GPI_U]YP
M]II]Y?LPL;2>Y*_>$,9?'UP*BFAEMYFBGC>*13AD=2"/J#7H<MRHGUB.&ROY
M--?4"PN=+DQ(DNT;@5[KGGGC-<UXS@F@UJ%KB[ENC-:QR*T\821%Y 5P/XAC
MKUIJ5V=.'QTJU7D:LFKKOLG^NSL<]1115GJ!7IGPHML6NI71'WG2,'Z D_\
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MA_\ 0!6E45I;1V5E!:P9$4$:QIDY. ,#^52T/<SJR4ZDI+JV%%%%(S"BBB@
MKR'X@^&SI.K&^M8\6=VV>!PDG<?CU'X^E>O55U+3K?5M.FLKQ-\4JX/J#V(]
MQ5QERL]/+<=+!5U/[+T:\O\ @'SW16GKVA77A_5'M+L9'6.0#B1?4?X5F5U;
MGZ=3J0JP4X.Z84444S0**** "BBB@ HHHH **** "BBB@ HHHH *] ^&OALS
MW1UJ[C_=1$K;@C[S=V_#^?TKG/"OAJ?Q'J8C *6L1!GE]!Z#W->VVUO%:6T=
MO;1B.*)0J(O0 5C4E961\MGV9*E3>&IOWGOY+_@_D24445SGP84444 %%%%
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M^62_W?J>_P"5==7-4E=V1^?9YF2Q53V--^Y'\7_P.@4445D?.!1110 4444
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N5UWX?Z3JY::V!L;E
MN=\0^5C[K_ABNJHIIM;'10Q-;#SYZ4K,\5U;P)KFE%F^S?:X1_RTM_FX]UZC
M\JYP@JQ# @C@@]J^C:I7VBZ;J0/V^Q@G)_B>,;OSZUJJO<^FP_$LTK5X7\UI
M^!\_45[#=?#70)R3$MQ;9[12Y _[Z!K,D^%%J2?)U291VW1!OZBM/:1/8AQ!
M@9+5M>J_RN>8T5Z1_P *E&[G63CT^R__ &=3Q?"BS#?O]3G<>B1A?YYH]I$T
M>>Y>OM_@_P#(\PIT<;RR!(D9W8X"J,D_A7L5K\./#]LP,D,UR1_SVE/_ ++B
MN@L],L=.7;8V<%N/^F<84GZGO4NJNAP5N)</%?NH-^NG^9Y+I/P]UO4F5KB(
M6,)ZO/\ >_!>OYXKT+0O!&DZ&RRK&;FZ7GSIN=I_V1T'\_>NBHK*4VSYS&9Q
MB\4N5OECV7]7"BBBH/'"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#GM=\$Z3KI:62(VUTW_+>'@D_P"T.A_G[UY[J_P\UK369K:,
M7\(Z-#][\5Z_EFO8Z*N,VCV,'G&+PJY4^:/9_P!7/G22-X9&CE1D=3@JPP1^
M%,KZ$O-,L=07;?6<%P/^FD8;'XFN?NOASX>N6)CAFMB?^>,I_DV:U55=3Z.C
MQ+0DOWL&O37_ "/&Z*]/E^%%F6_<:G.@]'C#?RQ4!^$HW<:R<>GV7_[.J]I$
M[UGN7O[?X/\ R/-Z*].C^%%L"/.U29AWVQ!?ZFM*V^&F@0$&5;BYQU$DN ?^
M^0*/:1,Y\08&.S;]%_G8\@ +, HR3T [UT6D^!=<U4JPM3:PG_EI<?)Q[#J?
MRKUVQT73-- ^P6,$!'\21C=^?6KU9NKV/(Q'$LVK4(6\W_D<IH?P]TK22LUT
M#?7*\[I1\BGV7_'-=71163;>Y\Q7Q-;$SYZLKL****1SA1110 4444 %%%%
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MA,0&'T;H?QQ7IM%5&3CL>AA,QQ.#?[J6G9[?UZ'S[?Z5?Z7+Y>H6DMNW;>N
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M^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\
MZ!^M?]^(O_CM'_#1/A/_ *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'Z
MU_WXB_\ CM'_  T3X3_Z!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?
MB+_X[1_PT3X3_P"@?K7_ 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_
M ([1_P -$^$_^@?K7_?B+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?
M\-$^$_\ H'ZU_P!^(O\ X[7S;11[& ?7:Q])?\-$^$_^@?K7_?B+_P".T?\
M#1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\ Z!^M?]^(O_CM'_#1/A/_
M *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'ZU_WXB_\ CM'_  T3X3_Z
M!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?B+_X[1_PT3X3_P"@?K7_
M 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_ ([1_P -$^$_^@?K7_?B
M+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?\-$^$_\ H'ZU_P!^(O\
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M^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\
MZ!^M?]^(O_CM'_#1/A/_ *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'Z
MU_WXB_\ CM'_  T3X3_Z!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?
MB+_X[1_PT3X3_P"@?K7_ 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_
M ([1_P -$^$_^@?K7_?B+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?
M\-$^$_\ H'ZU_P!^(O\ X[7S;11[& ?7:Q])?\-$^$_^@?K7_?B+_P".T?\
M#1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\ Z!^M?]^(O_CM'_#1/A/_
M *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'ZU_WXB_\ CM'_  T3X3_Z
M!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?B+_X[1_PT3X3_P"@?K7_
M 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_ ([1_P -$^$_^@?K7_?B
M+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?\-$^$_\ H'ZU_P!^(O\
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M^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\
MZ!^M?]^(O_CM'_#1/A/_ *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'Z
MU_WXB_\ CM'_  T3X3_Z!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?
MB+_X[1_PT3X3_P"@?K7_ 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_
M ([1_P -$^$_^@?K7_?B+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?
M\-$^$_\ H'ZU_P!^(O\ X[7S;11[& ?7:Q])?\-$^$_^@?K7_?B+_P".T?\
M#1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\ Z!^M?]^(O_CM'_#1/A/_
M *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'ZU_WXB_\ CM'_  T3X3_Z
M!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?B+_X[1_PT3X3_P"@?K7_
M 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_ ([1_P -$^$_^@?K7_?B
M+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?\-$^$_\ H'ZU_P!^(O\
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M^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRC]H@D?#RRQWU2//\
MWZEKU>O*/VB?^2>6/_84C_\ 14M73^-'/B?X,CYMHHHKO/G@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC&82JN58?=W ]1S@UW7AZRN4\7:O#J5_XHU6<6UPEU->6H@T]_EP0J$G//0
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MPF,&-3D@^6#N&1Z>F:IS9$:*=G?<\D.C:F-4.FG3;L7P!)M?(;S1@;C\F,]
M3TZ<U+=^&]<T^U:YO]&U"U@0*6EFM715#<+DD8Y[>M>V6,H;XA> F:TU:.XC
MM+Y1=:PD2W$\0A<Q[@C$_+EA\P&<]^:X#P'J]UXCU?4_#NN7LUT-?LFMXY;F
M0R%)TS)"<D] V[CU:CG>X.C%.U]_\E_F<0]A>1V$=\]K.MI*Y2.X,9$;L.JA
MNA(]*KUVOQ%<:8VC^%(<!-#LU$^,\W,N))3GN,E1[8-<55IW5S"<>65@HHHI
MD!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 =U\%O^2O:+_VW_\ 1$E?5]?*'P6_
MY*]HO_;?_P!$25]7UR5_B/:P'\)^O^04445@=X4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7"_&G_DD.M?]L/_ $?'7=5P
MOQI_Y)#K7_;#_P!'QU4/B1E6_A2]&;O@;_DGGAW_ +!=M_Z*6MVL+P-_R3SP
M[_V"[;_T4M;M)[E0^%!1112+"O*/VB?^2>6/_84C_P#14M>KUY1^T3_R3RQ_
M["D?_HJ6KI_&CGQ/\&1\VT445WGSP4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!HZ?XBUO28&@TO6+^RB8Y,=M=/&I/T4BM'P9XCBT'QY8:]JWVBY2"5I)
MBF'D<E2,_,1DY/<USM%*R92DTT^QK:SXCU/6))(KG4KZ>R$K/!;SSLR1C)QA
M22!@''%1V7B/7--LS::=K.H6EL<YA@NG1#GK\H.*S:*=D'-*][E@:A>+8262
MW<XM))!(]N)3Y;..C%<X)]ZM6GB+6["Q-E8ZQJ%M:'.8(;ITC.>OR@XK-HHL
MA7:-)/$>MQ:A]OBUC4$O/+$7VE;IQ)L_N[LYQQTZ5!<:KJ%V(!=WUS.+;/D"
M69F\K)R=N3QSSQ52BBR#F9H:AK^LZM D.JZM?7T49RB7-R\BJ<8R Q.*BEU;
M49[V"\FU"ZDNK<*(9WF8O$%Y7:V<C';'2JE%%D',V:5IXCURPDGDL=9U"V>Y
M<O.T-TZ&5CU+$'YCSU- \1ZV)8Y1K&H"2)76-_M3Y0.<N <\!CU]>]9M%%D'
M-+N.1VCD5XV*.I!5E."#ZBMO_A.?%G_0T:U_X,)?_BJPJ*+)@I-;,T+O7M8O
MXIHK_5;ZYCGD$LJ37+N)' "AF!/)  &3V %1/JNH2):))?W3+9?\>JM,Q%OR
M#\G/R\@'C'2JE%%D',R]J.MZKK'E_P!KZG>7_E9\O[5<-+LSUQN)Q4L_B37+
MG3_L%SK.H36> OV>2Z=H\#H-I.*S**+(.9]R_'KFK0O:O#JE[&UFK);%;AP8
M%888)S\H()R!UI--UO5=&+G2-3O+ R8WFUN'BW8Z9VD9ZU1HHL@YF6QJVHBX
MN9Q?W0FNXS%<2><VZ9#C*N<Y8' R#Z5']MNO[/\ L/VF;['YOG?9_,/E^9C&
M_;TW8XSUQ4%% 79H3^(-9N=-73KG5KZ:Q4 +;27+M& .@"DXXQ3K+Q'KFFV9
MM-.UG4+2V.<PP73HASU^4'%9M%%D',][FKI^MO8:'K&G"-W_ +42)&?S2%0)
M(),E.C'*@ GH-WK65110#;9JP^*?$%O8K9P:[J45JJ[5@2\D" >FT'&*+KQ/
MK=YJ5OJ,^IW!OK>(0QW2/LE"C.,NN"3R>22?>LJBE9#YI=R_>Z]J^I1E-1U6
M^NT,@E*SW#N"X! ;D]0"1GWJR_B[Q)*\3R^(-5=H3F)FO9"8S@K\OS<<$CCL
M36/13L@YI=R[#K.J6_V3[/J5W%]AW&UV3LOV?<<MLP?ER>N,9IUMK6I6\,]L
MFI7L5I=MFZBBG8+-GKN&<,<>M4**+(7,SJO%'B/3;O0=+\/^&UODTNP:29FO
MMHDFE<\DA20 !P/J:Y4$@@C@CH:**25ARDY.[-*[\1ZWJ$$<-_K.H7443!HX
MYKIW5".A )X-4KBYGO+A[B[FDGFD.YY97+,Q]23R:BHIB;;W-F#QCXFMK:.W
MMO$>K0P1($CBCOI55% P% #8  XQ65<7$UW<//=32332'+R2,69CZDGDU'11
M9 Y-[FE>>)-<U&S^R:AK.H75MQ^YGNG=..GRDXIB:YJT<B21ZI>J\=O]E1EN
M'!6'_GF#GA.?N]*H4460<S[EBVU"]LX;B&TNYX(KE-DZ12LJRKZ, ?F'L:=I
M^J:AI-P9]*OKFRF*[3);3-&Q'IE2#BJM% 79?;7=7;5!J;:I>F_4$"[-P_F@
M$$$;\YZ$CKW-:?@S4M!T;64U37HK^>6RD2>SAM=@5Y%.1YA)R!D+TSWKG:*5
MM+#4FG<LZC?SZIJEUJ%VP:>ZF::0CH68DG]35:BBF3N%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 =U\%O^2O:+_VW_P#1$E?5]?*'P6_Y*]HO_;?_ -$2
M5]7UR5_B/:P'\)^O^04445@=X4444 %%%% !1110 4444 %%%% !1110 444
M4 %>;?%?XIMX&6WTS1X$N]9O%W(K@E84S@,0.22<@#V/T/I-?/WB@Q#]JS3/
M[2QY&^W\KS.F?+^7'_ _UH 9-XC^.FG69UF\LY&LE7S&A:T@.U>IRB_O /7/
M2O3_ (8_$6#XA:%+.T*VNH6C!+J!3E1G[KKWVG!Z]""/<]H<;3NQC'.:^?\
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MU?Y7]QPM%=U_PI;Q_P#] #_R<@_^+H_X4MX__P"@!_Y.0?\ Q='/'N'L:O\
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M  I;Q_\ ] #_ ,G(/_BZ/^%+>/\ _H ?^3D'_P 71SQ[A[&K_*_N.%HKNO\
MA2WC_P#Z '_DY!_\71_PI;Q__P! #_R<@_\ BZ.>/</8U?Y7]QPM%=U_PI;Q
M_P#] #_R<@_^+H_X4MX__P"@!_Y.0?\ Q='/'N'L:O\ *_N.%HKNO^%+>/\
M_H ?^3D'_P 71_PI;Q__ - #_P G(/\ XNCGCW#V-7^5_<<+17=?\*6\?_\
M0 _\G(/_ (NC_A2WC_\ Z '_ ).0?_%T<\>X>QJ_RO[CA:*[K_A2WC__ * '
M_DY!_P#%T?\ "EO'_P#T /\ R<@_^+HYX]P]C5_E?W'"T5W7_"EO'_\ T /_
M "<@_P#BZ/\ A2WC_P#Z '_DY!_\71SQ[A[&K_*_N.%HKNO^%+>/_P#H ?\
MDY!_\71_PI;Q_P#] #_R<@_^+HYX]P]C5_E?W'"T5W7_  I;Q_\ ] #_ ,G(
M/_BZ/^%+>/\ _H ?^3D'_P 71SQ[A[&K_*_N.%HKNO\ A2WC_P#Z '_DY!_\
M71_PI;Q__P! #_R<@_\ BZ.>/</8U?Y7]QPM%=U_PI;Q_P#] #_R<@_^+H_X
M4MX__P"@!_Y.0?\ Q='/'N'L:O\ *_N.%HKNO^%+>/\ _H ?^3D'_P 71_PI
M;Q__ - #_P G(/\ XNCGCW#V-7^5_<<+17=?\*6\?_\ 0 _\G(/_ (NC_A2W
MC_\ Z '_ ).0?_%T<\>X>QJ_RO[CA:*[K_A2WC__ * '_DY!_P#%T?\ "EO'
M_P#T /\ R<@_^+HYX]P]C5_E?W'"T5W7_"EO'_\ T /_ "<@_P#BZ/\ A2WC
M_P#Z '_DY!_\71SQ[A[&K_*_N.%HKNO^%+>/_P#H ?\ DY!_\71_PI;Q_P#]
M #_R<@_^+HYX]P]C5_E?W'"T5W7_  I;Q_\ ] #_ ,G(/_BZ/^%+>/\ _H ?
M^3D'_P 71SQ[A[&K_*_N.%HKNO\ A2WC_P#Z '_DY!_\71_PI;Q__P! #_R<
M@_\ BZ.>/</8U?Y7]QPM%=U_PI;Q_P#] #_R<@_^+H_X4MX__P"@!_Y.0?\
MQ='/'N'L:O\ *_N.%HKNO^%+>/\ _H ?^3D'_P 71_PI;Q__ - #_P G(/\
MXNCGCW#V-7^5_<<+17=?\*6\?_\ 0 _\G(/_ (NC_A2WC_\ Z '_ ).0?_%T
M<\>X>QJ_RO[CA:*[K_A2WC__ * '_DY!_P#%T?\ "EO'_P#T /\ R<@_^+HY
MX]P]C5_E?W'"T5W7_"EO'_\ T /_ "<@_P#BZ/\ A2WC_P#Z '_DY!_\71SQ
M[A[&K_*_N.%HKNO^%+>/_P#H ?\ DY!_\71_PI;Q_P#] #_R<@_^+HYX]P]C
M5_E?W'"T5W7_  I;Q_\ ] #_ ,G(/_BZ/^%+>/\ _H ?^3D'_P 71SQ[A[&K
M_*_N.%HKNO\ A2WC_P#Z '_DY!_\71_PI;Q__P! #_R<@_\ BZ.>/</8U?Y7
M]QPM%=U_PI;Q_P#] #_R<@_^+H_X4MX__P"@!_Y.0?\ Q='/'N'L:O\ *_N.
M%HKNO^%+>/\ _H ?^3D'_P 71_PI;Q__ - #_P G(/\ XNCGCW#V-7^5_<<+
M17=?\*6\?_\ 0 _\G(/_ (NC_A2WC_\ Z '_ ).0?_%T<\>X>QJ_RO[CA:*[
MK_A2WC__ * '_DY!_P#%T?\ "EO'_P#T /\ R<@_^+HYX]P]C5_E?W'"T5W7
M_"EO'_\ T /_ "<@_P#BZ/\ A2WC_P#Z '_DY!_\71SQ[A[&K_*_N.%HKNO^
M%+>/_P#H ?\ DY!_\71_PI;Q_P#] #_R<@_^+HYX]P]C5_E?W'"T5W7_  I;
MQ_\ ] #_ ,G(/_BZ/^%+>/\ _H ?^3D'_P 71SQ[A[&K_*_N.%HKNO\ A2WC
M_P#Z '_DY!_\71_PI;Q__P! #_R<@_\ BZ.>/</8U?Y7]QPM%=U_PI;Q_P#]
M #_R<@_^+H_X4MX__P"@!_Y.0?\ Q='/'N'L:O\ *_N.%HKNO^%+>/\ _H ?
M^3D'_P 71_PI;Q__ - #_P G(/\ XNCGCW#V-7^5_<<+17=?\*6\?_\ 0 _\
MG(/_ (NC_A2WC_\ Z '_ ).0?_%T<\>X>QJ_RO[CA:*[K_A2WC__ * '_DY!
M_P#%T?\ "EO'_P#T /\ R<@_^+HYX]P]C5_E?W'"T5W7_"EO'_\ T /_ "<@
M_P#BZ/\ A2WC_P#Z '_DY!_\71SQ[A[&K_*_N.%HKNO^%+>/_P#H ?\ DY!_
M\71_PI;Q_P#] #_R<@_^+HYX]P]C5_E?W'"T5W7_  I;Q_\ ] #_ ,G(/_BZ
M/^%+>/\ _H ?^3D'_P 71SQ[A[&K_*_N.%HKNO\ A2WC_P#Z '_DY!_\71_P
MI;Q__P! #_R<@_\ BZ.>/</8U?Y7]QPM%=U_PI;Q_P#] #_R<@_^+H_X4MX_
M_P"@!_Y.0?\ Q='/'N'L:O\ *_N.%HKNO^%+>/\ _H ?^3D'_P 71_PI;Q__
M - #_P G(/\ XNCGCW#V-7^5_<<+17=?\*6\?_\ 0 _\G(/_ (NC_A2WC_\
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MYX=_[!=M_P"BEK=I/<J'PH****184444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'L'W#^T(_P I]F45\9_\)SXL_P"AHUK_ ,&$O_Q5'_"<^+/^AHUK_P &$O\
M\51[!]P_M"/\I]F45\9_\)SXL_Z&C6O_  82_P#Q5'_"<^+/^AHUK_P82_\
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M<^+/^AHUK_P82_\ Q5'L'W#^T(_RGV917QG_ ,)SXL_Z&C6O_!A+_P#%4?\
M"<^+/^AHUK_P82__ !5'L'W#^T(_RGV917QG_P )SXL_Z&C6O_!A+_\ %4?\
M)SXL_P"AHUK_ ,&$O_Q5'L'W#^T(_P I]F45\9_\)SXL_P"AHUK_ ,&$O_Q5
M'_"<^+/^AHUK_P &$O\ \51[!]P_M"/\I]F45\9_\)SXL_Z&C6O_  82_P#Q
M5'_"<^+/^AHUK_P82_\ Q5'L'W#^T(_RGV917QG_ ,)SXL_Z&C6O_!A+_P#%
M4?\ "<^+/^AHUK_P82__ !5'L'W#^T(_RGV917QG_P )SXL_Z&C6O_!A+_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW3PV5EIA0.0GWG+/G"@G&.O3UKL/"7AFST/Q,]]HUU+=:3JWAVZGM6G $J8
M#(X'&0>XX_*DYI%0HN35SR.XL+RTMX)[JTGAAN5+0221E5E X)4GAA]*KUZ?
MK]MIEWX;^'D6O7[:?IYL9S-.D1D8 /G  !Y)P/09S5'5/!FAR^!]4UW1+?Q#
M8OIK0[EU>) EPLC[/D*J.02">OZT*7<'1>MOZTN<->V%YIMQY&HVD]I-M#>7
M/&4;!Y!P><&J]>U>-M-\':U\0K72]6OM4BU:\M[:!);98S!;LR ('!^9B<@G
M&,!A[UR*^"]%\/:--J/C>ZOF8W\UC;6NF% [F$[9)"S@_*#QC&>GK0IIH<J#
M4FEL<'17I]A\,]$OM>MVBU*\.A:AI$VH6L^U1-$T9 9'&"&VD\XQGH#6%8V'
M@2]U"Y=)M?\ LZ1HMM8)&CW5S(2=Y#!=BJ!@X/)Y]*?,B71DMSC:L1V%Y+8R
MWL5I.]I"P66=8R8XR>@+= 3[UZQHO@_0=%\;^#=02#6%M=6DE\JSU%$6:*:)
ME +_ "X*'=D8 /0YJEJV@6FJZ9XLN-!N]6BVZS#;BSFN5$,TKR8)90 " Q^4
M]AUI<Z*]@TM?ZTN>645Z9_PA/@H^*O\ A#QJVK'6]WV?[=LC^R?:,?=V??QG
MY>O6J@\'^&M%\'V&L>*Y]6\^:[N+26UL#$?GC?&0S#  P<]<DC&,&GSHGV,C
MSZBNE\>>&;?PKXD%G87$EQ9SV\=U;O* 'V.,@-CC/!Z5S54G=7,Y1<79EE=-
MOGTU]12RN&L8Y/+>Z$3&)7X^4OC /(X]ZK5[_:>'M2CTZT^'LND7G]FW&C,9
M[[[,[11W[GS0Q?&,*5"]>IQ7F&A>%M*A\/ZAKOC*6^@M+6[%A':V04323XW,
M"7!"A1_GUA33-IT'&UCEK.RNM1NDM=/MIKJX?.V&",N[8!)P!R< $_05/!HN
MJW/V7[-IMY-]L#FV\N!F\\)G?LP/FVX.<=,<UZ3I'@K0G\1>$;CPWK&LPP:U
M'?.TZRK#/#Y4;?*"J\'.58\@C., U8T#3/[8TKX9V/VV\L?,BU8_:+*7RY4P
MSM\K8.,XP?8D4.?]?>.-!O?^MO\ ,\@HKULV/@^^\ ^ ;35%U6!;R:XB$T,D
M2[7,D:RLY*G*[L;>X4<YKEE\$1Z>OBV379)XX]!'D0F+"F:X=]L74'*D L0.
M<8YIJ2(E1:V_K2YQM6&L+Q-/2^>TG6SD<QI<&,B-F')4-T)]JKUZ7!9QZA\'
M_#%E,66.Y\1M$Y0X(##!Q[\TV[$0AS7/-**]4;X?>$;GQ/JWA;3K_6/[8LXY
MI(IYA']G)0;@A &XX& 6XR02!T%%[H^CZU\-_ FFZ=#>IJ5_-/%;R,T?EB0R
MQB9I,#)4?PXY '.:GG1I["6O]=;'E=%>JR_#/1+V[O\ 1]%3Q$FIVL<ABO+V
MV5;.Z>/DJN%RH;!P2?\ Z^*OAGPEHNCZ0WBZ^U1=0U:W%V@L%0QVL+DA&<,,
ML3@DA<=QZ9?.A.C);G"58:PO$T]+Y[2=;.1S&EP8R(V8<E0W0GVKT>Y^'WAG
M3-6\7C5+W4_[/\/BT:-H&C,DOF@9!RN,EB #QC/.:GT32-$_L_PSJ276M2Z5
M<>(O(BL)[A&5>/D8IMVY+8W8_AR!SS2YUT&J$KV?]:V/*:*]-\5^'=!UK4_&
M]UHG]H)JFDW+W$D,\L9CE'G,)F50H(5>".<X-<IXBT"TT/P_H$ADF;5-2MFO
M+B,L#''$S?N<#&<E02<D]J:DF3*DXW_KK8YVBNJ\,:7X9O-.>369-8O+]I=L
M>G:1""XCQ_K&9E(QDXP.?SXZ<?##2&\:+ICW>I6MC<:$=5B-Q&HGMSR-LBXP
M<$'(&/3/>AR2W"-&4E='EU3V=E=:C=I:Z?;375Q)G9#!&7=L#)PHY/ )KMI_
M"'A_6O",FK^#)M4$UO?16DL&I&/]YYAPK*4'')'!S77>"M"\'^'OBY9:1;WV
MJS:W8LZ-.ZQ_999?*.]0!\PZG!)ZC%)S21<:#<DGLSQ2I[RRNM.NWM=0MIK6
MXCQOAGC*.N1D94\C@@U!7LGBCPQI7B#XI>-[G6[F[MX-+MHKK-J%+,!''D8(
MYR,XY'.*;E9D0IN:T_K?_(\;HKOYO!&BZYI.CZAX+N-05;[5?[+EAU((S1R%
M0V\% !M"G)J#6M'\!6;:GIMIJFL1ZG8JZI<7,2-;W$J'!0*@W+DY ).!W]SF
M0.E):G'WEA>:?*D=_:3VKN@D59XRA93T8 ]0?6J]>P>,?#]KK_B*X-Y),G]G
M>#DOHO*8#=(F  V0?E^8],'WKB]*\)V>I>";759+N2WN;C7XM++N1Y4<;Q[B
MY&,Y!]\8_.DI)JXY46I61R=3W-E=67D_;+::W\^(31>;&5\R,]'7/53@\CCB
MO0_%W@7P[X?L=13R_$=A=VO_ ![7%_;J]K>G=C"M&ORY'(R?KZ42>"K?4=3T
M1=1UF^&GQ>%X]6O)9W\UX8@S Q0C'"Y(P.<9)YZ4<ZW'[&2=NIYK17::AX=\
M-ZEX1U#7/"%SJ2'2I(Q>6NI["S)(VU71D 'WN"#_ /KZ:?X>>"O^$^F\&6]_
MKG]J,"(9V$1A1O+\P*PP&;CJ1CT]Z?.A*C)['DM%%%48A1110 4444 %%%%
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M_B_^-4?\,[>$_P#H(:U_W_B_^-5ZO11[2?</JU'^4\H_X9V\)_\ 00UK_O\
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M@B<\!B5)9L9XX_QKSZBAQ3%&I**L=M8^+-%U;PR-&\;PZ@Y@NY+NVO=.$?F
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M_"EO '_0 _\ )R?_ .+HHHYY=P]C2_E7W!_PI;P!_P! #_R<G_\ BZ/^%+>
M/^@!_P"3D_\ \7111SR[A[&E_*ON#_A2W@#_ * '_DY/_P#%T?\ "EO '_0
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MG)__ (NC_A2W@#_H ?\ DY/_ /%T44<\NX>QI?RK[@_X4MX _P"@!_Y.3_\
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BA^W\U3E3,SS8/J [$444<TNX*C36JBON.MZ=****DU/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>iclr-20211231_g4.jpg
<TEXT>
begin 644 iclr-20211231_g4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)Y<FYE+"!%
M86UO;FX   60 P "    %   $*:0!  "    %   $+J2D0 "     S$S  "2
MD@ "     S$S  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                       R,#(Q.C$R.C$X(#$Y.C4T.C P #(P,C$Z,3(Z
M,3@@,3DZ-30Z,#    !" 'D <@!N &4 +  @ $4 80!M &\ ;@!N    _^$+
M(&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN
M/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G/SX-"CQX.GAM
M<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS
M.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X
M+6YS(R(^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D
M9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID8STB:'1T
M<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B+SX\<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M860S,2UD
M,S-D-S4Q.#)F,6(B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+R(^/'AM<#I#<F5A=&5$871E/C(P,C$M,3(M,3A4,3DZ-30Z,# N
M,3,P/"]X;7 Z0W)E871E1&%T93X\+W)D9CI$97-C<FEP=&EO;CX\<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M
M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^/&1C.F-R96%T;W(^/')D9CI397$@>&UL;G,Z
M<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M
M;G,C(CX\<F1F.FQI/D)Y<FYE+"!%86UO;FX\+W)D9CIL:3X\+W)D9CI397$^
M#0H)"0D\+V1C.F-R96%T;W(^/"]R9&8Z1&5S8W)I<'1I;VX^/"]R9&8Z4D1&
M/CPO>#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP86-K
M970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q ,$1@5
M&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$'" @*
M"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@!2 2. P$B  (1 0,1 ?_$ !\   $% 0$!
M 0$!           ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$"
M P $$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G
M*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%
MAH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35
MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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MY_E0!9HK/?68!]U7;\,5&=;7M 3]6H U**RAK8[P$?1__K4]=:A/WHW'TP:
M-*BJB:G:O_RTVG_:!%64D209C96'J#F@!U%%% !1110 4444 %%%% !1110
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MHTX[(\6KC:]7>7W:#GD>1RTC,['J6.2:;116QR!1110 5/;7UU9MFUN)8?\
M<<C-044FD]QIM.Z.BL_&FI6[ 7/EW2=]PVM^8_PKI-/\7:;>D)(YM9#VEZ?]
M]=/SQ7G-%83P].72QW4LPKT]W=>9[&"" 0<@]"**\NTS7[_2F @E+19YB?E?
M_K?A7=:/XDLM6 0-Y-QWB<]?H>]<-3#RAKNCW,/CZ5?39]C7HHHKG.\****
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M45H:QI,FE76TY:%^8W]1Z'WK/KZ",E)71\S.$J<G&2U1V?A#Q 6*Z9>/DXQ
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M_P#%'C'P[%HEY#_:7F/$I98T8EW?M@^F?Y5I^$M9FU3PAI-_J!/VEHR&.>6
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MU$*;)JR20N%[J1^E>9ZEKUS'N\A2V*=HWB=Y-J3\$]:A8^[L"A&YQOCXBYU
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MBN9V-;0M U36$7 $:'JS_P JZ<>#-6\(V\&OV4ZS75J?,9-A(QW^O%=!H2M
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MAQ8F*4KKJ+71:?-Y]DC$Y8#:?PKG:U-%E^:6(]QN'^?RKI.4UZ*** "BBB@
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MX0X:*YC<'W# U,E=6%!\LTSZ\.F'RTD,N"XR1M' I8K-$((1ICZD[16HR $
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M*=HP>AVUYN+E*51,^FR5KZL[]W^2/F__ (1?5M&?=%$\L:]U%2#4@WRW*E9
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M1\-1O\5.1_!;.?U4?UKEQF(^K4)5K7Y5<UHU?858U;7Y6G;T9U-%==17RO\
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M^S;9%B;<"1._8#L=HY]LCUKT6_:!I&C0JKKPR>GTKJHHQ:Q)90QI#:QC"1(
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M\9R3+I86/HW+<54LH[U+A3(G&?6KGB[YM. ?<5V\JHSFKB[Q8+XD>4O,%?\
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MX8K"\1R1ZEI[16[*TZ,,Q \MSVKRZ6,HU*LJ76/<]&I@ZL*<:EM&/TB:3[/
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M]161J[95JT6K):]VQ;DTZWCL-DVTQ%#G\:\Z\-^ /"NG^*%O8[PS2F4ND9<
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M7 FNI=Y)W-N/%=SX&2271VC3YA'-WZ8[USXB%H'H9?/]]J2W=LT]SL1"SL<
M"J_C61M/\.VFB*_SN-\F#VSG'Y_RKN[>T@TZW>:7:6 W,Y["O+/$=Y_:^L37
M+?<)VH#V Z?G7DSERH^KH/VE17V1RAM,<@\]L=J[[P[XT\^UBL-6!62,!4G[
M,/>N7%J#4B6Z)VS7(JCCL=M:,:FAZ9&ZR1AU</Z;3Q2D[Q\WZ5S?@VV2[U)U
MEE<+&N5C5L;JZB[MOWA\MMH_.NNG)R5SRJD5&5B$;<U)G JE*;N+_4B-AWR.
M359M5FA($]I(/]I1D5I=D61IM]ZN#^*&JB'3;?3(V^>=_,D _N+T_,_^@UU2
MZW8NK.TZIM!+;_EP/QKQGQ'J[:YKUQ>G/ELVV('L@X'^/U-:TE=W/(S2O[*A
MR+>7Y=3+HHK;\(Z4=7\36L!7=$C>;+Z;5Y_4X'XUTMV5SY6G!U)J"W9ZUX7T
MXZ5X9LK5QB18]SCT9OF(_,XK@_%\7]F:S<1YVQR'S4^A_P#KY%>I5P_Q0T9K
MWP\-1@!\ZRY?'>,]?R.#],UC3J<LF^Y]#FV CB,(HK[&J].IY?/J8\PG-/@U
M-VC;:Q )[&N8FDD#9ZKZU)'>B"W9Y7V1@99B?Y4<^I\U]13BE$A\2ZG^_C"M
M@@FLVVN_M+*KGCO6#?ZN+J_9VR8\X7Z5<LKB*3[C8K'=W/H8X/V5%)K4]H^$
M?C-+.XDT2[D"I(^^W)/'NO\ +\S7L$MZ[C*G.:^09)O+(:.0J5.0R]0:Z;3?
MC5KVBQ)!.8;^-!@"8D./^!#^M0U<]/!5FH\C1](B_9&^O%<IX\\7PZ3HIM4D
M!N[S]U&N>0/XF/I@5Y;-\8=;U6S5K*RM[7>#DEC(1_*L&W:]O]4-[J,SW$Y^
M8LYS@>@'841IW>H8['0C3E&&YN2Z3!,I41@C'4#%<=K.C2Z7J,4Z<PEP"V.F
M:]+TT0S2H+EO+1NK'C%9WBJQBEL+F*U?SD ^5]N,]ZZITURW1\7@L=.G6M+9
MNQZ;X$T/3;73H)8XDDE= 6DD&3T[5Z+$B[1@8XZ5Y5\)]5_M#PO:,S?.B[&^
MHXKU:+[@SZ5YZN]&?H%&$(QM%6(+FPCFMI\CG9P/6OF?XYZ)]GFL[]4P-QB9
MA],BOJ>,98C^\N*\L^*WAS^UO"-ZFW+Q8D3VVG-7?E5SH2OH>+^ OAPVMVZ7
M^H*1"?N(!]X>M=GJG@*&R@62TAVE?2O0/ <4$6AVNU%*^4, CVKJ);.*X5O,
MB5E88( _E7/9R?,5*,7'D9\XW9F@81.I# \T@O750.6KV#7O D5VI94R#T<#
MD?6N2A^%UY<ZI##]L>*W,@,A4<[!U_2NJ->VC/F:N22N^38[SX;Z<UCX/AGF
M7;->,9VSU"GA?T&?QK4U^'=#%,/X3M/X_P#ZJUHXTAB2.)0J(H55'0 =!4=W
M!]IM)(N[+Q]>U<N8X?ZUA9TNK6GJM4>K"BJ=%4H]$<A0#@Y%*002#P1UI*_)
M=CE.MM+W[3!%*%R=HW?7O5GS';H *YK2;B43K;)C:YSDGIQ721KL4;S7Z3@,
M=/%8>,KZ[/U/<H1A.FI"A')R33L,>]#2JGWCQVJO+?QHI.[  YKKE.V[.B--
M-Z(DD2+_ ):A6[C<,UA:G)!I.K6=[&%CCNI/LUQC@-G[A/N#P#[TLNON[2!8
M&VKT9AUKS_QUXK$FFK;HW[XS(RX/((.:*-1NHK$XFBE1E*70]7EG55/S<^U9
M[:J%3A@??-<\-7EGAC;.-R G\JY6[UN]9)YHH)?(BR7D"$J .]=.8TFK-'EY
M/B55<H]CO;G6E&3OXK'O/%MK!C,F[_=KCMMQ?:6=3N;Y5LPI8LAST'(KG],U
M>);&;4=211"S;;:(?>?W]S7G1P\GJSWG4@CK-2\:/Y3&,B-<_?<\5F:3+/XH
MU5+*WG:21SD@#H.YK&;PQXF\1:I;2-8>2DPS"C<+$O8D>M>R^"?!5MX6MS-)
M^]O77#S'^0]!74J$(HYGB97T+_A[X?Z3ICB6XC^V3J/O2\J#["L[XB>,F\.:
M='9Z-"&U6^8P64"H/D[&3 _(5V,U]!8Z;/=W,@2*)&D=B>@ YKR;P$DOBCQ1
M>^-]6&Y$<P:>A'$8'<>^#^>:[J<8Q5S@G)R>ITO@?P<GA+3Y)[LBXU>Z&ZZG
M8Y;)_A!]/YU9UB2*Y#6\R"2(_>1U!!K4N;Y3C!()XZ]ZR+BUE+D[@V:IL5C!
M;3K2VC\NSACMU'18U %496F3[QW#WK8NH-OS,X./6L*68J[,6R">E%V*Q$R?
M:'"JH+,<8(KI8HUAA2-!A5  K(T>+S[AKAA\J<+[FMJO@N(\6JE=4([1W]7_
M )(Y*TKNP5KZ!#NN))CT5=H^I_\ U5D5U.E6_P!GT] 1AG^9OQ_^M7+D&&]M
MC5-[1U_R_KR)HQO(N5A:[J#+,L(.0HYK=KGO$5CYDB3+D!A@X]:_0,3S>ST/
M=R]P5=<QC2M;R LX(?'##O74>$--V6CW<@(\YOW0/7:.]<]I&BOJ=^L98K A
MS*3Z5Z+&D<2!4P%484#H!66%I7?,SOS#$)+DCUW)EC7;AAD'@@]ZXSQ'!J?A
MNPDFTZ"348-Q9=S9,6>Q]0":[-7#=ZSO$]X+?PW<#O)B-<^I-=E9>XV>5AI-
M5(K<\]LVGEA:6\(>9^78#J3UK,G&IG5H8K:Y>*W!&^, 8;)KH+8)#9DMU-+:
MQ+<WULRCG>,_3->1"][GT]644FFM#M].L;72K;R-/MXK:(G<4B0*"QZD^]70
M=QR>3[U 3SBI$:O4BSY5K5DPIV:C4T[./>K)9Y?\:M9^S:;9Z:C8:9C(X]AP
M*\?M\L<FNH^+^I_;?'<L*ME+9%C'UQD_SKF+7A:\?$RO(]W"QY8(NA]B8K/O
MY<6\KCJJDU9F?:OO6)JEWY=G+ZLN!^-805V=$Y61ZI\!(6<:OJ3_ -R.%3^;
M'^E>OQC_ $9!WQDUYU\';+[#\/XGVX>]E:0>XZ _D*]":143D].*]ZBN6%CY
MZL[S;).QSZ5#)=*@PG)]J86DGX7Y5I3"(ER>IK4RN-)+')ZU\T_$_2_[*^(6
MHJJXCN&%RGOO&3_X]NKZ6KR?XY:'YVG6&MQ+\T#&WF(_NMRI_ Y'_ JJF[2.
MC!SY:MGU/%*ZSX::W_8GCJR=WV0W1^S2GT#XP?\ OH*:Y.E#%6#*2"#D$=JZ
M=SV9Q4XN+ZGUI<D7 42@B:$[E91G>IX/^?:HKQ4:YLVV;99'3<V,'@C_  K)
M\%:RGBCP;;7GG$7!0PSG&3'*!@D?HV/>MJ*%)%:*<2.(YV7>XQG=AMRGTYQ^
M!%0G8^7E%QDXLT]2A\ZW*CKV/H>U?-&H7)G^(\US)G_C]:/D<C:C_P"?PKZ7
MW,%$4A)8#(8_Q#U^M?/WQ1TI?#OC;[7!&$BNI?M$8 P-Q1]W_CP-5AZ<?;JH
M^AQ9C.3PDJ2^U_DSU#X9ZLESI<]I&RD6D[PE1_#CD?H175WTGE0KM8@3,$/L
M.<UY!\)[TV7B;4+:63$=T5D7)_C"\X'J1D_\!KT;Q3J"KI$FV0QACM4CKS_*
MIQLU1E*3+RM>WH02>UDS*U_4+;7[Y[33VDCN8$9Q(." O\Q7.QVTT]M)->20
MK*C=^3M'<\<\>E5Q=3VTJS"-)E5@0P;FNCBTJ[N(_-2V<HT8D#JN1@^_<]B.
MHKYKE56I[1K4^OC4]E2]E?0R;+69)(2@#2(IP/-CZCVSS6@KV$ZYD5H&'=3D
M?D:SSYHW*><''RU"0W/7%*]C*<8R>B.@@@ 7=&ZR)V9:MI'[5B6$S6R?(Q /
MXUKV^H0R<,<'Z8JHS74YY4VMBRL5/$=1?VA9K((S<+O/\(R3^..E):ZI97EY
M/:VTV^:W.)%VD8^A[UNK,P=RP(Z9K5UY%F,9++'D@#M5C%97B2X\F(C:<F+
M..*K9"CJSSC68_)O)7^559NC+G%<=KLOFQE5& 6 '/'6NHU0C[9*S-N*D$*>
M>OX5R>J,)KZV3;R9T&W&/XA41-9;%RXE^QV.=V3L^7([_P"37-5K:W.0ZV@/
M"'<W'.>WZ5DUZV$ART[OJ=]"-HW[A7T=^SII!M?".HZJZX:^NA&I(ZI&.O\
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M!113X87GE$<8R3^E(@FL;0W<X7HB\L:Z%0%4!1@ 8 J*UMDM81&G/<GU-34
M4M8TFTUW1KK2]1C\RVNHS'(O?![CT(Z@^HKX]\9^$[WP7XFN-)OP6"G?!-C
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MB_T6U<BQ1A_K)1UD^B]O]KZ5QOPT^'=UX\US#[X=*MF!N[@#K_L+_M']!SZ
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M>L<".[ >N O2NNLGUV_L4E^Q1Z<[9_=SD.R_D<5YE#\=(U4>9H<X;N4OA_\
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M!BV]C/<_<3:O]YN!6M:Z9#;D,_[Q_4C@?A5VB@ HHHH **** "BBB@ HHHH
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MG^-1'PGK.<?90??S5_QKA>6XU?\ +J7W,CDEV,:BMU?!VKMUCC7ZR#^E7(?
MMVW^ONX8_P#<!;_"M(93CINRI/YZ?F/V<WT.6I55G8*BEF/  &2:[NU\$V$6
M#<RRW!],[5/Y<_K6W::=9V"XM+:.+U*CD_CUKU</PUB9N]62BOO?^7XFBHR>
MYPVG>$=0O2&N%^RQ>L@^8_1?\<5U^EZ!8Z5AH(]\V.97Y;\/2M.BOJ<%D^%P
M?O15Y=W^G8WC3C$****]<T"BBB@ HHHH **** "CK110!GW6DQRY: B-O3L?
M\*R9[6:W;$J$>A[&NFI" PPP!'H: .5HK>FTJWEY4&-O]GI^54I=&F7_ %3J
MX]^#0!G458>PNDZPM^'/\JA,4B_>1A]10 VBC%.$;GHC'Z"@!M%3I97+_=A?
M\1C^=68M'G?_ %A6,?7)H SZ?%!).VV)"Q]NU;,.D01\R9D/OP*O*BHNU%"C
MT Q0!FVVCJN&N3N/]P=*TE4*H"@ #H!2T4 %%%% !1110 4444 %%%% %74M
M,LM7L)++5+6*[MI1AXI5#*?_ *_O7A_C+]GN0227?@JY5D//V"Z?!'LDAZ_1
MOSKWJBJC)QV-J=:=)^ZSX>U71]1T.^:SUBRFL[A>L<R%21ZCU'N.*I5]Q:GI
M&G:U:&VU>QM[V _P3QAP/<9Z'WKS+Q!^SYX<U)VET.ZN-(D/\'^NB_)B&'_?
M5;*JNIZ5/'0?QJQ\U45ZEK'[/_BZPW-IK6>J)V$4OEO^(? _4UR-_P##SQ?I
MN?M?AS40HZM' 9%'XKD5HI)]3KC6IRVD<W15J33;Z'/G6=Q'CKNB8?TJ%8)7
M<HD3LPZJ%)-4:71'16E;^'=;NV"VFCW\['H([5V)_(5T.G_"3QSJ.#%X?N(E
M/>Y98<?@Q!_2E=(EU(1W9QE%>T:-^SCJL^U]>UBVLUZF.V0S-],G:!^M>E>&
M_@WX0\.;)?L']I7*\^=?$28/LF-H_+/O4.I%'-/&4H[:GSMX3^'/B3QE(ITF
MQ9+7.&O+CY(5_'^+Z*":]]\#?!;0_"CQWNHD:MJ2X*R2IB.(_P"PG//N<GTQ
M7HZJ$4*@"JHP !@ 4M8RJ-GG5<74J:+1!11169R!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!Q_C3XH>&_ LD<&K333WD@#"TM$#R!3_ !')  ^I
MR>P/-0^"_BSX9\<W[V&F/<VMZJEUM[R,(TBC&2I4L#C/3.>"<8!-<M\/(;:]
M^.7CJ[U9(WU6VF5;/S,%DARR%EST^41#([-CO56Q\=07OQ:TO^V_AO)I>K7;
M&U@U&[E8-L!^^JM$ QXQNZ@'&<'% CVFBO'=*76OBAXL\3F7Q-JVAV6CW+6=
ME;Z7,8<D%AODQRWW<XZ\D C'.*?%?BG6OA#+K2:C<KJOA?5=EQ);RM&M["NW
M.\+@-]X9R.BGU- SWRBO)[3Q/<>,?B[;S:3J%U'H&C:2E[<Q03LJ3R2+N56
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MQ0![Q17G7P.\0ZGXC^'?GZS=27<]M=O;K-*=SLH56&X]2?F(R>:]%H&%%%%
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MVA_:'F737'F^1Y6,JHQC<W]WKGO76444 %%%% !1110 4444 %%%% !1110
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>iclr-20211231_g5.jpg
<TEXT>
begin 644 iclr-20211231_g5.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" @>!L<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?VO8_P#/[;_]_5_QK\@=H]*-H]*/]38_\_\ _P E_P#M@_XB++_H%_\ )_\
M[4_7[^U['_G]M_\ OZO^-']KV/\ S^V__?U?\:_(':/2C:/2C_4V/_/_ /\
M)?\ [8/^(BR_Z!?_ "?_ .U/U^_M>Q_Y_;?_ +^K_C1_:]C_ ,_MO_W]7_&O
MR!VCTHVCTH_U-C_S_P#_ "7_ .V#_B(LO^@7_P G_P#M3]?O[7L?^?VW_P"_
MJ_XT?VO8_P#/[;_]_5_QK\@=H]*-H]*/]38_\_\ _P E_P#M@_XB++_H%_\
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M_P#M3]?O[7L?^?VW_P"_J_XT?VO8_P#/[;_]_5_QK\@=H]*-H]*/]38_\_\
M_P E_P#M@_XB++_H%_\ )_\ [4_7[^U['_G]M_\ OZO^-']KV/\ S^V__?U?
M\:_(':/2C:/2C_4V/_/_ /\ )?\ [8/^(BR_Z!?_ "?_ .U/U^_M>Q_Y_;?_
M +^K_C1_:]C_ ,_MO_W]7_&OR!VCTHVCTH_U-C_S_P#_ "7_ .V#_B(LO^@7
M_P G_P#M3]?O[7L?^?VW_P"_J_XT?VO8_P#/[;_]_5_QK\@=H]*-H]*/]38_
M\_\ _P E_P#M@_XB++_H%_\ )_\ [4_7[^U['_G]M_\ OZO^-']KV/\ S^V_
M_?U?\:_(':/2C:/2C_4V/_/_ /\ )?\ [8/^(BR_Z!?_ "?_ .U/U^_M>Q_Y
M_;?_ +^K_C1_:]C_ ,_MO_W]7_&OR!VCTHVCTH_U-C_S_P#_ "7_ .V#_B(L
MO^@7_P G_P#M3]?O[7L?^?VW_P"_J_XT?VO8_P#/[;_]_5_QK\@=H]*-H]*/
M]38_\_\ _P E_P#M@_XB++_H%_\ )_\ [4_7[^U['_G]M_\ OZO^-']KV/\
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MM:?_ ,_UM_W^7_&C^VM/_P"?ZV_[_+_C7XP;1Z4;1Z4?4/[WX!_K[+_H&_\
M)O\ [4_9_P#MK3_^?ZV_[_+_ (T?VUI__/\ 6W_?Y?\ &OQ@VCTHVCTH^H?W
MOP#_ %]E_P! W_DW_P!J?L__ &UI_P#S_6W_ '^7_&C^VM/_ .?ZV_[_ "_X
MU^,&T>E&T>E'U#^]^ ?Z^R_Z!O\ R;_[4_9_^VM/_P"?ZV_[_+_C1_;6G_\
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MT_\ Y_K;_O\ +_C1_;6G_P#/];?]_E_QK\8-H]*-H]*/J'][\ _U]E_T#?\
MDW_VI^S_ /;6G_\ /];?]_E_QH_MK3_^?ZV_[_+_ (U^,&T>E&T>E'U#^]^
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MVM9?\_EO_P!_5_QH_M:R_P"?RW_[^K_C7Y0[1Z4;1Z4?5?,/^(;P_P"@M_\
M@'_VQ^KW]K67_/Y;_P#?U?\ &C^UK+_G\M_^_J_XU^4.T>E&T>E'U7S#_B&\
M/^@M_P#@'_VQ^KW]K67_ #^6_P#W]7_&C^UK+_G\M_\ OZO^-?E#M'I1M'I1
M]5\P_P"(;P_Z"W_X!_\ ;'ZO?VM9?\_EO_W]7_&C^UK+_G\M_P#OZO\ C7Y0
M[1Z4;1Z4?5?,/^(;P_Z"W_X!_P#;'ZO?VM9?\_EO_P!_5_QH_M:R_P"?RW_[
M^K_C7Y0[1Z4;1Z4?5?,/^(;P_P"@M_\ @'_VQ^KW]K67_/Y;_P#?U?\ &C^U
MK+_G\M_^_J_XU^4.T>E&T>E'U7S#_B&\/^@M_P#@'_VQ^KW]K67_ #^6_P#W
M]7_&C^UK+_G\M_\ OZO^-?E#M'I1M'I1]5\P_P"(;P_Z"W_X!_\ ;'ZO?VM9
M?\_EO_W]7_&C^UK+_G\M_P#OZO\ C7Y0[1Z4;1Z4?5?,/^(;P_Z"W_X!_P#;
M'ZO?VM9?\_EO_P!_5_QH_M:R_P"?RW_[^K_C7Y0[1Z4;1Z4?5?,/^(;P_P"@
MM_\ @'_VQ^KW]K67_/Y;_P#?U?\ &C^UK+_G\M_^_J_XU^4.T>E&T>E'U7S#
M_B&\/^@M_P#@'_VQ^KW]K67_ #^6_P#W]7_&C^UK+_G\M_\ OZO^-?E#M'I1
MM'I1]5\P_P"(;P_Z"W_X!_\ ;'ZO?VM9?\_EO_W]7_&C^UK+_G\M_P#OZO\
MC7Y0[1Z4;1Z4?5?,/^(;P_Z"W_X!_P#;'ZO?VM9?\_EO_P!_5_QH_M:R_P"?
MRW_[^K_C7Y0[1Z4;1Z4?5?,/^(;P_P"@M_\ @'_VQ^KW]K67_/Y;_P#?U?\
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M #^6_P#W]7_&C^UK+_G\M_\ OZO^-?E#M'I1M'I1]5\P_P"(;P_Z"W_X!_\
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M-(>$C7W8X'ZUT]?!G_!03XE2:GXNTGP5;2D6>FQ"]NT!X:>0'8#_ +J<_P#
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M8J,4Z5DE9=#1_;E_Y(WX5_["</\ Z3RU\.$[03Z5]Q_MR_\ )&_"O_83A_\
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MM8VUQ)<NH.U5:-D4$^[,OY5](^$M1M=0_;/\8BV*LUOX<B@F*_\ /021$_B
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MU*YU*29<]U?#@_\ CU?A^!^-^A^T\=<WU.E;;F_1_P#!/-Z***]H_%0HHHH
M**** "BBB@ HHHH **** $?[K?2OTK^(WA?Q!XQ_9)T32O"]O/=:S+I.FF**
MWF$3D!(RV&+ #C/>OS4;[K?2OTK^)'CK6OAS^R3HFO>'[L6.J6^E::L<S1+(
M &2,'Y6!'0^E>?BK\T+;W/T#A7V?L<;[:_+R:VWMK>U^I\A77[.WQQLK66XF
MT76$AA0R.W]J1G"@9)_UOI7HFA_ +P;K'[(=S\1;JSNIO%/]GW5U]K:\DVF1
M)G56*9P>%';FO-[S]L;XMWUI/;3^)XWAF1HW7^SK894C!&?+]#7TEX#M9=4_
MX)]W-I91M<W']D7RB*,9;(GE.,>N.:FK*K%+FLM5L;Y71RO%5:T<,I32I3?[
MSE=GI9JW7<^?/V/?A+X;^,'CS6=+\3VLMW9VNF&YB6&=XB)/-1<Y4@GACQ70
M_#_X&^$?$'[67BCP'>V4\GANQ2X,%NMRZNI01[<N#N/WF[]ZVO\ @G7IUQ+\
M0O%.HK$QLHM+6W>;'RB1I495SZX1C^%=)\)?^3_/''^Y>?RAI5)RYYI/9%Y;
M@L//!8&=2FFY5;-M;K71]T2>(/!/[.WP)^($FA>)+"[U:_OC'(D-P'GM]/B?
M 7<=PY)!8DY.#V%<5^V=^SWX<^&-IHGB;PI ;#3=0F-K/9JQ>)'VET="22 0
M&X]A7"?MI$_\-&^+/]RU_P#2:.OHO]O#_D@7A+'_ $$K?_TFEI1YHRIRYF^8
MVQ"P^*P^8T/81BJ+]UI6?Q-;_(\_^ O[.'@[3OA7)\3_ (G,\NE>4US;V&YE
MC$(.%9PO+LY^ZN<<CKGCJ_"GP_\ @-^TQI.K67A32)O".MV,>Y74&)P&)"N5
MW%77/!'7Z<&MCXOV[^+OV&=%FT)&E@MK"PFF2'D[(MJR\#T8$GZ&OE+X'_!+
MQ1\:M2U*W\-W,5BME$KSW5Q(\<?)PJ94'+'DX]J(WJ*524[-,*WL\OJX? 4,
M+&K&<$WI[TF[ZJ72Q],_L6Z-X.\*^,]8T"2WO!\3-.CN[;4)@S&U:W2=%^7G
M;G(0],]:Y?\ :0L?A;XA^-5KH]K9ZF?&MYXCL;;6)&>18)('"*X0[L [2G(
M[U5_8GT.?PQ^TEXJTBYNHKZYL-,N;:6Y@<O'(ZW$()5CR1D=:YGXN:;>6_[:
M@N9;2>*VE\2::8YGB8(_,'1L8/0_E2Y?W[=^EQRK?\(E*'LHV]KRVM>UNO\
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ML306&PU.*E[/6G.#C.]OB4[:^70_/ZBD4[E!]:6O7/R(**** "BBB@ HHHH
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M3-7=<^'^B_$S]L+Q+H^O02W%B-*BN L,S1'>L4 !RI!QACQ706?_ "?-??\
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M!V.I8K NCAZ;C"G97;NW)J\KZ::O3OY;'UM^P7_J/&__ %TL_P"4M6?#FC?
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M&5Y*=7VDF[ZI22M&+>UU9+LWH06WPA^%WQZ^']YJ/@/3_P"P=7M=R*JY1DF
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M?Y'RGXI_Y&K7/^PA<_\ HUJZOX)?"F?XO^.(M&69K6QBC-Q>W*#+)$"!A?\
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MY'X5YU\<O@_X9\"_&#P1X?TFUGBTO56A%U')<O(S;K@1G#,25^7TKU7X[_\
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M/$8E9C57N0^'SE_DOSL:U?!G_!03X;2Z7XOTGQK;Q$V>I0BRNG'19XQ\A/\
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MK551AS'NY-E=7-L7&C%>ZM9/LO\ /L?3?A#PW;>#_"VDZ%9C%MIUK':I[A%
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M_8>G?] ^U_[\K_A1_8>G?] ^U_[\K_A1_KE'_GQ_Y-_P _XAU+_H*_\ )?\
M[8_(?RW_ +C?]\FCRW_N-_WR:_7C^P]._P"@?:_]^5_PH_L/3O\ H'VO_?E?
M\*/]<H_\^/\ R;_@!_Q#J7_05_Y+_P#;'Y#^6_\ <;_ODT>6_P#<;_ODU^O'
M]AZ=_P! ^U_[\K_A1_8>G?\ 0/M?^_*_X4?ZY1_Y\?\ DW_ #_B'4O\ H*_\
ME_\ MC\A_+?^XW_?)H\M_P"XW_?)K]>/[#T[_H'VO_?E?\*/[#T[_H'VO_?E
M?\*/]<H_\^/_ ";_ ( ?\0ZE_P!!7_DO_P!L?D/Y;_W&_P"^31Y;_P!QO^^3
M7Z\?V'IW_0/M?^_*_P"%']AZ=_T#[7_ORO\ A1_KE'_GQ_Y-_P  /^(=2_Z"
MO_)?_MC\A_+?^XW_ 'R:/+?^XW_?)K]>/[#T[_H'VO\ WY7_  H_L/3O^@?:
M_P#?E?\ "C_7*/\ SX_\F_X ?\0ZE_T%?^2__;'Y#^6_]QO^^31Y;_W&_P"^
M37Z\?V'IW_0/M?\ ORO^%']AZ=_T#[7_ +\K_A1_KE'_ )\?^3?\ /\ B'4O
M^@K_ ,E_^V/R'\M_[C?]\FCRW_N-_P!\FOUX_L/3O^@?:_\ ?E?\*/[#T[_H
M'VO_ 'Y7_"C_ %RC_P ^/_)O^ '_ !#J7_05_P"2_P#VQ^0_EO\ W&_[Y-'E
MO_<;_ODU^O']AZ=_T#[7_ORO^%']AZ=_T#[7_ORO^%'^N4?^?'_DW_ #_B'4
MO^@K_P E_P#MC\A_+?\ N-_WR:/+?^XW_?)K]>/[#T[_ *!]K_WY7_"C^P].
M_P"@?:_]^5_PH_URC_SX_P#)O^ '_$.I?]!7_DO_ -L?D/Y;_P!QO^^31Y;_
M -QO^^37Z\?V'IW_ $#[7_ORO^%']AZ=_P! ^U_[\K_A1_KE'_GQ_P"3?\ /
M^(=2_P"@K_R7_P"V/R'\M_[C?]\FCRW_ +C?]\FOUX_L/3O^@?:_]^5_PH_L
M/3O^@?:_]^5_PH_URC_SX_\ )O\ @!_Q#J7_ $%?^2__ &Q^0_EO_<;_ +Y-
M'EO_ '&_[Y-?KQ_8>G?] ^U_[\K_ (4?V'IW_0/M?^_*_P"%'^N4?^?'_DW_
M   _XAU+_H*_\E_^V/R'\M_[C?\ ?)H\M_[C?]\FOUX_L/3O^@?:_P#?E?\
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M8_&7RI/^>;_]\FCRI/\ GF__ 'R:_9K^P=,_Z!UI_P!^%_PH_L'3/^@=:?\
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M (4?V-I__/C;?]^5_P */K7D'_$2(_\ 0+_Y/_\ :GY2>6_]Q_\ ODT>6_\
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M_?)K]6_[&T__ )\;;_ORO^%']C:?_P ^-M_WY7_"CZUY!_Q$B/\ T"_^3_\
MVI^4GEO_ ''_ .^31Y;_ -Q_^^37ZM_V-I__ #XVW_?E?\*/[&T__GQMO^_*
M_P"%'UKR#_B)$?\ H%_\G_\ M3\I/+?^X_\ WR:/+?\ N/\ ]\FOU;_L;3_^
M?&V_[\K_ (4?V-I__/C;?]^5_P */K7D'_$2(_\ 0+_Y/_\ :GY2>6_]Q_\
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MR:/+?^X__?)K]6_[&T__ )\;;_ORO^%']C:?_P ^-M_WY7_"CZUY!_Q$B/\
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M?\*/[&T__GQMO^_*_P"%'UKR#_B)$?\ H%_\G_\ M3\I/+?^X_\ WR:/+?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM>"/^ANT/_P81?\ Q5>-_P##O_X0_P#0/U/_ ,#V_P */^'?_P (?^@?J?\
MX'M_A0![)_PMKP1_T-VA_P#@PB_^*H_X6UX(_P"ANT/_ ,&$7_Q5>-_\._\
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M\$?]#=H?_@PB_P#BJ/\ A;7@C_H;M#_\&$7_ ,57C?\ P[_^$/\ T#]3_P#
M]O\ "C_AW_\ "'_H'ZG_ .![?X4 >R?\+:\$?]#=H?\ X,(O_BJ/^%M>"/\
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M4 >R?\+:\$?]#=H?_@PB_P#BJ/\ A;7@C_H;M#_\&$7_ ,57C?\ P[_^$/\
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M^I_^![?X4 >R?\+:\$?]#=H?_@PB_P#BJ/\ A;7@C_H;M#_\&$7_ ,57C?\
MP[_^$/\ T#]3_P# ]O\ "C_AW_\ "'_H'ZG_ .![?X4 >R?\+:\$?]#=H?\
MX,(O_BJ/^%M>"/\ H;M#_P#!A%_\57C?_#O_ .$/_0/U/_P/;_"C_AW_ /"'
M_H'ZG_X'M_A0![)_PMKP1_T-VA_^#"+_ .*H_P"%M>"/^ANT/_P81?\ Q5>-
M_P##O_X0_P#0/U/_ ,#V_P */^'?_P (?^@?J?\ X'M_A0![)_PMKP1_T-VA
M_P#@PB_^*H_X6UX(_P"ANT/_ ,&$7_Q5>-_\._\ X0_] _4__ ]O\*/^'?\
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MM#_\&$7_ ,57C?\ P[_^$/\ T#]3_P# ]O\ "C_AW_\ "'_H'ZG_ .![?X4
M>R?\+:\$?]#=H?\ X,(O_BJ/^%M>"/\ H;M#_P#!A%_\57C?_#O_ .$/_0/U
M/_P/;_"C_AW_ /"'_H'ZG_X'M_A0![)_PMKP1_T-VA_^#"+_ .*H_P"%M>"/
M^ANT/_P81?\ Q5>-_P##O_X0_P#0/U/_ ,#V_P */^'?_P (?^@?J?\ X'M_
MA0![)_PMKP1_T-VA_P#@PB_^*H_X6UX(_P"ANT/_ ,&$7_Q5>-_\._\ X0_]
M _4__ ]O\*/^'?\ \(?^@?J?_@>W^% 'LG_"VO!'_0W:'_X,(O\ XJC_ (6U
MX(_Z&[0__!A%_P#%5XW_ ,.__A#_ - _4_\ P/;_  H_X=__  A_Z!^I_P#@
M>W^% 'LG_"VO!'_0W:'_ .#"+_XJC_A;7@C_ *&[0_\ P81?_%5XW_P[_P#A
M#_T#]3_\#V_PH_X=_P#PA_Z!^I_^![?X4 >R?\+:\$?]#=H?_@PB_P#BJ/\
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M._\ X0_] _4__ ]O\*/^'?\ \(?^@?J?_@>W^% 'LG_"VO!'_0W:'_X,(O\
MXJC_ (6UX(_Z&[0__!A%_P#%5XW_ ,.__A#_ - _4_\ P/;_  H_X=__  A_
MZ!^I_P#@>W^% 'LG_"VO!'_0W:'_ .#"+_XJC_A;7@C_ *&[0_\ P81?_%5X
MW_P[_P#A#_T#]3_\#V_PH_X=_P#PA_Z!^I_^![?X4 >R?\+:\$?]#=H?_@PB
M_P#BJ/\ A;7@C_H;M#_\&$7_ ,57C?\ P[_^$/\ T#]3_P# ]O\ "C_AW_\
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MX=__  A_Z!^I_P#@>W^% 'LG_"VO!'_0W:'_ .#"+_XJC_A;7@C_ *&[0_\
MP81?_%5XW_P[_P#A#_T#]3_\#V_PH_X=_P#PA_Z!^I_^![?X4 >R?\+:\$?]
M#=H?_@PB_P#BJ/\ A;7@C_H;M#_\&$7_ ,57C?\ P[_^$/\ T#]3_P# ]O\
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MVO!'_0W:'_X,(O\ XJC_ (6UX(_Z&[0__!A%_P#%5XW_ ,.__A#_ - _4_\
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M /"'_H'ZG_X'M_A0![)_PMKP1_T-VA_^#"+_ .*H_P"%M>"/^ANT/_P81?\
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MM>"/^ANT/_P81?\ Q5>-_P##O_X0_P#0/U/_ ,#V_P */^'?_P (?^@?J?\
MX'M_A0![)_PMKP1_T-VA_P#@PB_^*H_X6UX(_P"ANT/_ ,&$7_Q5>-_\._\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA7^U-XL\;_M.:O\ #N^L-)BT2TN=0ACGMXI!<%8&(3)+E<G'/'Y4 ?5-%%%
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M?]<$KQS_ (*"?\FYWO\ V$;7_P!"->S_  G_ .26>#?^P-9_^B$H ZNBBB@
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MLC8/Y?2OH#XE?$[XD?$KX!^%-9^%>E3'5/$$>^]N+=T#V*JN'5"QX)<%0W4
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M2RN;IB[JKHQ:+<>2%VJ1GINKZQH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQZD1NK*N?8 5]%44 >%_#/\ 8Q^&OPQUBWU:UT^XU?4[<AH+C59A*(F'1E0
M*#[XKUGQEX+T7X@^';O0O$&GQ:GI=TN)()AW'1@>JL#R".16W10!\NK_ ,$[
M_ADNK?:3>:\UINW?83>+Y?TW;-__ (]FO=5^%?AB#X=7'@:UTQ+'PU/:/9O:
M6K&/]VX(;YASN.3ELYSS76T4 <'\)?@EX4^">G:C8^%;2XM;>_F6>=;BY><E
MPH4$%B<<"O*?%G[ OPS\4>))]65M5TE;B4S36-A<*L#,3D[0R$H#Z*1UXKZ2
MHH \7T[]D#X8:/XDT+7+'1)K.^T5H'M/)O)50-$<JS+G#$GDD]>]>A?$'X;>
M'/BEX?;1?$^EQ:I8%Q(J2$AD<=&5@05/)Z5TU% 'C7AO]DGX;^$]!\2Z/IVF
MWD5CXAMEM-05[^5V>-22 K%LKR>HKK_A3\'?#/P7T2[TGPM;3VME=7)NI5GN
M'F)D*JN<L20,*.*[:B@#Y[^(W[#?PV^(6N7&KB*_\/WMS(99_P"R9E2.1CU;
M8RLJD]]H%=I\'?V</!'P/6:7P[82/J,Z>7+J5[)YL[+_ '0< *N>R@5ZA10!
MY=XN_9M\#>./B-9^.-6L;J;Q#:/;O%-'>2(@,+;H\H#M.#[<UT?Q/^%OA_XP
M>&/^$?\ $MO-<Z;YZ7'EPSM"V],[3N4@]SQ7744 <-HWP5\(:+\,QX 32Q=>
M%MLB&SO)&FR'<N?F8YSN8D'.1QBO%9_^"=_PUDU S1ZAX@@M"V39)>(4^F2A
M;]:^HZ* .:^'OPY\/?"WPU!H/AK3TT[3HB6*J2S2.>KNQY9CZFNEHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^@W%_P!\/_A7R;11_9-'^9_A_D'^M6,_DC]S_P SZR_X7/X-_P"@W%_WP_\
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M_A7R;11_9-'^9_A_D'^M6,_DC]S_ ,SZR_X7/X-_Z#<7_?#_ .%'_"Y_!O\
MT&XO^^'_ ,*^3:*/[)H_S/\ #_(/]:L9_)'[G_F?67_"Y_!O_0;B_P"^'_PH
M_P"%S^#?^@W%_P!\/_A7R;11_9-'^9_A_D'^M6,_DC]S_P SZR_X7/X-_P"@
MW%_WP_\ A1_PN?P;_P!!N+_OA_\ "ODVBC^R:/\ ,_P_R#_6K&?R1^Y_YGUE
M_P +G\&_]!N+_OA_\*/^%S^#?^@W%_WP_P#A7R;11_9-'^9_A_D'^M6,_DC]
MS_S/K+_A<_@W_H-Q?]\/_A1_PN?P;_T&XO\ OA_\*^3:*/[)H_S/\/\ (/\
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M_DC]S_S/K+_A<_@W_H-Q?]\/_A1_PN?P;_T&XO\ OA_\*^3:*/[)H_S/\/\
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MX]SL?[<L?^?A?R-']N6/_/POY&N.HH_M"KV0?5X]SL?[<L?^?A?R-']N6/\
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M .26>#?^P-9_^B$KQC_@H)_R;G>_]A&U_P#0C7L_PG_Y)9X-_P"P-9_^B$H
MZNBBB@#Y)^+^L2:U\0M6=V)CMY/LT8[!4X/ZYKC:W?'G_([Z_P#]?TW_ *&:
MPJ^_HI1I12[(_!<9-U,34G+=R?YA1116QR!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:M\7-%UY-?L+>PUG1;W[)/\ 9,^6^0>0"3@@@@\\U%X?N/&I_:PUZ&Y.I?\
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MDL\&_P#8&L__ $0E>,?\%!/^3<[W_L(VO_H1KV?X3_\ )+/!O_8&L_\ T0E
M'5T444 ?&GCS_D=]?_Z_IO\ T,UA5N^//^1WU_\ Z_IO_0S6%7Z#2_AQ]$?@
M6(_C3]7^85>T"WCO->TRWF3S(9KJ*-T/\2EP"/R-4:T_"_\ R,^C?]?L'_HQ
M:J?PLBDKU(I]T?0OB;P5\,_!\<$FK:9!:K.Q6,EI6R0,GH:P/-^#/_/"W_\
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MU#IL=YK=W%L5G.T)$I[GKR2>!U_"LKX.>,5\<3>)[.]B2-[F4W2PCY@$=0C
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M-\3:_;>%?#FJ:U>9^R:?;27,NWJ5122*^,/#7B[XT?M1:SJLWA_7E\,:-9L
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M>25]L2,1SM'7'<GVJO\ %']C'1/!'PQOM<T+5-0;Q%H]O]KFED<!)PG,FT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M SG/.2.*B_:R\/7OA'X>_"#1M2;-_9:)<13[CDA\QDJ?IG'X5]C^#_@QX(\
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MDL\&_P#8&L__ $0E '5T444 ?&GCS_D=]?\ ^OZ;_P!#-85;OCS_ )'?7_\
MK^F_]#-85?H-+^''T1^!8C^-/U?YA1116ASA1110 4444 %%%% !364-U /X
M4ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1E#=0#]12T4"$Z=*6
MBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %"Y5MRG:W]X
M<&BB@#3M_%&LVJA(=7OX5'18[EP/YT3>*M:N%VRZQ?R#T:Y<_P!:S**CDCO8
MU]M4M;F?WBRR/.V97:4]<NQ;^=)115F04444 %=E\'?^2E:'_P!=&_\ 0&KC
M:[/X._\ )2M#_P"NC?\ H#5AB/X,_1_D=V _WNC_ (H_FCZUHHHKX$_=PKC=
M;_Y"D_U_H*[*N-UO_D*3_7^@KR\P_AKU.G#_ !,HT445X!WA1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %96K>$]$\03)-JFC:?
MJ4J+M62[M4E91Z L#Q6K13NUL!SG_"M?"'_0JZ)_X+XO_B:/^%:^$/\ H5=$
M_P#!?%_\371T4^:7<5D<Y_PK7PA_T*NB?^"^+_XFF?\ "L/!W_0I:'_X+H?_
M (FNFHI\TNX61S/_  K#P;_T*6A_^"Z'_P")KH;:UAL[>."WAC@@C7:D42A5
M4#H !P!4M%)R;W"P4445(RQI_P#R$+;_ *Z+_.NXKA]/_P"0A;?]=%_G7<5[
MN7?!+U.'$;H*Y3XM?\DK\9_]@6]_]$/75URGQ:_Y)7XS_P"P+>_^B'KUCE/&
M/^"?G_)N=C_V$;K_ -"%%'_!/S_DW.Q_["-U_P"A"B@#Z2HHHH ^;?\ @H)_
MR;G>_P#81M?_ $(U[/\ "?\ Y)9X-_[ UG_Z(2O&/^"@G_)N=[_V$;7_ -"-
M>S_"?_DEG@W_ + UG_Z(2@#JZ*** /C3QY_R.^O_ /7]-_Z&:PJW?'G_ ".^
MO_\ 7]-_Z&:PJ_0:7\./HC\"Q'\:?J_S"BBBM#G"BM*U\,ZQ?6Z3VVDWUQ X
MRDD5L[*P]00.:6X\+ZU:PO-/H]_#"@W/));.JJ/4DCBIYXWM<U]C4M?E=O0S
M*Z^Q\"V+>'-.U?4_$<&DQ7[2+#&]I)*3L.&Y7ZC\ZY"O3+O0[?6OA?X0$^M:
M?H_ER7>#?,P\S++]W:#TQ^HK"O-QY4G:[_1^IV8*E&I[1N*DXQNDW9?$EW71
MOJ83> (+^UNY="U^SUR6UC,TEJD3PR[!U95<?-CVK M]+2XT&\U+[9$CV\R1
M"U/^LD# G<.>@Q7?>"O#D7AV;4-5TS6;#Q'JL%I*D&GZ>YW-N7!<[P"0HR=H
M!)KEM+L[9OACKMV\$;74.H6T:3,@WJI5B0#U /I6<:CNU>^J]=?N.FIAHVC+
MD46U)V3;6BT:=WKY7[=SF:6N\UBXM/AS]BTRWTJPU#5FMXY[VZU&+S@K.-PC
M1"<  $<]>:I>(M/T_5O#6G^)+&V32Q)=&QO[:')B20 ,)$!Y *]O6M8UKV=M
M'LSDGA'%2CS)RCNNWSZM=?U./S17I"W<YN/L_ACP5;ZGHJ85+B\T]I);G Y<
MR-C;DYZ=*2;PO8:1\;--TE+93827,+FUE^=5#H&*'/4 DU/UA:W71O[OR-7@
M)63C*Z<E&]G:[[/JM#SC-+7=R>+-*T_Q')ID'AS3)]%%T87-Q"6N)%W8+>9G
M*GN .!Q4<FDZ1X7\;>(;*XLY-6>R9DTZPVLPFD)!7?MYPJG/OBJ]L^L>ER'A
M%O&HFKV>^CU?SV=NOD</6O#X=DF\*W6N><HBM[M+0P[3N)92V[/IQ7>6>CWW
MBC1-:_MKPK:Z.EK8R75K?6UI]E99$P0A'\0(SG([5S^F3&/X1:G( K%=;MV"
ML,@XB)P1Z5'MN;X=TTN^YK]35-WGJG&36C6WD<;5O1],EUO5K+3X&19[J98(
MS(<*&8X&?:N@^(&E0MKEC>Z5;K%9:U;QW-O#"ORHY^5T 'HX/'O74:?J%MX=
M^+.C:/I]C8R1VSVVGS326ZNQE# R2*>S[B1N] *<JWN7BM;-_<33P:]MR5)>
MZI)>M]K>JU.#TSP_]N\0RZ5<7L%BT1E5[B7E R G';J1@?6LBO2M)O(O%7Q5
ME@OM.T\00I>H(X;5463:CD,X_B8$ YK#T&TL-!\(OXCOK*+4KJXNC:6%K<$^
M4I49>1P/O8X %)5FMUK9:>M_\ARPD9*\'HG+5WV7+T^=EW;.0S1757WB+2?$
M.AWHOM.M-,UF':UG-IL!C2;G#1NHX''(:M+2KI;;2["'PUX;CURZ:(-?7MY8
M-.!*2<QH#\H &.>]:.HTM8Z_A]YA'#1E*T9IJU]-^UK=_P!-;G"5K^+/#LGA
M/Q!=:5+.MR]OMS*BE0<J&Z'ZUN_$K0ETN'0;]M-71[S4+=GN;&/[D<BOC(';
M(P<=J;\9#_Q<?5O^V7_HM:F-7VDHVV:?X-(TJX7V-.IS_$G'[I*3V^[T,;PW
MX9D\21ZJT<Z0?V?927K;U)WA?X1Z$^M8U=O\+V_T?QA_V KC^0KA@U7&3<Y1
M?2QA5IQC1IS6[O?Y,=25U?A.:RM=-N98=)_MWQ"TJI;VLEN\L,46,M(5'#'/
M&#6YXAT6YU#P+?ZOJOA^#0M1L[F)8I+:#R%GC?(8&//8@8/O4RK*,N5KR_I&
ML,&ZE-SC+6S>SV7=[)^7ZG'Z]X=?0;;1YI)TE&I6:WBJJD>6&)&T^IXK)KT[
MQ3KEEH/AGP9,--M=0U6328PK7R>9%#&">0G0L23R>@%86JQV?BCP?<Z_;6%O
MINI:?<)#=PVB[894D^XX7^$@\''%13K2:3DM+VO\S7$82$9RC3EJDG;7:R;U
M[]?3ST..HKO=;NK/X=36^DVVDV&H:FL"2WUUJ,/G?.Z[O+12<* ".>M5-<TW
M3]4TG1/$>GV:6"7-[]BO;*,DQ)*"IW)GHK*>G:K5:]G;1[,RE@W'FCS)RCNN
MW3YVOK^%SC*6O1/B9J.D>']=UO1=)T:S+2.1->2QY>-C@[(1T0+TR.3S4%A=
M?9[&R@\+^&(M;;R5-Y?7FGM/NF/+(N>%5>@QUJ56<H*?+N7+!J-65+G3<=[)
MO6]K)=?/IYG&:3ITNL:I9V$#*LUU,D$9<X7<Q &?;)INH6,FF:A=6<I4RV\K
M1.5.1E3@XKU);8>%?'W@^XBT>SL9]86 W5C-$)5MI/.VL8LGY&X!]JR+J"/Q
MU\2;ZVOX;6RT_3WN9KA[& 1.\4;$DL1]YCP,GUJ(XB[YK>[:YM+ *,.2_P"\
MYK>6J3^6]SSNEKL;?QUI=S>);77AC2X]#=@A2&(K<QH>-PESDL.O/%:WAGP?
M9Z7\4]3T+4-MQ8V]K<D2R(&^3R]RO@_Q $'ZBM)5N1-S5K*YSPP?M915*::;
M4>JLWMOT>OW:V.(\/Z2FN:Q;V,E[#IZ2[LW-Q]Q,*3S]<8_&J##:Q'7!QFO1
M/!VI:5XH\<:+ID6@V-KI433;59/,EF A?!E8_>.0#CH#5+PCH*P^';_Q"='?
M7;A;K['96:Q-)&K8W-(ZKU & !TR:3K<K?,NVFG5LN.#52,?9M/65WKLE%[?
M/32[.&HKT2ZTBX\3^&]7NK[PW_8>J:;$+J.>WLWMH;B/< Z%2,;AD$$>]36>
MG3Z;X1T>^\/>'K+Q!Y\1:_N9[?[4\<NXCR]F?D &.<<YH^L*VVM[;_/<%@)-
M[Z6OL[VO;;???I;6YYM16UXNGTNXU**73+.33B\*FZLG! @G_B5,\[>AYK$K
MHC+F2=K'GU(>SFXWO;JA:***HS"BBB@ HHHH ***NV&AZEJL;/9:?=7B*=K-
M;P-( >N"0.M)M+5E1C*3M%7*5%:__"'Z_P#] /4O_ 23_"LEE*,RL"K*<$'J
M#Z4*2ELQRISA\2L=+X7\&PZ]H^I:I=ZO%I%E8/''))) \N2YP.%YZU9_X1/P
MU_T/-K_X+9ZU/ ^GQZI\-?%UM+?6VFHUQ:$W-V2(UPV<' )YZ=*QCX'T\9/_
M  FGA\_]M)?_ (BN+VC<Y)S:L^B\EY,]GV$8T:4HTHRYE=MR:UYFMN9=$NAS
M%PB0SRI'*)HU<JLH! < \'!Z9ZU'76>%YK2STJ5[+1QK_B)Y]JQ36SS0V\('
MW]HX8L?7H!6OXJT6>Z\!OK6I:##H.IV]ZD ^SQ>0L\;*3DQYX((ZULZRC)1:
M\OZ1QQP;G3=2+V5[6=K>NU_+\;Z'GE;%]X=DL?#.E:RTZ-'J$DT:PA2"GED
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M3PKITE4<MTGUUOV>S:ZK_(YVBDI:W.$**** "BBB@ HHHH **** "NS^#O\
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M ";G>_\ 81M?_0C7L_PG_P"26>#?^P-9_P#HA* .KHHHH ^-/'G_ ".^O_\
M7]-_Z&:PJW?'G_([Z_\ ]?TW_H9K"K]!I?PX^B/P+$?QI^K_ #"BBBM#G-*U
M\3ZS8VZ06VKW]O @PL4-TZJH]@#@47/BK6[R%X9]8U">%QM>.2ZD96'H03S6
M;28%1R1O>QK[:I;EYG;U!37H\VCIXJ^'/A>UM=5TJWN;*2Y,T5[>I"PWLNW@
M_0UYS364'M4U(.=FG9K_ "L:T*RH\ZE&ZDK;VZI_H>@^%]!M/ FOVFN:MK^E
MM'9,94MM.N1<33MM("C;P <\YK*M]2M[CX=^)HWDCBN;K589UM]PW%2')P.X
M&<5R.T>F*-HJ/8W?-)W>GX.YM];48\E.%H^]UO\ $K-W.^UJWM?B/]BU2UU6
MPL=66WC@OK34)A "R#:)$8\$$ <=:COM6TCP]I>B>'XYTUB"#4!J&IS0 ^5(
MW"^6F>H"@Y/<UPNT=QFEH5%:1OHME_7;H$L8VW-17/+=]_EY]?T/2O%]C)XB
MU:[U&;QG8MX>E<O&BW9\R.+M&MN.0P''3&:MZIJ6GR_&#PUK<%_;-I<QMV#F
M9=T(1 I$O]PY'>O*=HI-M0L/I:_1K[_U-GF%VY*&KDI;MZI_EJ]/Q-":53XA
MDD#*8S=EMV>,;\YSZ5Z=<:[93>+O'D-CJ]OINI:A)']@U1I,1E5 WH)!]W=Z
M^U>1 4NWC&.*TJ454M=_U=/]#GH8R5"]EN[_ (-?^W;GJ/A6SM]'O-4AU;Q+
M97.K:EI\]I!MO/-AC+ ',DIX&< #\<US5K=06_PMU:P>XA^U_P!L0N(E<%F4
M1D%@.ZY[UR6T?2DV_G25'6[?;\#26,]U1C"UE);W^+]3U#X<ZA977AMI]08>
M9X5F;4K<,/\ 6*ZD"/V_>!#7&>%=86U\;:3JE_)A$OX[F>0\_P >6-6;SQ)I
MUOX7?1](L;BV-V\<E]<74H=I"@X1, 83<2>>:YK%3"G=S;5K_P!?G<JMB;*C
M&+3<-6^[Z?<DD>EZ+;P>'?BH]W<:IITUG=1WLL=Q;W2N@#1OM#'^%B2.#6+H
M-W8>(/![^'+V]BTR\M[HW=A<W&1$VX8>-V'W<X!!Z5QVT>E&*KV/5O73\+_Y
MD?7+:*/NWEI_BM=?A='6WFA:7X8T'4!?WMCJNMW*K':0V,WG);<Y:5G'&<<
M>]='KC2>*M.TIM%\2V.F:3!9QPRZ?<7GV8P2*/G)3^/)YR,UY?M'I1M'I2=%
MR:DY:_UT".+44X1A:+5M&T]'?5]?/Y=D=WXZ.G77@_PV-,U.&^BTT2VLH=]L
MS.SEMX0\[#S@_2J/Q8OK?4?B!J=Q:3QW-N_E[9(F#*?W:@X(KD=O>E"XJH4N
M1IWO:_XNY%;%.M&4>6U^7_R5-+\&=S\*Y(#-XCM9KNVLWO-)FMX7NI1$A=L
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M>&M'\2111ZOI-CJT<3%HTOK9)@A(P2 P.#]*QV^%O@KI_P (=X?_ /!7!_\
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MBV:*;:$74)6-A$/WCJBDLW/?L*]<^(-K->?#OQ';V\3SW$NESQQQ1J69V,1
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M%RGF?QWTF]UC1/"T=C:3WLD/B;39Y%@C+E(UF!9SCHH')/:L_P 47-UX1_:
M@\0SZ-JNHZ/J.A)I:7.EVC7/E3BX9\2!>57##YCQUKUU5QTI<'Z5,:EE:PW&
MXW&&-3+]T5&JU(.E8FB%HHHI%!1110 4444 %%%% !1110 4444 %%%% %C3
M_P#D(6W_ %T7^==Q7#Z?_P A"V_ZZ+_.NXKW<N^"7J<.(W05RGQ:_P"25^,_
M^P+>_P#HAZZNN4^+7_)*_&?_ &!;W_T0]>L<IXQ_P3\_Y-SL?^PC=?\ H0HH
M_P""?G_)N=C_ -A&Z_\ 0A10!])4444 ?-O_  4$_P"3<[W_ +"-K_Z$:]G^
M$_\ R2SP;_V!K/\ ]$)7C'_!03_DW.]_["-K_P"A&O9_A/\ \DL\&_\ 8&L_
M_1"4 =71110!\:>//^1WU_\ Z_IO_0S6%6[X\_Y'?7_^OZ;_ -#-85?H-+^'
M'T1^!8C^-/U?YA1116ASA1110 445W<>F^&M#\%:#JNI:3=ZE=:D\ZMY-Z80
MOEL .-IZY_2LYU%"VE[G11H.MS>\DHJ[;OW2Z)]6<)25W>EZ/X:\<?:K+1[.
M^T?5XX'G@2>Y^T13[!DH3@%3CI6/J&AV=MX T76$#B\N[N:&4ELKM4 C [5"
MK)OE:L_Z_P C66$FHN<6G&U[KR:3W2=]5NCG:*ZS0_"MI9Z6FN>)7DMM,?\
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ML#0**** "BBB@ HHHH **** "BBB@ HHHH L:?\ \A"V_P"NB_SKN*X?3_\
MD(6W_71?YUW%>[EWP2]3AQ&Z"N4^+7_)*_&?_8%O?_1#UU=<I\6O^25^,_\
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M+FQLUC:&5_XBKDY0$^QQFH(?'=L_BB\OKG28?[)N[;[$]A" #'!@!=C$??&
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M\O[3<?:(Y97; .,A, =@ *ZKXP>#[[Q]\+_$'AW37ACO[^U\B)KABL8;(/)
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MQ)I>J?';7H?$_AO7/%&G^&[>WM]/T_3=+:^MXII4\R2:1 =NX@JJY!X!K2\
MZC##\;-.G\)^#_$7AW0-4M)H]9AOM'>RM%F3#03*/NJY^93C&1BNN\3^"_$>
MF^.)_&'@VYL#?WULEKJ>DZJ72WO A)CD61 3&ZY(S@Y%3>%?"WBB^\:P^*O&
M%]9PRVENUM8:+I$DC6T&\CS))';'F.0 !P !3<H\OR_K3UU%K<\\_9]^&VBZ
M[#XBU[6[2/6)X?$>I1Z?#=KOBLU%RQ9D3IO9\DMUX [5V'@I5\#_ !J\7^'V
MQ!INOPKXCLL\*) 1'= ?CL8_[U;/PC\%7_@/P_JECJ#P22W.L7M_&;=RP\N:
M9G0'(&&P>16?\:_AWK7CC3=-N?#%Y;Z=XAL9)8DN;@E5^S3QF.=<@'G:0P'J
M*4IJ<VF]&-*R5D<WX3C_ +?^'OQ2\=2I^]\2PWWV8L.1900R10CZ'#-_P+/>
ML.%3XF\%_ [P-/+)#HNM6"W&HK$Y0W$-O C" D=F9AD=PI%>R77A&.U^'%QX
M6TL)%&ND/IMMOX49A,:D^V3DUR,GPCOKKX:^"]-CU&+2O%GA>*![+4HE\V))
MDCV.K#@M&XR".#34XWOY_I9?<%F:7BKX+^'-3M=.ET:VL_"&K:9<17%GJNFV
MJ1O%M8;D;&W>K+E2&/>O/?%GB?2M8^.^NIXF\-ZWXHTWP[;6\&G:?INEM?6T
M<TJ>9)/(@.W<055<YX!KJ]6\'^/?B.MKI/BU]#T?P[%/'/>)HLTLL^H>6P94
MRX B0L 2!DX&,UI^)_!/B'3?'$WC#P7<6 OKRU2TU+2=4+I;7:H3Y;JZ F-U
MR1G!R*49<NDG?^NX/79'(>!]2@A^-&GW/A3P?XB\.>']4M)H]:AO='>RLQ,@
M#03*#\H<_,IQC(Q6;I^BV_@&?Q':^/\ X<77BI=0U"XNF\2V=DFHF>"1B45U
M_P!9%L7"\< #BO1?#7A3Q1J/C*/Q1XPO;.*6UMGM;#1=(DD:VAWX\R21VP9'
M(  X  K)T/PS\2/AW%/I'AZ;0_$&A^>\MC/K=S/%=6B.Q;RVVAO-"D\<@XXJ
MN9;)]OZN(Z/X+C2(?ASID.@ZY+X@T>,R+;74^1(B;R1"P/(,>=N#S@"NY!KB
MOA?X$D\ >'[FUNKU-0U*_O9M2O;B*+RXFFE(+!$_A48 'TSWKLUZ5RU+<S:-
M8[$E%%%9&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G'Q.\)
MZY-XH\,^,O#,%OJ&K:&L]O)IEU)Y2W=M,!O5'Z*X*@@G@]*]'I&JXR<7<F2N
MCPCXB>%?%OQ\TNWT2Z\,CP+80R^<VJZE<QW%XC8(VP+"2 &SAB3]TD8KTCX:
M2:LO@[3[36]'70]0L$%F]O$ZM"ZQC:LD1!/R, " <$=*ZIEI-M:2J<T>6VAG
MRV=SSOX@>%=5UKXH?#+5K*T:?3](N[N6^F#*!"KV[*I()R<L0.,UZ%)&LR/&
M_P!QU*M]",&I=M!6H<FTEV*L>#^&_A+X@NO@1HOA^:-=$\4Z!J+WVG-<L'B\
MR.X=X]Q4GY'1ROJ :W=7\0_$KQ9I4FBV/@UO".IW $4^O7%_#+;VRG[\D"IE
MW;&=H8#MFO6O+INTUK[5MW:(Y.QY?\5O#6NFX\ ZSHNGS>)9_#-^T]Q9B9([
MBZ1H#$65G(7=GDY(ZTWQ'H?B6U\6Z3X_T#1UN;Z33A8:OX=NKA$F>+=O0I)R
MGF1L2,9P03S7J6TT;:2J.R5@Y3S?2[KQOXR\6:3>W>DS>"/#>G%II[.:ZBEN
MM1D*[5C<1Y58ESNZY)Q4_P ,_#.IZ#XJ^)%W?VK6]OJNO&\LG+ B:+R8UW#!
MXY!&#@\5Z#M-&VE[31I(?*>?Z'X9U.S^.GBG7Y;5DTB\T6RM(+G<N'ECDD9U
MQG/ 8=1WK+^&.D^(?!GBSQ9H]]X>F?2=4U>[U>WUZ&XB, 67#"-DSO#9XX&/
M>O5MM(5H]HVFF/E/"_#/PAUVX^ OAC19=FB>+]"N_P"T;)K@ATCG69V"N5)R
MKJV#CLU;.O:Y\2?&6BW/A^U\&#PS>WD9MKG7+K4(IK6!&&'>%4^=SC. P'7F
MO6MM&VJ]JV[M>8N7LSRO5?AO<:3XB^$-MHEHTVB>&#<PW$I908HS;"-&()R<
ML.V:T?C9X7U3Q7X?T&VTFU:\FM]?T^\E565=D,<P:1^2.@&?6O0]E.V5/M'=
M/L'+T!SND8CH37DLWAOQ=\-?''B+6_#&DV_BG0?$,RWEWIAN1;W5M=!=K/&S
M?*ZL.H)&#7KFVBHC+E*:N>)^,=/\<_&C2U\-77A4>#/#ES+&VI7>HWL<]R\:
M,&,<4<9(!;&-Q/%;?BOPWX@\,_$%/&GAC38]=BN;!-.U31FF6&:5(SF*6)V^
M7>N2I4X!!ZUZ<RTFTUI[1[):$\IYUH<WC7Q=XQT[4M0TV7P7X;T^.1CIDES'
M-<ZA,PVCS?+RJQIR0 <DX]*?\)?#.I^&[OQTVI6K6RZCXDNKZU)93YL+[=KC
M!XS@\'FO0MIH"TG/1JP<IYO\:O#NO7FGZ/XA\)6BWOBK0;EI;6W+!?/BE0QR
MQDD@8P5;_@%;O@;P>?!?PVL/#Z'S;F"Q9)GSS+.ZDR,3W)=CS76[:0K4^T?*
MHCY=;GAV@_"?7V^!O@*P01:1XU\+F*\M4NB&C$RDAHI"I/RNIP2.G%:FO:E\
M1?'^EMX>@\+3>"6NBL=]KTNHQ2K#'D%S;",[F8@8!8+C.:]=\ND*UI[5MW:%
MRGF/BCPOK_A;Q[#XQ\+Z>FOQS:>FFZII$DZQ3S)&<Q31.WREQD@AB,@]:LZ'
M<>-?%OC'3=3U'2Y/!GAO3D=FTR2YCFN=0F88 E\O*K&G) !R3CTKT7;1MJ>?
M35!RGE=GJGQ \#W>J:;=^';KQ_IDMU)-I^HV][#'*D3G(AG20C[G(!7.16E\
M&O ^H>#=-UZ?4K>TTVXUK4Y-2&E6#[X+%64 1J< $G&YL #)XKT+::-M#J75
MK;ARCD-2U&J_C4E8FJ"BBBD,**** "BBB@ HHHH **** "BBB@"QI_\ R$+;
M_KHO\Z[BN'T__D(6W_71?YUW%>[EWP2]3AQ&Z"N4^+7_ "2OQG_V!;W_ -$/
M75URGQ:_Y)7XS_[ M[_Z(>O6.4\8_P""?G_)N=C_ -A&Z_\ 0A11_P $_/\
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MG6B0&8>C$<D>U<SMI^VC;2C",%:*L74JU*SO4E<0#-(5]:?15&0P#TIU+10
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MJ*+A8BV&I%7%+2T!8****104444 %%%% !1110 4444 %%%% !1110 4444
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M/Q)X,\0ZK>:/K&E2PR6_BG1;=8A>V[<@@.K('X*LHS^%<CXN\/\ B_P_\1O
MOAV#XJ>*I;37VNQ/-)]FWQ^4BLNS$6.2QSG--4KNW-_6XN;2]CZ'HKD?!?@[
M4_"UQ=2:AXSUOQ4LR!4CU;R=L)!SN7RT7D].:ZP'-9-6>C+3%VBC;2T5)0W:
M*7:*6B@ I,4M% "8]*-M+10 W:*-HIU% #=HHVBG44 )C%+110 4444 %%%%
M !1110 4444 %%%% !1110!8T_\ Y"%M_P!=%_G7<5P^G_\ (0MO^NB_SKN*
M]W+O@EZG#B-T%<I\6O\ DE?C/_L"WO\ Z(>NKKE/BU_R2OQG_P!@6]_]$/7K
M'*>,?\$_/^3<['_L(W7_ *$**/\ @GY_R;G8_P#81NO_ $(44 ?25%%% 'S;
M_P %!/\ DW.]_P"PC:_^A&O9_A/_ ,DL\&_]@:S_ /1"5XQ_P4$_Y-SO?^PC
M:_\ H1KV?X3_ /)+/!O_ &!K/_T0E '5T444 ?&GCS_D=]?_ .OZ;_T,UA5N
M^//^1WU__K^F_P#0S6%7Z#2_AQ]$?@6(_C3]7^84445H<X4444 )7:1:_JW@
M_3++2]7TNRU72[F);RVM;Y=X5'_B1E.5SZ?I7&5U5CXTM)]&M=+U_2%U>WLP
M5MKB.8PW$2DYV;L$%?8BL*L7)+W;K\?D=N%FH.7O\KMH^GFFK/3Y;FEINE^&
MOB"\]GING7&@:VL+SPHLYFMI=H)*_-\RG ^E9UVV?@SIY_ZC,_\ Z*6G?\)M
MINBV=U%X;T1M.N;F,PR7]W<>?,L9^\J< +GUZUC3>(%E\$V^@"!E>&]DN_/W
M<$,@7;C\.M8QA.ZWM=;N[ZW.R=:CRR5TY.+3:5D]596LM=[NR1T_QLU2YE\;
M& S.(K2V@\E58@*3&K%A[Y/7V%,^,FK75[XAL8IIF9(].MI0N<#>Z;F;_>)[
M]:Y[QMXD7Q?X@GU-+=K59(XX_*9MQ&U N<^^*3Q?X@7Q1JD5XL#6X2TAMMC-
MNSY:;=WXTZ5)Q]G=;+_(6*Q4:CQ'+*_-)->:7-_P#T_3Y#/\2O US(=T]QH.
M^60]7;RIAD^^ /RKS'P>K2>,=&1068WT6 /]\5H7'CZ==8\-ZE96_D7&C6<=
MJ!(VY9=I;)XZ AB,5=L_&^@Z/K46KZ7X;DM]0$OF'SKOS(H\G+&-=O!QD L3
MC-9QA."?NWNK=.[_ ,SHJ5J%:46YVY97V>J:CMIO>+WL;4+?\51\5/\ KVN_
M_2A:QX]/GN/ VCPZOK%IH6CEY9K:$1O)/=DD!I&5>H&, G%9T?C5(]5\67?V
M-MNN131)'Y@S#OD#@DXYQC%.M?%VE7FAZ?INOZ/-?_V<ICM;FSN?)D$9.=C9
M!!&?QI^SG&VG;M?:VEQ.O0G=.726][:SOK;7;7UW-;Q,MC_PJG218WMQJ,,.
MJ31K-<Q>65S&I*J,G"]/QS5+XG8#>%?^P%:?R-0ZMXXLM6\*OHG]CBS@@G\Z
MP^SS<19&&\S(S(3R<Y')]JK:]XIL?$6AZ;#/ITT>KV-O':)=I./*:)#QE,9S
MCC.:=.$XN+:ZOMU(KUJ,XSC&2UC'OO'=:Z^E^GW'H6J'[+\4_&NIQIOO=.TP
MW%J,9VR&-%W@>J@DUYGX5U[4--\46%];W$KW3W""0LQ;S@S ,K?W@03UK2U+
MXAW$WCV?Q-8VP@:4!&M9R)%=-@1D;U! J:T\8Z!HMU_:.D^&7@U9?FA:YNS+
M;P/_ 'D3 )QVW$U-.G.$+.-[I+IVV9=:O2K5>>%3E2G)]=;NZ:LM[::VV1T_
MAU4\,?$3Q\-/PB6>GWC0CLA#H0/P/\JYWX07D\WQ$L(Y)I)5O1)%<^8Q/FJR
M-D-ZUC>'?%3Z-<:W/<1/>2ZG936K/OP0TA!WGUZ=/>HO!/B%?"/B:PU9X&NE
MM6+&%6VELJ1U_&J=&7)-;MJWKH1'%4_:T)7M%2;:[)RO^1CG"LP'0$C]:=36
MY8GU.:45W'ABT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]XJTCQ#<0:AJGASQ5IVFOJ5K'Y<=VOVJ)E?;T# '# <9KTGX@9_X7W\*>?\
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M&2]A&#P@8<ANKXYKWI6-<]2"A:Q<97)J*1:6L34**** "BBB@ HHHH ****
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MQ3MKQQ]:V/B9\-(O''PRNO!^G30Z+;ND,4#"(M'"D;*0H4$<87%=HHPH'7
MH]HE&T>[\^PN5WU/'/@3FPTKQ[H^H1F7Q3INH2QZOJ32M(=1=HBT4^3]T%.
MO08XKEO@#X-\9:I\(M NM+^(LVB6$@G,5@NC6\XA N) 1O8[FR<GGUKUO0?
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M9_?8>MCKUZU*M, J1:Y35#J***104444 %%%% !1110 4444 %%%% !1110
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MO_0S6%6[X\_Y'?7_ /K^F_\ 0S6%7Z#2_AQ]$?@6(_C3]7^84445H<X4444
M%)2T>@[G@4 -VT;34DD;PX\R-X\]-ZD9_.D",P)56(7J0,X^M #-M+MIS(RJ
MI*L W0D<'Z4E ";:3;3U5I&VJK,WHHR:2@!N#1M-.HH 9M]J7;3NM*RLC$,I
M5AP0PP10 S::-IJ:.WFF7,<$L@]40L/T%)+!+#CS(I(_]]"O\Z+CL]R+::7;
M3MK;=Q5@N<!L<9],TE A,4M%% !1110 4444 %%%% !1110 4444 %%*%9E8
MA6(7J0,@?6DH **** "BBB@ HHHH ***5E90I*L W()&,_2@!**** "BBB@
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MO=3 !YB!C>P'&3U.*O;*-M+F=K= MU%6EI!2U!84444#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,4M% "8H-+10 W;[4;?:G
M44Q6(]M+MI]% 6(RM)LJ6DQ0%AFVC;3\"B@+#-M&TU)10%AFVF[:EI* L1[!
M2[:?1B@5B/;2A:DHH'8;M]J6EHI %%%% PHHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+K-E<Z2T#20O',KFX)'RHB@Y9F) VCG)KI;>U@L[:.WMX8X+>-=B0Q(%15]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110 4444 %)MI:* &[:7;2T4P$Q2T44@"BBB@!*3;3J*
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M_@0?_B:/^&>?%O\ TX?^!!_^)KZ=HH_M3$>7W!_JQ@/[WW_\ ^8O^&>?%O\
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M_@0?_B:^G:*/[4Q'E]P?ZL8#^]]__ /F+_AGGQ;_ -.'_@0?_B:/^&>?%O\
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M],_^^J/^$;O/^F?_ 'U75T4?4*/F'MYG*?\ "-WG_3/_ +ZH_P"$;O/^F?\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)10
MM%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10
MM%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10
MM%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10
MM%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10
MM%)10 M%)10 M%)2T %%%% !1110 444E "T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM3QK_P!#=KG_ (,)?_BJ/^%J>-?^ANUS_P &$O\ \57+T4>SA_*@Y8]CJ/\
MA:GC7_H;M<_\&$O_ ,51_P +4\:_]#=KG_@PE_\ BJY>BCV</Y4'+'L=1_PM
M3QK_ -#=KG_@PE_^*H_X6IXU_P"ANUS_ ,&$O_Q5<O11[.'\J#ECV.H_X6IX
MU_Z&[7/_  82_P#Q5'_"U/&O_0W:Y_X,)?\ XJN7HH]G#^5!RQ['4?\ "U/&
MO_0W:Y_X,)?_ (JC_A:GC7_H;M<_\&$O_P 57+T4>SA_*@Y8]CJ/^%J>-?\
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MO_Q5<O11[.'\J#ECV.H_X6IXU_Z&[7/_  82_P#Q5'_"U/&O_0W:Y_X,)?\
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MTZQ_X'2?XUSE%%EV#ZIA_P#GW'[D='_PLKQ=_P!#3K'_ ('2?XT?\+*\7?\
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MX ')/M19=@^J8?\ Y]Q^Y'1_\+*\7?\ 0TZQ_P"!TG^-'_"RO%W_ $-.L?\
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M"[L=\9S0!1HKU[X[? */X+V.D7":X^KF_EDC*O:B'9M4'/#'/6O(: "BBB@
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M,M6^(VAP>(?$6I'PWHEPGFP1K&&N)D[.<X"*1R"<G'.*]$U#]A/PAKVGS_\
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M#:E^#7_)N_Q8_P!V/_T&EU \>\#_ /(Z^'O^PA;_ /HQ:]$_:Q4'XWZOD?\
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MX@TRX\2:UJ$JDWFH0":*T65OW2-R .".0"><GTKR?]A;_DO-C_V"KK^24_\
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MU+X:/X0T*Z>W-C<27D9"8!9$6(*"/E!],"N^_;4FDC_9S\,HC%5DO[-7 _B
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MWW_#T\C5JV)DT^ESN/$'PS^#O[+OA'2F\9Z,?&'B'4."LB"4NP WE$)"HBY
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M$?D)XQ_P3\_Y-SL?^PC=?^A"BC_@GY_R;G8_]A&Z_P#0A10!])4444 ?-O\
MP4$_Y-SO?^PC:_\ H1KV?X3_ /)+/!O_ &!K/_T0E>,?\%!/^3<[W_L(VO\
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M?G_)N=C_ -A&Z_\ 0A10!])4444 ?-O_  4$_P"3<[W_ +"-K_Z$:]G^$_\
MR2SP;_V!K/\ ]$)7C'_!03_DW.]_["-K_P"A&O9_A/\ \DL\&_\ 8&L__1"4
M =71110!^:7Q9_Y*EXN_["MS_P"C#7*5U?Q9_P"2I>+O^PK<_P#HPURE( K2
M\,Z;%K'B;1]/N"P@N[V"WD*'#;7D53@]C@FLVMSP'_R/7AK_ +"EK_Z.2@#U
MO]I3X'^'?A%INA3Z')?R27LTD<OVR<2#"J",848ZUX/N'J*^U/VKK>*[UKX9
MP3QK-#+K022.095E)0$$=P13OC1K7@/X$ZIH^J6W@BPO=:ND>."&&-((XXU(
M+.<*1NR0 <9^E,#XI# ]#FD#J3@$$U]T^.H_A]K'P]TOXI:KX:2Y%K;I=PVJ
MJJ-,TF%6*3'# ,1UXXS[5%\+_%_A?]I+PQK>EZAX4MM.^QA(VA 5]JN&V/&P
M4%2-IZ>E 'PY2>8O]X?G7L?P2@^'_ACQEK<_CV[B<:;.;>QM[B%I(Y7#L&D8
M $'&T<'CYJ]C^&?QP_X6A\0#X<3P%9'PO(95CNEM]WEHH)5I,KLP<#C_ &J
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MTVVM4KJ[;LUV/F$L%ZD"@'=TYK[,\?\ CSPC^R]_9GACP]X1@U;47@$]S<3
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MKE/BU_R2OQG_ -@6]_\ 1#UQ'Y">,?\ !/S_ )-SL?\ L(W7_H0HH_X)^?\
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M[(4)P!@=6/.!['->GVO[(^D>+M/U7_A!/B5I_BO5],7=/8"V\H9YPH8,>I!
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M*<LK8#$XRM5::JSYE:^VN^F_WBT445J?3!1110 4444 %%%% !1110 4444
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MH-Z96\[S,YW[\YW9[UZ#??M+_%'4-';3)_&FH&U9=C% B2D8P09 H<_G4_\
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MA?\ KY#_ -*1^>]%%%>R?UR%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!UOPA_Y*MX._P"PM;?^
MC%K].Z_,3X0_\E6\'?\ 86MO_1BU^G=>?BOB1^$>(W^]X?\ PO\ ,*Y3XM?\
MDK\9_P#8%O?_ $0]=77*?%K_ ))7XS_[ M[_ .B'KB/R$\8_X)^?\FYV/_81
MNO\ T(44?\$_/^3<['_L(W7_ *$** /I*BBB@#YM_P""@G_)N=[_ -A&U_\
M0C7L_P )_P#DEG@W_L#6?_HA*\8_X*"?\FYWO_81M?\ T(U[/\)_^26>#?\
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M\$E1R3SDUB6MKX7^'_QL\46<5_8:6D]@QT34+C;<6NGW4J(XW$9&%RZ!N<4
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MBIRUDI7LKK5/\4"K3M-7V1@?%SX!>"?A-X2US[7XQ^U^-HY5>QT.*1"5A:4
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M;=(HY!)%!(ZL#L/?CIT->L_L&?\ (@?$7_KI'_Z)>O$/V,?^3A_"7_7.Z_\
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MTZ5)7TAZR"BBB@84444 %%%% 'M'[''_ "<1X:_ZYW7_ *(:OTPK\S_V./\
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M.,[1SBJFC_$B&[TGXHS:U,PU?Q1!"81'&2K2"X\QAD?= 7IGTKSBBCE74O\
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M1GAKPUX?\-^#?^$<LK:!%:ZLI[J&,*UR\#"-G9A][+*QR?6@#PRBNRT#X/\
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M\5V5Y=^*=*O=]GJU\"L\=J5PT$FX;F&<$9Z5Q4ZTZEFDK=NJ]?U.>-1RL_\
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M+-Y^XF1Y"_()[Y)QBNUD^)&K?$KQ9X,>!+32/%UE(MM%K;3E(I,,3&K1XVH
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M7D\QK=2Y5#ZA1@ ^^*Z7AWS/LW?=_EL:^R=_([7XP.?^%<?!M<G'_".N0/\
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M-^S>[R?$*72'^;1M4TZ\AU*$_P"K:$0.P9ATX8+@]LU6T3'_  S?XMPVX?\
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MHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >T?L<?\
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M)UF_T&^CO=,OKC3[R/[EQ:R&-Q^(JG105**DG&2NF;7B/QMXA\8&+^W=<O\
M5Q%_JQ>3M($]P#P*CL?%NMZ9HMUH]GJUY:Z3=MNN+*&8K%*< 98#KP!^59-%
M*RV,E0HQ@J:@N5;*RLOD%%%%,V"BBB@ HHJ]8Z%J&IZ?J%]:6<EQ9Z>B27<R
M#Y8%9MJEOJ>*"92C%7D[?\'1?B4:**M:3I-YKNI6VGZ?;27E]<N(X;>(9:1C
MT H'*2BG*3LD5:*M:II=YH>I7.GZA;26=];.8IK>48:-AU!JK0$9*24HNZ84
M444#"BI+>WEN[B*"%&EFF=8XXUZLQ. ![DD5-JFEW>B:E<Z??V[VE[;2&*:"
M3[T;CJI]Z">:/-RWU*M%%3FPN5L5O3;S"S:0Q+<>6?++@9*ANF<$''7F@=TM
MR"BKU[H>H:;I^GW]U9RP66H*SVD[@;9U5MK%?H>*HT"C*,E>+O\ \#1A1110
M4%%%% !1110 4444 %%%% '6_"'_ )*MX/\ ^PM;?^C%K].Z_,3X0_\ )5O!
MW_86MO\ T8M?IW7GXKXD?A'B-_O>'_PO\PKE/BU_R2OQG_V!;W_T0]=77*?%
MK_DE?C/_ + M[_Z(>N(_(3QC_@GY_P FYV/_ &$;K_T(44?\$_/^3<['_L(W
M7_H0HH ^DJ*** /FW_@H)_R;G>_]A&U_]"->S_"?_DEG@W_L#6?_ *(2O&/^
M"@G_ ";G>_\ 81M?_0C7L_PG_P"26>#?^P-9_P#HA* .KHHHH _-+XL_\E2\
M7?\ 85N?_1AKE*ZOXL_\E2\7?]A6Y_\ 1AKE* "BBB@!**[?0OB9;Z'I-K8O
MX(\*ZHT"[3>7]D[SR\DY=A( 3^%/UCXI6^K:7<V:>!?"6GM/&4%U9V,B319_
MB0F0X/X4 <-7MEGHNK^-O@SX:TSP-.);BSDN'UO2;:Y6&XFF9ODE*DCS%VX
M]*\2_AXZUZ/XA^&<C>&/#GB?P;;WVIV$]HHU![<F66SO%.'5@@W(IX(SZ]:
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MKYP 0=P'/3%;?C;3;OP'XJ3PWX0\ 65]%Y49M=7N=/:^FO\ <@/FAVR@4D]
M,"IOC!'>1_$[X83Z@T3RBRTQ)[FW4"W,JS?O A4;< YX' H QOBEX9L/&OQQ
MU#0_#$>H?VU>:K<1WK:@T?D*^XDO'L&0@ 8G=S@"LQ/#?PRDU+^Q!XEUH7QD
M\@:T;6+^SS)G&=F?,V9_BSTYQ75PW2>'?VI?$1U;S-,MM3N]0L8KR="B(9U9
M4D#'C&2O(]:\R7X2^+I?%'_"-?V%?+J7F>43Y+>6JYQYF_&W9CYMV<8H Z3P
M;\%[C6O'7B;PIJL_V'4=)T^>YC=' B>1"FQF8C_5E7W9ZXJ]X/\ #7AF[\;0
M:=X7\1ZS)/'IM^]YJ4<20)(4A)VP@@G8V"#NY(]*[!=>M=:^+'Q.FTZX6X@M
M?"$]D+J,\2M%'#&S@]P2IP?2O.OV>?\ DH4G_8&U#_TG:@#.\&^"=,NO#-WX
MH\3ZA<:;X?@G%I#'91A[F\N"-Q2,-\H"KR6/ J7Q!X+T2\\*W'B;PC?7USI]
ME,D&H6&J1HMS:[_N2;D^5T8\9&,&NU\'ZV\WP%LH]-\+Z3XMNM%U.=KZRU&V
M>XDACE 9)T1&!QP5)YZ57O=>U9_A1XFOI/"?AOP9IE]Y-D/L^GS0W&H-Y@;9
M%ND/"8W%B,=NM '-6O@WPOX=\+:'K/BZ]U9Y-<226SLM&CCRD2-L+N\G&20?
ME SBL7QYX5L/#-UIT^D:I_:^CZG;"[M9F0)*@R5,<J9^5P1^/6NTL;_Q=X+\
M"Z#);6UEXV\(:E&TR6=UIQNHK.?<1)"2/F1L\\$ YS67\7O#6FZ5I?A75[;1
MO^$7U/6+>66\T(.Q6#:P"2JK?,BN,D*?2@#SBBD4TM !1110 4444 %%%% !
M1110 4444 %%%% !7WU^RC_R0W0O^NEQ_P"CWKX%K[Z_91_Y(;H7_72X_P#1
M[T >O4444 ?F?^V-_P G$>)?^N=K_P"B%KQ>O:/VQO\ DXCQ+_USM?\ T0M>
M+U^C83_=Z?HOR/JJ/\*/H@HHHKJ-CL/"'@G0_$FEO=:EX\T;PQ<+*T8L]1AN
M'D90 0X,:$8.2.N>#6VWPI\**I/_  M[PN<#H+:\Y_\ (=>:45BX2;NIM?=_
MD9N+WYOR!L!B <@'&?6O>/AMJ6@:5^S3XIG\2:'-XAT[_A([1?L=O?-9MO,3
M;6\Q5)P.>,<YKP>NSL?'T%K\']6\%FSE:YOM6@U);L,/+58T*E".N3FIKP=2
M*2[K\R:D7))>:/3?A+XP^%UW\0-(M-/\!7&@:O=3"#3]6OM6?48;2Y;B*1H&
M50P#8[\>E3?"71[W2=7^,>LZSXBM=&\6Z.IL_P"WKY7=;:>:=DFG&Q2P8[2
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M\O->7/??=V\[<MN7RM8;HOA6W^)_Q!U*+1(UT#0R9K^1[H[TT^U7YF+$=<=
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M5";23[CH5\53HX:O[1SE4YDT[6=H3DK::.\4K];N_2V%JW@?P!X/U)_#VO\
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MZN50X>4L_P J("< G.37;^']"T&U^#'Q/U;PWJ=S>:=<VUG;O:W\2I=6LBW
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MQ( R*[R'YVVD$@8QFG>%5#?L^>/06V@ZOI8+>@WOS75>.-,N?A]XHA\-^#O
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M &$;7_T(U[/\)_\ DEG@W_L#6?\ Z(2O&/\ @H)_R;G>_P#81M?_ $(U[/\
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M:^WXNPYOE5SQG<O8@_C2\5ZYI?QZ_M#4;6VUWP'X,U'29I5BN(+71H[24HQ
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MSHH\0:F-'*[?L(NG\G;Z;<XQ[5 OBS6DUF'5UU:\&JPHL<5Z)CYR*$V!0W4
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MO W_  EWPS^%\W_"1:!HGD:7.GEZQ>F!I,S9R@VG(&.?K4/@GP5_PJ[3-?\
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M0_%#;F75H99I5A=LYDAMW;9&W)QC.*YWP3\4KWPK;ZQI^H:=:^)]#UAEEO\
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M.3\O0^M<R!6\(N,YM];?D:134F^XM%%%;&P4444 %%%%  .2!W)Q7JB?LO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .M^$/\ R5;P=_V%K;_T8M?I
MW7YB?"'_ )*MX/\ ^PM;?^C%K].Z\_%?$C\(\1O][P_^%_F%<I\6O^25^,_^
MP+>_^B'KJZY3XM?\DK\9_P#8%O?_ $0]<1^0GC'_  3\_P"3<['_ +"-U_Z$
M**/^"?G_ ";G8_\ 81NO_0A10!])4444 ?-O_!03_DW.]_["-K_Z$:]G^$__
M "2SP;_V!K/_ -$)7C'_  4$_P"3<[W_ +"-K_Z$:]G^$_\ R2SP;_V!K/\
M]$)0!U=%%% 'YI?%G_DJ7B[_ +"MS_Z,-<I75_%G_DJ7B[_L*W/_ *,-<I2
M**** .DTOXE^+]$L(;'3O%.L6-E"NV*WM[V1(T&<X50<"G:A\4/&6K64UG>^
M*]9O+292DL$][(Z2*>H8$X(KF:*8!7IGC/4+6;X,?#&VCN89+FWN;\S0K("\
M0,D>"PSD9P<9KS.DVCDXY- '?_M"7UOJ7QB\47-I<175O),I2:!PZ,/+7H1P
M:TOBAK%E_P ))\-[F.ZBGAL]"TS[0T+A_+*2LS*<=& [=:\L"[1@# ]J @7H
M,=Z /H:]UZ'P'\;=>UZ;6[6+P_XL2ZMX=5TF\66:U63:R3,J'<FUMO7G@XZ5
M6TMO%^CZDE[XI^+3_P#"+PGS))]-\0M-/>(.B11JVX,W3Y@,9KP$1A<D*!GK
MQ2"-0V0H!]<4"/3O OB'2O$%CXT\,:MJ(TF/Q#(EY8ZAJ#EUCN8W)19GZ_,K
M%2WKS79_!/X>1^#_ !P\^LZQI<FI/I]XEA9:;>)=,_[A]\CLA(1 H(&3DDCB
MO)O _BJP\-S:C;ZMH\>M:/J4'V>Y@W!)HP#E9(I,':X/X'H:Z*U\<>$/!%AJ
M3>#-)U8:S?VSVG]H:U-$PM8G&)/+2,<L1D;CTS0!'87ULO[.^JV9N(1>-XFA
ME%N9!YA3[,1N"]<9XSTK:^%6I-)\.==TCP[K=IX=\:37T<PN+JX6V:YM F#%
M',W"$-DD9&<UX^J!<8'08%*4##!&1[T >]Z#I)L_"/CO1-7\7V.I^+=6T^-H
M[=M2$L$:12ARIG8[3(>3M4]!7+V>G+XN^ MC86.H:?'J&CZK=W=U:7=VD$GD
MO&NUD#$;_ND8'.:\L\M< ;1CTQ2,BM@E0<=,B@#WM?%_B+X@>$_#C^$_'#:#
MJFFV,>GW^BSZJ;!6\OA)XRS!6!7 /.<BL/Q=XTNO"\WA,W7BZ\\8^)=,OQJ-
MX?[0>XLK?:1LA0GAGZY8<<XKR!D5N& (]Z7:!P!@4!J>L>+/AQ:^,?$%]XA\
M->(M#_L'496NV_M"_2VFL2YW-')&WS$J2>5!R*3XU3:'_P (S\/+/0-134[.
MRTV:!IA@,7$QW,4SE0S9(!YP17E!C5N2H)]<4!0,D#GO0!T?P]\93_#_ ,9:
M;KL,0N!;.1+;DX$T3 K(GXJ3^.*ZS4OA/IWB.\EO_!?B;1KG29FWI9ZI>I9W
M5H#SY;K)@';TRI.0*\R44C1ANJ@_44#/3_$-WHWP]^'U]X3TW4K77]>UBXCE
MU2^LOFM[:*(Y2"-R/F8MRQ'':M9=5LA>_ AC>6X6S6'[2?-7$&+W)W\_+QSS
MVKQKIQ2;1SQUZ^] 'LL>J60U#XZ'[9;XO(F%L?-7$_\ I>?DY^;CGCM6!\ [
MZVT[QY-+=7$5M#_95\GF3.$7<8& &3W)KSG8./EZ=*4KNX(R/>@#TC^WDTGX
M*^ 9;6>)M2T[7;J[^S[QO0@QLA9>H!(ZUJ^,O!-K\3?$EYXH\,:[HT5CJC_:
MKJTU.^2UFL)6 ,BLK8++NR05SG->1;.<XY]:1HPQY4$^XH ]I\':EX&\+_%2
MS@TZ[MTM[729+./7KI2]N^ILIQ<[6!Q&"=HX]#6MX-M=5\._$70M>^('CVUN
M+6WO%,4<.KB]:=SD*2JL0D8SDEL8 Z5X#M]J:L:KG"@9Z\4 >N^&H8_#FH?%
MRRO+VR\Z31IEB:&Y1TF+3HP",#AC@]!S7D:]!2>6O  &!T&.E.Q0(])^*5_:
MW?@'X70P7$,\UOI5PDT<;AFB8S @,!T..QI/@'J$-IXNU:SN+B&V@U+1+ZS9
MKB14C9C$2BDDX^\!CWKSC:.<#KUI"FX8(R/>@9['\//%VH:G\+X?">C>+'\)
M^(M-O9+FVW7K6D-_#(!NC,@. ZL,C=Q@U'XPU36='\":G8^*O'=YKVO7S1QV
MNDV>L-=001AMSR3D$HV< *N>O/:O("N1@C(IJH%X  'M0(]BTWPU<[+#6?AG
MXOAT:":W3[;97FM"TN+2X Q(&#$!T)Y!&>#6M??%#1_#_P 9/#>LF]CU&2#3
M/[/U[6-*38L\SJRO-'@#)4%?F &2O%>#M&K=5!^HI<"@#WVWC\:6^J)=7_QB
M4>$EDWMJD.OLTLD(.<+ &\S>1Q@CK6?X'\40:M_PGZ:#KG]B>*=4N8Y-+U+6
MKH">2U5COB^T-]V0C:<\9Z9KQ'RUW9VC/KCFE*AN",B@#Z \%Z3-IJ>+-.\1
M>,K&^\3ZWHL]G:6KZJ)X4Y5R99RVQ6)4 #/8YKA?%%Y;GX&^!;);B&2[M]1U
M+SH4D#.@+K@D#D XX/>O./+7;MVC'IBC8,YQS0!ZAH<EA\1/AKI_A274[/2=
M?T2[FGTYM0D\J"[AEY>+S#PKAAD9P#FJ.L^$-&\"^#]0CUF\L-4\6WLD:65M
MIMV)TL8@<R22.AVEF'RA<GUKS_;NZC(I%4*, 8'L*!GH7Q%O;>Z^'_PRBAN(
MI9;?2IDFC1P6C;[0YPP'0X]:DU*^MF_9[T2S%Q$;Q?$EQ*UN''F!#;@!BO7&
M>,UYR%&2<<GK2[!G..: %6G4BC%+0 4444@"BBB@ K[Z_91_Y(;H7_72X_\
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MZ?I__"=IJ>M^)[ZW2[_X1_3)UMH[*)QE//F()WL.=JCCO3K/P3X)^*^FZF/
M\&I^'O%%A;27HT/4KE;J&]A09<0S8#"0#G:PY[5S?6([V=N_3_/YVL8>T6_3
MN>0;:-M6M*TN]UV\BM--L[C4+N7[EO:Q-([?15!-3:UX?U3PW>?9-7TR\TJ[
MQGR+V!X7QZX8 UT<RO;J:Z;&?MI-M:EGX9UC4%LFM-)OKI;YWCM&AMG<7#K]
M]8\#YBN1D#IFGWGA+7=-UB'2+K1=1MM6F8)#8S6KI/(Q. %0C))/H*7-':XM
M.YD;:7%>G_%OX*ZE\-].\.WZ:7K L[S2+6[U"XO+5ECM;N3.^ MM 4@X&UOF
MKB=!\%^(?%,<LFBZ#J>KQQ?ZQ[&TDF5/J5!Q41JPG'G3T)C*,ES)Z&-2U)=6
MTUE<2V]Q#);SQG;)%*I5D/H0>16K:>"?$=_I#ZK:^']4N-+09:^BLI&A ]2X
M7%:.26K9>BW,6DVUZ-\$_A+=?%;Q!<P-9:F^D06ES))>V$!94G2(O%&S;2H+
M' QU.>*X?6-#U+P[J#V&KZ?=:7?Q@%[6\A:*501D$JP!&14*I%S<$]43S)RY
M4]2E2UW'PI\ V7C2\UJ]UF]GL/#F@V+:CJ4UJ@>=D!VK'&#QN=N,G@5TFDW'
MP=\5:G;Z.VA>(O"GVIQ!#K3:FMV(W8X5I82H&W.,[3Q6<JRBVDF[;VZ?UY$N
M:3:M>QY'16WXT\(WO@?QAJOAR]*37NGW!MV:'E9.A5E]F!!_&F:QX,\0^';.
M&[U70=3TNUF_U<]Y9R1(^?1F !K53BTFGN:7BS%VT;:[_P  ^#=,\1> ?B1J
M]ZDK7NA6%K<63)(557DN-C%@/O?+V-<7<Z7>65K:75S:3V]M>*SVTTD95)U!
MVDH2,, 00<=Z2FI-Q[:?A<FZ;:[%3;1MK0MM!U.\M[:XM].NIX+FX%I!+'"S
M++.>1$I P7P1\HYYKO\ XJ?!/5OA]X7\,:LNDZQ''>Z1'>:I+>6K+%97+.R^
M4QVC9T7Y6YYI2J0C)1;U8.44TF]SS#;2[:ZGXEZ?I&E>*G@T33M2TG3_ +-;
MN+;5D99P[1J78AN=K,25]B,50NO!/B*QT==7N= U2WTIAE;Z6RD6$CUWE<?K
M5*::3VN"::3,7 HJU9Z9>:A#=S6MI/<Q6D?G7$D,9984R!N<C[HR0,GN:O:I
MX-\0:'I\%_J6A:GI]C/@Q7-U9R1QOGIAF&#3YE>URM#(HJYI.C:AK]ZMGI=A
M=:E=L,K;V<+2R'_@*@FEU?1-1\/WS66JZ?=:9>*,M;WD+1.!_NL :=U>W4=U
ML4J***8PHHHH **** "BBB@ HHHH **** /:/V./^3B/#7_7.Z_]$-7Z85^9
M_P"QQ_R<1X:_ZYW7_HAJ_3"OC<Y_WA>GZL\''_Q5Z!7C_P"UI_R0?Q#_ +]M
M_P"E$=>P5X_^UI_R0?Q#_OVW_I1'7BT_C7J=61?\C7"_]?(?^E(_/>BBBO9/
MZY"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJLV#MN(Q@=-K!@HXX]JHZ#%#X;^#.O:Q+&C7NOW::39,Z@E88_WD[K^.Q<T
M>>\L0 "S$X  Y/M7I5Y\,_#7A)HK+QAXNFTW6VC2233M-T\W1M0P!597+*-V
M""0,XKSB"1X;B*2+_6QNKIQGY@<CCZBO6/$6M?#_ .*VK2ZUJNIZGX-\0W2J
M;L&U^UV3RA0I<;3O4''3% ')>./AX_A.RT[5K'4[?7O#VI;A::E;*5RR_>CD
M0\HX]#7'M(JXW,!]37H7C/P7KGAGP7:O9>(+7Q+X*EO-\5QITI,,=T5(_>1D
M;D<C/6O3M<\)>//AS]BT+P/X+:>WAMHWOM8?38KI[^=E#.-T@.(U)V@#'0T
M?.!8 9)P/6D,BCJRCC/6OH"\\$#2OBM\*=8NM 7P]/KMVGV_1FC"QQ7$<H5R
MJ'.$<$,%Z"N5\9_%,:#XHN=+\.Z5I]EHFFZKYXW6RM<7<D<I)>20C.&.1M&
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M<LT@*:!902116YSL>*2,;U<#!RQ^M?.TGE^:_EEC%N.S=UVYXS[XH ;12T4
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MS4+*UE\,VFI:5J-Y)I-I.ZP+*+1OG"\#)8%AQQGBO!;W4KO5;@W-]=W%]<L
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MQ.T# 4 9-4/&_C/PQXX^&?AFTF_M:S\6^'],7288XXXVL;B,2%@[.3O5L,>
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M<K^HKP"OT7!M/#TVNR/J:#O2CZ!11176;A1110 4444 %%%% !1110 4444
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M" 1R#17M']>A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** .M^$/_ "5;P=_V%K;_ -&+7Z=U^;/[
M/VAS>(/C-X3MX4+>3>+=2$?PI'\Y)_(#\:_2:O.Q7Q(_!?$:<7C:$$]5'\W_
M , *Y3XM?\DK\9_]@6]_]$/75URGQ:_Y)7XS_P"P+>_^B'KC/R0\8_X)^?\
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M $%=7_[^)_\ $T?\,3^#_P#H*ZO_ -_$_P#B: /BVBOM+_AB?P?_ -!75_\
MOXG_ ,31_P ,3^#_ /H*ZO\ ]_$_^)H ^+:*^TO^&)_!_P#T%=7_ ._B?_$T
M?\,3^#_^@KJ__?Q/_B: /BVBOM+_ (8G\'_]!75_^_B?_$T?\,3^#_\ H*ZO
M_P!_$_\ B: /BVBOM+_AB?P?_P!!75_^_B?_ !-'_#$_@_\ Z"NK_P#?Q/\
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M_P!!75_^_B?_ !-(#XMHK[2_X8G\'_\ 05U?_OXG_P 31_PQ/X/_ .@KJ_\
MW\3_ .)I@?%E%?:?_#$_@_\ Z"NK_P#?Q/\ XFC_ (8G\'_]!75_^_B?_$T
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M?^'?_@;_ *#.M_\ ?V/_ .)H_P"'?_@;_H,ZW_W]C_\ B:/[6PO=_<'UVB?
MU%??/_#O_P #?]!G6_\ O['_ /$T?\.__ W_ $&=;_[^Q_\ Q-']K87N_N#Z
M[1/@:BOOG_AW_P"!O^@SK?\ W]C_ /B:/^'?_@;_ *#.M_\ ?V/_ .)H_M;"
M]W]P?7:)\#45]\_\._\ P-_T&=;_ ._L?_Q-'_#O_P #?]!G6_\ O['_ /$T
M?VMA>[^X/KM$^!J*^^?^'?\ X&_Z#.M_]_8__B:/^'?_ (&_Z#.M_P#?V/\
M^)H_M;"]W]P?7:)\#45]\_\ #O\ \#?]!G6_^_L?_P 31_P[_P# W_09UO\
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M#.M_]_8__B:/^'?_ (&_Z#.M_P#?V/\ ^)H_M;"]W]P?7:)\#45]\_\ #O\
M\#?]!G6_^_L?_P 31_P[_P# W_09UO\ [^Q__$T?VMA>[^X/KM$^!J*^^?\
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M /$T?\.__ W_ $&=;_[^Q_\ Q-']K87N_N#Z[1/@:BOOG_AW_P"!O^@SK?\
MW]C_ /B:/^'?_@;_ *#.M_\ ?V/_ .)H_M;"]W]P?7:)\#45]\_\._\ P-_T
M&=;_ ._L?_Q-'_#O_P #?]!G6_\ O['_ /$T?VMA>[^X/KM$^!J*^^?^'?\
MX&_Z#.M_]_8__B:/^'?_ (&_Z#.M_P#?V/\ ^)H_M;"]W]P?7:)\#5;TC1[[
MQ!JEMINF6<VH:A<N(X;:W0L[L>P _G7WG:_L!^ (Y@T^IZY<1]T^T(F?Q"5[
M'\._@OX.^%<)7PWHD%E.R[9+MLR3R#WD;)Q[# ]JPJYQ1C']VFV1/'4TO=5V
M<A^S!\"1\%?!3B_\N7Q'J96:_D3D1X'RPJ>X7)R>Y)KV:DI:^3JU)5INI/=G
MB3FZDG*6["F31)<0O%(BR1NI5D89# \$&GT5D0?GK^T)\";_ .%'B"XO;."2
M?PK=R%[:Y49%N2<^5)Z8['H1[UY#7ZPWEC;ZE:RVMW!'<VTJ[9(9D#(X]"#P
M:\8\2_L??#SQ!=/<6]I=Z-(QR4T^<K'G_=8$#\,5WT\0K6F?MV2\?4HT8T<S
MB^9:<RUOZKOZ7OY'P+17VW_PP[X-_P"@MK'_ '\3_P")H_X8=\&_]!;6/^_B
M?_$UM]8IGT_^O62_SR_\!9\245]M_P###O@W_H+:Q_W\3_XFC_AAWP;_ -!;
M6/\ OXG_ ,31]8IA_KUDO\\O_ 6?$E%?;?\ PP[X-_Z"VL?]_$_^)H_X8=\&
M_P#06UC_ +^)_P#$T?6*8?Z]9+_/+_P%GQ)17VW_ ,,.^#?^@MK'_?Q/_B:/
M^&'?!O\ T%M8_P"_B?\ Q-'UBF'^O62_SR_\!9\245]M_P###O@W_H+:Q_W\
M3_XFC_AAWP;_ -!;6/\ OXG_ ,31]8IA_KUDO\\O_ 6?$E%?;?\ PP[X-_Z"
MVL?]_$_^)H_X8=\&_P#06UC_ +^)_P#$T?6*8?Z]9+_/+_P%GQ)17VW_ ,,.
M^#?^@MK'_?Q/_B:/^&'?!O\ T%M8_P"_B?\ Q-'UBF'^O62_SR_\!9\245]M
M_P###O@W_H+:Q_W\3_XFC_AAWP;_ -!;6/\ OXG_ ,31]8IA_KUDO\\O_ 6?
M$E%?;?\ PP[X-_Z"VL?]_$_^)H_X8=\&_P#06UC_ +^)_P#$T?6*8?Z]9+_/
M+_P%GQ)17VW_ ,,.^#?^@MK'_?Q/_B:/^&'?!O\ T%M8_P"_B?\ Q-'UBF'^
MO62_SR_\!9\245]M_P###O@W_H+:Q_W\3_XFC_AAWP;_ -!;6/\ OXG_ ,31
M]8IA_KUDO\\O_ 6?$E%?;?\ PP[X-_Z"VL?]_$_^)H_X8=\&_P#06UC_ +^)
M_P#$T?6*8?Z]9+_/+_P%GQ)17VW_ ,,.^#?^@MK'_?Q/_B:/^&'?!O\ T%M8
M_P"_B?\ Q-'UBF'^O62_SR_\!9\245]M_P###O@W_H+:Q_W\3_XFC_AAWP;_
M -!;6/\ OXG_ ,31]8IA_KUDO\\O_ 6?$E%?;?\ PP[X-_Z"VL?]_$_^)H_X
M8=\&_P#06UC_ +^)_P#$T?6*8?Z]9+_/+_P%GQ)17VW_ ,,.^#?^@MK'_?Q/
M_B:/^&'?!O\ T%M8_P"_B?\ Q-'UBF'^O62_SR_\!9\245]M_P###O@W_H+:
MQ_W\3_XFC_AAWP;_ -!;6/\ OXG_ ,31]8IA_KUDO\\O_ 6?$E%?;?\ PP[X
M-_Z"VL?]_$_^)H_X8=\&_P#06UC_ +^)_P#$T?6*8?Z]9+_/+_P%GQ)17VW_
M ,,.^#?^@MK'_?Q/_B:/^&'?!O\ T%M8_P"_B?\ Q-'UBF'^O62_SR_\!9\2
M45]M_P###O@W_H+:Q_W\3_XFC_AAWP;_ -!;6/\ OXG_ ,31]8IA_KUDO\\O
M_ 6?$E%?;?\ PP[X-_Z"VL?]_$_^)H_X8=\&_P#06UC_ +^)_P#$T?6*8?Z]
M9+_/+_P%GQ)17VW_ ,,.^#?^@MK'_?Q/_B:/^&'?!O\ T%M8_P"_B?\ Q-'U
MBF'^O62_SR_\!9\245]M_P###O@W_H+:Q_W\3_XFC_AAWP;_ -!;6/\ OXG_
M ,31]8IA_KUDO\\O_ 6?$E%?;?\ PP[X-_Z"VL?]_$_^)H_X8=\&_P#06UC_
M +^)_P#$T?6*8?Z]9+_/+_P%GQ)17VW_ ,,.^#?^@MK'_?Q/_B:/^&'?!O\
MT%M8_P"_B?\ Q-'UBF'^O62_SR_\!9\24Z&*2XF2&*-I99&"I'&I9F8]  .I
MK[<B_8?\%+("^J:PZ]U\Y!G\=M>E?#_X$^"OAK(MQHVCI]N Q]NNF,T_X,WW
M?P J7B8+8X\5Q_E=*FWAXRG+HK67S;_R9Y]^RO\  >X^'.F3>(=>@$7B#4(P
MB6[<FTAZ[3_ML<$^F /6OH&BBO/E)S=V?A.99C7S7%3Q>(?O2^Y+HEY(*Y/X
MN,%^%/C,DX T6]_]$/765XK^V)XXB\#_ +/_ (GE:39<ZC$--MU[L\IP?R3>
M?PJ#S#F/^"?JE?V<[ D8!U"Z(_[[%%=G^R;X-E\#_L_^$;"XC,5S-;&]E0]F
MF8R?R844 >O4444 ,DC2:-XY%#HX*LK#((/4&OB+POJDO[%?[06HZ#JQ>/X:
M^+)//L[L@E+5\_*2?]C.QO\ 9VMVK[@KC?BO\)] ^,GA"Y\/>(;;S;>3YX;B
M/B6VD XD0]B/R(R#0!UT$\=U#'-#(LT,BATDC8,K*1D$$=014E?#^F^(/BW^
MQ;-_9NKZ=+X]^&J/BWO+?)>U0GH#R8_]ULKZ$5[=X)_;0^$_C2UC8^)$T.Y8
M?-;:NA@*G_?^X?\ OJ@#W*BN&7XZ?#IU#+XY\/$'H?[2A_\ BJ7_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
MXJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?
M#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^
MAX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^
M#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^
M*H [BBN'_P"%Y?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BB
MN'_X7E\._P#H>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%
MY?#O_H>/#_\ X,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H
M>/#_ /X,H?\ XJC_ (7E\._^AX\/_P#@RA_^*H [BBN'_P"%Y?#O_H>/#_\
MX,H?_BJ/^%Y?#O\ Z'CP_P#^#*'_ .*H [BBN'_X7E\._P#H>/#_ /X,H?\
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M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
M'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z
M U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT
M?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_
M .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44
M ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_
M * U[_X'R?XT?\,&_"#_ * U[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'
M_#!OP@_Z U[_ .!\G^-?0U% 'SS_ ,,&_"#_ * U[_X'R?XT?\,&_"#_ * U
M[_X'R?XU]#44 ?//_#!OP@_Z U[_ .!\G^-'_#!OP@_Z U[_ .!\G^-?0U%
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M,GT:XD#%U'62%^-Z^O (SR.]9SHR@KL\[%Y/BL''GDKQ[H]]HHHK \0****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]MGL>4Z!_P $U9+/P=;:MX_^(UAX,U"Y5=EFT*-'$[#(C>1Y%!;UV^_6N/\
M'/\ P3T\9> ?AWXH\8:CXFT9['1(9KI8((Y':[A0;E=&' WCL>AKK/\ @JE>
M:E-\6/"-E<,YT:/1FFMXV_U9F,SB4@>NT1CZ&O4OASJ6J:I_P3!\0OJC2R>3
MHNHP6LDQ)9K=7<)R>PY4>RBES3LI7W(6*QL:%+$NHFIR2M9:)OH>5?LZ>%/C
M#J7[)WB/4/"GCG1=&\$1QZH;K1[O2Q-<2!8V\\"7'&\9QZ9KY_\ V=_V</%/
M[1WB"73O#JQ6>GV:(]]JEWGR;96^Z..6<X.%'H3P*^V_V-_^3 ?&G_7+7/\
MT4U-_8E9O!W["'BOQ'HJK_;ACU6\W1C+^=%$5B!^@12/K3<W'FMW%+'5,/\
M6'32YN=16G>^K[_,\\O/^"9ECJ$-Y9>&OBUI^J^);-<SZ=-;(%C;T;9(SKSQ
MDK7QKXZ\#ZU\-?%VI^&?$-FUCK&G2^5/"3N'3(93_$I!!![@UJ?"/Q]XO\!_
M$2P\1>#I)Y_%;&01[8C</<F12'#)UDSDGG/(SVK0^.7C?QO\0_'1UOX@V+V/
MB&2UCB*R6)M&:)2VQMA SU(S[>U;14T[-W/<P\,52J\E:HIQ:[6=_1=#OOV#
M]&TC7/VHO"<.M1Q2P1)<7-O'-C:URD9,?!ZD')'N!7U=^W!K_P"T1H'C6VN_
M ']K0>"(+5)!-H$*RR>=D^9YXP7QTQQMQ[YKX-^#/PY\=_$;Q<$^'EK-<>(=
M)1=122VN4@D@"N%$BLQ'(8CIZU]9:7_P4/\ B9\'=?N/"7Q0\(6>L:IIK+%=
M26LPM[G[H()QNC8D$'(P*SJ1?/=:^1YF.H5)XM5J*C-I6<6_Q$7]NGPSXX_9
M\U3P'\7-,U6\\6W-I/:RS0:<JH[C)@F(+#:X;;D@=5S7S!^S[^SQXK_:*\3O
MH^@+#;06L:R7^J76?(M5/ SCEF)!PHY."> *_2"WC^%W[?\ \(-4O+;1_L^J
M0E[=;BX@6.]T^ZV J1(OWEY'<AAU%<!^PA:GP?\ LB^/M8T[;_;\5UJC.\8R
MQEMX=L0_\=R/K6:FHQ?*K,XJ>,CA:%7V$'"IS)-/5)OJO+_@'G-U_P $S+"]
MCN].T'XMZ?J/BFU3,VFRVR!4;N&V2%U&>,E:\V_9)\ ZY\,/VX/#'AGQ'8MI
M^L:?)>)+$3E6!LYBKJW\2L,$'N#7F7[+WB35M+_:0\ :G:3S'4;S6X(KF3<2
MTR32!9@YZME68G/IFOT(^+VEV=M_P4 ^"-_"JK?7>E:E'<;1R5CAD\LG_OMQ
M^%7)RC>+=[HZ,35Q&'<\-6GSJ4).]DK-)]NA\Z_MQ^!;GXG?MM>'_"5G=0V-
MWK.FV-I%<SJ6CC8M.<L!R1QVKP?]H[]G;5OV;/%>E:#J^L6>M3ZA9&^2:RB>
M-47S"FTAN<Y4FOJOX^?\I,_AG_N:?_.YKC?^"J/_ "6;P?\ ]@ _^E,E%.3O
M&/D7@<14C/#4$_=<+_,\MN_V.=?L_P!G.#XPMXCTUM(FLX+P:;Y$@G"RRK$%
M+9VY!<$_2OO[]EOX$W7PK_9UUSPC/XBTS6)M4EO+A;^QSY$0F@10K9/5<9/L
M:\L\2*?^'5-L",?\4_9=?^ON*G?L"QJO[%OC<*H ^VZKP!_TZQUG.3E%W?4\
MW&UZ^*PLY3EI&I;;[ON_$\@^!'[//Q)^$G[0.I>$O /Q%\.P:]_PC0O9]6%E
M]JMGMS<(IA"MG#[@K9]/K7@/QV\.>+;K]H;Q/H>M74?B;QG-J4=M-/IMOY27
MEPT<841Q]N"HQZ@FO<O^"4Z+'\;-?"J%_P"*98\#_IX@KL/A]I5GJO\ P5+\
M3?;55OLMQ=74"M_SV6TB"D>X#,?PK7F<9N_1'JO$3P^+K<]I.,+WLDWL9&A?
M\$U1IVAV-S\0?B9IOA'4KW BL8XHW <C[F^210S#/.T8KQ;]I3]DCQ7^S:UK
M>W]Q#KOAN\?RX-7M$*A9,9$<BG[K$ D')!P<=*ZS_@H_K5_JW[3FJ6%Z[O8Z
M;I]I%91OG:JO$)'*CW=FR?8>E?1]]<2^./\ @EO)>>(7:XN[?0GDBFN#ERT%
MPRP')YR0B#/O2YIQ49-[F<<5BZ,:&(JSYHU&DU9*U]K/?0\&T/\ X)Q^-O$7
M@KPUXFL?%&B-::S;VUXT<L<D9LX)8Q(7=B<'8#R!U/2NK\4_\$R[F/P/<ZUX
M-^(-KXKO[>)I/LGV9$BG91EDCE1V^;J!GVSBO6OVE-8O-)_X)S>'!:3M!]KT
M?1+2;8<%HG6$,OT(KF_^"3]Y._AGXCV+2L;."]LY(H,_(C/'*'(';.Q<_05'
M//E<[[')+&XUX:>+516A*UK+75=?F?&7P'^ WB/]H+QU_P (SH/E6<D,9GO;
MR[SY=I$&"DL!R6R<!>Y],5]++_P3J\+:EJEUX;TCXVZ5>^-;529='-O$6C8#
MD,BREP!QGC(KSW]F7]HW2/V;/C[XWNM<LY9M U>[N;.>2U4-+;;+J1D=5_B7
MD@@<]#VQ7TQ9_"/X&?M ?$*X\;?"SXDW/A?X@W,CWQETJY"RB5P=\AMY0&R<
MG.,#DU=24D^R.W'8K%4JK=W"G;1J-U?^]V/SS^)GPWUSX1^.-4\*>(K=;?5=
M/<!_+;<DBD921#W5@017,5[+^UEX'\<^ /B]<:=X^UV3Q1JC6T<EKK$G6YML
MD(<'H00P(['N:\:KHB[I,^AP]3VM*,[IW6ZV"BBBJ-PHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^H/^">'CBU\-_'6
M;P_?6\T]GXJTZ32RT*%C&^0RLV!PIPRD]!N&:^7F8(I8] ,U]W0ZQ9_L&_L[
MZ%=Z;96US\7O'$'VAKJY0/\ 88" V,'^% RC;T9R2<@8K*IMR]SRLRDI4?8)
M7E/1+]?1;GB>J?LWS?##]K3PQ\/O$K1W.CW^L6\EO<9&VZLWE^7([$[2A'KG
M%?L/'&D,:1QHJ1H JJHP !T %?BA\,_#?Q)_:9^,UH^G:I=:GXK\U+V;6[Z0
ME;)8V!$K'^%5.-JJ.3@ 5^T^E17<.EV<>H3QW5^D*+<31)L220*-S*N3@$Y.
M,\5R8B^B;U/D<_YDZ,:DTY):V_/YDMY:0W]K-:W,23V\R-')%(,JZD8*D=P0
M:_(GX*_LTM\4OVIM=\+Z7-'#X8\,ZQ-/>7!89^RQ7!"1H.Y8@+[#)K]:?$MK
MJ5]X?U*WT>[BT_5I;>1+2ZGC,B0RE2%<KD9 .#C/:OQ6\7:/\1_V7_B]=PW&
MHWFA>*[:0SKJ5G*=EY&[$^8IZ.C'.58=<@C(HH7M))ZCR%3E&M"G-*36G^9V
M?[=WC\>/OVD->\NUN+.VT>*/2HDNHFC=_+R6?:0#M+,<'N #7S[7W+XTO;']
MMO\ 9BU;QO)86]G\5/ B9OWM4"B\M@I8G']UD#,!_"R,!P:^&@=P!'2NNF]+
M=CZ_+YKV*HVM*'NM?K\]PHHHK4],_63_ ()K_P#)L5G_ -A:]_\ 0Q11_P $
MU_\ DV.S_P"PM>_^ABBO(J?&S\AS+_?*O^)GU/11169YI\K_ /!2C_DV.\_[
M"UE_Z&:_)ROV._;H\$W7CK]F7Q;;64;375BD>II&@R6$+AV _P" !J_'!6#
M$<@UZ.'^ _2.'9)X1Q6ZD_R0M%%%=1]0%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUBPG:7W+_,_(;-&:_7G_ (=Y_ __ *%FY_\ !C/_ /%4?\.\_@?_ -"S<_\
M@QG_ /BJ/K$ _P!8L)VE]R_S/R&S1FOUY_X=Y_ __H6;G_P8S_\ Q5'_  [S
M^!__ $+-S_X,9_\ XJCZQ /]8L)VE]R_S/R&S1FOUY_X=Y_ _P#Z%FY_\&,_
M_P 51_P[S^!__0LW/_@QG_\ BJ/K$ _UBPG:7W+_ #/R&S1FOUY_X=Y_ _\
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M -"S<_\ @QG_ /BJ/K$ _P!8L)VE]R_S/R&S1FOUY_X=Y_ __H6;G_P8S_\
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M/X'_ /0LW/\ X,9__BJ/K$ _UBPG:7W+_,_(;-&:_7G_ (=Y_ __ *%FY_\
M!C/_ /%4?\.\_@?_ -"S<_\ @QG_ /BJ/K$ _P!8L)VE]R_S/R&S1FOUY_X=
MY_ __H6;G_P8S_\ Q5'_  [S^!__ $+-S_X,9_\ XJCZQ /]8L)VE]R_S/R&
MS1FOUY_X=Y_ _P#Z%FY_\&,__P 51_P[S^!__0LW/_@QG_\ BJ/K$ _UBPG:
M7W+_ #/R&S1FOUY_X=Y_ _\ Z%FY_P#!C/\ _%4?\.\_@?\ ]"S<_P#@QG_^
M*H^L0#_6+"=I?<O\S\ALT9K]>?\ AWG\#_\ H6;G_P &,_\ \51_P[S^!_\
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M_P!"S<_^#&?_ .*H^L0#_6+"=I?<O\S\ALT9K]>?^'>?P/\ ^A9N?_!C/_\
M%4?\.\_@?_T+-S_X,9__ (JCZQ /]8L)VE]R_P S\ALT9K]>?^'>?P/_ .A9
MN?\ P8S_ /Q5'_#O/X'_ /0LW/\ X,9__BJ/K$ _UBPG:7W+_,_(;-&:_7G_
M (=Y_ __ *%FY_\ !C/_ /%4?\.\_@?_ -"S<_\ @QG_ /BJ/K$ _P!8L)VE
M]R_S/R&S1FOUY_X=Y_ __H6;G_P8S_\ Q5'_  [S^!__ $+-S_X,9_\ XJCZ
MQ /]8L)VE]R_S/R&S1FOUY_X=Y_ _P#Z%FY_\&,__P 51_P[S^!__0LW/_@Q
MG_\ BJ/K$ _UBPG:7W+_ #/R&S1FOUY_X=Y_ _\ Z%FY_P#!C/\ _%4?\.\_
M@?\ ]"S<_P#@QG_^*H^L0#_6+"=I?<O\S\ALT9K]>?\ AWG\#_\ H6;G_P &
M,_\ \51_P[S^!_\ T+-S_P"#&?\ ^*H^L0#_ %BPG:7W+_,_(;-&:_7G_AWG
M\#_^A9N?_!C/_P#%4?\ #O/X'_\ 0LW/_@QG_P#BJ/K$ _UBPG:7W+_,_(;-
M&:_7G_AWG\#_ /H6;G_P8S__ !5'_#O/X'_]"S<_^#&?_P"*H^L0#_6+"=I?
M<O\ ,_(;-&:_7G_AWG\#_P#H6;G_ ,&,_P#\51_P[S^!_P#T+-S_ .#&?_XJ
MCZQ /]8L)VE]R_S/R&S1FOUY_P"'>?P/_P"A9N?_  8S_P#Q5'_#O/X'_P#0
MLW/_ (,9_P#XJCZQ /\ 6+"=I?<O\S\ALT9K]>?^'>?P/_Z%FY_\&,__ ,51
M_P .\_@?_P!"S<_^#&?_ .*H^L0#_6+"=I?<O\S\ALT9K]>?^'>?P/\ ^A9N
M?_!C/_\ %4?\.\_@?_T+-S_X,9__ (JCZQ /]8L)VE]R_P S\ALT9K]>?^'>
M?P/_ .A9N?\ P8S_ /Q5'_#O/X'_ /0LW/\ X,9__BJ/K$ _UBPG:7W+_,_(
M;-&:_7G_ (=Y_ __ *%FY_\ !C/_ /%4?\.\_@?_ -"S<_\ @QG_ /BJ/K$
M_P!8L)VE]R_S/R&S1FOUY_X=Y_ __H6;G_P8S_\ Q5'_  [S^!__ $+-S_X,
M9_\ XJCZQ /]8L)VE]R_S/R&S1FOUY_X=Y_ _P#Z%FY_\&,__P 51_P[S^!_
M_0LW/_@QG_\ BJ/K$ _UBPG:7W+_ #/R&S1FOUY_X=Y_ _\ Z%FY_P#!C/\
M_%4?\.\_@?\ ]"S<_P#@QG_^*H^L0#_6+"=I?<O\S\ALT9K]>?\ AWG\#_\
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M_P#!C/\ _%4?\.\_@?\ ]"S<_P#@QG_^*H^L0#_6+"=I?<O\S\ALT9K]>?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTQ\3_P#H<;[\D_\ B:/^&F/B?_T.-]^2?_$UYE11[&E_*ON#^ULP_P"@B?\
MX%+_ #/3?^&F/B?_ -#C??DG_P 31_PTQ\3_ /H<;[\D_P#B:\RHH]C2_E7W
M!_:V8?\ 01/_ ,"E_F>F_P##3'Q/_P"AQOOR3_XFC_AICXG_ /0XWWY)_P#$
MUYE11[&E_*ON#^ULP_Z")_\ @4O\STW_ (:8^)__ $.-]^2?_$T?\-,?$_\
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M-,?$_P#Z'&^_)/\ XFO,J*/8TOY5]P?VMF'_ $$3_P# I?YGIO\ PTQ\3_\
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M/_Z'&^_)/_B:\RHH]C2_E7W!_:V8?]!$_P#P*7^9Z;_PTQ\3_P#H<;[\D_\
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M_P 37F5%'L:7\J^X/[6S#_H(G_X%+_,]-_X:8^)__0XWWY)_\31_PTQ\3_\
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M@_M;,/\ H(G_ .!2_P STW_AICXG_P#0XWWY)_\ $T?\-,?$_P#Z'&^_)/\
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MH_X:8^)__0XWWY)_\37F5%'L:7\J^X/[6S#_ *")_P#@4O\ ,]-_X:8^)_\
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MQOOR3_XFO,J*/8TOY5]P?VMF'_01/_P*7^9Z;_PTQ\3_ /H<;[\D_P#B:/\
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M?_$T?\-,?$__ *'&^_)/_B:\RHH]C2_E7W!_:V8?]!$__ I?YGIO_#3'Q/\
M^AQOOR3_ .)H_P"&F/B?_P!#C??DG_Q->944>QI?RK[@_M;,/^@B?_@4O\ST
MW_AICXG_ /0XWWY)_P#$T?\ #3'Q/_Z'&^_)/_B:\RHH]C2_E7W!_:V8?]!$
M_P#P*7^9Z;_PTQ\3_P#H<;[\D_\ B:/^&F/B?_T.-]^2?_$UYE11[&E_*ON#
M^ULP_P"@B?\ X%+_ #/3?^&F/B?_ -#C??DG_P 31_PTQ\3_ /H<;[\D_P#B
M:\RHH]C2_E7W!_:V8?\ 01/_ ,"E_F>F_P##3'Q/_P"AQOOR3_XFC_AICXG_
M /0XWWY)_P#$UYE11[&E_*ON#^ULP_Z")_\ @4O\STW_ (:8^)__ $.-]^2?
M_$T?\-,?$_\ Z'&^_)/_ (FO,J*/8TOY5]P?VMF'_01/_P "E_F>F_\ #3'Q
M/_Z'&^_)/_B:/^&F/B?_ -#C??DG_P 37F5%'L:7\J^X/[6S#_H(G_X%+_,]
M-_X:8^)__0XWWY)_\31_PTQ\3_\ H<;[\D_^)KS*BCV-+^5?<']K9A_T$3_\
M"E_F>F_\-,?$_P#Z'&^_)/\ XFC_ (:8^)__ $.-]^2?_$UYE11[&E_*ON#^
MULP_Z")_^!2_S/3?^&F/B?\ ]#C??DG_ ,31_P -,?$__H<;[\D_^)KS*BCV
M-+^5?<']K9A_T$3_ / I?YGIO_#3'Q/_ .AQOOR3_P")H_X:8^)__0XWWY)_
M\37F5%'L:7\J^X/[6S#_ *")_P#@4O\ ,]-_X:8^)_\ T.-]^2?_ !-'_#3'
MQ/\ ^AQOOR3_ .)KS*BCV-+^5?<']K9A_P!!$_\ P*7^9Z;_ ,-,?$__ *'&
M^_)/_B:/^&F/B?\ ]#C??DG_ ,37F5%'L:7\J^X/[6S#_H(G_P"!2_S/3?\
MAICXG_\ 0XWWY)_\31_PTQ\3_P#H<;[\D_\ B:\RHH]C2_E7W!_:V8?]!$__
M  *7^9Z;_P -,?$__H<;[\D_^)H_X:8^)_\ T.-]^2?_ !->944>QI?RK[@_
MM;,/^@B?_@4O\STW_AICXG_]#C??DG_Q-'_#3'Q/_P"AQOOR3_XFO,J*/8TO
MY5]P?VMF'_01/_P*7^9Z;_PTQ\3_ /H<;[\D_P#B:/\ AICXG_\ 0XWWY)_\
M37F5%'L:7\J^X/[6S#_H(G_X%+_,]-_X:8^)_P#T.-]^2?\ Q-'_  TQ\3_^
MAQOOR3_XFO,J*/8TOY5]P?VMF'_01/\ \"E_F>F_\-,?$_\ Z'&^_)/_ (FC
M_AICXG_]#C??DG_Q->944>QI?RK[@_M;,/\ H(G_ .!2_P STW_AICXG_P#0
MXWWY)_\ $T?\-,?$_P#Z'&^_)/\ XFO,J*/8TOY5]P?VMF'_ $$3_P# I?YG
MIO\ PTQ\3_\ H<;[\D_^)H_X:8^)_P#T.-]^2?\ Q->944>QI?RK[@_M;,/^
M@B?_ (%+_,]-_P"&F/B?_P!#C??DG_Q-'_#3'Q/_ .AQOOR3_P")KS*BCV-+
M^5?<']K9A_T$3_\  I?YGIO_  TQ\3_^AQOOR3_XFC_AICXG_P#0XWWY)_\
M$UYE11[&E_*ON#^ULP_Z")_^!2_S/3?^&F/B?_T.-]^2?_$T?\-,?$__ *'&
M^_)/_B:\RHH]C2_E7W!_:V8?]!$__ I?YGIO_#3'Q/\ ^AQOOR3_ .)H_P"&
MF/B?_P!#C??DG_Q->944>QI?RK[@_M;,/^@B?_@4O\STW_AICXG_ /0XWWY)
M_P#$T?\ #3'Q/_Z'&^_)/_B:\RHH]C2_E7W!_:V8?]!$_P#P*7^9Z;_PTQ\3
M_P#H<;[\D_\ B:/^&F/B?_T.-]^2?_$UYE11[&E_*ON#^ULP_P"@B?\ X%+_
M #/3?^&F/B?_ -#C??DG_P 31_PTQ\3_ /H<;[\D_P#B:\RHH]C2_E7W!_:V
M8?\ 01/_ ,"E_F>F_P##3'Q/_P"AQOOR3_XFC_AICXG_ /0XWWY)_P#$UYE1
M2]C2_E7W!_:V8?\ 01/_ ,"E_F>F_P##3'Q/_P"AQOOR3_XFC_AICXG_ /0X
MWWY)_P#$UEZ%\#?B!XET]+_3?"6IW-HXRDIBV!AZC<03^%<KKGA_4_#&HO8:
MOI]SIEZGWH+J(QOCUP>H]ZA0H2=DE?Y'74Q><48*I4J55%[-N23^9WW_  TQ
M\3_^AQOOR3_XFC_AICXG_P#0XWWY)_\ $UYE16GL:7\J^XY/[6S#_H(G_P"!
M2_S/3?\ AICXG_\ 0XWWY)_\31_PTQ\3_P#H<;[\D_\ B:\RHI>QI?RK[@_M
M;,/^@B?_ (%+_,]I\-_M@?$S0+I7GUB+6;<'YK>_MT((_P!Y0&'YU]<? O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYYKS.IA.-17B[FN)PM?!S5/$0<6U>S[,****T.0**** "BBB@ HHHH ****
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M6;,=2U!A)/ H,IV)GC&4_P#'C74_%#_D^;P;_N6O\I:ZCXL_\GE?"W_KQ?\
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M27Q7?,GR\UUKHO+O]QXI\ ?@!J'QKU>Z+W#:7H-@0+N]V@MN/(C0'C=CDD\
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MS?"T\'CJE&C\.C7I)*27R3L%%%%;GCGZ$_L3_P#)#+;_ *_[G_T(44?L3_\
M)#+;_K_N?_0A17QN)_C3]3^L.'_^13AO\$?R/>J***YCZ \$_;9_Y(9<_P#8
M0MO_ $(U^>]?H1^VS_R0RY_["%M_Z$:_/>OILM_@_,_G?C[_ )&R_P "_-A1
M117JGYN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:">K'!R?4^E>:T5-/#4Z;ON_,Z<9Q!C<;35*7+&-^9J,4DY=WW9]>^*/VQ/
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M>PQ8JN3U*BOD"BKJ86G4DY/KOYG)@N(L=@:,:$.62CK'FBFXM]8M['N?@?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9-Z]&P2,CZTT5ZJ=S\T:L[!1115""BBB@ HHHH **** "BBB@ HHHH ****
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M*U-K&TJ><78L!M!Y*E,>N*\Y^/'A?XA>%]#\*Q>._$,&IK-&S6-@)B\UJH5
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M10 4444 %%%% !1110 4444 ?H3^Q/\ \D,MO^O^Y_\ 0A11^Q/_ ,D,MO\
MK_N?_0A17QN)_C3]3^L.'_\ D4X;_!'\CWJBBBN8^@/!/VV?^2&7/_80MO\
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M2^&=GX#FEMCX=M6#Q1K !*"'+C+YYY8T:E\8O$FJ_#6R\"7$ML?#UHRO%&L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?AGX=_%35)O#OA_3=>T+66MIYK*^O+V.YBE:*-I-LJ!%V!E4\@G!Q5'1L_\
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M?7US>B%=D7VF9I-B^B[B<#V%*-&459/I8=;-J-:<JDJ=[SC.S=UHM4]-4_\
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M &3V X%53HN#6NU_Q,L=FD,7":46G+V>[O\ !%QWMK>Z?K<^B]-T'1?$FI?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K5\,>)+GPGK4.IVD%G<SQ!E$=_;)<1$,"#E&!!Z\>E95%)I-6
M9<)RIR4X.S1Z9_PT%XA_Z OA/_PGK;_XFN.\7>+KSQIJB7][;:?:RK$(A'IM
MFEK'@$G.Q !GGK]*Q*3GUK*-.,7>*.RMC\5B(<E6HY+S/7_V;5+:A\0,#/\
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M_%;XE7/A7]GGX5W/ACQ$EIK5K%:K(ME<HTB#[*05= 3QG&0PZU\B;:38%)(
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M"!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8<H1%;!'&1PVT]1SR:\?\26%K#^SWX%O4MH4O)M6U%);A8P))%7R]H9NI [
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MMKMI]PZBBBNH^?"BBBF 4444 %%%% 'Z$_L3_P#)#+;_ *_[G_T(44?L3_\
M)#+;_K_N?_0A17QN)_C3]3^L.'_^13AO\$?R/>J***YCZ \$_;9_Y(9<_P#8
M0MO_ $(U^>]?H1^VS_R0RY_["%M_Z$:_/>OILM_@_,_G?C[_ )&R_P "_-A1
M117JGYN%3V-]<Z7>P7EG/):W=NZRPSPL5>-P<AE(Y!![U!12&FXNZ.U_X7=\
M0_\ H>/$/_@QE_\ BJQ/$GCCQ%XR^S_V]KFH:S]GW>3]NN7F\O.,[=Q.,X'Y
M5BT5G[.*=TCJJ8S$U8N%2I)I]&V=#\/?$%AX5\;Z+JNJ:?'JNFVUP&N;.5 Z
MR1D%6&T\$X)(SW KN-;^!\.MZE<WWA#Q7X;U+0KB1I8?M6I1V<\",<A)(Y,$
M%<XXSTKR:FLH;L":F4'?FB[&]#%4X4O85Z?-&]UK9I[/771V6C732VI[O=:Q
MHW@GPSX)\"1Z_9^(;^'Q+!JUY>6;EK2P4,J^2DAQGJ68C@8JUHNNZ6G[4_C.
M:;4[2WL]2;5;2WO9)0("\J.L9+] I)'/3FOG[;VQQ28&,8XK'V"L]=STO[:F
MI0:IJT)1:5WM%6MW^9[A\+]6NOAO+XP\"WWB:'POJ.K0V\MIKFGWP>"&YC)9
M%>:(G".KLI(Z$\UKQZEXL\*V&IW_ ([^*-Y<6:VLBV>E:/XD-S/?3,,(/W;,
M$C!.6+8X&,<U\\;1V% 4+T&/PH="[NWOOH*GG#I4XTXQ=HWY?>=K-MVDE92L
MWY>=UH ]^M>M_$KQ EOX&^#\^FWL1U#3=,D<^3("\$JW!9=P!RIX!YKR6E]>
M.M;2CS-/L>30Q4J%.I"*^-)7[6DI?H?1?Q?\6>'+3X?ZAK7AZ\A?6/B))!<:
MA:0L"UE'$H,T9 .1OFYYZ@5R/C;Q!#:?!_X./975O+J.FF]F>%9 SQ,+LNF]
M0<KG //45Y#MZ\4@7N!64:"BDK[/]+?D>KB,YJ5Y5)<J7-%1TZ>\IM_.2;\K
M^1[9X[\$VGQ@\3W7B_PKKNBPV^K$7-]8:IJ$=I/83D?O0P<C>N[)#+G.:O0>
M*-#TOQ[\(/"6E:K!J&D^&-3BFO-7!V037$MPCS,A;'[M=H 8XSR:\%*@]1FB
MCV.B3>BV%_:RC.56G22G-IR=][24K)=$VDWOY66AT?CR>.?XB^(9HI$EB?59
MV21&!5E,I(((ZCWKW:YU[3#^UIXAOQJ5F;%])F1;H3IY3-_9BK@/G!.[CKUX
MKYFQ1L&,8&/2JE2YE:_2WY?Y&.'S.6'DY*-[SC/_ ,!YM/GS?@>N_"&WB\1_
M##XA^%8=0L;/6=1?3[BTCU"Y2W2989)#( [D+D!QP32Z.MC\0/AG:>"+G5K#
M2?$OA[4+B33GOIQ';7D,I_>1"7[H8.-P)(!!ZUY"5SU&11M'I0Z5VW?S_0(9
MDHTX4Y0NE%P>N\7)R^34G=/R6F]_9M/L;3X(^#_%3:AJ^FZAXKUZP.DVNGZ7
M=+<BV@=E,LLLB94'"@*H)-8OQ.O[6Z^&OPJA@N89IK?2[E)HXY S1,;ER P'
M*G!SS7F87C@8% 'H*%2U4F]?^!853,>:E*A3A:#CRI7O;WE)MOJVUY'IK:A:
M_P##,+6(N8?MO_"5M-]F\P>;Y?V11OVYSMR,9Z9IW[16H6NI?$&WFL[F&[A_
ML?3T\R"0.NX6Z C([@\$5YCM[]*-OI35.TN:_?\ $BKF#JX?V'+TBO\ P'F_
M/F/H"S^(>E^#;CX+:C<S)=V5KHUU::E#;N'DBBFED1P0#PVULX/I7-1?!?3]
M)U^'4KOQ?H5QX+2X65;ZUO5>YGBW9$:6X/F"0CC!  /.<5YQX5UZ3PIXCT_5
MX;:WO)+.99?L]U&'BE ZJRGJ",BO1+;Q9\*+#6E\0P^%->;48Y?M,>C27L1T
M]9 =P&_;YA0-_#Z<5A*$J;]WK_F>S2QE#&P7UGE7*U9-R5K1C%O1/F3Y5>.C
M[/5E3]IK_DO'C'_K['_HM:N_L^ZS9:;<^*+=-3L]"\3WVF^1HFJWQ"Q03;P7
M&\@A&9> W:O./%'B2]\8>(]2US475[[4)VN)BHPNYCG '8#H/I69C\JV]G>D
MJ;[(\F68*&8SQM-73E)J_:5_N>NCZ/4^EOAO87WAWQL]SXZ\>V=UJFH6-W96
M-K_; O%,DL+*'FD#%(TYP,G))%>?WWDZ7^SI=Z+-=VK:G;^,6+P0W"2$J+55
M+K@_,F01N'!KRC:.F!BC ]*E4=;M]OP-ZF;*5+V4:?22NY-OWK7OW>GEZ'I_
MPYU"UM?@[\5[>:YAAN+FVT]8(9) KRD72DA5)RV!R<5K7UA:_&KP7X5.GZOI
MMAXIT&Q&E76G:I=+:BX@1B898I'(4X4[2I(/%>-;<GF@KGJ,U3IZN2>M[_A8
MPAF-J<:-2%X*/*U>U_?<TT^C3=NNGJ>[PZ1HO@GX"^/M%;7].U'Q-=7%A-<0
M6,ZR11HLK!(T?.)'&7+;,@ CFO!WR8V]<4NT>E+S50ARWN[W.;&8N.)]FHPY
M5"/*EOU;^_77^D>\?%+XA1>%?CYX<\3:7<PWL5C8:?YIMY ZN@A"RQD@]U+
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MHO306BBBMCA"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%(
MIK"G44 -P:-OO3J*5@&XHQ3J*+ -Q1BG446&-Q28]J?1BBPAN/:C'O3J*+ -
MQBC'O3J*+ -Q^=&/6G446 ;BDQ3Z*+ -"TN*6BBP#<?E0!3J*+ )BC;2T4[
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M<5=VN>0>(O!?B#P@T(UW1-0T<S#,?VZV>+?]-PYJ'0/#.L>*KPVFBZ7>:M=
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ML[^Z?Q5>? _QC?\ SZ[J.I+8WUP0 UU]GNHECF;U8JVTMWVU*?\ D9OVB_\
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M!'Q@N+;7==\07'A#Q)]GCAU)6T][N"\:-0HEC*'*LP R&&,\YJ'JU*<=-?\
M@'92E&E&I1PE;]Y[GO-\MTD^91D[65[=5=+Y&MJ0MO& ^%WCQ;.WL=7O]<73
M-46UB$<5Q-%-&5G"#@,RMAL#&16C\0/C3X@\._'?6-+T6:+3M#BUIH)]-C@0
MQ7A,N)6F!!\PN2W4\ @#&*XW6_B+H*ZUX%T?0DNH/"7AF]CN#<W:#S[J5I4>
M:=D7..% "C. *Y[QYXDT_7/C#K6O6<QDTNYUE[N*8H5)B,NX':1D<=NM9QI\
MS]Y:6?YZ'97S#V5-_5ZMIN<.9IVNU"TGZ.6[V;U/1?BG\5M;^&/Q4UKP_P"#
MI8_#OA_2[SRETVUA3RISPSF7()?<6(P>@P!TKJ= T72_#?[95S;VUFD.F/93
MW;6D7RHHETXRNBXZ#+L!Z5XA\9/$EAXN^*WB;6]+F-QIU[>F:"5D*%EP.<$
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M]WVKII/ _P 0_!/A#PQIWPXM;>P^TZ?%J&IZQ'>6L-U=3RC=Y>97#"-%*@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS0W\<ODO:NA$BR9QM*]<YXQ7<7'P!\?VVFO>/X<FQ&GFO;+-$UTBXSDP!O,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK>2+86"8^^!G[IZ>E='XT^+'PP^+'P5T#2=:U/4M(U_0;(+;VL5NS"6=8?+
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M4\ZQ%+,)YBDN>5[JWN^]NK7O^)T7B6[L?#_B;4K?P=K.H2:%Y@%O<EWADF4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF]D_O5_U"BBBK, HHHH **** "BBB@ HHHH **** "BBB@ HHHH _0G]B?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVF*I*,8^8=^"12E3DY<R\BL/CZ,*"P]1.UI)M?WFFOR/<_%7BB/_ (5A\/\
M6K3P#HGB[3(=*33+B\O(9Y9+2YB)#1/Y<@"AL[QD<Y-<_P"/M6U/_A5/A^&Z
M\-:#X/L-2UG[9;:78PSQW4NQ-AN")'8",Y"CH3CCBO+/"_CCQ#X)FDET#6K[
M1WE&)/L<S('^H'!_&J>M>(-4\1ZD^HZKJ-SJ-^V,W%U*9'XZ<FLXT6GY'96S
MB-6D]'S.*C:T;:63=[<SO;;I?=GHW[2@^V?M!^*8Y9MBM>QQF1NB+L09^@%=
M1X^L7^'?C5O"7A/X<6.I/&(UMM6U&SDOY[_<H/FKD^7M)/  P*\.UK6K_P 1
MZI<:EJEW+?W]PVZ:YG;<[G&,D_0"MVU^*GC.QT+^Q;?Q3JT&D[/+^R)=.$"_
MW1SP/:J]E+EBNR,EF5"5?$59)IU)<R:2;2NW;7:]UJMK=3Z)\0:M_8/[0?@.
M779H+-KSPM%ILE];A5MX;B2&2(LA7Y0JN<<< 5\^Q_"+Q<WCA?";:'>+JYG\
MDH86V@9_UF[&-F/FW9QCFL+4/%&L:MH^GZ5>ZG<W6F:?N^R6LTA:.#=][8#T
MS6M_PM3QF-"_L4>*=6_LK;L^R?:WV;?[O7I[=*4*<Z:]VW8O%9CA,=)^VC)+
MF<E:U]5%23_\!TE]\>WHOP-T:V\/_M+V^D6>HIK$-K]OMH[V-=JSL+29<J,G
MJ>!SS69\#;::U7XH13PR02CPC>Y212K#][#V->5Z?J%UI-]!>6-Q+:7<#AXI
MX&*/&PZ$$=#6U?\ Q$\4:IJ5]J%YKU]<7M]:&QN;B24EYK<X)B8]UX'%5*G)
MMZ[I?@8X?,:%*$$XM<LIM):JTXI6NW?2WG<[OX5V%S\3/AOXC\ 6R>?JT-Q#
MK6DQYY+ B*X0?5'#?\!)KI[7QQI.D_M1>&HC-&OASPXT>A6TKG$:JD;1&0^@
M,KLY->&>'_$.J>%=4AU+1K^XTS4(0PCN;5RCJ",$ ^X)%9\C-([,[%V8Y9F.
M22>I-#HW<KO1_J%/-O8T:*C'WX.+;Z-1;<5][=_)1/>M6O-3L_',_AA_@GX;
MFU<W)B1%M+LB7+<2!O-P5(^;=TQS7 _'35;K5OBMK\U[/IMS=QR)!++I <6Q
M:.-4(3>2QQMVY)Y(K-A^+'C2WT3^QXO%>KQZ7MV"U6[?:%_N]<X]JY2BG3<9
M79./S"&(H^RIWLW?515K7LO=6N[U=O)+4]E^"FI7FC_#'XMWMA=SV-W%IMJ8
M[BVD:.1#]H R&!R.":X_1_C-XWTC5;6]'BS69Q#(KF*XOI)8W4'E61F(((R,
M$=ZYNPU[4=+T^_L;2]FM[/4$6.[@C;"SJIW*&'< \UGE<U?LU>3DM_\ (YI9
MC5C2H4Z,G'D36CMKS.5_Q/J73+/2O"?[3WC/1[+3K(1ZYHTD>GV-U\EL\\\$
M4PB.",*QWJ "/O8KG/ >L:KJ'C^QTNQ^$'A?1M6L[E9)+NZM+R--/,;;C+(3
M+\H3&?PKP[6?$6J^(+Z.]U/4+B^NXXTB2>9R754&$ /L.E;&J?%3QGKFCC2=
M0\4ZM>:;MVFUFNG9"/0C/(^M<_L)6WZ6ZGMK.J/-)J+C%3E))*.TG?EU7NV[
MJ_H>A>'=5\70VWCKQAX;NM.UJTDU5DU?0DLVN(9XG9G6Y\EP?W>[(!^\N>:B
M\1:1I/C'X0:SXMF\(1>"=5TZ[@@MY;+S([34_,)#HL4A.'0?-E3C%>5>'_$F
MK>%=06^T;4KK2KQ1M$]I*8VQZ9'4>U6/%'C;Q!XTF2;7M:OM8DC&$-Y.T@7Z
M \#\*T]D^:Z_KR.%9E2E0<*B;;35G9QN[^\F]8VO>RW:WLVCUW]H#P?JMYX8
M^&^O6MM->Z<OA>PM9C I?[-((\@.!]T,#D$]<'TK*^RS^!?V>9X-9A>VO/$&
MN6]W8V,ZE9#! IWS;3R%8L%!/7%)\2/B9>:/J7@N\\(^))K6>#PKI]G=2:;<
ME2DB(0T;X[J>QKR[7?$.J>*-2?4-8U&YU.^<8:XNY3(Y'ID]O:HIPE**3V.K
M'8O#4<35J4KN;7+T<=4DW?KITZ/KI8]0_:(T'4=9\?/XLT^VN-0T#Q'%#=V%
MW;QF1.8U5H<KG#(P*[>O J'XD6,W@WX,^"?"VJH8->>\NM8ELY.)+6"0(L:N
M/X2VTMM/.*X?PS\1O%/@N"6'0?$.HZ1!+R\5I<,B$^N.F?>L74+^YU6\FN[V
MXEN[J9MTDT[EW<^I)Y-:1IR7+%[(X:^/H3]M6IQ?/5WO:RNU)VZN[6E[67?<
M]0_:H8_\+PU_)SB*U S_ ->\==EJND:OK7BGX/P>'M7CT77H_"$4UC/(<>9,
MLDY$0[9<949X.<=Z\$US7=1\3:E)J&JWDVHWTH4/<7#;G8*H49/L !^%.OO$
M&J:HVGM=W]Q.VGPK;V;/(<V\:DE50]@"21]:7LGR1C?9?H:?VI2^LXBNXNU2
M7,M;/XN;=;/S74]T\&S'XN>+G\.>,_AY:65S(LGVOQ!IMH]A<6)523-*!^[(
M!'((&<TSP1J\7_"@+NUT_P ,:7XTN-#UR6>[L[Z.5V2"1 $N46-U)&5*D\XS
M7D^L_%;QGXATK^S-3\4ZM?6&,&WFNG9"/0C//XUBZ'X@U/PQJ$=_I&H7.F7L
M?"W%K*8W ],CM[5'L6U^AU+.*4)II.5U).345*SM;35/E:O=ZN[6A[3#XBU&
MY^%7C+5+?P-X9\&Z/<6Z:?)=I;W*37K-(K"&'?(06&W<3C Q7@XK:\3^-_$/
MC6:.;7]:OM8DCX0WD[.$^@/ K%%;TX<B=^IXV88Q8J4.6]HJVME?5O9:+?;7
MU/8/V<,_;/B%_P!B??\ _H45)^S%J,$/BKQ!IC6EG?WNL:'<65E:7Y(AN)LJ
MXA8@@_.$*\$=:\QT?Q!J7A]KMM-OI[%KNW:TN# ^WS86QNC;U4X''M5!9&AD
M1XV9'0AE93@J1T(/8TI4N;FUW.C#YDL/]7:C=TW*_FG]_3R/H+X=Z[JNH^/K
M.ST[X2>%]#U/3YQ/+?W5I=QIIWEG<99"9?E"XS[]*RD6Z^)GP=\4Z?HZK>ZS
MIOB677+BSL4/^D6TJE#+&A^8JC#IU ;FO.-8^*GC+Q#I TO4_%&JWVG !?LT
M]T[(0.@(SS^-8.E:M?:%?17NFWD]A>1',=Q;2&-U^A%9*B]^IVSS:DTJ6LH/
MF3TC%ZI;)::6O=[[:'4^'?AK?ZGX5\0^(]0DDT72-+@_=SW$) N[AF 2W3.,
ML>2<9P!S70?%UC_PKOX2#)Q_84IQ_P!O,E<3XH\>^)/&S0MX@UR_UCR?]6+N
M=G">X'05GW^N:AJEI86MW>37-M81&&UBD;*PH6+%5'89)-:\DVU*73_(\]XK
M#4Z52C0B_>BE=[M\RE=K9:*UE?N>C:[_ ,FN^'/^QFO/_2=*E_:@)_X6M)R>
M-+T\?^2L=>:RZUJ$^BPZ1)>3/I<,S7$=F6_=K(P 9P/4@8HUK7-1\1WWVS5+
MR:_N]BQ>=.VYMJJ%49]  !^%*--QES>OXEXC,(5L,Z*3NU3_ /)(R3^^Y[PO
MB.R\(^(_V?=7U$A;"UTQ6F<]$4W,J[OPSG\*\Q\=?#/Q-I/Q"U#1_P"RKW4+
MJXNG:UEMX6D%XCL2DB,!A@P(.1ZURFHZUJ&K6]C!>WDUU#8P_9[6.5LB&/).
MU?09)/XUMZ7\5/&6B:,=)T_Q1JUGII&W[+#=NJ >@YX'TJ8TY0=X_P!:W-JV
M/PV+C[.LFHJS35KW48Q:?KRJSZ=G<^@]#FBL_P!H3P!X>\V.XO\ P[X6ETR_
MEC8,HN%L[AW3(Z[=X'US7F6EZ?<^./V>9=,T:-[O4_#^N2:A>6,(W226\L84
M3!1RP1EP<= U>7Z/KVI>'M434M,OI['4$#A;F%R)!N4JW/N&(/U--TC6M0\/
MZA%?Z7>W&GWL9REQ:RF-U_$4E1<=4^WZ_P"9M+.*=5.$X/EDYWUVC)02L^ZY
M%?O\SU3X(Z1>^%;'Q;XQU6VEL="MM$N[!9+E"@NKB=/+CA3/WCDY..@'-'Q"
MTN[\6?!_X<ZYI,$E[8Z38R:1?I;J7-K.LI8%P.1O5@0>AQ7G?BCQYXC\;21/
MK^N7VL&+_5B\G9PGT'05WWPW>T7P[;2^&/'A\">,HY'2^74;Q[>TO82<QLDB
MJ0I7H5;KU%*491?M'O\ U_5S3#8BC7@\#33Y.5ZMI2;YHNZ3TZ+W;ZJ^M[&J
MOA/4_#?[*NLW.I0O:'4-?M)H+:8%9!&(W <J>0&YQGKMS2?#'PW)\:OAJG@]
M&SJN@:M%>6[=Q8W#!+G'LC!7_&J7Q&\46ND_#V7PTWBA/&?B35M335-6U."1
MY8(A'&4CB61@"Y^8DD# P!5?X>W-C\,/".M>*CXCL)M<U33)-.TW2;&<O<1-
M*VUY)UP @502!DY)![5G[W(WU;T.Q2H1Q<*3UIQIVGJMM7OM>]G97][0YGXP
M^*H/&'Q%U>]LL#2X7%E8(O1;:$".,#V*J#^-<:M-Z4X5W1CRI)'QF(K2Q%6=
M:>\FW]XM%%%:F 4444 %%%% !1110 4444 %%%% !1110 4444 ?H3^Q/_R0
MRV_Z_P"Y_P#0A11^Q/\ \D,MO^O^Y_\ 0A17QN)_C3]3^L.'_P#D4X;_  1_
M(]ZHHHKF/H#P3]MG_DAES_V$+;_T(U^>]?H1^VS_ ,D,N?\ L(6W_H1K\]Z^
MFRW^#\S^=^/O^1LO\"_-A1117JGYN%7[/P_JNI64MY::9>W=G#GS+B"W=XTP
M,G<P&!@<\U0K[&_9?8C]EOXBX)_UE]_Z21US5ZKHQYDNI[N39;'-,2Z$I<MH
MRE?T5SXYHKVKX4_LSW?Q6^&=]XIL]=@L9[:Z>V%I=18BP@0M(TN[Y0 Y)^4_
M=K2\0?LIF'X>WWBKPOXSTWQ;!I\;/=0V<>W&T9<*P8Y('."!D4OK-)/E;UV+
MAD&95**KQI7BX\RU6J[I7N[=5:YX'17K7BKX"_V'\%=&^(MAKG]J6E\T:S6O
MV;RS;ELJ?FWG.'&WH.M1ZM\"6T/X(:7\0+S6=EQJDJQ6FD+;9:3<Q"G?N[JI
M;[O<"J]O3?7K;YF$LGQL7).GM#G>J^%[.]_PW\CRFBOH/2_V23:Z;IK^+_&^
MD^$=5U-<VFEW #R$GH&)9<'D9QG!XZUQ.L?L\^+='^*EGX#>&&34KT[[:Z5C
MY$D/.9<XR  #D8R,8I1Q%*3:4C2KD>8T8QG.B_>:71N[V32=TWTND>94^.&2
M=ML4;2-UPBDG]*^BE_9)TFXUJ;PW;?$[2)?%T0._2FMV7# 9*[M^>G/W<^U=
M7^Q[\.;?PO\ $S7AJVKV\7B?3TN-/ET'R]S&,-$3.'S@KG ''>LIXNFH.4=;
M>IZ&&X:QM7%4L/72@INU[Q=FMUI+?^[>Y\FVME<WMTEK;V\MQ<NVU8(D+.Q]
M HY)IU_IUWI5TUM?6D]E<J 6AN(FC<9Z95@#7T!K7@ZTT?\ :>T5?"GC*TO=
M6U'6)Y9)5LMRZ;,6;Y&0M\^,D=1TJ/XE_"'QC\3/VCM0\-R:G;:QJRVT$MUJ
MHM?LL,4.Q<,4#-TR!P>336(5U?16N93R*M&G/D3E-5%!6Y6G=7W4F[_*RZNY
M\]T5])VG['-KJ_B6/1](^(NDZI<6[E=2AAC'GV@"GYA'YGSC<%4\C&[\*X"S
M_9]UG7/C-JOP_P!&NX[N73G;SM1F0QQI& N7902>K   G)-7'$TI7L]M3GK9
M!F5'EYZ7Q2Y59IWEVT;_ . >5T^*"6X)$4;RD<D(I/\ *OHJU_9'TWQ!<ZCI
M?AOXE:3K7B.P1C/IP@*!2#@C>'/?C..":[G]B+P;I^CZMX@N[C6(9/$"QR65
MWH1B_>6PCFQYA;/()&,8K.IBX1@Y1UL=^#X9QE?%TL-7M!3O[UXR6F^TM6NU
M[^1\<\C(/!HKUKQ-\&TU_P"+,?AGP1K]OXMN+\R7$L\<1ACM#YC;U<Y/"C'/
M?(&,UVY_8Y@NKRXT73_B-HE[XLMT+2:0$P00.1D,6_\ '>.]:/$TXI<S.&GD
M.85I35&GS*+M>\;-]D[V;\E<^;J*]*^&_P $=0\:_%>;P)JERWA_48$F,SM#
MYQ1HP#C&X9!SP<]*ZGQY^RW=_#KP3KNOZOXCLX9[.3_0],V#S[N+S1&)"-WR
MY!W8&[@53Q%.,E%O5_J84\EQ]:A+$PI>Y'FN[I6Y=7>[O_GLCQ2PT^[U6Z2U
ML;6>]N7R5AMXVD=L#)PH!)XK6_X0'Q2!D^&=8 ]?[/F_^)KTC]CW_DX+P[_U
MRNO_ $GDKUCXY?M*_$7P+\7M6T#01;SZ?;O"((&L/,9]T:L5W#DY)/2L:E>:
MJ^S@D]+GJ8'*<'4R[^T,75E%<_):,4^B=]T?(DT,EM,\4T;12H<-'(I5E/H0
M>E,K[ _;!\&+XHT[X>:K;:2EKXRUN5+.2TC 5Y&>-6V-Z['.W)Z;JXP_LCZ;
MI>J6.A:Y\2M)TSQ3>*IATI;<R$LW1=Q<=3P..>U$,7"4%*6E_F&+X9QE'%5,
M/07/&-O>;4?B5TO>:U\MSYRHKW3PO^RS=ZE\6-5\!:WK\6D:E:V@O;:>&W\^
M.[B) RN64@X/3V/I7+> /@?J'C?XNWG@22[_ +/FLY+A+F\\GS!&(B1NVY&=
MQQCGO6WUBGKKLK_(\MY+CXN$72UG)P6J^);IZZ?.W<\THKZ'T+]D5O%>G>++
MC1_%D,[Z%J4FFK]HM1%%.T:QL[E]YV*-[=C]SWJ1/V.+C7O#/]J>$?&^C^)Y
M8Y/*N(X?W<2$$;L2;CT'/(&0.*CZU1ZR.Q<-YK)7C1OHVK.+O9V=M=;>7ZGS
MI17O?B+]E)[7P!J'BCPWXQTWQ9'IJLUY!9I@+LY<(P8Y('/(&17&?!WX&ZQ\
M7Y+^XM[NVT?0]/&Z\U6].(X^,X'J<<GD #J>E6L13<7*^B.2>2X^G7AAG2]^
M:NK---=[IVTZZZ=3S>BO:_'7[,\VA>"[CQ7X6\46'C71+0XNY+)=DD..K;0S
M @9YYS@YQBKOA/\ 96F\6?"C2?&T?BFSTZ"[+/<I?Q>7#:Q+(Z,YDW<_<&!M
MY+8J?K-+EYK^1HLAS&59T%2]Y1YMU;EO:Z=[-7[,\'I_D2^3YOE/Y7_/3:=O
MYU[;\1_V89/!_@%/&6A^*;'Q7H*E1--;1;"@+;=PPS @-P>0?:O?+'X>^%?^
M&4'T$^-[/^PWE+-XC^R_NU8W&XKLW9X;Y>M93Q<(I..MW8]'"<,XRM4JTJUH
M.$.=:QU[6?-:SU][9=3X3HKV?P+^S@?%?A_5O%&I>*K'P_X/LKI[:/5KB(M]
MH"OM\Q4R,*20!D]3BH/B1^SN_@_P3%XQT#Q-8^+_  T9!%)=6J>6\9)VY*Y/
M&>.N1GI6WUBGS<M]3RWDN/5#ZQ[/W;<VZOR_S6O>WG:QX_15S1])N]?U:STR
MPA:XOKR98((5ZN[' 'YFOH%OV1]-TO4['0]>^)6DZ7XIO%4PZ6L!DRS=%W%A
MU/ XY[552M"GI)F&"RO%Y@G+#PNE97;25WLKMI7?;<^<J*],OO@3JFA_&C3?
MAYJUY%;7%[/'&E] ID0QN#MD"D@GH1@XY!KTFX_8WM]-\6?V)JGQ"TO39KD@
M:;%+$/M%WP,GR]_RC=D#DDXZ5$L32C:[WU.JCD.8U^;DI?#+E=VE:7;5H^:J
M='&\TBQHI=V(5549))Z #UKT3Q9\!_$OA?XJ6_@-%BU#5;LH;26$E8Y4;)WG
M/W0,-G/3::]2C_9-C\,>)=&LU\?Z+<>+([B&Y.AM^Z9U5U8A&+9)P"0"HS1+
M$4XI:[AA\BQ]><XJDUR2Y97LK/LKO5^2NSYSU/1M0T698M1L+K3Y67<L=U T
M3$=,@,!D53)Q7TS^WNQ_X65X?[XTK_VJU1?L<_"[1O$$VN>-?$<$=UINA#$$
M$RAH_,"EV=@>#M4# /=L]JA8E>P5:2.VID,Y9Q+*J$[V?Q/31*[;]$?/R^%]
M::Q^VC1]0-EC/VD6DGE8]=V,5F5]2#]NKQ%+XJ#0>'K$^&1+M^QA&:?R<XR6
M!QNQSC&.U>;?M):MX$\1>++;6O XE@2\C8W]LUHT"+*#PZ@@#+ \@=QGO3IU
MJCERSA:_S^\RQF78"&'E7P6)YW%V:DN5OSCJ[K\4>245]/7W[#M_::E8Y\6V
ML.B26_G76IW=N(A"Q("QJN_YB>3DD 8]ZX_PC^S'-KFEZUK^K^*+#P[X3T^]
MFLX]5N4WFY\N0IYBH&QM)''S<GIGK36*HM74B9\.9K3FJ<Z-F[]8[+5N][):
M[[=+W/$:*]E^)7[.,G@_P'%XTT'Q-9>+?#3.$>ZMHS&R9;8#C)!&[@\Y!/2M
M3PO^RK-XI^%.C^-D\4V>G6UYN>Y6_B\N*TB5W1G,F[YC\HP-HR6Q5?6:7+S7
MTV^9@LBS&5:6'5+WE'GW7P[73O9KT9X-3_(E\GS?*?RO^>FT[?SKVSXD?LQR
M>#? <7C+1?%-EXJT#<@FGMH]A0,VW>,,P(!X/(/M7OUO\/?"K?LH+H)\;V8T
M)I2Q\2?9?W88W.XKLW9^]\G6L9XN$4G'6[L>EA.&<96J5:5:T'"'.M8Z]K/F
MM9Z^]JEU/A*MJ#P/XDNH8YH/#VK30R*'22.QE964C(((7!!'<5F:I!%9ZA=V
M]O<+=P12O''<*,"502 X';(Y_&OOCQ=XP\9>#/V<? -]X)LY;[56L["*2.*R
M:Z(B-MDG:.G(7FKKUW3Y5%;]SGR;*:68*O*O-Q5)7]U<S>MM-4?".I^&]8T6
M,2:CI-]81L<![JU>)3[98"LZOO;X?>./$GC3X.^-KCXOZ1'IFF0Q,L4MY:&V
M:92C9'EMW#!=I Y+<=*^8/!OP'/BOX(^(/B"=;^R_P!DR2Q_V?\ 9MWF;%1L
M[]PQG?Z'I44\5>ZJ*UG;ON=..X>E3]E+!2<U.,IVDE&24=VTW]W?H>445ZQ\
M(O@/_P +4\%^*]?&M_V;_82,_P!G^S>;YV(FDQNW#;]W'0]:F^#O[.>H_%'P
M]=^)+[6+7PQX9MBRMJ%XN[<5^\5!*C Z$DCGBMY8BG&]WL>11R;'5_9>SIW]
MHFXZK9:-O71+SL>7Z?H6IZM#/+8:=>7L4 S+);6[R+'P3\Q4'' /7TJC7W7\
M /AFGP[^'_Q$EL?$&G^)M'U&VW6FH:>W!*0RAU=<G:PW+QGO7S3\%?V>]4^+
MFG7VKR:E;^'_  Y8_+-J=V,KN !8*,CH""22 ,BL8XJ#<F]E8]3$<.8FE##1
MIIRJ55)N.EERO>][6MK>]CRJBOI#1_V.XM>T_5]5TSQYI^J:):6YE@O;"$2F
M5U#%XW7?\A "]SG=[5YO\'O@;K'Q>>_N8+NVT?0]/&;S5;TXCCXS@>IQR>0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"V6\#23%D9%+QKP6"L>F23C%?+_B;XQ:L?B]KWC7PQ?7&C3WMU(\+1D!C$2
MJN#P<@ D'C-1'VE:<FGTM?YG;7G@<GPU"E5@W%57)Q;BY-<MKZ.UK[7?O6\S
MZM_9INM/N/B!K<6B?"Z3P?86MNT<NK7TDLES*WF#$9+CC."Q )^[7*_LF_\
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M>Z0HS;(7#N%/(!R!GOCVK,^%VF7/Q#_8LUKP[X: EUR"=Q-:QL!)+B59=O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444@$VBEHHH **** $Q2X
MHHH **** "DQ[TM% ";:-HI:*+ %%%% !2;:6B@!,48I:*+ )^%&*6BBP"4M
M%%%@$VT;:6B@!-M+BBBBP!1110 FVC;2T4 )BC%+118 HQ110 F*3%.HHL T
M"EQ2T46 3%+110 4F*6B@!-M&*6B@ HHHH ****8!1110 4444 %%%% !111
M0 4444 %%%% !1110 444Z&&2XFCAAC:661@B1H,EF)P !ZDTA[Z(_0?]B=2
MOP+M"1UO[DC_ +Z%%=]\#? LGPW^%F@:%.NV\A@\RY [3.2[C\"V/PHKXRM)
M2JRDNY_6^3T)X7+L/1J*THQBGZV.\HHHK ]@*^8?VC/V2?\ A.M0N/$WA PV
MNMR_/=:?(=D5TW]]6Z*Y[YX/L>:^GJ2MJ56=&7-!GE9EEF&S:@\/BHW7XI]T
MS\H/$7PW\5>$[QK;5_#VI6,RG'[RV8J?<, 01]#6/_8^H?\ 0/N_^_#_ .%?
MKOM!&#R/>F^2G]Q?RKU5F<K:Q_$_,Y^'5)R;AB6EYQO^J_(_(K^Q]0_Z!]W_
M -^'_P */['U#_H'W?\ WX?_  K]=?)3^XOY4>2G]Q?RI_VH_P"3\3/_ (AS
M'_H*_P#)?_MC\BO['U#_ *!]W_WX?_"C^Q]0_P"@?=_]^'_PK]=?)3^XOY4>
M2G]Q?RH_M1_R?B'_ !#F/_05_P"2_P#VQ^17]CZA_P! ^[_[\/\ X4?V/J'_
M $#[O_OP_P#A7ZZ^2G]Q?RH\E/[B_E1_:C_D_$/^(<Q_Z"O_ "7_ .V/R*_L
M?4/^@?=_]^'_ ,*/['U#_H'W?_?A_P#"OUU\E/[B_E1Y*?W%_*C^U'_)^(?\
M0YC_ -!7_DO_ -L?D5_8^H?] ^[_ ._#_P"%']CZA_T#[O\ [\/_ (5^NODI
M_<7\J/)3^XOY4?VH_P"3\0_XAS'_ *"O_)?_ +8_(K^Q]0_Z!]W_ -^'_P *
M/['U#_H'W?\ WX?_  K]=?)3^XOY4>2G]Q?RH_M1_P GXA_Q#F/_ $%?^2__
M &Q^17]CZA_T#[O_ +\/_A1_8^H?] ^[_P"_#_X5^NODI_<7\J/)3^XOY4?V
MH_Y/Q#_B',?^@K_R7_[8_(K^Q]0_Z!]W_P!^'_PH_L?4/^@?=_\ ?A_\*_77
MR4_N+^5'DI_<7\J/[4?\GXA_Q#F/_05_Y+_]L?D5_8^H?] ^[_[\/_A1_8^H
M?] ^[_[\/_A7ZZ^2G]Q?RH\E/[B_E1_:C_D_$/\ B',?^@K_ ,E_^V/R*_L?
M4/\ H'W?_?A_\*/['U#_ *!]W_WX?_"OUU\E/[B_E1Y*?W%_*C^U'_)^(?\
M$.8_]!7_ )+_ /;'Y%?V/J'_ $#[O_OP_P#A1_8^H?\ 0/N_^_#_ .%?KKY*
M?W%_*CR4_N+^5']J/^3\0_XAS'_H*_\ )?\ [8_(K^Q]0_Z!]W_WX?\ PH_L
M?4/^@?=_]^'_ ,*_77R4_N+^5'DI_<7\J/[4?\GXA_Q#F/\ T%?^2_\ VQ^1
M7]CZA_T#[O\ [\/_ (4?V/J'_0/N_P#OP_\ A7ZZ^2G]Q?RH\E/[B_E1_:C_
M )/Q#_B',?\ H*_\E_\ MC\BO['U#_H'W?\ WX?_  H_L?4/^@?=_P#?A_\
M"OUU\E/[B_E1Y*?W%_*C^U'_ "?B'_$.8_\ 05_Y+_\ ;'Y%?V/J'_0/N_\
MOP_^%']CZA_T#[O_ +\/_A7ZZ^2G]Q?RH\E/[B_E1_:C_D_$/^(<Q_Z"O_)?
M_MC\BO['U#_H'W?_ 'X?_"C^Q]0_Z!]W_P!^'_PK]=?)3^XOY4>2G]Q?RH_M
M1_R?B'_$.8_]!7_DO_VQ^17]CZA_T#[O_OP_^%']CZA_T#[O_OP_^%?KKY*?
MW%_*CR4_N+^5']J/^3\0_P"(<Q_Z"O\ R7_[8_(K^Q]0_P"@?=_]^'_PH_L?
M4/\ H'W?_?A_\*_77R4_N+^5'DI_<7\J/[4?\GXA_P 0YC_T%?\ DO\ ]L?D
M5_8^H?\ 0/N_^_#_ .%']CZA_P! ^[_[\/\ X5^NODI_<7\J/)3^XOY4?VH_
MY/Q#_B',?^@K_P E_P#MC\BO['U#_H'W?_?A_P#"C^Q]0_Z!]W_WX?\ PK]=
M?)3^XOY4>2G]Q?RH_M1_R?B'_$.8_P#05_Y+_P#;'Y%?V/J'_0/N_P#OP_\
MA1_8^H?] ^[_ ._#_P"%?KKY*?W%_*CR4_N+^5']J/\ D_$/^(<Q_P"@K_R7
M_P"V/R*_L?4/^@?=_P#?A_\ "C^Q]0_Z!]W_ -^'_P *_77R4_N+^5'DI_<7
M\J/[4?\ )^(?\0YC_P!!7_DO_P!L?D5_8^H?] ^[_P"_#_X4?V/J'_0/N_\
MOP_^%?KKY*?W%_*CR4_N+^5']J/^3\0_XAS'_H*_\E_^V/R*_L?4/^@?=_\
M?A_\*/['U#_H'W?_ 'X?_"OUU\E/[B_E1Y*?W%_*C^U'_)^(?\0YC_T%?^2_
M_;'Y%?V/J'_0/N_^_#_X4?V/J'_0/N_^_#_X5^NODI_<7\J/)3^XOY4?VH_Y
M/Q#_ (AS'_H*_P#)?_MC\BO['U#_ *!]W_WX?_"C^Q]0_P"@?=_]^'_PK]=?
M)3^XOY4>2G]Q?RH_M1_R?B'_ !#F/_05_P"2_P#VQ^17]CZA_P! ^[_[\/\
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M3^XOY4?VH_Y/Q#_B',?^@K_R7_[8_(K^Q]0_Z!]W_P!^'_PH_L?4/^@?=_\
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M^'_PH_L?4/\ H'W?_?A_\*_77R4_N+^5'DI_<7\J/[4?\GXA_P 0YC_T%?\
MDO\ ]L?D5_8^H?\ 0/N_^_#_ .%']CZA_P! ^[_[\/\ X5^NODI_<7\J/)3^
MXOY4?VH_Y/Q#_B',?^@K_P E_P#MC\BO['U#_H'W?_?A_P#"C^Q]0_Z!]W_W
MX?\ PK]=?)3^XOY4>2G]Q?RH_M1_R?B'_$.8_P#05_Y+_P#;'Y%?V/J'_0/N
M_P#OP_\ A1_8^H?] ^[_ ._#_P"%?KKY*?W%_*CR4_N+^5']J/\ D_$/^(<Q
M_P"@K_R7_P"V/R*_L?4/^@?=_P#?A_\ "C^Q]0_Z!]W_ -^'_P *_77R4_N+
M^5'DI_<7\J/[4?\ )^(?\0YC_P!!7_DO_P!L?D5_8^H?] ^[_P"_#_X4?V/J
M'_0/N_\ OP_^%?KKY*?W%_*CR4_N+^5']J/^3\0_XAS'_H*_\E_^V/R*_L?4
M/^@?=_\ ?A_\*/['U#_H'W?_ 'X?_"OUU\E/[B_E1Y*?W%_*C^U'_)^(?\0Y
MC_T%?^2__;'Y%?V/J'_0/N_^_#_X4?V/J'_0/N_^_#_X5^NODI_<7\J/)3^X
MOY4?VH_Y/Q#_ (AS'_H*_P#)?_MC\BO['U#_ *!]W_WX?_"C^Q]0_P"@?=_]
M^'_PK]=?)3^XOY4>2G]Q?RH_M1_R?B'_ !#F/_05_P"2_P#VQ^17]CZA_P!
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M?W%_*C^U'_)^(?\ $.8_]!7_ )+_ /;'Y%?V/J'_ $#[O_OP_P#A1_8^H?\
M0/N_^_#_ .%?KKY*?W%_*CR4_N+^5']J/^3\0_XAS'_H*_\ )?\ [8_(K^Q]
M0_Z!]W_WX?\ PH_L?4/^@?=_]^'_ ,*_77R4_N+^5'DI_<7\J/[4?\GXA_Q#
MF/\ T%?^2_\ VQ^17]CZA_T#[O\ [\/_ (4?V/J'_0/N_P#OP_\ A7ZZ^2G]
MQ?RH\E/[B_E1_:C_ )/Q#_B',?\ H*_\E_\ MC\BO['U#_H'W?\ WX?_  H_
ML?4/^@?=_P#?A_\ "OUU\E/[B_E1Y*?W%_*C^U'_ "?B'_$.8_\ 05_Y+_\
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MV/J'_0/N_P#OP_\ A1_8^H?] ^[_ ._#_P"%?KKY*?W%_*CR4_N+^5']J/\
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M1_8^H?\ 0/N_^_#_ .%?KKY*?W%_*CR4_N+^5']J/^3\0_XAS'_H*_\ )?\
M[8_(K^Q]0_Z!]W_WX?\ PH_L?4/^@?=_]^'_ ,*_77R4_N+^5'DI_<7\J/[4
M?\GXA_Q#F/\ T%?^2_\ VQ^17]CZA_T#[O\ [\/_ (4?V/J'_0/N_P#OP_\
MA7ZZ^2G]Q?RH\E/[B_E1_:C_ )/Q#_B',?\ H*_\E_\ MC\BO['U#_H'W?\
MWX?_  H_L?4/^@?=_P#?A_\ "OUU\E/[B_E1Y*?W%_*C^U'_ "?B'_$.8_\
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M\GXA_P 0YC_T%?\ DO\ ]L?D5_8^H?\ 0/N_^_#_ .%']CZA_P! ^[_[\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^^WKRRBC^V\Q_P"?S_#_ "#VD^YZG_PT%JW_ $"K/_OMZ/\ AH+5O^@59_\
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MG_WV]'_#06K?] JS_P"^WKRRBC^V\Q_Y_/\ #_(/:3[GJ?\ PT%JW_0*L_\
MOMZ/^&@M6_Z!5G_WV]>644?VWF/_ #^?X?Y![2?<]3_X:"U;_H%6?_?;T?\
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M'_G\_P /\@]I/N>I_P##06K?] JS_P"^WH_X:"U;_H%6?_?;UY911_;>8_\
M/Y_A_D'M)]SU/_AH+5O^@59_]]O1_P -!:M_T"K/_OMZ\LHH_MO,?^?S_#_(
M/:3[GJ?_  T%JW_0*L_^^WH_X:"U;_H%6?\ WV]>644?VWF/_/Y_A_D'M)]S
MU/\ X:"U;_H%6?\ WV]'_#06K?\ 0*L_^^WKRRBC^V\Q_P"?S_#_ "#VD^YZ
MG_PT%JW_ $"K/_OMZ/\ AH+5O^@59_\ ?;UY911_;>8_\_G^'^0>TGW/4_\
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M^@59_P#?;UY911_;>8_\_G^'^0>TGW/4_P#AH+5O^@59_P#?;T?\-!:M_P!
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MM_T"K/\ [[>C_AH+5O\ H%6?_?;UY911_;>8_P#/Y_A_D'M)]SU/_AH+5O\
MH%6?_?;T?\-!:M_T"K/_ +[>O+**/[;S'_G\_P /\@]I/N>I_P##06K?] JS
M_P"^WH_X:"U;_H%6?_?;UY911_;>8_\ /Y_A_D'M)]SU/_AH+5O^@59_]]O1
M_P -!:M_T"K/_OMZ\LHH_MO,?^?S_#_(/:3[GJ?_  T%JW_0*L_^^WH_X:"U
M;_H%6?\ WV]>644?VWF/_/Y_A_D'M)]SU/\ X:"U;_H%6?\ WV]'_#06K?\
M0*L_^^WKRRBC^V\Q_P"?S_#_ "#VD^YZG_PT%JW_ $"K/_OMZ/\ AH+5O^@5
M9_\ ?;UY911_;>8_\_G^'^0>TGW/4_\ AH+5O^@59_\ ?;T?\-!:M_T"K/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HK:T7P7K?B*/S-/TV:XBZ>;@*G_?1P*-:\%ZYX=C\S4--FMXN
MGFX#(/JPR*Z?JU?D]KR/E[V=OO'RNU[&+1117,(**** "BBB@ HHHH ****
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M34/AOXETN!IKC2)_+49+1XDP/?:37-U=2C5HNU6+B_-6&TUN%%%%8B"BBB@
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M@FD?:8-\EZW1"[<GJ.<?+UKGPN"P6/K*5%-146Y1OU712?1]V*,8S>APVJ_
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MY5QYI@:>'I*I3I..MKJ7-%KUW3^5B9Q25TCGJ***^8,0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBK6FZ9=ZQ>):V5O)=7#_ '8X
MQD_7V%5&+DU&*NP*M:/AW7)O#FMV>I0??MY Q7^\O1E_$9K<O_A7XHTVS-S+
MIA>,#<PAD5V ^@YKDJZ94J^$G&4XN,MU=6'9Q>IZ3\:+>6ZOM.UF*YEN=*OX
M5:%68E(V Y ';(Y^N:\WKU?X>V<GCSP#J?AR<%3:.LEI<N#M1CDA2?8Y_!JY
M+Q=\-=8\&PI<78BN+1CM^T6Y)56/0$$9%>OF&&JXA?VA2BW":N_)[->E_P #
M2<6_?1RF:***^=,@HHHH ^B/@?\ \B'%_P!?$O\ .BCX'_\ (AQ?]?$O\Z*_
M;LJ_W"C_ (5^1Z4/A1Z!1117JEGG_P </^1#E_Z^(OYU\[U]$?'#_D0Y?^OB
M+^=?.]?E/$W^_+_"OU.&M\04445\D8!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0CO7DXHH4X(->9B<9/%1IQFDN2*BK=EW(E)RL>T? #5FNK'5-*<>9#$RS)W
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MLVQ&+]E[2WN;>>VKU\BI5'*U^AZ+\9/%6F>)M2TJ;2;Q;I8(G#,JL-K%@1U
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M2#@-,Y8_K77_ *Q?[&\,J23M;3:WIJ_Q*]M[MK%>BBBOC#G"BBB@#Z(^!_\
MR(<7_7Q+_.BCX'_\B'%_U\2_SHK]NRK_ '"C_A7Y'I0^%'H%%%%>J6>?_''_
M )$.7_KXB_G7SO7T1\</^1#E_P"OB+^=?.]?E/$W^_+_  K]3AK?$%%%%?)&
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %&:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#CIG/7VK)Q7H^GZ+YGP7O-2^WWRE7<?95GQ;G$@'*8_R:BT3X?Z38>%X=?\
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M[@2,<KQP.34ULKKT*<ZDFO<M>S3:OT8G!I7.#HHHKR" HHHH **** "BBB@
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M\BZ102FX-P>G(JFM/N+F:\F,L\TD\K=9)7+,?Q-,%>%/EYGR;=+F?H+1114
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7LGP*=H_#GB1T)5E<$
M$=CY9KQNK-KJ5W91NEM=SVZ2??6&5D#?4 \UZ67XM8'$*NU>U_Q5BX2Y7<ZW
MP?\ $;Q GBC3%N=5N+BWDN%BDCF;<K*QQ_6NUUV;3_!_QLL;V95MK:\M2'DQ
MA0[97<?R&3[UXF&,;!E)5@<A@<$'UJ6\OKG4&5KJZFNF484S2,Y ]!DUUT<T
MJ4Z/).\I*2DFW>UNGS&IM*Q[]J&GZ_\ \),\EEX8\/SVS2>;'JD@&['7<V.=
MWTK,\-^-XF^*5]#J-Q9>9-;+:K<6A;RFD5BVW+=_F(^HKQ9=4ODM_LZWURMO
MT\E9F"?EG%:/@^^TC3]:1];L1?Z<RE'3!RA[, ",X_K7HQSGFK0=-<OO7?,]
M/32*TUWU9?M-58])\+?"V]\-^/H+Z]NK=+".=FMV\WYYV(.U0OK@G/TJ33;R
M*S^/]\)7"":-HD+'&6**0/T-4-/NO OAW7%UV'7+N^,.YK;3_+8F(D8QD^F:
M\Y\2ZY)XC\07NJ.OE-<2;U0'[@Z 9]@*TK8FA@:4%12NJG-92YM$NZV\EN#:
MBE;N>NZ/\/\ 5-.^*\VL7/E1:<UQ)+'*9!F0N#M4#KGG]*N>%\_\+Q\3_P#7
MJO\ **O#GU>_DDB=[^Z=XO\ 5LT[$I]#GC\*(]5OH[I[E+VY2Y<8>99F#L/0
MMG)Z#\JYH9M0I./LZ;24^?5WZ-6V%[1+9=3UCX>Z#I^H3>++W[%;ZEK=O=2B
MWM[H J.25.#ZMD9]JZSP;_PD)T;6/[>M[6Q8QG[/9VR*I5=IR2%]3_*OG>&\
MN+>X,\-Q-%.<DRQR%6.?<<U*NL:A'-)*E_=++(,/(L[!F]B<\T\+G-/#J'[M
MW5[V:2=^KTNVO4(U$NAZE\$86OO!WB>RB*FYE&U8R<'F+ _#-.^%49T@>(?"
M.J,MAJ=U'\@9ASNC((![D @UY+;75Q9R^9;SRV\G]^)RC?F*2:XFN)S-+-)+
M,3DR2.68GUR>:Y:.:1HPH6A>5.ZWT:=[]-'J)5+6TV/7_AK\/]3\%:_<:OK;
M06-E:0NGF&4$/G'/TP.]3_"'4TUGQMXOU"$$1W&)$X[%VQ7CUSJ5Y>QK'<7E
MQ<1KT265F _ FDL[ZZT]F:UN9K9F&&,,C(6'O@UI1S2EAITE1IM0@V]7=MM6
MWLM@4TK66PRXD;[7,X8AQ*S;N^=QYKZ0T5K+Q+8Z'XOG8+)9V<@D^N &S]"K
M?G7SGIL=O/J-LEY*T5J\JB:1>JJ3\Q_*O3?$/B[P]X>\!R^'/#=[-?M<,=\S
M@C:K'+9) Z], =ZTR;$0PRJU:K7+:]F]7).\;(=-\MVSS;6M4DUK6+W4)/OW
M,S2?0$\#\L5[%\-_LO@/X<W6OZC&Y^V.&VI]]DSM0#..O)_&O#\5;EU*\N+9
M;:6[GDMTQMA>5BBXZ84G KS,#COJE:6(:O-IV\F^I$9<KN>V?#[QOX1.M_V=
MH^DW&F37W#/)C:Y ) /SGGK63X+\/GPU\;+VR"[8?(FEA_W&*D?ET_"O(HY)
M+>19(W:*13E71B&!]01TJP=7U!KH7)O[HW(78)O/;?M]-V<X]J]".<<RI>UI
MJ].5U:R5NJMZZE^TVNMCKH<_\+L4?]1C_P!FK7^)%G:7_P 9+.VOVV64P@28
MDX&WGC/;/ _&O-!=3BX^T":07.[?YV\[]WKNZY]Z6ZNI[Z8RW,\EQ*1@O,Y=
MOIDUQ?7H^RG2<+WGS_\  (YM+6ZGONI:;KFC^*+2UT'2-,T[04,9DOA$@;;_
M !Y)Y!["J_B+/_"]?#G!P;-L?E+7ATFJ7LT*PR7MR\*\K&TS%1CI@9HDU:_D
MN8[A[^Z>XC&$F:9BZCT!SD5ZD\ZIO2,';FC*UU96>R5E9&GM%V/:_#7_ "7;
MQ /^G4_^TJ\MO%%U\0[I);XZ<7U%Q]LQGRCO.&ZCOBL:/5+V.Z>Y2]N$N7&'
MF69@[#T+9R>@_*J[LTLC.[%W8Y9F.23ZDUYN(S"->"AR[3E+?N]C.4KH^@[<
M>-+76K?3[RWLO$>BR%=U](BH=A^\2,GD?3FO*OBQ9Z58>,IX=(6..$1J98X<
M;%EYR!CIQCCUS7-QZOJ$%OY,=_=1PXQY:3L%_+.*I^_>M<;F<<51]DHO>]Y/
MF:\D[7MZMCE/F5API:1:6O ,PHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#T#X-^+K;PWKEQ:WT@BL[Y0GF,<*KCIGV()%:FK? G4;
MC5I'TV\M6TV9RZ22,=R*3G& .<>U>5U9BU:_MH/)AOKJ*'IY<<S*OY XKVJ.
M.HNA'#XJGS*+;5G9J^Z]#125K21Z#\3%\/>%QI&EZ5;PR:A:NDMU<(!N(7'R
ML?5CR16[\2/"]Y\2%TC6O#S17T)@\IX_,"E,G.>?J01VQ7BO<G.35BUU"[L-
MWV6ZGMMW7R963/UP:U_M*G4=6%2G:G.VD=+<NUM/OT#GWNM#UCQ[+#X;\&>&
M?"TD\<^HQSPO*L9SL"MU_,X'TJG^T-_R'M+_ .O5O_0Z\M:1Y)#(SLTA.XNQ
M).?7-2W=]<Z@P:[N9KIE& TTC.0/09-+$9HJ]*K2Y+*7(EKLH_F$JETU8]6^
M/61;^&O^N;_R2G_'+AO"?T;^<=>376H7=]L%S=3W(3[GG2L^WZ9/%+=:A=WW
ME_:;J>X\O[GFRL^WZ9/'05>(S2-=XBT+>TY.NW+;\QRG>^FYZ=^T5_R&-*_Z
M]I/_ $(5-\=_ETGPQQ_RS?\ ]!2O*KR^N=096N[F:Z91@&>1G('MDTMUJ%U?
M*@N;J>Y6/A!-(SA?ID\5.(S.-9XEJ-O:\ORY12G>_F>W?$35(=#UGP#?7/%O
M"[F0XZ J@)_#.?PK1\2VNK7VLI<Z5X;T'6K*X562^N,%^G\1[@=L5X!=:A=7
MRQK<W4URL?"":5GV_3)X[4L&IWMI"88+VYAB/6..9E4_@#7;+.U*=2\'RR:>
MC5TTDNJ:L[=B_::L]HCUBZU#XPZ%:7CV,MQ9PSAFL-Q5=T9.TENXQV]:\W^*
M+,WQ UHDY(F Y_W5P*YJWN9K.8303203#I)&Y5AGKR.:2::2XE:6:1YI6.6D
MD8LQ^I/6O-Q69/%4)4I1U<^;?RM;_@F<I\RL>S^--'G^)_A30K_03'<R6RE)
M;;>%*DA01SW!7\C7)^(O MGX+M=#^T7\DFNW%Q$9+-64QHNX9/3/H/?FN(M;
MVYL6+VMS-;,W4PR%"?R-,>:267S7E=Y<Y\QF);/UJ\1F%#$7JRI?O&DF[Z:6
MU2MOIW&Y*6MM3W'XA:;I^K?%3PU::IM-G);MN5C@.P8E5/L3BM*&S\0:?XWB
MM[/2M-TKPY'(!]HCB16D3'3/7<3Q@"OG^ZO[J^D22YNIKF11A6FD9R/H2:DE
MU>_F\OS+^Z?RSN3=,QV$=QSQ7?\ VU3]K.K[-IN2E=-)Z)+E;MMUTL5[36]C
MVZUS_P - 7?!_P"0>/\ T%*\A\;9_P"$RUS_ *_)/YUG?VM?_:OM7V^Z^T[=
MGG><V_'INSG%5Y)'FD:21VDD8Y9V))8^I/>O-QF81Q5-P4;7G*7W]")2YE8]
MJ^'U]<:;\%]4NK60PW$3SO'(H!*D8YYKS2_^(GB74[5[>XUBX>%QAE7:F1Z$
MJ!61'J%Y#:M;1W=Q';-G="LK!#GKE<XJMBIQ&95*M*E2IMQ48V>NC!S;22/5
M?A!>6^I^&=?\--.MM=W:,82QQNW)M./H<?G6A\,_!.H> ]2O]:U]H;"T@MVC
M!\T'=D@D\=N/QS7C:Y1@RL58'((X(J>ZU&\O55;F[N+A5^ZLTK.!],FNC#YG
M3IQI.I3O.E?E=[+YJW3R&II6NM4>I>"7UO4[?7=8\-:O$EU)=R3-HTT0(;+9
M!R3QD'],5M^)(?[2^'NI7OB[2;/3=3C#"V>/'F,V/DQWY/;/2O#;>XEM91+!
M+)!*.CQL5/YBGWE]=:@P:ZNI[IAT,TC/C\S6E/-HPH.G*#;::LW>-WULT[/T
M:0U4TL>J39_X9YAX_P"6G_M<UH>+-"O?$WPG\-_V8BW)MHHY)<.!A1$0WY&O
M&_[0N_LGV7[5/]E_YX>8WE]<_=SCK3K?4[RUA:&"\N(86^]''*RJ<]<@&E_:
ME.4>2<'9TXPWUTZ[![1=NECU'2_F_9[U#_KI)_Z-%7-4TZ3XF?#711H[QRWN
MG[5FM2X4Y"[2/ZCUKR%;^Z2T-JMU.MJQR8!(PC/.?NYQ3+:ZGLI/,MIY;>3I
MOA<H?S%2LT@XQI3A>/(H/6ST=[K0.?I;H>NWEH?AW\(;[3-4EC&IZBS[+=&#
M%=V!^@&<U%\4O^28>$/]R+_T37DUQ<37DADGEDGD/\<KEF_,T^>_N[J&.&>Z
MGFAC^Y')(S*O&. 3QQ14S2,J<Z,86BXJ*UVL[W?<3GI:QZEXD_Y-]TG_ 'X_
M_0FJ]\6/^0?X%_ZZQ_R2O('O[J2S6U>ZF>U7[L#2$QCZ+G%+<:E>72Q">[N)
MQ%S&))6;9_NY/'X4YYI&=.4.3>,([_R.]_F#J:6]#TC]H/\ Y&;3?^O0_P#H
M9KHOB5JD>AZUX#OYQ^Y@=F<XZ+B,$_@#7B=W?7.H2*]U<S73J,!II&<@>F2:
MF_M2XGN+62^EEU"&%P?)N)692N1E1D\ @8XIRS52J5YQC9U'%KRY7?7N/VFK
M\SUCXC?#F[\6>(5UNPO+4Z7<Q(9;B28 1*HP6]QCFJOQZ1(X/#B1OYD:Q.%?
MU&%P:I7D/P]UQ()XM4N="@ 'G::J.5<]3ZC/;-8?Q.\;6_C#4K1+")X].LH_
M+B\P89^F3CL. *]'&UL/'#XB4>7FJ..TN:^MWI9-+UUN7)JS\SCEIU-6G5\6
M<X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5\-_V9<PV[W%K?06+6ZAD&3&_&"",X[YK$\(Z[&NG:KI-WJ$FF-?,L\5^K,
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MB#_H!ZC_ . K_P"%5-0T'4M(C1[[3[JS1SM5KB)D#'T&11_PD&J?]!2^_P#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGASV?UAJ]GVOO'MT[?.V@E?J6_%7B>U\/^*M2L]/T733:1W+"47%N)&D.?F
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MOP[H]GJ[R(S7\LD"W$J2;C\FP_=7&,8%8'CB^M[Y?#_V>>.;R=*@BD\ML['
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M4 -VTNVEHH 3%)MIU% !28I:* &XHVTZB@!N*,4ZB@!NVEQ2T4 -VT8-.HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSWTWE6T,D\N"VR-2QP!DG ]!7?'Y=:^)/.<02<_]MA63\*^?&$?_ %ZW!_\
M(35'U./MJ=*_Q-K_ ,F:_07+JD4=<TBVL?#/AR]A5A/?13/,Q8D,5D*C [<"
MJ$'AW5;JT^U0Z9>2VV,^<D#%/SQ71:DK2>&/ *I;_:W*2XM_^>I\\_+^/2K^
MJR:HGB!KW4?%-KI%PLH(L[:X>4VX!XC"(-O'2MI86G.7,TTK0VLEK%-N[LOE
MNQ\J,/P7X/F\42WA:VNFMH;:5UE@0D&90"J$XZG/3K6'+IE[#??8I+2>.]R
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MPH] HHHKU2SS_P"./_(AR_\ 7Q%_.OG>OHCXX?\ (AR_]?$7\Z^=Z_*>)O\
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M<NFUKVULNE_D+F=@6EHHKD$%%%% !1110 4444 %%%% !1110 4444 %%%%
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M+*!<'!ZY%<YBC;4O&5'!TTDEKLN]K_D@YG:QLVFM0V_@_4-*9)#<7%W%<*P
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MUU&X222&$."L8!8Y0@8S[FL-:6EKE=23@J;V3;^^W^2)Z6"BBBL@/HCX'_\
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MOI5C6/"=UH]BE\)[6_L'?R_M5E+YB!NNT\ @_45DJ%5P]HHZ"L[7,6BNEM_
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M[-WXJ?\ (W.W\+6ENP/J/*7FNTTN".U72A=":.:/PS*\?D >:,N=Q3/?837
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MVXEO+(6$B@-@)A1D<]?E%=%/'4^5<SUTO_Y4_P#DD4I+^OF6_'GRV7A98O\
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M73,U2=HI]6-2O$U"]>XCM(+!&QBWM@0BX';))YJO7D223LG<@****D HHHH
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MF@4)%<7L):15'0$@C=C_ &LU!;^--1B\1_VW*T=S>!&C"R+A%5D*[0!C  /
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MLHB'D7^Z68D@>PKGEKFQ52G/E4-UO:Z7R3_';T%*W0=1117"2%%%% !1110
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ME52[!5!9B< #J33 2BGS0O;R-'*C1R*<,C@AE/H0:90 4444@"BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?7/ >B3644DQTOS;:[AC!+1$MN5RO7!SC/M6,XJ5."Y$W"+LN]IM:][*[_X
MNB_KJ4M2\.V$VC2ZMHEU/<6MNZI<V]T@6:'=]UCC@J>F16C<>#]&TK2=)U+4
MM2N(H+ZT658($5Y7D.<@=E0#;R?6H=%LY]#\%^(+V^C>W34(H[2UCF&UI6WA
MBP![ #K3/';'^S?"(SQ_8\7'_ FK)TZ<*3K2IKFY4[:V3YK7WZK6WZ"TM>Q0
M\3:';Z2FF7-E+)-8W]L)HWEQN# D.AQQP13=9T.'2-(T>9I'-]>Q-<21'&U(
M\X3WR<$_E6WX5TUO&OAE]#4_Z78W:7$)[^2Y"R_EPU8?C+5H]8\27DT'_'I&
M1;VX'01(-J_H,_C7/6I4XTG72TG:WD_M?<U;T:$TK7'>&]!AU:/4+N\N&M=/
MT^(2SO&F]SD[551ZD]STJS?:+H]YHMSJ.C7ESFT91/:7ZH)"K' ="IP1GJ.U
M.\%Q:K'#J=]HUPINK:-?-L3'YAN(B<-\IX8#N*TI(;?Q-X9UF]O-"AT>XLHA
M)%>VR-"DKDX\LH>"3[5I1HPG024/>:D];ZVOJFMK6V:7KJAI*Q1_X1[1]%L;
M237KJ\6\NXQ,EI8QJ6BC/W6<MW/7 J.3PC%'X@T6V2[-SI6JR)Y%VB[6*E@K
M @]&7TKJ/&6M$SV6HP>&-,U:QO+:(Q7<EO)(VX* T;%6X*D8QBHI+B[77O U
MK=V=CIA%XLZ:?:1LC0J\B\ON)Y;&<5V3PM!2=-+2+C;1ZW:6K>CNG?3Y:7*Y
M5L9D_A/P]I6M+I6H:I=->M<B)A;HNR!2V!O8]6Q@D <5SLWA^YB\2MHNW-T+
MK[,..^[ /Y<TSQ0[-XFU9B3N^URG=GG[YKOA(LGE^.B!^[TW:W_7\/W0_'&&
M_"N:-*EB9RA&/+R/I_+U;\UI]Y-E(PKK1+>STGQ>MAJ%R]E8SP1;"5VW!W,"
M6X[$'&/6J\GAW1]!M[8:]=WGVZXC6;[)8(A,*,,J79N,D<X%.\/.1\/_ !8[
M?,?.LV/O\[U+\1=/N=2UP:U:0RW.G:E&DD,L2EP#M ,9QT((QBJG&#H*O&%W
M;;6R3G/7Y62[:]PZ7L5Y? [7&L:=;Z;>)=6.HQF>&ZD79Y:+G?O'8KCFI;;P
M_P"&]8NQINEZI>G47)6":ZA5;>=^RC!W+GL36OX-TD>%=>M;:\:%M2U33ID^
MQ7 PL+MCRT?GJP'3CK3-#O+^XU^&SB\&:/8W<,@9YI+655M]IR78[^ ,9K:&
M&I>ZY02<G9KWG;1:*VSUOKJMNC'RKL<YHWAR":RU+4-6FFM++3Y%AE2! TK2
M,2 HSP.AR32ZMHNE-H_]J:->320I*(9K6\55F0D9##;PP..W2M;3;K6<^(-:
MTJY@O,W1%W8I 9$FC8DB78<Y7.?<9INH6EMK7@^_U>?18]#N[:6-(I+=6CCN
MMQPR[&[@<Y%<_L*;I<L8ZV;N[ZV;U35ULMG;[VA65CBZ*2EKPC,**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HI/TKIH?&=O##&A\,:'(54*7>!RS8'4_/UK:G"$K\\N7Y-_D-'-4#M
M]:W-6\30ZI9M FA:58,2#YUI$RR#'8$L>M8G<?6E4C&,K1E=?UW$SLOB@;C_
M (2Z3R_.V_9;?[F['^J'I3HVNC\+=4_M3S3']JB_L[[1G=N_CV9YV[?PK1^(
M?C/7='\3-:V.JW-K;);0%8HR HS&">WK7":MKFHZ]()-0O9KV11A3,^<?0=J
M]K%UJ5'$5W%MR?,K626NG=WMTT6IK)I-G2_%L_\ %;W'_7"#_P!%BE^&W^L\
M1_\ 8'N?_0:E^(EC<Z]>VWB"Q@DNM/O+:(&2%2WER*NUD;'0C'>D\)V=QX<T
M/7]6U"%[2">Q>RMUF7:TTC\?*#R0!R35N,O[2G5M[MY2OTMJ[A]NY+_9NH:E
M\,=%73K6ZNG2_G+BU1F(&T=<5-X$L=:\/ZI)>ZK!>6.AQPR"\^V!DCD4J0%P
MWWB3C&*K27%_;_##1#8274;F_G#FU9P2-HZ[:7P'<>);KQ):H[WT]@SXO%O"
M[0^3_%OW\ 8K6GR+$47:7-:&VVR_#N/J@\&++?>%=:L='G6WUV:>-E7S!')+
M;CJB,>^>H[U6TN[U_P !ZAYFJ:??-I\@*7-K<!O*F4C&,G*Y]Z;<>$[76-'O
MKW0%EN[FUOI5DMD.YA;Y/ENJ]3QUJWX#N/%0UJWMX?MDEAO NHKQ6-N(OXMV
M[@#&:RIJ2E1@TTU\+CJGJ^GYZ_(2Z#_!>FW&N>#?%]IIUNTTTKVYBA##.!)G
M&3@<"LO_ (5CXI_Z TW_ 'W'_P#%5KQ_9%\,?$+^S^+$74'D;>FSSN,>U>?[
MF_O-^=88CV$*=*-1-M1>J:2^.7]UB=K*Y[#-&T/Q0NXW7:Z:"58>A$(KQ\&O
M5;J^M['XJP+<RK!%=:5':>:QX0O#@$^V<?G7GEYX5U?3KYK.;3;H3JVT*L3,
M&]U('(-;9E%S;<%>TY_C:PY_J='?_P#(A^$/^O\ G_\ 0EJW\1O#^NWGC?5Y
MK33M1FMGD4I)#"Y0C8O0CCK57Q)&='T7PKH<_P NH02M<W$603%YCC:I]\#.
M*F^)%[K<?CC5TMKC4DMQ(H187D" ;%Z8XK6LH*C*-1/3V:TWNH._]=QO;7R_
M(CULWNF_#V#3];\Q=0>]$MG!<',L4(7#GGE5)Z UBZ\P_P"$3\-<Y.RZSS_T
MT%;N=0G^'>JR:_YS!98O[->\SYGF9^<(3R5V]>U<'7#C)\MK7M*"6NZM+K]V
MGDT1(]0U&.UUS5KBWO9$6+2##?$L1\]N84\Q!_P(+Q_M&N7\;:C)JMKH-Y*<
MRS6DDC#/3,[G%<QBBLZV.=:,ERVYM_O37W+03E<6BBBO+)"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ^B/@?\ \B'%_P!?$O\ .BCX'_\
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M ]345%+FEW MZAK6HZM'#'>WMQ=I",1+-(6"?3/T%4Z6BB4I3=Y.[ ****D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG;Z5.KJ5:VC@>+Y25*8PV00/6IGEZJ8F=.EI[S223=M=+OHO/47+=M(\I_B
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M?FGU7W XV,NBBBO/)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<MYMS9W:.)H7/W@@ ^?GIR.M;FN>(+'0=>\.3)',-)FT1;9T'$JPON&[_>&
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MM/K-HQLKZ<K3ZV=U^FSOH',=EI5CH?A*\CU.[UBUUFXMSYEO8V(9E=Q]TNQ
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M<\\5SFWWHP:53%.<'",4KV;M?IY7LOE^0G+2PM+117"(**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^B/@?_R(<7_7Q+_.BCX'_P#(AQ?]
M?$O\Z*_;LJ_W"C_A7Y'I0^%'H%%%%>J6>?\ QP_Y$.7_ *^(OYU\[U]$?''_
M )$.7_KXB_G7SO7Y3Q-_OR_PK]3AK?$%%%%?)& 4444 %%%% !1110 ?A1Q1
M10 4F*6B@ HHHH **** "BBB@ HHHH **** #CTHHHH **** "BBB@ HHHH
M**** "BBB@ X]**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M14C:?PK2GAN:"G*:C?:]]?N3_&P[=3E**U/$&AMH>NW.FK*MV8V CDBY\Q2
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M17[=E7^X4?\ "OR/2A\*/0****]4L\_^.'_(AR_]?$7\Z^=Z^B/CA_R(<O\
MU\1?SKYWK\IXF_WY?X5^IPUOB"BBBODC **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:=K:;;W[A%JUCF=4LAINJ7=F)5G%O*T7FJ,!MIQD?E72VO\ R2G4O^PI#_Z
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MN6< +@D]S@XS["LZXOK1M T>/Q-IUV56 _8=0L94#/%D_(V[(.#GW%:&O:I
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M]4N]0N-HGN9#(P4< GL*K5\_4Y>=\NUS(****S **** "BBB@ HHHH ****
M"BBB@#Z(^!__ "(<7_7Q+_.BCX'_ /(AQ?\ 7Q+_ #HK]NRK_<*/^%?D>E#X
M4>@4445ZI9Y_\</^1#E_Z^(OYU\[U]$?'#_D0Y?^OB+^=?.]?E/$W^_+_"OU
M.&M\04445\D8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?4ON8?7\)_S]C]Z/4**\O_X:2\!_]!.;_P !G_PH_P"&DO ?_03F_P# 9_\
M"CZAB_\ GU+[F'U_"?\ /V/WH]0HKR__ (:2\!_]!.;_ ,!G_P */^&DO ?_
M $$YO_ 9_P#"CZAB_P#GU+[F'U_"?\_8_>CU"BO+_P#AI+P'_P!!.;_P&?\
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MAB_^?4ON8?7\)_S]C]Z/4**\O_X:2\!_]!.;_P !G_PH_P"&DO ?_03F_P#
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MO_X:2\!_]!.;_P !G_PH_P"&DO ?_03F_P# 9_\ "CZAB_\ GU+[F'U_"?\
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M)_S]C]Z/4**\O_X:2\!_]!.;_P !G_PH_P"&DO ?_03F_P# 9_\ "CZAB_\
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M?4ON8?7\)_S]C]Z/4**\O_X:2\!_]!.;_P !G_PH_P"&DO ?_03F_P# 9_\
M"CZAB_\ GU+[F'U_"?\ /V/WH]0HKR__ (:2\!_]!.;_ ,!G_P */^&DO ?_
M $$YO_ 9_P#"CZAB_P#GU+[F'U_"?\_8_>CU"BO+_P#AI+P'_P!!.;_P&?\
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MAB_^?4ON8?7\)_S]C]Z/4**\O_X:2\!_]!.;_P !G_PH_P"&DO ?_03F_P#
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MO_X:2\!_]!.;_P !G_PH_P"&DO ?_03F_P# 9_\ "CZAB_\ GU+[F'U_"?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@_WQ?X5^H4445](?-!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJRMP49)Q]::DFW'L)Q:2EW%HI%8-R#D4%E7)+  <'FJ)%HH!#<@Y%(653@L
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M!^\_TS'S>O''-:/B;QVN@_$_4M)T[1]*71O[2:"YMYK-)&N<OAR7(RO)( 7
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M):6WLU]Z?7NU\^AEC'S13;UOM=/[FNG9/Y=3(HHHKUCR0HHHH *"<#)X%%%
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M5P-T0E\H@,R_Q #)P>,@4RWUH_$3P/XK;5[.R.I:1;QWMI>VMK' X&\*T;;
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MM^$?"OB;['!87U])/:WWV.(1QR-&5Q($' )#<X]*[?6HM;TF\C?PAX=TK7?
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MEB)N5]5'HW_-V1S^SE5P\%&VCEU2_E[LM>(/],^#_@BXFYGAO[NUC)ZF(,I
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_ ,_P#Q=/\ MC _\_/P?^1/]CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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MT,\7_@&?_BZ/[8P/_/S\'_D']CX[_GW^*_S/GFBOH;_AD*Z_Z&>+_P  S_\
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M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
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M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
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M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
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M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
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M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
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M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
M?N]_PEFA_P#09T__ ,"H_P#&C_A+-#_Z#.G_ /@5'_C7X0[V_O-^9HWM_>;\
MS1_9:_G_  #_ %JE_P ^?Q_X!^[W_"6:'_T&=/\ _ J/_&C_ (2S0_\ H,Z?
M_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P" ?N]_PEFA_P#0
M9T__ ,"H_P#&C_A+-#_Z#.G_ /@5'_C7X0[V_O-^9HWM_>;\S1_9:_G_  #_
M %JE_P ^?Q_X!^[W_"6:'_T&=/\ _ J/_&C_ (2S0_\ H,Z?_P"!4?\ C7X0
M[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P" ?N]_PEFA_P#09T__ ,"H_P#&
MC_A+-#_Z#.G_ /@5'_C7X0[V_O-^9HWM_>;\S1_9:_G_  #_ %JE_P ^?Q_X
M!^[W_"6:'_T&=/\ _ J/_&C_ (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>
M;\S1_9:_G_ /]:I?\^?Q_P" ?N]_PEFA_P#09T__ ,"H_P#&C_A+-#_Z#.G_
M /@5'_C7X0[V_O-^9HWM_>;\S1_9:_G_  #_ %JE_P ^?Q_X!^[W_"6:'_T&
M=/\ _ J/_&C_ (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /
M]:I?\^?Q_P" ?N]_PEFA_P#09T__ ,"H_P#&C_A+-#_Z#.G_ /@5'_C7X0[V
M_O-^9HWM_>;\S1_9:_G_  #_ %JE_P ^?Q_X!^[W_"6:'_T&=/\ _ J/_&C_
M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
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M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
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M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
M?N]_PEFA_P#09T__ ,"H_P#&C_A+-#_Z#.G_ /@5'_C7X0[V_O-^9HWM_>;\
MS1_9:_G_  #_ %JE_P ^?Q_X!^[W_"6:'_T&=/\ _ J/_&C_ (2S0_\ H,Z?
M_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P" ?N]_PEFA_P#0
M9T__ ,"H_P#&C_A+-#_Z#.G_ /@5'_C7X0[V_O-^9HWM_>;\S1_9:_G_  #_
M %JE_P ^?Q_X!^[W_"6:'_T&=/\ _ J/_&C_ (2S0_\ H,Z?_P"!4?\ C7X0
M[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P" ?N]_PEFA_P#09T__ ,"H_P#&
MC_A+-#_Z#.G_ /@5'_C7X0[V_O-^9HWM_>;\S1_9:_G_  #_ %JE_P ^?Q_X
M!^[W_"6:'_T&=/\ _ J/_&C_ (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>
M;\S1_9:_G_ /]:I?\^?Q_P" ?N]_PEFA_P#09T__ ,"H_P#&C_A+-#_Z#.G_
M /@5'_C7X0[V_O-^9HWM_>;\S1_9:_G_  #_ %JE_P ^?Q_X!^[W_"6:'_T&
M=/\ _ J/_&C_ (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /
M]:I?\^?Q_P" ?N]_PEFA_P#09T__ ,"H_P#&C_A+-#_Z#.G_ /@5'_C7X0[V
M_O-^9HWM_>;\S1_9:_G_  #_ %JE_P ^?Q_X!^[W_"6:'_T&=/\ _ J/_&C_
M (2S0_\ H,Z?_P"!4?\ C7X0[V_O-^9HWM_>;\S1_9:_G_ /]:I?\^?Q_P"
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MG+NS\RXGJ2EBHTWLE^;"BBBO7/C@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /9_A5^R_KOQI^&NM^)?">IV>HZQI,XAF\-
M[2ETZG&UU<D+@@L1G^XPZT[_ (8R^-7_ $(%_P#]_H/_ (NN0^#?QF\2? SQ
MI!XC\-W 28#R[FTFR8;N+.3'(/3T(Y!Y%?=MEXNG_;+T275?AE\1O$WP[\:V
M,*_;M">YE-B>P(*\#/\ >7GU6O.K5*U&5].7OV^X^EP6%P6-IJ.JJ+HFO>\U
M?KY'R!_PQG\:O^A U#_O]!_\75;XS_LVZQ\"?"OAG4?$NK6,>MZV"_\ PC\0
M+7%J@&69V!V\$J..Y.,X-?8FO?$\?L7Z/CQKX\\2?$[XB7]MNM]+N+F5=/A!
M_B^;C /\1RQ[!:^!_B?\3_$'Q@\8WOB7Q+>&[U"X^557B.",?=CC7^%1_B3R
M:=&I6K2N[<OY_>3CL-@L'3<(W=5]&U[OK;KY'*4445Z!\X%*K-&RNC,CJ0RL
MIP5(Z$&DHH _9[]EKXE3_%GX$^%/$-Y)YNHM;FVO)#U::)C&['W)7/XT5YO_
M ,$Y6+?LUVH)X75;P#_OH&BOBZ\5&K)+N?M^ J2JX2E.6[2_(^H****P.\^8
M/^"C7_)M5Y_V%+/_ -#-?E17ZK_\%&O^3:KS_L*6?_H9K\J*^FRW^#\S\MXE
M_P!]7^%?J%%%%>J?)A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(MV&/D/^_611@CJR#\J7UN,82E)-..Z]2ED]2=6G"E-.,[VEK;3>_4^)=P&
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M,KJI5/:1O:QY.*P_U:IR*:DM[H****V.,**** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MH-"^(7BKPOILVGZ-XEUC2-/F9GDM;&^EAB=B "656 )( '/8"N?HI-)[E1E*
M+O%V#IP.****9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZJP."#]"#6\9J3M:S."K0E32DFFGU1T?PZ^'/B#XL>*K?PWX7L1J.L3QO+'
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M?1B.]#KKF?+JDKE0P#]G'VJ:E)M+[M/QT/G*BD4[E!]J6NL\8**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBD\Q?[P_.@!:*0,&Z$&N[^!?@6#XF?&+
MPAX8NR19ZEJ,<=QM."8AEY /<JK#\:F4E%.3Z&E.G*K.-..[=BSX)_9^\?\
MQ"TE=6T;P^_]D.=J:C?W$5G;R$=0DDS*&_#-9/C_ .$_B[X7SV\?B?0[C2TN
M/^/>Y.V2"?'79*A*-^!K9^/GQ*U'XE?$;5I9Y6BT:PG>QTK2XSMM[*UC8I''
M&@X'"@GCDDUW7[+>J7'CR?7_ (2ZQ-)?^'?$&EW<]I;S-O%C?01--%/%G[AP
MA4XQD'FN=SJ1CSRM;M_P3T8T</4J?5X7YMD]+-^EM+^I\_T5[A\,OA7X)U7X
M$>)/'?B^[U*TFT77H;$Q:<RE[J-H<^1&K?*'9R/G/W5#<&H]2\#_  _^('PM
M\5>*O UEK/AO5/"WD37VDZM?)>QW-K*_E^;'($0JRL1E2,8-7[:-[6\C+ZE4
MY5*ZNU=+K9;_ )'B=%>V'P!X#^%'A'P[J/Q"MM8\0^)/$%HNHV_A_2;M;)+.
MS8D1R33%')=\$A .!U-<]\3/!'A2+1_#?B/P%J5S=Z;K;R6TFAZA(CZAIURA
M \MMOWT;<"KX&>G6FJJ;M;YD2PLX1;;5UJUU5_ZVW/-*T?#?A^_\6^(=,T/2
MH/M.IZE<QVEK#N"[Y78*J[B0!DD<GBO9O$_@WX6_!75$\+^,;'Q!XO\ %<44
M9U:32-0CL[;3I74,88\HQF=01DG:,\5I^%OAC8> _P!H?X+ZOX>U*;6?!WB3
M5[&]TF]N8Q'.H6Y198)5' DC;@XX.0:AUE:Z^7F;1P4N=1DT[-*26ZN[?UO9
MG@&KZ5=:#JU[IM['Y-[9S/;SQA@VV1&*L,C@X(/2JE>Y0?#'3?&7Q'^*OB/Q
M/J-QI'@WPUJ-S/J%Q9QA[B>22X98;>$-\N]V[G@ $U+X;\#_  R^-LUWX?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9?9ES?<M%]Z/-M_F$OC&X[L>F:2BBNH\H**** "BBB@ HHHH **** "BBB@
MHHHH **** +FCZI-H>KV6I6Z0R7%G.EQ&ES$LL3,K!@'1@0RY'*G@CBO6/\
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M_>N73]>IQ5:O+A(4W;F?G]E:I/YM_<AM%%%=1Y04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =YX ^,VN?#?2
M[C3]+T[P]>03S&=FU?1;>]D#%0N%>120N%'R],Y/>NG_ .&JO%W_ $ _!/\
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MM%%)YB\_,..O-49BT4;AG&>>M&0,9[]* "BBB@ HHHH **** "BBB@ HHHH
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MOIW\MG^9VU'&7M$FE&\M4U;=VNM[]FGVMJ?-C?=->[?M.?\ (J_!'_L2H?\
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MEK&KKGU# @CL17#3A=4T^W^1[]:MR2Q,H-7<]/3WMCN_"MYX@M_"N@6OP?\
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M;3A?PAH]YM(CF7&&D1!N81D[2Q!(-:?PMNM,^ 5_?:KK'Q;T3Q5X6:QN+?\
MX171+F>[.J[XV5(Y(70)"N2&))R,<5#\/;#PUK7[&=YI7B35/^$?6]\;N+#5
M7A:6&UN%LXF E"_,(V7*E@#C(.,"L]E;I=;7_(ZDN:5[^]RRWL[;6N]O2]K>
MAF^"/$%O^TM8^(O"OB+0=#LO$UMI5QJFAZSHNG1V,@E@7S&MY5B 5T= W49!
M%8'B0K)^Q_\ #PEMB-XIU3+ 9P/+AYQ6MX57PW^SKI/B/7/^$ST3QAXQU'2Y
MM*TFQ\.2O<0VHG7;)<S2LJ@%4R @R26K&3QCH%E^S_\ #73[B:WU&[TKQ;=W
M]]HX<>:;8^21N7LKA64&M/M)P7NW_1G/=>S:JM<_*[^G-&U[==_.UCT5=0\7
M^9##\)/A'9OX!BBCC@U#Q#X<BDEU3"C?+-//T+-GA&  Q6OHGPP\.^&?V[/#
MVAG1K2#1+[3CJ-QI.%N+>!Y--DDD2/=D,JODKUQ@8Z5RWQHTG0/BUXWU;QA/
M\:=(;P;>O]HBTN>6<ZC:0XXM4LMNW*@;000O0UUB^/O Y_:E^'GCJR\4:;!X
M6FT!K-H[FX_TC3FBTZ2!8[H8PK,Q4#!.<UAKRNW5/OOY^9W^YSQYFM)QMK&U
MKZV2V6W4X'X??&C3-8^)6C^#G\!^%V^'VH:BFF_V:VF(UWY,C[!*;H_O3+R&
MW;L9[8KLO@[XEU3X4W7Q^\&Z?'I=Q8^%M,U)[66[TR":61X[R.,"5V4F1,?P
M-E<\XXKYO^%^H6NE_%3PK?7EQ':V5OK-M--<2G"1QK,I9B>P &:]M\,^,/#.
MJ_&[X]6EQXDT_2M/\96^J66EZS=N19EY+Q98V=P#M1E7[V.XK:K32NDM+?J<
M.%Q$I6DY6E=I=-'';TO;R/G?Q!KMSXGUJ]U:\2WCNKR0RR+:0)!$&/\ =C0!
M5'L!BO7OV6K74M!\4WWC6:;3[#P1I<+67B"ZU8MY%Q;SJ5:U15!:25P,JJC@
M@$X%>0^(-''A_6[W31J%EJHM93%]MTV4RVTV/XHW(&Y?? KUSX=ZYX;\;_!2
M]^&>M^(+?PAJ4.M?VYIFIWRN;*X9HA$\,[*"4( !5R"!D^M=%7^'9;/\CS<)
MIB.:3]Y7:UW?:_\ 5]CM/BMX?@L_!?AKP/\ !S1[C5/!WC>[6]76))1)=:E=
MQ[MMDXP!#Y']P\G[V:^8[BWDM;B6"5=DL3E'4]F!P1^=?6/P5\<>$OV8X[RR
MUSQW9^,'U:XC\JR\,(;NTTB7E?[1\V15!E16("(,D9R>E?,WC?P_#X7\5ZGI
MEOK-EXAMX9CY6J:?+YD-RAY#@]B0>0>0<BLZ#:;CT[]SHQ\8RC&JGKLXJUH]
MDK=]7^>IZY\%_P#DVSX^_P#7GI?_ *6+71:YXGTCX8_LY_!O6=-\,Z+>^+]0
MAU(#4-2L8[A(XDO'!<QL-LDAX4,^=JC '-<3\*?%.D:/\!?C3I-]J-O:ZGJM
MKIR6%I(^)+DI=*SA!WPHR:@^*7B;2=6^!?P8TNRU"WN=2TJUU..^M8WS);,]
MXSH'';<I!'M4.+E.S6G-_P"VFT:JIX=.+5U3_'VGYV/1?&GCC0]'^$?@7XGV
M/@GP_#X]\0RW>GW$SV"/8)]F<;ITM#^[$KB1 200 #@#-<_X^73_ (B?!WP'
M\1)]%TS2O$4GB630-1.E6JVT%ZBJDL<C1+\H8 E3@#.:YCQUXETJ_P#V<?A9
MHMMJ%O/JVGZAJ\MY9H^98%D>'RRX[!MIQZXJ]'XJT=?V9?">AG4K<:Q;>.9-
M0FL=_P"]CMS;HHE([+D$9H4>5)K>[^[7\"Y5E4E*$FK<D7T^*T6WZWN>B?'S
MXLZ9\*?V@?$F@^%O!7A<Z/#?*-2CU'2HKA[QF"F1 6'[E "541[<8SDDUG_'
M+QSI?[/GQ8U?PGX!\(>'H=+M_*N;MM:TZ/4);AIHUF,0>4$I$JR!%"8/!))/
M->9_M+>(-,\3_M">,M7TB^@U'2[K4O-@O+=P\<B87Y@1U'%6/VK_ !)I7B[X
M]>)]5T34(-5TR=+-8KNU??'(5LX4;![X96'U!HITU[B:Z:^N@L1BI)5G%JZG
MIMHO>O;RT1ZYHGP_\-:5^W-X'T^PT>VC\/:S!;:M_9$R"6"'S[)Y&C"MD%0W
M(!Z<>E?.'AB&.3XFZ3"\:/"VLQ(T;*"I7SP,$=,8[5[AXF^,>@^%_P!I_P"'
M7C6TO(]8TC1]'TF&\>Q82%=MKY4RCU90QX]1BL_1_A[\/O!?Q/T_Q9>_$S0-
M;\)PZHM[;6.FM*VHSCS0T<<L3(!"!D;F9N #CM2A)Q5Y7U2_4JM3A5E:G;2;
M;U2T?+^&C._MM-\*:'XR_:KO-6\-6&J:=HL\3V>GM$$1'^V,$12H!1"VT,$Q
ME<BN,^&_C*#X_6'C'PKXH\,^';=[7P_>:II%_HVE164]C-;IY@7=&!O1E!4A
M\GWJWXE^('ANZO?VI6BUNRD7Q%<6[:05E!%\%OB[&+^]A>>.U>>_LT^)-*\+
M^+O$ESJ^H6^FV\_A?5;6*2X<*'FDMV5(QZLQ. .]3&#Y)2>ZM;[D:U*T56IT
MTUROFOM_-+?Y;&KX+M=)^$_P/L?B+=Z)8>(/%'B#4YK#18=6A\^ULH8%'G7!
MB/RO(78* V0.N*U-#U2R_:/\$^-+35] T?3/&_AW2I-=T_6-%LDLA=00E?/M
MYXHP$;Y6!5@ 0>M87@7Q!X<^(7P;@^&_B36X/"VJ:3J,FI:%K%\C-:,)5 FM
MIBH)0$J&#XQGK6K8S>&OV?O!'B^.T\6Z5XQ\<>)=.;185\/L\MGIUI(09Y'F
M95#NP4*JJ..IJY+5W^*^GI_E;<P@U:-FO9<NNV]M?.]]OET-/POX+F^)'[/_
M ,)/"]O+Y$FK^.KZT\W^XK1P[F_!<G\*S/%GQYT[P/XLU'P]X+\$>%3X,TVX
M>S6#5M*CN[C4E1MIEFG;YPSX)^0K@$5%X=^*EKX%^"?PRN=,O;:;Q'X?\97>
MJOIN\>8(MD6TLO96VLN:?XI^&/@'XA>*;_Q1X?\ B?X>\-^'-2G:\FTW7/.C
MU#3V<[GB6%4(FVDG:5;!&*22N^=::_G_ %8J4FX+ZNUSVC?5;<J[^=[_ "N7
M]8^ ^A>+OCK\.]/\.B;2?"/CRQAUJ*WWEY+"$AVN8E8]=OE2;2>Q6LO4OV@M
M%3Q)/H<'P_\ #"?#99VM?[-_L]#>-;AMOG?;/];YV/GW9QGMBI]6_: TW1_C
MEX$USPO9W-SX4\$VUOI&GP3KLGO+5 PF=AV:3S)"!V!4&J^L?"?X<-XBG\26
M_P 3]%F\#O.UW_9@64:WL+;OLHMMF-_\&_=M[T]=/:7VT_KOL*37O?56K\VN
MVUEW^S>_X>1ZSXRT'PW??M8>//ANFEZ=::9XJT6'3]+<6T:?9+P6L<MM(A"_
M(69=K$8SO.:\7_9\T6W\.ZGXU\9:_IT-S:^#=*G86E["'C?4)28+>-E88)#L
MS8(_@)[5N?MAZY/H7[5>KZMI;FUNK$Z=<VQ!^:)DMH70'W&!71_M5>(="TWP
M3I</AO,)^(MVOC74X-NTP QA(X/=?--P_P!3[U$+\L8_S)?\'\#:LX>UJU'O
M2E+\7I]TOS/EO<6Y;ECR?K1117I'RX4444 %%%% !1110 4444 ?JK_P3C_Y
M-KMO^PK>?^A+11_P3C_Y-KMO^PK>?^A+17QN)_C3]3]JRO\ W&C_ (4?4-%%
M%<QZA\P?\%&O^3:KS_L*6?\ Z&:_*BOU7_X*-?\ )M5Y_P!A2S_]#-?E17TV
M6_P?F?EO$O\ OJ_PK]0HHHKU3Y,**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [KXF?$Q/B'I/@
M6R73FL3X9T&+16<R[_M!1W;S ,#;G?TYZ=:X6BBIC%15D:5*DJLN>>X44451
MF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[9)Z5Z9\6/$WP6A^*GC./4? ?BRYU!=:O5N9X/$,4<<DHG?>RJ83M4G) R<
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M*7( ] *\[;5[SX7_ +*?ABY\.7,NG:EXUU2]_M74[5BDWD6Q"1VN\<JI)+D
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M8A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFCZ>FK:M96,EY;Z<ES,D+7EXQ6& ,P&^0@$A1G)(!X!KUS_AG/2?^BT_#/\
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MXA@U=;H;?)$20LA4\[MV6';&.]><T4W%-)=A1K3C*4UN[W^9[#HWQ2\&^+O
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MH44451F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIYMZ-HRP0%0DK 9XC9CP:\Y\%>!=<^(?BBU\.Z#8/>:M<,P$1(01A02[R,V
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MC*L 1D<4>TCS<M]0^KU53]KRZ'$T445H<X4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 445M>"5#^-/#RLH96U&W!5AD']ZO!I/17*BN9I&'YJ?WU_.G!@
MW0YKZM_:)_:=^(_@?XX^-?#^B:Y:V.D:?J#06ML-)LW$:!5.,M$2>IZFN?\
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M'5-0TR!;718BMEID"*%"6D*B.'@=RJAB?5C7&TXMM)LBI%1FXQ=TNH44451
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MH*H_A?&U_0BOE7Q-\2-4\6>#/"/AF\BM4T_PQ%/#9/"C"1UED,C>822"<GC
M'%7/@_\ &#Q'\#_&D/B;PS-$EXL;02P7*EH+B-NJ2*""1D C!!! -<LJ,G3:
M7Q:_BSUZ>.IQQ"<]86A?R<4E=>C^]'OG@/\ X1F/PS^TO)KZZRT/]LQI>?\
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MR HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCY#?7 ,,</U6Z9SZC;FO'_!EQ-X'^$'B[QU=NQUWQ/*_AW2I&^_M;$E_./\
M@)2//K(?>NK^+&K:_P##?]F?P3\+M>W6FM7E_/K-UILHQ/96@;%O#*.JEG,D
MFT]..*\7\4>.M0\5Z-X:TJXCM[;3_#]FUG9P6RE5.YS))*^2<R.S9)X' X%1
M3@Y+RV^2_P S?%5H4IV2L[7MVE*U_N6WF<YC%%%%=QX 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M ?JK_P $X_\ DVNV_P"PK>?^A+11_P $X_\ DVNV_P"PK>?^A+17QN)_C3]3
M]JRO_<:/^%'U#1117,>H?,'_  4:_P"3:KS_ +"EG_Z&:_*BOU7_ ."C7_)M
M5Y_V%+/_ -#-?E17TV6_P?F?EO$O^^K_  K]0HHHKU3Y,**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *='(T,BR1LT
M<BG*NI((/J".E-HH LWVI7FINKWMY<7CJ,*UQ,TA ] 6)Q3?M]U]C^Q_:I_L
M>[?]G\UO+W?WMN<9]\5!12L5S/>X4444R0HHHH **** "BBB@ HHHH ****
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MF(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[WAW_P &+_\ QJC_ (=N_&#^]X=_\&+_ /QJOU0HI_VC7\B?]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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MP?WO#O\ X,7_ /C5'_#MWXP?WO#O_@Q?_P"-5^J%%']HU_(/]6\#Y_>?E?\
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7I/0]+!Y3A,$^>E'WN[U84445R'KG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>iclr-20211231_g6.jpg
<TEXT>
begin 644 iclr-20211231_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)Y<FYE+"!%
M86UO;FX   60 P "    %   $*:0!  "    %   $+J2D0 "     S W  "2
MD@ "     S W  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% %74K"/4M/EM9> X^5O[I[&O+;B"2UN)()EVR1L58>]>N
M5R'C32>%U*%?1)L?HW]/RKY;B' >VH_6(+WH[^G_  /\S"M"ZNCCJ***^ .0
M**** "BBB@ HHHH ***55+, H))Z "@!**M+IE^XREE<,/:)C_2G?V/J0&?[
M/NO^_+?X5LJ%9[1?W,=F4Z*EEM;B#_7P21_[Z$?SJ*LG%Q=FA!1112 ****
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M /?]?\*\9HH_L_#]OQ8?V9A?Y?Q9[-_PO2R_Z D__?\ 7_"C_A>EE_T!)_\
MO^O^%>,T4?V?A^WXL/[,PO\ +^+/9O\ A>EE_P! 2?\ [_K_ (4?\+TLO^@)
M/_W_ %_PKQFBC^S\/V_%A_9F%_E_%GLW_"]++_H"3_\ ?]?\*/\ A>EE_P!
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M_NCL![ <54KKC'E5C]2RW!K!X=4^N[]0HHHJST0HHHH **** "BBB@ HHHH
M**** "BBB@#U[X=^(/[4T;[!</FYLP%&3R\?8_AT_+UKL*\#T'6)="UJ"^AR
M0C8D0?QH>H_SWQ7N]M<Q7EK%<V[AXI4#HP[@URU(V=S\ZSW _5L1[2"]V6OH
M^J_4EHHHK,^?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBJ.M:M;:%HUSJ5ZV(;="Q&>6/91[DX'XTTFW9#2<G9'GGQD\5_8]/C\/V<
MF)KH"2Y(/W8\\+^)'Y#WKQ6KFL:I<ZWK%SJ5ZVZ:XD+MZ#T ]@,#\*IU]7AJ
M*HTU'KU/M<)AUAZ2AUZ^H4445TG4%%%% !1110 4444 %%%% !1110 4444
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M;4XW=SZOA[ ^TJ/$S6D=O7_@#****Z#[H**** "BBB@ HHHH **** "BBB@
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M<6J;EIW3=OO6YR>K:>VDZO<V,C!S Y7<!U'8_E6IX+\0'0=>1I6Q:W&(YQV
M[-^!_3-,\:_\CEJ/_70?^@BL&KC[T%<]R,%B\(HU=>:*O\T?1P.1D<BBN/\
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M>/)K&1E-UK!UO7W;-Q<6[ 6MN@'$2<<_4<5Q=;1UNSCJZ-1[!1115&04444
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MT5Q;VD<<B-U!#FO.:I2O*R\C&4.6*;WU_ ***?#%)<3)# C22R,$1%&2Q)P
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M(\6:0;'6;6.ZMV^9&_B0]F5AT/N*\$\8? ;6=(9[GPRYU:S'/E'"SH/IT?\
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M;Q_5?K]YS-%%%;GV@4444 %%%% !1110 4444 %%%% !1110 4444 %* 2<
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MR/\ &C_A7WBO_H!W7_?(_P :/;4OYE]X>WH_S+[T<Y171_\ "OO%?_0#NO\
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M4>UD)\28MJRC'\?\R&SM(;"RAM;9=D4*!$'L*FHHK(^:;<G=[A1110(****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX-05[QXR^%\7BG6O[2MKY;&1D"S#R=_F$=&ZC!QQ^ KG_P#A1LG_ $'U_P#
M0_\ Q==*J1MJ?*5,LQ$9M0C=?(\GHKUC_A1LG_0?7_P$/_Q='_"C9/\ H/K_
M . A_P#BZ?M(F?\ 9V*_D_%?YGD]%>L?\*-D_P"@^O\ X"'_ .+H_P"%&R?]
M!]?_  $/_P 71[2(?V=BOY/Q7^9Y/17K'_"C9/\ H/K_ . A_P#BZ/\ A1LG
M_0?7_P !#_\ %T>TB']G8K^3\5_F>3T5ZQ_PHV3_ *#Z_P#@(?\ XNC_ (4;
M)_T'U_\  0__ !='M(A_9V*_D_%?YGD]%>L?\*-D_P"@^O\ X"'_ .+H_P"%
M&R?]!]?_  $/_P 71[2(?V=BOY/Q7^9Y/17K'_"C9/\ H/K_ . A_P#BZ/\
MA1LG_0?7_P !#_\ %T>TB']G8K^3\5_F>3UT'@KPT_BGQ-!98(MD_>7+C^&,
M=1]3T_&NX_X4;)_T'U_\!#_\77<>"?!D/@[3YH5F%S<3ONDGV;<@=%QS@#GO
MW-3*HK:'1A\MK.JO:QM'Y'211)#"D4*!(T4*JJ,!0.@%.HHKG/J0HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748560024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-08704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICON PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">South County Business Park,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leopardstown,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 18, D18 X5R3,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D18 X5R3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">ORDINARY SHARES, PAR VALUE &#8364;0.06 EACH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICLR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity common stock, shares outstanding (in shares)</a></td>
<td class="nump">81,554,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filler Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001060955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">South County Business Park<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leopardstown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D18 X5R3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Brendan Brennan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">Brendan.Brennan@iconplc.com<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">291-2000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755940408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor firm ID</a></td>
<td class="text">1116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor name</a></td>
<td class="text">KPMG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor location</a></td>
<td class="text">Dublin, Ireland<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357746871832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 752,213<span></span>
</td>
<td class="nump">$ 840,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 3a)</a></td>
<td class="nump">1,712<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net (Note 18)</a></td>
<td class="nump">1,342,770<span></span>
</td>
<td class="nump">715,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled revenue (Note 18)</a></td>
<td class="nump">623,121<span></span>
</td>
<td class="nump">428,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NontradeReceivablesCurrent', window );">Other receivables</a></td>
<td class="nump">56,760<span></span>
</td>
<td class="nump">35,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and other current assets</a></td>
<td class="nump">114,323<span></span>
</td>
<td class="nump">53,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable (Note 14)</a></td>
<td class="nump">50,299<span></span>
</td>
<td class="nump">28,118<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,941,198<span></span>
</td>
<td class="nump">2,102,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Other Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net (Note 7)</a></td>
<td class="nump">336,444<span></span>
</td>
<td class="nump">174,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 4)</a></td>
<td class="nump">9,037,931<span></span>
</td>
<td class="nump">936,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets (Note 5)</a></td>
<td class="nump">4,710,843<span></span>
</td>
<td class="nump">66,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets (Note 23)</a></td>
<td class="nump">198,123<span></span>
</td>
<td class="nump">84,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">70,557<span></span>
</td>
<td class="nump">20,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Non-current income taxes receivable (Note 14)</a></td>
<td class="nump">18,637<span></span>
</td>
<td class="nump">17,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset (Note 14)</a></td>
<td class="nump">48,392<span></span>
</td>
<td class="nump">12,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments (Note 3c)</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">4,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Investments in equity-long term (Note 3b)</a></td>
<td class="nump">22,592<span></span>
</td>
<td class="nump">15,765<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">17,387,090<span></span>
</td>
<td class="nump">3,435,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">90,764<span></span>
</td>
<td class="nump">51,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue (Note 18)</a></td>
<td class="nump">1,323,961<span></span>
</td>
<td class="nump">660,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities (Note 8)</a></td>
<td class="nump">949,629<span></span>
</td>
<td class="nump">399,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable (Note 14)</a></td>
<td class="nump">59,433<span></span>
</td>
<td class="nump">12,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Current bank credit lines and loan facilities (Note 24)</a></td>
<td class="nump">55,150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,478,937<span></span>
</td>
<td class="nump">1,123,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Other Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Non-current bank credit lines and loan facilities (Note 24)</a></td>
<td class="nump">5,381,162<span></span>
</td>
<td class="nump">348,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities (Note 23)</a></td>
<td class="nump">159,483<span></span>
</td>
<td class="nump">60,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Non-current other liabilities (Note 9)</a></td>
<td class="nump">41,861<span></span>
</td>
<td class="nump">26,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CapitalGovernmentGrantsNoncurrent', window );">Non-current government grants</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Non-current income taxes payable (Note 14)</a></td>
<td class="nump">172,109<span></span>
</td>
<td class="nump">14,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability (Note 14)</a></td>
<td class="nump">1,085,976<span></span>
</td>
<td class="nump">10,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies&#160;(Note 16)&#160;</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total&#160;Liabilities&#160;</a></td>
<td class="nump">9,320,263<span></span>
</td>
<td class="nump">1,585,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, par value 6 euro cents per share; 100,000,000 shares authorized, (Note 12), 52,788,093 shares issued and outstanding at December 31, 2020 and 53,622,206 shares issued and outstanding at December 31, 2019.</a></td>
<td class="nump">6,640<span></span>
</td>
<td class="nump">4,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">6,733,910<span></span>
</td>
<td class="nump">617,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OtherUndenominatedCapital', window );">Other undenominated capital (Note 13 (a))</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (Note 22)</a></td>
<td class="num">(90,937)<span></span>
</td>
<td class="num">(35,477)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,416,080<span></span>
</td>
<td class="nump">1,262,895<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Equity</a></td>
<td class="nump">8,066,827<span></span>
</td>
<td class="nump">1,850,236<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 17,387,090<span></span>
</td>
<td class="nump">$ 3,435,606<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CapitalGovernmentGrantsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent capital government grants, which are amortized and recognized in earnings over the grant period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CapitalGovernmentGrantsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherUndenominatedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other undenominated capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherUndenominatedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749913832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - &#8364; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in EUR per share)</a></td>
<td class="nump">&#8364; 6<span></span>
</td>
<td class="nump">&#8364; 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">81,554,683<span></span>
</td>
<td class="nump">52,788,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">81,554,683<span></span>
</td>
<td class="nump">52,788,093<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748847528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 5,480,826<span></span>
</td>
<td class="nump">$ 2,797,288<span></span>
</td>
<td class="nump">$ 2,805,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>&#160; Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Direct costs (excluding depreciation and amortization)</a></td>
<td class="nump">3,972,612<span></span>
</td>
<td class="nump">1,979,883<span></span>
</td>
<td class="nump">1,974,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">585,330<span></span>
</td>
<td class="nump">342,449<span></span>
</td>
<td class="nump">332,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">314,987<span></span>
</td>
<td class="nump">66,126<span></span>
</td>
<td class="nump">61,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration related (Note 6)</a></td>
<td class="nump">198,263<span></span>
</td>
<td class="num">(759)<span></span>
</td>
<td class="nump">4,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring (Note 15)</a></td>
<td class="nump">31,105<span></span>
</td>
<td class="nump">18,089<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">5,102,297<span></span>
</td>
<td class="nump">2,405,788<span></span>
</td>
<td class="nump">2,372,433<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">378,529<span></span>
</td>
<td class="nump">391,500<span></span>
</td>
<td class="nump">433,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">2,724<span></span>
</td>
<td class="nump">6,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense (Note 24)</a></td>
<td class="num">(182,423)<span></span>
</td>
<td class="num">(13,019)<span></span>
</td>
<td class="num">(13,276)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Income before income tax expense</a></td>
<td class="nump">196,680<span></span>
</td>
<td class="nump">381,205<span></span>
</td>
<td class="nump">426,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (Note 14)</a></td>
<td class="num">(41,334)<span></span>
</td>
<td class="num">(47,875)<span></span>
</td>
<td class="num">(51,133)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest', window );">Income before share of earnings from equity method investments</a></td>
<td class="nump">155,346<span></span>
</td>
<td class="nump">333,330<span></span>
</td>
<td class="nump">375,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of equity method investments</a></td>
<td class="num">(2,161)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">153,185<span></span>
</td>
<td class="nump">332,964<span></span>
</td>
<td class="nump">375,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(633)<span></span>
</td>
<td class="num">(1,870)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to the Group</a></td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 332,331<span></span>
</td>
<td class="nump">$ 373,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per Ordinary Share attributable to the Group (Note 27):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="nump">$ 6.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 6.15<span></span>
</td>
<td class="nump">$ 6.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of ordinary shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">67,110,186<span></span>
</td>
<td class="nump">52,859,911<span></span>
</td>
<td class="nump">53,859,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">68,068,311<span></span>
</td>
<td class="nump">53,283,585<span></span>
</td>
<td class="nump">54,333,461<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357746786296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 332,964<span></span>
</td>
<td class="nump">$ 375,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(60,092)<span></span>
</td>
<td class="nump">48,129<span></span>
</td>
<td class="num">(1,313)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding', window );">Currency impact of long-term funding</a></td>
<td class="num">(525)<span></span>
</td>
<td class="num">(1,603)<span></span>
</td>
<td class="num">(2,710)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital (loss)/gain - investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain/(loss) on defined benefit pension plan</a></td>
<td class="nump">4,266<span></span>
</td>
<td class="num">(4,138)<span></span>
</td>
<td class="num">(2,226)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of interest rate hedge</a></td>
<td class="nump">113<span></span>
</td>
<td class="num">(910)<span></span>
</td>
<td class="num">(923)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Settlement of interest rate hedge</a></td>
<td class="nump">778<span></span>
</td>
<td class="num">(905)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">97,725<span></span>
</td>
<td class="nump">373,306<span></span>
</td>
<td class="nump">369,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less net income attributable to noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(633)<span></span>
</td>
<td class="num">(1,870)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to the Group</a></td>
<td class="nump">$ 97,725<span></span>
</td>
<td class="nump">$ 372,673<span></span>
</td>
<td class="nump">$ 367,495<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment that results from the process of translating the impact of long-term funding into the functional currency of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357744266216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Other Undenominated Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Redeemable Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,971,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="nump">$ 1,354,281<span></span>
</td>
<td class="nump">$ 4,658<span></span>
</td>
<td class="nump">$ 529,642<span></span>
</td>
<td class="nump">$ 983<span></span>
</td>
<td class="num">$ (69,328)<span></span>
</td>
<td class="nump">$ 888,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">373,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(1,313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding', window );">Currency impact of long-term funding</a></td>
<td class="num">(2,710)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital (loss)/gain - investments</a></td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain (loss) on defined benefit pension plan</a></td>
<td class="num">(2,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of interest rate hedge</a></td>
<td class="num">(923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Loss on interest rate hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to the Group</a></td>
<td class="nump">367,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">21,621<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">21,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">26,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,035,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(146,931)<span></span>
</td>
<td class="num">$ (69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(146,931)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue', window );">Exercise of call option on noncontrolling interest shares</a></td>
<td class="num">(5,048)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,048)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,622,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">1,618,055<span></span>
</td>
<td class="nump">$ 4,635<span></span>
</td>
<td class="nump">577,961<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
<td class="num">(75,819)<span></span>
</td>
<td class="nump">1,110,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling interest adjustment to redemption amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Exercise of call option on noncontrolling interest shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,048<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">332,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">48,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding', window );">Currency impact of long-term funding</a></td>
<td class="num">(1,603)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,603)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital (loss)/gain - investments</a></td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain (loss) on defined benefit pension plan</a></td>
<td class="num">(4,138)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,138)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of interest rate hedge</a></td>
<td class="num">(910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Loss on interest rate hedge</a></td>
<td class="num">(905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to the Group</a></td>
<td class="nump">372,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">13,189<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">13,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">25,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,235,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(175,000)<span></span>
</td>
<td class="num">$ (82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="num">$ (140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">52,788,093<span></span>
</td>
<td class="nump">52,788,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,850,236<span></span>
</td>
<td class="nump">$ 4,580<span></span>
</td>
<td class="nump">617,104<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
<td class="num">(35,477)<span></span>
</td>
<td class="nump">1,262,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling interest adjustment to redemption amount</a></td>
<td class="num">(4,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,522)<span></span>
</td>
<td class="nump">4,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Exercise of call option on noncontrolling interest shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,665)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">153,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(60,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding', window );">Currency impact of long-term funding</a></td>
<td class="num">(525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital (loss)/gain - investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain (loss) on defined benefit pension plan</a></td>
<td class="nump">4,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of interest rate hedge</a></td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Loss on interest rate hedge</a></td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to the Group</a></td>
<td class="nump">97,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">118,589<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">118,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">133,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issue of shares associated with a business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,372,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issue of shares associated with a business combination</a></td>
<td class="nump">5,658,155<span></span>
</td>
<td class="nump">$ 1,960<span></span>
</td>
<td class="nump">5,656,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Replacement share-based awards issued to acquiree employees</a></td>
<td class="nump">$ 209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">81,554,683<span></span>
</td>
<td class="nump">81,554,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 8,066,827<span></span>
</td>
<td class="nump">$ 6,640<span></span>
</td>
<td class="nump">$ 6,733,910<span></span>
</td>
<td class="nump">$ 1,134<span></span>
</td>
<td class="num">$ (90,937)<span></span>
</td>
<td class="nump">$ 1,416,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to Retained Earning Share Repurchase costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AdjustmentToRetainedEarningShareRepurchaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment that results from the process of translating the impact of long-term funding into the functional currency of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest, Accretion To Redemption Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest, Increase From Business Combination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748222152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1">48 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 332,964<span></span>
</td>
<td class="nump">$ 375,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">314,987<span></span>
</td>
<td class="nump">66,126<span></span>
</td>
<td class="nump">61,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Fixed asset impairment</a></td>
<td class="nump">20,037<span></span>
</td>
<td class="nump">5,411<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Reduction in carrying value of operating right-of-use assets</a></td>
<td class="nump">45,339<span></span>
</td>
<td class="nump">28,480<span></span>
</td>
<td class="nump">30,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">2,161<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Charge/(credit) on interest rate hedge</a></td>
<td class="nump">891<span></span>
</td>
<td class="num">(910)<span></span>
</td>
<td class="num">(923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of financing costs and debt discount</a></td>
<td class="nump">12,890<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">133,844<span></span>
</td>
<td class="nump">26,271<span></span>
</td>
<td class="nump">26,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">73,894<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(60,616)<span></span>
</td>
<td class="nump">927<span></span>
</td>
<td class="num">(1,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign exchange (gain)/loss</a></td>
<td class="num">(6,054)<span></span>
</td>
<td class="nump">5,979<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">3,589<span></span>
</td>
<td class="num">(6,949)<span></span>
</td>
<td class="nump">2,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">113,513<span></span>
</td>
<td class="num">(175,040)<span></span>
</td>
<td class="num">(101,545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Unbilled revenue</a></td>
<td class="num">(17,656)<span></span>
</td>
<td class="num">(5,748)<span></span>
</td>
<td class="num">(55,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="num">(69,121)<span></span>
</td>
<td class="nump">291,844<span></span>
</td>
<td class="nump">86,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other net assets</a></td>
<td class="nump">108,259<span></span>
</td>
<td class="num">(2,209)<span></span>
</td>
<td class="num">(11,976)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">829,142<span></span>
</td>
<td class="nump">568,035<span></span>
</td>
<td class="nump">412,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(93,750)<span></span>
</td>
<td class="num">(40,885)<span></span>
</td>
<td class="num">(38,948)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of subsidiary undertakings (net of cash acquired)</a></td>
<td class="num">(5,914,475)<span></span>
</td>
<td class="num">(47,931)<span></span>
</td>
<td class="num">(131,272)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment in equity method investments</a></td>
<td class="num">(2,450)<span></span>
</td>
<td class="num">(2,450)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Loan to equity method investment</a></td>
<td class="num">(10,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sale of available for sale investments</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">47,902<span></span>
</td>
<td class="nump">21,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of available for sale investments</a></td>
<td class="num">(480)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,603)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchase of investments in equity - long term</a></td>
<td class="num">(3,577)<span></span>
</td>
<td class="num">(3,212)<span></span>
</td>
<td class="num">(3,890)<span></span>
</td>
<td class="num">$ (13,300)<span></span>
</td>
<td class="num">$ (16,900)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(6,024,235)<span></span>
</td>
<td class="num">(46,576)<span></span>
</td>
<td class="num">(162,027)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Financing costs</a></td>
<td class="num">(30,328)<span></span>
</td>
<td class="num">(1,554)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and facilities</a></td>
<td class="nump">5,905,100<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit lines and facilities</a></td>
<td class="num">(877,780)<span></span>
</td>
<td class="num">(350,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchase of noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(43,923)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of equity compensation</a></td>
<td class="nump">118,589<span></span>
</td>
<td class="nump">13,203<span></span>
</td>
<td class="nump">21,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(853)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of ordinary shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
<td class="num">(146,931)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_PaymentsForShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Settlement of interest rate hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(905)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">5,114,728<span></span>
</td>
<td class="num">(208,333)<span></span>
</td>
<td class="num">(125,406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate movements on cash</a></td>
<td class="num">(7,727)<span></span>
</td>
<td class="nump">6,870<span></span>
</td>
<td class="num">(650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease)/increase in cash and cash equivalents</a></td>
<td class="num">(88,092)<span></span>
</td>
<td class="nump">319,996<span></span>
</td>
<td class="nump">124,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">840,305<span></span>
</td>
<td class="nump">520,309<span></span>
</td>
<td class="nump">395,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">$ 752,213<span></span>
</td>
<td class="nump">$ 840,305<span></span>
</td>
<td class="nump">$ 520,309<span></span>
</td>
<td class="nump">$ 840,305<span></span>
</td>
<td class="nump">$ 752,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_PaymentsForShareRepurchaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Share Repurchase Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_PaymentsForShareRepurchaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748996552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of business</a></td>
<td class="text">Description of business <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2021 we had approximately 38,330 employees, in 142 locations in 53 countries. During the year ended December&#160;31, 2021, we derived approximately 47.1%, 46.4% and 6.5% of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749754408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant accounting policies</a></td>
<td class="text">Significant accounting policies<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) &#160; Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) &#160; Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) &#160; Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d) &#160; Pass-through/ Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pass through/ Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(e) Direct costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(e) &#160; Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time i.e. the full-service obligation is in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Investigator payment costs are recorded and reported reflecting investigator activity over the life of the contract. Investigator payments are made based on predetermined contractual arrangements. Timing of payments may differ from the recording and reporting of the expense which is based on activity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(f) &#160; Advertising costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All costs associated with advertising and promotion are expensed as incurred. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(g) &#160; Foreign currencies and translation of subsidiaries</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc's financial statements are prepared in United States dollars. Transactions in currencies other than the functional currency of the individual entities within the ICON Group are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the individual entities within the ICON Group are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. Foreign currency transaction gains and losses are reported in other comprehensive income ("currency impact of long term funding") rather than through income where the foreign currency transaction is 'long-term investment' in nature i.e. settlement is not planned or anticipated in the foreseeable future.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(h) &#160; Disclosure of fair value of financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i) &#160; Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair values at the date of exchange of assets given, liabilities incurred or assumed and equity instruments issued in exchange for control. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(j) &#160; Goodwill and Impairment</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill represents the excess of the cost of acquired entities over the net amounts assigned to assets acquired and liabilities assumed. Goodwill primarily comprises acquired workforce in place which does not qualify for recognition as an asset apart from goodwill. Goodwill is stated net of any provision for impairment. The Company tests goodwill annually for any impairments or whenever events occur which may indicate impairment. An impairment charge would be recognized for any amount by which the carrying amount exceeds the reporting unit's fair value up to the amount of existing goodwill. The Company performs a qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. No impairment was recognized as a result of the impairment testing carried out for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(k) &#160; Intangible assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight line basis over their estimated useful life.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(l) &#160; Cash and cash equivalents</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(m) &#160; Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale in accordance with the terms of ASC 320 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Investments - Debt and Equity Securities'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Realized gains and losses are determined using specific identification. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2020 and December&#160;31, 2021 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(n)   Accounts receivable, net and unbilled revenue&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable factoring</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Transfers and Servicing'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. The associated finance costs are presented as interest expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(o) &#160; Inventory</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost and net realizable value and after provisions for obsolescence. The cost of inventories comprises the purchase price and attributable costs, less trade discounts. At December&#160;31, 2021 the carrying value of inventory, included within prepayments and other current assets on the Consolidated Balance Sheet, was $5.8 million (2020: $4.8 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(p) &#160; Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. </span></div><div style="margin-top:4pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(q) &#160; Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company adopted ASC 842 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Leases' (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 842), with a date of initial application of January 1, 2019. The lease accounting policy applied in preparation of the results for the year ended December&#160;31, 2020 and December&#160;31, 2021 therefore reflect application of ASC 842. The Company adopted the standard using the cumulative-effect adjustment approach. Under this transition method, the Company applied the ASC 842 as at the date of initial application (i.e. January 1, 2019), without restatement of comparative period amounts. The cumulative effect of applying the standard is recorded as an adjustment to the opening consolidated balance sheet as at the date of initial application.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 842 requires lessees to recognize the rights and obligations resulting from virtually all leases on the Consolidated Balance Sheet as right-of-use (ROU) assets with corresponding lease liabilities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The most significant impact of application of the standard for the Company related to the recognition of right-of-use assets and lease liabilities on the Consolidated Balance Sheet for operating leases for certain property, vehicles and equipment. Prior to application of ASC 842, costs in respect of operating leases were charged to the Consolidated Statements of Operations on a straight-line basis over the lease term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to certain practical expedients available as part of adopting ASC 842, ICON did not reassess whether existing or expired supplier contracts are or contain leases, the classification of existing or expired leases, or whether unamortized initial direct costs meet the new definition of initial direct costs under ASC 842. Additionally, the Company elected to use hindsight in determining the lease term and in assessing impairment of ROU assets, if any. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2021 and December&#160;31, 2020, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Although subleases are accounted for separately from the lease they relate to, subleases are accounted for in the same way as other leases.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(r) &#160; Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#8220;global intangible low-taxed income&#8221;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(s) &#160; Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(t) &#160; Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits are generally recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(u) &#160; Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Pension'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These plans are presented in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(v) &#160; Redeemable noncontrolling interests and equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Distinguishing Liabilities from Equity'. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(w)   Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 27 - Net income per ordinary share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(x) &#160; Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Compensation &#8211; Stock Compensation'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(y) &#160; Impairment of long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(z) &#160; Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We enter into transactions in the normal course of business using various financial instruments in order to hedge against exposure to fluctuating exchange and interest rates. We use derivative financial instruments to reduce exposure to fluctuations in interest rates. A derivative is a financial instrument or other contract whose value changes in response to some underlying variable, which has an initial net investment smaller than would be required for other instruments that have a similar response to the variable and that will be settled at a future date. We do not enter into derivative financial instruments for trading or speculative purposes. We did not hold any interest rate swap contracts or forward currency contracts at December&#160;31, 2021 or December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use derivative financial instruments to reduce exposure to fluctuations in foreign exchange rates. During the years ended December&#160;31, 2019 and December&#160;31, 2020, we entered into forward currency contracts in respect of identified exposure arising from euro payments. All contracts expired during the year in which the contract was entered into. No forward currency contracts were entered into during the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(aa) Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ab) Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(ac) Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ad) &#160;Reclassifications</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#8217;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the years ended December 31, 2020 and December 31, 2019 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#8217;s presentation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749770296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(a) &#160;&#160;&#160;&#160;Available for sale investments</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(497)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,902)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gain on sale of short term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized capital loss &#8211; investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Available for sale investments at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. Short term investments at December&#160;31, 2021 have an average mat</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">urity of 2.7 years co</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">mpared to 3.4 years at December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our available for sale short term investments by major security type as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity by period</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost<br/>Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1<br/>year</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1 to 5<br/>years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ($ in millions)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.</span></div>(b)&#160;&#160;&#160;&#160;Investments in equity - long term<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. Capital totaling $16.9 million had been advanced under the terms of the subscription agreements at December&#160;31, 2021 (December&#160;31, 2020: $13.3 million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'. There was an increase in fair value of $3.2 million (December&#160;31, 2020: $2.5 million) recognized in net income during the year bringing the carrying value of the subscriptions to $22.6 million at December&#160;31, 2021 (December&#160;31, 2020: $15.8 million).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span>December&#160;31, 2021, the Company had committed to future investments of $17.4 million in respect of these funds.<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160; Equity method investments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company&#8217;s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations. See additional details in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 2 - Significant accounting policies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our equity method investments at December&#160;31, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ownership Percentage</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recorded a loss of $2.2&#160;million representing its pro rata share of the losses in Oncacare since December&#160;31, 2020. From the date of initial investment to year ended December&#160;31, 2020, the Company recorded a loss of $0.4&#160;million. During the year ended December&#160;31, 2021, the Company provided a loan of $10&#160;million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. Oncacare continues to perform in line with expectations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749793848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">883,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has made a number of strategic acquisitions since inception to enhance its capabilities and experience in certain areas of the clinical development process. Goodwill arising on acquisition represents the excess of the cost of acquired entities over the net amounts assigned to assets acquired and liabilities assumed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company tests goodwill annually for impairment or whenever events occur which may indicate impairment. The results of the Company's goodwill impairment testing assessed at September 30, 2021 during the year ended December&#160;31, 2021 provided no evidence of impairment and indicated the existence of sufficient headroom such that a reasonably possible change to the key assumptions used would be unlikely to result in an impairment of the related goodwill.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749833112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,081,381&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,011&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133,551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,710,843&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,915.0&#160;million, Order backlog of $490.0&#160;million, Trade names of $202.0&#160;million, Patient database of $168.0&#160;million and Technology assets of $111.0&#160;million. These assets will be amortized over their expected useful lives of between 3 and 23 years. The valuation and useful lives of these assets remains provisional at December&#160;31, 2021. In total, $223.5&#160;million has been amortized in the period since the date of acquisition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 22, 2020 a subsidiary of the Company, ICON Investments Limited acquired 100% of the equity share capital of the MedPass Group. MedPass is the leading European medical device CRO, regulatory and reimbursement consultancy, that specializes in medical device development and market access. The acquisition of MedPass further enhances ICON&#8217;s Medical Device and Diagnostic Research services, through the addition of new regulatory and clinical capabilities in Europe. On acquisition, certain customer relationships and order backlog identified, which were valued at $11.7&#160;million and $2.9&#160;million respectively, were recognized and are being amortized over approximately 13 years and 3 years, the estimated period of benefit. In total, $2.0&#160;million has been amortized in the period to December&#160;31, 2021 relating to the acquisition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2022 to December 31, 2026 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">454,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,680,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749666184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business combinations</a></td>
<td class="text">Business combinations<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Health Sciences, Inc. - Merger Completion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences Group ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the year ended December&#160;31, 2021, the Company incurred $198.3 million of Merger-related expenses which were accounted for separately from the business combination and expensed as incurred within the &#8220;Transaction and integration related&#8221; line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in the $198.3 million of transaction and integration costs are acquisition related costs (as defined by ASC 805) of $57.1&#160;million. These costs include finders fees; advisory, legal, accounting, valuation, and other professional or consulting fees.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company also incurred approximately $86.7 million of Merger-related financing fees which are included in the &#8220;Interest expense&#8221; line item in the Consolidated Statement of Operations for the year ended December&#160;31, 2021. The Company deferred $76.2&#160;million of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The purchase accounting associated with the PRA Merger remains ongoing and the Company continues to review the acquisition balance sheet. The Company expects to conclude the purchase accounting exercise by June 30, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,308,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,658,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the preliminary allocation of the consideration transferred based on management&#8217;s estimates of Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,886,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380,342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(739,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,126,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(203,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the preliminary estimates of the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.134%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,915,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">490,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,886,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since July 1, 2021, PRA has earned revenue of $2,053.4 million and pre-tax net income of $169.9 million in the six months ended December 31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unaudited Supplemental Pro Forma Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following pro forma financial information was derived from the historical financial statements of the Company and PRA and presents the combined results of operations as if the Merger had occurred on January 1, 2020. The pro forma financial information is presented for comparative purposes only and is not necessarily indicative of the results that would have actually occurred had the Merger been completed on January 1, 2020. In addition, the pro forma financial information does not give effect to any anticipated cost savings, operating efficiencies or other synergies that may result from the Merger, or any estimated costs that have been or will be incurred by the Company to integrate the assets and operations of PRA. Consequently, actual future results of the Company will differ from the pro forma financial information presented below:</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,462,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,980,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income/(loss)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149,658)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The pro forma adjustments primarily relate to the amortization of acquired intangible assets, interest expense and amortization of deferred financing costs related to the new financing arrangements. In addition, the pro forma net income for the year ended December 31, 2021 was adjusted to exclude certain Merger-related nonrecurring adjustments; these adjustments were included in the year ended December 31, 2020 giving effect to the Merger as if it had occurred on January 1, 2020. The nonrecurring Merger-related adjustments include transaction costs, share-based compensation expense related to the acceleration of share-based compensation awards and replacement share-based awards, and financing fees. The Merger-related adjustments were tax effected using the rates applicable to the jurisdictions where they arose.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions &#8211; MedPass Group ("MedPass")</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 22, 2020 a subsidiary of the Company, ICON Investments Limited acquired 100% of the equity share capital of the MedPass Group. MedPass is the leading European medical device CRO, regulatory and reimbursement consultancy, that specializes in medical device development and market access. The acquisition of MedPass further enhances ICON&#8217;s Medical Device and Diagnostic Research services, through the addition of new regulatory and clinical capabilities in Europe. The integration of MedPass&#8217;s services brings noted expertise in complex class 3 medical devices, interventional cardiology and structural heart devices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounting for the acquisition of MedPass was finalized in the period ended December 31, 2020. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The acquisition of MedPass has been accounted for as a business combination in accordance with ASC 805 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company has made an assessment of the fair value of assets acquired and liabilities assumed as at that date. The following table summarizes the Company&#8217;s fair values of the assets acquired and liabilities assumed:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 22,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash &amp; cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,090)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash outflows</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital adjustment paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total consideration</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,556&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Goodwill represents the acquisition of an established workforce that specializes in medical device development and market access. None of the goodwill recognized is expected to be deductible for income tax purposes. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The fair value of the contingent consideration was estimated at the date of acquisition as $Nil. Depending on performance of MedPass for the 12 month period ended December 31, 2020, the total consideration could have increased by a maximum of $6.7&#160;million in contingent consideration. In January 2021, the contingent consideration was finalized and a value of $Nil was payable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In finalizing the acquisition of MedPass in the 12 month period from acquisition, fair value adjustments were made which resulted in an increase in accounts receivable ($0.2 million) and unearned revenue ($0.8&#160;million) and a decrease in operating right of use assets ($0.8 million), other liabilities ($0.8&#160;million), current lease liabilities ($0.1 million), non-current lease liabilities ($0.7 million) and non-current deferred tax liability ($0.6 million). Customer relationship and order backlog assets were also finalized.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since January 22, 2020, MedPass earned revenue of $13.2 million and net income of $2.5&#160;million in the year ended December 31, 2020. The proforma effect of the MedPass acquisition if completed on January 1, 2019 would have resulted in revenue and net income for the fiscal years ended December 31, 2020 and December 31, 2019 as follows:  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,798,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,820,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749697736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, net</a></td>
<td class="text">Property, Plant and Equipment, net<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">506,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">440,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798,968&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703,714&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(462,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(529,371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2021 and the year ended December&#160;31, 2020, certain fully depreciated assets were written off as they were no longer used in the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357750160312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Liabilities</a></td>
<td class="text">Other Liabilities<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (note 23)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities (note 15)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949,629&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399,769&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $323.6&#160;million at December&#160;31, 2021 and $138.2&#160;million at December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749754408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-Current Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock', window );">Non-Current Other Liabilities</a></td>
<td class="text">Non-Current Other Liabilities<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 10)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357845665288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text">Employee Benefits<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defined contribution or profit sharing style plans ("the Plans") are offered globally in a number of countries. In some cases, these plans are required by local laws or regulations. Certain Company employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. Contributions to the plan are recorded as an expense in the selling, general and administrative line in the Consolidated Statement of Operations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 were $23.7 million, $17.0 million and $16.5 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company maintains various retirement plans across the Group, many of which are required by local employment laws. In addition to the specific defined benefit schemes shown separately below, the Company maintains several other retirement plans with a total net obligation associated with these schemes of $8.0&#160;million. This balance has been recorded in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON Development Solutions Limited pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> 'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The plan has been closed to new entrants with effect from July 1, 2003.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,988)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,615)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,376)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,615)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,376)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(724)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,988&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(724)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain &#8211; plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,930)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss recognized in net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,898)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $0.2 million and $Nil respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 26 year duration, gives the same result as a full AA corporate bond yield curve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Actuarial gains on the benefit obligation during 2021 resulted from changes in the assumptions compared to those adopted at December 2020. Changes in the assumptions reflect the changes in market conditions from December 2020 to December 2021 and the actuarial gain is primarily due to the change in the discount rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets of the scheme are held on an investment platform with Mobius which invests in a number of investment funds with Legal &amp; General, Stone Harbor, Ninety-One and Barings.&#160;The overall investment strategy is that approximately 20% of investments are in senior secured loans, 18% in corporate bonds, 19% in high yield bonds and multi-asset credit fund and 24% in world equities respectively. There is no self-investment in employer related assets. The expected long-term rate of return on assets at December&#160;31, 2021 of 3.8% was calculated as the value of the fund after application of a market value reduction factor. The expected long term rates of return on different asset classes are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected long-term return per annum</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The long-term expected rate of return on cash is determined by reference to traditional corporate bond rates at the latest Balance Sheet date. The long-term expected returns on traditional corporate and government bonds are determined by reference to corporate bond yields and gilt yields respectively at the Balance Sheet date. The long-term expected returns on equities are based on the rate of return on government bonds with an allowance for out-performance. The long-term expected return on high yield bonds, secured loans and multi asset credit is based on the return on traditional corporate bonds with an allowance for out-performance. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The underlying asset split of the fund is shown below.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Applying the above expected long term rates of return to the asset distribution at December&#160;31, 2021, gives rise to an expected overall rate of return of scheme assets of approximately 3.8% per annum.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Asset Fair Value Measurements</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>Level 1</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Income Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">L&amp;G Life GPBF All World Equity Index Fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">L&amp;G Life DC Active Corporate Bond</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stone Harbor High Yield Bond Fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ninety One Global Total Return Credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stone Harbor Multi Asset Credit Portfolio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Barings European Loan Fund Buy &amp; Hold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2027 - 2031</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aptiv Solutions pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The acquisition of Aptiv was accounted for as a business combination in accordance with ASC 805 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Business Combinations'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021 and December&#160;31, 2020 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/ loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,620&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRA Switzerland AG pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,973)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,973)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation as at July 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at as at July 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749877288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Schemes and Stock Compensation Charges</a></td>
<td class="text">Equity Incentive Schemes and Stock Compensation Charges<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans will be an employee stock option, or NSO, as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans will be evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price will be specified in each Stock Option Agreement, however option prices will not be less than 100% of the fair market value of an ordinary share on the date the option is granted.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 17, 2003 the Company adopted the Share Option Plan 2003 (the "2003 Share Option Plan") pursuant to which the Compensation and Organization Committee of the Board could grant options to officers and other employees of the Company or its subsidiaries for the purchase of ordinary shares. An aggregate of 6.0 million ordinary shares were reserved under the 2003 Share Option Plan; and in no event could the number of ordinary shares issued pursuant to options awarded under this plan exceed 10% of the outstanding shares, as defined in the 2003 Share Option Plan, at the time of the grant, unless the Board expressly determined otherwise. Further, the maximum number of ordinary shares with respect to which options could be granted under the 2003 Share Option Plan during any calendar year to any employee was 0.4 million ordinary shares. The 2003 Share Option Plan expired on January 17, 2013. No new options may be granted under this plan.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Prior to 2018, share options typically vest over a period of five years from date of grant and expire eight years from date of grant. Share options granted to non-executive directors from 2018 vest over 12 months and expire eight years from the date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Legacy PRA  Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the legacy PRA equity incentive plans, which still have equity outstanding but have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Pursuant to the Merger Agreement, effective on July 1, 2021, each outstanding stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan was amended and restated and assumed by the Registrant effective as of July 1, 2021. The 2020 Stock Incentive Plan (&#8220;the 2020 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2,500,000 shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The PRA Health Sciences, Inc. 2018 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2,000,000 shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The PRA Health Sciences, Inc. 2014 Omnibus Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021 (the &#8220;2014 Plan&#8221;). On November 23, 2014, the PRA Health Sciences, Inc. Board of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The 2013 Stock Incentive Plan for Key Employees of PRA Health Sciences and its Subsidiaries was amended and restated and assumed by the Registrant effective as of July 1, 2021 (the &#8220;2013 Plan&#8221;). On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">920,746&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.32&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,112&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.13&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(329,870)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,881)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,107&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,737&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.83&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(193,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,681)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,746&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.53&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,177,130&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.78&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.79&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">989,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.70&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2021, was 5.39 years and 4.55 years respectively (2020: 4.86 years and 3.60 years respectively).</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outstanding and exercisable share options:</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.80 - 97.30</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.45</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.81 - 124.00</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.74 - 147.26</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.33 - 231.08</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.80 - 231.08</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,695,460</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.39</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">104.79</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">989,419</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding include both vested and unvested options as at December&#160;31, 2021. Options exercisable represent options which have vested at December&#160;31, 2021. From the date of grant, substantially all options vest over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzQ2NDQ_8b84bb10-99f4-411b-a818-270432b50926">five</span> to eight year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 years</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over twelve months. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.77&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combination*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested **</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(446,404)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents restricted stock units issued as replacement awards in connection with the Merger.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Includes 161,389 RSU's which vested on the date of the Merger.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December&#160;31, 2021 totaled $83.5 million (2020: $14.3 million). The share price range for the year was $115.11 - $206.71 (2020: $83.47 - $156.21).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December&#160;31, 2021 totaled $5.1 million (2020: $5.3 million). The share price range for the year was $115.11 - $125.74 (2020: $83.47 - $90.03).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period 2019 &#8211; 2021, 2020 &#8211; 2022 and 2021 &#8211; 2023. Depending on the actual amount of EPS from 2019 to 2023, up to an additional 71,890 PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-cash stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December&#160;31, 2021 is stated after charging $133.8 million in respect of non-cash stock compensation expense. Non-cash stock compensation expense has been allocated as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,844&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,819&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $23.9 million. The income tax expense for the year ended December&#160;31, 2020 reflects a net income tax benefit of $6.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2020 was $2.5 million. The income tax expense for the year ended December&#160;31, 2019 reflects a net income tax benefit of $8.2 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2019 was $1.9 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751170264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Share Capital</a></td>
<td class="text">Share Capital<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Holders of ordinary shares will be entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares will be repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company&#8217;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December&#160;31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, 193,417 options were exercised by employees at an average exercise price of $68.19 per share for total proceeds of $13.2 million. During the year ended December&#160;31, 2020, 144,172 ordinary shares were issued in respect of certain RSUs and 63,516 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2019, 329,870 options were exercised by employees at an average exercise price of $65.54 per share for total proceeds of $21.6 million. During the year ended December&#160;31, 2019, 237,119 ordinary shares were issued in respect of certain RSUs and 118,611 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no share buybacks in the year ended December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020 and July 20, 2021.&#160;On October 3, 2016, the Company commenced a share buyback program of up to $400 million. The share buyback program was completed during the year ended December 31, 2018 with a total of 4,026,576 ordinary shares redeemed for a total consideration of $372.1&#160;million. On January 8, 2019, the Company commenced a further share buyback program of up to 1.0&#160;million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $141.6&#160;million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, 35,100 ordinary shares were redeemed by the Company for a total consideration of $5.3&#160;million. During the year ended December 31, 2020, 1,235,218 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $175.0&#160;million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751166088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426,989&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,950&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,948&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,670&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,616)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,943&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,158&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory income tax rate is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,201,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,289,256&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,797&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,167&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,864&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,495)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,672&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,096&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax asset/(liability)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,037,584)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $14.0 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $10.3 million and $297.0 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $10.3 million U.S. federal NOLs, approximately $5.0 million is available for offset against future U.S. federal taxable income in 2022. The subsidiaries' ability to use the  remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $10.3 million are limited by Section 382 as follows: $10.2 million for the years 2022 - 2035 and $0.1 million in 2036 - 2040. As at December&#160;31, 2021, U.S subsidiaries also had disallowed interest carryforwards of $145.7&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $42.3 million. At December&#160;31, 2021 those subsidiaries also had additional operating loss carryforwards of $19.9 million which are due to expire between 2022 and 2028 and operating loss carryforwards of $19.9 million which are due to expire between 2029 and 2038. In addition, at December&#160;31, 2021 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $5.3 million.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of these US losses are as follows:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2035</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2036-2040</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296,981&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December&#160;31, 2021 was approximately $45.5 million. The valuation allowance for deferred tax assets as of December&#160;31, 2020 and December&#160;31, 2019 was $32.8 million and $27.7 million respectively. The net change in the total valuation allowance was an increase of $12.8 million during 2021 and an increase of $5.1 million during 2020. Of the total increase of $12.8 million in 2021, $9.3 million was in respect of acquired entity, $4.4 million was recognized within income tax expense and a decrease of $0.9 million was recognized in Other Comprehensive Income. Of the total increase of $5.1 million in 2020, $3.6 million resulted in a current year income tax expense, and $1.5 million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December&#160;31, 2021 and December&#160;31, 2020 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recognized a deferred tax liability of $0.8 million (2020: $0.9 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#8217;s tax treaty network and the EU parent subsidiary directive.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $38.8 million could potentially expire during 2022. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December&#160;31, 2021 were potential benefits of $202.1 million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2020 and December&#160;31, 2019 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $19.1 million and $20.2 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December&#160;31, 2021 amounted to a net charge of $1.9 million (2020: ($0.6 million), 2019: Nil) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2021 and December&#160;31, 2020 were $15.5 million and $0.5 million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020 and December&#160;31, 2021. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020 and December&#160;31, 2021. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749858232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring charges</a></td>
<td class="text">Restructuring charges<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A restructuring charge of $31.1&#160;million was recognized during the year ended December&#160;31, 2021 under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $4.8&#160;million relating to workforce reductions, an impairment of ROU assets and associated unavoidable costs totaling $21.9&#160;million and fixed asset impairment of $4.4&#160;million.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2021, a total liability of $28.4 million was on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $23.2 million from lease and lease related liabilities of which $10.4&#160;million is included within other liabilities and $12.8 million is included within non-current operating lease liabilities. The remaining provision of $5.2&#160;million relates to workforce reduction and is included within other liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.129%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,069)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,978)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,748&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357750196248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next twelve years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 23 - Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2021 and December&#160;31, 2020 and future minimum rental commitments as of December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749839576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">704,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,797,288</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,805,839</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 19)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">715,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,965,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,143,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,323,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(660,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(663,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(468,641)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(201.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivables when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2021 and December&#160;31, 2020 were $323.6&#160;million and $138.2&#160;million (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 8 - Other liabilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2021 increased by $194.4 million as compared to December&#160;31, 2020. Unearned revenue increased by $663.1 million over the same period resulting in a increase of $468.6 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2020 and December&#160;31, 2021. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contract when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Group's receivables and unbilled services was  $0.9&#160;million and $2.9&#160;million for the twelve months ended December&#160;31, 2021 and 2020, respectively.</span></div>As of December&#160;31, 2021 approximately $13.3 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 48% of the unrealized performance obligation over the next twelve months, with the remainder recognized thereafter over the duration of the customer contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749728152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</a></td>
<td class="text">Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">704,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,797,288</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,805,839</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 19)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">715,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,965,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,143,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,323,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(660,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(663,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(468,641)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(201.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivables when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2021 and December&#160;31, 2020 were $323.6&#160;million and $138.2&#160;million (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 8 - Other liabilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2021 increased by $194.4 million as compared to December&#160;31, 2020. Unearned revenue increased by $663.1 million over the same period resulting in a increase of $468.6 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2020 and December&#160;31, 2021. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contract when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Group's receivables and unbilled services was  $0.9&#160;million and $2.9&#160;million for the twelve months ended December&#160;31, 2021 and 2020, respectively.</span></div>As of December&#160;31, 2021 approximately $13.3 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 48% of the unrealized performance obligation over the next twelve months, with the remainder recognized thereafter over the duration of the customer contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749803528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provision for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AllowanceForDoubtfulAccountsTextBlock', window );">Provision for Credit Losses</a></td>
<td class="text">Provision for Credit Losses<div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2021 and December&#160;31, 2020 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts released during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,149&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AllowanceForDoubtfulAccountsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AllowanceForDoubtfulAccountsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749687400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographical Information</a></td>
<td class="text">Business Segment and Geographical Information<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#8216;CODM&#8217;) in accordance with ASC 280 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Segment Reporting'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates as one business segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#8217;s transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland (Ireland Segment) acts as the Group entrepreneur under the Company&#8217;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#8217;s global network. ICON Ireland enters into the majority of the Company&#8217;s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland. The </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">integration of entities acquired through the Merger into the global transfer pricing model remains ongoing and these entities were not substantially part of the Group's cost plus arrangement in the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's areas of operation outside of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland include th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e United States, United Kingdom, Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Hungary, Italy, Latvia, Poland, Portugal, Romania, Russia, Serbia, Spain, Sweden, The Netherlands, Turkey, Ukraine, Canada, Argentina, Brazil, Chile, Colombia, Mexico, Peru, China (including Hong Kong), India, Israel, Japan, Singapore, South Korea, The Philippines, Taiwan, Thailand, Australia, New Zealand, South Africa, Belarus, Bermuda, British Virgin Islands, Costa Rica, Croatia, Denmark, Egypt, Estonia, Finland, Georgia, Greece, Guatemala, Iceland, Jersey, Kenya, Lithuania, Luxembourg, Malaysia, Norway, Panama, Puerto Rico, Slovakia, Switzerland and Uruguay.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reportable segment and geographic information at December&#160;31, 2021 and December&#160;31, 2020 and for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,252,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,581,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">892,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,797,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,805,839&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) The distribution of income from operations, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">excluding restructuring, transaction and integration related expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607,897&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408,830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. These assets have been provisionally allocated to Ireland.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations, excluding restructuring, transaction and integration related expenses of $607.9 million was earned during the year ended December&#160;31, 2021 having added back restructuring expenses of $31.1&#160;million (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 Restructuring charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and transaction and integration related expenses of $198.3 million (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 6 Business Combinations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) to income from operations of $378.5 million as presented in the Consolidated Statement of Operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749858792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Disclosure of Cash Flow Information</a></td>
<td class="text">Supplemental Disclosure of Cash Flow Information<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,205&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,062&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,059&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749703736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">Accumulated Other Comprehensive Income<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss on defined benefit pension plan (note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,364)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gain on interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of gain on interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of loss on interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,937)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,477)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749699128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">Operating leases<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $49.9 million incurred in the year ended December&#160;31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs. Of the total cost of $30.1&#160;million incurred in the year ended December&#160;31, 2020, $27.6 million is recorded within selling, general and administration costs and $2.5 million is recorded within direct costs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and December&#160;31, 2020, the Group did not incur any costs related to variable lease payments.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December&#160;31, 2021 and December&#160;31, 2020 totaled $10.2 million and $12.1 million, respectively. During the year ended December&#160;31, 2021,  office consolidations resulted in the recognition of an impairment of ROU assets. The right-of-use assets related to these offices have been impaired and a charge of $15.4 million was recorded (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 - Restructuring charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">). An impairment charge of $5.4 million was recognized during the year ended December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2021 were 6.91 years and 2.51%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2020 were 4.45 years and 2.53%, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2021 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,698&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $49.9&#160;million and $24.3 million have been included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7b15ff89-21bb-47d6-8b93-387dc069fe0d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7ee1e415-4195-48f3-aa9c-3b52eaebf0fd">other liabilities</span></span> as at December&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749839576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current bank credit lines and loan facilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Non-current bank credit lines and loan facilities</a></td>
<td class="text">Non-current bank credit lines and loan facilities<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.862%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,001,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020 Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Series A notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Series B notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,501,213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,446,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,477&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2021,  December&#160;31, 2020 and December&#160;31, 2019 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the year ended December&#160;31, 2021, the Company incurred $86.7 million transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs/(credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,280,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,501,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300&#160;million. The proceeds of the senior secured term loan facility were used to repay in full (i) PRA&#8217;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the transaction. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is LIBOR plus an applicable margin of 2.50%, in each case, with a step down of 0.25% if the first lien net leverage ratio is equal to or less than 4.00 to 1.00. The senior secured term loan facility is subject to a LIBOR floor of 0.50%. On November 10, 2021, the Company achieved a net leverage ratio of less than 4 times and the margin applicable to the senior secured term loan was reduced by 0.25% with the overall rate reducing from 3.0% to 2.75%. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) LIBOR (or an alternative reference rate) plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders of under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December&#160;31, 2021, no amounts have been drawn under the revolving loan facility with the exception of $4.1&#160;million letters of credit given to landlords to guarantee lease arrangements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to monitor the phasing out of LIBOR. We have engaged with our lenders on the implications of the change and will continue to discuss with them as replacement rates for LIBOR become more prevalent in the syndicated lending market. The Company is therefore subject to interest rate volatility in respect of the senior secured term loan facility, any future draw down on the Revolving Credit Facility or in respect of any future issuances of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the credit agreement) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes (see below), subject to other permitted liens. Our long-term debt arrangements contain customary restrictive covenants and, as of December&#160;31, 2021, we were in compliance with our restrictive covenants in all material respects.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 27, 2021, the Company repaid $13.8&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.4&#160;million. On December 29, 2021, the Company repaid $500.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.8&#160;million. These repayments resulted in an additional charge associated with previously capitalized fees of $5.6&#160;million. The Company is permitted to make prepayments on the senior secured term loan without penalty.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. The proceeds from the Offering and borrowings made under the Senior Secured Credit Facilities, together with cash on hand, were used to (i) fund the cash consideration payable by ICON for the Merger, (ii) repay existing indebtedness of ICON and PRA and (iii) pay fees and expenses related to the Merger, the Offering and the Senior Secured Credit Facilities. The Senior Secured Notes are guaranteed on a senior secured basis by ICON and its direct and indirect subsidiaries</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">that guarantee the Senior Secured Credit Facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">2020 Senior Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 8, 2020, the Company issued new senior notes, (the "2020 Senior Notes") for aggregate gross proceeds of $350.0&#160;million in the private placement market. The 2020 Senior Notes were issued in two tranches; Series A Notes of $275.0&#160;million at a  fixed interest rate of 2.32% and Series B Notes of $75.0&#160;million at a fixed interest rate of 2.43%. The effective interest rate was adjusted by the impact of an interest rate cash flow hedge which was entered into in advance of the rate fixing date. This cash flow hedge was deemed to be fully effective in accordance with ASC 815 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Derivatives and Hedging'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The realized loss related to this derivative was recorded within other comprehensive income and amortized over the life of the 2020 Senior Notes. The effective rate on the 2020 Senior Notes was fixed at 2.41%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Merger, the Company was required to repay the 2020 Senior Notes prior to entering into the Senior Secured Credit Facilities and the Senior Secured Notes. In June 2021, ICON committed to entering into the Senior Secured Credit Facilities and the Senior Secured Notes and therefore committed to replacing the 2020 Senior Notes. The 2020 Senior Notes have been repaid and long term financing consisting of the Senior Secured Credit Facilities and the Senior Secured Notes have been drawn. The 2020 Senior Notes were repaid on July 1, 2021 inclusive of early repayment charges. The total repayment on July 1, 2021 was $364.0&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was $5,507.2&#160;million at December&#160;31, 2021. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749827640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 &#8212; Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 &#8212; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Recurring Fair Value Measurements </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in investments in equity-long term having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2021 and December&#160;31, 2020 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 and December&#160;31, 2020 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $3.2 million (December&#160;31, 2020: $2.5 million) recognized in net income during the year bringing the carrying value of the subscriptions to $22.6 million at December&#160;31, 2021 (December&#160;31, 2020: $15.8 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2021, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $13,748.8 million and are identified as Level 3 assets. These assets are comprised of goodwill of $9,037.9 million and identifiable intangible assets, net of $4,710.8 million. Refer to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 24 - Non-current bank credit lines and loan facilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information regarding the fair value of long-term debt balances.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749796152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impact of New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock', window );">Impact of New Accounting Pronouncements</a></td>
<td class="text">Impact of New Accounting Pronouncements<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of new accounting pronouncements adopted during fiscal year ended December&#160;31, 2021 (or previously)</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business combinations</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The amendments in this ASU require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. For public business entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption of the amendments is permitted, including adoption in an interim period. An entity that early adopts in an interim period should apply the amendments (1) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (2) prospectively to all business combinations that occur on or after the date of initial application. </span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has taken the option to early adopt the amendments in this ASU for year ended December&#160;31, 2021 and apply the amendments to interim periods from the beginning of the fiscal year. The Company has applied the amendments of this ASU to the Merger with PRA, completed on July 1, 2021. The application of these amendments has resulted in a $16.0&#160;million increase in goodwill and corresponding $16.0&#160;million increase to unearned revenue compared to the Company's Balance Sheet at September 30, 2021. Since July 1, 2021, the Company had amortized $4.0&#160;million of the unearned revenue adjustment through the revenue line in the Consolidated Statement of Comprehensive Income. This amortization has been reversed in December 2021 resulting in a net nil impact on revenue for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other accounting pronouncements adopted during fiscal year ended December&#160;31, 2021</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">'Simplifying the Accounting for Income Taxes (Topic 740)'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The Company adopted the amendments in this ASU on a prospective basis, except where the required method of adoption is retrospective or modified retrospective. ASU 2019-12 is effective for the Company for the year ended December&#160;31, 2021. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">'. ASU 2020-01 states any equity security transitioning from the alternative method of accounting under Topic 321 to the equity method, or vice versa, due to an observable transaction will be re-measured immediately before the transition. In addition, the ASU clarifies the accounting for certain non-derivative forward contracts or purchased call options to acquire equity securities stating such instruments will be measured using the fair value principles of Topic 321 before settlement or exercise. The ASU is effective for the Company for the year ended December&#160;31, 2021, and has been applied on a prospective basis. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8216;Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which removes the separation models in ASC 470 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8216;Debt&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for convertible debt with cash conversion features and convertible instruments with beneficial conversion features. The ASU also removes from ASC 815 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8216;Derivatives and Hedge Accounting&#8217;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> certain conditions for equity classification for contracts on an entity&#8217;s own equity. The ASU is effective for the Company for the year ended December&#160;31, 2021. The adoption of this ASU did not have a significant impact on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Impact of new accounting pronouncements which will be adopted during fiscal year ended December 31, 2022</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No other new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New And Recent Accounting Pronouncements Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749728872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text">Related Parties <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $30,000 (December&#160;31, 2020: $321,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December&#160;31, 2021 (December&#160;31, 2020: $41,000).&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $551,000 (December&#160;31, 2020: $9,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $197,000 was recorded as due from Afimmune Limited at December&#160;31, 2021 (December&#160;31, 2020: $nil).&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $465,000 during the year ended December&#160;31, 2021. $264,000 was recorded as due from Oncacare at December&#160;31, 2021.&#160;During the year ended December&#160;31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The full amount of this loan remains outstanding at December&#160;31, 2021 along with accrued interest of $23,000.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749775800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net income per ordinary share</a></td>
<td class="text">Net income per ordinary share<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted net income per ordinary share attributable to the Group for the years ended December&#160;31, 2020 and December&#160;31, 2019 include the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the year ended December 31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,110,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,859,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,859,537&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,068,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,283,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,333,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group (including NCI redemption adjustment)</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,809&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368,938&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357750197992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">T</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">he Company has evaluated subsequent events from the Balance Sheet date th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">rough March&#160;1, 2022, the d</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ate at which the consolidated financial statements were available to be </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">issued.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On February&#160;18, 2022, the Company's Board of Directors authorized a new buyback program of up to $100&#160;million of the outstanding ordinary shares of the Company. All ordinary shares that are redeemed under the buyback program will be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time. At March&#160;1, 2022, the Company has repurchased $80.9 million of ordinary shares of the Company since December&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has determined that there are no other items to disclose.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751321224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation</a></td>
<td class="text">Basis of consolidationThe consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of estimatesThe preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue recognition<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Third Party Costs (Reimbursable expenses)</a></td>
<td class="text">Pass-through/ Reimbursable expenses<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pass through/ Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(e) Direct costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(e) &#160; Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time i.e. the full-service obligation is in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Investigator payment costs are recorded and reported reflecting investigator activity over the life of the contract. Investigator payments are made based on predetermined contractual arrangements. Timing of payments may differ from the recording and reporting of the expense which is based on activity.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising costsAll costs associated with advertising and promotion are expensed as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies and Translation of Subsidiaries</a></td>
<td class="text">Foreign currencies and translation of subsidiariesICON plc's financial statements are prepared in United States dollars. Transactions in currencies other than the functional currency of the individual entities within the ICON Group are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the individual entities within the ICON Group are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income.The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. Foreign currency transaction gains and losses are reported in other comprehensive income ("currency impact of long term funding") rather than through income where the foreign currency transaction is 'long-term investment' in nature i.e. settlement is not planned or anticipated in the foreseeable future.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Disclosure of Fair Value of Financial Instruments</a></td>
<td class="text">Disclosure of fair value of financial instruments<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text">Business combinations<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair values at the date of exchange of assets given, liabilities incurred or assumed and equity instruments issued in exchange for control. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div> Transaction and integration-related expensesTransaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Impairment</a></td>
<td class="text">Goodwill and ImpairmentGoodwill represents the excess of the cost of acquired entities over the net amounts assigned to assets acquired and liabilities assumed. Goodwill primarily comprises acquired workforce in place which does not qualify for recognition as an asset apart from goodwill. Goodwill is stated net of any provision for impairment. The Company tests goodwill annually for any impairments or whenever events occur which may indicate impairment. An impairment charge would be recognized for any amount by which the carrying amount exceeds the reporting unit's fair value up to the amount of existing goodwill. The Company performs a qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text">Intangible assetsIntangible assets are amortized on a straight line basis over their estimated useful life.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and cash equivalentsCash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment in Debt, Equity and Other</a></td>
<td class="text">Investments in debt, equity and other<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale in accordance with the terms of ASC 320 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Investments - Debt and Equity Securities'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Realized gains and losses are determined using specific identification. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2020 and December&#160;31, 2021 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable, Net and Unbilled Revenue</a></td>
<td class="text">Accounts receivable, net and unbilled revenue&#160;&#160;&#160;&#160;<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div>Accounts receivable factoring<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Transfers and Servicing'</span> (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. The associated finance costs are presented as interest expense.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">InventoryInventory is valued at the lower of cost and net realizable value and after provisions for obsolescence. The cost of inventories comprises the purchase price and attributable costs, less trade discounts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company adopted ASC 842 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Leases' (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 842), with a date of initial application of January 1, 2019. The lease accounting policy applied in preparation of the results for the year ended December&#160;31, 2020 and December&#160;31, 2021 therefore reflect application of ASC 842. The Company adopted the standard using the cumulative-effect adjustment approach. Under this transition method, the Company applied the ASC 842 as at the date of initial application (i.e. January 1, 2019), without restatement of comparative period amounts. The cumulative effect of applying the standard is recorded as an adjustment to the opening consolidated balance sheet as at the date of initial application.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 842 requires lessees to recognize the rights and obligations resulting from virtually all leases on the Consolidated Balance Sheet as right-of-use (ROU) assets with corresponding lease liabilities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The most significant impact of application of the standard for the Company related to the recognition of right-of-use assets and lease liabilities on the Consolidated Balance Sheet for operating leases for certain property, vehicles and equipment. Prior to application of ASC 842, costs in respect of operating leases were charged to the Consolidated Statements of Operations on a straight-line basis over the lease term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to certain practical expedients available as part of adopting ASC 842, ICON did not reassess whether existing or expired supplier contracts are or contain leases, the classification of existing or expired leases, or whether unamortized initial direct costs meet the new definition of initial direct costs under ASC 842. Additionally, the Company elected to use hindsight in determining the lease term and in assessing impairment of ROU assets, if any. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2021 and December&#160;31, 2020, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Although subleases are accounted for separately from the lease they relate to, subleases are accounted for in the same way as other leases.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Income taxesThe Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#8220;global intangible low-taxed income&#8221;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_GovernmentGrantsPolicyTextBlock', window );">Government Grants</a></td>
<td class="text">Government grants<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ResearchandDevelopmentCreditsPolicyTextBlock', window );">Research and Development Credits</a></td>
<td class="text">Research and development creditsResearch and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits are generally recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension Costs</a></td>
<td class="text">Pension costs<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Pension'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These plans are presented in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock', window );">Redeemable Non-Controlling Interests and Equity</a></td>
<td class="text">Redeemable noncontrolling interests and equity<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Distinguishing Liabilities from Equity'. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. </span>Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income per Ordinary Share</a></td>
<td class="text">Net income per ordinary share<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 27 - Net income per ordinary share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">Share-based compensation<div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Compensation &#8211; Stock Compensation'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">Impairment of long-lived assetsLong-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative financial instruments<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We enter into transactions in the normal course of business using various financial instruments in order to hedge against exposure to fluctuating exchange and interest rates. We use derivative financial instruments to reduce exposure to fluctuations in interest rates. A derivative is a financial instrument or other contract whose value changes in response to some underlying variable, which has an initial net investment smaller than would be required for other instruments that have a similar response to the variable and that will be settled at a future date. We do not enter into derivative financial instruments for trading or speculative purposes. We did not hold any interest rate swap contracts or forward currency contracts at December&#160;31, 2021 or December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use derivative financial instruments to reduce exposure to fluctuations in foreign exchange rates. During the years ended December&#160;31, 2019 and December&#160;31, 2020, we entered into forward currency contracts in respect of identified exposure arising from euro payments. All contracts expired during the year in which the contract was entered into. No forward currency contracts were entered into during the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Issuance Costs</a></td>
<td class="text">Debt issuance costsDebt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Transaction and Integration-related Expenses</a></td>
<td class="text">Business combinations<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair values at the date of exchange of assets given, liabilities incurred or assumed and equity instruments issued in exchange for control. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div> Transaction and integration-related expensesTransaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy', window );">Restructuring</a></td>
<td class="text">RestructuringRestructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">ReclassificationsCertain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#8217;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the years ended December 31, 2020 and December 31, 2019 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#8217;s presentation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_GovernmentGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government Grants, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_GovernmentGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ResearchandDevelopmentCreditsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Credits [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ResearchandDevelopmentCreditsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748797544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ForeignCurrencyDisclosureTableTextBlock', window );">Adjustments Resulting From Foreign Currency Translations</a></td>
<td class="text">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock', window );">Estimated Useful Lives of Assets</a></td>
<td class="text">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ForeignCurrencyDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ForeignCurrencyDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Useful Lives For Property Plant Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748557336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Cost and Fair Value of Investments</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(497)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,902)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gain on sale of short term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized capital loss &#8211; investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Available for sale investments at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Available For Sale Short Term Investments by Major Security Type</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our available for sale short term investments by major security type as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity by period</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost<br/>Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value<br/>Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1<br/>year</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1 to 5<br/>years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total ($ in millions)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our equity method investments at December&#160;31, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ownership Percentage</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749725992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">883,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357746783128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,081,381&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,011&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133,551)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,710,843&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Intangible Asset Amortization Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2022 to December 31, 2026 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">454,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">338,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,680,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755840824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,308,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,658,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the preliminary allocation of the consideration transferred based on management&#8217;s estimates of Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,886,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380,342)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(739,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,126,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(203,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is expected to be deductible for income tax purposes.</span></div>The following table summarizes the Company&#8217;s fair values of the assets acquired and liabilities assumed:<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 22,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash &amp; cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,090)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash outflows</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital adjustment paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total consideration</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,556&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Goodwill represents the acquisition of an established workforce that specializes in medical device development and market access. None of the goodwill recognized is expected to be deductible for income tax purposes. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The fair value of the contingent consideration was estimated at the date of acquisition as $Nil. Depending on performance of MedPass for the 12 month period ended December 31, 2020, the total consideration could have increased by a maximum of $6.7&#160;million in contingent consideration. In January 2021, the contingent consideration was finalized and a value of $Nil was payable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the preliminary estimates of the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.134%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,915,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">490,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,886,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Summary of Proforma Information per Acquisition</a></td>
<td class="text">Consequently, actual future results of the Company will differ from the pro forma financial information presented below:<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,462,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,980,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income/(loss)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149,658)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>The proforma effect of the MedPass acquisition if completed on January 1, 2019 would have resulted in revenue and net income for the fiscal years ended December 31, 2020 and December 31, 2019 as follows:  <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.191%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,798,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,820,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749827080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment, Net</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">506,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">440,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798,968&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703,714&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(462,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(529,371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174,343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749796152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities (note 23)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities (note 15)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949,629&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399,769&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $323.6&#160;million at December&#160;31, 2021 and $138.2&#160;million at December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749778552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-Current Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Non-Current Other Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 10)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,861&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357744370280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,988)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,615)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,376)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,615)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,376)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(724)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,988&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(724)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,019)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/ loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,620&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 <span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,973)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,973)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation as at July 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at as at July 1, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transferred benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Summary of Assumptions Used in Calculating Pension Benefit Obligations</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain &#8211; plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,930)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss recognized in net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,898)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock', window );">Summary of Expected Long Term Rates of Return on Different Asset Classes</a></td>
<td class="text">The expected long term rates of return on different asset classes are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expected long-term return per annum</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Underlying Asset Split of Fund</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The underlying asset split of the fund is shown below.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Plan Asset Fair Value Measurements</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets<br/>Level 1</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Income Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">L&amp;G Life GPBF All World Equity Index Fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">L&amp;G Life DC Active Corporate Bond</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stone Harbor High Yield Bond Fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ninety One Global Total Return Credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stone Harbor Multi Asset Credit Portfolio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Barings European Loan Fund Buy &amp; Hold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Annual Benefit Payments which Reflect Expected Future Service</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2027 - 2031</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected Long Term Rate of Return on Plan Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(b)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756120360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Transactions for Company's Share Option Plans</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">920,746&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74.32&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,112&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.13&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(329,870)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,881)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,107&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,737&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.83&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(193,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,681)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,746&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.53&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,177,130&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.78&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.79&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">989,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.70&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Non Vested Shares Outstanding</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Information Concerning Outstanding and Exercisable Share Options</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.80 - 97.30</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.45</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.81 - 124.00</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.74 - 147.26</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.33 - 231.08</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.80 - 231.08</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,695,460</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.39</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">104.79</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">989,419</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Fair Values and Assumptions Used</a></td>
<td class="text">The weighted average fair values and assumptions were as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock', window );">Summary of RSU and PSU Activity</a></td>
<td class="text">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2021:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.77&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combination*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">589,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested **</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(446,404)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents restricted stock units issued as replacement awards in connection with the Merger.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Includes 161,389 RSU's which vested on the date of the Merger.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock', window );">Schedule of Non-cash Stock Compensation Expense</a></td>
<td class="text">Non-cash stock compensation expense has been allocated as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,844&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,819&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Non Cash Stock Compensation Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756133288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncomeBeforeIncomeTaxTableTextBlock', window );">Summary of Components of Income Before Provision for Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426,989&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Components of Provision for Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,950&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,948&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,670&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,616)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,943&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,158&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate</a></td>
<td class="text">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income tax expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,201,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,289,256&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,797&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,167&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,864&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,495)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,672&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,096&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax asset/(liability)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,037,584)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of Expected Expiry Dates of NOL's</a></td>
<td class="text">The expected expiry dates of these US losses are as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022-2035</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2036-2040</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296,981&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeBeforeIncomeTaxTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Before Income Tax, Table</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeBeforeIncomeTaxTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749711928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring Charges</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.129%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,069)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,978)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,353&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,748&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749667032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">704,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">873,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,797,288</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,805,839</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357750197992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Contracts with Customers, Asset and Liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 19)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">715,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,965,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,143,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,323,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(660,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(663,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(232,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(468,641)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(201.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755913960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provision for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AllowanceForDoubtfulAccountsTableTextBlock', window );">Schedule of Provision for Credit Losses</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2021 and December&#160;31, 2020 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts released during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,149&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AllowanceForDoubtfulAccountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance for Doubtful Accounts, Table</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AllowanceForDoubtfulAccountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357757168296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Distribution of Net Revenue by Geographical Area</a></td>
<td class="text">The distribution of revenue by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,252,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,581,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">892,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,797,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,805,839&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OperatingIncomeByGeographyTableTextBlock', window );">Schedule of Distribution of Income from Operations by Geographical Area</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) The distribution of income from operations, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">excluding restructuring, transaction and integration related expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607,897&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408,830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. These assets have been provisionally allocated to Ireland.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Distribution of Long-lived Assets, Net, by Geographical Area</a></td>
<td class="text">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingIncomeByGeographyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income by Geography.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingIncomeByGeographyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749801288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Disclosure of Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,205&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,062&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,059&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749745560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss on defined benefit pension plan (note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,364)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Realized gain on interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of gain on interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on interest rate hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of loss on interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,937)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,477)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755836056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Cost</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturity</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2021 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,698&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,432&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357914989640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current bank credit lines and loan facilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.862%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,001,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020 Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Series A notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Series B notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,501,213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,446,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348,477&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock', window );">Schedule of Financing Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs/(credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,280,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,501,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Financing Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751149768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,110,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,859,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,859,537&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,068,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,283,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,333,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group (including NCI redemption adjustment)</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,809&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368,938&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357753280552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Employee </div>
<div>Location </div>
<div>Country</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>Employee</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of employees | Employee</a></td>
<td class="nump">38,330<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_NumberOfLocations', window );">Number of locations in which company operates | Location</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which company operates | Country</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | United States | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">47.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | Europe | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">46.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | Rest of World | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NumberOfLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Locations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NumberOfLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherGeographicLocationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherGeographicLocationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357744167112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 09, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Carrying value of inventory</a></td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_MeDiNovaResearchMember', window );">MeDiNova</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage', window );">Business combination acquisition percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_MeDiNovaResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_MeDiNovaResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755524232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyAbstract', window );"><strong>Foreign Currency [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">&#160; Amounts (credited)/charged</a></td>
<td class="num">$ (14,316)<span></span>
</td>
<td class="nump">$ 5,979<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357744137992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies - Estimated Useful Lives of Assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building &#160;</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember', window );">Computer equipment and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember', window );">Computer equipment and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment &#160;</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Motor vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357750000520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Available For Sale Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward', window );"><strong>Reconciliation Of Debt Securities, Available-For-Sale [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments at start of year</a></td>
<td class="nump">$ 1,729<span></span>
</td>
<td class="nump">$ 49,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 9,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sales and maturities</a></td>
<td class="num">(497)<span></span>
</td>
<td class="num">(47,902)<span></span>
</td>
<td class="num">(21,686)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Realized gain on sale of short term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital (loss)/gain - investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">&#160; Available for sale investments at end of year</a></td>
<td class="nump">$ 1,712<span></span>
</td>
<td class="nump">$ 1,729<span></span>
</td>
<td class="nump">$ 49,628<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation Of Debt Securities, Available-For-Sale [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751766136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1">48 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod', window );">Short term investments average maturity period</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchase of investments in equity - long term</a></td>
<td class="nump">$ 3,577<span></span>
</td>
<td class="nump">$ 3,212<span></span>
</td>
<td class="nump">$ 3,890<span></span>
</td>
<td class="nump">$ 13,300<span></span>
</td>
<td class="nump">$ 16,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Increase in fair value</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of long-term investments in equity</a></td>
<td class="nump">22,600<span></span>
</td>
<td class="nump">15,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,800<span></span>
</td>
<td class="nump">22,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CommitmentToAcquireLongTermInvestments', window );">Commitment to acquire future long-term investments</a></td>
<td class="nump">17,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments (Note 3c)</a></td>
<td class="nump">$ 2,373<span></span>
</td>
<td class="nump">4,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,534<span></span>
</td>
<td class="nump">$ 2,373<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_EquityMethodInvestmentMajorityOwnershipPercentage', window );">Majority investor, ownership percentage</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany', window );">Period majority voting share capital can be sold to the company</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">$ 2,161<span></span>
</td>
<td class="nump">$ 366<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions', window );">Loan granted tp related party</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party, loan interest rate</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CommitmentToAcquireLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitment To Acquire Long-Term Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CommitmentToAcquireLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EquityMethodInvestmentMajorityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Majority Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EquityMethodInvestmentMajorityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short Term Available For Sale Investments Average Remaining Maturity Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount of new advances made to related parties in the form of loan and lease receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.7(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751551272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Available For Sale Short Term Investments by Major Security Type (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost Total</a></td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value Total</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 year</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1 to 5 years</a></td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=iclr_TermDepositsMember', window );">Term deposits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost Total</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value Total</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 year</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1 to 5 years</a></td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=iclr_TermDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=iclr_TermDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755996024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Equity Method Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 2,373<span></span>
</td>
<td class="nump">$ 4,534<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357750015064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Schedule of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Opening goodwill</a></td>
<td class="nump">$ 936,257<span></span>
</td>
<td class="nump">$ 883,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Current year acquisitions (note 6)</a></td>
<td class="nump">8,120,006<span></span>
</td>
<td class="nump">27,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Prior period acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange movement</a></td>
<td class="num">(18,332)<span></span>
</td>
<td class="nump">25,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Closing goodwill</a></td>
<td class="nump">$ 9,037,931<span></span>
</td>
<td class="nump">$ 936,257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357753287000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Summary of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">$ 5,081,381<span></span>
</td>
<td class="nump">$ 200,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(370,538)<span></span>
</td>
<td class="num">(133,551)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">&#160; Net book value</a></td>
<td class="nump">4,710,843<span></span>
</td>
<td class="nump">66,460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">4,056,642<span></span>
</td>
<td class="nump">144,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">528,022<span></span>
</td>
<td class="nump">39,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">204,685<span></span>
</td>
<td class="nump">2,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">170,525<span></span>
</td>
<td class="nump">2,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">$ 121,507<span></span>
</td>
<td class="nump">$ 11,173<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752985112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Jan. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 4,886,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 3,915,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">490,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 111,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember', window );">Medpass Group Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember', window );">Medpass Group Limited | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember', window );">Medpass Group Limited | Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756505912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Future Intangible Asset Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 456,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">454,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">338,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">222,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">208,175<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet', window );">Finite lived intangible assets, amortization expense, net, total</a></td>
<td class="nump">$ 1,680,037<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Assets, Amortization Expense, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751704936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Narrative, PRA Acquisition (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>Employee </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Employee</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Employee</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of employees | Employee</a></td>
<td class="nump">38,000<span></span>
</td>
<td class="nump">38,330<span></span>
</td>
<td class="nump">38,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration related (Note 6)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198,263<span></span>
</td>
<td class="num">$ (759)<span></span>
</td>
<td class="nump">$ 4,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,423<span></span>
</td>
<td class="nump">13,019<span></span>
</td>
<td class="nump">13,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,391<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld', window );">Business acquisition, share price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld', window );">Business acquisition, number of shares issued (in shares) | shares</a></td>
<td class="nump">0.4125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration related (Note 6)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Gross debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,200<span></span>
</td>
<td class="nump">76,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Revenue of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,053,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual', window );">Pre-tax net income of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Pro Forma Information, Earnings Or Loss Before Tax Of Acquiree Since Acquisition Date, Actual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_TransactionAndOneTimeFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transaction And One Time Financing Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_TransactionAndOneTimeFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748388360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,914,475<span></span>
</td>
<td class="nump">$ 47,931<span></span>
</td>
<td class="nump">$ 131,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="nump">$ 5,308,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of ordinary shares issued to acquiree stockholders</a></td>
<td class="nump">5,658,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Fair value of replacement share-based awards issued to acquiree employees</a></td>
<td class="nump">209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Repayment of term loan obligations and accrued interest</a></td>
<td class="nump">865,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">12,041,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate', window );">Payments to settle debt obligations that existed prior to acquisition date</a></td>
<td class="nump">$ 401,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748276296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations - Schedule of Acquisitions, PRA Acquisition (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 9,037,931,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 936,257,000<span></span>
</td>
<td class="nump">$ 883,170,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable and unbilled revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,308,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,851,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,120,006,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,886,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,099,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,391,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,259,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(380,342,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,625,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(739,278,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability', window );">Non-current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(144,403,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,126,952,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(203,297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,041,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751764376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details) - PRA Health Sciences, Inc<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 4,886,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 3,915,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">23 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 490,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 202,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 168,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 111,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755872888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details) - PRA Health Sciences, Inc - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="nump">$ 7,462,000<span></span>
</td>
<td class="nump">$ 5,980,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income/(loss)</a></td>
<td class="nump">$ 340,942<span></span>
</td>
<td class="num">$ (149,658)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357744103544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Narrative, MedPass Group Acquisition (Details) - Medpass Group Limited - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 22, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables', window );">Accounts receivable adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue', window );">Unearned revenue adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets', window );">Operating right-to-use assets fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities', window );">Other liabilities adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities', window );">Operating current lease liabilities fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities', window );">Operating non-current lease liabilities fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability', window );">Operating non-current deferred tax liability fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Revenue of acquiree since acquisition date</a></td>
<td class="nump">$ 13.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Net income of acquiree since acquisition date</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Right-To-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357753052568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Schedule of Acquisitions, MedPass Group Acquisition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,037,931,000<span></span>
</td>
<td class="nump">$ 936,257,000<span></span>
</td>
<td class="nump">$ 883,170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,914,475,000<span></span>
</td>
<td class="nump">$ 47,931,000<span></span>
</td>
<td class="nump">$ 131,272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember', window );">Medpass Group Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 10,170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating right of use assets</a></td>
<td class="nump">539,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">27,191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">3,033,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepayments and other current assets</a></td>
<td class="nump">158,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(368,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent', window );">Unearned revenue</a></td>
<td class="num">(989,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="num">(2,202,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability', window );">Current lease liabilities</a></td>
<td class="num">(219,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability', window );">Non-current portion of operating lease liabilities</a></td>
<td class="num">(320,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(4,090,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">47,556,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="nump">46,992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments', window );">Working capital adjustment paid</a></td>
<td class="num">(564,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">47,556,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, maximum value</a></td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember', window );">Medpass Group Limited | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">11,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember', window );">Medpass Group Limited | Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 2,883,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Working Capital Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357757252952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations - Schedule of Pro-Forma Information, MedPass Group Acquisition (Details) - Medpass Group Limited - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="nump">$ 2,798,180<span></span>
</td>
<td class="nump">$ 2,820,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income/(loss)</a></td>
<td class="nump">$ 332,521<span></span>
</td>
<td class="nump">$ 377,485<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_MedpassGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752994072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 3,724<span></span>
</td>
<td class="nump">$ 3,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building</a></td>
<td class="nump">82,017<span></span>
</td>
<td class="nump">90,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Computer equipment and software</a></td>
<td class="nump">506,322<span></span>
</td>
<td class="nump">440,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Office furniture and fixtures</a></td>
<td class="nump">107,507<span></span>
</td>
<td class="nump">91,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Laboratory equipment</a></td>
<td class="nump">29,210<span></span>
</td>
<td class="nump">44,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">70,123<span></span>
</td>
<td class="nump">32,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_VehiclesGross', window );">Motor vehicles</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">798,968<span></span>
</td>
<td class="nump">703,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and asset write offs</a></td>
<td class="num">(462,524)<span></span>
</td>
<td class="num">(529,371)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment (net)</a></td>
<td class="nump">$ 336,444<span></span>
</td>
<td class="nump">$ 174,343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VehiclesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vehicles, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VehiclesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752851912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">General trade and overhead liabilities</a></td>
<td class="nump">$ 459,814<span></span>
</td>
<td class="nump">$ 188,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Personnel related liabilities</a></td>
<td class="nump">413,185<span></span>
</td>
<td class="nump">161,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (note 23)</a></td>
<td class="nump">49,949<span></span>
</td>
<td class="nump">24,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedUtilitiesCurrent', window );">Facility related liabilities</a></td>
<td class="nump">12,055<span></span>
</td>
<td class="nump">9,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">7,204<span></span>
</td>
<td class="nump">8,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_RestructuringReserveandOtherLiabilitiesCurrent', window );">Restructuring liabilities (note 15)</a></td>
<td class="nump">7,377<span></span>
</td>
<td class="nump">7,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CapitalGovernmentGrantsCurrent', window );">Short term government grants</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">949,629<span></span>
</td>
<td class="nump">399,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses', window );">Amounts due to third parties for reimbursable expenses</a></td>
<td class="nump">$ 323,600<span></span>
</td>
<td class="nump">$ 138,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CapitalGovernmentGrantsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Government Grants Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CapitalGovernmentGrantsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RestructuringReserveandOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RestructuringReserveandOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedUtilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedUtilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357749723496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-Current Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Defined benefit pension obligations, net (note 10)</a></td>
<td class="nump">$ 16,262<span></span>
</td>
<td class="nump">$ 10,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">25,599<span></span>
</td>
<td class="nump">15,971<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Non-current other liabilities (Note 9)</a></td>
<td class="nump">$ 41,861<span></span>
</td>
<td class="nump">$ 26,366<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752174040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>May 07, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember', window );">Other retirement plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember', window );">ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember', window );">ICON Development Solutions Limited pension plan | Secured Loans and Multi Asset Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Percentage of investments (in percent)</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember', window );">ICON Development Solutions Limited pension plan | Corporate Bonds (including 50% high yield bonds)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Percentage of investments (in percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember', window );">ICON Development Solutions Limited pension plan | High yield bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Percentage of investments (in percent)</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember', window );">ICON Development Solutions Limited pension plan | Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Percentage of investments (in percent)</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Participant's contributions percentage of annual compensation (in percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan, cost</a></td>
<td class="nump">$ 23,700,000<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="nump">$ 16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">41,813,000<span></span>
</td>
<td class="nump">$ 43,988,000<span></span>
</td>
<td class="nump">$ 37,036,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear', window );">Net loss that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear', window );">Net prior service cost for defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod', window );">Pension plan period</a></td>
<td class="text">26 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Contribution to pension fund in the year ending December 31, 2021</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ExpectedRetirementPeriod', window );">Retirement period used as a basis to estimate expected cash flows</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">$ 7,643,000<span></span>
</td>
<td class="nump">$ 8,620,000<span></span>
</td>
<td class="nump">$ 7,047,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan | Aptiv Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ExpectedRetirementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected Retirement period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ExpectedRetirementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (s)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (s)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_HighYieldBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_HighYieldBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_AptivSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_AptivSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752878712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Funded Status (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">$ (41,813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (43,988)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">36,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,612<span></span>
</td>
<td class="nump">$ 32,016<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded status</a></td>
<td class="num">(5,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,376)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Non-current other liabilities (note 9)</a></td>
<td class="num">(5,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,376)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="nump">$ 2,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">(7,643)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,620)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,601<span></span>
</td>
<td class="nump">$ 6,014<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded status</a></td>
<td class="num">(679)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Non-current other liabilities (note 9)</a></td>
<td class="num">(679)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">(4,990)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded status</a></td>
<td class="num">(1,973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Non-current other liabilities (note 9)</a></td>
<td class="num">$ (1,973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751397416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Change in Benefit Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,988<span></span>
</td>
<td class="nump">$ 37,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489)<span></span>
</td>
<td class="num">(724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain)/loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,097)<span></span>
</td>
<td class="nump">5,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(411)<span></span>
</td>
<td class="nump">1,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">&#160; Benefit obligation at end of year</a></td>
<td class="nump">$ 41,813<span></span>
</td>
<td class="nump">41,813<span></span>
</td>
<td class="nump">43,988<span></span>
</td>
<td class="nump">37,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,620<span></span>
</td>
<td class="nump">7,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherChanges', window );">Transferred balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="num">(245)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain)/loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(484)<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(261)<span></span>
</td>
<td class="nump">704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">&#160; Benefit obligation at end of year</a></td>
<td class="nump">7,643<span></span>
</td>
<td class="nump">7,643<span></span>
</td>
<td class="nump">$ 8,620<span></span>
</td>
<td class="nump">$ 7,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">4,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain)/loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="num">(149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">&#160; Benefit obligation at end of year</a></td>
<td class="nump">$ 4,990<span></span>
</td>
<td class="nump">$ 4,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752837128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Change in Plan Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,612<span></span>
</td>
<td class="nump">$ 32,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,347<span></span>
</td>
<td class="nump">2,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489)<span></span>
</td>
<td class="num">(724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(386)<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">&#160;Fair value of plan assets at end of year</a></td>
<td class="nump">$ 36,198<span></span>
</td>
<td class="nump">36,198<span></span>
</td>
<td class="nump">34,612<span></span>
</td>
<td class="nump">32,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">2,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">&#160;Fair value of plan assets at end of year</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="nump">3,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,601<span></span>
</td>
<td class="nump">6,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(238)<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DefinedBenefitPlanSchemeContributions', window );">Scheme contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan', window );">Transferred balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(483)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(230)<span></span>
</td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">&#160;Fair value of plan assets at end of year</a></td>
<td class="nump">6,964<span></span>
</td>
<td class="nump">6,964<span></span>
</td>
<td class="nump">$ 7,601<span></span>
</td>
<td class="nump">$ 6,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">&#160;Fair value of plan assets at end of year</a></td>
<td class="nump">$ 3,017<span></span>
</td>
<td class="nump">$ 3,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanSchemeContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Scheme Contributions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanSchemeContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357744164168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Components of Net Periodic Benefit Cost (Details) - United Kingdom - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">665<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1,171)<span></span>
</td>
<td class="num">(1,214)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net loss</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="num">$ (208)<span></span>
</td>
<td class="nump">$ 467<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751637960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details) - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income &#160;</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost', window );">Actuarial (gain)/loss - benefit obligation</a></td>
<td class="num">$ (2,097)<span></span>
</td>
<td class="nump">$ 5,294<span></span>
</td>
<td class="nump">$ 4,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Actuarial gain &#8211; plan assets</a></td>
<td class="num">(1,176)<span></span>
</td>
<td class="num">(878)<span></span>
</td>
<td class="num">(2,930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax', window );">Actuarial loss recognized in net periodic benefit cost</a></td>
<td class="num">(625)<span></span>
</td>
<td class="num">(160)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax', window );">&#160;Total</a></td>
<td class="num">$ (3,898)<span></span>
</td>
<td class="nump">$ 4,256<span></span>
</td>
<td class="nump">$ 1,759<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748481384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details) - United Kingdom - ICON Development Solutions Limited pension plan<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751679256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details) - ICON Development Solutions Limited pension plan<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage', window );">High yield percentage of corporate bond investment</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Bonds (including 50% high yield bonds)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember', window );">Secured Loans and Multi Asset Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">44561</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Corporate Bonds Target Allocation, High Yield Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751826280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Plan Asset Fair Value Measurements (Details) - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage', window );">High yield percentage of corporate bond investment</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 36,198<span></span>
</td>
<td class="nump">$ 34,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | L&amp;G Life GPBF All World Equity Index Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">8,743<span></span>
</td>
<td class="nump">7,460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | L&amp;G Life DC Active Corporate Bond</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6,409<span></span>
</td>
<td class="nump">6,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Stone Harbor High Yield Bond Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6,965<span></span>
</td>
<td class="nump">6,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Ninety One Global Total Return Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,435<span></span>
</td>
<td class="nump">3,472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Stone Harbor Multi Asset Credit Portfolio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,359<span></span>
</td>
<td class="nump">3,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Barings European Loan Fund Buy &amp; Hold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 7,125<span></span>
</td>
<td class="nump">$ 6,622<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Corporate Bonds Target Allocation, High Yield Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_LAndGLifeDCActiveCorporateBondMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_LAndGLifeDCActiveCorporateBondMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_StoneHarborHighYieldBondFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_StoneHarborHighYieldBondFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_NinetyOneGlobalTotalReturnCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_NinetyOneGlobalTotalReturnCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_StoneHarborMultiAssetCreditPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_StoneHarborMultiAssetCreditPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_BaringsEuropeanLoanFundBuyAndHoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_BaringsEuropeanLoanFundBuyAndHoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756162504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Annual Benefit Payments (Details) - United Kingdom - ICON Development Solutions Limited pension plan<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2023</a></td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2024</a></td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2025</a></td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2026</a></td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Years 2027 - 2031</a></td>
<td class="nump">$ 3,859<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357740784264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">252 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 14, 2017</div></th>
<th class="th"><div>May 11, 2015</div></th>
<th class="th"><div>Jan. 17, 2003</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>May 18, 2020</div></th>
<th class="th"><div>May 16, 2019</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Feb. 13, 2017</div></th>
<th class="th"><div>Sep. 23, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average contractual term of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 4 months 20 days<span></span>
</td>
<td class="text">4 years 10 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable - weighted average remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months 18 days<span></span>
</td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,844<span></span>
</td>
<td class="nump">$ 26,271<span></span>
</td>
<td class="nump">$ 26,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit related to stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,700<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="nump">8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Cash tax benefit related to stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,900<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember', window );">The 2020 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember', window );">The 2018 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_A2013LegacyPRAPlanMember', window );">2013 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,052,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized', window );">Percentage of outstanding shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember', window );">Consultants Stock Plan, 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted', window );">Limit of shares issued or to be issued pursuant to options granted (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember', window );">Employee Stock Plan, 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member', window );">Option Plans 2008 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of option price for fair value of ordinary share (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroThreePlanMember', window );">Employee Stock Plan, 2003 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Maximum number of award as percentage of shares outstanding (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Award date, prior to 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Shares expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Award date, 2018 and thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Shares expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember', window );">Restricted Stock Units 2013</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional number of ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember', window );">Consultants Restricted Stock Units 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember', window );">Consultants Restricted Stock Units 2019 | Non-executive director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,500<span></span>
</td>
<td class="nump">$ 14,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115.11<span></span>
</td>
<td class="nump">$ 83.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 206.71<span></span>
</td>
<td class="nump">$ 156.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115.11<span></span>
</td>
<td class="nump">$ 83.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125.74<span></span>
</td>
<td class="nump">$ 90.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember', window );">PSUs Based on Service and EPS Targets | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock units to be granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation Related Costs Share Based Payments Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Limit of Shares Issued or To Be Issued Pursuant to Options Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_A2013LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_A2013LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroThreePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroThreePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=iclr_AwardDateAllYearsExcluding2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=iclr_AwardDateAllYearsExcluding2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=iclr_AwardDate2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=iclr_AwardDate2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iclr_NonexecutiveDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iclr_NonexecutiveDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752040056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details) - Stock Option and Award Plans - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options Granted Under Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">553,746<span></span>
</td>
<td class="nump">656,107<span></span>
</td>
<td class="nump">920,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination', window );">Assumed through business combination (in shares)</a></td>
<td class="nump">2,177,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">100,299<span></span>
</td>
<td class="nump">107,737<span></span>
</td>
<td class="nump">97,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(1,065,529)<span></span>
</td>
<td class="num">(193,417)<span></span>
</td>
<td class="num">(329,870)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled/expired (in shares)</a></td>
<td class="num">(70,186)<span></span>
</td>
<td class="num">(16,681)<span></span>
</td>
<td class="num">(31,881)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">1,695,460<span></span>
</td>
<td class="nump">553,746<span></span>
</td>
<td class="nump">656,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and exercisable at end of period (in shares)</a></td>
<td class="nump">989,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (USD per share)</a></td>
<td class="nump">$ 108.53<span></span>
</td>
<td class="nump">$ 87.80<span></span>
</td>
<td class="nump">$ 74.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice', window );">Assumed through business combination (USD per share)</a></td>
<td class="nump">108.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share)</a></td>
<td class="nump">177.76<span></span>
</td>
<td class="nump">159.83<span></span>
</td>
<td class="nump">140.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (USD per share)</a></td>
<td class="nump">111.29<span></span>
</td>
<td class="nump">68.19<span></span>
</td>
<td class="nump">65.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled/expired (USD per share)</a></td>
<td class="nump">128.46<span></span>
</td>
<td class="nump">92.21<span></span>
</td>
<td class="nump">88.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (USD per share)</a></td>
<td class="nump">104.79<span></span>
</td>
<td class="nump">$ 108.53<span></span>
</td>
<td class="nump">$ 87.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 91.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751443464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">$ 14.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">231.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member', window );">Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">14.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">97.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member', window );">Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">103.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">124.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member', window );">Range 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">125.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">147.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member', window );">Range 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">159.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">$ 231.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">1,695,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">5 years 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 104.79<span></span>
</td>
<td class="nump">$ 108.53<span></span>
</td>
<td class="nump">$ 87.80<span></span>
</td>
<td class="nump">$ 74.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">989,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 91.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">638,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">3 years 5 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">605,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">320,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">6 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">130,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">540,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">6 years 6 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">235,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">196,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">6 years 8 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">17,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756012504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details) - Employee Stock Option - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (USD per share)</a></td>
<td class="nump">$ 107.21<span></span>
</td>
<td class="nump">$ 49.15<span></span>
</td>
<td class="nump">$ 42.43<span></span>
</td>
<td class="nump">$ 43.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (in percent)</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (in percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (in percent)</a></td>
<td class="nump">0.56%<span></span>
</td>
<td class="nump">0.78%<span></span>
</td>
<td class="nump">0.57%<span></span>
</td>
<td class="nump">2.55%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752143832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding number of shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination', window );">Assumed through business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares)</a></td>
<td class="num">(161,389)<span></span>
</td>
<td class="num">(44,132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,763)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at ending of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice', window );">Assumed through business combination (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160.23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding number of shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination', window );">Assumed through business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at ending of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice', window );">Assumed through business combination (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191.20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357740740136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">$ 133,844<span></span>
</td>
<td class="nump">$ 26,271<span></span>
</td>
<td class="nump">$ 26,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Direct costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">18,551<span></span>
</td>
<td class="nump">8,557<span></span>
</td>
<td class="nump">14,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">41,457<span></span>
</td>
<td class="nump">17,714<span></span>
</td>
<td class="nump">12,042<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember', window );">Transaction and integration related *</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">$ 73,836<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357740663480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Jul. 22, 2016</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 08, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 03, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_NumberOfVotes', window );">Number of votes | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Total proceeds from exercise of stock options by employees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,589,000<span></span>
</td>
<td class="nump">$ 13,203,000<span></span>
</td>
<td class="nump">$ 21,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="nump">146,931,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember', window );">Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Ordinary shares redeemed (in shares)</a></td>
<td class="nump">35,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,235,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,026,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="nump">$ 141,600,000<span></span>
</td>
<td class="nump">$ 372,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_StockRepurchaseProgramAuthorizedPercentage', window );">Stock repurchase program, authorized percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
<td class="nump">193,417<span></span>
</td>
<td class="nump">329,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Average exercise price of option per share (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.29<span></span>
</td>
<td class="nump">$ 68.19<span></span>
</td>
<td class="nump">$ 65.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Total proceeds from exercise of stock options by employees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,600,000<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="nump">$ 21,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,404<span></span>
</td>
<td class="nump">144,172<span></span>
</td>
<td class="nump">237,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,132<span></span>
</td>
<td class="nump">63,516<span></span>
</td>
<td class="nump">118,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issue of shares associated with a business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,372,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
<td class="nump">193,417<span></span>
</td>
<td class="nump">329,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Ordinary shares redeemed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,235,218<span></span>
</td>
<td class="nump">1,035,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000<span></span>
</td>
<td class="nump">$ 69,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NumberOfVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NumberOfVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_StockRepurchaseProgramAuthorizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program Authorized Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_StockRepurchaseProgramAuthorizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357740611000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Before Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">&#160; Income before income tax expense</a></td>
<td class="nump">$ 196,680<span></span>
</td>
<td class="nump">$ 381,205<span></span>
</td>
<td class="nump">$ 426,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">&#160; Income before income tax expense</a></td>
<td class="nump">231,893<span></span>
</td>
<td class="nump">280,310<span></span>
</td>
<td class="nump">323,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">&#160; Income before income tax expense</a></td>
<td class="num">(278,413)<span></span>
</td>
<td class="nump">41,950<span></span>
</td>
<td class="nump">21,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">&#160; Income before income tax expense</a></td>
<td class="nump">$ 243,200<span></span>
</td>
<td class="nump">$ 58,945<span></span>
</td>
<td class="nump">$ 82,190<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748247016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">$ 101,950<span></span>
</td>
<td class="nump">$ 46,948<span></span>
</td>
<td class="nump">$ 52,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(60,616)<span></span>
</td>
<td class="nump">927<span></span>
</td>
<td class="num">(1,537)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense allocated to continuing operations</a></td>
<td class="nump">41,334<span></span>
</td>
<td class="nump">47,875<span></span>
</td>
<td class="nump">51,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract', window );"><strong>Income tax expense was allocated to the following components of other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Currency impact on long term funding</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity', window );">Total</a></td>
<td class="nump">41,383<span></span>
</td>
<td class="nump">47,943<span></span>
</td>
<td class="nump">51,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">18,469<span></span>
</td>
<td class="nump">28,963<span></span>
</td>
<td class="nump">35,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">1,654<span></span>
</td>
<td class="nump">2,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">35,478<span></span>
</td>
<td class="nump">3,022<span></span>
</td>
<td class="nump">5,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(52,717)<span></span>
</td>
<td class="nump">4,577<span></span>
</td>
<td class="num">(3,502)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">48,003<span></span>
</td>
<td class="nump">14,963<span></span>
</td>
<td class="nump">11,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">$ (8,452)<span></span>
</td>
<td class="num">$ (5,304)<span></span>
</td>
<td class="num">$ (868)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755470472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</a></td>
<td class="nump">$ 24,586<span></span>
</td>
<td class="nump">$ 47,651<span></span>
</td>
<td class="nump">$ 53,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign and other income taxed at higher rates</a></td>
<td class="nump">20,045<span></span>
</td>
<td class="nump">7,943<span></span>
</td>
<td class="nump">7,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research &amp; development tax incentives</a></td>
<td class="num">(3,120)<span></span>
</td>
<td class="num">(1,243)<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Movement in valuation allowance</a></td>
<td class="nump">3,101<span></span>
</td>
<td class="nump">3,581<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Effects of change in tax rates</a></td>
<td class="num">(128)<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Change in unrecognized tax benefits</a></td>
<td class="nump">5,246<span></span>
</td>
<td class="num">(1,672)<span></span>
</td>
<td class="num">(1,273)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Impact of stock compensation</a></td>
<td class="num">(9,083)<span></span>
</td>
<td class="num">(5,150)<span></span>
</td>
<td class="num">(7,383)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="nump">687<span></span>
</td>
<td class="num">(3,343)<span></span>
</td>
<td class="num">(397)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense allocated to continuing operations</a></td>
<td class="nump">$ 41,334<span></span>
</td>
<td class="nump">$ 47,875<span></span>
</td>
<td class="nump">$ 51,133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748249448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 19,606<span></span>
</td>
<td class="nump">$ 1,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right-of-use-assets</a></td>
<td class="nump">33,449<span></span>
</td>
<td class="nump">9,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="nump">33,354<span></span>
</td>
<td class="nump">31,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">Intangible assets</a></td>
<td class="nump">1,201,086<span></span>
</td>
<td class="nump">13,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">1,761<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">&#160; Total deferred tax liabilities recognized</a></td>
<td class="nump">1,289,256<span></span>
</td>
<td class="nump">56,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards', window );">Operating loss and tax credits carryforwards</a></td>
<td class="nump">86,893<span></span>
</td>
<td class="nump">42,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">5,846<span></span>
</td>
<td class="nump">6,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DeferredTaxAssetsOperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">36,106<span></span>
</td>
<td class="nump">9,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">4,596<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses and unbilled revenue</a></td>
<td class="nump">69,198<span></span>
</td>
<td class="nump">24,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther', window );">Stock compensation</a></td>
<td class="nump">25,557<span></span>
</td>
<td class="nump">3,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Deferred compensation</a></td>
<td class="nump">3,445<span></span>
</td>
<td class="nump">3,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DeferredTaxAssetContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="nump">64,924<span></span>
</td>
<td class="nump">2,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">297,167<span></span>
</td>
<td class="nump">91,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="num">(45,495)<span></span>
</td>
<td class="num">(32,768)<span></span>
</td>
<td class="num">$ (27,700)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets recognized</a></td>
<td class="nump">251,672<span></span>
</td>
<td class="nump">59,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">&#160; Overall net deferred tax asset/(liability)</a></td>
<td class="num">$ (1,037,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">&#160; Overall net deferred tax asset/(liability)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Contract With Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123403335&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123403335&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752373608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="nump">$ 45,495,000<span></span>
</td>
<td class="nump">$ 32,768,000<span></span>
</td>
<td class="nump">$ 27,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">12,800,000<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Deferred tax liabilities, undistributed foreign earnings</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Unrecognized tax benefit, potentially expire in 2021</a></td>
<td class="nump">38,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Total unrecognized tax benefits net of potential benefits</a></td>
<td class="nump">202,100,000<span></span>
</td>
<td class="nump">19,100,000<span></span>
</td>
<td class="nump">20,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties recognized as an expense</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Total accrued interest and penalties</a></td>
<td class="nump">15,500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember', window );">Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">42,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country | Tax Year 2022 to 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country | Tax Year 2029 to 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration', window );">Ireland subsidiaries additional tax credit carryforward for income tax</a></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OperatingLossCarryforwardsUSFederal', window );">U.S. Federal net operating loss carry forwards currently available for offset</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax', window );">Alternative minimum tax credit carry forwards</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">10,349,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">U.S. federal net operating loss carry forwards</a></td>
<td class="nump">10,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forward</a></td>
<td class="nump">145,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Tax Year 2022 to 2035 | Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">U.S. federal net operating loss carry forwards</a></td>
<td class="nump">10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">10,238,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Tax Year 2036-2040 | Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">U.S. federal net operating loss carry forwards</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | State NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">296,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">44,370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | State NOL's | Tax Year 2022 to 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">227,538,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | State NOL's | Tax Year 2036-2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">25,073,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration', window );">Ireland subsidiaries additional tax credit carryforward for income tax</a></td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingLossCarryforwardsUSFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, US Federal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingLossCarryforwardsUSFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2022To2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2022To2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2029To2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2029To2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2022to2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2022to2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear20362040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear20362040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357740600824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Expected Expiry Dates of NOL's (Details) - United States<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">$ 44,370<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">296,981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's | 2022-2035</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">227,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's | 2036-2040</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">25,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">10,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's | 2022-2035</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">10,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's | 2036-2040</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2022to2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2022to2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear20362040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear20362040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357743975832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at start of year</a></td>
<td class="nump">$ 19,078<span></span>
</td>
<td class="nump">$ 20,156<span></span>
</td>
<td class="nump">$ 21,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Increase related to acquired tax positions</a></td>
<td class="nump">170,047<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase related to prior year tax positions</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease related to prior year tax positions</a></td>
<td class="num">(1,695)<span></span>
</td>
<td class="num">(1,271)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">18,613<span></span>
</td>
<td class="nump">2,931<span></span>
</td>
<td class="nump">1,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(844)<span></span>
</td>
<td class="num">(369)<span></span>
</td>
<td class="num">(347)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse of statute of limitations</a></td>
<td class="num">(3,338)<span></span>
</td>
<td class="num">(2,770)<span></span>
</td>
<td class="num">(2,518)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">&#160; Unrecognized tax benefits at end of year</a></td>
<td class="nump">$ 202,065<span></span>
</td>
<td class="nump">$ 19,078<span></span>
</td>
<td class="nump">$ 20,156<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752704680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 31,105<span></span>
</td>
<td class="nump">$ 18,089<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of long lived assets</a></td>
<td class="nump">15,400<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Fixed asset impairment</a></td>
<td class="nump">20,037<span></span>
</td>
<td class="nump">5,411<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">28,353<span></span>
</td>
<td class="nump">10,748<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">$ 6,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="nump">75,391<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="nump">86,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember', window );">2021 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">31,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of long lived assets</a></td>
<td class="nump">21,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Fixed asset impairment</a></td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Workforce reductions | 2021 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember', window );">Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">23,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember', window );">Lease Liability | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">10,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember', window );">Lease Liability | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">$ 12,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_TransactionAndOneTimeFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transaction And One Time Financing Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_TransactionAndOneTimeFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751164696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Summary of Restructuring Charges (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 31,105<span></span>
</td>
<td class="nump">$ 18,089<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755877416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Restructuring Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Opening provision</a></td>
<td class="nump">$ 10,748<span></span>
</td>
<td class="nump">$ 1,637<span></span>
</td>
<td class="nump">$ 6,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional provision in the year</a></td>
<td class="nump">26,674<span></span>
</td>
<td class="nump">18,089<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_RestructuringReserveUtilizations', window );">Utilization</a></td>
<td class="num">(9,069)<span></span>
</td>
<td class="num">(8,978)<span></span>
</td>
<td class="num">(4,782)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending provision</a></td>
<td class="nump">$ 28,353<span></span>
</td>
<td class="nump">$ 10,748<span></span>
</td>
<td class="nump">$ 1,637<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RestructuringReserveUtilizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve Utilizations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RestructuringReserveUtilizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357836027704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Non-cancelable operating leases for facilities expiration period</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748343640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 5,480,826<span></span>
</td>
<td class="nump">$ 2,797,288<span></span>
</td>
<td class="nump">$ 2,805,839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_TopClientMember', window );">Top client</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">441,173<span></span>
</td>
<td class="nump">337,904<span></span>
</td>
<td class="nump">350,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients25Member', window );">Clients 2-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,291,946<span></span>
</td>
<td class="nump">754,906<span></span>
</td>
<td class="nump">704,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients610Member', window );">Clients 6-10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">752,325<span></span>
</td>
<td class="nump">350,865<span></span>
</td>
<td class="nump">347,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients1125Member', window );">Clients 11-25</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,077,073<span></span>
</td>
<td class="nump">501,643<span></span>
</td>
<td class="nump">529,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_OtherCustomersMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,918,309<span></span>
</td>
<td class="nump">$ 851,970<span></span>
</td>
<td class="nump">$ 873,044<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_TopClientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_TopClientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients610Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients610Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients1125Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients1125Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_OtherCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_OtherCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755353720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Summary of Contract Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Billed services (accounts receivable)</a></td>
<td class="nump">$ 1,349,851<span></span>
</td>
<td class="nump">$ 722,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses (note 19)</a></td>
<td class="num">(7,081)<span></span>
</td>
<td class="num">(7,149)<span></span>
</td>
<td class="num">$ (7,380)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ContractsReceivableGross', window );">Accounts receivable (net)</a></td>
<td class="nump">1,342,770<span></span>
</td>
<td class="nump">715,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled services (unbilled revenue)</a></td>
<td class="nump">623,121<span></span>
</td>
<td class="nump">428,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ContractsReceivableNet', window );">Accounts receivable and unbilled revenue, net</a></td>
<td class="nump">1,965,891<span></span>
</td>
<td class="nump">1,143,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue (payments on account)</a></td>
<td class="num">(1,323,961)<span></span>
</td>
<td class="num">(660,883)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Net balance</a></td>
<td class="num">(700,840)<span></span>
</td>
<td class="num">$ (232,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent', window );">Change in unbilled receivables</a></td>
<td class="nump">194,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent', window );">Change in unearned revenue (payments on account)</a></td>
<td class="num">(663,078)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Change in advance payments netted against unbilled contracts receivable</a></td>
<td class="num">$ (468,641)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent', window );">Change in unbilled receivables (in percent)</a></td>
<td class="nump">45.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent', window );">Change in unearned revenue (payments on account) (in percent)</a></td>
<td class="nump">100.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent', window );">Change in advance payments netted against unbilled contracts receivable (in percent)</a></td>
<td class="num">(201.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contracts With Customers, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752080792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses', window );">Amounts due to third parties for reimbursable expenses</a></td>
<td class="nump">$ 323,600<span></span>
</td>
<td class="nump">$ 138,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent', window );">Change in unbilled receivables</a></td>
<td class="nump">194,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent', window );">Change in unearned revenue (payments on account)</a></td>
<td class="nump">663,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Increase in advance payments netted against unbilled contracts receivable</a></td>
<td class="num">(468,641)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Bad debt expense</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, remaining performance obligation (in percent)</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contracts With Customers, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748816952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provision for Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Opening provision</a></td>
<td class="nump">$ 7,149<span></span>
</td>
<td class="nump">$ 7,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Amounts used during the year</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(2,561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AccountsReceivableCreditLossExpense', window );">Amounts provided during the year</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">2,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AccountsReceivableCreditLossReversal', window );">Amounts released during the year</a></td>
<td class="num">(544)<span></span>
</td>
<td class="num">(510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments', window );">Foreign exchange</a></td>
<td class="num">(113)<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">&#160; Closing provision</a></td>
<td class="nump">$ 7,081<span></span>
</td>
<td class="nump">$ 7,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccountsReceivableCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Credit Loss Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccountsReceivableCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccountsReceivableCreditLossReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Credit Loss Reversal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccountsReceivableCreditLossReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751753128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts', window );">Income from operations, excluding restructuring, transaction and integration costs</a></td>
<td class="nump">$ 607,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">31,105<span></span>
</td>
<td class="nump">$ 18,089<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration related (Note 6)</a></td>
<td class="nump">198,263<span></span>
</td>
<td class="num">(759)<span></span>
</td>
<td class="nump">4,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">378,529<span></span>
</td>
<td class="nump">$ 391,500<span></span>
</td>
<td class="nump">$ 433,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration related (Note 6)</a></td>
<td class="nump">198,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember', window );">2021 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 31,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) From Operations, Excluding Restructuring, Transaction And Integration Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357744117160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 5,480,826<span></span>
</td>
<td class="nump">$ 2,797,288<span></span>
</td>
<td class="nump">$ 2,805,839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,365,909<span></span>
</td>
<td class="nump">1,181,292<span></span>
</td>
<td class="nump">1,252,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,175,515<span></span>
</td>
<td class="nump">416,884<span></span>
</td>
<td class="nump">388,916<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,581,007<span></span>
</td>
<td class="nump">925,563<span></span>
</td>
<td class="nump">892,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 358,395<span></span>
</td>
<td class="nump">$ 273,549<span></span>
</td>
<td class="nump">$ 271,592<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752132696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">$ 607,897<span></span>
</td>
<td class="nump">$ 408,830<span></span>
</td>
<td class="nump">$ 433,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">161,862<span></span>
</td>
<td class="nump">295,360<span></span>
</td>
<td class="nump">314,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">183,436<span></span>
</td>
<td class="nump">35,402<span></span>
</td>
<td class="nump">37,997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">231,971<span></span>
</td>
<td class="nump">56,921<span></span>
</td>
<td class="nump">60,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">$ 30,628<span></span>
</td>
<td class="nump">$ 21,147<span></span>
</td>
<td class="nump">$ 20,850<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755295528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 534,567<span></span>
</td>
<td class="nump">$ 258,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">118,253<span></span>
</td>
<td class="nump">118,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">121,174<span></span>
</td>
<td class="nump">36,723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">239,828<span></span>
</td>
<td class="nump">65,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 55,312<span></span>
</td>
<td class="nump">$ 38,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756655432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 106,205<span></span>
</td>
<td class="nump">$ 13,062<span></span>
</td>
<td class="nump">$ 13,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes (net of refunds)</a></td>
<td class="nump">$ 55,105<span></span>
</td>
<td class="nump">$ 27,604<span></span>
</td>
<td class="nump">$ 29,836<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752994072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Currency translation adjustments</a></td>
<td class="num">$ (75,986)<span></span>
</td>
<td class="num">$ (15,894)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax', window );">Currency impact on long term funding</a></td>
<td class="num">(9,854)<span></span>
</td>
<td class="num">(9,329)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Actuarial loss on defined benefit pension plan (note 10)</a></td>
<td class="num">(5,098)<span></span>
</td>
<td class="num">(9,364)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax', window );">Loss on interest rate hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(905)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax', window );">Amortization of loss on interest rate hedge</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">&#160;Total</a></td>
<td class="num">(90,937)<span></span>
</td>
<td class="num">(35,477)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Realized gain on interest rate hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax', window );">Amortization of gain on interest rate hedge</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (4,658)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Amortization Of Cash Flow Hedges, Effect Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Currency Impact on Long Term Funding, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756228488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 51,200<span></span>
</td>
<td class="nump">$ 31,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Income from sub-leases</a></td>
<td class="num">(1,338)<span></span>
</td>
<td class="num">(940)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 49,862<span></span>
</td>
<td class="nump">$ 30,148<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751361128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases Operating Leases - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 49,862,000<span></span>
</td>
<td class="nump">$ 30,148,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Costs related to variable lease payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">10,200,000<span></span>
</td>
<td class="nump">12,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of long lived assets</a></td>
<td class="nump">$ 15,400,000<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">6 years 10 months 28 days<span></span>
</td>
<td class="text">4 years 5 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (in percent)</a></td>
<td class="nump">2.51%<span></span>
</td>
<td class="nump">2.53%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">$ 49,949,000<span></span>
</td>
<td class="nump">$ 24,334,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Liabilities<span></span>
</td>
<td class="text">Other Liabilities<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">$ 49,900,000<span></span>
</td>
<td class="nump">$ 24,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">47,500,000<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Direct costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357744267080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases Operating Leases - Operating Lease Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 54,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">45,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">29,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">20,758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">17,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">59,858<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">227,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lease imputed interest</a></td>
<td class="num">(18,266)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 209,432<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357752062392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current bank credit lines and loan facilities - Schedule of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 08, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 5,501,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_LongTermDebtCurrentMaturitiesGross', window );">Less current portion of long-term debt</a></td>
<td class="num">(55,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_LongTermDebtExcludingCurrentMaturitiesGross', window );">Total long-term debt</a></td>
<td class="nump">5,446,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less debt issuance costs and debt discount</a></td>
<td class="num">(64,901)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,523)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net</a></td>
<td class="nump">$ 5,381,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Credit Facility | Term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 5,001,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes | Senior Secured Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series A notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.32%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series B notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.43%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtExcludingCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Excluding Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtExcludingCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorANotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorANotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357741681464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current bank credit lines and loan facilities - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 29, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 08, 2020 </div>
<div>USD ($) </div>
<div>tranche</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 09, 2021</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,423,000<span></span>
</td>
<td class="nump">$ 13,019,000<span></span>
</td>
<td class="nump">$ 13,276,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,205,000<span></span>
</td>
<td class="nump">$ 13,062,000<span></span>
</td>
<td class="nump">$ 13,059,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IssueOfSeniorNotesNumberOfTranches', window );">Issue of senior notes, number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,507,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,507,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Term loan | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage', window );">Basis spread on variable rate, step down percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio', window );">First lien net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate', window );">Decrease in basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Term loan | London Interbank Offered Rate (LIBOR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio', window );">First lien net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Term loan | London Interbank Offered Rate (LIBOR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio', window );">First lien net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Credit Facility | Senior secured credit facility and senior secured notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Credit Facility | Term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,515,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of senior debt</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">$ 13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 40,800,000<span></span>
</td>
<td class="nump">$ 40,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtRestructuringCosts', window );">Payments of Debt Restructuring Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Senior secured revolving loan facility | Revolving loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember', window );">Letter of credit | Senior secured revolving loan facility | Revolving loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes | Senior Secured Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Notes 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 364,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series A notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Series B notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread On Variable Rate, Step Down Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, First Lien Net Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Increase (Decrease) Basis Spread on Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IssueOfSeniorNotesNumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issue Of Senior Notes, Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IssueOfSeniorNotesNumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VariableRateComponentAxis=iclr_VariableRateComponentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VariableRateComponentAxis=iclr_VariableRateComponentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VariableRateComponentAxis=iclr_VariableRateComponentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VariableRateComponentAxis=iclr_VariableRateComponentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorNotes2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorNotes2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorANotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorANotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorBNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorBNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357753246552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current bank credit lines and loan facilities - Schedule of Finance Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on drawn facilities</a></td>
<td class="nump">$ 93,809<span></span>
</td>
<td class="nump">$ 13,406<span></span>
</td>
<td class="nump">$ 13,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of financing costs and debt discount</a></td>
<td class="nump">12,890<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="nump">75,391<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_InterestExpenseCreditOther', window );">Other financing costs/(credits)</a></td>
<td class="nump">333<span></span>
</td>
<td class="num">(910)<span></span>
</td>
<td class="num">(923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="nump">$ 182,423<span></span>
</td>
<td class="nump">$ 13,019<span></span>
</td>
<td class="nump">$ 13,276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_InterestExpenseCreditOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Expense (Credit), Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_InterestExpenseCreditOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_TransactionAndOneTimeFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transaction And One Time Financing Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_TransactionAndOneTimeFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357755466104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current bank credit lines and loan facilities - Schedule of Maturities of Long-term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 55,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_LongTermDebtMaturityYearFiveAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">5,280,613<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt, net</a></td>
<td class="nump">$ 5,501,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtMaturityYearFiveAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, Year Five And Thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtMaturityYearFiveAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756126824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Increase in fair value</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of long-term investments in equity</a></td>
<td class="nump">22.6<span></span>
</td>
<td class="nump">$ 15.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair value, nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets at fair value</a></td>
<td class="nump">13,748.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="nump">9,037.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Identifiable intangible assets, net</a></td>
<td class="nump">$ 4,710.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357748592776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impact of New Accounting Pronouncements (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 9,037,931,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 936,257,000<span></span>
</td>
<td class="nump">$ 883,170,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=iclr_AccountingStandardsUpdate202108Member', window );">Accounting Standards Update 2021-08</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with customer, liability, revenue recognized</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers', window );">Increase (decrease) in revenue from contracts with customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseRevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Revenue From Contracts With Customers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseRevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=iclr_AccountingStandardsUpdate202108Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=iclr_AccountingStandardsUpdate202108Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751609608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_EquityMethodInvestmentMajorityOwnershipPercentage', window );">Majority investor, ownership percentage</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity method investment, aggregate cost</a></td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_DSBiopharmaLimitedMember', window );">DS Biopharma Limited | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue earned from related parties</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 321,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amounts due from related parties</a></td>
<td class="nump">12,000<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember', window );">Afimmune Limited | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue earned from related parties</a></td>
<td class="nump">551,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amounts due from related parties</a></td>
<td class="nump">197,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amounts due from related parties</a></td>
<td class="nump">264,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses incurred from related party transactions</a></td>
<td class="nump">465,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions', window );">Loan granted tp related party</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party, loan interest rate</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iclr_InterestReceivableRelatedPartyLoans', window );">Interest receivable, related party loans</a></td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EquityMethodInvestmentMajorityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Majority Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EquityMethodInvestmentMajorityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_InterestReceivableRelatedPartyLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Receivable, Related Party Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_InterestReceivableRelatedPartyLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount of new advances made to related parties in the form of loan and lease receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.7(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_DSBiopharmaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_DSBiopharmaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_SubsidiaryOfCommonParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_SubsidiaryOfCommonParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357836008824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)</a></td>
<td class="nump">67,110,186<span></span>
</td>
<td class="nump">52,859,911<span></span>
</td>
<td class="nump">53,859,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive share options outstanding (in shares)</a></td>
<td class="nump">958,125<span></span>
</td>
<td class="nump">423,674<span></span>
</td>
<td class="nump">473,924<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)</a></td>
<td class="nump">68,068,311<span></span>
</td>
<td class="nump">53,283,585<span></span>
</td>
<td class="nump">54,333,461<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357756165864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to the Group</a></td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 332,331<span></span>
</td>
<td class="nump">$ 373,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Noncontrolling interest adjustment to redemption amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,522)<span></span>
</td>
<td class="num">(5,048)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to the Group (including NCI redemption adjustment)</a></td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 327,809<span></span>
</td>
<td class="nump">$ 368,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="nump">$ 6.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 6.15<span></span>
</td>
<td class="nump">$ 6.79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140357751402984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Feb. 18, 2022</div></th>
<th class="th"><div>Oct. 03, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="nump">$ 146,931,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember', window );">Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value</a></td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="nump">$ 141,600,000<span></span>
</td>
<td class="nump">$ 372,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>iclr-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iclr="http://www.iconplc.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iclr-20211231.xsd" xlink:type="simple"/>
    <context id="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie1b609ddf6c34171b1ba74b522bc4160_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i412657424e8a46e09c66a2345306a17a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib6f10a8ae3df4827be9831c930c77331_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2fff4332a1d4c0698311a5bd0290b3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7acc5e38562846649f0134d3bdc33705_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="ifdac2dc9cabd4d0d9b3df33a7ae8822e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-10</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i19229e729ec74c57a20161ea7ce568f9_D20210701-20211109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-11-09</endDate>
        </period>
    </context>
    <context id="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-29</startDate>
            <endDate>2021-12-29</endDate>
        </period>
    </context>
    <context id="ie8f0b47b5969447b80a94a01cfae1776_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7cb2372376cf46b9a240ab10ece87d9c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8206c39f2c184b8bb182915d7fa1390b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99488b9a03124af7977f8d50703f350a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i82b500db472f497aa1b840c473c52982_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i61027c17b46042b1b491d04374d1f997_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4cd379f284664447a1d6537e6eb39f2e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i90ad54f2c49046fdacfa10fdbb3eb49a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib573afa6334547daa0d3c19f31f8dbef_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie3e24d855ba14a97a64dd8c818215580_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia0c29cae9c2c47cdbf7580c35f3f4e38_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic1855db4bb0b4dbb98b316a593a03fa6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i67da3acc2801492294d95197efa72153_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaa0833c316264e0ea3f2e1469249cc7b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie1f8d018bbf94621ae5409b6eda9be54_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i68a8df88a51a4914b34c331af346e762_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8c9c424a36dd4a109577161d2940b41b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5e62c0f5e8c74f1aa308fbbfc8707376_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie6d50f7cd15643d798684811166d0ba9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i750b3a109f9044d3af3bdc0259dc0293_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa2834e916024d02918294df579c7494_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i94be34191abe4629b7ebef1ad29ea857_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0962b68ff61246e5a9f5b9e8d38e3989_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90ce1847176642a7a8d12c476ee2b2d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc0b7e51cfbd494db946ce79e9bb7c29_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i02a3c3f480da466f979b83dd7f24aaa6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f26675e42484470a39567b27487f173_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17db85087b8349beb2ce7a3c58760e87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if485c36ee8d54bf0a345ece247288e1c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c2f810ef5f14db3a7c717dc50d0207d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6be1e93cc2e4a22825aee8e63f813bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a8bfe01d1774f4e96679362547f99f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ica03b62926534e1c96e97c487693f9b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfbb11854a164b7bb15d92889e4c2bb4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd6e0d8b7e5144638aef2b48835ca0f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5839a28afffc48f8a9ce6fc8cd0b1215_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7670eea39a0649e3b66786e7d2cf4f1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccd478baae434af395e71d177b28bd2e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i50822bc1a62345aca0219ef6e28bf127_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad57efdbfd9c4bd3a89a3bbc5b80f396_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherGeographicLocationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2a7dd4344dd34202b588af91a6812de7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2987d6914a1d4cc68e8c95d19b068254_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57ebfffca8f94564b236e3cf355daa0a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f2e7237f254495a965fa61e435b32cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i98447e8a7c144589ae3d680ab7ea1f11_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id2e9789e124d454fb74080cfc1ea1d70_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i34a011f87a9d4997aa40aa4d09a4fc8d_I20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MeDiNovaResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-09</instant>
        </period>
    </context>
    <context id="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">iclr:TermDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34fdb5db483e4be88aed63d7fba68086_D20180101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic87e1dcfa6f645709ebb66f6f1e00a7d_D20180101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i79b2e8fe7b204f0c9abe56bd2cd862ae_I20200724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2020-07-24</instant>
        </period>
    </context>
    <context id="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2d3fa59c20354798b3fe32fbe88700c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib27d114693994c1bbb27bce87b357b48_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i727c1622461843c1a81f8f6fb66f40aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i391000958f6f4ad4b03f663ad0a01ee6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ca96102037f405a834d371c8285ea8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32a2e822e6e146128cc9a04440ccd362_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a9a1d8583f64d51af91b99d7a6b4135_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86eec55be971443da0d8c545532a4f94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8dbf4b780c904be2bf1341d2e01a6247_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8dd17c1d14eb4336b8de511f325caec7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2760f7ce2844eeb9454a223b0d6bdd9_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i0c3d250f7b48429daff67944653a547e_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i9fdaf7dd9b454d2b8940cc6620aa6239_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i20ad6864825548d6963d2ca543226afa_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i34c5cbb5923847049004e8c7917d853b_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i653318d9e6234778be8ddf6cd1ffc904_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="iea4c19eacf6342068eda7cdb8712f339_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i502149ae91374acc8a5f8e388394c164_I20200122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-22</instant>
        </period>
    </context>
    <context id="i7de8b4b9115b4c429dc042e5ecb81b66_I20200122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-22</instant>
        </period>
    </context>
    <context id="ic7fa7bd0b2d84f9bb5d970eebb2b2cc0_I20200122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-22</instant>
        </period>
    </context>
    <context id="i586effbcf5d3481cb59812fdb908734f_D20200122-20200122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-22</startDate>
            <endDate>2020-01-22</endDate>
        </period>
    </context>
    <context id="ibdff042d535e43268017baca8988f1a5_D20200122-20200122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-22</startDate>
            <endDate>2020-01-22</endDate>
        </period>
    </context>
    <context id="ibd05d6e491a44874be7f139b3e968b8d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic93da52af8c448b795d98224ecc5b70b_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i616118ad6d404416b3fa77b7e269701f_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1ec6866f5ee348deb48316da2665156b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i08c50c20b0824778afb5ac1731634e8a_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i42dfcdcf3ee74f698b4cc05d9992198b_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i5baf4cdf019f4d0082973e733aaf95ff_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i1704b22ade43460f8a75f94af7619d42_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i8b46d27d792a425aa8aa8c08a233f77e_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i54b4e53fcd7342a8bab594419987a4b2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2ea2f6a48cb4ba19857680cfba954e9_D20200122-20200122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-22</startDate>
            <endDate>2020-01-22</endDate>
        </period>
    </context>
    <context id="i00c03d2629a049ada2da2d86c94ddd58_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia31f39dce85e49bda0b0796d89773f47_D20200123-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-23</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1001c2ebac745e5abfbd3e906c6f1d0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MedpassGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icf72293147ed4ca08c6367f48b6a674e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11b91c2328484f58921510f5691f05a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27d941fab37b403093cfa434f63692f7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2b89aca039eb4e798c4afcd95f0f1b09_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i216dac94d38a475db23d353853c31110_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i213553f0a50c4dd38db19e9a04a338ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic55595e1f75246f1aadac4c6ddd9900e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee612b419754414e8828f427b68f7002_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia159cefdf37f4364a9843092cf3a2325_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27a855a3bed8480bab49ff8e8735587d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:HighYieldBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i49cd9b5fb069425c885e4e858a9cd7db_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c04b88d67624c00974b95408ed71c3c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib9509a32705e43b195f8a5dee756c081_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iece79a92c4da478a8144d377620226a2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d7dd97703d84c88a35a15329488f10f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2722f8b4561c498cb1416e166b7ad02c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63bf8a993c2147649f1d3f6fb9bebb7c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic522ae4b5b4b4ec5b45ddca4c8a8a60f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e1ef306fa1d450b985b7cfbaf9ce6f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4eef861e44254199911aaf8a9ce379f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40941b5fcb9547c4aec232ca49dbee5a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i37cabf6d514a484e8c75d7747a3e6cee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21d1d31dbff94254ae22cf50de458c51_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib955eed4b9ce4d00a2bd4e2ce7b5a191_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf105ea7475a47ae9ce9c72b2859f1b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9487d796fcc149dbb3f7bcd120e40e56_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:LAndGLifeGPBFAllWorldEquityIndexFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id748b57582fe44e5b3492d06beea0921_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:LAndGLifeGPBFAllWorldEquityIndexFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i77d9586a1ce944dd8bc0eb9cfc5adc1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:LAndGLifeDCActiveCorporateBondMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie033646e348048399b773047abffe484_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:LAndGLifeDCActiveCorporateBondMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64cfe0b0c94c43f6b451b69b6c85fb20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:StoneHarborHighYieldBondFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1216803a75bf46db999c06ae0853a289_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:StoneHarborHighYieldBondFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i517f5d381f324edebe16b610b9162167_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:NinetyOneGlobalTotalReturnCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0dda409457ee4051a9ab0dd254b58fe5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:NinetyOneGlobalTotalReturnCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a7054f2015f4b71993232abe485627d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:StoneHarborMultiAssetCreditPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ac9953fae724a3596870ee57bc6901a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:StoneHarborMultiAssetCreditPortfolioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf8195e9a7884d23b49443cc99b9ce4b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:BaringsEuropeanLoanFundBuyAndHoldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id45f53eaf45c4c91b83e80ae121a0eda_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:BaringsEuropeanLoanFundBuyAndHoldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6eb058c3c334fa9bc0c1e5cd98974fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77b64280f32c462596b287ec2de84d69_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6b045e97c954a34891096fb9cf8d23b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0c8fd01370246349a9908b32d1373e7_I20140507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:AptivSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-07</instant>
        </period>
    </context>
    <context id="idec677308af14edcacc6c913d5dd56c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87320a0e379947f09f57eb63148701a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i536575760ce54ae2893373d1d02dc0d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie88381d966f7484480244edbb8c5b099_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1f40d11c0c8476391b481d08399f03b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i68dd1b4a3d3641879b1d63d1751d2f6a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03867c06634a4d5ab2189dd7fe751c3d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i00041bfad6e143b8a90b3fb840be4f61_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i52e1bbc1869b4151944d394318356ae3_I20170213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-13</instant>
        </period>
    </context>
    <context id="i82ba7a6e4424420f8f44f4aaed17b2c2_I20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-14</instant>
        </period>
    </context>
    <context id="id13244e709104dbb91bd8e7035149dd0_I20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-14</instant>
        </period>
    </context>
    <context id="i9238ad4bc0c9411fa4d50e26b14d2e1f_D20170214-20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="i4f3c204e0dce42b98babf937edce3e3e_D20170214-20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="ia2ef196657454b409ef6b9ff50ada92e_D20170214-20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:OptionPlans2008Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="i35ae564697d142d9bd558468bc6260be_I20030117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2003-01-17</instant>
        </period>
    </context>
    <context id="i00bc75888c8147eba2c8e5dde8818f99_D20030117-20030117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2003-01-17</startDate>
            <endDate>2003-01-17</endDate>
        </period>
    </context>
    <context id="i6e4e19cbbee143049fbca064c93a8efc_D19970101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1997-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i718ff08202614127a3831397cc22d119_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDate2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8d541f61a07d4ac29868fce496e97445_I20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2020LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-18</instant>
        </period>
    </context>
    <context id="ief51d6a7563d4bc8ab4a279609f4a22d_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2018LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="ic851a23a9692444896ff76991dcb6a7c_I20130923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:A2013LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-09-23</instant>
        </period>
    </context>
    <context id="ibbca4abf2817496684bb2ab04067235b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia7ea21c26dac40328506c0cba3319723_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i953fc3f9f5114324bcd9a4293c83b977_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib049563e613d4855a95f4886886e70d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a89202c30764a8e9ad0c13560be2ae0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibcc6762b3d2c402e97ea3771e8aeb750_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22c88a1dd7ca45d48c661d231dd100b2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6de01c93a2fb457e98a862dc99d4abdd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7eb517873331422d82ddeb24ae81abab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f9f44ae168e404abf9f671dd8805b74_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib8a3088705f84bc0ba8f033ac2ceb1b4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifbcd9f1bcda345dca2a0d46fb1c81d47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i671a1d31e3054ac49e3a79c6e68909c4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d77c5373ca24c15b6733894571c4107_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia7a8bb4ad4a743548875aefa396266a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i08fa3aedb11a4eae933e80b642a4260d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i19db711be5e345a3a0c59dabb49c870c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7db9820d8aa244e2852525ef7396441a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i46b83645e00244b685127e098dab3ac7_D20150511-20150511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-05-11</startDate>
            <endDate>2015-05-11</endDate>
        </period>
    </context>
    <context id="i092c95b988b148d88d0639ad4cfc0a58_I20150511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-05-11</instant>
        </period>
    </context>
    <context id="i454968911a6a4e2aa2a973ab9436c62a_I20190516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-16</instant>
        </period>
    </context>
    <context id="i13e925d1823c400d84b4408ce6181505_D20190101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iclr:NonexecutiveDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie4af659507f244f3be56ce1d3a1e11dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idfcb074b2ed840d0889e5704a9ace54e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id023f7897c634581b20db0f0c13adc57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id13136d269d54783b5556de26f903c56_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21ce434056744af495320d8e2505e585_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ia5199d2dbdbd4fe9afdad9bb0b6011c8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i289f65e4064e4e14973a986310115295_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1cf76ea842904bb687cb878a30fd91b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib87cf475a42848d990b63ce6c940842c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0e29a847bcb402b8b35bd56be034dca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib014ca4b61704308b759eb2b4e4cbe13_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73e2c7ebf97b43da88211b323320aa76_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1846e9d35064408781a6a5388df65c41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54544aae1c2043709f665f7d1cc9eebf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i302f632b409e431a99d19fa4a3ec38d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6eb358d140d045a48a95a6f2a26b3d5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceBasedGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8aedbfe82f84258b4f5fb8ae5be9756_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic3104d5908eb42a781a65f9e3b34447b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1a4ebf926a04a1399759e8c4dd65228_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if5c3ba2a7a9949e4b4296e482b3406d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia28188c5a298446189940f3d7538dc9f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63e7f286996a495b9fbebdd313a6affa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4c449fefc2cd4b4399d71b4faba625e0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7b5db980b4e4123a417be9e69e6a306_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9da48aa526a04e8c802268f3ee3f55f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie59648bd657b4adbaa014e0c1010eef4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10a8b70f27484636b98e9821a55c5304_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i00c3280bc64040eb92d3e3380fb6b522_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if98fe533fad34c48891d45c338b523fb_D20160722-20160722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-22</startDate>
            <endDate>2016-07-22</endDate>
        </period>
    </context>
    <context id="i64c25c9fbdc24c8e8f96527346976256_I20161003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-10-03</instant>
        </period>
    </context>
    <context id="iebd957ddedf34e7eb4e6d9840ebd08ab_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0bc02d64aa5f4b4d8b36a740dd3bc014_I20190108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-08</instant>
        </period>
    </context>
    <context id="ia044a3b1cbe441bc85cbe89198164aad_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i53e8433bda4546de9704023960c6b72f_D20191231-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-31</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id3d7547a1a224157af8991715ce82080_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if8ff896c629e4b8490976274f366db14_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5b675ea0523544f39cc9dc1c1d30c495_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifc9dba39f11143b7a99700fa9154586e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2aabd4a6d84543e59b0b347ddb8394d7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icd1b1b778ce1423d993f536ec42792a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8b603335e3c141be945379a94b120638_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1def15985c34968963f6b9121b38e63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i844861916668498588f0491ce84b368e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7ad5c604007471b856dd9490f6f5c80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2022to2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bf376e140f446a785d5f08cdd6bfebc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20362040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i983be088cf6b46e6ac433beda8d697ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iecd57dd26a63495fb590d21da1ee1dd2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2022To2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie7a5026822b54a889031ee7975200e68_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2029To2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i441eef7611ae4627900c2aa94e200087_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i15c96a63b4834593b815f76192244271_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2022to2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4899bcc705b74b12bfb11fcc895a643d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20362040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9da9a786e8de49f39d28567667a24931_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5533029580bc4f90b5489c2ed50c777c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i58e5f687cc39462f8d659f4d701f5ac0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i896d44f274c24721bd6b58ccbd470666_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iae97c86e7991410685e37fea162dced3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iclr:A2021RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia73c34c13a8742aa9e45adff138292ef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iclr:A2021RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie267803461c24ea8b3916fbd1ae6771c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8dc5a2134f884432820063e1b886264a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id23f0621c3b244fd89bd3711026df87b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04f1dd5a84134d2894c1da8788efa67c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9faa218b12a4b3cbf68ef2876caf309_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3b459699c0644968482717272d94004_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia579ed66ea164732848f24e059ca35c5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie82ad39f10bb41e4a084c8444e8989e2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b0fe21c6d5f44e195d836fd2b3861df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0595a59077864be3995b98eb22ddb2b8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icf29ed6c91d7496d942630ab211f4988_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i485faa3e5fc04aacbcde0602daee7a53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b863197bb30417a90a009a4abea9561_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4e2bfed171104f319e9a84bb08cd25c7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice57c280ae3940bca26f984dc95288ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if28103989f8142d59279653ff6548119_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i45550d1365114ceeb217ab47d70cb97c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if73f3bd5251f468199c2f39f63ce992f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb97c73d747941d58453e74f92d14e13_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieb24ee78b3b34864be5c6ac9dba168fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf7560d016044c24b3bdac4149860edf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iedf131d1b8644060b1d2530e00834656_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i74f149fe5aaf499d867e3e597050ca23_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6939b2d79b084dc0a660f3b73a074210_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7ddd5c933e7b4f74b37135036f3084df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i555b937d50554bbdb3d03c3c137d6aa2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i639f5002243748caaade65a18fa1abd4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibadbd19679bc427dba0f5f5ae0f7fd8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57430deb2fc84136b5fd0563c9976335_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9169f6af6160491cb03265cd3846ea11_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84dbafe769b9418dae1e4cb9de53c5e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a66c15d3893461486dcf165a1add471_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e8457bcc7054ec4a4014e91fdf31028_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75873ccb8a5c422b9bf776cba332d63d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie38942652cf84800b863e3e7022c6277_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e95612f074040ca8329b4a89d847966_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c03db364d544bbd8c5f621de598194c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ee2cf622d234c2aa3264bc99d1d99f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0acaa265f49241d68f4649867f4f00a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i452b01c0112d4ccd9b653f71e8f9dcbb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa28345cbd8749e8a4e0f211a8ca39ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c04ffd49dae4f0992771a4e20c9df7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21502e982c90437c9bfab920645d67a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a8f70dc107f44d0b434efabb00c6480_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife6231795e2c4c7b85a8443de30f290a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb0064f5e15c4dab8c532e6ad71f7603_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82f9f7da96f842ad91fb773f1d6c7517_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i86b692f1ce7e413c834c8a2488e2c0ac_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="ib0abb09c8d394db38d57f51554da92af_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib58d47ddfc2141cabb5fab1f21a38d72_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id5a30f909b8e4e1fba6812998b6bf24d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if83f4a5e20174093b9f01e04ee9c1d6d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if05006669b12476d9fce3bf96834b1c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic3fdf86501a24ebcbc7842721c5fffa2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a42a3fb378b499bba8795f930f41618_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5dd5a8e35954342aeb8de12c5800669_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i4f5d4c306fa444b4bdb0bf1fe82e8279_D20201208-20201208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorNotes2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-08</startDate>
            <endDate>2020-12-08</endDate>
        </period>
    </context>
    <context id="if4a6b701f2454838a6d52713b838fb03_D20201208-20201208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2020-12-08</startDate>
            <endDate>2020-12-08</endDate>
        </period>
    </context>
    <context id="i52b4c03037324b8685b2023af8543025_I20201208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorANotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-08</instant>
        </period>
    </context>
    <context id="icc237be9542b46be97a5052ea2194da9_I20201208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorBNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-08</instant>
        </period>
    </context>
    <context id="i61d39490d9d341c6a04dd22b7c2e3548_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorNotes2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c29619485354cb987ceeeec9f4fd1ad_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorNotes2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i071a74bae9594a1c88d29e82ccf0ce67_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">iclr:AccountingStandardsUpdate202108Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i1e15468a473f4c8da1405b2a6d723f2a_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">iclr:AccountingStandardsUpdate202108Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3368954c9a64c52b38aa3707ffc38a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i968ed30311b94d908cfbb9557550531c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4794a4624e34b81aaa3d969dd0bc3b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie76f68691f174c19a8058971dbcc477c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0813a3b3dd0749b2b2e5f5ef20260483_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24a1e9760cab4726b37a107bc29fd4cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id23d592eefe04b35928d0cc687d6a2ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i05316c63db6641378950248cee4a1582_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i509ce783c2ea4a39bdebdb581d6ed480_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9315b0dbc9034bb8aee3c7fc387583e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ccacdd571674f36bbf5930a33df99f2_I20220218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-18</instant>
        </period>
    </context>
    <context id="idf645606cd69465ab48f7e54e02bf243_D20220101-20220301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="employee">
        <measure>iclr:Employee</measure>
    </unit>
    <unit id="location">
        <measure>iclr:Location</measure>
    </unit>
    <unit id="country">
        <measure>iclr:Country</measure>
    </unit>
    <unit id="vote">
        <measure>iclr:vote</measure>
    </unit>
    <unit id="segment">
        <measure>iclr:segment</measure>
    </unit>
    <unit id="tranche">
        <measure>iclr:tranche</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80L2ZyYWc6ODMzZjhkMWY4YTE0NGFkZjgyYTgzZTBjOTEyYTU1YWIvdGFibGU6ZDkxNDZjYmYxNGNjNDI2MzhjYTUzNTk0ZDBhYjE4ZGIvdGFibGVyYW5nZTpkOTE0NmNiZjE0Y2M0MjYzOGNhNTM1OTRkMGFiMThkYl8xLTEtMS0xLTM2MjQ4_855218ed-2ccc-4242-b5ea-8d2f3be63dce">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80L2ZyYWc6ODMzZjhkMWY4YTE0NGFkZjgyYTgzZTBjOTEyYTU1YWIvdGFibGU6ZDkxNDZjYmYxNGNjNDI2MzhjYTUzNTk0ZDBhYjE4ZGIvdGFibGVyYW5nZTpkOTE0NmNiZjE0Y2M0MjYzOGNhNTM1OTRkMGFiMThkYl8yLTEtMS0xLTM2MjQ4_699e300b-5b51-4bd7-9e41-50e062be39fb">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80L2ZyYWc6ODMzZjhkMWY4YTE0NGFkZjgyYTgzZTBjOTEyYTU1YWIvdGFibGU6ZDkxNDZjYmYxNGNjNDI2MzhjYTUzNTk0ZDBhYjE4ZGIvdGFibGVyYW5nZTpkOTE0NmNiZjE0Y2M0MjYzOGNhNTM1OTRkMGFiMThkYl8zLTEtMS0xLTM2MjQ4_da3a8372-3e64-4d23-8457-e1a886b7812c">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80L2ZyYWc6ODMzZjhkMWY4YTE0NGFkZjgyYTgzZTBjOTEyYTU1YWIvdGFibGU6ZDkxNDZjYmYxNGNjNDI2MzhjYTUzNTk0ZDBhYjE4ZGIvdGFibGVyYW5nZTpkOTE0NmNiZjE0Y2M0MjYzOGNhNTM1OTRkMGFiMThkYl80LTEtMS0xLTM2MjQ4_77ac5a63-ee22-4050-922f-544b755c0cc1">0001060955</dei:EntityCentralIndexKey>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i19db711be5e345a3a0c59dabb49c870c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzQ2NDQ_8b84bb10-99f4-411b-a818-270432b50926">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7b15ff89-21bb-47d6-8b93-387dc069fe0d">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7ee1e415-4195-48f3-aa9c-3b52eaebf0fd">http://fasb.org/us-gaap/2021-01-31#OtherLiabilities</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI1_5675ed70-f41c-4701-aefd-c56dc0a139a9">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTMw_60e75eb8-e450-4984-8419-1841c4486c54">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTEw_c13b3c6b-d5c4-4178-b3db-99ca15b9f386">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zODY_62f93544-323c-4397-b2b2-1a1f1fb7ed16">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zODY_2197e99e-1cdc-4c5e-9ff2-637535604e4a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI2_2f17b5bc-0dad-430e-9202-faf03047cb5d">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI3_cafb89e8-3af1-4dcb-a655-4f51421a870f">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTEx_a0bbe5f6-b783-4681-9385-ab2b5ce172d9">333-08704</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV8xLTEtMS0xLTM2MjQ4_b0b89b38-dc21-472a-854e-544896bb596b">ICON PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV80LTEtMS0xLTM2MjQ4_9ae391c0-bf3b-4796-89b9-41ccaabe3eed">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV83LTEtMS0xLTM2MjQ4_40ad60d7-6496-4459-884c-2fe635fa3a8f">South County Business Park,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV84LTEtMS0xLTM2MjQ4_6bdac5f6-5f85-470a-b630-06ca91458e40">Leopardstown,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV85LTEtMS0xLTM2MjQ4_2073c2bc-6345-4891-92c0-a485fcde9d1f">Dublin 18, D18 X5R3,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OGZhZTk3ZTIwNGFjNGIyNGE2ZDg1OGE3ODRlZmU0MDkvdGFibGVyYW5nZTo4ZmFlOTdlMjA0YWM0YjI0YTZkODU4YTc4NGVmZTQwOV85LTItMS0xLTM2MjQ4_83f6afe3-a27b-4d25-a9ce-39cc089c29c5">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE3_09bef33e-596f-4a33-b354-62fd8ceee52c">Brendan Brennan</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTIw_56180847-a63e-4599-bce3-1f01ec9f4e42">South County Business Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE4_2c5b49f5-f6fb-4500-849f-a36ace2f293e">Leopardstown</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTEy_38881283-d248-4c4f-b11f-530c418b720b">Dublin 18</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8yMTk5MDIzMjU5NTA0_27bba55b-e473-4464-add1-9b7f779d7c75">D18 X5R3</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8yMTk5MDIzMjU5NTA0_9d0961cc-9fb8-4cce-b671-230595a38364">D18 X5R3</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE5_b0f6225d-8a27-4210-b2e0-261dbbf53c59">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelEmailAddress
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTEz_69e0f9d9-0c84-4472-a4cd-3b28d94fe94d">Brendan.Brennan@iconplc.com</dei:ContactPersonnelEmailAddress>
    <dei:CountryRegion
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTIx_8ba4146e-2749-452b-81b9-16fef41e5406">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTIy_3d26bee7-4b55-47cb-8f61-bd7f0ebe6876">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iebb65bdd07a945be9b3e6c5653b8ba33_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTA2_8c5d7bf7-95f0-4c8c-ae41-22657d5e15c4">291-2000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OWFiMzk2Y2EyODU1NGZiNTk1Y2Y1ODAyNjhlMDJjYmMvdGFibGVyYW5nZTo5YWIzOTZjYTI4NTU0ZmI1OTVjZjU4MDI2OGUwMmNiY18xLTAtMS0xLTM2MjQ4_6b4a7462-62fa-4eac-a4d1-707bab7b9874">ORDINARY SHARES, PAR VALUE &#x20ac;0.06 EACH</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OWFiMzk2Y2EyODU1NGZiNTk1Y2Y1ODAyNjhlMDJjYmMvdGFibGVyYW5nZTo5YWIzOTZjYTI4NTU0ZmI1OTVjZjU4MDI2OGUwMmNiY18xLTEtMS0xLTM2MjQ4_893e1401-9990-40bc-bafd-cbb7845f0caa">ICLR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGFibGU6OWFiMzk2Y2EyODU1NGZiNTk1Y2Y1ODAyNjhlMDJjYmMvdGFibGVyYW5nZTo5YWIzOTZjYTI4NTU0ZmI1OTVjZjU4MDI2OGUwMmNiY18xLTItMS0xLTM2MjQ4_f8baef3d-e4ef-40dd-819f-d15a3ebabb55">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8xMjA5_d3078a8e-b4e8-40d1-9fc4-e69f526cc9d3"
      unitRef="shares">81554683</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTIz_8dfb88ea-8d8e-4f39-ac73-553298d696b7">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI0_574a7ff0-5ff8-4b50-9dc6-b6079a1b77bc">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI4_e75f0899-e552-4748-95e5-8eec7e840f66">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTI5_37a05d08-9784-41ab-a78c-462808c5081f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE0_2f144bc3-6565-41e0-bb0b-60ab0e848b76">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE1_309db595-387b-451a-815f-5b94573d5734">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTE2_1891a428-5ae4-453c-a0a1-166b5bbc5f85">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTA3_f4c84c4d-466c-47fc-afea-cf5ea741e900">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xL2ZyYWc6MDdhYTAyMWUzYzg2NDNlNjhmZGE3NTc4Mjg4Y2I2ZjgvdGV4dHJlZ2lvbjowN2FhMDIxZTNjODY0M2U2OGZkYTc1NzgyODhjYjZmOF8zOTA5_2f9d6378-0b00-4060-9f46-c5acca7b6575">false</dei:EntityShellCompany>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i412657424e8a46e09c66a2345306a17a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxMzQzNQ_4c9d5fa3-39ee-434c-9d07-88f258aabb3c"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio
      contextRef="ib6f10a8ae3df4827be9831c930c77331_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxMzU0Mg_bf81259e-f340-4523-90f8-c922d214a250"
      unitRef="number">4.00</iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio>
    <iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio
      contextRef="ie2fff4332a1d4c0698311a5bd0290b3c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxMzU0OQ_a2a4c6ad-3e7b-41ac-bb34-1c8bc5ba9fa3"
      unitRef="number">1.00</iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7acc5e38562846649f0134d3bdc33705_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxMzYyMw_4615bc1e-39bf-4d0b-af5d-ce80766b5e85"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTQ2OA_4e97f4d0-4354-48f1-9b92-7b177fa613ce"
      unitRef="usd">13800000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTU1NA_dc177634-8b5c-4a58-949e-5c25d84412ba"
      unitRef="usd">40400000</us-gaap:InterestPaidNet>
    <iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio
      contextRef="ifdac2dc9cabd4d0d9b3df33a7ae8822e_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTYyMg_d988fb6d-3c8b-49a6-aaaa-1fc1c71665b9"
      unitRef="number">4</iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio>
    <iclr:DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate
      contextRef="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTcwNA_aeb50050-ebbd-4166-86b4-e94a7c938557"
      unitRef="number">-0.0025</iclr:DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i19229e729ec74c57a20161ea7ce568f9_D20210701-20211109"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTc0NA_e6fbd43d-e269-4aab-bc75-3d09d7579e1b"
      unitRef="number">0.030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTc1MQ_de264374-829d-493c-ad8a-b74bbd62fc73"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTc5Nw_03040b24-64d4-467b-830a-8c6ee609e2c0"
      unitRef="usd">500000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTg4Mw_6245d4ad-c16e-46cf-b677-4adb487a2239"
      unitRef="usd">40800000</us-gaap:InterestPaidNet>
    <us-gaap:LineOfCredit
      contextRef="ie8f0b47b5969447b80a94a01cfae1776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTg5Nw_68b68790-3cbc-49e7-b0fc-187a35910da3"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i7cb2372376cf46b9a240ab10ece87d9c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF80OS9mcmFnOjZjZDZhMTI1MzA1ODQ0YjA4MTRhNjY2MTlhODY3Mzk0L3RleHRyZWdpb246NmNkNmExMjUzMDU4NDRiMDgxNGE2NjYxOWE4NjczOTRfMTY0OTI2NzcxNTk4MQ_20737a0d-7682-4607-beb6-9dcaf228e39c"
      unitRef="usd">4100000</us-gaap:LettersOfCreditOutstandingAmount>
    <dei:AuditorFirmId
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF83OS9mcmFnOjExZTNjYTNhODM0MDQ4OWQ5MmYwMGFmOTAyOTllMjMzL3RleHRyZWdpb246MTFlM2NhM2E4MzQwNDg5ZDkyZjAwYWY5MDI5OWUyMzNfMjE5OTAyMzI1NjkyMw_5af24a7c-3b42-45c1-bae2-ae09ae75142e">1116</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTUvZnJhZzozMDNmNmE2YjZiNzI0M2I2ODU5YWQwZWM1OTZjYjE3Zi90ZXh0cmVnaW9uOjMwM2Y2YTZiNmI3MjQzYjY4NTlhZDBlYzU5NmNiMTdmXzIxOTkwMjMyNjY2NjY_2c92eaf3-abc7-487c-b3c1-9b907cc5b8e7">KPMG</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTUvZnJhZzozMDNmNmE2YjZiNzI0M2I2ODU5YWQwZWM1OTZjYjE3Zi90ZXh0cmVnaW9uOjMwM2Y2YTZiNmI3MjQzYjY4NTlhZDBlYzU5NmNiMTdmXzIxOTkwMjMyNjY2Njc_67be6c76-ae57-4ceb-9558-853384460566">Dublin, Ireland</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMtMS0xLTEtMzYyNDg_0ae1a5ea-4bb3-4a90-9893-20aab8e69662"
      unitRef="usd">752213000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMtMi0xLTEtMzYyNDg_aee5d0ea-fcee-4931-828a-61625c8b173b"
      unitRef="usd">840305000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQtMS0xLTEtMzYyNDg_092a8a3a-6a65-49d4-8ba9-41f145d47298"
      unitRef="usd">1712000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQtMi0xLTEtMzYyNDg_61a76701-4587-404c-9e86-b2ff37945a5a"
      unitRef="usd">1729000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzUtMS0xLTEtMzYyNDg_0ef43c3a-4515-4a3c-ba93-b376e34361cb"
      unitRef="usd">1342770000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzUtMi0xLTEtMzYyNDg_17572d12-2c85-4344-8b61-fa1f00e9f090"
      unitRef="usd">715271000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzYtMS0xLTEtMzYyNDg_769536b9-4a5b-4432-8d17-4d3b01d7107d"
      unitRef="usd">623121000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzYtMi0xLTEtMzYyNDg_123da609-332b-44f0-8f0c-b3086df20991"
      unitRef="usd">428684000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzctMS0xLTEtMzYyNDg_02b74c5f-3401-4ab0-b44c-5cbf397ca6be"
      unitRef="usd">56760000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzctMi0xLTEtMzYyNDg_71875f3b-8aea-4e2c-8343-621cc989bfd2"
      unitRef="usd">35394000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzgtMS0xLTEtMzYyNDg_3a52b51a-5653-4bef-a00c-babd9519d56a"
      unitRef="usd">114323000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzgtMi0xLTEtMzYyNDg_34d807ba-4aaa-462e-b605-842fc656ef29"
      unitRef="usd">53477000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzktMS0xLTEtMzYyNDg_f29de971-28bf-4675-87cb-18003b19e592"
      unitRef="usd">50299000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzktMi0xLTEtMzYyNDg_09762fa0-f06a-47d9-b87a-30345d557c5a"
      unitRef="usd">28118000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEwLTEtMS0xLTM2MjQ4_f14166c9-bc4a-4a63-aae6-ad3904a0ac7f"
      unitRef="usd">2941198000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEwLTItMS0xLTM2MjQ4_6863f4be-55b4-4f2c-ab9b-2980925a3f0d"
      unitRef="usd">2102978000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEyLTEtMS0xLTM2MjQ4_d8e7d134-625c-4a8b-86eb-65b9af17e6c7"
      unitRef="usd">336444000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEyLTItMS0xLTM2MjQ4_d41d55ea-2eb2-4107-990e-b359d4cc36b4"
      unitRef="usd">174343000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEzLTEtMS0xLTM2MjQ4_a862c8c9-b3e2-4daf-a428-76df83471701"
      unitRef="usd">9037931000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzEzLTItMS0xLTM2MjQ4_57ec6b93-0938-42e0-b859-f8c61e38c9da"
      unitRef="usd">936257000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE0LTEtMS0xLTYxNzI3_7a852abe-c5a5-459f-bb4e-0da7f7f55faa"
      unitRef="usd">4710843000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE0LTItMS0xLTYxNzI3_76c6bb9b-f61a-4839-b7a8-661d021f4f37"
      unitRef="usd">66460000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE0LTEtMS0xLTM2MjQ4_e3515871-313d-4411-92bb-d49b3c2938ff"
      unitRef="usd">198123000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE0LTItMS0xLTM2MjQ4_e6220b0a-e824-4e63-8e06-946bf979026a"
      unitRef="usd">84561000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE1LTEtMS0xLTM2MjQ4_b552c89a-6705-4c50-93ea-3205dc0db0ee"
      unitRef="usd">70557000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE1LTItMS0xLTM2MjQ4_ceb5df3d-4269-43cc-b2e5-7c575d3ff813"
      unitRef="usd">20773000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE2LTEtMS0xLTM2MjQ4_abac4edc-e9ca-47ed-8111-a3c84ff05b85"
      unitRef="usd">18637000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE2LTItMS0xLTM2MjQ4_3465a30a-d019-4873-9113-4ab5acb4f740"
      unitRef="usd">17230000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE3LTEtMS0xLTM2MjQ4_4bf2c602-fb38-4e81-9440-2b47edf66dea"
      unitRef="usd">48392000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE3LTItMS0xLTM2MjQ4_e5af5c18-7cf4-4e42-b024-999ddbf5746a"
      unitRef="usd">12705000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:EquityMethodInvestments
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE4LTEtMS0xLTM2MjQ4_e69e29fa-8d04-47f9-aedd-fb2283bd47ae"
      unitRef="usd">2373000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE4LTItMS0xLTM2MjQ4_d171af92-2677-48dc-b3cd-e278d5e217cc"
      unitRef="usd">4534000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE5LTEtMS0xLTM2MjQ4_603db20a-7871-4cf8-9139-c42661c3ae8c"
      unitRef="usd">22592000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzE5LTItMS0xLTM2MjQ4_1562b99b-0333-4047-90eb-606487b0801c"
      unitRef="usd">15765000</us-gaap:OtherLongTermInvestments>
    <us-gaap:Assets
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzIxLTEtMS0xLTM2MjQ4_752496c8-fb6e-4417-81f2-d17c0fcaa3a1"
      unitRef="usd">17387090000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzIxLTItMS0xLTM2MjQ4_cb294eae-ff97-4e09-95fd-4a78925a9071"
      unitRef="usd">3435606000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI0LTEtMS0xLTM2MjQ4_9242c90b-ead5-4a61-b4de-62900bb9b7ed"
      unitRef="usd">90764000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI0LTItMS0xLTM2MjQ4_3c97c0dc-d866-4b0c-aa49-9dc2d754b91a"
      unitRef="usd">51113000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI1LTEtMS0xLTM2MjQ4_c04c5bda-b86e-433b-b360-0cc3d6d69398"
      unitRef="usd">1323961000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI1LTItMS0xLTM2MjQ4_fc0efe1f-0aa8-4da2-acca-8e699a35a161"
      unitRef="usd">660883000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI2LTEtMS0xLTM2MjQ4_0ad61c77-6ef6-4632-a81b-b418c1cda74e"
      unitRef="usd">949629000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI2LTItMS0xLTM2MjQ4_c6b449b7-c8db-46be-8ab8-6572b059cecd"
      unitRef="usd">399769000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI3LTEtMS0xLTM2MjQ4_9a6e7f48-d448-4cc8-b982-057ca7e6279f"
      unitRef="usd">59433000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI3LTItMS0xLTM2MjQ4_9f4131db-9c9e-4bfa-aad4-6eef6e6fc9df"
      unitRef="usd">12178000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI4LTEtMS0xLTM2MjQ4_91113a5a-19de-4a49-b92f-a8053e29303b"
      unitRef="usd">55150000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI4LTItMS0xLTM2MjQ4_2fe55496-d7f5-4f7e-8e9c-20768ae2624d"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI5LTEtMS0xLTM2MjQ4_812f126f-49f1-4068-af2b-2d0244e9086a"
      unitRef="usd">2478937000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzI5LTItMS0xLTM2MjQ4_d7a42403-b116-4c50-b37b-35d9b21a7b36"
      unitRef="usd">1123943000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLineOfCredit
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMxLTEtMS0xLTM2MjQ4_6a956329-c1ad-4330-8901-d212f8447374"
      unitRef="usd">5381162000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMxLTItMS0xLTM2MjQ4_ad2db86b-f7a1-4fe8-93fe-e5ba3a11bfdf"
      unitRef="usd">348477000</us-gaap:LongTermLineOfCredit>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMyLTEtMS0xLTM2MjQ4_76515a1f-9ac9-4a72-9240-e467d1887814"
      unitRef="usd">159483000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMyLTItMS0xLTM2MjQ4_db1ac003-5966-415b-b7d8-c3667963ecc5"
      unitRef="usd">60801000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMzLTEtMS0xLTM2MjQ4_01ceccb2-ea8a-4fee-b0a1-dee00d83996d"
      unitRef="usd">41861000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzMzLTItMS0xLTM2MjQ4_e50c235b-689a-4e9a-b72d-dd716d7af23d"
      unitRef="usd">26366000</us-gaap:OtherLiabilitiesNoncurrent>
    <iclr:CapitalGovernmentGrantsNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM0LTEtMS0xLTM2MjQ4_a30f4935-f1b2-47ec-bf5a-65632cbd36e6"
      unitRef="usd">735000</iclr:CapitalGovernmentGrantsNoncurrent>
    <iclr:CapitalGovernmentGrantsNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM0LTItMS0xLTM2MjQ4_5a014360-1e25-4c51-89b1-07dfb34374ab"
      unitRef="usd">838000</iclr:CapitalGovernmentGrantsNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM1LTEtMS0xLTM2MjQ4_3f392eac-dff9-4815-9e1e-5c53c57a4007"
      unitRef="usd">172109000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM1LTItMS0xLTM2MjQ4_71e27f93-7788-478a-a242-e2b9b1131bdd"
      unitRef="usd">14539000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM2LTEtMS0xLTM2MjQ4_8ed259cf-5299-4dc9-b1e4-fb3072684ed7"
      unitRef="usd">1085976000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM2LTItMS0xLTM2MjQ4_9fbbb577-a75b-4fdb-bf0b-637cf27fc84a"
      unitRef="usd">10406000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM3LTEtMS0xLTM2MjQ4_296debce-668d-4ab0-af61-68e65cb931a0"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM3LTItMS0xLTM2MjQ4_8eae87c3-bd6c-4ed0-968c-e427d9a60598"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:Liabilities
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM4LTEtMS0xLTM2MjQ4_b87b0fac-5427-4a95-a925-3584145b0578"
      unitRef="usd">9320263000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzM4LTItMS0xLTM2MjQ4_4b1f314f-d453-45cf-a797-295c5a51332e"
      unitRef="usd">1585370000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQwLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246OTQwYjFkMGM2ZTA4NGQ2YjhiY2I0OTEwZDlkMDM5MzlfMzE_65d96420-9326-4edb-8a55-0cc59c60a654"
      unitRef="eurPerShare">6</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQwLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246OTQwYjFkMGM2ZTA4NGQ2YjhiY2I0OTEwZDlkMDM5MzlfMzE_876554a4-1a0d-44da-81e0-64a3e94edf64"
      unitRef="eurPerShare">6</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQwLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246OTQwYjFkMGM2ZTA4NGQ2YjhiY2I0OTEwZDlkMDM5MzlfNTY_819b2761-0e8e-46c8-ad63-4a829d386fbd"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQwLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246OTQwYjFkMGM2ZTA4NGQ2YjhiY2I0OTEwZDlkMDM5MzlfNTY_f78e2535-a889-49e8-9e97-f29a37daaea8"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246M2JiM2NkYTRhYzE3NGYwOGE2N2MzYjM5YmE5YjkxMTBfNA_d441f569-592b-474c-9d4d-d9f74119c285"
      unitRef="shares">81554683</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246M2JiM2NkYTRhYzE3NGYwOGE2N2MzYjM5YmE5YjkxMTBfNA_d4f450ec-e3fb-4b7f-909b-fbb845eb5901"
      unitRef="shares">81554683</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246M2JiM2NkYTRhYzE3NGYwOGE2N2MzYjM5YmE5YjkxMTBfNjI_cbe15b1c-308c-4111-9653-3ae6dacb79ca"
      unitRef="shares">52788093</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTAtMS0xLTM2MjQ4L3RleHRyZWdpb246M2JiM2NkYTRhYzE3NGYwOGE2N2MzYjM5YmE5YjkxMTBfNjI_e80b6aa4-97d7-42f7-952b-20f5deabb28d"
      unitRef="shares">52788093</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTEtMS0xLTM2MjQ4_97d787a4-a40b-4196-b661-fe3a82c4162b"
      unitRef="usd">6640000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQxLTItMS0xLTM2MjQ4_45a3a62f-b90e-4ec7-82e6-80b9b4c902ee"
      unitRef="usd">4580000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQyLTEtMS0xLTM2MjQ4_263e7821-5a56-42da-835a-070e2148678f"
      unitRef="usd">6733910000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQyLTItMS0xLTM2MjQ4_579e8f8f-248d-4b76-b758-f958f3c8d7f2"
      unitRef="usd">617104000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <iclr:OtherUndenominatedCapital
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQzLTEtMS0xLTM2MjQ4_25e2a37e-b718-44fd-9db6-81324968ecb7"
      unitRef="usd">1134000</iclr:OtherUndenominatedCapital>
    <iclr:OtherUndenominatedCapital
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQzLTItMS0xLTM2MjQ4_ded16c14-bb69-46d3-bdd3-768213314f48"
      unitRef="usd">1134000</iclr:OtherUndenominatedCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ0LTEtMS0xLTM2MjQ4_04545224-57dc-45a5-b6ce-f6b5624bd93b"
      unitRef="usd">-90937000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ0LTItMS0xLTM2MjQ4_ba7c2241-b531-47cf-b374-ca8549aeb6dd"
      unitRef="usd">-35477000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ1LTEtMS0xLTM2MjQ4_e5d50fb2-0480-4f01-b11e-4ee52f99273b"
      unitRef="usd">1416080000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ1LTItMS0xLTM2MjQ4_afe5f1f4-6cba-442f-b01e-911962e55ef5"
      unitRef="usd">1262895000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ2LTEtMS0xLTM2MjQ4_035a3efe-1176-43af-9fe3-3153e075c5d0"
      unitRef="usd">8066827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ2LTItMS0xLTM2MjQ4_70bf581f-ed38-488f-8248-bc523e37ae3a"
      unitRef="usd">1850236000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ5LTEtMS0xLTM2MjQ4_b367b29f-fef4-47de-8771-811858717417"
      unitRef="usd">17387090000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMTgvZnJhZzpkM2E2ZDVjZDZiMDg0YTJhYjZiOWQ0ZjQyYjEyOTJiNC90YWJsZTo1ODQ0ODM2ZjZlZTg0OGE3ODgzMTg2YWI1Y2ZiOGQwNi90YWJsZXJhbmdlOjU4NDQ4MzZmNmVlODQ4YTc4ODMxODZhYjVjZmI4ZDA2XzQ5LTItMS0xLTM2MjQ4_41d1903f-3995-4639-83cc-a81183c63498"
      unitRef="usd">3435606000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzYtMS0xLTEtMzYyNDg_7a2c7ebd-e50f-4560-b9e0-e7bdac828d4a"
      unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzYtMi0xLTEtMzYyNDg_1677b326-9919-4971-8033-bc763410ca3e"
      unitRef="usd">2797288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzYtMy0xLTEtMzYyNDg_55996e85-c606-4181-b640-f7938ff06240"
      unitRef="usd">2805839000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEwLTEtMS0xLTM2MjQ4_6d568cfa-e9e9-4510-81fb-ea1fb31a16b5"
      unitRef="usd">3972612000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEwLTItMS0xLTM2MjQ4_e10fab7a-f33e-405a-b2e8-a1834e2f63af"
      unitRef="usd">1979883000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEwLTMtMS0xLTM2MjQ4_65e0ceea-91b5-4efb-9a53-fb79cd2048ab"
      unitRef="usd">1974135000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzExLTEtMS0xLTM2MjQ4_552e8627-2836-4b0c-aab0-96737f645281"
      unitRef="usd">585330000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzExLTItMS0xLTM2MjQ4_76fb2540-3464-4a44-ad96-37a54d95f522"
      unitRef="usd">342449000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzExLTMtMS0xLTM2MjQ4_5c67a942-8a24-45d9-abef-ebec661c278a"
      unitRef="usd">332663000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEyLTEtMS0xLTM2MjQ4_1308801e-811c-4e85-8bf4-e60911ae775b"
      unitRef="usd">314987000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEyLTItMS0xLTM2MjQ4_ac49e85b-6dc2-4ae3-8fc2-9ce306e330f0"
      unitRef="usd">66126000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEyLTMtMS0xLTM2MjQ4_128993a5-f4da-4cff-8157-bc7ed2708bf6"
      unitRef="usd">61550000</us-gaap:DepreciationAndAmortization>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTEtMS0xLTQxODY5_e53909c9-bca9-4b53-864a-29db9b2653d3"
      unitRef="usd">198263000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTItMS0xLTQxODY5_fe8e6288-a9b5-44fb-99da-94c64100e038"
      unitRef="usd">-759000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTMtMS0xLTQxODY5_0c2e0a80-fdfc-4ab1-a7b0-30ee603e4096"
      unitRef="usd">4085000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTEtMS0xLTM2MjQ4_13b1a532-7f36-4b9a-8764-bf722e9e4b5d"
      unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTItMS0xLTM2MjQ4_95f4ecb0-fa01-4a43-8db7-743e0b575fad"
      unitRef="usd">18089000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzEzLTMtMS0xLTM2MjQ4_37debfd8-2d19-4b54-9291-79a03f95fe22"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:CostsAndExpenses
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE0LTEtMS0xLTM2MjQ4_c953dfa2-6eaa-4eb9-a515-48a321f404d4"
      unitRef="usd">5102297000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE0LTItMS0xLTM2MjQ4_0da7149b-cf9b-4172-8ae6-86df7b6740a7"
      unitRef="usd">2405788000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE0LTMtMS0xLTM2MjQ4_bb5fd3b1-d20f-49a6-96b8-bab0e79291b5"
      unitRef="usd">2372433000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE2LTEtMS0xLTM2MjQ4_a85e88d7-8f0e-4b36-84cf-5a91df23fe08"
      unitRef="usd">378529000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE2LTItMS0xLTM2MjQ4_67969542-7a25-4e18-a9ca-223750d49b0d"
      unitRef="usd">391500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE2LTMtMS0xLTM2MjQ4_0310d1ab-f4d6-499c-90bb-67373ec1f6cc"
      unitRef="usd">433406000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE3LTEtMS0xLTM2MjQ4_a02777d6-b3af-4bf9-810d-3e5aa893488b"
      unitRef="usd">574000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE3LTItMS0xLTM2MjQ4_54d9c16f-42a6-404c-94cd-36743333736d"
      unitRef="usd">2724000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE3LTMtMS0xLTM2MjQ4_46458df2-5e84-4640-bd85-fce92f61aca9"
      unitRef="usd">6859000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE4LTEtMS0xLTM2MjQ4_48b61847-3fca-43bb-9e02-ae745a32a9c0"
      unitRef="usd">182423000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE4LTItMS0xLTM2MjQ4_4b71a155-f5dd-49df-be0e-69b1d7a57ae4"
      unitRef="usd">13019000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzE4LTMtMS0xLTM2MjQ4_122473b8-f2ff-4126-aa7e-40e6863a3c78"
      unitRef="usd">13276000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIwLTEtMS0xLTM2MjQ4_ca7d6da1-595d-4b3c-9fa2-43c33c1c9d50"
      unitRef="usd">196680000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIwLTItMS0xLTM2MjQ4_ab869176-0b91-4305-afae-a88087b1ab42"
      unitRef="usd">381205000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIwLTMtMS0xLTM2MjQ4_4f171f6e-e306-40f3-85d1-1760c174e604"
      unitRef="usd">426989000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIxLTEtMS0xLTM2MjQ4_cbdad50f-2541-4a6d-b75d-b4cbe5700050"
      unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIxLTItMS0xLTM2MjQ4_e72834d5-d7c7-4b1d-9c48-9d6fe29bfd1e"
      unitRef="usd">47875000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIxLTMtMS0xLTM2MjQ4_5969e262-ec8a-497b-88a1-70ef4984a9d8"
      unitRef="usd">51133000</us-gaap:IncomeTaxExpenseBenefit>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIzLTEtMS0xLTM2MjQ4_7f813b2d-ebca-47c4-807a-48c3bcb7a5cc"
      unitRef="usd">155346000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIzLTItMS0xLTM2MjQ4_39c36607-3cce-477f-92da-e59141501138"
      unitRef="usd">333330000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzIzLTMtMS0xLTM2MjQ4_132ae423-85e2-4116-a9e0-681bccab5593"
      unitRef="usd">375856000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI0LTEtMS0xLTM2MjQ4_27c8126a-da2c-429b-8f41-eeea81541256"
      unitRef="usd">-2161000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI0LTItMS0xLTM2MjQ4_83c21625-eb23-4fa9-9ea7-544457097810"
      unitRef="usd">-366000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI0LTMtMS0xLTM2MjQ4_5744e42e-a844-4cb4-9811-9c0cab704a8c"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI2LTEtMS0xLTM2MjQ4_128c3eef-571d-4921-9701-7489812e6f3a"
      unitRef="usd">153185000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI2LTItMS0xLTM2MjQ4_47cacb30-5293-45a9-b586-9a4f718c9ce5"
      unitRef="usd">332964000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI2LTMtMS0xLTM2MjQ4_ec347aae-f5a2-4847-a708-00ed52069ca5"
      unitRef="usd">375856000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI3LTEtMS0xLTM2MjQ4_5d896dc4-6f8b-4873-80e3-50e9a0740d4d"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI3LTItMS0xLTM2MjQ4_a42dacf3-4ad4-442c-8edf-b83e96345b0f"
      unitRef="usd">633000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI3LTMtMS0xLTM2MjQ4_15868ff6-e700-4cd1-b877-8209980ffc2c"
      unitRef="usd">1870000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI4LTEtMS0xLTM2MjQ4_63cfbd98-ef12-458e-9b51-f0fb2ee510b2"
      unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI4LTItMS0xLTM2MjQ4_04b8633d-57c4-4ba9-8aa1-f9d106d713a3"
      unitRef="usd">332331000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzI4LTMtMS0xLTM2MjQ4_1247ac87-8d26-4019-9795-72b41f85a9aa"
      unitRef="usd">373986000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMyLTEtMS0xLTM2MjQ4_1eba59bc-4ae0-422d-b395-7bcb760b342f"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMyLTItMS0xLTM2MjQ4_108f2223-9d61-4a08-9df1-d2699c2774b2"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMyLTMtMS0xLTM2MjQ4_0f27168d-ba45-4e3a-8531-3c9ecf5939da"
      unitRef="usdPerShare">6.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMzLTEtMS0xLTM2MjQ4_3544084e-5bf0-43ee-9a63-988a3882fb49"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMzLTItMS0xLTM2MjQ4_af3a474e-67d1-47e2-bb30-f7bb916252d3"
      unitRef="usdPerShare">6.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzMzLTMtMS0xLTM2MjQ4_65e07872-9721-455d-afc1-91ecca2fe8ad"
      unitRef="usdPerShare">6.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM2LTEtMS0xLTM2MjQ4_c7eb21f6-a710-448c-9747-aed1b2481182"
      unitRef="shares">67110186</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM2LTItMS0xLTM2MjQ4_2c72b890-9ef4-4b82-b8af-743fd94e702e"
      unitRef="shares">52859911</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM2LTMtMS0xLTM2MjQ4_c94794f6-7f97-4434-a55b-d57cabd97a15"
      unitRef="shares">53859537</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM3LTEtMS0xLTM2MjQ4_829aae10-8226-41dc-a1e4-c73f00e2a725"
      unitRef="shares">68068311</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM3LTItMS0xLTM2MjQ4_7e95d890-1cf4-43ed-9be3-def373a5bce3"
      unitRef="shares">53283585</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjEvZnJhZzo0NmJmMGZiZGE2MmQ0ZDU0OWViMWQ3MTk3OWVjNTllYS90YWJsZTplMzliZDk3OTEwYTc0MzZlYjI5MTYwYTAyZmRhYTA1NC90YWJsZXJhbmdlOmUzOWJkOTc5MTBhNzQzNmViMjkxNjBhMDJmZGFhMDU0XzM3LTMtMS0xLTM2MjQ4_23ba4a7f-07a8-4627-aaa3-f14f49da3140"
      unitRef="shares">54333461</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzMtMS0xLTEtMzYyNDg_128c3eef-571d-4921-9701-7489812e6f3a"
      unitRef="usd">153185000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzMtMi0xLTEtMzYyNDg_8bfd6a38-0ae5-4d0e-96e7-08ea8631dc68"
      unitRef="usd">332964000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzMtMy0xLTEtMzYyNDg_0055555f-83f9-4a62-978c-232c2ce859b7"
      unitRef="usd">375856000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzUtMS0xLTEtMzYyNDg_7e7084bb-f5d1-437b-a17c-ce4fdda0ac6d"
      unitRef="usd">-60092000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzUtMi0xLTEtMzYyNDg_9dbc0a1e-947c-49e7-8587-f21d60b800dd"
      unitRef="usd">48129000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzUtMy0xLTEtMzYyNDg_c4f50ba5-b858-42a6-a92e-e108a7b86087"
      unitRef="usd">-1313000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzYtMS0xLTEtMzYyNDg_4259ab57-73a1-44ad-bddd-5a1555a6dfa6"
      unitRef="usd">-525000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzYtMi0xLTEtMzYyNDg_f2bcbb24-5dd1-49a1-b722-46bb7623cce8"
      unitRef="usd">-1603000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzYtMy0xLTEtMzYyNDg_7b9489d6-b44e-4e4f-853d-9807927c05a9"
      unitRef="usd">-2710000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzctMS0xLTEtMzYyNDg_fed95ab9-6069-44e4-8b65-3cb4e5f4e16c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzctMi0xLTEtMzYyNDg_51ca3b53-afb8-43a9-a44a-650af86c3d6f"
      unitRef="usd">-231000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzctMy0xLTEtMzYyNDg_402308a7-79a7-48ac-b0c3-ac8163be027f"
      unitRef="usd">681000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzgtMS0xLTEtMzYyNDg_94e6c84f-61d2-4401-a356-d264cd61cef2"
      unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzgtMi0xLTEtMzYyNDg_5c204a9b-9e7e-4724-84bd-82d2e98a3bc0"
      unitRef="usd">-4138000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzgtMy0xLTEtMzYyNDg_964d8bbd-4460-48be-b7f8-69b3f3acc2b5"
      unitRef="usd">-2226000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzktMS0xLTEtMzYyNDg_646f1bcb-d39e-430a-a4af-9d3ccd21f079"
      unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzktMi0xLTEtMzYyNDg_0eb928d7-98ea-4533-b16b-5c1a3d1c755f"
      unitRef="usd">910000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzktMy0xLTEtMzYyNDg_ea138d26-d772-4bad-ac90-42413f3f2641"
      unitRef="usd">923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEwLTEtMS0xLTM2MjQ4_cfeb2c54-9a53-4060-a19e-676f108b1490"
      unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEwLTItMS0xLTM2MjQ4_4a742b48-7f30-4b49-928b-a9327496e3a3"
      unitRef="usd">-905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEwLTMtMS0xLTM2MjQ4_a1e4869d-51b0-4df4-96f5-94a79867f17b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEyLTEtMS0xLTM2MjQ4_a81bfbd7-72cf-463c-b9e1-94fb16a2a7ae"
      unitRef="usd">97725000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEyLTItMS0xLTM2MjQ4_e0a5c844-3b4b-4c6d-832d-1c237b022fc5"
      unitRef="usd">373306000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEyLTMtMS0xLTM2MjQ4_78254037-e0c0-4024-964a-28a30c3c3f81"
      unitRef="usd">369365000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEzLTEtMS0xLTM2MjQ4_05387a2b-f0b7-4eba-85da-abad67a7bdbf"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEzLTItMS0xLTM2MjQ4_ce3b6b72-6117-4222-8323-c115d104cc79"
      unitRef="usd">633000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzEzLTMtMS0xLTM2MjQ4_d1285d22-f89c-4ce7-b230-21ce321d9f82"
      unitRef="usd">1870000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzE0LTEtMS0xLTM2MjQ4_92072ebc-7dba-4f42-b373-7765688c5044"
      unitRef="usd">97725000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzE0LTItMS0xLTM2MjQ4_208b0af9-7224-4b17-a4cf-d3154001aa95"
      unitRef="usd">372673000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjQvZnJhZzphNTdhNGY3NDgzNmU0MTdmOWViOTQ2M2JjMmMwZjQwMi90YWJsZTpkZGEyOTFjMjY4Mjc0NzZkOTA5OWZlNTM4NGU4OTUwOC90YWJsZXJhbmdlOmRkYTI5MWMyNjgyNzQ3NmQ5MDk5ZmU1Mzg0ZTg5NTA4XzE0LTMtMS0xLTM2MjQ4_7d9a1494-c0b0-4627-b10f-77c3f046df77"
      unitRef="usd">367495000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i82b500db472f497aa1b840c473c52982_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTEtMS0xLTM2MjQ4_73271088-329c-4ba1-bb1b-bb9025c409df"
      unitRef="shares">53971706</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i82b500db472f497aa1b840c473c52982_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTItMS0xLTM2MjQ4_4433bbeb-b17a-47d4-a45a-84c5cfc118c4"
      unitRef="usd">4658000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i61027c17b46042b1b491d04374d1f997_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTMtMS0xLTM2MjQ4_c31e0258-7843-41e7-bfde-0516e7166b89"
      unitRef="usd">529642000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4cd379f284664447a1d6537e6eb39f2e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTQtMS0xLTM2MjQ4_a92a2cf9-d530-453a-8852-c7f0acf092e8"
      unitRef="usd">983000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i90ad54f2c49046fdacfa10fdbb3eb49a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTUtMS0xLTM2MjQ4_cbb9af43-6534-4add-8db9-5c7e252f261f"
      unitRef="usd">-69328000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib573afa6334547daa0d3c19f31f8dbef_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTYtMS0xLTM2MjQ4_21628dd8-dbd3-48c8-93af-23977b789927"
      unitRef="usd">888326000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3e24d855ba14a97a64dd8c818215580_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTctMS0xLTM2MjQ4_fb31b8b8-6f56-4063-8d6d-b12213568193"
      unitRef="usd">1354281000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ia0c29cae9c2c47cdbf7580c35f3f4e38_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI0LTgtMS0xLTM2MjQ4_54f5e165-adf9-4e8a-a882-9bf8b9eb3f0c"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLoss
      contextRef="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI3LTYtMS0xLTM2MjQ4_5a5a980a-2dfe-4f1c-b6ec-230afbe9b05f"
      unitRef="usd">373986000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI3LTctMS0xLTM2MjQ4_6c276494-b8d4-4d8f-b73a-9d3c025dcb4d"
      unitRef="usd">373986000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="ic1855db4bb0b4dbb98b316a593a03fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI3LTgtMS0xLTM2MjQ4_ab1c77d7-069a-4845-a338-c64557944d6c"
      unitRef="usd">1870000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI4LTUtMS0xLTM2MjQ4_0886b741-eeb3-498a-9998-e825acba3443"
      unitRef="usd">-1313000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI4LTctMS0xLTM2MjQ4_6632a3a5-0790-4fbe-87ed-19b24a090825"
      unitRef="usd">-1313000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI5LTUtMS0xLTM2MjQ4_ae72943b-2097-4220-a650-b80a8a5e7a80"
      unitRef="usd">2710000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzI5LTctMS0xLTM2MjQ4_959dde07-882d-46bf-8ac1-bacf1f6a20b7"
      unitRef="usd">-2710000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMwLTUtMS0xLTM2MjQ4_0a269133-3509-45ae-93ad-442c5b418c8c"
      unitRef="usd">681000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMwLTctMS0xLTM2MjQ4_2cbfc87e-5c59-43d6-aafc-82f085395e8f"
      unitRef="usd">681000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMxLTUtMS0xLTM2MjQ4_c571356a-a650-4d05-bea8-511d470630de"
      unitRef="usd">-2226000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMxLTctMS0xLTM2MjQ4_ce9d9b2f-888a-4125-83c4-fc6ce00f94a3"
      unitRef="usd">-2226000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i67da3acc2801492294d95197efa72153_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMyLTUtMS0xLTM2MjQ4_ddaece84-3212-45ac-a832-9773da1f7a43"
      unitRef="usd">923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzMyLTctMS0xLTM2MjQ4_6e0b09ed-74f4-4b51-a879-3d6f3976c7f6"
      unitRef="usd">923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM0LTctMS0xLTM2MjQ4_6ed9bf2c-6cab-4e22-b76f-be90f9c7642a"
      unitRef="usd">367495000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM1LTEtMS0xLTM2MjQ4_7b61c0d3-926f-483b-8ffb-2b148a9629b8"
      unitRef="shares">329870</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM1LTItMS0xLTM2MjQ4_a6ff4a95-b6ca-4f08-a9e6-9e620cd8af0d"
      unitRef="usd">22000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iaa0833c316264e0ea3f2e1469249cc7b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM1LTMtMS0xLTM2MjQ4_e02b5908-d037-4415-844e-0c59424e5d4b"
      unitRef="usd">21599000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM1LTctMS0xLTM2MjQ4_85674716-ebad-4f22-b533-41d2a36896b0"
      unitRef="usd">21621000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM2LTEtMS0xLTM2MjQ4_7ec8cc7a-1f14-4fda-b4a9-cb0ced9f61ad"
      unitRef="shares">355730</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM2LTItMS0xLTM2MjQ4_05f5cec7-9c09-4f94-a9f5-6f60a3d73ba1"
      unitRef="usd">24000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM2LTctMS0xLTM2MjQ4_6de58050-f000-48d5-87be-142af60b022f"
      unitRef="usd">24000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaa0833c316264e0ea3f2e1469249cc7b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM3LTMtMS0xLTM2MjQ4_3843ccad-4ca9-41b6-8d56-83a225cf7a11"
      unitRef="usd">26733000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM3LTctMS0xLTM2MjQ4_205f599e-4514-4a40-9d2f-d70c8d249348"
      unitRef="usd">26733000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="iaa0833c316264e0ea3f2e1469249cc7b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM4LTMtMS0xLTM2MjQ4_1ad99d92-c55d-412f-918e-adc233138d26"
      unitRef="usd">13000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM4LTctMS0xLTM2MjQ4_9d00b51c-ac35-4a45-a3cf-1993f29f3904"
      unitRef="usd">13000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTEtMS0xLTM2MjQ4_444bc5ac-806b-4e52-825d-126eac4544e4"
      unitRef="shares">1035100</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0ec77bd1bb884bb2b2f6cc02ac7b2ffb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTItMS0xLTM2MjQ4_ae7bc840-e23a-417a-9595-0a128d1799cc"
      unitRef="usd">69000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ie1f8d018bbf94621ae5409b6eda9be54_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTQtMS0xLTM2MjQ4_67ac1795-85cb-4542-b7a1-b8aee1461740"
      unitRef="usd">-69000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTYtMS0xLTM2MjQ4_49bdacf2-b231-4ea2-89ad-4b08c4612715"
      unitRef="usd">146931000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzM5LTctMS0xLTM2MjQ4_a8e0d067-56e6-4b01-9a24-9c730bad0a64"
      unitRef="usd">146931000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts
      contextRef="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQwLTYtMS0xLTM2MjQ4_1f23b167-28a2-475a-923c-a5109fdf5456"
      unitRef="usd">107000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQwLTctMS0xLTM2MjQ4_9fa41fec-bb78-4a7e-8586-2bb1e79e8ada"
      unitRef="usd">107000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ic1855db4bb0b4dbb98b316a593a03fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQxLTgtMS0xLTM2MjQ4_37bae16a-aff8-461c-ad40-1299daa6964c"
      unitRef="usd">32592000</iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination>
    <iclr:RedeemableNoncontrollingInterestAccretionToRedemptionValue
      contextRef="i8b4a72dd20f6488382e2906ecc62ce5b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQyLTYtMS0xLTM2MjQ4_a0c86861-4994-405c-92a2-6203a14df269"
      unitRef="usd">5048000</iclr:RedeemableNoncontrollingInterestAccretionToRedemptionValue>
    <iclr:RedeemableNoncontrollingInterestAccretionToRedemptionValue
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQyLTctMS0xLTM2MjQ4_65faa3af-5a61-4fdb-96a7-a1d7a9162693"
      unitRef="usd">5048000</iclr:RedeemableNoncontrollingInterestAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="ic1855db4bb0b4dbb98b316a593a03fa6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQyLTgtMS0xLTM2MjQ4_54d66df7-02c5-4bdc-a06c-5fb0415f7379"
      unitRef="usd">5048000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="i68a8df88a51a4914b34c331af346e762_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTEtMS0xLTM2MjQ4_52f8e91e-afc3-4328-acdc-5c2e091d788d"
      unitRef="shares">53622206</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i68a8df88a51a4914b34c331af346e762_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTItMS0xLTM2MjQ4_52ac2123-4421-494e-8f49-a73dc57f1e03"
      unitRef="usd">4635000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c9c424a36dd4a109577161d2940b41b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTMtMS0xLTM2MjQ4_1a3140b2-c381-4902-97c9-c41088b9b7ef"
      unitRef="usd">577961000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e62c0f5e8c74f1aa308fbbfc8707376_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTQtMS0xLTM2MjQ4_10110c35-da0c-496c-9d28-e16c5d369aa6"
      unitRef="usd">1052000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie6d50f7cd15643d798684811166d0ba9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTUtMS0xLTM2MjQ4_773c005d-06c4-46fd-88d8-4554c715bd3b"
      unitRef="usd">-75819000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i750b3a109f9044d3af3bdc0259dc0293_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTYtMS0xLTM2MjQ4_7f9c3007-021f-4321-b42e-e730c2429f50"
      unitRef="usd">1110226000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTctMS0xLTM2MjQ4_a402df5a-d126-4442-9c6d-17b81c9b394a"
      unitRef="usd">1618055000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i94be34191abe4629b7ebef1ad29ea857_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZToyMzMyMDQ3NDY5Mzc0NjM4YjI1MGIyMTJkNDg2ZjU1YS90YWJsZXJhbmdlOjIzMzIwNDc0NjkzNzQ2MzhiMjUwYjIxMmQ0ODZmNTVhXzQzLTgtMS0xLTM2MjQ4_fa3f036d-f947-47c0-9094-0890d442c3fa"
      unitRef="usd">39510000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockSharesIssued
      contextRef="i68a8df88a51a4914b34c331af346e762_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctMS0xLTEtMzYyNDg_33667cfe-7fb0-411e-8150-2820206fec99"
      unitRef="shares">53622206</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i68a8df88a51a4914b34c331af346e762_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctMi0xLTEtMzYyNDg_e9ea9d85-c3a6-44ca-ba3b-ac59eac30cdd"
      unitRef="usd">4635000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c9c424a36dd4a109577161d2940b41b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctMy0xLTEtMzYyNDg_dc919e29-bf40-4600-9050-3470f37c9094"
      unitRef="usd">577961000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e62c0f5e8c74f1aa308fbbfc8707376_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctNC0xLTEtMzYyNDg_6ddd5999-b1fe-486c-84b0-5aa1e6b54a0c"
      unitRef="usd">1052000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie6d50f7cd15643d798684811166d0ba9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctNS0xLTEtMzYyNDg_1b532770-0ac0-4967-b5fd-cb7b1d190ca2"
      unitRef="usd">-75819000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i750b3a109f9044d3af3bdc0259dc0293_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctNi0xLTEtMzYyNDg_130d5894-fe22-4528-95ba-3f2d669387b2"
      unitRef="usd">1110226000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctNy0xLTEtMzYyNDg_a24b1808-3664-4b7b-8571-7cf335f0934e"
      unitRef="usd">1618055000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i94be34191abe4629b7ebef1ad29ea857_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzctOC0xLTEtMzYyNDg_b58a8d81-2a22-4745-90bd-429c1ed2dd0d"
      unitRef="usd">39510000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLoss
      contextRef="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzktNi0xLTEtMzYyNDg_acf1ccb1-b412-4619-80c3-567dd7a5739f"
      unitRef="usd">332331000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzktNy0xLTEtMzYyNDg_ac2a0960-c8c2-4b46-897a-53ea067ec6c5"
      unitRef="usd">332331000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i0962b68ff61246e5a9f5b9e8d38e3989_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzktOC0xLTEtMzYyNDg_80ba1fbe-51cf-4508-a8cd-f64996f32205"
      unitRef="usd">633000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzEwLTUtMS0xLTM2MjQ4_1206e32c-fd72-4c81-86c9-38fac7b4a77f"
      unitRef="usd">48129000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzEwLTctMS0xLTM2MjQ4_da4d52c0-fe71-42ae-817f-6264702e763d"
      unitRef="usd">48129000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzExLTUtMS0xLTM2MjQ4_4116f192-bf00-4af0-a421-a5a10f53c403"
      unitRef="usd">-1603000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzExLTctMS0xLTM2MjQ4_b4bfee4b-3f32-4542-8a9a-f1a1d2e7a3d3"
      unitRef="usd">-1603000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzEzLTUtMS0xLTM2MjQ4_f23d069b-3ca8-4b5d-98ed-34e5d9b381a5"
      unitRef="usd">-231000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzEzLTctMS0xLTM2MjQ4_1acceed8-c36c-401a-8a82-92351bbe16a8"
      unitRef="usd">-231000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE0LTUtMS0xLTM2MjQ4_cd4ae131-4321-4300-b7a0-ceeb6378d9b2"
      unitRef="usd">-4138000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE0LTctMS0xLTM2MjQ4_9b3fdb94-0400-4971-8543-c6cac2351ce5"
      unitRef="usd">-4138000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE1LTUtMS0xLTM2MjQ4_fe748d3a-452e-4067-ad07-41f14dfb7e41"
      unitRef="usd">910000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE1LTctMS0xLTM2MjQ4_5517ff9e-aaef-4697-9b55-67be41fedb15"
      unitRef="usd">910000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i14400d3c3e9442ff89a383982c73f0cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE2LTUtMS0xLTM2MjQ4_729e23f2-f045-418c-b14a-a71afab5df61"
      unitRef="usd">-905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE2LTctMS0xLTM2MjQ4_9a1bac8a-c261-4533-b502-686f1af8ff44"
      unitRef="usd">-905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzE4LTctMS0xLTM2MjQ4_5959010d-140b-4518-a081-7a6cebbc01de"
      unitRef="usd">372673000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIwLTEtMS0xLTM2MjQ4_04453c52-520a-48cb-aa83-5ce1f0b930cf"
      unitRef="shares">193417</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIwLTItMS0xLTM2MjQ4_18855576-bd61-4f1c-bb14-62b26e6d87c2"
      unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i90ce1847176642a7a8d12c476ee2b2d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIwLTMtMS0xLTM2MjQ4_e74e1630-09cf-4fbb-8b9a-a2f922e2a971"
      unitRef="usd">13176000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIwLTctMS0xLTM2MjQ4_59ce2128-257a-459c-bc12-4b19d33152d3"
      unitRef="usd">13189000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIxLTEtMS0xLTM2MjQ4_63ada338-4800-442c-bd01-bbf96f2b73af"
      unitRef="shares">207688</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIxLTItMS0xLTM2MjQ4_b0c4e09a-0686-4160-804e-f9cdf8ab1d3b"
      unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIxLTctMS0xLTM2MjQ4_a01f1626-93a5-4315-a558-ef1898a3914f"
      unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i90ce1847176642a7a8d12c476ee2b2d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIyLTMtMS0xLTM2MjQ4_1f8d88fc-7a79-43d2-8d84-0f19c99db6d5"
      unitRef="usd">25981000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIyLTctMS0xLTM2MjQ4_bf3a9c03-2aa7-401a-b2da-3008976970b4"
      unitRef="usd">25981000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i90ce1847176642a7a8d12c476ee2b2d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIzLTMtMS0xLTM2MjQ4_8422cc47-bc60-4a0f-b950-d2ed19b45dea"
      unitRef="usd">14000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzIzLTctMS0xLTM2MjQ4_be382ddc-dd15-4613-be5d-9fc25c4912fb"
      unitRef="usd">14000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTEtMS0xLTM2MjQ4_ad8b53dd-49f3-4300-9503-3653aa0a11fc"
      unitRef="shares">1235218</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i8ee37a0edacf4e4f9d13903f8823a3a8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTItMS0xLTM2MjQ4_9bb5fe4b-c94c-4d0c-a7d7-d3258d0d18ff"
      unitRef="usd">82000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="icc0b7e51cfbd494db946ce79e9bb7c29_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTQtMS0xLTM2MjQ4_a75a16b3-cc23-4970-9045-6792cc924c35"
      unitRef="usd">-82000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTYtMS0xLTM2MjQ4_94efc3fb-369c-4bbe-8ce4-40ae8536e4f6"
      unitRef="usd">175000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI0LTctMS0xLTM2MjQ4_be65803b-0bbc-4244-acf2-44239621c805"
      unitRef="usd">175000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts
      contextRef="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI1LTYtMS0xLTM2MjQ4_8aa89681-8bf3-4b87-8c7c-253844fe7625"
      unitRef="usd">140000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI1LTctMS0xLTM2MjQ4_621b49b1-926e-4a03-afd2-2773f37d8516"
      unitRef="usd">140000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="id9014a01a4164f5a8456350cf58cce30_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI2LTYtMS0xLTM2MjQ4_76cfa8ab-891a-4a7e-a521-063918ff5e86"
      unitRef="usd">-4522000</iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination>
    <iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI2LTctMS0xLTM2MjQ4_e1ce2994-a53e-44fd-bf4f-f8de6e845886"
      unitRef="usd">-4522000</iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination>
    <iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i0962b68ff61246e5a9f5b9e8d38e3989_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI2LTgtMS0xLTM2MjQ4_43394604-51a3-4854-a3e0-2b081d1780d7"
      unitRef="usd">4522000</iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i0962b68ff61246e5a9f5b9e8d38e3989_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI3LTgtMS0xLTM2MjQ4_1fa2250c-f16f-4a54-b8e5-5ca4758d0516"
      unitRef="usd">-44665000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="i02a3c3f480da466f979b83dd7f24aaa6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTEtMS0xLTM2MjQ4_8dff6dc2-0713-46f6-9062-eb691e05ebbe"
      unitRef="shares">52788093</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i02a3c3f480da466f979b83dd7f24aaa6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTItMS0xLTM2MjQ4_debaacfe-2bcf-46ab-8013-a45cd516ddee"
      unitRef="usd">4580000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f26675e42484470a39567b27487f173_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTMtMS0xLTM2MjQ4_12b9b272-a321-48ac-904f-a345240768e2"
      unitRef="usd">617104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i17db85087b8349beb2ce7a3c58760e87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTQtMS0xLTM2MjQ4_13cda993-bc27-48f8-a636-001dc75f3eb3"
      unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if485c36ee8d54bf0a345ece247288e1c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTUtMS0xLTM2MjQ4_ead7af4a-a27a-4183-9dee-01b50aa909d3"
      unitRef="usd">-35477000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c2f810ef5f14db3a7c717dc50d0207d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTYtMS0xLTM2MjQ4_a0dd4834-b480-4aa0-b1d9-80c59f47b96f"
      unitRef="usd">1262895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTctMS0xLTM2MjQ4_3ab3828d-17f5-4881-a26f-4d11ad7fc5b1"
      unitRef="usd">1850236000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ic6be1e93cc2e4a22825aee8e63f813bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTpkMzUzNDU1YzY0Yjc0ZDZjYmY0YTRhY2FjNTQ1ZmZlZi90YWJsZXJhbmdlOmQzNTM0NTVjNjRiNzRkNmNiZjRhNGFjYWM1NDVmZmVmXzI4LTgtMS0xLTM2MjQ4_ea4514ec-e820-497d-8ce9-3cad89171911"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockSharesIssued
      contextRef="i02a3c3f480da466f979b83dd7f24aaa6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctMS0xLTEtNDE5ODk_c0911bae-ed2b-477b-b5c2-b5dee618125e"
      unitRef="shares">52788093</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i02a3c3f480da466f979b83dd7f24aaa6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctMi0xLTEtNDE5ODk_71dc7e3a-4dc7-4382-b305-58a190d48359"
      unitRef="usd">4580000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9f26675e42484470a39567b27487f173_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctMy0xLTEtNDE5ODk_85858af7-bb28-4071-8270-af9533645e20"
      unitRef="usd">617104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i17db85087b8349beb2ce7a3c58760e87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctNC0xLTEtNDE5ODk_45c6acc0-5794-47ff-ac76-94859b4c03e8"
      unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if485c36ee8d54bf0a345ece247288e1c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctNS0xLTEtNDE5ODk_5040e1ba-fa12-4dde-ae2b-123d644fa7e0"
      unitRef="usd">-35477000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c2f810ef5f14db3a7c717dc50d0207d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctNi0xLTEtNDE5ODk_bde55093-076f-40e9-91ac-40ffb97a5803"
      unitRef="usd">1262895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzctNy0xLTEtNDE5ODk_f6e6f4d7-4065-4632-98b6-9957c9378c07"
      unitRef="usd">1850236000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i2a8bfe01d1774f4e96679362547f99f0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzktNi0xLTEtNDIxMjU_29ee85dd-6e1f-4f80-90eb-27bde1e28839"
      unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzktNy0xLTEtNDIxMjU_1618a999-b629-4fd3-98f8-86a729c6960a"
      unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzEwLTUtMS0xLTQyMTI1_7750534a-a6b0-4430-9c69-eb58524832e6"
      unitRef="usd">-60092000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzEwLTctMS0xLTQyMTI1_0e6d79a4-60bd-43e7-acd0-4ed6e316b3ce"
      unitRef="usd">-60092000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzExLTUtMS0xLTQyMTI1_4a63af06-152b-48d5-978f-f077773fe477"
      unitRef="usd">-525000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzExLTctMS0xLTQyMTI1_e46d3564-4875-41a9-9c0b-6d8af8372bc0"
      unitRef="usd">-525000</iclr:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE0LTUtMS0xLTQyMTI1_17a2b20c-c634-4d00-96b6-ddace8cdb8bf"
      unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE0LTctMS0xLTQyMTI1_eb01dbe4-49e9-4b8f-844d-988310a77e03"
      unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE1LTUtMS0xLTQyMTI1_be7f180e-5823-4d7a-8913-0e25dd2ce279"
      unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE1LTctMS0xLTQyMTI1_2b9b813a-0438-42ed-bbde-6af314913791"
      unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4428b28af735412e8a5cf4d80b91b044_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE2LTUtMS0xLTQyMTI1_187ec990-f835-4ce3-879b-85e6071a719e"
      unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE2LTctMS0xLTQyMTI1_6f062662-6a02-4789-94d9-8104a7c7b461"
      unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzE4LTctMS0xLTQyMTMz_8c117ae8-4d4d-470a-9633-d443dc2c9d3b"
      unitRef="usd">97725000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIwLTEtMS0xLTQyMTUx_622d7f94-8096-430b-8bb0-9546d0ff3b54"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIwLTItMS0xLTQyMTUx_e7aca88d-4fdd-49f6-a1d0-2fc05b3d1b8d"
      unitRef="usd">77000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIwLTMtMS0xLTQyMTUx_94a2cfcc-9ad8-401d-9353-731be7931594"
      unitRef="usd">118512000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIwLTctMS0xLTQyMTUx_c79d99de-cbf4-4417-a482-133074a35486"
      unitRef="usd">118589000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIxLTEtMS0xLTQyMTUx_4fa56c28-f840-4ba3-9a71-12b04b416b0c"
      unitRef="shares">328634</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIxLTItMS0xLTQyMTUx_e266db60-a189-4410-aba2-e6274a85e908"
      unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIxLTctMS0xLTQyMTUx_3c835bc8-dc59-49f5-839d-5a9450aa8d80"
      unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIyLTMtMS0xLTQyMTUx_712b91e6-8347-478f-ac88-6c6a9067412c"
      unitRef="usd">133553000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIyLTctMS0xLTQyMTUx_3b613aa2-fe1b-4b7e-9f57-ce2e80071c48"
      unitRef="usd">133553000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIzLTMtMS0xLTQyMTUx_b6af9701-0a77-4d88-80f3-a55a11ec9d50"
      unitRef="usd">853000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzIzLTctMS0xLTQyMTUx_5e70926c-9a30-40b8-b700-0c2057c705cb"
      unitRef="usd">853000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI0LTEtMS0xLTQyMTUx_16771fa9-834b-43f7-87d1-ce3b849c5930"
      unitRef="shares">27372427</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI0LTItMS0xLTQyMTUx_4d65e9a7-7a70-4660-9d94-6459136b6471"
      unitRef="usd">1960000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI0LTMtMS0xLTQyMTUx_28873f2e-e7fc-4c5e-a6de-acb558de4cb7"
      unitRef="usd">5656195000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI0LTctMS0xLTQyMTUx_038e187f-75f4-4959-be74-e35627545444"
      unitRef="usd">5658155000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i76ad7e3e6f994a4bb982c917c7dc5b16_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI1LTMtMS0xLTQyMTUx_034175e3-4ec0-4acd-8114-587dd04e8fff"
      unitRef="usd">209399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI1LTctMS0xLTQyMTUx_c9cf6b99-569d-4580-976b-d06d89e9dd23"
      unitRef="usd">209399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:CommonStockSharesIssued
      contextRef="ica03b62926534e1c96e97c487693f9b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTEtMS0xLTQxOTg4_03ed2196-ac0a-49e8-8aad-d780c15ad44a"
      unitRef="shares">81554683</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ica03b62926534e1c96e97c487693f9b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTItMS0xLTQxOTg4_03807c85-37b3-4a30-b711-3f5af1fea660"
      unitRef="usd">6640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icfbb11854a164b7bb15d92889e4c2bb4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTMtMS0xLTQxOTg4_8d6f59ea-76b6-4077-b48d-411b9249bf06"
      unitRef="usd">6733910000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icd6e0d8b7e5144638aef2b48835ca0f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTQtMS0xLTQxOTg4_857f2cf1-b726-4dcf-a7f9-ab2df5955399"
      unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5839a28afffc48f8a9ce6fc8cd0b1215_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTUtMS0xLTQxOTg4_892ef9f4-dd7c-4c50-af52-3e224a811b7e"
      unitRef="usd">-90937000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7670eea39a0649e3b66786e7d2cf4f1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTYtMS0xLTQxOTg4_3dd370de-0aa0-451e-9188-4a7fb72ed4b7"
      unitRef="usd">1416080000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMjcvZnJhZzowMjlmZWFlYTA1MTE0NGI4ODJhOTI3ZmZlMGFjZWEyYS90YWJsZTo3MWRkNTAzYTEyNTQ0NGJkYTdkMzY4ZDkwNmEyZTFhOS90YWJsZXJhbmdlOjcxZGQ1MDNhMTI1NDQ0YmRhN2QzNjhkOTA2YTJlMWE5XzI4LTctMS0xLTQxOTg4_3cf6b105-d157-423b-b5b0-3d5d0bc52ab5"
      unitRef="usd">8066827000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMtMS0xLTEtMzYyNDg_c887a750-f8ae-4ca0-85f7-1b0e5c898603"
      unitRef="usd">153185000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMtMi0xLTEtMzYyNDg_e0183486-a8d0-4c59-9697-83da81f06eda"
      unitRef="usd">332964000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMtMy0xLTEtMzYyNDg_976dce0f-bb61-4455-8bf4-923f14937e9c"
      unitRef="usd">375856000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzYtMS0xLTEtMzYyNDg_767005ef-d688-46ac-bd55-c991d43dfa9d"
      unitRef="usd">314987000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzYtMi0xLTEtMzYyNDg_c21900df-6e51-4ad2-8b7b-b66d76e92a57"
      unitRef="usd">66126000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzYtMy0xLTEtMzYyNDg_12435389-0cdd-400d-b089-e9e20ec8fea4"
      unitRef="usd">61550000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzctMS0xLTEtMzYyNDg_ffd94fb6-c4e2-491d-b18c-bc239455910e"
      unitRef="usd">20037000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzctMi0xLTEtMzYyNDg_cb1e2716-274b-40f7-9cd9-5c367f130fa7"
      unitRef="usd">5411000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzctMy0xLTEtMzYyNDg_37176d86-6496-4d4a-87ca-838ca6b22549"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzgtMS0xLTEtMzYyNDg_18332793-106a-4d15-912f-bf4b8c50aeb1"
      unitRef="usd">45339000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzgtMi0xLTEtMzYyNDg_360c5d6f-4634-412e-9401-94fd4c1cdf71"
      unitRef="usd">28480000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzgtMy0xLTEtMzYyNDg_761e1a29-0efe-45e5-a5d5-b37c31e90cfb"
      unitRef="usd">30372000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE2LTEtMS0xLTM2MjQ4_91826338-4977-46a8-b81e-d394dc178de2"
      unitRef="usd">-2161000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE2LTItMS0xLTM2MjQ4_ecf131ee-77f0-432f-a775-6bf6ff86f62d"
      unitRef="usd">-366000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE2LTMtMS0xLTM2MjQ4_5c42276c-5d04-47b0-b75a-97a0d9b1f3b9"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE3LTEtMS0xLTM2MjQ4_f0cd7e58-ac02-42f0-8c0a-17e65f897103"
      unitRef="usd">891000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE3LTItMS0xLTM2MjQ4_7499fb61-a100-454c-84d6-23cbf1999be3"
      unitRef="usd">-910000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE3LTMtMS0xLTM2MjQ4_60ff6e4a-ab50-4062-a090-2db27809169e"
      unitRef="usd">-923000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE4LTEtMS0xLTM2MjQ4_d17eec7b-0509-43d9-aa0c-9e7858032a71"
      unitRef="usd">12890000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE4LTItMS0xLTM2MjQ4_bbcb8531-06c7-495b-a9c6-d72b40d10bc5"
      unitRef="usd">523000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE4LTMtMS0xLTM2MjQ4_49375343-ad3e-4645-a8f6-d437d1ed910c"
      unitRef="usd">540000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE5LTEtMS0xLTM2MjQ4_8ae5e49f-9f94-4c5a-ac2d-931a8d315291"
      unitRef="usd">133844000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE5LTItMS0xLTM2MjQ4_7a7b1b5e-b44f-4a36-bbaa-05630b7b6b29"
      unitRef="usd">26271000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE5LTMtMS0xLTM2MjQ4_2eabc0c7-9ae1-4e97-8f1c-7444d865189a"
      unitRef="usd">26819000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzEzLTEtMS0xLTUyMTcx_41b566cf-23e8-4b70-8b87-c2b0d6d7708d"
      unitRef="usd">-73894000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzEzLTItMS0xLTUyMTcx_bca9a000-4363-4d09-bfd7-f07b27c3891a"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzEzLTMtMS0xLTUyMTcx_e3914ec7-9d69-45f6-adc1-b51c5869f30c"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIwLTEtMS0xLTM2MjQ4_57a9f8d4-b3e9-4017-8f1b-40bce5470de7"
      unitRef="usd">-60616000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIwLTItMS0xLTM2MjQ4_45862641-50f9-48d1-bd8c-16c74d86e731"
      unitRef="usd">927000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIwLTMtMS0xLTM2MjQ4_5ba2c0d1-ba45-4d05-a8c5-dabcbc987dd9"
      unitRef="usd">-1537000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE1LTEtMS0xLTUyMTgx_1540d195-7b7f-4125-9bcc-9f7d18206c03"
      unitRef="usd">6054000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE1LTItMS0xLTUyMTgx_e0ac4bd9-081b-4f8d-a573-2fdfab65d3f5"
      unitRef="usd">-5979000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE1LTMtMS0xLTUyMTgx_1e021499-f3d5-4350-9dd7-9c36ceb432f6"
      unitRef="usd">-590000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE0LTEtMS0xLTUxMTcw_41992e74-16eb-4456-93cd-9a6cf334ce5a"
      unitRef="usd">-3589000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE0LTItMS0xLTUxMTcw_2e129b9a-f9ad-4b93-83d8-e63db8d3c98e"
      unitRef="usd">6949000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzE0LTMtMS0xLTUxMTcw_c273e83c-89bd-4243-85ab-6b55a37b749e"
      unitRef="usd">-2018000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIyLTEtMS0xLTM2MjQ4_06aed684-4f7c-41b1-973a-aae9a2a4ea21"
      unitRef="usd">-113513000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIyLTItMS0xLTM2MjQ4_5f4979db-a1c9-4547-82ec-5418f1556205"
      unitRef="usd">175040000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIyLTMtMS0xLTM2MjQ4_a1980c4d-0c60-4e9b-b70b-c2082bd59229"
      unitRef="usd">101545000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIzLTEtMS0xLTM2MjQ4_f964e10b-e3c7-47fd-a91d-7f61bfce6b39"
      unitRef="usd">17656000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIzLTItMS0xLTM2MjQ4_82d75da3-f14c-4804-af6f-39e0a90f326d"
      unitRef="usd">5748000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzIzLTMtMS0xLTM2MjQ4_cf15929b-b44d-4f55-8cd4-21cf90a52d50"
      unitRef="usd">55790000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI3LTEtMS0xLTM2MjQ4_f7f5b360-4e25-4bcd-a130-46964121877e"
      unitRef="usd">-69121000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI3LTItMS0xLTM2MjQ4_d6b35307-ff60-4a03-a2cb-87e4cbe00653"
      unitRef="usd">291844000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI3LTMtMS0xLTM2MjQ4_fc15d517-9981-441c-80a6-f42b46cfb458"
      unitRef="usd">86567000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI4LTEtMS0xLTM2MjQ4_512937f5-7076-4ae4-ac69-548e38d902ba"
      unitRef="usd">108259000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI4LTItMS0xLTM2MjQ4_a1f7772f-32ec-4d07-b14e-ed634f8905f9"
      unitRef="usd">-2209000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzI4LTMtMS0xLTM2MjQ4_c98e8412-152c-41d5-b29d-7f1cd9fb2e85"
      unitRef="usd">-11976000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMzLTEtMS0xLTM2MjQ4_3c30e955-5bcc-4e45-8afa-4fe1c981d255"
      unitRef="usd">829142000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMzLTItMS0xLTM2MjQ4_4289511f-cd1c-406e-93bc-b0222c70d629"
      unitRef="usd">568035000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzMzLTMtMS0xLTM2MjQ4_238b3575-90cf-4a9e-b2e1-48a5e2d74b67"
      unitRef="usd">412541000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM1LTEtMS0xLTM2MjQ4_84ff00e1-fb4a-405a-ae08-85e47054cd6a"
      unitRef="usd">93750000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM1LTItMS0xLTM2MjQ4_4189a269-d91c-4a05-bf8c-db4b31503b12"
      unitRef="usd">40885000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM1LTMtMS0xLTM2MjQ4_0b3567b2-ae87-45cb-9b48-4c42ad94b3aa"
      unitRef="usd">38948000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM2LTEtMS0xLTM2MjQ4_eee15f3f-ca34-4204-ade8-2a1253afbfa5"
      unitRef="usd">5914475000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM2LTItMS0xLTM2MjQ4_a7047fe3-821b-497b-8fdb-0b1d928ae618"
      unitRef="usd">47931000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM2LTMtMS0xLTM2MjQ4_f9ecb903-f780-46e2-94a6-293fae410e12"
      unitRef="usd">131272000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM3LTEtMS0xLTM2MjQ4_5b4fd2da-8968-44ad-bdb8-68b1581c972b"
      unitRef="usd">2450000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM3LTItMS0xLTM2MjQ4_fd2fd418-130c-464d-bdbf-a5e2560a2532"
      unitRef="usd">2450000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM3LTMtMS0xLTM2MjQ4_90c1b9f9-5583-429b-a4c7-d9e62d3f395c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM4LTEtMS0xLTM2MjQ4_31ebcc51-1b03-4ae2-b768-ed25fcdfa1e8"
      unitRef="usd">10000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM4LTItMS0xLTM2MjQ4_fcf05af3-8820-4353-8a1b-a1dbe5a55410"
      unitRef="usd">0</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM4LTMtMS0xLTM2MjQ4_a64ceb56-5d8a-4202-a2e4-24fd83195bff"
      unitRef="usd">0</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM5LTEtMS0xLTM2MjQ4_8805caac-68f1-407f-ba28-be1fb12181c6"
      unitRef="usd">497000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM5LTItMS0xLTM2MjQ4_2a367d4f-c338-4926-83e8-af30ae69230e"
      unitRef="usd">47902000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzM5LTMtMS0xLTM2MjQ4_4c5757f9-54bc-49be-b330-9d3498b280b5"
      unitRef="usd">21686000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQwLTEtMS0xLTM2MjQ4_2439d89c-6cf9-46a5-b0fd-73a30ce60100"
      unitRef="usd">480000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQwLTItMS0xLTM2MjQ4_33a6aa27-9cd1-4640-8427-a1b13ca439c7"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQwLTMtMS0xLTM2MjQ4_7fe9cb4d-199c-471d-9293-af96fbb581e8"
      unitRef="usd">9603000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQxLTEtMS0xLTM2MjQ4_23a303a3-8edc-48e0-949d-6bb3569573bf"
      unitRef="usd">3577000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQxLTItMS0xLTM2MjQ4_f04b9246-c10e-4712-9040-05c31487a181"
      unitRef="usd">3212000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQxLTMtMS0xLTM2MjQ4_b667d836-aadb-42e2-be99-eb73abb29e28"
      unitRef="usd">3890000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQyLTEtMS0xLTM2MjQ4_7f5cd34f-7d77-4bd7-90eb-11f5bea3b390"
      unitRef="usd">-6024235000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQyLTItMS0xLTM2MjQ4_752da563-c73c-432c-a1d0-a6557768b5af"
      unitRef="usd">-46576000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQyLTMtMS0xLTM2MjQ4_dfc4a5ca-493e-4045-a3eb-53d46ff54fa2"
      unitRef="usd">-162027000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ0LTEtMS0xLTM2MjQ4_1c15313d-6c94-486c-b51a-025979aabce5"
      unitRef="usd">30328000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ0LTItMS0xLTM2MjQ4_af1d685d-e9fe-4c3b-83cf-f206dbff9532"
      unitRef="usd">1554000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ0LTMtMS0xLTM2MjQ4_65cc921e-f1ce-460d-b28d-d7b0bb507e99"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ1LTEtMS0xLTM2MjQ4_bb3398ce-654d-4c8a-97fa-1cf338872261"
      unitRef="usd">5905100000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ1LTItMS0xLTM2MjQ4_1b6afa83-fd13-48e0-b1c4-a793cbd740a7"
      unitRef="usd">350000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ1LTMtMS0xLTM2MjQ4_574f189e-38be-4fb9-b7e1-5277ae4287e8"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ2LTEtMS0xLTM2MjQ4_e954d510-c763-40b2-8b2f-3eaf64aa2b09"
      unitRef="usd">877780000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ2LTItMS0xLTM2MjQ4_1ce1cfd7-29b2-4419-967e-a05f64165b49"
      unitRef="usd">350000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ2LTMtMS0xLTM2MjQ4_2bc2fd9f-6b16-4c36-961c-4a089d3b410b"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ3LTEtMS0xLTM2MjQ4_facbe4cb-6396-4929-be43-fafeee8a6e46"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ3LTItMS0xLTM2MjQ4_b6034294-138d-4d68-9a34-ca80011801cd"
      unitRef="usd">43923000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ3LTMtMS0xLTM2MjQ4_f5b27b1d-dfd0-4ed8-bd0f-ef250105da60"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ4LTEtMS0xLTM2MjQ4_515a240d-c047-457c-80d0-3a417397a321"
      unitRef="usd">118589000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ4LTItMS0xLTM2MjQ4_20e5ef88-054d-4676-95af-2661f44c980c"
      unitRef="usd">13203000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ4LTMtMS0xLTM2MjQ4_e0abc193-6364-4657-9974-d5792333dad2"
      unitRef="usd">21645000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ5LTEtMS0xLTM2MjQ4_0beb118f-b8ae-4777-95c5-73681b978015"
      unitRef="usd">853000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ5LTItMS0xLTM2MjQ4_35529819-a935-481b-95ca-c51d5f723109"
      unitRef="usd">14000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzQ5LTMtMS0xLTM2MjQ4_b79a2bbf-5da1-45ec-9223-890ca6be60be"
      unitRef="usd">13000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUxLTEtMS0xLTM2MjQ4_c2dd3487-b3e6-4b50-9b28-c0ce70c23e79"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUxLTItMS0xLTM2MjQ4_a4f7fdac-d949-48cc-8f6f-c53003b0d8d5"
      unitRef="usd">175000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUxLTMtMS0xLTM2MjQ4_460864ae-3b5a-4d3a-b9d2-5a10787927f1"
      unitRef="usd">146931000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <iclr:PaymentsForShareRepurchaseCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUyLTEtMS0xLTM2MjQ4_de6766af-1163-4369-8f89-981dfbc53428"
      unitRef="usd">0</iclr:PaymentsForShareRepurchaseCosts>
    <iclr:PaymentsForShareRepurchaseCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUyLTItMS0xLTM2MjQ4_9b6cca19-9b44-44af-b1d5-e02fc4e40247"
      unitRef="usd">140000</iclr:PaymentsForShareRepurchaseCosts>
    <iclr:PaymentsForShareRepurchaseCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzUyLTMtMS0xLTM2MjQ4_225bc7bf-75f4-467c-aca0-a7d64d1f4f00"
      unitRef="usd">107000</iclr:PaymentsForShareRepurchaseCosts>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU0LTEtMS0xLTM2MjQ4_936f7d74-dd14-4b30-8d3b-88b895185397"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU0LTItMS0xLTM2MjQ4_d9505087-aaba-48b6-a5aa-424fabbc64e3"
      unitRef="usd">905000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU0LTMtMS0xLTM2MjQ4_6ab082e0-c001-40d6-8db0-7d50fb45f3d8"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU1LTEtMS0xLTM2MjQ4_5c5b836a-98ef-460f-a0f0-86b3a017adcc"
      unitRef="usd">5114728000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU1LTItMS0xLTM2MjQ4_a759bfcd-6f30-486f-afb7-8fa76fb7fc9b"
      unitRef="usd">-208333000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU1LTMtMS0xLTM2MjQ4_9e16f7c7-20bb-4fd5-8f14-641bb9ae65bf"
      unitRef="usd">-125406000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU2LTEtMS0xLTM2MjQ4_3db7508d-ef68-42c8-a656-5123947acbc8"
      unitRef="usd">-7727000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU2LTItMS0xLTM2MjQ4_181a4a1a-c255-4458-ad2a-011014ceeffb"
      unitRef="usd">6870000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU2LTMtMS0xLTM2MjQ4_dbdd8f5d-50b5-4fe3-b19a-9954bf7d006b"
      unitRef="usd">-650000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU3LTEtMS0xLTM2MjQ4_94f02218-ef94-419a-99f7-7e7bbb4753cf"
      unitRef="usd">-88092000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU3LTItMS0xLTM2MjQ4_271b1f50-e03b-4b5c-8d01-537547792dc6"
      unitRef="usd">319996000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU3LTMtMS0xLTM2MjQ4_e06c9b50-0d08-42b0-ae4a-f6f3f18c1f6d"
      unitRef="usd">124458000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU4LTEtMS0xLTM2MjQ4_7fb336eb-73ba-4e33-9b52-163287f1e2ae"
      unitRef="usd">840305000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU4LTItMS0xLTM2MjQ4_b0ce09dd-29eb-454b-994e-23eeca7590f0"
      unitRef="usd">520309000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie3e24d855ba14a97a64dd8c818215580_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU4LTMtMS0xLTM2MjQ4_ba07e387-3235-4c72-9449-0cd63be4dce2"
      unitRef="usd">395851000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU5LTEtMS0xLTM2MjQ4_eccc27c0-77e6-4612-8830-507b171115f7"
      unitRef="usd">752213000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU5LTItMS0xLTM2MjQ4_eeba804d-e4a0-4874-b72c-1f0efbdf619c"
      unitRef="usd">840305000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzAvZnJhZzoxZDgyNDkwZTg2Y2E0MjU2YWM5YzAxMjEzZjdkN2M1My90YWJsZTpjMDI2NWNlMmFkNDI0NWZiYjNkMmI4NTBkYzY2M2I4My90YWJsZXJhbmdlOmMwMjY1Y2UyYWQ0MjQ1ZmJiM2QyYjg1MGRjNjYzYjgzXzU5LTMtMS0xLTM2MjQ4_08025f13-9f12-4169-8695-faa869dccd35"
      unitRef="usd">520309000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzE3MjA_5d52c6b2-f3d0-4bc7-bbe8-49b94212f82f">Description of business &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2021 we had approximately 38,330 employees, in 142 locations in 53 countries. During the year ended December&#160;31, 2021, we derived approximately 47.1%, 46.4% and 6.5% of our revenue in the United States, Europe and Rest of World, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON&#x2019;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#x201c;ICLR&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <dei:EntityNumberOfEmployees
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3Xzk3Mw_ff449fdc-1ae9-4a48-b016-7cd051e0ec07"
      unitRef="employee">38330</dei:EntityNumberOfEmployees>
    <iclr:NumberOfLocations
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3Xzk5MA_ce41e8e4-d996-4e2b-8c7a-49e6a5b515d2"
      unitRef="location">142</iclr:NumberOfLocations>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzEwMDY_cd4c1a3f-c783-4424-aa22-58abcf1a37c9"
      unitRef="country">53</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iccd478baae434af395e71d177b28bd2e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzEwNzE_76a30cb1-facd-46b8-8596-987080f37909"
      unitRef="number">0.471</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i50822bc1a62345aca0219ef6e28bf127_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzEwNzU_d727428b-d899-43d5-9fbc-cd52a89fd0ab"
      unitRef="number">0.464</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iad57efdbfd9c4bd3a89a3bbc5b80f396_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzYvZnJhZzo5NWUwNjkzNTU0YTM0ZDhiOGFhYzlhNDNiY2RlYTg1Ny90ZXh0cmVnaW9uOjk1ZTA2OTM1NTRhMzRkOGI4YWFjOWE0M2JjZGVhODU3XzEwODI_bad24c20-6e11-4ccc-bdf6-08e7654b4ccb"
      unitRef="number">0.065</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDM3_763e8f54-d3f3-4eda-b299-36965bdacd93">Significant accounting policies&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) &#160; Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) &#160; Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c) &#160; Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. Contracts range in duration from a number of months to several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clinical trial service revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consulting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#x201c;units delivered&#x201d; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(d) &#160; Pass-through/ Reimbursable expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pass through/ Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) Direct costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(e) &#160; Direct costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time i.e. the full-service obligation is in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Investigator payment costs are recorded and reported reflecting investigator activity over the life of the contract. Investigator payments are made based on predetermined contractual arrangements. Timing of payments may differ from the recording and reporting of the expense which is based on activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(f) &#160; Advertising costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All costs associated with advertising and promotion are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(g) &#160; Foreign currencies and translation of subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON plc's financial statements are prepared in United States dollars. Transactions in currencies other than the functional currency of the individual entities within the ICON Group are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the individual entities within the ICON Group are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts (credited)/charged&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. Foreign currency transaction gains and losses are reported in other comprehensive income ("currency impact of long term funding") rather than through income where the foreign currency transaction is 'long-term investment' in nature i.e. settlement is not planned or anticipated in the foreseeable future.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(h) &#160; Disclosure of fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#x2013; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(i) &#160; Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cost of a business combination is measured as the aggregate of the fair values at the date of exchange of assets given, liabilities incurred or assumed and equity instruments issued in exchange for control. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(j) &#160; Goodwill and Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the cost of acquired entities over the net amounts assigned to assets acquired and liabilities assumed. Goodwill primarily comprises acquired workforce in place which does not qualify for recognition as an asset apart from goodwill. Goodwill is stated net of any provision for impairment. The Company tests goodwill annually for any impairments or whenever events occur which may indicate impairment. An impairment charge would be recognized for any amount by which the carrying amount exceeds the reporting unit's fair value up to the amount of existing goodwill. The Company performs a qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. No impairment was recognized as a result of the impairment testing carried out for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(k) &#160; Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight line basis over their estimated useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(l) &#160; Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(m) &#160; Investments in debt, equity and other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies short-term investments as available for sale in accordance with the terms of ASC 320 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Investments - Debt and Equity Securities'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. Realized gains and losses are determined using specific identification. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long term investments  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2020 and December&#160;31, 2021 qualify for the NAV practical expedient in ASC 820 '&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value measurements and disclosure&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(n)   Accounts receivable, net and unbilled revenue&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts receivable factoring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Transfers and Servicing'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. The associated finance costs are presented as interest expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(o) &#160; Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost and net realizable value and after provisions for obsolescence. The cost of inventories comprises the purchase price and attributable costs, less trade discounts. At December&#160;31, 2021 the carrying value of inventory, included within prepayments and other current assets on the Consolidated Balance Sheet, was $5.8 million (2020: $4.8 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(p) &#160; Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2-8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(q) &#160; Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company adopted ASC 842 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Leases' (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 842), with a date of initial application of January 1, 2019. The lease accounting policy applied in preparation of the results for the year ended December&#160;31, 2020 and December&#160;31, 2021 therefore reflect application of ASC 842. The Company adopted the standard using the cumulative-effect adjustment approach. Under this transition method, the Company applied the ASC 842 as at the date of initial application (i.e. January 1, 2019), without restatement of comparative period amounts. The cumulative effect of applying the standard is recorded as an adjustment to the opening consolidated balance sheet as at the date of initial application.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 842 requires lessees to recognize the rights and obligations resulting from virtually all leases on the Consolidated Balance Sheet as right-of-use (ROU) assets with corresponding lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The most significant impact of application of the standard for the Company related to the recognition of right-of-use assets and lease liabilities on the Consolidated Balance Sheet for operating leases for certain property, vehicles and equipment. Prior to application of ASC 842, costs in respect of operating leases were charged to the Consolidated Statements of Operations on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pursuant to certain practical expedients available as part of adopting ASC 842, ICON did not reassess whether existing or expired supplier contracts are or contain leases, the classification of existing or expired leases, or whether unamortized initial direct costs meet the new definition of initial direct costs under ASC 842. Additionally, the Company elected to use hindsight in determining the lease term and in assessing impairment of ROU assets, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2021 and December&#160;31, 2020, the Company did not account for any leases as finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Although subleases are accounted for separately from the lease they relate to, subleases are accounted for in the same way as other leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(r) &#160; Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#x201c;global intangible low-taxed income&#x201d;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(s) &#160; Government grants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(t) &#160; Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits are generally recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(u) &#160; Pension costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Pension'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. These plans are presented in accordance with the requirements of ASC 715-60 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(v) &#160; Redeemable noncontrolling interests and equity&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Distinguishing Liabilities from Equity'. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(w)   Net income per ordinary share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 27 - Net income per ordinary share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(x) &#160; Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Compensation &#x2013; Stock Compensation'.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Replacement awards&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(y) &#160; Impairment of long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(z) &#160; Derivative financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We enter into transactions in the normal course of business using various financial instruments in order to hedge against exposure to fluctuating exchange and interest rates. We use derivative financial instruments to reduce exposure to fluctuations in interest rates. A derivative is a financial instrument or other contract whose value changes in response to some underlying variable, which has an initial net investment smaller than would be required for other instruments that have a similar response to the variable and that will be settled at a future date. We do not enter into derivative financial instruments for trading or speculative purposes. We did not hold any interest rate swap contracts or forward currency contracts at December&#160;31, 2021 or December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We use derivative financial instruments to reduce exposure to fluctuations in foreign exchange rates. During the years ended December&#160;31, 2019 and December&#160;31, 2020, we entered into forward currency contracts in respect of identified exposure arising from euro payments. All contracts expired during the year in which the contract was entered into. No forward currency contracts were entered into during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(aa) Debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Debt issuance costs relating to the Company&#x2019;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#x2019;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(ab) Transaction and integration-related expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#x2019;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;(ac) Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#x2019;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#x2019;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(ad) &#160;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#x2019;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the years ended December 31, 2020 and December 31, 2019 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#x2019;s presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDE4_ae9610f9-fe8f-4856-a1c5-7160c71a6178">Basis of consolidationThe consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDEx_892f0efe-219f-4059-839f-61782487eb4d">Use of estimatesThe preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDQ3_7a997313-9024-4112-aac0-88c2af1b6727">Revenue recognition&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. Contracts range in duration from a number of months to several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clinical trial service revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consulting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#x201c;units delivered&#x201d; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDI4_92974f15-59d9-40a1-809f-b17a6c8dd664">Pass-through/ Reimbursable expenses&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pass through/ Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(e) Direct costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(e) &#160; Direct costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time i.e. the full-service obligation is in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Investigator payment costs are recorded and reported reflecting investigator activity over the life of the contract. Investigator payments are made based on predetermined contractual arrangements. Timing of payments may differ from the recording and reporting of the expense which is based on activity.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDU5_f66616d6-1386-4e41-8591-615d2b8f5c66">Advertising costsAll costs associated with advertising and promotion are expensed as incurred.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzk4_84f673b9-6b18-4f1e-ab98-214fab0b3ea3">Foreign currencies and translation of subsidiariesICON plc's financial statements are prepared in United States dollars. Transactions in currencies other than the functional currency of the individual entities within the ICON Group are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the individual entities within the ICON Group are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income.The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. Foreign currency transaction gains and losses are reported in other comprehensive income ("currency impact of long term funding") rather than through income where the foreign currency transaction is 'long-term investment' in nature i.e. settlement is not planned or anticipated in the foreseeable future.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <iclr:ForeignCurrencyDisclosureTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzk5_f5042e72-61bd-4eaf-9dc3-b7e2303e3438">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts (credited)/charged&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:ForeignCurrencyDisclosureTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTo5YWRjN2NlNjFiZTU0YjE2YTFhZDEzZWY1NTNhYWI5Yy90YWJsZXJhbmdlOjlhZGM3Y2U2MWJlNTRiMTZhMWFkMTNlZjU1M2FhYjljXzMtMS0xLTEtMzYyNDg_650367f1-215e-45ce-a0c9-5e3208946cb9"
      unitRef="usd">14316000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTo5YWRjN2NlNjFiZTU0YjE2YTFhZDEzZWY1NTNhYWI5Yy90YWJsZXJhbmdlOjlhZGM3Y2U2MWJlNTRiMTZhMWFkMTNlZjU1M2FhYjljXzMtMi0xLTEtMzYyNDg_74aaeed9-0056-46ea-800d-4ee966bcd001"
      unitRef="usd">-5979000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTo5YWRjN2NlNjFiZTU0YjE2YTFhZDEzZWY1NTNhYWI5Yy90YWJsZXJhbmdlOjlhZGM3Y2U2MWJlNTRiMTZhMWFkMTNlZjU1M2FhYjljXzMtMy0xLTEtMzYyNDg_7549a526-aca4-416b-b483-053f02616da2"
      unitRef="usd">-590000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzcy_f4deeecc-d971-4f76-9a49-323c7827cd75">Disclosure of fair value of financial instruments&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#x2013; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDE2_bdb7ee8b-67a5-42ab-bfb4-6665ab9ee91a">Business combinations&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cost of a business combination is measured as the aggregate of the fair values at the date of exchange of assets given, liabilities incurred or assumed and equity instruments issued in exchange for control. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt; Transaction and integration-related expensesTransaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#x2019;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDI0_82342197-ad02-41b4-a90c-b66e4baf1612">Goodwill and ImpairmentGoodwill represents the excess of the cost of acquired entities over the net amounts assigned to assets acquired and liabilities assumed. Goodwill primarily comprises acquired workforce in place which does not qualify for recognition as an asset apart from goodwill. Goodwill is stated net of any provision for impairment. The Company tests goodwill annually for any impairments or whenever events occur which may indicate impairment. An impairment charge would be recognized for any amount by which the carrying amount exceeds the reporting unit's fair value up to the amount of existing goodwill. The Company performs a qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzEzNTYz_64cf21a2-317d-47d3-9f86-5dcfa00f71c5"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzEzNTYz_a2926e0e-a351-4523-afed-8930dec70186"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzEzNTYz_cf1d387f-5133-490c-847b-a1b3c58b7741"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDUx_97530add-7b2a-4b83-bbb5-2760937c160d">Intangible assetsIntangible assets are amortized on a straight line basis over their estimated useful life.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzU3_bc4fa5a5-8a38-472d-8c7c-349ff84db71b">Cash and cash equivalentsCash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDE0_52652300-2949-4627-a854-162cea6d7e64">Investments in debt, equity and other&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies short-term investments as available for sale in accordance with the terms of ASC 320 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Investments - Debt and Equity Securities'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. Realized gains and losses are determined using specific identification. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long term investments  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2020 and December&#160;31, 2021 qualify for the NAV practical expedient in ASC 820 '&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value measurements and disclosure&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzc2_dbf61845-f8f8-4cec-afae-85e1ec837be9">Accounts receivable, net and unbilled revenue&#160;&#160;&#160;&#160;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.&lt;/span&gt;&lt;/div&gt;Accounts receivable factoring&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Transfers and Servicing'&lt;/span&gt; (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. The associated finance costs are presented as interest expense.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzYx_fc368864-9849-410b-aee9-cdc9b0bed679">InventoryInventory is valued at the lower of cost and net realizable value and after provisions for obsolescence. The cost of inventories comprises the purchase price and attributable costs, less trade discounts.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzE4MTM3_1857aaee-4261-42ee-ba3c-29a89e1597f7"
      unitRef="usd">5800000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzE4MTQ1_cc8dc847-754c-428f-8992-5930a9c902f8"
      unitRef="usd">4800000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzQ2_bf662893-e6d4-4dcf-a7eb-0a9f53d1233c">Property, plant and equipment&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2-8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzUw_352e2bac-0066-4ac8-ac29-112a1ba9b7b9">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2-8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2a7dd4344dd34202b588af91a6812de7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzEtMS0xLTEtMzYyNDg_0af6a7a0-b6ad-4bba-b4e3-c828d38a7c1a">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2987d6914a1d4cc68e8c95d19b068254_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzItMS0xLTEtMzYyNDgvdGV4dHJlZ2lvbjo5ZGY3YmIwYTFmNmU0MDA5OGYxOTEzMzkxYjk0MDBjZl80_9e212f85-ce4e-4d02-a482-0d1eb0567e84">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i57ebfffca8f94564b236e3cf355daa0a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzItMS0xLTEtMzYyNDgvdGV4dHJlZ2lvbjo5ZGY3YmIwYTFmNmU0MDA5OGYxOTEzMzkxYjk0MDBjZl83_6e723416-bdfe-44ac-a8f8-97b073624a96">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8f2e7237f254495a965fa61e435b32cc_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzMtMS0xLTEtMzYyNDg_845011f5-2354-42f5-ba27-29f304284cff">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i98447e8a7c144589ae3d680ab7ea1f11_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzQtMS0xLTEtMzYyNDg_ea711cfb-02c5-491d-a1c9-751804bcb344">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id2e9789e124d454fb74080cfc1ea1d70_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90YWJsZTozM2IxYmI3ZjQxY2U0MjAxYTVlMTQ2MzEwNDI3NTYxMS90YWJsZXJhbmdlOjMzYjFiYjdmNDFjZTQyMDFhNWUxNDYzMTA0Mjc1NjExXzUtMS0xLTEtMzYyNDg_21527f3b-234f-488d-814d-15d39061f9de">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDAy_e5a8ba52-b0ed-45b0-b514-30b9b7087f6e">Leases&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company adopted ASC 842 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Leases' (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 842), with a date of initial application of January 1, 2019. The lease accounting policy applied in preparation of the results for the year ended December&#160;31, 2020 and December&#160;31, 2021 therefore reflect application of ASC 842. The Company adopted the standard using the cumulative-effect adjustment approach. Under this transition method, the Company applied the ASC 842 as at the date of initial application (i.e. January 1, 2019), without restatement of comparative period amounts. The cumulative effect of applying the standard is recorded as an adjustment to the opening consolidated balance sheet as at the date of initial application.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 842 requires lessees to recognize the rights and obligations resulting from virtually all leases on the Consolidated Balance Sheet as right-of-use (ROU) assets with corresponding lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The most significant impact of application of the standard for the Company related to the recognition of right-of-use assets and lease liabilities on the Consolidated Balance Sheet for operating leases for certain property, vehicles and equipment. Prior to application of ASC 842, costs in respect of operating leases were charged to the Consolidated Statements of Operations on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pursuant to certain practical expedients available as part of adopting ASC 842, ICON did not reassess whether existing or expired supplier contracts are or contain leases, the classification of existing or expired leases, or whether unamortized initial direct costs meet the new definition of initial direct costs under ASC 842. Additionally, the Company elected to use hindsight in determining the lease term and in assessing impairment of ROU assets, if any. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2021 and December&#160;31, 2020, the Company did not account for any leases as finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Although subleases are accounted for separately from the lease they relate to, subleases are accounted for in the same way as other leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDI5_c87c990d-67ae-45b3-ba04-663014fe7d0b">Income taxesThe Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#x201c;global intangible low-taxed income&#x201d;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</us-gaap:IncomeTaxPolicyTextBlock>
    <iclr:GovernmentGrantsPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDU2_dd60d033-e6eb-49a5-9f55-6f969a138806">Government grants&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.&lt;/span&gt;&lt;/div&gt;</iclr:GovernmentGrantsPolicyTextBlock>
    <iclr:ResearchandDevelopmentCreditsPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzcz_14fb93c6-36c8-4088-b5bb-5e19a266951c">Research and development creditsResearch and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits are generally recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</iclr:ResearchandDevelopmentCreditsPolicyTextBlock>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzc4_732db34a-5d91-4bcb-a460-a129885f48e1">Pension costs&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Pension'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. These plans are presented in accordance with the requirements of ASC 715-60 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzQ4_42115973-137a-49a5-9ac6-bdbe91063503">Redeemable noncontrolling interests and equity&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Distinguishing Liabilities from Equity'. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. &lt;/span&gt;Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.</iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage
      contextRef="i34a011f87a9d4997aa40aa4d09a4fc8d_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzI3MTU0_85a6a283-349f-4dcb-aeb8-9e5ff859a1af"
      unitRef="number">1</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzk0_de883bf1-f99d-424b-9ffe-ca197b54843a">Net income per ordinary share&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 27 - Net income per ordinary share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzYy_2884847f-dd7c-4802-b99a-6271d897f616">Share-based compensation&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Compensation &#x2013; Stock Compensation'.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Replacement awards&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1NDI1_549f64bd-a49a-4971-9d31-e11542d9db07">Impairment of long-lived assetsLong-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1Mzkz_76de7011-fc7a-4dc7-b352-c593d2b6673e">Derivative financial instruments&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We enter into transactions in the normal course of business using various financial instruments in order to hedge against exposure to fluctuating exchange and interest rates. We use derivative financial instruments to reduce exposure to fluctuations in interest rates. A derivative is a financial instrument or other contract whose value changes in response to some underlying variable, which has an initial net investment smaller than would be required for other instruments that have a similar response to the variable and that will be settled at a future date. We do not enter into derivative financial instruments for trading or speculative purposes. We did not hold any interest rate swap contracts or forward currency contracts at December&#160;31, 2021 or December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We use derivative financial instruments to reduce exposure to fluctuations in foreign exchange rates. During the years ended December&#160;31, 2019 and December&#160;31, 2020, we entered into forward currency contracts in respect of identified exposure arising from euro payments. All contracts expired during the year in which the contract was entered into. No forward currency contracts were entered into during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzIxOTkwMjMzMTAyNjI_b78f8aae-46e7-4816-abb9-b37350cf05ab">Debt issuance costsDebt issuance costs relating to the Company&#x2019;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#x2019;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</us-gaap:DebtPolicyTextBlock>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzEzMTk0MTM5NjA5NTc3_edf6066a-44ae-4fed-8590-3270b035b83f">RestructuringRestructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#x2019;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#x2019;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xMzkvZnJhZzowYTcwMmYwMTVhNWY0MjVjOTM0NmNjYTk5Zjk4NjEzMS90ZXh0cmVnaW9uOjBhNzAyZjAxNWE1ZjQyNWM5MzQ2Y2NhOTlmOTg2MTMxXzM1MzU4_ae222efe-b337-4d8e-9f53-86864cfbac43">ReclassificationsCertain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#x2019;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the years ended December 31, 2020 and December 31, 2019 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#x2019;s presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE2OTA_da7a7eb8-522c-4eb1-9245-a6239da70ed3">Investments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;(a) &#160;&#160;&#160;&#160;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales and maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(497)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Realized gain on sale of short term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized capital loss &#x2013; investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Available for sale investments at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. Short term investments at December&#160;31, 2021 have an average mat&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;urity of 2.7 years co&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;mpared to 3.4 years at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table represents our available for sale short term investments by major security type as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;br/&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 1&lt;br/&gt;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1 to 5&lt;br/&gt;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total ($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.&lt;/span&gt;&lt;/div&gt;(b)&#160;&#160;&#160;&#160;Investments in equity - long term&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company entered into subscription agreements with a number of funds. Capital totaling $16.9 million had been advanced under the terms of the subscription agreements at December&#160;31, 2021 (December&#160;31, 2020: $13.3 million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 qualify for the NAV practical expedient in ASC 820 '&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value measurements and disclosure&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;s'. There was an increase in fair value of $3.2 million (December&#160;31, 2020: $2.5 million) recognized in net income during the year bringing the carrying value of the subscriptions to $22.6 million at December&#160;31, 2021 (December&#160;31, 2020: $15.8 million).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;December&#160;31, 2021, the Company had committed to future investments of $17.4 million in respect of these funds.&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160; Equity method investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company&#x2019;s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations. See additional details in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 2 - Significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The majority investor has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table represents our equity method investments at December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Ownership Percentage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oncacare Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has recorded a loss of $2.2&#160;million representing its pro rata share of the losses in Oncacare since December&#160;31, 2020. From the date of initial investment to year ended December&#160;31, 2020, the Company recorded a loss of $0.4&#160;million. During the year ended December&#160;31, 2021, the Company provided a loan of $10&#160;million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. Oncacare continues to perform in line with expectations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE2OTI_05481d99-07d3-4f1a-bb16-f98f8f2cac4c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales and maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(497)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Realized gain on sale of short term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized capital loss &#x2013; investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Available for sale investments at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzItMS0xLTEtMzYyNDg_30414e56-465c-4a5f-9414-d2058f5adaa2"
      unitRef="usd">1729000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzItMi0xLTEtMzYyNDg_8a09c594-02fb-4b2d-910d-2cd771aafd4c"
      unitRef="usd">49628000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzQtMS0xLTEtNDUwNjg_2fbf93fe-23b4-4733-8930-d6bc4d012c00"
      unitRef="usd">480000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzQtMi0xLTEtNDUwNjg_1de2854b-7169-476a-b276-cfe73344e1fb"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzQtMS0xLTEtMzYyNDg_3002c541-a290-48bb-b6ec-4bddd3e67dd1"
      unitRef="usd">497000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzQtMi0xLTEtMzYyNDg_6146f07b-2ce4-4f22-90bf-1bf0e788cd43"
      unitRef="usd">47902000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzYtMS0xLTEtMzYyNDg_c6407b54-8cfc-4e49-bffc-de854eaa7c24"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzYtMi0xLTEtMzYyNDg_430cc213-b7d1-4dba-a16d-405db37992c7"
      unitRef="usd">234000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzctMS0xLTEtMzYyNDg_a2ddbdff-df3c-4ae2-8069-901d57a1776a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzctMi0xLTEtMzYyNDg_a86c7ae1-4d4b-4f29-b54b-c3a952f878b4"
      unitRef="usd">-231000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzgtMS0xLTEtMzYyNDg_7dc06407-b2df-4f92-b2d0-0bbc7dadcfa8"
      unitRef="usd">1712000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTplYzVkZjVjY2RlMzU0ZjVmYTUwZWQ4NmJiMDEwOTBkYS90YWJsZXJhbmdlOmVjNWRmNWNjZGUzNTRmNWZhNTBlZDg2YmIwMTA5MGRhXzgtMi0xLTEtMzYyNDg_7faa0535-75cc-4044-9916-c6ad4aa7e995"
      unitRef="usd">1729000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzIxOTkwMjMyNTc0MTg_dd08cd59-dceb-4402-999a-d02c856a1648">P2Y8M12D</iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod>
    <iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzM3NA_61e2c136-368d-4f34-8349-c18a3dd2fb82">P3Y4M24D</iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE2ODg_91175537-b821-4af9-a8ca-f28a5fa468c9">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table represents our available for sale short term investments by major security type as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity by period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;br/&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;br/&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 1&lt;br/&gt;year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1 to 5&lt;br/&gt;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total ($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzUtMS0xLTEtMzYyNDg_706d1a18-9fc4-47d2-840e-03da5d176b4a"
      unitRef="usd">1700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzUtMy0xLTEtMzYyNDg_8da6af95-2396-4dd0-a2c6-90fb807799ec"
      unitRef="usd">1700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzUtNC0xLTEtMzYyNDg_9f2c3ae2-a575-42c5-8c1a-ef03c26d4246"
      unitRef="usd">500000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i62a3d1f7e9f94f56981cb4263b7a4bbf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzUtNS0xLTEtMzYyNDg_f867fa6c-291e-4f7e-b3e5-8ee831956e04"
      unitRef="usd">1200000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzYtMS0xLTEtMzYyNDg_75db7691-1bbd-4fe9-bec0-e0c88c5cff21"
      unitRef="usd">1700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzYtMy0xLTEtMzYyNDg_dd5f927a-c341-4924-b326-d6b4733b6afc"
      unitRef="usd">1700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzYtNC0xLTEtMzYyNDg_426baa54-cd31-426b-aa61-c0c1982ed36b"
      unitRef="usd">500000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90YWJsZTo2YmRhMGJhODFlOGE0MDE2ODgyMDhkNzgxZmI0Nzk5NC90YWJsZXJhbmdlOjZiZGEwYmE4MWU4YTQwMTY4ODIwOGQ3ODFmYjQ3OTk0XzYtNS0xLTEtMzYyNDg_1436fc91-f225-4cfa-9da2-e2689946d6a1"
      unitRef="usd">1200000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i34fdb5db483e4be88aed63d7fba68086_D20180101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzEwMDg_6344e6cf-9dbf-479c-855a-434218669d7c"
      unitRef="usd">16900000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="ic87e1dcfa6f645709ebb66f6f1e00a7d_D20180101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzEwODc_61f6a837-8447-4a38-82dd-a1e278ffb400"
      unitRef="usd">13300000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE0NDc_8b877ce6-8ebc-4fdc-92bc-67ad5c066ff0"
      unitRef="usd">3200000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE0ODE_835f6090-2d6c-4606-a0af-77514c95df98"
      unitRef="usd">2500000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE1Nzg_1e270284-484d-48d0-8e7c-577d24930fc2"
      unitRef="usd">22600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE1OTI_fc69e375-a63c-45db-83fc-691e37f0db13"
      unitRef="usd">15800000</us-gaap:EquitySecuritiesFvNi>
    <iclr:CommitmentToAcquireLongTermInvestments
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDIvZnJhZzowMGZmMmQ2NDEwMzY0ZjMzYjEzOWY3YjY1YWQ2ZDVkNy90ZXh0cmVnaW9uOjAwZmYyZDY0MTAzNjRmMzNiMTM5ZjdiNjVhZDZkNWQ3XzE2NDkyNjc0NDE4NTUz_85e31fb4-41fa-49f7-9b03-f370adc117f1"
      unitRef="usd">17400000</iclr:CommitmentToAcquireLongTermInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i79b2e8fe7b204f0c9abe56bd2cd862ae_I20200724"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEwOTk1MTE2Mjg5NTE_540a0e34-bd0d-4f1c-8419-995ca3c955fa"
      unitRef="usd">4900000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3Xzc3_bb54b333-55e9-4995-8cf5-286efafbef2d"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <iclr:EquityMethodInvestmentMajorityOwnershipPercentage
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzYxMw_770c50aa-5f45-426f-9d83-a73157f62d41"
      unitRef="number">0.51</iclr:EquityMethodInvestmentMajorityOwnershipPercentage>
    <iclr:EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEwOTk1MTE2Mjc5Mzkz_3876afe6-3db0-4cc2-9950-e47bc05a4602">P18M</iclr:EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany>
    <iclr:EquityMethodInvestmentMajorityOwnershipPercentage
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3Xzc3Mg_770c50aa-5f45-426f-9d83-a73157f62d41"
      unitRef="number">0.51</iclr:EquityMethodInvestmentMajorityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzExNjI_279e47e7-6ad0-4f61-8ba6-b22c3c6cfeb7">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table represents our equity method investments at December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Ownership Percentage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oncacare Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90YWJsZToxMzhlNTEwZTJjYjM0M2JlODJhODU3MTkyMGM0ZTJlYy90YWJsZXJhbmdlOjEzOGU1MTBlMmNiMzQzYmU4MmE4NTcxOTIwYzRlMmVjXzQtMS0xLTEtMzYyNDg_a2e0a09d-1ab3-491a-8ce7-625cd6215df8"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90YWJsZToxMzhlNTEwZTJjYjM0M2JlODJhODU3MTkyMGM0ZTJlYy90YWJsZXJhbmdlOjEzOGU1MTBlMmNiMzQzYmU4MmE4NTcxOTIwYzRlMmVjXzQtMi0xLTEtMzYyNDg_c241ee5e-7f8e-4d96-b052-71a0e8c90b53"
      unitRef="usd">2373000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90YWJsZToxMzhlNTEwZTJjYjM0M2JlODJhODU3MTkyMGM0ZTJlYy90YWJsZXJhbmdlOjEzOGU1MTBlMmNiMzQzYmU4MmE4NTcxOTIwYzRlMmVjXzQtMy0xLTEtMzYyNDg_0f3a767e-7f46-49d8-8863-f3a60e9d4043"
      unitRef="usd">4534000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEwNjI_faa29d64-ceeb-4901-9394-3975505d6c57"
      unitRef="usd">-2200000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEyMDk0NjI3OTA3Mzgw_64bb842c-2c93-4bed-bcbe-474e54751e59"
      unitRef="usd">-400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions
      contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzI3NDg3NzkwNzEwNDc_5000bb67-b3c4-4b01-a473-68b0ef798d19"
      unitRef="usd">10000000</us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNDUvZnJhZzo0ZWYwODJiYmJkNDQ0Y2ZjYmQ1ZjViODJmYTJmZmY3Ny90ZXh0cmVnaW9uOjRlZjA4MmJiYmQ0NDRjZmNiZDVmNWI4MmZhMmZmZjc3XzEzMTk0MTM5NTM1MzUw_5a4231ef-e97f-4a32-8d69-2fdf4559ad32"
      unitRef="number">0.016</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90ZXh0cmVnaW9uOmEyZTc4MjY3ZmQyNTQ4MDNhMTdhYTI5ZjZjNTJmMzk3XzEwODU5_a14f6aa2-30ae-4818-824c-e00a8604402e">Goodwill&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;883,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year acquisitions (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior period acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange movement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,037,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has made a number of strategic acquisitions since inception to enhance its capabilities and experience in certain areas of the clinical development process. Goodwill arising on acquisition represents the excess of the cost of acquired entities over the net amounts assigned to assets acquired and liabilities assumed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill annually for impairment or whenever events occur which may indicate impairment. The results of the Company's goodwill impairment testing assessed at September 30, 2021 during the year ended December&#160;31, 2021 provided no evidence of impairment and indicated the existence of sufficient headroom such that a reasonably possible change to the key assumptions used would be unlikely to result in an impairment of the related goodwill.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90ZXh0cmVnaW9uOmEyZTc4MjY3ZmQyNTQ4MDNhMTdhYTI5ZjZjNTJmMzk3XzEwODY1_a5d09a72-851f-4345-a8f2-d86b5e366e77">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;883,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year acquisitions (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior period acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange movement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,037,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzItMS0xLTEtMzYyNDg_af26083b-6373-4ea0-b31c-99658203bfae"
      unitRef="usd">936257000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzItMi0xLTEtMzYyNDg_8a3a0c29-32cf-446b-a05d-10fe5e2487c3"
      unitRef="usd">883170000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzMtMS0xLTEtMzYyNDg_204de165-abc0-4aa4-b780-4e7c3671366c"
      unitRef="usd">8120006000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzMtMi0xLTEtMzYyNDg_27384fdd-29db-411d-8672-17ecb607a0fe"
      unitRef="usd">27191000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzQtMS0xLTEtMzYyNDg_3f69f660-0960-421e-a5c7-bb1345be0ee2"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzQtMi0xLTEtMzYyNDg_92f170ce-99d1-4ce4-b73f-7a45386d8e7c"
      unitRef="usd">123000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzUtMS0xLTEtMzYyNDg_d14e280b-bb26-480f-97ae-f81cecac1065"
      unitRef="usd">-18332000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzUtMi0xLTEtMzYyNDg_041236c4-f85f-464e-9568-42c76aa8e42b"
      unitRef="usd">25773000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzYtMS0xLTEtMzYyNDg_0a7afb56-c3d8-40bb-b60d-21f37f7d6b6d"
      unitRef="usd">9037931000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90YWJsZTphN2RkZjg4YzA3OGI0YzYxYWY2NzAzYmE2MWI5ZDU0Ni90YWJsZXJhbmdlOmE3ZGRmODhjMDc4YjRjNjFhZjY3MDNiYTYxYjlkNTQ2XzYtMi0xLTEtMzYyNDg_786832d8-d524-46e9-b0c3-8e0f55aa7177"
      unitRef="usd">936257000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTEvZnJhZzphMmU3ODI2N2ZkMjU0ODAzYTE3YWEyOWY2YzUyZjM5Ny90ZXh0cmVnaW9uOmEyZTc4MjY3ZmQyNTQ4MDNhMTdhYTI5ZjZjNTJmMzk3XzEwODY3_64cbbaa8-ac9d-4c99-8b69-b2a5afacbfab">Consequently, actual future results of the Company will differ from the pro forma financial information presented below:&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,462,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,980,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;340,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;The proforma effect of the MedPass acquisition if completed on January 1, 2019 would have resulted in revenue and net income for the fiscal years ended December 31, 2020 and December 31, 2019 as follows:  &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,798,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,820,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;332,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;377,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzg5NjU_74f8fa6d-f23a-4a56-8b56-ef8acf9bd99c">Intangible Assets&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,056,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;528,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,081,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(370,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net book value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,710,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,915.0&#160;million, Order backlog of $490.0&#160;million, Trade names of $202.0&#160;million, Patient database of $168.0&#160;million and Technology assets of $111.0&#160;million. These assets will be amortized over their expected useful lives of between 3 and 23 years. The valuation and useful lives of these assets remains provisional at December&#160;31, 2021. In total, $223.5&#160;million has been amortized in the period since the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 22, 2020 a subsidiary of the Company, ICON Investments Limited acquired 100% of the equity share capital of the MedPass Group. MedPass is the leading European medical device CRO, regulatory and reimbursement consultancy, that specializes in medical device development and market access. The acquisition of MedPass further enhances ICON&#x2019;s Medical Device and Diagnostic Research services, through the addition of new regulatory and clinical capabilities in Europe. On acquisition, certain customer relationships and order backlog identified, which were valued at $11.7&#160;million and $2.9&#160;million respectively, were recognized and are being amortized over approximately 13 years and 3 years, the estimated period of benefit. In total, $2.0&#160;million has been amortized in the period to December&#160;31, 2021 relating to the acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future intangible asset amortization expense for the years ended December 31, 2022 to December 31, 2026 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;454,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,680,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzg5NjY_40218e06-f601-4036-bc0a-f3f2fc8827c8">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,056,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;528,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,081,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(370,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net book value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,710,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2d3fa59c20354798b3fe32fbe88700c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzItMS0xLTEtMzYyNDg_5a552991-3cb2-4d5a-a165-b7024ff96c55"
      unitRef="usd">4056642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib27d114693994c1bbb27bce87b357b48_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzItMi0xLTEtMzYyNDg_66b9df81-de60-48bb-8dcb-05244efc4c3d"
      unitRef="usd">144251000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i727c1622461843c1a81f8f6fb66f40aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzMtMS0xLTEtMzYyNDg_d551341f-3f26-4d36-be3b-c79a819dbcfa"
      unitRef="usd">528022000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i391000958f6f4ad4b03f663ad0a01ee6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzMtMi0xLTEtMzYyNDg_f9d92cc5-3b30-4300-a6fd-e5dc7be53374"
      unitRef="usd">39269000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5ca96102037f405a834d371c8285ea8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzQtMS0xLTEtMzYyNDg_797ec232-b679-496a-9e6f-e2de70b33b15"
      unitRef="usd">204685000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i32a2e822e6e146128cc9a04440ccd362_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzQtMi0xLTEtMzYyNDg_7f553f9b-b7f3-4d1f-b0bb-ac229ee34eb9"
      unitRef="usd">2766000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6a9a1d8583f64d51af91b99d7a6b4135_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzUtMS0xLTEtMzYyNDg_8a4b03eb-7033-46ca-9abf-080cc0b08075"
      unitRef="usd">170525000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i86eec55be971443da0d8c545532a4f94_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzUtMi0xLTEtMzYyNDg_7642f8f9-6177-43a7-b959-7b9f04652d60"
      unitRef="usd">2552000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8dbf4b780c904be2bf1341d2e01a6247_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzYtMS0xLTEtMzYyNDg_8456770b-55b9-438b-923e-35a3b8866f49"
      unitRef="usd">121507000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8dd17c1d14eb4336b8de511f325caec7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzYtMi0xLTEtMzYyNDg_52744d38-5c3d-4ab0-84cd-a44b2310d7b3"
      unitRef="usd">11173000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzEwLTEtMS0xLTM2MjQ4_e5eadc00-04a0-4a75-b515-00223be968bd"
      unitRef="usd">5081381000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzEwLTItMS0xLTM2MjQ4_58d5aa4e-7e68-4fe9-a58b-cee45de05534"
      unitRef="usd">200011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzExLTEtMS0xLTM2MjQ4_bc2b33bc-8815-4106-b2aa-1a26511f3705"
      unitRef="usd">370538000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzExLTItMS0xLTM2MjQ4_2f0f7567-8700-4b7c-8a53-0fb2640f80ef"
      unitRef="usd">133551000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzEzLTEtMS0xLTM2MjQ4_50be8bcb-03db-44ff-8ad5-f5f452bb09fe"
      unitRef="usd">4710843000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo1NDAwZDRiZDk2Y2U0ZjZiYTYzZTY5ZDYwMjFhOTY1MC90YWJsZXJhbmdlOjU0MDBkNGJkOTZjZTRmNmJhNjNlNjlkNjAyMWE5NjUwXzEzLTItMS0xLTM2MjQ4_843b0eec-9f3f-47d8-a37e-5fdbcba2de52"
      unitRef="usd">66460000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib2760f7ce2844eeb9454a223b0d6bdd9_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5MzE_c15f0b24-44ee-44be-8e13-b2fc06adb8df"
      unitRef="usd">3915000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0c3d250f7b48429daff67944653a547e_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5NDM_e7c480b8-3d03-4f00-b5e4-090fb986f404"
      unitRef="usd">490000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9fdaf7dd9b454d2b8940cc6620aa6239_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5NTU_afc478c5-8296-4c9d-8b6f-91ab65207362"
      unitRef="usd">202000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i20ad6864825548d6963d2ca543226afa_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5Njg_181b7ac9-b433-46ed-87ee-6700c2e065e0"
      unitRef="usd">168000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i34c5cbb5923847049004e8c7917d853b_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDQ5ODk_e9b5ddcb-ba9e-42f8-a0cb-2a638a8d6c19"
      unitRef="usd">111000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i653318d9e6234778be8ddf6cd1ffc904_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzIxOTkwMjMyODE4MTc_05866679-8392-49cf-996b-ea947b621e8a">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iea4c19eacf6342068eda7cdb8712f339_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzIxOTkwMjMyODE4MTk_1ac1101b-76fd-4243-99da-82c76b41bc92">P23Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDU4Njk_0a46adae-ffdb-4c76-bb42-e30663ae71fd"
      unitRef="usd">223500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzExNg_422d1bf6-0d6e-4a02-8220-0a5beb0eb14d"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7de8b4b9115b4c429dc042e5ecb81b66_I20200122"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzU4MQ_738a697a-0a13-4e76-bdd9-4141c147dc38"
      unitRef="usd">11700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic7fa7bd0b2d84f9bb5d970eebb2b2cc0_I20200122"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzU4OA_d4d2bae4-7cc3-4302-9452-f22b61c29a40"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i586effbcf5d3481cb59812fdb908734f_D20200122-20200122"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzY3OA_7ad78cc3-918b-48af-8822-4bf359ad4733">P13Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibdff042d535e43268017baca8988f1a5_D20200122-20200122"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzY4NQ_41c80633-428e-430a-bce7-86012813f53b">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibd05d6e491a44874be7f139b3e968b8d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzEwOTk1MTE2NDU4MzE_de46c8d8-174d-4b7c-a146-7cb5c0f8ae2c"
      unitRef="usd">2000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90ZXh0cmVnaW9uOmQyMjFjM2RjMDIwMTQ3MDM4NWM1MmJjMWUxZjRlM2QzXzg5NTg_db896293-cc5b-4f1c-81d8-53706fa04401">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future intangible asset amortization expense for the years ended December 31, 2022 to December 31, 2026 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;454,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;338,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;222,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,680,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzItMS0xLTEtMzYyNDg_47b452d1-4c75-4efd-990b-70e64c443671"
      unitRef="usd">456973000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzMtMS0xLTEtMzYyNDg_1bc59918-e331-49c8-8dd1-6096ac1317ee"
      unitRef="usd">454235000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzQtMS0xLTEtMzYyNDg_ca1fd802-2268-4532-82ad-4eb6d26aedd1"
      unitRef="usd">338463000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzUtMS0xLTEtMzYyNDg_37ba14c9-a0de-439a-92fc-67cca1c3c5ea"
      unitRef="usd">222191000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzYtMS0xLTEtMzYyNDg_a0087344-2cad-420b-aad3-9fdf003ffe8f"
      unitRef="usd">208175000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTQvZnJhZzpkMjIxYzNkYzAyMDE0NzAzODVjNTJiYzFlMWY0ZTNkMy90YWJsZTo2YTBkMzA3ODViMzg0OGZjYjQ4NmE2NGQzZDliM2Y3OS90YWJsZXJhbmdlOjZhMGQzMDc4NWIzODQ4ZmNiNDg2YTY0ZDNkOWIzZjc5XzctMS0xLTEtMzYyNDg_4726ec7e-7e1e-4e61-8e74-4cddd2dbe6da"
      unitRef="usd">1680037000</iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8yMTk5MDIzMjcxODY3_0e839103-5244-4b85-89f7-fb9675e2f8cd">Business combinations&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;PRA Health Sciences, Inc. - Merger Completion&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences Group ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating one of the world&#x2019;s most advanced healthcare intelligence and clinical research organization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#x2019; commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In the year ended December&#160;31, 2021, the Company incurred $198.3 million of Merger-related expenses which were accounted for separately from the business combination and expensed as incurred within the &#x201c;Transaction and integration related&#x201d; line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in the $198.3 million of transaction and integration costs are acquisition related costs (as defined by ASC 805) of $57.1&#160;million. These costs include finders fees; advisory, legal, accounting, valuation, and other professional or consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company also incurred approximately $86.7 million of Merger-related financing fees which are included in the &#x201c;Interest expense&#x201d; line item in the Consolidated Statement of Operations for the year ended December&#160;31, 2021. The Company deferred $76.2&#160;million of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The purchase accounting associated with the PRA Merger remains ongoing and the Company continues to review the acquisition balance sheet. The Company expects to conclude the purchase accounting exercise by June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Merger Date fair value of the consideration transferred consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,308,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of ordinary shares issued to acquiree stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,658,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of replacement share-based awards issued to acquiree employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of term loan obligations and accrued interest *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary allocation of the consideration transferred based on management&#x2019;s estimates of Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;934,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,886,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(380,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(739,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(144,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,126,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(203,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary estimates of the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,915,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;490,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,886,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Since July 1, 2021, PRA has earned revenue of $2,053.4 million and pre-tax net income of $169.9 million in the six months ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Unaudited Supplemental Pro Forma Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following pro forma financial information was derived from the historical financial statements of the Company and PRA and presents the combined results of operations as if the Merger had occurred on January 1, 2020. The pro forma financial information is presented for comparative purposes only and is not necessarily indicative of the results that would have actually occurred had the Merger been completed on January 1, 2020. In addition, the pro forma financial information does not give effect to any anticipated cost savings, operating efficiencies or other synergies that may result from the Merger, or any estimated costs that have been or will be incurred by the Company to integrate the assets and operations of PRA. Consequently, actual future results of the Company will differ from the pro forma financial information presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,462,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,980,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income/(loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;340,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The pro forma adjustments primarily relate to the amortization of acquired intangible assets, interest expense and amortization of deferred financing costs related to the new financing arrangements. In addition, the pro forma net income for the year ended December 31, 2021 was adjusted to exclude certain Merger-related nonrecurring adjustments; these adjustments were included in the year ended December 31, 2020 giving effect to the Merger as if it had occurred on January 1, 2020. The nonrecurring Merger-related adjustments include transaction costs, share-based compensation expense related to the acceleration of share-based compensation awards and replacement share-based awards, and financing fees. The Merger-related adjustments were tax effected using the rates applicable to the jurisdictions where they arose.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions &#x2013; MedPass Group ("MedPass")&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 22, 2020 a subsidiary of the Company, ICON Investments Limited acquired 100% of the equity share capital of the MedPass Group. MedPass is the leading European medical device CRO, regulatory and reimbursement consultancy, that specializes in medical device development and market access. The acquisition of MedPass further enhances ICON&#x2019;s Medical Device and Diagnostic Research services, through the addition of new regulatory and clinical capabilities in Europe. The integration of MedPass&#x2019;s services brings noted expertise in complex class 3 medical devices, interventional cardiology and structural heart devices&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounting for the acquisition of MedPass was finalized in the period ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The acquisition of MedPass has been accounted for as a business combination in accordance with ASC 805 '&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company has made an assessment of the fair value of assets acquired and liabilities assumed as at that date. The following table summarizes the Company&#x2019;s fair values of the assets acquired and liabilities assumed:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;January 22,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash &amp;amp; cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepayments and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,090)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Working capital adjustment paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Goodwill represents the acquisition of an established workforce that specializes in medical device development and market access. None of the goodwill recognized is expected to be deductible for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** The fair value of the contingent consideration was estimated at the date of acquisition as $Nil. Depending on performance of MedPass for the 12 month period ended December 31, 2020, the total consideration could have increased by a maximum of $6.7&#160;million in contingent consideration. In January 2021, the contingent consideration was finalized and a value of $Nil was payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In finalizing the acquisition of MedPass in the 12 month period from acquisition, fair value adjustments were made which resulted in an increase in accounts receivable ($0.2 million) and unearned revenue ($0.8&#160;million) and a decrease in operating right of use assets ($0.8 million), other liabilities ($0.8&#160;million), current lease liabilities ($0.1 million), non-current lease liabilities ($0.7 million) and non-current deferred tax liability ($0.6 million). Customer relationship and order backlog assets were also finalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Since January 22, 2020, MedPass earned revenue of $13.2 million and net income of $2.5&#160;million in the year ended December 31, 2020. The proforma effect of the MedPass acquisition if completed on January 1, 2019 would have resulted in revenue and net income for the fiscal years ended December 31, 2020 and December 31, 2019 as follows:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.190%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,798,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,820,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;332,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;377,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <dei:EntityNumberOfEmployees
      contextRef="ic93da52af8c448b795d98224ecc5b70b_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8yMTk5MDIzMjczMDI4_f67970d1-56f8-45da-a8d4-43b6fcdd5831"
      unitRef="employee">38000</dei:EntityNumberOfEmployees>
    <iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1Mjgw_372a76e0-e134-4d9b-94d9-6b8da205b354"
      unitRef="usdPerShare">80</iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld>
    <iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld
      contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1Mjky_572edba4-7183-4f1d-a32a-2a51af1879bb"
      unitRef="shares">0.4125</iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzA5_7d091025-cb95-4742-b7ec-b1a8c870f051"
      unitRef="usd">198300000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjQ2NzI5_7d091025-cb95-4742-b7ec-b1a8c870f051"
      unitRef="usd">198300000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjQ3MDcy_9c3c57b1-61fb-40c5-8089-3daa09e57249"
      unitRef="usd">57100000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <iclr:TransactionAndOneTimeFinancingCosts
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjQ2MTA3_9553d913-0fde-4665-9f78-5534b2b2a2f3"
      unitRef="usd">86700000</iclr:TransactionAndOneTimeFinancingCosts>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i1ec6866f5ee348deb48316da2665156b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjQ0MzMw_bdfe0c3e-5755-4400-805d-ddc31c5631b7"
      unitRef="usd">76200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8yMTk5MDIzMjcxODY5_58a5cd3d-52fd-4374-b25d-6df72119d095">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Merger Date fair value of the consideration transferred consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,308,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of ordinary shares issued to acquiree stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,658,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of replacement share-based awards issued to acquiree employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of term loan obligations and accrued interest *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF8xLTEtMS0xLTM3ODU3_a8e3b6f8-8a11-4853-836c-382c8339fb27"
      unitRef="usd">5308646000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF8yLTEtMS0xLTM3ODU3_a523b998-40d3-43c0-a4c9-ea892157be24"
      unitRef="usd">5658126000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF8zLTEtMS0xLTM3ODU3_2b02452b-d565-4bca-abec-8d7e0128348c"
      unitRef="usd">209399000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF80LTEtMS0xLTM3ODU3_d54cb4b8-6558-42b8-9f34-878f622f82ef"
      unitRef="usd">865800000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWQ5ZTM2MGUxYzFjNDg5NzkxODNmODdkY2UyMzllYTgvdGFibGVyYW5nZTplZDllMzYwZTFjMWM0ODk3OTE4M2Y4N2RjZTIzOWVhOF81LTEtMS0xLTM3ODU3_2d8d7109-96db-49c8-be80-422222ff6721"
      unitRef="usd">12041971000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate
      contextRef="i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzM4_7b0073d5-6981-4c51-8876-6487135b602b"
      unitRef="usd">401600000</iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8yMTk5MDIzMjcxODcw_e8e5e49c-53c0-4989-a99a-a0bc22a0c66d">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary allocation of the consideration transferred based on management&#x2019;s estimates of Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;934,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,886,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(380,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(739,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(144,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,126,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(203,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;The following table summarizes the Company&#x2019;s fair values of the assets acquired and liabilities assumed:&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;January 22,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash &amp;amp; cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepayments and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,090)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Working capital adjustment paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent consideration **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Goodwill represents the acquisition of an established workforce that specializes in medical device development and market access. None of the goodwill recognized is expected to be deductible for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** The fair value of the contingent consideration was estimated at the date of acquisition as $Nil. Depending on performance of MedPass for the 12 month period ended December 31, 2020, the total consideration could have increased by a maximum of $6.7&#160;million in contingent consideration. In January 2021, the contingent consideration was finalized and a value of $Nil was payable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8zLTEtMS0xLTM3ODU3_8d2de5a7-44ba-4a7c-83b1-db4cc33327b3"
      unitRef="usd">259971000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV80LTEtMS0xLTM3ODU3_9b863d51-f82c-4828-827a-42ba373cd028"
      unitRef="usd">934308000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV81LTEtMS0xLTM3ODU3_868adc1d-1885-4f40-89e7-ca0135b48322"
      unitRef="usd">125156000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV82LTEtMS0xLTM3ODU3_7a2bb5b3-1bc1-48ca-814b-4ffa5be35dcd"
      unitRef="usd">156851000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV83LTEtMS0xLTM3ODU3_ba7c7b51-fdf5-4406-81e3-858f2f6c6d59"
      unitRef="usd">177345000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV84LTEtMS0xLTM3ODU3_46f600a3-80ff-45e1-a942-8b79d7551b0b"
      unitRef="usd">8120006000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV85LTEtMS0xLTM3ODU3_cce450c6-5c46-4094-a6ae-0c832617982d"
      unitRef="usd">4886000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMC0xLTEtMS02MTI5Mg_e1cf49b9-ee4b-4644-8150-c94beaa6a0d4"
      unitRef="usd">28099000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMC0xLTEtMS0zNzg1Nw_46d6ad0f-836a-486c-bd1d-5bafd510e3c2"
      unitRef="usd">35391000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMS0xLTEtMS0zNzg1Nw_bc8d6f15-1f73-41dc-875f-376950869d73"
      unitRef="usd">50259000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMi0xLTEtMS0zNzg1Nw_e1e0d535-500d-41b6-b08a-98da2f104e95"
      unitRef="usd">380342000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xMy0xLTEtMS0zNzg1Nw_178d7a88-06af-46ed-83d2-1f3d1d8bafd6"
      unitRef="usd">36625000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xNC0xLTEtMS0zNzg1Nw_e432cbfb-96b8-498c-90b5-e6471de48667"
      unitRef="usd">739278000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xNi0xLTEtMS0zNzg1Nw_05fd24a8-6780-4e7a-a1eb-41c201bb39f5"
      unitRef="usd">144403000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xNy0xLTEtMS0zNzg1Nw_71dfc75f-490b-4074-8e18-4b21a777e48c"
      unitRef="usd">1126952000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8xOC0xLTEtMS0zNzg1Nw_5dbfe0ba-d575-4e60-b4fd-c157ea22838f"
      unitRef="usd">203297000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6NDg0YmMyMzg3N2RkNGVlOGJmMjIxNGM3NzI1ZjQyYzUvdGFibGVyYW5nZTo0ODRiYzIzODc3ZGQ0ZWU4YmYyMjE0Yzc3MjVmNDJjNV8yMC0xLTEtMS0zNzg1Nw_856eadab-258d-495a-bf0c-c5149aca6fef"
      unitRef="usd">12041971000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzU4_4b80a466-3d64-4782-ba09-1414f1bf9d73"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjI5NDA4OQ_cccc938e-1ef6-424e-9c75-c0fd10e20739">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary estimates of the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,915,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;490,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,886,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib2760f7ce2844eeb9454a223b0d6bdd9_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8xLTEtMS0xLTM3ODU3_0b8b6812-e2e6-46c5-b9a7-d74644f607b4"
      unitRef="usd">3915000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i08c50c20b0824778afb5ac1731634e8a_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8xLTItMS0xLTQxNDQ1_3a723fe6-e3ca-4950-85ad-28e412f53ba6">P23Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0c3d250f7b48429daff67944653a547e_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8yLTEtMS0xLTM3ODU3_71ce1789-1627-4d9e-990f-9ae953c7eb42"
      unitRef="usd">490000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i42dfcdcf3ee74f698b4cc05d9992198b_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8yLTItMS0xLTQxNDQ1_8fa7b234-7dae-41b4-b4e9-09eb069fd833">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9fdaf7dd9b454d2b8940cc6620aa6239_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8zLTEtMS0xLTM3ODU3_16c8680a-5571-4b89-97ec-3cbee3d396e5"
      unitRef="usd">202000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i5baf4cdf019f4d0082973e733aaf95ff_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV8zLTItMS0xLTQxNDQ1_5b96ffc8-0839-4b38-9f11-152f788b6b7d">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i20ad6864825548d6963d2ca543226afa_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV80LTEtMS0xLTM3ODU3_b2a748f9-7d34-4a47-9f47-973a82552a93"
      unitRef="usd">168000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1704b22ade43460f8a75f94af7619d42_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV80LTItMS0xLTQxNDQ1_72417e6a-e068-46b0-a408-2371989066ef">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i34c5cbb5923847049004e8c7917d853b_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV81LTEtMS0xLTM3ODU3_a8ec0426-afc4-40a6-9415-293fd38038b6"
      unitRef="usd">111000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8b46d27d792a425aa8aa8c08a233f77e_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV81LTItMS0xLTQxNDQ1_c61b83e4-3d28-46f7-9886-d59d07f08d75">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i616118ad6d404416b3fa77b7e269701f_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZDE4NzEwZDYyNGUwNDFkNmIzM2VlZjcxMzFmODc1N2EvdGFibGVyYW5nZTpkMTg3MTBkNjI0ZTA0MWQ2YjMzZWVmNzEzMWY4NzU3YV82LTEtMS0xLTM3ODU3_bab1bd4d-6871-4062-86c6-57e90c509ad8"
      unitRef="usd">4886000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzYx_56a889df-f756-454c-8117-bcc262113e23"
      unitRef="usd">2053400000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <iclr:BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual
      contextRef="i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1MzY5_24ae4c64-2f78-44ee-81fc-2331786a0a9b"
      unitRef="usd">169900000</iclr:BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6YjFhYWJhN2QyODA3NGI0YWJhNGQwYWRlYmI3MzJkY2IvdGFibGVyYW5nZTpiMWFhYmE3ZDI4MDc0YjRhYmE0ZDBhZGViYjczMmRjYl80LTEtMS0xLTM3ODU3_6b50cd7d-f8ff-401b-9771-15120655cfa6"
      unitRef="usd">7462000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i54b4e53fcd7342a8bab594419987a4b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6YjFhYWJhN2QyODA3NGI0YWJhNGQwYWRlYmI3MzJkY2IvdGFibGVyYW5nZTpiMWFhYmE3ZDI4MDc0YjRhYmE0ZDBhZGViYjczMmRjYl80LTItMS0xLTM3ODU3_7d81393c-3c63-4908-b30f-f4abefdf99b1"
      unitRef="usd">5980653000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6YjFhYWJhN2QyODA3NGI0YWJhNGQwYWRlYmI3MzJkY2IvdGFibGVyYW5nZTpiMWFhYmE3ZDI4MDc0YjRhYmE0ZDBhZGViYjczMmRjYl81LTEtMS0xLTM3ODU3_862f613e-36c7-4b13-baff-77b859931b5c"
      unitRef="usd">340942000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i54b4e53fcd7342a8bab594419987a4b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6YjFhYWJhN2QyODA3NGI0YWJhNGQwYWRlYmI3MzJkY2IvdGFibGVyYW5nZTpiMWFhYmE3ZDI4MDc0YjRhYmE0ZDBhZGViYjczMmRjYl81LTItMS0xLTM3ODU3_54e402a5-dcd1-447d-b74c-b6ab64c08587"
      unitRef="usd">-149658000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1NDY3_9f0b22fb-74b4-41ca-9dc9-2b561dfcf1df"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8zLTEtMS0xLTM3ODU3_c97feed3-1619-46b1-858e-e148a1fcdde7"
      unitRef="usd">10170000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF80LTEtMS0xLTM3ODU3_e43475fe-d295-4ef5-9195-ef4313582667"
      unitRef="usd">45000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF81LTEtMS0xLTM3ODU3_5f522d46-be71-4f95-8c1f-b0914da06a1b"
      unitRef="usd">539000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF82LTEtMS0xLTM3ODU3_d6414e92-567b-43ac-aeeb-2be6d597efc4"
      unitRef="usd">27191000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7de8b4b9115b4c429dc042e5ecb81b66_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF83LTEtMS0xLTM3ODU3_4b848ac0-d7f8-4b1c-bb23-c22a08509c32"
      unitRef="usd">11725000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic7fa7bd0b2d84f9bb5d970eebb2b2cc0_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF84LTEtMS0xLTM3ODU3_ad3b59f8-1250-46d7-abab-8c71215dfdf3"
      unitRef="usd">2883000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF85LTEtMS0xLTM3ODU3_7dce69c4-27a8-4867-ad7c-c2a765a07649"
      unitRef="usd">3033000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xMi0xLTEtMS0zNzg1Nw_04f9d643-6630-4196-a1f6-3fc145b9579c"
      unitRef="usd">158000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xMy0xLTEtMS0zNzg1Nw_97d08f73-101c-47f2-9cdb-db4a7e2e8a19"
      unitRef="usd">368000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xNC0xLTEtMS0zNzg1Nw_a36a223b-67de-41e1-9bed-e4cca959db70"
      unitRef="usd">989000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xNS0xLTEtMS0zNzg1Nw_69383d75-e745-4b62-aa42-3b3c7262e220"
      unitRef="usd">2202000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xNi0xLTEtMS0zNzg1Nw_d8de1815-ece0-417d-ac30-061ca4e7aeb3"
      unitRef="usd">219000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xNy0xLTEtMS0zNzg1Nw_0d0c2957-5483-433b-b238-9c7d88c4adb3"
      unitRef="usd">320000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8xOC0xLTEtMS0zNzg1Nw_66d44c9f-f0f8-497b-8995-7e0f0404ce9c"
      unitRef="usd">4090000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yMC0xLTEtMS0zNzg1Nw_680abd31-94a1-4c6c-9cd8-707dc3176798"
      unitRef="usd">47556000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="id2ea2f6a48cb4ba19857680cfba954e9_D20200122-20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yMi0xLTEtMS0zNzg1Nw_a207aa26-d845-44b0-a249-aecdf620cf74"
      unitRef="usd">46992000</us-gaap:PaymentsToAcquireBusinessesGross>
    <iclr:BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments
      contextRef="id2ea2f6a48cb4ba19857680cfba954e9_D20200122-20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yMy0xLTEtMS0zNzg1Nw_454d18c6-4c4c-45a7-b985-3b9e5f5ab391"
      unitRef="usd">564000</iclr:BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yNC0xLTEtMS0zNzg1Nw_193bdc48-f417-4d70-9db2-b9597bbf6dba"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="id2ea2f6a48cb4ba19857680cfba954e9_D20200122-20200122"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZWIwNzNmNDAzOWMzNDljODk0NTVlZmE1MjVkMzk4OGQvdGFibGVyYW5nZTplYjA3M2Y0MDM5YzM0OWM4OTQ1NWVmYTUyNWQzOTg4ZF8yNi0xLTEtMS0zNzg1Nw_7eb6412e-fb5c-4c17-8239-4737c64b6041"
      unitRef="usd">47556000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84Nzk2MDkzMDI4NjM1_0b5e66fa-ae40-410f-8cb6-527bea24c9cb"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1NDc2_d3dbe106-32df-4e0a-ac54-f1b536c2c631"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i502149ae91374acc8a5f8e388394c164_I20200122"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1NDkx_27bb7701-5578-4d8b-a34b-abd3d252fd3a"
      unitRef="usd">6700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i00c03d2629a049ada2da2d86c94ddd58_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl84MjQ2MzM3MjE1NTA4_162ece96-8f8f-4c64-9611-a1dbe98b653d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4ODU0_04bbbdcb-2327-422b-94fe-e4512f0a970c"
      unitRef="usd">200000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4ODgx_3b492f16-3678-4414-b603-2c5a7544e6ed"
      unitRef="usd">800000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4OTM1_ee50cf10-1cd8-4cc1-ae5a-f0efd9546b65"
      unitRef="usd">-800000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4OTYw_e0438840-cb13-4357-b2e4-9836fdc0950d"
      unitRef="usd">-800000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM4OTkz_f28719d5-8250-4b26-8377-8ebc7184e4c5"
      unitRef="usd">-100000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM5MDMw_3dee4db4-a228-43ab-ad65-71ffc8bd0c77"
      unitRef="usd">-700000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM5MDc1_a4eaa168-07b8-4f2b-a168-c4d8fbef393c"
      unitRef="usd">-600000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="ia31f39dce85e49bda0b0796d89773f47_D20200123-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM5MjA3_7688af1b-49d7-41e2-a5bc-05635282759b"
      unitRef="usd">13200000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="ia31f39dce85e49bda0b0796d89773f47_D20200123-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGV4dHJlZ2lvbjphYzM2Y2Q2ZmQwZDg0OTkzOTA3MzgxM2E5YjI5YTBjZl8xMDk5NTExNjM5MjI5_81eac5c0-d1aa-400c-94d8-fef24675e86c"
      unitRef="usd">2500000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZGI1ZGM1Nzg4NTkyNGJjODhjN2RlZmUyMzAxMzE2ZGEvdGFibGVyYW5nZTpkYjVkYzU3ODg1OTI0YmM4OGM3ZGVmZTIzMDEzMTZkYV8zLTItMS0xLTQxMTAx_f6520679-7084-4153-a5ad-c159adf808d4"
      unitRef="usd">2798180000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ie1001c2ebac745e5abfbd3e906c6f1d0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZGI1ZGM1Nzg4NTkyNGJjODhjN2RlZmUyMzAxMzE2ZGEvdGFibGVyYW5nZTpkYjVkYzU3ODg1OTI0YmM4OGM3ZGVmZTIzMDEzMTZkYV8zLTMtMS0xLTQxMTAx_e7650ebc-3091-4208-b745-398ba09331a6"
      unitRef="usd">2820796000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZGI1ZGM1Nzg4NTkyNGJjODhjN2RlZmUyMzAxMzE2ZGEvdGFibGVyYW5nZTpkYjVkYzU3ODg1OTI0YmM4OGM3ZGVmZTIzMDEzMTZkYV80LTItMS0xLTQxMTAx_72b3a2e0-a987-4287-8f99-35467286317d"
      unitRef="usd">332521000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ie1001c2ebac745e5abfbd3e906c6f1d0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTIzL2ZyYWc6YWMzNmNkNmZkMGQ4NDk5MzkwNzM4MTNhOWIyOWEwY2YvdGFibGU6ZGI1ZGM1Nzg4NTkyNGJjODhjN2RlZmUyMzAxMzE2ZGEvdGFibGVyYW5nZTpkYjVkYzU3ODg1OTI0YmM4OGM3ZGVmZTIzMDEzMTZkYV80LTMtMS0xLTQxMTAx_de7256a8-5409-4514-bfa1-cebf00c323b5"
      unitRef="usd">377485000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90ZXh0cmVnaW9uOmIzOTlhZmZkYWQ2MTQ2OGU5YmJmMDY3MTI5OGUzMWQyXzQ5_db6f38d8-560e-4700-9cd0-e0e1730e527a">Property, Plant and Equipment, net&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;506,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;440,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;798,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and asset write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(462,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(529,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment (net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2021 and the year ended December&#160;31, 2020, certain fully depreciated assets were written off as they were no longer used in the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90ZXh0cmVnaW9uOmIzOTlhZmZkYWQ2MTQ2OGU5YmJmMDY3MTI5OGUzMWQyXzUy_41ff5303-db1b-4727-9024-7777e9b0ecc2">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;506,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;440,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;798,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and asset write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(462,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(529,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment (net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzMtMS0xLTEtMzYyNDg_57aa0634-5827-4ab3-8f4d-f7bf9d3dcfe7"
      unitRef="usd">3724000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzMtMi0xLTEtMzYyNDg_402e06c2-ec43-4f96-9ea7-1666c4f56709"
      unitRef="usd">3724000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzQtMS0xLTEtMzYyNDg_c236efcc-88df-4485-9d58-c70675bb039e"
      unitRef="usd">82017000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzQtMi0xLTEtMzYyNDg_6f415464-e64c-437d-9783-2f17a502309c"
      unitRef="usd">90139000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzUtMS0xLTEtMzYyNDg_909cc8a6-96b6-4e17-ac15-64a3b3b04844"
      unitRef="usd">506322000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzUtMi0xLTEtMzYyNDg_d025e8be-0a9b-44e1-9e7c-291887da2118"
      unitRef="usd">440930000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzYtMS0xLTEtMzYyNDg_557414de-144f-47af-bd45-e458c361e15b"
      unitRef="usd">107507000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzYtMi0xLTEtMzYyNDg_167bbcc7-f800-4fa2-bf3c-ba14a6623394"
      unitRef="usd">91933000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzctMS0xLTEtMzYyNDg_d45c3394-ab23-4e23-8d47-9fc4b118c019"
      unitRef="usd">29210000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzctMi0xLTEtMzYyNDg_5ddc56b6-262c-4270-bd77-aa7e6f546309"
      unitRef="usd">44567000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzgtMS0xLTEtMzYyNDg_6f53a597-56bb-49a5-ab09-b5ef9ae76547"
      unitRef="usd">70123000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzgtMi0xLTEtMzYyNDg_3c89b3c3-ea73-422c-ac3f-0cef64e4431e"
      unitRef="usd">32261000</us-gaap:LeaseholdImprovementsGross>
    <iclr:VehiclesGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzktMS0xLTEtMzYyNDg_52e9a32d-8967-44c0-9eba-8c5b4dc289e6"
      unitRef="usd">65000</iclr:VehiclesGross>
    <iclr:VehiclesGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzktMi0xLTEtMzYyNDg_fae0ca4f-199d-4aed-accd-57c0b4ae15ea"
      unitRef="usd">160000</iclr:VehiclesGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzExLTEtMS0xLTM2MjQ4_5e11a4b3-78d0-42fc-a347-f0466fd11df6"
      unitRef="usd">798968000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzExLTItMS0xLTM2MjQ4_8257c799-86ac-440f-80ae-f0dca8e6ddd4"
      unitRef="usd">703714000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzEyLTEtMS0xLTM2MjQ4_06fa4140-8385-4f4f-8539-1f6a6d9bfc10"
      unitRef="usd">462524000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzEyLTItMS0xLTM2MjQ4_3e62c321-1627-4156-98a8-6d72ac070557"
      unitRef="usd">529371000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzE0LTEtMS0xLTM2MjQ4_226fc2b8-da2b-4f98-a4eb-a2773bdf5f7e"
      unitRef="usd">336444000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNTcvZnJhZzpiMzk5YWZmZGFkNjE0NjhlOWJiZjA2NzEyOThlMzFkMi90YWJsZTo5MzlhYWVkMmJjZDM0N2FlODFiNTFhN2RlOTE2YmZiNi90YWJsZXJhbmdlOjkzOWFhZWQyYmNkMzQ3YWU4MWI1MWE3ZGU5MTZiZmI2XzE0LTItMS0xLTM2MjQ4_62078c3a-cfde-4aeb-a95e-1e1a79ae8cb9"
      unitRef="usd">174343000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90ZXh0cmVnaW9uOjlkYjZmZjU1OTlhZTRjYzI4NzYxYjQ1M2E0ZDYyNTJlXzI3NDg3NzkwNzAwMDY_4a9655c7-92da-4ff2-b0de-0ba1c803a323">Other Liabilities&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General trade and overhead liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;459,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Personnel related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (note 23)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Facility related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring liabilities (note 15)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short term government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;949,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $323.6&#160;million at December&#160;31, 2021 and $138.2&#160;million at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90ZXh0cmVnaW9uOjlkYjZmZjU1OTlhZTRjYzI4NzYxYjQ1M2E0ZDYyNTJlXzEyMDk0NjI3OTA2MTAz_196da644-0974-47fb-a142-f2b97a6b6cda">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General trade and overhead liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;459,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Personnel related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (note 23)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Facility related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring liabilities (note 15)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short term government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;949,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $323.6&#160;million at December&#160;31, 2021 and $138.2&#160;million at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzItMS0xLTEtMzYyNDg_d0f9925e-7b0a-42ce-9bfd-0ab39dbe09e3"
      unitRef="usd">459814000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzItMi0xLTEtMzYyNDg_89bc0adf-c6eb-42b9-a501-17a02102f123"
      unitRef="usd">188638000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzMtMS0xLTEtMzYyNDg_5feea2ad-0d60-44d6-b314-5e2c4626078f"
      unitRef="usd">413185000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzMtMi0xLTEtMzYyNDg_615f0f6b-8a70-4605-af14-40a46ecd30c4"
      unitRef="usd">161363000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzQtMS0xLTEtMzYyNDg_5f69ce9b-216f-4d6d-a783-09f1f3330de3"
      unitRef="usd">49949000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzQtMi0xLTEtMzYyNDg_09f1eec6-2c9c-4321-b545-fbd916376e8a"
      unitRef="usd">24334000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzUtMS0xLTEtMzYyNDg_b82562c7-53f7-4d40-ae87-932976e9b9bb"
      unitRef="usd">12055000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzUtMi0xLTEtMzYyNDg_7eda55c6-fd0f-4b3e-958f-eab99367ef18"
      unitRef="usd">9441000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzYtMS0xLTEtMzYyNDg_a40f02cd-9533-4a5e-9bff-db8135cf43be"
      unitRef="usd">7204000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzYtMi0xLTEtMzYyNDg_42fdb50b-874f-496e-bcf3-22ea68be1de1"
      unitRef="usd">8726000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <iclr:RestructuringReserveandOtherLiabilitiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzctMS0xLTEtMzYyNDg_2bd90b33-68ef-4e50-9749-f7a4da80a520"
      unitRef="usd">7377000</iclr:RestructuringReserveandOtherLiabilitiesCurrent>
    <iclr:RestructuringReserveandOtherLiabilitiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzctMi0xLTEtMzYyNDg_4ea7de47-85bd-495d-8de1-adfb313c2205"
      unitRef="usd">7219000</iclr:RestructuringReserveandOtherLiabilitiesCurrent>
    <iclr:CapitalGovernmentGrantsCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzgtMS0xLTEtMzYyNDg_87c6a4d9-f820-4a19-880a-a33e5a10173e"
      unitRef="usd">45000</iclr:CapitalGovernmentGrantsCurrent>
    <iclr:CapitalGovernmentGrantsCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzgtMi0xLTEtMzYyNDg_eef75b92-e8bd-417b-b691-63b4fb5b1d01"
      unitRef="usd">48000</iclr:CapitalGovernmentGrantsCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzktMS0xLTEtMzYyNDg_12b70f64-721f-4813-925a-40f2bc5ef46e"
      unitRef="usd">949629000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90YWJsZTplMjRkYmY1Nzk2N2I0ZjdiOWNjMWQyN2YyNjdjZTVjMC90YWJsZXJhbmdlOmUyNGRiZjU3OTY3YjRmN2I5Y2MxZDI3ZjI2N2NlNWMwXzktMi0xLTEtMzYyNDg_23066ba7-a601-47a7-b2f7-2dd51744bdc8"
      unitRef="usd">399769000</us-gaap:OtherLiabilitiesCurrent>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90ZXh0cmVnaW9uOjlkYjZmZjU1OTlhZTRjYzI4NzYxYjQ1M2E0ZDYyNTJlXzEwOTk1MTE2MjgxOTY_12507025-6d4b-4234-87ed-14dd1ea90477"
      unitRef="usd">323600000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjAvZnJhZzo5ZGI2ZmY1NTk5YWU0Y2MyODc2MWI0NTNhNGQ2MjUyZS90ZXh0cmVnaW9uOjlkYjZmZjU1OTlhZTRjYzI4NzYxYjQ1M2E0ZDYyNTJlXzEwOTk1MTE2MjgyMTI_d68872d8-f548-4fe8-bc30-dbdc4e841c65"
      unitRef="usd">138200000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90ZXh0cmVnaW9uOjQxODhjZTY0MTU4MDRkNWY4N2ZjOThiMDA0MTAyOGUwXzQ3_515e8d6b-448c-4074-9cfc-315cd950c969">Non-Current Other Liabilities&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defined benefit pension obligations, net (note 10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90ZXh0cmVnaW9uOjQxODhjZTY0MTU4MDRkNWY4N2ZjOThiMDA0MTAyOGUwXzQy_33f0020d-36cc-4f8a-b013-ac65c352ad51">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defined benefit pension obligations, net (note 10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzMtMS0xLTEtNDQxNTk_20300024-b3e7-4f88-85f3-a5c91546826b"
      unitRef="usd">16262000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzMtMi0xLTEtNDQxNTk_790b5b9e-4af7-458c-a265-9a12910189f5"
      unitRef="usd">10395000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzMtMS0xLTEtMzYyNDg_29a8d832-c3ae-4c43-8ac3-f4aceba6aed3"
      unitRef="usd">25599000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzMtMi0xLTEtMzYyNDg_0de9961a-0f53-462b-a4aa-c8f7f6d92626"
      unitRef="usd">15971000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzQtMS0xLTEtMzYyNDg_7c059534-63cd-4b45-a5ae-f157be1402aa"
      unitRef="usd">41861000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjMvZnJhZzo0MTg4Y2U2NDE1ODA0ZDVmODdmYzk4YjAwNDEwMjhlMC90YWJsZTo3ZGU0NTQyMDY3OGQ0ZmQyYTIyYWI3MGJiNzk3MDU2ZC90YWJsZXJhbmdlOjdkZTQ1NDIwNjc4ZDRmZDJhMjJhYjcwYmI3OTcwNTZkXzQtMi0xLTEtMzYyNDg_ed5d1832-9224-4a26-bc6d-4af12bf29dc5"
      unitRef="usd">26366000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2MzU_7605130f-9b13-4718-aa93-758b817ce5b5">Employee Benefits&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Defined contribution or profit sharing style plans ("the Plans") are offered globally in a number of countries. In some cases, these plans are required by local laws or regulations. Certain Company employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. Contributions to the plan are recorded as an expense in the selling, general and administrative line in the Consolidated Statement of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 were $23.7 million, $17.0 million and $16.5 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company maintains various retirement plans across the Group, many of which are required by local employment laws. In addition to the specific defined benefit schemes shown separately below, the Company maintains several other retirement plans with a total net obligation associated with these schemes of $8.0&#160;million. This balance has been recorded in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;ICON Development Solutions Limited pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; 'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The plan has been closed to new entrants with effect from July 1, 2003.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss - benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain &#x2013; plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss recognized in net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $0.2 million and $Nil respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Benefit Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used in determining the benefit obligation at December&#160;31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 26 year duration, gives the same result as a full AA corporate bond yield curve.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Actuarial gains on the benefit obligation during 2021 resulted from changes in the assumptions compared to those adopted at December 2020. Changes in the assumptions reflect the changes in market conditions from December 2020 to December 2021 and the actuarial gain is primarily due to the change in the discount rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets of the scheme are held on an investment platform with Mobius which invests in a number of investment funds with Legal &amp;amp; General, Stone Harbor, Ninety-One and Barings.&#160;The overall investment strategy is that approximately 20% of investments are in senior secured loans, 18% in corporate bonds, 19% in high yield bonds and multi-asset credit fund and 24% in world equities respectively. There is no self-investment in employer related assets. The expected long-term rate of return on assets at December&#160;31, 2021 of 3.8% was calculated as the value of the fund after application of a market value reduction factor. The expected long term rates of return on different asset classes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expected long-term return per annum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Bonds (including 50% high yield bonds)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Secured Loans and Multi Asset Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The long-term expected rate of return on cash is determined by reference to traditional corporate bond rates at the latest Balance Sheet date. The long-term expected returns on traditional corporate and government bonds are determined by reference to corporate bond yields and gilt yields respectively at the Balance Sheet date. The long-term expected returns on equities are based on the rate of return on government bonds with an allowance for out-performance. The long-term expected return on high yield bonds, secured loans and multi asset credit is based on the return on traditional corporate bonds with an allowance for out-performance. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The underlying asset split of the fund is shown below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Bonds (including 50% high yield bonds)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Secured Loans and Multi Asset Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Applying the above expected long term rates of return to the asset distribution at December&#160;31, 2021, gives rise to an expected overall rate of return of scheme assets of approximately 3.8% per annum.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Plan Asset Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets&lt;br/&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;L&amp;amp;G Life GPBF All World Equity Index Fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;L&amp;amp;G Life DC Active Corporate Bond&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stone Harbor High Yield Bond Fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ninety One Global Total Return Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stone Harbor Multi Asset Credit Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Barings European Loan Fund Buy &amp;amp; Hold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Years 2027 - 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Aptiv Solutions pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The acquisition of Aptiv was accounted for as a business combination in accordance with ASC 805 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Business Combinations'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021 and December&#160;31, 2020 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/ loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;PRA Switzerland AG pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2021 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation as at July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at as at July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="icf72293147ed4ca08c6367f48b6a674e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzE2NDkyNjc0NDM0ODc5_d1ff7140-98aa-4cda-b027-a4728c381dd5"
      unitRef="number">0.045</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="icf72293147ed4ca08c6367f48b6a674e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzEzMTI_66ee92b0-f24d-407c-b977-d26d6c46ca00"
      unitRef="usd">23700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i11b91c2328484f58921510f5691f05a1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzEzMTY_9ca17df3-d2c9-44d3-ba50-db5dfd9b6031"
      unitRef="usd">17000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i27d941fab37b403093cfa434f63692f7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzEzMjM_902abb27-8be1-4fe9-946a-087892937d11"
      unitRef="usd">16500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i2b89aca039eb4e798c4afcd95f0f1b09_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzIxOTkwMjMyODU5Nzc_8dfcc1a9-ee08-4321-b722-f79625be4192"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2NzQ_c416ef16-c56b-4375-ac3a-13954666bd16">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/ loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 &lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation as at July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at as at July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transferred benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzItMS0xLTEtMzYyNDg_ae131773-e58d-4b58-bf09-271e87f858b0"
      unitRef="usd">41813000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzItMi0xLTEtMzYyNDg_e4b1b93b-7f3d-47a4-9016-5d37744067d0"
      unitRef="usd">43988000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzMtMS0xLTEtMzYyNDg_1edfe815-8576-4168-b402-f2e20047e68c"
      unitRef="usd">36198000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzMtMi0xLTEtMzYyNDg_c6a5a580-9467-4e63-bd21-0831749b6fcc"
      unitRef="usd">34612000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzQtMS0xLTEtMzYyNDg_960d7805-6d52-45c0-ae8b-820a2ce7f197"
      unitRef="usd">-5615000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzQtMi0xLTEtMzYyNDg_f4745d2d-85ba-4a0f-8553-3a667080c32f"
      unitRef="usd">-9376000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzUtMS0xLTEtMzYyNDg_900f1c91-cd7d-4c4f-89de-6f9557d70157"
      unitRef="usd">-5615000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpiNjQ1YmQ4M2ZjOTk0MjYxOTcxMzY2NTc2MDFkMGUyMy90YWJsZXJhbmdlOmI2NDViZDgzZmM5OTQyNjE5NzEzNjY1NzYwMWQwZTIzXzUtMi0xLTEtMzYyNDg_8d133d93-edb1-4a8b-a806-3d2f9727a6de"
      unitRef="usd">-9376000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzItMS0xLTEtMzYyNDg_5098c3f8-5ae6-494f-88fc-890d3afaa516"
      unitRef="usd">43988000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic55595e1f75246f1aadac4c6ddd9900e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzItMi0xLTEtMzYyNDg_a621f0cb-e594-4764-b1c5-6a11b3525e9d"
      unitRef="usd">37036000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzMtMS0xLTEtMzYyNDg_3468aac5-ca60-4f77-bed5-60cf0caf8ec8"
      unitRef="usd">134000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzMtMi0xLTEtMzYyNDg_5e76462c-0e5f-4c02-8573-0d66d72ef86c"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzQtMS0xLTEtMzYyNDg_bfd2fc86-b4fe-4edc-bf58-fc2bde4baaaf"
      unitRef="usd">665000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzQtMi0xLTEtMzYyNDg_65525011-0c7a-4b30-81f8-e6bd443d02ca"
      unitRef="usd">746000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzUtMS0xLTEtMzYyNDg_e2d4b803-dec1-4b4e-bc23-4087399f9f21"
      unitRef="usd">23000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzUtMi0xLTEtMzYyNDg_7f8afc7c-5ae9-42f8-b578-148608394412"
      unitRef="usd">22000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzctMS0xLTEtMzYyNDg_4f1774b1-adf9-4ee4-8d30-a4fbbe9a6b1b"
      unitRef="usd">489000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzctMi0xLTEtMzYyNDg_58bbe8fe-3bed-4077-a140-2176ff3d9a2f"
      unitRef="usd">724000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzgtMS0xLTEtMzYyNDg_735e2e49-7950-4a54-8c76-6a00269b6d2f"
      unitRef="usd">2097000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzgtMi0xLTEtMzYyNDg_9dcfe2f0-b1bd-453b-9283-16765dcaecc3"
      unitRef="usd">-5294000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzktMS0xLTEtMzYyNDg_7b219394-6b5e-4554-ad84-873e76f169ce"
      unitRef="usd">411000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzktMi0xLTEtMzYyNDg_682094cf-0cf8-406e-aff8-a9f8212b1293"
      unitRef="usd">-1514000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzEwLTEtMS0xLTM2MjQ4_c9d855e4-6d23-4dea-8b29-c7c3896a9b62"
      unitRef="usd">41813000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpmMWI1NjZiZDlhMTY0OTM3OTQwMmUyZWZlODIxZjEwNC90YWJsZXJhbmdlOmYxYjU2NmJkOWExNjQ5Mzc5NDAyZTJlZmU4MjFmMTA0XzEwLTItMS0xLTM2MjQ4_75f324ca-0c8f-426d-bed9-dde7c13f5d71"
      unitRef="usd">43988000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzItMS0xLTEtMzYyNDg_b84e3a8e-c7fa-4b89-a912-399997d0a9fe"
      unitRef="usd">34612000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic55595e1f75246f1aadac4c6ddd9900e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzItMi0xLTEtMzYyNDg_4b775926-b11d-48b6-8796-3213dffd1f18"
      unitRef="usd">32016000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzMtMS0xLTEtMzYyNDg_8b6b40a6-bb74-4e3a-8d5b-84e9719314c1"
      unitRef="usd">2347000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzMtMi0xLTEtMzYyNDg_bc6589ff-401e-4f6b-8744-7f0187654d58"
      unitRef="usd">2092000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzQtMS0xLTEtMzYyNDg_7cf88e93-a1f1-4678-930f-2bcdcf45fc1b"
      unitRef="usd">91000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzQtMi0xLTEtMzYyNDg_96fd1a7c-b365-4d4d-a498-37d2b803d5a3"
      unitRef="usd">109000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzUtMS0xLTEtMzYyNDg_d06b09c9-7e76-4387-af60-d25ae6693763"
      unitRef="usd">23000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzUtMi0xLTEtMzYyNDg_36b62f6a-ef85-40da-baa0-9e93067175b1"
      unitRef="usd">22000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzYtMS0xLTEtMzYyNDg_c7f5a1ea-e31c-43c0-8ed5-46e399a32a50"
      unitRef="usd">489000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzYtMi0xLTEtMzYyNDg_bfe50c20-3eac-44e7-9f3a-83c4ce76bab6"
      unitRef="usd">724000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzctMS0xLTEtMzYyNDg_964ab63f-6602-456c-93a4-acb379c946f7"
      unitRef="usd">-386000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzctMi0xLTEtMzYyNDg_50bb107c-9b94-4a1b-b0fb-18789b911b2f"
      unitRef="usd">1097000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzgtMS0xLTEtMzYyNDg_c8cb385a-15ef-40e8-b47f-6b15ec5b1f7b"
      unitRef="usd">36198000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpjZjNhY2I5YjI0ZTY0N2M1YmNjZmQyMjQwMjNkOTM3NS90YWJsZXJhbmdlOmNmM2FjYjliMjRlNjQ3YzViY2NmZDIyNDAyM2Q5Mzc1XzgtMi0xLTEtMzYyNDg_f63d2921-ce7f-4282-9688-a3ea6f1ebc05"
      unitRef="usd">34612000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2Mzc_9abedcc1-1f8f-4598-98a7-24e451bbea8b">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzItMS0xLTEtMzYyNDg_68eaa6e1-28fa-4f03-bc97-749b42930a94"
      unitRef="usd">134000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzItMi0xLTEtMzYyNDg_02311fe7-802f-4990-8b7d-760c109b8069"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzItMy0xLTEtMzYyNDg_bb8437b8-057b-4dab-8f97-b61c866ea4ff"
      unitRef="usd">107000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzMtMS0xLTEtMzYyNDg_f64b7bda-85d3-4771-9ae3-16fd9edd5af4"
      unitRef="usd">665000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzMtMi0xLTEtMzYyNDg_03e724c4-6424-4b91-a8b9-2e1dc8a15e9e"
      unitRef="usd">746000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzMtMy0xLTEtMzYyNDg_3bd7823c-8bc6-4228-831f-ea6921ec4b42"
      unitRef="usd">867000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzQtMS0xLTEtMzYyNDg_2b2c0a85-14c9-4a7c-80d3-c4d08cbd8690"
      unitRef="usd">1171000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzQtMi0xLTEtMzYyNDg_36d2de9b-bff2-4555-b4bd-ed91f50d85fd"
      unitRef="usd">1214000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzQtMy0xLTEtMzYyNDg_200b379d-5d40-4869-b703-5f855643e2b6"
      unitRef="usd">574000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzUtMS0xLTEtMzYyNDg_9f2b8ebe-61f4-414a-823b-679f680344c0"
      unitRef="usd">-625000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzUtMi0xLTEtMzYyNDg_91720149-69d7-4331-b3d6-524cb8124884"
      unitRef="usd">-160000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzUtMy0xLTEtMzYyNDg_7b16a1cb-3871-4820-9fe8-f932f0b4e2b6"
      unitRef="usd">-67000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzctMS0xLTEtMzYyNDg_7f743aa6-c3c1-4944-a959-ffa4cfc37ea4"
      unitRef="usd">253000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzctMi0xLTEtMzYyNDg_9fef6115-729b-4b6c-8e87-ba7d7c5d5477"
      unitRef="usd">-208000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTowYzFmZmE1ZDYwMDY0MjlkODc4NWQ4OTJmN2FhZjVhNy90YWJsZXJhbmdlOjBjMWZmYTVkNjAwNjQyOWQ4Nzg1ZDg5MmY3YWFmNWE3XzctMy0xLTEtMzYyNDg_8f15685e-30de-41b4-8867-02a5e459bfdc"
      unitRef="usd">467000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2NDc_159e71d9-1740-4486-8ffd-71f3ff82d2a9">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used in determining the benefit obligation at December&#160;31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzEtMS0xLTEtMzYyNDg_57248b3e-752b-46f0-baf5-e39f1947ffaa"
      unitRef="number">0.015</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzEtMi0xLTEtMzYyNDg_b000d3a8-0833-4458-830d-8944a7c5997b"
      unitRef="number">0.021</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzEtMy0xLTEtMzYyNDg_d57e5942-fc5d-4284-8149-0b0a9b28bda4"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzItMS0xLTEtMzYyNDg_0aa08a3c-73f7-4640-a8c4-8052b4ced899"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzItMi0xLTEtMzYyNDg_07568e7a-b7f0-428e-be12-7fdfb38cb2a6"
      unitRef="number">0.033</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzItMy0xLTEtMzYyNDg_5f32ee84-3992-459f-a1d6-49cabe48fef8"
      unitRef="number">0.037</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzMtMS0xLTEtMzYyNDg_469ab44b-6692-4261-9e77-ff4560ed7f3b"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzMtMi0xLTEtMzYyNDg_4306d6d1-5aa5-46e9-8e0f-358be2cbeb0a"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0OGRkN2FjZjMyZmU0NzM2OWY0N2ZhODQ4MDA5ZDQ5NS90YWJsZXJhbmdlOjQ4ZGQ3YWNmMzJmZTQ3MzY5ZjQ3ZmE4NDgwMDlkNDk1XzMtMy0xLTEtMzYyNDg_2aa55040-263e-4fd3-955d-f0eb55b26e78"
      unitRef="number">0.021</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2MTk_0efb29d2-e7a5-4533-9bf8-dbc0c429e9ab">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss - benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain &#x2013; plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss recognized in net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzItMS0xLTEtMzYyNDg_6c801d84-d602-4d6e-a545-e79dd5a66748"
      unitRef="usd">2097000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzItMi0xLTEtMzYyNDg_38ec61e7-daf3-431d-9ce2-f6773470cb9b"
      unitRef="usd">-5294000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzItMy0xLTEtMzYyNDg_7483fe63-c62d-4241-a14c-121995557169"
      unitRef="usd">-4756000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzMtMS0xLTEtMzYyNDg_26e15845-5ae8-4277-9957-3e9405c13bf8"
      unitRef="usd">-1176000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzMtMi0xLTEtMzYyNDg_a4132b2d-6fb6-435f-b0d2-f461ee7c3476"
      unitRef="usd">-878000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzMtMy0xLTEtMzYyNDg_f07c40d7-bc30-4c3c-bcf4-5299101a6a09"
      unitRef="usd">-2930000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzQtMS0xLTEtMzYyNDg_ecfa4fcd-6838-4e8e-b011-2fcc957b8f4a"
      unitRef="usd">625000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzQtMi0xLTEtMzYyNDg_73ebf4fc-4f20-43e7-97b5-321e5619db7f"
      unitRef="usd">160000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzQtMy0xLTEtMzYyNDg_dd99602d-e3a3-43e3-acc6-73982523fd1c"
      unitRef="usd">67000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzUtMS0xLTEtMzYyNDg_1b0f8b88-d6c4-4b49-afcd-873942a93fe9"
      unitRef="usd">-3898000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="if60c978a165c4ca9ad93ec6984fb45fd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzUtMi0xLTEtMzYyNDg_f30ad0a5-dce6-45d8-b33d-80b9fd5c2e2f"
      unitRef="usd">4256000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="icb831fb32bd3435e8e0055841d1ea263_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTozNmEzZDczOGJiMWY0YWQ1YmY0MzU0OTlmYTJkNWZiMy90YWJsZXJhbmdlOjM2YTNkNzM4YmIxZjRhZDViZjQzNTQ5OWZhMmQ1ZmIzXzUtMy0xLTEtMzYyNDg_f8ca6148-1224-419a-97b7-219050360763"
      unitRef="usd">1759000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzI3MTA_876c0c10-c184-4b0f-8c60-0b50d049ad0a"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzI3MTc_167aa00d-4f6a-4d15-b443-79c00512364f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphNjA3OTk4NTRiYzU0M2YzYWZiZmQ0OWM2YTJjZGFjOC90YWJsZXJhbmdlOmE2MDc5OTg1NGJjNTQzZjNhZmJmZDQ5YzZhMmNkYWM4XzEtMS0xLTEtMzYyNDg_1642602a-7b03-43e2-b64e-f0ed06b2b8f7"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphNjA3OTk4NTRiYzU0M2YzYWZiZmQ0OWM2YTJjZGFjOC90YWJsZXJhbmdlOmE2MDc5OTg1NGJjNTQzZjNhZmJmZDQ5YzZhMmNkYWM4XzEtMi0xLTEtMzYyNDg_f11117ca-5aad-41ee-b794-bd61a3882a4b"
      unitRef="number">0.015</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphNjA3OTk4NTRiYzU0M2YzYWZiZmQ0OWM2YTJjZGFjOC90YWJsZXJhbmdlOmE2MDc5OTg1NGJjNTQzZjNhZmJmZDQ5YzZhMmNkYWM4XzItMS0xLTEtMzYyNDg_9aab379d-f6b5-45d0-9631-51a81ee59d17"
      unitRef="number">0.037</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i213553f0a50c4dd38db19e9a04a338ad_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphNjA3OTk4NTRiYzU0M2YzYWZiZmQ0OWM2YTJjZGFjOC90YWJsZXJhbmdlOmE2MDc5OTg1NGJjNTQzZjNhZmJmZDQ5YzZhMmNkYWM4XzItMi0xLTEtMzYyNDg_e47bced1-fb9f-4c04-97f5-f50994e58fda"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzIxOTkwMjMyNzg5MzY_b53a5ed3-2412-4181-9471-25d7df7cb699">P26Y</iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="iee612b419754414e8828f427b68f7002_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzM2NzE_3e1b6019-8e21-48a7-aed0-58e3354c63fc"
      unitRef="number">0.20</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ia159cefdf37f4364a9843092cf3a2325_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzM3MTg_478855b2-ddba-49c6-8f6f-c9186b4ab51d"
      unitRef="number">0.18</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i27a855a3bed8480bab49ff8e8735587d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzEwOTk1MTE2Mjg4MTI5_d174c1b6-5dda-4432-8e2e-8cbd157601ad"
      unitRef="number">0.19</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i49cd9b5fb069425c885e4e858a9cd7db_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzM3OTA_d53537b4-c636-4545-b058-97712c8fe059"
      unitRef="number">0.24</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i9c04b88d67624c00974b95408ed71c3c_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzM5Mzg_e06614f7-e8ac-4d32-b4db-d7f407644af6"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <iclr:ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2MjU_2bad8bb8-d6e3-43d3-be0c-2dc7d2104807">The expected long term rates of return on different asset classes are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Expected long-term return per annum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Bonds (including 50% high yield bonds)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Secured Loans and Multi Asset Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock>
    <iclr:DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage
      contextRef="ib9509a32705e43b195f8a5dee756c081_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzEtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjozYzNkZDA1YTkzYjI0MmRmOThkMGMxM2Q0ZWMzZGI1Y18zMQ_abe687e4-c8b0-4368-8684-37058dc15df8"
      unitRef="number">0.50</iclr:DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="iece79a92c4da478a8144d377620226a2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzEtMS0xLTEtMzYyNDg_36f231a2-7b4a-4a28-b959-ee82b52fa57e"
      unitRef="number">0.028</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i6d7dd97703d84c88a35a15329488f10f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzEtMi0xLTEtNjE5MjQ_f0e23c89-bd04-4830-b99a-79be648f72ec"
      unitRef="number">0.028</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i2722f8b4561c498cb1416e166b7ad02c_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzItMS0xLTEtMzYyNDg_fa160e83-6084-4dfc-b171-3eb7ca5f499f"
      unitRef="number">0.055</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i63bf8a993c2147649f1d3f6fb9bebb7c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzItMi0xLTEtNjE5MjQ_f453008c-5032-4231-a9de-ee08853e0472"
      unitRef="number">0.052</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ic522ae4b5b4b4ec5b45ddca4c8a8a60f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzMtMS0xLTEtMzYyNDg_e0809cee-50c0-4489-b21a-67df6fe4267b"
      unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i1e1ef306fa1d450b985b7cfbaf9ce6f2_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo1NDkzMDU1NzJhNjA0ZDRmODA2Y2E1MjFiMjA5NjIyNS90YWJsZXJhbmdlOjU0OTMwNTU3MmE2MDRkNGY4MDZjYTUyMWIyMDk2MjI1XzMtMi0xLTEtNjE5MjQ_3fde2398-238e-4f44-9504-8e2a4ce12cf2"
      unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2MzI_64614ee9-9014-43d9-8253-e10a2cd0ddd4">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The underlying asset split of the fund is shown below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Bonds (including 50% high yield bonds)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Secured Loans and Multi Asset Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <iclr:DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage
      contextRef="ib9509a32705e43b195f8a5dee756c081_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzEtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjozYzUzNzllYmU3MjI0NDJkODVkOTQwNjRjZGZiYjllYV8zMQ_abe687e4-c8b0-4368-8684-37058dc15df8"
      unitRef="number">0.50</iclr:DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ia159cefdf37f4364a9843092cf3a2325_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzEtMS0xLTEtMzYyNDg_0c2d6cc5-eb82-4c3e-acc0-1f5a974ff35c"
      unitRef="number">0.37</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i4eef861e44254199911aaf8a9ce379f4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzEtMi0xLTEtMzYyNDg_d71a4191-139e-4bc4-bb32-9666f9efaeb5"
      unitRef="number">0.40</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i49cd9b5fb069425c885e4e858a9cd7db_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzItMS0xLTEtMzYyNDg_479a4574-4fc1-4190-be93-2b220a297fe6"
      unitRef="number">0.24</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i40941b5fcb9547c4aec232ca49dbee5a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzItMi0xLTEtMzYyNDg_d4ee230e-b71c-4e3b-9198-d3ee13c47848"
      unitRef="number">0.21</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="iee612b419754414e8828f427b68f7002_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzMtMS0xLTEtMzYyNDg_48bcdd49-9cfd-4883-89f2-a0130f65a06a"
      unitRef="number">0.39</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i37cabf6d514a484e8c75d7747a3e6cee_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzMtMi0xLTEtMzYyNDg_7b7d7627-1ba7-46d6-959d-764928d99338"
      unitRef="number">0.39</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ib9509a32705e43b195f8a5dee756c081_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzYtMS0xLTEtMzYyNDg_d85e92c0-05b8-4006-928c-829484049e7b"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i21d1d31dbff94254ae22cf50de458c51_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTphZGRiZTA0ZjZkNDA0MGY1YjIxMzM4ZGE2YTQ4ZWIyMi90YWJsZXJhbmdlOmFkZGJlMDRmNmQ0MDQwZjViMjEzMzhkYTZhNDhlYjIyXzYtMi0xLTEtMzYyNDg_efc6827e-39c0-452d-a67f-9888241d4963"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i9c04b88d67624c00974b95408ed71c3c_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzUwMDE_e06614f7-e8ac-4d32-b4db-d7f407644af6"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2Njc_b2e7c1cd-e19d-49cf-a782-b509efcb14c2">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets&lt;br/&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;L&amp;amp;G Life GPBF All World Equity Index Fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;L&amp;amp;G Life DC Active Corporate Bond&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stone Harbor High Yield Bond Fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ninety One Global Total Return Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stone Harbor Multi Asset Credit Portfolio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Barings European Loan Fund Buy &amp;amp; Hold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib955eed4b9ce4d00a2bd4e2ce7b5a191_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzMtMS0xLTEtMzYyNDg_e6261d36-0c19-48e5-8982-077ae4a075df"
      unitRef="usd">162000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idf105ea7475a47ae9ce9c72b2859f1b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzMtMi0xLTEtMzYyNDg_30de57a7-ad7e-4b19-bbd9-796b19f95b11"
      unitRef="usd">11000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9487d796fcc149dbb3f7bcd120e40e56_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzUtMS0xLTEtMzYyNDg_b2f34527-ee17-4ec0-a8ff-1f05fd428283"
      unitRef="usd">8743000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id748b57582fe44e5b3492d06beea0921_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzUtMi0xLTEtMzYyNDg_3b554b40-367e-4486-a422-e3fdec973ad9"
      unitRef="usd">7460000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i77d9586a1ce944dd8bc0eb9cfc5adc1b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzYtMS0xLTEtMzYyNDg_fb0a5ee3-bd14-4218-a6bf-5d633eaca431"
      unitRef="usd">6409000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie033646e348048399b773047abffe484_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzYtMi0xLTEtMzYyNDg_d9af3fd2-1c03-458e-aedb-324dc089696c"
      unitRef="usd">6797000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i64cfe0b0c94c43f6b451b69b6c85fb20_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzctMS0xLTEtMzYyNDg_b4814198-537c-4467-9e0e-414e6e69d648"
      unitRef="usd">6965000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1216803a75bf46db999c06ae0853a289_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzctMi0xLTEtMzYyNDg_82453d3f-2846-43ab-ad4d-cd3be1e38ad4"
      unitRef="usd">6861000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i517f5d381f324edebe16b610b9162167_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzgtMS0xLTEtMzYyNDg_9972edc4-6b8d-446b-a277-672d1ebf491f"
      unitRef="usd">3435000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0dda409457ee4051a9ab0dd254b58fe5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzgtMi0xLTEtMzYyNDg_4ddb6a95-f39b-4a3c-ace7-7d1ec014811e"
      unitRef="usd">3472000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3a7054f2015f4b71993232abe485627d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzEwLTEtMS0xLTM2MjQ4_d53a0b27-ee11-4564-a102-0970c84aab84"
      unitRef="usd">3359000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4ac9953fae724a3596870ee57bc6901a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzEwLTItMS0xLTM2MjQ4_e20542b4-5b30-4731-96e0-16222c1de979"
      unitRef="usd">3389000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icf8195e9a7884d23b49443cc99b9ce4b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzExLTEtMS0xLTM2MjQ4_35af977c-5837-4f9a-90e2-f5b36efa96d4"
      unitRef="usd">7125000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id45f53eaf45c4c91b83e80ae121a0eda_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzExLTItMS0xLTM2MjQ4_8142eee1-fa03-4a8a-8329-920dbdeefaeb"
      unitRef="usd">6622000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic6eb058c3c334fa9bc0c1e5cd98974fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzEyLTEtMS0xLTM2MjQ4_a71baf8f-70e0-4550-8108-4de54f320107"
      unitRef="usd">36198000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i77b64280f32c462596b287ec2de84d69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTplMjRlNTA3ODVmMjQ0MmRmOWI3MTg4MzE1YTJkMWRmYS90YWJsZXJhbmdlOmUyNGU1MDc4NWYyNDQyZGY5YjcxODgzMTVhMmQxZGZhXzEyLTItMS0xLTM2MjQ4_3eab716e-0199-4c75-b22a-3d535ce85cd4"
      unitRef="usd">34612000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i216dac94d38a475db23d353853c31110_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzUxMDM_b6a4c5d8-d38f-4617-98bf-d41713210e5f"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzk2Mzg_575c99e4-7981-4f2e-aeb7-d006263f94e0">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Years 2027 - 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzEtMS0xLTEtMzYyNDg_d70d4cee-b1ec-459d-89ce-b3248bbe0a96"
      unitRef="usd">256000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzItMS0xLTEtMzYyNDg_e23ed646-4f64-49b1-aac3-bcf9c6cd52ea"
      unitRef="usd">340000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzMtMS0xLTEtMzYyNDg_ce9e7b5e-6009-4a61-974e-2e4f4584cdb6"
      unitRef="usd">417000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzQtMS0xLTEtMzYyNDg_4e55faec-3d88-4990-8eda-677c46a8a038"
      unitRef="usd">453000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzUtMS0xLTEtMzYyNDg_f5eba913-dc65-41ac-a520-a9ae814a1729"
      unitRef="usd">788000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="if6b045e97c954a34891096fb9cf8d23b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0MGFjMzY2NzYwZTg0MThiODdlZjczNTY0Y2Q3ODAxZS90YWJsZXJhbmdlOjQwYWMzNjY3NjBlODQxOGI4N2VmNzM1NjRjZDc4MDFlXzYtMS0xLTEtMzYyNDg_fd37cc0d-77e5-4a0c-8b5d-d884e4fcc297"
      unitRef="usd">3859000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <iclr:ExpectedRetirementPeriod
      contextRef="ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzUzNzQ_2578dd9b-3037-45d3-8d86-dc8730cfd724">P10Y</iclr:ExpectedRetirementPeriod>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="id0c8fd01370246349a9908b32d1373e7_I20140507"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90ZXh0cmVnaW9uOjg5Y2M2ZmIzMDZjODRiNjlhNDYzZjQ0MGY3MTA2ZWViXzU5MjY_33396be8-0bf2-49ea-a14d-bb354f717ca7"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzItMS0xLTEtMzYyNDg_1def5095-c64b-4983-826a-8c5645a4a5f9"
      unitRef="usd">7643000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i87320a0e379947f09f57eb63148701a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzItMi0xLTEtMzYyNDg_318c7f0a-b8d8-42de-b84b-27c4116ce6b8"
      unitRef="usd">8620000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzMtMS0xLTEtMzYyNDg_39c8381b-3253-403a-8744-e4908a408d2d"
      unitRef="usd">6964000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i87320a0e379947f09f57eb63148701a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzMtMi0xLTEtMzYyNDg_92869ff3-1c20-4a6e-94ba-3c823e9c1454"
      unitRef="usd">7601000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzQtMS0xLTEtMzYyNDg_69469b2c-1d5b-4982-b7fe-fe59922b5347"
      unitRef="usd">-679000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i87320a0e379947f09f57eb63148701a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzQtMi0xLTEtMzYyNDg_05506413-5147-45f5-97cb-b0d76a07a266"
      unitRef="usd">-1019000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzUtMS0xLTEtMzYyNDg_ac7d4f52-9852-46f8-a519-ca82d66a21e7"
      unitRef="usd">-679000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i87320a0e379947f09f57eb63148701a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkZjQ5NDZkMTJmN2I0YzUxYTZjZDQyMTdlY2JlZDcyZC90YWJsZXJhbmdlOmRmNDk0NmQxMmY3YjRjNTFhNmNkNDIxN2VjYmVkNzJkXzUtMi0xLTEtMzYyNDg_ada0dd19-1cf4-4e74-b2df-2a9fefeb2de8"
      unitRef="usd">-1019000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i87320a0e379947f09f57eb63148701a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzItMS0xLTEtMzYyNDg_31f6f13f-ad66-4ce9-b545-5ddf3f171b2b"
      unitRef="usd">8620000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i536575760ce54ae2893373d1d02dc0d6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzItMi0xLTEtMzYyNDg_9c9f8186-a720-4dfd-9d59-80eeb5494fec"
      unitRef="usd">7047000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzMtMS0xLTEtMzYyNDg_746c8119-ea6c-4eb9-b2e6-581b509b7ca1"
      unitRef="usd">150000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzMtMi0xLTEtMzYyNDg_ba3a8163-3fd1-4f19-9425-99a56a672c76"
      unitRef="usd">139000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzQtMS0xLTEtMzYyNDg_82ac8ba7-7ea0-402b-a7b3-e65415f6e9f6"
      unitRef="usd">12000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzQtMi0xLTEtMzYyNDg_1d90c8b8-0272-4e13-8748-cd4062af4e56"
      unitRef="usd">21000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzUtMS0xLTEtMzYyNDg_f44c53bc-fcc5-48b4-93c2-c618d9927c09"
      unitRef="usd">95000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzUtMi0xLTEtMzYyNDg_7e0ad531-3bbc-4e8b-8007-14cc875e25c7"
      unitRef="usd">81000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzYtMS0xLTEtMzYyNDg_5eceba5f-eaaf-4a0b-8048-f0c5c6dea432"
      unitRef="usd">483000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzYtMi0xLTEtMzYyNDg_f9e313fc-9b22-47d8-92e2-dccf32833935"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzctMS0xLTEtMzYyNDg_03cae1e1-13d7-4116-80c6-f3f3719c31f9"
      unitRef="usd">-82000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzctMi0xLTEtMzYyNDg_0392b20c-28af-42a1-9881-084ace9b8569"
      unitRef="usd">-23000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanOtherChanges
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzgtMS0xLTEtMzYyNDg_d85be970-7819-4b3b-801c-bf6170f23c8b"
      unitRef="usd">76000</us-gaap:DefinedBenefitPlanOtherChanges>
    <us-gaap:DefinedBenefitPlanOtherChanges
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzgtMi0xLTEtMzYyNDg_a995b56d-3674-4e46-b5ef-11a6ea3d9dad"
      unitRef="usd">-245000</us-gaap:DefinedBenefitPlanOtherChanges>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzktMS0xLTEtMzYyNDg_f09a679e-991b-4836-a62a-0eb12ed38678"
      unitRef="usd">484000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzktMi0xLTEtMzYyNDg_9fa721cc-ed24-4ac9-89a9-ac01257c8fa2"
      unitRef="usd">-406000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzEwLTEtMS0xLTM2MjQ4_cbf417de-5acc-42f4-88a1-4c00d897fdf2"
      unitRef="usd">261000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzEwLTItMS0xLTM2MjQ4_d6c022cb-e0f7-4670-a35a-564714e90e59"
      unitRef="usd">-704000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzExLTEtMS0xLTM2MjQ4_ea1c716f-901f-48a7-ad87-deea51f1d612"
      unitRef="usd">7643000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i87320a0e379947f09f57eb63148701a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo5Mjk1Yjk1ZjUzZDg0ZTM4OTc4NWIwNzc3YmYyNzY1OS90YWJsZXJhbmdlOjkyOTViOTVmNTNkODRlMzg5Nzg1YjA3NzdiZjI3NjU5XzExLTItMS0xLTM2MjQ4_a5a0560e-3fbd-4082-afd1-be24e2b2d596"
      unitRef="usd">8620000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i87320a0e379947f09f57eb63148701a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzMtMS0xLTEtMzYyNDg_549f0170-7a07-4515-a4a7-c91b5383b090"
      unitRef="usd">7601000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i536575760ce54ae2893373d1d02dc0d6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzMtMi0xLTEtMzYyNDg_a2758e9c-008c-42f6-9c0f-2ebb14906f19"
      unitRef="usd">6014000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzQtMS0xLTEtMzYyNDg_d2ad17bf-0375-499c-98ea-60ee38fe2570"
      unitRef="usd">15000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzQtMi0xLTEtMzYyNDg_213c645b-bcb9-4e81-9e00-a6084be855b3"
      unitRef="usd">21000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzUtMS0xLTEtMzYyNDg_e9187675-38cc-4454-b581-1168d9b8fbe5"
      unitRef="usd">-238000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzUtMi0xLTEtMzYyNDg_35e21bac-0b0c-4bed-a46b-141e9147c97d"
      unitRef="usd">519000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <iclr:DefinedBenefitPlanSchemeContributions
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzYtMS0xLTEtMzYyNDg_597e8571-73ac-46c4-a038-29a9710f8493"
      unitRef="usd">128000</iclr:DefinedBenefitPlanSchemeContributions>
    <iclr:DefinedBenefitPlanSchemeContributions
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzYtMi0xLTEtMzYyNDg_ce0199d8-39ad-4cfe-b511-2ad78b683141"
      unitRef="usd">105000</iclr:DefinedBenefitPlanSchemeContributions>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzctMS0xLTEtMzYyNDg_15398ed8-5697-4a1c-913e-8e850e7285c1"
      unitRef="usd">95000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzctMi0xLTEtMzYyNDg_7a416b7f-623d-4709-b47f-4b8f1e3ebfbc"
      unitRef="usd">81000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzgtMS0xLTEtMzYyNDg_fbd3d246-7bdf-4144-b6c6-c41d90ec088e"
      unitRef="usd">76000</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzgtMi0xLTEtMzYyNDg_533953db-bf54-4b38-91a6-560beda03505"
      unitRef="usd">245000</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzktMS0xLTEtMzYyNDg_6520e2b0-aabb-4b04-9642-8d36da73d110"
      unitRef="usd">483000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzktMi0xLTEtMzYyNDg_afab7200-294a-46ad-9ff5-b0461d35eef7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ie88381d966f7484480244edbb8c5b099_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzEwLTEtMS0xLTM2MjQ4_c4c7d44f-c2a3-48f8-8541-23e4734a4e9c"
      unitRef="usd">-230000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i6170124b7e8d4bfdba500b061d184400_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzEwLTItMS0xLTM2MjQ4_c4a5b274-a29c-4759-b530-0d343344fb51"
      unitRef="usd">616000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idec677308af14edcacc6c913d5dd56c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzExLTEtMS0xLTM2MjQ4_6df965ba-c1b9-4a86-8d2b-835313495930"
      unitRef="usd">6964000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i87320a0e379947f09f57eb63148701a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo0ZWNhMDM3N2Y3ZGU0NmEwYjQ3ODJkNzdiN2ZhZTUyZi90YWJsZXJhbmdlOjRlY2EwMzc3ZjdkZTQ2YTBiNDc4MmQ3N2I3ZmFlNTJmXzExLTItMS0xLTM2MjQ4_719c12c0-ecf6-4303-8d22-7b851a908e7e"
      unitRef="usd">7601000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkMTk2YmVmNWNhMTI0MTkzYmFhOTgxNDNmYTljMmI1YS90YWJsZXJhbmdlOmQxOTZiZWY1Y2ExMjQxOTNiYWE5ODE0M2ZhOWMyYjVhXzItMS0xLTEtNDYxMzc_82437cff-d10a-4a75-94f3-5a42c73d5f47"
      unitRef="usd">4990000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkMTk2YmVmNWNhMTI0MTkzYmFhOTgxNDNmYTljMmI1YS90YWJsZXJhbmdlOmQxOTZiZWY1Y2ExMjQxOTNiYWE5ODE0M2ZhOWMyYjVhXzMtMS0xLTEtNDYxMzc_6a95dcbb-8caf-4d52-9c83-ba241301c7a5"
      unitRef="usd">3017000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkMTk2YmVmNWNhMTI0MTkzYmFhOTgxNDNmYTljMmI1YS90YWJsZXJhbmdlOmQxOTZiZWY1Y2ExMjQxOTNiYWE5ODE0M2ZhOWMyYjVhXzQtMS0xLTEtNDYxNDU_c670aa3f-f263-4c96-96c2-ee59897c17b4"
      unitRef="usd">-1973000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTpkMTk2YmVmNWNhMTI0MTkzYmFhOTgxNDNmYTljMmI1YS90YWJsZXJhbmdlOmQxOTZiZWY1Y2ExMjQxOTNiYWE5ODE0M2ZhOWMyYjVhXzUtMS0xLTEtNDYxNTE_9573d7d3-0fd9-4360-a8ac-f92741fea671"
      unitRef="usd">-1973000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i68dd1b4a3d3641879b1d63d1751d2f6a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzItMS0xLTEtNDYyMTU_3039c141-f093-4b72-af4c-9f4de53e5f0e"
      unitRef="usd">4890000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzMtMS0xLTEtNDYyMTU_b6f68f5c-c055-4bb1-adad-33c33f3f00e4"
      unitRef="usd">207000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzQtMS0xLTEtNDYyMTU_348454f3-ab11-4a41-a462-0157ccf0991a"
      unitRef="usd">19000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzUtMS0xLTEtNDYyMTU_35d89df2-eccc-4794-9608-76e2a2a8332e"
      unitRef="usd">135000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzgtMS0xLTEtNDYyMTU_9ffe2d6e-471e-43e5-b0ed-8b854e9d5ef5"
      unitRef="usd">113000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzktMS0xLTEtNDYyMTU_e33a93f1-c97e-4aa0-9b9b-7de2f6f3bc34"
      unitRef="usd">-1000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i40b6d9d3c2644d949eb6af4c732fe51d_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzEwLTEtMS0xLTQ2MjE1_a5825ceb-b561-4f49-b2f1-35eaddc4a06e"
      unitRef="usd">149000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib1f40d11c0c8476391b481d08399f03b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZToyNjQzNzI1Y2I0NDM0MmYwOTY0MmM5M2Q5ZjFkZmUwYy90YWJsZXJhbmdlOjI2NDM3MjVjYjQ0MzQyZjA5NjQyYzkzZDlmMWRmZTBjXzExLTEtMS0xLTQ2MjE5_50a1b37f-e2de-44f7-a782-6b617b9b10d2"
      unitRef="usd">4990000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i03867c06634a4d5ab2189dd7fe751c3d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzMtMS0xLTEtNDYwOTQ_f07b340a-37bb-4250-a864-4b831eef73b7"
      unitRef="usd">2849000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzQtMS0xLTEtNDYwOTQ_37b3bbef-93c9-4122-962a-6288a912ff62"
      unitRef="usd">15000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzYtMS0xLTEtNDYwOTQ_60d6f5af-93f5-4a0b-9e1d-3b487c4a37a6"
      unitRef="usd">135000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzctMS0xLTEtNDYwOTQ_c6ec70f2-a0cd-4595-be88-03aef6e24cfc"
      unitRef="usd">135000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzgtMS0xLTEtNDYwOTQ_02348716-66cf-4d84-be5e-8724aca45b6c"
      unitRef="usd">113000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i5fbaba98f4384a59bb3c41bf71c3a9fd_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzEwLTEtMS0xLTQ2MDk0_69049b17-192a-41cc-9671-151507c2e58b"
      unitRef="usd">-4000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i00041bfad6e143b8a90b3fb840be4f61_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjYvZnJhZzo4OWNjNmZiMzA2Yzg0YjY5YTQ2M2Y0NDBmNzEwNmVlYi90YWJsZTo4MGNkZTgwOTk3YmU0MjdlYjM1NDljODExMTdkMjYyMi90YWJsZXJhbmdlOjgwY2RlODA5OTdiZTQyN2ViMzU0OWM4MTExN2QyNjIyXzExLTEtMS0xLTQ2MTA3_b4a1a615-8578-498f-9dec-64fc48c348bb"
      unitRef="usd">3017000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3ODA_b51e98d2-5145-47f7-93d8-47e40a26e5cc">Equity Incentive Schemes and Stock Compensation Charges&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Each option granted under the 2008 Option Plans will be an employee stock option, or NSO, as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans will be evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price will be specified in each Stock Option Agreement, however option prices will not be less than 100% of the fair market value of an ordinary share on the date the option is granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 17, 2003 the Company adopted the Share Option Plan 2003 (the "2003 Share Option Plan") pursuant to which the Compensation and Organization Committee of the Board could grant options to officers and other employees of the Company or its subsidiaries for the purchase of ordinary shares. An aggregate of 6.0 million ordinary shares were reserved under the 2003 Share Option Plan; and in no event could the number of ordinary shares issued pursuant to options awarded under this plan exceed 10% of the outstanding shares, as defined in the 2003 Share Option Plan, at the time of the grant, unless the Board expressly determined otherwise. Further, the maximum number of ordinary shares with respect to which options could be granted under the 2003 Share Option Plan during any calendar year to any employee was 0.4 million ordinary shares. The 2003 Share Option Plan expired on January 17, 2013. No new options may be granted under this plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Prior to 2018, share options typically vest over a period of five years from date of grant and expire eight years from date of grant. Share options granted to non-executive directors from 2018 vest over 12 months and expire eight years from the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legacy PRA  Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following represent the legacy PRA equity incentive plans, which still have equity outstanding but have been terminated as of July 1, 2021, as to grants of future awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;Pursuant to the Merger Agreement, effective on July 1, 2021, each outstanding stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;PRA Health Sciences, Inc. 2020 Stock Incentive Plan was amended and restated and assumed by the Registrant effective as of July 1, 2021. The 2020 Stock Incentive Plan (&#x201c;the 2020 Plan&#x201d;), was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2,500,000 shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The PRA Health Sciences, Inc. 2018 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2018 Stock Incentive Plan (the &#x201c;2018 Plan&#x201d;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2,000,000 shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The PRA Health Sciences, Inc. 2014 Omnibus Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021 (the &#x201c;2014 Plan&#x201d;). On November 23, 2014, the PRA Health Sciences, Inc. Board of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The 2013 Stock Incentive Plan for Key Employees of PRA Health Sciences and its Subsidiaries was amended and restated and assumed by the Registrant effective as of July 1, 2021 (the &#x201c;2013 Plan&#x201d;). On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;br/&gt;Under Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;920,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(329,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;656,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(193,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed through business combinations *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,177,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,065,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,695,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;989,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Represents stock options issued as replacement awards in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2021, was 5.39 years and 4.55 years respectively (2020: 4.86 years and 3.60 years respectively).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Outstanding and exercisable share options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Range Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.80 - 97.30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;605,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.81 - 124.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.74 - 147.26&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.33 - 231.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;14.80 - 231.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,695,460&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5.39&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;104.79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;989,419&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;91.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding include both vested and unvested options as at December&#160;31, 2021. Options exercisable represent options which have vested at December&#160;31, 2021. From the date of grant, substantially all options vest over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzQ2NDQ_8b84bb10-99f4-411b-a818-270432b50926"&gt;five&lt;/span&gt; to eight year period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value of Stock Options Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options granted during the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Share Units and Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#x201c;2019 Consultants RSU Plan&#x201d;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#x2019;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU Outstanding&lt;br/&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU Outstanding&lt;br/&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed through business combination*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares vested **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(446,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;572,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Represents restricted stock units issued as replacement awards in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** Includes 161,389 RSU's which vested on the date of the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of RSUs vested for the year ended December&#160;31, 2021 totaled $83.5 million (2020: $14.3 million). The share price range for the year was $115.11 - $206.71 (2020: $83.47 - $156.21).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of PSUs vested for the year ended December&#160;31, 2021 totaled $5.1 million (2020: $5.3 million). The share price range for the year was $115.11 - $125.74 (2020: $83.47 - $90.03).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The PSUs vest based on service and specified EPS targets over the period 2019 &#x2013; 2021, 2020 &#x2013; 2022 and 2021 &#x2013; 2023. Depending on the actual amount of EPS from 2019 to 2023, up to an additional 71,890 PSUs may also be granted.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-cash stock compensation expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income from operations for the year ended December&#160;31, 2021 is stated after charging $133.8 million in respect of non-cash stock compensation expense. Non-cash stock compensation expense has been allocated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Direct costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and integration related *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $23.9 million. The income tax expense for the year ended December&#160;31, 2020 reflects a net income tax benefit of $6.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2020 was $2.5 million. The income tax expense for the year ended December&#160;31, 2019 reflects a net income tax benefit of $8.2 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2019 was $1.9 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i52e1bbc1869b4151944d394318356ae3_I20170213"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwNDE_f9fcc277-6576-46a6-9ba9-68a299b482e6"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i82ba7a6e4424420f8f44f4aaed17b2c2_I20170214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwNDc_d4e783e2-0e32-44a4-9628-72f561adb70d"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id13244e709104dbb91bd8e7035149dd0_I20170214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzExNDc_cdba0fcf-5245-488b-b094-c338999ba3b9"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted
      contextRef="i9238ad4bc0c9411fa4d50e26b14d2e1f_D20170214-20170214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEzNDc_3d7f316f-98a0-4c9f-a487-32e11f210154"
      unitRef="shares">1000000</iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i4f3c204e0dce42b98babf937edce3e3e_D20170214-20170214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzE1NDU_5fb5cf45-68ce-46e4-9ac1-f6fefd34783a"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ia2ef196657454b409ef6b9ff50ada92e_D20170214-20170214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxMTQ_6554767d-b305-499e-8272-eea4ceecd557"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i35ae564697d142d9bd558468bc6260be_I20030117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzI1MTI_e810a213-e1c3-4f1e-9206-1f22be02bb20"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="i00bc75888c8147eba2c8e5dde8818f99_D20030117-20030117"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzI2ODk_eb2f3f03-7f33-4589-ad89-e6ac0b91da6e"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i00bc75888c8147eba2c8e5dde8818f99_D20030117-20030117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzMwMDg_cbb570f5-4960-44b8-a37e-7ec7d164062d"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6e4e19cbbee143049fbca064c93a8efc_D19970101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzMzMTY_b33f7d1d-b990-45ba-ba79-6e618b3ee658">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i6e4e19cbbee143049fbca064c93a8efc_D19970101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzMzNDk_62f44530-7d89-4262-9769-2d39dbb4bbb2">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i718ff08202614127a3831397cc22d119_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM0NDM_a6f8fc34-b75d-44b3-bae1-27809cfc3bf7">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i718ff08202614127a3831397cc22d119_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM0NTc_6189d98f-b3b8-4512-a37a-4b8cd11e81c8">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i8d541f61a07d4ac29868fce496e97445_I20200518"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxOTkwMjMyODQ5NDU_d2c8de27-cfc7-4733-a65f-4beed8a263e5"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ief51d6a7563d4bc8ab4a279609f4a22d_I20180531"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxOTkwMjMyODQ5Nzg_93025f4d-52cf-43cd-ade5-253b23b4896c"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized
      contextRef="ic851a23a9692444896ff76991dcb6a7c_I20130923"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxOTkwMjMyODQ5NTY_5375ab65-137b-4773-a941-d48d969ffc98"
      unitRef="number">0.125</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ic851a23a9692444896ff76991dcb6a7c_I20130923"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzIxOTkwMjMyODQ5ODk_f37224b3-9903-427f-ad69-0ab02f7721b3"
      unitRef="shares">2052909</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3OTQ_1e016177-7951-42d5-ab1a-a8908a26fe37">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;br/&gt;Under Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;920,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(329,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;656,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(193,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed through business combinations *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,177,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,065,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,695,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;989,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Represents stock options issued as replacement awards in connection with the Merger.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ibbca4abf2817496684bb2ab04067235b_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEtMS0xLTEtMzYyNDg_5f576153-572f-4e49-b0a0-41b43f997a76"
      unitRef="shares">920746</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ibbca4abf2817496684bb2ab04067235b_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEtMy0xLTEtMzYyNDg_f66d68b2-31fa-4fba-b0cb-414f2afc7741"
      unitRef="usdPerShare">74.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzItMS0xLTEtMzYyNDg_893a136b-186c-489b-80e1-4b1204eda4a1"
      unitRef="shares">97112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzItMy0xLTEtMzYyNDg_364eeb34-f2c7-403f-8ff4-6f717b7d468b"
      unitRef="usdPerShare">140.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzMtMS0xLTEtMzYyNDg_33058866-2875-4c58-8bfc-153f579bfe67"
      unitRef="shares">329870</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzMtMy0xLTEtMzYyNDg_4816c53a-532c-4f63-85cb-966dd05512e0"
      unitRef="usdPerShare">65.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzQtMS0xLTEtMzYyNDg_edcf4fe4-626b-46b0-bdce-c61b06b942ab"
      unitRef="shares">31881</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i932cfe30d1fc4e2dac117ae7106c84ae_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzQtMy0xLTEtMzYyNDg_727a0ad1-f610-4441-bb7c-bd3ad028fa06"
      unitRef="usdPerShare">88.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia7ea21c26dac40328506c0cba3319723_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzUtMS0xLTEtMzYyNDg_04e1636c-7a85-4815-bfb0-cf583221eb55"
      unitRef="shares">656107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia7ea21c26dac40328506c0cba3319723_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzUtMy0xLTEtMzYyNDg_51ee4bf1-b1c9-4122-941a-328f4071abd1"
      unitRef="usdPerShare">87.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzYtMS0xLTEtMzYyNDg_a9977e0d-1a61-45c3-9f43-7449ba88fd40"
      unitRef="shares">107737</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzYtMy0xLTEtMzYyNDg_271efc84-cc14-49bd-90e6-68f647397c34"
      unitRef="usdPerShare">159.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzctMS0xLTEtMzYyNDg_a270f785-2c15-48a3-9773-a3b026ea17d0"
      unitRef="shares">193417</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzctMy0xLTEtMzYyNDg_4ada7b09-32b9-4f7e-8415-2a87b532a7db"
      unitRef="usdPerShare">68.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzgtMS0xLTEtMzYyNDg_48af46e7-81a2-4434-888f-e4fa86ad79c9"
      unitRef="shares">16681</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i7f136a7c3dec45e08e982802f90db1fd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzgtMy0xLTEtMzYyNDg_4f47f0c2-d792-41d2-b145-0b23c4a7232c"
      unitRef="usdPerShare">92.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i953fc3f9f5114324bcd9a4293c83b977_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzktMS0xLTEtMzYyNDg_d9449117-898d-4345-88e8-5c71665d867c"
      unitRef="shares">553746</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i953fc3f9f5114324bcd9a4293c83b977_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzktMy0xLTEtMzYyNDg_0f19a509-7789-4222-800f-ae2aec1148cd"
      unitRef="usdPerShare">108.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEwLTEtMS0xLTQ1NDc4_59e76a24-f2ab-4b3f-af54-d2ced20b4c19"
      unitRef="shares">2177130</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination>
    <iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEwLTMtMS0xLTQ1NDg1_06462842-1142-4e33-9e00-df6318dba2ff"
      unitRef="usdPerShare">108.78</iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEwLTEtMS0xLTM2MjQ4_391b019d-7e41-44f6-8b00-53603b4b4119"
      unitRef="shares">100299</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEwLTMtMS0xLTM2MjQ4_5b908a81-14f6-4889-8ef0-5b88006b94ce"
      unitRef="usdPerShare">177.76</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzExLTEtMS0xLTM2MjQ4_c10cb1f0-a295-4e88-807f-b061ec32da90"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzExLTMtMS0xLTM2MjQ4_b7dec31c-432a-463e-8ea4-b94795e9cce0"
      unitRef="usdPerShare">111.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEyLTEtMS0xLTM2MjQ4_5877c10d-eebb-44b7-b1b0-77b118665bfd"
      unitRef="shares">70186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEyLTMtMS0xLTM2MjQ4_1aa957a0-aa56-4b56-bb50-7a37f0d74be8"
      unitRef="usdPerShare">128.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib049563e613d4855a95f4886886e70d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEzLTEtMS0xLTM2MjQ4_ae58f409-69ce-48ff-8208-81fe3f24e3fb"
      unitRef="shares">1695460</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib049563e613d4855a95f4886886e70d4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzEzLTMtMS0xLTM2MjQ4_9cf4c2aa-6d6d-42aa-ac1e-4651eb67d4d4"
      unitRef="usdPerShare">104.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="ib049563e613d4855a95f4886886e70d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzE0LTEtMS0xLTM2MjQ4_6763cd60-c36a-4972-ac58-d993c977b9a9"
      unitRef="shares">989419</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="ib049563e613d4855a95f4886886e70d4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpiZmQ3Yzk5NGMxNzg0NDg2ODc2MmQ2MTA1Mjc1NmU1NC90YWJsZXJhbmdlOmJmZDdjOTk0YzE3ODQ0ODY4NzYyZDYxMDUyNzU2ZTU0XzE0LTMtMS0xLTM2MjQ4_0f0b3324-8b8c-4d66-9948-267306d51aed"
      unitRef="usdPerShare">91.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM3MjA_3a148b44-2b41-4c44-b8ff-85de91d13cae">P5Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM3Mjc_43d49586-347e-43c3-b07f-273a0b122c36">P4Y6M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM3NDg_1a9eec0a-4885-4073-9ca3-b1d989ec1f37">P4Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzM3NTU_df72a692-64df-4e19-94ad-e7a729e2b208">P3Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3OTg_249d25da-73d1-4e9f-9b54-dff32b0bb2c9"
      xsi:nil="true"/>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3ODY_bc01b009-140e-4159-a75b-3b1fcfbc8567">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Range Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.80 - 97.30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;605,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.81 - 124.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.74 - 147.26&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.33 - 231.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;14.80 - 231.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,695,460&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5.39&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;104.79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;989,419&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;91.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i0a89202c30764a8e9ad0c13560be2ae0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjoyNWE3MzQ3ZGNmZDQ0ZmEzOWM3MmE2YmY0OTZhNmVlMV8xMjA5NDYyNzkwNTU1MA_867c60f6-830f-4ee8-b790-f770a96d645e"
      unitRef="usdPerShare">14.80</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i0a89202c30764a8e9ad0c13560be2ae0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjoyNWE3MzQ3ZGNmZDQ0ZmEzOWM3MmE2YmY0OTZhNmVlMV8yMTk5MDIzMjU1NTcy_8e526fcd-256c-4dfe-926c-656fdcd2f12e"
      unitRef="usdPerShare">97.30</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ibcc6762b3d2c402e97ea3771e8aeb750_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtMS0xLTEtMzYyNDg_217193e5-a522-4933-8f9e-84552ca8f002"
      unitRef="shares">638118</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i22c88a1dd7ca45d48c661d231dd100b2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtMi0xLTEtMzYyNDg_ab29762f-d972-46d1-b9d3-bb670fc864ba">P3Y5M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ibcc6762b3d2c402e97ea3771e8aeb750_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzMtNS0xLTEtMzYyNDg_c3832c51-9eb1-4cdf-b3b1-b96b76990a18"
      unitRef="shares">605624</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i6de01c93a2fb457e98a862dc99d4abdd_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjozM2ZkYThkNTQyYTk0M2M1YWZhNThhZDQ3MzllZDBhZl8yMTk5MDIzMjU1NTY4_2ad2eac8-ff80-4475-b450-f18caeb80aca"
      unitRef="usdPerShare">103.81</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i6de01c93a2fb457e98a862dc99d4abdd_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjozM2ZkYThkNTQyYTk0M2M1YWZhNThhZDQ3MzllZDBhZl8yMTk5MDIzMjU1NTc0_f88f77e3-fd73-4973-831e-9cbaad1629d9"
      unitRef="usdPerShare">124.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i7eb517873331422d82ddeb24ae81abab_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtMS0xLTEtMzYyNDg_e6fb948b-86a4-49bc-ac91-263521b7d2e8"
      unitRef="shares">320310</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i1f9f44ae168e404abf9f671dd8805b74_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtMi0xLTEtMzYyNDg_7fba8f03-88db-4de5-964b-e6233aafd980">P6Y5M26D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i7eb517873331422d82ddeb24ae81abab_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzQtNS0xLTEtMzYyNDg_027f30c2-57f4-4406-b83c-c347b511143c"
      unitRef="shares">130920</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ib8a3088705f84bc0ba8f033ac2ceb1b4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjoyNWE5NGQ3MDQxMjc0YTM0YTNlZDU5ZTIwZjQyODY2NV8xMjA5NDYyNzkwNTU1Mg_021f4de6-3aad-4b97-90d1-09ecb88c6282"
      unitRef="usdPerShare">125.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ib8a3088705f84bc0ba8f033ac2ceb1b4_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjoyNWE5NGQ3MDQxMjc0YTM0YTNlZDU5ZTIwZjQyODY2NV8yMTk5MDIzMjU1NTc0_74a7efc3-4e36-4dcd-9736-6df2f53a2c64"
      unitRef="usdPerShare">147.26</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ifbcd9f1bcda345dca2a0d46fb1c81d47_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtMS0xLTEtMzYyNDg_f5333a11-afed-4f77-8a03-ad69764862dd"
      unitRef="shares">540296</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i671a1d31e3054ac49e3a79c6e68909c4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtMi0xLTEtMzYyNDg_54c74a48-9979-4713-9490-2913b7087877">P6Y6M21D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ifbcd9f1bcda345dca2a0d46fb1c81d47_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzUtNS0xLTEtMzYyNDg_a7f60715-3487-4212-8e2c-2ef4b557e965"
      unitRef="shares">235808</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i8d77c5373ca24c15b6733894571c4107_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjo0YzJiNGQ1NjdmYWY0MjQ3YTk4YjEyMGZkMTM5ZDMyY18xMjA5NDYyNzkwNTU1Mg_f9abc912-8b1e-41b1-95e1-8371d0ac4577"
      unitRef="usdPerShare">159.33</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i8d77c5373ca24c15b6733894571c4107_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjo0YzJiNGQ1NjdmYWY0MjQ3YTk4YjEyMGZkMTM5ZDMyY18yMTk5MDIzMjU1NTc4_7232790c-d811-4dd1-ba62-f206afa7e20f"
      unitRef="usdPerShare">231.08</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ia7a8bb4ad4a743548875aefa396266a4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtMS0xLTEtMzYyNDg_f14b5e5f-cfc6-47fe-bda7-d21a6ad9cc1d"
      unitRef="shares">196736</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i08fa3aedb11a4eae933e80b642a4260d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtMi0xLTEtMzYyNDg_89a0da1b-a646-4b06-a903-1b41529b7235">P6Y8M4D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ia7a8bb4ad4a743548875aefa396266a4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzYtNS0xLTEtMzYyNDg_1defcd6d-ac94-4b5a-9b0e-0e2bd783b96a"
      unitRef="shares">17067</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjphYmY1YTYwN2U1MTQ0YWJhYmQwZWU0YWY3ODhiYjc1YV8yMTk5MDIzMjU1NTc1_5d675925-5625-45f7-8f11-18936c4cf5e5"
      unitRef="usdPerShare">14.80</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMC0xLTEtMzYyNDgvdGV4dHJlZ2lvbjphYmY1YTYwN2U1MTQ0YWJhYmQwZWU0YWY3ODhiYjc1YV8yMTk5MDIzMjU1NTg0_2e0ff810-bc5d-4401-bd50-9c19c19b1ca4"
      unitRef="usdPerShare">231.08</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ib049563e613d4855a95f4886886e70d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMS0xLTEtMzYyNDg_6fcdc5f4-3829-4a0a-8d24-37f6ab9d4620"
      unitRef="shares">1695460</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i21a0a6dfec1548f2ac2e42217567355a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMi0xLTEtMzYyNDg_977a204f-ea49-464f-a089-ccc9713d882a">P5Y4M20D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib049563e613d4855a95f4886886e70d4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctMy0xLTEtMzYyNDg_9cf4c2aa-6d6d-42aa-ac1e-4651eb67d4d4"
      unitRef="usdPerShare">104.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ib049563e613d4855a95f4886886e70d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctNS0xLTEtMzYyNDg_e7152e2f-d055-4656-afb2-6965bceac92f"
      unitRef="shares">989419</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="ib049563e613d4855a95f4886886e70d4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo3NTA0Yjg4Yjg1ODY0MDdiYjk2YmZlOWQwMWJkMTBhNy90YWJsZXJhbmdlOjc1MDRiODhiODU4NjQwN2JiOTZiZmU5ZDAxYmQxMGE3XzctNi0xLTEtMzYyNDg_0f0b3324-8b8c-4d66-9948-267306d51aed"
      unitRef="usdPerShare">91.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7db9820d8aa244e2852525ef7396441a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwOTk1MTE2MzA3MjMw_4d690d79-1296-49b1-9bcb-ff0d300c4cb7">P8Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3ODc_4fa3f8e5-d6cc-4743-9c07-c9042f95cb70">The weighted average fair values and assumptions were as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzItMS0xLTEtMzYyNDg_747d5e4e-ba69-43b1-815d-4600b95e1584"
      unitRef="usdPerShare">49.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzItMi0xLTEtMzYyNDg_82d057de-fbd9-42ba-bc15-017dc3cc34c6"
      unitRef="usdPerShare">42.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzItMy0xLTEtMzYyNDg_1a578098-6293-4b8e-8ab1-d3f9cc53c38a"
      unitRef="usdPerShare">43.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzUtMS0xLTEtMzYyNDg_b8995133-1fe4-44aa-a208-100fec10f217"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzUtMi0xLTEtMzYyNDg_18f65bfc-e9dc-4aac-abbc-51078047f5cf"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzUtMy0xLTEtMzYyNDg_72266808-332c-494f-9c04-22097b17b61e"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzYtMS0xLTEtMzYyNDg_6f5d8aa1-2d7f-4589-9a5a-6afcd432782c"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzYtMi0xLTEtMzYyNDg_ba2a2e3e-d5a7-43d2-b527-09d3fd42c151"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzYtMy0xLTEtMzYyNDg_d1de1b28-c446-4ef8-9669-eaf71cf9275c"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzctMS0xLTEtMzYyNDg_28e16823-df08-454d-993a-f23ae0084746"
      unitRef="number">0.0078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzctMi0xLTEtMzYyNDg_86957329-d6ea-4739-b2b1-89c6541d369d"
      unitRef="number">0.0057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzctMy0xLTEtMzYyNDg_1ce03ada-d214-4085-ab89-70d9c04ba345"
      unitRef="number">0.0255</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzgtMS0xLTEtMzYyNDg_b683c2a4-6119-4c7b-8e2b-1cb36ca49563">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzgtMi0xLTEtMzYyNDg_000048e9-90ef-41b6-8f2c-3f6d4c89fa88">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTpkNjgwZWNmOWM0ZTQ0NDRlYWUyMjljNTAwNTIyYWQ2ZS90YWJsZXJhbmdlOmQ2ODBlY2Y5YzRlNDQ0NGVhZTIyOWM1MDA1MjJhZDZlXzgtMy0xLTEtMzYyNDg_2d274236-6105-4d99-81cb-78d5b2716d32">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzEtMS0xLTEtNDU1ODA_c0523906-1278-4bef-908e-5dfcf565232a"
      unitRef="usdPerShare">107.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzMtMS0xLTEtNDU1ODA_2cef8112-8923-4099-8969-dcd629039f5b"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzQtMS0xLTEtNDU1ODA_243153d1-a0a5-4012-9dd7-86692fa74886"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzUtMS0xLTEtNDU1ODA_bbe43812-ae42-4cc7-baa1-3f857a406f9c"
      unitRef="number">0.0056</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTowMjg2YmVlZmNlYjY0ZGVjOTdlMGUxNmY3Mzg2MzIzNi90YWJsZXJhbmdlOjAyODZiZWVmY2ViNjRkZWM5N2UwZTE2ZjczODYzMjM2XzYtMS0xLTEtNDU1ODA_e170c87d-862d-4ad9-b94a-b4895d291df7">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i46b83645e00244b685127e098dab3ac7_D20150511-20150511"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzYwNTg_75c6da66-5b4d-4b29-9870-d41d7c5bab83"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i092c95b988b148d88d0639ad4cfc0a58_I20150511"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzYwOTg_54a32d13-f31b-4724-83be-b87e8ab511ac"
      unitRef="shares">4100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i454968911a6a4e2aa2a973ab9436c62a_I20190516"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzY3NDk_29a92bc6-94a9-4c62-a694-4f0a9315ddeb"
      unitRef="shares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i13e925d1823c400d84b4408ce6181505_D20190101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzY5NzA_03307477-5f6c-4d0b-a02a-273b9be454d8">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3NzU_b103a535-8399-4897-b097-2bd482f77e4d">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2021:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU Outstanding&lt;br/&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU Outstanding&lt;br/&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed through business combination*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;589,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;171,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares vested **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(446,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(83,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;572,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Represents restricted stock units issued as replacement awards in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** Includes 161,389 RSU's which vested on the date of the Merger.&lt;/span&gt;&lt;/div&gt;</iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie4af659507f244f3be56ce1d3a1e11dd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzEtMS0xLTEtMzYyNDg_6efd4d23-63f2-4974-a2c5-8a498bc122c8"
      unitRef="shares">159641</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie4af659507f244f3be56ce1d3a1e11dd_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzEtMi0xLTEtMzYyNDg_2d828bab-b045-448c-978b-21d3ba279558"
      unitRef="usdPerShare">137.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idfcb074b2ed840d0889e5704a9ace54e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzEtNC0xLTEtMzYyNDg_0a96d207-6ede-42c5-b9f2-dc38ca93c4af"
      unitRef="shares">341424</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="idfcb074b2ed840d0889e5704a9ace54e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzEtNS0xLTEtMzYyNDg_9874072f-6a3d-4c63-87ea-cde93671a1f4"
      unitRef="usdPerShare">145.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtMS0xLTEtNDk4NjE_2af6dbba-1ca9-426b-acc4-46ed23dc1ce0"
      unitRef="shares">0</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination>
    <iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtMi0xLTEtNDk4NjE_8e0d37c5-dd69-4df7-bbea-637d3ab3de84"
      unitRef="usdPerShare">0</iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtNC0xLTEtNDYzNTA_c336be86-53a6-4276-8948-96d39a9fb921"
      unitRef="shares">589517</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination>
    <iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtNS0xLTEtNDYzNTA_544cc4f8-5748-4135-aac6-3dcb44d2eb41"
      unitRef="usdPerShare">206.71</iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtMS0xLTEtMzYyNDg_6d3e1776-6682-4393-ae1c-4f549660362d"
      unitRef="shares">55444</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtMi0xLTEtMzYyNDg_758d41a3-afd3-431a-9586-520659650037"
      unitRef="usdPerShare">177.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtNC0xLTEtMzYyNDg_f9756040-064d-41dc-88a5-43f2db7f7f13"
      unitRef="shares">171316</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzMtNS0xLTEtMzYyNDg_463825e0-4dd7-473c-9aaf-1b5dd6dcf7c5"
      unitRef="usdPerShare">214.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzQtMS0xLTEtMzYyNDg_ecb760da-4aa2-4f71-a50d-bbb1e0ead31a"
      unitRef="shares">44132</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzQtMi0xLTEtMzYyNDg_11bec073-059e-489f-8cd4-9658ad0a8435"
      unitRef="usdPerShare">115.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzQtNC0xLTEtMzYyNDg_2288f34e-192a-4f2c-b3c6-a34c5d28186a"
      unitRef="shares">446404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzQtNS0xLTEtMzYyNDg_f93803e4-aaa2-45a8-b966-149e6823a8f2"
      unitRef="usdPerShare">186.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzUtMS0xLTEtMzYyNDg_40e3fb0d-111a-43ea-bf90-9c96fb4a7521"
      unitRef="shares">16763</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzUtMi0xLTEtMzYyNDg_e6437d3e-1ace-4587-9256-bed44810708a"
      unitRef="usdPerShare">141.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzUtNC0xLTEtMzYyNDg_319fd785-662d-4174-9d76-aad1495bfb0e"
      unitRef="shares">83068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzUtNS0xLTEtMzYyNDg_7c54b3af-4493-497d-bf17-0ace46351b59"
      unitRef="usdPerShare">188.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id023f7897c634581b20db0f0c13adc57_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzctMS0xLTEtMzYyNDg_d11a83bf-f4d0-4c01-a75e-6692347d973a"
      unitRef="shares">154190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id023f7897c634581b20db0f0c13adc57_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzctMi0xLTEtMzYyNDg_13903c25-1bd8-4ef6-aafa-5e9b02e09284"
      unitRef="usdPerShare">160.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id13136d269d54783b5556de26f903c56_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzctNC0xLTEtMzYyNDg_beac734e-3de0-4b76-9058-64c37c3f345a"
      unitRef="shares">572785</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id13136d269d54783b5556de26f903c56_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTo4Y2RmYzAzMzhmNjI0ZTJkYTVmNGEzOTBiMWQyNWM4ZS90YWJsZXJhbmdlOjhjZGZjMDMzOGY2MjRlMmRhNWY0YTM5MGIxZDI1YzhlXzctNS0xLTEtMzYyNDg_f51a9cad-c36a-4ea2-b7f3-4430eeb12ca3"
      unitRef="usdPerShare">191.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i21ce434056744af495320d8e2505e585_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEzMTk0MTM5NTY3OTY4_868cc105-41cc-4ce5-b726-69c46f094ba4"
      unitRef="shares">161389</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcxOTY_e66e44a9-c0ca-43c1-a38a-356e0b498392"
      unitRef="usd">83500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ia5199d2dbdbd4fe9afdad9bb0b6011c8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyMDQ_6484504a-b601-437c-8d95-878649543d42"
      unitRef="usd">14300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i289f65e4064e4e14973a986310115295_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyNDY_f1b84534-52d7-4415-b32a-daf9827f7d93"
      unitRef="usdPerShare">115.11</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i1cf76ea842904bb687cb878a30fd91b0_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyNTE_93856341-d4a9-44e9-8253-2bf71b954b35"
      unitRef="usdPerShare">206.71</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="ib87cf475a42848d990b63ce6c940842c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyNTk_c0ee621a-7419-4352-98c4-b813e5fa754d"
      unitRef="usdPerShare">83.47</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="ia0e29a847bcb402b8b35bd56be034dca_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzcyNjQ_d5751957-29c9-4eb9-b62d-5df69bffe2b1"
      unitRef="usdPerShare">156.21</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczMzE_4d411f0d-9a2e-449c-b30f-4fb079a97c2f"
      unitRef="usd">5100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ib014ca4b61704308b759eb2b4e4cbe13_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczMzk_bb67dff3-6900-4a35-9ae8-5ca5efcd6090"
      unitRef="usd">5300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i73e2c7ebf97b43da88211b323320aa76_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczODM_90f4335e-f2f7-4093-a3f7-5ecde7a47078"
      unitRef="usdPerShare">115.11</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i1846e9d35064408781a6a5388df65c41_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczODg_6015400f-ee0e-4110-bd69-4410004869f5"
      unitRef="usdPerShare">125.74</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i54544aae1c2043709f665f7d1cc9eebf_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzczOTY_f225900d-8019-47b1-9c95-b6aae2c18703"
      unitRef="usdPerShare">83.47</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i302f632b409e431a99d19fa4a3ec38d9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzc0MDE_3d9d1c31-dc87-48fc-af11-ef27901bf4d2"
      unitRef="usdPerShare">90.03</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i6eb358d140d045a48a95a6f2a26b3d5d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwOTk1MTE2NDc3MDc_261bb19a-3180-4c2d-b818-ddb71679ea6d"
      unitRef="shares">71890</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensation
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzEwOTk1MTE2NDc5NjU_7c2e2cdc-bb43-44e2-a6e2-ad3a7f46f33f"
      unitRef="usd">133800000</us-gaap:ShareBasedCompensation>
    <iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3ODg_42569849-1931-44e8-917a-05c2dcb12b16">Non-cash stock compensation expense has been allocated as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Direct costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and integration related *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger&lt;/span&gt;&lt;/div&gt;</iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="id8aedbfe82f84258b4f5fb8ae5be9756_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzMtMS0xLTEtMzYyNDg_4ecaa933-fadf-46ba-bece-5ca3d3d802ba"
      unitRef="usd">18551000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic3104d5908eb42a781a65f9e3b34447b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzMtMi0xLTEtMzYyNDg_2cd876b6-4d1a-40e6-9c9b-41d168f272bf"
      unitRef="usd">8557000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie1a4ebf926a04a1399759e8c4dd65228_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzMtMy0xLTEtMzYyNDg_6601bdf0-f1b3-4048-8c50-d72ca27d9f34"
      unitRef="usd">14777000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if5c3ba2a7a9949e4b4296e482b3406d4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzQtMS0xLTEtMzYyNDg_08141759-5c2e-4bd6-9a73-7eecefbef960"
      unitRef="usd">41457000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia28188c5a298446189940f3d7538dc9f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzQtMi0xLTEtMzYyNDg_5fe4ff46-2e88-4990-8b92-aeebecb6dc47"
      unitRef="usd">17714000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i63e7f286996a495b9fbebdd313a6affa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzQtMy0xLTEtMzYyNDg_58a54fc0-8812-49d4-ac33-107ac887497f"
      unitRef="usd">12042000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4c449fefc2cd4b4399d71b4faba625e0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMS0xLTEtNDY0ODU_b4a774c8-04f4-490a-838c-24b2526fb9d5"
      unitRef="usd">73836000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie7b5db980b4e4123a417be9e69e6a306_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMi0xLTEtNDk4NjQ_fd39d6bf-6dfd-4f30-b27c-0651c25262c2"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9da48aa526a04e8c802268f3ee3f55f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMy0xLTEtNDk4NjQ_07c26a57-3f84-48a0-bc5a-4036a7200f98"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMS0xLTEtMzYyNDg_a58799bb-074a-46e5-9c88-93efbb106ed5"
      unitRef="usd">133844000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMi0xLTEtMzYyNDg_2b5db54a-af6a-4a1a-8502-9780074ac267"
      unitRef="usd">26271000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90YWJsZTplYTMzYTc3NDQ0OTY0YzcwOTI5NWQ0ZWVlNzkwZGRlZC90YWJsZXJhbmdlOmVhMzNhNzc0NDQ5NjRjNzA5Mjk1ZDRlZWU3OTBkZGVkXzUtMy0xLTEtMzYyNDg_1446f200-7cc0-4106-b24e-99a0a515b7a7"
      unitRef="usd">26819000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzgxMTQ_690c4337-c64e-4288-b4e7-9818cfb6dc0a"
      unitRef="usd">22700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzgyNzA_1ea1f15b-6b51-4091-b990-5ef2a0c0c8fb"
      unitRef="usd">23900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4XzgzNTY_8bcda93a-edc9-4230-8ba8-22d8d03f50f0"
      unitRef="usd">6900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg1MTI_748782c6-fd16-42e5-b065-7a0ff7f350b5"
      unitRef="usd">2500000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg1OTg_dcabb8c7-4e6a-4d2c-9ebf-0f1409f91065"
      unitRef="usd">8200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNjkvZnJhZzo1NmQyNmIyM2Q0M2M0N2VlOWExZjhkYjA5ZmJmMWJiOC90ZXh0cmVnaW9uOjU2ZDI2YjIzZDQzYzQ3ZWU5YTFmOGRiMDlmYmYxYmI4Xzg3NjU_ca414dca-e862-4c85-b9bb-5747100edbe1"
      unitRef="usd">1900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzE4MTQxOTQxODY2NDM0_7b211642-ea09-4b15-acb4-e0f17be08b2f">Fair Value&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1 &#x2014; Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2 &#x2014; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3 &#x2014; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recurring Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in investments in equity-long term having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2021 and December&#160;31, 2020 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 and December&#160;31, 2020 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $3.2 million (December&#160;31, 2020: $2.5 million) recognized in net income during the year bringing the carrying value of the subscriptions to $22.6 million at December&#160;31, 2021 (December&#160;31, 2020: $15.8 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-recurring Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2021, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $13,748.8 million and are identified as Level 3 assets. These assets are comprised of goodwill of $9,037.9 million and identifiable intangible assets, net of $4,710.8 million. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 24 - Non-current bank credit lines and loan facilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information regarding the fair value of long-term debt balances.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzI0NDQ_8b877ce6-8ebc-4fdc-92bc-67ad5c066ff0"
      unitRef="usd">3200000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzI0NTQ_835f6090-2d6c-4606-a0af-77514c95df98"
      unitRef="usd">2500000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzI1NTI_1e270284-484d-48d0-8e7c-577d24930fc2"
      unitRef="usd">22600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzI1Njk_fc69e375-a63c-45db-83fc-691e37f0db13"
      unitRef="usd">15800000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie59648bd657b4adbaa014e0c1010eef4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzU5MDk_67a9e0e0-33b7-4167-ab49-de4b8265b0ad"
      unitRef="usd">13748800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="ie59648bd657b4adbaa014e0c1010eef4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzU5MTc_3945dfda-1fb5-4d6e-a59b-91d96751279c"
      unitRef="usd">9037900000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="ie59648bd657b4adbaa014e0c1010eef4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzIvZnJhZzplNDU3ZDMwYTA0MmY0OGRmYmFkMjg4NzYyNmZiMGI1MS90ZXh0cmVnaW9uOmU0NTdkMzBhMDQyZjQ4ZGZiYWQyODg3NjI2ZmIwYjUxXzEwOTk1MTE2MzU5MjU_7fb27e04-f61e-458c-bce5-4076b5af659e"
      unitRef="usd">4710800000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzUxMDA_64cd4e0a-a176-4159-85d8-43a80bfe196c">Share Capital&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Holders of ordinary shares will be entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares will be repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company&#x2019;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December&#160;31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, 193,417 options were exercised by employees at an average exercise price of $68.19 per share for total proceeds of $13.2 million. During the year ended December&#160;31, 2020, 144,172 ordinary shares were issued in respect of certain RSUs and 63,516 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2019, 329,870 options were exercised by employees at an average exercise price of $65.54 per share for total proceeds of $21.6 million. During the year ended December&#160;31, 2019, 237,119 ordinary shares were issued in respect of certain RSUs and 118,611 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There were no share buybacks in the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A resolution was passed at the Company&#x2019;s Annual General Meeting (&#x201c;AGM&#x201d;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020 and July 20, 2021.&#160;On October 3, 2016, the Company commenced a share buyback program of up to $400 million. The share buyback program was completed during the year ended December 31, 2018 with a total of 4,026,576 ordinary shares redeemed for a total consideration of $372.1&#160;million. On January 8, 2019, the Company commenced a further share buyback program of up to 1.0&#160;million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $141.6&#160;million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, 35,100 ordinary shares were redeemed by the Company for a total consideration of $5.3&#160;million. During the year ended December 31, 2020, 1,235,218 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $175.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <iclr:NumberOfVotes
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyMDk0NjI3OTIzMDUy_55b60308-77ac-4b46-aee3-fa672da3faae"
      unitRef="vote">1</iclr:NumberOfVotes>
    <iclr:NumberOfVotes
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyMDk0NjI3OTIzMDYy_0ca133f9-35d3-4491-a2e8-410b92fec553"
      unitRef="vote">1</iclr:NumberOfVotes>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i57296aeb6f304d0db0503a497edaa448_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2MzU5MDE_0377f49e-2b79-44c4-952b-700d8f37df3c"
      unitRef="shares">27372427</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzc4Nw_aae8ad32-e3f2-4973-91bb-cd46a907f331"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzg1OA_1958f897-b279-45f7-8e92-50e9f39052ca"
      unitRef="usdPerShare">111.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i15bf5ac4079e41af87a6535e03501d67_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzg5Mw_3ef711e8-9ba1-4885-b27d-a96af6c0b6e1"
      unitRef="usd">118600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="if1c65ea1d12441dfac914cf8076eb0cd_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzkyMw_c693dcbc-abaa-46ce-a487-7695963083ed"
      unitRef="shares">446404</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i9c8a8718938c42a9bcaa38dc130c81ef_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzk4NQ_070e0753-12db-45dc-af9f-b151faae9c24"
      unitRef="shares">44132</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTg_9b79d1fa-b58a-4b0a-a801-11bc13436a90"
      unitRef="shares">193417</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzExNjk_84cb1fcb-7f8e-4428-9db4-73ba98fb7758"
      unitRef="usdPerShare">68.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic8bed517994946fc9699e55280fc7d6b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyMDQ_e027de7a-d048-47e6-88ea-069cf4623a54"
      unitRef="usd">13200000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ia5199d2dbdbd4fe9afdad9bb0b6011c8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyMzQ_560b3a2d-3590-45bc-8085-95de9fa67efc"
      unitRef="shares">144172</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="ib014ca4b61704308b759eb2b4e4cbe13_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEyOTY_68db9da5-8c0c-41c7-99d9-fd9fd8c0c7fe"
      unitRef="shares">63516</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE0MDk_37e6ef04-94e0-4a9e-93ec-4f9acb1235a0"
      unitRef="shares">329870</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE0ODA_249763c3-0987-4cbf-8bfe-e9f0d86faccb"
      unitRef="usdPerShare">65.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3119f9b2f1ba470493211caa9ed77ebb_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE1MTU_a80872b9-6570-4e74-b8db-c1c64ea87ca8"
      unitRef="usd">21600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i10a8b70f27484636b98e9821a55c5304_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE1NDU_fa286365-2e0c-4d55-827c-1b76350cb8c5"
      unitRef="shares">237119</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i00c3280bc64040eb92d3e3380fb6b522_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzE2MDc_d734a1fc-d6c3-4f61-93dd-bd2a858e01d1"
      unitRef="shares">118611</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <iclr:StockRepurchaseProgramAuthorizedPercentage
      contextRef="if98fe533fad34c48891d45c338b523fb_D20160722-20160722"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzI1MTE_8d27351f-0307-47d3-8ca5-e6079c2f6869"
      unitRef="number">0.10</iclr:StockRepurchaseProgramAuthorizedPercentage>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i64c25c9fbdc24c8e8f96527346976256_I20161003"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzI3NTY_0beecf2e-a8e0-41a2-bcea-da4ddc289aab"
      unitRef="usd">400000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="iebd957ddedf34e7eb4e6d9840ebd08ab_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MDkw_9db3f2ee-9fb4-4424-b2cb-fc3f9c2986b6"
      unitRef="shares">4026576</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="iebd957ddedf34e7eb4e6d9840ebd08ab_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTAx_3340b63b-0246-465e-b15f-49d8bf83a268"
      unitRef="usd">372100000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i0bc02d64aa5f4b4d8b36a740dd3bc014_I20190108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTE3_26a518d3-b2b3-448c-ae0e-458da1afcd94"
      unitRef="shares">1000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ia044a3b1cbe441bc85cbe89198164aad_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTMw_7d36122d-8d65-4861-92a5-2a7833515251"
      unitRef="usd">141600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i53e8433bda4546de9704023960c6b72f_D20191231-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTQ2_5c3ea27a-739f-48b5-a213-5a1951d2ff1e"
      unitRef="shares">35100</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i53e8433bda4546de9704023960c6b72f_D20191231-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTU0_ee2c7733-8160-4adc-a025-9b17d8df92b3"
      unitRef="usd">5300000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="id3d7547a1a224157af8991715ce82080_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTY4_9bffa382-f47d-444e-9455-32092fefbab1"
      unitRef="shares">1235218</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="id3d7547a1a224157af8991715ce82080_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzUvZnJhZzo4ZWI4YzgyZTdiNDY0MGRiYmY2ZDYyYjBmZGYyYjkwZC90ZXh0cmVnaW9uOjhlYjhjODJlN2I0NjQwZGJiZjZkNjJiMGZkZjJiOTBkXzEwOTk1MTE2Mjg2MTc5_15d81a82-327c-4830-b61a-47a967cf519e"
      unitRef="usd">175000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NTc_735b6055-4aae-4946-9610-6445ace808bf">Income Taxes&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The components of income before income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;323,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(278,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;426,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The components of income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax (benefit)/expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense allocated to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense was allocated to the following components of other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ireland's statutory income tax rate is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other income taxed at higher rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effects of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,201,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax liabilities recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,289,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss and tax credits carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Overall net deferred tax asset/(liability)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,037,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $14.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $10.3 million and $297.0 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $10.3 million U.S. federal NOLs, approximately $5.0 million is available for offset against future U.S. federal taxable income in 2022. The subsidiaries' ability to use the  remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $10.3 million are limited by Section 382 as follows: $10.2 million for the years 2022 - 2035 and $0.1 million in 2036 - 2040. As at December&#160;31, 2021, U.S subsidiaries also had disallowed interest carryforwards of $145.7&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $42.3 million. At December&#160;31, 2021 those subsidiaries also had additional operating loss carryforwards of $19.9 million which are due to expire between 2022 and 2028 and operating loss carryforwards of $19.9 million which are due to expire between 2029 and 2038. In addition, at December&#160;31, 2021 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $5.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected expiry dates of these US losses are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Federal&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;State&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022-2035&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2036-2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The valuation allowance at December&#160;31, 2021 was approximately $45.5 million. The valuation allowance for deferred tax assets as of December&#160;31, 2020 and December&#160;31, 2019 was $32.8 million and $27.7 million respectively. The net change in the total valuation allowance was an increase of $12.8 million during 2021 and an increase of $5.1 million during 2020. Of the total increase of $12.8 million in 2021, $9.3 million was in respect of acquired entity, $4.4 million was recognized within income tax expense and a decrease of $0.9 million was recognized in Other Comprehensive Income. Of the total increase of $5.1 million in 2020, $3.6 million resulted in a current year income tax expense, and $1.5 million was recognized in Other Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The valuation allowances at December&#160;31, 2021 and December&#160;31, 2020 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has recognized a deferred tax liability of $0.8 million (2020: $0.9 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#x2019;s tax treaty network and the EU parent subsidiary directive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to acquired tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The relevant statute of limitations for unrecognized tax benefits totaling $38.8 million could potentially expire during 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Included in the balance of total unrecognized tax benefits at December&#160;31, 2021 were potential benefits of $202.1 million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2020 and December&#160;31, 2019 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $19.1 million and $20.2 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest and penalties recognized during the year ended December&#160;31, 2021 amounted to a net charge of $1.9 million (2020: ($0.6 million), 2019: Nil) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2021 and December&#160;31, 2020 were $15.5 million and $0.5 million respectively and are included in closing income taxes payable at those dates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020 and December&#160;31, 2021. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020 and December&#160;31, 2021. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <iclr:IncomeBeforeIncomeTaxTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4MzU_7837f12b-723a-47bc-962f-841b71536c89">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The components of income before income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;323,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(278,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;426,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:IncomeBeforeIncomeTaxTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzMtMS0xLTEtMzYyNDg_c5c35c09-441f-4a0f-86c1-da8fb0d5e504"
      unitRef="usd">231893000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzMtMi0xLTEtMzYyNDg_3c7151a8-075e-4613-a446-9e2891294da5"
      unitRef="usd">280310000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzMtMy0xLTEtMzYyNDg_c6e80c1b-2591-44db-a50b-f66a9cf3979e"
      unitRef="usd">323726000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzQtMS0xLTEtMzYyNDg_d0a5bc03-9d5d-471a-9015-4a70741943f2"
      unitRef="usd">-278413000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzQtMi0xLTEtMzYyNDg_1ec70091-6c00-40a4-9a71-a69915452b49"
      unitRef="usd">41950000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzQtMy0xLTEtMzYyNDg_d93c32de-7a11-4c63-bb25-d600d233aecf"
      unitRef="usd">21073000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5b675ea0523544f39cc9dc1c1d30c495_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzUtMS0xLTEtMzYyNDg_2fbcaf3c-7a8b-45e7-b915-3acba79b0016"
      unitRef="usd">243200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ifc9dba39f11143b7a99700fa9154586e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzUtMi0xLTEtMzYyNDg_dd074ff0-1b16-47cc-ab9b-a602e78202a0"
      unitRef="usd">58945000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2aabd4a6d84543e59b0b347ddb8394d7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzUtMy0xLTEtMzYyNDg_0830a6b5-4aad-477d-a3d2-143a146e4505"
      unitRef="usd">82190000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzYtMS0xLTEtMzYyNDg_6b48f98f-f412-4080-8a55-90eee3cfbef4"
      unitRef="usd">196680000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzYtMi0xLTEtMzYyNDg_d3ba0f36-fea4-43c3-b51c-bfa66d47a98e"
      unitRef="usd">381205000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo5OThkMGYzMzFhZGE0Mjg1YmNjNGFkN2VlZTM4MDcyNS90YWJsZXJhbmdlOjk5OGQwZjMzMWFkYTQyODViY2M0YWQ3ZWVlMzgwNzI1XzYtMy0xLTEtMzYyNDg_07afac91-23b7-49a5-a366-85e8643414fd"
      unitRef="usd">426989000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NTM_396d616d-4e36-452d-81d6-e411549e462f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The components of income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax (benefit)/expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense allocated to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense was allocated to the following components of other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzUtMS0xLTEtMzYyNDg_0e5f784c-ed69-4a14-b968-892ab694b9af"
      unitRef="usd">18469000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzUtMi0xLTEtMzYyNDg_81f07fa5-9975-42ac-9352-a91e5380cf9d"
      unitRef="usd">28963000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzUtMy0xLTEtMzYyNDg_4263a75c-9d0b-4298-b71e-07f82b7c1942"
      unitRef="usd">35955000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzYtMS0xLTEtMzYyNDg_81497290-19a2-4d6c-822d-20f729fd9b3f"
      unitRef="usd">35478000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzYtMi0xLTEtMzYyNDg_8aad226e-bd8b-4d46-8da0-53826f87f19a"
      unitRef="usd">3022000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzYtMy0xLTEtMzYyNDg_eaa5d65d-51a0-44ca-8ba7-1db3dfad6768"
      unitRef="usd">5073000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5b675ea0523544f39cc9dc1c1d30c495_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzctMS0xLTEtMzYyNDg_7f9be069-b363-4e92-a057-758a4cf2f89d"
      unitRef="usd">48003000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ifc9dba39f11143b7a99700fa9154586e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzctMi0xLTEtMzYyNDg_5abba59e-14d4-44b9-a563-38785f40ab2f"
      unitRef="usd">14963000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2aabd4a6d84543e59b0b347ddb8394d7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzctMy0xLTEtMzYyNDg_4eea3ab5-d1c2-4eed-9bc8-5bac8754d279"
      unitRef="usd">11642000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzgtMS0xLTEtMzYyNDg_4899cbc3-a2bf-44b2-a5ee-82a5885d12ad"
      unitRef="usd">101950000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzgtMi0xLTEtMzYyNDg_ac056aa3-b2f6-4001-93b0-4b20aa8a4eaa"
      unitRef="usd">46948000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzgtMy0xLTEtMzYyNDg_d0c4f34b-4cb6-4c99-bf8d-50833c15e26e"
      unitRef="usd">52670000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzExLTEtMS0xLTM2MjQ4_f995a56a-b828-4435-bced-eae5de3f09d3"
      unitRef="usd">553000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzExLTItMS0xLTM2MjQ4_fece122d-ead8-4591-bc86-e8341b48bce9"
      unitRef="usd">1654000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzExLTMtMS0xLTM2MjQ4_a36868a5-5aae-4cb0-bacf-ca2c018b1a8d"
      unitRef="usd">2833000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEyLTEtMS0xLTM2MjQ4_ca6affdc-af4d-4eba-9539-42ba6ca9904c"
      unitRef="usd">-52717000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEyLTItMS0xLTM2MjQ4_e5ea67d9-5d64-4956-abbb-6a74744cefad"
      unitRef="usd">4577000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEyLTMtMS0xLTM2MjQ4_9171c768-3b50-480d-94e0-2a7d502c1399"
      unitRef="usd">-3502000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5b675ea0523544f39cc9dc1c1d30c495_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEzLTEtMS0xLTM2MjQ4_02912249-ddc3-4007-8e5e-6ba3d17cc4e4"
      unitRef="usd">-8452000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ifc9dba39f11143b7a99700fa9154586e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEzLTItMS0xLTM2MjQ4_0b784b59-b3b7-411c-a7e2-7731f0f5fc6b"
      unitRef="usd">-5304000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2aabd4a6d84543e59b0b347ddb8394d7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzEzLTMtMS0xLTM2MjQ4_cd324021-4c74-49c0-ac24-b8e902752ca5"
      unitRef="usd">-868000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE0LTEtMS0xLTM2MjQ4_129193f6-50c3-4845-ad0c-506136296397"
      unitRef="usd">-60616000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE0LTItMS0xLTM2MjQ4_08a05fee-5671-46cc-bc4a-00f1956b63f6"
      unitRef="usd">927000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE0LTMtMS0xLTM2MjQ4_079c7597-ffae-4fa0-8a2c-b82a1cbe9686"
      unitRef="usd">-1537000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE2LTEtMS0xLTM2MjQ4_09d08b56-a572-49f5-89ac-d29e92f11b4a"
      unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE2LTItMS0xLTM2MjQ4_23bff1af-f0ec-4288-a7e6-d97e5f5ee4f4"
      unitRef="usd">47875000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzE2LTMtMS0xLTM2MjQ4_13d35868-8e91-4a50-b194-248ef7ea8984"
      unitRef="usd">51133000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIwLTEtMS0xLTM2MjQ4_5071dc51-d307-44cf-bc22-bd98ea5795ca"
      unitRef="usd">49000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIwLTItMS0xLTM2MjQ4_ed423173-5dc6-4501-bb18-ca2f811209e1"
      unitRef="usd">68000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIwLTMtMS0xLTM2MjQ4_be6d9187-8cb5-426d-98a8-30bbc6e88e95"
      unitRef="usd">25000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIzLTEtMS0xLTM2MjQ4_080ba941-8ee6-4155-b747-dcdff78f8783"
      unitRef="usd">41383000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIzLTItMS0xLTM2MjQ4_773b02d0-e240-4280-877b-fc95de07fcd7"
      unitRef="usd">47943000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo3OTJkYjFlZWNkM2E0Yzk3OGU3ZTUwNmFiZjNmYjZmZS90YWJsZXJhbmdlOjc5MmRiMWVlY2QzYTRjOTc4ZTdlNTA2YWJmM2ZiNmZlXzIzLTMtMS0xLTM2MjQ4_5a08348a-460b-4799-b9cd-3197e0aeee52"
      unitRef="usd">51158000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NTA_89e6bfef-3ef2-497f-a20c-5887cbaecb6d">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other income taxed at higher rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effects of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzMtMS0xLTEtMzYyNDg_c7734cb8-1a73-4088-8f6d-b641ab963ba1"
      unitRef="usd">24586000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzMtMi0xLTEtMzYyNDg_af8d605f-53df-4660-bd1d-50f373d42dcd"
      unitRef="usd">47651000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzMtMy0xLTEtMzYyNDg_e51267ac-0c8b-4399-8267-ce6a413961e9"
      unitRef="usd">53374000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzQtMS0xLTEtMzYyNDg_5d3ebf5d-5b0d-4d09-8553-d9294c01351d"
      unitRef="usd">20045000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzQtMi0xLTEtMzYyNDg_51468266-ec22-49d2-be61-24fce426f26f"
      unitRef="usd">7943000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzQtMy0xLTEtMzYyNDg_d6c97d41-1628-4795-97b3-2b389083400d"
      unitRef="usd">7356000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzUtMS0xLTEtMzYyNDg_dac662a0-0106-437d-b901-22323b09f565"
      unitRef="usd">3120000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzUtMi0xLTEtMzYyNDg_d86a4424-ffc9-45e1-94ff-9e7da60eb579"
      unitRef="usd">1243000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzUtMy0xLTEtMzYyNDg_b4064f62-41e6-4fd3-8caa-1c9d9a3f7c3d"
      unitRef="usd">893000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzYtMS0xLTEtMzYyNDg_b6d37989-c05c-46e4-a03e-306749c9dc2a"
      unitRef="usd">3101000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzYtMi0xLTEtMzYyNDg_9f20b1e2-1d27-404e-a912-c32b373d8a34"
      unitRef="usd">3581000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzYtMy0xLTEtMzYyNDg_ee79deb7-6ae7-45ed-9c8f-cac64ea71366"
      unitRef="usd">-10000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzctMS0xLTEtMzYyNDg_9d7dcd3e-237f-456b-a08c-f5fabb76e2a6"
      unitRef="usd">-128000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzctMi0xLTEtMzYyNDg_cdb27d3e-ad92-424b-9002-30b8214d625d"
      unitRef="usd">108000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzctMy0xLTEtMzYyNDg_34bfb424-2362-4322-aebc-177b447ffa19"
      unitRef="usd">359000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzgtMS0xLTEtMzYyNDg_df010ddc-151a-4781-8881-562dbfeed68f"
      unitRef="usd">5246000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzgtMi0xLTEtMzYyNDg_c4e273d1-4d03-4509-af7b-0c7efb8a0040"
      unitRef="usd">-1672000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzgtMy0xLTEtMzYyNDg_3f497115-c767-41c9-ba13-a0f73f041e48"
      unitRef="usd">-1273000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzktMS0xLTEtMzYyNDg_2bd945fa-6306-4efd-9660-3a7d3807c8ed"
      unitRef="usd">-9083000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzktMi0xLTEtMzYyNDg_48a8473a-fe48-4c83-9c9b-7bb68d7a82a2"
      unitRef="usd">-5150000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzktMy0xLTEtMzYyNDg_dbd4f620-16b6-4619-a153-519a0ae89e02"
      unitRef="usd">-7383000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzExLTEtMS0xLTM2MjQ4_8e7a0605-298c-45b9-a077-d34a7bc681a2"
      unitRef="usd">687000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzExLTItMS0xLTM2MjQ4_3859fd33-35d4-4a17-82d3-e1e225af3b00"
      unitRef="usd">-3343000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzExLTMtMS0xLTM2MjQ4_49c228e6-1a55-4989-882f-2dbb72673009"
      unitRef="usd">-397000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzEyLTEtMS0xLTM2MjQ4_a50da586-8d3e-455f-8633-4aa5a55235b8"
      unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzEyLTItMS0xLTM2MjQ4_e9d80bda-a732-4a44-942e-f6e140b444b8"
      unitRef="usd">47875000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTo0MDU1OWQ3YWVhZTA0ZjJiOWRmNGE1MGE4MDEzMzJmMy90YWJsZXJhbmdlOjQwNTU5ZDdhZWFlMDRmMmI5ZGY0YTUwYTgwMTMzMmYzXzEyLTMtMS0xLTM2MjQ4_e5c9e6d7-4ddf-4dc6-b6e9-ca95e0f3d17a"
      unitRef="usd">51133000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NTU_51485398-a0ba-4285-8338-3075022824cb">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,201,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax liabilities recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,289,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss and tax credits carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Overall net deferred tax asset/(liability)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,037,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzMtMS0xLTEtMzYyNDg_2830ae1e-72ac-4f97-b3a3-d7d63db00003"
      unitRef="usd">19606000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzMtMi0xLTEtMzYyNDg_f456aef0-be2c-42a1-a4ce-037648207875"
      unitRef="usd">1359000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzQtMS0xLTEtMzYyNDg_47ed33f5-0c18-420c-a7ec-2f4644a9638b"
      unitRef="usd">33449000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzQtMi0xLTEtMzYyNDg_ad7f6013-6025-4851-af2b-f46220a8e4fb"
      unitRef="usd">9402000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzUtMS0xLTEtMzYyNDg_71b34ccf-8057-443a-95b5-030318121bf8"
      unitRef="usd">33354000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzUtMi0xLTEtMzYyNDg_b22d7abe-5813-47cd-90dd-b9e5ccda12aa"
      unitRef="usd">31629000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzYtMS0xLTEtMzYyNDg_197da601-bc12-4fc5-a673-90c6e0bdec50"
      unitRef="usd">1201086000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzYtMi0xLTEtMzYyNDg_f63b00b9-46db-47ed-8819-75125cb348ff"
      unitRef="usd">13398000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzctMS0xLTEtMzYyNDg_c33d734b-6704-4502-b70c-3a74d0263bbb"
      unitRef="usd">1761000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzctMi0xLTEtMzYyNDg_c8caa976-2e5b-4e82-8e4c-f0fadb5b2190"
      unitRef="usd">1009000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzgtMS0xLTEtMzYyNDg_3bf55f03-9bbb-45d3-8a59-17b2109168b7"
      unitRef="usd">1289256000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzgtMi0xLTEtMzYyNDg_70576892-e689-4b27-9982-925d17625dff"
      unitRef="usd">56797000</us-gaap:DeferredIncomeTaxLiabilities>
    <iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzExLTEtMS0xLTM2MjQ4_a4ee9901-16d3-456b-b50c-0402cd1e4e79"
      unitRef="usd">86893000</iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards>
    <iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzExLTItMS0xLTM2MjQ4_4527b80a-1c49-49da-8255-a78a80a1f712"
      unitRef="usd">42794000</iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzEyLTEtMS0xLTM2MjQ4_f6f0c2da-c9ab-4249-88d9-597ea77f64b5"
      unitRef="usd">5846000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzEyLTItMS0xLTM2MjQ4_b9d82fc2-ff9e-4eb9-ad16-2bde59b0e211"
      unitRef="usd">6040000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <iclr:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzEzLTEtMS0xLTM2MjQ4_cae887a7-2f7d-4d4c-ad51-3914e18c1fe1"
      unitRef="usd">36106000</iclr:DeferredTaxAssetsOperatingLeaseLiability>
    <iclr:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzEzLTItMS0xLTM2MjQ4_4b8f7036-24f0-4863-a7a4-01730113f0e7"
      unitRef="usd">9394000</iclr:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE0LTEtMS0xLTUzNDQ2_25d4139c-48cc-419f-8f9c-0dd979adf64d"
      unitRef="usd">4596000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE0LTItMS0xLTUzNDQ2_482e82b1-f077-4e33-8696-e6834c8ae549"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE0LTEtMS0xLTM2MjQ4_8a71bac3-60a3-411c-a52d-2774cf25f461"
      unitRef="usd">69198000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE0LTItMS0xLTM2MjQ4_dd7bb491-6225-4609-acff-f66b4bd7082f"
      unitRef="usd">24368000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE1LTEtMS0xLTM2MjQ4_61b333ed-c7ca-4e4e-812f-7e49ceb46148"
      unitRef="usd">25557000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE1LTItMS0xLTM2MjQ4_8d0fa302-b283-442e-9815-14cdff5657e5"
      unitRef="usd">3672000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE2LTEtMS0xLTM2MjQ4_478031f7-437b-4255-8fab-c732ea293a91"
      unitRef="usd">3445000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE2LTItMS0xLTM2MjQ4_b0db8b02-1906-4c8a-a52e-88fb4bd54425"
      unitRef="usd">3184000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <iclr:DeferredTaxAssetContractWithCustomerLiability
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE3LTEtMS0xLTM2MjQ4_3f2e46d8-da05-4a41-a438-05c440db71ac"
      unitRef="usd">64924000</iclr:DeferredTaxAssetContractWithCustomerLiability>
    <iclr:DeferredTaxAssetContractWithCustomerLiability
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE3LTItMS0xLTM2MjQ4_abb6e06c-5a65-4c62-b576-8b7c0184cfb8"
      unitRef="usd">2257000</iclr:DeferredTaxAssetContractWithCustomerLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE4LTEtMS0xLTM2MjQ4_98fad342-cba8-4e6f-8284-9af803a718f3"
      unitRef="usd">602000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE4LTItMS0xLTM2MjQ4_54f68961-6207-4cbc-bcf4-f84e6c289933"
      unitRef="usd">155000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE5LTEtMS0xLTM2MjQ4_600581bb-589f-4c90-ba7f-07bda8d66d9d"
      unitRef="usd">297167000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzE5LTItMS0xLTM2MjQ4_14c2b8ec-4ea3-40e1-b5f6-e0c42ae2842a"
      unitRef="usd">91864000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIwLTEtMS0xLTM2MjQ4_b467790f-958b-4407-b232-67637a76464d"
      unitRef="usd">45495000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIwLTItMS0xLTM2MjQ4_b87c93f7-6932-466f-b43d-98be801af1f6"
      unitRef="usd">32768000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIxLTEtMS0xLTM2MjQ4_5e664aeb-1f31-4a10-a873-ac1c5e1b8839"
      unitRef="usd">251672000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIxLTItMS0xLTM2MjQ4_b926468a-4d1e-4518-8d8c-bfc82ae9e14e"
      unitRef="usd">59096000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIyLTEtMS0xLTM2MjQ4_9bf7817a-ddbc-47b9-9523-d8a511aabcc0"
      unitRef="usd">1037584000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpjYjNiY2JjM2UzZGI0N2IwYmYzNTJiZGQzOTkzZGIzYi90YWJsZXJhbmdlOmNiM2JjYmMzZTNkYjQ3YjBiZjM1MmJkZDM5OTNkYjNiXzIyLTItMS0xLTM2MjQ4_3e63f834-84d0-49ee-9bc0-2b1d165b8e2f"
      unitRef="usd">2299000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration
      contextRef="icd1b1b778ce1423d993f536ec42792a4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzkyOQ_d74bb9d1-266a-4a2e-8a15-d7e1f6592426"
      unitRef="usd">14000000</iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i8b603335e3c141be945379a94b120638_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEwNDQ_f7af84da-5d5e-4358-bf3c-553ca4ff8742"
      unitRef="usd">10300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="if1def15985c34968963f6b9121b38e63_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEwNTE_24fa8940-8886-46e5-b32c-56fe18446ef6"
      unitRef="usd">297000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i8b603335e3c141be945379a94b120638_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzExOTM_f7af84da-5d5e-4358-bf3c-553ca4ff8742"
      unitRef="usd">10300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <iclr:OperatingLossCarryforwardsUSFederal
      contextRef="i844861916668498588f0491ce84b368e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEyMjk_3037bb34-93a7-4a3e-931e-ab1c186f9d8c"
      unitRef="usd">5000000</iclr:OperatingLossCarryforwardsUSFederal>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8b603335e3c141be945379a94b120638_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzE1ODE_043ebecc-b75a-4cad-bb9e-55ba84c5a38a"
      unitRef="usd">10300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia7ad5c604007471b856dd9490f6f5c80_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzE2MjM_e443259a-c1d8-477b-8a86-be6c993e9a8a"
      unitRef="usd">10200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i5bf376e140f446a785d5f08cdd6bfebc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzE2NTM_7a3bdbce-9fe3-44c3-a578-8aba3dac6349"
      unitRef="usd">100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i8b603335e3c141be945379a94b120638_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEwOTk1MTE2NTQ1NTc_867e3596-e1a0-4cad-9f86-ed8c60b5ddb5"
      unitRef="usd">145700000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i983be088cf6b46e6ac433beda8d697ec_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzIyMjU_1f6e4ad8-c223-4f9d-806d-6a08a8621179"
      unitRef="usd">42300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="iecd57dd26a63495fb590d21da1ee1dd2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzIzMDY_9a3af0d0-87bf-441a-9ffe-d86ccdff29f5"
      unitRef="usd">19900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="ie7a5026822b54a889031ee7975200e68_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzIzOTE_5170682b-4c36-4a7e-933a-77d564327271"
      unitRef="usd">19900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration
      contextRef="i441eef7611ae4627900c2aa94e200087_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzI2NTI_f8bbaa40-628a-4d80-a673-1988827a39c8"
      unitRef="usd">5300000</iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4NDM_c9367ed3-898c-4371-b235-a457f721fc1e">The expected expiry dates of these US losses are as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Federal&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;State&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022-2035&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2036-2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="ia7ad5c604007471b856dd9490f6f5c80_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzItMS0xLTEtMzYyNDg_f247a4eb-ab99-4d5d-9e4b-d27d4cccbd5c"
      unitRef="usd">10238000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i15c96a63b4834593b815f76192244271_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzItMi0xLTEtMzYyNDg_04b5ca2a-b462-470d-b6b5-a0324ea665d1"
      unitRef="usd">227538000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i5bf376e140f446a785d5f08cdd6bfebc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzMtMS0xLTEtMzYyNDg_1e26a441-d471-4c77-b79d-29a6a9a1e192"
      unitRef="usd">16000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i4899bcc705b74b12bfb11fcc895a643d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzMtMi0xLTEtMzYyNDg_d098ea73-8633-4f5a-98bd-c6c4d004322b"
      unitRef="usd">25073000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i8b603335e3c141be945379a94b120638_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzQtMS0xLTEtMzYyNDg_7f173b20-3992-426e-a729-93163ae2279c"
      unitRef="usd">95000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="if1def15985c34968963f6b9121b38e63_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzQtMi0xLTEtMzYyNDg_96ccaaab-8c08-44ee-893b-df60e922f4de"
      unitRef="usd">44370000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i8b603335e3c141be945379a94b120638_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzYtMS0xLTEtMzYyNDg_1d8b2afa-5dc5-4f31-b8f9-dbb080a27837"
      unitRef="usd">10349000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="if1def15985c34968963f6b9121b38e63_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTozNjNhNTI4Y2FiNGQ0M2VkOWIzMjUzMWNhYjg0MTBkMi90YWJsZXJhbmdlOjM2M2E1MjhjYWI0ZDQzZWQ5YjMyNTMxY2FiODQxMGQyXzYtMi0xLTEtMzYyNDg_ce832440-dabe-497e-99de-08a7f25c1f12"
      unitRef="usd">296981000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
      contextRef="i844861916668498588f0491ce84b368e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzI4MTA_62f65a92-2112-43db-9962-bdeb6aea3cd2"
      unitRef="usd">800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMwMzg_475c94e0-9bb4-4ccb-acf2-f063ce354a01"
      unitRef="usd">45500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMxMTA_00753b7f-c9a2-470a-8f69-02175dc994f9"
      unitRef="usd">32800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMxMTc_f8c1dda9-4165-49a4-8969-d80c88923358"
      unitRef="usd">27700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMyMDE_e664c6c2-4033-4660-930e-5e3ea3675517"
      unitRef="usd">12800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMyMzM_23cc198e-b95e-490d-a7fb-438b6c24411f"
      unitRef="usd">5100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMyNzI_e664c6c2-4033-4660-930e-5e3ea3675517"
      unitRef="usd">12800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzEwOTk1MTE2NTQ3NTI_03f4d3ee-9fe9-43b2-a8a6-7b3f2591d4dc"
      unitRef="usd">9300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i9da9a786e8de49f39d28567667a24931_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMyODI_67904eee-f4ac-4276-80fe-ae19f05049d9"
      unitRef="usd">4400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i5533029580bc4f90b5489c2ed50c777c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzMzMzA_9e527d92-28aa-4130-bf65-1c807b840cfc"
      unitRef="usd">900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzM0MDQ_23cc198e-b95e-490d-a7fb-438b6c24411f"
      unitRef="usd">5100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i58e5f687cc39462f8d659f4d701f5ac0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzM0MTU_f790240d-c4ec-426c-92fd-cfd610cce6a8"
      unitRef="usd">3600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i896d44f274c24721bd6b58ccbd470666_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzM0Njk_9ca1d0af-b678-4dc3-a6f0-fd9839255bfd"
      unitRef="usd">1500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzQ1NjA_afe5580d-1752-4573-b08e-7f0f4a1f1c9c"
      unitRef="usd">800000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzQ1Njg_ea8f7e65-9b4c-4528-86e1-3907742a3147"
      unitRef="usd">900000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzY4Mzk_78108a8b-6b98-4f3a-ab4f-b4f042789417">&lt;div style="margin-bottom:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to acquired tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzItMS0xLTEtMzYyNDg_9a4298f7-ad2a-43a0-957f-7586e6cc691d"
      unitRef="usd">19078000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzItMi0xLTEtMzYyNDg_5eb1d8ae-738d-4ea5-90a6-5a67c463fb68"
      unitRef="usd">20156000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie3e24d855ba14a97a64dd8c818215580_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzItMy0xLTEtMzYyNDg_c2c7670a-d6ad-47ad-bebf-7cc8336225a7"
      unitRef="usd">21433000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMS0xLTEtNTM0NTM_1c416707-4ffb-4318-8d52-72c81681014a"
      unitRef="usd">170047000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMi0xLTEtNTM0NTM_66e114e0-36ea-4aca-b83e-60f4235a46c8"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMy0xLTEtNTM0NjM_803fdf72-2f99-4cdc-91c1-3c2f3ca346f8"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMS0xLTEtMzYyNDg_d2ae1d94-9e68-4a19-9ccb-b9f597a30f05"
      unitRef="usd">204000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMi0xLTEtMzYyNDg_f1a5ead1-3160-477d-99ab-64d1dab4e610"
      unitRef="usd">401000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzMtMy0xLTEtMzYyNDg_581e26ba-70e8-4bfe-a4c7-ae58c1312e1a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzQtMS0xLTEtMzYyNDg_34917c83-380a-4319-bedc-11e53820b226"
      unitRef="usd">1695000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzQtMi0xLTEtMzYyNDg_cece85f4-296e-494c-af48-38ff1f61e782"
      unitRef="usd">1271000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzQtMy0xLTEtMzYyNDg_ea9375d5-aa29-498a-8f14-a24313e09e3e"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzUtMS0xLTEtMzYyNDg_d909df72-fc08-47e8-8ce3-474724b11dbd"
      unitRef="usd">18613000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzUtMi0xLTEtMzYyNDg_70a53313-61bc-4d0d-994f-6a515d20c72c"
      unitRef="usd">2931000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzUtMy0xLTEtMzYyNDg_e47202e7-8307-4f3f-83f9-910219895ff5"
      unitRef="usd">1588000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzYtMS0xLTEtMzYyNDg_ee4eb465-df13-41f8-a573-859716bccd53"
      unitRef="usd">844000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzYtMi0xLTEtMzYyNDg_6fff2dc5-a1c4-4e3a-94b5-2ba8e6c4de2d"
      unitRef="usd">369000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzYtMy0xLTEtMzYyNDg_9fbe015d-2d4b-41d1-8af7-d96c36fc27b6"
      unitRef="usd">347000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzctMS0xLTEtMzYyNDg_f06bdd04-e934-44d9-b303-fe6c0cfc3ce3"
      unitRef="usd">3338000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzctMi0xLTEtMzYyNDg_eccc153d-aa6b-4450-a161-a40726f6424f"
      unitRef="usd">2770000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzctMy0xLTEtMzYyNDg_5bff28a0-9826-49e9-a722-cde27855c5f7"
      unitRef="usd">2518000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzgtMS0xLTEtMzYyNDg_648934e0-5c91-4619-9cf5-0eb60ee4cdfc"
      unitRef="usd">202065000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzgtMi0xLTEtMzYyNDg_3a4fcfa9-a869-4026-9403-c589ff7c0bf1"
      unitRef="usd">19078000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90YWJsZTpkMzQ5ZDlmMWU2YmU0NzA5ODVjMjZlYmU3ZTc2MTY1ZC90YWJsZXJhbmdlOmQzNDlkOWYxZTZiZTQ3MDk4NWMyNmViZTdlNzYxNjVkXzgtMy0xLTEtMzYyNDg_40f670ed-d82a-4828-97b6-b1232ba6d4ea"
      unitRef="usd">20156000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzU2NDQ_68ee2dfc-8fbd-41e5-bf25-931190808bf9"
      unitRef="usd">38800000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzU3ODA_8cfb4fb4-e02d-4cfa-8878-76588aa8d70f"
      unitRef="usd">202100000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYwNjU_6334d045-02fb-425d-9bec-7133b720b86c"
      unitRef="usd">19100000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYwNzI_8f59304a-85ce-4c6b-9d2c-469ff3e0f8e2"
      unitRef="usd">20200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYxNzk_35b441c8-8b4c-42e1-aa02-ea9fcd462aa2"
      unitRef="usd">1900000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYxODc_a38d8002-16a8-490f-823b-7d9eba804018"
      unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYyMTA_0df3acea-d514-4afe-a1bf-cbc910d237b3"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYzMjA_f4543833-5e4d-489b-bd44-cf763b7b5d1b"
      unitRef="usd">15500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xNzgvZnJhZzphYTBiZTM4Zjk3MjM0MTQ3YmNiNjI0MTczOGFiNGY1Mi90ZXh0cmVnaW9uOmFhMGJlMzhmOTcyMzQxNDdiY2I2MjQxNzM4YWI0ZjUyXzYzMjc_5a757c9f-5dd1-4563-b308-4868bbdf4917"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE0MDY_f7bdd610-2eb1-4edb-97ef-5b20422631fa">Restructuring charges&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A restructuring charge of $31.1&#160;million was recognized during the year ended December&#160;31, 2021 under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $4.8&#160;million relating to workforce reductions, an impairment of ROU assets and associated unavoidable costs totaling $21.9&#160;million and fixed asset impairment of $4.4&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net charge&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, a total liability of $28.4 million was on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $23.2 million from lease and lease related liabilities of which $10.4&#160;million is included within other liabilities and $12.8 million is included within non-current operating lease liabilities. The remaining provision of $5.2&#160;million relates to workforce reduction and is included within other liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional provision in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,978)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCosts
      contextRef="iae97c86e7991410685e37fea162dced3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzIxOTkwMjMyNjYxODg_8708d642-7992-4243-85b0-af5cde6d57b3"
      unitRef="usd">31100000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ia73c34c13a8742aa9e45adff138292ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzI2Mzg4Mjc5MDczNzMw_2235fb73-1360-4d50-8ac1-9f0dbc416e6b"
      unitRef="usd">4800000</us-gaap:RestructuringCosts>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="iae97c86e7991410685e37fea162dced3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE1MzkzMTYyODAwMzI5_27e23d06-85fd-4de5-93bf-ab4483157c7a"
      unitRef="usd">21900000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="iae97c86e7991410685e37fea162dced3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2MzY0NjY_4871355c-a202-406f-964d-82c5e89b57a5"
      unitRef="usd">4400000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE0MDk_e44879ab-d0a1-490b-bd5a-d8da8cccb233">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net charge&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzMtMS0xLTEtMzYyNDg_45dc1f03-6121-4a1b-bc4b-884687c5e60d"
      unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzMtMi0xLTEtMzYyNDg_bd56a70d-e6a1-44b4-b77a-9f7abaa4a515"
      unitRef="usd">18089000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzMtMy0xLTEtMzYyNDg_87968755-a4b2-459c-9dda-5b7a8dff9475"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzQtMS0xLTEtMzYyNDg_23b19524-ba51-4aa1-8b73-6578241e80ef"
      unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzQtMi0xLTEtMzYyNDg_ee7df673-2f7d-4f49-b444-2914f6080b64"
      unitRef="usd">18089000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTo4YTQ2Mzg2N2MxOTY0ODg0OWE3MmM3ZGIyMjM1MGJjZS90YWJsZXJhbmdlOjhhNDYzODY3YzE5NjQ4ODQ5YTcyYzdkYjIyMzUwYmNlXzQtMy0xLTEtMzYyNDg_55d2fd4a-36e7-4fdf-bd83-079340446ef3"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringReserve
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2Mjg1ODE4_70079421-223b-448f-91d8-cf95423b3a9e"
      unitRef="usd">28400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie267803461c24ea8b3916fbd1ae6771c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2Mzg4MTU_05822a0b-2290-4890-b025-047435b99c23"
      unitRef="usd">23200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8dc5a2134f884432820063e1b886264a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2Mzg4MjI_efa3b510-e80e-4f00-8581-3f7c8d866298"
      unitRef="usd">10400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id23f0621c3b244fd89bd3711026df87b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzEwOTk1MTE2Mzg4MzE_b14eaaae-6bf0-4fee-9022-3e355a180c40"
      unitRef="usd">12800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i04f1dd5a84134d2894c1da8788efa67c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE1MzkzMTYyNzk0NDQx_63723ba5-1d3c-4fde-b451-0f5aa0309f24"
      unitRef="usd">5200000</us-gaap:RestructuringReserve>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE0MTQ_a10ed1f9-d6d8-4b15-9e47-50439aaa7afc"
      xsi:nil="true"/>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90ZXh0cmVnaW9uOmQ1Nzg2MmJmYTJiMDRkMjBhZGMwNTRjMmI2ZDhkODI3XzE0MDA_de2c4a17-6d5e-4341-972e-e3e750dcd875">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional provision in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,978)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzQtMS0xLTEtNDcwMzg_72a437b4-82b4-4082-802e-2d7da052138e"
      unitRef="usd">10748000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzQtMi0xLTEtNDcwMzg_cd264c21-a1ed-48c7-ba80-dcb033ef667b"
      unitRef="usd">1637000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie3e24d855ba14a97a64dd8c818215580_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzQtMy0xLTEtNDcwMzg_2a8b9a52-af1c-4e39-8f27-00953b87a13e"
      unitRef="usd">6419000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzUtMS0xLTEtNDcwMzg_61592d2f-7354-42e3-9b86-d2de48a8c58d"
      unitRef="usd">26674000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzUtMi0xLTEtNDcwMzg_cf0d24e4-b005-4590-984a-7330a8a99edf"
      unitRef="usd">18089000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzUtMy0xLTEtNDcwMzg_fd778dfd-d444-4a15-84bb-8d0dcddb4345"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <iclr:RestructuringReserveUtilizations
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzYtMS0xLTEtNDcwMzg_0677217d-1826-4e6f-9fb1-981863f12b5f"
      unitRef="usd">9069000</iclr:RestructuringReserveUtilizations>
    <iclr:RestructuringReserveUtilizations
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzYtMi0xLTEtNDcwMzg_cac9acda-6287-4541-a985-c549f411494e"
      unitRef="usd">8978000</iclr:RestructuringReserveUtilizations>
    <iclr:RestructuringReserveUtilizations
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzYtMy0xLTEtNDcwMzg_dbceff4e-ec90-42d0-bce5-4dd35dffaa64"
      unitRef="usd">4782000</iclr:RestructuringReserveUtilizations>
    <us-gaap:RestructuringReserve
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzctMS0xLTEtNDcwNDU_75952c77-0262-4c59-bf4e-d2d7d8c106fc"
      unitRef="usd">28353000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzctMi0xLTEtNDcwNDU_58f2b86c-b624-45d2-b0a1-4a74f1912c0f"
      unitRef="usd">10748000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODEvZnJhZzpkNTc4NjJiZmEyYjA0ZDIwYWRjMDU0YzJiNmQ4ZDgyNy90YWJsZTplZmM5NjE1ZDZjMTk0NmQ5OTQyMjZlNmYyMTM5NWYwMC90YWJsZXJhbmdlOmVmYzk2MTVkNmMxOTQ2ZDk5NDIyNmU2ZjIxMzk1ZjAwXzctMy0xLTEtNDcwNDU_07ed51f3-8ab2-44bb-8471-1072656d2c17"
      unitRef="usd">1637000</us-gaap:RestructuringReserve>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODQvZnJhZzo5MDQzNTcwODQwZGU0YjI1OTY3ZmY1NDZhNGEyYzkyOS90ZXh0cmVnaW9uOjkwNDM1NzA4NDBkZTRiMjU5NjdmZjU0NmE0YTJjOTI5XzE4OTk_8e7f100e-e098-4355-b605-04eccd1c1bab">Commitments and Contingencies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next twelve years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 23 - Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2021 and December&#160;31, 2020 and future minimum rental commitments as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODQvZnJhZzo5MDQzNTcwODQwZGU0YjI1OTY3ZmY1NDZhNGEyYzkyOS90ZXh0cmVnaW9uOjkwNDM1NzA4NDBkZTRiMjU5NjdmZjU0NmE0YTJjOTI5XzE2MTM_c2181052-781b-45c8-8da5-f89c4de514e1">P12Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90ZXh0cmVnaW9uOjkwZjQ1N2QyYWQ5NTRjZDliYjM4NGY3YzNhNjE4MGNkXzIzNA_753afc7e-66b6-46bd-9463-2b228a78c737">Disaggregation of Revenue&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue disaggregated by customer profile is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Top client&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;337,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 2-5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,291,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;754,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;704,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 6-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 11-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,077,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;529,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,918,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;851,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5,480,826&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2,797,288&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2,805,839&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Billed services (accounts receivable)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,349,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;722,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses (note 19)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,342,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;715,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,965,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,143,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$ Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue (payments on account)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,323,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(660,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(663,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(700,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(468,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(201.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivables when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2021 and December&#160;31, 2020 were $323.6&#160;million and $138.2&#160;million (see&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; note 8 - Other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services as at December&#160;31, 2021 increased by $194.4 million as compared to December&#160;31, 2020. Unearned revenue increased by $663.1 million over the same period resulting in a increase of $468.6 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2020 and December&#160;31, 2021. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contract when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The credit loss expense recognized on the Group's receivables and unbilled services was  $0.9&#160;million and $2.9&#160;million for the twelve months ended December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;As of December&#160;31, 2021 approximately $13.3 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 48% of the unrealized performance obligation over the next twelve months, with the remainder recognized thereafter over the duration of the customer contracts.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90ZXh0cmVnaW9uOjkwZjQ1N2QyYWQ5NTRjZDliYjM4NGY3YzNhNjE4MGNkXzIzNg_ca904744-fa1b-4446-bc59-c61bae57637c">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue disaggregated by customer profile is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Top client&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;337,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 2-5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,291,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;754,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;704,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 6-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 11-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,077,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;529,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,918,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;851,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;873,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5,480,826&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2,797,288&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2,805,839&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9faa218b12a4b3cbf68ef2876caf309_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzMtMS0xLTEtMzYyNDg_5a88d0b1-a12f-46df-b05f-4a2aa9587977"
      unitRef="usd">441173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3b459699c0644968482717272d94004_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzMtMi0xLTEtMzYyNDg_887a3d42-8b96-4a5c-9c28-1db230b15d3f"
      unitRef="usd">337904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia579ed66ea164732848f24e059ca35c5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzMtMy0xLTEtMzYyNDg_372fa5ac-2580-4bf4-9565-b977fe2db5e4"
      unitRef="usd">350287000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie82ad39f10bb41e4a084c8444e8989e2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzQtMS0xLTEtMzYyNDg_d28fea6b-1b2d-456b-a555-3b221216cee2"
      unitRef="usd">1291946000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b0fe21c6d5f44e195d836fd2b3861df_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzQtMi0xLTEtMzYyNDg_1c87e032-2065-4573-ba0c-61efa813d8f9"
      unitRef="usd">754906000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0595a59077864be3995b98eb22ddb2b8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzQtMy0xLTEtMzYyNDg_85fce5e0-170a-4775-954d-301ad55b85fb"
      unitRef="usd">704963000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf29ed6c91d7496d942630ab211f4988_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzUtMS0xLTEtMzYyNDg_ab1c0a76-10a6-483d-adc9-ac0751de93b5"
      unitRef="usd">752325000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i485faa3e5fc04aacbcde0602daee7a53_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzUtMi0xLTEtMzYyNDg_99b05ef7-ac2e-4070-a1cd-5a32a608fece"
      unitRef="usd">350865000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b863197bb30417a90a009a4abea9561_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzUtMy0xLTEtMzYyNDg_089452a0-c358-4e54-b08d-433948687cb4"
      unitRef="usd">347832000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e2bfed171104f319e9a84bb08cd25c7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzYtMS0xLTEtMzYyNDg_57d52bdc-c29a-440d-8814-c03f513b3334"
      unitRef="usd">1077073000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice57c280ae3940bca26f984dc95288ba_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzYtMi0xLTEtMzYyNDg_4241910e-a0d9-4a83-a426-41376f2ddc57"
      unitRef="usd">501643000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if28103989f8142d59279653ff6548119_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzYtMy0xLTEtMzYyNDg_7f09b521-ecc0-4229-b5ae-4473dbb2d5f4"
      unitRef="usd">529713000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45550d1365114ceeb217ab47d70cb97c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzctMS0xLTEtMzYyNDg_cde7e362-74f5-40c4-9b74-03fda3de34c2"
      unitRef="usd">1918309000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if73f3bd5251f468199c2f39f63ce992f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzctMi0xLTEtMzYyNDg_69bcd5df-78d6-4f67-9df1-f8c28b8a20d8"
      unitRef="usd">851970000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb97c73d747941d58453e74f92d14e13_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzctMy0xLTEtMzYyNDg_139907cc-aaa1-480d-aa9f-99d5806ecc10"
      unitRef="usd">873044000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzgtMS0xLTEtMzYyNDg_6a6f424a-3ff7-44f8-90b7-a98a2b96da9e"
      unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzgtMi0xLTEtMzYyNDg_da56b7b7-1e90-4dbc-8036-fa7b1a630010"
      unitRef="usd">2797288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xODcvZnJhZzo5MGY0NTdkMmFkOTU0Y2Q5YmIzODRmN2MzYTYxODBjZC90YWJsZTpkMmZlMDA0YmMwM2Y0YTJmYWI0ZDFiNGU5MTk5Yjc0MC90YWJsZXJhbmdlOmQyZmUwMDRiYzAzZjRhMmZhYjRkMWI0ZTkxOTliNzQwXzgtMy0xLTEtMzYyNDg_44beeff9-1cfd-400c-a117-3b363d91588e"
      unitRef="usd">2805839000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzMyNTI_db5d3371-a15b-4c67-927a-051c75c8414f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Billed services (accounts receivable)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,349,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;722,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses (note 19)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,342,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;715,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,965,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,143,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$ Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;194,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue (payments on account)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,323,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(660,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(663,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(700,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(232,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(468,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(201.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:BilledContractReceivables
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzItMS0xLTEtMzYyNDg_41062c42-517f-4ec8-b888-ab081c19f26e"
      unitRef="usd">1349851000</us-gaap:BilledContractReceivables>
    <us-gaap:BilledContractReceivables
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzItMy0xLTEtMzYyNDg_b953a424-4bf2-445f-aa7b-e8ec290da691"
      unitRef="usd">722420000</us-gaap:BilledContractReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzMtMS0xLTEtNTE3MjY_a900c36b-4e52-4daa-acfe-9aeba8322792"
      unitRef="usd">7081000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzMtMy0xLTEtNTE3MzU_8b15cfac-fd61-4ea9-a8dc-2a3eed1f4802"
      unitRef="usd">7149000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <iclr:ContractsReceivableGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzMtMS0xLTEtMzYyNDg_912b24b3-e448-4928-8aff-bdfdacd50e63"
      unitRef="usd">1342770000</iclr:ContractsReceivableGross>
    <iclr:ContractsReceivableGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzMtMy0xLTEtMzYyNDg_9e5a4a3d-353a-4e86-b7e9-2b64a2ad0030"
      unitRef="usd">715271000</iclr:ContractsReceivableGross>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzUtMS0xLTEtMzYyNDg_769536b9-4a5b-4432-8d17-4d3b01d7107d"
      unitRef="usd">623121000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzUtMy0xLTEtNDM1MTM_123da609-332b-44f0-8f0c-b3086df20991"
      unitRef="usd">428684000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <iclr:ContractsReceivableNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzctMS0xLTEtMzYyNDg_36db84b4-9d5f-4be0-b204-c88e1aa4cfa9"
      unitRef="usd">1965891000</iclr:ContractsReceivableNet>
    <iclr:ContractsReceivableNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTpmYTkyYWEyNmNmNTk0ZTAyOWM0ZWIzNGQzNjQzYzJjYi90YWJsZXJhbmdlOmZhOTJhYTI2Y2Y1OTRlMDI5YzRlYjM0ZDM2NDNjMmNiXzctMy0xLTEtMzYyNDg_c4b317ca-3280-490c-846f-a2bc3a1712e6"
      unitRef="usd">1143955000</iclr:ContractsReceivableNet>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzItMS0xLTEtMzYyNDg_35d91a08-7964-46b1-bedd-a696b86806e8"
      unitRef="usd">623121000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzItMy0xLTEtMzYyNDg_0600b449-dd18-4d6c-b6be-9663efe55f9d"
      unitRef="usd">428684000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzItNS0xLTEtMzYyNDg_ffcbdd76-a1ca-40d9-9b87-b13e716dad8f"
      unitRef="usd">194437000</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzItNy0xLTEtMzYyNDg_a4cb4626-691b-41d8-9d0c-c0a4d6ab6a8b"
      unitRef="number">0.454</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzMtMS0xLTEtMzYyNDg_6a6350b5-e8e3-4a64-9ba9-d8426ea902e1"
      unitRef="usd">1323961000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzMtMy0xLTEtMzYyNDg_b8bc3964-475f-41ce-bb02-62cec6a2f16e"
      unitRef="usd">660883000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzMtNS0xLTEtMzYyNDg_77bf5642-1e0a-469b-a108-ca04b3c392db"
      unitRef="usd">663078000</iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent>
    <iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzMtNy0xLTEtMzYyNDg_12dd4cfe-e751-4df6-ab72-8efe76c38617"
      unitRef="number">1.003</iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent>
    <iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzQtMS0xLTEtMzYyNDg_4dd74bd0-ca59-44a4-83e4-30c01aaf0fba"
      unitRef="usd">-700840000</iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzQtMy0xLTEtMzYyNDg_60a78a79-9642-403f-87a2-dab0ba89d615"
      unitRef="usd">-232199000</iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzQtNS0xLTEtMzYyNDg_d4dfb342-69bc-4875-8bad-4f419d96c932"
      unitRef="usd">-468641000</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90YWJsZTplYjU3N2UxNzQ2M2E0OTIwOWI0ODM3ZDM1MGJiMWRlOC90YWJsZXJhbmdlOmViNTc3ZTE3NDYzYTQ5MjA5YjQ4MzdkMzUwYmIxZGU4XzQtNy0xLTEtMzYyNDg_c4115f4c-a31d-4ea4-947c-979c78d3e707"
      unitRef="number">-2.018</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzEwOTk1MTE2MzEyNTA_12507025-6d4b-4234-87ed-14dd1ea90477"
      unitRef="usd">323600000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzEwOTk1MTE2MzEyODI_d68872d8-f548-4fe8-bc30-dbdc4e841c65"
      unitRef="usd">138200000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzIwMjI_c88ef5e3-f426-48c1-a55a-ec7aaa5ff0f7"
      unitRef="usd">194400000</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzIwNjc_1ca88b97-501a-43f1-b408-59d3375646b4"
      unitRef="usd">663100000</iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzIxMTI_3b0cf5ad-101e-4697-ba6b-153741878910"
      unitRef="usd">-468600000</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzI4NDc_65c83a1b-2c2d-4e80-88e7-d4b4b7e32cb5"
      unitRef="usd">900000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzI4NTQ_7b65171e-3d19-4b03-afb7-390cdfb0d970"
      unitRef="usd">2900000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzI5MzU_a3e40685-1b56-4a02-a63a-9acbb9e91ea7"
      unitRef="usd">13300000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ieb24ee78b3b34864be5c6ac9dba168fd_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzMxMDE_d625ca99-e6f2-46f1-98b6-8e1e8947839e"
      unitRef="number">0.48</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ieb24ee78b3b34864be5c6ac9dba168fd_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTAvZnJhZzozNGQxYmNjYTcyNDI0MGI0Yjg0Zjc3MWYyZTk4ZDVkYi90ZXh0cmVnaW9uOjM0ZDFiY2NhNzI0MjQwYjRiODRmNzcxZjJlOThkNWRiXzMxNTk_b0d6f721-dccc-4cac-bb6c-35b369265929">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <iclr:AllowanceForDoubtfulAccountsTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90ZXh0cmVnaW9uOmRmMGQ0ODY4ZjExNTQ5YWQ5MDJjMWFiYjA4ZjkxZGMyXzIxMw_c4e61c96-c5d1-484e-99cf-287c28516581">Provision for Credit Losses&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2021 and December&#160;31, 2020 comprises:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts used during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts provided during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts released during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing provision&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:AllowanceForDoubtfulAccountsTextBlock>
    <iclr:AllowanceForDoubtfulAccountsTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90ZXh0cmVnaW9uOmRmMGQ0ODY4ZjExNTQ5YWQ5MDJjMWFiYjA4ZjkxZGMyXzIwOA_1cdf88bd-1070-413f-bc94-be4a66d0d180">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2021 and December&#160;31, 2020 comprises:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts used during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts provided during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts released during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing provision&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:AllowanceForDoubtfulAccountsTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzItMS0xLTEtMzYyNDg_83237d60-0c45-4aa2-9cfb-4d9a428c39c1"
      unitRef="usd">7149000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iaa2834e916024d02918294df579c7494_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzItMi0xLTEtMzYyNDg_e814c736-92cb-4a08-b7ef-b92c9df370d4"
      unitRef="usd">7380000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzMtMS0xLTEtMzYyNDg_69676835-d379-4451-8417-5d10ecd60fe5"
      unitRef="usd">116000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzMtMi0xLTEtMzYyNDg_2ed8756d-7eec-438d-b08a-97cbd7583860"
      unitRef="usd">2561000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <iclr:AccountsReceivableCreditLossExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzQtMS0xLTEtMzYyNDg_833af661-56e6-4d59-88a0-6362a75debd9"
      unitRef="usd">705000</iclr:AccountsReceivableCreditLossExpense>
    <iclr:AccountsReceivableCreditLossExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzQtMi0xLTEtMzYyNDg_ededeb9a-68d3-4eec-800b-2324a05b1d71"
      unitRef="usd">2692000</iclr:AccountsReceivableCreditLossExpense>
    <iclr:AccountsReceivableCreditLossReversal
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzUtMS0xLTEtMzYyNDg_49a15c5d-c7a4-4a33-affa-a1e46fbcc129"
      unitRef="usd">544000</iclr:AccountsReceivableCreditLossReversal>
    <iclr:AccountsReceivableCreditLossReversal
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzUtMi0xLTEtMzYyNDg_ad2b72ee-0e05-480b-96ae-f976a1463e6e"
      unitRef="usd">510000</iclr:AccountsReceivableCreditLossReversal>
    <iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzYtMS0xLTEtMzYyNDg_e98f9f27-40e5-4079-84c6-5ca8552bd423"
      unitRef="usd">-113000</iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments>
    <iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzYtMi0xLTEtMzYyNDg_02be0d70-1020-487d-aeb5-f96072601d68"
      unitRef="usd">148000</iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzctMS0xLTEtMzYyNDg_72be83a6-e0e6-4869-aa0b-e6358a742e21"
      unitRef="usd">7081000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTMvZnJhZzpkZjBkNDg2OGYxMTU0OWFkOTAyYzFhYmIwOGY5MWRjMi90YWJsZToxODMxM2ViZGUzMmI0MDk1YjM4M2JlNTQzZGFjM2IxNi90YWJsZXJhbmdlOjE4MzEzZWJkZTMyYjQwOTViMzgzYmU1NDNkYWMzYjE2XzctMi0xLTEtMzYyNDg_ae1fb8dd-2050-402f-bcd9-abafcf4c9e10"
      unitRef="usd">7149000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzUzMjA_180a7406-2146-48fe-b04c-c7d48e773931">Business Segment and Geographical Information&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#x2018;CODM&#x2019;) in accordance with ASC 280 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Segment Reporting'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates as one business segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#x2019;s transfer pricing model.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Ireland (Ireland Segment) acts as the Group entrepreneur under the Company&#x2019;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#x2019;s global network. ICON Ireland enters into the majority of the Company&#x2019;s customer contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;integration of entities acquired through the Merger into the global transfer pricing model remains ongoing and these entities were not substantially part of the Group's cost plus arrangement in the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's areas of operation outside of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ireland include th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;e United States, United Kingdom, Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Hungary, Italy, Latvia, Poland, Portugal, Romania, Russia, Serbia, Spain, Sweden, The Netherlands, Turkey, Ukraine, Canada, Argentina, Brazil, Chile, Colombia, Mexico, Peru, China (including Hong Kong), India, Israel, Japan, Singapore, South Korea, The Philippines, Taiwan, Thailand, Australia, New Zealand, South Africa, Belarus, Bermuda, British Virgin Islands, Costa Rica, Croatia, Denmark, Egypt, Estonia, Finland, Georgia, Greece, Guatemala, Iceland, Jersey, Kenya, Lithuania, Luxembourg, Malaysia, Norway, Panama, Puerto Rico, Slovakia, Switzerland and Uruguay.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reportable segment and geographic information at December&#160;31, 2021 and December&#160;31, 2020 and for the years ended December&#160;31, 2021, December&#160;31, 2020 and December&#160;31, 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;a) The distribution of revenue by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,252,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,175,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,581,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;925,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;892,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;358,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,480,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,797,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,805,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;b) The distribution of income from operations, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;excluding restructuring, transaction and integration related expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland *&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;295,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;607,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;433,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. These assets have been provisionally allocated to Ireland.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income from operations, excluding restructuring, transaction and integration related expenses of $607.9 million was earned during the year ended December&#160;31, 2021 having added back restructuring expenses of $31.1&#160;million (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 15 Restructuring charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;) and transaction and integration related expenses of $198.3 million (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 6 Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;) to income from operations of $378.5 million as presented in the Consolidated Statement of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;534,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEyNjg_c85eed66-44ac-495c-9f6b-0246c2c0e5c9"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzUzMTY_353b99ad-6801-4e40-b980-92a55c908d5b">The distribution of revenue by geographical area was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,252,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,175,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,581,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;925,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;892,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;358,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,480,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,797,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,805,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzQtMS0xLTEtMzYyNDg_20ef6187-c06b-4f53-a8c4-cb82ba948fa4"
      unitRef="usd">1365909000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzQtMi0xLTEtMzYyNDg_ea70656f-1e22-45d6-8081-67e18359d5b4"
      unitRef="usd">1181292000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzQtMy0xLTEtMzYyNDg_7c996328-2592-4540-aa6e-b2cb9219c170"
      unitRef="usd">1252834000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf7560d016044c24b3bdac4149860edf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzUtMS0xLTEtMzYyNDg_31f5d782-0ad1-49da-aada-f062143df8e9"
      unitRef="usd">1175515000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedf131d1b8644060b1d2530e00834656_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzUtMi0xLTEtMzYyNDg_80e7ca9c-2d5f-471d-9f6c-4d40fc5d9bfd"
      unitRef="usd">416884000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74f149fe5aaf499d867e3e597050ca23_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzUtMy0xLTEtMzYyNDg_dc7dd54f-255f-4f53-810d-bc0f8723aa32"
      unitRef="usd">388916000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzYtMS0xLTEtMzYyNDg_e7fda06b-9993-412d-8cae-00eeb61b405b"
      unitRef="usd">2581007000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzYtMi0xLTEtMzYyNDg_a73f3af6-621b-4389-9abb-975a983427b9"
      unitRef="usd">925563000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzYtMy0xLTEtMzYyNDg_bf226acc-0a8c-4d09-915a-b33898e3e474"
      unitRef="usd">892497000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6939b2d79b084dc0a660f3b73a074210_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzctMS0xLTEtMzYyNDg_e24de07a-d088-4df0-9319-aa8bf15e9eea"
      unitRef="usd">358395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ddd5c933e7b4f74b37135036f3084df_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzctMi0xLTEtMzYyNDg_65aced16-a9b3-4eb0-86f9-dfaafb209c8e"
      unitRef="usd">273549000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i555b937d50554bbdb3d03c3c137d6aa2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzctMy0xLTEtMzYyNDg_af1d14e3-8cc8-4166-b687-fdfe91c33f12"
      unitRef="usd">271592000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzgtMS0xLTEtMzYyNDg_b03961ba-5a98-4b0d-b456-50c800d4813a"
      unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzgtMi0xLTEtMzYyNDg_37d8fac1-c350-4fc1-8215-7e61b457c646"
      unitRef="usd">2797288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZToxNGFkYzg5ZDMzYmM0MDJkOGEyNjIzYjNjNWYyODI0ZS90YWJsZXJhbmdlOjE0YWRjODlkMzNiYzQwMmQ4YTI2MjNiM2M1ZjI4MjRlXzgtMy0xLTEtMzYyNDg_b022205d-9275-44f9-92f7-fb5ae8181977"
      unitRef="usd">2805839000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <iclr:OperatingIncomeByGeographyTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzUzMTc_128bb1e0-d42b-4683-8d1b-545060494a70">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;b) The distribution of income from operations, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;excluding restructuring, transaction and integration related expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland *&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;161,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;295,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;607,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;433,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. These assets have been provisionally allocated to Ireland.&lt;/span&gt;&lt;/div&gt;</iclr:OperatingIncomeByGeographyTableTextBlock>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i2732caa487244b8483347f781dcfd5a5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzMtMS0xLTEtMzYyNDg_580b043a-21af-48d8-9580-190c7ab34b66"
      unitRef="usd">161862000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="ieba2f52dcb744d56bbfe8fa90c4b5c4b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzMtMi0xLTEtMzYyNDg_b61ad059-a764-4043-9241-f53d1b87ba79"
      unitRef="usd">295360000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="if60afd270c9f4590b4d76c9cbd2a40aa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzMtMy0xLTEtMzYyNDg_7a5810a3-8aac-49aa-a75c-4552a1ecc860"
      unitRef="usd">314287000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="iaf7560d016044c24b3bdac4149860edf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzQtMS0xLTEtMzYyNDg_d34d3aa6-d3e5-4422-8e34-7932899144c5"
      unitRef="usd">183436000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="iedf131d1b8644060b1d2530e00834656_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzQtMi0xLTEtMzYyNDg_b29977aa-7ccd-4845-a5d7-48a5eed7f65c"
      unitRef="usd">35402000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i74f149fe5aaf499d867e3e597050ca23_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzQtMy0xLTEtMzYyNDg_7577cfdb-9dee-4017-948f-fcd0e87a536f"
      unitRef="usd">37997000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="if8ff896c629e4b8490976274f366db14_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzUtMS0xLTEtMzYyNDg_af60fcbe-b91b-4337-ab84-79dc9107a14c"
      unitRef="usd">231971000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i375acf25b82541c09fbd5a29237942b2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzUtMi0xLTEtMzYyNDg_138830f8-a130-4e7e-b3ac-cbfe41f5afe5"
      unitRef="usd">56921000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i06cf0ad924b3485ba272411f1b3b9dca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzUtMy0xLTEtMzYyNDg_c164471d-8b2e-4bca-83f2-ed3e89e23e93"
      unitRef="usd">60272000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i6939b2d79b084dc0a660f3b73a074210_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzYtMS0xLTEtMzYyNDg_b87e6e6f-0b12-4be5-82aa-44fe1599c77e"
      unitRef="usd">30628000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i7ddd5c933e7b4f74b37135036f3084df_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzYtMi0xLTEtMzYyNDg_01e86f1a-e364-4093-bc09-c51122aa42fb"
      unitRef="usd">21147000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i555b937d50554bbdb3d03c3c137d6aa2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzYtMy0xLTEtMzYyNDg_a6e0379a-2aba-4b7b-bf19-970b8fc83cbe"
      unitRef="usd">20850000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzctMS0xLTEtMzYyNDg_cfb5acce-54c3-4269-a0c9-2f4e0bd8168e"
      unitRef="usd">607897000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzctMi0xLTEtMzYyNDg_fd81baa7-c7e8-457d-8e82-9222ec90d1f7"
      unitRef="usd">408830000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTo5NDRkMTczYTlkZGE0NzU5OGEwYTAyNjc4ZjI1MDVmZS90YWJsZXJhbmdlOjk0NGQxNzNhOWRkYTQ3NTk4YTBhMDI2NzhmMjUwNWZlXzctMy0xLTEtMzYyNDg_57b1f8ab-897d-4012-bdf9-bcad4207989f"
      unitRef="usd">433406000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEwOTk1MTE2NTAzNDg_524a70cb-e206-4168-85c9-03d95bec00e7"
      unitRef="usd">607900000</iclr:IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts>
    <us-gaap:RestructuringCosts
      contextRef="iae97c86e7991410685e37fea162dced3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEwOTk1MTE2NTAxMTY_8708d642-7992-4243-85b0-af5cde6d57b3"
      unitRef="usd">31100000</us-gaap:RestructuringCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEwOTk1MTE2NTAyMzk_7d091025-cb95-4742-b7ec-b1a8c870f051"
      unitRef="usd">198300000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzEwOTk1MTE2NTAzMzA_0a33e5a9-9244-421b-b5f3-8ebc28701563"
      unitRef="usd">378500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90ZXh0cmVnaW9uOjQ1MDI2YWNmMzQ5MjQ1OTZhN2NkYWZjMjhlNjUyMTVhXzUyOTc_1676d38d-7cc2-4956-8dcf-f24b99c787db">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;534,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="i639f5002243748caaade65a18fa1abd4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzItMS0xLTEtMzYyNDg_095a04a2-777a-44fd-8678-0195a1031e6c"
      unitRef="usd">118253000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ibadbd19679bc427dba0f5f5ae0f7fd8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzItMi0xLTEtNDM4NDY_f2ac65ca-be88-4ff6-b04b-35f581440ed5"
      unitRef="usd">118361000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i57430deb2fc84136b5fd0563c9976335_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzMtMS0xLTEtMzYyNDg_94ebd2cf-fa06-4f61-95d8-514b63cfc9ca"
      unitRef="usd">121174000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i9169f6af6160491cb03265cd3846ea11_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzMtMi0xLTEtNDM4NDY_3c5f866e-041f-4cd9-96fc-aab917f8cd9f"
      unitRef="usd">36723000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i844861916668498588f0491ce84b368e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzQtMS0xLTEtMzYyNDg_11bf78d7-e5b0-4462-86ab-1324efaef611"
      unitRef="usd">239828000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i84dbafe769b9418dae1e4cb9de53c5e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzQtMi0xLTEtNDM4NDY_48430bae-2bba-4638-b156-81bd5983e4bd"
      unitRef="usd">65152000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i7a66c15d3893461486dcf165a1add471_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzUtMS0xLTEtMzYyNDg_3659ec7e-e215-4897-ad34-8aea7ae9232a"
      unitRef="usd">55312000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i2e8457bcc7054ec4a4014e91fdf31028_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzUtMi0xLTEtNDM4NDY_4b4820a1-f040-4a75-9717-61ab4dd9940a"
      unitRef="usd">38668000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzYtMS0xLTEtMzYyNDg_08ce0ec7-7a82-476e-8fc2-3ac932186ad6"
      unitRef="usd">534567000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTYvZnJhZzo0NTAyNmFjZjM0OTI0NTk2YTdjZGFmYzI4ZTY1MjE1YS90YWJsZTozYTJhNzA5ZDI1OGE0MjlkOTk2MTMxOWQzMDE1MThlZi90YWJsZXJhbmdlOjNhMmE3MDlkMjU4YTQyOWQ5OTYxMzE5ZDMwMTUxOGVmXzYtMi0xLTEtNDM4OTM_e730c4ce-3b9c-40e8-ad31-1cf3e6d71e53"
      unitRef="usd">258904000</us-gaap:NoncurrentAssets>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90ZXh0cmVnaW9uOjFiMWIxNTU2ODUyZTRhOGY4NTE3NGMyMGY1OTRiMDE0XzY1_c147d58f-2fc4-4589-b026-5062f060e0ea">Supplemental Disclosure of Cash Flow Information&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes (net of refunds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90ZXh0cmVnaW9uOjFiMWIxNTU2ODUyZTRhOGY4NTE3NGMyMGY1OTRiMDE0XzYy_02d9f8e2-6be4-460e-b6a0-2923768a2dac">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes (net of refunds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzMtMS0xLTEtMzYyNDg_119b8523-0251-4b44-8e48-c9e9439c01d6"
      unitRef="usd">106205000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzMtMi0xLTEtMzYyNDg_b97c2358-8926-417e-a05f-0beed0162017"
      unitRef="usd">13062000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzMtMy0xLTEtMzYyNDg_0bbbbdec-b78b-4448-b8f7-b0094b82c07d"
      unitRef="usd">13059000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzQtMS0xLTEtMzYyNDg_ac53d390-4f7f-4582-93b6-5baf5dcd3a90"
      unitRef="usd">55105000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzQtMi0xLTEtMzYyNDg_76e20607-c136-452c-9dc5-93dde3b75796"
      unitRef="usd">27604000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8xOTkvZnJhZzoxYjFiMTU1Njg1MmU0YThmODUxNzRjMjBmNTk0YjAxNC90YWJsZTo0M2FlZTAwNDk4MWI0MjgyOGYzMTU1MmU3NDczNDcwMC90YWJsZXJhbmdlOjQzYWVlMDA0OTgxYjQyODI4ZjMxNTUyZTc0NzM0NzAwXzQtMy0xLTEtMzYyNDg_b1c6a86c-bb12-41e1-8a17-25b930b49364"
      unitRef="usd">29836000</us-gaap:IncomeTaxesPaidNet>
    <iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90ZXh0cmVnaW9uOjk2MjBkYWI0YzUyZjQyOTRhMjQ3NTM4N2ZhMjI4MzBkXzUz_5b39722a-293d-4774-b155-6c716bb68717">Accumulated Other Comprehensive Income&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss on defined benefit pension plan (note 10)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Realized gain on interest rate hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of gain on interest rate hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on interest rate hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of loss on interest rate hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90ZXh0cmVnaW9uOjk2MjBkYWI0YzUyZjQyOTRhMjQ3NTM4N2ZhMjI4MzBkXzU1_6207ffc6-93f8-4be2-9c9e-64c469c84c74">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss on defined benefit pension plan (note 10)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Realized gain on interest rate hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of gain on interest rate hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on interest rate hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of loss on interest rate hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzMtMS0xLTEtMzYyNDg_4ae0f300-351b-4949-b863-b691e0b97c62"
      unitRef="usd">-75986000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzMtMi0xLTEtMzYyNDg_ae9a6aa1-9cb9-4497-bbed-4bb2065aa677"
      unitRef="usd">-15894000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <iclr:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzQtMS0xLTEtMzYyNDg_52638d33-1a72-442f-a43d-aafefd28f76b"
      unitRef="usd">-9854000</iclr:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax>
    <iclr:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzQtMi0xLTEtMzYyNDg_51457d0b-1ef0-4fca-8a01-71dc5eee85a4"
      unitRef="usd">-9329000</iclr:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzUtMS0xLTEtMzYyNDg_a629401a-e4d4-4053-b317-8bc94f52dc45"
      unitRef="usd">5098000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzUtMi0xLTEtMzYyNDg_d9e8b22d-670b-4fe4-8b41-9887b6d69c3b"
      unitRef="usd">9364000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i75873ccb8a5c422b9bf776cba332d63d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzctMS0xLTEtMzYyNDg_88f9b824-aad6-4164-9627-867fb4a33479"
      unitRef="usd">0</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ie38942652cf84800b863e3e7022c6277_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzctMi0xLTEtMzYyNDg_d2403708-e9e2-44e3-9810-1611c06d5847"
      unitRef="usd">4658000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <iclr:AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax
      contextRef="i75873ccb8a5c422b9bf776cba332d63d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzgtMS0xLTEtMzYyNDg_bbf1a564-2c2b-4e0b-85a7-fb644acb3c20"
      unitRef="usd">0</iclr:AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax>
    <iclr:AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax
      contextRef="ie38942652cf84800b863e3e7022c6277_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzgtMi0xLTEtMzYyNDg_0aff8cf2-ba91-44e1-b718-680af184e108"
      unitRef="usd">4658000</iclr:AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax>
    <iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzktMS0xLTEtMzYyNDg_85c1617e-8c7a-4f47-a505-10cc1c30298d"
      unitRef="usd">0</iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax>
    <iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzktMi0xLTEtMzYyNDg_e102ba48-dce9-420c-a63d-bfcc897ff2d2"
      unitRef="usd">905000</iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax>
    <iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzExLTEtMS0xLTM2MjQ4_7aae4f04-4c38-4645-87d8-bd1639df7cb3"
      unitRef="usd">1000</iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax>
    <iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzExLTItMS0xLTM2MjQ4_cc195544-dea5-4463-b8b8-b111ccdcaa42"
      unitRef="usd">15000</iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzEyLTEtMS0xLTM2MjQ4_6fee589e-b900-49d8-9f95-f06253ab30a0"
      unitRef="usd">-90937000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDIvZnJhZzo5NjIwZGFiNGM1MmY0Mjk0YTI0NzUzODdmYTIyODMwZC90YWJsZTo3MmU1YWM4YzM4YTE0NjE2OGVhMzgwYjg2MDQzNzc0My90YWJsZXJhbmdlOjcyZTVhYzhjMzhhMTQ2MTY4ZWEzODBiODYwNDM3NzQzXzEyLTItMS0xLTM2MjQ4_cfc4845b-e619-4940-a403-90cca0cf2fe7"
      unitRef="usd">-35477000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODk_4b2a6938-a0e1-4aaa-8ac1-daafe1bbe5fa">Operating leases&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Lease costs recorded under operating leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from sub-leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Of the total cost of $49.9 million incurred in the year ended December&#160;31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs. Of the total cost of $30.1&#160;million incurred in the year ended December&#160;31, 2020, $27.6 million is recorded within selling, general and administration costs and $2.5 million is recorded within direct costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021 and December&#160;31, 2020, the Group did not incur any costs related to variable lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December&#160;31, 2021 and December&#160;31, 2020 totaled $10.2 million and $12.1 million, respectively. During the year ended December&#160;31, 2021,  office consolidations resulted in the recognition of an impairment of ROU assets. The right-of-use assets related to these offices have been impaired and a charge of $15.4 million was recorded (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 15 - Restructuring charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;). An impairment charge of $5.4 million was recognized during the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2021 were 6.91 years and 2.51%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2020 were 4.45 years and 2.53%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable leases as of December&#160;31, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Minimum rental &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $49.9&#160;million and $24.3 million have been included in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7b15ff89-21bb-47d6-8b93-387dc069fe0d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODg_7ee1e415-4195-48f3-aa9c-3b52eaebf0fd"&gt;other liabilities&lt;/span&gt;&lt;/span&gt; as at December&#160;31, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2OTA_4003a9a9-c237-4e9d-9e86-bf210f44f727">&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Lease costs recorded under operating leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from sub-leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzQtMS0xLTEtMzYyNDg_a10b892a-8232-4a26-985e-d5c3a7fd66da"
      unitRef="usd">51200000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzQtMi0xLTEtMzYyNDg_4ee96532-634c-4cbc-a4fb-3d8cc74c1064"
      unitRef="usd">31088000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzUtMS0xLTEtMzYyNDg_27274e38-ff97-4564-b37a-245f2051bb60"
      unitRef="usd">1338000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzUtMi0xLTEtMzYyNDg_fccb8038-fc7a-4e50-9d83-492a44903ae6"
      unitRef="usd">940000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzYtMS0xLTEtMzYyNDg_07e48bf3-c9ec-433e-998a-9adcc08f75bd"
      unitRef="usd">49862000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTplOTMzY2VlY2U0MWE0NDkzYmRiODc3ZmU1ZDQ1MmEyZS90YWJsZXJhbmdlOmU5MzNjZWVjZTQxYTQ0OTNiZGI4NzdmZTVkNDUyYTJlXzYtMi0xLTEtMzYyNDg_7363772f-889c-4e2a-a457-db10a153b073"
      unitRef="usd">30148000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzExNA_537944ee-08f2-4cfe-b94b-849ed619c010"
      unitRef="usd">49900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if5c3ba2a7a9949e4b4296e482b3406d4_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE0MA_cc92361d-1742-4ca8-aab4-c18be56cb8c9"
      unitRef="usd">47500000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="id8aedbfe82f84258b4f5fb8ae5be9756_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzIwOA_dcf6a4af-4f5a-462a-b484-e82445cf1c88"
      unitRef="usd">2400000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzI2NQ_c0eed4ae-674c-412b-bb1e-d85eb64a9435"
      unitRef="usd">30100000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ia28188c5a298446189940f3d7538dc9f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzI5MQ_1cca5ff5-12a3-4fbb-9983-1eb5af62f275"
      unitRef="usd">27600000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ic3104d5908eb42a781a65f9e3b34447b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzM1OQ_96a12db9-dd08-47f8-b91b-103838c26d87"
      unitRef="usd">2500000</us-gaap:LeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2OTE_9b0ae7bd-a5e4-411f-aad1-9be2b5adb991"
      unitRef="usd">0</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzQ0NA_07592614-c09e-4407-86e5-19153ae0a265"
      unitRef="usd">0</us-gaap:VariableLeaseCost>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzgxMw_b3f680f6-4545-4c96-82ef-e04ff74af598"
      unitRef="usd">10200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzgyMA_b7de676a-11da-4f7f-823c-b62a679dbeda"
      unitRef="usd">12100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEwOTk1MTE2MzA0MDA_f1f17faf-c947-4ad8-ab41-2bce0f5acd74"
      unitRef="usd">15400000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEwOTk1MTE2Mjk3MjU_35fe85aa-eb90-403a-8630-63d2d51bc033"
      unitRef="usd">5400000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEyNzg_ea4cfda4-f9b0-4d7b-85a9-9fc3478af5d8">P6Y10M28D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEyODU_43c010c8-5aa0-41fa-8e52-7e0fcf836e7c"
      unitRef="number">0.0251</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEzOTE_5304ebe4-d240-4dce-8e13-aa4a75629687">P4Y5M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzEzOTg_63832733-6536-4ff0-bfa0-29f0c740a078"
      unitRef="number">0.0253</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2ODc_37765990-a8e1-4c87-a33c-2abd48cfa84b">&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable leases as of December&#160;31, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Minimum rental &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;227,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzMtMS0xLTEtMzYyNDg_0a4c33b1-19c4-42db-8ea3-836495ca64de"
      unitRef="usd">54292000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzQtMS0xLTEtMzYyNDg_fd6dbffb-7726-47f8-a31c-4623c1186b57"
      unitRef="usd">45469000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzUtMS0xLTEtMzYyNDg_69889cb3-311e-4443-8d02-1a249bbaf29e"
      unitRef="usd">29607000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzYtMS0xLTEtMzYyNDg_3b07b3f4-ff32-4d2b-a227-af48671cd2eb"
      unitRef="usd">20758000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzctMS0xLTEtMzYyNDg_7afd4ba9-e78d-4612-b71c-2520208c0137"
      unitRef="usd">17714000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzgtMS0xLTEtMzYyNDg_387336c5-3d7b-48f6-a940-bf6b0c2c86ad"
      unitRef="usd">59858000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzktMS0xLTEtMzYyNDg_c8fc885f-6b1d-455c-b330-7c4822f25306"
      unitRef="usd">227698000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzEwLTEtMS0xLTM2MjQ4_6705616c-d182-4e38-a9a0-e29ddc09e3c5"
      unitRef="usd">18266000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90YWJsZTpkOWRhYTBlZjRiMjg0ZWVkOTRhNzZmMjFiMzlhMTBlNC90YWJsZXJhbmdlOmQ5ZGFhMGVmNGIyODRlZWQ5NGE3NmYyMWIzOWExMGU0XzExLTEtMS0xLTM2MjQ4_93709fa7-31c3-48c7-b4b4-391efde51fb9"
      unitRef="usd">209432000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7e95612f074040ca8329b4a89d847966_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzIxOTkwMjMyNTgxNjM_4e4f6989-566d-482b-af9f-ec1d36724284"
      unitRef="usd">49900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3c03db364d544bbd8c5f621de598194c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDUvZnJhZzpiNTZjNDA4MTlhMzI0ZTM3YWYyYzlhNmFkZWViODFlNi90ZXh0cmVnaW9uOmI1NmM0MDgxOWEzMjRlMzdhZjJjOWE2YWRlZWI4MWU2XzE2MTQ_dbeed5b0-d37a-4172-8a6b-6799b8bb3d4a"
      unitRef="usd">24300000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzM0NTY_796f17d7-e5fd-4634-877a-bcb5165ab111">Non-current bank credit lines and loan facilities&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company had the following debt outstanding as of December&#160;31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,001,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020 Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Series A notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Series B notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,501,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,446,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less debt issuance costs and debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,381,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2021,  December&#160;31, 2020 and December&#160;31, 2019 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the year ended December&#160;31, 2021, the Company incurred $86.7 million transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense on drawn facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and one time financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing costs/(credits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the contractual maturities of the Company's debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current maturities of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,280,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5,501,213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300&#160;million. The proceeds of the senior secured term loan facility were used to repay in full (i) PRA&#x2019;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the transaction. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is LIBOR plus an applicable margin of 2.50%, in each case, with a step down of 0.25% if the first lien net leverage ratio is equal to or less than 4.00 to 1.00. The senior secured term loan facility is subject to a LIBOR floor of 0.50%. On November 10, 2021, the Company achieved a net leverage ratio of less than 4 times and the margin applicable to the senior secured term loan was reduced by 0.25% with the overall rate reducing from 3.0% to 2.75%. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#x2019;s current corporate family rating assigned by S&amp;amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) LIBOR (or an alternative reference rate) plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#x2019;s current corporate family rating assigned by S&amp;amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders of under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December&#160;31, 2021, no amounts have been drawn under the revolving loan facility with the exception of $4.1&#160;million letters of credit given to landlords to guarantee lease arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We continue to monitor the phasing out of LIBOR. We have engaged with our lenders on the implications of the change and will continue to discuss with them as replacement rates for LIBOR become more prevalent in the syndicated lending market. The Company is therefore subject to interest rate volatility in respect of the senior secured term loan facility, any future draw down on the Revolving Credit Facility or in respect of any future issuances of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Borrowers&#x2019; (as defined in the credit agreement) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#x2019;s, the Borrowers&#x2019; and each of the subsidiary guarantor&#x2019;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes (see below), subject to other permitted liens. Our long-term debt arrangements contain customary restrictive covenants and, as of December&#160;31, 2021, we were in compliance with our restrictive covenants in all material respects.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On September 27, 2021, the Company repaid $13.8&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.4&#160;million. On December 29, 2021, the Company repaid $500.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.8&#160;million. These repayments resulted in an additional charge associated with previously capitalized fees of $5.6&#160;million. The Company is permitted to make prepayments on the senior secured term loan without penalty.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the &#x201c;Offering&#x201d;). The Senior Secured Notes will mature on July 15, 2026. The proceeds from the Offering and borrowings made under the Senior Secured Credit Facilities, together with cash on hand, were used to (i) fund the cash consideration payable by ICON for the Merger, (ii) repay existing indebtedness of ICON and PRA and (iii) pay fees and expenses related to the Merger, the Offering and the Senior Secured Credit Facilities. The Senior Secured Notes are guaranteed on a senior secured basis by ICON and its direct and indirect subsidiaries&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;that guarantee the Senior Secured Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;2020 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December 8, 2020, the Company issued new senior notes, (the "2020 Senior Notes") for aggregate gross proceeds of $350.0&#160;million in the private placement market. The 2020 Senior Notes were issued in two tranches; Series A Notes of $275.0&#160;million at a  fixed interest rate of 2.32% and Series B Notes of $75.0&#160;million at a fixed interest rate of 2.43%. The effective interest rate was adjusted by the impact of an interest rate cash flow hedge which was entered into in advance of the rate fixing date. This cash flow hedge was deemed to be fully effective in accordance with ASC 815 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Derivatives and Hedging'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The realized loss related to this derivative was recorded within other comprehensive income and amortized over the life of the 2020 Senior Notes. The effective rate on the 2020 Senior Notes was fixed at 2.41%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, the Company was required to repay the 2020 Senior Notes prior to entering into the Senior Secured Credit Facilities and the Senior Secured Notes. In June 2021, ICON committed to entering into the Senior Secured Credit Facilities and the Senior Secured Notes and therefore committed to replacing the 2020 Senior Notes. The 2020 Senior Notes have been repaid and long term financing consisting of the Senior Secured Credit Facilities and the Senior Secured Notes have been drawn. The 2020 Senior Notes were repaid on July 1, 2021 inclusive of early repayment charges. The total repayment on July 1, 2021 was $364.0&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s debt was $5,507.2&#160;million at December&#160;31, 2021. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyNzYwNzA_00dee637-e16f-4d4c-beb6-5211c2c5e109">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company had the following debt outstanding as of December&#160;31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.862%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,001,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020 Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Series A notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Series B notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,501,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,446,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less debt issuance costs and debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,381,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;348,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3ee2cf622d234c2aa3264bc99d1d99f6_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzQtMS0xLTEtNDAxNzc_5398cc11-926b-491d-9280-15e4b2d9c3f5"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3ee2cf622d234c2aa3264bc99d1d99f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzQtMi0xLTEtNDAxNzc_7b4e8056-3bcd-47cb-9b45-afff27a94537"
      unitRef="usd">5001213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0acaa265f49241d68f4649867f4f00a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzQtMy0xLTEtNDAxNzc_333ca487-93cf-4416-a7fe-c1aff9cb2e71"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i452b01c0112d4ccd9b653f71e8f9dcbb_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzYtMS0xLTEtNDAxNzc_adb3396d-94fd-40a0-a7d6-6f3301926b0f"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i452b01c0112d4ccd9b653f71e8f9dcbb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzYtMi0xLTEtNDAxNzc_ce55c552-45a5-4a47-b4e8-0031fa9f7224"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifa28345cbd8749e8a4e0f211a8ca39ca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzYtMy0xLTEtNDAxNzc_23a08795-4430-4a4a-89c7-d91777cb4393"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1c04ffd49dae4f0992771a4e20c9df7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzgtMi0xLTEtNDAxNzc_b064da60-7352-45b7-88a1-9437592c1f36"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i21502e982c90437c9bfab920645d67a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzgtMy0xLTEtNDAxNzc_e9d81e82-e9c7-4fea-96d4-2a7c287f6ca3"
      unitRef="usd">275000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7a8f70dc107f44d0b434efabb00c6480_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzktMi0xLTEtNDAxNzc_205ab1e1-e918-4e76-9e21-8449900b765e"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ife6231795e2c4c7b85a8443de30f290a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzktMy0xLTEtNDAxNzc_504094b3-e88e-4958-99f8-6a0458da5a95"
      unitRef="usd">75000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzExLTItMS0xLTQwMTc3_e3b51c03-9668-4467-b1f3-bac4e50ae4ad"
      unitRef="usd">5501213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzExLTMtMS0xLTQwMTc3_c133b315-4c44-4957-8968-3aa8258164ba"
      unitRef="usd">350000000</us-gaap:DebtInstrumentCarryingAmount>
    <iclr:LongTermDebtCurrentMaturitiesGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzEzLTItMS0xLTQwMTc3_a26eec70-fd9d-485b-bb97-54d2e7bb1086"
      unitRef="usd">55150000</iclr:LongTermDebtCurrentMaturitiesGross>
    <iclr:LongTermDebtCurrentMaturitiesGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzEzLTMtMS0xLTQwMTc3_2e2b3355-905e-43b9-b8fe-dacca2a6345e"
      unitRef="usd">0</iclr:LongTermDebtCurrentMaturitiesGross>
    <iclr:LongTermDebtExcludingCurrentMaturitiesGross
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE0LTItMS0xLTQwMTc3_0c9414c9-adf7-45f5-88a4-1474666b9d48"
      unitRef="usd">5446063000</iclr:LongTermDebtExcludingCurrentMaturitiesGross>
    <iclr:LongTermDebtExcludingCurrentMaturitiesGross
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE0LTMtMS0xLTQwMTc3_c3d3e585-a2f6-46ed-a30a-6559116cc60c"
      unitRef="usd">350000000</iclr:LongTermDebtExcludingCurrentMaturitiesGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE1LTItMS0xLTQwMTc3_b3f78ffc-99a6-4bf0-afb8-c7ab12dff6b8"
      unitRef="usd">64901000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE1LTMtMS0xLTQwMTc3_b04b4182-fce1-40ba-8c1d-d7451359c684"
      unitRef="usd">1523000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE2LTItMS0xLTQwMTc3_e669ec93-b8d5-4d9d-9bbc-1764caf8fb1e"
      unitRef="usd">5381162000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8206c39f2c184b8bb182915d7fa1390b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTowY2NmMzIyNWI5NzM0YTlkYjhkYzdkMjk4N2QzOGQ5Ny90YWJsZXJhbmdlOjBjY2YzMjI1Yjk3MzRhOWRiOGRjN2QyOTg3ZDM4ZDk3XzE2LTMtMS0xLTQwMTc3_15bda1d5-a982-44c6-bb71-04540686796e"
      unitRef="usd">348477000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ieb0064f5e15c4dab8c532e6ad71f7603_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE1OTQyOTE4NjI1OTA5_7fea364d-a1bb-45d6-aaa4-e55e80f1f522"
      unitRef="usd">27600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:InterestExpense
      contextRef="ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NTU0MTI_b65d6e80-0465-4c14-abfb-72cbf1ef8381"
      unitRef="usd">86700000</us-gaap:InterestExpense>
    <iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyODM5Njk_a0ab506b-100b-4ff4-9873-53f23e10b104">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense on drawn facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and one time financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing costs/(credits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock>
    <us-gaap:InterestExpenseDebt
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzItMS0xLTEtNTY2MDg_fd384c01-a8a5-4059-aeaa-fcc522a22d28"
      unitRef="usd">93809000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzItMi0xLTEtNTY2MDg_79682265-14ae-41d3-918c-442d0852580e"
      unitRef="usd">13406000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzItMy0xLTEtNTY2MTk_ebafc52e-2223-4df8-9f92-2ca51672059c"
      unitRef="usd">13659000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzMtMS0xLTEtNTY2MDg_7fad7581-a6a4-4724-9480-b71f7e9ac029"
      unitRef="usd">12890000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzMtMi0xLTEtNTY2MDg_49bffb54-74f1-443c-859f-7c2b90a24eeb"
      unitRef="usd">523000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzMtMy0xLTEtNTY2MTk_26ea0010-44fd-4d4a-b717-3b65a8849234"
      unitRef="usd">540000</us-gaap:AmortizationOfFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzQtMS0xLTEtNTY2MDg_003a9f76-94cb-4131-85f4-6bfddf220af2"
      unitRef="usd">75391000</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzQtMi0xLTEtNTY2MDg_d4a7dc94-cc62-4347-bd2c-3a55f61e60b7"
      unitRef="usd">0</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzQtMy0xLTEtNTY2MTk_f14af4d2-f4e3-4ba2-80fd-4eb5192f47ac"
      unitRef="usd">0</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:InterestExpenseCreditOther
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzUtMS0xLTEtNTY2MDg_5eb8e957-2e39-49cb-9afc-c4bce3b18a27"
      unitRef="usd">333000</iclr:InterestExpenseCreditOther>
    <iclr:InterestExpenseCreditOther
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzUtMi0xLTEtNTY2MDg_e9b4ffc2-4042-4442-b591-e8b343f0b7df"
      unitRef="usd">-910000</iclr:InterestExpenseCreditOther>
    <iclr:InterestExpenseCreditOther
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzUtMy0xLTEtNTY2MTk_08eea5bc-7d8c-4d8a-a92a-c99e5c438436"
      unitRef="usd">-923000</iclr:InterestExpenseCreditOther>
    <us-gaap:InterestExpense
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzYtMS0xLTEtNTY2MDg_c7bab059-20fe-46a3-909e-441509963704"
      unitRef="usd">182423000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzYtMi0xLTEtNTY2MDg_6b868668-27b5-4cc5-b471-67d3bd1c6e24"
      unitRef="usd">13019000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTpiODQ1YzJmYzE5MmQ0OWQ3YmIxZDZhMzhmZjI4NDRkNC90YWJsZXJhbmdlOmI4NDVjMmZjMTkyZDQ5ZDdiYjFkNmEzOGZmMjg0NGQ0XzYtMy0xLTEtNTY2MTk_2eadad39-add8-44ed-97e1-a985b848f2cd"
      unitRef="usd">13276000</us-gaap:InterestExpense>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyNzYwNzE_fa7685cb-058a-4cc2-8a42-24f35065bfe4">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the contractual maturities of the Company's debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current maturities of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,280,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5,501,213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzEtNC0xLTEtNDAxNzc_bc6b6732-330c-4756-a597-22ffe24ff443"
      unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzItNC0xLTEtNDAxNzc_dc49a1b4-5d5c-453e-b7b6-7fd19365b94a"
      unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzMtNC0xLTEtNDAxNzc_90afd248-2749-498e-9af8-07d221f1a2fa"
      unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzQtNC0xLTEtNDAxNzc_b1121475-17ad-4b8c-8368-51405fce84ba"
      unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <iclr:LongTermDebtMaturityYearFiveAndThereafter
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzUtNC0xLTEtNDAxNzc_4caf1676-faa4-466c-9a21-58441a5a5557"
      unitRef="usd">5280613000</iclr:LongTermDebtMaturityYearFiveAndThereafter>
    <us-gaap:LongTermDebt
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90YWJsZTo1NmU4NzNiOWQ2ZGY0OGUyYjFkMzNkMjBhZmM4Mjg4OS90YWJsZXJhbmdlOjU2ZTg3M2I5ZDZkZjQ4ZTJiMWQzM2QyMGFmYzgyODg5XzYtNC0xLTEtNDAxNzc_c35c835b-8b12-4404-b752-d132993abac4"
      unitRef="usd">5501213000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i82f9f7da96f842ad91fb773f1d6c7517_I20210701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDY5NDY_fd59e292-88b2-44b6-9416-faf6cf19fe99"
      unitRef="usd">5515000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i86b692f1ce7e413c834c8a2488e2c0ac_I20210701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDY5NjI_d637553e-8346-4dc0-87e2-4ed2841f3b86"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i82f9f7da96f842ad91fb773f1d6c7517_I20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyODI1MTY_ce794da7-8b6a-4987-9a60-51f2a2322767"
      unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i412657424e8a46e09c66a2345306a17a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1ODE_4c9d5fa3-39ee-434c-9d07-88f258aabb3c"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <iclr:DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage
      contextRef="i412657424e8a46e09c66a2345306a17a_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzIxOTkwMjMyODI1MjM_1b5ba939-eb1b-4580-a13b-bb41dabb54eb"
      unitRef="number">0.0025</iclr:DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage>
    <iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio
      contextRef="ib6f10a8ae3df4827be9831c930c77331_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1ODg_bf81259e-f340-4523-90f8-c922d214a250"
      unitRef="number">4.00</iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio>
    <iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio
      contextRef="ie2fff4332a1d4c0698311a5bd0290b3c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1OTQ_a2a4c6ad-3e7b-41ac-bb34-1c8bc5ba9fa3"
      unitRef="number">1.00</iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7acc5e38562846649f0134d3bdc33705_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg2MDA_4615bc1e-39bf-4d0b-af5d-ce80766b5e85"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio
      contextRef="ifdac2dc9cabd4d0d9b3df33a7ae8822e_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1Nzk_d988fb6d-3c8b-49a6-aaaa-1fc1c71665b9"
      unitRef="number">4</iclr:DebtInstrumentCovenantFirstLienNetLeverageRatio>
    <iclr:DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate
      contextRef="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1NjA_aeb50050-ebbd-4166-86b4-e94a7c938557"
      unitRef="number">-0.0025</iclr:DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i19229e729ec74c57a20161ea7ce568f9_D20210701-20211109"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1Njc_e6fbd43d-e269-4aab-bc75-3d09d7579e1b"
      unitRef="number">0.030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic937a37d42a54ac7834666d81193e6ca_D20211110-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzE2NDkyNjc0Njg1NzM_de264374-829d-493c-ad8a-b74bbd62fc73"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib0abb09c8d394db38d57f51554da92af_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwMjI_f646e6a6-247b-4533-9aa4-d53cef94bece"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib58d47ddfc2141cabb5fab1f21a38d72_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwMjk_4f774598-d7fb-415c-a615-bc8a1afabb71"
      unitRef="number">0.0060</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id5a30f909b8e4e1fba6812998b6bf24d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwMzY_929cfa78-bf39-4fef-92f2-725eeb9733a5"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if83f4a5e20174093b9f01e04ee9c1d6d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwNDM_1dd67775-ee91-4a80-8108-c0d34aa051eb"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if05006669b12476d9fce3bf96834b1c1_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwNTA_81bae241-1db7-44ee-927b-4e7dbbc4a5c2"
      unitRef="number">0.0160</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic3fdf86501a24ebcbc7842721c5fffa2_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDcwNTc_6a5c0a81-9046-48e9-b6cb-d0f4300e681f"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCredit
      contextRef="ie8f0b47b5969447b80a94a01cfae1776_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2MzM5ODM_68b68790-3cbc-49e7-b0fc-187a35910da3"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i7cb2372376cf46b9a240ab10ece87d9c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2Mjk4NzM4_20737a0d-7682-4607-beb6-9dcaf228e39c"
      unitRef="usd">4100000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc0ODI_4e97f4d0-4354-48f1-9b92-7b177fa613ce"
      unitRef="usd">13800000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="i5b97c59b5eb348439384a035a5759f64_D20210927-20210927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDg0NDc_dc177634-8b5c-4a58-949e-5c25d84412ba"
      unitRef="usd">40400000</us-gaap:InterestPaidNet>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc1MDE_03040b24-64d4-467b-830a-8c6ee609e2c0"
      unitRef="usd">500000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="i25647c02fbd343adb600b26ef014a5fa_D20211229-20211229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDg0NTU_6245d4ad-c16e-46cf-b677-4adb487a2239"
      unitRef="usd">40800000</us-gaap:InterestPaidNet>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="i3a42a3fb378b499bba8795f930f41618_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEyMDk0NjI3OTI4ODc3_ce792621-d277-4dec-8367-383668188c40"
      unitRef="usd">5600000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if5dd5a8e35954342aeb8de12c5800669_I20210701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5NjY_71ae2a19-f4ef-4f50-aa3e-c821cea32349"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if5dd5a8e35954342aeb8de12c5800669_I20210701"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5NTg_a63c6228-c9ad-4542-bc89-5850862eaaa1"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i4f5d4c306fa444b4bdb0bf1fe82e8279_D20201208-20201208"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5ODA_30eb2192-fd86-427e-ae76-c5e31a31dce2"
      unitRef="usd">350000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <iclr:IssueOfSeniorNotesNumberOfTranches
      contextRef="if4a6b701f2454838a6d52713b838fb03_D20201208-20201208"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5OTU_0b41030e-fa6c-44f8-a405-5103a8eb2034"
      unitRef="tranche">2</iclr:IssueOfSeniorNotesNumberOfTranches>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i52b4c03037324b8685b2023af8543025_I20201208"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDc5OTc_dd209dbf-8d8a-4314-bdd2-3897824c5f19"
      unitRef="usd">275000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i52b4c03037324b8685b2023af8543025_I20201208"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwMTI_0035465f-9e44-4810-a0b6-614834ce355d"
      unitRef="number">0.0232</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icc237be9542b46be97a5052ea2194da9_I20201208"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwMzI_a3c623fe-b51c-4116-a9a0-b2d60338d8bb"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icc237be9542b46be97a5052ea2194da9_I20201208"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwNDc_f78ada2e-bc7c-4092-b1ea-6097994a87fb"
      unitRef="number">0.0243</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i61d39490d9d341c6a04dd22b7c2e3548_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwNTQ_45a59cad-f3b5-4fba-89c1-9cbe479d3408"
      unitRef="number">0.0241</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:RepaymentsOfDebt
      contextRef="i7c29619485354cb987ceeeec9f4fd1ad_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDgwNjE_732dba79-1077-43ee-b15e-a8afcb91ed9b"
      unitRef="usd">364000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMDgvZnJhZzo4M2MyNzgzOTk0ZTc0MTlkODRjMmI0ODRmMGZkMmVlYS90ZXh0cmVnaW9uOjgzYzI3ODM5OTRlNzQxOWQ4NGMyYjQ4NGYwZmQyZWVhXzEwOTk1MTE2NDg3NDI_afad51a8-09b8-46f6-8933-f8694dd8d29e"
      unitRef="usd">5507200000</us-gaap:LongTermDebtFairValue>
    <iclr:NewAndRecentAccountingPronouncementsDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0Xzk5MTc_190fb9bc-14a4-466a-bf72-85412b06e775">Impact of New Accounting Pronouncements&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Impact of new accounting pronouncements adopted during fiscal year ended December&#160;31, 2021 (or previously)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers'.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The amendments in this ASU require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. For public business entities, the amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption of the amendments is permitted, including adoption in an interim period. An entity that early adopts in an interim period should apply the amendments (1) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (2) prospectively to all business combinations that occur on or after the date of initial application. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has taken the option to early adopt the amendments in this ASU for year ended December&#160;31, 2021 and apply the amendments to interim periods from the beginning of the fiscal year. The Company has applied the amendments of this ASU to the Merger with PRA, completed on July 1, 2021. The application of these amendments has resulted in a $16.0&#160;million increase in goodwill and corresponding $16.0&#160;million increase to unearned revenue compared to the Company's Balance Sheet at September 30, 2021. Since July 1, 2021, the Company had amortized $4.0&#160;million of the unearned revenue adjustment through the revenue line in the Consolidated Statement of Comprehensive Income. This amortization has been reversed in December 2021 resulting in a net nil impact on revenue for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other accounting pronouncements adopted during fiscal year ended December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASU 2019-12 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%"&gt;'Simplifying the Accounting for Income Taxes (Topic 740)'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;. The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The Company adopted the amendments in this ASU on a prospective basis, except where the required method of adoption is retrospective or modified retrospective. ASU 2019-12 is effective for the Company for the year ended December&#160;31, 2021. The adoption of this ASU did not have a significant impact on the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;'. ASU 2020-01 states any equity security transitioning from the alternative method of accounting under Topic 321 to the equity method, or vice versa, due to an observable transaction will be re-measured immediately before the transition. In addition, the ASU clarifies the accounting for certain non-derivative forward contracts or purchased call options to acquire equity securities stating such instruments will be measured using the fair value principles of Topic 321 before settlement or exercise. The ASU is effective for the Company for the year ended December&#160;31, 2021, and has been applied on a prospective basis. The adoption of this ASU did not have a significant impact on the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2018;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; which removes the separation models in ASC 470 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2018;Debt&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for convertible debt with cash conversion features and convertible instruments with beneficial conversion features. The ASU also removes from ASC 815 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2018;Derivatives and Hedge Accounting&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; certain conditions for equity classification for contracts on an entity&#x2019;s own equity. The ASU is effective for the Company for the year ended December&#160;31, 2021. The adoption of this ASU did not have a significant impact on the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact of new accounting pronouncements which will be adopted during fiscal year ended December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No other new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</iclr:NewAndRecentAccountingPronouncementsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="i071a74bae9594a1c88d29e82ccf0ce67_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0XzI3NDg3NzkxMDAzOTQ_f53c7f1f-f449-4d3f-a024-c4b97d701c7c"
      unitRef="usd">16000000</us-gaap:Goodwill>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i071a74bae9594a1c88d29e82ccf0ce67_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0XzI3NDg3NzkxMDA0MDk_254f73d4-03ff-46a7-b5a8-6d07c6d49f07"
      unitRef="usd">16000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i1e15468a473f4c8da1405b2a6d723f2a_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0XzI3NDg3NzkxMDA0MjQ_2efea23f-433f-43df-813c-82c8fd49f838"
      unitRef="usd">4000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <iclr:IncreaseDecreaseRevenueFromContractsWithCustomers
      contextRef="i1e15468a473f4c8da1405b2a6d723f2a_D20210701-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTEvZnJhZzplMjA5N2UyOTYzOTQ0MDM1OWFjODYwNmJlZWM2YTg1NC90ZXh0cmVnaW9uOmUyMDk3ZTI5NjM5NDQwMzU5YWM4NjA2YmVlYzZhODU0XzI3NDg3NzkxMDA0Mzg_7a9f1b69-0cdc-4446-b0a5-21ad3e015eef"
      unitRef="usd">0</iclr:IncreaseDecreaseRevenueFromContractsWithCustomers>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzExMjM_6f91d677-5bfe-4e28-9fbe-43172c8957b6">Related Parties &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Subsidiaries of the Company earned revenue of $30,000 (December&#160;31, 2020: $321,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December&#160;31, 2021 (December&#160;31, 2020: $41,000).&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Subsidiaries of the Company earned revenue of $551,000 (December&#160;31, 2020: $9,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $197,000 was recorded as due from Afimmune Limited at December&#160;31, 2021 (December&#160;31, 2020: $nil).&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $465,000 during the year ended December&#160;31, 2021. $264,000 was recorded as due from Oncacare at December&#160;31, 2021.&#160;During the year ended December&#160;31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The full amount of this loan remains outstanding at December&#160;31, 2021 along with accrued interest of $23,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="id3368954c9a64c52b38aa3707ffc38a7_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzc1_bab37963-1c46-4590-91e8-af7ce9f77849"
      unitRef="usd">30000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i968ed30311b94d908cfbb9557550531c_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzgz_6d89bebd-dc96-4d47-9a38-e2d68234f96f"
      unitRef="usd">321000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="ia4794a4624e34b81aaa3d969dd0bc3b2_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzI2NQ_f88cf5ce-079c-484c-8a6d-3b12287d55c3"
      unitRef="usd">12000</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="ie76f68691f174c19a8058971dbcc477c_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzMyNQ_85dc583b-4d2e-40d2-8545-3d68046e235b"
      unitRef="usd">41000</us-gaap:DueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i0813a3b3dd0749b2b2e5f5ef20260483_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzEzOTE_8e6fbd6e-88d7-4669-897c-784e60eb3851"
      unitRef="usd">551000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i24a1e9760cab4726b37a107bc29fd4cb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzEzOTU_4eb5b847-6949-495a-8407-c537acc54c16"
      unitRef="usd">9000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="id23d592eefe04b35928d0cc687d6a2ff_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzEzOTk_e4695538-733d-41dc-902a-cd86bc52c78a"
      unitRef="usd">197000</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="i05316c63db6641378950248cee4a1582_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MjgzNDUy_59ef9a59-acdf-42b5-bed1-094c90cd880f"
      unitRef="usd">0</us-gaap:DueFromRelatedParties>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i509ce783c2ea4a39bdebdb581d6ed480_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzY1Mg_713e4b8b-e162-4e3b-9be0-234957eba0f8"
      unitRef="usd">4900000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i509ce783c2ea4a39bdebdb581d6ed480_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzY2Nw_7a325f57-eed7-468f-96f8-55ef86cc914c"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzMzMzI_9853e251-7edf-41b3-9f3c-43febb6d9152"
      unitRef="usd">465000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueFromRelatedParties
      contextRef="i9315b0dbc9034bb8aee3c7fc387583e3_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzMzNDM_03bab295-f67d-44ca-88fc-bf4242210519"
      unitRef="usd">264000</us-gaap:DueFromRelatedParties>
    <us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions
      contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzMzNTc_e3440cdd-1391-4350-ae3f-abc6f90a888d"
      unitRef="usd">10000000</us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="i8ddc44575d474df2b5dc85eb4348b493_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEzMTk0MTM5NTM5MTMz_efff4a41-8d89-484d-8a7f-4d1c43426da3"
      unitRef="number">0.016</us-gaap:RelatedPartyTransactionRate>
    <iclr:InterestReceivableRelatedPartyLoans
      contextRef="i9315b0dbc9034bb8aee3c7fc387583e3_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwOTk1MTE2MzMzNjg_47f67620-6a54-4f22-83cb-c4f44f5c13ee"
      unitRef="usd">23000</iclr:InterestReceivableRelatedPartyLoans>
    <iclr:EquityMethodInvestmentMajorityOwnershipPercentage
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzkwNw_770c50aa-5f45-426f-9d83-a73157f62d41"
      unitRef="number">0.51</iclr:EquityMethodInvestmentMajorityOwnershipPercentage>
    <iclr:EquityMethodInvestmentMajorityOwnershipPercentage
      contextRef="ie1b609ddf6c34171b1ba74b522bc4160_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTQvZnJhZzo1OGMzNjJkZDRjZjI0YzU0ODI3ZGRmYzAzMGI0ZDkwYi90ZXh0cmVnaW9uOjU4YzM2MmRkNGNmMjRjNTQ4MjdkZGZjMDMwYjRkOTBiXzEwNjY_770c50aa-5f45-426f-9d83-a73157f62d41"
      unitRef="number">0.51</iclr:EquityMethodInvestmentMajorityOwnershipPercentage>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90ZXh0cmVnaW9uOjkyY2E3MzU1NGI1OTQxNDQ4YjI0YTFjNWI4Y2JhYzYzXzEyNTA_557a7071-9f04-4f3a-8321-9664df30bd24">Net income per ordinary share&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There is no difference in net income used for basic and diluted net income per ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per ordinary share attributable to the Group for the years ended December&#160;31, 2020 and December&#160;31, 2019 include the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for basic net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,110,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,859,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,859,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive share options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;958,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;423,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,068,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,283,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,333,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;332,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;373,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest adjustment to redemption amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Group (including NCI redemption adjustment)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;368,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90ZXh0cmVnaW9uOjkyY2E3MzU1NGI1OTQxNDQ4YjI0YTFjNWI4Y2JhYzYzXzEyNTE_f6b8a789-aec2-4327-9c7e-e39928ef0f6c">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for basic net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,110,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,859,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,859,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive share options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;958,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;423,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,068,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,283,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,333,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzEtMS0xLTEtMzYyNDg_c7eb21f6-a710-448c-9747-aed1b2481182"
      unitRef="shares">67110186</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzEtMi0xLTEtMzYyNDg_9abdbd24-ee2a-4e12-8a5a-5c3547aad4f2"
      unitRef="shares">52859911</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzEtMy0xLTEtMzYyNDg_d218de40-b04d-43ba-aab3-bc1272274b6d"
      unitRef="shares">53859537</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzItMS0xLTEtMzYyNDg_9ebd6706-0c88-4ecf-82fa-4267962f63a0"
      unitRef="shares">958125</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzItMi0xLTEtMzYyNDg_cd676465-d4d2-495d-afe7-eaef9c45a615"
      unitRef="shares">423674</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzItMy0xLTEtMzYyNDg_ccef9010-2078-491d-a90f-6f40f1d7a248"
      unitRef="shares">473924</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzMtMS0xLTEtMzYyNDg_829aae10-8226-41dc-a1e4-c73f00e2a725"
      unitRef="shares">68068311</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzMtMi0xLTEtMzYyNDg_cc054119-115d-45de-9e88-cc0849abe29e"
      unitRef="shares">53283585</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZTozNjk5ZjljOGI1MWY0MWUwODZlY2ZmMTNkYzg4Zjk4ZC90YWJsZXJhbmdlOjM2OTlmOWM4YjUxZjQxZTA4NmVjZmYxM2RjODhmOThkXzMtMy0xLTEtMzYyNDg_da6380a5-3dff-4c30-a2d7-9d84b68dbc0e"
      unitRef="shares">54333461</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90ZXh0cmVnaW9uOjkyY2E3MzU1NGI1OTQxNDQ4YjI0YTFjNWI4Y2JhYzYzXzEyNTI_3ad1b9f5-0078-460d-9fd0-62f61f8e6524">&lt;div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;332,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;373,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest adjustment to redemption amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Group (including NCI redemption adjustment)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;368,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzItMS0xLTEtMzYyNDg_63cfbd98-ef12-458e-9b51-f0fb2ee510b2"
      unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzItMi0xLTEtMzYyNDg_04b8633d-57c4-4ba9-8aa1-f9d106d713a3"
      unitRef="usd">332331000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzItMy0xLTEtMzYyNDg_1247ac87-8d26-4019-9795-72b41f85a9aa"
      unitRef="usd">373986000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzMtMS0xLTEtMzYyNDg_8be2bb1e-5c75-433d-b04b-f84fd7c913ad"
      unitRef="usd">0</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzMtMi0xLTEtMzYyNDg_5668ecb8-86c8-4459-bfc7-925689dfd3a5"
      unitRef="usd">4522000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzMtMy0xLTEtMzYyNDg_07e997df-6dba-4316-9ff3-fa86ac11d715"
      unitRef="usd">5048000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzQtMS0xLTEtMzYyNDg_8241e1bb-975c-4628-99dd-d535d6cadb95"
      unitRef="usd">153185000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzQtMi0xLTEtMzYyNDg_a32173be-ec8b-465d-b4b5-b0688677e15e"
      unitRef="usd">327809000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzQtMy0xLTEtMzYyNDg_f40e2abe-22f9-4261-be42-4da945777af7"
      unitRef="usd">368938000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzgtMS0xLTEtMzYyNDg_79f38bf1-03d7-46ce-b5da-c23f0976cd8c"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzgtMi0xLTEtMzYyNDg_d2f43893-83fd-4237-80f6-72a1f57e946b"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzgtMy0xLTEtMzYyNDg_7c6cf6f9-e13b-4362-bdc6-26f51bdb2cbc"
      unitRef="usdPerShare">6.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzktMS0xLTEtMzYyNDg_9736b798-d73d-4b7c-a461-b6720a1db16f"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzktMi0xLTEtMzYyNDg_d157abba-d3d6-4d3d-bcf2-184837c10241"
      unitRef="usdPerShare">6.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i99488b9a03124af7977f8d50703f350a_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMTcvZnJhZzo5MmNhNzM1NTRiNTk0MTQ0OGIyNGExYzViOGNiYWM2My90YWJsZToyNDUwODRiZWFjYzU0MmZmYTE3MmRmNTIyMDkzOTYzZi90YWJsZXJhbmdlOjI0NTA4NGJlYWNjNTQyZmZhMTcyZGY1MjIwOTM5NjNmXzktMy0xLTEtMzYyNDg_566106a3-4155-4cc4-9aa5-a71c12adca1f"
      unitRef="usdPerShare">6.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMjAvZnJhZzo5OTRkZWExOTIzMTQ0NDU2ODVlOThhOWQ2MDliYjc2Zi90ZXh0cmVnaW9uOjk5NGRlYTE5MjMxNDQ0NTY4NWU5OGE5ZDYwOWJiNzZmXzE2MzM_21302a9d-eae6-4ace-9f06-b53938d4221e">Subsequent Events&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;T&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;he Company has evaluated subsequent events from the Balance Sheet date th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;rough March&#160;1, 2022, the d&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;ate at which the consolidated financial statements were available to be &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On February&#160;18, 2022, the Company's Board of Directors authorized a new buyback program of up to $100&#160;million of the outstanding ordinary shares of the Company. All ordinary shares that are redeemed under the buyback program will be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time. At March&#160;1, 2022, the Company has repurchased $80.9 million of ordinary shares of the Company since December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The Company has determined that there are no other items to disclose.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i9ccacdd571674f36bbf5930a33df99f2_I20220218"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMjAvZnJhZzo5OTRkZWExOTIzMTQ0NDU2ODVlOThhOWQ2MDliYjc2Zi90ZXh0cmVnaW9uOjk5NGRlYTE5MjMxNDQ0NTY4NWU5OGE5ZDYwOWJiNzZmXzE2NDkyNjc0NDUyODQ_39b6cb12-0543-455f-a4e9-5b1eec4849e5"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="idf645606cd69465ab48f7e54e02bf243_D20220101-20220301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZkZjRiNDczZWM0ODQxMzZiOTE1MTZkMzBiMWEwYjI0L3NlYzo2ZGY0YjQ3M2VjNDg0MTM2YjkxNTE2ZDMwYjFhMGIyNF8yMjAvZnJhZzo5OTRkZWExOTIzMTQ0NDU2ODVlOThhOWQ2MDliYjc2Zi90ZXh0cmVnaW9uOjk5NGRlYTE5MjMxNDQ0NTY4NWU5OGE5ZDYwOWJiNzZmXzIxOTkwMjMyNjU5Mzk_65e2facb-5913-413c-b675-0f6923fc62c1"
      unitRef="usd">80900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>150
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M6JS U,E89&O*GQ$PBYZ5;,=3751IPE6BGF$:4T9NBNQNC\/B(K[O'SJC8R?
MD#R#Y'5!VIH#C-H-S5H7E45H.OYP0V;78XS*N+/K=Z&:\DA(F+72LPXJTR)"
MPI067,EG^([;47'U:P^#-/;NX@9=0X9Q##$I/]C^(&44^<#;R7#)!>1'J^KV
MGLE%D</?(#BC\N$ 0S:QP,6]&T6^W8A69%SRFHDUE3$D)!N.0IJXX.*&_BWD
M6!_!K-]"#ZV ECA3W,$IXHX.R*4[(G\,YS[*:0*&B_O\MYPSD2MPYS^3]?Z%
M:8D<-1^&9V*&B]O\=\-8;9I6+%QI.L& 3+!P<8>_313XGK@GKO?R[A59L*B0
M0-@*A"M]F%].;\+Y%[)X&\XG"QCZ<$X^A=<?)^27GT?^4?"KTW>.R"0<O\4R
M4!-1/#P"0'B+$[XDB^?L3J1MP!:!Z?AZCI&8".+AYK\=-#)YBE:4+]E>N[8(
MW82+R_!WC,F$$*]3"(E$ED'\!R.('@Y(E:D3\#/8%+P<O9>P"ZO3KUJ!JUZ&
M92^Z:'P\'[G#87 T@OWPV$9HPHG7*9Q\UNG .PXV HN/YH*SF$SSO&@/PQ;-
M+V@=XIDHXG6*(I]$"ML3ZM\R.Y!Y*Q&N=",P(!,CO$XQ8IMS5FE3N?HA_!;M
M8+BB9:A,8/ Z!88I5TQ65;O.@.D6M94,5[20F5#@=0H%,'4P=V0,:<I2M%NM
M1>B:2MC3810Q$ *9N%H.&*0)"%ZG@##)F%SJ^7P#"F6V4>;'K;"XH"TQ]DQH
M\'!#GXZOYB0LXD1!G ^58F :935QE=)E*QFN9ZD)?>/\?L=: J9$Q\]Z'_ 8
M4IXV+HO<Q_ZB3]Z$X0R#,\' [U1.?%7FM$+A,K9I]$TD\/%($,)0Q>5P[9LW
MBX 59>?Y#F[/S<3MULQ7<++5P"QBEC+>-V;O=WPD5%/5SQKV<^%R5U\P*N/X
M?C?'!S )4%,>LR?RCK6O)5S*<1S7.7).AD.,S#B^C_MS4P*-!03'2&&BQJS]
MX__MV9]OW-;_L?2[2W5HD=Q?'6+$QH1]W#3_2W%HD=PM#K$GJL:/ ]Q ?[0V
MM,@UM2$&9_PXZ.3'/U(06A0[%(2!<>>@4Y[>I2"T**$%86 \.L!MM=[4V@4A
M&><LW5O,6(0N(/V+*2?ZFU-TI>T\O,>]]7NX24:3=#M\K92X8DW9KRE_2R+!
MUVG4A\()(S8V'N#>NWTJII_EB?;=@ OX0W2A&=<.<-<N-V4H&=V_['$!+-@&
MQN<#2RXMRA"[@CH/>=IJ$?%.W$,/HEH;T6#G]9I.JLN7B#DI$\7J35MSMGE1
M&5:OY\SEU5O.]U3GY#E)V3TT=?K',%.R>G%8'2BQ+E_6W0FE1%;^7#$:,ZDO
M@/_OA5#; ]U!\_KV_%]02P,$%     @ $8AA5/$>Z:,/ @  6P4  !@   !X
M;"]W;W)K<VAE971S+W-H965T,BYX;6R-E-N.FS 0AE_%XGH5 DEHNR)(R::'
MJ(H4[6J[%U4O'!B"M3Y0>RC;MZ]M",U*"<H-]HQG/O]C/$Y;I5]-!8#D37!I
MED&%6-^'H<DK$-1,5 W2KI1*"XK6U,?0U!IHX9,$#^/I- D%93+(4N_;ZRQ5
M#7(F8:^):82@^N\:N&J7012<'(_L6*%SA%E:TR,\ 3[7>VVM<* 43( T3$FB
MH5P&J^A^G;AX'_"#06O.YL15<E#JU1G;8AE,G2#@D*,C4#O\@0?@W(&LC-\]
M,QBV=(GG\Q/]BZ_=UG*@!AX4?V$%5LO@8T **&G#\5&UWZ"O9^%XN>+&?TG;
MQ<:? I(W!I7HDZT"P60WTK?^',X2HN1*0MPGQ%YWMY%7N:%(LU2KEF@7;6EN
MXDOUV58<D^ZG/*&VJ\SF8;9J"H9D*[O?:\\I#=%BW6*8]XAUAXBO(**8[)3$
MRI#/LH#B/2"T>@91\4G4.AXE;B"?D%ET1^)I'(WP9D.1,\^;W5HD^;DZ&-3V
M2OP:P<\'_-SCYV-XI4G)M"#;S:43' =$492,Z%@,.A8WZ9!4P"41X]G?][NO
M(R*2041RDPBN\JOW:9RP:0[6=4>V&CB5%^]3>';A!>BC;VM#<M5([.[^X!U>
MCE77,/_#NV=G1_6124,XE#9U.OE@3TEWK=P9J&K?/@>%MAG]M+*O'V@78-=+
MI?!DN V&]S3[!U!+ P04    "  1B&%4$O-YN@@(  !Q(0  &    'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;*V::W/;MA*&_PI&[;3QC!P1%X)D8GO&L=W6
M,VF<B9/3SS %6YR0A$I"<GQ^_5E>)%+$Q6KG?$A,R0OP77"QSR[ALV=5?:]7
M4FKTH\C+^GRVTGK];K&HTY4L1/U6K64)OWE452$T?*R>%O6ZDF+9#BKR!0D"
MOBA$5LXNSMKO/E<79VJC\ZR4GRM4;XI"5"\?9*Z>SV=XMOOB2_:TTLT7BXNS
MM7B2]U)_6W^NX--B/\LR*V199ZI$E7P\GUWB=U<L; :T%O_)Y',]ND:-*P]*
M?6\^W"[/9T&C2.8RU<T4 GYLY97,\V8FT/%W/^EL?\]FX/AZ-_MOK?/@S(.H
MY97*_\J6>G4^BV=H*1_%)M=?U/,?LG>H%9BJO&[_1\^];3!#Z:;6JN@'@X(B
M*[N?XD>_$*,!F#D&D'X .78 [0?0UM%.6>O6M=#BXJQ2SZAJK&&VYJ)=FW8T
M>).5S6.\UQ7\-H-Q^N+J[M/]W<?;Z\NO-]?HP^7'RT]7-^C^CYN;K_?H%'V[
MOT9O?CY!/Z.L1%]7:E.+<EF?+33<N1F_2/N[?.CN0AQWN9;I6T3Q')& 8,OP
MJ^.'!X?#%^#OWFFR=YJT\U&7TYNJDJ5&EW4M=?W.,R/=STC;&9EK1E&O$*P-
M2IL+^?<FVXH<;F%=JVXJWD[5;+/M1102@NG98CM>$],L9@$-PKW9@5*V5\J\
M2B^W(LO%0RX1Y !4@TIXMEM9ZZ*1B]Y\4EHB*DYLPKN9PY$B'&$RD6TS(HE=
M=+@7'?I%IZG:-/(JF4I86I _1R4DN4XNCJUR0U,)922*@HEBTR["(8FP73/?
M:^9>S=_*ARS/Y1(T;V6YD7ZMW-# "<4$3Z2:9HS$/&9VJ=%>:N25>J=7LAJM
MK35J(^/6(8_X="U-*QK2Q*$OWNN+O?H^5W(M7KH ;3:9:O6F_2X6[2ZV28[-
M ,",DNE&,\U"RJ+(KCG9:TZ\FF_+5!42:?%#CL-V%P7,&@6)J20@23+1:UJ1
M&./8KA<' PD"K^*O2HO\B%7MISFX?\(P3N*)3ILA!G\BE]01M+ W@7<!^WKZ
MQ@,1,'DEQ* RJO3+'*UST;@/8=:D\743=>-<$UD?7#_[0=Q3SAB;+HEIAR-&
M&76LR, ?[ ?0[THMGR'?]"KMX=7/,;Y[$M HH=,T8S.DG(2./8$'^& _?6Y+
M+<JGK-D(78#U>D.[7I,E+,)!S*8[V&+(.1LEIT.Y W:PGSMW$!-"9^43JIIR
M\%0]GF[JB71"[=HM]$EB;"0?BUW,0NZ #Q[H@_WXZ;9(J<K3(W:TB94H"$=/
MNY=JFI$@BERQ.] '^_'S:20R^S=I$YO4P3&GAGZ+642H*TH&.F$_GJ[EHP3U
MRT9UM\JOR#6!PV*:3 LIBQDFD:O^PP.8L)],-Y#6] LJI%ZII:WX2^VJ+=BA
MD1'.IA4#FMHUDX%-Q,^FVY%*:$5DZ\)IKF!G:ED5.^4/5N7$PB$2&NMM,<-A
MQ!WK3098$7P$5R^=NZ\??AB6-(Z"9%I<62P!'2$/N$/CJ"$ZKB/ZF FH6C.=
M22]7R< EXN?2OG*' J[9R-8%L&$IXE-V6LQ"C+$C_9"!2<3/I&^E%%5Y;*%.
M+/T-E)0)GS+48LAY$,<NO0.4R"M0:C-[/CRI7K!#K\F7A"6<3(M*BQU-DH@[
M.C<R@(CX0710"/=1X,^/Q.1,F# Z3346,VB87,4E&7!$_#C:[84'47Y'*>3U
M3*/&INL]<B5*]"C2P[4G#D\L35.(0V-?FV8.*)$!2L0/I<-J?A0M5ITF:@B+
MXL1 J,400TV3N I8,E"))$>4]$?F'SJ @_K!,:XM_@\/E)J,""DT7WP*$XLA
M9;&SJZ0#3:B?)F.'U+X\S:6 NM3,"8[BE%J0 ULL-EY!F7:0P@)'<4H'W%!_
MMW7@A".=)7;E9@/%H-:;)E^+&>&4.SA)1Z_Y_#@;"W]26UF517M9"=>[/A-:
M$0VG:DVCF#KR&!VX1OU<<Y;51R5A:GV/AX,I-VQV4/$YL$$'RE$_Y0Z*ZEUT
MO+RBV=)S!7$(%)N*MADR5QE%!]91+^N:,Y=W]5JD\GRVKF0MJZV<75RIHLCT
M\/8J566S9V690K#_\A/FP?O>*W[2?;3Z9M)NBA&OR:%' PRI%X9VCUJV=%)'
M"=NCW>1;0DD .W+J@:5#"^.01BX_!AS2V(N7^Y6HY$KE2UG5OZ*N!?(29@ 7
M];=3=]4R*T7U@NKF%O4<ME>%MB*'0I(CN:D42MM'#[FZ,WF/<!#,@^Y?/PJ)
M#71C5?9?N9SO8IR<S%%(YE$<SX.$[@RSNM[ KFA?@VYTK>&B 8#0Z!JZY>(!
M[K([*6F-0CKGA,Q)P/_Q##AY:WV:9HO'.3."T=8(QH[GR :>,S_/+Y= [TR5
M4-NL1;8\A68P%>L,XM%Z8&%2F$>4)GBJUF:((\@)#KT#KID?UUU9LRF7LE0%
MQ(F6RYW@W7.FZ(TXL9^W6#"-Z;0O>LWJ4/G :.9G-'1NFV*3MXK[%^ZJ@!RP
M:LYPMW*'E+[.('8'3 R?)H%95MKL:.BLEMC :^;G]1>I1=;T=DV+!U%N930S
M\8L9;@J=J4R+(>$D3EQG<J-#.3^KNVI]G*1^^2F&9N9]GZJLLDWRQ@'G,3%6
MUX+H. P(=?".#9!F?DAWLD<,:+/*/W0C-,XY':\_+);VUQ^+T7EX\\<(?XKJ
M*2MKJ)(?863P-H*)JNY\O_N@U;H](G]06JNBO5Q) ?H; _C]HX(@[S\TI^[[
MO[*X^!]02P,$%     @ $8AA5!YC5'Z' @  U 8  !@   !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6R=55U/VS 4_2M6)DT@,?+5I!U+*Y6V""0&%87M8=J#
MF]PV%HZ=V4X+^_6SG1 5:*$C#_7'O>?<<QSW)EES<2]S (4>"LIDW\F5*D]<
M5Z8Y%%@>\Q*8CBRX*+#22[%T92D 9Q944#?PO-@M,&'.(+%[4S%(>*4H83 5
M2%9%@<7C*5"^[CN^\[1Q0Y:Y,AON("GQ$F:@[LJIT"NW9<E( 4P2SI" 1=\9
M^B>CV.3;A!\$UG)CCHR3.>?W9G&1]1W/" (*J3(,6 \K& &EADC+^--P.FU)
M ]R</[&?6>_:RQQ+&''ZDV0J[SL]!V6PP!55-WQ]#HV?R/"EG$K[B]9U;M1U
M4%I)Q8L&K!44A-4C?FC.80/@=W8 @@80[ L(&T!HC=;*K*TQ5GB0"+Y&PF1K
M-C.Q9V/1V@UAYBW.E-!1HG%J,+J^FEU?7HR'MY,Q.AU>#J]&$S0[GTQN9^A@
MB@4PE8,B*::'Z OZ_*D7QIUOR$4RUS&9N$IK,$QNVM0[K>L%.^J-(3U&H7^$
M B_PM\!'^\.]YW!7.V_M!ZW]P/*%._AF"BO0EU(AOD!GA&&6$DS1E$MB;]FO
MX5PJH>_:[S>*A6VQT!;K["AV+3)=03PVAW>$2BS0"M,*T %A:')W@TH0=?1P
MV]'6]%U+;_Z>JT&<N*O-TWLKXYGF3JNY\W^:ZQ'A2N5<D+^06>WU[E;1-7^T
M(<GWFN>%^'TRGYF(6A/1ATP0*:OW#42O9/7\*.K$O?"%_M>)4=#M];ROX7;Y
M<2L__I!\W92EPDP'E^]YB/?U\#IQAP=WH^>8?O\=BR5A$E%8:*AWW-4<HNZA
M]4+QTK:A.5>ZJ=EIKC\[($R"CB\X5T\+T]G:#]G@'U!+ P04    "  1B&%4
MV>MLCC0&  #Q%P  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;)58;5/;
M.!#^*YI<YX;.%&))?N4@,T#H'3-78 B]?A:.2#RUK526@=ZOO_4+=I!DE>,#
MB9UG5WIVI=U'.GD6\GNUY5RAER(OJ]/95JG=\7Q>I5M>L.I(['@)OSP*63 %
MCW(SKW:2LW5K5.1SXGGAO&!9.5N<M.]NY>)$U"K/2GXK4547!9,_SWDNGD]G
M>/;ZXB[;;%7S8KXXV;$-7W'U=7<KX6D^>%EG!2^K3)1(\L?3V1D^7I*H,6@1
M_V3\N=K[CAHJ#T)\;QZNUJ<SKYD1SWFJ&A<,/I[X!<_SQA/,XT?O=#:,V1CN
M?W_U_KDE#V0>6,4O1/XM6ZOMZ2R>H35_9'6N[L3S7[PG%#3^4I%7[7_TW&'#
M:(;2NE*BZ(UA!D56=I_LI0_$G@$.)PQ(;T!T W_"@/8&]+T&?F_@MY'IJ+1Q
M6#+%%B=2/"/9H,%;\Z4-9FL-]+.RR?M*2?@U SNUN+BY7MW\?;4\N[]<HM4]
M?'RYO+Y?H9O/Z.;V\N[L_@H Z!!]72W1P8>/Z /*2G2_%77%RG5U,E<PA\;3
M/.W'.^_&(Q/C88*^B%)M*W19KOGZK8,Y3'Y@0%X9G!.GQR5/CQ#%GQ#Q"+9,
MZ.+]YI[%?/EN<YPXV- A'[3U1R?\W?$G7M;\V.'*'USYK2O?[<J6H\XP; V;
MRO"T"/S8BTEX,G_:#YV)(U$2D3A^BUM:<+$7Q#09<&\8! .#P!6,IN8=5SN6
M\M,9%+6*RR<^6_S^&PZ]/]"%J%2%8!$B_@)%L.*5*V;A,&+HC-DRDU"04-HZ
M/^ O:5ZOLW(#E00FD&:LJU4P*"N$5-F_[8N/MA!WXP1[(:$0N1 3+<0F#B=1
M$L=4"[$5YV,:V$,<#80C)^$55%P@^ EM>,DERSMR:Z@T6:4D:XJRC5UDS":(
M TH]C9P)HS[Q_43C9H%1$H;43BT>J,7N7+IR9B,5F]/ ?A)'&BD3%D):M:VS
MM*!P$'AV2LE *7%2NI>LK%@Z,,I*Q3>R8RAYSA1?HX-KH3@*K8LRL2PBV/7:
M6KLP88=1H"?-!/E>/+$:L3>V(^\710N679VJ6C;;KN." RN9WM/;?&$OT,A8
M8!AJG4[' IM(%M[KK=B=+J%@1Z5&I;*RP>:6PAXAB;[\+$#B>T%D%&4;D$;$
MIQ/["I.1%W'RNBI347#T*$6!0(%V"]#.BI@YBN* )#HI"R[!@>?IG$P<\/&]
M<(+2V'8Q_04EQ:'%*-A2#3<K%VIF*/)U(B:(0,QU&B8JC(.);HG'AH_='7\@
MT2^T?O\0W[Y_?'.;XYCX1"\'5B!M]<Y;5E8<B::2,\H '+QGO3UP..?P/D-(
ML9=7GE9V@:76A6&LMR@+CL:8Z&5D:<'Y)$SBJ:2-B@.[)<>50>>U[$VDS50"
MAZ #J+$2;;@HC@QB%ER \625&)4%=DN+MUFKM@S^BT?$F2RAME==^> _ZDS]
M1 576]'TLR=8OG"L5/9J8@H%Z*G4UV6K!4>;/Z.:6' 1")FI!3LJ#^R6'JN!
M[/^B9VJ&0X)#K+.SP&BHZP\+:JJ?C>H#N^7'-5?H:KH^6M1%0'%L-&03!W(O
M"8TB:<$YLD-&C4'<&J.AT1<1II3,'FK%'G+8@@*5 MZ72HI6%;?ZJBFH-KK$
M)1CZDZ<).0RIKNQM*!Q'$]DBH_H@;O7AH*FV'/TI1;VS$L/&:<Z:1PL.\D@I
MUOE9<!%-XJD\CC*$$.=9>8\@B!!T(^&HQN1/U.V^2<ZO73'ZZ#HQDE$Z$+=T
M.&=5EJ*#YH:DF49;Z*R5N_<3[VN#(Q+K8351X1'18VH#3:EO,@H(XA80RRRO
MVS/$.\CX-C+&&C%1X1'66Y 5%4UT5C+*!N*\/EA\:R_]@ Y[ HVZX:BLBP<@
M!759O*Z5EF"%1*TJ!1(=-KUS48Q=G;B[>K\HLK(?P1Y#L_6&$1QA<*QW- LR
M(* 8$VSL-@N2 C*@T40\QX9.W U]6!V_8&5V59!=84SUN5Y8D $E,0WT6K.T
M(4'X0^O'&JOYWEUHP>6FO5.NX!!6EZJ[5!S>#O?69^UMK?;^'!\ON]OGT4UW
M&?Z%R4U65BCGC^#2.XI@6K*[7^X>E-BU-ZX/0BE1M%^WG*VY; #P^Z.  M0_
M- ,,M_R+_P!02P,$%     @ $8AA5(%Y$0=.!   ] T  !@   !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6R-EUUSVR@4AO\*X^E%.U-' EE?'<<SB>UN,]-\
M3)QT+W;V DO88BN!%E"<]M<O2([B2$B;&TO([SGPG ,'F!^X^"DS0A1X+G(F
MSR>94N47QY%)1@HLSWA)F/YGQT6!E6Z*O2-+07!:&Q6Y@UPW< I,V60QK[_=
MB<6<5RJGC-P)(*NBP.+7)<GYX7P")R\?[ND^4^:#LYB7>$\V1#V6=T*WG-9+
M2@O").4,"+([GUS +RLX,P:UX@<E!WGR#@S*EO.?IG&5GD]<,R*2DT09%U@_
MGLB2Y+GQI,?Q[]'II.W3&)Z^OWC_6L-KF"V69,GS/VFJLO-)- $IV>$J5_?\
M\(T<@7SC+^&YK'_!H=&&W@0DE52\.!KK$124-4_\? S$B0$,!@S0T0!U#68#
M!M[1P'NOP>QH4(?::5#J.*RPPHNYX <@C%I[,R]U,&MKC4^9R?M&"?TOU79J
ML;R]V=Q^OUI=/*Q78/.@']?KFX<-N/T*EK?7=_?K;^N;S=6/-;BZT>TUF(+'
MS0I\_/ )? "4@8>,5Q*S5,X=I4=C?#K)L>?+IF<TT#-$X)HSE4FP9BE)WSIP
M-$;+@EY8+M&HQQ5)SH '/P/D(F@9T/+]YJ[%?/5N<QB/T'AM9KS:GS?@;Z.P
M(GJ%*<!W8,D+O:PSL]Z>"+AB"2\(^.MB*Y70*^?OD>YF;7>SNKO90'<WNL;0
MVJ\ME8UM4-N:4O*T@+X'(W_N/)T&N"_S/!0'L[>RE446^I$?M+(W!'Y+X(\&
M[%9E1(#D3:0:HL^ D3J,"C^/A"IH.PI&0[6LA" L^05T\)G,<5/ TG_T:C7Y
MLL6O<>B?$$\#UXU1)WY]V2R"*.Z$S^(,>M"S1R]LH<+W0=&BU%/*1"OG;#]5
M1!1@5[&4LKV-+.P/QD?=>6$1P<#U.EP6%0JA:^>*6JYHE.N1Z>TPI[])"A)<
M4H5S\#'G4GYR]GI7U/6,LB?2),Y:Q*+>H-P.7%\Q11[LL/5%003M9'%+%H^2
M722JPH)J($/B-%1 3T6][6EI"K:$Z3<%RN,V7>:8V1#C_JQ#0="A[(NF,^A%
M'4R+"B$TL+"A^[I)N>.H!1>*_FY6FIZ9E.EIJ;,&A*Z1("/IWEJUCEY/AP-A
M9]8M+:)I##M)7EE5:&#-P9/=%XZ"Z7.5RMLJ_UXLV!M+&$9=K+YH&KM^%ZNO
M&EAO$+TRH5&F!VX6F:T.6V%0;P1Q&/8JB$7FA9[G!ET@BRZ(O< ?H'K=C:$W
M2O6=2%EO(PT*P$H)NJT4WN8$* X8U]^9$CS7EOLVE59D[W]KBD4R#;QNP;2I
M8!0.9?#U* #'SP+#&>QAZST7_"%X55I!^QN]-;>V\P *PAZN11>$L[B;6^?D
M.%P0L:^O%5+S5$PUI\GV:WMUN:@/[)WOE^9*4Q^S7]TT]Z%K+/:429"3G7;I
MGH4Z!Z*Y8C0-Q<OZT+WE2A_AZ]=,7\N(, +]_XYS]=(P';07O<5_4$L#!!0
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M D646B79G(-W8FW*9IG?@Z0"8S[_ ##\.T !C&R>T_9/F_[K:/[MC.(XA&'
M3H??+,KP3AE^H;(#U%RT?;(]-1!3@B*X$].J-NT(HY%J-#:-*(H90:K9Q#2+
M(ZS:7)HV Q9CI%WQRC2+H@@CQU22W522IAUV3*5P8L'>4JRMF+_FT_LZCLRJ
M?/[[,E\M>%&*(/3'-JU^@'_?"2<#@EW/2;'XC\?#Z.[BU+N.-^*0D+IVT04U
MO >'.(Z8-B^]9HHTMI/&O-)&VZ+@V?P'J(HD*T40:(B_^*] @SA"5#:]S! R
M@!CJJ]UGI:@-=VK#P]2FZXTXEH#\$:SR[&D@8L$:/&XS$:*?;))#4PP*8:!)
M-JT4(T5QM%,<>15_S82SK=(_11B<MP$:O%OE9?E^^"2"H\!:FGWC[5Q;6189
MFIB^D2_]-HKL>"<[]LH^GU?;I$B%VD9F*QD(UQ#GMB:F/_!,?*K ICMG;D1\
MLNF/+3./D.;;EWU6RAA@( \?@7\4Z[RHTC];IQ:^DG;0 (6 '5CRQ9-U0W:]
M*G)BI#MXGY6J>>_ !+V:/XF9KB?Z4*W04.'P6"AY"/U ;$Y(8*X< MKP)?A3
M%>G#MFJ07.5 '!? 59%O-U9M)A<Q"TE,'0(E%J&?BY/OO)BG(IB+-6TX#?)-
MO<;E/KFM1SQL*D)Q%+JF3-(%DN,46>>%F($&,J3SN3/;)R'2N#NV=D7CV#$>
M"2SH)]9U66Z;P=0N6*3S^FS8CFN;I54)AF+C%TUJ6Y]*]G_I6P$+QB@-L6L%
M),>@'V1'*[:ND$DO1/3E8>;R$,<H)-^@'W!-<M%DRXMF XK=UT8O_KW^; \!
M%FZQ$&/=5?K,5,D2<-!/N%9RVDS_/"\=$VHR:J ?&<8]1JH^23+H1]D=WVR+
M^3)I-V?^,XUK?;3772UD@@&F,' X+))P0GXX>779YA!9@ .).$+K@:,SU$[:
MVHG=TIMN<W7 %=7!2\HA/^5:IRGD%#@]!YF $RL0ZDI[K%29>YFAGX3[87V>
MB*2@C>HUGS,U']WAVK-^)@X'-"!Z_M-KIHY%0A/U0+,Y'1^2X\;6'-=$)\5,
MG-)<22Z2\$0]\%25':#F IG<@PQ& :7Z7C A2AC6K,:6[F@8Q@SJF\9RV8!J
M4+ZT6 U"&D%C>UEZ@S!P'GR1Q#?RX_NHPL&TZW1_KEQ13F(9L6/R[GN^WN1%
M'>]>FG,CR5+D9ZDWZYXB$X?0>1!$DH;(3\,;1UB0*75];"[X0DQ FVNO\ZTU
MSYXB$X<8T1@Y)$H@(C\0WS*H39$)2'>PPA*.V _'EX>$*39AA6/JRM^Q1!6&
M___*$98(PGX$^6M'V))B883U(\%5OYTJ;Z]"Z:?*$?4C;)*$1!!IT?&RUTQ5
M+&F#_;0YMH:$+5$=LL"H<O:9J;)E2,?^D/[:0A(V$Z\!TOWDLL]*%2\I@/W)
MV9N5D["EK$@@CO1A])FIXY!(P7ZD'%E0PI;Z8VR4'_NL5,V22-A/I!<6E+ E
M"8L#JFOML5*U2C1A/YK>JO*$32KAL,YV'3<1))=(#Y>.K3P1DTXPQ@0Z4A0B
M\43\F=2+*D_$3),@AI$6>D>=F7H+23LRV[L*7;=I).^(GW=_6>6)F A$0<@B
M1U @$H'$C\ WK3P1DWI0KSP1RQT^1^6)[-T?\V/QF,H3L50?::S?GQCWFJF2
M)1*)'XD'59Z(A6CZC(Y[C%1]DGK$3[U759Z([08:PA1!E\-*BA$_Q5Y<>2(6
M,L&0!D&@>V9H5IXB_5ZQI3?=YNJ *ZJ#ES@DAY0K#ZD\=1TQU2D"7:FM:$E<
M,B4)24^2=FBU!@56[9:T#(51%,187[(#+-6;WA*6]!5)G%TW-4N7,*(!PMH=
MPY'%D-!(6YPQM10Y80@#;?]/+'808LWJTF(UP)2$>C'2UAMB*'+=^*(2]O2H
M7/3X:@J57*:OR$.GU(0K<]U:H)*LU$_6MRNF7%"3JP-"]?MI5X>932UFBI4Z
M7LE@>OA=Q%=79J@E$26$,9<3[CW,XL?NR[?UE!Y<6:22KO2HRN(KG^B1$*6O
MJ"Y>4$MUD8J3-M7]K==.E2<Q1_V8.Z(N0RTD8T$0Z^7M?CM5LV0>]3/OV,H,
MM=RDHTA/6?NLU,>G).28'W*OK<LP$Q:.K<$D)I@_)WRS<@LSDSR"F/[T3I^5
M.@I)'.8GSI'%%F:B")I/I_F-5,625\S/JQ>66IA)D3#42UD]1JI221KF)\U;
M%5J8"9DX#)V[2C*&]3#FV#H+,S,Y&#!*775CMO>@I#^;>U&AA9G9&Q11W:BT
M,/,A$OTX.7;T!1WQEDF$,3_"_K)2"S.IAE'$L".C9I)JS$^U-RVU,)-C^D-^
M(V;F@*Y'_)CD'/-S[IA2"S/I!3&F5"_+]=NI#]Y*SH5^SAU4; DM&5)D:.RS
M4A5*ZH5^ZNV<HRNP)&69S]/FM8;GM%J"!#QL2]%&Q&@QZP_U:Q/UI/?X<FC"
M#84X1 0Y2K>A!%QX8*GS18*M\VYY X'1"!J/0W2&2GX=,SUMMG?'H"N!#24A
M0S\A[[@X:LQYD[HUHQZTVR"I#^9EZUZ+FCK)7)S<"\Z!2.U6^0]N+TR%9B44
M!3&.8WU )D0U.W4\DJ/ABQY=\91IH%6_B<]ZT0C37YX8'6*ICD&R-GQ-/F?7
M;>9S4<!8A$)=MFG(F%Y#&]NL0HR-6V03BZ&E3F.Q&L1BN?4ZC:TW ED0Z0?P
MX=X+</4KEY^3XBD59Y$5?Q0M@P]U1T7[%F/[I<HWS3MQ#WE5Y>OFXY(G(B6M
M#<3OCWE>_?Q2OV:W>Y?T[']02P,$%     @ $8AA5+*CO*2("0  0RH  !@
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M7H#?5PX'4?_" 8;+\O$?4$L#!!0    ( !&(852U^^\7PR<  )F$   9
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M+:IM=JC+8E4X_^)1"YO@HX]6LN K7O!J8L'+J^QO==7N?/9]M7;K=(%' %T
M\4I!?'5UYXIOW&J1/;Z<9U<75Y=WK/<X'/DQK?=X8KWK>,QW<LSLOZZ7OFV
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M5Q=?1<8C[;$R; ^2S+?NX)]G9Y>SK%C#$8K-D5$A()SYF2B#@-MOL[.KWM-
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M5X&7.,1[!UII79?U]DCNAG!MV"I81VHMLP3W*8RPIG@14;N1:<IBIC#K@(!
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M8L-:IHOL>[[_X(=IB+=Q\=Y,+"?84A+8E= ]^WG\I1IE45F*=AP&1D"A87(
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MATF*!$-OE,!PV55V!C[7&TXT\+Z2*QI\GOR#7'TO84\QV^$2,"#DZU5!%.7
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M[%SJ_)M&XC[K(HXK0AE45P&),D- ;13JPP*J^>LX& @^V+C(!"&<V [JNN3
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MJ7X3:/3=4@@T!O$H&.XPO^AY0G$N]CZS.OT#&WKD@DC=DMW!?@I='_Y< OI
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M$F#%K@Y#M;QV;.F8!6"L%G]Z1WXX@HK9S,_;Z+"T>Q\@PRVX7\'[X,.8WP4
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MYLSXS4ZYHV@R/JX# %?;0+ZD3'<F+U6QI#A3SNFY^*HAN%:"K_N\4OB_A>&
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M7.D2KRN^U;#H\N9] @?NA%L6>HJS'>MVTSO/HAD88"1_E2FA=JCA6(]P:M7
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M.A_YZ*F_E.;(OVK=F!+NQQ]1V\+A: '>;PW*Z/"%#FA^YOSF/U!+ P04
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MO<O_RK8:\LF#S)KM3>U0;Y\J9/$)G(DJ(*,X*Q/*/=>[\8VR W@P.#Q2*^0
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M%$L#6V\X!OKS-+12G!XKG:.^S,,G5O[1MS#HQR-#/!AFSU&)/HY"SK5I&'B
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MCYTLS2XKYO^JBK,CGXI775V#I>G+H\X\Z"'.6&5.%I/N@@@:B4X4AI=ADHK
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M]3W_*_$RS^L.?%NX,UQV)8@5#(P/JNR4B#/4$REA0@!L?GONW7[D1%&"F$-
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MY<>-DBCL:0$^7U=P5?L/'3!\P_K%?P!02P,$%     @ $8AA5&X\'C<V!
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M%F0!\4W(DOVT[XL3=.8ZQ93F_FC+V8_9$P%BJFW&CL?!$'()Q\#S5%TM/SY
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M#![8$4QP;=H R6&2!..A(%>6FJ 8&(Y+KH^P2C@E/3]4<U$+HW-Q-!SU9PV
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M]%GC3XJ]"."\="X>%F)@^C?;_ U02P,$%     @ $8AA5 )>#?TM+P  ;JX
M !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL[7UI<]O&MN!?06EJQE*5
M1$MRG#AKE6SGYNJ]+"[;N:FIJ?D $DT1,0@P:% R\^OGK-VGL8F^E?=J/N2+
M+9) +Z?/OO4W#TW[P6^<Z[*/VZKVWYYLNF[WU=.G?K5QV]POFIVKX9=UTV[S
M#CZV=T_]KG5Y02]MJZ?7EY>?/]WF97WRW3?TW9OVNV^:?5>5M7O39GZ_W>;M
MX:6KFH=O3ZY.](NWY=VFPR^>?O?-+K]S[USWZ^Y-"Y^>AE&*<NMJ7S9UUKKU
MMR<W5U^]?':-+] 3_RK=@S=_9[B59=-\P ^WQ;<GE[@B5[E5AT/D\-^]>^6J
M"D>"=?PA@YZ$.?%%^[>._@_:/&QFF7OWJJE^*XMN\^W)BY.L<.M\7W5OFX=_
M.MG0<QQOU52>_LT>^-GG,.-J[[MF*R_#YVU9\__Y1P&$>>'%Y<0+U_(" >(I
M3T2K?)UW^7??M,U#UN+3,!K^05NEMV%Q98VG\JYKX=<2WNN^>U?>U>6Z7.5U
M!Q!:-?NZ*^N[;-=4Y:IT/CM](W^=??.T@_GPK:<K&?LECWT],?;5=?934W<;
MGWU?%ZY(!W@*"PVKO=;5OKR>'?&U6RVR9U?GV?7E]=7,>,_"[I_1>,\FQKN)
M.]9]9O_G9NF[%K#E_\Y,\%F8X#.:X+.)"5[FOO19L\Y>-;6'&8H<<7$,E$>.
ML[+CO-\X\X4KLG59Y_6JS*O,=_ %4$_GL[)>5?O"91T\/?H #(N_O6JVN[P^
M9'E=9'E5X=<E_.KW2U\69=X"<!;9#?S@#<Z4=>?:E;RY:YLUO'*> ?QJGQ/=
M>1Z/ 0T$5,'\ .5-?N^RI7-UYJH2\!J7O\AP0ZWS0%&TJC#U(=L#!K5=_@&.
M"D9<_;$O6]AO6=/*=ZXM&YBD=;K9\-,K"YYWNF<<_!=X*^<5KMMF2T_C8_@;
M3>!+_'4Q@P7/ Q8\GSV]7SV-^KWO2N CSH^=_U$C.!T! 05<>)?S%O"WB;-'
M!$'F778'8"W=)KMS-6R\J@YX*&Z'<+&$WP($RUWEO$+PU[H,L/-P.@1Z#SRH
M!JY-P.P:^/3!Q=71D?^^+^YX$=TF!^:R7@,CIA%AW4U+\VYQ6CKJW'O7\8M5
MF2_+"H O Q6E7U6-W[=."  7BO-.O=,E9SF)]OC>U'):=^_JO2S ?009Z.%#
ML6\11LE+C'M &*MN#^,K]@) *UPZ[+I5_&J\@1$CNX ;7C3PG(+CWC->\\'K
M2D;WUKH*MP\G(SN!_U<-D"V+PAK'Z?+ZKEQ6+L#14%6>+?<><-#C3K9+I,]'
M:.'S0 N?SV+R6UG/V[B>,7(X;A"[J?>&A;F\K7T\Q"6QIGM@)0"S/*OWVR6<
M"APSGP_"W+OVOD3&!"!#KL>BU[5\3G!P^L!Y]K I5QMA-IV[ UH"'I:RTA4L
M&/AC!?K!/2@^.SI66 *\#P,H0PY/=2T<GR6I<V+K@$BP8/J;!!(>\'I-7P%R
MYW'-1 'YL@%FT "OU.\7R/WH38 %'#8N&'&8608AI07&EF4U ,##JG%;!X C
M\OQWK[+/+S^/M)_O=B L#><!7NX[M_-?9:=79UE9P!;*]8%!(4LX]6?,?_(
MVZ^ST^O>TT!-I&F"C,B:957>\23"BG0L>/'9&< 61 ^(#I9L1N0@5:T<//39
M&0JR9D6D,/8,;G9Z6C^<%R%]^OQ,$>]/%^CK80.R[+1I@9K.Z"7<%?!<#T/Y
M-?*EZ8D -HI642X2D($:AS3\)TIZ/#V7PQMRV@ .OVK+)?RV1%T;#C]!K_"<
M#G;3P[_P "@:@%N 9M7D>>BFBJP!3,F 73E ZX5;,$?:5]6%CI:>(F#/#L4
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MG",LAA7MX9(7V6_ R2SFD,0,N@C]D,.P6U0-=I/8BQ;8%#&K0"1X$&9,4$!
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M=HM#:..?Z%U@L750!0;-@<,.B0OPWI5DM3PX]Z&")\CXQC\ M'_L0<5W;74
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MDSWR#"K<!)0D5A!$-_)T%=$<4.$#C='.P*;9H*Y*#DJSW"',#C)778L!/85
MDM@-^@0ILN*RZ^P4C,'7' 'A>26(-?@^^4 ^""_^6+$G #O04^6;54FH[L!L
M;0X.16OM,#V%MNHWL"61@0$&J/>(47FA_C!]W8::)%33?U2\Y./@STF DM-
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M=#K$6E#>9Q7KV/'BZMDLS=S&NN\;0N-1NCMZ#":%P1><%A>\5)0OBETUJ'@
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M8)7K#)<)<1M^66++MD?6)]%P1(4)OM=S$B=JY:"D0-+D$"FW^ZV,%FHI1A;
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M% +4?L?>.X=8?QGK(0 !?G*ORY^;^]Q>2CJ=RH I$[>]JW%#<E),+J- *+;
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MC@WH>V5MZ#<<8/A[+O\#4$L#!!0    ( !&(8531 U/PIP,  "8)   9
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MG0'-;Y2RQXX+4/\:S?\%4$L#!!0    ( !&(851X*+Q>G0(  '(%   9
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;(54VV[;, S]%<(;A@0P:EM.&K=+
M B3I+GTH%K2[/ Q[4&S&%FI+GB0W[=^/LA,O*]KLQ1(I\O"0\M%TI_2]*1 M
M/%:E-#.OL+:^# *3%EAQ<Z9JE'2R5;KBEDR=!Z;6R+,VJ2H#%H;G0<6%].;3
MUK?6\ZEJ;"DDKC68IJJX?EIBJ78S+_(.CEN1%]8Y@OFTYCG>H?U6KS5908^2
MB0JE$4J"QNW,6T27RY&+;P.^"]R9HSVX3C9*W3OC.IMYH2.$):;6(7!:'G"%
M9>F B,;O/:;7EW2)Q_L#^L>V=^IEPPVN5/E#9+:8>8D'&6YY4]I;M?N,^W[&
M#B]5I6F_L.MBQ[$':6.LJO;)Q* 2LEOYXWX.1PE)^$H"VR>PEG=7J&5YQ2V?
M3[7:@7;1A.8V;:MM-I$3TEW*G=5T*BC/SC\IE>U$6<+@*]^4:(;3P!*L.PS2
M/<2R@V"O0$0,;I2TA8$/,L/L7X" ^/2DV('4DIU$O,+T#.+(!Q:RZ 1>W#<9
MMWCQ_YKD,H-K:;G,!34+"V/0&K@2)BV5:33"S\7&6$V_RJ\394=]V5%;=O1*
MV3M24-90';6% X67QGL2Q:GRTM0\Q9E'LC.H']!S$\)J@[J?$CSWA# 0$FRA
M&D-=FR%\(1T+F4-^&,9;N(C/?3:>T"Y)8C^:A+!JM$9IX0FY)L7\;H013CT&
M!E)9A/,A)'[$0I\T#VSB1Q<1K+50&FJD)3O.@7=O$A:Q]Q"Q&$A")! )^)@6
M-'Z$2CU@Y4H-HL2/8S8$-O8GDQA6=!7/>?IA//$OXNB(\TOW$QSIH$*=MVHW
MD*I&VDX2O;=_4!:=COZ&=Z_1#=>YH+9+W%)J>#89>Z [A7>&576KJHVRI-%V
M6]"CB-H%T/E6T;SVABO0/[/S/U!+ P04    "  1B&%4N&M;:70#  "(!P
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M9R&7:$?^!NCS43&O,V&XIE*-;!MH[PL_U1-Z43MG_X0'_6.+__RF6&U]NTO
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M 6;?0G\*UG\$S]7GUPD7@B_5Z8+&(&[Y .[/.+BA_B,5-!_DS_X+4$L#!!0
M   ( !&(851 3V(RF0<  +@4   9    >&PO=V]R:W-H965T<R]S:&5E=#0W
M+GAM;*58VV[C.!+]%<+;,YL.%%G479DD0)+NF>D%>C9(^H+%8A\8B;:%R)*'
MI./.?/V>HF1%B6]9[(LID\6ZUZF2SE:->M S*0W[,:]J?3Z:&;,X'8]U/I-S
MH=UF(6N<3!HU%P9_U72L%TJ*PEZ:5V/?\^+Q7)3UZ.+,[MVHB[-F::JREC>*
MZ>5\+M33E:R:U?F(C]8;M^5T9FAC?'&V$%-Y)\W7Q8W"OW'/I2CGLM9E4S,E
M)^>C2WYZE1&])?A6RI4>/#.RY+YI'NC/I^)\Y)%"LI*Y(0X"RZ.\EE5%C*#&
MGQW/42^2+@Z?U]Q_M;;#EGNAY753?2\+,SL?I2-6R(E85N:V6?TN.WLBXI<W
ME;:_;-72)O&(Y4MMFGEW&1K,R[I=Q8_.#X,+J;?C@M]=\*W>K2"KY0=AQ,69
M:E9,$36XT8,UU=Z&<F5-0;DS"J<E[IF+CW\N2_/$/M6YK,D_[(["+C43=<'N
M3),_L.MFCA30PGKQ>B;4%,='7\1])?7[L[&!%L1KG'<2KUJ)_@Z)W&>?F]K,
M-/M8%[)XR6 ,]7L;_+4-5_Y>CA]D[K* .\SW?+Z'7]#[)+#\@AW\[F"C/*%8
M%^Q&/"$%#;M42M13:9__?7FOC4(^_6>/L+ 7%EIAX2YA\'>QK"1K)NP+9&AA
MTU4S%)QUO:B?_JZ9U8G]<V&#<%.!;IOG]XOZ,I/@6J$.RWK*# 6P*\;R+X34
MX-B\UH VG[705HNFU6)!6O1$3U(HS22%E"$@<GXO51\49V/+LPGV:I=GIYV)
MFOT&30QX?;=UA8?+1ZD $^SC#ZGR4DMVH\H<+ED:;<"+3!)F@V/*,M]SDC!F
M[U@2NH'?,\X2AR,7WS$>>BX/>KX%.PK\S$D3[ST.X\B-0G8M4!^5/>).FG(Z
M25,7UP^(S\ @=KB7T(7$3;U>//:<)*!]'F5N^D(^SP(GY(F5#RE9+W\L?RQ*
M94EB)V[UR'S7YP?T@+NC*.C<P+W4C0)VJ1%[L#(SU2RG,W:_U,@7K5G>S._+
M6K1A.&:^PQ.X*O"ZJTDZL,%S_"RC@R1QD_B%#8X71T[D9Z0CY]SUMYF1> Y/
M8TOBIR[4.V '9]R)L\@)XU:=T$TR]DUJTH822K8*V-3>>CU+,[B65,ZXFWCL
M^%:BF6F4-;+;PEW3)6 )_Q!7C=Z#5,_;VA<KH0H<UG!377>M956:F2V"SQ+@
MJ-P]L!#UL!"]&1;^@(C.1@L#>NBE;3"PES6U^5.]@$'G(VNZ>I2C"[9'Y[C7
M.=ZO<]O82>5/=3LOV);1(.JJIHB^B"["]7$0KB'";06WO<*W6W4 \<J!EOFS
MELTK+8=)-41 3<D!8S>R[!G%A@:O]X9&WU)3>8:T/Y:6#WCVL'<(_[9<V4')
M0\*?$P"?BV*.@Q3XE[+ #2,6>Y$3^R$**G!3#AKNAZ[GL0#8&7 0NV'&  $.
MP!1GD9N$1!0FKA^S*"04B$$4Q<P/(B?U4@MJ00 B/^ N_<]BP!T1Q?B3 !R2
M7J$U25_9D1MDS^7]NF3W9&K29VKRUDS=\-JOHE3LFZB6W1!D<;(+W5?]>F!I
M4W._-,K"U5J,Z,1,2,SCLQ@Q$+.2R#&AN]35I^Q?:*[MN+0%TC:Q?K,+?=\M
M'GX-,Y='M/IN&- :T#HP_!2YM #8@<%C4Z%@*AH:D44_#7X^E(]E@0& /96R
M*MC/?TM][O^"@VU/MZ5^.)DH*5&$!N9JPY0PDGG47W["$B58?#>*L/3"JW(B
MD1U>-VUL>SK@; KY<_6V'1#53^!=D'P</P,Y6R$(N:CR)6P&(77(J3V_0D-X
M. %(-QB"^X$(948$\Z:0E7M($[U'[NN$6%)+W<B*?RRK)[;.@HT(3ZE)M\Q?
M!!N#!PT,;XONSICNCA] X'7$ C=JH[.G=-.^=-.WEN[MW5?KJ1NLE_1V![6W
M5>=^A@=ZQ%"(Z(2\&'IWS;RG]LJP =#_VU=[K_]OG=T IDX<<@I>D+AQR(*0
M.R'PFH97@''RIF'NN _?N_XI K9&G*90WXO=A/>C700D#L/U9 >L3C@Z 8V/
M/F ;0-Y-(H_M7')\S(["$%.BWXY[D1MSVHF=T OM5AJ[F!3Q)CV1I>DFV"0.
M[%G(B>-1&J MI"UU2AWG\# 8069F1\'8<_V 18GO)"EA&4>S@.N.V6# HS1%
MC9+X=M9;UJ7YOR8],ASOSM6R@"]X#!^E&<44[TJK69G/UO[96>K[9L6L+XGL
M?YD53W*A9]O>W:DH:RVWE<A^ 3W3UFOYD*ELF;(9W'<O9<T$2BFW<+G1P794
MRILZV%%)+FR6&OF@WP.8%$("530"2 GC1!$5"*WVI2IT$J3MG:Q@S-1A4UD#
M%JL668MY69?T"F^_>% M193A3L(Q OF.%_K#5W%[AU!NJEJ3E6S;P3%+ B=%
MYJZK:;U^:0Q$O7!3KVB *[:P_-CQ$]X^I##P1:92@BQP95B_V%!V[1)(Y/0R
MI:PJE&9V=)VL\W8 :: E72HYO-VFW[;L&P^^)LV)BKZ9$9(L:]-^6.IW^\]R
ME^W7J&?R]IO>9Z&F)?I7)2>XBMZ.-Q/5?B=K_YAF8;]-W3?&-'/[.).BD(H(
M<#YI&K/^0P+ZCY47_P502P,$%     @ $8AA5!S+<@*4"   DA8  !D   !X
M;"]W;W)K<VAE971S+W-H965T-#@N>&ULO5AM;]LX$OXKA*^WFP!L+5*B7M(D
M0-)V=P.TUR)I]W XW =&IF-A)=$KTDESO_Z>H63%3ARW>[>X+S9%D?/"F>>9
MH8[O;/>;6QCCV=>F;MW)9.']\F@Z=>7"--J]LDO3XLW<=HWV>.QNIF[9&3T+
MFYIZ*J,HG3:Z:B>GQV'N4W=Z;%>^KEKSJ6-NU32ZNS\WM;T[F8C)>N*RNEEX
MFIB>'B_UC;DR_LOR4X>GZ2AE5C6F=95M66?F)Y,S<71>T/JPX-?*W+F-,2-/
MKJW]C1XN9B>3B PRM2D]2=#XNS5O3%V3()CQ^R!S,JJDC9OCM?2?@N_PY5H[
M\\;6?Z]F?G$RR2=L9N9Z5?M+>_>+&?Q1)*^TM0N_[&Y8&TU8N7+>-L-F6-!4
M;?^OOP[G\#T;Y+!!!KM[1<'*M]KKT^/.WK&.5D,:#8*K83>,JUH*RI7O\+;"
M/G]ZT9:V,>RS_FH<._BLKVOC#H^G'J)IP;0<Q)SW8N0S8H1D'VSK%XZ]:V=F
MMBU@"IM&P^3:L'.Y5^);4[YBL>!,1E+LD1>/CL9!7OQ-1]G;RI6U=:O.L'^>
M73O?(37^M4=%,JI(@HKD&157?6(S.V=O;+.TK6F]HZ=!][D!B S[U-G;*B0U
M'MEF ':=^UZ5!-DCM]2E.9D D\YTMV9R^GEA6+EE0-4KN>X-&)X\CL)\!;J=
M81K3VL&@&BAU1^P?1G?,4"@9 F&::].-P7@R$SV>$04[J%KF%W;E=#MSA^RB
M,S5&[ 636)(7,8WRB,<BPBB6,<]DRKZTE8?&*Z\]9:/,<IZ(^) E@A<J8E+P
M*(O91[^ )IG$',S#5,Z+1+%<<E&0+%&D/,V#U%Q@A<(HD2DO\H+MB;$:8ZS^
MNQC_L:CN5?('H_I_C>,3E4?LS:KK8-+VY$/ !8*8%B'>O$@I\+%".-6C:&,R
MR7(6\TA*IC8"G>0\BF(FDK!;")XFDGVV7M?@QR>:F8CZ9$D0\B1G2O(T(\?F
M!FMG8>G!M6G-O/*'TR?F*@45/%4)DSR/X\<9"6F9R)"07&49.XBYBN3A8.<!
M_%1X.E \CA+\YVF.WS3BJ4@/62&Q07 59[M.D6D$K-2DRUN$N?55NZK:&X;J
MVVFJ7XY0$,<)2S*>9XHIP04,W"'J#@FP)0[F#1E!$K=SR ;;::XS"ZJUMVM^
M6 >VO&=5@V3T#+E=6TCPIFO8?-7.2%Q2L#1G4@TA>1',S"G,,+1(:$"FJGP?
M^M(1?>E^]*$GF:UJ0Y9?&AQ36=55.)X>D*VS=34+?E^:I>UH\#PP&46<0KOR
M%I"^Q+Y=6-UKTO-8)7K0[?V/CL+Y8%>WMFL'>F?5'&F*=_/.-B%LNK$K2O"%
M]FAO5C7M=V@X^A5ZN:SO*0BT]**KW(*YT1VD3> "A\X.GOL%Z!\I\.=SPG"6
M?K<%B(N0K]1?0>>0?Q3&KX/D?GQ(S  \Y6F?,JD2E#(QC[.$H?%"6]6&0/69
M^G!J,!\Z%^BZ,-T%?,J(1Z@%?=YE/%8ITL#!W7+!?M#-\C7ZM5L<PK)9LP;$
M88BD=X1F(:-# BEJ"^&WP.\'>VO":OA\J^M5GVP$KSN-O> K$ Y^52ZP$]O?
M(81ECZURH=L;@E-0U9MX("18041@.E6P-^.*5=LAGV_:ZM\#20T<Y<"%,DG)
MJC23O749[+H8(#G'>=ORMX!@Y%!OWD'!HSP.5"04N901)-=$E>:!NN+@9%QD
MAP-HP2TOUNSR8LTO>T";C:#-OANTU'YMG-!G R[JJ)Z^[5,?1^KZ;/^9F.BR
M BK 8%=(@FI>E1J!^(1<#GR(_2.MD]PSAU3O0;TU_[[2UZ )7^TNQ7N-?Q[>
M ;</GOC1D]EC3V[(DV[PQ&UXLMSP9+99H/2#)UOS]8,GH=('BUHBDP':WX/G
M1^A]^XR"(R).%!]_S]FR)G/)'//[JNK10YT63R-"+7('N1SN<R_M_.7*F9>#
M!W',$Q2(@B>19#];.[NKZIIF8U186)3* HSL 8(*%X^UW]2VH=4#(PBL+/(A
M;P7/4H'?*"IH25YP"8"KE&=%MNU&+^>(?>R+)P@2[7Y_GO2ZQ#I"5JF[[A[4
M>*>[F6-Y&OK2!"6^2+[AO.(Y,)F";2+VWN!2N!6:. 4II/ ZAJ"G[H'LBI3]
M\)=<"OF:G95EMX+=0PWHK5RU$%:':G%KVI5A:8'V-B>BC%%MKYY"7BJN5 8B
M DL\',;6$HJ%(L+*$_0U8,5V4P':*TE=CX24@2<0,Z'6A7U7@LHBXR+-6(&6
M/DW8KSOXD6KNKJT'"?J]0A$#X<"I4]H10;;!B5(%!F0*W(;C^WB+T"*76E2W
MI_*G!^MXW!.[@32C. -')Z':<%GLO0OD(['EWTUL[Q"^DI"(045\%M@>+_[V
M\?V/.WEGK^SG><>L%9E>T6RM"#%#'GZY"KD^$,3F5> G,Z,CZWO9QRP 9I O
M9103\XN(RSBG@Y(X,XPPG^(E<EVDE&C4FU^@?YA7U!VS0K$$>9E%_=XX"<U^
M05<NL>^8B_&8B_^AZ3LW-U7;$L8).._ZIO2L;YNHPH3D_;)97:DFG _5=5=@
M]EJS.S!G(5.W#:.>['K+.-,;IT?C?##N^=)?N:T(_BG=VI=GM:%4H7?K@F7W
MU",&BH^RD H1.@GB>MS!D_[:T07>HWO3<,W0)?AQ#<.E=55?W$1&75DV$M[Z
M?Y>(95>!+X+R;2'(/I:@T5IOAIO?OYEZIT UU#N)P[T6K*^4.\3@(IN*&/11
MQ%2&5 XB-M[7H3^$ECRA6U^<%O2;H*UZKY?.]"T:M<1A6%=-Y8<+'35A,=T1
MP8!9%/Z5R+\1(D.M\!@@Q)Q'J=H1JEW FVY\)VQ,=Q.^AM+]!/G8?S(<9\</
MKF?]=\:'Y?W7V@^Z0VH[5ILYMD:O,C5!CQ.^@/8/WB[#5\=KZ[UMPG!A-"B(
M%N#]W%J_?B %XV?HT_\ 4$L#!!0    ( !&(850']@I?S (  .L&   9
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M=.,MVH/^6;V]+C\+LY7*0HT;,DWZHT$$IKV"VH73NW#LK[6C\0]B1;<V&J]
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MWWE^S@]:O,!L#('/@'O</V O&"(1=/:"5^SM G"#C=*VJ-?PU]G"6$V\^?N
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M%'+BBMZ>J.P&6E](:JCMP!KH7K/3_P%02P,$%     @ $8AA5 ZD_*CV P
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MP3M5B)J" _=KKA".WO-%B?IX&AC2926"O,<][W#9"[@1@[>R-FL-5W6!Q3Y
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M3-0$"EP;J/=+QN1NHP-4,^WH'U!+ P04    "  1B&%4%KQ-X^X"  !_"
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M!J"_;SE7YXG9H&GL%O\#4$L#!!0    ( !&(852^<G$>JP0  ),1   9
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MY2RXG%[DB?/W#M\Y=&9K35PE"Z4>G7%3SH+0)00""G0,S/[6< U"."*;QM/
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M4TUW:"9&KNL"^R -ENMZ6&!#!64-\/M*8N:W$[M!UZ(G?P%02P,$%     @
M$8AA5)!#TGF+ P  & T  !D   !X;"]W;W)K<VAE971S+W-H965T-C@N>&UL
MO5==;]LX$/PKA%H4+7")2.K3J2T@=5 T0.\N:-J[AT,?:&EM$9%$EZ3MMK_^
M2%F1'$M6"P3PBTV*.\O9$3FDICLA'U0.H-'WLJC4S,FU7E^YKDIS*)FZ%&NH
MS,A2R))ITY4K5ZTEL*P&E85+,0[=DO'*2:;ULSN93,5&%[R".XG4IBR9_/$.
M"K&;.<1Y?/")KW)M'[C)=,U6< _ZR_I.FI[;9LEX"97BHD(2EC/GFES-*;:
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M&@/\?2%0%.R+N7D4E]_1/U!+ P04    "  1B&%4FR\+HV@#  !""@  &0
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M-0C& 6GPLVD$)Q'W^X'YV0]&S_;@@(*&04S3*3W",6A>]/3WW"9*VY)I,$8
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MD;WZ:MNI;R=&KGUWO)3&-D-^6-BO&U#N@-W/I30O$]=P-]]+\_\!4$L#!!0
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M@\6/:V98T(*R$_#[0DISV[$.FA)Y\@=02P,$%     @ $8AA5-.)RW A!0
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M$6M;I]EHI^N\73_;2*)KE\2C_%G-T=86 GUHUYWCUK<9_:WN,Y5KGA50CU>
M=,XF$!*Y^_RUNU$B-Y]KED)!7IK+#:/@2CT WJ^$4/L;_06H_@@Y_Q]02P,$
M%     @ $8AA5/"=#*R5 @  (08  !D   !X;"]W;W)K<VAE971S+W-H965T
M-S@N>&ULE57;;MLP#/T5P>A#"[3U+;<6B8$FV:5 .P3-NCT,>U!L)A8J2ZXD
M)]W?CY(=-\W2;'N))8KG\)"4F.%&JB>= QCR4G"A1UYN3'GM^SK-H:#Z4I8@
M\&0I54$-;M7*UZ4"FCE0P?TH"'I^09GPDJ&SS50RE)7A3,!,$5T5!56_QL#E
M9N2%WM;PP%:YL08_&99T!7,PC^5,X<YO63)6@-!,"J)@.?)NPNM)U_H[AV\,
M-GIG36PF"RF?[.8V&WF!%00<4F,9*'[6, '.+1'*>&XXO3:D!>ZNM^P?7>Z8
MRX)JF$C^G64F'WD#CV2PI!4W#W+S&9I\G,!4<NU^R:;Q#3R25MK(H@&C@H*)
M^DM?FCKL ,+>.X"H 43[@,X[@+@!Q"[16IE+:TH-389*;HBRWLAF%ZXV#HW9
M,&&[.#<*3QGB3#*N-%JT)JDL%DQ06UM-+L@<KTM6<2!R269*7KB:D5M1WQMT
M.B?WD,TH(C\I697D)GVNF&:N-Z=3,)1Q?89$Z%6^>MVQ@AG(T/XXGY+3DS-R
M0I@@7W-9:2HR/?0-)F6E^6F3P+A.('HG@3 B]U*87),/(H/L+8&/U6A+$FU+
M,HZ.,DXAO21Q>$ZB( H.")K\,SR\.B(G;CL4.[[X;QW:K?"/.[216P.%_GDD
M1J>-T7$Q.O\1X]SVG=1]?X UB H.=:<F[CEB.S+62=2_&H0#K-QZMV@'_ 91
MT+_JM7YOE'=;Y=VCRK_@H&,"+R_XIUQJ?79(8_>/V'$<=:-P3^(!MWZ_,^CN
M*?1W7EL!:N6&D'U E3#U+6NM[9R[<<][SS[&^5>/JU>:>GC>4[5B^ XY+)$R
MN.RC-%4/I'IC9.G>]$(:G!!NF>,,!V4=\'PII=EN;(#V7R'Y#5!+ P04
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M_.K]UR%YD\R&*+H2_!]6ZGH1S )0THKT7'\6^]_H(:'$^BL$5\,OV(^V&0Q
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M0>#-2JJ&&MRJM:];!;1RH(;[41"D?D.9\/+,G2U5GLF-X4S 4A&]:1JJGJZ
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M>8#Y?"V$?KC).ZA_89G]!U!+ P04    "  1B&%4@0G8/)$%  ".&@  &0
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M!'6$_E_X\O1P6Q.^.CD<C@W-P-7DP'D^IR??-0LE#<!O(=L&/ 9?P+O%GW^
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M=?KHM*BN!E5#\<(4RTNNL/0VCQN\3H'0 ?A^Q;G:-_0 S05M\@-02P,$%
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MNH)V >@OE+*'C;O W7N=_@-02P,$%     @ $8AA5,]W*W3/ P  #A   !D
M  !X;"]W;W)K<VAE971S+W-H965T.#DN>&ULO5A=;Z,X%/TK5J219J3=@(&D
MZ2B)E(^NIMIVMVHUNP^K?7#A)K'&8,8V3?OO]QH(I+/!M-6H+PTVG'._#A??
M3O=2?=,[ $,>4Y'IV6!G3/[9\W2\@Y3IH<PAPSL;J5)F<*FVGLX5L*0$I<(+
M?'_LI8QG@_FTW+M1\ZDLC. 9W"BBBS1EZFD)0NYG SHX;-SR[<[8#6\^S=D6
M[L!\S6\4KKR&)>$I9)K+C"C8S 8+^GD=E(#RB;\X[/71-;&AW$OYS2XND]G
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MZ*8<OEA3'H%_ORJ7X(MDJ?C/ (@T@$@)B P NHVS.%VEX+YX^Y9?#-SQ>,K
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MHQY^@2T50S,7+]4WXG2C U1-2'H"$.!F^<8( %L&A?'_, 3 EC+A*,[\CC$
M7O.FYT,?]1 ':GD3N3]\$JA-7+3D>!+ GJ)%+>DB,^D.G AJ+1=-)8(>["D1
M=#:+FEEUS%0P1]?4J=I]Z+M]WZ@E4&0FT,$=O]9S 2'VW##N0="R)QHUQXYM
M^NAZB@TB%,5!#ZZ62E'P [H^:CD2C>+([^SZJ(,I_:"WJ:&6*9&9*?^KKE^;
MN6@RR WMJ*?7H99ID7E8'='[:TV7(*#?V^E02[_(3+^C>W^M[[+IQJ$]F71#
M\5JZ]<QT.ZKWU[I>P8AMOP]&2ZS>J&EV=._W.N;8";1?_V?CG%V<Z%NK/S!7
M!21 2K9*SK4C5=V\N@BJ-I(=RKN4-9.29>5R3W!"N#Z@WF\9DR\;?3W37,?-
M_@%02P,$%     @ $8AA5%#PR,%4 P  :@L  !D   !X;"]W;W)K<VAE971S
M+W-H965T.3<N>&ULS59=;YLP%/TK%MK#-JT% PGIE$1J0Z=5VJ9JV<?#M <7
M;H)5L#/;:=I_OVM#*4T)ZD,?^I+XXY[C>^X!<Z<[J:YU 6#(;54*/?,*8S8?
M?5]G!51,'\L-"-Q9254Q@U.U]O5& <L=J"K], C&?L6X\.93MW:IYE.Y-247
M<*F(WE854W=G4,K=S*/>_<)WOBZ,7?#GTPU;PQ+,S\VEPIG?LN2\ J&Y%$3!
M:N:=TH\IC2S 1?SBL-.=,;%2KJ2\MI.+?.8%-B,H(3.6@N'?#2R@+"T3YO&O
M(?7:,RVP.[YG_^3$HY@KIF$AR]\\-\7,FW@DAQ7;EN:[W'V&1M#(\F6RU.Z7
M[)K8P"/95AM9-6#,H.*B_F>W32$Z #H^  @;0+@/B \ H@80/1<0-X#85::6
MXNJ0,L/F4R5W1-EH9+,#5TR'1OE<6-^71N$N1YR9G__;<G-'+D0&PCI EO;)
M DV8R,G2R.R:+&2%3YEFSJ=%P=0:MX]<8+XM@<@5^2;%4<9TT8<XO[5C(&]3
M,(R7^AUB?RY3\O;-._*&<$%^%'*K\3@]]0TJLGGY69/]69U]>"![&I*O4IA"
MDW.10_Z8P,=2M/4([^MQ%@XRII =DXA^(&$0TIZ$%L^'!SWP]-EP>C*@)FK=
MC1Q?=(!OB6[!D7TO\L>FG"K%Q!J-%H9<W9%NW"6[<\NG.Z9R\N<+4I(+ Y7^
M.Y!0W"84NX3B PG]D(:5).NFDDEM>JVOF<:.R5Y?-W,:19,XGOHW74.>AH7C
M,*&/H]*^J(FM\4V/FE&K9C2H)N4*KZ\^!8_HQBW=^'6XE;0))2_F5LTTZKHU
M&8WV;%@\C<*@9,^K'JHX29)^KR:MELF@EB5^6KA8?R!K$*!0EKW@6(Y7*M=&
M,7OW#53LI#WEY'582(.'"SYX,1,;JF[I8QKO&[3H":-)0O?>S+0O+ SBL-](
MVOEDT6%%6$K-FKX!7>3"P%K5TA24S&!1WP_5+GPX*7PE=C[<Z#1Z.3NC)[=>
M$DVB\;Z=3\."?2N'0FHE?J<)J0";!-O,:4QN*TS]_6U7VX;QU+5)>^MGMI%T
MS<T#3=V%?L7>@PM-2E@A97"<X*.EZL:NGABY<:W.E338.+EA@<TP*!N ^RLI
MS?W$'M"VU_/_4$L#!!0    ( !&(850V &GEY@4  . 9   9    >&PO=V]R
M:W-H965T<R]S:&5E=#DX+GAM;+U9;6_;-A#^*X31 2D0V"+UZL(QT+RU&=8U
MB)OMP[ /M$S'0B51(RD['O;C1TJ,9$F4['9=\B&6Y+OG[GA'/G?R;$?95[XA
M1(#G)$[YQ6@C1/9N,N'AAB28CVE&4OG-FK($"WG+GB8\8P2O"J4DGB#+\B8)
MCM+1?%8\NV?S&<U%'*7DG@&>)PEF^TL2T]W%"(Y>'CQ$3QNA'DSFLPP_D041
MC]D]DW>3"F45)23E$4T!(^N+T7OX[LXN% J)WR*RXP?70(6RI/2KNKE;78PL
MY1&)22@4!)8?6W)%XE@A23_^TJ"CRJ92/+Q^0;\M@I?!+#$G5S3^/5J)S<4H
M&($56>,\%@]T]Y'H@%R%%]*8%__!3LM:(Q#F7-!$*TL/DB@M/_&S7H@#!>3W
M*""M@%H*T.E1L+6"W5)P8(^"HQ6<EH+=YY*K%=Q3%3RMX)T:M*\5_+9"W[(&
M6B%H*_0%/=4*TZ(<ROP5R;_& L]GC.X 4](235T4%51HRYQ'J2KVA6#RVTCJ
MB?EB@QD!5SB+!([!V341.(KYV]E$2' E,@DUT&4)A'J KDDX!C8\!\B"T\?%
M-3A[\Y8K<&[ NAK&^CF/QP"A LLSJ%^?[ J"VI4M%>0-F(#2I5[';DY'MC3R
M":BWW[YT)Z!^.!TU.):0CT<2@M,QL(+2PUZ0NV&0SZ&0(':95>U0$V4BB[>J
M8%15,"I@[1[8F[_R2.S/P56,.0=T#;[(0Y_G; \6@H9?P1^_2 5P)TC"_QPP
M9U?F[,*<TV/NUSQ9$J;LJ)+BX)_BTU2D)8Y;X"C.V<[A;+(UF'8JT\Z@Z2]4
M[=&,T9"0%0=K1A- G@D+(TZ40[R(EV:*13A8[@%)LICN2>'E&Y.+I3WOT$48
MN,'4LJS*U7)?&"1M9-D=P=NN((*>XQX*-H)WJ^#=P> _LU642CK6NT(2[8J0
MA*S.P1;'.>F)\,;M^NTK9[J.N]UT.=[4AKV>>Y7GWJ#GE_E^B65B9.*>&$X&
M:M"O$/W7*/F@,A<,!E"",I+E+-S(QN(EDG. <[&A+/J;K !.:)Z*GC3<!9TT
M.);52D/#MVGEV_2[R@*<1:E^9B2S:2?;M@L[5=^5@LAV$0R:<A^Z<HZ%/-?W
MS,%!JV9GZW^H^DN->KC>KFTH^AN#8-_^,(DZT#.(?C"(VCZ" ^F&!_T*//'\
MU4MR4(."@B4Y*-1C5?!1VVHD>*@J84U*$ VZ^0D_1TF>R 2=OOUAS4'0?HT#
M -;, X>IYZ0C()-41%(A9Z1BW?6M:>&OCIB#UMBR?AKRO*8-.,P;-YH#]<I\
M+MAQ"+D^UJ'W*DFH3WWH#Q\&FME?.'_5Y/CA6K_6X,U:]UP73=MG@D%P:CO0
M;Q\(73D;30._;^_4= .'^>;]EC!51%5OD[$H+#J<LK=1E55&"LY4'UG=OE7G
M8=4X&Q>AM!PT.AXX[JY!5\X+QG#:7@*#F#MV*VZ3?ST]'ZP)#@XSW(_O^K3!
M5MMG.LEO3**R[S/10U<2M=FAV=_7)(B&2?"!<"$K0,B"+W?68QH)6>\/B\=V
MJ3<MU*2"X&ML970PLPS30YO7(\YS&5ZD7B#QC(1".1$2)J?Q%*@X90&0;41S
M'N\!WF&V*G>_V,CAG2893O?']K_VJ-&D.)YC.:V4&^2@(W<_:B7<((=L'Q[L
MD>;:U.2&AB>L>\**EWBIW//EZPF5;W!V?RS=-9LAYU7279,0^K;A93#=]S\F
MW=UY1F;11NUL=\4\V0E[[60;IB-Y9,">TPW5)(J&AZ-J91:&,[N)6?,D>I7Q
M"-6$A88)ZTZE\[ EY9R&$58'UBX2&X#!,N=21WH3TF0I RYH[%@&@^X&\V4?
M[2"_9]5K3D%'IJ;_U$D@PUAD["1,@J9.PB WU$G8-7/8WS<^'8GP1L,>'?QN
M38)6<Y)LNEY3DCT\YWSG^PZ->DC# >JRM4',FW:I>G+P8EG]]O$)LZ=(UDU,
MUE+/&OLR<%;^G%#>")H5[YJ75 B:%)<;@E>$*0'Y_9I2\7*C7E]7/^K,_P50
M2P,$%     @ $8AA5"E>),Y$ P  N L  !D   !X;"]W;W)K<VAE971S+W-H
M965T.3DN>&ULS59-;]LX$/TKA%H4"=!&(B7+4FH+B.,6&V"+!G73'A9[8*2Q
M)40B79*VL_]^24J6'5D1<@IRL?DQ[_$-'S&:R8Z+!YD#*/18E4Q.G5RI]:7K
MRC2'BLH+O@:F=Y9<5%3IJ5BY<BV 9A94E2[QO-"M:,&<9&+7;D4RX1M5%@QN
M!9*;JJ+BOQF4?#=UL+-?^%&L<F46W&2RIBM8@+I;WPH]<UN6K*B R8(S)& Y
M=:[PY1S[!F C?A6PDT=C9%*YY_S!3&ZRJ>,915!"J@P%U7];N(:R-$Q:QY^&
MU&G/-,#C\9[]JTU>)W-/)5SS\G>1J7SJ1 [*8$DWI?K!=W]!D]#(\*6\E/87
M[9I8ST'I1BI>-6"MH"I8_4\?FXLX N#P&0!I *0+")X!^ W ?RD@: "!O9DZ
M%7L/<ZIH,A%\AX2)UFQF8"_3HG7Z!3.^+Y30NX7&J>2&I;P"]),^@D2?T#6O
MUIP!4Q+Q)6HV9Z#?%Z!;P;>%]5M/T1/@V1P4+4IYKBGN%G-T]OX<O4<%0S]S
MOI&497+B*JW6G.FFC;)9K8P\HPP3](TSE4OTA660/25P=9IMKF2?ZXP,,LXA
MO4 ^_HB(1W"/H.N7P[T>^/S%<!P/9..WSOF6SW^&;Z%+0+8IP1@U9-O!*/3E
M49<+">AL!@R6A3I'__RM6=&-@DK^.Z I:#4%5E/0K\D4J4NYIBE,'5V%)(@M
M.,F'=SCT/N]UW->JBGJFM"JH5?6]D/JTT)YF*M@VP7$81OKVM\>^G8;Y$2;>
MZ&G8_#0L(&$<Q6W8DYQ';<ZCH9R3&P&E?N$#MQ>V3.&;<73<:AJ_JJ/U::,C
M#XB/H]CO.-H3%GD^[A@_/PWSB3\F8;^C49MS-.CH'2L49&BAJ (Y<(=QRQ>_
M&5^Q=RC\WJLZVQQW;,8G,HX"W/6V)S# \:CK;4\8P=[8[_<6'WWP\*"[WU4.
M8N@&R8&)O!U?#Y\%[+^NK_Y)V22!K_O*KJVG<:,H#KI%N"<L(CCV.K:Z1RU-
M!6)E6T.)4KYAJO[BMZMM^WEEFZ[.^LRTI;95.M#4/>TW*E8%DZB$I:;T+L;Z
MJ8FZ3:PGBJ]MXW3/E6[#[##7K34($Z#WEYRK_<0<T#;KR?]02P,$%     @
M$8AA5,8\Y[16!   #Q(  !H   !X;"]W;W)K<VAE971S+W-H965T,3 P+GAM
M;+5876^C.!3]*U8T#ZVT+=A@/JHTTC39U<[#:*MIN_OL@I.@ 3MK.TWGW^\U
MH9" @[)2^I* N?=PS[%]+C#=2?53KSDWZ+TJA;Z?K(W9W'F>SM:\8OI6;KB
M*TNI*F;@5*T\O5&<Y75257K$]R.O8H68S*;UV*.:3>76E(7@CPKI;54Q]>N!
MEW)W/\&3CX$?Q6IM[( WFV[8BC]Q\[)Y5'#FM2AY47&A"RF0XLO[R5=\MR#4
M)M01?Q=\IP^.D:7R*N5/>_(MOY_XMB)>\LQ8" 9_;WS.R](B01W_-J"3]IXV
M\?#X _V/FCR0>66:SV7Y3Y&;]?TDF:"<+]FV-#_D[D_>$*H+S&2IZU^T:V+]
M"<JVVLBJ288*JD+L_]E[(\1! HY.)) F@?03PA,)09,0G)L0-@EAK<R>2JW#
M@ADVFRJY0\I& YH]J,6LLX%^(>R\/QD%5PO(,[-O(I,51\_LG6MT@^:RVDC!
MA=%(+M&CDF]%/<.PP-!1Z-6"&U:4^AJ27IX6Z.K+-?J""H&>UW*KF<CUU#-0
MG[V+ES6U/.QK(2=JP01]E\*L-?I=Y#P_!O" 6,N.?+![(*.("Y[=H@#_AHA/
ML*.@^?GIOB-]<78Z3D?8!.U<!35>< )OOE4*I@89]H[X.^Q\S>]&8,,6-JQA
MP_-A77.W!XEJ$.LF;S,,M"CH\G:HZ# LC-(P.8Y:#*,HB>(.ZX@(;8G047T6
M?,F!2EXSN7KE@B\+<^V=(574WB$:E6K\#B[5]GCT@.A-Y$<XZJDV#$M)W-/,
M 85I$+LUBUM&\2BC9E,?S#UB92DS9BQ+B3+8D(78%F*%H-<H9LW:N;7C074A
M#H*PQ],1%2<Q[3$=1E$,8&ZF2<LT&5T=#J8[IH_9FC4'JX.1G26<'9FAA(NJ
M'E-\;1O?&P>_LYAC*RMMJTO/V(39+U14&^B%"#RWE%"#X:I"RZW(H2"7[.E0
MT+2G^3 DZF_'80BA;K6QWS46?Y31LS2L=#8!W[54DJ!7MBLL3L->V,(1!HN%
M)B?*/^B+>'QC*%Y"&QN96DPZ+'))X\9=0\#!):R[03G4""=@RWW%AV$D2:.!
MXL.P@*;TU(+IVA ./\F^<=<A,+VP@3> 1^N+#M;J, A'-.P+-XPBR2E;PUU/
MPN--Z444UKZ>#+B8'E.IZPDXONAZ[2P8)Q=9KXECA4&CZ*ON"/,)Z:L^C*)^
M?$KUSJ]Q^DFKE7062L8M]/^O5C)TPQM*8MQ[EI@[XD(:]Y\X7&@!]8E;.])Y
M*QGWUK]L*QU3J'-6<E%G)9VSDHLX*QEZ89CX?M\?'&$X'#JK*PQ'X2F].V<E
MG^6LI'-6<FEG;0 /7P)NDI"2OG:.,!KX?7-UHD7]QP#OX$VYXFI5?W'0\%2W
M%6;_6MF.ME\UOM;O\KWQ!WRWV'^;Z&#VGTJ^,[4JA$8E7P*D?QM#86K_]6%_
M8N2F?A]_E0;>[NO#-6<Y5S8 KB^E-!\G]@;M-Z#9?U!+ P04    "  1B&%4
M3YZ0CR0$  #-#   &@   'AL+W=O<FMS:&5E=',O<VAE970Q,#$N>&ULC9??
M<^(V$,?_%0US[20S1VSY-SE@)H'K- ^9RY"[]J'3!V$+[(DM44F&7/_ZKF3B
M@"W<O(!LOKO:CU9:+=,#%R\RIU2AUZID<C;*E=K=.HY,<UH1><-WE,$O&RXJ
MHN!1;!VY$Y1DQJ@J'<]U(Z<B!1O-I^;=DYA/>:W*@M$G@61=543\O*<E/\Q&
M>/3V8E5L<Z5?.//ICFSI,U4_=D\"GIS62U94E,F",R3H9C:ZP[=+[&D#H_BC
MH =Y,D8:9<WYBWYXR&8C5T=$2YHJ[8+ UYXN:%EJ3Q#'/T>GHW9.;7@Z?O/^
MFX$'F#61=,'+/XM,Y;-1,D(9W9"Z5"M^^)T>@4+M+^6E-)_H<-2Z(Y364O'J
M: P15 5KOLGK<2%.#'!TP< [&GA=@^""@7\T\#]J$!P- K,R#8I9AR519#X5
M_("$5H,W/3"+::P!OV Z[\]*P*\%V*GY TMY1=%W\DHE&J,%9Y*71484S="*
M[KC0@R?!]X7)-&PT=&:R+#8;*D"S$;Q"SXJH6G'Q$ZW  [I:4D6*4EZ#YQ_/
M2W3UZ1I]0@5#WW->2\(R.7440.A0G/08\'T3L'<A8.RA1\Y4+M%7EM'LW($#
M].T2>&]+<.\->ES2] ;Y^#/R7 ]; EI\W-RUF"\_;(XG S1^FU#?^//_-Z&0
M&YF67-:"HK_NUE().&1_#TP1M%,$9HK@PA1-YHE"#Z*0.9)MTH5..M\@[-V$
MOZ KO9ZW9OS%+$XSOK;EO)DP,A/J4K6?>T&81%-G?YJ(OBJ(HQ"?JY9]5>C[
M<="JSIC#ECD<9(8B R4$ZA3+$%<Y%;"-S4(K6(Q,+T8.%09>ZS6P;NO&?WB*
MZ+I!V$'LJ^))X'<(+2(_C.R 40L8#0*NJ*1$I#GZE52[+U Z]W G[*#"*XVH
M:6$()=K*%O4"&OM8GX8S-HL*>STXBRJ9^':XN(6+!^$>^9X:%*@]>U+6I+ES
M2KCU"(#9D.)>&#YV.UMM81&%27<_]D5C[-IYDI8G&>3Y"D4W55*?M30G;$LU
MF$[3Q=V7V-8^Z>#T1=CM:)9]C1].[#23EF8R2+-H$6HF:,JWK/@7SI3F65-&
M-X6R(DUZD81>T"T9?=$81['7@;*IO/C"IL/N^]WJ#H(]5#LHN3I+<(^G+P@*
M!O1KTNP^Z\WG]N.8N$GGA"QLLA"'G>.VM,EB/[E$==(QX$&J;[K\6</'O0FC
M).X&WQ>-?;]7!:RR27PA=N\]=F\X(VW11O15YX*:*I":?D=QR! 4.587;(N@
MM18F4_8FQ>O?11@XNK0669S$89>V+PLQN.O@.B=]7D7%UO3+$H*NF6KZG?9M
MVY/?F4ZT\_Y>]^JF?WQWTS3ZCT1L"R9123?@TKV)(0.BZ9V;!\5WIIM<<P6]
MJ1GF\'^#"BV WS><J[<'/4'[#V;^'U!+ P04    "  1B&%4,3'0:NP$  !V
M$@  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&ULM5C;;N,V$/T5PET4
M";".1.IFI;:!;-QN VRQ02[;9T:F;2*4Z*5H.^G7=R@KDB)1BA_:%^OB,\,S
M,^0<4M.#5,_YAC&-7E*1Y;/11NOMI>/DR8:E-+^06Y;!/RNI4JKA4:V=?*L8
M719&J7"(ZX9.2GDVFD^+=[=J/I4[+7C&;A7*=VE*U>L7)N1A-L*CMQ=W?+W1
MYH4SGV[IFMTS_;B]5?#D5%Z6/&59SF6&%%O-1E?X<D$\8U @?G!VR!OWR(3R
M).6S>;A9SD:N8<0$2[1Q0>&R9]=,".,)>/PLG8ZJ,8UA\_[-^Q]%\!#,$\W9
MM11_\Z7>S$:3$5JR%=T)?2</?[(RH,#X2Z3(BU]T*+'N""6[7,NT- 8&*<^.
M5_I2)J)A@/T> U(:D%,-O-+ .]7 +PW\(C/'4(H\+*BF\ZF2!Z0,&KR9FR*9
MA36$SS-3]WNMX%\.=GI^DR4R9>B!OK <C<T5_;Y:05%R)%?H@:5;J6 ^H 6'
MMXIE"< >-E2CKU N=,=SAK1$]WR=\15/:*;1K52FHH7]@H&18LO"[U6>,W!+
MLR7ZQND3%UQS\':V8)IRD9_#\(_W"W3VZ1Q]0CR#8>0N!W0^=31$:O@Z21G5
MEV-4I">J!4LND(<_(^(2;#&_/MW<M9@O3C;'\7MS!\I3U8A4-2*%/Z_77YE%
M#5D4=>HN!WQ[E6^O\.WW^+Y5T$*4?OV,ML)4SU2'_=SQ+:QM;4O\T5U8N#--
M93_'<>B&4V??S*\%Y05Q!7I'U:^H^H-4BYXTEJOQ+F=C6DPF&\&CDZ QM.?Y
M?MPBV$7%ODOL!(.*8#!(\*N4RP,7PL8JL+#R K_%RH+"(>G)6UC1"@=IW62:
M9FO^)!CJSUK8&1G#['4G[<):<)X73^P,HXIA-,CPN]XP96,5=4>+0MRB9 &Y
M;D_.)A6CR1 CH[:7^98F;#8".<V9VK/1_-=?<.C^AAZDIL)HBW51@A@F$KKA
M/VQIBVABR?,D)D$[SUU<$$9Q9(\JKJ**3V\DQ[DPU$.P6XN(.UQ Z"%4\VR-
MA,R/+=X,D<!8'%I^0I5ZA3W*@:J>;NYVPIV$D]AK)<4"\TD4^_:LX(8&XO^V
M"9;^WI5GXK=K:$&%KN_VL*W5 )-!MM\8['.:4\[*D'1;28@[?=H"B[W>A-:B
M@H=5Y:264_IX5\T@[C#LHOHR6 L)'E:2JR11.U@&[ 6VSSD[3MA=!OD4\%:Q
M/<MVS$JY*QMAC!OMK^3<A1'?"WNZ)*[U!0\+S+V6R3."#9NA3<TNRTJRJR(D
M"(*H3=(B-F'4(X&X%AL\K#95C_F09E=*0*>#-DL+"D_Z)F@M.'A8<1XS1E7V
M0;&[PA+Z,6EKM@5&2-#3J7$M0'A0@?HU$7>E(6SL7$I2%IT)@AY.M7S@>)"3
M1?D&EG?<S4L<X; S#[NX&$_"GA*36I/(L";]H&)'CV=+ :=;"D<7!!IT*GW2
MU9JQ'_AQ>X+:<!Z)PE9/6)2XYI9X3*+([6EFI!8O,BQ>%E'_8 ]"NKI$ MQ<
M^V5H%I6+W4:'?L^X<9P9%+#!S=7W/>PDA$ 9TY9*.6=OLO=Z;HV,=).,72\*
M^CH&J26-#$K:_T?ZFG0/2X3$[0VLTSCCFR\R?U&UYG#*%FP%9NY%!&52QX\<
MQP<MM\6Q_TEJ+=/B=L/HDBD#@/]74NJW!_,EH?K4-/\74$L#!!0    ( !&(
M852DC);I\ 8  '4G   :    >&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6S-
MFFUOVS80@/\*80Q8"[2QQ!?9+I( 2;QB ?H2)$V'8=@'6J9MHA+ID732#/WQ
M(R5'M".*<9H%\)?$ELC3'>_XW/&LPUNIOND%8P9\+PNACWH+8Y;O^GV=+UA)
M]8%<,F'OS*0JJ;%?U;ROEXK1:36I+/HP2;)^2;GH'1]6UR[4\:%<F8(+=J&
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M*1QNJU4;VAY(THCZ6:-^%E5_O.F/@M,)+[CA3+\!*S'EVB@^61E[V_K.XD\
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MZ*5ULH@MA8<PV:=N,O$$)B]%8-(F,"3) '7_/NXAG,4A7&_^IS13,@_@;)\
MG'D 9W$ OUPS9?W@S4X^"1YS^AOO(Y5,S:OWNFP@N-6O7_5IKC;OCIU4;TP]
MN'Z:OAO7;X!Y,?4+:1^IFG.A0<%F5F1R,+#AH^IWO.HO1BZKMYXFTAA95A\7
MC-K:Q0VP]V=2FOLO[@'-FW;'_P%02P,$%     @ $8AA5,7>[7 ; P  H P
M !H   !X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;+U7;4_;,!#^*U:$-)"
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M, ;Z_91S];PQ4VWY43+\ U!+ P04    "  1B&%48X>,U\\#  !;#   &@
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M9J:%F9S GI<>A&ZP<)Z/$]65@J$;SIM2JZZ46TLT4 0UBL"*XC;;8BHT!2K
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M2\!3M EH^@1\HT91V0E:G6(HF(;BX9MS/.S2-X+S05<,@<.W8G#8Y5U_L(%
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MN5(\*QX3@F,B<@']?L.Y.@SR!>H[O.5_4$L#!!0    ( !&(852BFD,&5@(
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M;"]W;W)K<VAE971S+W-H965T,3 Y+GAM;)U42V_;, S^*X)/&[!&L=,7"L=
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MN.:S&QHX-XSD$*#MXACL+-)0Q65+KQA<2*#SVEH\!F&RIO^%XB]02P,$%
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MI':68UMI7@;=CFH.LXJ#>X$#<>$+9RJ1\ >+,3X%L+6@1I6[5S5S>Q'G&-V
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M1(_**(R!?K_FNF;JA0G0#-_3?P%02P,$%     @ $8AA5/$,>^)@ P  ZPL
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MDOC<%%*M6K.9M,I6C3)T01E$X"LM1<;!?9GB]#2 *<O4U0H=:K5"DQ$CG,R
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M-7&&#L1T2;)$?Q>;/V@YH=#FBT2B\F_8E+&> U&FM$A+L&&0,E[\DI]E(;8
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M1.1 )KQG(PO-"(;F*QN(#NUX/'5W M??*SC_#L&F:RRYHUX'-'OYMKTT[]]
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MU'\'((R _IYSKK8;8\#];TS^ %!+ P04    "  1B&%4'V;.A0@#  !H"0
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M*8$-1K=N>T>WU]XH8TR2"?+=M\AS/'=@0P_7PYT!>'PUW(U&U/AM[?B&S[_
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MO0=WWD?^YCWEM__?&_\"4$L#!!0    ( !&(8527BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ $8AA5#VF]\O\"
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M5A]@]6FQIO/;Y?SF^G)R/[MDGR<WD]OIC"V_SF;W2P<P H#1R0#9NP5W( <
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MRRX>*#SQ&1#;Z#70Y^L>*#P!&A!["9[*8V<>*#P#&IQNEYP=GUQ07"J NE8
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M[JIW!^@]5.\!T'NHW@.@]U"]!T#OH7H/@-Y#]1X O8?J/0!Z#]5[ /0>JO<
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M2P$"% ,4    "  1B&%4!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !&(853K?]I@[0   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M !&(85297)PC$ 8  )PG   3              "  <L!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ $8AA5'D=R&%C!@  RAT  !@
M     ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M !&(853Q'NFC#P(  %L%   8              " @:4.  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    "  1B&%4$O-YN@@(  !Q(0  &
M            @('J$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ $8AA5!YC5'Z' @  U 8  !@              ("!*!D  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( !&(8539ZVR.- 8  /$7
M   8              " @>4;  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    "  1B&%4@7D1!TX$  #T#0  &               @(%/(@
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ $8AA5*B7W^?'
M"@  5SH  !@              ("!TR8  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( !&(852RH[RDB D  $,J   8              "
M@= Q  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  1B&%4
M\8/6;U4%   X"P  &               @(&..P  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ $8AA5+7[[Q?#)P  F80  !D
M     ("!&4$  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !&(852?7Q\22 ,  #H'   9              "
M@5V+  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ $8AA
M5&S$VPT' P  C 8  !D              ("!W(X  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    "  1B&%4,O:7HV8"  !%!0  &0
M        @($:D@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( !&(852\MW&R !$  /(X   9              " @;>4  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ $8AA5'K6@]C=$0  \CT
M !D              ("![J4  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    "  1B&%48-F70Z$(  "0&   &0              @($"N
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( !&(850Q8USJ
M4P\  &TM   9              " @=K   !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ $8AA5&X\'C<V!   1 H  !D
M ("!9-   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  1
MB&%4[!(N7J8#   ("   &0              @('1U   >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( !&(8530UQI1"P@  #L4   9
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M970R."YX;6Q02P$"% ,4    "  1B&%4P7K4A=T"  "1!@  &0
M    @('<^@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M !&(853X!C/EY@0  ,$,   9              " @?#]  !X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ $8AA5).Q"JF'#0  RB<  !D
M             ("!#0,! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    "  1B&%4(H^E_R0'  #+$0  &0              @('+$ $ >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( !&(850Q-&<T-0@
M !47   9              " @288 0!X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ $8AA5+^5F!6>!   1PL  !D              ("!
MDB ! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  1B&%4
MK,ZE5+,$  "<#0  &0              @(%G)0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( !&(850&** J/@0  *<)   9
M      " @5$J 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ $8AA5 )>#?TM+P  ;JX  !D              ("!QBX! 'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    "  1B&%4_8*!@5H#  !)!P
M&0              @($J7@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( !&(8531 U/PIP,  "8)   9              " @;MA 0!X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ $8AA5'@HO%Z=
M @  <@4  !D              ("!F64! 'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    "  1B&%4N&M;:70#  "(!P  &0
M@(%M: $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( !&(
M852>2;24=@@  &T5   9              " @1AL 0!X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ $8AA5&UI5=$, P  108  !D
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M=#0W+GAM;%!+ 0(4 Q0    ( !&(850<RW("E @  )(6   9
M  " @9N/ 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
M$8AA5 ?V"E_, @  ZP8  !D              ("!9I@! 'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    "  1B&%41H'CJ,\"  #B!0  &0
M            @(%IFP$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( !&(8513FVN\:0,  !,(   9              " @6^> 0!X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ $8AA5%GWZ!;B @
M6@8  !D              ("!#Z(! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6Q02P$"% ,4    "  1B&%4MN2/&X@$   ""P  &0              @($H
MI0$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( !&(853-
MF/%8=@(  ($%   9              " @>>I 0!X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L! A0#%     @ $8AA5/F=VEOR @  ?P8  !D
M     ("!E*P! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !&(8506O$WC[@(  '\(   9              "
M@4._ 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ $8AA
M5'S#8-J1 @  !08  !D              ("!:,(! 'AL+W=O<FMS:&5E=',O
M<VAE970V,2YX;6Q02P$"% ,4    "  1B&%4-3K4YAT#   /#   &0
M        @($PQ0$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0
M   ( !&(850)A,GH60,  .0)   9              " @83( 0!X;"]W;W)K
M<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ $8AA5+YR<1ZK!   DQ$
M !D              ("!%,P! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q0
M2P$"% ,4    "  1B&%4.811ZIX"   4"   &0              @('VT $
M>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( !&(851&YG#(
M2@(  +8%   9              " @<O3 0!X;"]W;W)K<VAE971S+W-H965T
M-C8N>&UL4$L! A0#%     @ $8AA5&._E3'4 @  K@<  !D
M ("!3-8! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    "  1
MB&%4D$/2>8L#   8#0  &0              @(%7V0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( !&(851Q/*=U7@0  &@6   9
M          " @1G= 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#
M%     @ $8AA5"P;1[*  @  908  !D              ("!KN$! 'AL+W=O
M<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    "  1B&%4?30RD" $   (
M#P  &0              @(%EY $ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM
M;%!+ 0(4 Q0    ( !&(852;+PNC: ,  $(*   9              " @;SH
M 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ $8AA5& Y
M_/M9!   _@\  !D              ("!6^P! 'AL+W=O<FMS:&5E=',O<VAE
M970W,RYX;6Q02P$"% ,4    "  1B&%40N/9UTL#   [#0  &0
M    @('K\ $ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    (
M !&(853A\=I.E (  !L&   9              " @6WT 0!X;"]W;W)K<VAE
M971S+W-H965T-S4N>&UL4$L! A0#%     @ $8AA5*AFZ(QO P  +@L  !D
M             ("!./<! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"
M% ,4    "  1B&%4TXG+<"$%  "0%   &0              @('>^@$ >&PO
M=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( !&(853PG0RLE0(
M "$&   9              " @38  @!X;"]W;W)K<VAE971S+W-H965T-S@N
M>&UL4$L! A0#%     @ $8AA5$10&I!> P  ?0H  !D              ("!
M @," 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    "  1B&%4
M:TP8;$(#  #S"0  &0              @(&7!@( >&PO=V]R:W-H965T<R]S
M:&5E=#@P+GAM;%!+ 0(4 Q0    ( !&(851$9F85= (  /(%   9
M      " @1 * @!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%
M  @ $8AA5#<2H1L<!@  S1P  !D              ("!NPP" 'AL+W=O<FMS
M:&5E=',O<VAE970X,BYX;6Q02P$"% ,4    "  1B&%4NTCF,!T$  "=$
M&0              @($.$P( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+
M 0(4 Q0    ( !&(851@%OZNA04  &T9   9              " @6(7 @!X
M;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ $8AA5($)V#R1
M!0  CAH  !D              ("!'AT" 'AL+W=O<FMS:&5E=',O<VAE970X
M-2YX;6Q02P$"% ,4    "  1B&%4%:#%EC8#   J"0  &0
M@('F(@( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( !&(
M8519?37=!@0  *P-   9              " @5,F @!X;"]W;W)K<VAE971S
M+W-H965T.#<N>&UL4$L! A0#%     @ $8AA5!Y6*-97 @  NP4  !D
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M=#DR+GAM;%!+ 0(4 Q0    ( !&(850C&6:);@0  ) 0   9
M  " @:A! @!X;"]W;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @
M$8AA5 ')R_5X!0  M1X  !D              ("!348" 'AL+W=O<FMS:&5E
M=',O<VAE970Y-"YX;6Q02P$"% ,4    "  1B&%40^!%N%0#  "7"P  &0
M            @('\2P( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4
M Q0    ( !&(851>^PVLA 0  )H3   9              " @8=/ @!X;"]W
M;W)K<VAE971S+W-H965T.38N>&UL4$L! A0#%     @ $8AA5%#PR,%4 P
M:@L  !D              ("!0E0" 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX
M;6Q02P$"% ,4    "  1B&%4-@!IY>8%  #@&0  &0              @('-
M5P( >&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    ( !&(850I
M7B3.1 ,  +@+   9              " @>I= @!X;"]W;W)K<VAE971S+W-H
M965T.3DN>&UL4$L! A0#%     @ $8AA5,8\Y[16!   #Q(  !H
M     ("!96$" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L! A0#%
M  @ $8AA5$^>D(\D!   S0P  !H              ("!\V4" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,#$N>&UL4$L! A0#%     @ $8AA5#$QT&KL!   =A(
M !H              ("!3VH" 'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&UL
M4$L! A0#%     @ $8AA5*2,ENGP!@  =2<  !H              ("!<V\"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @ $8AA5,7>
M[7 ; P  H P  !H              ("!FW8" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,#0N>&UL4$L! A0#%     @ $8AA5&.'C-?/ P  6PP  !H
M     ("![GD" 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L! A0#%
M  @ $8AA5!L?]UMF!   SQ,  !H              ("!]7T" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,#8N>&UL4$L! A0#%     @ $8AA5**:0P96 @  U04
M !H              ("!DX(" 'AL+W=O<FMS:&5E=',O<VAE970Q,#<N>&UL
M4$L! A0#%     @ $8AA5#A4D730 @  % @  !H              ("!(84"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#@N>&UL4$L! A0#%     @ $8AA5$&S
M=4'\ 0  (P0  !H              ("!*8@" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,#DN>&UL4$L! A0#%     @ $8AA5!*@DG5= P  %PT  !H
M     ("!78H" 'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L! A0#%
M  @ $8AA5+.$+?\E!   BPX  !H              ("!\HT" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,3$N>&UL4$L! A0#%     @ $8AA5,8PZZO( P  O0L
M !H              ("!3Y(" 'AL+W=O<FMS:&5E=',O<VAE970Q,3(N>&UL
M4$L! A0#%     @ $8AA5).1+7_^ @  AP@  !H              ("!3Y8"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,3,N>&UL4$L! A0#%     @ $8AA5 GL
M;SB* P  B L  !H              ("!A9D" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,30N>&UL4$L! A0#%     @ $8AA5/$,>^)@ P  ZPL  !H
M     ("!1YT" 'AL+W=O<FMS:&5E=',O<VAE970Q,34N>&UL4$L! A0#%
M  @ $8AA5/";PW5^ P  &0T  !H              ("!WZ " 'AL+W=O<FMS
M:&5E=',O<VAE970Q,38N>&UL4$L! A0#%     @ $8AA5')]9G?V @  /@H
M !H              ("!E:0" 'AL+W=O<FMS:&5E=',O<VAE970Q,3<N>&UL
M4$L! A0#%     @ $8AA5'O$JB^3 @  K@8  !H              ("!PZ<"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,3@N>&UL4$L! A0#%     @ $8AA5&[N
MFO=0 P  ; H  !H              ("!CJH" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,3DN>&UL4$L! A0#%     @ $8AA5*,.;FYZ @  5P8  !H
M     ("!%JX" 'AL+W=O<FMS:&5E=',O<VAE970Q,C N>&UL4$L! A0#%
M  @ $8AA5,1S6O!0!   #1   !H              ("!R+ " 'AL+W=O<FMS
M:&5E=',O<VAE970Q,C$N>&UL4$L! A0#%     @ $8AA5'B\/8N> @  A <
M !H              ("!4+4" 'AL+W=O<FMS:&5E=',O<VAE970Q,C(N>&UL
M4$L! A0#%     @ $8AA5&CI<D('!   U!   !H              ("!)K@"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,C,N>&UL4$L! A0#%     @ $8AA5(>=
MT=L0"    C   !H              ("!9;P" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,C0N>&UL4$L! A0#%     @ $8AA5&JCJF O P  .0D  !H
M     ("!K<0" 'AL+W=O<FMS:&5E=',O<VAE970Q,C4N>&UL4$L! A0#%
M  @ $8AA5"RD4MYR @  3 8  !H              ("!%,@" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,C8N>&UL4$L! A0#%     @ $8AA5(2""<@! P  >P@
M !H              ("!OLH" 'AL+W=O<FMS:&5E=',O<VAE970Q,C<N>&UL
M4$L! A0#%     @ $8AA5!]FSH4( P  : D  !H              ("!]\T"
M 'AL+W=O<FMS:&5E=',O<VAE970Q,C@N>&UL4$L! A0#%     @ $8AA5$GN
M1\;I P  >0\  !H              ("!-]$" 'AL+W=O<FMS:&5E=',O<VAE
M970Q,CDN>&UL4$L! A0#%     @ $8AA5!_.G4<. P  @ @  !H
M     ("!6-4" 'AL+W=O<FMS:&5E=',O<VAE970Q,S N>&UL4$L! A0#%
M  @ $8AA5*JAS1UV P  @@H  !H              ("!GM@" 'AL+W=O<FMS
M:&5E=',O<VAE970Q,S$N>&UL4$L! A0#%     @ $8AA5'K,(;CR @  V0H
M !H              ("!3-P" 'AL+W=O<FMS:&5E=',O<VAE970Q,S(N>&UL
M4$L! A0#%     @ $8AA5%G4\7<] P  [!,   T              ( !=M\"
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  1B&%4EXJ[',     3 @  "P
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52P4&     (P C "L)@  KO,"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>350</ContextCount>
  <ElementCount>710</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>124</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100010003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100030005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100050007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100060008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Description of business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Descriptionofbusiness</Role>
      <ShortName>Description of business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210031002 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Significantaccountingpolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210091003 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210151004 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210181005 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210231006 - Disclosure - Business combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Businesscombinations</Role>
      <ShortName>Business combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210331007 - Disclosure - Property, Plant and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnet</Role>
      <ShortName>Property, Plant and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210361008 - Disclosure - Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilities</Role>
      <ShortName>Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210391009 - Disclosure - Non-Current Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NonCurrentOtherLiabilities</Role>
      <ShortName>Non-Current Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210421010 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210541011 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210621012 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210641013 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210731014 - Disclosure - Restructuring charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Restructuringcharges</Role>
      <ShortName>Restructuring charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210781015 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210801016 - Disclosure - Disaggregation of Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenue</Role>
      <ShortName>Disaggregation of Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210831017 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210871018 - Disclosure - Provision for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ProvisionforCreditLosses</Role>
      <ShortName>Provision for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210901019 - Disclosure - Business Segment and Geographical Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation</Role>
      <ShortName>Business Segment and Geographical Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>210961020 - Disclosure - Supplemental Disclosure of Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>210991021 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>211021022 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>211071023 - Disclosure - Non-current bank credit lines and loan facilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Noncurrentbankcreditlinesandloanfacilities</Role>
      <ShortName>Non-current bank credit lines and loan facilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>211131024 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>211151025 - Disclosure - Impact of New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ImpactofNewAccountingPronouncements</Role>
      <ShortName>Impact of New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>211171026 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>211191027 - Disclosure - Net Income Per Ordinary Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShare</Role>
      <ShortName>Net Income Per Ordinary Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>211231028 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>220042001 - Disclosure - Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies</Role>
      <ShortName>Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ImpactofNewAccountingPronouncements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230053001 - Disclosure - Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SignificantaccountingpoliciesTables</Role>
      <ShortName>Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Significantaccountingpolicies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230103002 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Investments</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230163003 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Goodwill</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230193004 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/IntangibleAssets</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230243005 - Disclosure - Business combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsTables</Role>
      <ShortName>Business combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Businesscombinations</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230343006 - Disclosure - Property, Plant and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables</Role>
      <ShortName>Property, Plant and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/PropertyPlantandEquipmentnet</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230373007 - Disclosure - Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilitiesTables</Role>
      <ShortName>Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OtherLiabilities</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230403008 - Disclosure - Non-Current Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NonCurrentOtherLiabilitiesTables</Role>
      <ShortName>Non-Current Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NonCurrentOtherLiabilities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230433009 - Disclosure - Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsTables</Role>
      <ShortName>Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EmployeeBenefits</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230553010 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>230653011 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/IncomeTaxes</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>230743012 - Disclosure - Restructuring charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesTables</Role>
      <ShortName>Restructuring charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Restructuringcharges</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>230813013 - Disclosure - Disaggregation of Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenueTables</Role>
      <ShortName>Disaggregation of Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/DisaggregationofRevenue</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>230843014 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>230883015 - Disclosure - Provision for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ProvisionforCreditLossesTables</Role>
      <ShortName>Provision for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ProvisionforCreditLosses</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>230913016 - Disclosure - Business Segment and Geographical Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables</Role>
      <ShortName>Business Segment and Geographical Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>230973017 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>231003018 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>231033019 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OperatingLeases</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>231083020 - Disclosure - Non-current bank credit lines and loan facilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables</Role>
      <ShortName>Non-current bank credit lines and loan facilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Noncurrentbankcreditlinesandloanfacilities</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>231203021 - Disclosure - Net Income Per Ordinary Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables</Role>
      <ShortName>Net Income Per Ordinary Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NetIncomePerOrdinaryShare</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240024001 - Disclosure - Description of business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DescriptionofbusinessDetails</Role>
      <ShortName>Description of business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Descriptionofbusiness</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240064002 - Disclosure - Significant accounting policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails</Role>
      <ShortName>Significant accounting policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240074003 - Disclosure - Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails</Role>
      <ShortName>Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240084004 - Disclosure - Significant accounting policies - Estimated Useful Lives of Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails</Role>
      <ShortName>Significant accounting policies - Estimated Useful Lives of Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240114005 - Disclosure - Investments - Available For Sale Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails</Role>
      <ShortName>Investments - Available For Sale Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240124006 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240134007 - Disclosure - Investments - Available For Sale Short Term Investments by Major Security Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails</Role>
      <ShortName>Investments - Available For Sale Short Term Investments by Major Security Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240144008 - Disclosure - Investments - Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails</Role>
      <ShortName>Investments - Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240174009 - Disclosure - Goodwill - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails</Role>
      <ShortName>Goodwill - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240204010 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Summary of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240214011 - Disclosure - Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240224012 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets - Future Intangible Asset Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240254013 - Disclosure - Business combinations - Narrative, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails</Role>
      <ShortName>Business combinations - Narrative, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240264014 - Disclosure - Business combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails</Role>
      <ShortName>Business combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240274015 - Disclosure - Business combinations - Schedule of Acquisitions, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails</Role>
      <ShortName>Business combinations - Schedule of Acquisitions, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240284016 - Disclosure - Business combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails</Role>
      <ShortName>Business combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240294017 - Disclosure - Business combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails</Role>
      <ShortName>Business combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240304018 - Disclosure - Business combinations - Narrative, MedPass Group Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails</Role>
      <ShortName>Business combinations - Narrative, MedPass Group Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240314019 - Disclosure - Business combinations - Schedule of Acquisitions, MedPass Group Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails</Role>
      <ShortName>Business combinations - Schedule of Acquisitions, MedPass Group Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240324020 - Disclosure - Business combinations - Schedule of Pro-Forma Information, MedPass Group Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails</Role>
      <ShortName>Business combinations - Schedule of Pro-Forma Information, MedPass Group Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240354021 - Disclosure - Property, Plant and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails</Role>
      <ShortName>Property, Plant and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240384022 - Disclosure - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilitiesDetails</Role>
      <ShortName>Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OtherLiabilitiesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240414023 - Disclosure - Non-Current Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails</Role>
      <ShortName>Non-Current Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NonCurrentOtherLiabilitiesTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240444024 - Disclosure - Employee Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails</Role>
      <ShortName>Employee Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240454025 - Disclosure - Employee Benefits - Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails</Role>
      <ShortName>Employee Benefits - Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240464026 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails</Role>
      <ShortName>Employee Benefits - Change in Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240474027 - Disclosure - Employee Benefits - Change in Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails</Role>
      <ShortName>Employee Benefits - Change in Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240484028 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Employee Benefits - Components of Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240494029 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails</Role>
      <ShortName>Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240504030 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails</Role>
      <ShortName>Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240514031 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails</Role>
      <ShortName>Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240524032 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails</Role>
      <ShortName>Employee Benefits - Plan Asset Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240534033 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails</Role>
      <ShortName>Employee Benefits - Annual Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240564034 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240574035 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240584036 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240594037 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240604038 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240614039 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240634040 - Disclosure - Share Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ShareCapitalDetails</Role>
      <ShortName>Share Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ShareCapital</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240664041 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Income Before Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240674042 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240684043 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails</Role>
      <ShortName>Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240694044 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240704045 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240714046 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails</Role>
      <ShortName>Income Taxes - Expected Expiry Dates of NOL's (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240724047 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240754048 - Disclosure - Restructuring charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesNarrativeDetails</Role>
      <ShortName>Restructuring charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240764049 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails</Role>
      <ShortName>Restructuring charges - Summary of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240774050 - Disclosure - Restructuring charges - Restructuring Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails</Role>
      <ShortName>Restructuring charges - Restructuring Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240794051 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240824052 - Disclosure - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenueDetails</Role>
      <ShortName>Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/DisaggregationofRevenueTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240854053 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Summary of Contract Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Summary of Contract Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>240864054 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>240894055 - Disclosure - Provision for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ProvisionforCreditLossesDetails</Role>
      <ShortName>Provision for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ProvisionforCreditLossesTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>240924056 - Disclosure - Business Segment and Geographical Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographical Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>240934057 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>240944058 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>240954059 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>240984060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241014061 - Disclosure - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>241044062 - Disclosure - Operating Leases - Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails</Role>
      <ShortName>Operating Leases - Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>241054063 - Disclosure - Operating Leases Operating Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails</Role>
      <ShortName>Operating Leases Operating Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>241064064 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails</Role>
      <ShortName>Operating Leases Operating Leases - Operating Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>241094065 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails</Role>
      <ShortName>Non-current bank credit lines and loan facilities - Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>241104066 - Disclosure - Non-current bank credit lines and loan facilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails</Role>
      <ShortName>Non-current bank credit lines and loan facilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables</ParentRole>
      <Position>124</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>241114067 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Finance Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails</Role>
      <ShortName>Non-current bank credit lines and loan facilities - Schedule of Finance Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>241124068 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Non-current bank credit lines and loan facilities - Schedule of Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>241144069 - Disclosure - Fair value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairvalueDetails</Role>
      <ShortName>Fair value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>127</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>241164070 - Disclosure - Impact of New Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails</Role>
      <ShortName>Impact of New Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>241184071 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/RelatedParties</ParentRole>
      <Position>129</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>241214072 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>130</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>241224073 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>131</Position>
    </Report>
    <Report instance="iclr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>241244074 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SubsequentEvents</ParentRole>
      <Position>132</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" original="iclr-20211231.htm">iclr-20211231.htm</File>
    <File>exhibit121-2021.htm</File>
    <File>exhibit122-2021.htm</File>
    <File>exhibit22-2021.htm</File>
    <File>exhibit231-2021.htm</File>
    <File>iclr-20211231.xsd</File>
    <File>iclr-20211231_cal.xml</File>
    <File>iclr-20211231_def.xml</File>
    <File>iclr-20211231_lab.xml</File>
    <File>iclr-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iclr-20211231_g1.jpg</File>
    <File>iclr-20211231_g2.jpg</File>
    <File>iclr-20211231_g3.jpg</File>
    <File>iclr-20211231_g4.jpg</File>
    <File>iclr-20211231_g5.jpg</File>
    <File>iclr-20211231_g6.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1498">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>156
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "iclr-20211231.htm": {
   "axisCustom": 1,
   "axisStandard": 41,
   "contextCount": 350,
   "dts": {
    "calculationLink": {
     "local": [
      "iclr-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iclr-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "iclr-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iclr-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iclr-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "iclr-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 955,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 3,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 7
   },
   "keyCustom": 98,
   "keyStandard": 612,
   "memberCustom": 69,
   "memberStandard": 52,
   "nsprefix": "iclr",
   "nsuri": "http://www.iconplc.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover",
     "role": "http://www.iconplc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210031002 - Disclosure - Significant accounting policies",
     "role": "http://www.iconplc.com/role/Significantaccountingpolicies",
     "shortName": "Significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674042 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)",
     "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Components of Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684043 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)",
     "role": "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails",
     "shortName": "Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694044 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704045 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "if1def15985c34968963f6b9121b38e63_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714046 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)",
     "role": "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
     "shortName": "Income Taxes - Expected Expiry Dates of NOL's (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i8206c39f2c184b8bb182915d7fa1390b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724047 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)",
     "role": "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie3e24d855ba14a97a64dd8c818215580_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754048 - Disclosure - Restructuring charges - Narrative (Details)",
     "role": "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
     "shortName": "Restructuring charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "iae97c86e7991410685e37fea162dced3_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764049 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details)",
     "role": "http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails",
     "shortName": "Restructuring charges - Summary of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i8206c39f2c184b8bb182915d7fa1390b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774050 - Disclosure - Restructuring charges - Restructuring Provision (Details)",
     "role": "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails",
     "shortName": "Restructuring charges - Restructuring Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794051 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "role": "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210091003 - Disclosure - Investments",
     "role": "http://www.iconplc.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824052 - Disclosure - Disaggregation of Revenue (Details)",
     "role": "http://www.iconplc.com/role/DisaggregationofRevenueDetails",
     "shortName": "Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9faa218b12a4b3cbf68ef2876caf309_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854053 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Summary of Contract Assets and Liabilities (Details)",
     "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Summary of Contract Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864054 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)",
     "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i8206c39f2c184b8bb182915d7fa1390b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894055 - Disclosure - Provision for Credit Losses (Details)",
     "role": "http://www.iconplc.com/role/ProvisionforCreditLossesDetails",
     "shortName": "Provision for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:AllowanceForDoubtfulAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924056 - Disclosure - Business Segment and Geographical Information - Narrative (Details)",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
     "shortName": "Business Segment and Geographical Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934057 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
     "shortName": "Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i2732caa487244b8483347f781dcfd5a5_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944058 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
     "shortName": "Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954059 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
     "shortName": "Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)",
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails",
     "shortName": "Supplemental Disclosure of Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014061 - Disclosure - Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210151004 - Disclosure - Goodwill",
     "role": "http://www.iconplc.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044062 - Disclosure - Operating Leases - Lease Costs (Details)",
     "role": "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails",
     "shortName": "Operating Leases - Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054063 - Disclosure - Operating Leases Operating Leases - Narrative (Details)",
     "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
     "shortName": "Operating Leases Operating Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:VariableLeaseCost",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:VariableLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064064 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)",
     "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails",
     "shortName": "Operating Leases Operating Leases - Operating Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241094065 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Long-term Debt (Details)",
     "role": "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails",
     "shortName": "Non-current bank credit lines and loan facilities - Schedule of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241104066 - Disclosure - Non-current bank credit lines and loan facilities - Narrative (Details)",
     "role": "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
     "shortName": "Non-current bank credit lines and loan facilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "if4a6b701f2454838a6d52713b838fb03_D20201208-20201208",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iclr:IssueOfSeniorNotesNumberOfTranches",
      "reportCount": 1,
      "unique": true,
      "unitRef": "tranche",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114067 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Finance Cost (Details)",
     "role": "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails",
     "shortName": "Non-current bank credit lines and loan facilities - Schedule of Finance Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241124068 - Disclosure - Non-current bank credit lines and loan facilities - Schedule of Maturities of Long-term Debt (Details)",
     "role": "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails",
     "shortName": "Non-current bank credit lines and loan facilities - Schedule of Maturities of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241144069 - Disclosure - Fair value (Details)",
     "role": "http://www.iconplc.com/role/FairvalueDetails",
     "shortName": "Fair value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie59648bd657b4adbaa014e0c1010eef4_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241164070 - Disclosure - Impact of New Accounting Pronouncements (Details)",
     "role": "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails",
     "shortName": "Impact of New Accounting Pronouncements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i071a74bae9594a1c88d29e82ccf0ce67_I20210701",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241184071 - Disclosure - Related Parties (Details)",
     "role": "http://www.iconplc.com/role/RelatedPartiesDetails",
     "shortName": "Related Parties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i509ce783c2ea4a39bdebdb581d6ed480_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentAggregateCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210181005 - Disclosure - Intangible Assets",
     "role": "http://www.iconplc.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241214072 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails",
     "shortName": "Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R131": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241224073 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)",
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails",
     "shortName": "Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R132": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ic47ad9035b164ef0baad0b72c3443557_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241244074 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.iconplc.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i9ccacdd571674f36bbf5930a33df99f2_I20220218",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210231006 - Disclosure - Business combinations",
     "role": "http://www.iconplc.com/role/Businesscombinations",
     "shortName": "Business combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210331007 - Disclosure - Property, Plant and Equipment, net",
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnet",
     "shortName": "Property, Plant and Equipment, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210361008 - Disclosure - Other Liabilities",
     "role": "http://www.iconplc.com/role/OtherLiabilities",
     "shortName": "Other Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210391009 - Disclosure - Non-Current Other Liabilities",
     "role": "http://www.iconplc.com/role/NonCurrentOtherLiabilities",
     "shortName": "Non-Current Other Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210421010 - Disclosure - Employee Benefits",
     "role": "http://www.iconplc.com/role/EmployeeBenefits",
     "shortName": "Employee Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210541011 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020002 - Document - Audit Information",
     "role": "http://www.iconplc.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210621012 - Disclosure - Share Capital",
     "role": "http://www.iconplc.com/role/ShareCapital",
     "shortName": "Share Capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210641013 - Disclosure - Income Taxes",
     "role": "http://www.iconplc.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210731014 - Disclosure - Restructuring charges",
     "role": "http://www.iconplc.com/role/Restructuringcharges",
     "shortName": "Restructuring charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210781015 - Disclosure - Commitments and Contingencies",
     "role": "http://www.iconplc.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801016 - Disclosure - Disaggregation of Revenue",
     "role": "http://www.iconplc.com/role/DisaggregationofRevenue",
     "shortName": "Disaggregation of Revenue",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210831017 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)",
     "role": "http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AllowanceForDoubtfulAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210871018 - Disclosure - Provision for Credit Losses",
     "role": "http://www.iconplc.com/role/ProvisionforCreditLosses",
     "shortName": "Provision for Credit Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AllowanceForDoubtfulAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210901019 - Disclosure - Business Segment and Geographical Information",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation",
     "shortName": "Business Segment and Geographical Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210961020 - Disclosure - Supplemental Disclosure of Cash Flow Information",
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation",
     "shortName": "Supplemental Disclosure of Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210991021 - Disclosure - Accumulated Other Comprehensive Income",
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome",
     "shortName": "Accumulated Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211021022 - Disclosure - Operating Leases",
     "role": "http://www.iconplc.com/role/OperatingLeases",
     "shortName": "Operating Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211071023 - Disclosure - Non-current bank credit lines and loan facilities",
     "role": "http://www.iconplc.com/role/Noncurrentbankcreditlinesandloanfacilities",
     "shortName": "Non-current bank credit lines and loan facilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211131024 - Disclosure - Fair Value",
     "role": "http://www.iconplc.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:NewAndRecentAccountingPronouncementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211151025 - Disclosure - Impact of New Accounting Pronouncements",
     "role": "http://www.iconplc.com/role/ImpactofNewAccountingPronouncements",
     "shortName": "Impact of New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:NewAndRecentAccountingPronouncementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211171026 - Disclosure - Related Parties",
     "role": "http://www.iconplc.com/role/RelatedParties",
     "shortName": "Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211191027 - Disclosure - Net Income Per Ordinary Share",
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShare",
     "shortName": "Net Income Per Ordinary Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211231028 - Disclosure - Subsequent Events",
     "role": "http://www.iconplc.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220042001 - Disclosure - Significant accounting policies (Policies)",
     "role": "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies",
     "shortName": "Significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:ForeignCurrencyDisclosureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230053001 - Disclosure - Significant accounting policies (Tables)",
     "role": "http://www.iconplc.com/role/SignificantaccountingpoliciesTables",
     "shortName": "Significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:ForeignCurrencyDisclosureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230103002 - Disclosure - Investments (Tables)",
     "role": "http://www.iconplc.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230163003 - Disclosure - Goodwill (Tables)",
     "role": "http://www.iconplc.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230193004 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.iconplc.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230243005 - Disclosure - Business combinations (Tables)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsTables",
     "shortName": "Business combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230343006 - Disclosure - Property, Plant and Equipment, net (Tables)",
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables",
     "shortName": "Property, Plant and Equipment, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230373007 - Disclosure - Other Liabilities (Tables)",
     "role": "http://www.iconplc.com/role/OtherLiabilitiesTables",
     "shortName": "Other Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230403008 - Disclosure - Non-Current Other Liabilities (Tables)",
     "role": "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesTables",
     "shortName": "Non-Current Other Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230433009 - Disclosure - Employee Benefits (Tables)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsTables",
     "shortName": "Employee Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230553010 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230653011 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.iconplc.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230743012 - Disclosure - Restructuring charges (Tables)",
     "role": "http://www.iconplc.com/role/RestructuringchargesTables",
     "shortName": "Restructuring charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230813013 - Disclosure - Disaggregation of Revenue (Tables)",
     "role": "http://www.iconplc.com/role/DisaggregationofRevenueTables",
     "shortName": "Disaggregation of Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230843014 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)",
     "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AllowanceForDoubtfulAccountsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230883015 - Disclosure - Provision for Credit Losses (Tables)",
     "role": "http://www.iconplc.com/role/ProvisionforCreditLossesTables",
     "shortName": "Provision for Credit Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AllowanceForDoubtfulAccountsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230913016 - Disclosure - Business Segment and Geographical Information (Tables)",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables",
     "shortName": "Business Segment and Geographical Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230973017 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)",
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables",
     "shortName": "Supplemental Disclosure of Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231003018 - Disclosure - Accumulated Other Comprehensive Income (Tables)",
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables",
     "shortName": "Accumulated Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231033019 - Disclosure - Operating Leases (Tables)",
     "role": "http://www.iconplc.com/role/OperatingLeasesTables",
     "shortName": "Operating Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231083020 - Disclosure - Non-current bank credit lines and loan facilities (Tables)",
     "role": "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables",
     "shortName": "Non-current bank credit lines and loan facilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231203021 - Disclosure - Net Income Per Ordinary Share (Tables)",
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables",
     "shortName": "Net Income Per Ordinary Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityNumberOfEmployees",
      "reportCount": 1,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240024001 - Disclosure - Description of business (Details)",
     "role": "http://www.iconplc.com/role/DescriptionofbusinessDetails",
     "shortName": "Description of business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iclr:NumberOfLocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "location",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064002 - Disclosure - Significant accounting policies - Narrative (Details)",
     "role": "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails",
     "shortName": "Significant accounting policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074003 - Disclosure - Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)",
     "role": "http://www.iconplc.com/role/SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails",
     "shortName": "Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i2a7dd4344dd34202b588af91a6812de7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084004 - Disclosure - Significant accounting policies - Estimated Useful Lives of Assets (Details)",
     "role": "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails",
     "shortName": "Significant accounting policies - Estimated Useful Lives of Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i2a7dd4344dd34202b588af91a6812de7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i8206c39f2c184b8bb182915d7fa1390b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114005 - Disclosure - Investments - Available For Sale Investments (Details)",
     "role": "http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails",
     "shortName": "Investments - Available For Sale Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124006 - Disclosure - Investments - Narrative (Details)",
     "role": "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134007 - Disclosure - Investments - Available For Sale Short Term Investments by Major Security Type (Details)",
     "role": "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails",
     "shortName": "Investments - Available For Sale Short Term Investments by Major Security Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144008 - Disclosure - Investments - Equity Method Investments (Details)",
     "role": "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
     "shortName": "Investments - Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i8206c39f2c184b8bb182915d7fa1390b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174009 - Disclosure - Goodwill - Schedule of Goodwill (Details)",
     "role": "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails",
     "shortName": "Goodwill - Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204010 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)",
     "role": "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
     "shortName": "Intangible Assets - Summary of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i616118ad6d404416b3fa77b7e269701f_I20210701",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214011 - Disclosure - Intangible Assets - Narrative (Details)",
     "role": "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
     "shortName": "Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i203c240f0b4043b2ba07c7260e4b5072_D20210701-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i82b500db472f497aa1b840c473c52982_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i82b500db472f497aa1b840c473c52982_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224012 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)",
     "role": "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails",
     "shortName": "Intangible Assets - Future Intangible Asset Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ic93da52af8c448b795d98224ecc5b70b_I20210701",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityNumberOfEmployees",
      "reportCount": 1,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254013 - Disclosure - Business combinations - Narrative, PRA Acquisition (Details)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
     "shortName": "Business combinations - Narrative, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i616118ad6d404416b3fa77b7e269701f_I20210701",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264014 - Disclosure - Business combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
     "shortName": "Business combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i61ca62ec9b19450eb0a1a4c95b5fefc8_D20210701-20210701",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274015 - Disclosure - Business combinations - Schedule of Acquisitions, PRA Acquisition (Details)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
     "shortName": "Business combinations - Schedule of Acquisitions, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i616118ad6d404416b3fa77b7e269701f_I20210701",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i616118ad6d404416b3fa77b7e269701f_I20210701",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284016 - Disclosure - Business combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
     "shortName": "Business combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i08c50c20b0824778afb5ac1731634e8a_D20210701-20210701",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294017 - Disclosure - Business combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
     "shortName": "Business combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie7d767e1144441f5938f1a05e7bf5bbd_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i502149ae91374acc8a5f8e388394c164_I20200122",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304018 - Disclosure - Business combinations - Narrative, MedPass Group Acquisition (Details)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails",
     "shortName": "Business combinations - Narrative, MedPass Group Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314019 - Disclosure - Business combinations - Schedule of Acquisitions, MedPass Group Acquisition (Details)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
     "shortName": "Business combinations - Schedule of Acquisitions, MedPass Group Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i502149ae91374acc8a5f8e388394c164_I20200122",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324020 - Disclosure - Business combinations - Schedule of Pro-Forma Information, MedPass Group Acquisition (Details)",
     "role": "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails",
     "shortName": "Business combinations - Schedule of Pro-Forma Information, MedPass Group Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "iaef7ba1891c74824aa331ae1e0706128_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354021 - Disclosure - Property, Plant and Equipment, net (Details)",
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails",
     "shortName": "Property, Plant and Equipment, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384022 - Disclosure - Other Liabilities (Details)",
     "role": "http://www.iconplc.com/role/OtherLiabilitiesDetails",
     "shortName": "Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414023 - Disclosure - Non-Current Other Liabilities (Details)",
     "role": "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails",
     "shortName": "Non-Current Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie1b609ddf6c34171b1ba74b522bc4160_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i2b89aca039eb4e798c4afcd95f0f1b09_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444024 - Disclosure - Employee Benefits - Narrative (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
     "shortName": "Employee Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i2b89aca039eb4e798c4afcd95f0f1b09_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i216dac94d38a475db23d353853c31110_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454025 - Disclosure - Employee Benefits - Funded Status (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
     "shortName": "Employee Benefits - Funded Status (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i216dac94d38a475db23d353853c31110_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i213553f0a50c4dd38db19e9a04a338ad_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464026 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
     "shortName": "Employee Benefits - Change in Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i213553f0a50c4dd38db19e9a04a338ad_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474027 - Disclosure - Employee Benefits - Change in Plan Assets (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
     "shortName": "Employee Benefits - Change in Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484028 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
     "shortName": "Employee Benefits - Components of Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i9c04b88d67624c00974b95408ed71c3c_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494029 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
     "shortName": "Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ib2b5722812194c35ad6c0a22b6bd705e_D20210101-20211231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i216dac94d38a475db23d353853c31110_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504030 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
     "shortName": "Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i216dac94d38a475db23d353853c31110_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ib9509a32705e43b195f8a5dee756c081_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iclr:DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514031 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
     "shortName": "Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ib9509a32705e43b195f8a5dee756c081_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Description of business",
     "role": "http://www.iconplc.com/role/Descriptionofbusiness",
     "shortName": "Description of business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ib9509a32705e43b195f8a5dee756c081_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iclr:DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524032 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
     "shortName": "Employee Benefits - Plan Asset Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ic6eb058c3c334fa9bc0c1e5cd98974fa_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "if6b045e97c954a34891096fb9cf8d23b_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534033 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
     "shortName": "Employee Benefits - Annual Benefit Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "if6b045e97c954a34891096fb9cf8d23b_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564034 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i953fc3f9f5114324bcd9a4293c83b977_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574035 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ibbca4abf2817496684bb2ab04067235b_I20181231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584036 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594037 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "i79e3123f2af54a8cb5851c0d49fdef09_D20210701-20210701",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie4af659507f244f3be56ce1d3a1e11dd_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604038 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "ie4af659507f244f3be56ce1d3a1e11dd_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614039 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id8aedbfe82f84258b4f5fb8ae5be9756_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iclr:NumberOfVotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634040 - Disclosure - Share Capital (Details)",
     "role": "http://www.iconplc.com/role/ShareCapitalDetails",
     "shortName": "Share Capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iclr:NumberOfVotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:IncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664041 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)",
     "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Components of Income Before Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:IncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20211231.htm",
      "contextRef": "id9ad61eae3ef4807b2e31474544cced7_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 124,
   "tag": {
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "United Kingdom"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address",
        "terseLabel": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard",
        "terseLabel": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report",
        "terseLabel": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r954"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filler Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r963"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees",
        "terseLabel": "Number of employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r949"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r964"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well Known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r950"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "iclr_A2013LegacyPRAPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2013 Legacy PRA Plan",
        "label": "2013 Legacy PRA Plan [Member]",
        "terseLabel": "2013 Legacy PRA Plan"
       }
      }
     },
     "localname": "A2013LegacyPRAPlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_A2021RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Restructuring Plan",
        "label": "2021 Restructuring Plan [Member]",
        "terseLabel": "2021 Restructuring Plan"
       }
      }
     },
     "localname": "A2021RestructuringPlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AccountingStandardsUpdate202108Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2021-08",
        "label": "Accounting Standards Update 2021-08 [Member]",
        "terseLabel": "Accounting Standards Update 2021-08"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202108Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AccountsReceivableCreditLossExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Credit Loss Expense",
        "label": "Accounts Receivable, Credit Loss Expense",
        "terseLabel": "Amounts provided during the year"
       }
      }
     },
     "localname": "AccountsReceivableCreditLossExpense",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ProvisionforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AccountsReceivableCreditLossReversal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Credit Loss Reversal",
        "label": "Accounts Receivable, Credit Loss Reversal",
        "negatedLabel": "Amounts released during the year"
       }
      }
     },
     "localname": "AccountsReceivableCreditLossReversal",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ProvisionforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Amortization Of Cash Flow Hedges, Effect Net of Tax",
        "label": "Accumulated Other Comprehensive Income (Loss), Amortization Of Cash Flow Hedges, Effect Net of Tax",
        "negatedTerseLabel": "Amortization of gain on interest rate hedge"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAmortizationOfCashFlowHedgesEffectNetofTax",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Currency Impact on Long Term Funding, Net of Tax",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Currency Impact on Long Term Funding, Net of Tax",
        "terseLabel": "Currency impact on long term funding"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInCurrencyImpactOnLongTermFundingNetOfTax",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income Loss [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax",
        "label": "Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax",
        "terseLabel": "Amortization of loss on interest rate hedge"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax",
        "label": "Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, after Tax",
        "negatedTerseLabel": "Loss on interest rate hedge"
       }
      }
     },
     "localname": "AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AdjustmentToRetainedEarningShareRepurchaseCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to Retained Earning Share Repurchase costs",
        "label": "Adjustment to Retained Earning Share Repurchase costs",
        "negatedLabel": "Share repurchase costs"
       }
      }
     },
     "localname": "AdjustmentToRetainedEarningShareRepurchaseCosts",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Payments Netted Against Unbilled Contracts Receivable",
        "label": "Advance Payments Netted Against Unbilled Contracts Receivable",
        "terseLabel": "Net balance"
       }
      }
     },
     "localname": "AdvancePaymentsNettedAgainstUnbilledContractsReceivable",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AfimmuneLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Afimmune Limited",
        "label": "Afimmune Limited [Member]",
        "terseLabel": "Afimmune Limited"
       }
      }
     },
     "localname": "AfimmuneLimitedMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments",
        "label": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments",
        "terseLabel": "Foreign exchange"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ProvisionforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AllowanceForDoubtfulAccountsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Doubtful Accounts, Table",
        "label": "Allowance for Doubtful Accounts [Table Text Block]",
        "terseLabel": "Schedule of Provision for Credit Losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsTableTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ProvisionforCreditLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_AllowanceForDoubtfulAccountsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Doubtful Accounts [Text Block]",
        "label": "Allowance For Doubtful Accounts [Text Block]",
        "terseLabel": "Provision for Credit Losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ProvisionforCreditLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_AptivSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aptiv Solutions [Member]",
        "label": "Aptiv Solutions [Member]",
        "terseLabel": "Aptiv Solutions"
       }
      }
     },
     "localname": "AptivSolutionsMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AptivSolutionsPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aptiv Solutions Pension Plan",
        "label": "Aptiv Solutions Pension Plan [Member]",
        "terseLabel": "Aptiv Solutions pension plan"
       }
      }
     },
     "localname": "AptivSolutionsPensionPlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.iconplc.com/20211231",
     "xbrltype": "stringItemType"
    },
    "iclr_AwardDate2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award Date, 2018 [Member]",
        "label": "Award Date, 2018 [Member]",
        "terseLabel": "Award date, 2018 and thereafter"
       }
      }
     },
     "localname": "AwardDate2018Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AwardDateAllYearsExcluding2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award Date, Prior to 2018 [Member]",
        "label": "Award Date, All Years Excluding 2018 [Member]",
        "terseLabel": "Award date, prior to 2018"
       }
      }
     },
     "localname": "AwardDateAllYearsExcluding2018Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_BaringsEuropeanLoanFundBuyAndHoldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barings European Loan Fund Buy And Hold [Member]",
        "label": "Barings European Loan Fund Buy And Hold [Member]",
        "terseLabel": "Barings European Loan Fund Buy &amp; Hold"
       }
      }
     },
     "localname": "BaringsEuropeanLoanFundBuyAndHoldMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held",
        "label": "Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held",
        "terseLabel": "Business acquisition, share price (in USD per share)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date",
        "label": "Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date",
        "terseLabel": "Payments to settle debt obligations that existed prior to acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders",
        "label": "Business Combination, Consideration Transferred, Shares Issued To Shareholders, Per Share Held",
        "terseLabel": "Business acquisition, number of shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iclr_BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Working Capital Adjustments",
        "label": "Business Combination, Consideration Transferred, Working Capital Adjustments",
        "negatedTerseLabel": "Working capital adjustment paid"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredWorkingCapitalAdjustments",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Pro Forma Information, Earnings Or Loss Before Tax Of Acquiree Since Acquisition Date, Actual",
        "label": "Business Combination, Pro Forma Information, Earnings Or Loss Before Tax Of Acquiree Since Acquisition Date, Actual",
        "terseLabel": "Pre-tax net income of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossBeforeTaxOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Lease Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Lease Liabilities",
        "negatedTerseLabel": "Operating current lease liabilities fair value adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLeaseLiabilities",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Revenue",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Revenue",
        "terseLabel": "Unearned revenue adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredRevenue",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liability",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liability",
        "negatedTerseLabel": "Operating non-current deferred tax liability fair value adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiability",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Lease Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Lease Liabilities",
        "negatedTerseLabel": "Operating non-current lease liabilities fair value adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentLeaseLiabilities",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Right-To-Use Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Right-To-Use Assets",
        "negatedTerseLabel": "Operating right-to-use assets fair value adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingRightToUseAssets",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities",
        "negatedTerseLabel": "Other liabilities adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Receivables",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Receivables",
        "terseLabel": "Accounts receivable adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentReceivables",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current",
        "negatedTerseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset",
        "terseLabel": "Operating right of use assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability",
        "negatedLabel": "Current portion of operating lease liabilities",
        "negatedTerseLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability",
        "negatedLabel": "Non-current portion of operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BuybackProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Buyback Program [Member]",
        "label": "Buyback Program [Member]",
        "terseLabel": "Buyback program"
       }
      }
     },
     "localname": "BuybackProgramMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_CapitalGovernmentGrantsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Government Grants Current",
        "label": "Capital Government Grants Current",
        "terseLabel": "Short term government grants"
       }
      }
     },
     "localname": "CapitalGovernmentGrantsCurrent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_CapitalGovernmentGrantsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent capital government grants, which are amortized and recognized in earnings over the grant period.",
        "label": "Capital Government Grants Noncurrent",
        "verboseLabel": "Non-current government grants"
       }
      }
     },
     "localname": "CapitalGovernmentGrantsNoncurrent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable",
        "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable",
        "terseLabel": "Increase in advance payments netted against unbilled contracts receivable",
        "totalLabel": "Change in advance payments netted against unbilled contracts receivable"
       }
      }
     },
     "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent",
        "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent",
        "terseLabel": "Change in advance payments netted against unbilled contracts receivable (in percent)"
       }
      }
     },
     "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_Clients1125Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clients 11-25 [Member]",
        "label": "Clients 11-25 [Member]",
        "terseLabel": "Clients 11-25"
       }
      }
     },
     "localname": "Clients1125Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Clients25Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clients 2-5 [Member]",
        "label": "Clients 2-5 [Member]",
        "terseLabel": "Clients 2-5"
       }
      }
     },
     "localname": "Clients25Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Clients610Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clients 6-10 [Member]",
        "label": "Clients 6-10 [Member]",
        "terseLabel": "Clients 6-10"
       }
      }
     },
     "localname": "Clients610Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_CommitmentToAcquireLongTermInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment To Acquire Long-Term Investments",
        "label": "Commitment To Acquire Long-Term Investments",
        "terseLabel": "Commitment to acquire future long-term investments"
       }
      }
     },
     "localname": "CommitmentToAcquireLongTermInvestments",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Related Costs Share Based Payments Disclosure [Line Items]",
        "label": "Compensation Related Costs Share Based Payments Disclosure [Line Items]",
        "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Line Items]"
       }
      }
     },
     "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Related Costs Share Based Payments Disclosure [Table]",
        "label": "Compensation Related Costs Share Based Payments Disclosure [Table]",
        "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Table]"
       }
      }
     },
     "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureTable",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ComputerEquipmentAndCapitalizedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment and Capitalized Software [Member]",
        "label": "Computer Equipment and Capitalized Software [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndCapitalizedSoftwareMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consultants Restricted Stock Units Twenty Nineteen [Member]",
        "label": "Consultants Restricted Stock Units Twenty Nineteen [Member]",
        "terseLabel": "Consultants Restricted Stock Units 2019"
       }
      }
     },
     "localname": "ConsultantsRestrictedStockUnitsTwentyNineteenMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ConsultantsStockPlan2008PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consultants Stock Plan, 2008 Plan [Member]",
        "label": "Consultants Stock Plan, 2008 Plan [Member]",
        "terseLabel": "Consultants Stock Plan, 2008 Plan"
       }
      }
     },
     "localname": "ConsultantsStockPlan2008PlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ContractsReceivableGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "iclr_ContractsReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable",
        "label": "Contracts Receivable, Gross",
        "totalLabel": "Accounts receivable (net)"
       }
      }
     },
     "localname": "ContractsReceivableGross",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ContractsReceivableNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable, Net",
        "label": "Contracts Receivable, Net",
        "totalLabel": "Accounts receivable and unbilled revenue, net"
       }
      }
     },
     "localname": "ContractsReceivableNet",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DSBiopharmaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Biopharma Limited [Member]",
        "label": "DS Biopharma Limited [Member]",
        "terseLabel": "DS Biopharma Limited"
       }
      }
     },
     "localname": "DSBiopharmaLimitedMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread On Variable Rate, Step Down Percentage",
        "label": "Debt Instrument, Basis Spread On Variable Rate, Step Down Percentage",
        "terseLabel": "Basis spread on variable rate, step down percentage (in percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRateStepDownPercentage",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_DebtInstrumentCovenantFirstLienNetLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, First Lien Net Leverage Ratio",
        "label": "Debt Instrument, Covenant, First Lien Net Leverage Ratio",
        "terseLabel": "First lien net leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantFirstLienNetLeverageRatio",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "iclr_DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Increase (Decrease) Basis Spread on Variable Rate",
        "label": "Debt Instrument, Increase (Decrease) Basis Spread on Variable Rate",
        "negatedTerseLabel": "Decrease in basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseDecreaseBasisSpreadOnVariableRate",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_DeferredTaxAssetContractWithCustomerLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Contract With Customer, Liability",
        "label": "Deferred Tax Asset, Contract With Customer, Liability",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetContractWithCustomerLiability",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration",
        "label": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration",
        "terseLabel": "Ireland subsidiaries additional tax credit carryforward for income tax"
       }
      }
     },
     "localname": "DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DeferredTaxAssetsOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease, Liability",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards",
        "label": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards",
        "terseLabel": "Operating loss and tax credits carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost",
        "label": "Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost",
        "negatedLabel": "Actuarial (gain)/loss - benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period",
        "terseLabel": "Pension plan period"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iclr_DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Corporate Bonds Target Allocation, High Yield Percentage",
        "label": "Defined Benefit Plan, Plan Assets, Corporate Bonds Target Allocation, High Yield Percentage",
        "terseLabel": "High yield percentage of corporate bond investment"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsCorporateBondsTargetAllocationHighYieldPercentage",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_DefinedBenefitPlanSchemeContributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Scheme Contributions",
        "label": "Defined Benefit Plan, Scheme Contributions",
        "terseLabel": "Scheme contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanSchemeContributions",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Financing Cost",
        "label": "Disclosure Of Detailed Information About Financing Cost [Table Text Block]",
        "terseLabel": "Schedule of Financing Cost"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_EmployeeStockPlanTwentyZeroEightPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Plan, 2008 Plan [Member]",
        "label": "Employee Stock Plan, 2008 Plan [Member]",
        "terseLabel": "Employee Stock Plan, 2008 Plan"
       }
      }
     },
     "localname": "EmployeeStockPlanTwentyZeroEightPlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_EmployeeStockPlanTwentyZeroThreePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Plan, 2003 Plan [Member]",
        "label": "Employee Stock Plan, 2003 Plan [Member]",
        "terseLabel": "Employee Stock Plan, 2003 Plan"
       }
      }
     },
     "localname": "EmployeeStockPlanTwentyZeroThreePlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_EquityMethodInvestmentMajorityOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Majority Ownership Percentage",
        "label": "Equity Method Investment, Majority Ownership Percentage",
        "terseLabel": "Majority investor, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentMajorityOwnershipPercentage",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company",
        "label": "Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company",
        "terseLabel": "Period majority voting share capital can be sold to the company"
       }
      }
     },
     "localname": "EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iclr_ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Long Term Rate of Return on Plan Assets",
        "label": "Expected Long Term Rate of Return on Plan Assets [Table Text Block]",
        "terseLabel": "Summary of Expected Long Term Rates of Return on Different Asset Classes"
       }
      }
     },
     "localname": "ExpectedLongTermRateOfReturnOnPlanAssetsTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ExpectedRetirementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Retirement period",
        "label": "Expected Retirement period",
        "terseLabel": "Retirement period used as a basis to estimate expected cash flows"
       }
      }
     },
     "localname": "ExpectedRetirementPeriod",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite Lived Intangible Assets, Amortization Expense, Net",
        "label": "Finite Lived Intangible Assets, Amortization Expense, Net",
        "totalLabel": "Finite lived intangible assets, amortization expense, net, total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNet",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ForeignCurrencyDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Disclosure",
        "label": "Foreign Currency Disclosure [Table Text Block]",
        "terseLabel": "Adjustments Resulting From Foreign Currency Translations"
       }
      }
     },
     "localname": "ForeignCurrencyDisclosureTableTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_GovernmentGrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grants, Policy",
        "label": "Government Grants [Policy Text Block]",
        "terseLabel": "Government Grants"
       }
      }
     },
     "localname": "GovernmentGrantsPolicyTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_HighYieldBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "High Yield Bonds",
        "label": "High Yield Bonds [Member]",
        "terseLabel": "High yield bonds"
       }
      }
     },
     "localname": "HighYieldBondsMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ICON Development Solutions Limited Pension Plan",
        "label": "ICON Development Solutions Limited Pension Plan [Member]",
        "terseLabel": "ICON Development Solutions Limited pension plan"
       }
      }
     },
     "localname": "ICONDevelopmentSolutionsLimitedPensionPlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_IncomeBeforeIncomeTaxTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Before Income Tax, Table",
        "label": "Income Before Income Tax [Table Text Block]",
        "terseLabel": "Summary of Components of Income Before Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeBeforeIncomeTaxTableTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest",
        "totalLabel": "Income before share of earnings from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) From Operations, Excluding Restructuring, Transaction And Integration Costs",
        "label": "Income (Loss) From Operations, Excluding Restructuring, Transaction And Integration Costs",
        "terseLabel": "Income from operations, excluding restructuring, transaction and integration costs"
       }
      }
     },
     "localname": "IncomeLossFromOperationsExcludingRestructuringTransactionAndIntegrationCosts",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_IncomeTaxBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Benefit [Member]",
        "label": "Income Tax Benefit [Member]",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxBenefitMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent",
        "label": "Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent",
        "terseLabel": "Change in unearned revenue (payments on account) (in percent)"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contracts With Customers, Liability, Current",
        "label": "Increase (Decrease) In Contracts With Customers, Liability, Current",
        "negatedTerseLabel": "Change in unearned revenue (payments on account)",
        "terseLabel": "Change in unearned revenue (payments on account)"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractsWithCustomersLiabilityCurrent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current",
        "label": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current",
        "terseLabel": "Change in unbilled receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractwithCustomerAssetGrossCurrent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent",
        "label": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent",
        "terseLabel": "Change in unbilled receivables (in percent)"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_IncreaseDecreaseRevenueFromContractsWithCustomers": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) Revenue From Contracts With Customers",
        "label": "Increase (Decrease) Revenue From Contracts With Customers",
        "terseLabel": "Increase (decrease) in revenue from contracts with customers"
       }
      }
     },
     "localname": "IncreaseDecreaseRevenueFromContractsWithCustomers",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_InterestExpenseCreditOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense (Credit), Other",
        "label": "Interest Expense (Credit), Other",
        "terseLabel": "Other financing costs/(credits)"
       }
      }
     },
     "localname": "InterestExpenseCreditOther",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_InterestReceivableRelatedPartyLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Receivable, Related Party Loans",
        "label": "Interest Receivable, Related Party Loans",
        "terseLabel": "Interest receivable, related party loans"
       }
      }
     },
     "localname": "InterestReceivableRelatedPartyLoans",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_IssueOfSeniorNotesNumberOfTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issue Of Senior Notes, Number Of Tranches",
        "label": "Issue Of Senior Notes, Number Of Tranches",
        "terseLabel": "Issue of senior notes, number of tranches"
       }
      }
     },
     "localname": "IssueOfSeniorNotesNumberOfTranches",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iclr_LAndGLifeDCActiveCorporateBondMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "L And G Life DC Active Corporate Bond [Member]",
        "label": "L And G Life DC Active Corporate Bond [Member]",
        "terseLabel": "L&amp;G Life DC Active Corporate Bond"
       }
      }
     },
     "localname": "LAndGLifeDCActiveCorporateBondMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_LAndGLifeGPBFAllWorldEquityIndexFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "L And G Life GPBF All World Equity Index Fund [Member]",
        "label": "L And G Life GPBF All World Equity Index Fund [Member]",
        "terseLabel": "L&amp;G Life GPBF All World Equity Index Fund"
       }
      }
     },
     "localname": "LAndGLifeGPBFAllWorldEquityIndexFundMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_LeaseLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liability",
        "label": "Lease Liability [Member]",
        "terseLabel": "Lease Liability"
       }
      }
     },
     "localname": "LeaseLiabilityMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limit of Shares Issued or To Be Issued Pursuant to Options Granted",
        "label": "Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted",
        "terseLabel": "Limit of shares issued or to be issued pursuant to options granted (in shares)"
       }
      }
     },
     "localname": "LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iclr_LongTermDebtCurrentMaturitiesGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Current Maturities, Gross",
        "label": "Long-term Debt, Current Maturities, Gross",
        "negatedTerseLabel": "Less current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrentMaturitiesGross",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_LongTermDebtExcludingCurrentMaturitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Excluding Current Maturities, Gross",
        "label": "Long-term Debt, Excluding Current Maturities, Gross",
        "terseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtExcludingCurrentMaturitiesGross",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_LongTermDebtMaturityYearFiveAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, Year Five And Thereafter",
        "label": "Long-Term Debt, Maturity, Year Five And Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityYearFiveAndThereafter",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_MeDiNovaResearchMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MeDiNova Research [Member]",
        "label": "MeDiNova Research [Member]",
        "terseLabel": "MeDiNova"
       }
      }
     },
     "localname": "MeDiNovaResearchMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_MedpassGroupLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medpass Group Limited [Member]",
        "label": "Medpass Group Limited [Member]",
        "terseLabel": "Medpass Group Limited"
       }
      }
     },
     "localname": "MedpassGroupLimitedMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_NewAndRecentAccountingPronouncementsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New And Recent Accounting Pronouncements Disclosure",
        "label": "New And Recent Accounting Pronouncements Disclosure [Text Block]",
        "terseLabel": "Impact of New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAndRecentAccountingPronouncementsDisclosureTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_NinetyOneGlobalTotalReturnCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ninety One Global Total Return Credit",
        "label": "Ninety One Global Total Return Credit [Member]",
        "terseLabel": "Ninety One Global Total Return Credit"
       }
      }
     },
     "localname": "NinetyOneGlobalTotalReturnCreditMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_NonexecutiveDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-executive Director [Member]",
        "label": "Non-executive Director [Member]",
        "terseLabel": "Non-executive director"
       }
      }
     },
     "localname": "NonexecutiveDirectorMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_NumberOfLocations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Locations",
        "label": "Number of Locations",
        "terseLabel": "Number of locations in which company operates"
       }
      }
     },
     "localname": "NumberOfLocations",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iclr_NumberOfVotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Votes",
        "label": "Number Of Votes",
        "terseLabel": "Number of votes"
       }
      }
     },
     "localname": "NumberOfVotes",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iclr_OncacareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oncacare",
        "label": "Oncacare [Member]",
        "terseLabel": "Oncacare"
       }
      }
     },
     "localname": "OncacareMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OperatingIncomeByGeographyTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income by Geography.",
        "label": "Operating Income by Geography [Table Text Block]",
        "terseLabel": "Schedule of Distribution of Income from Operations by Geographical Area"
       }
      }
     },
     "localname": "OperatingIncomeByGeographyTableTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses",
        "label": "Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses",
        "terseLabel": "Income from operations, excluding restructuring and other items"
       }
      }
     },
     "localname": "OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OperatingLossCarryforwardsUSFederal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, US Federal",
        "label": "Operating Loss Carryforwards, US Federal",
        "terseLabel": "U.S. Federal net operating loss carry forwards currently available for offset"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsUSFederal",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OptionPlans2008Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option Plans 2008 [Member]",
        "label": "Option Plans 2008 [Member]",
        "terseLabel": "Option Plans 2008"
       }
      }
     },
     "localname": "OptionPlans2008Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax",
        "label": "Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax",
        "negatedLabel": "Actuarial loss recognized in net periodic benefit cost"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment that results from the process of translating the impact of long-term funding into the functional currency of the reporting entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction And Translation Adjustment, Net Of Tax, Long-Term Funding",
        "terseLabel": "Currency impact of long-term funding"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxLongTermFunding",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Countries [Member]",
        "label": "Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Customers [Member]",
        "label": "Other Customers [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCustomersMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherGeographicLocationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Geographic Locations [Member]",
        "label": "Other Geographic Locations [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "OtherGeographicLocationsMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses",
        "label": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses",
        "terseLabel": "Amounts due to third parties for reimbursable expenses"
       }
      }
     },
     "localname": "OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OtherRetirementPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Retirement Plans",
        "label": "Other Retirement Plans [Member]",
        "terseLabel": "Other retirement plans"
       }
      }
     },
     "localname": "OtherRetirementPlansMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherUndenominatedCapital": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other undenominated capital.",
        "label": "Other Undenominated Capital",
        "terseLabel": "Other undenominated capital (Note 13 (a))"
       }
      }
     },
     "localname": "OtherUndenominatedCapital",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OtherUndenominatedCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other undenominated capital.",
        "label": "Other Undenominated Capital [Member]",
        "terseLabel": "Other Undenominated Capital"
       }
      }
     },
     "localname": "OtherUndenominatedCapitalMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_PRAHealthSciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PRA Health Sciences, Inc",
        "label": "PRA Health Sciences, Inc [Member]",
        "terseLabel": "PRA Health Sciences, Inc"
       }
      }
     },
     "localname": "PRAHealthSciencesIncMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_PRASwitzerlandAGPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PRA Switzerland AG Pension Plan",
        "label": "PRA Switzerland AG Pension Plan [Member]",
        "terseLabel": "PRA Switzerland AG pension plan"
       }
      }
     },
     "localname": "PRASwitzerlandAGPensionPlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_PaymentsForShareRepurchaseCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Share Repurchase Costs",
        "label": "Payments for Share Repurchase Costs",
        "negatedLabel": "Share repurchase costs"
       }
      }
     },
     "localname": "PaymentsForShareRepurchaseCosts",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_PerformanceBasedGrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Grants [Member]",
        "label": "Performance Based Grants [Member]",
        "terseLabel": "PSUs Based on Service and EPS Targets"
       }
      }
     },
     "localname": "PerformanceBasedGrantsMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_PerformanceShareUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Share Unit [Member]",
        "label": "Performance Share Unit [Member]",
        "terseLabel": "Performance Share Unit (PSUs)"
       }
      }
     },
     "localname": "PerformanceShareUnitMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Range1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 1 [Member]",
        "label": "Range 1 [Member]",
        "terseLabel": "Range 1"
       }
      }
     },
     "localname": "Range1Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Range2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 2 [Member]",
        "label": "Range 2 [Member]",
        "terseLabel": "Range 2"
       }
      }
     },
     "localname": "Range2Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Range3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 3 [Member]",
        "label": "Range 3 [Member]",
        "terseLabel": "Range 3"
       }
      }
     },
     "localname": "Range3Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Range4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 4 [Member]",
        "label": "Range 4 [Member]",
        "terseLabel": "Range 4"
       }
      }
     },
     "localname": "Range4Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ReconciliationOfDebtSecuritiesAvailableForSaleRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation Of Debt Securities, Available-For-Sale [Roll Forward]",
        "label": "Reconciliation Of Debt Securities, Available-For-Sale [Roll Forward]",
        "terseLabel": "Reconciliation Of Debt Securities, Available-For-Sale [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfDebtSecuritiesAvailableForSaleRollForward",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Provision of Income Taxes [Line Items]",
        "label": "Reconciliation of Provision of Income Taxes [Line Items]",
        "terseLabel": "Reconciliation of Provision of Income Taxes [Line Items]"
       }
      }
     },
     "localname": "ReconciliationOfProvisionOfIncomeTaxesLineItems",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ReconciliationOfProvisionOfIncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Provision of Income Taxes [Table]",
        "label": "Reconciliation of Provision of Income Taxes [Table]",
        "terseLabel": "Reconciliation of Provision of Income Taxes [Table]"
       }
      }
     },
     "localname": "ReconciliationOfProvisionOfIncomeTaxesTable",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_RedeemableNoncontrollingInterestAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest, Accretion To Redemption Value",
        "label": "Redeemable Noncontrolling Interest, Accretion To Redemption Value",
        "negatedTerseLabel": "Exercise of call option on noncontrolling interest shares"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestAccretionToRedemptionValue",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest, Increase From Business Combination",
        "label": "Redeemable Noncontrolling Interest, Increase From Business Combination",
        "terseLabel": "Noncontrolling interest adjustment to redemption amount"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ResearchandDevelopmentCreditsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Credits [Policy Text Block]",
        "label": "Research and Development Credits [Policy Text Block]",
        "terseLabel": "Research and Development Credits"
       }
      }
     },
     "localname": "ResearchandDevelopmentCreditsPolicyTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_RestOfEuropeAndOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest Of Europe And Other Countries [Member]",
        "label": "Rest Of Europe And Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestOfEuropeAndOtherCountriesMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_RestOfEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest Of Europe [Member]",
        "label": "Rest Of Europe [Member]",
        "terseLabel": "Rest of Europe"
       }
      }
     },
     "localname": "RestOfEuropeMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_RestrictedStockUnitsTwentyThirteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units Twenty Thirteen [Member]",
        "label": "Restricted Stock Units Twenty Thirteen [Member]",
        "terseLabel": "Restricted Stock Units 2013"
       }
      }
     },
     "localname": "RestrictedStockUnitsTwentyThirteenMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_RestructuringReserveUtilizations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve Utilizations",
        "label": "Restructuring Reserve Utilizations",
        "negatedLabel": "Utilization"
       }
      }
     },
     "localname": "RestructuringReserveUtilizations",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_RestructuringReserveandOtherLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve and Other Liabilities, Current",
        "label": "Restructuring Reserve and Other Liabilities, Current",
        "terseLabel": "Restructuring liabilities (note 15)"
       }
      }
     },
     "localname": "RestructuringReserveandOtherLiabilitiesCurrent",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]",
        "label": "Schedule Of Adjusted Earnings Per Share, Basic And Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share"
       }
      }
     },
     "localname": "ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]",
        "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]",
        "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]",
        "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]",
        "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Non Cash Stock Compensation Expense.",
        "label": "Schedule of Non Cash Stock Compensation Expense [Table Text Block]",
        "terseLabel": "Schedule of Non-cash Stock Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfNonCashStockCompensationExpenseTableTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]",
        "label": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]",
        "terseLabel": "Summary of RSU and PSU Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Useful Lives For Property Plant Equipment",
        "label": "Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]",
        "terseLabel": "Estimated Useful Lives of Assets"
       }
      }
     },
     "localname": "ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_SeniorANotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior A Notes",
        "label": "Senior A Notes [Member]",
        "terseLabel": "Series A notes"
       }
      }
     },
     "localname": "SeniorANotesMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_SeniorBNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior B Notes",
        "label": "Senior B Notes [Member]",
        "terseLabel": "Series B notes"
       }
      }
     },
     "localname": "SeniorBNotesMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_SeniorNotes2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020",
        "label": "Senior Notes 2020 [Member]",
        "terseLabel": "Senior Notes 2020"
       }
      }
     },
     "localname": "SeniorNotes2020Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Credit Facility And Senior Secured Notes",
        "label": "Senior Secured Credit Facility And Senior Secured Notes [Member]",
        "terseLabel": "Senior secured credit facility and senior secured notes"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_SeniorSecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Notes",
        "label": "Senior Secured Notes [Member]",
        "terseLabel": "Senior Secured Notes"
       }
      }
     },
     "localname": "SeniorSecuredNotesMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_SeniorSecuredRevolvingLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Revolving Loan Facility",
        "label": "Senior Secured Revolving Loan Facility [Member]",
        "terseLabel": "Senior secured revolving loan facility"
       }
      }
     },
     "localname": "SeniorSecuredRevolvingLoanFacilityMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share",
        "terseLabel": "Share price of equity instruments other than options, vested in period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination",
        "terseLabel": "Assumed through business combination (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized",
        "terseLabel": "Percentage of outstanding shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price",
        "terseLabel": "Assumed through business combination (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Available For Sale Investments Average Remaining Maturity Period",
        "label": "Short Term Available For Sale Investments Average Remaining Maturity Period",
        "terseLabel": "Short term investments average maturity period"
       }
      }
     },
     "localname": "ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iclr_StockOptionAndAwardPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option And Award Plans [Member]",
        "label": "Stock Option And Award Plans [Member]",
        "terseLabel": "Stock Option and Award Plans"
       }
      }
     },
     "localname": "StockOptionAndAwardPlansMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_StockRepurchaseProgramAuthorizedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program Authorized Percentage",
        "label": "Stock Repurchase Program Authorized Percentage",
        "terseLabel": "Stock repurchase program, authorized percentage (in percent)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedPercentage",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy",
        "label": "Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy [Policy Text Block]",
        "terseLabel": "Redeemable Non-Controlling Interests and Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_StoneHarborHighYieldBondFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stone Harbor High Yield Bond Fund [Member]",
        "label": "Stone Harbor High Yield Bond Fund [Member]",
        "terseLabel": "Stone Harbor High Yield Bond Fund"
       }
      }
     },
     "localname": "StoneHarborHighYieldBondFundMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_StoneHarborMultiAssetCreditPortfolioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stone Harbor Multi Asset Credit Portfolio [Member]",
        "label": "Stone Harbor Multi Asset Credit Portfolio [Member]",
        "terseLabel": "Stone Harbor Multi Asset Credit Portfolio"
       }
      }
     },
     "localname": "StoneHarborMultiAssetCreditPortfolioMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TaxYear2022To2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2020 to 2026 [Member]",
        "label": "Tax Year 2022 to 2028 [Member]",
        "terseLabel": "Tax Year 2022 to 2028"
       }
      }
     },
     "localname": "TaxYear2022To2028Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TaxYear2022to2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2022 to 2035 [Member]",
        "label": "Tax Year 2022 to 2035 [Member]",
        "terseLabel": "2022-2035",
        "verboseLabel": "Tax Year 2022 to 2035"
       }
      }
     },
     "localname": "TaxYear2022to2035Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TaxYear2029To2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2027 to 2036 [Member]",
        "label": "Tax Year 2029 to 2038 [Member]",
        "terseLabel": "Tax Year 2029 to 2038"
       }
      }
     },
     "localname": "TaxYear2029To2038Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TaxYear20362040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2037 [Member]",
        "label": "Tax Year 2036-2040 [Member]",
        "terseLabel": "2036-2040",
        "verboseLabel": "Tax Year 2036-2040"
       }
      }
     },
     "localname": "TaxYear20362040Member",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TermDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Deposits [Member]",
        "label": "Term Deposits [Member]",
        "terseLabel": "Term deposits"
       }
      }
     },
     "localname": "TermDepositsMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term loan"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_The2018LegacyPRAPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2018 Plan",
        "label": "The 2018 Legacy PRA Plan [Member]",
        "terseLabel": "The 2018 Legacy PRA Plan"
       }
      }
     },
     "localname": "The2018LegacyPRAPlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_The2020LegacyPRAPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2020 Legacy PRA Plan",
        "label": "The 2020 Legacy PRA Plan [Member]",
        "terseLabel": "The 2020 Legacy PRA Plan"
       }
      }
     },
     "localname": "The2020LegacyPRAPlanMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TopClientMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top Client [Member]",
        "label": "Top Client [Member]",
        "terseLabel": "Top client"
       }
      }
     },
     "localname": "TopClientMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TransactionAndIntegrationExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction And Integration Expense",
        "label": "Transaction And Integration Expense [Member]",
        "terseLabel": "Transaction and integration related *"
       }
      }
     },
     "localname": "TransactionAndIntegrationExpenseMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TransactionAndOneTimeFinancingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction And One Time Financing Costs",
        "label": "Transaction And One Time Financing Costs",
        "terseLabel": "Transaction and one time financing costs"
       }
      }
     },
     "localname": "TransactionAndOneTimeFinancingCosts",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_VariableRateComponentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Component",
        "label": "Variable Rate Component [Axis]",
        "terseLabel": "Variable Rate Component [Axis]"
       }
      }
     },
     "localname": "VariableRateComponentAxis",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_VariableRateComponentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Component [Domain]",
        "label": "Variable Rate Component [Domain]",
        "terseLabel": "Variable Rate Component [Domain]"
       }
      }
     },
     "localname": "VariableRateComponentDomain",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_VariableRateComponentOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Component One",
        "label": "Variable Rate Component One [Member]",
        "terseLabel": "Variable rate component one"
       }
      }
     },
     "localname": "VariableRateComponentOneMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_VariableRateComponentTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Component Two",
        "label": "Variable Rate Component Two [Member]",
        "terseLabel": "Variable rate component two"
       }
      }
     },
     "localname": "VariableRateComponentTwoMember",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_VehiclesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicles, Gross",
        "label": "Vehicles, Gross",
        "terseLabel": "Motor vehicles"
       }
      }
     },
     "localname": "VehiclesGross",
     "nsuri": "http://www.iconplc.com/20211231",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r221",
      "r443",
      "r449",
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r364",
      "r395",
      "r547",
      "r555",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r835",
      "r909",
      "r912",
      "r944",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r364",
      "r395",
      "r547",
      "r555",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r835",
      "r909",
      "r912",
      "r944",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r221",
      "r443",
      "r449",
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r364",
      "r395",
      "r481",
      "r547",
      "r555",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r835",
      "r909",
      "r912",
      "r944",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r364",
      "r395",
      "r481",
      "r547",
      "r555",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r835",
      "r909",
      "r912",
      "r944",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r216",
      "r217",
      "r443",
      "r448",
      "r910",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r216",
      "r217",
      "r443",
      "r448",
      "r910",
      "r929",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r223",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]",
        "terseLabel": "Non-Current Other Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NonCurrentOtherLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r46",
      "r801"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r31",
      "r224",
      "r225"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net (Note 18)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r24",
      "r861",
      "r890"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable (Note 14)"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r26",
      "r861",
      "r890"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Non-current income taxes payable (Note 14)"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedUtilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r16",
      "r49"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Utilities, Current",
        "terseLabel": "Facility related liabilities"
       }
      }
     },
     "localname": "AccruedUtilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r44",
      "r312"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and asset write offs"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r68",
      "r73",
      "r502"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Actuarial loss on defined benefit pension plan (note 10)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r64",
      "r70",
      "r72",
      "r73",
      "r737"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r70",
      "r72",
      "r73",
      "r893",
      "r920",
      "r924"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (Note 22)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r82",
      "r83",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r69",
      "r73",
      "r82",
      "r83",
      "r84",
      "r140",
      "r141",
      "r142",
      "r696",
      "r915",
      "r916",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Estimated Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r599",
      "r600",
      "r601",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net [Abstract]",
        "terseLabel": "Income tax expense was allocated to the following components of other comprehensive income:"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r144",
      "r145",
      "r146",
      "r147",
      "r157",
      "r232",
      "r233",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r347",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r642",
      "r643",
      "r644",
      "r645",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r789",
      "r841",
      "r842",
      "r843",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.",
        "label": "APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition",
        "terseLabel": "Replacement share-based awards issued to acquiree employees"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r557",
      "r559",
      "r604",
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r408",
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "negatedLabel": "Share issue costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r227",
      "r266",
      "r268",
      "r271"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "iclr_ContractsReceivableGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for credit losses (note 19)",
        "periodEndLabel": "Closing provision",
        "periodStartLabel": "Opening provision"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails",
      "http://www.iconplc.com/role/ProvisionforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ProvisionforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedLabel": "Amounts used during the year"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ProvisionforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.",
        "label": "Amortization of Deferred Hedge Gains",
        "terseLabel": "Charge/(credit) on interest rate hedge"
       }
      }
     },
     "localname": "AmortizationOfDeferredHedgeGains",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r92",
      "r119",
      "r377",
      "r770"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of financing costs and debt discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r119",
      "r295",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "Realized gain on interest rate hedge"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember": {
     "auth_ref": [
      "r244",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced with cash flows derived financial assets that are being securitized for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans. Excludes mortgage-backed securities.",
        "label": "Asset-backed Securities, Securitized Loans and Receivables [Member]",
        "terseLabel": "Secured Loans and Multi Asset Credit"
       }
      }
     },
     "localname": "AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r132",
      "r198",
      "r204",
      "r211",
      "r258",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r691",
      "r697",
      "r741",
      "r799",
      "r801",
      "r859",
      "r889"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r62",
      "r132",
      "r258",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r691",
      "r697",
      "r741",
      "r799",
      "r801"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r726"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r237",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "terseLabel": "Cost Total"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r239",
      "r242",
      "r882"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "1 to 5 years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r239",
      "r241",
      "r881"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than 1 year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r234",
      "r238",
      "r276",
      "r866"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r236",
      "r276"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "periodEndLabel": "Available for sale investments at end of year",
        "periodStartLabel": "Available for sale investments at start of year",
        "terseLabel": "Available for sale investments (Note 3a)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r561",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r561",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r705",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BilledContractReceivables": {
     "auth_ref": [
      "r58",
      "r837"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "iclr_ContractsReceivableGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.",
        "label": "Billed Contracts Receivable",
        "terseLabel": "Billed services (accounts receivable)"
       }
      }
     },
     "localname": "BilledContractReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r13",
      "r311"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r541",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r541",
      "r553",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of share capital acquired",
        "verboseLabel": "Percentage of share capital acquired (in percent)"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Summary of Proforma Information per Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill, expected tax deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r661",
      "r662"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "verboseLabel": "Net income/(loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r661",
      "r662"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r675",
      "r676",
      "r678"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total consideration",
        "totalLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r675",
      "r676"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Fair value of ordinary shares issued to acquiree stockholders"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r673",
      "r675",
      "r676",
      "r681"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Repayment of term loan obligations and accrued interest"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "auth_ref": [
      "r680"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
        "label": "Business Combination, Consideration Transferred, Other",
        "terseLabel": "Fair value of replacement share-based awards issued to acquiree employees"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r683"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration, range of outcomes, maximum value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r674",
      "r677",
      "r682"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/Businesscombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Transaction and integration related (Note 6)"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Net income of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Revenue of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepayments and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable",
        "verboseLabel": "Accounts receivable and unbilled revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedLabel": "Other liabilities",
        "negatedNetLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "verboseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r665",
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "netLabel": "Estimated Fair Value",
        "terseLabel": "Intangible assets",
        "verboseLabel": "Value of intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r665",
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment",
        "verboseLabel": "Fixed assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r666"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Net assets acquired",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage",
        "terseLabel": "Business combination acquisition percentage (in percent)"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations",
        "verboseLabel": "Transaction and Integration-related Expenses"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r946"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Capitalized Computer Software, Gross",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r40",
      "r121"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r19",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r114",
      "r121",
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r114",
      "r756"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease)/increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Disclosure of Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.",
        "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]",
        "terseLabel": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan"
       }
      }
     },
     "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r55",
      "r340",
      "r869",
      "r897"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies\u00a0(Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r341",
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r140",
      "r141",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (in EUR per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Ordinary shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r30",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Ordinary shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r30",
      "r801"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary shares, par value 6 euro cents per share; 100,000,000 shares authorized, (Note 12), 52,788,093 shares issued and outstanding at December 31, 2020 and 53,622,206 shares issued and outstanding at December 31, 2019."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Third Party Costs (Reimbursable expenses)"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r77",
      "r79",
      "r80",
      "r90",
      "r875",
      "r905"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Total comprehensive income attributable to the Group",
        "totalLabel": "Total comprehensive income attributable to the Group"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r77",
      "r79",
      "r89",
      "r689",
      "r690",
      "r700",
      "r874",
      "r904"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Less net income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r77",
      "r79",
      "r88",
      "r688",
      "r700",
      "r873",
      "r903"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r181",
      "r182",
      "r221",
      "r739",
      "r740",
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r181",
      "r182",
      "r221",
      "r739",
      "r740",
      "r926",
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r181",
      "r182",
      "r221",
      "r739",
      "r740",
      "r926",
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r181",
      "r182",
      "r221",
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "verboseLabel": "Percentage of company revenue (in percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r181",
      "r182",
      "r221",
      "r739",
      "r740",
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r127",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Contracts with Customers, Asset and Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r269",
      "r422",
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "auth_ref": [
      "r419",
      "r421"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "iclr_ContractsReceivableNet",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "netLabel": "Unbilled services (unbilled revenue)",
        "terseLabel": "Unbilled revenue (Note 18)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r419",
      "r420",
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with customer, liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r419",
      "r420",
      "r444"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "negatedTerseLabel": "Unearned revenue (payments on account)",
        "terseLabel": "Unearned revenue (Note 18)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesSummaryofContractAssetsandLiabilitiesDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with customer, liability, revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r482",
      "r532",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Bonds (including 50% high yield bonds)"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r97",
      "r839"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Direct costs (excluding depreciation and amortization)"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Direct costs"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy": {
     "auth_ref": [
      "r327",
      "r328",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.",
        "label": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r639",
      "r648",
      "r650"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current tax expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current tax expense:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DatabasesMember": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files).",
        "label": "Database Rights [Member]",
        "terseLabel": "Patient database"
       }
      }
     },
     "localname": "DatabasesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r131",
      "r138",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r383",
      "r384",
      "r385",
      "r386",
      "r771",
      "r860",
      "r864",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (in percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r25",
      "r379",
      "r864",
      "r887"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r361",
      "r383",
      "r384",
      "r769",
      "r771",
      "r772"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r52",
      "r374",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate (in percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r52",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate (in percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53",
      "r131",
      "r138",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r383",
      "r384",
      "r385",
      "r386",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r53",
      "r131",
      "r138",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r383",
      "r384",
      "r385",
      "r386",
      "r409",
      "r410",
      "r411",
      "r412",
      "r768",
      "r769",
      "r771",
      "r772",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r368",
      "r768",
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt discount paid"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r368",
      "r380",
      "r383",
      "r384",
      "r770"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less debt issuance costs and debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt Issuance Costs"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Available For Sale Short Term Investments by Major Security Type"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r770"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Gross debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r612",
      "r613"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax asset (Note 14)"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r133",
      "r640",
      "r648",
      "r649",
      "r650"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax (benefit)/expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred tax (benefit)/expense:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r27",
      "r28",
      "r629",
      "r862",
      "r886"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities recognized"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r612",
      "r613"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability (Note 14)"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred tax (benefit)/expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r630"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Overall net deferred tax asset/(liability)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets recognized"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Other non-U.S subsidiaries operating loss carryforwards for income tax",
        "verboseLabel": "Net operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Additional operating loss carryforward",
        "verboseLabel": "Net operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax": {
     "auth_ref": [
      "r635",
      "r637",
      "r638"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax",
        "terseLabel": "Alternative minimum tax credit carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses and unbilled revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r631"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance for deferred tax assets",
        "terseLabel": "Valuation allowance for deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r613",
      "r632"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Overall net deferred tax asset/(liability)"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r637",
      "r638",
      "r685",
      "r686"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "terseLabel": "Right-of-use-assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "terseLabel": "Deferred tax liabilities, undistributed foreign earnings"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r26",
      "r455",
      "r456",
      "r479"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Defined benefit pension obligations, net (note 10)"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r471",
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial (gain)/loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r457",
      "r497",
      "r526",
      "r532",
      "r533"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r457",
      "r498",
      "r527",
      "r532",
      "r533"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "verboseLabel": "Prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r455",
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "terseLabel": "Non-current other liabilities (note 9)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan",
        "verboseLabel": "Transferred balances"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsTransferredToFromPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r506",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "44561",
        "verboseLabel": "Expected rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation at end of year",
        "periodStartLabel": "Benefit obligation at beginning of year",
        "terseLabel": "Benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r465",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Plan participants' contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r509",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashMember": {
     "auth_ref": [
      "r482",
      "r484",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r473",
      "r482",
      "r484",
      "r530",
      "r532",
      "r533"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r482",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equities"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year",
        "negatedLabel": "Net loss that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year",
        "terseLabel": "Net prior service cost for defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Years 2027 - 2031"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r492",
      "r533"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Contribution to pension fund in the year ending December 31, 2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r457",
      "r496",
      "r525",
      "r532",
      "r533"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r470",
      "r482",
      "r484",
      "r485",
      "r532"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of year",
        "periodStartLabel": "Fair value of plan assets at beginning of year",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency exchange rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r455",
      "r479",
      "r532"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r457",
      "r461",
      "r495",
      "r524",
      "r532",
      "r533"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r493",
      "r522",
      "r532",
      "r533"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change, classified as other.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Other Change",
        "terseLabel": "Transferred balances"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "negatedLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r475",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Plan participants' contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency exchange rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r481",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Percentage of investments (in percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r459",
      "r494",
      "r523",
      "r532",
      "r533"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "terseLabel": "Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Actual plan asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined contribution plan, cost"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Participant's contributions percentage of annual compensation (in percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r119",
      "r310"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r119",
      "r195"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r63",
      "r706",
      "r707",
      "r709",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r137",
      "r701",
      "r702",
      "r703",
      "r704",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r443",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Equity Incentive Schemes and Stock Compensation Charges"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueFromRelatedParties": {
     "auth_ref": [
      "r136",
      "r351",
      "r353",
      "r354",
      "r358",
      "r359",
      "r360",
      "r793",
      "r867",
      "r899"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.",
        "label": "Due from Related Parties",
        "terseLabel": "Amounts due from related parties"
       }
      }
     },
     "localname": "DueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per Ordinary Share attributable to the Group (Note 27):"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r91",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r158",
      "r161",
      "r164",
      "r165",
      "r166",
      "r170",
      "r171",
      "r724",
      "r725",
      "r876",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r91",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r161",
      "r164",
      "r165",
      "r166",
      "r170",
      "r171",
      "r724",
      "r725",
      "r876",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r167",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net income per ordinary share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r756"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate movements on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Personnel related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit related to stock compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Cash tax benefit related to stock options exercised"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Workforce reductions"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r82",
      "r83",
      "r84",
      "r140",
      "r141",
      "r142",
      "r145",
      "r154",
      "r156",
      "r174",
      "r263",
      "r408",
      "r413",
      "r599",
      "r600",
      "r601",
      "r644",
      "r645",
      "r723",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r764",
      "r915",
      "r916",
      "r917",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Equity method investment, aggregate cost"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r41",
      "r199",
      "r255"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments (Note 3c)",
        "verboseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r736"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "verboseLabel": "Carrying value of long-term investments in equity"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Increase in fair value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r726",
      "r727",
      "r728",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r370",
      "r383",
      "r384",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r532",
      "r727",
      "r808",
      "r809",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r726",
      "r727",
      "r729",
      "r730",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r370",
      "r482",
      "r484",
      "r489",
      "r532",
      "r727",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r370",
      "r383",
      "r384",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r532",
      "r808",
      "r809",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r726",
      "r727",
      "r729",
      "r730",
      "r731",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair value, nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r735",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Disclosure of Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r244",
      "r245",
      "r251",
      "r252",
      "r253",
      "r267",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r378",
      "r406",
      "r714",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instruments [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r296",
      "r298",
      "r301",
      "r305",
      "r840",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": {
     "auth_ref": [
      "r726"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets, Fair Value Disclosure",
        "terseLabel": "Identifiable intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r301",
      "r844"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Total cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r296",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r301",
      "r840"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets (Note 5)",
        "totalLabel": "Net book value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Country"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency [Abstract]",
        "terseLabel": "Foreign Currency [Abstract]"
       }
      }
     },
     "localname": "ForeignCurrencyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r750",
      "r752",
      "r753",
      "r755"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Amounts (credited)/charged"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r120",
      "r753",
      "r755"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedTerseLabel": "Unrealized foreign exchange (gain)/loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currencies and Translation of Subsidiaries"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r540",
      "r542",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan [member]"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r311"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Office furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Office furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "terseLabel": "Realized gain on sale of short term investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r119",
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r180",
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r284",
      "r286",
      "r801",
      "r858"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Closing goodwill",
        "periodStartLabel": "Opening goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill (Note 4)"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails",
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Current year acquisitions (note 6)"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillFairValueDisclosure": {
     "auth_ref": [
      "r726"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Fair Value Disclosure",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange movement"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r119",
      "r285",
      "r288",
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r290",
      "r657"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Prior period acquisition"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r119",
      "r309",
      "r314"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Fixed asset impairment"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r308",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r198",
      "r203",
      "r207",
      "r210",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income tax expense"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r86",
      "r119",
      "r196",
      "r255",
      "r871",
      "r901"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Loss on equity method investments",
        "terseLabel": "Share of equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r84",
      "r95"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax",
        "totalLabel": "Income before income tax expense"
       }
      }
     },
     "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r315",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r616",
      "r627",
      "r634",
      "r646",
      "r651",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity.",
        "label": "Income Tax Effects Allocated Directly to Equity",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeTaxEffectsAllocatedDirectlyToEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r155",
      "r156",
      "r197",
      "r614",
      "r647",
      "r652",
      "r908"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense (Note 14)",
        "totalLabel": "Income tax expense allocated to continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Income tax expense:"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r81",
      "r610",
      "r611",
      "r627",
      "r628",
      "r633",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Movement in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r609",
      "r615"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Effects of change in tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign and other income taxed at higher rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "terseLabel": "Impact of stock compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedLabel": "Research &amp; development tax incentives"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes (net of refunds)"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r57",
      "r868",
      "r900"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable (Note 14)"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivableNoncurrent": {
     "auth_ref": [
      "r22",
      "r888"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Noncurrent",
        "terseLabel": "Non-current income taxes receivable (Note 14)"
       }
      }
     },
     "localname": "IncomeTaxesReceivableNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "negatedLabel": "Unbilled revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r118",
      "r836"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other net assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r85",
      "r194",
      "r767",
      "r770",
      "r877"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense (Note 24)",
        "terseLabel": "Total financing costs"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r100",
      "r375",
      "r382",
      "r385",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense on drawn facilities"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r112",
      "r115",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r63",
      "r482",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal NOL's"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r59",
      "r801"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Carrying value of inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r18",
      "r60",
      "r128",
      "r173",
      "r281",
      "r282",
      "r283",
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r99",
      "r193"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r257",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment in Debt, Equity and Other"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r250",
      "r857",
      "r883",
      "r928",
      "r962"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r12",
      "r43"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r785",
      "r787"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Net operating lease costs",
        "verboseLabel": "Net operating lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r13",
      "r311"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lease imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Non-cancelable operating leases for facilities expiration period"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r48",
      "r132",
      "r205",
      "r258",
      "r348",
      "r349",
      "r350",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r692",
      "r697",
      "r698",
      "r741",
      "r799",
      "r800"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total\u00a0Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r37",
      "r132",
      "r258",
      "r741",
      "r801",
      "r865",
      "r895"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r51",
      "r132",
      "r258",
      "r348",
      "r349",
      "r350",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r692",
      "r697",
      "r698",
      "r741",
      "r799",
      "r800",
      "r801"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Other Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r25",
      "r864",
      "r887"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r23",
      "r860"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Current bank credit lines and loan facilities (Note 24)"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions": {
     "auth_ref": [
      "r793",
      "r870"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the amount of new advances made to related parties in the form of loan and lease receivables.",
        "label": "Loans and Leases Receivable, Related Parties, Additions",
        "terseLabel": "Loan granted tp related party"
       }
      }
     },
     "localname": "LoansAndLeasesReceivableRelatedPartiesAdditions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Distribution of Long-lived Assets, Net, by Geographical Area"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r25",
      "r369",
      "r381",
      "r383",
      "r384",
      "r864",
      "r892"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term debt at fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r138",
      "r345",
      "r373"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r138",
      "r345",
      "r373"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r138",
      "r345",
      "r373"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r138",
      "r345",
      "r373"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "totalLabel": "Total long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Non-current bank credit lines and loan facilities"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/Noncurrentbankcreditlinesandloanfacilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r53",
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit, Noncurrent",
        "verboseLabel": "Non-current bank credit lines and loan facilities (Note 24)"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r53",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r13",
      "r311"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r175",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Description of business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/Descriptionofbusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r114",
      "r116",
      "r120"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r76",
      "r78",
      "r84",
      "r87",
      "r120",
      "r132",
      "r144",
      "r149",
      "r150",
      "r151",
      "r152",
      "r155",
      "r156",
      "r162",
      "r198",
      "r203",
      "r207",
      "r210",
      "r213",
      "r258",
      "r348",
      "r349",
      "r350",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r725",
      "r741",
      "r872",
      "r902"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income attributable to the Group",
        "verboseLabel": "Net income attributable to the Group"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Net income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r158",
      "r159",
      "r163",
      "r166",
      "r198",
      "r203",
      "r207",
      "r210",
      "r213"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income attributable to the Group (including NCI redemption adjustment)"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r151",
      "r157",
      "r170",
      "r232",
      "r233",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r347",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r642",
      "r643",
      "r644",
      "r645",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r789",
      "r841",
      "r842",
      "r843",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/SignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NontradeReceivablesCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Nontrade Receivables, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "NontradeReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which company operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r198",
      "r203",
      "r207",
      "r210",
      "r213"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income from operations",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r779",
      "r787"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r773"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Impairment of long lived assets"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r775"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r775"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities (note 23)",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r775"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current operating lease liabilities (Note 23)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease liability.",
        "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r774"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating right-of-use assets (Note 23)"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Reduction in carrying value of operating right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r784",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (in percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r783",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "U.S. federal net operating loss carry forwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrderOrProductionBacklogMember": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.",
        "label": "Order or Production Backlog [Member]",
        "terseLabel": "Order backlog"
       }
      }
     },
     "localname": "OrderOrProductionBacklogMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r49"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r67",
      "r70",
      "r501"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Actuarial gain/(loss) on defined benefit pension plan",
        "verboseLabel": "Actuarial gain (loss) on defined benefit pension plan"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r64",
      "r71",
      "r751",
      "r754",
      "r763"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "terseLabel": "Currency impact on long term funding"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r65",
      "r70"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Loss on interest rate hedge",
        "verboseLabel": "Settlement of interest rate hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r70",
      "r74"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedLabel": "Amortization of interest rate hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 7.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax",
        "verboseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r70",
      "r74",
      "r75",
      "r501"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Actuarial gain \u2013 plan assets"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": {
     "auth_ref": [
      "r70",
      "r74",
      "r75",
      "r501"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included.",
        "label": "Other Comprehensive Income (Loss) [Member]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r66",
      "r70"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 6.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "verboseLabel": "Unrealized capital (loss)/gain - investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r49",
      "r801"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities (Note 8)",
        "totalLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Non-current other liabilities (Note 9)",
        "totalLabel": "Non-current other liabilities (Note 9)"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other liabilities.",
        "label": "Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLongTermInvestments": {
     "auth_ref": [
      "r41",
      "r898"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term investments classified as other.",
        "label": "Other Long-term Investments",
        "terseLabel": "Investments in equity-long term (Note 3b)"
       }
      }
     },
     "localname": "OtherLongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Non-Current Other Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r49",
      "r342"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "General trade and overhead liabilities"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r26",
      "r863",
      "r891"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NonCurrentOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r111",
      "r117"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Settlement of interest rate hedge"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtRestructuringCosts": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.",
        "label": "Payments of Debt Restructuring Costs",
        "terseLabel": "Payments of Debt Restructuring Costs"
       }
      }
     },
     "localname": "PaymentsOfDebtRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedTerseLabel": "Financing costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Share issue costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r101",
      "r103",
      "r235"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Purchase of available for sale investments",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r104",
      "r679"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Purchase of subsidiary undertakings (net of cash acquired)",
        "terseLabel": "Fair value of cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Investment in equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLongtermInvestments": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.",
        "label": "Payments to Acquire Long-term Investments",
        "negatedLabel": "Purchase of investments in equity - long term",
        "terseLabel": "Purchase of investments in equity - long term"
       }
      }
     },
     "localname": "PaymentsToAcquireLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r103",
      "r792"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-term Loans to Related Parties",
        "negatedTerseLabel": "Loan to equity method investment"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Purchase of noncontrolling interest"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r481",
      "r483",
      "r489",
      "r508",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r532",
      "r534",
      "r537",
      "r539",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r516",
      "r535",
      "r536",
      "r539",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension Costs"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r509",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r561",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r38",
      "r39"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepayments and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r108",
      "r131"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Drawdown of credit lines and facilities"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r101",
      "r102",
      "r235"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "negatedLabel": "Sales and maturities",
        "terseLabel": "Sale of available for sale investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r107",
      "r594"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from the exercise of equity compensation",
        "verboseLabel": "Total proceeds from exercise of stock options by employees"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r76",
      "r78",
      "r84",
      "r113",
      "r132",
      "r144",
      "r155",
      "r156",
      "r198",
      "r203",
      "r207",
      "r210",
      "r213",
      "r258",
      "r348",
      "r349",
      "r350",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r688",
      "r694",
      "r695",
      "r699",
      "r700",
      "r725",
      "r741",
      "r878"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net Income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r44",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r317",
      "r932",
      "r933",
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r43",
      "r311"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r20",
      "r21",
      "r313",
      "r801",
      "r884",
      "r896"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment (net)",
        "verboseLabel": "Property, plant and equipment, net (Note 7)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r42",
      "r313",
      "r932",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r20",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r20",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r226",
      "r229",
      "r230",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable, Net and Unbilled Revenue"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r509",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r509",
      "r792",
      "r793",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r792"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses incurred from related party transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.",
        "label": "Related Party Transaction, Rate",
        "terseLabel": "Related party, loan interest rate"
       }
      }
     },
     "localname": "RelatedPartyTransactionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r509",
      "r792",
      "r796",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r790",
      "r791",
      "r793",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r110",
      "r131"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayment of credit lines and facilities"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "terseLabel": "Repayments of senior debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r319",
      "r321",
      "r324",
      "r334",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/Restructuringcharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r119",
      "r318",
      "r328",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Additional provision in the year"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r320",
      "r321",
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring charges",
        "verboseLabel": "Restructuring (Note 15)"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r321",
      "r329"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending provision",
        "periodStartLabel": "Opening provision",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r33",
      "r413",
      "r602",
      "r801",
      "r894",
      "r919",
      "r924"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r140",
      "r141",
      "r142",
      "r145",
      "r154",
      "r156",
      "r263",
      "r599",
      "r600",
      "r601",
      "r644",
      "r645",
      "r723",
      "r915",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r505",
      "r506",
      "r507",
      "r509",
      "r512",
      "r517",
      "r518",
      "r519",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r505",
      "r506",
      "r507",
      "r509",
      "r512",
      "r517",
      "r518",
      "r519",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r505",
      "r506",
      "r507",
      "r509",
      "r512",
      "r518",
      "r519",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r540",
      "r542",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r505",
      "r506",
      "r507",
      "r509",
      "r512",
      "r518",
      "r519",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r540",
      "r542",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r191",
      "r192",
      "r202",
      "r208",
      "r209",
      "r215",
      "r216",
      "r221",
      "r441",
      "r443",
      "r839"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r431",
      "r432",
      "r446",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Disaggregation of Revenue",
        "verboseLabel": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities",
      "http://www.iconplc.com/role/DisaggregationofRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Distribution of Net Revenue by Geographical Area"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r94",
      "r351",
      "r353",
      "r354",
      "r358",
      "r359",
      "r360",
      "r927"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue earned from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue, remaining performance obligation (in percent)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving loan facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r782",
      "r787"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r181",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Net Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r73",
      "r762",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Plan Asset Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Summary of Assumptions Used in Calculating Pension Benefit Obligations"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Cost and Fair Value of Investments"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r240",
      "r243",
      "r246",
      "r247",
      "r248",
      "r249",
      "r879",
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r518",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Underlying Asset Split of Fund"
       }
      }
     },
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativeMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationMedPassGroupAcquisitionDetails",
      "http://www.iconplc.com/role/BusinesscombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Disclosure of Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Summary of Components of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r53",
      "r138",
      "r383",
      "r385",
      "r409",
      "r410",
      "r411",
      "r412",
      "r768",
      "r769",
      "r772",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r516",
      "r517",
      "r520",
      "r521",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Annual Benefit Payments which Reflect Expected Future Service"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r296",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r291",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r304",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of Non Vested Shares Outstanding"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r44",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r794",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r331",
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r325",
      "r326",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r321",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r198",
      "r200",
      "r206",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r561",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of Information Concerning Outstanding and Exercisable Share Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r568",
      "r579",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions for Company's Share Option Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted Average Fair Values and Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Future Intangible Asset Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Senior Secured Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r187",
      "r189",
      "r190",
      "r198",
      "r201",
      "r207",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r220",
      "r221",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment and Geographical Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorSubordinatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A senior subordinated note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior subordinated debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors. However  senior subordinated notes are junior to Senior Notes and Senior bond holders.",
        "label": "Senior Subordinated Notes [Member]",
        "terseLabel": "Senior Secured Notes"
       }
      }
     },
     "localname": "SeniorSubordinatedNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Total compensation costs",
        "verboseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Shares vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at ending of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Outstanding number of shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at end of period (USD per share)",
        "periodStartLabel": "Outstanding at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Shares vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of stock units vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Assumptions:"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional number of ordinary shares which have been reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Ordinary shares which have been reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Stock units to be granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled/expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average fair value (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r570",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options Granted Under Plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (USD per share)",
        "periodStartLabel": "Beginning balance (USD per share)",
        "terseLabel": "Weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Vested and exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and exercisable at end of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Maximum number of award as percentage of shares outstanding (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r558",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Average exercise price of option per share (USD per share)",
        "verboseLabel": "Exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled/expired (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r561",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Minimum Range Exercise Price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Number of Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Number of Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Maximum Range Exercise Price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Shares expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r587",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average contractual term of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable - weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percentage of option price for fair value of ordinary share (in percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Life"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r126",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant accounting policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/Significantaccountingpolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r618"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Unrecognized tax benefit, potentially expire in 2021"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return for which the resultant tax benefit has not been recognized in the financial statements because it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State NOL's"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r56",
      "r82",
      "r83",
      "r84",
      "r140",
      "r141",
      "r142",
      "r145",
      "r154",
      "r156",
      "r174",
      "r263",
      "r408",
      "r413",
      "r599",
      "r600",
      "r601",
      "r644",
      "r645",
      "r723",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r764",
      "r915",
      "r916",
      "r917",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r174",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r29",
      "r30",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issue of shares associated with a business combination (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r29",
      "r30",
      "r408",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r408",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issue of restricted share units / performance share units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r29",
      "r30",
      "r408",
      "r413",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of share options (in shares)",
        "verboseLabel": "Options exercised by employees (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r56",
      "r408",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issue of shares associated with a business combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r413",
      "r560",
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issue of restricted share units / performance share units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r408",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of share options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Number of shares authorized to be repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r29",
      "r30",
      "r408",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedLabel": "Repurchase of ordinary shares (in shares)",
        "terseLabel": "Ordinary shares redeemed (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r29",
      "r30",
      "r408",
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedLabel": "Repurchase of ordinary shares",
        "terseLabel": "Ordinary shares redeemed, value"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r30",
      "r35",
      "r36",
      "r132",
      "r228",
      "r258",
      "r741",
      "r801"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r130",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r407",
      "r413",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Share Capital"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r781",
      "r787"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Income from sub-leases"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r765",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r765",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r765",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r765",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r802",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOfCommonParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to an entity under the control of the same parent as another entity (that is, a sister company).",
        "label": "Subsidiary of Common Parent [Member]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "SubsidiaryOfCommonParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r618",
      "r626",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "terseLabel": "Schedule of Expected Expiry Dates of NOL's"
       }
      }
     },
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carry forward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Exercise of call option on noncontrolling interest shares"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "negatedTerseLabel": "Noncontrolling interest adjustment to redemption amount"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names &amp; brands",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/BusinesscombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r244",
      "r245",
      "r251",
      "r252",
      "r253",
      "r378",
      "r406",
      "r714",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsAvailableForSaleShortTermInvestmentsbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r144",
      "r145",
      "r146",
      "r147",
      "r157",
      "r232",
      "r233",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r347",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r642",
      "r643",
      "r644",
      "r645",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r789",
      "r841",
      "r842",
      "r843",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/ImpactofNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r320",
      "r321",
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r608",
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits at end of year",
        "periodStartLabel": "Unrecognized tax benefits at start of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r621"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Decrease related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r623"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Total accrued interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest and penalties recognized as an expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Increase related to acquired tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r621"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increase related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r620"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Change in unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r624"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Lapse of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r625"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Total unrecognized tax benefits net of potential benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r176",
      "r177",
      "r178",
      "r179",
      "r183",
      "r184",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Net change in the total valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r780",
      "r787"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Costs related to variable lease payments"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentbankcreditlinesandloanfacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Motor vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/SignificantaccountingpoliciesEstimatedUsefulLivesofAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive share options outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r160",
      "r166"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of ordinary shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r158",
      "r166"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3,4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(b)(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(s)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123403335&loc=d3e9972-128506"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123403335&loc=d3e9979-128506"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55302-109406"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10(3))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.7(e))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5)(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r947": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r948": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r949": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.18)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r950": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r951": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r952": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r953": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r954": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r955": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r956": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r957": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r958": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r959": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r960": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r961": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r962": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r963": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r964": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>157
<FILENAME>0001060955-22-000005-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001060955-22-000005-xbrl.zip
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MQ[%[@%[#L-\JR-0AI*P_\F!]'BFL;^[4+K1CO"P5J &Y'#Q<B^_CE2A@E]#
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MG^-:']T_/.KW^.WPNNWCSP_[O:U1/[V]3<,G_<0,GY5"N21=!"M 11DAR"Q
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M^!SR\X[/F]/Z:BX'WD.MR"2/+DD PPXRZ6R]P.@(99%R7O&]VCB/H&9%P?E
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M11B4+;*:LX'B5&RE<CF +!BUBU"[%NM4$#04%LF@BFN1;IT)%*>C4>O4YKI
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MFX1N5C0V8 K!Z(+D%* VP7HGB(R+R08A%]58"VJWU<=.Q<M@**#S'K+2$0*
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MH7S@2Q3!TP5%)J9%3"RF5M2Y0,R(XAU:HPT);83,MDU.[_T&,OE(V<C:'3F
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M(H%5+@B1%&( 8@X(WX)^]C.5%!ISX;93B;?3ILZD4(U!!*_!!!V]-)4702D
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M@U=..N54#B#.>[K->! ]$^!-)S@V+E"VMH;#X'1=JK&P!RQ,2*A-:D//S5D
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MB]V],DW.%PJ]T:;\>#I\YBW !D&A$7E!DAC)X8J4J9(+X)E?,;\(18@7P:_
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M=2>K9(T?0"_'I:?J'+V27)W%!0E.O6Y<:952I185=B PE(=CE^)H6^OCP=/
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MD7<ZSQ6Y<IS=DT1>L"659V1BW_MD@D\MC^6'%>Y<<' B%9QCA"DS_HWWW?$
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MR-$[(9^#G1&6#8*W61*4&"J3%A84\: ;G!]]];Z:PK]Q8SHBO3:OC P(0C]
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M#/MM8.O4RNG\H>HM;+([XZ(I^-S,U$[9'#T*C[CP'% B*>/$U"0!-N6*.P3
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MJ@@V -M#?]>T_?SM/UZ]Z&'^Y1)RU;5''GZ55MM>ZFV+TUE2J?3? >X;"(P
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M)H15L&:RDQL?,OL-)\!^KY5,'ZN=TL;T2!?#5(]X8+]3#^XB8<\ %)1[])"
M&+?=]?>SJ09",MD%>QRFFM$F:=$3H 6^^KCQ6PN98L-D5$0WBRFZ5\2Y&9-1
M8YX:_Q)HYH;*D1)'MS0RR(V2:V#];T+7!!6L1W1/F&,PC[Q&ID1@KM)@@^!@
M8^?J,L.8K-VO]QF8WW'HO1/@G%-[Z=/W[TZ?Z72U%7Z2H''!(C=0Z'S!MD50
M5)QSK."L\YK(E%7C3FD43 7JCH2M'JLF$V0_(]['BI!':!.#5>SP&/FS&IQ
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M,'<\!:E5.&YA#Z^,>0I;?W]"J)@H:,ZQ_BWI),^TB:4/W.IYOQBNA87?Q=M
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M?_>@X;SQCYFWK6L#B+6\>87,-!XHF&![AD</#[.JIET"![I"L5)XL0DG]?S
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MS9:\X-@W_9M]RN5;A2]4&V".G*?S+'HZS_C%^RI:74:MU*-GS^['P3<YUHP
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M>&6ON2JJF;P\-8[==;^ B.7(UC?[V.:R "E3TK1AY:'A7.9G[+NG85M*YW=
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M;H._YC;X:DFAJHE2OPB?/%[.JI/&3KCCS60<_C0]""'=Z$$PS^?D'E:A%6M
MZS8A>)Q52%QK)GLLEU6="8D4PXK#W?\A>93C*<'PG5U>*O6M'O;XU\"71S^'
M_;8:[=WHO=D-WN)&.IIOW#P8_0YV6AT,E\1W/QN/9#S*:<'T$S@A48<YAYO@
M7@HOH14C^@Q\"K!1>A6:@8&&9[;E6ZS/&\8O^U"P4CTW2^",Z?'27_!'NXQB
MIQS4TTTMK:QL&D 0)$*!<#7*W8Z&Y=9>R\4PHHU=O@9=K'6#2GQ6=M%E QY-
M).YDB53=Z&^'MP]N21I\HCHO MGHM"%&4HJ"N28[OXTCXC,"$" 6\YV)Q>A%
M,'9K=.8!+B,JJBHJ\_WVS4";W'4-:^3(H@5+2+1C\7)45Z:7B%\?]NZR.YGV
M.@U^[\X ?M#\&O=MWPV^<^?6I>ZN'";GLDL8V77K@DAL,N=[6I4H:/FG*%,,
MKMEUL^KE;\5?EQ2N;W3Y ZC,FH -;PN7S;G$1Z=E"@+#<[H$,%.JR%?H^D'W
M"KM8/.L5K5<AI#,%4-XG"R''QF%*2-"6<TY9'HC<6.:7M'U+# ?Z2"WDS>(S
M(6V/68#>2^GFXFZ8E4@MAT@E16*%IAA*5541E2P+J5Y3U?WRI?<FBWA'S^"'
MK#X=(PK^X0,?V<%%D\T3YJB$K*,MC?% H4+*%TMK"8PYKYA%P+DK:89V=%("
MS+4*OEY8*,T:>>HU-%!6ZU,UGN%3[A._UFU][\]:ZF@Y^^^W0>9!A(&R!1;C
M?ZG)!#O W,+,Y50HJ>;2?5C%2"$F3]+E_2Z#]K_!^OG,5N*C)@S&1UB)S]VL
MTFZP#%>,P-+/7L$Y'@RV8MN #9;6QI8>8NVJ;WK2@E*?3QP;01M*-:7<2ABQ
M5Y)YY=$A"W9-%V9*<\EAF#8SF,98$" :I%N/HON4)_>Z50AFWF2-?9X+ZGBE
MHD4"?OG@*^L'INO#$)3!TSLK!RU7."6)U8PGK%L>_M@;Z]&HAD8+ W9^SBK"
M9F+=8-6L-K4A;9,,8<SW<:',Z_(EG4(U8Q?BRQ33T]*L4<R_A]N$;W5LQ#E$
MJTW8)DG4H5H(.DKU4WU2DGV]LDNZRS0'K[!9LV'>'LZ/8.RBUYD55P8<S6TG
M,V6I!_U+^<5Y"&D.Y"[$3RA* =XB"YVC1ZG.<ZP)EZ> ,'0Q!.'-!M -[!VR
M),V6*?XBC\P'U9PJ:FN)UQ[<?SY:A7V/XV:\,X@55R39F8]TY,88R'M2L_R%
M9J66%"E6QFCX(H03,SD6G3ME-9%P:F\JP4;FUC,5/!?-!+5T&1WO;\+)7 I6
M5G$L-I8=%&[#%[C"-1#J%_;M4<9IT;.<NRS7:(D(TP'XCEXXG@32+%>P1=B5
MX-[ 3G[(@/?-/88/ Z"+AZ'YSQ][23.%W#GG?N#@+H3?KHVFKFF8P!DZT!V0
M*?SWP/(:[6$0ZKK =K\YAH<G#BEUM*;B3\3O/EE.[8N04YZ%S=:&@"A?KRBE
M8,E&2YLMVB)>C?2S+]4Y?3S@(Z-])$N$Y'V>N-K#3=NLACK KTME6:GL[N=7
M*KNN6KQIU>*X7*U5)I:EBUOCD?IK0D(A+1I+\MA5."B9%-="?5^B%IB2N@A_
MHWRH,Q+NG-K>LFEO*\PJVB&(UR&E!L0.R9B<17,@RS42[:[QS*[C&S% U).Z
M[) P[9WW$OM*'CTS=A'T!7%L*&ZB7T"[&$9/?_V9@JI\$=.D/>9C_%H^J'X+
MCYA]_O#7AT=_C9[N\RO?[8+@?UH;0<2;[\HFH&OG2V@N&:>K_[ZMXSB]OPCB
M=3RBV2JUPH8BAY<S)-<YE!(M$:]9[*E=W<Y+N]YH[X;]"7UH&CTEKNV+@_03
M1=4B%AH\E'L+VR]7K$Q2),1J$IXJ^P%34]+M%,53"7!,.$#GX&H0+Y4R?1@(
M&-FSN(C! J]NZ)G8^1G12UJ0:C="^ZX\0.SZD?)4-!X<_7@WO[V'AR.-'88O
MHZ0?3<)WRC+K$+'P,<U#A#HG%%A*QSAMJ6II20M#A[:;Y5(&TC_1098LQ.4$
M8A F%/6TT4)+:7C-B>#E1G>__RII_>E@GC62RF8KLK7KAI&R5:.U0_<BRB*1
MCX%5;=I*JJ?!1:O)C#2Z=_A5BN8'[U:^##84XU#'B]]/N/"")5@I/]9S=B@0
MR-K,-&(23=+_+I8;;$>IL=_A#^0@ M)SZ_'41K_F$S+G>;0Y0<^AW.#>:*\K
MRP_;K33L,RR;L"CNC/9'B=*G>R_/=>E3&$UYL ]-7<T8,J?>[H0UO_GNN08_
MI=/L\W#K;*_<OOW:!YI?7/$HBXX.''7['3K]UQ?;!N77<O:T"-[9XZ5J<C/Q
MMG=#_PX(B'VEDLUJ$ @)R<*8]9I_[C][,AXY(FNQ]M5BL@GQ*NV_UNK"*C35
M@W3P\3CI7;'?JF0*;O0KQ1(6.6[$'GF^:0D7T>BZR\$FO^IM'J2NI0=5<;)L
M.E3_HH^00/$>6&NT0B:_U7OC! +IX:0MDB6I3QCTD[;H/75\OAA/3P1M!IOB
M2X:5(7->AMOA=>_T4;QC.5C.Y*CET[2S*M66((D^%>[4<+2'^"%#_PHT)8>A
M(%SXV]UO#[ZQH^S:<GQ\RY$"0G&&#[]_.V?XE_O.>A1B/[QGLOV3W\3MZ8+%
MN/_L-UB+1ZFW\?:M6W=<XUBDZT6V)RRWF5*C<5L\#HMIV51AQ?Y^?,0?_3P+
M _5B/'K:U.1;"]>7BH$9()_Z+]:2B]*TKT]$T3TS@IGX"1\$9=$+'(/M>G^S
M(OX++&<FVZP9J_W'_XH9-:FC'O!A6 H&U(SC^747BVO>U\VV?ZS^:U58_?'.
M+I G[ "[01]7&$R?NTO^]M$XCV6-YJMED.Q#WGX, 2=]'*/=V#GG]GG/&<N7
M HP J9< ]+IS[^!.]&L5BH&Y-DOO; =][',ZQ<A+U!)2$1JEM"WSHFH3&.YO
MMP_NV:4/1@^DL4@2'NK6[+@1B/[*];J6R[J+ZM@5"[0;\A:W_"TX#L+O%K[I
M?D<0(J()87A(0#LXU.$9QD9]H TKF8B]Z7=C0Z>]Z%RR8W/$Z.(GJ<PO+.GP
M>1C;7XO@HMWY"V9V[_>#?Q[<'/#77'TUL@9*"V/<JN->O!DUX=55J=;B9;P@
MT94P4T>G@VOS:-Z&QWF-+3_\+-G6OW?WX#!N_3T&C#.)B7LD7V%'8"W9$O>;
M[F;JV]VYE\E3$E[CR73=\)0+0[_M]PTZ>Z]CEM4@[K+*J>-L,!/3L\('5D&?
M[0YMVQ)=PS&@37)2+DW18*5A3K_7:("7+5\B4P/6,ARB*3V*<T(RIIMU.,^6
ML^V++Y%"(35R+8M*C3EB>_"L2;1P;@ $^J-V/CPD&K**G.QHI(;I&E]Z94Q=
MF$>!(EM]MG XX7,BE^UC1 V0L-,,%>TT"- [6S8R=+-R(:^=8:9W/ -6"?K-
MLUO:T=!8 \"W.L0X]/]V]T[*T[RN9L:;&LYKH_R^8N=[KVV8?TD]R,<QPM,N
MC:$(>CMT;NJ26@&_/@B7;E<'")M_?7#CYI!QE;CI]L'MY&R$[XI#N[ +C68I
M_-20."Q9URS-8)GPY[+;:N\<9O% >A6<=H3/I);/:AE3JL%BK>5!W%9->!SN
MP]C_O7U'.]_"=JQF\9Z#[Q2V<W'1\7Y: "]H\\+QHBE7-**'IUQN<.=JL=@L
MF_V8^NW?.KGY-8DJI<-=\4;A,=R=ASKUMT^0X32!&W_'*C#\AM9(+PVQUB.F
MIEO!ZO8=!QY)X)-EV-7J2RH)R[\WDDL5@)^,R2FH>*:GY:(BL'[O\3_NO^\4
MWB?)C/33I\&,%%E+0-IS5I7G?VE(/TONC03H^^CT0^,WYQ^ZZLPH?VC3*B)L
M$JS'VI]KJX@-%/E\N(G Z2,_I1LXS(,B7!)A5H)]TQ+9TO!XLQ*T5>3V%; F
M$S#*$ 1<O-&@[&N.=VM97'E.)F$9DTTCY!'IF!.$5+$]?1EW3<JV:3DWG2Z)
MZ,.C>\%%9(U\MEW'.0%+1(!SYK:)6#* +@.0,*1DD(Z'[>Y-]N7 L^Y]?O"L
M*[*M@@5,1::8O(O;(>.$6@1W]Z2,1X<HYE3"0"=4X&H++:M<T)21[>4UB&_&
M:CV#GXI<.5*(9=1P=SGGA*NTK'-X"9!X!S_]K 1%P>1"]ZLD71*A3T1)9Z=H
MCQ[I.>4?DG5I8T&JEH=;B@[?:U+Y1/\[ZTQR@^G/F'%JC@X#-Y_S3P.$5X-$
M4<*(9 F3O#%=VCOS3CR&!\BFQZ"#%DH,5.^F9M'.JB(8WZ^[T?'% CQR%[&+
M/GYU[X9]=@,DNC=ZW[QQ,S'/?Q@*VET,([=W,XS<'F(8N7/WUELRC'QW][49
M1CY+*X)V+3WHA*9R(NMP5R>%GK(\JD\;K*O)A9VE$D9J:[0YS?GJGVC=3:J[
M7JNP6@YNR%ZW<S!1*DVDA :%&AN4K3;,\=U_]L2U!>Z@^+I0C839)ORTWWD8
MM;[^%";IV#ZK3&#+A".=%#"C469"$)X:Z0+/PT:H>$,3C!ADV>-EO:,AUT;3
M[!84%B5V %^\0V,#??4ULAXU=2UT&)=93%D#X-O0K.CX4%E1++*# 96LVKI8
M:O5.&Q1BWGH]>E!.68D6[H<[RJTBWVA-"$0PN4)K>S ZVO4K*CHI4\+L53P*
M( :]>UN814VA\]Z=$25[6YZ>6C_$.Q.N5C(;<\FM@QL<-FK_SG>_/3C\:CRZ
M^\W!W:^XEK\YN/>5\?[8R6S5 =_(,/9EF&?8VN%'?Z!C:$Q16LFPASL P_8)
M0-B(-PFC,=I/M*S'Y4GTBWZ.G?1A[WI:[D\7YO89RJ=>FO]Z;F0ZQQIU7PG&
MRS^4Z%K%8PA3:I!1$IF?CNZ?J!\&_UGI<80W>RQ(X,^(^OJ/TN@#J"P:>_W)
M;0\'7=5\Y#AG"0*B=SR U:6O!3R]GQJL3339!#CC!U,2)2ZC2AS^IAP PAVK
M([<NB\6E:&@EU$BIB*V3_R"U$D?DA-4!NRV&I:\3M])]BPQBQ?Q)QN.T]_77
M\%INW'1-G2GT(2L4U7]J1ST#RJW9EY#I.Y*%I.DSSN!94Y^ANAK;LR,-4&K-
M)I%),7U1*[ *GEYU!D=L>@H(4IAD*5/8HIEL9B>EU.K#9%76QW-"_JPV[(;@
MI\XZZ=Q9R)?6I5U92K="$H!.<N*"V%10%U,E;::&(?)1X=C9T(/%8JGB$:OQ
M(;:R1>;S<+2)^^B46]:42@21WTQEQ9-("=>EY([.1!D*"XLV)#V!3ZW%Q5S,
MFE723.Q*/Y2LS"%>+5\X2C$;F1+\X]A&52S-5^U04(T!#\.+H,NW,<VKEZ62
M)5!JO A+9E)KTMLW760F@"\'F&KJN[KRF=0G2W$)I((6S0T9?/H=*OE@F59;
M6@3!SSR5 &,)53HAGU)8"$0%\@D4>F_VZ08+MJB9]/'@84H?SZ7%OOHW%C.5
MB7!VS8J5-LBEA'FG:K)KI=TGW6U8)HNJ$Z,NF22E5":H@XM2A+BQ?VL*UI-T
MILY,=9B;RCSF1J, X9SG:PDAR"YNW"NV8)Y=!EHW0Z3"AE%EE6&S6QTUUA.3
M@:,]$KK+F@KS=#/BM,@U6I?>GF92?#VKR5N$E1SF>YI0+[W=/#J2"CX2;!!*
M7T,-I(N8IL*PB(;DH3L?@6-\)RZKNGI1UBHYK2@(8 5:2CXT(KH+:[Q_TKBS
M(A^L@]$CP6(M3![9<A+7-8#;WURA&L '&3'E]>YRT,7$M3'@1 _&3+>F&'A#
M VK0 #A)<JXU8*P155 ,/%>H5\$Z/;E[5TJ2ET8V&);@J:=H3ZZ  +*K-D4?
M^4&A1;@K;UG_**,8K8FA@&,Y=ZZB0BJH<6-QYD+KG-H?JNR880%PWLS90OZD
M$3T!H9SL^X_=#@>RYS;^H@DMO=]YJ8C->=4*5))L_<-E5#D\-8!B7A5QTA(F
M%T4B:K@&6RD73 %+6AIV,;G0^2F1EN'E@O>-XT3U$O0B88P'/4E3D]_R2J08
M?##ZM6E=BX")2G76*NO.)#JY,5-814HHN90\Y:*:[:_1\+^;853)RL(0+I)W
MS)J,N<BR8_W#^G?CT>87R@K;W6AQ=::[[)BQ^8, *&]21/^;$0/>J-=\M4WN
MS2J=!@0A<J?SUJ')A O5\X1'I>!7I*</1O=-RL >1RF%)-;"H*E>F/F-.*95
M."QV-#LN\J3M#G@BJ_]SNP08B?;AV=KO$]C#9]W=31.'D?V$U3%.=-P2E2"-
M10K85,?2J@EK"EKU+9+$,:327 !_:Y,NPIAKAR@>CKE"B&7W#K]BOXU7=<;G
M;LVJ!R]@3?%F2;&GOKI<";-1FK2(H.[.W0M&GFI7C-V1/HK3(/?],=+=34KF
M8:"@PO#U/"E &S"TG$623RF>N-L%LP2USZM_,CPP8(DFT$T%3KL3Y02H.N4Q
MF)EN^9Q[()GA,+0%%*]EV/>JFZ.GBOI7[B?A-'M(2RHB3%7XTOVP2L(F?.!F
M5+\H=05?N0L_"+]XN)Q)&>&^%M*A5):. #SV7G5V4VO K @^WN96.UJMPFJ;
MA8_,)?E04M&[:L1W=M>([PS6B.^\K0K%!Z@1?RA)[.$E_8J5=]5W=,SZ%G'3
M:@?...F7">HB0@75_49;:$V&C4TF BF2?'@;*EX*5%"P@\@8)JC.4*M/QC;R
M1MOL@XF@O*_Y.+RGY'?:.XH1UJ:FUV=V<@34(Y!WII2_]V]4G<)J[0['(.HH
MG,*FE924L+U\3<;#SA?LA^F=J">I,\O/46)0)EJ7Q>OZ_;RNSE$.MX'E3#0X
MC2^M]@P(95F)@7[J%=[:7$K/J?R1EM,Q)E5;P(.CP\"WBZE/RI\?WKNE78F*
M7OTNE>1M@E0()?SA;:BY#K)'BA OK6I%&[2]TJOEO"V, :'TL!S)L0D"ATXJ
MK1$BS*XA8L'=4#& GLM1R).%_"PNQGUM1"?^1H 08M:4H@T-;>A#&4D:L1#Y
MN-&=6U]%'C6,UMJJHAU9JO1;8>O<#5_,I1) F\];G)\*M7-$8$B"E]/R)@[F
MU;.'CY?[_T#X<ASKO<6+:$<X'=UH5@6+H1K+<6PI]".1;$UV/:'$E!_"C-2%
MT"0E$5 -U/KPJ'D?4'4P^NDB26)(&>"21Q&0C&6B)YL66HKDU((C5JTDW*R&
MN.G)R*=I[ 'K.':FD6<V*4>9)KET#%6,TA6+DSD(4])_WW$8]"K,-X-7']FR
MYK$.[X;&9@PL&!* X0T^0)XO5].2;G/OG@?^L 5TVIR6K&/'DZ-*)>>UJ F5
M[6N<$K14^1!4VH(F6Y,\%[;[LP,)!TR5F0HK"F6YG!.16*2HINBE&L[6(9.=
M0*N48HUZ@;JK@-.JGED8#N[W<\#ZF%[3=!//V[!.XP!Y[O<" !I2?VWPMSG"
M:X7FI:,7P+).,W)R"&!)B9]F-10.8\\R45J-F.:Q8 EROV)KE^BWNM.F90D,
MU;I@NQ?E]C0L7?;!O(JUH]KQWNAU,>+VM]?%B#<[/79%,,.!RVO$(\_5 OB%
MK*!=X)*JM3H+SCV13+86@$M'H&C>,7;ID,6/G;XP5JES0"@*JY."."-N_V&F
MUKD@?*O6'81B+-3;VG]M;TO=)H%0I--"$O(E<T  %QMCSILA=ZZ&H_)XJ5!4
MOS1*Y2E5$:U>\0$\VSTR$#T;F3"+9^)8NY$Y^XDP/ HB;8D>!T-KA*AZJZ-N
M6I>K<(.,?NA)?;%85<40592Y\P?'!^/1_4U;P402\3 Z+I:;A7!#XO46<OC]
M7 +L'O;6_X23/KC>P2GGWX]7X7P4O,L_G^S_^O !_B@L46D["0"B/TKCP6-;
MVKYM+!SJW7"E>@J'JYP!M]Q=A,-],=J[_]OQS=24789U,J^+A8)@M_%P5S@Z
MC&!4+JLN$XK<$2ZFP%SYH46^)N9GU0R99:HT#:1!X[KS#K"U+YPTPLR@WM>V
MU35X)!H/B(6I<_T9KVW(JVY5T7KB<O[U3":O)[U#AS0QOT8%KR_)GDDC0B4&
M)TXT&UXVJ+[6N7.XL]4DPXU.JI,3-LAT':JY\R+.[=:L11SHNIG!X?U%9-*1
MGXC\'K\?.U4D%SZIO/V 0#L/8=>4PZ+B]H)ER7NF+#OT2:NE.Q>[4; =9^42
M.DRM-4C,JJEQ72Z-"!G76#;KI#BL+&K9.L<6,/%VK01;*[4!.5T.+LP#&'.$
M$HD52;K0">)PP04O$HA-+K[B>Y-3ME#T2NB^& =4JED/N4/8?RX.,AF,Z&=Y
MY\2U2DX*K0:!Z<I/PJ*$!V03)%=5N!V.P.!>A!.N7(,6YA'":>% 2BF^F(JF
M'P,\04N:9M2CC$20TSI+[20#Z$W)6GKSP./12+\S*JDP+Y4@7"(!"1[5]5[)
M-*4]TBP5Z-#O$<78ZVBP%TQP]#CD]!G+6%;#N11OW+.VC6:.V":F'5NIH"7G
M7V?Y#2E>J@L1U[6RCP67<YD)6R6$86<+914FM,QD!+(5XD5\PDY2Z3RXQU2X
M/1/P[6:M:RWJZ6UWHJY%Y("%7\2ND)=THHXQL$WNMN/PBH-/+]A2TTLD/FPC
M"X1_O:E$<<'%G)CG.>^H>?*V;4Z,=JVI<V(?=X"@6W95QRY5Q.T1MR(, 7C
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MOQ$R-QJ%0Z[7FQ_^;-;,GC 5%QT(A:4-5@X^$&)94D>=4)"ONK0=?ZF'C';
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M=KH&G4AO"$EM9+M;XNYAFH0QTYWAG)"P74XB5+M:H6I1_4RM'JDZ,V-#<+,
M8A!"Z!@>"J<!<:X3OA7-K@S:&;CF((!:O8R0AO 3I!:8)U0;\(O$W>E52*>S
M$-3L5+J,,]W3^,V;<@!;1I0QAF#"=HL/[A!!O%2)D';59]X'-)L5<Y:.U%T:
MK+FL9%P'+!&FAO,7R^:\+F<G/0D_OK#0$QM3GA8'!:%<EDAW17%AN:^N=>EH
M55A"&(9&X.\=$2Y+"[W%. /G8A>VM8%%%\DK\.Y><[I<A./US-+7Q51ZV3UQ
MCN6*U-NQ+55T_95,?Q>-()I.2!B@2I\7!]UGF+U\RXA3$S;*.6*Y8\\]4^WB
MGOGDA^0-3U,[/+$\CF)S[.BYXH!^5<8LK'$9-8?'Q6#)%U9U",*N^O'[#+M&
MXY$M>4#"#DR;OG-;GV*6W_[8N?J"L*%IHDX.TFD=3N S@J6-/4(8"M(ET^_C
MH=:6^,X MXXI+L-T9%&J%+4&I'P)1@S',R8_[^)WD(]>M"SP1D=SE0T(.[DJ
MVL)R05*#F.?9?H&,DQP$BA?:*Y>!>",9N>.17[@5BN\[AOK$H>!5HV%TO?"N
M.@"5F&,QC=WN.8Y-*),+-SFOGI(W.;4&CBK)B!,@*8K440QP[:2IA7@,L_ZB
MO$A:S#Y=7 S)5]K ZC$/42 @ZY3-KE)JZ[22(II/<]DKPF?4M_+,%"#8T/J!
M].0+U>168-:9B(]B !C#B<]U@ADT%( %;0\).%^.'F["J@T.XB_(%(R.%G V
MB_'HJ*N*_:?%-"H7'P>WZ]0^WYX<TW"*BL!D$_']E9P(>ZAM]*FMPA/&\;[@
M42C/A4#Q":*&/.AG>-B^X<GRLS%N,56)V?\I2\T=EU":N>J'!KS:I0!A''6L
M<089$\ML5,4,I6X7:=HXZ V:883,5^EK8BD'D=Z$YF96%2?+!NABU>_,M'C/
M3X7525A=8\M#RDF<D+NIL%T=CS.R,@GQ+>0T@\7PL$BACV_-4W@=@CGJEG%4
MPKFRC#)JO3<\#6-;___LO6M7&]>6-OI7:J3[W<'G",7@.(GM?O=X,1"'CB\T
MD'B?\^6,DFH)*BY5:=<%K/SZLYYY69>2L+&-#0CMT>W8(%6MRUQSS<LSGSD/
M&L[S3*%?8)0GC W6U-JB;H0&57;&SEK.K<NR0J4-DU=0,*YSKV.C\5=BCMQ@
MQZY)'&L& >82Q<\=V5@!(C:,IJMB1#4."2^NS:5MYVE?D%76MJ67+K5"L(4.
M:Y;/N+0 >'C>:AF0=!QA/DS2?M:MX<J00?)7E:/BCV)LAK@Q 7<GF+8"X2-R
MH0O#S?$D"-Z#\5$O5'4@.;1H)T\>Y,BT%XC"<M\^O^"TF"ZD)XGDWO(P#L>1
M,4W3OZK:!^ZI^>WR7(#0/S/.SVOSN.O"I$Z=Z[Y(I,3037$**X(?413#8T1Z
M_/9YJ60S%$*AB\R/R!<^4F+=F65!VY>."*!6_]XX\)+]VL43***1O+0VR>:)
MU5P1>3(U\77?.?(\VUCY8VW7N*\6VI\$=Q#LRHF+N*[Z1;1 OQGVH0Y-E'&1
MYG+TK,#:<THGUQG$A!8A7N!J1,&K.+<CA79_!Q4<HXJV*DQNO-:V40?V\5;[
MMTP?+S38U*I$#^7^>^N4%FK]XLM__#Y05(O]L;5P@8]F9<<@&:[=0:N&LWF3
MC_.4T=94!\=ZEG&'P9RAFPA@/F!UI0Z4VKG.<.7"D+!&,EBD <U",DT#7N<I
M8(%$8EQ3(BZM?4T2XGL2 I2 Y$F%&PPY/5HNK4,9\+TFEX2 0;3)J><WEA0$
MJ1#M3RW9"BG_879L<F38"UUR8:4*Y&WG,Z9]]>W"?'%;;9RQ0";NE!BO("GN
M4X'*T^(GKS%%4YY5@0^J[5PKSG6 MU:ZZ/2F'M3$#<3:1B'&Q.O+@=#&"7E=
M+@T1S'M7AAI@FE$EE'4"ZE^#8CX;%/-X%4 Q-^XNU)S!Y^@^3%Z/%$3@ ^%:
M[S<$9"O(FD]-RG!6MJ?[AJ*/]4D;XY29W=4&[L'_6!7BA=X?X'LA LWIJ51M
MQ7$5XN@3:F=I+ -G?NJ*':(!H_!&BQY4Z4:1*\HD0;VXMQ!NCAQU4.*EM2]@
MEJO*AS5<NRRQ&/SGJ0V ^Z#S4SQV@(::"S,UX>L6R*B=)@-TCVQ!%VW)HSHI
M#J?9);,[(53G.<]C]<VZ'0]E(C,.#JB"FI)C0I>LN@EVL@C%=)*GMQ*)4$DX
M':*6)*=&[94IP">9/7FHST9LCH^E;V+P+"&LBGP4-05EQ3_2/E71U^"RT<N$
M<L".)B5F!>X509P%TCYUPEVAP(PFE<6#96K&&6D^%<@..H<1)+KG&F,%*^!"
M?,)W*ZDJBC?\]"PZIA*#<&8)(94I<@!C S63_2:7=4=]+9V&<6TQ$!G.D5J,
M##I:>89+7:0U)76Y_(]Z<L[#4'Y=6>MDVKB">.M[B_JQNN,8-IP^&8O=:I,N
M2@-RY!S!"M*LA3L6<9?6 09I31>[FB,84*[EJCR8@^1H>\2=ZDT=L .#:4!B
M*AP2<9V0H+F4K+OBND@"KW&U#, I0K!*)J-8B\'Z4.%-B H;>@3TA0%=C%@M
MK,R#I&K05!Y2:L[28L*5.[P]=[+/Q>=[N0&ORQZ9RROOBQY]M$L+61[,]^-3
M%RZHY2ECZ#8GF)YYY[X7-TMW< _7(8OUJ:)B%'L5V2S^#/<UGOH1$FA:Z,(;
M*S]/L!.UW!JY5(@KG/#LVAKTPH)R\-2M5F3(8(6D5T'KJ8R)/D_=+$<4+)&I
M.VAF?+CAI:_O1#L2*62D9#6\W9)@2!O?[Q^_^/[!JA^J-YV]L:4I;+Z ;"XH
M,176AEB1<&S8EZ034,?NBF#TUI6SQ(%\DC(-)6NF^#S@E:;P J&5HX<Y%X*:
M9E*NPU4\$1'.:.[:-[B'YEQ9[YX]"(MK^/?P:L!T@_H\Q#%,"AH!.T^X291;
MU5 $'^F&&'P4\BM6%EI?TS'-JIC,I3W3K'0\&=<SU]7=( *#4VAH_IX^:7GV
M\(*8:LASH ^X!W.!8BVK;69$Z:#98&L7V*<(X19!D81:CR)Q$EZ2G!(K*UET
M(=>?B9NE%5L0( <$)))SR%'&=6>^P$L("QIJ'6PR=6,8P!6W:L4J[8RMVA/@
M-)HF'^UHF.]8*X?M@_^[L[;6]L/M+1Z-$,[D=7NF3AW4^,'NF]=>/;;BPM%F
MVWE8EPQ8^(M*\Z](/DOU<.1#M]8ZR3D]D9;9XG[P5-P+E=$K$@W[65@K5,A.
MJVGWS'Z*1,PMHC)W+0FRN<](<POD(\@49W8)$N: )Y&!=KZQ9)&BA+7N"IB'
M 1"2CP53X*<M;0#LJ_,<5J^\BOQN:QP3?1NCHN9:ZFQ:2CM)^\C[H#+', ,H
MJ"V+,1,UXQILX^P1<C&U)[-HE:9M:@>]"5HB"/J%0"(!!(30#)/OWER4H(CX
M/_3O[\A-@LRV1K6KO%0 "(W(&1.&45TF3JH57)9R/,4E7V4< Q< I\"$'?3,
M5+-":ER4,C>DK*8*&5(R((5V!(T>XS,07</Y80?[$<ZEO.V$^2209]:%A>:X
M_5J@PTB%&A##X1$A2TN;H"$I36G[&9*2S+UAKPJ[$0V#@.C9+O<:ZGOC$/+0
MR4CIE:()F\[>:KR*P39:GX(.<XYUSLS$077=2'0[*N^E$>,5VOX@R.24#U08
M?Y@5Q?,*U&>N=Z8J*WF>E2:TM""#D!2<8&;K"BW9.NXGJ 6F]@/;JU^SCT6C
MU90E\I.WJV.]URNR<O^\?2\I7I>"79=3O.ZHW<-YE7^DT]DS9P0\_8ICO*1F
MQRH-IG^K$86B3J?,6)E55R1N7N_YQ_9\-ZPWOYD])D0]&MM8ZWN]K]>TKX>^
M[N)F=E4*/X2C)_1_UGM\37M\H(VBGB;??(O?0@OW?=TA][]=_//^L6]39A9V
M(SJH!L8+1RE@S7$'<%QK,..@!=>&S&H<#$8H+#L?ZPU>*:M%.3]=K]NJIK0"
M\,)K@^::G9-3\DIN;K-G*44&$$O@)E8>A+LLDAU30JW%X-I4.]6^W=2I9_*S
M#!YQHP$R;G<P4K93"BAQWPH?8ON&F;0UO%#@A3_=:7BA^W(^/4V:>OR_O\O'
M1;V)J-?6]J.M_^_TI^%?L]/O4!!^V:_B'7_TR];L_3.F:MB4S5Q"TT)#X%_+
M'!__N#U[CP59U0 CXOK]D'Z8&73W.Z%9.!%9Q5'_6Y,^98(DF0T32-3);I51
MK'W?6J'(7.TRF$"+AW72"N3F;P\2QVI 20^DSES\C;EK>(TR-+(A?FO*.'%0
M'.4Y%0@;#+&-4 .P"G\UTUE1S8T6L5*=K=3C MS1-@Z@C:K2PG]>FL.!.!<%
M+M@9A;,KCBOBB-8>XY@S\3%1#/\V)*E&Z?@=BI'*;%/D>D+_>_95I9R\4%?#
MP=V@EP(B!GU$Q*YD,@4;X?_]_0-V7[>>J"B-:N:0<4>&Y4 2,X*6"3FLJ%!6
MZ+1(#LER[J96)5L3GXLV"(3L&H:-YP/'1!YR*]7V- '-0>5ZA%;K49>!%,.:
MD##@T". 65*DTIB2,IR?B69(4-ZS-*\]Z<SN66XFR4Z&/I-4QX$3^(9%G5>.
MH,<X95W9F"+9V-UY\V! *2U*)_E,,!>L]X;"^\2=& #SXZPT$F3P)^@-G$*R
M:@=CG:9P0K@H_E<SJCN<#H04!GYF4%OF%$?DVUM-%=E*$ HW=655E5S]+J?4
MOF]<V1^EJ9E8S[4CSYMW#;>G(0@DEBN8OJS>LNG=S'%+7E><$14@][+S- 2'
M1E5G!%GG[;*RHHV79L*#0Q50'W]83QX2;@HO_8,),]*T(5]X[F":^3CI9LS[
M)Z^[5/SNK_I<JAH(1L-]!@+</J&.A!I!0/Q>X;&=[8][T'-@X.CC>0L'VA7"
M<[839&?*R7G/D(^?UC/.<Y\ZT1AXE DG],@<8(+@SEX"XV16V3_G3F+LT SX
M!G1H<BXO48MI0KR&F\I&1>-VO,QC+Y;1(0?RN^@RYFH00OR@^$]TM'!<Z)QD
MSF,%K$QRF2"46C&0*F-2I@[4 BAE5\OR&*ZB0$$V$?4Q!$:;A/*BFIHO/\8W
MZ4D[ZZ;<'$NH,3*#Q(:PY2N$J?* I79AJ2X(JW&>-X2/5A8_?&X)UHG+6.P"
MF6AYSDU(P()J:R.%P?9+PH7E7L@\*L+TSUC8)CC1P28I-DKND_Y&71Z/_MS#
M?BW!CILY_Q^(@MS$@"X)CR@21\6W,:US-YQ*"E50<&-<,4NSWK:OL6UZ>0R2
M7"&9NH=!ZYJ^Y4P*G/J!:+L;+HV3G7Z&#ZUW]:9V-;BV8JO ]_>*MY,+@@1J
M?,60\8HD3;<>2^ZL-C%REIITZ5'H&5E07KTE=>X4^4/6#7J($ 79.^3TXFN3
MO(8I7)9H&X5G'+&M35PB#"W;>J)\D@(SZSUB^;>V'ZH?["HI4)]WCOH*<[$4
M&FB=GG3L>_0IS-QCW!YR9 5V>]--K7%"!&(<*^*^QJH$B"]5NQ9[<#K7YU[J
M.#'B'(]WK3ET@M1)+I=5%'X=&ON%&37HO.PZ:%!%GQ"8NF]*B.S5G+Y#_8X*
M=NAAMWI@2!SAT5X687<[_%P]E$LN+Q?K\I/F6J#0 O:6+$_-?NL\S0N"2,.X
M:MM9\_2''RXN+H;YN"IGQ7AH'_<#Q?9_,,WI#[?!_?FJ)_#$=\(K4%HV3F>F
M)SLA$9Q=\P*UA)PZT)HEEKC^1OE A_+(%Q5%=J)O(4*2SO(,;++G57&NGQ<P
M<' 7^JK*Z %-E6AC:RF!3UUI(04FJ4L=_<T:N5KTV7\*"K$[:"(PE7S*KE];
M^^IU-B?.YOQ\I[,YM^%L\WVX-6!$/<C=4E63BXJ3O$0<,ZEIT:#EO%>^,A>N
MJS$:>Z?"OIS/4N+$8OZ=DLB>7PN%F78_JIB[>^./UR]V'PP2:FF$&_+$H'F)
M=8+!RMGXVY487Y2*3;QR3 [=)0 %&421E(4#\PU%E4FFVMS:GW7=S;X.2\QM
M*U!^[LRTJ+:)&]UQV<;6LR5RMD1"CH/OAUUJ7E363%GA"U@;%#K*52DU&3!=
M7D[DW421+FF\?B$9QXN8^>K,.D"UR>BT%)42VU+C5ZOK$'EF'B.D]@9QM=#R
MJM @%$G935^I"-LQ,ME115CGHRX,<VX_?/3PDS8ZV3C>>]$\&+B:;3N,+O-U
M:I29=6]RH6OK/W'I)%WDJVRON=2UUB$._+J0;1T7G+I,M!K*5;EIUVN3?>6P
MI0TX(#@_G3-W" AV&FUCHT=8&6UH+1R?18)-TRRT/'. 1#$JP@;"@ ^+'K7I
MHO%!^.R8**RH.X(OYLU'3550DN8:F@KE*:?V>DVUN<:_58!M[+$M"L4MU[@+
M\"BZSJ/<+1K;:E1WU65>"_/BVFO&91!=>$0!R(W J[[<$G>>ZC8Z#M0>I>AY
MC -'!J=WEC!0U>GXG>-H<DSEY,Y&^Q)UCN<3A+>X>EZ?Y62%*K7E]%90$EK_
M@RA^>ZF<(.I!&A$]/D]++>'T?5%H9MJ 7CJ,H6&!>/-1\DEJ?/$V4+N69Q7X
M74[M=S9>_/;B@?73A4L"II:I3T$/#ZI3<&LKWY9ZZT'V99-\$9-%4WT3^OT1
M/L2#1DBYI_+CR\$?J/<<MW&C3XJUQ2M6C?YBZ@X?6+L&B=W:OEHR^%,.Y;6Y
MD#?K;>"4OH <X:P2$I))TIAV7]V+^+3T]BR(CP[(DZ=LN:]PQU/%G[A4&QYR
MCA/R<_EGBK3DV) +OD==*X*YZ"2(K)XP(111=&E+RI(/8E0'0; ^"S4BJ;V=
M-Q]&CLAIUK%='4AR%5A!E"2\D5#(S<LQ;(E84D\K[M=&QE/K&SG6=ALOR*(5
M'2D(X9'=(Z= %3451K:T=J"M@-=HY"80SQ=ZF%[(T64IB^=L<O/T<N5RE4Q!
MM+K?$%M.J_OUL>7+WGM)O@;AGW #"WMAH .9U40C@E0]7B_TM2ST-JTS=9.#
MGUDF[W(KR&G;6D_!&CS)QKNW9P]PFA:VX-'#]19<RQ:\MAKM;U-7B[K)_N-X
M;&W&9$L8 +8_NO0KJ/NUEH^<4==1%OWET+O*14@=MPLU]@$WT)38>,@ I^#+
M4DO_I(KX_M4/$59/E\JDMFN+/@4_G<)"Y(=84SDMT/*N-<KNXZQ@:[G;>Z)J
M9]8U:LG%X%N#[BS\\K"NVLJNHKWQ%6YUW )/76>NN12SL+NHE'Y.>++4>O#V
M2",/X!HH&1M15?6$C0;D(Q:[_.N3&F3DK>,V][))W+>K[^"624'-5BB*PVOB
MU24W;6EZ03L]LMB(;=K8P%W3;!"G[\X-Q$[-.D\^&/AC)/43:KM,C*Y0"O1?
M*\MC!/.V?AHFQ_)W9+UC8)M=J,R^?NQ</TWU<:?.N7JF@=E,4;[X4G GQPKY
M.=H@1[,*XU&!AYL9\'.A!:/O)TVE!(W0N$G#$#U^XEJFQ.R&[/M4>*Q+>.U%
M^.@+H\C<":XERF]'Y,YM?*J#\[N@9.-@VHA&'+9ZX9 &A42#$,,R92"ZZ5X9
MY@]_1F/?O<-D [$5$)(Q<I%7><^GEJUR@]?_0%$%/KA>S'W,Q K+'!UK.91"
M#9-,$S;7)-[QQC%Y:9< !)N7:69@\>$U.!ES')Y!P,H'C2@,+UB.9LS);3 '
M)[O#Y*4Y1;OTPZ,==](Q;Q$'P8"FR1Y]D;/:R2[_% [&)^G*.R\6KOZ>*(D=
M,KO61HP^:A6>/[G6_$$?)K^&;3F6?AV9E[-\HA[^HM=7"S*XI)B[Z#O'JKS$
ME[17(072 A78). !RS(B4Y0X0N_P*_Z/8VY"'\@:@VO0)8+AHU\+Y' ?B9R0
MZKPPD683E>6C# ($$5&-FU8-G.*DOK+@.EM0FZ(J.90XFH==".PIG8^I@=EY
M5734W,3M"!6036<:JK$VSA3109A@0J_+H#'W,''2L[R958WDS)BY5],$''YL
MPH(ALMCNW3DZZ;7((OG-M25-P6V%)7[!N3BK<]$$VD7F ""R \P:$0]IR,U%
M?JP!.=:FVK4)RKTN3$AMB:1G**;%/$I\6HULCQT'RY: ZL&6:-Z349*%1[Y&
MO9@ADD5O([O\6/A;:AV&(Z51&IXDY9R<F:+\H<0MBK^UCGNT%]:<$C&G1_W%
MYT';R>&DN&$);6N.!0>Y2,_6D)RG&!1%(2S5O1>+HMGS!'IT."7,BOW$>?A+
M@%XYL:A0#XW@4 163>A7G*$I&[GK.?7[O BRSL2 &SP"%(:$4'?8SFF5D:TF
M"H,I'!N^Q_I[0<'+">4%(!JQ0HRZNO<;Q6IN,0](;U-J=<"K[L30F0A>-5%5
M;X6LNY<4S:_PU :N955>-I!1?V=L:NOR-GFYOV>->WO,".O-_76G%4DK$^57
M=:@1PT1+T-6>E2)UT\6[*>]1Y)[<53L/IS/J,.ZU)%)*=E&KUOVZ8*X">HSS
M/P>@^)?6 )@JF2E-V"[)M97,JLX>P<TFY\/5SKKV=FG+-8).$'2_K!%TUX"V
MD*-B?0G@'NAJD<,]GE/#)3LV>[!;JW'_IEC(3.)%"FSFWI/O\VDW#=N>&)2W
M,I;!U=/15]AA9,YONP1%$=1O6D,,$ M<@@.J$.37-8YTW/GTG'(-TL929G9%
MSK%;%D_]1KPTGU#K<6@?-47QE;T\TK_%A=-N*G5535UJ6Y0T&P^R79+6H< <
M.ENC S @V'CK)U,'K2Y/T"?LQY%S&Q@T"E.C93?*&6RLC_C4O<O;L;5A?D!'
MI=:84O<D\DP: 2W"LIW8D_CIM$[KO<%9*5*RO0AE$A\!#^A3"Y1J2M*\3O[=
MI8+(L4H-%AXQFDN-KE6'[7R]&Y^S&PZYZ]QF6M1S4V:P17E?+HQ8]]+BZ6)I
MX.L32M:N9IS%;$5;#S]^"=U$N D 6*D>$>016>-LR%O?*S.*$Q&PRK%\P!'S
M""&/YEOX:A;>^P L3=PV\X7N#O%6H-?#8H\'9<8?M^IW,G2!%5NO)CSTK1VN
M02K@/ZO;UK>'2-+F[#JNA'W'E;#JR:-E-933E+&*4@AU[A&"I?8T<'A>HEF7
M(\]]<03QK<$>+OC#?(VON!-&"@\B3ETS&K9@N=$4TUMH_M)308 ="T\DK]07
M,;I04AA0=. ;"N0)$9\\K'$M*48&?>@^C_#I&]T!GTB5?/MUX9M8&-R1BZA\
MXM@\VN]0YH*LM#4!\C7=Z8*#I0B4O5@XI<AH#A=SHWAMG="NC$Q[04A->PU9
M'U%[/Z3C%'G<]!OP"-R?O?&)/ZC>"U-,4LZ,2S.>_,,Z&:KX6U #7$G=W&S-
MV?$R*2?E?R49I[R_2/CE-LWM5[L[7H-2BTFG@7U7:;$GW;I<84'(_6IFL&FY
M1='[-@3YHZS,]TOS("=8C]RH[<N$],84QC>"ZBVKZ;G,0;.K+OD.Y?XDM(-=
MF4Y3%R=U3EL.8G1S:I(]L%64UUGI<+6%XW0PHJ(CB-99559"G;A\A%R1$LSP
M9-D,M0,\,=DYV$8C"7'ARE!IAZ$I+PM,S#MJ6H@T/OGYX?;- T>W,&WB/*/F
M]G%]Q.:K\>_&_NA(NU3^:@B=CGH#N\^O*NSN:]/5C-"A/M(;W[]ZO<<DHB0I
M>-ZK>H@.:.ARQD]D'EJKQ9FE;$J]T9@>TN[Z+L@YK?LZ2%Y:=90<V"V:&=HG
M^Q8N*B*E1)^+ZCEVK%P$/'6</?[ 3&@6K_<8RC!.ZWI.Y86N*Z?<VZY&?0H$
MOUU2JR9KQ\>%\GAD"^ %A8TE">Y5<U=2(LN4Y.>T*]I\6F5(;4K?23!$<>U,
MB=7<5(PT(=[2@CFDU(8H(;B^)Z;]?&94BY\;W]![DNR\//Y WFY]2#[ID 3=
ME]B)==K/KDW-Y3N';.[1KP](%NP^@I'(GH[44:1N?'^R>WB 0[+)A$;$M6N8
MT5"!0:EV6_(OQ'[3-UFNZ:_2D-%^"Q\1&3D>GU45<?3NJPTUN$19VT.73QO)
M94VK5HH-U?$.;%@:0AY.*@LGA;1]9+!Q+U'AYY$U<I ]?>99)>G[2Y_K9MXK
M&':L%((F2<[L!J(YKAN$EDYQ6H^C)DHRS$"_<3I+Q_*\20=P0.^I,@<& '@M
ME&9$YD4SV]XD$.WB:YV%1A$7@IA/7;$V1\&QM0*0H;A<TW:9(FE\DU\I]8X&
M1FX&GAO$":^_,/Y6&W6WKX_%@H;X;RNM%?H?4P&P1GS5!&_HE-K?%5EMOJU=
MQP6L7 :G;*)![U@<2^Z FD\-W8A\V^2^'4Z6SD/J_"4S=2?" YKMD5GV06E@
M:X_*O.J(P5@[V'(_W$7=TAI[$5.=M&$V^^8=4G?<=+LT6CC,76!).[C^XD27
MP9ES@ ^1&*P;?J #&S++IKUI,_RK &;;GTTPZ4<]G@?)\<G^*V8]AY:; 3G:
ML1BX<8&]BO"2"B"#@DA.J\J^J865D\KH::D((2]6<\\--G,[K/51O^&C#LT/
M&.*?@ ?8@;STA;@GTI4 0'6Z"#;^?'ER^&#P[=N689!XM_?=K/%<=SD9V<+;
M<MP2 ]^46/2ML)_SA,14)5H#^T\^;!6Q%/<(A8D-47'6,&GU3@W+2O[4IQ+I
M"ZY".I9U!5"^X+;ICN^52Z 5-$I%2K#11>7.<K#($+</$W_13:,!/:-<G=Q&
M6H_<.#_/T5$]*?*)T3H1=D <>3VQ-H,9/7D5_X)6DYM4PVHY YW>IAUJY ]
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M+2Z-]/XQ);5)P :L,K7<0P34M+QW:[M7:BS$V;K-FR63R*#,E_3/W.DF%]^
M4>DWAM;[YX?R<8GO@^,DJAL+R>)J8GI#<@M?P,'/FX9[E,'TM((@7"DS/%M:
MG9Q54X/J!O:[HI)+<J2=;EGPG@8^_*,WTV)'-SB^5 J5G[N*H-1*3$U1(*XR
M@]W6A$"7,62T'B0(IV4\L)WB;[ON4U.[!98O#I*T:_-FRH 6"MY.NP:U]+5[
M]C#YH^E0JB+Z@%;>#O0_MQ[2(<<\<";M<+:"!0^):^@.& B\SY>4%GE#KKQU
M0B>31/;8%=6P"LIA&9L.'YMPN?195>1P]U%DWG+I7U1YI0)!=7D52XV.E09J
M!PRR\4@0%@>+"ALXPE*!([7:6@!)P_:YX:V^I/4>?X$RE_%99348=ZYSA(;*
M&\AU4]=%&WBCI_H/ZK&FCLMN6I-!I;;"@'[J+VN6A=[R\_7MC[-/..OY]R$<
M5-)2.;V]V,MD KL"(5 ]N$Y19#7WN*GTNU,I;U PD<@3AB=V (U"90C!IP'8
MP<U\$#:^"6-H[^3(<?3%6B@7H-ZB6HNK9CZNN=G"U]GXY5C(D[10>*=D'E;X
M F-<1!LUKXRZ<N5A#'/(R+NWG!21#@?BM=OG68N+L.>37"I>?;B=HHLH[6A[
MU;+V<I@JD6E>9Q(7#,.<\LBQ*M63,^.BD2'S0VV(]I<J0KDN,I<"])9W-,CE
M1"$1M">SYS95A';I:_8Z920(:%W "BE9)+IHSRIH4JTC\HVLOX78W*Q+>F6Y
MN4$@]/5"2V_9P3T,%#Q0O!R/1*RC9L/]5G;>?6M\=B(4$IPTBO!-"O,^5UI9
M?8;BE;5QEPMG&J*IX8PMW5#/85<3T*4:A,^W)B4#NT!\FP=L3$#+".F2,;4C
M0V"?1QO-N-$A@KCI,A]3D^7B%%;2$8]U3N69R+G4@9N= \83(,DX^$IK,D9<
M.&^?LAOJ>G8@2"H]8N\<'_/E$73M,APV*PJ%C(UI:I[XSLS%PX&.[5:>V!Y)
MM" F'UQ@+O@3%W^QOTTI>+H%(3@,,H@"2@/@&%%WJ<P%(N%,XK-P?SG>*_=H
M;B:9][B:)8BO>;M[1:_DZDCRJ=@)BV?[*1<G46*'B0)X-^V"JEZRZTW&3!6$
M Y$21K,/9M'C+\;Q0:BSY@QMA[#^TC\"+3^H_P!TV0!T'!<.EA$HMYI=2/H%
M,!I>WY J\A?*F4'8TXJ*F?5+K "X.D^%QJZN?(K9T>L(&M%A-K ,ILV%8*TE
M8A'F<)VEXW>4JT[IK1(B<'$-(?! 2$J30C3.LJMIUBF-1N;?[V:MFU-531O6
M6HSFH>_K[PD77<#BM6<#;D5F1;Z!.2I]7>P9FABZ5[D!NQ039;@-M,$Z.$@6
M$U8+!>?X*.U3H I7.6;FE)Q>B0P!:K3&ZEU9710F.T6WV73F,$LLN%+;JLI-
MW)*0HIZ%FC.9 ^4,CHJ\0E: )7)UTN.QSZ7?^LQ:(HS0'>/#5A R,R$^.I9K
M:]/0,#GE4B$G$$;S^5NPMLY4RNF#@1<CZ5<26J&IB<[N_=.M)SXX'RQEJS9?
MFYX:CZ+A54K^LH)1FCE\S<N,#'>1$C]T/H6[VLJ:DSXC"AHXG2BB'I\)G)0K
M)@3 [\1TJ)@$I^D2]-8@./?NT8X6"GCJ1@W1ZCT<-H/NZCI'X)(<Y=HJ=VLT
MCS>U#DS'S4,1=<O7S-+YW3^!@5X1K^CEI>LB=76D<;PRJ/I?#6"2KN&W0H^T
MMXJ]RHIY0'0X;4Q!F4062<<?S__TX"8?Z)XU\S$"\$ F,Z%1FC=Z\ 'D-R43
M#^DSC+V=\ZJF,*Z1Q*.WUOS/2$="BE")S.1SP%AP"W"&BOR6UN> BC.77?**
M,!8# I^41*SJ(!C6#&EA\@V"!5NV6"FK=% _Z%<9: '?R\BOY;A9@XB@<+S*
MU0SSK\6MHJ#G+O>M\4Q[@V1/ZUBE\.[ %[,>4?P'7]Z/<JA[OA6J^\7].QAO
M'4XXPB2RH:7&#5%\$K4.>>!%(  ^E#=0QP&WJ3CZJ3 =NF*'O-SDAPJRT.I0
M.[O3^2;%K\N%/';>BGB[%]*B2'M61,3MB#A7ZS[:H =K5["=R>/ U"+[FRH?
MZ%[XK1M)ZB>X2>H@%,%-=*D6NW1O6'H/>._L\COAN17N=$921\CSY=>/8) %
MWRIG2,<M%\>8DCAYVPE! >D4Q59A:3J!/)UUH]":"*T2 1PL-2I<6UO0X:%!
M(-+(-) _2G?:>L5(04Z8'4:2G,!K73I=F+X21#4?/XGW!AWUX\-E4*2[AHY:
M#349,3YJ\F^'#N(<%" NJ&>8LSW@<@T"+6S9 RYI,HGX=5.[=_9\T;>0^X;3
MX0Q4;]AYPX 0H5+*Y$NL=AKBAK!'=,,:EP^2YW5N]8V:H(/D&,RY:6&/+/]F
MD+PIQZ1Z@^,\<.8"#-0#5S:ACQDF.Z[=;T$Q6&$O!_9CZ=$FIWG[67*XEQR?
M'!WL[1_K*@0<!D(R+1<Z%\0>,JVLO:5)G<C0 N3O?M-P9"*ZS>GM&R_W=_:H
M)2IT76W.3-E0;*&WK+3FB*YBFW[UK'%N'#KZJ:>*)EO*6O%VC@0'DF*67M^C
MB#>3/L,)=AT!YV'CIN$O\_*=R0X(WLQ7G;)H+O1$[ZP5-LVY)9C:53Y)O/43
MHP$HU[59D".*+LQ"2V2?4"7VUJB8JLCUAPU#%\Y/=E=84TW:BU0(O-NJ*JA;
M>M]1&41=Q_WU/I"*1PKPP*#C[9R"[Q,#O\D&T3>5)*/C'R4<)2CQSAC!8Q-.
M!368UI=P5*Y.GZQZ+.BMB;KRI2VABM*6>MK%J5TT4$;'"XJ@6B&DZ(Q1#9%H
M/W- <@2C0M]&.[!,\V&]*)_T[)3^4NK1$0-WS$\<[8GFOF#DSI0PG/Q[4!9/
MYF)CG5=!''1DK&O3+ 0WEU'SQ,P\ TFFMQ0F<RFOE#O-2RB, \:"\J*"!!<!
MK<I1Q2DN6EFOG'PT5'AJY>\^+;;R@<BWAEM'LF3946R.BQ1YNIG5>JF6:#@^
M" ?9#$E[^"YMC,9_[ ).$>!C[_OR@OJ8,>.1':_\Q.I.^N>Z?NB3"&-V(RN@
MYVE8S]&:8W-GG6FCBK/J0KWAB3%%8CV@3CU,1^MU<48)6"XFHX_1WUP#7KHH
M)8?#7_VK&@$P5Q3#Y%>K84;I^)TS+!HN2F6(/J[11OKQ2N_/BIHGE13I). )
M2-4'CN]6>WQ:PX;0,I>?T;6 73,?9U<T0$ :NYD]<:)&RE,T JHW&VNQ^RT.
M*Z55Z+Q0XN;BQ'?INUY(,(QKFEUYPGJ?O]4^'[?IG*O)SW-ST;BBN:DZ#(%9
M<'$V%[1"@V\)]L,>50)O7\ BF>)]]IJ1.C-T(<Z;=QQ$0?AGO;'?;&/?Y;--
MAA@*Y703ALQ:ZJ=&UD_*62>E?K+G-*\<+D.!L9\>3+Z3-A(A4LBDEF0_0_PD
MG< 7&%G'GM52FT%T=5E10WM7B&8MHQQ<,]H%Q860K3LZ;ZW:&R;_0TE>=B-#
M/Y/RLH6@[_5[XG&;]WD;'MFTI*Y\ACNDC*CN@>[JN9CNUI>?HAH?B W?)I"?
M8$IC_><T -/(?4QV,7=JD\E^B\V_60=6DR9DS6R.#&1@U25>D*WPS+V#Y:=O
MC<&J871:#(H)VZHO^(K:7(:38Z@.F,VLT\=XG3D#,CD:SX@5:?##H?LBB)ES
M=<$%<CED@1J@(CC)35&$, N'XC]JX28)S/ \B7/,=,7!\"^!&7Z3&DZ^(5W&
ME!Z<^UI,8<OU271RW[4LROE?HX[**TM9^C;1.%I;<5AW=C9O.)G#5+L#R<,6
MU:G/]<=TT1GL-.G\.@FD87@9BOA-T'1=S]!.T^2P&\8N9"O;W"S9Y\&2A9"6
MDWZ' T"!%J*VP:XZ&'[KS1A:8P$#1CWZE(?$%<EK8I!^LOJJ[C<ZBEP6DTY,
M.U]U/7<2% [[62^!CCI8*,ND4JQ9BXGPH HA9VH9M@:(.JIIE:::07)$@'/:
MY1D= 7*(Q4\7(G8.2Y_)1G16T6HAGOW]*6R)<JIL3K.Z:H6]04?.<3Q7"1T>
M)7;'*1VC3//^>:(Y606_H?J[7&I4?$/ 5"@^XU4BXW]PV9(,=)2:T@F4RL!E
MDXC:VW7;8%2:R].0@B"$2GE:202?GNA!OM3N=]6%=1EANT>CI-S61U58L,P.
M<JEH03R(J9*X6HC*G*TXZ'?!FT"MXZ"1%X5,K^Q!7]J@O/OGYC*IX!1- U,X
M:.Z,&HV,( ?V+7:6^:EK5:UVLS5T&U>[8.R1)+R,')BJW_<2CJ9,9&J]4T!P
M-(&8^=+-I:VW[WH5IS(!</B_<5!Y*K*= M)!P%Y*T-FEY*I@0SL7P?3"GHLJ
M##Y^(Q(1FFLF.,%4(=8OF'%,F#&>+WB^R(D*E]HW*,#5Z#Q4!Y>WM-9S#7H!
M:+(S,V-MB678U6'D!#=BU<I]*WN0 ET4#)VSF8UG]UJH:\U<EOPAC28)$N9"
M8O1]PZ](#O7))VGS#F6N8Y;UP(7#UYZK".[ZM=MXOOM >D$-DF-KOR6_P6XN
MK4_.Z/@R"_M+NI+W!K>,M>6TR:14QXZI%3LM7C4SI>^TV(2SGJ&ZJ!6 '!JW
MUWQ7T8N0IYK:HY5IY;VFBG?W=@?)V]_>\*"8<B.XK:Y?-]\?=,S6*J!C;M:N
M_;5J6D[^?SS9N.I6Q-Y'5X!;;P05P9(XUAH3NKK3HE-3L49DRRTLJ=H&E<.$
MU A*(/D6KXW#2&A4#$X9?4-\,@(.L<7B[(7%VJRPHXS2#(5Y=!-P@$A9T=A$
MO6"(N2TR4"2'C<">-6KS6CJ]^V\0#!E*NQ66.EG#<U;J7*UD3:KS7!8NF+^U
M;%(T?YUU0G4P099ZTA4!\E WPU?VG.?@RFMU]5VI360&<E@F#<; H;\X;$*)
M.XD19)J'I]*FQI1,^>.[X:"F)+02N99D["">[ >9PHRX\R^L<$<$1="F4Q#;
MU@-$B^P2D\2%(N0J6ZAQ>"HBI0#9$# R(!M&>XKQ9J!$-(<?A.IU7,]:+@\G
MO[IPL4Q *&BFS&Z"BS+RA>AW@7<76ZBN0=?J<T:A*KD!)5C>G)$!&"@*AS(7
MU/ESIRJ.A68,9@_3HS-8;NN)1KSM&G>S+!6#@NVD206>=/4(@T;< VU>5N<L
MCYIP($.#[%6JW6;4H>LHO]!*GFK*.GBYG6O8+G4Q?%RHYC!5%;5XA"\]/I3W
M%C2_KW>(*J:U3J'A*D8ZL1J )]I8_QH]#Z1ES-0>)9P=)^%]<(UPD7!\(<)!
M:PV=(OE25T'9$KV1Y%*7L;,A!H(:8\='[XN-^5!_M',6M6K/TJ#\A\IU0[C<
MV![1MIY+[LE?/+.JR+EL3$HA!P$\AS2,LUVI>/[>U2V<A+QH5(#?N'IXAJ.*
ML$3RC\A*!N"$O6B5DLR5W3),2SG./#NS?0B14F4.%1D*H.RYO0%.R1UJI+]!
MY7O+CXR_]X*:?]'O$N=RM*YTH>#,C/ # IVU=3?F\V#2J5*/2&]/5N^(5SN8
M&U4 !]QU<@!=9&K!\727_?)J! ZQ4R<%+,FIP2]F9_E]K)=Q[5FN= VDV7DU
M)CXQYQ'VX4>S:B9-)GE?R=(+< 3L,U(Z8R T%?PCI@Q4VETM"',A@U,R+1EI
MZ+&!UFT5?AKGM6L0X4H3VG$3LHIZ+BP,8!8F G]?-HVG?^9%.?"=#,.V=Y?P
M%O-M6K"YU_9:JWCZ*X)*-0$FA])%Q=SU821[1SXEYX@N.ONTC QB,6%+7*IK
MZ-X7O?<3J+]?OWG[?W#DOCF=]]/D-8>3((=O0HF# ?#6JL\2-@2I U<7+EX'
M\Z5I+%:XI*FNO*MK189Z)A>UY3SB(3"]PG@U3JV5)L,VH\-_A71M^ I38J-(
M8@T@^E9R>GRXL[M_ T(:=/ [Q T@'4]0VF@E:A\Z7\A%*M:,9HDWW+2&*Q*E
M^814 "89FR\NV>LQ#1)-QJ_R*L,!L'82<6!8RV:FQE19M5I\3WEV9[SV7DL@
M6*J&C KV\Z!"8BQG1JB5K6TR_B"IS%J^K[G;"FJW;E:^7[YX?O(__S<CO=+3
M3NLJ"D8_N&0H7=XE6+;(DF)1BTM[?4L?4*%2>V0-^5-HB1*&=I+N@)!SFQ)D
MK("'G+G("_[JXGX?J(I8R^/URN/>SMN;L E.R*QM%+&UXV@8Q%CPV*_ [(3_
MQA3'/6;*"87?$6ZQ>]H8(,68]HAM6+(?ED9A2(<N26B+L$/K@UD\1R6I853B
MOXGD6+-5'#5D9-BI-'JLY<=X%9+6Y9P2T:CVKX#:R%#_'G8+6TO[MY+V_>GH
MZ,;M"P3]:I4^CEU'80\D#3XBMQJK7^&8,8$5U2L(:IQ=I5BT-!KG[-]2%%+U
M!-%@X$PFZ+_)/6="3WL&LO!_=P2D<AQM*;.TH5+R'25_ZBR@0"-5Y-F,)R#M
MMS\Z3T&NGD<\G11B*NSIKYDJG<RUN" .^.Q&\B#(EZ-JNS:GQ+)>&T9=@T\\
M+= KB. 338"+H&G922QJ(,V30.@&!&'1A,DJ"Y F'1370\Z=5)TZYE"_Z4MX
MXPCB3OT"QF<#OGS(CO=A1$XA@F;<BB)B>DT$5$F1Q+.+DV?<(-)GKV #P:J'
M-%)G6&H\>Z$12^9%I3O,\P52Q!6E3D363%!C, VQ&Y'W2J"Y*,H/E?H.4+'Y
M8M!;HCE*PK9D5HYH,*H5.*N:L%" :(K#4O53OJQ=4<\">'H9-EH2"7@1!K&I
MY0 .;;/ZF;*=1BO8H3=. [;@*"$E2:I>7%Z^*0RB^*+JC@#[)AC3BOB[Y^$I
M.$UGKEA[(?[.#13"C[NB$B5M) (DKK&D[C\.BBJ@?$VNJU!0&MA1T$%-<FH.
M]2"<I%DV$-;'POJY24!])?AB_!$7"91!7T(.:E+GYON@]<@!8]*A(*#FG#NZ
M+%C328["48JB40+'N/^RGVVRG(&P8:\K3K$8R=@34@%[(7UOQ#26>H@BO6@B
M8!P!$9(:P^7=DA^80IML^.2Y\#V'O*8C=&C/VZ:?]:09D45%Q1IDKSMPJ@)'
M.1<UH"%RR^Q3T+,ARA_=D0&BH#'O\;P*W%RMY)6FU-R*<'!MAS26%#O@;G7%
M#.K<#)"]!$K9G(+>U_Y;NA6ZKVONB3Z,#C*G]!:ZL^:"O<-AMW['I@ 8D4.C
M;],R9!5=)FU%U.)]'EO&;C0=X:P%U>NK,VAZ-.]E51I6#D;X;S06TLT@PDUK
M:[A0$]]%SO&(?E4.)/5>I'8Y\=<30ETTXSI7WG%ZH)WK63[*6Z*G*'(!KYP"
M ,_/<KD?=,"I#>:G>/"&,#TURR5!YKGNO"NM0 (2$[^//#,_G6M7$(N.W"H]
MZ?Y@);?O'E;R$[;YIJJ".FL-R(VPZE?STCS76;  CCDLS:J9@^L1A4K>2BXV
MNFFI1QZWQ7TM-^B+3@A$O5MBG\/+?.3?0K!U=80$)R-VG%@#5&D_ ](['J,2
M:CF$N'@-87/,/JB=L9RN$F):9:9P.$L/T_'\;)4O[]NM,O)D]^V;QO1O=H_Q
M=?G(L2#IW&?E,P-G2%/K+Z$9F_,R2AP/O7;M<V&O1M.TEV[>"*; M?\$S@CS
M<[7/8@V!JBPS1@+A?YNZVN0+&3M%\YLGG/4$US\9/?;Z+5)/RL;OMK8M@NA<
M*--X#FSAQ.9Q-"98,I^,3\_3O*!YP-CS53(.9KA0:,8M&4?V4??%*J:--X0'
M G%\(T+Q"=O"Y43P26!U ;!J?UC,?7%R[>(W3MQ9SLIYKS-2>5X5YXQ<1)0A
MJ@_RAAWO)+Z.:#1@<1?<YRDO\VDW#0UYF%\BJJ'YWBRSW^\?Z"BH&+Y,7T !
M:;-/ALD<6L-P:MV"CK'>],4YN)/1HLNA!Y*-P^/=@P=A* B>QQ$71U'T/_KF
MJXCK3W4>45Y"!H?)<S-!0(4[[2S*D1YI<L)JN..U\>><TM3HT$5,:4QS-%<_
MVBL^%U/XV*)4M6^]6UV42 H:[$;!D8!S#H*Z,.>XRASXWG6G"%4KV_<<HX!K
MM!G0?2%;GEG7Z91)MDOVWJ06U"LROVCHR6X\](O]26W+Z83> _DX7,4I]WQL
MO[MI70%C7-<+NN^BMU&=DE7\I%HGY.49#<H0W+4D+CUR%*TN/=56:KOR"WN*
MR\W@X@:PD/L>T6$-^BWUNKUXMQA4G6[/=&!2?:Z8,,+&2:.2S^D7<S>+RLDH
M$+B&6^+5**ZT1_/[A@.K7+V0;*0!EQD"7%#XCWYZ(%;.A-(DZ+"'^PMVV2G%
ME*MA\LJ+;.,>)XJ#BF-PS.SQT3I9XN>0$G,C=A<A*2FSRGCTJ15,8JM9(.HX
MLS=50X6;U@"R"X:X-YN+TF&$S4'?69>!7?*B@OK;U68B7#0:E Z-5.B8A@UB
M,?0^Q724B#;]-LTRQ A%W8>K#6('&D#4#D6'X]2=%H)P,#TN!@G#6=B7]_*=
MS*0%@:TON#Q4JT("^\PW&HHX90G+CK00P&D#R0+07\^MC5MI]9+PZ:'G(SBP
M[B7(&"*V5#TX<I EU3W]4K2%Z#.;Y"(<&K0$>P(5A&C_"$7:XA /$T(\O$00
M+QP%OB7C.S'2G;HBL"\*P)!H3.?6B]A$(^.@BXE<$C,EDZ:&;X9G@Y5&NY_@
M<[[ZW,7&74!\]RPWDV0G@RE)1QFFS!M"\?#M\L*4IJ91=V5C/;:-W9TW#_B5
M]F]\3+V)XV-]TFQ(&:)E7<U[,^[H'0&7?=C$0R+T]'S]KMS<K*$FGEZ:"THB
M7Y0<IJ!%%)X8,TI+)VE28T2J+SAR[TX1)BZ3G)FK%=%$QJ"7/!MH@I$^Q8=1
M#8 !6R%1H4H*1=-P<R25 Y?D(MHZ2H_DP4/\MDD(/:B$A[2D:M6Q4,V\:(<]
M5'3AR,JY=YK E1L$YCV*T$A!;D)!SA43 /LN2@+'6C20<>-52[#^_^X@ KQS
M7O=;!3(&"[RK*U!,@1Q'Q[:&RK7-3EON:EM/+2Y@(E3*[&BVC<!%C*,B[&=%
M);.@I;"V;R&=@[$4B[W20&_$EQ_5F@U)63GF9FXY8J+)"68%TW9U+0L*TG5;
M,^3>LH'N22*(]\"XNKE(/8GO*H?24[84^?1>>JP[484@3 $QV3*M9$0L QHF
M@STP]]S\=B5]U9TT3 C8T\3"T0 <\;& =HO1<'*G^&?U?&(\.?!TU3Q:M,]X
M3\4#='82^M6.38DN#1I(\S&X^[?)05,,J2NFI@V&;\3CF4G?)7_,DD,*(@[B
M0TI,&UE5U1ICY*VV>J5(Q[);\+*-LX1>PGC9/;/:#(UQ3Q;?@),]10XMZ/O(
M!:2:X6L"E3"@(?B2*><JLTKRJ5:7PUO^TC2?1CB0Y8P #L8C2!M-.8JM,9VU
MP559P86O)RGUG&-/@70P?F%-M$+=]",C^##1;.YSWI!>JNH]."5M4SF<\J00
M;T"46* [MR?F$Y78W?3(=^Q5L#FJ47@Y%\.[KCO*9JQPD'GK<9#?(5\@T]+8
MR,5P>M/5F?;S][IT2[/N8[>6^/VD3CM)K:3!JO_ _PH^N['S?&?W06@<<LVA
M*9Q/47W,6QIZ !)L3F9T(E 7N9\A+9<]5_;LIDQT<.KJ:2C&$%E3XOC;$4JT
M _Y3,4FFQ!2\'%P25>PRPD38[3H%D82($UF30;!TK*J UQSG8(.BX/E"=Z _
MCH&&,0#2B03;E=#4V,[8=29(_O@=W8!HS_#C[8=;#Z^ME_C-BS/,9HH4'[])
M'OW\\.'64SO!GR2^+'X06<VYW64Z^[H8/LB='+-Q#=\8<1[/!#'P#AK^X?L_
M#02Y)D50TG\6__C82UQ'Q)E] GE=:&HO^Z6L;S0E<KA 2\+/4FI"=T9";GGQ
MNB3/&0ED_[!!)$-ABD+:H5>YW.MDH\G%TF$.%&N*JR^ ;3RZ>["-VZ,(: F?
M![=Y(.C*1YH&&0N*830ABKU'@>@*T.'EB4N)Y6'W->K7R*\+R(N83Z2FFIR2
M<UQ0&/-E+,ZQZS[W0]!7)!MQR%CBIU&^G"^O@<OQ5)HYYUM9'_5@,;D6WL>D
M$8;)VS-KK&O!D61S@LMP>3OMZ/-5293N0.X"]":4+N3C!]%Y,+-*O-N%(W$E
M$\=\ZWDIJPMKC%^VM11"X$(^"=.SB1"&3'R>SH-ZE?2"J3FN,9_&X\:5%.K6
ML)B6A: 6K+P 417B65TA^1N8$54]#_3\K<CE^058?1"\6(/N&K1F+AK3$F^+
MZA68M"Z23Q]HAM)MT7YCA[X1M*(&*E23[+V0EI1+N'AIT!+:A5C#MRV\)HJ0
MV"7B,*]:UO15QW.:<TJ;!SSH>X?H>$BLN=HA:Y",/G9"HZ"F%H"K)G8#(==Y
MS&5+<CY)4R!718.Y <_4%[YMBCA-Z'_/OK'+>A"4MAR;<5?G0G9]6.?GZ?@V
M$)5_M:7Z&&HJ(-%AMD)$.V:\+D&Y#B]>XQ9OD>0QBO2^8ZJTVG45#S*?KLA/
MDYO<.2;B^HZ)]/CB==?D,L[SP#WL<3E*J'W&--2IQI[<< +'-GXKN[-Z&6=5
M3U-WFD%VGCX9"0'C-4KVE!4BJJY:I,;%F*@*(+H2'8;/7A<Y])QP$;,G,YZ#
MO$UWQ#>6X5H=4ILZ&+J?R7V2Y#Z%M 1L[YB*VS/450BI6_QT?:!ZBRZ.-UF>
M]8L2?DKUS95NO.M6E9T9:[LPZ#%^F2LSRV/>:,HQ^D+N9:L0>'=!KA3Y0]*4
M#*M(7>7E*+56DR_" QU>ALB.>YYB$UBA\G <K)860C\9<,F[N/L"A1@QS2=+
M3AW-0C> .NDF1#H^/D,\UPJO,J^1W# B<6%!%Q8R[>SK'70J<).#II[G78$<
ML):KR\[Q..ITEF?%K2@DO1G]^";:>UHY)39?JA9]C@1V/H=0V,X_.'ZSC>@*
M[R+=ZI%XXH;&)R]R,EI*(B+PW>5=K\1=$I2@K7,4J!DFDFV D>*),74.4?5Q
M$UZ$JO!C>!Y-.+8SFB"B$P0XM*[5%>W$/(ST+E/,7<VC20Y.5"/=RI30S<F;
M>#%[4"2'OE>%)%+DGI/<C^RK9$#<94-*:,DM0Y4''@XO5[U[!<5:Q2Z^' H?
MNF?[G;5L?3=@A9/TQW[D+N=DX\7>X=$#1+:GAOE-'9F^/5LY-#0(*T,#A&<C
MB$_*W[]'GV!#!6QV*[D,%CDMP+2IYEB^-#+CE)A:Y9'<DX2O:]S51?X.W[&G
MD!PQ,Z_TPDV9=O]V8BEN4!<R1([KA"7,(A2'CB[;\1RF$[OMW#E9+CX?< [R
MV$QZH86<<8"'<0>G%-9 UX.:7+WE%FF@Q5R)BR?\)(AT=.O"/'/H)KW](N87
MW)D0HV7ON V]V&^+>W5L1V?WDW0*-)(]3+@>[JW50&*N5F+S@>HKM:(#D!W"
MDWXU'2 GA,OX1P@H[DH!11^>^W!H44.*S),B#<[B^)["F8*8VZ'?=FG+RA8Z
M/ G?0)U;SET$C\H;!W/Q7!-6F1B$XX#[XP%D/<-$[KUE5#^WY5#XJ^/F!7(_
MZFKD!$PJV%T&]:HQ8FDCFC.W_Z>%B[68I2=1E6\K=H5([MIBC'6-U-HTGUEL
MTS+]B^"X7+D,\Q&5@GQ'"ULR]$=I+6!7>#(9\X=/39;;"_[8YP"8IH2*<*2'
MIA3B1/E6(BAQ'*_0#1.0Z@ Z3RY4.D.,7'Q?0?)G1 D^D^:B-'CGWS31 (06
M01H]QHX,\T0$7\B,7;2,JR(88QE^WY1GL*/[BHCQ6%-J>,WT]:[R*/" X-PY
M7RCPI:XU@7)9VB0$2UQCEN3+DR172(EH.MZ*B;V/UKGN'W]<A5SW+<&]?8!A
MT-JT:2$&UBNBJ5G6V^DN9M[@Q4UU1CYH?!D-G^^*RTT/T4U(&88%%^108P'=
M7H0)"-LE!$W.0XY/9NP/M8.63D7EN=96R:N0A&Q*Y2#4D8':W%&ACF]+RN0*
MJ'_W+1X#/BT.(/O5"(GT*4]/H5::MS=(@[LKS+I3H")>*^$WTL72Y*1;K^!)
MU$Y=AZ%K1$*C6%/-4\J.V1D%K55[:K9'QA"N/Z=8,;NBDCH:-KJ!XJ5V.E,K
M5F-TFN+8#HUTI\G3Y# =(\XH*1?[DN?+7M!?P[2FGB!X_&BN%YO/&6C-<Z-(
M+&,_CWH;[5DKJ1[YGL,C]H6M ..[?LR.[=@Z\/:H4 W0!Q;"52BBJ('6GDK[
M)CU0"U#VN/W4["WF@\M%'$\&]5*95W4X4<G+L$&!HBAE3&O.&%P<A"*8L)!8
M %)BM]#N8\BKC0OJ;AF=%@&)YI3Y" X7^G.9>LG)4DX/?M8H;;CPL<X,%8,C
M-02\,W6 "1-[AAU3NVHPUA8*3F;6ON.:4:Y6D3I%*[LS.L-$F3@.TEMI]E>*
MPT5MVQ#[ALKZ"G"XF"AG.9?NM[Q?=I7U[)-0TS?>3&CWZ VVT(ZFYDNC3D\5
MW"G:4#R'*?$83*W.&B2E-9*-VV$I;2*H%9@?"PX%EAV:47'/V"SOIC2TS'^:
MQ84?:3_G/\YGWXXL,H$92>0P0_U[C*';C;T\C*C/O.;&\_U.0\A8H[])2XK!
M3<+*_:0J4.+2N_O\_81 99TZEDZ.AJ!'#5?WL+G-X8_WOJVMI/D8RB:=P2EI
MJ653R%D2?+56"DZZ9UB-\'71N"(K+(M TX1HSQ%18-66M3+B&A3Y.'K8U#DX
M\13Y=O _?Q[L#)+#G:/]?^V_'/09- ZINJ5-]H(G;WQ_>+CW_0-M<7M.VFRO
M[DZC3WFK?Y*\3$>[5<W&P?&\-':9N;T\(6@:]"1#C)8N))Y_G!M00T% P=EF
M"U>'K0F9'YPV)5'$1%T^W'V<URXXJ?QYZB$MO1V"')OU@K(\H]0,4B\9M\35
M0BY] L&3-"U\&Q*K7U5E8 7!OFC8=M*5EO)AEF0DKH %IW9B(CP 5H"3D?#4
M2%K)K4B0DC$:7W[@; RDG=>,3VQX^S!(*B>>5/M/>DV;-_(6>U)-><K?"F]J
M G#G8VV#!_[NAE/P,I%@>"FQP.!NU-Z=]!F!K%-[RHCFM\VEO=ZXLJ+7$("^
MZ1MEO5,J;=%*KL#,N>=JJO1A*FDYIPA5WVA!J2BPQ@\*#51EDP0X;_!)L3CH
MWU995>A"365:&L5U+)S:ZSV=JYKV% 8:\!-*!D=)X7F"\2A.LPA=<(]9)LSV
M!#%S*O[.9"=]\;<5#3)0?*TVZL3R5@TP:0WN^XE%E*0T#ME4GJLDMOG*X#0B
MB6@3M*$,/ B@^NP75Q_!&?"SNH9Z<KHGZ7E5VTV8*Q:2+R2N514D4%A0S%NE
M4)MQ.O-@E![?-I$AP2*.2&,%B<.QHVNKS/FFQJ!>""L18MC3%C,FF5N3)F%N
MOCTSIFZC;&0]VAI(-U<JXK&"@%:O]M-P BD4F";$_.SP-NRI-$/^_J>]X]'6
M\*?_I6Z=O+#AWG76LLS/]9T$@+=>TX2[#CB((-D]I75G2O_C@/R=;C:@)48=
M:0'J"VL%MDRV'BZ^-O-#YU@Q^VYDCP&-I\^WWA?U+F0J ^_W!R44VH69;3GE
MNHCM,0F?NG0ZC=(^\I<ACTW77QU.6LZ-QIAEZ:MOG$-#X:1)MGY.-JF?S.DI
M\/ZJZG7@W[S?AR.++!OK '!SXDD.%ST7VFC*OC0/1%97_2KXA+/XT)[%)\.M
M+SZ+X4%LKN\D)AM;VW9TNG&O-8#ASF1X@*[X;&2GY)@G:WF(Y6'KB96'GZ]!
M-Z.5\?4KYF0##KM3S.&3K)P\_E\.Y=S 0,XN^>3#X;:5J.2ZA6G5I8B6OJ)H
M #/41VY39L@+(^//Q0U83DKJQ$4+RNY+PXPF7E^,JPZ<Q]P"2,DN72H[M_?E
MF"BN> ^0UV3H@XL(W4DC\X^RL:-O")!\R( !BL.\<2GDE; ^84MUP51GP51]
MMER#E<HQ2&EM<'2)43&G/G-H(![:I!(4:*B1M#! J%V:[+27V)\,U,_"UWQ\
M@#2P_]QZ-'R4C,!D .BL-<J^BK7SB589&V6_6*-L1_(M",J8_#PE_%I78L#!
M6F[HQ GZ8.TBTIM=*2NK'ZMJ1]7 G)&<\O'?+G+G&#ZX_59?WT&NKB:7::-M
M!3/*HC1$'E(:1$LX")NBUA 1<S2ZL"X"2* K"H0+>D)5EC2FI?O,06PH_HB7
M%H7KC9$90'@][R#+N 1@'&O7QP?/^5?K)]E][H@:O:$ DSU%Z+->:F0%-)E,
M).KX>PF.C7)QQS-(R3N^\JZV;")':R:%ST>7/%XA=,DWN5.CPE*N9EF)2_0W
M)G+Q05K[MXZI@&'RYE.NY8D:QKD" -$7(2^F1%$CCF#2<Q1VG9&^ 2$J4D)!
ML%LJ!JPA#65 I=>D.Z@KI(L,V6-VQNW #*HD.=)15%U&:>U,*U[X5B5=K#%D
M4-JX>'B GD-&<DQ]IG("EU#Y.(6/7>,RA)2CB'(O%LU1<$I5\!+0%^PU4;>;
MW<R5FM)]XG_ON8IPZ^'WX2JZ<4F1(;>4E%?9'U,G#A^\EY ^*>8@JA0@\ *,
M[L;NT:L'@TB]1J^.*^I1V]'. S(V1OQ2HUX:G/^N<ELJUR7C0B!2")^'-,@<
MJ<JUR+*DSEIHDS+5,EY&4QC%0>IR2(FPG9[<Q1PJDT0<KK@QB*YK0>64)76\
M!GNF0$H]MC( /D9<[[>R#NC;<*K*>61N)G?FQXT'CP&]U6I+&"*/M$O(@.0X
M'W_P.^T59W*379Q1E"2.-OF@A@K%/T+("=DRZ.D5)X"#^#B<YPV4S-\N6 A%
M0X(9HF&7JYLE@U3$._B N2""#H$G&K9_[[(YOX$\A:FUP(@%3I):4=$<'E57
MZ Q,A7*[#').-O;W=A]XS>!QW(-D_]71#_N_'8&.>$2LKS2X07)B"J-_?VOM
M:2P2E >CU1)AUB$XU<!>4-/9664M2YD:YG P3:GT.UANGRJ$RUV>%B"A!=9G
M(K,,MNGR%9,-(RDB/!+7ASIMRPU1FN0(..OGM/VO'-5RLG'T_-4#[5R*TELX
M"YNDY"AA&FM"VDI<"9ZLF7ASK:*W!S_K:$UH0-R8EUK>:\M1%-2K!N/*=KKT
M8%PO<DOW;H9 T_"]XB,4N!^9TPQX/M3_@"(?F:OH$92CK<T(NC3KF,K2D3XW
MK;MN6242S@.:R_Y&IK'(F2#*^5;62'Q=C16C+NBD1M<YA&7PL3/NPSSN&RJK
MB@E8>B?+=@97JC!.;^R>O#IFGU?;F/92VBR\+%*!L-#>!PT6 'T)DMJ]L3G+
M@0P)[B(A.6]_IP_('R,4RR@FEKG\)%-U[]:SY)!=S?S\_.25NG5L(!HH7&N0
M$"@*2R%L7=5%H^&1P)0D)>+(5<.EX(=PK7AP+424#WN1Z4.Z]K*!'P1WU6_=
M2'@O]XX.=6Q=$U1V"-#"F7K.9%7Z8_&+!ZY,K8$2/T71NZ^X$09+OTT1[*"1
M\0="HAQH4BGMF#N#:C_F\H'CWM?@K@.Y7> #K:S/Z!T<R]PXV/OS'_^Q]?./
MSQXX%3_\^$=I%##':GN[L+6-<:);>M[B$H/NHXN-6GUZ$TX+SPF<(3!!*C 3
M@I'JU% ,G#FJ$2HOB!G8]XI6:1-D]P!]J&<(30T$0&O0V9,+U/2SCD&EQGTQ
MJW*K*:K)9I-2/6KP!3XRH/@B8IJ"6G0!V,._X&V? @4WLU</%RW?.S7Z*S#6
M=M5:QCB3.ND)K"O?#K'X9'IQBL/>?- $):,;J])X"MIE!N0P<>]4VX-\/;M/
M&%Z@"E3!5*I/^)JWUZ?<]V2@$#VOXH@4<M6:R+D)'-';6>3_]8U[N@:\;^T=
M:N,[=2_ZSH$EWE>13F<%/K7'YD5J_(1XDP&^SR.3DW(ZL-=Y>TD[BGF\S/XD
MK4A2VJ:3B7C^?.%HYQ!A">KJFKSTD#I "9&HX@PN#(P\,*['G9" T]>B.G$Q
M/20^7!^ZC;1-C[?W7^4@Q:PF]D#M3-._X8Z_J=,Q8N5[!O#HXYWC0?*G,>=6
M!^VE39-:Y\'^%!5(U+F01O'\S;^&($T!9K&T5D['-)EIUYY9B_=O3D8TL"]:
M?(RK8'Q[RMSU@Z*Z'ZY.*.#[.-":^DD>:M)['9]!Z%%I6^DW/"2?8BH\DA+W
M =_8^_Z=M=+:(V(DO@E Y4K?E!EBO""03P<U!4&WTG*1ULO.'TIE&"T7.\.J
MF+FWJ%9JQ_Y*V(!2HS++7D0GHO)<W$BDAV& ,-R"C(1K3+IX'%Q++#D7^F(M
METW[8PQGY)\F)!Z8'G<*<BWH'=>-SA'P>>:],HU45D5KY(-6CMF)0.58+[+.
M LII;:OC=XN6Q6F$R T-37\7[ K<_KU=MD#U2_2RMW:MSZHN"I M7;@0IBKV
MJ%71UHRQ^A>/=KC)>?)Z_U\G[(T<6B5N'Z6O%!!N9/Z"HL6NHS%BM,$TE.BL
M% <Y2C-5TE$.+-2HPOXKWX.VOJ;&9-\&TLIE44L.:^+O2V>?P.;>K<J26\B)
M07ZL%Y^+-O3O2:2(*3A#5$?DL\RM?1R(Q0F'%N1)B#B]1P0T]/"#P+*(-*7W
M).S,;#=) ^HCBAU8'9Z661S0SW(V^_GK($]:AHWF/K522^;NA4$R*<S[7 X\
MT9AJ! 0W"K7L<$<C,/@&G":%;6X'N(D"_I#J;^!X\\1BJ*D:CUSY]QP$EK@S
MQ8)C1QFTB"2IFV3PE2Z^PYX3=4QD^^'^6?0'Y9++( I54/V -\*=+'IKO.<.
M+MC3BW$/D@>)@<4M95S9[#C>2E<7*C';H)2T#9NOR?N%J-)[!ZI!Q49M?-9J
MP7 ,X[$(H55V ^+?.Q_'SJQ+"[5%&VT#0RT[$ V@4$I=$>0!!1O6QAJ_DXYU
M33ZE1AG&:GBN'9:!'V/]/'MW2K<YA53HCHLX,CQ95J,,5E65A4T%^,(V7-H%
MY8YR/,K2P?IBSFPC%,&T$K,4_&NM\F3XM@Q$K:'7C-).H$$A<6'-H^"8U')(
MV(F!5J%-/3$&U:3Z(\=<?%F\QL6@5[XLZJTK@HRZ9ODV:KZ$<./@7T</6!C(
MPM+;@THC]3JP2UE-)=LQX+0&CDM)>:PP6JG?R/*4J#TT[C20\6@YM3I1@B^?
M=##SG-*GY,8F:&-+X](J( L\I[B0'$)VOR50*&XF!PI;:[LACD54@K!RK&R.
M:FN2(#($I)]D.;BJWQEG"UD-'R4C^TS>L:BK^E9U>/C3\'&A+;,DD/ORX-7Q
M Q2MOLO;Y =<L,CP+'Z0"U6M7N+I34"TI4I1\YZZPH1UH?R*0QJ6$!AV6U_Z
ML<7>^L&KHYV!O(257S ->>""^2QVGZ^I%UN@)90K"-3#IV@M5"HZ8S,!X7HZ
MAHU)MK7K5.S"L8)<0AE=1I'H4^YH:SU9$!H0PHL$<-,5;_JW(+NS2?:*L/(R
MM9&SMR13%=2O<?"3L$D<-<C;9KG+\NK@:&=-'_//'W]: WP^;<7T3N(S'1W!
M5X;*?5/'?GH$_W#7!XDTM\H="5C5(E/M$E/B4RF#J^8R0W2*2GU8%;?RUV/O
MX-MED!IS^Y/3O"![TWE:':T=!]3<5NP<O?CC6+T%K"MTI!3YLB*VVNK7O9V
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M\#F:/4P03@Y0#W'UA.*#)5[RNKH LB@O""7)?;VI<*F=]W$2 8*(_&]SRB@
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M\QT=XG<&C4WBZA@'<1SVKOV%DD>_<()[T/)I>]#(W,,'A0Y>B8D=(ZPZX%J
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MAZ3NM1S".X0_((1'GF\[G'<X?V XWW$X[W#^P'"^ZW#>X7SU</X-O^91,IW
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MS![Q [_Q_@^H@:4'X["\<CDQB]2**5^G[.\P,BL[3T<H-6.V;,H7<& GM.=
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M YU$'@D?X!"5/0^15D41,ZFOT1@X/(+AE(6PKQE]EH43K@ ^#V;(SW3.\&O
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M2LHLJ%3#KDX5*'+2>(RBW8O8($E1XYJAGC.-E X-/"W=&86#1>6TR#V;&PQ
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M !0:+(I*(DOVB-> "/Q'XG;UE+ E&DS*#Z>R-;(WS&/?[AFI^$\W#L7Y3Y*
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M7=6PC4<)DMZ>+R[CFG):Y5IO6YLI]@M[$%*=S1<-JTZJV9XP7B]+SR[LC _
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M=I PAK-E,S\Z0#RZ(>!>L&,O>(2<F6<X0LOC\2M]3X>0;M'O-&KMQJ9)H:X
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MOP<UL-662S7FC7)EDMLQ&0[!>-"W C <4,(R?;Q;15K.^:-AROJXB5FZ9^O
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MK9@,"2AJ%GQ229@ #"?Z/>:*FPMYE)Z.20CPDP@1QU?HM\1DTN1G(HD!XF>
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MIKTY:"7-IBISAH=DXX$4^Q;!-\A-@C^ ]#9]*.K>Y=!R9- YY;BC$U3(*,*
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MA6HI642294O+582W]!52D.2=WV@F 57D X%*'N*-*>=@ZD!9#YA)JL!34=-
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MH^U+?W!PR-],K#B14Z,(F0$:>2?;+$KKD6IX^0CE.E'J.9Y0=+?+3D&8U33
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MTH2GFPVW%@$S,Y.&!&ET(FSP5_*6Z@3UE\S$C1_'LP))+:JL8R5=_)E"6EF
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M,15;SP3S3,76YT:OFJJEIF+K\P1Q5OT:UH,3F(JM-2E+:D!3Z2AI4V;0@,"
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M_'4'IIZ$R[$OBETM#]PV]:0ZP39MQ/>WWYP:="?6(\J!=Z!PW*/#K@*$I!R
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MG JUM&Q1A4ISF ZG1!D/R(*7Z%0L0/H7A4##\8B18#-9R^<Y%ZISXCI]JBV
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M[N-W8^$Z<[(6$/'VD=W W<WT\I!ELQC?FC@/BN:7+"9#XQ(<YPHN-N*''R:
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M29+PH2LFRTB43HUK+M)9U6.R"#L5,)JWM4WNO%A%HQ9&WW20>U.[:P\(%BF
MD;.B4I:KB7:11!+QT^O'5KD>UN6$PXQ,.,Q3N5Q)<,3S<>B-*V5W]NK_UHFS
M MV:4U;D,G!U+W_)*5"_YC"KPL'R^[V05D;9%;4H0:.6B"AYAZJI2G@I#[Y
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M:C0I#O+=?.&'#T*L=OA02SJ3OGY7P$2$2\UUN,QEIV43'MOEOS<)O\L>M49
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MCIAC+0%*E'2"!VOBP'9@8$HS_*XL._([]6JZ+F_*=3WBY2K8"-%I'^Z_E[!
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M\CW:R0/ IB_B3@1+Y&$3T;!H\9)#3G$:.6SI!N+"#@0@J @4B;!N:%URKU=
MEP2)*\H6F,G,0J0D7XG-)-B+;R)R@15;H)F"U*.FP0O+,(+]"5QP^4PV2%#W
ML#L@"'(7-(Y<+X(1!O-%3)I/8*%?08D24[22SYWHJTBD$B&A43"C!AG-UE0
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M M;F-'$F4$C"%HX'&H(3SZR)!$*LB--*#Q< D"1\LN^)_T!J.=H(0NRFO.5
MDKP \X>++[C3%O7>/CQKK+[<5A&WT0UZ*Z:@*6'!@)D3W(ISYN/*F!*)K%,]
M(+85:U!P&0JJ X]B,,Q[[O$;WP-VC,S11TN_$X<!X#*%5;!@("8ELL :24 -
M;Y<S?[I\)=+" 6_,EDIL_[O*D6\2K$=5TF_13O>)NA?AN?WAQ6C-VK4[WV82
M=N%Z9@9=GZ$K.]SO0K6>E?J@513;=K8&;TK:I:%--'+0(R"#\CY>W;R]^H?U
MJQ^.X?[?"!]IQP<G^BKTYI3QPWP<^JH]Z/OK/[[(SJ#20Z$"0-*)K^:P>"!W
MUEM!TBVNX8MPA;=(K!??7;W]\MU+U!)N(V=.#A(.C2/E'AT TMHKNRQKYEY]
MCN+FQJ![!%GH">Y3]L>4FX1_I:$X71Y9KO\S-5,GVS0V"(-UV*OSE>U)U?2'
M+=W$L*=[D8.PG+AT^7*4$$91[4AQ$ ('WO.?G> K$NN/XM[ZGS#Z:GT0OG]0
MRFQDF=UH S< GV+601)YX^6.!J8*V:S7(]'AC/;51ZOK:J 54]O:,!BF:0:#
M2,&O!@;=<'TV/?BF/NAD"-,*3-X]-UKU<+]OL9LXVF'/#94NR(7_R_-B4JLI
M*=2[;PL1Q%D\(^6'G M>'<3^,:JH_:/5/ H*[6C_L*ZR=*>-KOWS5X8J8B@A
MS=>ZYA"J2X\!,F)+A=3T#V(>1DXPP0Q%] UC!0Z?68\3QZ'K.;M*-9L/Z(00
M9FO5ZO]B=$SB)?42U]!=*"(Q1F=?%IL-?T9BBIY^5Y '0]^;3=7\YA0 ;5M^
MZ)+%,+-3S@3;_*2A,@>6?!R\M%^BS_#=MYDW]A*KT]B0)'DF9(MBJ4/?#^\1
M3%Y,J0+SN<P3D'$5'#8>DW](0DTZ9JT-$,5 ;8K8X.$FH>!<P,4RHF#[)$0/
M%B8*^ +.&:\FO/[O)0!GZG%("4:18$6%2"0/>4208</IUPC#;/ZU:[+3\!,M
MBQE1*+"$/'4:V4LCU2.!BZUA+-5:@6I-T@C%U=3&2J G='BQ3C#TZQ]@SW)V
M@"!5I(Q4B6>1N/5BE=ABO<?@G$!]JCT+EEG60*O;&W9ZN622O\&%8,#IF,4>
M(E5?YQ&$Q _&4>APBKY$2ML:+Q-ZA#?&EWE/"NF=*'J0G@P]]8+KT^BE==#T
M@R_*;)SSQ^*T2$-=\/@FBV=3Q!9+.G =#+T*#0:A(2YPW:4@C5Z##QCQ !,>
M5F( 5#)+P[H*'K+$O/M9J!6R$6D>'Q>VL"D/2E!8#3X'5 7\2T06.W>/T7*R
M)$6<9DW)*V"G87T++] P7BN@@8B-"3K>A%,R8C=<"/5>ZL:;+!.9\9CE%-JJ
MH 3%$U'!)#B]R,&\GV4@HQ@LF?Z1AUY:;X-O</YA6HO$D5DL5-9G)=T2>588
M15BO(PP$)[#%Z<MR:5(>08:%Y:P\XB(4R*=!0S?-%A>D[GTD*&N%+CZP0(]3
MPRB/BX38I>]$EG,+&_H$>,6)=45@IQ]BJ1+R96.%D5CX>,!3B@%]14Y>@EO"
M-<"NF/?]*A"BOO5!"/)\O_CNZM</W[TLX?/ZA-EBD6.'B3P2RKX) 5B$?&DP
M#"9@R50^QCX+B)E+:.%%EN_$I%9AEB%1-%JP]@,@-CIZDWL<BTMPQ33#6+A(
M_!'9T04K/\$TN:RP$Z-IC.^QBY<7J$&;B3FC#5<F2),?U:14L 41,[T9-K[H
MA[@VWR\[;ZX2Y?/!XCT.9'T6O-L.5S(#2!,^J?O.95FRH\(L;+43.@&4:%#
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M4HP+/%(PZ_44[7=6H6C_!9;P4*K)JL>HC$P%Y>&[+29;5IQ3CE]C;<HX_0U
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M93J>I-M*.0N5J[?@_Y6]>EB<D0@#6FD19@BBWK5U$:7CB5!G#F&^,PP3.VY
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M)(1=,\&)43B"[N MZ0<RD YD!7F7+U(H^X?SN'JX6^2Z(%WE7@5Z\P!!" R
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M'P)/\N$S2L:XHD!!_.IT LQCB32%G^$_QH#62]Y7\J5R!XF#*,X(X"UYAUB
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MOF@Z]$0E.XJ/)DP2.0*CU#>YI,2'#)Z1]:^5>)L61](#Q  5(/E/2,*Q/]O
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MED\Z%]0D!:4U%]U1JDPW F0]#)CURP#!*<>R4LXXU21(0125HU7IB-]=*?>
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M1K4XTANGK+\/P]'@Q(U.!CE??:R68_XD1B4_;LN&*V(OG+- _?O"56ZQX92
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MH0,1!()3!IB6%I0R&"1*ZHQ6S&BO-C8Y;N,;RI\?!7NU1$7N4XG]H)C"$_Z
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M+3ZB58=IH($PKSBW!C.CI1$L[;U36!',N4(%IDV!J;L.TV@IMLHJ$)&+/-&
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M6 I,JV2F::T@*,*-LR:/O:C2;'&9[%>H<?7DNN2)B84:5Y@:I]U8@I)T5')
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M)@D.=3D+BC>J>/F*7(M<BUR+7!N?UW"K/OU;B/U!*%IU/5HUF?$=2*(#H9%
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M2UXXDE6>%KA#F2PJKZB\HO*:<DSI(HF&>4\CMY1J*BRXN5$R('_,79GE?:_
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MR_I(Y<*AR"SB\"_B3(,J8E@@H2TQ.">B"G,K%>-%%1555,JYG[0J.E]615K
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MZ^A[=C3J)I!=O3N8#VZO*6)A@==A@63-0W91):)Q1$)3!AZRLD@;PA".5(1
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MZWG,^IFX4K+BNVB'U<M^ %NSF*QX:9YB>>S'_M@WK;7](<1,KK%  LD2";R
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M)3T2 8,3K5P^+D=89)3%P3B2F"LQ^OO@ZL^/[? H_O*3'\;0'?]<#9HN=D.
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MU$WK!X4YQYC1H):DX $X@;;(J&01\8DQK16EDM2G"F#1(1>T."IUF8^KV*+
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ME&-8O)@KQ(7R2&/06\QRHIA1EE&RM0VLH2.T:5$\H8#QMD\(*&"\?3"N'@F
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M#Q86N=K>7_ 8<^8"GF:.+F0S>/TPTH^%(;X=@KAR2&!SL8"Y@+X3!5CVL^N
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M<#*M:9RNZ)SW!P\/Y@EP 7=Y.PU&KMRK<PD>5A():C,,WZNU;$;(Q.;6S:E
ML6;83]H_-%YA7N@YUV-B<R?!S_IJ"S:Q7M.3,.&%DJA;?7Z'7!_!'1J9+'0N
MF@>A%E;LBEIOS-C,#LZXP 48/EL0WUQ("WO"#;0S ZBQ.PGV3&AP9\%DU8H
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M YHS#.+,Q-^C$<X-'BIZ&P/YYFW;\.@_Q9^K%TT":SW==R^$E=SS]>3$VS.
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M'?=NGP^XPQ9!7/XH_;VH BZ.S+$A :V ]4+,(ME@[@6%L ,LG=B0D)7>)0.
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M&[>+K$?=4F <\Z)1Y=!P^9TL:1XD/9WKL[4)73BXOPHU<7'?%ID%U_F XFN
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M!F]I6K'"H3'"Q44*OX9CWIQ9I]5=A8&K$RJ-H&(BBJ[J<HR2K&%'GU_+TN;
MZ6\UF%1K!SZJY WBJR\#&R7Y_V"UU= 5V7\&9_U"C^ 6ZHIPN*L:J0P<M^@+
MR-G2B 7Q<C"S;?K9^L//EI72'8S01]'O'2],7M['2"\=5UF+XZ:QS04V9U)=
M],-VHE55..5$+PD%WN43;?5EIZTP'VG6ZRV.E:U]WK6--D4EM>H!EJLC1QCK
MP37X $?S= W99VW(R,4.76K1T0IC$ M/7<^?0GL;ZSW](M&=[P\2W?D\'LIO
M6 2H1P7"Q(S/=X9C_4DKK?OH].T,!V]148"3!\*LS#(ZXVL5_('/Z2&%:65Y
M&@=1G'*?U>$2$2"%SJ,PB5DX0\VJ<V$8>@%4IM2H*-<LIH(:GN693DPZ&_PI
M%P1+5F6](A698=W;.+Z:!NYA*@?G.T%7OOF4$Z0(CTG"$QV&E&<JRZ(TM*2:
M+%1IDCU>Y;*70QR$U,EP9!/A9P,X1L?=TYIB$E3,MM[L[@R_@STQ&94)HSDM
M^YVX@@;8:F3FQTWJN)H&UO:<GDY\3@DM2E]^WVAC*VJ5MF#3=/S)=R&=2K2^
MPAN[^_UF&QZQ_!4_;SSHMU;$#$S4:I!.A:*XQT>!FST].1@]*@N.JG+9JGV
M3_/28OJ^JIQQ&[SD,NT6#6W>J,RT&8&K3LSUZA8P1]7N!O4X"75-5U&XEOYC
M7_.!5.JC25U-7>4NQC965XUK@4T'8CR(PN!SGB^'N>$JMB9=6#N8O8^-^B*;
M\'1:X^7ZO0SV\OXF.%LV2IJ7S9"V+[AJ/+&))K^M;.8*-F][<Q;'?%16G0V'
MWSH+.>T&$SRB4[1VX'\CR&>6\ES1/$\YIR'\I\*<4R,SY6CMPCC,F[1V6SOO
MIZ,=?_@T&IPF@2TZ\.C/8WVZ@2+&!>;<))?J=VNPX:2/WBK3>Y_!=[%%>^/&
M57]5#F%%B!>09Z>FM^+MO2_A8<9XPDD6!S'-#9*.(1&KR )00,9D+.<1-R_>
M1&$XPXCWKX;L ENTE.>-[ME;8+4]+4=ZODZ_6D=?RWYQ5?+@%50P"K8.5('P
MM\_RO7EE1XHO.:BJ+BIXE *Q!NHB0],=%64W7K,\P4N&;E%*#!R>1WFI:R:K
M+[XL9L?2@G@Y0N<&M:BK%^R BD<A4]A\!O=D536@@/\MOH:30Z[EP<U "9=Q
MC6E;/%/=F8P&LMR6Y1Q3A;V5T[4..K  -\.FGKH]RZ_5N Z'"R\,8@JTL1WW
MXENUBT?;Z#<EVM#,.U]FKF 69SQG';!NNI3MU:^NN-=P2GL\!Q;PL]\ZG?L.
MW;_S&QN4SV?<'BLO$9X9'BJ=9;$P46#R7 644!'DQNA \B@'.4DS&O-IWR<-
M0Y; =*L0YC_."9>AX"R*%$D9@4^GO<2=RX[I,CN%5[[H QX2)_UN+O&:54P"
MVR(J=D(L%^Q^[]HJK*8$;I8?M!]0NF6^4,N-%W4,Z#ZPYCK.'+4YZM9U8.Y.
MQA::R59\U?ZFTY7KG<UK"?0FM2*6\%O!7=[JK@;C?#LPR4^'6.G8M94,5N%@
MS\?-;E6WLD_-<=E?[A1ZT2AUQWYC%VP$K^W,EMNYEM':H(!]"J]8>%UBDR;5
M6*<':.T&-W6#9I<,/K$Q'MM CH,2-].Q=Z.4RRUZUVJY&>18I*)?83?F$OBS
M ZP3)&DGZ%PA+1_8F6W0;2_V)IZ"C?'CH6H$K'7Q!R9#WS82G+MVTVT,%+C&
M>%2_Z^=>+K!_?DBR# R,U 1*I3* ^2:!R',>)"2-5):G)HEF&P]DG,<J3!+"
M-14RY*'.\D1I6*J0*CY3+F"7(W#)Z6;&^0'1>J\>\E1%!/BJ1*618#RBH=!9
MF#"3I%J),#91)I\8WL_"K#(*9*<5/#+,&E88@GZP/8=VX6S*NNB\>O'I\Y?B
MQ6]6T8 %;TD"7#RT^:6_W)<6Y$]MZ6#A6N[*[&FV#++_95-05!E3FP+K-'_U
M<OW!Q7]GT?&I^O%P(5WT._ MH1UN.UP=8 YB_53E",Y,0/"2X<B61M9MB0,U
M%P.IAK9PG00V7&)X=^34=U&FT>>/H 3CJ$I.IG<;[!>WI>"')PQ=<ZU%:KV[
MFR$7T+ID?6:011JK4*\1!PNT"D;5BX/I#LE[<M+C;3+T/WI<?@L^2W G=!D)
M#T[AV-O$S%#IWOKB?8>OTEJW:[Y*8R0MF"18W&^Z ;#5+A(NS?Q!*Y1GGUA^
MN;V);)RNNIG?A\T^ZN_6,FTU.CL4YG*MJD"BS7L577@D[(KOR$?GW IXR/OA
MR.A&=U2]3E,C]?TW]G1]=\D';.E')&(/&>H&9JH;.M@NS(PY;P'/,=C3S@^R
M/LAPU(7C@!4._JE/!UOHG1MQNS]N2J98IZI]5BH4H<8%;COSP=S]N^;<,M?A
M.[7?_1<P"FK[PITS.V?;=?"6]A2=:?!'N>U.FO1/2WCI(SYR&$4-5Q>/2D__
MJ."'*@%9?5 *15=D7I;+][I]WT"W5O7(V:$U1_)]B(7;KK>ZW*06+ZFD ;&[
M?<U"A 5FI'7MBKG^?@^CT#@/,U??9"L]R53%QZH_O='%[N7$O$[]]L:L)JH\
MZ(T=Z4YY\WHKF4?Z%%&S$,7?1R7&S9O6,6IW7R1J*:$=;H5B>N>QZ*6_;M&^
M6O5)^#X)$C[E/HDK^QZFW;@\-"13N<DTHUE&LCQ4>9ZP+(L3H4.U*.I\,_?O
MX<7;#;V;3_H4])^'R+1R;N%):'&OX\COD/#IL81^1!R&'*SS0$L/1>H]4J>M
MFZ',;3TZP@:X\K<V+ I:WP(!3,]C&3\MP_)PC[\^;7A?J/P.W/O/2<]3C)!H
MO;.!IJ;/))>FSCQ#N_*AL/^_;*B6=2E(Q]*C:-^0C?5F0U57(]4 \>!D.ZMX
MS@N4!D%E4OKR-;U((S:]BS(:7-65U&IPKMN!UP;V6O^Z_L:NTG<$=E'WU!E(
M];@W?'_\=-CZ%.:L.1=HU5M;; 92KT$8X(/W15=Y^$2'O>OQ#,HZ^W(*+GGX
ML!A?\^EE\5F=/9B[E#91T4;@XD5[.V#Y?U7X-ST G\?Y14J<SQ\,'K B-=@=
M;5JP ][;-1^'@Z./",:P8<$(5HGJG<VMZ)#1W"14J(#3',N9TRC(51P%.HH8
M)2H'[3A3I&ND2E-)A#$BHR3.N0QYRJC*649S1?D,=&"+9*(W1%5D43$<+,0S
M:F6_<N;>?)R>'2] $.J[1!.MIQ-ANBT/I(>\P&ZE.O?9[J>&B4 MHNO*U3F(
M?7S@(0<1L*2"Q+6];*Y>ZE/Y#^^PFG*8#KCM6/=<U+'$SJZTC 6'<WQ;W:+6
MS'/&4&'JX#U]X3#H/0_-[5.ADA?'%@*ZF(;3<XWR#?_?X[UNF3)Z4$UKJ36J
M:]W4:D]'UICH&JFOA(0K9EQ*_P;BO%%U=NGK@;V@M2H6^:,>IK8YO0ZZ13L$
M2;LOT EMX,\-SVK0YDN?C?BX]2,1,1>4FDOTVHZTZR"@/?'RJ(N'TD>;<-?O
MUN=<:1TLC[HX3#%-%T918"0VT2B9!B)F)) LCQ4129+&,^D[!=^7<1QG)-4T
M%4EN.!,6GC4-%8MGFFCJ66_ E3:*]>^ZQ_G*\2VSNOJJ'>JV ]VV]C/WT"#>
M.!U@;K"'? 6CPLJHRN)UKD#=G#QGKBW]R,ABGPQ!1Z@C7170@O0>%AXSS/0F
M&$/W(!S>F7*<5<V YWKGJZVMZ:@KEMB5N" XZ?S'^->;OOM&\\:VK';>W5&$
M.A3ODF0,T5&*,DW1T,,.(;^PS[:8YPTP\C* 7/:X'+NL14EVX:I^T!%Q@#*P
M!+T2.=25,8E&DZ2IAM2:!-3WQQS>A7>*+NP8/FH-:7S<P-5WKB,627EBCRKW
M-]/& XO@234:6^?*);'^V(@KSZZ&\&8EQ>;I9(3:S:UOR6YE*0M<&5-CE3K%
M&3]ML+LYN'<;:75L-?*\R?VVD&L+KIM/M74)6=;3#YZ41_X.SQ"BK<*;U<?6
MGZ7-=A=<<0ES;91?2GUVYD64;93#$2Q>[S:J:Q>GUR4$JC?PV'#.?]>3T;"B
MDD!B@%[C7B7]WW0[7PO[L)8 O&B-<KVS<^E(;6-?Z[4N;QML;]]? ZX!V9&F
M29&[GMSSRMV)5G"5>"YY&<>(.EEQ+\I1UV9:_0V1]-2'9XK:C9@RB*V.\JK
M70!/<(K+F]'-P^"DI_.(O+KTDK+AIC2]*PQ@U9#*EE/2 BCB*8)+QDT-O.;2
MVB5L\=!%!>N!VU%==Z0-K=3V.!8,;>ZSI^?)=]&X:?:U!-4\VTQJ8QGM'=SX
MVH6I=6NE'W>]S"\+#_8--[ F!Q[P;O&M;G=![("Q/&Z 6C95>*VS?;UJ0P$W
M9KJ*FYZ.AJ*<@,I;7G"-U9,6?M/6#S2>6Q()MU>JN=4;F]'*-^?.N00DMR:3
MJUJNHHS5+'1L\K%VH_VM"^]C6VHC2RECSP-FP$?Z&$$YX-*M&N$5=IO+EIY;
MLB^4/U6G4I.TQ*<X83R^5J(M_NS357LJ[4B+^G;XN :"J;WM?"Z<*=9<2P2'
MH-QEWK\&$)__[ 7K,+UK+U^(DHG:6JGE0NC&4M1-8S.N>TNK(K9,76I@H_+&
MH%%E7>U6Y]EL#*"QY_Q[XD0@SFNCW^Q]?9D;K24&<,,M]9RE$+A"E**UU4 U
MQ%,\,U&MH$-W#N??@E7\Y>L/]AJ9I>,I(Z F06YV\+=:]YL=]3[1U,5L3XLI
M'LT8QU\QKZ4> 0.:MYR3,YF7Z&G3S]N[W2/"X9*$?CC_[?Z#/F+\W*,]6S]V
M][Z=;9]L7VSO;9SOG&P=BC0S&4>2HD2G <VB).!"Y(&(TYB%TH1L3L)?PPIH
M1DQ*$YJD\'6:9$)'-G;.3#P;^!'CNBWX>GAVOY@T6E !<=5$SINZ%JY\HYS.
MUE.GOQ<NGV,KSA1>7>8[:UA63]C9:DUN7_1[B>Y:,>A5</0VA5KQ$UI<5Q\&
M* L[ZTQT;1U57RJYDAK5GS71D.5BG<) Q^$@T\W-YV&DOP][%JK<$Q,9+J=I
MF*I)\=;V';UXFS37O?-ZYQT?6002[]GBF]H5:HQ+\D'9!P?JIE5I4)G18ES9
MQ:!.=*],LI?I!#?&ZC,U.W7/()? Q6_SSUPDN>(L24!-""IR+4R22HE8L G3
M\,DL 0AG6D<LUR&CD4YX&"NE,QK%$NYDY(LWG;TICP4WQI%;E*#<QGZ/%(\R
M\X]:$[2(QN2J:;W)K-J3ZEQ4Z0I=;&0<SW!%(CNO([-1F#3UB+(\W J+HA@B
M]8=NT##-"AO+&-6HTO$U\FX4GE+$ 8)7T6/!!]^L9:^M5Z*^=XOAZ-Q=LH9(
M%FA@XEAJ7@D[@*K\?ZV6 %4-<[N:Q?)[((7$L 1!FBK-:="#59VHSF.I@</G
MS<KE*)H8R+[&^GDQ6]0+>0F?22V3*PK74@[ZQH%*KEN.C[N&"E^5O5Y5]AH]
MY;+7:Y2Q+H-ZLS+U%9?W[B^]Q>.V48F^KR!XWOWH-BJX-BI9L#NR_8R8@!A9
M[)'GV>T+U^]]PS&QG9,-MK,GXT.M3!(F"0\H11_+:!5D+ ^#F*2A"&,FLMC,
M$,%2%H8J8C$W,0W3A,=Q:)*<4Q$;IF@RAYFDGOMGY%A%;#%)[%53V)ZT4DU6
M\ ME?&@(CQMW^[7N:22I1GHX.N*#TM(^'0U!N_51=0Y %7KZS5(_]OF 'WFN
M2!<:JK[?Y!$I#7\7^:_+G7RT=CCZ!OI5ZMIU:R?RL46KCT'2>19*^;XNT.Q]
M#DL#YNCG5<,'/*U;C]<[C6K!<IZLN<6_:9OA&?B$-18<@]2>%.V**<Q8V'(F
MFR.O/J[&555%V3NL=[XVWM);"?.?BC[;J1_Z_,7P2"K]R: K2QY.[ULZQK:J
M8?8(\;*>A5^DRB*K^Z:0  -N])<UXS[I-H3G1F5H;H(D&W5MI]^STQ98>?6%
M'G)-"-$&3*(X3@.J,HVDE'&0)5E"I1%<TAGXXIR%*7R;D30U-%5Q9E0"%HH2
M:0IK-H^[JKT UP^_S;:$^T_&P]/7\QM7EC#.=N5\O7E;)@1PUU8-A+XOP?LD
MK=#_',)M)Z31$[*"UT(A#;$=U);Z6$RJ*KW7=<((;HERMG)';3W"V#^_DI >
M8Y>[7-HV-BC C<&//5^;@;ZJ\7BOXW_5_C/&!:LF"I?AFP//NR@EV$I=XKM5
MU(E6;U;^6HN>>R[^,@E;-2<5*G.=JNRZ#&2I1V?\ZYN]]T#=U#5N<#HCWNW+
M8FK33$< JC$ZS&BL'!]."E#W+2($Y\7:>M^UTB3PN%K@"G4QH&ACI-7(L:MY
M\<:ZT23\W$;\.>_:GL=$&2IH&FM),>*3B#QB4:+B4$0\%(0>1I2\6"R-4/;D
M]R57TKER)5Z_]QZ9*BQ4; TPW+TQ4-L6LP$#5@Z ^+.&A;$>%_S2BZP]5[KG
MJM+!-9,]6UNR+#FNG<VM2J]N?SCH;_?_)CN;[\ZV+_;#@Q/X$_3H[M?]>/]D
M/]K_^C=<_\^WG?-IO;IQ=M#?/S_8!%V\MW&Q<_*IOWVQTT5/Z^!$=7=._CD^
MV#SXMO/U[QB\,+*[MW&H>,I3Q!=FA,B :A$%.:$LX F)<_AEJ-6,6HUDE*LX
MC[0($2 _S7@6QFE(P/V/\UC,%#0WENP!49:N'N64.QDK)$6 ;2EB&G&5&2)U
MJA(I%$NE?*2XQOQC]HJ7UNGLGQL57J-M^.,6P;VQ )=;,"@S6(F >9^H:/(8
M?+.>WC75>-\/1Y]AM/7AQ9:= ;I?=E7W\#O/^[AN'8:P/R.5YT$(YEE 3<0#
M(:(D,'EF<,."%2RGC]__=:'\*EJ*7G  V[/'3PO]NOSA=VS1Z?'SU]V!W6_V
MHM_;=BU&%[^#. 7SN.<WOST'[M<^\)CGZQF+T<8<C^ _53[8AR77K?GY[[&:
M_5T:KU-"%_XZ7(\6_NZRVT;1>A*G]W/;_%JW_;>="3<;,-]X O_?"Q"KY9)P
M^0T=ZX$*O-2 4Z2-^=WWO[\..Y$]DN6#?N8>Y/0'WJ7IB(Q0HDPOJ%O+!Q)F
M-D8];=G6T?&?>%V_O?V&A1?N6*N\4X[]Z4U'V)J.&V\E8_]7S@N*]QM-"D(O
MS)SYX>D#^:IV0GP89M&F2.[OY5V:Y,%>?_Y^>&6]'G"%P#\I?KO=9KA:)BS!
M>E]NP&#Y7S'V" KH($]OC)N\?-BYYA3<IQB8/PO_<ZOW>E2Y-O^%%I+63 HU
MQ5B3D3"1<0[V3)11D8&%DQ%P?55J>!3GH7",-<ZLK!EK@GC:R%QL6J+C6/_K
MK7/C7W1L,!^=@1_CUX-)/U##<> ?4%'3Q$_4]-S_^F=QL'<*S_L'QO?/R3[Y
MU-N^^ +7_-/?W_MR=O#U;[K3_[.[#??:W?OCV_YG?\U__CP6?=7;[</8OG[J
M[WS=.3GX\.5B9P]_/CC>V?NC=[!Y1/;[6V=@QK+M#Y^._W.Q-=[^'/[XN/=N
MC,B^\$Z'<4@CJED2T(2!I\F9"7+X)% D9)EA7'%.7KR)UE*2SU#;S%<!-Q1S
MG1N>C)5 ^64$"D=&):ISV$6$JA"$"0@4J@Q+<YG2G*) B?*50%EN@=)M"Y2,
MA[ED.0U"8D1 !5%!'H4J((A5$G%N%/C";VB^EI!LB23*%49;Z8;#8/7E+M_M
MOOFSCL1RVXY_^5Z48J&[0&[VBG,%^M,3@#\5L;M,$O[ENX[WAI[C[W+1N!)V
M-Q)V?U?6T\[FE[.=DZ-#$'$FCXT.2"QH0-,X#K(\#@.5" D:+2(R#$'89;.T
M@#>4=/./^<_:3L_\V$F:<I5C_5J44&U"P;D*14ID3&G,F#MV87GLKN'1W/C8
M-0T0T_VA57"A1\/5<;SI<>RVCV.D-,D8%4$:)3D<QX0'@J1)((V&HTFICHS
MR%5&(O+[$AW)7S-BA!O?U2C 7O?;_Z<,@.MZ=$LBB5X]J@4P&EH4N/>C81\7
MX+),WLH$N(4)4 =00B(9C0).\C"@F1"!2+0$ST<I%>LD52I"?R>=D3>_/5+D
MY+F?N;M7_S<^<ZL Q-T; >6!3"*:&)"D 9$:;')#2)"'P@21,*%.LTPJ&L.!
M3-?RD"S'F5S%'NY1,GS2\%CL>780. .7NK*0ZA8<!QL&YE7BK%RE>[%//L J
M?!P6Q>[ 2<I&%=K*+;H3B;@_8Z+(A(;($AUDTF U(<T#8> GI<%9TIRGDM!E
M=(M6Q^_.395+C]_JF-WLF$T9'C0.I211'(A410%5@@<\2E1 0Z9$G.8YD>F+
M-R2F2W3$?LW(PY?!J-3ZDI\B!XX#OBM).V^K[Y^8<_28^MXB!K8  QU>8+U$
M_SOLX2PV)%/=)^ Z5AWHJ^O&V]'C7;/'?ZR,A3N18G+&6.!$*:&,"92)L2!$
MDR +DQQ\J$BQE$=IFO [,Q96@8TE"VP@;B7\]'"G>'5:;W9:IVP.GB4RY1K-
M#2HPV &F/29 9,QS1DR69H*BS1$]B4C'5:7"OGX\AJ>KX01K4<M3UZ@E)K<M
MI'[X0^ZE)K9075UFJP?JQD6V=SZ-OT1%W=W/RA(JD!OH#QV)),R5,@EHC"B-
M1"1X2@4C1$@*.]06^%[#YEO5XSV:ACB:L>=2)4.,_P2"* ,:(B?X4QB$0LA4
M<24-SVR!;S0;#?\YO_1.A?6=EP>O1.%*%*YZ'9Z'*)PREF'Q>,AB%J1,@FL;
M4AKD>90$,N&*<I[J/&=WU.NP-*+06MS_MFW#;V;;_'\]6+4*/;^$E:F010I+
MU=' +^T.%N0 +9[,C!V^WOD\_]N(F ,NKNX<PQ!ZYYU>][^3KFI]Q>*>UE50
M:+\?65+F48DKAFS*?7BQ8U\QU1UT^Y-^Y\4&^.(CC]GS ]%1',BU!=4L%@YI
M,4.5(^X:P/OI$3_2.*AR59O+LW!'W^NZX?18$M![@CGHRM[HM9VR/9BQ:=G<
MR(5LN-GYI/N\B[08VV[ISEWTHB6EX57E:S49H3_V1.7RS\,?5(C\YSM[$KY_
M=*A4F$G%\D!)+0)*0P(R-N>!"HG,6,*CA(*Y2=;3:6'D897D<-YVO-==AQRR
M#G?HLFWW4\&UU;:[EVVW'>]L'((, .LL3H(XR10X-C$-LICF 5AL/%:*&)$1
MA#ZB"W;:(AD9WA&YS/WS@31"K%-[:H7* N9>'D4I8S%XOAF) LI-'O!,\L"0
MC#/#:9+)? :59;F-&C/L]89GEJ?!VB8C[4'-"DN=-&NT++)P!(*ZGN"7W!XZ
M[XS/3RWC%VC?^:;#Z^N#%#TLM TX=^NA<_!NBFU#L_60D'L!H8FN!T)SHT*^
M>QK ,MR6++[T"6#V+ 4DR16(+#]3)OI$ZS]N@4WS1-:ZM Q1D#N8RSO!(UHF
M'*:?6MI[Q%Q:$B J)#:PUN;><,Q[]WS:YX:Q9F?MB4^I9;S\!_';;S2QSW6Z
M/E9P^)&=KWF9Z-5T5=,5862!53-5W$Y0_PKZ-[I&?=:3!X>#>_401?M&V' /
MU>JSU(U&RS?@)])M548I'O?P[S4S%+>I:?^5$NN_4&H\(3Q6D4EU;G)J6))G
MD124)+%(.17"+*@28E>EQJ<BFB57*=J[?_"B6_>G)$\TGNG2WT.RW_\$]_KS
M>'?S?6_WP[MP>]/&*\^W-X^_[5P<_3CH;X4[%]_8SMNI]/?)0??@ XR[_XYN
M?_U"]_?^/MO>VZ>[FUMGNQ_^CN%^?7R'W;UOX7\NOLQ6 H6)BGB4!;F1"%:C
M2)#14 =AK#A349H(RL%<69_M5%^.%K#KAL=6PF4E7*Y;=[,2*C<5*N=3<'^*
M)]SD+"!QG@14J3#@1"9!'AJ1A6F:YUHNH5!9B8J5J+B6J-BNBG:^6@JGW8'>
M!R\>0T8V8K02(#<4(#MOVP($:RQC[#+C+&4!)9(%F8QXH$T82Y(H2I#P,EQG
M*P&R$B!/6H!L(%\TR(^]8YC8H^/WW>]6E!0K6?+3LF3*PS%9DAJ>R(#D$?(5
MI\A+J4&@:)W%4<X2'5(T1NZJT^$Q._!O4EI\HPCJDD21, G3>?4_G86AU&NT
M+-[='/T2(OSN9^5I*X"?['=;1;(>5L[/ AJE3(DTR:,@$@)+/W4>""W#0(<R
MRR23QI#H3IS.^Y"UCQ@'6XG%E5A\/+&XBL'=E3B<BL$IQ4Q.4A[@>@4T)Q3,
M7I(@"CU"THN$F[N)P2V3.%P)N9606WHAMXH>WK'HFXX>4I((SAD-I(I!],&_
M LZ3*)"AC/*,:!4GXDZBARO1MQ)]*]&WBGLNAQ2<\H<C&B=&@C]L"&$!E88'
MN>(DT"3)\IPF*N'1G<0]ET8*MF$-;$/:-+C!KPEK@"<9%V_">R6@@.V8ES!;
M"'#>;/*S%,6Z<SH<C0VLP+#3+=JP Q'QF ._=XZ'9QIF?*W"2Y#<RA%>N!;"
M8*:%<*1-3\MQ89]1HBV<VHTEM04QZ(+0&=B[P$A&NCB%K^-8X8*B!6NVWFDB
M-HRT'!X-8%K<K2<UF"N"N&K;N6NP9/\["@^\M_[O!*>!%_[6LY<,%V(]6$ $
MH?4 I[;HPK:%J_!.N@\3QT?G4^W N,UP$;J#B9VA>]IHJ^N>PW7^>%.RGF*K
MJZV9A3WU>J1[L+F^Z[K#]5_MWF0O>L/Z$BY RD[&BR^9*9)_2-$5$3)UC!I_
M'H_*,9SR(QT(.+S? HY6PVO>.^/GQ8M_M_N-NX-@:N9N^M+SUJ5:G8?I%""E
MV=:4)L[^D;&B.7@U62C 0N,J,T3J5"52*)9*Z0TZN$:KC;&UE[2.(TU$GE":
M2<4S;C*91)HJ0Q5G+]Z\$K\Y53_[YU9;8WA9&H#DQ#9S$)=S1-[T?KY#;3IW
M0JY\P:D)B;*(2+!R34HT92H1)",QDYF2FHI,Z\<"([);4%O-..P4$U'(4??4
MZ5E0S+H!%L0[@PGVX*.^-&"!@8Y\ZZ',QY@:10R _[F!T1]3HP13@F8Q3('.
M,JY5$JO4")YD898@Y$24+0;VGK'^9S@//\)^P>VRD-%C$9S94[7Z;X%/<;:-
M1$7(2)A( [:Z, %-<QEDC/& QI1$69+D*L6P;;(^BT96IL3!>E'.>.'J.Q](
MV%JP5ZQYI^W9+;R]M7"S+4:*>C4?'>7UC;:=S%(=(<9D8A+*TC#70B3PLXET
M&/)4M;?=+*#>:MO=Z;;;W92'2602GL5ID%&:!I3'69 1I0(.\C7-C!$4.6NC
M>#U>N.U^:QOL2N,"@.!3Z%:,[7[K6DE7U%Z(%6*=OM;N]TJ;[L!:+KA#O=(I
MJ@B"%8+#R1B< :Y $%?/<.@FE?4_Y3K WI.]B9H_D&/=4Y?L]_^"2P4ZR4*G
MX(4[&_^4[@P(7?WC5*NNAXW;^/RVDY&P\_(^L*KL;5ZCI._*:ZB7][4GU->\
MF(S*@PT.F.H6$AP@^.S!0;6*EW9E1KISAFAZZ )*6$OK]S6]-UC\F\B3V_)3
MS,B3=W;GU:&K]]]WNB6(_4J.+) C(;S+82:R-)4Z"3(M9 #FA0QR C\E*5=,
MAB#E38CX6[-!ITI[W8V*N27KP6I+W,F6V-U\=YC%S"1A'@8$?)6 )F$2\)";
M($U91&7.E,DM^-]L-J;2+'7T!ZWDSD"CP$6JB8ZR_!%6-&,??4?@/\M/)!^-
MSO$?E529-GH*;,._R;ZZJS#YO.VTVD8+ME&T<W%TB(9(2#(:T(PJ^$.%(&-2
M&; T583F<6@D@6U$UI/%HN6>[=J?Q(=>;8Y;;8[=O:U#(Y-<QRD+>(+\1.#2
M!EEL0.WD$7QL0B6B&,Q7MIY=8K[>HSDT/\[3>7 #;&,NKN_#O.1LP.C!7GM^
M_.C*>-!4_"A,C<I9'*6)9C07&<\CQ?,<G*-0LBP!NV:^<%EK)4/0.0?5U>^.
MQPY?UDS&8(NWT@\WM']OJY0L%.U;.R9\?LN+WEMYT=<#%]W9_':^<R+!"GY'
M=_:^7!QF#+P0<)P#&AD>T-RD02[".#!Q&G(EHR@UF']-UV>I'RN%-2]%Y@)_
ML\>ITWG\#(9=]409BC6&6H*JCN)$@ Z,$A6'(N*A(/0PHNQ% Q!W]F1>?=(>
M."+_2BZ,E'><M@8_>WP\5'-9).\A(/XH@>IC7D+E@^2ZB8!*<W#),Z/!,P^I
M"67.A6:)4$2J+"%<.\,H3 F]CF&T;6?Z"0JE+Z50"@^^[I_M;O[9W>__^6UG
M\^]PGQR<[/?_C@Y._NG"Y_W]O3_[('SB6:'TJ7=PLD&W^WCMWR!L/IT<]'>Z
M(,#Z.U^WX/.#8_BO?W B76AO[QN,_1W9/CEB,*9#1D,>ZI@&0H78(Q') (YH
M'N0YDSP&9XP9_N(-O2RX#!IK*&Q5 >\LW (N37$G:HI<;Q/LG@WTJ#CNGOZE
M1YC4XT=U!5% GMW2R_A0(.=?',<!8SH'_9-C#[5A <D2;;@1VA %:SV[U/^J
MPJ-EF/;[<(QN='',1[HBSP6%M#N0')QLW8JW6A;0]/=I5HWRNUAOPJ4<3@:6
MOV(X:B0G=$N4*O#98;<UC*>7<*GH]BPR];"C?\!2(\4&\E/:XA3[) .^_D""
MN_\=[EH]U89^NT6SG@-N(72[]J7?'0Q'LX4G(^5X0DY'0^3=X'XF?$!!\Q'B
M\A?_+LM*\./N]/N__%Q>HQ<IC)?E?+^%06)UE*7X^#R&O^Q=<,9/]<@J2J3Y
MT+J#55/X3U@/I>%4]FQH?0DBT(/A6'=()^A\;BR.7W?<2Z?P?A)\VYO@ZB]2
MA$]/HUJ8==P$;O7A$!R[.J6.+7/#K5GH7L]^\J!"UKH"\R7LMA_S2M*V).W^
MC^VSPS0%PS3D/&"&(EY%@OG;+ YX&D<L-0E1%&Q]-DNX^J]Z*\P5LOJ'[$V0
M6K=W/B4+\9S#CKU/4ISY^\#QCI2[X1\[:BO;?"G"6S[X0W\>]M3>$+:Z'^U<
MFI(S%*QZ\.RV3-,NDVS[XMO%89RE"3<Z"6(EP@"6!QER6!AHF@H9,DZ3D+QX
M8\4()O9M@>8,A8G#_%ZSX050@;B;_N3@6(W..RX4$=L$X-;;W9T.'/OAK-#A
MSO%?R9WEWT0RWCZZ/[EC1L-^9V-R!/K2[QUV7YKZ?BEQ%KB,RT.#\^#"Y\?.
MR=8A27,0+3H-$JY WI@D"C+!DT 0(F.92*-%>AD-3IN1)9X/%O+85M85Q#@+
M[?#%>:)9NIN'YK7)\_6,Q3]#:Q/GZU$2WSU/2[:>1?? EG./M[W>)"PIJ\R2
M -A7VKA3J^.?POM_,F_\MJPF<*00S_5=GQQ.^VTQU7_J'"\A=<[\E2[U7*=4
M<;<A[7AFKWL91\D3G(OP3DA(%G9YWHEBO,7=KT'P=?7=KTTN\O#+^<H&CX<3
MN(6Z&<'(SYSGY>CWK\+['[O][EBKA:?Y,G*9ZX*S+GM3_RKI=B>NM>_;A[$<
M]^"^9P=[?Y[LGVR'V^3/'GSW>'?S2[R]]^U\^\-V"+_K[9]/]^V_N]C]\ 7>
MX8_>-KCAVQ=_7^SWOX ;CH4A\L?NWM;9_L4G^-T_)_^Y^'L&QXX3'7)8LB#B
M(@YH'O$@D^BI$R950B*F3#8W;_<H<*4/MNW_M6*-^>7 EG^R<"V^T[J0>"6G
MKB>GNFTY)0F-M&8Z2$VF ZKR)! A(T$:\5!G,@\%BU^\(6MQ.MLSMD)I7PF.
MVPB.GZRT7PF.1Q$<4\B4H8EYFJ0H.&@"!H[*@BQ+L#"6)Z'.%0TI" ZZQN+9
MRMA'AV2? NF(/+?];6#:[\]-?E8/N![ZTU.M&&K6X+J2-$0DLDA&C] NBQ5W
M\-.T.-VR37G8$OE^-.ROJG5O6!6"B5G#.<E50@,X!@*$(RQ"'N<TB/.4L9"I
M1+(4NR47H;:59;I5KA.C^(MK%WW)8K,^L^AB]>3\?KCU#BZLZ]7G8WL7V[#/
M>\UJQ_'0-6/J 6[2^7=J-\7<<D??0;?O:D??PXX^W][\%L*NCG?W-N+MBZ.S
MPX0*D5$B R+S.*!"JT!( >Y#2C6C*8LTRQ&:=9'F]]M[O;,YU?A[R5Z;:L""
M@_"]6^XU/KCI7LN4DI2RE"D8LS)$,"4SI@6-:29H'E\E/9/I+?81!E%L#-1'
M!$(H/L$;=+^C$ON$<%]:_<5'%B_3%_JN-MN"S;85PYCBG8MO9SLH2C?E(0-5
M+$22!B)&:E,!*\)I&@=))D)MTCQ3$>RU*+Q"DH(TJVO78;N,;+7ZT/9AN3;S
MLDL0EOF[[@U/RV)M_*68@#S5*-(:E=M[5O+"WN-2CB8(7C@83*P,]77W?'S#
M\KM;[LH9QZBQ^<[W1K!!W2@^P8=//\)["XEV 8X1CHGM[&U'VQ=?S@X9IS"9
MV@0Z3PTBYY @4TD>$*,,90QLK9@@S.IL6_J_;#7FN-P+733L3OFY+2>"!?]S
M,M"=./3%=_4>++>;Q2Z 387B #<FVHT.)@QA:>38;[9; 57>L.+^3IH#6?3B
M6B;Y ^76K 5.U^^KT+H\<!^&0W4&$F>S0N=9FA+%O7?^E)W"2?@2[VYND1T"
M]SWY L_:N-C?>Q?O?WUWOOMUG^Q??#D_.('3,7W*^N_.#_8DW3[9CP_Z?Y_O
M[/U-MS=WCK?WU/'^WA8[.#DXV8$3NGWQS4-2?6&'/*(F 7,XB$,.%D(6(285
ME0&"A&5)2&E(9GJTF8#_PPP)6!:4BD0D29XEN9(R42IBV71-8SGM,Z[B=(GJ
M;)/JE8^:5S")J6560AK>XW;Z+(^UFO3TKBG?\'EOI_WHD#,5YCP%\<PB@WAZ
M+."9(8'*$L%TG"0ZG2UY?2K%G6F\3@F]^W))T%MQ>C^WS5=5F$M2SG2-D-NS
MK&AJEWG=F#-S7IKH@0DSYX?+KU42=<N7GU\5=6^O?_\E45?+A.7@2-T]U=B-
MW#FJ+)MKYDKFO. OD?V<]UZK[&?3YW@BZ<Z?-!Q=NO/T>(=\@O$=T?V+C7CW
MPU:X?['_8Q^^NW,!U_;?D>VO8#AN?@EWNE/ISOZ[^.##I_[NYO')]J:D^R>?
M3G9@7 =@?(+1V=W?@_N<]+Z!$4K^<[$U6\]E2!)FL0C DHH#JGD8B#B209XG
M#%8R%H:#I9G'R1IA=T7&]T"<4BM9L?2R OSG+*8ZAUU$J I!3H"LH,JP-)<I
MS2G*BBA?R8I'DA53-549CWDH21[$1(*/2I&Y+F0JB$*CF28T2V7\XDV6Q6M1
MNBAN_1BRXAX*S)?#FGH[&8TPFF]S3+8[WC&K%)U7%N$DF:&??U8EYW=?7+!0
M\'A,0N42?PZ$8B6,[DX8;<\8+B2D2D<)"[B084 YIX%(,_A)@Q1*TBA.$@G"
M:"TBX5H8SN8W'K7(\YD?P]M61*R.X>,=PRF;@*1Q1HU2 <F5"&@4J2!+4A)$
MJ4;TVI2#;?#B#4G7P(Q;HC/XRP98_H(M/_)8.TV3X*<,@>LZ4D]/ MV;(?#7
M9"2/>:$W*C"Y#84[8TXIENG^T"JXT*/A2@K=2 K-=J7%)LE-DH1!F,,?E$0Z
MX$RF@1!13)G0H=8$X\T9B<CO2^29K [BO9D"5QS$U8&[V8&;4OLY,>#C2QWD
MN8H"*C5:W[$)4DY9G"4*R2^00O/6S56K,,#5Q^W]< 3_'" <XS$?'.E.?_C=
M8K(^!^__U<-J_065V*74\4OA C/2%2?V;%G.S>B85G+I.G+IRXPAH"*J218*
MT/PD"6"-39"G7 <FBZ267$9APD N96MQ/-NC,!,M6T4#GK0)L#J,#WP8IXR$
MD,):)9+"Z6,FH+"X0<Z2#.QSF2:<9YH2\>(-86OI4C5AWQ);J$:=[*CA! OT
MRB/6J%8A-ZE660XKXVUO6-RF=./NIN=72N;>X:P\;2UP5V@;JU3PW8OV_1D[
M*^0I-X(E@8P5"/10@,65A"H@D8E3DZI$).K%FWPMC-.U/+YUY/<^).Q]E9VL
MY-Q*SJW*XYZJG)LR8=,LR6("(DXQ0L&$U7D@0AD'F0X-8YRG49K>=7G<XTNY
M-EC%=._1_?'W+16.19\KW>$=U]"*#;/%>,3'^J@KVZ4V#I$ _["DS9;[:7#,
M[8?C CD+'"M45SN&>^Q_''6UNZ@C81TL71DRS9=MN1)&AXO3:MD]'0VE+HKU
M3GGRX9JNM<B1.[@>41-(WA) _9"ZJ&\]+&SWK^?2@.$,QFYLEI$*OX($UKR/
M07,8<($!+T='!3]K_*B\$E^FUVV\7%' 'E$W86)X\AMEK N8DJ-J16RG=._<
M,H=UX2O=D6NW'G7.CO5 XQ3#'Q;C7\H)?MJ5Q[#5D#!'P9*/=>,RUXH-:SGI
MC:L%K,G&JJ<V'H3CP2V!:P7_K[!7^S-L3-]X$GI"Z6EB\LOP"6I(@@'L;/S)
M\I>9YF-Q*Y0OH/RNZQ;C\IO%Q!CDTX)O'FNN1L-A'SZ#%[>\9[R#>W\X '%S
MWCD=PHY#8>=#V9Y6Z)L^=_O+$Z-/\-W.AI.>0I:TR:#7_>9)B-QT>?ZAYA*X
MZ1NYUO%J\J[3@?Q8["!_^.[\C?IP_S4:OD=UOS5P6A\^>N:MD_%A0J40G&<!
ME[D*J,SS(!,)*&K"&3=<"L/%="<N.)4IUSJ+:)Y28V3.P)^)XXBG2G(F\YE6
MRSE@35-@6Y2LI]A'"3O8+M5KN]6ZW[5OG_268N-"K^'#^A(N0)E/QHLOF>EA
M>DC!9]-YK=/2^/,F/?2TZJ$_KB#+3OF1#@1(@F\!-_!BKWGOC)\7+_[=;E3N
M#H*I^;[I5,T[QU,8 0_2M<_NO6M_:S &&8K2=,.J[F7LWO^[E!D@)[9^[%_L
M? ,3_WQ[\UV(IOWNYC]XWKO[%^][VU_WPX.]G6_;,S+C[_/MD_<GV^03F/A;
M9]M[\.S-;;KS=3O:[O]YLOWURP]XA]XV^?OB/Q=';.?DRR&<^<SP1 6&Q#R@
MG"4@,N /;3(N32Y4GLN9YGU8"*E8%AK%J&"4:Q:IS"1<"".-GA$9]>QWW/3_
M3!?_5<]<CB[^]PBSI3^"K%/3>VX/G8CGO=WV#RG,('B,26 2F$\:QDD@9,@#
M$QMB9):15,Y@/ZR:^U?-_4^IFWW5W+]$S?T/G3%<P-,T+!:7(*VZ^W^]XO.W
M,(HA&!O.RT9'_;A[6JQZ_'^YOEVB8L-9+DD8,YKFF8B-CHD1.LO@-,CDNLG:
M2PS'#Z,G5)_S<V:EASJ/=C8WS@XV/W4/-K^1??(E/#@YP,3$Q<'>/CO8W#\#
M<_-X=V\_VGX[#77^)=S>_./;SH<_O^WNP55[G_H[_3^/=TYV>CN8U#B!,7Q]
MAQ[/V;S>?\89(WD>!;$4)*"*\8!C1YU(0T*-R1/)&$*=ARQ92^@B3-]5]_]*
MBOR<%!$D55%$DSS.<RHC(> #(766BIBE@F;7386NI,B#2I&I%&F2B%R9+(()
MQ=Z;3(@@4U($(2.4:B.IC-6+-Q&E:V0.U?>J'>#N,98L!C".OS<\>@XM #<0
M.2E)99000I,HH[&,>!:9S"1&)(FA(><KPV7Y1,YL[[]B+(II9(+88)6_PGB:
MCD4@TQP6-%="&O[B#2/96DAN;;:L:OWO\/S%.5P2Y@S/'.6*BC V21)S%?(P
MTCI9J?RE/']3*M_D*B=2LB 6,:C\. P#GA@5:*9D*C2+XY2^>!/G:R19$B+(
M7SONLC?"6B4\(47G__#^Z>\=,<*PTZKIOR5\F.1Y$H%\B5-0]HQG,:B.-)(9
MR9CFV4KY+Z'PF>WU3_-42Q*30"1I'M \X4&N$Q-HHG0:BC@6$7OQAH1T+<G8
M$OD;J_,7$TYT1HA.-'C]$<FDS'E(*0VE!!N.K)3_4IZ_Z9)HPUAL<A&(U,1@
M?(,9+K#_@TM"<JUCJD6.S*II<FO0K96W?PW 'SZVA96*C[G@A5XY_"V9D_"<
M1RIC&?@95+&(FSP2>:Y2G@@:Q6RE\Y=/YLRV]6<</44M@C2,0>8D$G0^%R8(
M,U =H8"_4FSK3\,U1FZM\U<._UVV.R5:2\:$SM.(TECQ4&6245 AA%/C$'Y7
M.G_ISM^TSD\H,9G)@R1*4W#X>1J(G.5!*G(3TH01E82H\QE;IG#;K^OO:WD\
M@ <<G?NFG)6C/\4W* Q%-%B9AU1H(@R&BQ718<030M.5TE\^H3/;8YY1EJ3@
MT0>@/L#1CS,1Y"360<QX++(,,S;(D$FB-18N&37!LS]_*DIEA&!,@L9Q(C*E
M6129F##)M4Q72G\IS]^4TF<DI53%6<!DK +*11AD5*J 4RI@Z4*5BAC.7[06
MW1Z^9PD\_85=U4_ 'AB.><^V]M[&^[_>!/PB(NJNX&96(NKA1-2[,RN>K)FP
M3;9/_J:'FFFN9!@&(>7( I"R0+"(!6%(2 Q.9Y()]>(-6PNS:"W.[@J!_-JB
MXB&"!L_JV-X5>LKJV#[LL=UJ'UN6*<8YU4&J$0_0Z#S@#.Q[L (H4SID+*:8
MPPO7PNAI'%IO=4SUA$?4=H ]8@/9G=_CETVD;$@YZ4\<.@3O#V$H%_RGF1.>
M6$#W)B#*#V Y-99BH[$2*Z%\AT+YQXPM)23!Z@D99!E84#0*$X30X$'$26*]
M]S1D+][$F&2)LQ5X\I(<QP>PB%;'\4&.XY2-1$QH4I:D ;;4!52D<# YBX/0
M")+0T&2A-B_>1'&\QN;T53S*<7QXY.2;,IQ7X[TOK)=K,9U?&QCM00:WH\<=
M,1Q^ZWSGO8F> L:Y=\S"7[91[ZZF9 GUTW)9B[!_5ZKH#E71Q8QER$*A,X$]
M?3&2_%%C0!4I%AAF*"-"A#F2_-&U- K7,GI7R8"[TPK+!_6\DGJ_M-1[ *-\
M)?7N7.I-&> @R42HM0QR$YN IBH+>)SJ@!D%LI 3I1EY\29)UFAR5VSGCRSR
M'@OW^2%!+#M/!69X=]#Y<]([[WAXK;7.UMO=G<YI3R+*,.P=Z9%VY;!_VM-6
M(B$H[[CH;.O1D1YUSKKCX\Y?GS8Z_ZMY#W[\+"WJ= %W&DB'+>R_Z3!S-6+X
M>I!<.3P:=,M[SH?UP=_\S\W0'A+P:*4F&:5:BYPRRC%+]_^S]^9-;25=GO!7
M43 SW55/*.G<EZHWB/!C; \UA2C;V&[XA\@5!$*BM1C#IW]/WBL);>P""WP=
M%11"=\GEG-]9\BPX2!>"*35!K/ T)HKKJN*^[9RZ9KL8SZ=RO)> DGFKFJEI
M)YP79;GJ-^WP]U6QZC=EK>HK4+WCB8]\H6#Z\ J&[\YW=D]@[.]H8_.CV+Y\
M=^")2+F0*\K;"#]<1#H2AAQ-'DL;G YI;8/50>"M7P>,P"0M^%2O314KN"])
M8<\"%4!4CFM.3; I264XEX)9P56L2.H%D%1C<_L@*L\U=AJQ@!GB"6/D1.0(
M&YR<T;DV P<#P^#;"6HR%_:>Y&024) "*'( 38$Z;7)FFI046RLIJQ#J19#3
M[I<#FSQ7V@L$6K?,%<%#K@B>D"'624&Q8I+FXV5Z.SG-IE?=EZ: =H+4DFLJ
M!-=!&@F0Y0&=&*72)EO1U$N@J>/# Z*)4]8;E"-:<R<8H"D%\D_F@G<T8BDB
M7ML@4M]&4T6SA+D(_OO2%>->>.>$H4QSA0$:,8_:*T/ 3A',573U NAJ9_/D
M(!HG0JZ7Y:P!;8HFL#(Q?*16,FT!,3S)4>Z$W$97A48/ #6DIZ(SB(NC4 90
M[D<-7IK=H@>-SPK_H!?3H%5K-;^7XM+%_GF,[1LKTX-VQ8@.)H),Y$II%W7A
MWPTD-U+ ?%@Z7 U+AY<T>%>_QI=B0'\W4YPB(;"A_!]AT,W=2GXYHMGZ 41S
MOGV\?;&S^8YO[_H#++24N?R!9H8B;CS(-B,=BM9PY20E45M0P6=M^ )Z;MK:
M:#F06[0^2<8IECH&JSQH](K0Q$ #JK;V:;?VY(!83P@F#JE<48=3SF!K@P55
MQJN<LNR\R;K+_-[F]>N59GT^R"N[".0-G^7Q_B1,=..I;;9[99.?'MQB6[EG
MT.)60.NUK=S?JF];]7LJ0<Q3CL%J!#V>.>HL5EY1B2-W BLZ0U9S?M$YJ349
MAK"39EVCE?"Y7?A\X8WCDP-L.1CLN3]ZR@<[0&'(.4Y19#A7Y8J*I #$1MGZ
M=5G5(Z4F=TQS67)<R9NA,REW.^N$89NT_(>0NUR-6I"5C6_NTS/L.J?<RVHB
MEKU[MCVPW8L:I67%^)JM]0:NUPS-_-?I=E]#[]]6&WBX?UHT$/N[>=HL8A5'
M_=BN9<BRA=UL,21@-&YL-(0I;KW75B0=F0:) C) #A.S,:%TDA6W&N_OTJ4J
M=G,-=GL8=]+73FY(MI4KLN=>:2,%<LR&B/YZ?/BC<7C *0W$)8EPD*#W64P!
MXBE&V H7'8Z.\%PV%<]K??]G1!L1EK)_4>L=V6[,?0:;.0MH^-UV#/\ Q-<^
M=#N#L_7QQV;9$[ 5;3XLJ+T;=#MG$4@>M/=1P\$FL.G;3SMU$ V'.>BK \28
MQ4@W-D_=H-N+13LUH*7L,[9M#[19M''K@4H)7 $LT,NL/_/$R4Z&^6FGMGN2
M^PSZLJ=AEEJ3/0QA%J,AIT$7AMP=-57L%9SP'_]+4Z+^S+[N\C6;Y6ORHS>;
M]K#= 1;WM4\@Z6S7']6 2?/WO3Q66)'#HV(9\I')Z'7M>#X[XW$;QJD>CC"W
M<MG6:SM3C1?KXV:.?K'#/#^S,^7O; X-K!CJPU: Y\ F92!.T;OO/E)6A:@=
M=X80X;C/_E"/.8TB>@>VJY2+.;HR"7\R&GSAVQ\/%-AZTB@+[$\8XC$+XA ,
MXH033[@*GNEL!:Y?E^@\Z5RX#]%XE:QR 3L:-$_&@3%J%([1@99&O<<5T:PH
MT>R\.0C926TC1\I[ELMP4F2XH"A1ZB3QU%B>JW*L7U>#<T0S()BS.P#L@Q:
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M5* D*![QO(!-& 8 ]VB6&0%S=;]ZU@5:%P5J3E1G&\ZE5\ I[".,/JLQ957
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MF<.OU2]M9$=_U(87'%Y49:$726W&O?#."4.9Y@ /!F,>M5>&J* %<Y74?CT
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M;B/WDJ-\:H-R5#N06?((3 6BM+38&I?=L&9]OBG&F,B*-*E8ZS5_U$Z!;(X
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M'QR=YJR]6Q59_&)!X^'-$!N7)W1[\^1R>W.+-XZWR0%V(DJ9++*1YYA,G!#
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M'F$AF:":*F'<V@9A-_BC2FD2^Z.S[)=!3N^ !T!(]':Z?W=ZO8JJED=56^)
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MUD"CR_%GG50KXL"[H/RMU[9@6IW36/.V%WOU&CRI-WIN?E(W_L^@F1_E+FK
M1[95:]GS7AY0-QX.6F78SGKM+2@!%E[RMG,*"W51BT.:*!\2876;6>_H=\K,
M)M\\L_V<NE0;C[S(-AE_F1.BIKX]M?#05LZ#@F>$"-.#"9UUNN7RI'QE,R]2
M#G#]48NVVX95RL^ R^TXU"C/JUX[/VKZHUJS5^L.VGE>L+-YL^&BO./%("[6
M:[OP[M%T0"GVL#"3X_O/WM06]6J#LSPT/UR(5OP>6[WAR&;NLVT@[Q;<?IK'
M52PAK.#4PXI$L'(?AMO@LZH6:C;?/DKS&BU1+[: D [KM<-A;^F\EC: '&L"
M/!:2OI8I;70]O*M0]8IV!Y_[\+^B"A(,=M@5I-C3AZD<J\-.A4B:V$58^2]@
M7HVF#)LSGBQL,%"*+;+M1L)DQ%QYP=:^K']>'W-8_\CV:_\#6PB3*S:D),C,
M)3W;LEWX8[=KVX?E8T M!V+]'$L#CV/RV\GO([K8RBI#&S;L$Y +X!<,-41X
MT0(VN!K!'7EAQ /U(64N?-_GV/W>]/&*)"= I]4\;?;OSP>P-M]A#3)(#5,;
MZ[7>P!T/QVOA(3^:IX/3/-)KS=\2JF8L8)\4I29K##%P;['VDDD%FH235BH>
M%ZH/5Z;P=2$?DYR7%WB['-^;8DFFV/*?V!T)._C53];90?27TS#>@=E]<@&F
M,#PSS\>+@T!24H1C9+2UB/N0TQBH0I8KJCW3) 2P<?GZ?-3&_WD<5 *8CQED
M"C#K(_ZY 'ZXHM3\Q4(HO1LT3H\@@30<O:)7RU(D7)-26;\F2ZX [$5?$5,[
M!TE^KS3,1[+)53[F+7SR%G3O3[#,AVV X_!2LBZ?G4LN<Z:EE#$:ZC!*E(><
M->:1,TJA0&60GDO8)KRV0=GZ?"G6VC#'LGXO(B $3$9/&=5@0":A#04#$I1@
M:4C"PI*""/"("&Y(RJV(8$E$L'=@O"4J) :[[DUNO<N0LR*GVXJ0@G$2PR9L
M$+6.KR6">^=D4Q4,)\DZIAS'#!OFD^6,)\ $0U-A<A,SI -B*CIX:CHXWCXP
MF%KG0"SFFO Y[=H@PZ5%6"O@4\-4()D.Y (Q.::#854(T.Q;%^OW4,9OSJ!>
M?25^K*GWLI;9[ QZ\RJ[]=U.KU>(Y _=SN"L#C?!G2##2\MOL5U;FJS%8[*)
M6UC&V0-><-A0?\YKWDQ-G[7NJ5R6'JC%IZ 8]XXZY[ F$;084!W \':QU3FO
M#U6+V1GT0 O/YEJG"+&<F\=YLP^#A7?WX9J<&'.5*0/*2Z_CFX664EQ6VNVC
M8=RS^@=UVE@00<Q$QZ,RVG.;<C9SPHDX;&ZK_G%-##5,8OCKSGC@%3(L1H:M
M'SN[)^> #A<[FU]$X](?Z)"\)]:@&+$>-HD$Q0XE9205+G)BZ-J&7B LIDHS
M9 ,.M&,'AFD;#+TCT'I=C.TKCP(HOI/!O9W9)DFUS@+-^-_#QWT^BK%_'_RY
M#D?N#4C/Z=?>>KO3 /4<L+9S5O#GYWP44NC^?V<C&19DTL/TVN%XIQU'UMJ5
M:P5,_%XS-&WV*M9KMZ]8?>A^B4/_R<+4P,+_-7* E+Z;_]=L'X;.:6%T-?N]
M*T]CZ:DH[\@^DK8]A,MAF0J/1^NB4)WR@T9]/D<O\:"ZE.['2:K/0@) -L)_
M!8]8G_FE(/H1X()X*)PGN3)3X9^%B^&!Q<M*]U S>^Q\?V"[%R/;%)[7[UU?
M=.<!%F(]@WFOV2NLU(SRO=I1;!6#GG!KY@48>@0+UW :M,-HS:86HMA96,&Q
M[_$,=(U\MA5&.Y$Z+1!JV<%3'.SVKEN>H8S-^U\\]LWGMS5%!)+CU.=EDFSQ
MF#]R3>2FOP,1U_YSY&D?RJBA<^T__I<&4??GL.[&]/G2?S[%N&\<Y011CY$[
M'VW]_^Q]:U-;.;;V7W'QGCDS4X4RNE]ZJE)%-TD.76/324ARX$M*5S#XPK$A
M!'[]N[1M;K9)<&R,;=0?:(*]]]:6M!ZM)3WK6=!L<$DZ\:(&S:J$GP?='E/*
M^VRI!Q;RYSF,>35','LU=LSRA&=T?QSES<_^3N>O7C=O^]UX!+=N0/^M;?8^
MV]9YW$VYW[<JL]CJA+=YNS3DC9?S_N"C)1,'6?PY7N/J_==,;(R)2.1%EIYA
M2B#KF46$&<&EE"X0.7H,)KT1*B7KA<V:U=+!92P$S/-.G-9CJC/WCL '^B"9
M&"*JQ:5HC:RXULBTC,!E<+X&];DK1(!'94AXX$SJ.<CL TY'46XIRBU%N:4H
MMSP=2E]'?,_.5;[QYF["M-O]J*+4LAK""O^89E>0R&"]X8%IRY4(CK+ ! /'
MS#-"R*]*M8!+?T==H?\%PI8M[\_;YU54/AXI['3>?/<06=\+% X/>Q$^CP]'
M&*M"9O^U>&(H* YQPWNRWW[/ZY6PX FN'^]_W]WST,9]VMCSM+[]]J3^[M-E
M_7)44'R'-K8_-P^V#Z\.VG6QN_?^LG'\1L SKJ!-I'&U?U'_\O[B8&_GZG^O
M=L;+3$?"B%(,1:%S#H_0R"5L$%4D:I6TT X/<G@(&]N?G$G7J:B]O'!08D*P
MA*W G@> IN"(B<9B;AG@5/A%N9<"2JL(2J,9-MP19YA#*K&0JQQP9#"12 2F
M%.=8JI!!B6T:/5ZWZUE Z0D48Y;&7<P[?+5O>8LO[_V>WFY^%\V8!;E9$_=8
M"P3-#X+&I6-(#"EJ(I 62B).)/A%'%.4:*08<Q6E]ANOF=PD9N;2@44Z9JY6
M^%1^1;'"I[?"$4? 2RNLT#C3JA3B43+D B4(:PA:N'$R^6R%?%.2F04IET=!
M9BX",8LWTD%_3][EGR[/^44*(ZRF[L%B]J'Z\'+PVR,P>NS4N0#T_ !Z7 +&
M2!R4QKEZE:"("X^1C=HA3;&E/JI$C-IX+0"?QRFP4P=J2Z3M4A!J31'J5YW'
M@E#+@E C+F3*E*=  P1RSB)N<8+?!$/,2JFPQI[1M/':;#(U+M:R? BUB-+P
M$SY=A6VJQ@^YSX-2%.;Q(SK_CEN+%>$)NF7EUXPG]VH'I3/[MVE9.YTA;[^B
M[9<%9'X+R*=Q%Q?C1+PAR <5LH@T+" F1"23$4(%A8F8@XO[)#B]#!7F"RB^
M3%!\<D>Z@.(B07'$J]:!,!8,0Q$&%KQJ"/FMQA*Q0)-15%D9XNQ>]?* XN0*
M]#_1]2M4^Q=&M5\8<760F)/3M28P./-L_ FQMY#;"[F]D-L+N?W)R>T+'O+?
MQ] P)^BZ"&MIEE#+_*6L[51([JO!)UT*VL?+Y'ZVZU]V2./X "*$UE%];Q_O
M[M491 D7]?:GRX,O!ZW=[9WO!\=PW:BZ>GO_^_[Q)]IH_WFR^^4-M..]J%]Y
MT=C>NCS8^[-UT/[$Z\=OV_6]+3R)D"ZPT9XEC82-$G&3MUMT\D@;')A-=J#[
M^@#WL]0@+2@R"XIX(801D20E*)>)6!NLYUZ&$(S!.&84F:"M55#DV5%D9'_"
M2DH2]@Y%83CB2G+DB!=(6D(<$U1$$S9>,[6)V;QJ-*P6C7S!CMFU/&U6)BFT
M\7N8XZ@3BE)-*#'<,V&#]-A2ZJ0+"HN?JGP^ GR&O9^E_0JR3(4LX\1PQJ6V
M%J#$6XD13THA%T/6PO$ .#;IZ/7&:\+X$O%1BY$E&!ZCM"52P'INC0V&12^-
MYLEQD<+/5%2+D3VMD8TLWR+"BBVI1SB*A+C'-.=A,(2#E$'1F+3TN4K)0Y)Y
MJT3Z7OJUN]*:C_VS7U^\'QL K1ZN+&#QON[^ BQ3 \LX7]FE0)/7$CF>(N(Q
M>.22T"AYZD+DSEJ;-EY+.4[E>-:MA1=N90M8O8N5S6)E(\NW%!!A8T(0]LHB
M[AA&FB2-(J BYRQ@ZNW&:\77//1>@C.P2JKT;C&FO]\O\E)B\44OYV,;@?=*
MD/Q^62E8W Y8P:*IL&B<OAEIX$YCEK=622Y2'9'SE"&.M6+&)),HR04[EBB2
M*':X@ 6_V.$3V^&(3Z"2MLDKG\_U#.(4W ' 6HT(UQ)K9C@G%.QPA=*XKXE[
MT-@XR73G]<VUW5BX+C,*#DHSO(2-A6D8U,_ABEP/R%\P'@7PI@(\/^9X\$24
MXHX@&Q( 7HP<Z0"1D(4US$5CI2-NXS779CD4K(K)/8O744QN%I,;/3;08%DZ
M1<1<K(KS*61S$4M*E$R)!6-SKJ^BXV=S:RX:M^"%?:NJE )WJ?WCT#8[__Q7
MJ]M_$5L-2[; WXS#.QB%_\ 8%-+1_.#G<&S%5TQ$&KE!R@B,N!6PXGLED;08
M4VF<#!E^Z"8VX\5!ITZ**AL-2[+1\/B$Q6*-3VJ-(\Z "3Y%FC "/QN< <$<
M,E0S1*22(G@;O6<Y;YN:9:+JK&VP_[;;@W]V:@.)#G]9B]_]((LMUXZK#7[_
M-2=AC4.2!3@)PX'Y8S@N;X;#\@%&95C_:P)WN6#3%-AT,NXI.!A/9CB23D3
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MQ!TWR.;02\,RPZDU+,4LJ+>IS1QV?9^_[%;!W8*[STY>+&C[8M!V)*Q.#-N
MK4#!1XFX"!HYQ@!ML3,I"$\C39DC1&?G"!7(+9"[)I [][JN!7+7&')'3SNU
MMY)PC0BEX. 28_-.ID(0-6&!F<1*LDQ04F+.8OM+4UQV1'UCYFJ2#U_W[$5
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M@*YBK_O")XC_2J2R%N. >)(6\4 $<IPSI(P'IP=&27*($!K-UO@$Z<5^'@X
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MK0U$#%]"R?CI8-(+2FWD3CCN>/3P/Q&"MQ!V6FWE,-8L/M3*PN1XQ7= 0VP
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M!"']#.7-_QH$)I5C_@6BBBWOS]OG59 V_-;NS<SJ[W3>?/<0:-T5(MDZ/(1
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MT[@)GK6T6 G?5VL]?\#2UKNFV.(L<)1QGZQ3,&*(&FX1ES8@DY) 8(HPJ$S
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M=#B&3)@R<)V(1%+Z+ :N.2"3B$@KRJVW7#CI9^6Y+Z,SM;2!YJKX=(7>^DQ
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M41.OKP$N$S_F.<#<?$/H-@4 'C%@_?_BH?6GQ5\?WQ3%7.1_N=GQ $/P^.?
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MYOP7TP&L]^ UF05U-@_JG^+QX *JLVNC^@W4A/UJ@)J=CO4@4O\+G-]WB[]
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M]FNLG<564:C(777A6]WN[+RPQ6I;+E@G;";Z3$_0VFT659MRQLY!H]6XN+J
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M<&2BU, >B$$FEY5S)@FC+,,)B^S#G$QKKSJRO%967^GB<IG\L,TSL2+: /0
M- MQI0(RQCHD>2#!.AXEP5L['"^KXG.EBR^?Q<_4Q8K1+Y71#\_\=.YHZBQ2
M.,)^Z7(%&.X5LE%H3T $(K%+8_25Z_[[FKH7GYC1OS#_PP]K2.D':_0(Z*H\
M^8O@UV0#1L8-45XSQ#3.T4[ ]UT,'A$2!=,4.TKEU@ZIRRD]&'^LW(3/HJ:K
M8ON5FCZ?FDXT@/%1B\01-3+7<^(>68!HT-J42 +,5CJW3:]3-6D,5&JZT7;
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M+J6RVR]\Y"_[_[/WIEUM)4O:Z%_1XG;?KGJ7DLYYJ'.7UZ*,[:;>DBB[</G
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ML$='_3BVVT%)QFOR?5]XL;O[PWO??%8;&,G'L)P:Q0'V'5,\L$1(WHHUH4_
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MU-+4!F82P<YQ$KG%FGO-.8_::!-IY<JM%Q1^G'/E M4I6ND0<30@+N W*X1
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M=)WAJL/L*FEG4BPQ!^Z?((E+38SQ-#&3)//1&%IE,JV?=LZX#](X'T1(2.D
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M3K"DGE,DP%=%/'J-G-8:68<U\<0D*F-.VV+<U+4@*Y^]>F];JX*@M8<@33&
M#XBJ)YH[[1S1U! 15+*$&>P*"+K#X5$%0<\#03.Q:V<$LYSRS 1*$><B(6N5
M0U%'3PT.5AJR\4916N?TT;EI2P2@)26PK[15MY5#'$6OU-SBT_=C: UK[5X^
MUJG]4C0J)>;V1ARO*&/OEQ<PB::3_[[7W^Z-W#"-VI,@U14Z5>"T/'"ZZK4
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MCXLC%EB5_",?0?A>/_O@O>[TZ:]&6_S5!\,IG\?DN%I^@EY[\M8X+@(#G<K
M""RT_HTH2=['YB2EB">F?J]3:_>Z1R@_\U58I3B*L$4T 95QB%;W#-8G'S8
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MTB.P^Y@T5 I#S<:;&S;"; )DO4S2*Y.Y\@IEK_,:3!7Y%45*T96PP+S;ZY&
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M(,Y)O/:.K#.V(GU^E<(MW\Y/*URE4XOIU)093YG5 &>=*KK3HL#(!,T0A\"
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M_#/J)'36RTUXO0A/VW%]FX>@K6=O,?[PQ736+'6#9^XXN/W"#>BMU]JQ""8
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MFE3O059;<3B(X6HN?6WSH!L+,5W/0_;^.FM=U$8UW]M_[#1J1;DEK%>SW>^
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M_XQP*R/6I^P/G_E^X>__T>GU[SA.Z@U*''SG,6X<P?MWM_G.EF=%1S.5E*!
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M+'=2!^=Q!@:^SAA;Y_+U> Q%+/??HL!VO$MWO&/Q<6K7B_;MJ\+U,N<00U7
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MEP2O22?+3&?4M4'N*D!O;>^HL7'#L+$D@E*YT5XA&OVCAK3E,TI$RI.@J.P
MN'4J>)Z +0_FU8GH!BF6Z??()^F'A=_D;3JM'$%[/WB/15U!VCRK,:'&A$W
MA/OJ2]30K%8CRE!?LDW3E/J2XXP4)F/[T>4NOI;[[RV_ P@!M>-:>9K4E/[*
MPR'1%RM)!_D/T7?C/.GND%/U]]]TA[XF)^J!6JI.[Z!!["-H0###LBX-J$,'
M!^\6Z5"@)LFXAQTB_72D&USA!D^Q058I1N4S<50XO,,XQ7MV<<MH '2G.<Z
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M;W$5VF=4^JNUV+?=<&-O"/]Z63]\\W]02P,$%     @ $8AA5/N/]PHX)0
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ME,Q<!P861A^?HT][TSB>?_SPX?OW[S]][_[$^.3#X<%!Y\,_O]X-1-.]M&U
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MU78^7)'8I<%&[,A U'$%-CO\T>6*\Y\IT#89EP,Z">D83&H8@2=BJ#2<S%E
M/4IT&50/0[%NNIW4><YS* ?168)T,I@[_LAY>-@BGQYT^ 5.V]%AR8I2\ N<
MM_2WW=)*)V+HCH+M,"Z%5,<V<-N.NTW8)F'OF)9.R+W+.=#W1,PV,#.8BAWM
MY,A<7T*+!9K=+K?.@9[_>Q+%:$='CR1* OP.$TQN&"?0[S+AG(3>RY"[820'
MLD7V-T>ND)/3(QD,-923'#W.@B"9;Y.2Y&0T.3FB=E*USMCK**8SS%OZ%I%Q
M$MS!THO8N!=%)#:T?S=&HY"4LR,9B364E 5F1Z)V!&XTJ"7V5HK$;0AS()>/
M)G?S/12F\GFG9$GG^K=SGHTLJ6*_>KNI@R'OPG:;@])&&RDW_-X3K'"< -@<
M!FY <E^9*3DSF/4:K=,YDL<4E4R#?2Y#@MN:@VA6N=INW=70T*V#H&"9,&WK
M6=9N$[9F@0RFC,=#PF>Y-J.7K^[O\#7Q$D[C%P2SM05IB$_!^>Z1/)TP6ZR"
M!@>)6&D[>G$$'4Y&B",FL.4"<_UG E/QE<13YF]#0RO@*1A^="2/+VH8+A$X
M$D/K%?-GQOSO--#-SU@TKS<G.\>=$KL_Z]S"Z34R)-<Z*:S(DVZ)Y9Z!:*,)
MF8T=K\7X24#8./O$3"FIX2B4$89)SBLY WYP"AC]VB7#6JB$;H'R<$)!4*5[
MK[UKK'53**6S3JGIG@%)8PLMGG=#=[>TLT);G7=+-H8"#]JHMM;G<Y#,9BY_
M8>/U+TQ-*T.P]4KM\  4VX&:@:#=)")4;B7\W6FYYHZP HR"@1T,8N@PL.T^
M\>HTWR0Q3-7:I[T9>(KT+T'J]?.<A-&&S#3%HN"UB'[H\%KB+7SEY%$[*>Y6
MBL-%FL@#G!O14!"CR^/2KO6FRB%FKA1"5AD@)P^IY3PP,EEJ -2;+8='W1+3
ML90?;31=RN9UL7L\//9ZWI\)C:CY\78#P J->(Q103U&YG; 'QU YN2P[71@
M.DLW+N6_ND$"WO$E_$E]PL47XOQ^3#@G_K8%H#%*A6B<8/Q05S20"$=0@0;N
M"AU.CI"=X%0)SC*JDIN=:-NR8H)%(1ZG(!Z:6\!J:">/>2</&HKDUH>AB0(M
MZ^:QF+C752E-D2NDYPRD1\^@*RB7)44EIGM&U$ZPU(KF@3.L ^3FKDZ_GK[1
M1J80G',,)#=1.T# OJ @?U5\)R9*>_4KK' WBCYSELQ?QW!58*@7B"X&X I'
MG!H6;(K5$6AW(J!M++R:/#1"IQ .#.X5CIS,C92=K&RTJ[R!R)AC54B.B.UO
M<9_9B5!>A!YDI:"7AP SK4,?DU#FF'42DEA3'FI!U(<3NQA.+!@1&4"P"0*1
MBAWZS@+HCPZ W3%(S*Y1C%$#4'VLL8NQQH*KH&96&P./=9-MIFUU("DTZ#$>
MKC7A6POU83^>$GY'W1$-:*Q_R[303:'W3CHEZ8 "B).#TN)Y-U)M%9T5ZNRT
M6[+W%'C01NVU/I]F&JNJMT)+G>&QL 8[6JB4[EEZ)S)NJ)YJ "@4%5Z_*OAM
M &X_A==JI54]K4;J2PFF7I%AZ*6XF=3RJ(U*K7J6S=2;&DZ]HCOJ@*(KG/0J
MV-5"I7<]FP?LA9 +$@)8[=S;0K=Z!7>$^;>%\$(&Q,F@M'C>C51916>% NMV
M2S:9 @_:J+36Y[-A:J82C$)E'8'**F0@%!G4]M3,]6F^24*?^%BQ+C'<9'0@
M*7B&7G\A+:",9Q*V(X'O^ :3<CEUPPFA8?IW?Q30B0PQ;\9%-5P%3T\P&TB'
MIQ*30\/L0R>';,?C'"\P^M7D^H(^/ 5/3S&%QXRGB*/-%Q8*<\]F<Q;B55DV
MOB?Q ^&4^=1+O[YDD6',M3E\!:\QQE'PU$IYO<"()UF T\F0+A8THMUQ'XV9
M)4<>2(@OK>48 ZLDF<VWH+M-L2@DX1PS:+0LJCSO4\RK,I!#OI,'F+3<?'P#
MD!0/F@F? <)P4MAY-Q.*1JCJ)>-8Q'-T)"//=\2..T,.?\G.OQ,/F#F\+.3%
MQ']T8\+&CR1.>.B&?L^+$S=8[-Z]($A?PMI,0IIB4PA)!U-J=(0DP^\@ ;B7
M2!+$<9\D(F=-.$LZ=J("\[?@SR(-]RMQ<;(;5!)I!ELA!B(_1D<,<CS.Y?#F
M,>X8COH\#&%%I'\]N"];X',M2 5[N\#>0J2X="L02!8:/T/33IZ*,CJWH8?)
MZ4]$O$%+(M!W@YAY?Z!A#4:4H!$<*C[1#VT:PZV//!\?=4KN.Z=%@!9HG!2/
M4-@"DY-'Y:2X=ORMYH-9 +LA]/H(]_%QM^R4H1FO6QD'-V5+TT#YQG@4*OT$
M5'HQDMY0$%H?;S?EUJ+&B&C0%\X36,'T"<"\LJ#HH%;(SBGF\FU/=G)U4&0[
M29234;43*1V^]I,8G^$&WW^"V9G/A'LT0OT\@.])OU'HZ55I4 C9&0A9\8BA
ML9#E2),IIDOB'$%=*G4[6U5/BRSN6?Q&Z&0*CGWOB7!W0A9>)/9>"TN]MF;;
MA":%-)Z#-!8/1YJKO-SUD(Q8)Z4VYQA+2(7XVDY"3?:YQ\$W:/8P^/;6&VPE
MXGI9.\' :_%P9AO;*U DV@--N]VUH6ZY9Z'G1M-"PT;5K5Z?#H6L8?RV>/RS
M%;V&F81(85F/-A?*$M;&I3NGL?:CSRM=ZJ,Y)YA'6'RB2%@X*826SK7ANR\E
M/15KJ7L$FKMVYELI[Z!&V(P,W6>#PJG+'@IIQ]AER:LLV-\1 -HYT89U:M?[
MU0<13S"(6%(@<SGI;8P,YF8QGZ8C/[X@8\;) V=/%/,FX(]<<]."F)OB4:BQ
M$[P:4,O=];2@]$N)W%E@=^#/-;%HM_K+\^LU96$S_I\"_TM*HM;P?\?Q:HZ'
M$0NHCR^U/9(YX_!O%7?H>$PX\?&U/Y$"'3/^@LD2&XC$]I K9.8,9*9V&Q8R
MLR3'R>BIDYV,*/D XH(LF4'2<L&"_UW#['BXW(<$%B,'%S^=,'#;HN'4C3^#
MZ_9((Q*SW'N"#UBN&#DQOB*R B. DBF\X-TUOHSV+J0IA/(<+XPHA!+^=5)J
M49,MZ'5R!#M(L8,D.TBS$[.5!QHSLK%_1KB FR9&H]/<]CMT.?%H7-2]&D*]
M')P>X"44A1RT^_PR-[E9GA[\2V'9@JK%7//^77-]H(2H8%\'[YLHV+?(+I1(
M'(%%!*'Z=_]H_9)[), >#_2/((F-+\B$AF%Z2">.Q'HS?&,6]#6+W>!;R*$#
M*+B_A ;.TKL:"\!VT2ND1=QD44C+*D$H)@N2Y-F@/":45(EM >ER\H0)!;^\
M$-I"^7HD4<P3+TXXS)5GE,%6VK4^T'/:[934GEX!Y'BM2T$KFTBCT$\-@/H8
MT.E1MR3,7,J/-@:#RN:UH>&C!4JA%(_QRI<>L]IN"I5-]_)$-_]E>NJU.3>U
MP"LXC$&[PCE>%8?S)\(K31:)G3O&BXE8^6P1J=B<X_5P%:P^Q;M9NJQ>_7P9
M;&DCAR_9;$;E2[9@Y5VR,(8Y 0]?OWQ5'02%_7+6*7D<(0=/&)XK$'><P5EH
MN&N:0%2LMW.\YF;$N=9OHC!5[F3"R23U^![)$PD3HLF[JM[U*^SLH%/R@,0J
M++GC"6@[;A@Y"O4PZGV%LTZWY)"^DC-M]!<JIM=,YRF U*NY,W&-TX!)+51K
M/<_#B%#$B4?H$PII$HYH$!"?RUD!CL3<]6(W.[1(0N+R</$]X_/T1B0+70DL
MZQ(8U])\*VH4:A<#,X6 6T:;LR3N1R<CS^&9#&7H'$GB?XFM-*-RT8QQ)R/4
M 2%,2<WUSE&[$\>M"X#1/O&V-"GV'8Q1%6*&[R>:;=S8WD@>%B&4R_2[S4^T
M;:1<L84?XU5]B^1])=*4C6]W+/[FJZ.A#_U>U"FD_ 2DW":MWG9G_YW$Y-\=
MN\48Z-L)\M]*D/.YD9><^#2^8S"[!@_DE'=7.%"GG9+G"E?3(B4X1\+;<<3,
M)5$ 4?@09]V2N'T-=]IHY%?-L/$#4[50%-H4P_1FC&JABLN>*QR0">X*L&E\
M)FS"W?F4 GVYYPD-GV!4PZM7@N<8O*]^EC,%+S:Y/(+\@XH[+A9GW4A/FD*M
M5YSG&/2O?L];AZ-M5*7:3&CHTS6'7Z]^ST5-J<W8W7;[4YLW,,<QIZ-$'O/<
MDS@]E!F]Y#OT.'%?23C,"5!(3Q>K2FTJ/7FJLFKEV7'5Z&6U)]*V$S)]'LL,
M:KR(U9\3+AI$U\]>D&"F]$J2T3L)X38(5 CI$5:EVK:0IJGIXHK;DO(?G07M
MJRE</^XD>4-)OF/A)( MQI=Q:% 2[R2Q)H0H)!,#_YM9SR62B?3M"P+3D/V/
MJ%%W K@L+I+,YX$H6NT&RYEGXTLWFMX$[+NY.V4"4>%0G71*7JO/P\]_@\<S
M6*D'<;34IS*8>B.ORARNPJ\Z[9;D6Y@RMHVNE0$G#$L%F0-6Z/,SK *W.8];
MJ)-[GI?,D KHCJ^78J$*3J;X7,T3D;:6_K&1$I)"!Y]W2MZ[S\%-'UA=@9P:
MA#N6Y2?:- 5)$UZMINT<''1+#F;TV-=&_:HQ[\;Y![H :_4IWAP].&FX$%NI
M15-'-)S<$5?_ '2]5ZUV1-5X<%A(.%[ <"20]DZZD<XK[ZO0;]UNR9G+.@/:
MJ,G69E/\'U^X,SS05()1:*TCT%K*!0(?B5_$$WSM/-1<F^>U/QL>E!@"5;#R
M&,N#*EE9PMMVGXC4,V'USZ\N1DA-JWMO@D'!\Q/@>2&]2X?G:Q\Y&=Z=")@Q
M2#M#<#,<.S%X S' :N<)YS" D1O^X8E$G@##VV[H!\P-QZYG=GO* *#"CCT%
M.[:@VT7Q<PG?002.Q. (%"(2CTB<)98=+TNFWL@&-@:K,(_/NB41=&.^MM%^
MUN?$\CD#/&W")X.OR,CPD?1M85/H\7/0XX7\0G-Q6'TC09RQ(2$.4K+3[+7L
M:VC);X"@7B3 0SLX*>0\-1&)=EOY31;P#0W=T!/N].MKBQ)D"LG @&/AD&Y3
M99&2(3S]G:!H\BZUFBD6'7W;/4:%62%"HJSVMD5H2=-N]Q$BM7@:3E,0ENWK
MO8(.&)"'!;=O^;);RZ;X"<=LMN0*W13K!:.EA6BVF' !I972?3N;NUZ,&;K?
MTWN%LMY<"+]Z(I5 NYRO!B3%BCB&%5$LPRW@RFS=[\X2M+,*>\>S_&P85F+6
M!ZA88B=83+TA!UNY_AZ).%Y^<+E!9&JMDV)58?2IX(.D()P41FMGW+129UE?
MQ9HXPPKUBOEOI>S?DUAF4#P0WN<^^"[\13R&IVMR5_97K C,NBKZ7B3.$CH
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MTGV(JB$%0"J"I18?JB'CV6RZZ'Q<_'.\^/1L.5^@^]SUZ_VU0R]Z39H0,:N
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MC-W2LKC\>?D2_!S^]J?_#U!+ P04    "  1B&%4J++E*/#3   ]Q@D %0
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MVBIDG'&0UD</?#L$N,5U.+3]=U%QCW9/BX3<E\%O'P8V&0Y2>19,S;FG@"Q
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ME3&)AQ!9%CK7<6R1!<XU2X0Q%>MUDFWFAUS'<7QF[Z#G'D<GUP:\]_60?N$
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MHP_I2P0C N-H)-.2.^8%)F:3S<1=)TF -FF$'5#V$$C<]HR_3FL;K/-YT87
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M<J9-,"P&C$S%J'+6&IQK/=)A&YR'*HLX.,D:FNNQU$-L>(\6AUDH:NU924Q
MO?#..\X"6E/G%$N98I)!MLFZW@+HX>L<^J? _4O:SJ9HX&EM@K5<3E?YHVT
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M,!DMCUDOVM+>+=^#*WX0R8<*A&#">J@WC5/ 8!S2B^J"R$IP;_E6YM[UR<=
M@J;:[ON=?_)I/OS\%>)-;)%"0Y6#9,X9HJV)G+10#!-(6A&:QZ!@*R;<\Z!C
M,'R?NCQ(B\'3+U]KX)[!'$\FTWI/9-W;@M76.>*@*^B9MB4S[^I8/86@3?%D
M7-%DX]\!Y/$'$JTLUB#VW #KXG7:!EC3\.)6: \37S0SZOK]GKU:I$'4<3O
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M%[_CV?E)T%G%=CL5%+8FD)G72W3LNN@<V2X.JG:ZX]]9]!=*OYX =T@?'C"
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M9V,JC&H,0@7M;** .DDO3G9__ Y+P\VO?T^GR%1]NUR?KW_E1]%WN&;F7@=
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M@T.=C7&:)/79N"<;PBMWNX)^#WUWNV3=1H&7>:V\);2^.;Q#:,U[!=H 09<
M+'/R.K(UG8>U*-M:A-X%IO;I%<V#RZ&4G]J8L!_XES?IE57([!,IX$7=\83(
M&:+BY5U($XR(VN38IWS'-V+,G5T^)^S+J=2_CW2"]:/A5YMAG)5;^9M#QM0U
M6[W'J/:3\[X#6<8ZNW,A?2PL]MC:U5 "ERRULO@$F%  5>>IRNBM[9@@<!3L
M?2*-_\#).P;@J:L!O&5;E.<$LN27Z0<LFA(BW,A-+Z%Z$\F"JP7!E" @5&6
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MEM;$\8>K)HZ>?=\L4@"?V0,R$1,$&25(H4H4*(K5Z; TO=4X#W#WF7863'9
MW9]&AQ14,WRTE\7"3H**EDU- 1ZK!R-KA8"9[5#;$C5SB#;LJ87M5$,\HJDR
M U?GGU9;$&WRB@0[AN1MCNZI?/BT6EY\_/3=Q9J7M/6:ORLMSC9?=5(5UNS9
MX/6I=7W)1!"MD:!X74M>R4(1G[(.YQ'U=3K<,QT.D"6'%#+P)!#?QJR>Y&J\
M-#Y U=+R7%>V!4EDD-)7DPH%0P<6:#-RA*^3:"][R@XT.Z2BV$^.\[(.Y9=Q
MBAHK"5=!FEC!& H0D@N@6\]0E,2#/K#PYY$C?)U.>YE..]!LMAK:4XR34:BT
MN#E45:I/U3F0VD0PJF6(IQ3!5JE0E>*H'IO7<V>0KY-J+Y-J-[(=4NWMT2Y>
M*3Q.+1T4J068X!&2KPA.!$9(%8=TM&=O]YTE'"063R:,W9Q"&'5F RI#=JE5
MRF"G/&D5(4HTHM6R=GA@A='[*.*(ULJC.4[M1L1#RCV94!TG%%11*A3 4%/K
M=6TAHFHM31SE(DM&?6"71!.._HAFX"%,@0.<SJ/X._L)[X.Q$=\>WOUX=L^Y
MW:--'Y#8MFD5645 #P9C@%BK!<PJ1BU-)1.G.?GM-837J;?-U#LBVAWQ4?+3
MJTYPN=3,5I O$5L DVQ9JP8H4#'\KQ)'=SCV?"ML'-#\/3@81S'YB(^S!R@B
MRJI#J>!KCJT"F( H#-L5IKV.*K-K<V13>J0*7J?T84[IGDP^QB/UBQ7=[F%[
MCQ:LUQ6](3">,FLAM:@/44!3<C:'ZF,51S:?QXS_=3(?YF3NQN'C/,0?L)JE
MA(R@AJBU9I]#>S90VBUA=BYGM+F& RL(T>V :I]IUE1L0>DR"/063(D$R6D'
M241I,PDI>IE'+S#->J=#]KU ?IAIUDK:*H1B2R@SL8R4"%ALBS601#I:DREV
M(>TS2[,>Q81'TZS'('(L":I#QO2:9KT8GV8]BBQS9*IN@_2QL%@'%U'I=K8K
M><\),D((R4**N146PTBV3R?;XV'OJ#3K@R/O&("GOBG[A59UN?J,9YDV<O_&
M<%QE[59GM%/) 3K+>M)*L5CLX_"/6$MDT=W.G7O@*NOA9QR@+]P=P.7TVN^0
M<O:>W:#5HE6EVN39-L'6[W_][5HX_L?(+$!C"6"(;0^L-4#B*143>I5*'Y_C
M4;%>,)NFA^W!A>9 >FFPJYYQ_>G.+[9B:F=KVD__C(%"[;5GQC:*NY6TK[1(
M/A4,N2A#40;MT0F/50GA!.$N?3(&BK?W''X,R2.I#$8HGJ4I9X@8"R2*A2T,
MLO708L9_ZIO#?Q)D=JZ*%M/L#9B6UQF]0_#5&I^MQW2[O5E7C1S@;C MJX;9
MIJ-@Z9&[/ME9AT$1E8@9*K648>)7O$TF$+P(A123R;+3C'N!!YT[$7$OD!_*
M02?O>LO/].LYGF^^]Z?V%]J@F^LI*GHLJD!.Z%BU(0&/P4"IK=Y22L+E/DOD
M(T(=_R'H*)8L^Z#5X3#I =&NO(0APG4]VWQ4O/T<4DX&YC"2[(#$['2QPB#Y
MA&!<);8"@@0LTH&D6B*IBCKT\=CW0),G3@/WPY(Q '1@Q]OE^IQ76CRE]=5A
M@".9LBD(TI7$JV8[!XA105#9!_Z1RJ9/<[\[HLQOJ4\(U7)*/?>PO^F4/_KX
M=SJC%9Z^.2MORF?6;ZN!WUSS*[?Z6EB18@[>2L@E\U8J)%M\U@M^&U!3$>SA
M=XKI&"/F<R),/WRFOBKXP/;8&O-&T6>E=?/XN+IY-//EX!K)AL(V8+053.4_
M@@L%K"S"%?(QW;[:?^#:8-CSG@,7>JGWP4R/*<]P-Y;Y6_Q]<8ZG.YRZWO<U
MNY^3/BG<K9/-0%4:PNARC28*B=+K:(6(T12CBS^Y[PMWK'*\.2M]>XKK];OZ
M846XOEC]M3G^_.J-&Y5"DIGWD.!:3Q"I(%+2X+"0+&A2K'W\Q@'"[;2F7.;1
MOZO_OCRG]8G.F&I.H1U023"^)0\6+7BK=-*BB8ZL'K1T?/.U\Z\04T/ZS3JQ
MO<IZ6!=M4#^NUQ=4_G:QXGWL,A1^,TO6;S+K8;W1]?HDF!BB\@ET**)%BR;
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M)Y_RS2%604"0M@7I:JFS,+FH/JGD3P@V/ZEF WD<N48AU*V3XUVQJHBU*N6
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M&47)A*5$DN; %65,A3IW51YC.0G..XJXQD:_3(9N8'):V:R<(EJ4L%:.@5A
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M>B:?<PSZTX:4@?1F?G\OOKF?99@PR@:BE% $-UY/0G&H)8BH4VFJXBJY%<T
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MT&>B:HIJ53N377.B!2[F/YO!!.OI:X@65../JGG"D^DD73U6TY%<^$KH5XW
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M4>@T?I 40ZEEX@NG\3XI10<'-Y?),\Q8IQVDW1'C6!W"A J;F_MBZ_%51?
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MW<T"6N[U)-PX7)!VJ9P:/"$TRW6MG\Y-WT%J/J#5KAP_WMCG2+-_OD)3X/'
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M:7T>W/=;*E?4*2@K<0J$1V?B)&*Y]^LAFX:^$_"23*&RH"?:*6KC\H*FB)C
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M>[=OYT8^_'J#$(:&VT4O<SUMG9R".>Z]H_,@+/^:X/"?+5,V^ZGT5RT>JA2
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M@G2'BQ;:"ZR8[&</S#2.FCI+ VIA;7>6?.[/X);$$!4F#ZGB$HUHU*K<:<-
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M:K*VR<(,[V1[U T.N.N[#U\ ILGFSB&>,X,]FQ6RQL K<6Q/:VO^EIG.)NX
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M#176^AK\/[:>X\_IQ$G]4:8D>'>.BS6#='(A-'L;PH.S,4IT]-I%X'([W<O
M[R_ZYMD*A':FCD) 7MYX_$K@R8C"3/^NVBL/:.L!=<_B:;)*.;J([=DU^7E4
M<)Y,OJ[#]8LQNY=?9XX_)8NM49?=/&B4)XQL6/I+'7?<[?PF+27+=.[9>N@
MD=''!YFO-TR@K>.'5H.&HV?>&/' :S(EF0L'C+L00^;%>VVHK<-'<ZVX7Y?T
M_B?>4^IAA<H^?U\ />1]_>6()^.N>Y'+KO(")IXX&RN5F*'6.)T3H4I5;.3C
MVWR5<ZL;RE $&5P<.,V+4ENO1S-U;6[FYO!16)*NV7R(LGYFV1,SY>N4V61]
M^;#BL4@MW2;5IQ']TU.-KO%]>9/U][>D47/AO$0S%:?'2NG-D3*EA"[?47W7
M=Q>CK><-DM@=:8RFCS\T3O\#%(A7#EKCBB 'HU&PSKCFSZZ2D>N0O3;%@*=\
MA!>X:+8^COR3C-F4*TJL$MFG(9">M\]K;VV8&/(LJ8"=PZ..FU/AY]_^8]1:
M<3,J[\8$:2#QNYV-$YZ0%X#Z']Z_=;W3$-YI:H($UGQ[S:P,M5$<9\V& 6P'
MA /.ZJ/X%)!-9H,7Y1QU'A>4;ILXAJ\8TQYY@6V@H^1G4JYOLZCS,^><,D_I
M#'IQ\;3U="[=N4#RC"6W_\>R<.J9F"_;,CE["7<4&5ASX/0W+JKS1WS![3CY
MG"0B #W 8<C* ^1'GUDRWVSK4Y)(_OJ3YH]I*@7R?*?^C./*E$>\U+DK3 W)
MLXYPL^?EIFG74A[]>.J.Q&$>Y[#QCS%T3EF89@;[+16!9W,JYR*4--.CQVW:
M1VR]\PV,(^6UPWN>HBJ\,Y4]?RMR9BQFK]-X,655J^*[V$D_E#N0!6'-4#X^
M$^27WDG9B"&I8*;7$NOFQ8PO9!Q9" [\6A2,%7+V<-_/_=.YH^BY?&V!_*RI
MWD>5]([>I5YB?!+2>T3U_[O\@0"9O^%R1<4!X_>E?BR=A-?7R,@G:8#S_8CV
M8DHT_.H8Z*[(6\TMC0HUTRM8"Y)'MK(>H/P+BXC!PWQ'IL314[N\"N^;Z48/
M_P;JI?Z$)@T(ZF$%".[]<XQ6%;H@(JC/<*5^%UM]39K>CD%8)WG&#0+JJD3Z
M(!\T V,KK%:E9+S!S/\#F9#7UT#[K.-NA6ZUV8%SH'HPQ]EG!:),L$ 9J1K&
MXU;0]]>DZ+$6TQ/<)2$@3$-PX+*7NMF"?6Q95FW'[3JLP\,"45K$)#"GLK*-
MO"J_*"')1PO_C%%IU&H)-TG3 N!2!Q&H5"T'"-EX^LC]<S>/)_9O]MW:Y"S0
M+NW1&\4-G&2YCE1JL[+.^X8W#67\M(Y_]- E7AH :?J0&/_2N#3)R0TM_P0#
M @\- WX:%IPIAUUP>H#%7H\,T&:S>?'B&Y&<;2]5Y&*E6S&E_3SDRA$.WW44
M^PN/L*:NJX<L+O)"B%5E21D[M9  V';J"8;HQ20,7EQ QKR<^?\[$5RV&)(+
M+IP?]O)C[D/^PMI?=>3KD[M2CG9"VJU%PFG$D=RG\IE[FA3$5V'!/+W!KB?,
M79C77'FGXDH_8U(#V?I-U_GPF=U41A2_44+)]?M.")2<^;/'ML=_:VN1R/\'
M;F! ==>#M]-F:*191P8 KY8GO[!ZO"_XT]+FS&AA(8B!_9E%O'?M@MFFXWJ?
MXSD(),+Y J#.2GH!&#D%[%%GUC6G"-]D9,D4_6N\W']-A_7/>FN_8E:;MN5"
MRFJG-VU>,@#\.W>DMD=)&:K:4E\UYXK??IF@6Y7:XROF7^R.]LW'O_UP=?V<
M,L++E8WM6E'>RE13JB:H]Y88IF\<^HS9TAJC73O%MKWZ[(SO;,J6W48D[/V@
M797"OLMK+92\+3A^I]@F73X$.Q"RK"P"N7L;KC<JZM^=T1E\UULKVQ7YINT.
MWUQZ0M4\UVQHF!W_!.U_2PMYO_05LE6+,QS8&'E+W?[Z!= I1CK#ZW#,LL(N
MR([^QB6>8'!/3[+'GQJFN/Z$!>)E@';1"N5(NI/'TRYDMKGW^VCLQ)CX",64
M[LR)OQ?1*;9N.4N5.[;"T  :+X-> %9#EN\&!^4I[JX!,ZTQE'<1/<"06MOR
MX3>E-WX4O&0NY)3:_9;H=8'32&N+K=AWDKXL9@4&\Z(0NOK#O-_F21%RDG]E
M$"YS.:/62AOM^#:X!QY\U6D%=83.(I'NJ2[=L9Z'BE#10(V2E@P7S_1>(ZJI
ML?RR0U)M.#G4; 4. VTK5  ^?"!9S;A09N&0/#^-L#>OCY>#W@@?DC!H\(8W
M0%;52,Q??W8<RGB]%N5!RA'TR%%H8,B79(:=JMG%OLMEI_Z**4CYS=MU[ZFK
M<<"=K5Q3O"T%.R^(QGK0G;TL:D:"]CMV3CY4],?"S)1&[%E E-M#)2'HWBK,
MWK>4XV,<=!8Q_'N8D>'3X,_R"E1GENGRU#^^9!M@KA? @ZQT7<S8SSK%#TD9
M7Q:2)&DYB@G:K4H6#BA-JEM"UJ66J'X[+NG_011IV^]-QB=J%0SSJ$E+5OU'
M() R"9&O'B>"PE>8Z6ECZI4LO'YZX[DT;B%CJLR']6JSWD?+C"'X:OJL;I7J
M[4ZW:Q*%HD4U#3>_N+; 57DDS$(=2Y^\Y5$V\3!OY4-C\H0#2D(PE]=VHQW7
MJT;+/RNU&2XJH0B*$9W&7;7ZNNC%29)MZWAM(IRP>UP8X%M/RR[!+Q&J8O2N
M3\FGPY=2_<O*W?2Q 3C&1B\ 8#05TC[."NMD1$1LG#R^VO)70VIYL3-5;W,G
M+4^2BYD3EX8 W$IZ_9_0V;XMOFY/VF@KN3\G@(+(@T\RZ\[<68[,Q&)T-K<Z
M;,4+^S?\.MWWPEJN\5+!,YM6F)?L&U'%(E0V^_J=4(.&4X*1N:FHLKBZ1M;^
M]S!BNZLM[-_)<YTM6A45O)QTRXW^-E_'6;=OA4I5E?U2(1ROG&<G#"H+/7_T
MDF8<.K:XA4^A3 'E#H71%#\R7C#2D'D$ <8<N?6,T,^Q&MCJK-T$X-NUTPS-
M(4R/.Z#&CW%=WV0X?]*0'+$4QG0+N0+CVJ(JM)2ZFA\^I?X5 SV+9G)G^=>S
M98>X/A"[SN?HO=ZO&6(E\=W($+"[?P' ;-)[Z]%6;_G^>0!_./[W%0\&X)S)
MA/](%-C)P\EU^V/0,OON!_.+WE<#I67:JSQ3EFU!OR]8TM$7BOD0B_N ;QL>
M;LA!;_<D>7YQ3!;/L(&E@':D&6J_@?I>5,/.G-_5QC]C3S9'<*#9XMA +;:2
MI1:!!V_D8+O->N8-8?V:F5N7EQ3SR)ODVG%JMAI9SM#D?ZE_COE5IDXYZ%NB
M\FO""]/4NK[AFT=:51+$%'M>#&LTZ\)A]L^/(!JB4!RB+2M<\_7WRMQ_Y\BP
M@WAOB"+$4G^,39S !B]-+T9&@X(E )LT0;UQ6;;*IYVWJ\ G2#>R21G0P.)=
MY<GD!ZH7 .4XQ?[%0#.[FU$I92!6KI7S-MM);M+WY<]R:$BSR>B'BL5,8!<,
M6#XM30C-125ORYGA=4S(E3$U(\RBKJHE^MG5)(F#D(C6N<>CR&8@,)/]T8EN
MM"(3!?9^[[SSV(%YL.+9THNEWQ$;-1MH4#;WM1+$;D$87=IF;/Z+Z;F'[U;,
M(Y7Z\J8RI:WHJ=W#;VJ.^+;4+0 'DT.]OBKT:_LTN[V9%P&;;W6P^BO:ULK;
M8,?C#0?\+Q4!-GTVDS9YVU%]>RU**80/%R5A7C)HP<=K6;:E<X\<3QV(*#[$
MA:!8'TK=\,=H%S*6:L/\[0]9KVYR2XK>:9%Z$QO10Z8T9W/3V'REP65^,?SO
M=15Q:S[K1HH9@QA03^)M3N(08 [IJN??9S>A98; _9OJ<9K/U5'A] AT!S?3
M-1:KZ.F6VY#=^'VS"*GGB89HE.A9STJ1M./! Y*A8:S0TGLM,$-G2^0]_.@7
M=7L+.F\4#).N<$)2F#'!\YN@P'(^0X62N/MB'*C4.GI7N>.'YA3X%$Y<1X03
M3D-K]B$24JNZL"AI8H%96& J\%$B+F<O!^.5AK:L>GO]OYV:HNV>7[DO]'68
ML+AD"3AXV*P->ATOZI6C5-B<;Z2&B& #7FY>?Y_@F%-.?\!^%J-MN$S$YC*(
M*@C,[F_GZU&KG6%[?!(Z($NMC3H7,,GN+N;\&"NGYA$8-;]+!2PX&DS4G-A<
M93QCMC:BJ@NYV+]6S-3OY9LR&IFPPVX^DU#+P,!;:_=Z;LP_F+(F[4\KZ:/1
MOU,#+BZ$,?C_[9]Z ?@^)UWCR52\N=;N&AP<P^3-"?_Q)@KK!=">1,4_"]<$
M$0]C$I[$T("E/,4'H'T[-1<+].7%W:R\V+4\0V3,ZZ5(:Z@$K6<)6JTSK+P_
M/.-BV.]^QK'V52<2H'JI:!A]/QM@#H[G=11Z8X!(,I,:Z],:-\"P3,B<@6F"
M!(:$]X0@08C[Q4E=L^8L@:R-&ZF*>?;5']/3U_^QUIP@J70/Z)Y;NG^?>9$M
MKN3N237"C%_5-0ZWF>,\?TMX9G= ?=EHH,\4X2[2:14)'KK>OYO23V!Q7HGM
M6L=^-U ,+ZQ[]<U0VNT]KEGO>F9'J*B0IDX'QB-' .\&E"3)WAQ/$=>@)L<W
M9!6?'&D N%G?3A]PC/E95%P!_-J3I]8+I<XY].%KG$(%V;8 ,GC@UT&(H>7Y
MZJYN^!:G9[-8'XA291 A+47S##@)6.=M9%GA3L@B$TAWS\:R<V@S1)!5OC_V
MT1_*Y2NG6-"@+HO5ZA2)SB ]/A;A+ESP#*Q/U\7P %LW^'(N4FO$OKXBZ-DC
MY-O4:]5S]6/?_3U=(.GF%%!C\6Z>6"E4X'B<=]]QG*#79SW._&M<L[*,9->3
MM-32B:V\;#4=OIK>_Z;?#\' W;CA#-LUF*KG%V4\B]\7;0]QFR3^,.HHYQ&B
MYJNBI)7PQ$2MA7DU W(=(]JS2DC=L*B#CI+MUQG#''FC%9-XM* 3I.WUH%<5
M#C+GQA$69_!32#VF LJ4:W&F_^C6Z]M(XL#FIOF<)'+S#-+"-Y:'="VB09"+
M&+S&7FPL3]+-7MR[>!+VY ^7"Q&\:%@(L4TKV@J?:W@EKDU+Y1+/'E$O7PM!
MPF*X1;;IL$C--]^RT)S3#+6A'<H9=^'?P(LG\7[2UD>A<\,EF]<7I[+)<L>G
MOH$XB<C:R+GK5.GX#P_CQ-9 Y32$\(HW2^IN%DK35' >S(3N6Y/.F#._FZA?
MZ06GCX7M_"F<U\=V])\8K/Q3?G?>R]_)_*/R]3)?UJ/;5?GU+FEQ>/T#6&,
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M:5(:&A6";T#R-30:Z?V6^]\^5TJ4B<JZ%P"N#=]M\D6?64$Y$'1R(!'/'U>
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MPR\T_A/,DTH/$?P6O["P)BP7E9@]#G:]4M^QJU=@TMUD%R$KE2^_R[L9UWK
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MO-(DB&90Q!<&E 7QX,CHC]]R5SGXR4*;$TA7HE>3?=[%6/(T$3N1NA2YTK]
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MM1H'.]&35XO$5L!\("G+0V^]1Q2;1^'L3"$T=8IXY[I-\C?226TFI;VM8@\
MI:(\?XEC>GP@TF,?W&?$NN9Z/IFP8+FC>O3ZEZ+PEHKC&M'[GH(WM0T+!I>(
MG67@34S*?5(@>YEC@V4'5C3\_6(>3!\!]RFL#08%5.R(!.3-\^6(E43*M9,$
MA]*X]6Z:NCKG+=G5W>-73M*<<.1/'VSH1Y;A1;6RNJBA55S:MODN5!Z]MT]3
M.SB]*6O@F%P@D:/\ED/')-RWG49A@5NBN5F 0W+IO66K1]9<<>X=$+HV>"43
MZ+6[;_P ")=@!%X[)5*>?^*'E%%XO2B84<0YL(R+(X]U1=2#9#J0H9%E=[4;
M4T.65+1^D>(B.^YOX'(DY#X]\NK8!N.GBG"5LEOIJ@ ><F:G\OTNE]<[/ZJC
M!QO,>_9"&!,^>Z'K.BO;>R@>2U-?ZJ>%A=G4O:F%P7QR&^;=Z+_DI'*/'R0$
M8MBD'+, H7>BZI.K556U3="TK3S5Q7>R%B\^Q4@!;'>-V2\Z)0D'EBDE5LD%
M).@<MLGV_2<6?BI2=2C;4A+Z4IW-CBPW2U,37GHCD>A556,%T&23@9 X"*#'
M;1J9KDY@;="L D9?=0X[<\;H!2\L=A;U(/C4*$9^<#&AS,<]6JN"9*M,[,'\
M2 [=![Y!P/DWU5VS:/"@\7;DSB6Q[#@$+NE!N9CHP^I3.^W*5F]C@\>HBN":
MZ7PW[76T]G;RM *K'ZW)&1L^Y$'7$TYAW_V,A(/NRHOJLOBKIIX<=%-@G]YC
M0D/6QCW$C0S]-E:"^3=EJEVZIO_SDG]Z -"-1 3N@NONPPF5;<RU5F,KMMQ/
M?U>P^K^Y414&<96%,;Y;)?CJ9>U^8&V!!P7(*[7>H*78S[U,_X''?SK;)JLU
M&="M;;%N;@BW*ZL9W8*(+/[J)2;BYIW=3CY1^'A_(M='[VM9 6,/+2OU]M.*
M5#E^LP0,VJ\"%:.V+?KVM+F?\UTIZ'^KA:29#'=$H!*BJ__-!RMI21^]UJPK
MX/FJ=C0N_TC8:7)43]3\]]^^!S\ 3"L#!4J->,E:"0("97+_-&?_(V4*BU+@
M9-6,?+<V06GH"=%Y-(%M+M$O+]PSI"1+^X0$ WMHL]N[<XQ=W$R=9!=]J$;-
M;1O6*U$U_QO=J:(5<J-]PP!U>]_,S^-RX<PU32=)0;9.<J)._%F+CT;YF?-3
M.3D9=),5E>2]E5C[GL9]&F>OW]PUY# M$FLN'&-AZO+[ MK/5A^C(N7'M-NL
MC!#N3(ULI"VYWV:4+?,T%6AV)NK\;I_V&EJ?("N]*Q3O8I[\-D9R.UF2+-OH
M2#SI/I:":" ]THBZ"IEJO*^.D40?1=F6>R*B*Y=X=%F>XG7_LKD^XD"1U@Y"
MV^*93!OQ ^>;ZX0HEB6)4-$!G_)YJ2(1+/M+L+(N[JP\6R1_!X'?Q_SR-X]?
MM]-G7%O&P"B7NGQ0OUXTVB1,ZT[%2;&/0]NQ;'2P2M&$.RJ9=O5:5XSM2GD)
MD%%O?VRS]GJW%\I;=!N?T=%G=TU151TA-W:6#8'C/H9NLD_>/@" 'A95IXMY
MX4]1@GMSAIDA4LIS8.5D:H+R,VQ/5@4PSFQAHT )QXF9-X,782]F?-1&T\XF
MR)^X8'9'V</IPBZ2.1.$VNGS6*;?)9-'D6F<J<!=!^]GX#,8/U_ST9\Q7&_-
MB#/U[G$IY>]QUZ*5^R6D2(8/'2\JV(Z2*SR*+F,0I&>@#Y2*^_,C!0Y6U29]
MQ'0_'-^]Q_:=_N+.:H9G)RBB<[Z"W;'/%H;5\EF/U_+H>A7;3&T"UOK"U'Y-
M\<ELQU&NHU"/HD:RT!GX'4+7EE]?98A/!W991GB?FJ]F6\0[OQ2.='!CQ&[L
MS%S/\,,9U&$UB_2ZX-KF#>Q@%TPJ)XH9C RY6J=L#FO6/"(.IMKL6F2<LJIJ
M&7=T?A,WT^Z'&Z-P.Y;Z5&;42<S/HM%!,NR%H<&ES;P]'M?1;8^V)<G=N1^U
MTH=56@FDT@6OT6I7>-%<U6BAP\6D9 U]C8$4*R-"[O>N?<]W^2G0=65?1C5A
M>%=VRI$#9&67F\VHD/5:0M?88TN^67EU";" --V644H^MPQ8?0-/<_!^#R(H
M0:WF_2BN1ECC=E3"C]J:K3,%X3@CWWYGVV27Y)G_EH1&HPV=8OR"\%L:F/4[
M-4%@C<W$_JU\WE#10-$L^VI%&CU/CJB\:AC?KV/&G>[\6+-1AO$"/](*T*-O
M0M_D0B(2)+:[3:?N*?5WKR?/SNX&0SCY)BOMDEXC"2_0T:?YM6\%$HZS5-S,
M&B8*E$D=P0:KVB_*OVC7HB\Z4A46S7-,)K(8^FO &T0LE5?Z<R)U:WW83 K1
MA^(M.6M0O@NU22HUY_LKQ!HU'.TW1P>+I76]5W[U2W)M5BM(C>*$6^L!T(&#
M79 =JF^B\NKH![>L0O4T==-<E.\43L<(UHC#*KN76;9:T_@^Q,INC_V0CAON
M6N,<&'<W:D2=).E:%GE1JBC@^YL\L.*7_Y?I>Y8/@(02P;L@X@> W+2*\6#@
MB0[C Z!2^@&PA=PNS7<;19J6_YW._+^Y6#]/GW6"=RX,"<&]LVR.<2T%+JK3
M'CW^4$HUTOX' %,3A'55-\6:*=2VE0O4'%4J[Q+FP+%6MR&YL)E6;[A)Q9L]
M4T>5?G5%DD8=YCYW\[,URX#OV^$H>TAT>0]3 O^]0/MZ%NS]^)NCEI*"15,C
M8^/9)4/N)?%Y\*:A2$;4^NGAH?+1R9(*M-'/H2^+W9,DR *H'!I6]>5T;L2^
M=2T;<VYAKJ7":4S&#8#-TS='UZ#N5JUV#":_*/<YW:XHNY$E6-*Y<[3WYM5K
MGH(+$T[E$,T*$AA()^$7;].@QV&[$R:M-!MBNW6>IYQ7^7#W?3MIK9=J1YFC
MA3F0.OF>!H91.F_\2?;Y:^Q8?C<[ >!;'@$L?%5T-Y*9KPK$.")Q19L8"\^G
MB  :AP])BPTBNTD*<N,M-,?^JW#<_Q%!.UB61_N7A3M6?X/"?%'\P2M\897
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M4!!&:P +*AT3ARW.:<+&$==&D4_9*\IO3Z,3%#X]FFS9ILCBO2>L6\ED/$&
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M;H"G 9KM_!*.!QSFCX7K^]J?K$F<N6DB\!4OK1F30 4/  >&YB]A>[+GI&T
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MT_=%Y^EO[+4ML@\.#5]);T7ML1KG(-V8@.C[2+U72. I8H@EH7Y[XTNQR(T
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MVP-@K4CQ ? NX)<OAXUI<U'=QLNW[.&V7//66Q62G_(F%J/_[ZI&_F&20&F
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M15SCG/V?DQ;^DI34,X&O%6'!7_K(YAE24 [SL)67D]=L3G'P%MXF!W16ZNV
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MIP66H/8.:0*E;[(BW>R=36RP+7YHU20LD)F/:UM/$:DKWY=T1P_*"2G3;GE
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MJH,TB;5!\MWY;@@'3_;BS%(,]/)^1!K[8J0WI+$KTT*8I*IV>/<C51M!+Z/
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M[\_EZ7Q9G=H^(\(G@(N$5O<4EY]]BB[S)E\M]$GBD7D)],F^X'SOD!;$0!5
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MJB#M@@;1T,[W0F8MBE$ZU)5U+]B?1_*;@3:0F']26?MQ?,ZPDKXY?5U5$:Y
M5U^):F['2YS3U3'39#Q>R?M#!#NKL(4_R0%TU44?_JOKLBKCPZL7$4;?4]JS
MQ!Z7\/%5=+&UFHQUV:0Y>7&^5/=/,?JJX?E)M\@!&KUH-K(ZG,;W#/LH*JU.
MBXD'3!/8:;[PL5_XW3B+]SZNCK%WCA5AZH+VUHD$"Y2&PV&0JU]PQE>T+'ET
MI&,>6XQ RV]GAZ5$6/DDXP.5(^.K*6(XFK69$8[3=Z?J+56]I&@9?/.K@>_N
M#G'J_N&U8<)-C]K+I#S!)$9LJQ-L1PEADB>:U1^2/:@_OU[+5# E/C\35];5
M/ M\7Q:_^6:0W<ZDO%)G5S9&_:<\! /IL@.9@0*) )9]9C*L-/KPRD'^\/.*
M9/^,U[BTZ7F[N.XR;R.2-<8P_,QM"U8'TWYN!_O>]4YOQ;Y\A]@X]-V^O^2R
M#?VV:HWPI?!'=].'G09IVJ/-T8EF[[-S6$$W7<8/&US=N?(LQI$)1,U'UK0J
M[F/BG%#3EW</YVJ;^/'8U"W@=?#ZYA_+\NX;K[SN&Z^2_SS.2'  %]S9A^"X
M.(NX!4@%KVTF[IU>A<[2W.W6SW>87!L:GJ?WW?@&-^%/8WK^.6G;/.M2$5W1
MI<@2+5F*F*"WDHFDE2H#&/I375CI3#3XQEO2V( 3D3G)\%M J\>G$&?HAF:#
M=*3I"V(&.'^=61EGAR UZ=I14;E;],^Q(<,Y_5=BCX A<B(5#AFA2RX"_4S#
M;LC2\>8?[&C:ZEQZBV>$T,*Y K#0#%E^5)16EI>$]X_1!\_R3$06(6EE,4_'
MOD(?MJI-MLO:B,^*SE[KL3SU*!PK,69K'?!T<_E)BR&G$IX-7F-V\Z%1-@>E
MM9Q8KNAL;5.JT3>Y1\0#^@F4N)(+*T7S2R):A&Q,.NG>B+78T9>+"R+XIZH\
MKP=URKQ$?KU7-V)'\,K2^.--OPC$PY*618NJFA]UE-J1*<N)K>GW4:;8('T>
M'\96HQ3F[)Z07TU"2\9NH"FZ(*OFRU7UL4/WR-+L\(<<H/T8.W25A#*]T/$T
M&76P"'05I^H<&J=0X%CZ!27<8+38':5D<;8&/5W;1'OQ;8XO<\X6FH3:\^3V
M8C7E62HI?'72@/]>6=S[:F5L+^E?5VJ@W+[L.(0!Q_-YI8^R@*>1?F[SX^H>
M6KTN->\+3=/6=].;J,5H@&'LJQC2N/!'6.!YNIL'_QK9G;VB6@1QM%\XG=8(
MZ=.]55CFAS]FZN=N?P0-^D!+O6\D0@_-3'=3:^73%8"0,=;)[TV_""(#M>#U
M#R38(0ODDH(<.- VC2;YAY0SKDOG^B_1$\]5GEX.L&4@1>RM4AXKQ:_UCCW+
MM**=V*TS-;4H,K!$P$]63N _Y[YO(W ,D!\V'T9-&K>IV9&X@57VU<6(&BLB
M[3(#;$W#=PBF.J>)HEN0I@B68E\I&CUV2S;"4/1D^[I7GL9D=LA=VQ?R3,$7
M?'&>7[B0GX+GUKV\'1JYP>=!D#F:V$KYW*#.1R18\ D1[%L-95?J67B'8:QJ
M<)NY6I8!+''6Q)<_AV3*?SC%>G1::,G'^; _$IQO<*:@7E\3O-,_M-G:\#Z/
MK<7]"Y[43*ACZ'&;54]V3][463(5RO1<5[HNO,,11%?X7&PHR)'5O)HZYVI=
M"%BMTBILXYFU\/*=A^-1T:-8W8;1.JK"L](-S"/23WLZ;?@.Y3YOK%%73)">
M*5@(K,) 5TSQZOOMM4"*[AXS-F.W5FRF3WQ*\G%W:$&)4"^&]#1*<_JX^WY&
MBN3_(YY9W4AHY8KS=5-(U4)U^& M_49/YDHE)><:F)$5)/U>PYS>P]=#3:E_
MQ9DZ3R8F$9*+2-EF(^S'Q9&EO 5HD-$<^X+)^+-FP:1S@SPAWKAR@<V_*"+#
M=6IJ74UW%-6&O033K70S9_/-@DNG4Y(JE]5&.+*4GU=$CHX[<!IOX%A55$BK
M&XO9>B1L']P"_(3NKT"RN YD*I8YGZ0[U/N4!])7(J-)F^@CT+&H5W[W.Q!1
M-9;S\7,:,ZZ>:=J\UX'ESZJU*NH)AWXV\^H_\8#B.PENMCGNSJ?@5Q_"M)='
M,B!$_CW!.QS385LR?32)N2@.8K9"6H5YS(SJ;_.$ )P/A0K5+=M^*;NXA\?M
MG:S,-KOM%AA7)2MJCDE'+FEQV :*SG&M4K'8-XG%6)XQ[U#L6F5/M?&?7!JD
M^Z43GOU<<HPXD1$;7?OVK7KB.E2U9$GSYM$^<H&]@>5&2?F#1[> (1KX7'U8
M%\8/KRK-=CD[(V\CHO4@B;JJL?(I2VJWAFX;DS<<*9P66B_1!)E_6E FQZSS
M= 0+8L3AZ>=V[Y T'>.?S[1M:12$T[8(L5@ELU7X<=5N"<F&[QCM#M E=%VL
MVE\!:S+04[]@(-EFX)3#L*>'\);O!4<B_Z/"252.+R+<5@A+F[1ZB&5 TI#!
MLT\?(?KSY/X=O!_YF\,PM(^7=6S3A1;S^U5B3SV5MAAZ?M*=]KGR:##QEN D
MZM7*D#GO#4C7@0R@]#6F>75/!&>1 M(,<CI?SE\[JG T;S/KU>:':;T=<19D
M+^A+;-_1$(X61 L@IK[0LM,VI(N9*2@_BNX.WE"UU2<WP2?[;E'A1B5IE2M7
MWQDC9&783E_4?(G.BTG6=1RFN[]%X_:.Z"G+0VG)!)_==VXWY>D++C$$X7'8
M,3>I5O99/T%I=8%23T3,EO+-79*5,RW6Q.A&;KHLZ-CL*&!;(9R'D8G1W! \
M"/;!XT^F_LG,\_O257LRC%&MCTR!?KDV.X.2C]"5^Y%FPJN).[SV?6X!CG3K
M>J:Y0T=ZW@Q2!B]F5MS\OIK%G H_'8GR'&?(OF(U>#X#.IHC/ N$3^K7-)'O
M?T(I,6T?4+5ZVNXQ EEQJ:@, +4"F;^'/"+YQG5>&>:/Q=6B,8>AWV6? W]S
M!XC7(:Y$2@6.8<-^*:G4WDRZ"JI%2HITP?&QS8JT*LG7C>7.C#2-543<K_"_
ME'<*SG1'GUD0 +7/K+(V8]5$5U)SKB$(J2A/KA??DV(I\^2/;IZPE*5E)QOT
MB7X3)C^.\-_FV24R )ZXNJITN7UDJ)@5B:5^1VXJ2*6[9IF667'*)L46_I]2
M0#LS4^6SLG,?B3_DY:7O8 :6JNHXUR)39B (LSLRVB?W2<5P6 N:OR)++9X@
M8_NJ<G#_J!.%N X7[]6; 1RO2AG&GN1TZK$P_ JFC-&XATE)#2D6!(6)"OB/
M<]2EUAXJ_T,<H&>?_RHXONC:0^$6\"->&0O<F9T)'D\TND#/_'??R;MD$+]J
M//?)*OSWM, ?&X$[Q19OJBL/"I21;@&=$7>7/,Y]"T@EG6JX!7SU[KAVM%O6
M3D:^ VI4BG>\Q>(6(,D+-EN.O>SUIEH)#[X?:N_WE^;R#_FM_!RHD>'=,7:;
M;P&[^G<^/"]GQQ$A]G"CD3OG]Q0*^;\ZET7FK^>R_'T]^'-R:US6@W3E"O<6
M0.W9>(FN#UYKT6P@=%0^^W6>Q(:O\M;I7\9__"F_Y4C*?_5-_ EXG$QYF=[I
M6)4S?:]1ZSS@M_C]_7K?4!R"D#T",U765Z?T#@ >H'*=C<4XW%GI+I7*.\ "
MO+M8DYK@7!;MYM#IZ:+!J0.,WW,L%K$!V< >S1%>]%EIR'5DAB:M]=;;="K?
M/-+5D((CO=;R XNZ:F:S*!;S:9-09Y<CJL*7C8_K>$X0&B/J.R13)97>7,%0
M'>V5& _RL6\Q@\,JVKIHP86\Z_0!)O%#*YS$4]/LXXSN6LB_@F<RAG6Y+=7#
M9 ^EIG^O+D_^Y\3&GQ(?&FR]G+< M+X_#DIY^/L)?&OY?]1/N!]B^5<C^>XL
MJO4FXRR#-UDW:-V:W:MW3P)4U6:EQ4%T%7-''/]>_1)L]XI4U4'I>N*^>^9?
M'JU_*@+/HV;D"G%Y3$;^1* /X B9Y2^I:90U*6N\Y(DFIFWD]%F8)G]'OII#
M2V<Z"]5V\Y>OK_7KHC"NC<(M+RSW1=7H?_%!=J "& T;='8>985/R<8JU"H4
MGL82GE+KOHD3+B$Q[;IX@.LQ 'ZXD=:-7U'Z>+8KC3<;'FO))4]%RU#$S+<Z
M"UO^TIVG7++^2P'D2,9;UL;\Y!5QYSOE!N%AZIK2[]\+LRN_+M+3.HMXS&O1
MSK,AOQVR+<JNU?ML$L\C%6P6\*)%\)D)P-/L )BD#+ N/M-[[:]0J8>M"-I!
MU"41H_:T+R!3+KK,9;)K>.H76;$8?3M2J+>3&EX(5PBIU9![KV=.[1]KZIM-
M(7B5=^1*6*"1!GEBUIVK2<4G]'$S^$ /_& CV4G+<7VXCZ*NHG>LK,,VH;N[
M8/GU.^0 %+/$Q-$^NZ:;9T*MAY8?/O\H^3:SOMEHN_Z<D5Y5%)_E%C"G?FXZ
M':/ITLBT[K?2::,B6G48T<E?M"MJOZD!=4[ ) L!@KH'',6_YN*IP8J5:45P
M6#XV[BE>E\?R02!4P*>34TW&[G7@UOIAX0&1<!^O\/+%>9;U&_B\:-)V?RU=
M\P5-UNM*)M\6T1=R5^L.T,63:+#9$4O(%)DB'V)#QYBP8J./A>FA%H7,.#S/
MLN8D*6\=$OL+R9J#R(FK7\7,>,I7T=P*+MKC)50]6%0^85*M3>_;[HN?Y$LM
M*SXK8.O>!5451]T@C%<_44QE&VWK^X8'U\_/"V%",=8363(NG30L9\P><4@<
M5J0=2:_QT\&R5R2K.=;X(+M*(0;C=?!!V9M:T_7NC=TK.OET^B*.0:0\I'99
M\$C4WL#\5:D'F40E_L3_&V$ )FYI2R1@7QW*TM6K_8.RZ(I]SD=K?/%'H>.T
MA5Y\@\Y))MYJ_2.L[-"O]#T3!CQB'HO$'X3V-0@AH=UIT65?EFJD DY@\T!T
M-DJ67S5](Z56RB[O@"/$\YS4B5K.>Q4*F 9@K6%0(2\;S;(&7;1\771O..54
MY!<Z_V-H,#APEB)!JG@8-!_?Q[/" 10M:!=,,^UZ=^U@O1M41Y9UYK"#V('K
MU=9._4"I=!U'M=+'\6> 63%E%1ACO%!33+JS)_&M6QB,??^(<HG_$*[\7/>Z
MH%=R1AK_Z?"I@L%#QX8[%!T9W0H^/J:Z"=;-+./*W6\9/[*0NK=)_^5Y%"H-
MPT\N5N ZQ"9/%@9C/T3JR#)[U_AH> 3S/97;>6OP5%YN,8EG4PI"_XC<[R%6
M,"H C1P@D&: *Y_XFF$81/<XJ[/E9;;)!8X Y:A/B3.V)F*J+5XZB7* YD P
M_DVX@R^>_]FPEIE<.XNZ+@A-SEU3>FBK)^V3)B>[Y$=?I YYVX2TEFP#_>G4
M&;HIE9=O\_$53FG?"B%%>7>)2V1*$9D[%&[=>12:O]6=_Z?P([M4</T60 CF
MZ&3\\Y@[EIC]QHO=.V\WH<FQ-#JJQ;((/IZENO-%!49=>0O[))IG)*/W)6._
M%2;^'YFS=[_\_K)89FSF],I_1WPS <S<ND=U]?G"[MI1_ (O_Y*!M7'6=.T6
MP..DKB(E,?)7A3E_B'D:2#E<G%Y%^!#= CQ6;P%2&C*.*7A['!KG25*_ASO_
MW<G9&7T -OSW_QLAT#>_T 0S))C=#EM?U-F4=&'GR#!_F,!-I#R#1D7Y6E6\
MINTLN(,ALL6_@:#8V-^KA6MQ<%S%L( O41MO EER\F-?Q>+6W0+:+NY34C@_
M_M;L+=1:6;Q.],+J;<%I" EG>P< 9ICF9P:-%S&'>1(_P6;?V0 *YY]3P/+S
M VB,RQ_04OH>$4/'X!MK;IIDU[BOP@52P1"XRF77.^1=7&G1#^!"D[.:_A5<
M*ID<.>J*PV>R!0SFE&JRCYXS@6>W#6*#ZB0(82B10F3 3=/2E=&;(]#F#JZI
M7M=:W*+QPF67I-* ^;6/F 6'<XX$XMI3(;J%>7!&MS@*<6AE1"_<.IMQH?4#
MX_"T+I#C2RY50!E=-+EU24<$X[O(J@L!\20/0$[*JTKTG979TW.P0=O]A(>J
MW^[ G\N_H7^N#\^U-0XZ$[,[_"/$^@<XT?I-W$F'L,9F[RSO%O#6NT&Q%4_Z
MN\BR8V)$>ZY-K_7S93)7WK4_-=4CQX;<R)?? OX^74?*81_<I9GR#ZG7G+S(
M@5=6'L5_R - #>W.F2%S)YC@:V*6G-^_8HX,\$[?"$_[?522F]?N\;HNF32O
M0FNE%1(S.NL'H43 !U2/9!9\-P02U C>RX8H+XM3VT95]6KE:W;XB31!9>@O
M-FJJ\\N9R>OE144$;S$$2%4B&RNOHX[*2FS:V.N BQ;<4G?F[NWHG*-P,B$^
M%"ZS<[)XC:5W1([[W0(99OG-X[N\!D<:?\9^5C1?@NA8C/O#IH]I6'2L_C@+
M$NM1.&[4CQ7U0MITZ4X/)CMRFBT^"7YP0"7:-8Y H]AS*Z!0_GFJ-? L?(4.
MUQ1H\P(7E>G3IQMJDS@T_^,> V(KPOB #+ZQP?Z*X7.R99/Y11</4U<ZY[3!
M'?+1IQ,CL>TU-K]^7KS.=3,\F9T<7U'TTX)3179NR)B&PU+SW"+D!J&T_FKU
MLO21KLR/M;?[^<F1/R:O!B^S7F'F=>2&)(3DN)#8+#&_AVA2O@XHQHQNPG*;
MQ\(8WM<*L',.TR6[YG,KS%)P1$ND6(Q\,=F_+/[BSO!-JUC.V3.I+]O"(4Z-
MY%:D69G.YN2%Y+]FKZ,XUWZ^F4)>5N*:OC%$%$Z[%;V&A<O$WW#25@'?(VE'
MTH26SF,E6D0/59_LV>83WF&&^K[RT)JT#2YWW["^I8(WA>$IKH*4,,JD^7J@
MT@B9ID*^(,?LP8J+M";>]G<.RNJ'EN6>0;QZ-OI[IQ';SMX"<W-D0 $45-,O
M"H]%QD/MPR^EN?J5N'3M%L5Q.X 4+1M,I9+= &FV@^/N15H2"AF/19 /H5%'
ME@P^/-0$01 VF,KJVQG=Q?%6 A#4+M'):W=#L/+CTXR,/=$4I<S[Z&VU\R\Q
M;]%C719/W='\S]3*A:,R==@B)/S<H* A-PJS8"FL\.QG']>DY#2<>JP*CO*!
MGKDW@SPJS'+L7'4?N]IT"\)CBG^3H_OWUI_*T_7_.(HJ+\/Q%]RPX-]XI?]L
M'?99WRR^'5T,E7$6ZLOU3F(#94ST83$;OHKJ%@2E%\F':6D%M>WI3>2OC_7@
MQV;-[I@R2:D?-%%S47$Y'JR>.1IDA@?96;BS#3^$J/%$O5[^8((;UG->I M[
MG@)D:RWKPB@O;5NJ32Z(8[ ;CM9UI$V9K,P7F5/=-S_>A'>:Z+FC33:U5$U/
M&5KH8YUH!TGZ>&G.5 8?"]JU)PZVLS^W'*2+(@R5[J7X3L @PFSFM,&2'MT2
M_SI'50$]3LFM:2>OL4O=A^#Q7M9GVDC4%.(GI;6)B66,/P7['<.Y97@\'ZGE
M).TX\,VRC'1\<29[_6!%Y=DKWCI%5NL2  Z1"$6_Q.J958WR%^=Z/8- V2?$
M=#68F'1071X-R=X-I*6HKHY4:.,-GBB6;F;I>G&!2EE-WM*[DAX'''>1^.#%
M9E+S_G3R PEB/X%.;0+YA7ZQ=Q*+ <CXYVF4_=F."8J.FG5CN^PW@W8H0J(9
M7<+%IN1!/J\>#J0Y,X2FZ&I?63GSE-5G,)=Z#8C11MFQW?E+' !;G5GDJ0?E
MC.\O'A@L>=(F[?$T=;@Z<M!;3J0<NKVL+^R85OL66 *=G731B93N=(>;"O&B
M_I,C:[T#V-;\L;/T]9>JWT^M*AP5'ML4J''%4GNKTSL[)Z2MK6?H=:=^BNIC
MB*,-@.," *A*@+< DFU=#5QO[!_QX:GWTS58DNYS.<EW%KTHYX[=J8Y+Z>_>
M,52S?:IK[WN&"KFWTUX?CJ])_L8NF_Z9#@C]]K([?H_9TGC<O7D+D-!=W_P^
M!EY*=7.]J38 K[%H4/2R7+&,4HC^GN#_F_KR/K>I&Y'RN4OTICL\H:4PH2$:
M.? 7D:"_G:\H[!8P[@:^:2X!/X?F%5_)94QOE%HI LL(8[M$$J:H&-$$3E?R
MA+B9<ZMXPKKOO-;(;]OA_]_A'A2&L2IOSU:V/ 5'NVQ#&"36^!9 !0_U5L ]
MMZ#*/8:.N6DBT +?;$7*5^#@8+LSA)3W1& H9T[H&-'5&%==2DHX9)Q+>4"8
M!94\CPJ9,B97%_.4\'<J-J]=A!1Q%MNYUR+UIV>UIWZNGJH:IA[*/SV  'P?
M(9)XXF\!G^AO1D<Y$C2'5^R.VEY/G;Q3QO*_3!<)'AYR0O9,FP';S4 SX!!2
M"9+K(8Z]3T<=A8ZN$"+-^.WP (3G.=TOU_=P2:[5XLN2[MFY(@)=OGYWIF8\
M2(/2I;@X[>"/>.$0MY4 _PZ:0$V*)A+4C*RT/)H\1@T57[273*-?-O/O)2,9
MB?\OYN';]HD^$TE7AK.XW0SGS%! *KK=78[%?%UY.]8/W&)OGFB6#QV#*WKS
M&U6! 7UU..[HWW=$1?-_[!OZQX+QM W)V*3['Z!$]-KXT^52C6C1[VV,'6I5
MR-H6I?MAZOD[TI<;1UGIA"^S>Q;QEJLN5R\BZ%40M&A@%N[,JB$OA5R_EE:7
M_1YK.=EM&CB6_P_'Z(Z<#H_1O;&&B]:G>K/-(!@+W\%.Z@:R"_4I:IF(0KJU
MAZ<!T/#)N]BH9Y=2)20Z59<_P5X^,-<F3JNN'P473GWVK*O>O0>AL@>NT\+D
M)[DN]M7UO +CR^/].Z?;INGW8&_P;\541[Q]9U0W+T_!)X^K[J!=8,V_!=^P
MO;)X<'M0[_H=_?#/N/^OS$KIN'BBBE^K0$P^ (H$QIV[8/FN(XHS?>%AF.XN
M"K8N?6!^&W#9U<5)D61#J;]*27S_-G_3"WSG_A?8[E2?"Z!UPHAMOJ$!-5.K
M]X&6N@A:ZC(LEZN)&_(CT7Q=*_U#[D=*7$8]%TF@S,;@'T.@1IB7C(7E@:^O
MG"UFH"B1_3M,'_RFZ_1Y8(Y9?4."VA!T1M7B^XHLO8@M99ZWL&9?1"!K2HNB
ML2>W44C4>\A" L3Q2F%].W@55)!=MA^3&1MBFU%;$0!&:+!P[,R4^MP"+M^9
MXN_$):8*67/HK5MX3HT<<3K<76?K\6^-CCB&1N?,FG? %!M\C76O%MEXH%[X
MK\.+H08X^F*'MP"B-;]_"=-^+58Y?"Q6#ENB(CX6Y%4$*N[50U)/"&4S&ZL2
M>B=01\1T5T=25IC3*2U,A:*7(K@V/&("LG*-Z6.N@*S<6 2VMP#YY:D%Q,N5
M3:7179-&S.7"UHA&O$4R]!V6 1B8BGKH"ADAG$OO_+F7W?1S8FV:K[18 VRB
M,H)W8,O[L91Y=E_^Y@&WCF049R"C+QK[N2 UWC"%=]ZY.46XSB4&]% WR2[H
M2A2XL(E+,UU>)C@CVAK$P>)*=W?6,8*56*,GL$+V :W2$2>!C'&>]A '>*T(
M-GD2W7H5TK3SW84_.(/NMHZ=&MGJ/3C9>=!C*FC^0<;)+@G]R#J6Q+9OO3^^
MG,:Y_(Y:5OT/:KPU1NS2AGG6=]F1B1<DMQZ;)7JH5"7(&03LI)MGM99:$[V=
MHN74L-)GI#M9R=91^<;IS"PM@>9OJ./HS%Y5<1&#D' 'YT*"WI1,4Y*I=[#?
M%(;#K)S$,=<] !!@_K4TBQ4*T8LII4M3VU7 7OH4;S:-@EJ?=I>\<@R+>RUE
MD$7.Y ;FL]+JX'GI9?+6A8KB#1SF/O?97.R40 ZGVCFTTO+*T!(RXO#EFHC+
MV5:P1_V3+/D. PQHYB+;.,CO#YTEAASGS,-WF^D^37IGPNZX,;TN^.]ITK2_
M2I/^=TJ@[Q=S87*JG=<XILUE7UT6B1LM$"?].%^C[TSF1HQW]Q)#X0H2/]&O
M:FT?X9B1%LQ$^E^-Y?R?G'^*S@1,'F1_'MLV2Q,LIY,>*(MBJ?SH^T>!HY4:
M4I!VL..JUA\2AW^")S7,JU[W-)7A\RU@<T/\&A^F\-Y4;3&H:*W_7D"8[S\,
MX[6-B[RN42_1U85W@7/TL=I >$T=I]]/*(]A^M(]7^K4$(UEY-8T0_1E= ?X
M[1[@GWEI4$<3!L:,]%HVL7J$)R_WK"7?H61=%T72V+DIE23 ] @:HC!RQSO$
MA'M(^%NH%TO0JFA+"%8-*3Z"84Y<&;I&$MZ/;P%?RJ.#D!J,$NQM'[$-$PR=
MB5MOS#Y3 )\=Z^W.?/S%I5)+%::?5N!HO-G5QU!VT[C0#PUF+(B0_;N4UN\1
MU'W*9.#J&P?.':Q@*;I^:)U>'0 .\$C_HV+U_R2X]69,<3?8251LOLD]=TJ*
M48!1W\S;NC+4SA;D9+F]978 M=MY,L0D7F64>_6QX&&PHO#;^L$KWLSU VP^
ME*@=SVE(7)*"J5@&<E=^J"U,8%/K&WT/U>$5#F+H!'XS8U&:+(BPC2 S(TVN
M.U2LKBRM'W2>>?[4"EA0.;E3,'+U\;SEX^97F:JB5YF,$T,!=M9)I_\"^OX7
MHVC%O+@D:_#WN2>8/5&E["(=&/+2RB][!5"&Y>H_)\FJ:467-$J9S+G52A:7
M>WYQ5K# $%M2S2_S!. H&@S!@(I Y?!3Y6\*F$>B33OH6Y9EL-:\IIX8484[
MTT?[\G^K-E%+&)'T *3XK&&80DVE#'OY$:JJAK@''V40P:"*(A^,.U>)E[:'
MMI='^8EX$$<HAZDW:M3T]"O6-](IS]WAUR2X1M8U X[[5*IX'2NZ9QYC;VJO
MQZL_N &60A\@#>@>H871J4)38ZJH0_T5 ]$+$7A-I.TA@V_?830XU^@FVC<K
M34<E+4Y=K(E@8:D.2KWW^/M&;*B_VW=S ;> V>H[T* Q\@><INXJN$_UX-@H
M;N1?^D+_Y@+._MQ-5[U+?H>,\_FOG4-N :]TU]1V.'YIB(;27EEY/+/\NVK
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M+7'!HJ:2.>7+MHZJ_*8G(N)QP%/#]7,8#(O?73Z'^*MHCT\,:HH[3WQ[0O9
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MO19_TXH.^_M"QYSVB._9S2[M5/!)DIKN\)'V?+1:M38APMR/1D(XJ0:'^1:
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M&^J*,Y )Q-70Z(O/, ^1@[NL/+H$NTMD9;*PQWCFV6D+MUMMTZF0:/FZ'=T
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M)?&BW)H&8I8!T.$/F*8NC@?)'AA'+%2 ,U?%D;2&TE(N1:P#?6F4,!A%.W%
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MB-:BHF\TUWU1&A*2GS"U3NO+&6JLG<,JM(<JI%5>"*N1'LS R^.??>N+?$R
MDTJ?!(GC[3M@F 296ADQ53'G=%%[HUD;_O)I41Q(7F7+<:-@&-EAOY\:H42K
MX]HIJ0?IHA7GXQ1@B#3 *?/.3K+0-;#3' &!4DO#RJG*>JAUM"RPJB[[:BF
M\"=D5L;T)J$='+W238$##DRZ<+0)2N()AIENW-CU=64XVNA,I8B=9-GHE=1B
M(?-P*S\\H/%*-CT9P9AE>5IE'[JX][S8;,2Y9*%0D')'?3A%MUZA&LH0@_^N
M"%*PAOGP<@;-^H*H.Z+OD(_]RM1%L"/+JO&]?S?7.=>YC8.699.X_-V?9H?K
M7+U@WY,O-R_0MONYKE8BGQ.6<$W70N<)'JW+U&BV2']W&&DPWDPAZ;F+/<N*
M,"DV[")W$.EC%C@.^_Y :YAWPM!@0J?+RMR)P&?R63#Q55T^I^K$^L>?HM9;
M]AFRA+SJ*H/J[S!4DT8+!%268W:8UH )>^)7'W=N 5O/[&\!Z=A.0:E_DFKG
MB6UN_D>=>U73XL26V*_X)-A,;]K&OBGA![LIK/^/M[.,:JO=]GU:*.XM[NX4
M=RE0O$!QBI:B(81@P:6%HL4I4+RX!G<M[A;<W:5 <;WTW7N?O?=[S[WC[#W.
M.1_R(<G(R%I9>>8SYUSS___A/:.O6P.$6ZM#3-T4Y!PKLFCYAB7"G"I#@(!:
M$Q))FB>4/&S3TQJI;FO)[_W>_3R6:R\K*I>?4GK*RNMX)?3N_ QU2'7U&1\Q
MWJZD;=>[2TA'HGG(MKO7V5=A*?DW+J]:9DU#JP\^V=>(U5@>%14^  *%8?,7
M-C$SX%36ST]26C:RQ]5#;UL60OT.Y28KJ["#TDW@V6.\_77/%K/B'.E*5R)?
M6%S93;/9<?42#>H9D\WJO4M/%>F_JE9@RX%/B6M:[S=\L_S42NY@9WVW;GJ3
MF]UW7>/[DP_[Q;#/B\GC.27V)/!\ZX^@-Z2AIA*-!H[3IP7YRP\ G# D,<8A
MN+H(J0\#'"K+K="S$6R\<"0TUY *TEM;Q8J!V(/)(A?W:W$/ODF?,$>::R:?
MK3L-\6A5_@Q"Y\LJ\<A>8N^>RZFJJ0G '&:2-8D4@ (\%Y"L+EIO6 \MM\61
M)BL? "_D\I<&+4;OLN:%L^#R:Q<THN;QJ:^$!*]UTJ>$P&M>W.?7;9-#(KWK
MS:$]251TLNDAU0^ PY5/R'Q1J\9XUN?"M^<CU@2)FCAMY:^FG,$TAORH+&88
M3YVZ'8> XD QI2_^@MLNFCIIUN(2]:5313 3OP/?70_=K'"B"S8:^87P&0',
M]=BUCYR8$-W+)866*1VEST-T+JZK"9D=#N5W&QJIC1299?D;YBREME/"PK_%
M0__U'CHSLU6><,BL_[ZP;9*]%[16&D*J>".K NC]472'T.&\2*4403.[.JEO
MJ15'^K$AWB% (]8"F>IZ/)6^JJGI:.&L.B&BLI]@''&-ZHQ8C)N;YZ?!U*=3
M0_U7X\7L0VGTJ5]H#FL"%-:B5KUY&GT=L&U5D/4JXYF_)G^%;ULMN&ZB@PX4
M<3-W8R1S!)4*:TW#,B,V,%0$?E(AS(#<R16[5NFB6?/>D4LS+PJ3F5Y%#-5N
M51Z3AV>N6A7QJE9R% J"/'+KPCZ\^J#9CW&X[/>#;(*I$0%JN@)665R$"T%F
M#Q=6(NL#$@43&;H\+/M%R1PG4S+D>']6#4M[%+I.)"ID:LG.=I02B0<4+NV>
MZ]E&B>?;<_*74ENZWMLLKX5"A58;9^^'KOO5E34,QS+D&2?-:TF<+KCNKTAF
M<!4^.)LKQOAZQS:LL)(FE?AC@D%@R(NQIM$0U(#+TK&>5^+??84N!LFJ=9ZI
M54^$+?!TXEH+A('L<XV!Y6Y&#EYE.&S!\P':)I=XF&8&)8&-S.S-N82SD(TX
M2(6>)/F/F'[+7FJ!4BTR%[Z@>\+)4$+T;"OXSK%8G0+,%C)IM0GNL_.CXP#8
M6"+DR,CE7K)J@N457+*?U=Q/^NZ\'D;'#_Y@[OEYF>Q@&<MKMRAN(!PH1J:J
MD*9641UNF;A*O9[NAK02BS";9)X_L[1SO#@[%($80L:_\H.65CPP\5>_,:)U
MH+9/M5[C)Z.-Q)7-P/YO@N#,)RYIC8U</^:2)SS$T'9$);.VH[KB(@WG9#@*
MK8J+/H!L3)K59>G8,N\1-/I);74J$]T[SJRY7BW;*[W[HZ#B^;\ZU75_ZF7O
M9M<%4"Y?_95"78S=1<$\M>\)SKKT:"_,+4K\C*=HUKQ0Y?S4O:2T^*3QHDL<
M.:F3$O=4I+_0(D:^ICJ6PY#Q9$;7KR8=<XJ<)1.T:ZZ3%+\PWZT:DIA=Y"T+
MPPS5X4]<UX.NC_(0O;$)[QQ/73-WB?/F/]JXCW7)U]L=$<M.F+.G[KN2F\=-
M]; ?=-1[ +3W4(V=LK[$ )9=$<R.Z]289!$SX;9^T-V(H VOBB]PY>DH++KL
MVI.M_$0[_I@/O!]*:])$'@"0^=NZTFG'^4UW"I<N:50$KF+['_(VP*38C7C
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MAH]P%SRT.2+HM[YXJE5T9(@H\%I@DOM2F,50[BD<-G][ )PE\C*R1"9K+2S
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MXXW66W_AK96<+W3\-&T>=QRK7<\1=9PU#KYV*=#KE@HA1KN1[Z)+D.HNN.8
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M)/634JI].B? \J]!,4_#_)UZ_C Z0OZXZI8/OG*^3)&1ACU"4I)ST^#>$H5
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MQ7Y4]W&?EO[WVV2=XXTF*PLDIS.[]0MA*7T?NYASM=YC2_OI:VU ".)?=J<
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ME,@#!7U':N2\A1XQUZ*.J:KX8Z3,+*NR:3E7#B/9Q*.>T0/=U1X OX.2,Q5
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M\\4 U1D(0G&4<:"R(A_]!6=0H1'@J3;.0#-B1YCUIP&RRZNQG^''\/V0TP;
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M2< _WP2_T(9V,;= %8M[?1.K +7_@T'GP\N*K_4$_Y,GEWY]"N3KV HY_<6
M>W^0YK8B_FACX6I)&6<83P,["IGGVN5E37 "P,YMB@!>A8 .IF*.)AOHMBB6
MG-RUD-]J'-DV2_\&...WT1!+&)UDW:M"_.O2^N%FBE&-X.F>;NU>_-'ZX++.
MQ]@U1N5QTK/"46>@'S ##**M%S $'=K3J!SMH2[F+"S'>WD"V?);BB/;4F:_
M*TE? )2J@;\@R'\1SN]5%W*2Y;=.MC;8)PR!77A6OAQ/+!VOT89"9@ "6/7K
M=:XM0 A E:1RL@VX+TME1%&L>N!:#5M;XV6^]BUXPA_I /+!W0?_!,MOP]4Y
MS9EQ-_> I8UCF&!A.X.\ A,!'L3LRL^;.B#FGMJC.[U=D1&K'AG_,.ZIZRNU
ME1#IWQ]O*U*$4W\^X+4ST.]22<C'&U(VBZ8O H0AEHZ6^CG87B;;"O;!CX;/
M0%]:JYW5/0.I +1\3^9X51D!:)U*P"=[H*%A.%O;'[7[$BD_P7^F5_\.T4,)
MGWFH6-K3AT.)I6(\@^V#;Z*76')I'@V+[6S7MPT/<F%N9D>8$CVK-^Z5_$_A
M9R91M%_1#\>QX+C!Z457YG^QU9';!=Y<$7U*.I!VWX3E6IF%=*L)N-VB?A.C
M!K!?MN/L?OC<90!3'?4#Z-0H^"2$YS#6OAZV>:)P]#N0,%, C['W_)<Q4>8+
MS-]-&9<?&*T<O3S!/6SB]VK&WHG'XQK@)$30,EQ,:,>[WA.MSPWO?1,RX.:Q
MQ'9&%4\PAK-@]]B+2$K\W;G(N*>*0]+^2(@&2&S^G(D=$9[LI>[7!V_QWK42
M<H,J>M6J6)I/DV*0$\M1XTJW[@49ZL!;R^K7*>95D:\!*+'N[2EN\51W,1\1
M,N](<3\_?5E'L1 B\?N":P0$-_59T/4O:)E%"KX6<+,'0O1NC6>#"IF9T);V
MU%>0M[R 6$@9B*)RD,&_,B(O5CV$)7EI,8WODQL0[_PI+@[_,C]5G1@U[9:Z
MM#8.Y"L_?5S(AR/0Y0(XQT&Q.<-^SU+X$KB<K*$VR^Q]XOZS5XKQQ[U_0@,3
MU_ZIJOXN%^/#S0V%?(5XCN_-)&C7XW1>N<-(+]VC(,3/4_&*L_2=F"V?HL56
M'?STUN730_C2[;*8]9 LV(V&^A+E>J@!<3V,3?P/5%/C# 2TG+#U+[N^8[.9
M/.WZ"Q;L4MAIF8$@!;%:9NI2Y!LIZIW%HY1!:)D]YF8>_E$&MOA4<4K&<<AM
MKQ9>2VLB=OF&<V/]F=^D "8\C#P#.:CDTL6.U P.<WED_Q$N+Y#F7_A/;*M$
ME+.T]?!9O6S#YQ!_&(R[)M+%A*[(S)/C;15/E*;;A6.7;H @.9$ED1'!!KK]
M$=L"BWP?T[9$*'[/G"\CS3GC_XIQLC*.9.L!QDZ.FG'7J(45Z<1FC7%#7^/P
MO_8X PE.?>>2 >C;FG/A51<V+08+\DS!L[012X&,\IOUT'^3K'ZGT_T1S02M
M,V2$>G<3T+R>\_<X8RY]#6&C%GH!:W*XM[,R=8A;8#%98:#+^'Z]OFNAL7O2
MLS[]SYQJ3_*_)Q*H.B%MVGWI4M_$5:8<E?2!"9V_Z2;4Q 09\+%;3'V2^!I6
MR6]+@ND/TE;<Q'YOL% Q@%>6_IK'^&,S/#W7TPV[VLS[<G5TK@ [4TX0%YV_
MX9QV_3=62N(ZO1V?<N)X[P05F@339B\B?N_J*4GD^DHQX?AWR>[_U'_\N8FN
M':M8)',/%F)S?@P?Q;UP+0 >9 R%U1\'QJ3LM(@M6%JX/G7*\FP!FQYDK+BQ
M_2& 9Z#']7\I*OTS7C>7FG$WV""QK*?7]977V&BQ7S"MIO@6WU7#VZ;83EQ#
M3G#*+2W>/W4I?]#6X#V1M?*?1Z]JV4/1PI-:>^) >8W$OC68*^G#,,Q$!FD9
M8CM+4X=@:RGV(OKU0R[,+:>07!&:/Z2/?U-__HKFYK-=<DD?'GUH7,N9P@4)
M:^%X305O ((O@*UULP&O.0:GTK[#7CC-,-H"IC_)%#7+@/_1#.6?Q1'_S\?Z
M>U:JB+&?/CR@6"?EHZQUZDS4>GON^[!YZN89*$0[Y? P!IDUR].>X<+<R)V)
MZ_5)V.7X4[+[2[/(>-O]]'<>XO&?VF,,!J#"MHD'<85>7_JN]R!EDP_0-3VC
M,]"= HO1"@,]%NT2]C0^<[?2DO]8</QG$<=W0("_#/!ENC]S#R6SD)Z/7!*!
M2^KM]6;VC)R#QP5D?<VZ OPR\@[4MHL! 2O4-OZ7LUB(,WANY&FBX4.DD?N?
MG=,<5;UR1S35Y':Z7'B;HFV9O18W-"P"8KM^YTEDQ!H^))Z9\TMJ#?N(T5C>
M2#GJK7=4QKO6# -V6RW@]WX[>V=J7"5DC1BHR==%96;+&]46@@&<H45,4;2.
M!Q+W(5J2"M<+YV3)ND7? %>Z1?]CV8GD?11>E_%]_QXE[_1&2I9@=%LM58B6
MP@,9ACZ-'MQYV)XS)F-Z*?>/2Y\RN,\EO&A:SK-@7;I=DZ/L?ER>)4%<P"33
MHPX?\O,6 #_Q9\SO_.72[AH?]1$K>G$C,DM*TS5.=&99__XK-L[B"IBR;[[O
M+W'UH/4-: ,W2\7TQ==+7,@^R,*:I8KQGF;.(]-;72^_SXOEGVCQA>577(<A
MF!0NW.KE28MGEK5WF.\2G^XE5P)D\14QS-'XTF5UZ4>EW'=!U_8S!\ 1LN52
M:)J&2K?6;*'9!0)3# Q=P8KP1&!$O_;EPGH\8S<[5QEC,@MW?BZD=H2?YB1#
MBQL27QWA2#]W&#?PQ!M?_2;P#"[@#]=-[,2KUI1DX2\.U%@P^0+$*V14,] $
M4.T$"C"9)7A3I[>X' ;B4T(!E/.[OQ1:Q)XE!9R$=,E'(=%>A!-_CZ6D/Q<
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ME9,ID+"]\]P!%!R<)IJ\/GQT\8O1C% O]@09!GY\IV9T3L,]>&=,MHP*BW-
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M(L.?#DR4/U_,6QW_?F*+A1Z#)!V+XRYM+]+_Y4;O+@0C4 !:<0E(5@)]6R(
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M)QX1QHK5QP2OZI'NSL*2?8=U#RW98WR:?EBK#O,,9#M0/+H9YOZT'R%][L9
MA#HL*MJ%W KCQPJC@$FGN0O!3^!8/JYDZ<GJ$IMX2M1Y=H:*8CCS&Z!N1C>D
MBQ.*@7="ZGFY&)"+1:75>.C+0+(4T1*5>^BB_ 4F93F>V]^"#O9Z0\_5 "&F
MR'/M=E1Y#X[9J@$V(0;Z=NK2&IPLT-G_M"F)/S+=4NM S#J"MEZX40*#D%T!
M4ZNY(>F7#TN^S@:4J+:.US20Q?>P*67-@KXO?'8-+9Y)KQ-9?O&NCZ8Z%*4&
M""#?SPBL <]@1M:,X-S:K+[WIRQVG8 S7GN4]8<Y3^_+7<%DR+PTG,\O!3_1
M)!, [DN1WT>Y<M<J6?RKA._Y<I8<UFC&J1ZD&A7Z0A/WSD[,QO:Q*F76.RV)
M;?Y^LIY2#U2X!UON=Y+!Y&&.XC.MIABEKSJA=APMR>\W0SJ#2KPMUU$</[8U
M'BW0(.)PAE'> ;JI/Z?\4C$A" _C"V"4)Y1FLMS"O(!-]GV'B$\H#@@&&?8)
M%L?A2+#_\A_;?X:(N'06T$TH^J_F/W@TOB:YN/2L5H!#$"^@/"BI]^VKA5CL
MEX THR:X3ZL<].B0_;4)>MM\&@>".N-(<=D0!Y8.FIWD2I<;"H6,B_V-ZN!L
M-Q[%BZ?!:7V;1PG4Y,K4'CGC0X)RLH&PR+".F,L:X*]*![,,AFJ=$(/C_;8E
M+/VTHL!*JQXYQD'[S[ZIV^="UTS4Y8>O9'K-NV$-U6J,&*/2+0$AA4;(\\>T
MY8PW*_D^F?C'U(OHT6_+)Z6$%-AEG+5EPL6_RF> BJK9A#4$*P1815DQ)RC@
MSZ#H;A"[\R+;Q%CF9M^K=[]^9BI7<*/M.K$N.5"XQVP$VJT1LU+4'_KYXS[6
M\L5[BQ$L7Y?O\6NEJ$"3?;TBZ8OF5;W;S@5WIFI\\IV[W&0-&MV^S\V+38$A
M;X)I.Z$EW0CCDDV(W-:,J%7)G=-V621L[ +:[RT9)UA3LGGCG[?]_C.D8Y
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M[_A5Q30L;?MW'RHP3@6:4]",%U,P(^7^[[];FRY)OK75_&8F)QK;Y<?W %:
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MEGKT>6P3L3!%UV-7UMPAG^I;ALMNF^#)D-YICW%WI;U>U;AT"3;RFM&E 8>
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M'7H-"YTBCG0!\Z?/HE@_P,EB>(D([S$D8ACOG+7"<]E85^)@EHEU=5^GRCX
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MZ>E[)294%PH,[H;$3 A_,*P CO"G [2"#4P743A8Y ^\R4NI _&+NA,"1[I
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M-3M+@LZ%CX-CJ?\:2"-I=MKE>_V1*+F?? K 4F8,4K;@^H^1_D+R<);BBG_
MN[*'% S\:R3#OZ"4DB.A%6@T$=$"_.+#0_O72,B_D'CM&IYDG)P"VLCG_?]C
MTG],^K_+I%, 921]QBP/5]=WMP\Z:9>L.X2->I/-Z=: 'Z5N@&7"@*^:3P$C
M<N2"FD0VN8O9UV,!O-=&37.THT6+57BVTPMK#=58O]&R$XK)F@>QT/4+/J>
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M\T0R;;^9J$L?"L5>-^TB"*<O!/A=R\+_S+J 6'Y.F3HQ),4/,LLHU6-N(&F
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M I*,M0;NNQ(3G+ Q3W VH=J'1^_'?]/$JU8X"F2ZGI/V2\H&,A!EBI>/@!U
MQMFUEG.)9_M7+%0252O?N"NS1F:U-I6,5V9%7B;.P]B(.NWC-C?P"[$VRLP;
M=Q5^/'.]Q,/:O?Z+=KQ)BPC[\IP+%%-YG,7B4/1YV?SYYJ-7LY52S:Y*B0H*
M1YAOWEZMD'-X)%*08!=.L.FZC]^V\B\^EF87NWE_H=7TM?;^HD?LKSQ:X8\D
MN9!Y^2BPVSR294)W[H1.ZWWO)S/S@I4W[4_;/_#VZ^O/<ZRE%N)@;V:X&XA>
MIX +Z& )3YF"B:DHRV,&:T JDR95"W6!N;_OWESD[A8P8#!5) )LCEL3]?3
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M,+J5([:4-/$;N/,7CONGS2>GXK6.QJ?-+MG\ZOAD/N"DZ/-.GUM-('.UC29
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M^X2X1H^C7:/P:%'U65N 7#!7NSJ+#(43MN=L7ITQGO;^3=%R530F_&2"7'3
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M"7@"AN%A AZ#WG@S %^^#GWN6347LM7I>] FGLQJT,D[,SV,R7BY/]3!!'"
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MI'6:9Q5[;&9F"+)_D?:4S 0T@-Z91V83POQ'-M5TM+[VB;FHL70*KQ?P'M5
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MB7U.':, R?A/#-]D%#8K:Q/:VH.H BDASD,2VA2=NA1"!,N)T[**D\=.2ZT
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MRFB+)[B5E#JOFK+&Z6_?-/_FZ;5S?[M'FF@5@]V>*%$4PL<L<+"9KGMAL!>
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M*4BO&O10Q#<F6^,91DE1E)2T_BV3_^+P=$C4-1U3F&X<1HE 5E)U-IX)I2.
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MEMDZ%^F$&CB:5><'9@1JF9_R6H'I_=_A@F*%G+#(&)O5FA P0O!U&^M=FPM
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M]908J5SS9'R<9RYHEM4-FX]]+JA$-/]#0&E-G$J_C8ZA@6',HB3)FI<U[)D
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MZGSA/J>;*6K0R^4JJ,+"P>;D'(;RI>K3I](K-V(_J,>:(Q UGI1+LT&^[KM
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M2;RYLY_,T5".($#3/1^!0 #!I!!:AR'B^)M4'DJF*44,X\VRL'',G08B1M.
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M437/&3]]<6."H?3G0Z9JUX"6/%SZY:W%:T!C-&17!_*OFKH#5T5FLFFRWM>
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MIF[=&JIZ_\/[$V!;#)X*GOKH$K4[U20AGY/:QN]1^T+3=JAWRF_(5NG6EVN
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M\Y9NPQ?W;Z]D8PJ^>\E\+\2Y CTQ!BWZS6=II=;\$W@]RUT_!%*U=H83Y;X
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MV@*/:"A/LN9:>D_XB*S(GOD#2B0)T-I+ G3#_^4>IS-$.C0E,=@$1KRN2I2
MM9MGPWY"01>MB_YIC=ZQW>O!P-:X?CT36?LG2G&O9/T_CA*(K,@:X*K[9V_.
MVX66E/-M CP>]K_T\<]V( ?<\?D5](6G%0/B$&4MB\(_6S8D"TF !3W8LBJ!
M=YKY_,:%$2!07+3^3]7OSH.#B+;'B#T%M7_I(/=?(#37D@ A#2](@*]3621
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M\P()$ 5DD^/#,;]ZI!Q*B'PWL6,M=T-MX.Z%WZW;4;MK.&(B50]*KKUPRV%
M-9VBG%QIU>D9WYXDHOUQ2T990#1>:4FJD]IR*3FF!LRP776K1EX%+*:9>_,C
MU>-'.]^^ N2ON[K/$ASQVKY8PR4#Q*)&WQ3.P=BJME$[T/EJS&A?;&=P[XYB
M.5UST-UR@63+_6];>?9]^OCRW2T&;67C0$O0A+!;QHNITV$;9&--HFV8U3,K
M]_N)@8?7*,Z#L6 T:)':M:V>)A\64'N,2KIM9O9"-"1NV<":<.M!"\?C:7MD
M7$Z.^6!1+MG+$("\0-2=L-@'J W?%!N(KI#+JJ&.@!J[$G?WEOY$HK6\(H?R
MTR;QHP0LU3P54=JK0RF>^ZX C'>H5I7Z6N%@-!Q/:;E%[9WAKJ+NK&,.>E C
MI9)7/."V\\\P/_V[SXG\IQ@6$@=(@#UG+IJ6'2D'$B ;]44W<?HI5:E^^/W/
M"Y$1JJG"\D-%$T?ZW#JH*A!&(>&\LF7E0!)V>G;QT#UXR;@!KM5#D #470O
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M3(WV66[+65"_+^/NRD)%).5OO9E<A1ZY/EL+$&.8H;\A3"+ ==0T0!BKU;+
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MZ-$>IV4ISE46FS#HKPTW"M,TB_E]MH3U^53"=]C/GOWQT\8'.BU36TR&AQ"
MSQ)?1UV(0O"S'.H]LSE]M LN=D]<!%- .,FQA['AV49*!1 #[;^_U@1^*,H]
MB??FV5/CF:KQ*WC0T E*0?\\]Q0<6$Q^HY=4MO4?*^#]/MV.38L9W%T&*B,F
M8Z4UODI3E-MN*<"'UPR_V'-5<K4UJ1@D.85/OVBXFW6?[?X)-YDRHW/Q,X)P
MM^0CG6^[.K=.\_IAV&[@==C&\_$+F[ S3S#G^I?7#/IG]BV#Q'W:XG>P]8F
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MR8"U)'BR2L$B7+G9:B7UO">:L@<'XOO@(5Z3_B'T?>E9B4V;V#5XLVHFK]V
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M-)JQ (9M><5Z4X[.9+/+<DP7)S),NJ#LHP6H+K!0<536Z:NL.RF%[T6(7>)
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MB>2R[*CD#AP;H;N^E7+V]0;P2B#]!O#Y!G!D.R:W*&>/<WV0<)9YGBG7UG3
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M?@%QWM2P8I^CD1/ <&%Q/3,PE*PEKR:>'/Z[K+.EJU,$ALCSIK/GE"R7K,S
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M/<$E^:C.QV)M'.Z=>TO3L(:+<:5#IJM7(AD*I'4B]E(,HW'$,HR[#WJM8$&
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M?R+P+J6!>M?]D'+G/=H^H<'9+9@DR[?>3W43Q_V<RBC21QSD#.SVP77C IW
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MT '^&MJ4C?AZ!"2*0M3A<!<E^CO!Q.^?=2.Z]!Y*^B!RC4\Q?J(T,6L+;^#
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M45$V/'G\_$#;A7K:E52?/2^2^:T41KAHG$*,%3 GH'>P\.T<7K]T"\#[?LN
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MTD?&:+Y=BF'THY6!Z*5"9LWBO"B1KB0-7C"O%$N3-_*1Y&2 BV8 C73S"?F
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ME)>1&/Y;4WM9<M(NL7+!3["ZG+*K#,F<3-+4GX:1!1'Y\C..AQP@ZV+G#%D
M,W8SR\VN?FH#MYJLE>KJ@G8UC5)-\V<F[VH3SO,8 RYM2K[%J\*^'E$0*ZVM
M+ ^GZG0+*RO)%71SLFR'@(KQINGZ75-Q!E)KVR,;< X&_4H?AKN*?V;H<YRZ
M95FG1P;8<4!L@_OVTPM]D2NR^OYA52<8J2+&&KXF[=&-]*P7278Q AW\3V9W
M']%F5MP&!^(0,!Q?0:=$%%%GU5U0,=!#4_JX\S)'Q+!/@1>K-!:3P[5N-T=,
M+\J$K\X%IJ\V^9VO[%/-(HM$QEK\>@_ICHM'JL?HBF9-3,=:F^JI'6H6[,56
M/ZT!(1AA6:.,$%+\ZO!8*&&1OYS &59Y2B:RKK-^&VXTD(2XVJPDKB925[PP
M=S>#05:! @=O#QE(]S\B3.;+GA<U$0N5['5+CN%Y'(*W[@<;3F!WRO-R' 1_
MWRG*%@Z\TW]2H)S@Q6W^*SA&NVLDT)*+KQ)A3;E92HW!Z/4H@*\/J%V,7\X9
M16,>#FBSRK75=Z1)!+6>:CO3^X[.1$Q*8420D]^$X/TT^2GR=#_HJ\]9H=^/
MO56:Y6EUN<%I7]GM.#&?B>.BQ(YL?,+X3BYK:).7RJ0QABZ)V,RAYKMYQEBD
MXQEL1]N]&^Y4^J+I/49(CEZ^@[X%1T32X96IA]Z11CH:7$WO]+6A2[AD>V"N
M^7J[U(SV<@XJ?O?L"B5IDDM7=P5;GBWN^%;_,8T E5/*<JI$\!\]XQ,#WP,4
MZ.Z>^*:X*Q#-E+2QK][M6E?SLA#H:L'-;HQ&U7Z3[9K/C.,8ZH"Y$R?W -Q\
M"#W$\[\Q4F 9_7&N\A\F+7N [Q'\@6-_=R4'_RRT3/TEP_.!5JO5=27?D#BI
M7<("N0N]U=!(@G#6]++)&"]($%'S;Z7;YP8W($UD[2'#A)L1*6I\&#<]\_ZR
MX4YQ1&*C"3%F:.&788GKG+S^C>,UIL5:VS5_>[?D_^#'39\H 4U]B=2:!X&&
MM[[7,/)D'0OFJ"?2%11.N&+.CXZ\*35].,B7>H$:!2R"$WSB7"D.';HC'[1)
M+VMTPJ4*C3_^-_LFQ:U64H.F[$P'W-_[-&2RTRH\1 .?'6$N)D,/,P%P9@!T
M[8G_KD*XS(NL\@=/<H]JE 7M\A$#H =>2^P>X$#@60$>V#3[_TG-Q;OZ"-JT
MUT[L&SD3/ ="SA[@#R.'Y0\]YO4>("(C_/+LB"96<=;&Y4\'[.LX@#_4&/B^
MCJ,GO$83)<6O%5?LVS]L!RH.]-\J#L#_P,0![9LX&5%>GCRVL.U;(S\$9?YP
M780!^'U(:3:S@,;S0]2^;E1_YL V:ML#,*JD,E.M&@=[=TVW@#^$_? T/D2W
MPN22@[_,U[]DX_)%I2[.]\./47]^FQZ?6T?%3X@_(?Z$^!/B3X@_(?Z$^/\$
ML8A:QP'FSQK!-\>'+#/)ETV4P8.0-(UCWP^&5<BH4/)E:>IC*5(9X;$F>Y_^
M!5!+ P04    "  1B&%4=/O[13S(   JZ@  %    &EC;'(M,C R,3$R,S%?
M9S0N:G!G[+H%5)Q-MR;:A! D$"! < GNWGA#@.#!I7&"!NB@C6N X.X.P;UQ
MAQ < @1OG.#N[@S?]__G/W-FSER_=^Y:DZ?77NRJKJ[GW;7K?>O9=#]./RX!
ML&0E920!" @(@(]/+\#C,M:9A(N%&0 @+P]@!   *(#G"(* 9T_>JZ>&;* %
MX/F3C_#D:Z:E__470 ( 8(WLD "0G_K0G]K"@+\Z=_[^[!_\P1_\P1_\P1_\
M+PHQ5WMK4V8*"4,K&VMK   I"O%O/8'[I!ORHY[_RV^*B?[;1^3@ @!B8O[=
M_W=M@9+RUWQ_M,4?_,$?_,$?_,'_VN!DY^00X. 4X."CX. 7 '(+L+/_IWU/
M*@3@"K '6 -, <P "H $P!!@!;!Y:C\I$L#C\DL*<P<'6P$V-FLHJZ&)C9$I
MJ[&-%9N+H2T;!RL[&T!(Q,76T!ABZD!A9/K)PAI$=]C<1D=A80*B P/EV>5M
MQ4W-+:3=[$U5W134C-T@QOPF="+"&&A"+@(N5K96I@Z&%"Y6GZVA BX@RK]G
M%WCR_^IFHQ06LC<Q$U!Y+_G/$4\M$.4_K\79V9G5F8O5QOX3&P<_/S\;.R<;
M)R?+TP@6J*NU@Z$+BS64ZI\3O#>%&MM;V#I8V%A3_-4V-+)Q= !1.CI:F B8
M&9H!C4Q,@"Q&AEPF+!P<)H8LAB9<'"PF7%PFO$ ./DXS#B/*?]*;&/^+W=;1
M_O/?W";&;*:?3:U,K1V@3ZO!P4;)]O\LY],2_8OT/UW^IQB?Q@B(VYL:.IB^
M?S+AOU+,PL')PL&G]F\I9N7@8A=B^V_&";']-Q?Z/V&UA(5,C 6,_[HF&_M_
MT*N:VOW?R_9G"^'_(*K_$>93[S^<I_F?-A\J*JH0VW]-_=^O!=L_]]Z3]Z^=
M^O1)BO\/\(?D#\D?DC\D?TC^D/PA^?\7R;^K75/K)XGK_*1E'^< X@!D)*07
M2,^17R"]0$%&1D'#?OFD,=#P,+'0L0GPB @)\ CPB<GHWA*3TI#B$U"R4M+0
M,S Q,Q%1L'&Q,7+2,3(Q_C4) C(*"AHJ&N[+E[B,) 0DC/^G\?@#@(V"(/T\
M A&!$O ,&P$1&^&Q"T . " @(?R-?RL-$)XA/D=Z@8R"BO;R:4 M%N 9 B+B
ML^>(2$C/GS^]Z_GT/N Y-M+KMQRB+W"4#9$I[7 Y?:*S4*C$*MOQ5$:/J+F,
M['U1T=[@$Q 2T=#2T3,P<@-Y>/GX!<3?2TA*2<O(JJJI:X UM;2-34S-/IE;
M6$(=')V<75S=_+[Z!P0&!8?$Q,;%)R0F):=DY^3FY1<4%A575=?4UM4W-#9U
M='9U]_3V]?\<&Y^8A$]-S\PNKZRNK6]L;FWO')^<GIU?7%Y=W_P5%P( $>'?
M\)_&A?T4U[/GSQ&?(_\5%\(SY[\&8#]'>LOQXK6H,K*A'0XEIP\*KEAT5F4[
M*A67RA&>D?THVAMJ[F6:X[]"^SNR_V.!^?Y?BNQ?@?U[7+, =$2$I^0A8@-$
M #>2(?3?GOVQ/_;_FC$)WQJ,GK4\ BPLZS22=C?G*;VYWJ7*0<5"UC:N<I:2
MN-JZG#Z1S],\ J* FAX?C]Y:M1U%267>++.*@.)UJ_:D:@ON!@X%M9GB_5:<
M?0\(4.YDC% ? 1DQGQ\!(Y4Z<.V>Y**P[:;PO.ES7\?8:R(-B'W<*DNR?0A]
MKI*R!"[@?VBB%.BQ/H?JN1,LQLOY*MXSF]=*2"E,H/,DY 6P32<>(7RJYOF]
M]A<@?6E66<01]IGW0RW(L5!Q,;QW_,47[L+BX*+9MKN:6>_9Y^IQT=2$X?&!
MA?S?D/\W*?\R^1C-%;VQIF_GQB%YM,UY7;:7%]>/ -/V![4)G1ELAAX1G$JO
MD'X;7/,!^+7W<^-[AH$5/=(; ZDK7Y&DX@OH7M]--_FF@1N0OCAJIPZ??,?F
M(W2+FO"N>)J?1*T&OA$=9UIL*(&K0D^?'0+X'UKN)S5")S203/>[&_]BQV3%
M\<SU=V_HB^G M:0O,[/'O>NLVIKIUD1ZOG#3%U.!:T%RD<43_87:;3)QGBX/
M#@A&(1*.=G$?.R=(QD80)'"5_N>;D4MF]PW;5^Y'0.UN8B@*Q;5M^1!UP2BX
MZ.:,M*\\T^/3<;W!,6Z,CCEL5CC#Y1GM_9G??<'^F:ZGO 61?4(OZ/-[!IO&
M R^&J]CE2)2$4+4)Q 6$1P!90N=@XC&B_R/ !UM?:H5\EERCR2RT4]N!!]LI
M9?.RBMS#<_3LNJ17*Y3#C+J2GSJC)GZ<B$,G0^^#J=9^-N]Y)*E+IL$\4,_^
MQ,2Z$I5'TGOII?\]T],]H18SO6IO[_SY*1G/<;_%4_CY\C]WRLW^(F!%O,(6
MZD":HS!EW0498\@<>@=Z]OW='=/HG>#M^X7W&FRXVS("#KQOI""8Q1SM=RCE
MK[.S.M@<K-#.#:N%^XZ&(UH$5[9.LRTY!M@)(<[7- 97J&N1=M&'>A@>7.AC
M<X.Q.GW'LH'V AP:JCLHV_J52YD1-["HXUF70N$BTQ_XB&0>QKNC3X%[[J(J
M0Y9!1)IK9T599XYXJ5E7?K+'K"GULS1[8%M>E< XX3"!H@M@GNXM68A%R;?L
M$'J"?VUQZ<'"O#1_Y8F4_N;) 5,6%_+?(&\TP&C&#K'I( QA+Z>HM/\\F9@2
M"06D2%L=^L9(,T91Q8(>X42>>BA9+^DVQ?3OK!I]0://_H*F;B;Y\W7!!(F*
M\CO\K$D8Y?(QY5.2IT[+F*PD7X:A[WD?U$+/E)#!$A]G+>WGE@TNHV]P^FXT
M)O"QYWN_T_8="(8 8O[# XD!MDMBNF;Z7CEFT!;P#5F-%YQPP9YLO2$=.QEI
M4% &)>H-5P&-;%-(+Z#O"2N?D3[4]B[HS>L/FC8GKT,7(A6/8$TN%G):YJZ:
M83_319PRRH\$F1X!I*)D8 6??.MANI]MB:HW8)#S2KCV(<4"0=PC )W*6H2L
MK<Q$6:\R1T&0JKLDO!SLZCG[RI5,BH6*JW)'<RW%"E>CE^*OQ5.[F)K2L$K5
M"39\!-CU#8E*T,;.6]0<1(0,]Z3$-R- UQ?H/#LA7L9W3+GC=WKYBU$Q_+51
M%XD%]^?CI]VN0WA?C\[6QWH=F3M:00M3R7L??1&0*<XH0T[VN0S:QI)0:%C>
MN 9?&SS4+^O!(U?D6#2?8ZS-.P</&V0=Z@+93P*:<^8[5[?!XY^FI[)#F-(.
M_T[!OQGJC_XE=9V2JS))U/G[. W@T-Z4U.9G-E-2>D2-577?UV)F&H^ 3P6;
M6N.6]9SW<.Q(B4< 48$$@$E0T'2Z\IR..T[Y'1+N/PP-UC<CR>@IVJT3J-88
M>L@>Y<9[-2E C^CT6]W7Z'EFD\U%DY>C"TE8A(1]O-'L!43UA ?<E!&',#JJ
M;F6STK1$6GX_?L\X"<!5EOBO3'E82*-":(J36IEB0+ .0*[](M:Z+R:[H<GW
M%PYP?K2=Z-R5@)X\&/92_RJ=Y,.1.7NP].H^9V3BP[/6AX*3<N$)H-R"QM)P
MX7R_'9W1IL\9*?*R=D^J>Z:4W_*=A.F0SKQ!Y,+XYB597K&'[.A>4EY,O\=J
M$T;1(\"3? O#_O(1@',>&A9*_[%:OXOU@CQX]0S&&#*I&B*<$2#CFW/AFIG1
M%O#;IQJZLN!U*&Q=8L\U(7DK<D:B ?VMU_]0M?/I$> F9MF*YR1]_E8L'F@N
MP?:>3WJY'OFC)U2UMW"Q0S3D9!EENTZ#X-ZR%I>(K_L@O-F&X,IWBDRCQ';Z
MZ4C,E7D$9)G5EPHS6-H:VNQ_;%*>@!D;W_5NZP)QTXQN2-3M]VA,#\<-'-MP
MW<D2C_'?3Z#(!;H3*EKT_O1>$H\<QIN08(9V58E2]H5QEH9'>6,;"&@$Q,,L
M!9@7S5(=CM;N^M-*/-6.(+PR#D(D8(SQA 97K0NW\C;OP<L=)O\189K91<ZY
M7>6RW (?SK0>Q3;'>PEG^EU*II[V^ !QAC[*"CL(=*U24^!*Y@0>WL;6HDV?
M'=WW'Q*H2IO!1_6;"8G\5Y6U8Z!'6<-TVR+('%%;*\<?RE0<"56C@1OI4TIZ
M0W^4.IDY,>]I9JR-*2%M R&)MWE*[IC'Q8?.MD^+^$GDB%F-6PDQ+&)!*W)B
MS-IP)/-73 C ;9C1<T;/*\S29,(Z-C?W$=#"I5[X#8/OO(!\UTB#K-@.G#51
MEO_C=\6-"-ZP\CM2/;RA=G=0_4W]M7>3*UX9I%A"^(WB0EOCT@,W@MO_GO!I
MV5U1["XA1RK9GK7/.Z@:R&03H2;<THVXOXCPM.NQ\-"Z*OV.&UQCA31Y'HQ_
M&6,K49QQ=;!9L3]Q,3P$E6?I.@1VA3-7<7QR_ER-,Q$[#S_;-M!PG2XUH&O$
M&'#[55OHXJ>6J QGS6UJBKO[M?GM#/$;XHB=FGE!-V[L8*4HL0Q5>G$0I^8-
M@MZGJ#GK/5.MBO%R1[G:VG$KVN;T[WM*DGJ12TSC0N1']I"%1'V&Z/ULH;+<
M]Z[A#\</Y-\VM_7WE],QY48^^]=%&F/DZG5!!L@U0#*7P+CBO,H9*53&E('W
M+K3^1SC=VKD6K/D7LQ_D[[AXKCD>=HZO7F,XI]CL'2[O.J@66SI?5KWZKC^M
M]$! =UZNE]_8L=&XH,7CQM&A'+&SB6IS9/.C;@?_%DM6ZE@.RD#W=/!TZY*C
MW6'U5[8(0B*-?CRXEO4[(D5((@4.''X(U?[2I]8P#(_?N$FQ']'6\NSE<C\R
M_E&/5;= 6C97W0FEISIBEMK6):L]$I&0<!YWA#2_^Q9CC6>JO-\SKC_@7"RQ
MOB^)E%H ['U:.Y-G*%2G!]0BS8&/ #-OPVW%#&4^NY@L!0$:Z.:"37M*1,AQ
M@/F!![P+@BW8MR=[3EA*F)6PJ!&RPALBL1.1)WV'X8E9L!6MK5^75<C7/*$3
MRW2F:%KD:,4D>XPKK%#]B>2*0 NELV TD.I:8Z2(MI:OXLHR_JTK2#&-OES\
M6*K#?5^ M^7H5#C'G-]<^O[,>$OX<GFXUG4;23/@.9:MZ+X.;48/M(#1>DRR
M+<!#M<1%3D-/_'TC>Q^?@U!NR3U<?_7:J=M3\.AV12-QM9DS>F5<-1@*2JU3
M$&D)O$H\)[W%.5'7&J\E'J)2#G@$R#>X0PJ)'>Q[;-6>'A,+.W3R'V8#*-4,
MHB^1\-H]V*\2;5;+N.<6OM;#6>((EY&#P05)&8LYE3<AAY#@_/3D@PZ[--?L
MIQN4LB,GPZ$^J*4 X%4CSRF*'2/^141[$P;+V-$['+\"CWTA=W:GF?/XS?@J
MA+'VZ1!_]SP-(7:+L;LU=?B4/!ZDZ#86LLB'W-=RDU&#D'@A(W9@5^,.I]F[
MS%\V"A EBHV,=Q5)=SP-RRH5J0IV9+>+:AEYX>]?$8%EL"%<4*89M4241*&Y
M4]H3.XH;=ENPJZ4J/7"I&9E5]C(67FUV> [C;U7H8WGQ<C?H$1!J>V:HVEWR
M=L61Z: E)(<"J!<(C"GA:R6LSD&UCHAA,$YV?K\<6"O<Z+*P$L?]6>V6:+IV
MHG/96ECU_J"GR6(%M\:-I);])*)R8J2@DSM*FHQVUCN=JUR6*7==@)AIK?F#
MYPRR^D-V&9@Q8K3!@4;3@;+I)?%D<V@&M4&+2!E ^TD/ ;)#2HHLV2V<%*'V
MT\H=A3N](ZHR]28?<K,;,SI^[[RY,<W1U?L^00(0J#Q#A+><ZAQC_*JD'4\J
M\[DV0BYO/ ?J:$S"@.[5P/:.B-<<H\C7AVJ0\1Q1<7#C*=^@0XFPI@7Y('UV
MI9#X2J@(YMQ!LKY%Y$((Q]VPZ-UNMHHR^%-*_$)X4ZM%SJ(^=A4HQ#M$W.<!
MZ+/<ACNGKRUAZU')9/]NTV:LZ5;/D?S*WW:B^\SGP+"JX1>CNNF)P896W5&<
MI_5!\-.]\39RXA'@;]&YW$K&<=I-'3@Y_PCXH*Y9:VH(SQ>(8IH[A<F BUAF
M=L=_+.=DAUSO*'#+LT4E0*YBO,OL,MA]''3Z,MY6H58!R#LD'$=_OV[V67FJ
M!5??-)*6!^XC&&[4_I@57$7F+II*HW/ZQ3R.B)8$WIM,V<]2 &GR(VC)B"P2
ME-'SSE-Q6\*P3$-X[/1-"R!>)H:AT)"I.CBYG>8Z(\<IP"[E+-YK<[.^>S0^
MM>E4T/3C;CP_[LX:]3')H67=HC6V#J.4Y6CE,3KM:U9J9O!W?F!QR1LGE>X%
MKV/-Q6^O2]%B4)[4=R$+FU5Y-J?VAYA"/JN">.&O3D"010X(L>KH:3>=J$QI
MV)@TB-SR7CUXU4[[14?WE9/ <CJ%Z2"2<BRBI]8*KR5%=NXCZT]@C%?>M8AS
M[6880(7J,^\-9P?EJ3R\S8RKO\2=AMY%44U2682BV$.FK%E>80(M"N; :)+S
M16D3 )59AH[ZG#:$05VN HU3'D##3^7Z"EO.DW%>X]W'@?ZS%[ OV._4 6YH
M@&\)KR1-/G[O3*DD#7OK]5%GQ])C38D/%^5C_5>'8&]L><V<>:F$MLN^HNH/
M!N<!7XC@1]$/9=X(2L32<M@_CZ<GJ]77KG/1&$WV.',3YA0/YIR70[X6Z>?@
M56 A_<##^OK":IKB@EMO'CM10B=EQ#$TTK)0%!G93PV JH+"1Y6%5VY<;$W)
M%.LW(E(.KZ+_]@H6TC?N^#I7E/_:C8EL<;+\GQ(/S+_R&U_GRGYN( RU/%>W
M%]^4?-'&QOILS&J&6"E+%5M9-1\V8]-%1EMQM ^[K?_-A;GP(W##^XCL?$W@
M,K@6$VL^L26NE&*##VL9Y^C <^C3;P/='=X8/?V?8T-O![B\,Y!KP;"D]O?W
M."P_&3XF<L$];]V>6$6_N?"J31U3<P2Q0!^^ZS\5<0Z.(@.+937U(.W)HI%
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ML6'OUIYD2-ORM1O84%^@M&\Y*MZ4_SF9:/F'HX,*H">[8/1F[\E/Y'+CJT=
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MV;U4(UDIO]*'K[A'/1C36W>V&K,YJ_:';#@!:U@0U>#8ML_-W:H? 8S;O7Y
M&Y2Y]O(9A6H][4R.6$,JTH<6L&@6TSMLNYA7=GH3@P52OYV_AK$--=\Q1<[]
MDI\^O*FAC!]*Y]S2WTZ8HGK0>5]E"YU U-CE>H?21-I$V80R4?C:F"K3<@QO
MMA8LM%&Z![PA6CXWK.^NZYV4ABW?$*T 'P&)70F?IBCC'M[P'=A(LNQ;W\$]
MWI#5ND#>M*9Y.?9"=MX'B5*MGY>&VGJT]]_M#H;N.7)'G-S-[B!Q_G98@X*_
MM0;0JR-L'^K6)A%+&+QC*/&/;J;9XY14RZC5Z&<I34\1PNBE>U&4'1(%H-^U
MFR%F_TWULUAP$OOYZ%72(-;U![],-ZMOY.9B($M,+ B^@&-'D+HF]F*F7"7P
MTS>71&G)H4'C0WNI+-B;'1ZKG[E%5(1X(U(KS8VY:AE\=]D_1#Q>G<NZJ,A5
M&?>,S4/A586P0QR8__M5"P=FEU?GI>5T8_E\,OT9Z!<V*^2)(CZPDX;J@J1/
MM:U?#9<_+F8JZZ54/!7$%&%^>E<6O,3"@6]H&61W"VM'+4Y=+Z2[UK_,>J-M
M0E0E$C<2J.:MR3=/8+%Q4__XQ?$_K#RD1='[OFAE0?O6:=G.E?G+9J6]U+:!
MR<XERZ=L ]VL3G$;ZB^W_G0WX"[U<5'K839V;S2T<V\?;<U4I2D@#^$M\)N_
M5]5KZ#7=KKZR?N91H/H$-LS!DQ.)=D>4NBKC)S[ 6V#6>E3HADLI)194TMGY
M0!W:?MM[#0<'_9KC?VF+K#LEE3<K8Y7/# WCV]5R*VOZ,$=-*$F!O:\;N0K:
MI-W6<Q(:Z%H$C=>XK/IN4Y\:A^&M!I!-#FT_ M[4#!3=%5F9J-$15^O5=Q\&
M8N_H$SZ,C./?4_9S11[2"H!]KU3%/*%=3K,.D(#HH^D]P91D^5/=4P/>JLMZ
M4$'G[%>!^?'6<HX>@8SSG.=M,VXIOT9E.#WAFCV*H&,]O )?A\.7VX6?>5]P
M?.D4PME5,>? W!^L\D7#[ANR&2H;7$:53(<=0 7J@\\P7RT,O*AUIVG9$SWI
MHFDZRY$Z]@X\E\Z_)4PWVTK23;@35&>+$.!)Y,F$%$L*-0^8G>2BM7EB?KC'
M4+NB9A&:2TT>=U\U)^B[@>L>IJ7\RK4BL+[)B"R88>E))!WD9Z"@V]S5Q0QN
M :U8E)Y#^JR6=<P,YA'O-$&]XZWN&(T^I50G$Y1+RV "$KC](N7T$%+'0:2%
MOJ+ES%!S3GX9?1YQ]7HZCOZQCAY+_/<L0>;>3S&*;1^F2JYL.A8I\14>*#3,
M-X,JC:[5J;YPZ(H$O3O:C#R(R)B>HQ1(T/>/P[G;W>)MYMQ^ [LZ)4*O(+TB
MF0*QFLT,H/S,@[2^YCHS0!L6B75HRAW-%7^&1/BLI6#E5=$J)O*=E [3RS4>
M\&>R%^;MNQ,X^_J=!8O<5('3"/W=KIF]<M%VK,%\A'-<153ELF/6NLVIPMJR
MNDU<=2,UX<;*OL2W]XX%$E9[J2_@  ?R<.M\_SR(/:'-9%C)2""3IC>F#9['
M2[.R1P +E1#.>5FHJY@5LRU!M#J9F7^@;SC2< G+[@U-TU:?U0GZAS8.?D%/
M1GCLIP)YR$-8QP?,5 RUVI=;O]\U*?UV](2(M OX-X:L9WO^P&[8S#-@3@?U
M#BG.Y29LK;-1G@";&Z*P0KD0]-6/WPSO+3)Q^G0/,KR].6F[97&7/R]/+YH?
MS%F/$>MHZ5V93(QE3;2+;*EZ>\<3?3?DP*_?2Y333\CU"U)P!76]( ]R>Y_\
MP[4EY[!5]A' I=NM.[H)T;/O6'Y%Q)0T3V[[8Z)?3U/)H_K#S=%VX( ,>@,K
MI^3HC[R0(2Q?['SAW'V\PCX$P*G/%Q"#V$K++=5VJJDJZ;*NI&&0\[6<W8TZ
M<3BO5C24K&ZTS6[M+?)<GK515*1L[MXG^E.67^9S5QFT"V1Y%A3DG2SU!EW8
M\@_3QQCYPG,YG?;IBV.?>>]/?J_J,2A)F%JJ#$/(=AWF%S/BBRVU-=<R@31#
M]FGZ/&/:AC9>)]OCF4LM8=]$)+>\!48:3*-YN]KC T3U)3[*.9(5($<73@?G
M6 N[[#)?F3U566:I'5-ESSWEXQX!W/)[(!$T&AGGBJV5QAO=Q1AUF^\(^\,4
M$S(U/+C8.V53CX!RS9&=<D?[!.TPVH[[!C6G:QJ1/5[QLUWM:&V]TI!$['2_
M!GXF73S*528N>($*3OC*Y[DO?1QJYUI.DK:6>U0#@1CA"_\%5D"IO\CO6'JT
MC&0C!_*IGL732<S)E;+<U "">>13Y#G/]:J[L/CWKS97N>BK$LULLB\+FG1^
M#;^:,2A$16Z!CS6C9Z?=F2*1[=Q'N!)(ZBNNGFPP(^[CBNVC34EJ<M:I9^Z<
M*_A.]MP,*C>NTU&VCW</+V[8_.NT:Z4[L=J9YVX<D'VK1T$S!8B2W./\IH_O
M*5^HI 1GUKL"B2##H"/<55FTFTD.1'M/JM8RPTNC-HXF/5&'K4QDCM 3SY>X
M_CC_  K*K0UI/*OQ%G(CC"C^?]:SZ^FPZM1C<^!Q\N;$S?F/A3S9XX_[S 5T
MEU=B-<9QCM7,K+Y+B3^Z:X;XD?$U-"MVLM,D6;491SM.1"/4^IKAQUY343V,
MF2C3E+N_Z_,L?$?XA+IBMIFE2"34)!\Q'_+$>I]Z\7GMY)"TLI9W<EF9CG)-
M+HZRWUQ)=7$AEGD)9W8Y+'WK:EM?EYQZUP_">O*+D6_!I 7;W!Q7K>GK]KT-
MHU4[X>?Q'/\ (UX[X9F\G4FC/KTKV'P[,%!7/$@&,=L=*]3#.Z/S+/8.%=IC
MV3SK=7/7H1[_ /ZOY5C:I 'C8$<$885U%IIUU<74\-G;22JPW*4&<'MS5R7P
M%J\\;%DACXX!D&3^5;U9PMJSR<)@L7.2E3@VCR+3]UM<26[]B2OTJW.V(235
MWQ/X?O?#E\CWT(4/\HD4Y4_C68\JM 3N%<:::T/8K4Y*:<E9G&:Q)Y=]#*,C
M9*K?D:^V[(YB0YSQ7Q#XB?#!O[IS^5?9?AN_-[X:TR\[W%G%(1[L@/\ 6N5[
MGV^6_P (V> _-02L"YQ4$MQ@G)YJ$7?H:S9ZR74\_P#CG;//X!_<QLSK=Q<+
MUZUPO@KP!J&H-$;F40;L$(@RV/?TKU;X@3++X5E0#<[2($4#EFW<5K^$=#.E
M:6C7(_TAU!;_ &?:HC.2E9')7P=*M+FJHO:!H-IX?TF.SLHPJKRQQRS>IK28
MA5R>G:G$_E4,AW-G^'%:7[G1""A%1BK(C)R=S].HKE?&NC1:WHL@*CSXE+PM
MZ$=1723R9X_A[5P7Q)\<V?@[PY+<3D/<S QV\(/+OT_(=:E2:>@ZM*%2FX3V
M9Y?H.M1V_C"WT\GY[E73']W +?\ LM>@5\^^$+^:[\<V5_.WS-<J3[!C@_SK
MZ"KV<+-RB[GQ5;#QP[4(A7<Z!,ITZ%V/)4+^7%<-6UIEV\=DJ@\*3BGB5>*9
MW97*U9KNCNP<TN0*P;#6@_R2$?6MB.57&0V17G-'T=R0O4;,2<"I F[O2^6*
M0%=F84],GYFJ81BG #%,$1@LQPO IMTWEVDI8\;<5-7.>-];31M#5V^]-*$
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MOY59%U(/0?A3;:W*0?,NTU1N8KOSOW:$KGUIW TUNYNQ'Y5(MS-CK6?"+A5
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M%?:?A+0T\->$=,TA ,VMNJN1W<\N?Q8DUO5>ECGQT[4^7N;%%%%<QXP4444
M%%%% !01D8/(HHH YJ\@^S73Q]LY7Z5#6[JEKY]OYB#YX^?J*PJ '1N8W##\
M:IZDP.35JJU["9825Y([>M5%V8GL9^I8_L?ITKYLT:18_BR>O_'V?YU]*7YS
MHKG%?,^CQEOBU@]3=G^=;22NCBJ)6/HOQ&,^'<XZX-5/#_\ JS6CK41DT*-?
M7 J+1+5HX&)&/EJI,N.S,KQX,>&;MP.#;X_\>KD?A-+GQ9>H.0UNAY^M=GX^
M7;X5G!ZF _SKB?A.=OBF8]-T"C/XUSR_B)G-4DO:Q9U'CBUDENH)(H]^T$'
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MGWPN$FN-V&]Z /11#?F7;/SP(9]=>*4"!8G'03F/KX8TXW^ESXEZ"]V""AX
MMGO$[SKXV8;9;G*1:V,-I7N0&F,!K.,,W1T=?_Y_T=+*UBS?R$@UW/],?5I[
M064*37XSXH\YENH!WW$R_VEBI3XV.85#<B1L%1-9">4\G9 ZPR\@SY>OJ5.@
MY[.?]%,55'BVRU=N6*O'(6!^KDCE-001H-SR*H9,OI"/9U60/M"?2.:L]-7Y
M+"G1.*-)_9"M;#?]GCC+L/9)N?*/XRFRBMW66>3B.[8[:ES)D(O?WN6.YEWD
ME0;5!K@IMECX>)07,(-%7M89Y;-N^Q@R@QT%KC.!6T$-3PYNG4Y=I/1''[2&
M@4E QH0EK0 ?AUTM%$D1['Y<P9KLED0QQ3]CBZ%BW@F>VS.*;94;3_TQWRSR
M_8QS4(:EWBLVFD3T 5#N/:F@;ON\CK&?U+G'7:^!+>P!4%GN_0$G20"X^$'"
M#W_Z/TV1-'^$-$HZ&-MH77RNE>\2FDL-1< 3?8E(A+AZI !4!:78BW6MT-FC
M,4D:+GX$:[.TQLG08D&#43E-&E^,4)F/0DW@+/([SR%-O%#^U?7$;XJ-LE++
M)59[ R:X?6?1P7!@2G45V7CL>+Y\[J7.6K=XS[EQ;8:^7H:5@W4H57[=9]EA
M6MVR6]RCDU"4Y]74(]ESFZ=T,ALQQPSI'BNY@TRI%-)Z1I-'G1'V.;,&L^@9
M9Y+.IZ+8V)F3R#&?MH&^39&<8\YTC$BXD]#2\S?%V4=T->Y6@7OQMS(Z89F>
MS5A/U"XT^.3!$77;OEX:NF\2=W561<]CP(%Z,6GK*)=UV"<E@_FMQ'/\W+)M
M_LM,A8;1@A6G-78:JFEPV.T3O*/2B:H\@_W(H;7$E<!?$9\*/?P-B_3F;<$)
M@Z&[E ?<^3;Y<C._EA\ '.4F4S<R/HRSN\27U>V@^?D$Z"G6!3,V_@/@+2ZP
MCAZ^FC!#X>F^7:RES9@7?;,"^M&ZPH!AK&R*)Z<.?C(CJ<AVA#P%J>^8RJD4
M30[7KF4S&%P>M 1?:J[%7+ZOK<K;31)%.8SC&YU(FK?6TP&7 ^PL&C("Q4,?
M +X,R=L=+^:BWS-;\.T"RWV'.R'X2Y=3BE5O7$H6]8S),A3:LR)+'UWMRHA*
M**BR04][F:)>$BD.3&L[?MI(56Z "FXT=O?7T3W%K=ERG:!_ETT%TW?PO8\J
MU//182)5'&KX"91V[UX5!1"UE^_&I6O,BCX'\DH&B0XWFW=Q&G.XR-5OJ*H%
M<,)08]PB;?R0)[I1TVOU3O9]^6A^3^9=091K?D@AY9BA@YGL<J%$XJ*>>=A'
M"ION;F:/+8;[AL,RXD2RKX^)YSKY*&FW=@X/]:E=172*;J\HUYQUA9$X<27F
M ].M[85%%6])S91:-*/S;2>4WJ^?:<$;)GA,V!/>.=:L+_/3*?5HI@P^5VQ\
M3'HR;]6P4\MIR^3JU/(N4HFMZ(OONJZ8KZ5PU'"22Z/2.O%H>%&%.%Q,P6C8
MW$>K =Z[5AW<&N)<5P).3TOT&C-ZY_9=L$=]QT MI8I+V=61F??"0J.@:OWC
MA%:<J+)]O0,72SV5K7'_6\&EI9/"[<D<EFC?9\)]6^ J;+86V6[ &6D+(]SF
M"_+/%7$R,^AD,)I?K1V_FV@"A[">R1;@%RTH_Z-^#!E!LF0GU+L_7$DB.,>,
MV>;,P"@TG)@$028L'#\O\$\Q[>DA"5EV3>(./G2VOU):3MJ*W^?DZC<T?]_I
M&V(1=%*MDGQ-G>^J#YS,6Q!)'7@4=#MS"M/QBZ7/=N:GTIMS50,?0<H=3$07
M5QV7>!_K^>D*NC+&?=$RL\\%*J$2&J@UPR7#!CE5!0?8%MV4N@2@_JY-8WFN
M3)+1;=I:%E52@ I[\['I4TCP(ND#X%MXCQ+$G7Y/BOGI'%-8TKU^S%_R!T#0
M%"JA]U;HR,Z'LPUQ+L!^X['4VN0Z9,%TL#6J@+>L"MXK373;M Z.*$7;&3N0
MJLO+_OV?WFP.*=:_2W'<!GEMQ9CO&*+ZOBBMVJQ3Z601F4 S#B;0K.SS(1>&
M*"U2+&5UY F7I=X4&^RQ_W". FC%5;XQNYEI;S! V>A-\]%D]TGG9 O3F+9C
MQ<IO)2%C$HCF_8#?J=2=':HQ[:P84?$"UEA[(M1+&BVW/)%J3U+Y_$=\=()O
MG$CEM^ZZ <(_U^-.Z(*Z<9[/\%\=DC^K>QCO<9E"=!9Z*!<)Z3TQU.>B'CO+
MR5Y64S0QQ9+ <M<'P)-U.+V@O5^]?SU;N(-,9M.?NZ5RA\N*%6>HI"'STS=P
MNB;U5Z4U<?K3!-:/JD\K@AL0X44=7BV,^B:L1'QYSQ4_)"N<*#[+E=:6[H']
M@-1<]3:A?UU<P 0[KY<B)*5*ZZ#$/#_/"RQ=4J&5.$CA*8,N29W(*<<67VG;
M)V?= IPJYXLT=\]E/1_U/9.1LZ[KL@W4\1A*JBV(/5;'<)_#2U7%Q@]@%LD#
M$J_B\!X I=!SWE!J6'F1@.T4(9?+C/)6EN=5I$^;T37V6+-FAPXB<:T/#@^C
MG/#1BB3BU#EX\AGN^RJ"#!/T-EB_6'^;00N:9@45P0XH^=H8/(QC\:7"=I?L
M _ML"2Y@M=2@TL]31V>OKX=,B()8OD@E>@5L+O1FWY.Y'F:<+!M1,VU5XDR)
M+;E9F+C[XMFF?+>4/;5]^1Z"O]9;:E"A@]O4]'CT#SA2$+BA7ZO^WDS78PY4
M.]C<<S!R<A# 0:.LV_#[U1$HHOFQ!_^[G^^JNOE*98!%O&7E9S1498=?2-K$
M26.!+G9@]A=*I8*;$(I+D[7VE--$32<?FBWD[YBSB'NF[#+J:_<N:<H:C$[D
MN4B(?4P*5=!5#D0=O2LQ-02>_.&795<];:=.N1EYY">ZW^\78LR7)""M3!?B
MXWNBN *9@+*C:4ISR2S%"(B>2,/WI)]BCNV4Z=/+^TF._*N&YI\VQ^1"0.6^
M+&2?C+8ZOEB'9PH%KNV^5^'7D:UX<13>>1/U6F/8&.AM)ZH?_#<V!G((G-H;
M:X8H3SC _80;QIW,ZT);(X"J7\1#]NV?RI</EW2L[GRAJ#O;-V&#%GN(O":S
MR>"@HO!4FG2G'HS)=.J@G?J]*&C;D*W32^!389W!N/MG*O'R0O7US3H>AWT*
M7(K'4ZUXQ-!PB5\!:)>AY,UKL.YQ)U,2F3)EN-!1[CNT?<C5KR2I92XT7/OH
MM8YZRM>^MAX#BW@<#?<N>>$_\GV,6(N5PG367N;(K3O81+ZX8 GZ1=*+'[FA
MX<*ZSH-)/' +9/Q?!PE@0T:KP=;!(6M+G2W,J#%#*NB4?N(9OQ5+M-+N)Q:_
M7^P*OQR0TGA\?^W,V6"QAKPG^"EC8WXWO>4.J[;6R>T*4+$O=J)KOA;_:1'G
M1J:MH/QB&O\"$G;_R)3(@%!9,Y).PW-%%62M><MTESM_3U\_J;&A*/WB&=<G
M%6VDCM.E8'NECZJL\KO9"P&S TN&[OM,V1'(V5Y6#G33Z6!KYBUQ(=F3_<A!
MG6'P70[_";!%2K'<?$IWLO*,!EB#3'U^-TZ?N2#T@UV;LUS\];I@#L>0S..J
MBZ!].S1I2IUG?=+3XU3*V8Z0V5JF1I=4JN.6TX$?ENE@M.MHJ(6QLG#F@,!/
MP0XOX1\_(AKB8J?>S40RV"F(;9;NG#PM)^YA+"K%R^=C_;858J3;)<6X="FP
MWYW79Q\Q?K1W#>'8?^FO=%:PB]ASM\)\$&&&JH<7O<H7X!@__^ERX#]7.'"L
M.#S6&$!"=>"16D>^J+/P];=<'RSUW=%D0D%5-,T[KG":-(LM#*R_EZ.G2@:[
MJ(=L@E;9D&D#,@%_+:(!<3U1[21D4QO+0:(LONI1+WY63W9MG+N:@JSP4LSM
M@C_RL)KR 9/=>X6G;C^,)ND>Z63CSM=][\T\Y'W5HMB(@IWZ=06(KZSX_TO"
M:\<P<-QY?/TI)1>SBU9SFO'HF=KD'P?!"55BG\T!A7$3VPU3L23BG@RE:]U!
M\U6*".88Z]E?D-H7*?TI-SJH"NQ/DDC-1C/9 9( 0([Z6._N>9^4RK#QY%J3
M?F$JP3')4L1FQ>VK(^FJ56-?S]^;<1U*7U4S//?$&/Z$7&6$[!DN 0.?FNP*
M*!9?HDUH+-M^J"R$QR]^#!B]'S8U\KXH-=3C*C='U(2),D:\523]0*9&%(0U
MHOF-"_Y4Y0;X3F]-2Q:N]1EK-EU>C#COYRN"&EHL@^08!-(^>5+H$'6-O[T:
M819A'FFF]5GKC8Z]+9%X8\!FJ1! ]^4:X0O&7:_2WE5/[ < _0. >F^'2JY8
M!^M7Y'-%=2.]?5K^7W2O;S.MYY/EE?0S9.6=?9(ZMI33Y@U?OXFC!^TDGTHO
M)H28)GYQF>"#&W.4#-*2_/A1PURM_/Z,_8 GFPC/=%NUW+-@6U+L+:7(6W'J
MM1(_OWKN(=(-B7(_,1.GHZ6&\C*_\W^JZC$&FVJ4BLZ&O0DU.BV:W0O1JR@J
M_JS@2[=+@5*4G)IY6VNGF$&TD_'-86*T-,#]_NOM!5G,JK'W#6>'0>BRTQ?D
MEY9]!;Q=N^;%+.K^SS0)-*T<Z_Z0P"EZPGHM2;Z/=P*$]A2^.''O49=F)#LM
M3R/F[AQ1Y8)5NTK+@5\;) 95S4)/;O5@#+*H21!P.L_QN(S1Q<[^3@UB75,3
MRC[S.$KLM9@0<;6BNG3E*VN)2O'U#,Y!?UD8*%)8E<OIOK/29;P!LYGY - ]
M*Q&/+O==58HJC_7AJHFPDC*=UDE/>RZ;WV?^"(OF)=Y$<U]II*_("_^_NR\G
MS!/G9W@FCK6>(*+?K$4&DJ8HY(WL%GW]5#5\#')2_+"R[[1AR/SSQ>8L W?/
M15)5Z>IR_Y5FU!+?5G;QAZ%M9VUS)&ISSH,(O80&3\BH_H85MG[@9A8?2HOC
M(<C=@)S;*PRU<?\BEU@_DVI)&(@>9/^<?2@QD'./$-T2)AP@[B[)C0:/;^>T
MBG>M[J[N-B28M"9E=[T6DZB$);4;,,SQ2"^XM=9]NPV*:5E:Y@3)CC)/\O*Y
M)6Z[,V>.^$WER>)XC3#S,;X?,=/R(CNTT->L$(XH:9Y ICX F!T_I"\),LB3
MZBZE6Q'E6Y_[-G4R-+I?,7S(-WXWRHP1<B,HQ=]R*L^8_!+3>T]^1HI%Z)[!
M6%T'K[5/%_;F0)CP"0;/0[>WRW8UM9FLG!5JBX:3:3\^IXCWKV<^98/SY+IN
M*)#).^V"E96H$GO]U^(9*L;J]GH2])N.>G4O]3Y#C_.5QI.: H1IW[GB'W'-
MRGIZK3ZCO!U(=O,%>8 G%^K$W]+0"?]:S'!R?K.%=U.J;ZZMBN^C\$DCT)FW
M.G'O#H5=<59T:ACF*"VFES[4.)^Q?F+H3_S)R4U%I79V.VK;27A.3%G))8DO
M_M;_.:?BC3;6?(GO7LB_&(L23H*^TV? W\)F@]8X%X6&;TF!K9MY[39R*2;,
MFZ/[E]24XMW>N'=S=@;RV#\ 9N\YR/D0VPZZUGBE&857.CT_SAJCWO2:3/=C
MBD0#6CNV[?O7,I0'$C.L>)DC]7]GY*'Z<UVKGA$5]XY6_9"<./IMH$Q91>^J
M0^727!K1K'*6PV$XK5IBYW6N4V1@&(%C@U<L6E%\"\IMR]KV:K L6>%>>];C
M/G_/QMIDO7SPD]??C.442L7UA:M^?_#//?R0J@?N1_G>@/;OD>N$6&%_M'?G
MF_S?@\ E.IE#O6NW01X#V>]M:YQ]L'#-^FC]1^W>G\UB[+*-H_^N:=KJ/R;5
M7 G=^J5(V0?*?_6TS)%P?@7\ZKB[@0Q+ZS$EX#,^='*&VXRX4*KO3%@8H#$I
ME/K)6Z%A[.S?JM@7_77C]:=?&XG.NH9>7G0'OF@^,HV ":4>Z;U>PIG^DR)X
MH0=Y)?%</B#3R+LS$V#H<]*QJ*!#IS#':^NB*+= <Q??'< '=*![R:/CN6)_
M\UI_?_AG25?4V5!J .%&Y"!A)W>#&.DQ\ JM@O+8:V;2R.C0"$8?E,_G58EN
MO'\ 2/E-&.Q*#5)+)Q[I=OI!*&U+J68<BV5RAY%XAQ!$1NEM _@%2D9_LT_L
M<- _WM+/O="DR]M<L,WUA9/2\^40DYVC!\!J?E@U28]IG 2W(J4^)1KJO@\)
M;8[!0^:[]Y-/T$NS/5DYE/OB7:ML2KPH4WAGU%ER(29V#Y^VH[:8+8A#Y.#$
MX7'^' X"B!6=<3)_4H)5 E/PG+[],]U3I<_[JQ5D_-%KC/<)H:)^$M/KQ>HH
M^(".EZI=L+<"'W_099<^^P-@,0;CJO^Q!RF4(P.99)4ZT3KX._BY+)>E9[F]
MOEGG1*OU>]9HGKS.2ZH_7CT5>-C"N;46#DRX98Q, )0*;7]7NQ'LO'Y(ML#T
MB?\%E7$^%(U/BK6KN@/U_)VX*]E%PT\G0R?%F=7DUA#PAXTRM/[TZM-G'_O.
M%"W5NVCGG #]I&$_XVE/#5S!N0*@R=G /C=S[,CNB2P"SI+Z+FY71/F'=F<(
M@=YJ?;FNS"?<,<.!P;>BZ%\D^B=U+BJX4L',U_C>D?<L2]O>U7.V*5K>YOT+
MM'LO76C2-K3,(]U[]TPD5H&4/DBC!B1%RC>WMX-UL[\GU(&B.Z@@UWA-ED^V
M*)<HQ0JYBFA[SD&,HDO6AQR;Y.@QV7W9=?=Q%+$V[WY>9."9$N7-8D*?5+OM
MY&/=BXN3SWTN'0</@,8[D'B)<+KBC>0,33$!WM>\];5Q*5=Y#H&BT^F]*#:V
M;.FJXH""E43RY:-]<6%+=7D_TIWN--\OWMT<'+V<L](XMU+BH<>7-3H_[L@G
M>JL4&/98Z"RN>9W/6Q*Z;X4NO3W7!MV!+70<,\&-==@5-\_N1^_PI(/NS,TM
M'0NF92W-\=L<G;Z*YLJV%U$^*LA#YXBZ_H[6WE^KER)5-]J*_A]CXW^#O*LS
MW5]Y9BJZ&%<]"ITX R7X%=X!TMR814 OSJ;_??:O<R&L@5'="J$^1I;5@9YK
M:*X,0)3QFA:*2$H7/$:6:^6D_ZEFN"M+.R/#B3H) -*?SF)UX-(IEFLD(A\A
M<D42<[VIJ+KLWAZ#PB,L ;Z@UV3I17-1[XN3D_$C_=.T>P]2I(3T0Q^_=9@'
MIQ1*)!]7$Y)L&\Y;'LNQ\OU+45=L-2^QAGQQJS1FGL<]9;Y&U=&X!L?D?QJ9
M#7@V.9OW'"=T8BG-2?TG1_J]D_/B^_49>A\.,:$1_K'$@A7*:0%5S13VG%@S
MS=E9)4]6U#*P:2%4U;I 20S(HP%"3:+4F?F_1;TMVF?'0IQCYMZ1\/^C,E2M
MNLQCTG\P\ZEHUZ'G&B>$[^XG8_$9L5_E@%#@F > L=/H)PEB4057U[@&Z[_T
MKXXF\U>BWLW:N:"'/KI5O&8_T[P3A_96E @'T'<8CV<,:"'UEP-[2C+5_!C
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MM3<6[M.CUE3X\=ESFMUE_L?V5+GEI&JX 9/QM/4V3Z*:)1B.RI+15DB'#]_
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MZB@FITB -<7.G*]$N\D4#T4/^ ^AG:T8I];5=+].[^>?UH3]7L\N?0SO&#E
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MLNLN*GCJ9UF$CB_6MKX)EUO-J1#;O?GDMBJ4<D"JUT$/8#'^WK<FV@/CK N
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M #!1-0%F[2G^D::J_R46<T_"0)@8&NX7+-C=^EV!-9A^:GGX!_6_"KR)8E-
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MJ">WR.I6S*+]0&HJ-Z>2B-J,DB!E0ISHW(;1LG5&1D&ICV;'/3_&.]2C@L+
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M-0NKR/$IV%-"3 89*TQR:GG_I#V886+X^5/EB88L*-3I%G1D>\0;IA)U_@!
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M%;D=  $ %2W5WPOXCT5UAB+C6;ISY^D9*"=4L@)GJ*BIS]!0_R4UY6@PY3A
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M]2B@9,L=3Z" DB@^C1S*!CTF'2^ MK91?_C(@.A? 35)^?@WD4#3YG "&;"
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M 8,^?\67U&3 RI3@"*DL0JWOSY-(2-SX*O,@);#,@TU_'<.7^-I(;^=)5)0
M 17.3XU!#T[<*58WI43C&,5!B-Y_#;J?E?\5^\8'++A0-,5Q%%3R&H[MVCS&
M5B812!9D8'[TK[CZSW?Y.WY'@]I(EQL@?Z3)P *(6'K:2"RFY  DD0P<'_T5
M(,ZR)X1_81SYD_O_$8C0:V3@@SO+*0,<1T<&7&!(N+,9?&#U;^24A3?O)<$I
M5]O;_"NF'N_\*Z9,?T'^T>4?7?[1Y1]=_M'E_Y^Z%%W];O[S9=*U6C+PX@Z\
M6"^%D!RA\::M<X<O)BKJ+J'#=XX--[D<2_,(F8.+.>XQC'?UN9PAM&U\<&K@
M;SJ85A/+[-2IV+9DA+#G@UU%_21>RT&F-S'#QE-,HW8O#:D8,II?*+Y\7J"G
M^E1J9R.^A^./_S$RD^Y*K<CYNU,::[PQII$]A8&,EDI0W8'![8[," D6<?',
M"."_(BT<!<=T$K_EE=<@FL%\===^6#J-?ZSB>6[_T^#V2YCM7JSYJ>U26-0R
M+G"!R:_]QM-4/I,X>4C'Y46ZI7;35?5OWRTWQX\5Q^,JCOUN5 QK=8G,QFA"
MPI'UBRYEMPK*.HQ-HQ2.*.Z"0;MX1] WA=Y\W9%(;1HD R$GHJ:G^FI<IX,X
M5GTU3N _D?4.&H2U@L<(<C:.);5'9D4ZCY7OZR#2Z\]%URN/@^ \74Z'L3B_
M7XA#U3P2/1G N_H;'_Q",1D8.8U6))YJ$V*_MZ([7:.R^-7H%=]5ZJ5 "L%W
M,QL5E\=;3'"@)55E35<;GW@_9RQ"R960CE*RJIF9W,BH7#/>>HS4X]"2SU?N
MV/:_523MPN5HL]4Y'+.E<4++9:M;@8=]<W:NMY\2?5AMJ^QWC;=KV;H1?P?6
M[XX6;5.O=0WV0>Y<M8L2K]@/:HQ@AN'ME;[G1V1I%8GKFGS>LRNIFAF+H6/[
MT#;281B]J#O3OZ7]IX&TW.F =,<MXN50+;%G-UX=^(?[V 1[)K;.F)TH*ZH/
MU/MB!V8[K\\UW(N2D8BY@:C\)MFU?AK)]Z;=;K0Q5$*E;'!J8V_C96:$Y/=%
M>O',U_^BK+]L.(GNPCJ#V)HN.%G?( /O$E65MU^L$VF+_9+VX_WFYJYGI-]"
MLAO6WBTQOU5P*[P_7=&/SKXI:K?]J0>/N??F6'26OO7M8M->]R\5^FH^_)?5
M.!]3_0_BVH!2-3%6=[%P01WR"YGXIR;EU]-<"3L3WCHU,S7XD_Y $ZZMX3;#
M!*>208OR0H;WA5'%_*JT ;T/J@@#\IEUT'!K!@@SP:\(YS)+;-@H#Q!=T5@]
M08B[['1W0<W7"K5\A$SHLP6&3:%R$A5Y][+SC4P^6^B-TG*:YN(TL $8O6B8
MH+7_@%X@6[9Y]MZEE&=E2ZS:"[83RRG]55<2!26,[7I2JQK[7N+,<;6W;!96
MAIK2DPQ_?4?JXAC0AB3NT-K\C?EIQ\S@B$DWE?'J@^K5JIW.U0Z/.14TBG 9
M?'/LD*6287Y[NKH2?R^W170X>J*[,_B&DU!$UNW]-C4\QM39"K'@J,)\)>,B
M3[?&L:>KF$_=_CSZVO?,B,U;]R+$OY[Y?R#FO87UCAWHPGKDY=&*=4>7E<NR
M+@PV,K8#0I-AMA/X%R@=PM6E:$AG!O_P49^$AX=-,&N*V%[(".@>\UV!#_(G
M?%!;6 N<=>63#XIVIK=6"+K#)V)[?/>RG?Y.7!Y&'IUFF*A>R5(R;'WH=P!%
M0X2.9.CZ\\+:B^H*C\70)]HDEG7;;8E5DDC0O2$2M[^L 4:T!.\JM?PS6J_O
M9MB[Z.")!5CE\'@+ OU8+]S "28S%,3E>O7"*Y=[V!VJQ;R/ J_)0%T:&6CN
M@YG=0U2FA)]B_9+A=D_M/T O]%)J,*6N"JW'1D Y?08BFV3JQH^Z>[4O2]*6
MQ:].JV4(W9U@7J]=&0>I<1V61D2405(E1O.MLPJ-Y_1,6B/$<Y]SZJL!_XD>
M6SB(-C6@D00.+)0#9Z$Q!E]4TK;Y;M;FMT(&[!+W">TLU6"'?KFHI;)\$\XF
MA5=?&)'<R3WZK?>3NX(-"%/@^YE-O\E F(<F&5 [ R%PP;&;)T*=UH)@-HQO
MY3?B5RL!A7T+/171>3E;KMFH-'L!.:UT!V/?$/FNY[CMJNL9,@B)0"?$RF2T
M&F=-<2R/UE4/S3NTG/IW:+FF""(XC9*@%QCA4[&PJ5%WFTKG*KSE>^YG9?DM
M+>LR5^5![Z<HH]4S$-5F-:O%)MWCZA\I2QQK&KR?<WF\?U*U[ QE92A6'MT>
M8V[(5R\+68TO"Y:=6/J#?$;,A-BC<(^3;G-"T!^[D)3Q6;BO5KH!(=DK#FF:
M["<#;@G+$YD<AI:#$T_^+E"/2XI%Z@8/43HTE$+?_S@SBB(>Y^,NI_BHA1>O
MZ27GFJ[#>F7128L4/E&,Q&8D7+KAV2^S  N5B<D#5$"_PG*>$I+V^[ME?6NI
MG8Z%P@4GB2<?]GO&9U5!7_759"3Z+__=*G(Z1 !.@Z4XRA6G(?;PR6H2]VI&
M/80@_.D/:-+SON!XY4'#[&(,['29+_AT/&9S##+YJO(H*7F-F++T4*7Y>KTS
M5[\JYG$>KV:'6\Q4S>U#!\/V?H5W>_8^Q=4'^)X*RJ6+EOY5O'(Z )&_;/R_
M$%V>$WX=*T/,ML<4UZ 5PTNBID:S+2KPW1;2/O0QMK:S(UX96X?K"TZC:&0X
M,HAO24?.:OCY=:CC\7D/#NI9W9?!'WZ".W\4:YJ\SUBOCW]1Z9EFY'P7C]24
MV2+@064C)AKO@C1=EUD8'&^O)O=593D+C,!:1OB#U3UP)HU!8U.@H<&X-*.E
MW63HXQ'IBD*&R.G:Q+FQ.85$,\M%?:/G\3C3=?<N>+0?&>!1>;2+%!84K/"L
MNA#0+)27LEQ?_><6,I,R^$)!FE]QHFUM)F4N"/./R=@,V(#@>="]#HT%YR6G
MO;;AX71$P\L+FKJ<D$I)R1[3Q_O:ZD2+ND-K&S4P#V%C*58YJ,MH(/<A+]%Y
M<P#W=%(#RB=+8H#@77VTLFTP<H>6O4K-=BH(J_SNOD"'V1WG;81WT#>U8/DE
ME@E[J_+2 &]W=K/-^._"=SVHJN>W^;P8B1[06TY3:KLA!5:.4]%%B:9C);8I
M<S:AZ@+1;/F\!*DBU*WF%_E$K8+T:O.\8^4;.9SZ)H%_M8)+F1'B/)1>?4X\
MLY%C$=Z,8"=8#N\AO<7*GKBLL6IC\[4$.NY[O/9OR5[)+.FWU)4(98XO_I 2
M96I:NNYM4,>SXJUJ'('X?BL[U^=?"34=)(![,7^AP144EJ1_T2PP0 ;\V^8
MMG9KNL9G=LLJ(79[SAVLX 1GL6C79BLMLQC8$:U8W"]-KU?$D,I+=D>9/71_
M[5_GK6)@,/&6-*KX)NA;=!B]$\P-2ST1E%7S 7$TL)$!^O4N\[PP\$Q=TL0C
MVQUMP69\EBF^]E;GML^.9:.YGZE&CGK%=<XL\_B&Y_%ZW9MO*15[Y._P+]E;
MZ&H=P[4L7_C-;7!1W\),INDOZ;;$IZM?;M67!)JX=[!0@T*;E$=5%,:S'BN(
M7L=^ B6AO)W(@)\8SVQ,8T% PLFK-$F!L$3I!2/4JZP^9U6D\[PK8==S1'_
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M F0B^'!*550[?Y-067[>S*/QB?,;A,QV]3U+G<99/MX>+"$X(E?MBK!G87G
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MH=M0RC IYTB%Q_Z[+/@=7HRH@'\L@%K]ZNP\Y_R7(#]$O8.VWXLE'S]R+2J
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MYE'HX241FL+_YW^W\[\<-+-(PA77L!*KV!;3JU)FMR5<+=S;:N@C89_$J8"
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MQ(Q50I!%4N.L63\;M.7F+FMY]$)*YW=>U>PHZW(-10Y2LC"V!(YG)F3.5A&
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M;8ZTC/Z(9RP?I>W7A8J*9E0 RQ0$WF+Z:1(W55$J%7+\_DEAZ_!WS4%O1"=
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MK]->(:]H))U645T#X$O<IYWJ"@E4\)<;%9?^ICYA,N"I[5-DNCA6?='IW(L
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M).EDK$=T)FA8E&'AK3I0(TV!%'%N9=F]6$470_VOKEX'R*V$6SSN@3TP-N=
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M?9F@>IZ]0GA&J+,"Q@/=B8 GNZ+_VF'N?VWGN50DL-KNZCX\\"=PJMSV2/4
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MVON%N=Z<?+$7.#%414JK\F=YQ;Q+Y4I96O=OFV\EGR&:'/(3:@H#;F,5ZKU
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MXM/1QS5L.GBU\QRI<#\L" :>M?&$+7((EXVT^!*Y"<KS@?&7%IRJ(*/D!0I
ME.;G=W.G_%6PG( E^.>GAZ+S@F5B(^MQ)U2N$4Y_CZPCV&5&((&B9MZ!NG?,
M+-:3K)@;O9%KU"<JE=6B-,R1-LYD@X'>A8KOA(\?2ER:^-WZ?^3X;[P;#^.(
MO&4LS8::*&*4&#9"0'8<97?O4<-3# OKG8QVG@;%B:P9<]C'0^TG$.:^ %<"
MG'&JL2)VZYL3OTI7<"H0"_N.KAI.)ZC<-TEUAU_ZY.,;YK!Q%9+'E EU_@7@
MSPLLJ4%XKQ37/-4XEU38_G7ZVK^G4-PH+C7 C9_%M3)=^B'ZH\MY)^_;S;?
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MYZD^B*CNC%W9C0O P;DD*01\J];?YP+ V=)Z ;!&P5;MRXOWF:W;8[(4KW3
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M"PJ#S_I=&-557:.DG>(\Q\$\!SOCJ$'EZ*S&:>?UP?E1](EV3?S; B?P%:T
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MH@STS.*K1\ SZQ9:'/WU(_R?7W1V4L?7KS+'.&0U3OEW%^A9R=]VFF5L N/
M;\O69:B_^"MZG'__MKI[GHX[7#,1;?Q+9F?$ZVAT!K9N/PSD)((+P>T&8\X>
M%X"KYFM; 1"_@E=E?I!'MCWD['?"#9WO^+IGHFJ21OV[<TU$")S==\\D\8E=
MS2X@[OW7@]#KL;1?WMDEVESG'6J!W2+LW)H%^K\8RB0(AP4*:LR?.[RFP(UK
MCQS4"?Y$<?(>N52_)!$^MD'.-<25NP+EZ@GCF_,(MA?KZ%/#$8\-2Z'UW9Z$
M=M?AF?8:6XQ+J'Y^]+-DM%C 8H;[#ZJ\9/9YMX7OD!8N4V\YC/HX@Z]%\L]&
MJBO\.9_E@UWB-*3[W7%-&89O+P"4RO,X7]AO[LLWEJMEBDG\WC@J+CO[->/N
MMC_?,\L_8N<,&NB18<&M3QW.V$ 06^A?MU\#_/+)GOL<(MMB;TY,/A&%%UZ>
MZ/Z&L3D=,0=YY_J+%VC9Y%OW9K*?4[61^9/U@*[$1ZNXT\-NGJD5.KJLRR1U
M<-Q5QAV_W6O:D/W$%GDO-I:Q!HN,U>60Y+*/S^TCR%*GG[+7JU+G^H0@>6,\
MJ$-)[+4-]57XEC*QHO2'8^_J(B"IMUC\O\%EM108.*:G @0&#P;I'"\ 5 <[
ME+KSUE]/8L*<2P_\_%BV'IT:,D>Z*0E O*YS- JT767US!)+K7FS8K-Z(M 9
MR+_.SI>QX!7D+S_?_TZ;1U!+O?GT5?N*NI%MS+,;@[TCUWH+Y6\O%Q/[].OP
MVN,A"NP8(F9%&Z*[Q8 )#4,6UV'696TY^5A:[LM68*2.55VT]2&"7E0!@ZYK
M*MYTW>%B%X#@2P@>6BJF^Q6":V;0&WV$\J 4T!O#M28_X\,DT3R5[4)W+:T%
M61VEBK GILXM.$PYF;"IW#>V"_Y_HPFD2T%XQZOCIUPTBM=K9/1?==J -[Y\
MD2;GXGLGJH:T@_T>PCN<4YY0D^[,7P!P10GFD[=6US;"B-D$;A(+QC&*(DRA
MU:]X_68>UJSMPS=:SL^J9D3R\(T2C]L0G0&61MFOI5OVEL.#Y*%JUD9OVS@T
M"3L8:Z-0Y<M>0@NFN':50+AB4(Z68[*9F>&]%X]VNX>HM$&:<B@]QQ^R ME6
M"[C:R'VB;7T+4:-$#70/'HOPT#+_<24ZU\8 ?G)KVY\3-RW<S<Y:,2X&CJE>
M&P]KD11 ADKQ_]I_HW35S^2:Y!9=EF@YZDP>M_5BCV2**?WD0A/;2+F=:;*N
M[9;.@(=&GG'B8]1&.%MJ\6/HS")=&&*=W?W-FO%(E7H/_04@H77:^GT\!NF.
M I8:JTDT3AVE^T6:* 8L"+!PL(("Z>)D@PJ=C VL?Z]_[. ,2S05&5#JN^-B
MQ5'J7:Q&]"KS=H+>.E,;]=?R\"K&3LR"&# _1SF3;YJ#ZZ3.)PT^WY#:,CZ#
MXI?']<YSY11I-UH>?72243E?0-84<T'(S&S8+;A@Q9$K":SL?/S\I+V1O]*G
M[(,@',BY"5+H[;]FHJ?DX$ YLAY#RO+\5BY2QN'CN;AW]J(V!-RSV:3KEG?F
M2FAB\#H2SEH+9*EH,C?^EA 9(_9GWM?YH:JNOPG;O+9^'TXUC"&L28M@I4OM
M! Q9V]QO%C#_C&:3>*0+CV%2;/)_4T-:3JIL:18[4QL(H%5K=3IN[6BE$V^V
M/G0G>(S*5.L34Y1&LT=F#4>6;R2]JJ6!))I1 6)9R8.B@0U01B)UAZ_N9P_A
M^]T+"!]_<SO;<:SQ'*6BJ] >PV1%K3V9Q?GV<;^P#636/-!ZF?4\=LU*DI ;
M^M'=U$-;57JQ!KX[TZG20 $5!5UYV,89F0[^*5#]S3?\>'"A,\=*@:@Q-TC?
M$U!DINWCEF,_,$+(KCD_^]/YUR;HT?:Q><&O,@_\<C!'\/YW]PFH!^4+*2T:
MER(+Y-^M^(QDY9[#P]S'C]L4&J(T:BX=V'T%;L7V[V(/H9F#N-M;-J\M+RGA
MS/P#'M6KD5619-V^7;!P=LD:5?C*/'U)^<\GR[,FU<FOJ+=_2MML"M >?AO-
M&8$J,,YTVKD5]D%Q7[G,99_>07V+VGW =:5[*KRUV-\3+=8LL8SWYR? WT3V
MG*X^,&1<>6*L^B" #,%)[2+.,CM(NBD$;-8Y:F.7'&EY0'3&F@\OQFE)1SPT
M^Y83JYY/S5)X6I+_60"67E>6T22+$R8:7@"J^E?"G^P\$=?6M6B.(_&]=3M4
M:6A,67I5H_"2-W5A.SGF=0CE[?:]#69H5\86-2/VA?.MZ0WCG?SI/]ENRH?O
MMPR=#>D6732&QR;7_*ZD)V>\&$8AO+L0!$D#8C (?ZJ!1\X/E3:9VV)RT3\+
MN.)ZA^_[?'[J/6.Q=35:0!,62N+!6^7F.BG<)[!7E'8>UBV,B2$"SW19T9L?
M=E4WR:+&=P!4U)J#DUB<IYW;H;QQ.-YO]<QH03B&71+?F10&K5:D:K/+'Y3O
M+%YV/'H)\Z#8_-H77Y]Z9]Z[-&1]^4B).#U'3=U99&T!RFX?[[*M2TN=4H^Y
M:\9-VONHRSN*.K0*$"9:2)_%&)=04G>*;C#GAT&X1YPW.8=+7]YT4YQJMGXB
M'2>DL-IC72#><P9$"U?/TIT)A0_L^IE"Y=3A1R+M#XW2G]WYDOWI*.D!*X=F
MQ]#6=I,7XNS-,)(2;/IY8! 8!0'^/IZ+FZ8?X^B+"IU^H=$;3:5-D[^]I[AA
M3@ZOD1?X17I:0?PTS_:LP]=)ERTDDR'EUE2!&:"'X^G52,*&>9U"XMSE6S()
M-5 ATKY%*!<ZQ4U9K=T3J:UK @EN]88^:&?"/8O%%)SQX6.^DA[Y,PUY;#ET
MLS^L'EM$G?5QOO59RO%3FMC]3)WZ5W5YQF7@TO<:QKF.O]S43*D<.F$.QV>$
M 'E:"=GSATDX* VQ%8B";L?&8=BNK&Q^Z^"TX?C>2[;']./VW6[6N5N94$*&
M9<Q<>M@33&)N:SB2S=Z:JK3"F^YA5%9BG%;^U> _+P6C?^1N6FZFUY:?9TV=
MT(<?8SMEFD/;%:G[<3!J?Y.D#B \]5KG]H\B\&M+E8*.&WMTCZX?02,3)Z?>
M-7!$)&\W!RPH!M.W,*"Y1VS02XW/-/-=CWFN0I9D9!]S%<A1+,>\VT;N$*E3
M#Z/3P&3^=N](<DF_'\G&;$GM+XW=2;F>N"06Q<@TX&6GR[@VT]3:F6R?CX>:
MX/.0><1BR[%-*#(EX)D^ZJ"Q%:DF.N 9^NK34F4-%4.DL301#.+=D@[X!UC=
M*[H O.DN. XK5N=P:81-.Y"\"1T!,J@HJ<F:_?+469M5)V#,WRF-_/ 5,?KP
MQSG_LC+V;^5*5\8%X.%MZ,EJZT!C^/S^OT;[&Y/\[QU(N;#\_._B^1X>O?[
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M][!89/LUD/I+HXTS[5JI$GD%L"*#MZ+NL'UK+<H#(J1!63PC\<<A>  7?")
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M1/+_1MYW!C7U?NL&45!IHM*[-.G2>[#1A0A("P144 @0(CUTI2I50$"ITFM
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M6ZOG8+4AAQ:<'%%9L:I?51)>O>+M9HU'[RMQT7(1:S@E+P#ED1)G-]8#6"\
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M>+*OX#G8;] -CF+S+SY,S9USI'DGBIQ;GFX;Z[O#)6K# A\/\"CP7I"@AYY
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M6*N+=3%"^R/6_296G+$3*QJ8,JC,:9G9U 7@Y]IVC&\7AAF/CI#8LE'&U=Z
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MKO1G=EMVBJJI@3X7 +7AXNH E$X43VZ\Z7Z"3ZOF<9(*),?,7NV&A9X%X@*
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M),C/D-ZXET'I8X4Q)%K%PB3&2.T;GPORU(O!F[:I/H*[II43\SU_4: ;&TI
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M%!_I#^6^R!5>0O/2) :'I=9HRWLACCGD%7UTL#DKYRCY'O\8"UAV6J[%@&U
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M"SO.DH)QS95RT0)> ?;OKW\_!H0I%;=9@MZC7J;X%9KD?6!6_Q1_I92)ZP(
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MD-<^.J8']>5: QH;M!$>DY+6+]!V'86(M'U/LQT3X\K$A]_4IV:].,V 6P0
M7?P7O$6Y]O6(O#< A96L0N\14-@XSKIRDT'+P[[,7.#^H-H!O3K;]&>T2KXD
MOT%+''1_,V=GCG\%C?5BG'+>.ZLPTY!!S8+V8LL%QB5';SJ<XN7#YD?@JA"8
M+=U:V@N%TO5/[M1UXV0V;I/W:B1"2+Z"[<!^:Y."GIG]KC^(?#+R>]*6DV:W
MALU!W_X(Y54LWCD3.T_?# M.!U6#)6?S!@U1O"I3L-^%,<^^9N--9CV*FIWY
MY6RF6:-1>/:G&&Q(_ZW8[ZL:7&(TUW_W/S.<3GHGW-HA+BC$-U.>)P3#W0[)
M2_B#1'L;WC4QN'*ARJF;8DV$_"KGA81Y6FA96 "GMAJD40'K?!]>^]CQ*CY8
M;+NM-W'4A\U#@C4=[F:/JD,9)A$B9TW"WJ7PH(;LX.3/Y3\RH,<39X$=\EDO
MNKJIZ?BE@87[ZQEM$V;<Y34;,TKDLS!Y*RC<H6%6"OL]48:Q#.=FJO^8N[6:
M=KQ5+Z^;*]HP:HIY<EK!%@)BZ#O8T&\2MQ=8^ZYK?70S=YEH4Z"PO26I7YG2
M!2:_?@BKHC#Y!$'LC[KP/*0(2.:L+C)66+&7-SW9M"G3+2\L;1A*\D<8P +
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M6F+J),)30O+0]DM8OO1+6?X2!>I')3RLWX^=@(>7LQ1H$#V+IUOK2V"5B\]
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MJYP0I0Y)@VG)&\=QFMOXK62(LXVCC:U%;HVL#%LY&Q1<KJNQ<(];S]THJ9D
MX+;%.H"KXV"V&"[@9HH(BF^56N#W8^=QCM2X-B64_AA.M13KC-GSW$DB210>
M8"!*5%4T_(Q6GRE]'0=MRQ0"T:&V#ST\Y!?:SMJ6RF!5V$E#S-7TG_,*5*8"
M+N="F60DJAVMANJ\.T82EU[0?R:CY)M--<CK:F,/QQNH!IQZ,[;[7M,??(H
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MDE'K6ER>HR53)%*^#,65N'=F8N;Y>J73(CH I1L6!$JRG!IK+*GR[%*([L\
MEL!R)"OK+6.>R$7S53SXS[(-_@<820(,O>T<S1BI^#>5QPOJW4E^,;P(:!U'
M5FAFR4BEJ,<H6X53M.//>4I1 B!"N?H2Z9IA2C8NMY-](!@:$N6QTL8FZ'S<
M]KA'O**.Y4++/K,SFW;7T)QBWNA;8:]91F*=^%I-=Z Y9K$ O:HQ?MP28- X
M/JD;+V2GSR*/ $JI)#\B +QJDD;I&-Y#1R.SY2;,=*=7T8M5);7.TA.M"L)R
M'U1(@KV6)$!<;^++,8W\/[KOA$]1SQM32G_CB)JT8IE!6T8[?QA-.U'=.=HZ
M,U33U3(K^<63=HB;;,TAPNG3)2],G[ZKPEF\8HC:<U[(RIZR4/U8.5]+^EU_
MR[(-P^R PLOC^!(=:?B&_/-)/X5!5FE-F!1'E#6/%/6[_8U@A<6I(<4("\?2
M\5JXPLLG18QB5 7%,X"$(A5D]=5-)9D:+1&JS1/_Z7REH\@#Q16S*7_FG]/:
M"Q "(+J&M8I=$BE$[W61[^69TY=>'<Y@/H&R>MXX":>+W^U-3J29*"#OQ'U3
M$V-ILX"B+XHZ^EQNSLUC-WJR)6<\-_=$GN@K5JB4%*A_A?;)3,7]AE]S]S^J
M!LZT<N3[QJ@G:$Q[!BBJ/XLSM(8UO9>[0TSL[/_2K5>Z6^G6F *#TPG\6IQM
M0>>&<(KKNX7X-$6=5768T6^S7/>6C$\-0TJP90* -/#VRA(M:(G6V2N+^-DT
MQ!IC,%[8,/-I:+O=P-Y!D.*:ALQIM;<5L* (&_)LS/+WT0[CF^RSY84%1F-V
MSQZ C8O1'2*LT8-4?D<OH8JY \H/['03P2S8ZI5+-!XH7@+?I!F&/"Y<$LZA
M"I//\ N_4LN_8D9B0R.>_J-]3)CA)!P#SNJ/.PZY.EB)@"]L]75VUBSF\Z9@
M]I)9!&/%H>QQEFL07X]G&.Y*(WA5K%Q$JS[WD-M(TPU^UH*$1Y2/7V SNN1$
M8BN#>ZL=I?Q[(3[7J^]1$!VS1VT!^R IP>]DO!4R5,900G@9AY3]52MJ[*S9
M1*6SO;7K297+RT1 B^V#_*P)*M$F/&LV/\?-379&S&>YDO>!]Y%@JY6^\ED/
M<GV=R!/1C^8"5"BAEK5KN_:<3*2RU1;HI7>>.M?F8-D1A3^WZ"M])(S<2&X%
MZ7A@9YS;T-7?VOFGKQ55^EII3<$H*.'.0M\\+FU/ # 'CUN=X>HIC'Q':I!Q
M+OW*))6XQZ5<_ATX3DO>>"1RO8^F9MO(>P+E.$[Z1@I)>DHA\#-0!?.XZTPG
MW#E02[C.UJ,02LXEPOIC??G303Z?K-WKAW#9 <@E6".3=T"A5N+)?&=?/Z:Y
MJFKUL."M0%H=5F>Y@MSCW [1E?Z,&8)";@D9B+KHSG&X\IOG"8U-)"H8G_-L
M='*0X:_J0(AMZ9.K^B4/M3MAIA,O0D?1;VU>>$RF;Q$ 3AT,CI>8@5+(LW1O
MI:E]2E*>DU54QIW3=#S]<7RT#)/BG'&=$Q ,J;&6S+JHE*Y/$O[YLO'AYNI8
M^$Q3"\>[X!L31^<Q9#HW'8UF?"@2M6]Y+]]@8I1+]$=W4HG'1A<9"6NZ+RC/
M(->\:V4OEX@.E,:*U!V:;):IFTESOS?%?]\V# P*H@S'R_HJ]\"A,2YY\UL-
MS/=;/R,%S%)<-\V/7JP*)/73;24Y^ >--+E4#MK>2H>UBKC0K8KLT_#>J27>
M?$J*+H.1BUTN)^DC^!D6A$;DSSN-L7(R1W?0($G)HG,3B)$[7A2;_&IE04ME
M FR=8#;C%?-].:QKT5;PDU= 9)_K>]G1X.2>S1*\L'I_?,C:R"P!\)3<7R0"
MSXHU^R:N+1*%4R[9/!CN200^I)OS=]Y)<!J/Z?8WETXO^N4?U&SA%%T6)&J5
MOF;HS1=B+L*AZ:0;-X&'J=B=RE+^W"!#JW>&^G+\%/4D +Q;O<E8,D9_EI@W
M-H1IY15C^W;TLA<?- [<DC[_Q;A_\&L5WIXZ(1&@2/P,-@E%F.R^$7JA>K65
M\P8-131I;J6V6?>I)3O:K@RT'*"HU&U@S3T,O<U[II#4XARTJMP_HE-6'J<Z
MM.3C)M/"M"B*35TIQ3-ORQTXI33 O18^A\VIW&LQK\LC8Q;1Z\G^\GU#D3]A
M=^<SEF'9EK<XE4JYRM68W*;&4NORP0Y+A=LGN-SQ59J6RF'U_OATV[#P_"FX
M2$WC1^PGRV_HPR[KSFR2,04Y[L.1-%NV"DTY>7[<,#9S7)*Q.]F'!MR2)9;]
M^2Q>:9K;G24W/YJ/\:]SI/\/YTC]'-1"BXA^?YRSZ!+X4\<5=^7'YL<!ZJ@;
MRZ8OIV[WU']*;4@VDF\KV!-=,3^G[E\6Z-W90\,,@0\2E<F'T)-=R&W]]&WX
M4<!56ET+]2__/)3A?V/)<'3(O88J0FBIBMZFA>H^_>.M"DDAXGG^VS^J#Z_R
MW'?()4'\N]^F_)-B#$8#%_:4N#=7U+R9V-K>JD%XVDY/_-$*,U2C2/GO0R[N
MV8;YHM\.#E-">D(37IF;_"A/OB$]J]-Z4ALH@9'9=A)X,AD<8X4EA8VKTJ$W
M4*_,G9N+O#0NOBL7>1N&(\&*A8;-L3:EW0DNP$/,F$>1U]AB[&?;LI%Q#2TK
M&?^[_SK7B_8?8V*J3P7+1;_^.MP^!2X9?VCB #37&W\J^,>G/=M_(ZLN.071
M=G5+G>O6YOP1GM)1:G(S5U#<!28,]Z*]&HDJ<"S1O6QEKEN?I4KTFD=?X^O4
MU)=\Y-?HQA)=U7MA_]FW5__MY3[?E9$O13"!EW*_W\ZZF2]%0@\F6$H8=;L"
MSM*W!#9=1=U*?*8.=WX<U/Y38NQ1O,?_.#$V&KDHT.)W-UTR_3YM1=\J?^<Q
MB7&<;]V)&ZPU;4^";/Q5X\9N P!J?3'#&KKK83FMZJG;8Y"[KSUWB/ER2TE.
M ;8:$+2S'OB= *@;C9Y^K_^R>W:44QF+DL8S;?1V'%VZS5!2 N!#=8G#)2Q$
M/5-/G?>UVNXC/E\*P1&OBV#M<^@)@,DH/ D'GB?AW]3:L_(3_B;/\9?X7^)_
MB?\E_I?X7^)_B?\E_K\FGL.PNX]L^$@:<'WV?-%-!B<U.VF@>U'V_N \_,*D
M,R1@GP!XZT<:'F*?I:R>+5_E_,NI[NX/1#[J'4?@P5)NM86!@:'AB_("(H.7
M1,_S6\^FMXT#I]E&0VZ$=2^_&G@DA5NJN,F7_U4^[.-;_T,M5<!K*U^G^U]:
M*7_5_"ICLL+#['/(+;T?Y&#IO#R-;Z$][?9!+/R3T34_0KJD_0B 9P3 ?KGR
M"DLK 5 <<CKMY6D0]"@AS7+1_CX!<'UAX^(29;:7$@#OG _Q:03 DN'TN/H4
MW^^HAK1_K[WN\4VE5ZAU]QQTW&+(I/+Y=@)6;5]Y*^?BV,*"]K+O+P%^F24X
M3I^<HU'\60&>NF7TS)X "#(V5N5X4;#._I?BOQ3_I?@OQ7\I_CO%QCE'0R&=
MY:B<2!HI<@_>-'P76L _NG&YM'=Q]G:5E*0!?X0NE + 5C:E:]%'].=3@NV=
M/R=#>LC^OW "1_2_5KAI 5 ]W8=D___]H3?VKT;T&0#]'SQ]_.>)(XZ(5CG0
M.J._I>4YSJ\OA&P^BO[SF13143+MY?TD10#\XXP0R9<=O="Y[&CI_#K\4I=:
M6\Z*,BYQ]!H!,,<\2@ \X09</C.J@)=81!]<IWN?8GX'./V]H>Z==;REFB*U
MNK=2,B:G1P0^V:<DV)RB2.."58,.X5%"Z-E;\O0?CY0&$_H*+R!*=W20(1\H
M\]3OXX?' >_5*,GE 18)C20BRZ!N!^+")*1]S+K[*#+.XLNQ,OAC"- %)QA"
M'S(V6AFR_"9GU1Q%2S3^![/5_N+663_^V@!>XM_4)$?&'[(Q_)LFZG]U\%<'
M_QL=S+Y"[Z\HO\??UP[@B$+E9?XLAPY+##*RU(6.6D:^Y2, _D'CS0[T]PYJ
M F"CKYL (-9+PC/=1BKCL',ARTXO2+/^8=,%,_R/#FIA%PB*X3G4N![1E(Z1
MRNKF9)WNP-I8O2< #E=?$0"A90_9O0@ ,H[>G"/Q'0XL"R]V_-]69_,)@.Y[
M.'4"((>%$D>N>;!$YVNEB[9Z+R)A >0.?P%]69LOXRI&Q,A93?+BZA+6!"]X
MZ51R3 B SI_*?0V!TIC#_D6&)@UPH):?:[1?V.]6+&*;Y8QYF2^7LC7X*GX<
M'M+K@DVVZDHW_D M'91E]L"<;WL\:43=2R'!_\0)5SOA!6HC-8!.5?*  G8T
MC!QL]<,J*52#4[&DO;K8I6_^4BTTNPPS ^)\>'K.=8[0[[GD9WSY;\5;59'D
MREW-0NO5%1;]UB6F?;;92/T(0XY91#MHQ2HFIX'W0ZN6GV)J6!2.LUF&VP@S
MICC??3[_2TTQ2NFB(N0$ATUS4ZHIQ#)/V&G)O&8X_5%R81/[](/.5T #[KJ_
M\7>OXS3G*SEUAN45#36H5Z+C:X8\U1Z09NRWU9:M=%.<+42#T]T,-4'YRXD#
M"\R6O+1)B_FEYWW7@3-T/S(>"Y )X3]/T$E4C"_ TY?$A6PZSRJC7XD0 '3J
M."$=YDN'O0 )6>ZRPO,W^?.=N.(-E$Q.Y!+^W!,'&J9PZ<,?>S<1 .$W0K#E
M:YL%/[M_OW#OKYD*Z9K"5%^0PS?PM[@) .0E(HHH6[4Z8X&-XABU"(!>8Q%5
M]A&.'^$I_^%+8*W9]?H[C<HK3KZS^$B4!P%PC88 P!@.CJO711WDKB58_YU*
MW<M;2[^OXT@:E(,5324 HB&6T8J9RLFD@@%L?];Y=V-U/]+=7<&5REK/;?]9
MI\&?QEJ1FI]@3[FF,LC>_W<J_SQ6\S;:/^:"XB_S_F7>O\S[EWG_,N__I'FM
MT/@(/V1<P/-QZ.:,Q>,7C5H@WY]AD9]&:&G\W1UE]#51=]U[0=;V?S14_O>-
ME(LY?7N<$-G.UXS&M]QR=3+:CMVA#5/MYK.]&U4#\?]L_5Q#\[[I!S5R"TX(
M[(\EFBG%1,$6HG[O@ 4UP;$.0N"I\?/9W.B%7_26DASHCYN_(D ]#U-=$_;=
M0N\<D^8$3Q_2T669"S&/KV7JBA<\SX=^.J=<V:=RQ/./OSD.XMF31\D=/!!D
MH&:M*,.W+]0 )3&\NZ08,22;M1%:<KX7Q?-^::Z"X]CY.DWIR9U( N!M#O#<
MN?TV792O$R0#_^DPN4Q.W/6F)G"C_:YOK?(5+"]P=LT"V36];J#<TQE8@:V_
MZEYE\:%(TZM<+5G23Z.PS70]ASW$45M^Y;[<\ZR;3NW<G@LGWF]4WY04/%67
M5?SL'E3QRX4&/Z9,%6CH?K#@FWWPD_&7V5S#)^9S0,?4+&7%]FGVG6GA8\5'
M=HWMK<G%Z4:R@D/N3D7^4YM]9$/XW(%&*Z+/X]')DG)9-M/'!^V#9_:7")!,
MH'?I2.(2%[+]OS#Q7U5G955!MG-G+N67H')C/OB79PBZMM7B\F9]7G.),B="
MXCC^5/?XK/O_L/=><5$]4;IH(R)*!B6'5D%!HN1,JT@6D)Q!<I(LN:%%!)0H
M(*!$)0@(34O.-!D!R:')#4V2W$ULZ,#A/W/OG+ESY\[\SLMYN>>A'G:JO7;M
MM>K[OMJK:CO.*)7&7/%*'USR56V= YA  K5<'Y%<XQ\J^^^V)(?U5#)>7?P
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M]R'W__;I./AQ;/4EX(%6#_*4L?$2,!;=J+G]SW?0?OTK>1OE"3FVK=!_2[&
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M2KK;"MAU)E8C%4@U(J_JW2NAWV-XRLN"=U\,YPN:;T>2@#7;.-&7@"ZHW"7
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MW<'LTVS14?([=?F3=I/CQ]];GTGS0H:P#U9!V"=$/A>Y,GB&FQ,30BG7,$_
M>>L3A +G&,XYZP)A.LG[8"#AZO4PI5)TOZ+P -+#2+[L0KH&F[/HS&5$BR1
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MLN[!9()FJD=#&5ADY40UK?'SNL"B\(A7\M%F!S RG I!Y V*[>MIXZV\\H!
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MJ' YJUK(;^IGP2,+K;\AH/=*-[#DJ.+=@PILZK.Q/US\M<RQJ4)_FL&_<W)
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MO#W&&8T0X\SAZ&D@U@99M=X7S9-F83317F7RZ1#&2DT)Q-*0KSQW?'!S"&Y
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MDF>4!:.FIQEZ[E\G3 EJM)_]//[W\T#_DR+9ME6LIT[[#>0^:.99JTN^\ZM
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M>6U)F2N77C0U-'&BKECLH<\Q733PV!MG9[<N.E13Q/[ H^X\>?YQJ60^<2T
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M<I<\L1BLF ];[>#,N@9Z2=YE(5';>?5]Y9WO+,-44YP?O7WI;=R;RO?<A[L
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M0<%4A2T(#Q:3\*V_RLS8AQH4/_ ;FW#P&"_4M-7PZ[TEEW?_E_21O_JNVPV
MGP8-/]_PN@'DL;:\%#I2/I6] 21'8%%7'@TW@%%*VR(&7/WP1?OQE?GR+1N/
M:B+\SZ/0T_]:9;*K& <W+'MT TBL9+IN5KD!:*EO--'KV_1=N?^OEX6M>\*O
M*? Y7:R*M:7%15^GT@!?_YQ7(,7:'JRQ=%"INVG6U,GM8!ZC\XIMG(0&I]&;
ME3< (SP;9I!)IZ&E0>>QI:7:6*_=Y%Y6;5!RJ"E/SNO!C_1\V>VY4;E1ND9\
M!6GVL-X3:YEVSCNC@<QX6&<S7WRGC(\%8G*PH:M@_CFK^AI-W]'][.<G169X
MDK:E^\@Y96*GAHKB"!/I5 XNFSC)TY_?DQ('N=BPL@9R!;BTRXRE#O@%V;;R
M!:^'+=G;;+&H0&IGEW;8GK->H]]R[_?K;^6(:I]]Z#&W!<1ONF0J*?.=P>RB
MTFY!DN/QKVI$3M:0?DIBOT3*1^\4[LQSNZD<8/EI(Q3/%^*S<&3W=GB<._TT
MEGNO%L;4_ C6+O0=YKQ#B%F3NN@^O(R5E.0X:KX!?'%+(<XFJTQ6J<5)-Z%;
MV!VS97"Z&1BS_)%]L0<_97"+\W/#+ :_<JUVB7C8.=T%&E*!%9D70II=%J,N
M'OZ+)[51(.<3I], H$+@,'KU+(<"C#0KVAFLF\#\U ;6ON%1CVA)9ZN\*][:
MT^2NK\+;F6VEKRF5,Q]++K,J-*>@C&/K,H%5!Q8KMD0@F/EJ4!7E+JMQ[A0F
M-X#W_/V&,[+L_L9@ IV5.W@/UVS*ZAO YX_ B5].-OSUC6&H/?4'//J]^(=Z
M]@\]DAS6G<[H)2E4>2V,ZSU+^^%"/.79E4M>R2[-L]DR/&"*4!ZU6-2/AA1N
MK-3LZ0T@FK'.+ZVMB<@4!8Q5[K1Y4#?UOLK%H-OX6XR2P>\H30#;-%TVGMC#
MYE&C#V5KRO #+^XFJW=_*OVFV6U1 D]3JW4J@!;R#KLU@1'NEH,\.H+/A3I;
M_%1C4K@,8^[%?^SVZ J0*77*%IY"9&C? $(#><==H9+L>M$P\C8W>NK[I$1=
M0.37(^:$^=7D]%5/\*_-.A@MU!LJPYD"*QAD:,[)6^SDT68KG0Y>TVB;9H@*
M%D\29%#I+<SL=W-/ 0:(<()]Y8 ,+'S)<?  D_C^:S%@S13ZY8@V*;CA;4P)
MN$@=.(4W;*OU._@$!5<."_=YY19F6/:PL+$/"'&#>X<!;L%"U7A[G*05[BQ&
M&,J_0KX%5<]S'KN*Q33=VW/A#OEE9LGRHB(DJ%LP)T0X[AL6OL*;(7U:YTRJ
M[;=7GV!_G-NW>]DB^5)7&OEF2\=]4"MU:*O;F-YFR[>HXFAO382MN^1/S(\5
MP3\%=SGSI])VCY"O\^K2K6?(?DF[=%(D/)%3UCJ.C\HY?' I< /X27<#V%*9
M;(QUUL-N[)ZA7;2UFW)T6T(Z?;J%RGP$'KV?)@HYY@D$6LUR5]BM"7IN,#O+
M]<N?KJ-<D4T-F3U=8N$'V(W.@\*"ZL5GM=B7HH6?NLDU:>MM5F)6X$Z#N,&X
MR$)\^O92!XK)Y^F+\O<"X.2W!5_N_'HB?F3/[MGEI[RGCFERN@'T&#@R651,
M=J=P9*6TF_<)B M7N!9FBIU%OM^81[W&[/&U'YR&X8JJ?UCTE,Q"?-3BC1D-
M*0H.A6F$G3H:PEYI'#/<T^UK7EKU988.52@H<=;RFVME%N8O+*9;F#O-(Y-0
M@3DR".1H>[4";8'(V5N'Z8?G[*_&363>>1N]_X?%VYCG\0E_W8I-%GHIWD:P
M'L?[:P=U YA+9U@=H%R,]F!E,XGL-2CE%&<!8$V9N[P7F<:7\<8E4,_JX$6A
MBP"^18;:N*U_(F!C9!$_%:3'C)9/YHQ65QKD=]:!V-)N!._P?LV7RJP-9D4K
MXW1W:^&#;>A?$>2(H-1/;=J6!4=N0;9-C?4DV45'0G6V@8>;B:5O8 0V*&Q/
M3\-99RE2&]U"ORVQT^ R%.OCP>[S%5RM0^\_BEE9;6-N;>TRQ*N6<T/E;^4-
M-22LH[U9+OV*[^+=403K^OA :YA KSPI-$EVN()]T#7<4+Q"U2A6RSE=5%YZ
MQ=$+G+HE)'_1$K:H?/M_QB1QJS\Z43<H5_H^9EIV^2JY*P<;NYEZ+36FL& A
M4'"A'&E@MF;92\K5X,C=ZUZ<F9S);OK%N&O!ZO@G)+Y"W]ASI]K 0G'<=C5]
M)I1>_^7>_^;EQ/_!^-]OZJ'\_]^F'K=^,X]T]_#2YQC<X4]F3?C'B7K$Z(L>
MH>GW327@R$D.V2S>M%O/)B"N:^9XT!9T#\7X.LY"6@V]PI_IQ5$VO/F=6B5,
M+)R3+L%);[LA+0;\^FJM-O.4ZTV=!)7ID/<;K9#@%R?=0H7@:#_>C3U2!4<W
MJ;(BS==KVH]:YSX7=;8_T_U]1*64B8I**9A[2770MB@Z6H!-.?NLH">:-\;?
MP#3E%YI.QOOK=_>8-ZU,OI@>%:2" <<4&LBQ^;2K)?2$;?C^3@.BVJRY4/%;
M3=C80LL4L1KOMVEHO0*!C6-M; W!CLGU$ZQ)'3:\?9%ZJKBYNKDJ?=NCQ&+N
M;\Y;GX24.V2<;R3JY'6?ZYM;Q$=< I>7[FR?DX2"*Q$#>^"WIN>(0?A,HLC(
M/HTJ"V_S^VW0:QNOVF070D5#DZE+)ARW"G;%V6_M+ RAR ;2 >ZMC _.2^8%
MH&+"V)C/AEGRN[+%L6'P92[*+8M_TM*AS1P3UKFU#>'^-BK<0@I_EO?4^I/K
MY@EL3&_MI-@)%('$]70MT2)5RK>2I&J9TOC,K$=RA3[)D22.):,/XF!H<F1S
MW'Z?ES6YT:=9)PL/Z:6GPJL,8+270HA5T:P%X-AVERO4_:5H"UH(A:D>6BFJ
M_5+A$;\?J?)A^ ,FV0C?]037$NX5P-KF><7=X?33,=VN=O>%$CZQL>:;?'R3
M[XR%3@W!ELQ3<+O_H#DBOVQ[:LI >Z,E7"V=]97F_!O+V#GI#6X>>_JENY<O
MQCY<W^JOAPW5T?^,B^["7X4-=;,7*+WEY7[V0^F;[$ZRC=NM2Z2;U\P[J=E,
M^%!TDZ6>=UQ_][G NI=!IV!F$F 5I;^\Q P) #<_=#SOVNO.*()\,W\]\;!6
MDEGCMT2N0QMQ,+5KRGJ&H_>(9"/V(%(*3(T7PXA&B/'\3C:R-#O>:A[JYZ=Y
M^>=/1U:.  G)EB86U96NE):'S^_PNTPSL7!MH=#P8GM\V2>R*"U<_S*VUR.8
MY'LEG0N; ]$TD@0.E<?[EBS-=95ML[:<(D*[<Z2KKK)?Q_7+T;%H^#"ZZTIH
M+E,))4Y<:A;F?/;S":O8M_&_T'%?WUUG-'9@!1I!LPGD _?=A:+G-*, =056
MO-D5=FX"CV1=N1-[6>15"&'/;>IQ]\3"%A5PM548+KP9DXGRK*3ODOU3XN&U
MRQ^_%W[;%Q="IF9)OU,;8BOKEV\ 89S"<=L=-DB<= ;,SJUX29,J^]1C5C@*
MD*2XZ_/D4OY\HIE\HID#*H9S38%;;I_'1ZW7_3:)X]H]<DC=ADC("6O_"O[(
M!$@_=*G)<"":NB19@=_#,W4U*Z3Z%J%J7$Q!25/3 5FYSCD2QN\-J+SO-_[L
MB0DRABK+=,3?<6:\?E0[!;2]#WI_ W#X-6H_?AF_&&=W5#1O5"++[[#!L#9]
MFG\;\W3/\9&O*[;\KL-7)#VG6)O.3O.<&+4X+86:W=%D?Q.#VEB&"<OG\.'M
M,"JI #.(O2$2QQ4!E#>I8OT\]7Z,7-;JC4Y)9[4\=9HB "XYIS9[USL1GZ]K
M&PQ&P\5O (B6NN9%[L.A)?Y>LJP%R=^>.Z:7W!A;JFT8%5B!"2,_5T$E61*K
MNV2 J),AM7REPEX53,;,0NPI!U>XG0MPLL#6J00847B(:;EGL6T1<@-PME3K
ML4GO_'38>9'$\(G]!V?@&X_D32':)1OL8A,V<*!C-K74K6#[7'%A<J%!) /$
ML?R%D.XC]^O>;A##1J.C] CW6'RD@AB.NN.<MSC*BVV8>B==\>>O>*/@D84N
M+]>"+^;W[[>A> AE'U5?.F(J&+E(+"'*[7G;+B*B.B?[^7[!<F*NTGM6#X8Z
M]70)Y#;2T=ZCM4%9+=WQC(Z+0'QH0-F6A"8P9F0N3RKQRX>"QQ5M9W=KP,U\
M*D7P#K8]EC\-:6$?@JW4!1E 3U[^,51L,^E6K_#MGK6^_4=9PW*PQ693O"@J
M>)GC5'6_*Q_V<"M/4X6N/E_SC'@N\Y-&+X.M#JXG#"C& (E%Y%"KO$9?.7$]
MXAE_!9)Y.1<OJA$&$.D9'/?6\3V=U:DA/1'ALL&&=RC*V :06[7@I O+' ^W
M=LC-V.0=4G595BDZ&PE&"&)0J8)[>B2N G,.Y,^H\J($*/Y/E-+<"OJ_=DE@
M3X$)E]%M2^U9/ Y5OMT#[:>1%?*JIV:\ PD$<IYVH^I0-\M?@>-+= 6QB4A0
MRNO;Y:>]L+T&VEBKOMHT2&X,;LF3]%P^<7O664WKEYQL@RC8 \]H=]WS3KX!
MD*FF]<-VDDV31I-CWJZ,*QA/A"LBTV$?USC?QF6@11'\H8&/(8:&M<F[PU3%
MKBP3>W\MGI535Q&OFC9 [#II(728LVX0J:-?%CP,J/AF&[3K/% 8WZN9_ZT@
MCD_TWH\&.4!B#*;Y;2[JSQ#&[#;.!^U,@G_,!53@%UAT<Y0V)I_:1C1+X /@
M0+$(&[[DMD7.FKHDE8^UL[!9U]79?]SF'K^PJJ8YH@(,>L"H12Y5W;!@[1RT
M"Z("%</3_)OS@8,!TX0^V=5PVKK[H[D).!0U+%)?]3NU1Z<S4^][V3MM@1/#
M$/, 8TMML=0<8(#/OGK5>/%"[G%QM%0.PS97=5U4.?#*[5(5DR%B,6?8,GX]
M74==9!&1I8:A&AWF-95WEQS\"*OQ"$,A&8V"E=$T8PU<YW8V+^DK/VH,6W&V
M6-B #$ 3D^,=%W(>MBW:8/ AN^-AX_PH=K_)#0V[[^@W6$9?/[Z?WQ@;KJ<?
M M,Z.YA-5Y1I][N;4^!PQ), *3/*Z4J*P'V.^\<X3/)XX>&E#G1-Y5U5DJXL
MBUP%OWIV@9,MN.>:N5XE7<LZODC9_LH0U("W\1I\@68\0E<L+)8ZLX>GQ?E[
MT\!'=/-/X&)X+HR.G%<+[6;ZU:'C:;;PV/JXK4%6W(!_V&L>W8V+QE;B"U3Z
M<LPG#1*XHJ-T()#+U.:ZA0F-.IK(>8=S;CGYF]V#5IXYZDSGBBP'*C,6UH4C
MA8KG>2>GZH#S.L2)W6TM'XTC4S( @/PF%PL\0L$-#9KE[B3-_L<O8WJ^BX[K
MZ\-&E^\7*PS+$-X725IQ49H/#(Z&R  GZY'Z7TXR$>/%[W,":TET!LR5M\\4
M39>=85WRN+>T=Z$"?,K81X(3O[%[J.ZET&MR$(6OSS4?MJL\76<_>OV'E>;=
M0^P@;15;-TL(0>\CI-D[CV UO^63?.97SQ^<QU$:E=3Q2YW<$D9RR@Z;M\.Y
M4/%EEFLN*#6^BJK. PS&: ^P27A"ULUYZ^HL4SH&:A+*_VB09RZ_;X: &Y:T
MK#A]%4XVX*BI+_<:/.?9,[/F?"YIK^Y]MK)TV0]@P9DN'T1?\T#LT8&YZ&'*
M>6?O!(@%N2]_R&LR_J][-6OAL@^N@6M^9[LW !Q1V[GB%+P,\N)(9[S"2 IE
MX.MO9_"LK\.^E*%+..EQ:](S1:), Q:>#R'"G_T8>4P\MR:+ZHU2FI27DYF'
MGMJ"0'C^D1RB/<_A"!OR\0=3^]S_X/U+:Q$/4GZ^&S=_&<]\TCE:27(E!0S!
M*G?6*8GB41@=][_57J4.YUT3WU;2@N)(1MSBG7!Q:O^.SII/#)L:2O-&R*?0
M\TO;<%A3] S48M^?*=QS U^/!6E@*^.%*3$ME$Y,3/<=DU]6*9Z4X]^+,SZ0
M+(MOS%Q&F6+#T=FYV#-M?(@;QCM<<VH?*A)P)SOF2,BJ!F*29&K,_R;F,=M/
M37X.H0T.9,A(W&?](U=^C[=82WZ^2+TOR5$IR3YS&TO'9(8N4MGA8S#J2Z\5
MT'TH W8J%KMA$L9%@P_4W#OPE.1H!'D1Q[V-<_C<[_.J6N">QWA4%[X)(\9A
M?LG?.'[] %*89C4AFO <'?&ZAN(GGWE1_6'R8Y]7@AN*[N(VE#5AQ&]I1D)"
MU,;,DOL4->7XDMJ[)==-%B^<E]R-Z0L#Y/?@BWXM>U)MMTRK\SX,DS/^%(;Z
M9:I2 :F"4A=?#W,^%/^[4SBCXXX3,]&'^%!72D9A0U*W-<\SQ\XIDN.^*0I>
M!:]^9AL-? H\3]L]UM^[-E%,[FJIO@%$(%4QC5>@M@%G.!ZD_]NYS.6]T.\I
M4F[OA>C@/Q0?ZMN(O2M#T,41"C+8#4QQ)%(1'4]36-A<F$\I.M?I\\YFWDD(
M<7;9;_1BC/![@AHI\&B*U" WPG#R>:MR*-]HC/=QP::6VVIF9<4<+N &0/#4
M53L5I+*]P&2.GRO8SOF ZXD,_PP5<:@ =E>=!BA\,R(*<OFL9%?5RLQQ9"N\
M9".=6V)M+8^,5Q@6\ 50S'W-S'3+]NUZUF\&,/O)0< 3],S*6#^OM/88]>LG
M&I18]U?H=E,3*MC\3TTH54--Y\Q)CW0>I#-&CHG.4+SW9YEE$M3@U32@DF7W
M-]AJ%D9Y*KYQL=29 N\"-<]8P!65G'(Y;@.N']W=?940WU1!PC:;:?3GK$]-
MHX$+Y&89)N/ C"MEHZ]/4D]GT?G?SNY;>H0D)Q$H_2YYB#JQ#'B-</ 2^NUE
MDECHO+G^[FO]:M5'CV3C)X^+^QOI^N-BF_GQ@XBWD]31P-J)1 IM"'CMR)C:
MF++Q 3MU?U/^*1"?FPOA[UD4GH3:P3N*.5YTT5LO]6IFVTI5OUU.\L]$#7VE
M=V$8-ODL..YY"JJB*V3IZJD?<6I^BEI4U-8*Z7R:=LI>)RDQ(S*?8_].M!/Z
MK9L4F)R[,YL3YD5Z<!SP8D>K.5:K<#*S@CZ*M(W@RRJA8-&L=5Z=?I1)E579
M&Q=U?>24%]D!?+^HJ>DW6,(Y.ER,)W;[CR]?S3$U*R2\O?;LB4/#?GZ!BE>\
MDCQ;6N2[U@>N]WR7$X<K[$95HIP&'6P%9R+9XXG[I'1'^V,X> R#RZF>DTRP
M3N"8HA%+S#H4#?L(6(7VO2^1!_NL[U45GPGKWGFOK]M_QB1FZ*R-#\)DD>@Z
M4TIV-M3FO.FX.SM[JK'24S3B9F8@.<BMR2W9.UB?]365?R)Y,4MM]$64[A:)
MH$46/8P.^8XQ[2H]6W@*!9JKWBTKT5Y;&6=K,)7LD^/9D!OR':X,<-)Z(O"X
M9#=(522QT0U'UY66#CJUNN:?XAMWJ]MUM]5XTU,TCZDZ7M Z4D-&'8$:LMOW
MN;]NU"9T[QR_<A<4U@]Z$:751Y[B_50:G[,B!WP[R=:5/N>DGQLK.GC9[%2Z
MG5OWEBC(_!P6C=CCMLHPK[H-)D1DG6_:Z1E%<O-*ZL!MA-P-<):D=Z&OYT:$
M)'IS!?A[_+ 9]O55J//QJ$\R7W\SS$TW(*Z0%. ,>HY+BX#RLY?F.3>D)B0=
M/9I>4'C>G*OS3M\(DUYM09VF38V<$#TA1R$;ZM.W]Z8EK70>^I)QD-D-VN*X
MHKV6F+4I&DZK__V58T_(P[_F96O<B6P%?M-6%QR=>[4&! XS.U_S(:H1DR<5
M*L:UU<RU88=K:QIW >V$@38 =C\3K2@O>IZ\\K!\E]@*DN[%1]B*IDY6T<92
MQ_M61PK>,B#:@6ZE5P7VP7Y3@;'E3DIL$Z\GI#)VLB3.V2,JR]?$>[\1LS]9
M?4NKS%JF*FI<F1$NR#\)U-[ST,N^ 1@@<_2:,_=3U]=5>)+8[81[DENY4AP<
MFJ5Q7&&[ZS5C7E>@ES492F\9?<"T2GZK1%&]>7%&D^DC5F5V6CO=K">GH8R1
M'A5.3*Q2H'7UX@'W/<):S?G[F?8\F1?I:1W7LCC^S_F>(Y?/?SCT/1P0B9U/
M%%!"Z]AA8O0'V"S:URS-,HPFQ1"-*.0$V!5(7G<QOJ U)G<) I86XX\Z9VUB
M^1+?840,QK52M!1C9)*$A8M+'E,]<8><E5OGI8;33Z9S">Z*F]*?/_[Q^/\[
MQR3=83(?:IQ I80YJD3,/[L+:%A#=O-R5.GO#%M532HP8'(^-[-@3^LP&?'4
M3JPZ"Q.[I86:GI6\W.RE@%?44WFC4)5E4*B/NBGV9#\7<T#W3[FP/;+Z@C<K
M/T$]72]IJ)631.LP2E!.89CN0I12BZH\DV?.[<SE0'JV(2HE ZP+%HE7P?NO
MB#SBHL97=P3RU2.K:W!D42:3'U:.WD:93=<-?6,;C68/6FRP)7)>HH(2N)4Y
MXIQ9PXJ %=(!2@$?M[H?[XZB/B6X"J_^9.$Y)N+8Z=K,;9-/L14JM)XX6V.0
METXV:=#DK_8S=PPT=3&<.&XA<5YDSD WMRSO@<WJQXAG"_RRBG(9HJV$,[C%
M=]\2,_2VG0Z:6?NT73_%<H5YNL LFK&3-X#P_-1%N4=5SHW^)3,#8;/E]S2G
MD]O@PGEQMA*%J>V&7MP&FD<>0I;J _VS2)L=S_U&LQ/8?7Q9FVD.V5ML4:(;
MS%'I6\E5PY1E6<!@:?4#]?>S;E3R5!#]>52JI:Z+Z^O,1QIOO!)XHNLMB=EI
MYMG=!9\*?O'5S12E93;KITEVTJD+\/*_.K#-3C71GC@IQ+_&#)HC3J:\Q,B0
M7>]S5!!CETN"+RG;%XU?_2A8C8F3-!53 CHVG,5"]?DJBJUE0A6>.U)^/L7U
M4DXXWRL)6Z;KT"+M&R;A,4W0-^QMR(3-2%EH%:P)":D=H$U!:DD^2,-&EZWF
MC3(\S S+U7ZQ@J%D,YM0,(6_B+W* DMGNSQ$) 81FFN++QJQ?T*^_XGDQ^Q0
M2J*7.D5$SWV5:TX0U=+3,3\3\[]EO^C\B)3VK62,DC,U!.UNNX-F=0V2W7R\
M6^I%'2IH-6U_3>V>D'H=D.)76K,Y1B]5RVP@8!/LI?O<<Q_*R,:H[;ONVX7&
M028&H#JII0@;"6QS*3:CXYH>BVTPEVK2\C7?7^D8BN=46._I)Q>7U=,%L,#%
M\^+^>;SV)=] <B,EGY^7K8SO(#!M^]AEKC!>$S^(X:+$;V/&._UL2MVNX(H(
M!&(J'ICQ.&0@XJ&;M/=/7G7F82 " XJQ>&O+A@#1.6+[RB ^!C7:Y /F].WC
MK2/"[F**I-P/SH-LY%39HZ8>R>ER2JUHZ?2+Q^3!P6%6#0ZI\S^&8=(GBMKJ
MH-!%ALE7J/PI+]A]<G/BTP:*69^$+M07\W\G5H9&AP2+XG&/V)KX,3&S$W^
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MPAR&X0QOD5^&D4'*NMOXVFNK9LICL7TZM9J5&7H[Y32/W]PJ94BU&W"]786
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M@PK8#5\V+'6,=?X<C";I6(AL4)JB_AE$\7N)!U]P8L53?V8<(6DIMV(TF3?
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M+66A4G8>2?U*+"MUBWM'/D0C]QFPE[&1;B;MX" XJ"'8=8-VTKB.X&3=1'B
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MQ7^IBF;S-5<DQ8L?ZF #8S!_ZK^L3QP3!#GP_IIV]PE+^19/HD$LTV^@S!Z
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M\WO.POHRT'A^^D_]]HQ^&8,ATK2QTC]O5?,FW"K$$8<<:8^0S<,RNJ11*-F
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M2?\H5Q-.YH8L&2&CI_6DIF56S=YTLGQZ/.MSTNL;F()3^IY]I]T%TGE%-?4
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MR?H=+9,\!F%^S8N&^:/T_'1T60O#6>_3Z-/N6UCR+\ 7U>-0?[Z'"+;%9FQ
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MIQI< VY?_"N:6O.O:"KJZJ/ 5^J"DKQHP-_&_[-\K^I_HX7<C+;X;S34S6C
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M< 6NG%MB=&TM._368'GMM?2H)['GS_'[J#7G\LW8R8!GUCK"/V%5TY7/H)?
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M</EUCFX7,H]J5_4)E,7[L089"WU7-:CZ19G<G"#]6:MJ==J0WUG+[\!3ZD7
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M<<.$'13#KQ:5I5U-#P?^K;(;\[?S$@N(OU]5G75/W7NY=%#6U''L"OF>@9.
M-2@)X.-I!6V,(Y9N>*XRS9( 9 [A->(B"6@\?F*SZ$8C#&<A.29:)(#74OS(
M/Y3X)J;7]VIZ??S!W+_7F?_3927PSQ/P@8_\_Q8Q=0MG30\ZB^,XVJ ELNR_
M=$ME;IQ+P/<2OU8V'EQ>R2\RQHP2XAK9CNT2YKUC$:FX\KQ.D?C;"?B,/P.F
MJO'H_5X,W'(F,#(0#7[L$9ME&P_HBNWPAL>"*VMJW*4H(P']YR 2_^D.YAU*
M\%^G7I/:4O>%?D>#_5+82XR4Z0*#_]BQ?//L]ZB7I!O# L7[12Z7#-89%YB.
M:=0^JJRLC^55_X"^QWG>ZQ-.L]T<^6;$NT%XQ%E4P"BN264U.N[:,BO#<^%W
MZ6_/^-I%[E"9-5#[2U1$+[").:X[?^\K>%:GULE-13UG1\E6+)6)4I"?ZZ-$
M'&I86RQ;L];==8>Z,@W7Q5_32W-9;.F&O'"!Z6-"2FR/YW'!%K^WZ^DI'"I4
MMPXU-="$TK@RR0\>#Y0\BT6HRA]0TSJ<.K,H,?5,-:1^]!.6IWW2#_+> AG1
M0A31SX=[6@G@;).''Z,ZI82X.I$5.[^"HQ,L])U9%@_B(/@<S+$IVBQ^;HLO
MU0!'9:""N1#&Z# >+&?XEOI)W6EM%KZK;"MMEZ(T'U^E'&4\N[UQ"A]Z$W<F
M)DI9(M^!5R^F59)_/OI3KH)G]((</[/=RI8PD^A*CQ?B-)%;Y_CAX%0^^%&2
MU9FGF@I/9#9WQ%A)$=%[WU9?O%!+"XJ/T\74O?]*%/J"G4!%-11F=!3:'[SA
ML:L.=M'+ .8?A]_B*J*=\65?+/1W1=.>-G4PF.D1-&'O.2I#(>QAQC>:1P19
MX[MU.T2TM6<'I<FX7NZ4$G\<%+ZK>@&1"_OTQN(=Y5OCU58GJE&V615A&-HD
M<\!?8=0CYL**5PH7+G.T_[N86!'S6)'CJ0=MG#W-%\?X'MO)S"X'N0;U/3!Z
M0WU=6Z<>\)L*SGP/.HO?N#%,L+;)PU>:#,[:KXT;T3>Q:UUUR_92NA4:CS14
MMZQ/^= @AJ>R>6B3"\4MLZOF>WM[0KV]7NO-U<&0KR4XB$NLG MU9=V69.4V
M@XR1X3_YU3MNA0-[2!SB5<,EN&%+#!K$*1O\&5HAL;1W('*0]\5D$Z\W*])D
MRO15^=>5+P2K6?UBJAZTE"=FI9<5GW2KD3T*3>SSBQ .R'SZ\APZM<C4]8?P
M-S:FJ@=G][)0E,"#.^PI)9C>4.8&"=R9O5?^,AA1VD/*NPE%XX<:1Z+9)6+>
MTF[:TQ)">O/JWS+QP[*A).!L;TNW"OE=@]L_N@V2*=X^D'"5F&B32J >N\3M
MHN6C'F41EY9J>8>1^K7"AAH73\LTFR&6!+2;.]52:\Q8*-"/QP=)WSK_+34\
M'H^IZ=%'JW[$*'4Z$U@PCNR_]-Y59J7D^29ZFSS;FJ_I?.:UW17_6OC[&R/I
MAS6YH+MJO88XFJDH[!YZ9^_%]N3-4>M19,2K^6'Q@@:8GWVZ@BZOF^H3T6ZZ
M#H<1*Y-O$,)9&Q\GYIZ'AWI;X(N/]@01(''.+50=+(?QO8ZRY\J&&G<W=]YC
M&=KHT+5$?%W8RY(M\+$>R/HU]VMA-D7)A/*KTHJC4D>\OJ<K4SEH#-RY< O-
MXAKTC$VELUCAI_R^KT>6<.US295%\@%09;P>7GB&S=$N#"FJ9%53>ZB*JS\K
M4<H,2:-7'"F.K&. X>1:DU*N8MMK,[1L/H-0184R2G/(Y&83X%M!X?/N6CZF
M'^X0K;(/LZGFVI$2\^JJF&<J.4VHI* Z<9S1#QK%]4G1-8]W(K.C16_J:Y>?
MYK HF7)JGT/);\L4SHQ;@5L:Z3Q$_3"4,8Y.HHX;C&V<BE7UT(FY:T(%&MI2
M<1:LY%GP"],.#NWY'WZ_I8#O1LBGF);DT+9NX>YQ<44#=MNP3]4Z>A&W(T]=
ME[<)[G.':->?$4RL R@HU:/?K-[A'0B\9HV:Q%.B/:Y;:BJ/'-QO-N!T8DNW
MN7[I.M<%)7;#9[XO9%/$A@O6Q2Y7!!OUBQ>,%?'=BWK;>O,:W^P&68SO5E3&
MAPOUT/-.K+R\4T$I'=BM-E1(#K:!Y]SBE CB'#["H#YN8=QSQ5P30?W,*?+;
M!?)\ZJB)!T.!UX=E/O)\3?X8$U[G[5,,&^WA]*HQ2/DR>D>=U;&7;XX^Z@.0
MGU*W6WQ)./:YY+7/07" ;$TMYM&@OXQ[:8L9W@Z#][ 7J#2L&(/ - 8P S/4
MNJP29'TIZFPS(\B]-AJ>%A+ IBQ7\/[G#MNE05#9SIK-38,(Y1\%Q=)P<GYU
MZ[=D<77@X'*'R7L\N5E?TV@#*F/:$P_2K:P)C^ZB^>/]'%ZOK YTGE5H_LKQ
M?4J'E;?0#L_3=M%A&IN:'5R$> 3/N5<=;2!N-%+T+$7_ODV#>+G<Y.NH'&6[
M;%BK/W+R8X9JU<*;7*>SW])HTY19,GNR<R*D-^C@7>V'K0=3$2H?L_*7T^'&
M"6ZV'RK:'MT#I'XN5%DS0BQ2@QK.E%J\>EQ;.>0IKLCX6BI-K(KO@IK\S%ZQ
M_.:HTV0&]]N,!S]<>P#?D%#^T%;#D!K$2_ZAU>V/B!NUR0$*R'/*N6+HI*2(
M[\K"(6QL7Q4^*_:^D'8^A0?=B3&K^S*L;.''![5US)X,&VB_Y,X7I\B5]=;_
MDUL K'=W?5GR&I-&)%G0ZE6V16LZ9\?U!AZ"9#C'JZS$Z9OO!*(XF:,:^GY1
M4VK&F,<;-50XCVW<*&.AXVC#\;<6.G'Z!-%4D87OM,-[?+[=C7/M7-'_8B>_
M\(P).A0NH:]VAO&N[G_MM92K::?;[=NOV:>9_#Y>]24T67:@7\W4H-PQZ_C3
MVZQ_,FI^1QLYQ>#( ;5/$Q% _?4?MXSZ_UJS(?^GKTT8[#/L?U=Y;S^NKT7V
M4+8_W/PJU?%PU$RO_@O&_Q2=1._#G5,#CL56-5CQX$"FI0,$01":MQ(HV%"I
MWXC7V>X<02E=_6"KO/]*T.^"5^YLO6)OD^HY?''VLLU7K$,@-T[K97E2AN90
MD<DRQ\\[MJU2#ZZ_ON#UY1?2/>"1TMAXH^'6/JJ=N]]YL'J.PW[<I+Q0;,^J
M+GS0H*QJ2&S^,'&W1#IZ6NN.@4$A''$/._EK3"9 <NMF;;M_Q$]NEHXB5G(K
MSJ[=95AV>R#* )EGA_YH<\="H'S N2AQ?TI).V1LPE+Q:">&?$$X]K7BDU0?
MM*BWP<CE ;%R*^UQDW?/-6UD\C,W)>3)[D3&&:9E]7 5B2J]XX"Z0E)QSC-%
M6=CIV]BU ZCOU[*Z 5&G':J(;A/3-:>Y'W@J1S)=>0Z+A2)!=:SU*W]CSE+[
MF@LY^1TL!QTEY7&VAGEW7.^R?_G@,]CWMDO2LG/1QF@HR630S%+?V94Z<:O=
MJY/Q\_W7!Q=]F/*A,ZETTTNTGU%XQ+VJ@3[;XO32V$_D0U66)M%Z#F.^HM_-
M#9"+TZ>)])/^)K@SWVEL\QIBSV1]CX/\5#,S\GA5=[?,48B*D]I3 5,58*,Y
M5*>4JQ)2G#,)]<8]@XQL,H??/_V8OH",C>E\IN4$PS##]P_5QD-9^E8=S:G
M&'Q@R[Q^Q-GN"W8A^!$J.DOF,^7'UUSYG ]PU>.1*6<\D@TZFJ:9'+P.E.PA
M5[ YJ _J%\I1R9.O)J.9LE[D<KA'KBF;N!6DH_1JG9U21V/%H+*%?MPZ6H[X
MP6:Y!DI<2#ZZ>R >LK1',9G,;7+[I5G VXL(]B<E,[T7\5X_..K!ZD/;M6:-
MP[T^=GRZ^]M/ /;AVZ("*0M)$1)>_16U) # R]W"L3P+Y'/8RQ.&+)HP5S+?
MBF.Z[R,F*_% =:_[YRB+>]:4F3G*RA)EZ.P(+]@=U&.[]U$==9/^^M>+ZAV^
M-QT,.BI27W;6.!:U';\GA52.E,9UE155E8-%.<\79LS515S*1,I2;MQ4:_*G
MVXSV*2(!F)PF%0OTWDN"1+Y8?($.UWHLUT*>Z'R^B E89+7!F"O#3FO?(@5Z
M,Y.7GWGGP3SC@+/[=]F!M:(<#"0U$PH1@DL;*!D->)" ,HNJBN'81)<U]J1'
M'!\+6A-V>9DT5II4KY3TCX*K^V3T ZZ%F!Q87&.F5_%.Z%BYEYUL"'L.S?QN
M>5YH..6=3ZZFMTQAYIZ$N<XO2SUJVT3&;QP?8FHDU3K7'7;S9J8OVOOZLQPD
MOLQ;VI6::7/WM.-S;?!]^/;!X (8V=7W+;T(JBC[J7BJ,"7IH6>>U9>N\;'F
M@6^(&:%S6</;!CHM>SVVGY?VS&TQD<CZ.5&&(.(* )V$3.IXEMP,OYI]_9]2
M:/RK0HX"V<3LR\?0($:5BH\N#A\\M'Y' OX\7Q_U S'%DK/<2\E#N+_X;_A\
M7\ QQ)'4376")O&HDOA&!R(*BO+]:,9"B')IW-GD.3 "J2RFA^\:KKS^-[KP
M?Z.0%_X]'<9^&#:4>+,RN'%5]+C7&<R-MU=ZV_QU";RMSGMU(+SU E.7O_FQ
MEPB>!1V>FB(!BZ%%17]>E6X-U(!W_.N4&#%XP5^$]Q]CCEXX-6Y?U@("^']/
M"CV-V#N&^W)*TX=G?Q\&T:Y/18,(<;T4Q^XD>^^Q.\E_#/,?.HAJ7%;'JILG
MV9H9,9<'KR4V5X(.KH]>L[+^PQLT.A[NM6=_G5.Q/?9@R,9@W%Q#=3I%RQL9
M]LQ269_BIJ9[4WPF'E\14)MQT[M2A=J-":E(!H<0Z%0:6SG:RK'%86/<(^W\
MHCX+O ^LBD##:7/T@=A%&L %HH25AC"$Z@Y)'^G"V)E+J QMX(\D%'Z.6_%I
MW!XQCMS4.?9%\PB6 _[JGV%)OOZ*MV15>;#UX?4?9$M#7S[]V#XVW'O0PGM1
MC_-7]/"\&DZ-RSJRCC&%H9\@Z%_IZ.;9HSPM*7EF4]>M5KV7=ZK:87LCDF=3
MD"!R/#0JQ.(LQ):Y/>%T5J)HB]_53JH4UXUP("I32UXD[3!Y"BL8PM*>(MTO
MS5P%NS'DE#@Q(;1^]8(/>>/-704D+6?;)54:[,NBES-MYRM*5F29^X^RKU-
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M\)HX_A&"\MA. X./!QY& EK[20"UX;$6/3B_3 +V<"!\,H"O"#_4)[*F-I&
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MS@G."<X)S@G."<X)S@G."<X)S@G."<X)S@G./^.HB*]R88-,>58M6E:=YT@
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MMK&&ST@[()K&YTAZ<)CE_.L\;GNEXDOIX6-8YV"9WE<0OG+LL:+9'O,,<-A
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M)I'ZV*<5=#BC20.,^(#3Q-]_B:]#COS/+\#_UQ?TX?192?DLD:M!7$!2,0W
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M%<\*<._R>?)-9]-ZX>=R87R'1BF/B;>Q/VP[;\]?+W.M#?1*#L9 2:A&1E1
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M$S=RRQK[\AN Y%'< CS8Y'-14%"?.U2>=0\BEMQ947#E3I[9(:'8?JK2PX9
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M<M@?PKBTA_HL >-E#!BAT7/NA[8J+7#Q6L%H#:-'*N.OZ<WOV?61+*' ;E4
M\8=7(91DF]C)G6>M>:NL7-@Z_<7[2(8<^KL"Y3N0KN)<B=]2ZR\/54I%!G_/
M>=0PBN1^G17)C0;\.YC8!@M1.#)>/$0./^')LF ]H)(=7?5;NN)7C@//\OW*
MIR\+F;\<\$1 5E:?1EL<T,D<^2IV9F_QD)36S8/<DZJ'.G=Y'Q B&NK_I@&>
MO7HUV4J]RISGJ>&M_9.SY)M[W^Q>Y>W;AH0+=L;#DNAA#VA6$4EN -=.J,)U
MM^]>J0I05*&6>][ZT:4Q4RR7LO)S2W_D;= :.XF%UY79E?=Y$3?@V[>[ #X
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M*IBBZCC+:QKE(QA7"6XT]$:R2"\S[Y7/]8O\/S:Q\&DF[*VU;F3T='>L1.E
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M<SZSCHA>YTEMG770Z]4"7.P6%LX.6L]6Y=,Y5/2;Q=^-8<K43RQ,:7924M7
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M' Q+HX>V;JTO*#7D3[,"GAV&[M%^_,6W+K9[9OM$%]@$'W9>7#]J+X4&[>&
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M,Q/_>2]$<"52EHE[-IYD_7#H5J!B2'C>G2W%F2&0[46N_VJ$K$YBG<)%.KS
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M/%%LNE8Q*%A3HF;R?)P%6^MRL>8?'VEY&AF)<7!WK6+*-Y!FRK"SAR"JX;-
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MHD\#[Y&"3]4G,=-].S"GV"_]&4I*,Y_-WS9(K$'=JID"7RS[2#2?N]>^5Y"
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M/9U/]Q8LGZI5B@L*#%79^N/P8%YI%JO[%GZR=F[8&Z"PV/09'7J[1#F\0.I
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MBQ)>'L5Z"7XRS]#P(Y?GYS[@2#)9E^U)55-T<Z8T8Q^T'I@STC?2GY("<R<
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M8]%&P IB,<-IQ<8E/ )N(Z F\]&1(;1I*1%JJ^>N/[H#D?+U^VK+'=G[.(S
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M8<F?4<[N?SLR7II,-(D7\E%T<F.%:V*J@V77\UN3)6CYI#=4H+BQS<WY%;<
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M&ZHR$.'B\CA)73.*_.O#?^$K]34+'=D;_7E00UH-UQPX410IXLLLQ0&VSPA
MSM8&0+L4=U>ZST)A(>\)>FC1OZVM@T)V".+!3W6*.2LO!!6(KN/3C#*WYB6
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M5#5U)K.5\22L,!>\F!TH%R]AU8:#_Y2'(O9H^'Y'!/5OH]%7*6\.P//U]_[
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M.?ZDJ*@&YM0A,7E_)"U&:.)0DP4%)MG?Y>8DOAXCW&F/UO'"MG$^P >^7QY
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M6N[&*H9B6F4P)#(-WJ@P5_)L-K]EPN>QZ;?LU8\A.*:;J2\,1PPTRJQKGUX
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M2YU/6]>C48Z+[&JE\SK%M.ROOF?W5%K\^%5;OG'7( "0L("T0H.0!;A3C@O
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M(>EHI^U%@BH0].5>W/S&#R;=A[R^9N(;C4^H.%6<2,#4?*(6P7,R 9JN6]O
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M^IOY*^_3-2&*B-<FK+,3)8!W0[Z!W+T(RK^J?"%Z:3>6S#$AN5X5?[^N%1+
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M"T4=(N\/#6&9@\D39EV, ]4_]CN4;NAVFC[ZQRH2)ZU^EV/E/7"]1;]V8J*
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M.],]&8;X[F0-V8V-%"LGK1LJH[%MV[/1$LZ.#5%! O[/!"W++,]+0 4SNXN
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M#\/AJMLUU]8$10.L-A=V6YN0N\2OS-&NVS!E+%1SL0,]G,,?OG;)S=,2D^P
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MI..</L]X&G:V!^MZDAM6:F*0Y%ON9# 5F.7\>/FP]UMVS5?;)>O!:YOF$]^
M7&NRX5]=H:!YF,'IVS\CMFJ''(KZP8]02$-I]<!7^H.98C(4K)L6_O?CJ$MS
M*V73P_1"Z"I*HT<GZCW&VWIII$OJ"V$C6A)+A^83B3.[30M9%SR7@,'$LDO
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M=M2D>,9(@'#\RCO20H+W]#UG;J]6?KX#>$X*47W81:(8+>5,D%-+P0R1-6F
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M'5 .$GL9U#+A C>[,ZTZ>$"HW]=OD(X%/@_><.M> LAF)H'IM3 ])]P)OL+
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M?S[45@(JB.=7AOVI'&EG;YPU2RVLI<!\R'1#:M 4]$!!LI,[3.;$D!D.,37
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M[9+*,Z64TU.? !S(1)-&@7UV_7#-4>_;GQGDDQ;-^.%T[IU6V>Y"A+-MH?=
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M*1?*,=&X^&P'INI5MJ\(FT9,'&^;?BLJ4"G"[37/.?!<V-N=M=*#S3A5=X\
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M,WG39]^=;,P1"[AY+H?F >%=AF\'Z*J3J3$^-#!CXQ)J8+O:4'B]1CUKE(B
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MX+;415^:2_R(,TQ31J^L-L(<;Y<?RT;R:_>A)-LP'#W?:P?9TFX6?P\Q>B*
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M 6O$$E;I'UV!U6?(:-&RO5M.91@IJ6/#$).>=]-Q\]\"']'>6?Q9&DVF-MK
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MD=5>W^>7$3>S'M3%J+ATN/AOJ-GN1FJD&2TDSX'9D4>8,^R5XK*XB1NC]L(
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MP\F]C,0K: O%J#VIBVI.7,GDIE:D',9_=M27BU;DB+&194>-3?2Q5:(B-T?
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M&T=45F8S-&G):KA?;QU6Y\E /=]#@=TB4*ZHN!02#4T\9&W6!@=PC'M7 ?^
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M^/%9& 9SE%">&ILJ(\.7@YCFD>FK$HQ1[PJSK[7MW#/_S%HSVO(0N?\RW9N
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MBU!7A%A\.?\&58#F\ETX9(C1V+D6K;C#76+DZ'B#F,^O?CP3SG<)A'5/MJ>
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M]=\/P9J\ Z"%>':U#Y_^<+=8BM/[Z#<"&V08,8)]<'4/+6@ 6X++FYCN^AC
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MNOSF9. )*Y).L$A?DI.M'SMVY=*W79'P^/=:WL%>:OYFK:</;G(,Y)5M+V;
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MR]!PO")]""ZVH8FHX>[\33^GRA ,MM9VA;>9C><LPT@#2T87[@"]X8MDEW>
MG#N H@GZD+[C<G<]!N>-$-E5AMDDJ &)^=_%1(W$2DV:DRN[^5.W-S#< ?AS
M"1"NSE0*@MZQ8B5GOX:X'2.H&V8#)";'L,LZ(.>7(49FKS_9FWU;0I5_+^X7
M?38^C1!O"&[%S3K"_5I?RMK/;[:2O1_'M0JZ$S:33[<YN?*^"^W(]M;G^"X:
M5?'J7WAH=9BN[#0,RY^,&.RY/[IEW*J"W;K>3Q'8F6H:3ENS67^HQ>:!VS5E
M=%KF&("9C7TVV4/PMWID:SQEF1"EV74?-%F:/WUK5!-,<LBK,NQ@H25(>/U0
M@'F7;O4:7MQ7BMT03\P<$,U/?#6L/K1.^?M#Y%"M)"8ZE:\>?35N[C*B:?@?
M*6+>_V<IXO]]P]_XKS-*SO]Q?-GJT-\ZR_D/) $J!62A3$%*%(:EQNMW (;
M_VM&Z?_TOPPP5V4T;J];VUMUP]"=%-I*?@F?_D,&TJM%NQK-]CC#>=ID;%R
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M0X3WY!0>IOZ%_$HBA-3I=/=U+T0-4V,@'>*O;/5CV^19W62!+I!A]N&OI\[
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M#$0E[5S%M=XCX] !ZZ 5_+%GRH$C[ZY\6Q8FC-_ML'8Z_>S3%B7 ?W\JV+L
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ML\,7%4"MS'X,3ITS%O^<,+\KP?\(FN[CG!87=3*P]_)(.'9[:3AY8(WV^=U
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M*0-B:Q;_*O\T*/=BA"2H]9_NNG\>XLLW&Y__DT,#:G9<\F%9LE@F!&#BNSB
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M5#2?&A%K9#6\4,?,) %;'6N2_"0K0T:?<GU4R;K3MS'S35/5ZLN'U=W8,KZ
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M_?MYOYM1Y&WY]D)=^',K=>^%K<N_WL]T,S-J@R&@?65]C4KH2/B1F NKZ'#
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M#C7=Y$W[55!C)QVMDJ1M6S?L&6TEJ8YM#3</UGN#\EJD;>C8<2PRS?^=I&9
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M-$J.!X8T//#3Z\[&5HN7R(DORU(J:'C?:P?Z@AR^:P,E[B@7 OI7WX5G\<F
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M@P;1B=#U^+<7N-_>PZ_#$ZU3EK5#[Q$T)M(M$3BZ[,ACED)#WV)G]X:>:E(
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M4$4R"S_?-J+8&&+0MGNJ8:=32E@PR_Y[Z4?8+SXIEI>WDL@T*X:1P :3\*;
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MV/4H-@J% MQG. &=@$Y )Z 3T GH!'0".@&=@$Y )Z 3T GH!'0".@&=@$Y
M)Z#_92"6_TM0C4=8 ]V0IB T@O]6&\_33M=O*;"?NI/QJW_5DO<TN$FZ@_A4
MB-EHD?0<@XB$Q3VU^LB+'5MH%P+F_0[R['+DT\QQ78>7=1_?+7JO=.2!K+:+
MO^Y>OM/!LJF/T=Y+2V2[AE+)>Q8T1EJASB[&9ED[!=AF(YW2;%&%^LRN?_-O
MBA5\!C=6S&_T8?2T+<]P&-]_^K]^+[R3^)\.89C2H2U\:M2.;40&=HDPZX0I
M0X6'/1JUO!=Y.I7YT;NFIU,QM]7ITEP#Y!VM;'XJ>W[!*O/:C90.$N%A$Y5)
M)"P,[C#<:MZ_@Y-[#_R:#R(D.B%V> 9I ((XB(AN05R$=M@10].%J;4H%][Z
M^3 IA86>3ES>3""KA&@@PA^SF6E7TKTS@GA+')A%!6%5 VB 1I ?!B_YAP;X
M*Y=# \R8(N9T*<+)P*.S/C0 Y5PLQ940]L^1<CHDZC;\!9)D144T(G?S(=M+
M1!K@#7P3T6R93@/\<30Z/E4N#= >2]:7!QTP+], 9$X@>13/^J_CHM>/%BF]
MP''7_>.<HP&LLF@ 3020S+"Q]V\P)QK@?:D6#?#]-Y(&>&M, T3#V3<]-I46
MG:9QTQZ_^H\2,4@"VPG]A'Y"/Z&?T$_H)_03^@G]A'Y"/Z&?T$_H)_03^@G]
MA'Y"/Z&?T$_H)_03^O^0SO8%ASL^KAY3A_N:>2B% ,T 5TTQ2WUSQ\TXFOY/
M-."_?]W2S/^O9O--'*[O)X-*1K>I=-1R?2J,"B*P36W^&ZJ?!F!Z$48#W$D%
MT0"G,FD 7LJU_VAS/:8!M]?_G^!KI9B*(<%M*?=KU;'9?VV4*6T6Z&8V%G*+
M'0&>SD\*0T&6N3^E%([XR?#!PSZMN6[&CG.3-FN([J4.,^CP2]I'63[-_" [
MLPOA\W^O?V&E%_AUDVDF*F54X66#3V8OMT] E<#U](CD+'/UZ/5AH'>_GK:_
M[L@_6S(R),"'(!=SR$8$F3:[:Z4(">,8W-J(Q]%XUE->I2&N/CPDBG53L+2V
MM/;BKU]>%FEZFKL'!33 F<O/,*4&?QGHRO5O(C9+7+<R&N*E(DQ3:DNWI47S
M;CS+-%A+6FR.$$/;D&?^5V^@?1+_*>C'J9SPGH/-=F1H#2X<)IHWOJ+:'J\<
MZL&R?L-GQ;-\N.M\\/D+R(V;JX8T0.@M\C -</<,#7!$?4<#1!9IS>#:/2["
MF(D_! 0)4XUZ;[8VW$2Z0C<DYSNN[NP(?O3GW'-+BLPY*MG1\X6$0B[4&1 V
MVRMNHB?*1*L_CZ4U!M<QTP#^_KM6VP6F*!WP8!+&H^K AHO[3'1V9GYNC4C]
MI@*\0;<32&A'\&+^WAX";>X *;;FY+Y#Q57@*9@$/E6WM:8\*F"ZXCP-T QB
ME_)T>>/P=8R_[F)FS/R<L@))I)ZH#F\[T%1WG>N["#,DAR/<:G#Z5=4)/N0[
M5)EO4?047<G ,^BW5%&*$9&AG>WR-#FIM3)T\U'5OAGXPTQ4T-@<!&],%=IR
M[L^S*BM:[]D_FI_[.2;)K\0X-1S$9[>)JMF_DL5A;/=V^^V#POZ2&CG!/.;"
MG#/W_][YD?$&Y(AQ0(<_IEB2+^&-V*?U%E>DW-W00AI63E_:UX*Z;*CRX&\T
M0).*1>7:J L3WM>Z$;3YW0D=B>;D+=&O/H2?^I&/OV%H78817#DGEO%3K>\+
M:"83LN4&1I(X2H_+6R_<%+R"H7"X4@WRMZG-B8@#'G1WQ,'+2C)(;FM:F 8(
M@N AN<;:G"M(D7_?'?J_<"@!DL6^LU4U\%";<2SJS@0:H*5F(YTHL&V$&2K,
MJ$X>=I>Z'3Y^1YR>F1#D7S1" U"94@E[^A76D3C@JN+KM;OA[KSC[/%_GF?+
M05(K,,1=!M!6/^(+>N"X((N%49)QQ]5X3<J>!L@01O.6H Q_/,L'^2-=WR:>
MOQ!:8&[A&^#L&Y"F6P1O$:"O(!?,&)USUE094M#W8)?^/OJX1;@NSOHHC?.3
MXKH-2]L'%?XJ-!+DW/=>U:\1&>G7<''0]WSJ@]_3(].>GE".^P\CJ]Z5T;VU
MQ5 N;5(-XULPNTN!QUS>AN]'&51Q&"]9CCAMO<D)583P0#--RRJ5Y RN/-;*
ML<X52S<Q/,_.$\NSW LN*] IR9Y(1.8EMSSU_"+ZP=BT_A "=G#(Z44F![[]
MZZWCV34#GD)4[C5BSOS%L)6QA0NP#:S[>/IZ<W SV5^.X/N0?9?8T-3X-*8E
MG91#D2#+$>9(7D=(E*84[%'_8&MRPX]/^H[9DU=]8WMY(CAT]O43]K]^4P;,
MY6A(<#,8&$C9)6ZKCS_?S?R0P*0GS.DGG:C);L[RY]U.%KH?Q.B$8,"X8TZ1
M0T>U" GHM^I/?^1_F2^-D'?:HU_ ;#1>U'GPL3$JMG.4Y? TA8Z C%DD)^20
MMUNX GZGIT]/8*]/A6IJ48^>&P>KEK!U)XW,77Y@8J"\4?_ 4D-O..?<8T.Y
M^BQ4V?214;@?W1M#EO_8SS>HB>C1BCQ.@";0:7(//O%=>K1KNXGEI%472B'.
M8'[JIQJXU_OSV'W@U7W/U>12UUGT^ 3)@VR<;;L<\#J,:-1>ZN_L5:K:V:[S
ML)9_I5EY* K D:9;G;.;.#PD4(NP9:3V1#V?4^VW*9C>VMJ&AS5W-]6PPS^7
M'T!F0&=A"D<E#4RKJD-(%C=UMOR)NI&?-F.MQ9\3'MWJXLNXZKO_YBKZF<9J
M\%$(%4!1)Z,(2G9#%%M\CX;NHUCSJG+;NV[-]Y^QW]5A5.;3E[WBJP"TB;(7
M%2L;+%6P%-8;>G^C5T$>&X"*?:>4JRPIMYQL=41'AA!K2=!1=6=70G,?/CI%
M57@(,SZ2O'!4=JO\UU<LSUCTRI48/C_/QEYHSKKQH>1Q):PD+Z=#O9N-E4C@
M2*$[V5J"7(?JJ*NZ']*R3#\VIKU&N@Q<_KS4I5Q5OZNRZN#.$53.&^&LI@;1
M@?WY9YO45?WCPGW /]<)/T=MX>5ZF[$BP%))Q$66,ZHO+]7'B+Z^_;HL[!?S
M!?WGXKEK7M!>;PA0DXFB2>X_U(B-!C++5^V<C[2P6MPS?'O:6<AIXH6Y]K[Y
M?8(A.)BA*B]&2O%;I'& B-MCD11!H7Q1Y8*J7?W1%S I[:!^(F+&[TT9VQA$
MBYB=B@_D,^(PREZ6T\O7X>MU3,BXJ#3=;NWM&+-8?9S(HK%-N#,PJV.A1H!B
M6A(#:( Q@Z3QZ#\>4Q[;>W.G?;&8C_D'0T$I^1/WUAR.XL&K\H2Z[FVP478O
M-:P7Q #GF8+9DS]ED%6[2?RJJX^=.:7=.4I$.M.T/JK,7P-&NU+_0.AWV<:W
M._3PT;J/*X>+>+O5^C7R;XGPI][%5_=U(E0/9$@JH^IT>"16#DPH'WUO-=>Z
M!0U[%'MO.%.P9W F6N2LIK4RME!5H'P0T70/YD;8ZC$?@FD@9L:EJ5=MG,VW
M+*$?.2<\@"FMHM-]VA^#<'.%:=<1%H_T]1$/5V.LM0Y5?1<4?F>YUZL&8(:(
M,E@Y4@#9GX#$;T2CR$8=<VU6J(7YU]MCD;7.L%RLJ-?AL_U0'E/OCEZ(BB,_
M%'U\C]P]WL(!9'N"47--7TB=Q-/T%;^ %/8^7Y?+<ND5"1$I\4T.# 1.5U(0
MF8&PAP<V<I$[B*"'!EZSKI[^;D]?-3Q_U=[[P=@>)'%_Z4K%;9:)TP,YX<89
MV1L3K[<%1"43'C[/NR,FUJ94'[=9E-.4WSW%"-+2AZ13&8BZ:S3 H<W?FNE/
M^5"EA^3  LM[O'RH/U95YD*2GSJ_:;$'9-*/5J'?4B#X;;P,YZJJH*T6S&>U
MV@T^[-Z4^460G?_^3/!9Z&Y1OEE]IJ=GJ6Y"9%.0E6P!4UZSM<)!YO7X7W;?
M0N'E.YMK?OC8=RRLJ%E(Q,'(-U*D)0P%TAX2OG;Y#//@K5A,%_8[<2M-%5Q.
MX23O$S!S2ZV=ZF<Q]&6!&B*[#NPN%R:T!*]G<)U]5,SR)J1=*^T^9^I#K7>O
MWSF[^SS=&AN)NK(J5OTW$459K_Q%(7__::?7B*Z4!KW G88ZDDC]ZFQ'\?Q[
M[W8-5&WU#T66OPY<?Y*RQJ""%9!J$8TY$^#7BF.E_H:4)$7%Y*'(+_B.P&;1
M+(EA9[Y7QPP(\5G=CGD=W9M2ZN7Y1EF!C8<OMUVJHLB#.3%'<LGDQ[-,:3#B
M%V6X#S[T-J&&'<%[F#DCTX@+\TOC(U9V( 7&"AO8#WW7%^,S>[@Z,RLN*8XX
MM=,]NZ]M5".[(3L,DR*B&]$3%[=-"1(PE7)"6G8%6B.DK>Q1F]SU&6[=#\RJ
M\_PY5Z-VFS(LRKG6N0:F2.?\U;,SLHQO&.$-#] #1VR_5XQD=<WIB>AT&!-!
MJ8G*?O1C%\T ,R>>:4C"X]A*.[=ZK[UW ?HT?X\QO57E'=,8-5J^BBL7;8H]
M1Z:"&*!&,XMALTBV'_T3_"8CC+:+4V\>BCU[ 7.\\E/HG54/^Z:3=H]^RI#7
MSNR"77Y(*JH6D[&\"+MV_U^%!_*2BJ,!2M'OX0*]>/[ Y@"8%?TJN,.PIOS=
MPCM/VQXQ"%[C3@=#Q"XNW(Z!8+062&BY5]O?P&X-TZKZU,H;<C2D+W?M?+QD
M3']7F>P, '"YS6&WLZJMS;8G?? HTEQ!O+EP(%K-=F4/V^4"=SC%II4LL0K"
MFJS.@%L]0A0%9 CZSE1.(G;?R!<_X2!;6L!?HO.7^\7\85/H+;K=R_NW:O),
M29_J"_V5"T'#^5XW\J0V@B/$4#$W_PL(^?^AP,>!GJ/'O39)$<2'6],]PF'O
M?2H@E5,=U!)']0^"&E]B]!&,>]<;&LA9,Y#H )%8&H#1J$F&81G.0 BI[#K*
M9,T\-3UU4"6T('<TEZ29F>7/T.S&W3JM?O1N0]XHU$,-FCW1*ES.%WC^[9E?
M'VR4<)-5W9\U_,]I^R=1Y'#K*C3 [3XNQ,P:@GA 7%$RS_2*T]- +E63JJ"%
MT@(7LAYX>8.]8I'ZX]BIET'.A&W\4AM2P(F^D080J./.(A>T#-RP\/V[RPB?
M<!K#QPPF@M:+^$9]8;J'CZB]!TEK2W,^Q?Z01X2-[[RV<H\<FGP9%J.)[;N=
M?;E7]QI70/@T&L"Y[^ L]%@K,!PKOMC1#/B E7OU#&X,@\>%-5RMBYWS+M23
MO#GU4*0J@EUXDF?+.\2'WVC:&!L!SC+VZE*0CMR>3#$UEV !.3_P_,PYE+62
M)+6&GH=9:W. ?\*>&&MST/UC@D\?6_=XUPH:X"=JB?J^S/@_O0-NGT5$@QZ3
M"M%'[;%DXUT6#F.;CEQ8T[%_YCW^H$O=\0>SD-308_N,,:,!_I/*'W3 -.TC
M$XDRARLTP+FCN\=^VG3_O_*P^^_CE#6$?/".6B.SS7GP]/BJV8^OVOI8VQ^%
M%")V[I7O?XFR_V3C:W(9SKF&Y,*X&@G 7 AFZ!"8CGQZEK6-MA?2OLSI!XZW
MI$C/N_TRJ4AUR,$D2P7U:7W&\_-/\DOM&YOR<11#))5ICP80U</C#K;K:8!^
M%A-$DS9H?M$7<WC6D@;XFVFG1LB93:PDN+:/I(D3]L81Y6[V<6+4\0MQ&D59
MUN*,2PPC2;-+;0;><^"H(IC1+*B$!G"QT;K"1E*.\ER_$](<Y]]1+] -L2#5
M2SV5M%5(/ *O>^,6[#>!$YY^\%8X*WU>D!!BOA3\ W:;G.Z90^UNX";FA*I?
MRR%O#$N]7(@WJ/W0_4E[@<//[)SAO,=G8N/4,B0-=Q'D@KP",R5[YI %;:@]
MU-;BF_(@AW+9GL//8E^?S0NPJ9OUO:$!RD=CJ(#QAF\_]-WR_\I<^[QL%5>J
M$Q7P98R]*VTN?:?WU9$AO-?/D*2QN9X,M(@WR.V^88?-KIG(U\PA P]U82;D
M>)$LSQF/8#C/X&RE-C<W2M"B?9+PK9NE(Z_#Y=A)!</(P0A.:,L<O-B7I;Y\
M>*/83?XG5F_Q;A&\OTH0<7%)66-U228"1'@D\P%R05W6^[LSR<KC_4OI3%D;
MS:3Z;!^0OU;Q/MV5*\R'HRD4MJ.L.OM#S3N%6GC9[+5A*]&JPZ#BSXLWFU[C
MDX"P0:AE=\I A,$$>N6>MXM\L7Q*ODJ[4FV)=8$39B8E)U(29T,N1EG)3PC5
MC>:\Z155TY\LV0 ]I";L;78PUIT_9*.H$/"$I98@F5:KU)WHE]CL/,9XY@BF
M.,MS\=7A^Z9/7GE&@9>X\O+Z"EQ&DS_/2PT/MR;=NMS^AW^LN.-[UVQ#)N'8
M.5MW6(%"I,IL/5H.@!'8*2[YNB'.X4FQYB3CK=+ F1<UGASY1O%)II7@XL6%
ML3H-&;=UH&06H7NTLN?7(3?)B%PPBXZ",/JBV<E)]TO[4=.+%CX]@>=?APJZ
M%\O\HA-"IF TE-&WCN_LZ^625<CQ:(KR(5L_'PTH7V.<NMGG>N[=?O+^;Q!9
MS*\M5QIM)?JG+;6=2XUKL)2EA"ZZ^$WCS-ZD$7Z@X>/Q"?PGNX!KO7/ZN8C^
M!=ZVG0_/+C/B'-Y'-WS1D/B-TO')ZRU+P!;O5*G[2MI=C[HF*GJY>[W CJ1Y
M@ZQ%"&P;Q?%35/#V&3BKE0K5.I$U==:,J6<?Y6JO/)'F2-GK; MJ.K2&'NH0
M-M=5"!?5QJ_K#&YF5==\BCVH6GP>?CX T&V$AX#('M1S9L1+>H0A<[\ D; "
MEX)S'4=HU<ZXAK/TJC=:@-T-KL3-6 5<^+0XA@@,E\$9#Z.!/G&5=+?QQJ:O
M\AD K FX-1?SW"QC2Z'1:>AYGM!&?*JZ?$K6#='\\L)-C\<[I:0.<G\AC&=4
M7BVW@<>)>FM 1BJ"__&CREMEEQA -4(W&IN8Y882T>HCFBH4\ C($7+!%4'(
M5U?">YR>LIC4%HI]/5+RTO-GYT=.OG"I#J LFI/L>%QLSI+#9X"L=])7S ,\
M(M=0<Q?NB.3R.YKQTZLBD5?L!=5]BR3F1M>=YV*QYZ;Y01:!;C)W0XT4?%#*
M-Z,G?9POQ]G$C,\$O*A>QHORW6ES'MG<4B/RU//D#8=8VNG?'W>BX.S70!&\
M4GM1H)D459:&2#>1+'55@00Y;?<LY$L106G ?,*Y*0T)/BK3VYEU>^T_ZKZ%
M*_^LOV?UGO336J'5@.=S:TG2U9L\]+^,D38'X-^84\?R'7@%QD(HA/-6E@Q2
M[F0T6F!;<KG!E9->9K9&4UVBISWCK2HA!&.C2!-HW+9I19# ]+33B%C92)GS
MU<I'>MV4F425A? E^FRQ1 &,T-\?A5,;JOZ)#!/&[89&R;(++M-&UI1.S L2
M/8E4WM5!,=KU[#M,4AA!-.G5G9]50T;VS#KYJ"W7:7"%>W#4_'@E6QG=6A)<
M./<&[KMZA(=(6I-7K8J)/="&]K7E@[T)I+'^MZ>5/5]3JL59H5WJ5XAM :.M
MD GK64B;$0!'UH)\T_NFWW!//_Q:\=;BDZ(BUIDQ!G'5<RL)O!%E+CI8";G.
MG*B6'@8PB_ERM8H$G GY^-C<Z]%YC(\VW?8;7J<!=N)<RHD>#ZO(7<=3Z^$?
M84*A5)!P=$A("Q8;O-$\=OKKW1B]T[(=Y3 WXCM2/K&C@XW)>?H*46S@6$T6
M2E]< ?[$7OXQ75S"'+<4I3(G\'GSGW(*C@$Y#J<-WDV;I@&TJ^)[D_2&.,K4
MR#W73G.(TBO/')A?:!Z*%LLB:D_NB";C\Y_EJT#&AV*EUO.WY4&.P'&95DB9
M]DBA?94'ZW)R@,Q!T$)FB?X-T,K0\^=OF#13 D;CR'UW*@GHR'(4U^BQ^:\<
MW!0NT__[,<.H.&+3>.P*N!]Q 3.3CKN@[HGOVG&3[GA(B*YOEO<VRM[T[ZY\
M5(CS5M\ZZ[\BL8 9J<T+?#&9[U0CV-0>9,@>HJXP/[(5 .D'0N&M"'KU2TI-
MMGZSL>'J(&"D@MJ+&D72Q7;A"UDU[MA/:<PQ=YJN[E[>M :5@M8=9CTB<;QE
M:):_FJ?_P.3P\4OZN17?7!X6WRTNOCW DE\=_^2PCH1.H@$<<=B6=E!IG5]B
MP"TKEQJIR32?&@>R6_!#^X!;*7E7F7<9Z",V%?[U1*U5K:#6'P;*)".:BW]D
M6&:6EMWB2W%<^/3E767:F.9NRV,V$^_4X<W2!IP@KN6%LI6\TU9O4\?L ]6>
MQ2#..9E]O:2WF#6;>!K@WC3X-Y!@W,6#<=9+^%*2'>O$:>3^7!U\(8\Z,JTZ
MW""S#+RX%*L+N;3\.M:!7O=%,U=TPM"FP;X0$Y#A>A4Z$L-]W*#HZ5L>E\CQ
M:TBLFP=_\2&'B!A)Y#5!;VE18_6!LO]@'H^^ ]^5JK7N4$$V\\\R_D9?G0<Z
MCSB.TM2?2HVNR=A[XZ=8!]NLBB(=%&K_)@D&V.A?R?K*\\KK06JC?9RV/_)8
ML&$C9]E:9;CY04W(4Q0EM_PFOK)*:X'^)X]N:G4_<A/-EHN'B%'8CS+J' ]!
M*TE*FI?KH@LWNK^A%(G,B=N?^C^<YGRB/,D(LB+%<AUG&_7::K)46^*G#*<&
MGNJJTQI'N?X./)<ETV/H S^Z,CU]GB6AK;;;T.$KB8U:?NR=.S-3.* W/?5M
M; <20@.PK&.<C; 3'59)K4?<!C';+8F)_9-.KY5T IVE97]R><R=XU@(<+\J
M\*40QP<?L<IYUR #@6F2'0F5M_LW)7=EUFJ=?_R<\I5@&%\4OVIS8SY8;R;8
M=0'R'G-%W9+@V,$VBSI[^&O(G5YXUHY>R"^BM_I]RGS<Y)(*0_(>B /1I*ON
MC;)^@(6$PC3P1^;WQGR=GCHOV<DFX!J5=WN=)=7W28O1A>4ENAI7NM]E'.TQ
M;2M.Q7L9]>G#&:J/T]M 4FA8G9NPT284P^/N.W>J2\Y-^T7(&\E YK3R7E<(
M?X,:O*.&]:T#D<&H7]TQPS![&DOBF=^V9V3H$IH B)ZV]XI[Y8].:K@%'YI6
M(F_B>]6TB18#"Y4_4VQ:%%#I$6[X!W'6GBM,OP'HVP0&"@=;1\,%0GW%.Y2S
ME6[4VKJQ?:B!Y>6'G-!'OY1A 9^0 5_P^3J?GXKE61T@XA73G,,*(O.L.(7/
M#I3N3*_F[8BN"\_0 /24ET?QBV0T,/12"^^*I72ZF^"]8AL$BO'9QUR!)^ZO
M[F_\>(91DI@X;OMHFC)Y-[LE<P5AWU\'NE2(' ]XQJGK<)@U%F?!VO)VW4[0
M]HN5=];9'-R&^L,)3EUN2\.(<:$IE-]TT[&W>#K[7WE=1(&<0W7JGX"]M>TY
MH_5HL:!*@^KS7)E9G1,FBS>A5VF \T6&(WM7":YK,NS:*/@@KVU?)/PTQ6JD
M;,K,5#\7JDH#&$/K0D&3JPOS2_R/2()9L,S#F]1>U<IUGME]J6<).SC6Y4.(
MR5#S_'<-P5AU'CZ&,;KXO_!%8E*+3#CP?)VF^C7"^:8 4%C9^AL;:!QIBZN^
MZJ77[9?;U,&E<6TH.>^Q&;>$#3401@,4()T_#[;V,!]EN"?I0Y)I@*G*N2!6
MB0<C,J#G1XIL%V".Y#P4M* M[M[SGP2WZ$,]'M$W$!#,,;HWA+^2EYPY%]:.
M8X<%$%NIUT=3[0'^YJ]E+RU8::6\ASR>K#1!T$'2#QB:@7S';J66;#VW]$Z^
MH/K9AZ/8MF2#R;L;(O31W77O-C W-NI79V2P$B3$",81R<_/;1R_7N/6_;5L
MR@#L,MG*RBA8BJ8+J])@S'F?H*2$B"54)NUZ>0= O_R)O>X2F[J)V(00*L(2
MC;4Y5Y&\_WQ) L\_3B!E&F >NXY9D_"G =*ECO/QW]_@)%8AYXR&C@HD: #/
M3"I'D-;QN))= =Y$-.E@YK%HT-J-8VV4GDS)10\CR&*CE&]F2T<ADL=SK1PD
M@7-GW(, =URHTZ<>8)HQCS(B)(8U'_[WBX;^?RTDOO]IN 8M:#YXB85'S]K:
MWQ]<?.$O]=(C*U3T&4 XP>+4?8#WV+FEOS\& A-X'D@37[.FL!X?]_R_<B[^
M3^=N&)X&B(7+$7):^#;IG+#O ^Q" E^YNPN51?;4?.IZ_*MQHZ,[4^ =9R\-
MT-Q$!!\Q8_NHS,(TP&S!J8@0QH)Q=P_QW>=Q7@%.T<?3OX6 ^/$8^G9LKIO>
M8RAF/G;RY,TYM@]P^C\PP5F^,5\-N7M!)+]+=UFP!!W>9WXWF]K9]L #=0<1
M*H(^ZS_%=Y^EF*:FX;4YS+[\:ZW.? S!$+2O6.MQ>&X:\5=?&_CO+V'NHN3!
M79!+-PTPZ40#A  ?]6MS_@H(^W4L&]#[B@5]A^?^L?DO,.(2NQ#JN6,Y(#)\
MG M/]4%'S*,+VD&*UA3@UWV/BS1  YJ 'CKNVEVC^'-BOU74SQG)(NI J@ K
M,6:^]-X Y%K;3)#2+'=[']MRS2_XZUB&U-SI9L1"H3FQK!"I@V7X,_3@P06O
M(!:GP0273UG\$\76S:#2V%8(G]//E0._,"L6\;DO,@IJN2^?(:<5OXY"#\ *
M<^C0!C&R0Y[NT]GHBZNZ50E^S8Z0J5^8Z>AVLXXJD1QR.E'"DEP\QZ)E.U)D
M9YZL<ZA1-#>/;68:YW#M-],!G"J7@M^TJVSF?]S(6X\F]49.:0=FV=K\>IAL
MFH_P7W $213=L7F;YJJP[N,^'6::R#DM6^/Z@H20<$:8^Q]QKO6F4VZ0/8X[
MGPUXJ26?/->:7![AHJ18(U+ F564'.?X_"'^2MT8CX/R^8_BB LP?L(4NE4F
MQ."'09[>#(Y?H[!X N=FW?,\,/UT/Y=QL*Z:#>L=!HY LZ!W*][E@P;+OMA#
M")5NUA1<#[,CNQ(V&S6%1B@,Z=&NK7#U(/VUBK@.U:SHF.4W,9/S[FD&(5I*
MW?0"JKRQ;=-\9#4"T@K9S#N%#(?9HBUF6< 6 YNS994551V_/][KG';2:K=-
M$A(82G 0*DS+TC^CK)@CA,H<17M >O(6+\(4B!SFU(NIA0Q)LR5@W>O/1>;#
MZ]*^[H/\.WIC[1*29CU85P38B%Q9Z2M_@KZ9#KH+C*RPXTGWWQ=(S]Q7%LQ5
MV$&WX1B7S4F(4L-W.:Z77)*E!F[=R;O-?$E>SH7N+0WP3!O<U*'S.":A8PK&
M.:@0&PWA>#;L&[FNU*3)6E.#-!D6 CG704?LKQC?\,#(1[\Y[SF4_&'$P,X.
MD1J]^L0&(J6QLU+3OKFP%!3+D%$_U]S 1GY,S'RLR45(3?J@#IS-ZZ<!2AR'
M=QDWI7R9S/09'>@XFG_3 ?*>IK"A0VR:2>"+$Y,W0J&IF7&**X6LC*"[+!X\
M>6I6OV8*[IH.Q#GG#/,#6]!AFE?)Q;,%"!:R7:N+:BNQKKAQ4.AVOO2B6LJ;
MFQJKW!8#'NJ@@NGE@)!:*]SX0](>.\AB7D>\&_Z>EX0;2]YP!<6<71S1XF]5
M9<T3,KFQ8&$M>SJ(Q>PH!_6,:(8+@=^P:"UPG+-5-X *7K;8%?/D' B\>+>2
M<JZ$%#OAI8$BIT+,(IOREP]'_78&=Q'AC3 %LMXL)O(@83?L_4YFOLW8!%_M
MFQ?W$Y7?T@NGO$U)8WC<ZR69K>3P--3DCL!LP\)1K#WP_ Z.WCGKKBOR L1X
MJ$AN+_YA>6G*[1^OV:0ADV+HKU1NBE(_1<]M%L,%K3E8-2 XAIW[5E%LIJ04
MW[WPM"+,C^Y+L#ZPYJR+O?5T LF\<F$_>:@1FR#*L/E@;ZTPGI(ZOLB9/<TS
MG-3B/'LIY[>\4HVB1.[+H_X4,6^!S<TS5^?^C!8@FKD)A[,=H>K:WH2#00L"
M+MR'3W0(ISN,CB.I'=X3[(7.,X8\O^W'>368K@E]QX,=I@(9&S6(@YQ=O64%
MY.AEB*N982%M_FRK6?)+H!82#PL]8^O-Q$?*DTQNS,0O>B67%Z754!FZRV2Q
M3!IG I*"84HS+&SX%3*F@UNIIK=W>'O< NJH4Q<S_<+TD9W__+4HYT2ZVS9Q
M+#;D=S-LC"LXQFODV)G (&O=G['FU+8A^2 [O/M#KS(=T[@;P46[5]GO\#!P
MPOOM1E1&N-RO=!5@2:ON-,!(#A):VZ3:]U:F<&VWUMC9T\_A;/HY)LZ].[<V
MHTM^S(D'".@&-*-1&"=7MC X_Y#ZA4)R-[]U:W)B.EY#S-HI0!L[7LB>59.7
MZ!Q1/-G[,;>@7T_TDYT&409?]*;A?+^Z_\R-<B:*7)YMPU?/[!5KNTW#AD>7
M[_W^SL0Y%(QZ8W1UZ#'J5\+(L0QI$#R]_-N%1<UGU7TIP>R(X5X]4;$ZQ^G
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MQ;Q;=4),9__X22NQ?G<L-R.@0W9E^*#Q!G_D73U]\U?D4.5E9X;I.SL [L\
M!_$0W4F8U A<%-Y% YP3')#V"7Q1.E3^(O[0VC2TE;_O,A]SH9*/2H>AAM,1
M$O2"!N D.\Z%O2UWK==M+K$:7_G9>]V*'#/@_.!=Y_WA'ED2O4+'[OM,$6P-
M9B907SHE?] XTC,N&I</UG08EI](Y3:M&T0+;GE(+L5AH5NLXQ<B?G;.S+P;
MR!^M6#XNG#X87I@A.1,-19H@[Q,<0W?/]]0;+@[3VSSH\UEFJ;M*7+P_^9P
M$$DR(CBVQ$99F5>[S?!)>;1H2@P49@VY[4Q94=7&?.]?Y\LR>_7!_K.8)/=I
M=C:%G I;.%Q7:6AQ8L$5E03V6%WZ0^25F-2\3!$G&%83N&V)>Q'H73Z9M>@
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MY-MR%+!9529\8_VTE4BI)&%LTC__(9KIU)TR_I[HEER>=;OHV< ^($6"#"Z
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ML!Y/HRM8!ENQH@*SISOFI\=_D;;;+RO^'S8(7'V'T&% 3&I%1#0($C4S/7]
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M83-Z!83TQR^"98D+)R0SU"UKJ;?]0A?R9>@?+>@>R;#^>*\C7+IS#2#2OP:
MK&DK=0?-Y86/QJ8,M^(H?/QM,&<M-]=VE.\KT-BCRPR-S*\!-2=?1A.-&ZOJ
MS4DU%*I-#HV>D4)0&V4@O.TH'E1"Z/=[CDT>AV=6%/CD%T[D(F-8JH @=N-8
MV01V6O&)ZHN>6^M-IJ/(*\,7((H?Q0M;!?H1Y!G][2@_ECQ';-'*!"*GIOZS
M<+G!@S^,ZUP_@G5?] B)AVUDNJM7!$PU \_#IY9WYV2M2R:;,B21]4C$P$7]
M8?<*-'A_5T%Y^4J90,?6/A4K*^$_J*(6I_\'/IWT4*&]MD5-ZYLEI)O9>/'^
MHH_A<N&>\ J4#/?N&,+C$](.FY[$6HM9;57[5>:Y(2N$DYWPXZ)'WQ[8(@.2
M[=$ZMCI_$H:&3<<%!5:'+OW]BSEB*J?X2$D.?^U2?$?'E2YL->\TL)U&1D5]
ML8Z]:)CVTO.'M2CU8A07NWH"[.]-X=F6L\)G=+^OKU]VTBU05(4QT:^L]C].
M,]*89N-1Z^5\>X90P %)8D\$Q3L)TKAW:/_^19IK@'./I V%A47!93_O/?NZ
MPWM/GUM^L[WOM1%B31.(UK$Q_!,Y=&32C*J,8K5J[!Q/4/N^A=1D#Z(QZ2+L
M:-=KI_$7_]HWW!^$<JCM'-NS1SI'5<[N__UABUYCB\@/]$5.(:O&Q@RWV"(O
M%!?*,'QG'3"J (8"''>WJ_,WX.:AQ;_R-/?BMI8?^%GC[KZ0.YI5=NFF R=@
M_0EASZA<]R+K.9NY^!#)\4'^E3'W1\YE$%V*^P/+'5/&ZWDI?0O0P=#'^A;I
MG__[^E76:<MZ,]0=F128J\P8^SR<R?KDB):Z4/;R#O!'CX#>($>Q@ZSBSD!1
M49*M)(C#PK-0=2&M4M'4^BH/I8\6I#U[73>"YR!O7!6\DV#AXSS*8&SV-LGS
M=:D?50^"+R>2@[1=(WN\S*"R4=/RS"8B/NPJ(8ALW_(:T#%FWJ5^J6\J>2GX
MGPZ$9@J17.59DZOF&81TXIMZ^- #3:&"A-';@S0-/5TR_8'HTO3;'\5C:PMF
MYH??N=,,_CJ<M7S5N@*GX]ELSR:3)9DS"1J>2X(V7@.H\]&&B/O5.%_8H5'J
M9N [3%:G:6E9@ _&*Y0U7CD*J6A_0OYL&(@,0S.M!V^_X[R?@"]X&6ON/N]3
M&D2/I>QL?-;=P7@0><Q&B1<>\9A76@DJ<UW: 0)_K/GT<2%K^:+WGNW560,X
MLU0.J2VUSHB]DF?<".^2*H2 LO.9=<.RI7Z%7R6MO/L(8Q/"2&&>]\K5EJA9
MI;2([F4SE%*CY*$\QP_)Q\C1T\H_$S4(*^&1G=5 :DQJ2VH65;-M,QV(T2Z>
MW);PZ-(_BDF6BRJME_:O2^@]=CH>JT_[ID3PD"7A]FL 50#5)!(:H20S@E 0
MSMV$VX][C6S_3?.5?-#[WBDGF&>1[%Q D_WM+?C2\2*STVES)05B6<7/%LN\
M(%@S\01)>BZUX_RFAYG\9UA+E[NU:PEX)K/65BZET+?H>Q>'="JE5.NF-'5<
M&[Q0UEWM0DKV/<_8J:'68;2IE;!W<_;Q0MKR(A7.9FFC_4I[F2[X TI;J=3N
M$ S?E7OIG/K;YAZIR,.^A9<Y*R1.0^[PQ-//HW@P[%($9V+SV$H*6;9E<3(]
M$?HG-X93\_%[GF>'73VSA2Q1MF4![?FX$.._D_H%VZDS'Y/>OW!TPX3?H":(
M >_,<Z*]N2<D:'"Z)NABIH 1&.!(_MPC5-=.M>UDQ":6?.I]],P,)^="Z[P]
MV10Y.<'O"3Y22L0MW[0ZBRZ #1=/&^,9N!PH_1R#SYK1;[.>R \UJGKV&D*9
MQ &2_24<PW8+98,^B)AI_HJGSK'QZ6]GY:P/U-.=D/@>TV'_3+Y/JY]0/!)A
MP$;?Z6,+AB?!#;9BBA:DOI<U?M!I_TX$\U'/J#OK5-;#4I3ES@X29Y4LFKV0
MOOA7YF+-F7BUE$>$FU!+R@4KZB>_-N8KUW+U\O+?)>S]. F*4JP)5Y(*&ERD
M,#A<?#.AP*$T;P(VOQ/?Z>WZ<4SA5C>9[1U>CN@K_F^8LAJ\0-PMO G.\1TG
M"%V I<<2)X,XHQC&%2HY#9]_6:*[K\*WD0G>T 86[PKEU"$S@>#O:0'N+]=8
MF,9%5ME<=<0UQGR[U,5=%M==Y&L<98<M-QJ%WVU< RC]4Z]^9L;*.9<%I9=(
MG6BZ!+)=*N$EL6RM,(::CF:6S;/,QYAK0!BDW,%FSRD&57,F_*"3!L6#<W00
M3O_\Z9;L+T3XA<Y4%^5TOP7&)*S4'7W%UL&&^::2EWLWY6)&XY7;N5;0Y1-C
M>749!=.OV_#3XO(J2/&V=WU\]'MQ7[>C#ZPAKC)X_EJ<J>>2=HRPR2C*U-U_
MN?&]^=/:407S]W&B?SQ[G-8BS![%Q1\)#Y#FO$GM.AN#"N,^YGXMF,F]ZP1N
M6#C= 0LFUWLKABPIM[%1X>A:8/226=1;1S@_]$KK5$HUW#HGC*EX:B B+[4/
M^OWIPZC:3_>"Y!A788Z0I]!HUGM86-OC!-&B;6(6=Q50FG/9W!W./DH(1ARV
M2*-X%J/ B^EN;1(+T<(.+G8@&' %+4Z#Q8%P'\CNAZC2WB.]RVZOF9\ $;G)
MFR_V\ :^=-.\5WH#U$\1C"J.[N \'Z^%H3>G9X]X8USLOL>DT9A_YY$=NFL/
MTA)+-9FHDALO?IG/!RHWRI(JWERHWYVOUKJ2^V%3%1XI@-?$ M\@1X%RQ)\?
M6U!\)]%[.AW0V'ZU0;&(X;.9]C8,4;_*"6*=M_S3#9A\$O,C%C"G%7(>;VV3
M,"W@+;J:.#=>76-H9O7"$\*AXGXG2L! V,A3UD#IR_V=4UC#JM4OGVN &<S,
M>-&?P-U,&)+S[$J\5/?):=MBE"\-E+:)?/6NY]V=EKBA/P1V6&]N /-*W![$
M_1J@UFW9W:7'9(:K[+ZWHGB; %14L:S4CC&9F4/I@?U,[=OVZ><2'EJ^38\@
M54K>^&-CI>-(GCLW</JM4L)DCX-^Q>&RTU3FSI(C"YA+IT\+VG\(6_?2H[[O
ML?%2KM!?V92VF>/?L>3\)2.NQV,XZAB;=>D-KX?%LI),-2E8^L#0TI^KTA#4
M_[;E=/*3KS*3&3)7=%'!3Z@[.;53C)^H\-O>83R?@):;=.YV#K0-SFF=HM6H
M*C]_ZG0/?LZ=[@A/TYX\$;SOF/9Z'"HQ;0D!">RSTK[;U(J/UYM&"ODTPA"'
MXF:U6O!\ Z6]5"N7M"FL8OMSG#Y)6U9$,[$@4KO&AGF;\2ICJ# G3(W1X]GV
MD]MUUJ]^28L:^-"?E+>W>T'0>E$V55DA>]:B")_@!YL>_2#Z)W5P_D6)MKH5
M7V,9UHG#%E0ML-6+.\DJ_$BUZV@=.N3M,N2>Z3X9(2S$A9*&NO+/5YX7+.<]
M>WD^A)X><E\LXU8SF&B$+<T5V3[1TVC7/ML"*V?9_+W(.M7'":*S2'V.S"<#
MC/.L<%;L?Y$\@H(G3O %<"]\^K"" S! (UWQ5D1$=M649JF,=F.%;G>8\HN"
M7!8$"PT]*?;4S^UJT?%W5- JQ_(JRW.P]\5^!'>5*^B765D+SET,Y4K.=+T'
M1@BM@FY3!6='.8*8J=*IC" N#A6UL?Z@O.I,\:24&^ -?,$<UQ9G_VPN;4JO
M!<R@)6*42]=?=C*QL& E$*AS*8)GQ+*%> K3@YOX?F>U<Z$$2V;-S)R=WM4W
M?IM-6'OZ0:I#/Z'#]AO_,)(=MORU*G&60)W6?/4D$@6'/0+3F0[Z2R%@DCMJ
M(Y(#J082^:2M!AT;H#NKCB22IGM3SSK,F7[$?/O6)Q@=WD>A]N##D+1M](J$
M/Z^LN^8IW>165]:?+U:_)J_V".K503.6 3Z-PU>W)9JOGD8VJK_ JJ4NV] $
M#9>5S0MEY6];$]>//FL,NML\8U<;8<?]FZP_\1_C^?U3PHY!UC"J'GX(R0[H
MCV!4FR$&]'(N 0#'G5 ?Z0X+S[@H"7D$S;]AM VEN4QLH)AV^)W9]#4.V7,1
MS;?$Q.J-O/I7<[;30:%CW5Q?,XS*!L:F"E&9A;D^_J=66$(R]E%?O^6(BP3D
M4=^IK!!*_:/45N_MGGO)W)>QI%U_\Q(TZ$O8D#7X],(.Y<O[RH1@Y#CH5/E^
M5896OT$#KN$7V)KJ=QVP'T;*(K7F,FM+K&%6<4CW[7&MTI)I'%X#B^SNB&/#
MA7=*NPJB+AIW4QUH9*G"%-@5,2+*]XW.\Y4<9Y'-HFAC/C.8(_E<(BZI6J\&
M4;S#]B=(!]'UG%@/SVZZ>"'%N-)T"V]4C8.B^=,$_8C' RC1I,J5R"MYQ \B
MCV1U_'%T1I\?1MWOJ-_JY7;[$&V-X<SYR/?\0SN[HX<G:JUKNB0DD0B+>F==
MTVTW <,OH$/H _Q^8#&V=$G%>0I66=AN)?Q&Q[K+"0F 9S3SG0I^3&2(V/NJ
MJU=;3H0^VY-?WO/OAD>^P#2T7A"2"^+SMVKJ\[P%Y2U4DN+DGQD3 ;X!6, ;
MM0'JI;-7:7T3B)5+"0@9DU >ZVO(6;Q(D+%BR]*DEYS)F_:9N?W3*ZNAONDX
MR:MH7RAX]UB3$WF>]1IO/"5(4"8,7:C'?#B6%V0SQK"@-V?"TO+##W/'\@&S
M]0<.;[,_6^O=C7F/U[M*W\>_@('0B) +EJFO>/+B654)*I ;4W_:O6I*J7O?
MJ-G?GF^+AEA308OFIV?G9EN]%6C/M&A]WB<G/P.LDKSYV,+J6^S1"-;_NP[R
MF%<[T$FN;\QH;^O>-HJL'4U2(KD29T!O34Y628*L2KD]\R?3@)Y'2AE_/1;I
M\3)7F4I/I@-,$[:[7XSO&BRVUU/42.WD%H7?=0A^QK5BQ"#@0UR;%1$?<LD5
M0#]7=PV(R*R,CCO-03P>E^0?M%C9HYORIINB[TYSY]>X!J0] G&."Q54!H]J
M%^=5?:I4<3D4C15;]"E)#.4FDMF)U(K2T6RZ(1RR*[8\M9Q[_7WE^P3.DVL
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M\FEW#1@XR/R!7BCH[:9X)B7-&"ZQ*Y,60](.H\'!7F ]ISJ$'_M4S;86[20
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M=_5\;]FT-:DE7&P#9<I8UQVK0G^LU(#HNZ)O--<&()TL?HK&>;$#WEF>/A/
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MJGZPST&46_#FSXM=F2)8NR *3/M"AMRHTZ[UQ?K^LJG[EU M? EI/_5BX_L
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M)LV&&F-)8ZY YR&AR)?;*%K )=R@54VSI43\/J]T^:Z=XYCD!(YI>6TC3B#
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MK=D68*4*';$AIYY3*/MB)S_='^AALAVIE#)8KKFZ0VK*U/T5N_BNVRDFEF$
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MX85EQHGO2N!=4KEFW002>@46:C(F88QD2_&#)ZK?OQIB\K%]B8D$9+28M)'
M[$\;U]5BO'1UG4A:KCOV<6R9A+*?-Z(\+&=E"[>J3L>WESQ/JG[R1?GQ9GB5
M;*A<(K+$A56X2A\!.5U*N;7RQ?H[WP 4,526;"I21/IE]!<K6*AI0\@S%#Z=
M M2D+N&ONWXRJ<RT<OK,:,K:7Y#BV S7.0<DZ9(>7UB3M>V%R40W#V$]\,GQ
MO_CBTE?B%MJH2>_^YEFVYJKD%CSW6OW]]OER7L/T[3=OW@($4P3W;$"+.[?!
MG!%;8X3RYW7CKJL3^]N:QBF[O7+]/\3B>'\M_G#A]L/GGE60=0M('8M'T:@
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M. <\S(L6+=C]KYLI_Q.T"FX9/A7.LG6LK*-S(&N='\^@EUD3S=EQ)D^7$K4
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MZ=H.+,<(@G]$$KE8,@-^8AD#X]63U1;4.K*3*E^JLGIC6_AAGE,ZZPH>$W<
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M/Y"X77GMH?\)1LR^C\%?F>4@T*:X7"$06_-]E5;^7H$AQ(9<OJ>DPQ>F(M-
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MZ-920E8@^1-ZV@-Y6QM&D?Y5C):DD.,*>Z>X@^4_8D,"$K0N '[JX%#@]KU
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M:\@4K_SP'>*849Y0,-G*V-5HVG+I^Q\--1K/HI.5!CDX;%YLJA6:)]<\Z>S
MU"UJ0+<)>/SL#T KT?R*UE/ ]:O2]N,+")TXBRVO3:@:5HVO6T&D3P$F2[CS
M8ASTNO/^JTUM?N"#VZK[Y0FB.@7^#E,_XZ8Z)_T\NN\IS*]AAL(<T)JA@SRV
M"XM\!&JVI@>S&V4XGGM>)3I6#*^%ON_26T7NNJ1T^P'Y&#ITEXDWP,+QO5<%
MB7GY9Y_/WAV\Z,)\VND!RGK.K7C-;3LHN?$Q(@SY?H0*$7/TO"1S<5SQH.R^
M$DNWR!^#/RWJDPQREKA/K'2PP.2LH9A6*0BVS>PQ\1R0*"LFY%);3Y*(:SIA
M] 3]\G7R-0W$Y#81GO[]==J/_IM2*?VQB54!4XYJ'0TZS9_W#>-$)#,L0&^0
M YVP55S=-UWELZ+. 0>A53B71HD'\IWBTC1&?OR[O\(S5+.\")V!<JL$09Q3
MGN9=3+O;Y8=[C]E&<@LQXL9XL >)'>?70M(T;6B>?(E,XA+10B3E._[3#G&A
M49IF@70D[!B;S8ZI"T,?CU/$ S F)*-ZU@;E1&*"?H:KZ9TZ.8UW>OQ1/,>3
M']>^-RSDXT:&8KL?%0G?VG^],WH//F%]O-'Q6X!<14S5G09U,9T*9IX(Z:GO
M.KQOLJZE3 [_\%^TZE'GB+')[FY^8JOQW8%1;@_B^C3E?O/NU;$A[84-\@5H
MQ*(D R*[V.<94,PZ)0X!5D:1AF.>;XDC/^-HZPM3]8X.E9:>!5NY+B <XC("
M$2I># %&O=WU8M=4+2"%Y>X"*1'8^EJ[<P#TMM*JTK=$I;%I\#F :.B.$WDA
M7BS49'^PH$7^&\3>0?NV-OD@GN^FTX24JA9=JA!<(68I'&XK\S;TST@]W:>Y
MY>W;;P<TB>RV9(."4[WZ[T3+*)(8>#)K=%UJLS_N+?9*=\LCG$4F5^C#)L>?
M)P6H,*)QE_%-J"I)/R#^\3CO@OG1I)Z@B>BLV-E>.NC.1$OTAGU>[8DV1,%6
MLKCD+YB+B(Z(+KN&')=L52HYR\.MRQRF%#F_*)_K\* NOF>2UFP?:B_N9L"C
M+TJWS;77$K00>KSA>[CYBFS5[9?%USXGI4T.7XQO\\(>?"VWFW<-:LR'-A[Z
M38E>]KD"?/#]AUU%^#J]*$,<F'$T>W$^#>=P.2#;>AQZC:U>,.UOT)YK)J?O
M;G=KS;T=Q;=@FS>'VI!,(O6%$O\(Y6LA[J[- .-:97P4FT/8N]C"W) V[WH_
M?1+]V?6,IU(F/ M.HL5?19*8C<?VF@@-<\R=Q\$-&5E"<:X257?]L/FN O4I
M/2L"N"JSU-RIL VC5=5:EF*=#*.M28SYF>7&Y%GK("=,I+K^Y_^7_<W_5TBZ
MKOQPG]2Q &6,GBZ=F$ZG,W]"TE%LO#+]9!)(>8@-L/\FZ1R@CF8^!VP?Y%)8
M\;*6WLD*EDDPW[8LI&AH^:H;B<DXYDDCD!BNB8O%2!V@R7J\T^'<KW9.4_8'
M0RJX?IP#=E0"_"D=E@O'<A"F*K>@]\W:92YA-)99DR_S[N-%;:SO#S5JJ8.T
MNYIA%BPS!L/'D0<IY+ZOKD!>59_26:@0T1.AABKX>1RU8Q^XFUNQJSX=L?J7
M6G_G9#N1$]F5?(O,UH$;>G+1=O=R+:<K&PPY&>Z._C/VU;]=H)YWLRL+B[H3
M@#L'X*P2]_-9UE/:V0HK[+C^JQ\0NWF5A4F7F[YH2KW2(MS4(OSG[4581^ZM
MGGMJF_XXZ;$R2]/X0Q"JSQY\G%=\8H)Y@F[P[])]8KBJ5S74J.J-R18+WZ+I
MG43!3BX?&Y^RT&+GTG_=VO)H -URTIRP>=MTB>^3W"+2 2$<A[A%V-IN -(N
MD MF9&%\K'-NHL=95^S+,7U_[&X\_\7\0ZER[$0KH)ARW_4<P.0$ZPEC=/,;
ML>T13)RY9ZEXXU(1UR&;:%=:7NN)I6FIJ8D)Y.7(U U+SEP=$[V6P0>8E]E>
MJV7C 4;'P<;3#G@F33'M3%[^4>Q'*5*)DT<I1A0HFHQ56YI<J%OHM8!9)>@>
MB]XW2ZBPO]E)XK;*LH%JCV^J4N/XKNFPEHW)]6^$/%K1UMZUU/4GT/B\*PT<
MU"",IFG\ZUG]?X3>(^966@Z4D!.K;'?T;GZVVMP)C*M9I1*NUL"/(M[.Y9>'
M91YQUW9KZ-.?/#(Y0GGMZGP]O>)X#K@.QS<$'C%$WWW1%L?^YAF%0TZJ9^C^
MZ14R]]MSP!'[.: >?CG/898R<J*Q>QB&1#K+#(H-0(5)M*9$STA<FU"/F$LC
M23!B[3#Q@?3;!-TZYP<TE^H*OZE:HM^IRT+R+HUL-0#KW$+O$B?&"P(;)(*&
M[68X'O9^*KQS03\FX?Q5]#E-1U,7)IE;6C:75=MH*A&.F5\Y2>K'@I?//H7*
M\>A0'B[OU3JNA"P0&( 4FW, <ME%D<*9?U#9EO>2K..^PX9$$MD^ODBNRTS(
MX-\(/[*B)C'CA5I(7(:UHR[(L;= ^C\J!I"OKGX%,X/W&*X^:A+,Y_9\822F
MT)O/Z N,3?PB7\K:X*(U*K$'"JN_8S_\J.@.-"VC?2F!P9W?R.YT^WCDCGG7
MV(%D L]F*CH$%)874TTNU$&3=-KYICN?C.5J5P27N6?(I^H&6"J\IFD?(D:_
MHOB:X2*A<L/0,+C-1F?W1>*</N?9:"]SD/NM[(N8&%:QNUNN^NGGC+(+]R6P
M4SGTZ20"2!.@TMD4/8GIJ+<;*K4#B8GC](KT.#[7]]V(3[B4'+0EQS>3W66;
MDWQA]/Y+>^<9U>36Y?&H("H(@B =5$!00*2)4I+K123 100%I$9%:@A1::'F
M@B)*BU(5-$@-+7 IH00( @DH55J04 )!0'I"C1"2X5WS:=;,A_>=F?7.K!D^
M_+\]Z_S6><[>9Y^]SCI[-QU7BY5WPM)R^X6]%,I1F@'+D19;+>[ZFP5;OA 4
M;06VF2[4./XQ!T_H,YG'K5+IP*A:?)H)!Q#YG/?=N5T14M-+^YM1=5<J?OZ(
MNKY@"_"=APA[ABL-5J%$[)F)O&FZI,:%!=XGQ%1-Y=4Q"]^WSBC%977::Q8T
MFUD- QFG$74#TBZG**P[U";NZ+QH)4Q&__IQ[#N?^LK)(+>,_'&OG2A<5%15
M35J-ALH5AY:\W)3O4]:_+9B<?504KR,06P'Q[V*\*R C\7!:,H'M$+H!K$V[
M,1!JP&BU9_;!#I=%);5FTM,]%U%OJ(Y'^)[LV<Q_V(FO*Y.ENQ(G>)@W:*O2
M3O72@<2UIFB_0LG596\3Y#4.X,]D%+!"-GB!K>)%X0!:D2.9S2!>W#(Y?6B&
MM=--SE B;ME$E,/Y<HI2?>4S+&Y?*Q-E&"?@!$1^3DCTE\K55 ^P0&[D@"<.
M%ZWU/GR5+TOTE:M\C.8Y$F%YF]^L$Y[( 6B&6GM8?4RLQ"U3K'#LF9KW/2["
MED:!,O_3MP3_RVX.KORC-3\PQG*&Y[]*:CV[V(%// ;\E)!,43K<O9475(AO
M7)XA31>TX(C=YXY\.Z,H3*T9#T,M(;TRET)J]C*[X6J!V]5SXMND&T;*(EW;
MM?L3__K?$7G_:?+SZ <7Q/0L!105?)7?  0/0.&?J6OZB$#9#:']5>HK-JE7
M3A'IEH\%T;&A^WOU[PE-^TY<R $P8UJ;!E8VBO.K"57HCIGP#1UU+1]@T6=!
MR"WV $2"H/!3MHH'I;6LV#:A-+ Q"C/)B23W6J&ON3C%MA15[^>ZSEJ,H_73
M%B,&_JA76.W9)H%7<L];@_-S:QOKJM75:YWF9A,5],)=T.#9.A>;@+C<E,R%
MX*$KR?>*[F(4$1 _+&8S:SU,9#'=XO.>I!F]%%4:^ANCNRGR5HTHQ:\;:*#K
ML%OWH.=,D."QM6F7#T(F9]U%XFFHB)VMB&F4 /-9FP/DE(!0D%K6@GT(!Y#C
M)=BQ*YC\ER381]R!&WP=FP+6@7ZP:B''W4M?INPL^^.;WL\EV^+MV#WA$F1]
M0[7G&YDQP4X< ,K*N,9<M6J>5HF>\GTG5Z_(]XO[UKW#QO9SX<*L(X.$2Y[H
MJ^FJIJ/&>#K^\[8@)+X<%F2GX"G?NT(^&T><3(H[9#;Z^W =TJJL*SMEE-!M
M@ OQ7QM;HZ#U> M+9NL3*)ZJ9UWM?,Y<56]ST#.\>N5X<ULPK3&R?5(M.M3U
MY'CFGP0Y>T0EZ<Q?!NU;\OC'9/.  @T:V5C>]//AW]_D1I!<$2!S\OX!F"TW
MX> U#\UV6+"W=YZ'>8N7YKJHI;;\,7/U >/YARV2#%G5<X89NX [OZR=E]&'
MJ2!LUY1!Y#H]R@*3MAY5].FK3Z&$$9GMP<B7+&WL_"DO=2<+C[6>]2]B>^EB
MUI7GC$[8K7V"B_0RD9/5\:(O_*C""&K;-Z8>>&C",L]0)E-A<^;'TW*;=[^_
M\$8%BKLM4M*JGP^!NN#<3GK:/O78^D8_:NE<LJ5S%JWWN;W%BY4&M8(Q9IMD
M;S1;[G18)G'KJA"8$>1HBO(&/SQ??L<61/K <([?=46XMZ025/H5^UAFP*PR
M0E+>;^D:\P(G&F3=[B2]#A2L(]R=F98+T"3)4/0[E LA5@6%/;GICM7]BZ6-
M[$7XMU_YF5(HOEAYG[XON1IX(7'PSQO2)T.,YC[+\C&!LP:R[9#3WOIJM#I!
M&?,+TE>A@Q4JAX[[:IR2\SX%/E1NEVZ[M%KRE3%ZD^E>/#$ZORU1$@/;='BX
ME1'T $$!S\5RP6]93[\=1B?O5:F&O*'[#YA2:F#D^(TP0H!^Q<)"R&(T>C;(
MQ]TW-=7]\O*F8I*E;1&B=9(<3V?K\:J&M%]59V:;_?Q$^+:$=0X<^.2[;J)2
M=WQ6J5G]"%6<2V*&H!QJ4,^T9O#:TW%C+6OFP ?ECFT9-K,7[O1UY"B^M+&Z
M;N"58Z71)S[8.I3_(;_1WX$P=]%>PCAZ$W+*1#[8)BVLR$1L;-[%>UU$)E?I
MFD@_RY[I'7Z:F4UM75\P*_ RPXPZ0<X;_67?K?+(D.=N;8%KY],/&V6W]S+\
MERU:98^Q=;V"@5G^>5XV.ZHYK4'NFD8JL*TW&B6YIYZ I\GYUJK\B,4:&M18
MH!OR?:A_N.FKSHZ,7!'3S/G;PW5_ X&[ X\X '1:JE5+4X92T9G4I 512P?[
M9M6AKA*A:P]_7UD*YK;\"FQI-&SE ' @DO2)7^ZUC/ <FJ0A<<>G49U078=B
MYOBE!7882ST8_K1 %3C?QP%XP5^N,X_.Z&NZTP;_&M8*DI"MNO!AH' LXKCD
MD-15X;?-1W"&A4KS6E I;5URRIF)0JU^0B.NYD?HD#Q,."ZA) $#5>8[97S'
M&'NU$=2*/(YA$ JGG=SM&=RE$5-4@7'!HL6T*U7O4TWL+.6B-)S&4U[=>:+^
M-:>->G1C6>WS\C2(AXFGMH5+1BZKP"%+<%=_5\U(E_5SS\)MFEL/!P=@#7+A
MT 7?/9LRY73[X.(1_^JY=Y;.E9]8@OTP?=E<9EH[0;N&;IY:A;V0XI$J!)EP
MNHF!?WCT^]6;X+/J^M,1]\/UF7K%"!WG;R5+*S"6&8;Y6LA<X-Z QJ,FF["(
M>U>X'4$=7X*.1EF=I-!2SU2Y] S/A 7@QQTG"\J>-C*/3/8*+,9/(4^%.@Q4
M]8JU*U6C>Z0O!"UA,?IBN7@N@#7!YAR81[O+H^F0OF$!Z\YP@V"8 3K>?VJC
MMG9HD[?P>'5ES0LWD]='5&KE 'P?6Q*Q/-C.5/X&>YOQT5OHQH_5O]!0H^"5
M++KA#;*^8BDT_ ACN2E.X1N,,%(X7^E9\=U1H?:<O<?S1'DC>?<L\7D[-("I
MQ_.J0>'IM( P(G6T&2V8,+=D"3'WV;X[X>BB*G7J'/=6W)GK '<L",H+V=F-
MVC0=Z[A*=1K"[AM6$%;D)U(0*(AY$:J'86)^8W#7Q+)DD9KV[47V+703[I;X
MMN-3R'2=T75^L%Q6*=KB3V=)>E>J!"2>K?!]/\L7K::/E:;B'P\_I904R:C[
MZKXI3RPI>2()B#$H40V)'E+VO38*UX8%D+<&&?;*V<RH20/;*53<I@7?HHG$
M@FYHA'06C/&E)"OQIL]"1\?G'8DYZ,T!6V.5'"63-M-N;F'+/][\PY7'_NOZ
MGVL/(WSGT/\'.80?Y0#>4EN;MO[U='0_Q2!^B0+;Q,U4_@H\LU;2!SQ$Z;C!
MPS-F%9S]:?!Q!C!G+Q?I28U!"S+7I^-%C1F$/,Q\@'VL$0QZ"N5M@KM]]-Z'
M9]!T)HI63(VG5NK+:#.TVN\PTJ+]-_INY]]3'K/KY@47GY42*L&\X;%GR(HB
M*N\QAE_CU$XM!IY?MQUTTQSKD;O'_^/0QR* - _ .A[4KDM^/SGNT%*];8KG
M+WQZ<FBH^&8\_GYE>:M@'9@KX=B71<?R3SEB:[GI-:S3Y,)WIEC3#VL^0HU)
M+ $,R%--+/3Z0*CE)R_[X991E)"=5S#W"[P/3O:U8M5+#ZX3V=KQ<I?RCKE>
MXO<=QCY&9,-\_]:D[; ?B@?A/# UWNDT[LQTA>.&\;6='2^T7H*;XR5N_M)\
M,W+M<$-@LZRLOC]]VXC=WK>9H@M^Q/B^<.;)1"NO#%:B*^Y4IC7)%WB1T?Y*
M'T93',9U.Z]:D<4*19/ @?E4_&E9/[4'5[AO>EP;"5B'T[]3\A\>7S<KP?HE
MV]YC*Q2/&HY7K8HC+&B!)&4D/X(ZE8P7B"_S%W0'XB9W"V$^C^K=*6Y0F[&2
MP%!B7.!Y'$&$93#DS9+;O8, F=7IDC$N<+BW8DVG).GE@M5NF-DE&;VDF'5)
M%*62]I$4ZU 38^?FP<H?=*FL<9AU=#GZ0S$=,;UJ0_U,%>S\Q!)EC@?"BZHS
M2\(R3-+[76O75OAB$?>KW/5B^3$B&IAK[=43898X*2.)%)ME2F" 9<!,L&?]
MNIOB4DZ>ET3:\O')K]Z!-_&P'>K$F)\#U"/"$VW(4JX2[,7Z!^"CT,5T@>F9
M+726UFZF\/S J-)/.<]2.YZ]-:,GA M[N<#SB/K6;=W+.32^^TZ71W&5E9%D
ML_+ATR9"RF#-X:?72PTM&/GE>0CC^_1N[#?4S:'92-K::.?=67V]ALK:N%(=
MG=\UT5#WV\]"^]=8TCU*-(_^Z,HH2A7.B])QU=Z)[5["'DBSJHEB'QNM+(]4
M.SR"-QZQ^[@M6TAI>E,<KC(0>HZ.:H8(4(GALH/Z2"PT6#[X8P/E9;&*A'^<
MAJ9(393<S"OVN5H D>%\G8:4A (U:OK.#JVPA\[$/I1Y_T@?9W%I_/BE3"7)
MO^ZO/8,6T>'+@OOIX2%FN*J *;FOZIT=>H+,[N E5:L.DF9S@H+T6;6S:96)
MD6:83H8LN="T9$YY(:7J-KGFUE*P^[*(_!J[*_.86V:K#5I05#2]ZMM\@.E"
M[&FQCNM"FE<=0T=<>GS[L:&.9"TJ/WNHZ:2_ZH.+_<O>^GI/?1L>!YGQ.:!J
MQ?:429ME<1,:#+67VK("BQ(_\*7O"R!(CYZ:\MR*()9KZBW)-U)\46>E^)48
M.FT0441G,QX>A<.:&AB#!UY 87/V1ELO[G&=#]H-;?DD=#BUW<+T75^B"0A$
M).=?31[UX@#<**HT+'5_,SU,6J6<;J6T1Q-T$&T#=G:N375#BG4)5L=W[SVK
M0_PP9)EV?(X+'NZ7$:Q.,V3^VKV"@-_C#C7)]=CU%W-DKXV9S77R6?SLE%23
MKH08,.%;[YA)4^9G1LW^8HB'0&^N+<NL]?.^QXI6M*J\ZA63CGP;,^-G\8HM
M3]]/6E19GM#B/]A*+Z=*AZWPQ#5Q\-E*.)<.UR;FTMT/04Y5%FOE6N5^2H-;
M;^KKS2<H\JM4VVWQ\ NUJ;M$^X9M_OYN[1^]<N5?W2X3DU;,PTRFD'SVH4^?
M3XFB<.<(G:WE9OG,"A>*@<%)XN4Y=KH13B/X;<+0&HRX^E2K$AQH(I?F$O<X
M*1'Z4]\+>0CICA3Q2$\H<\//H2ZKNL2"RPDQ/UI=Q-3DU\1&(D7'RO^\_;3^
M_$?7W'N![#*V&T*\U+/#BSZ^@[6=V/A526KPI^TVO9+1&M8W"_7U+YHP"YC>
MK?_^)N<[GT!+H\/D76ZF)&,C*6(O>O^'YYDYBSMA6B%QP$M,XPOY;#%"Y#>O
MIRHZ3\=&#/T2LS]VG.@HN08<PH*=I<K76.*=T65BMELIP1-[F^;A&.VI/9Z[
M##<L+,\C550B/\__;(PD]'Y7PM)MP.>RDE(<+Q0Y>F0R^@6LU*4!>+)Z0$NY
M,/M!A\];N_P[QDXEH^%%T#9_"TH][67A0X-T9H+!9?%O[1?[-G:A//X&-Q N
M-NW3SOY3<!$O-"\#F$&3/C^W1&G+?'(9NR+.E?%8ZN6YB)-,\C.,;N:9=!!Q
M/N]5SDO/N_MK4XW-)G_=]],*)LB.8?O<K^DU^VQ%WP9*A"F\0.LD2O 72/Q&
M_++,1[+EB[@]*<_U8&= 6Y6G&7D:R,L<)H4+]FE;''9F!F%S&P<X@"KGU3\&
MN2J\K6\]$'>U,N.^+M9C .UJ.,>P(#D?9DC/UGU:/.U)B5]A^%E:Y]3:P+HJ
M;GW.N:@_&6>]*L/R86"(]6+>VLONW0/GD-I:NWH>6%7#:<DNRTN%WH%R6HT?
MZDJ;RE*["FB%(4 [IY\;%8MA=\<#:WZA.0#&-HDJX#=$ERG&LJ[4,FYE%B >
M-?OM/5(3M' _#I[^3C_6=Z)8[N67GJ"OBW8[J1D< *^D"5-VRDFN599>LN'D
MX%2;9E(;]LQA](?M8Z$_BGYB)<Y8_C7''4%"E$6$Z^T'A+8W.[=?EQ3TVW7E
M6#15O5P;E]KT2WCL>@M8Q/T044P3?;T?=8R&-QN]5CB ^RAXBE\O+NO$L\@K
M5TZI/:@]G*VE('EY K[V?2(HZOJ$>:@-?B9F(6.[)@1I8Q 9YMMB0Q7.I3=%
M 4]7-Y7F%\"XAV/\>6.+B]_?S!5_''7B4N*S]NM'"E>=RH@7&Q[FLX=EQ;2;
MCAH^+.C.<S #8G(7>&?S]B(2M-/5E$N><PD=XCKT!MJVV4L)H4%>57ENC%*%
MA-($?^F(WAEI/CDV'R>2.'4*_#FAS@<J9\6<F?YH2Z)8Q"@,ST83[9WPE%$O
MF_+<T\<&3QU)MIR5DA(:D7_BL:79.%Y=O;QUNNT.+@DI%*P@Z8,' >O169/%
MH$.A@34,;73LE%YO-/!"9=\*3G;YI*1E*DSCYFL=_;M$%C$^CD]]3J0FC*9V
ME,+N1)[0EH9/[;7';2R>:2JO15,=TIM5X!*PF<?W^R(N1QUS21 5^0&\O)=-
M.(N@WLPT'L0-Q?Y11YL=O5T1^=4GJ'<U-/FN(FBBVR44Q,31>J/ZG3)/+BR[
M<D\>GNWQ2*110OW4^&*^$ /DW3++DYP_7N8 #(CE58^64A>ZU]KQT/%1S*8+
M>?-O_9R#,Y=&: +,6T IQ><-:H6+ 9; K##:Q5(*M*!5\(>QO,LYRX0MK@>"
M'VBYS-?37U@@FE*H&@,S1<Z@8=U:R,?D&$=180H?9[IK4O4Q0@47KWW_C:N@
MYXHY8A7%OH3 T*)()6CY(31;ST@9YO4V]^K6Y*8@\<_S<P1NOW#IO3RV'!-B
M6-6OTO!;Q<@()LT#7@);R<,Y=PHGYN@>^GY8W;@\T5Z-Q Z)7:P:K?0AFTW%
M?RS;\G/R6R \"N^#""RSI5A@=F_%('Q34K)1=]BJFCUTO:$FQJ-511-9_1R5
M?ZU,O7AGMK$0D6F+'_(/68RWL,(C-4+J"WF_R@4G>D7YW[A&NK"IGSX0;YJ8
M+)*T?P"W?O??]P#D[]=_]DER-XA^9QGHL#J29HMX4UM-J/I(UU5*O@AB;H9;
M#*]D$BVX[K/ =&#=5!@8F>55C8+)\9NN2%W9YN&AEY% KR'\_F4O)K0'66HT
MWH":097'RO4\WGT< %=!2#'_#9;RSV>4U\T#"^%/B<R@HF]$A14<//UZC%)V
M8P[M'R[C\G]!\9\FWR;J_D<MP&*R?/_D^6;5]T^WG+]/MN;TT2DRCN'2AG>/
MVN!UJQV$Y_+6"J0*LZ\[;EE+)9G@1 (<SUU*O!-3[S[?SCK=9)':ON7:GYMB
MQTW."M1][ _1]  QET56,OD;!%SHPW\K;+#1QX[*LU>H4)\D]*VK;[LD,?L@
M(C;A_;GY^,IM/FG1Z-:!W.T8\+Q2=LR7Q1-K'$ "I++L.0'D44Y!)'8G[HR#
MJX9@8+.,T*V3J/>^0[>-I[N#HT0LDS_]RE[J*NJ/\M#U%QD :>L_W+='$J,M
M,TB1)1<NW[>984"MWPW8M?N- _  M((,'8=9>H'3/-L->AS <U$.8-IZ)]/,
M.;)+.0\/#'#4^S,);Q[:N^\XS(#5-H%51" '<%2- V@KX "B?5@/V-O12/HC
M#H#EU71/";.7 _F2N0D_,K>=F<(!T)>I<;(3]%4V'X0#B+?D /C'F<U[J_P<
MP"1I?[RA\ )+XZUXY%D.P(8.1 ;]@OR[+V3_[1"V"U'"2(_A-8$#Q 'B '&
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MVZG;)<!#!1EY&0 &!@;@'?H/<+O\\$S:T]H" %!2 K ! (#[ "P,4< ==(D
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M2^B XU; ]/@G>K!MA>37,32%8G=[[$)KUX^WNVI\-;:KIG1*PE7K@U37+.F
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M/;J(MM.&NK20T\VIL#6'G/,C5&N8[(4U&EHKE&YY\0IMU>M=O&+GF\KQH^Q
MH1IB*71\8*3TO/K330% S%)WWJG[XL;,#PFINAUN$V;=6B57B$6KT],7<VX,
M%"^.,\3C[[QBSN'6WIX\GY1AUV=.>GD@+A[-U^WH_K @X7R?G[3KZ^=?Z1P4
M]Y962F9?KVOJF^IMN]RDL!%RU>IX%G>GR>'V8V3UE"I9L52GFAB-7(T^]\[@
MKZ5@(OJW7-PW!Z5_LS'?\6%;QC7LLX0;H6]@)L_/H!#(>,IT0GX_6-')G;4Z
M9I3>IE=35BJCYMSQKEHA>+9RJ>K;8R5S9@;#S<^)MVX;)6S$2I\/H92$O[K!
M:(,;W>>OZ<2^98I59. E%@4LU-(-T;2%:C@X"9:DWZJ(8&ZB#9Q9B_;8Z(>S
M2W04:/(N%744J2%4'J2*(6):228KDQ0?++QE_O8]G';IU_KM'15(T2=KI1XF
M@28*BK:51WU2]3=<3CUX2KB?Z$=,5Z(<1()D$\ST8O4:^@DT_!2(-A0+56TM
MADLR\0"3JJKC&7/R[MXY4=L/'8U'65\@#U,^OZ$ZW%A;JBK2BO.:1"(5Z!?>
M!?''A]>PHZ4G,F/ED^1B=:U<1=^9QZH5"([:4,?=',E,>CDP.=9&$H '<+&(
M$[P[LMW^?:Y+IR*>JF>3-BB\A,12IEM0:N@>&K-#(7K^K;,!'-X]4=7U?7//
M-IU5'?*H1<697?& .RA03;IAC>I-\ZKK;JL]ER"QP]"@WD$:$C8H--%"_=LK
M^L;<$D6EKU-8!# L@?\>.\(N38$M,S3NXS]-Z&_WY7?7N@2'<"X>ANX2G'+@
M 9MY.$*3>G6POG2!GIJEN[\"JPQMJ)<_K^'\AI@@Y<!04,FJMA9X4$HIBQ53
MZ:WTK6\>36YLG2@JI>6[M8<K)6.?#;YTY&!O*./3?*UPH=>ARJ[T[E$6\U%F
M:&8 *R9\0!;P2""+-;"C[^U,;*4$OPVR@6WH6]REH=$3N"41USFA8D7\.'\B
MIU$=E5U%U\7#YL0$W0>KW6\$2OG\Y35BQ0:-K$\PT2V"(SG-O%VXXM_A^? ,
M24B9\<O!P6-]EZ)5GJ",0AG[+LHT4[V8+PFVSKUS0D<_);0#BB8,;9[C =92
M7\.2CY*T8)QQ?M3B%F;&_OOR#WLE.1(GU4H[-WI\DG%Y9$+Q^9,5C%XT7Y*<
M@F6:F[I9+U!.IV]"LFRN'6-F%C!>KG71\O>5'ADW1XOTF52.G[J'>>7/#Q\]
MY"ZA/[F0GA#]V$7<0E/JV,3$J;!8<D-WR&YN* DCJ:2.K*ZACK7A[A)Q48E)
MS7)UJ$FF=9E3WU 4NAH[KZNBCA3A!GA 3)?1ZJA#CZ?M?-HZ!J,34:)Y'PE8
M9'U$>/!],Z9_])M\T413WIC)SPFW1&O+#\LJ3Y)[&;;!;")$3O</[H73J]D<
MG&,^+W'D]4_$*ZJ>2,>%OPM?S*'4:9U/(FA[S?:-\.F?'J#4,&AXW&^UQQ/,
MY=QE&R6(=O_#.P,28%U'+<K9F<D6G:]Y'1/:#],#I"@7U"A,Y#>HOC#M6EV!
M/WDL\8\&]M.\"U@S:/RX[%V7&HN(A 2Z&4X:L'>$D-MKJ('-P:_GI'T-SHL%
ME>M_D_A&>.,J5,P.AYY=B&Z ^<4B*^4UL%&=!]A?H_ESM3ACZG462@WI_3_"
M-C=GXA:!Y._?ZJJ.L$8*SKU:\218I2HCFC<.C&JM-Z%JP:5:.^&&+;-8SZ(&
M48.AB90G8M8+18.#%%:E37N-/9]]LF13::HC[9N.KN7 (B;T@$_CW-7J\A'4
MF7GCS6NXH1:X\%R4?NWIP@ICFXS&ZI"1U2'))21EV)?S-//R=8O$ W;/RR1.
M8$\9G'WA?6X&57^G^Z;R2?K:V0,>GI*CV]TG)_Q&G?!(:Q+DLDT]I38MM&J[
M,90M]X\8 >%$ ]EIWE8M9%4XZNO6S0M'M9DPB:C3VZ 8^GBG!:M/V L+3''<
MRL?KU0 7DYY3>A#09L^'1J>Z_R@9^KI[P=#M#M$[NN&+>S&GHT./?8X2@P\?
MEF1<,U1JK]%9\7_^YB)2^CO+=M=7(*1I/#N_EV\#V ('9\P)Z"""#_4%[CI"
M6#M>N+U:.8T^! VMW[7469NZ+$M5&/%/H1L:_K-BSR_M),M"":@I@-H9#*Z+
MQFATTF[%N#T[9LS(_""05,X]:Z/F1:D>;(;T9WS=<DNDHU6-.=:=[D);(NGU
ML_L/6XD'J 4T-91+W_>P4-XRX+-F^V:V'/HG)2 [,_0FU0:85 )TF9J=JKK$
MZ^ NI1RI(S6;#NZL!MUZ3P0>S0H<ODSBF5&%C].A[[>MK)G,%%*]S <0^!'9
M-'ZO!3(UZVWK?>>D1^BN#9#(4NH0-?]7V@CT'GM.C>F3CP$CQ4P]RVG9#40\
MU#K 3^ ^#(J^H9:!+][T%M-U^J,#MV8>$B")>Z;>VY><)4Y<I9N4:;JX:^[G
MYICZ;N0]E\V<?:FP9\W37H^\(PU"V1 6)_Y_<@WRRE%IC8M]%7!NX^_)/T@)
MGVF-CB7YAZH8ZX=DCWS1D*5L58-X2*8G'UN-K[P:  &6#/-7<J1E*0/_9''P
M_H-<H!>Z$492\FE^% ,;9NG9A]TXW9^GC<KUW3MNR_&(:MHA 5*>9K*]T[0M
MWA/LV'Q#3XV[[GYN-5C/LS ;>C,^\^DGBU]V/+HG=7!_^B]XP ?G<T(3J;>&
M-KP;-0<>VU(BGJI ^&J4P-YH2'*+U-.DM8>7L3S3AL\V QHD%5?VZ8J2,T,/
M8LM*SP05.[.GENK^MM5/%N)N+@_U:JXRL+^>74;V/+)=%-:O:[W'^LM3)R9[
M<MV$WD^>6+E_ZD9,BM4WB;AP<EGE["S(D9CU?)YF2J'\^S2(K)JUI0M<.,X2
MRM5<W=L>78H-5)T0RHWIW<HSOH[$ XQ:'S2#=QS:%I5_R:E9:&366D,K2G=Q
MST;E&XQ?]00-$PM'-SG,T2Z*+.9 W)%-M:IQV:<F"[T= 3.9E>WR[_AV/_K=
MGMOW-"^FQLRX"IVC4HSBQL%[I;\&C.M7@J""?72&UDGTB?#L"=1K2\,O8&=S
M5FYIUL@ T5:(>+/)W6&!'0JC,>LDEZ/FV]VJ#._XV BY?OZV."[0E$EXG*T%
M>9-:(9K$[@7A*.K*@%I#!0Y2%MCZRQU&/_3PO;>L2IVOCEA(X*\<& [26I5>
M>^,T/O';^:IG;UP1PQW*R]A++,B#==M.,78L[L2BC>/T0WK^"8*G@"%-"1*\
M@G2B+7WN[++^G52Z(+:VM(&^(E];^]XA* H+NBS-2$YV[IG^PEU-6PNGP ,T
M#D\0M C'77CPPIY\4/'.Z/MD^BM*,!?M@B73V)3U2(]$@2X_(?A_?JFH[8XQ
MM<\[3=P%95"E"L-<TBOM,>:/H\_K/&' $5^T1_> +%7-\8=_)>?UFH 58)'T
M>M.7[A1^H:5WX=/X;J([Z!&M1.J5?^YG3\?WVNHP/K3A*Y:,F7'G>?'XIG\(
M^\*ZMZ+H-IDEEF@C:?5]9O5D7<V9BN<00D?;ZH\WQ03_5TDRNEQ[1(U-+5+4
M"0\_TTQZ=]EZ)1#&7WDRJ52U9%%!9LE]Y]\Y= /.ZZ]3AA=KI60MV5OTR'_.
M^8MIZF9@C7;SCJ50@EX*>U;YO-R ^:?K\HNC&[6H_8:J>%D=8DC!\2&'7*6@
MIN3+4+9B%?]_IMH8_Z;\AKHB*X  $UM/,@\,!%6Y'!09MR5+2GXPBJ0W*021
MHD]Z+'4R<XB$^ULK]09RUY4R5F?(!HI1A'/R-<.EM*V@BAF0O4.C+V&X9]R&
M"1UB0Y>>893;A:/\H/>,).6CR0?Y?@>3D+VH%BG;O5/77K58/I8ZAB.[PO1/
M6D?T\4N"!XHU';V&Y?NTBS2<LE8T6V@$%I 9RAYUYV][QM4"DCBVA@6+B^IU
M-X^73FEJX["?5HR?QLW?U<*17X+E1O.J4A%T2X'SCI/&-2L,</*;J,;%5B\L
M$5G0]TW?WL)?N>D]'8DI:<]Y>\6/O^,!)*>AL#L;_>L:K"GD5.YA6S/9SGT@
M<&/Y9Z/D"S3BZ\9 BT;6PY>C.P<#:U#;R)VF8N$@7XKUI%3_6T<\%0_37GZK
M<#=%YRIB;5KC2L ;Z%M'9T=R!^\B#'AYU4E*"%;H')+ Q.M):3]J,1G9:QAA
M,9_NG+Q!J_25F3<6!9/APAE%M?$C(^E-=\TO=)61 YI:2P;Z+9&?Z%,51;%%
MHC.]%Q5HF9*(V+  [P*EK/)9K;1:/""6$(('@.$7XMKHQWA .^O/V>V\_<B:
MV][&R^[7>.Y<AM$;-5A-2,R@>44FH^ &B09[B..6W$]$8Q+IF]%94JX[P@0^
MU1<-EQ"+=$D\ )4^9_^Z7ECIBMFP'-3WO1C9L>/R%;$NG6S7X.;2$7V!8^E*
M\375$<I8Z.H17V2@3N3$V*L<VW]Z^,J>_WP.1]6S02^>J+F7DQX,W4R84=+6
M)J](;C)-.Z5STH1X?I\E/PJ^+]>?A6P@2).A]:N8(E5D<&ZQNE79Y3(U4<+.
MO_)F"<$'\8'GN@D9T/I2[<%"4#)B!%#8[=C9_L2S8&!PVZ*)H),#R_0P\K[0
M&HOCMH^BJ. &\+Z@5QC9]35/EJE0V/:]N_U::91DR[/MHS$:*I"UC(2W;+D%
M;6H5E^"S*[C!8=[U9YE!'!9$_PP/^.C5' 9U>3I)L\\4Q_H1/@_KGKL VAQ'
M4:XJ+MR]"3$B$,/N\FXNYLUY^@H>W/4AVNUK >W&N%N_K8ES.8ID3&9-!,_#
MF^\ [2&/0_N^ I5BS?/D;&ZO5X*7+CW25)AAE!&TA1K]\99,T?(:*B4["[J?
M<!V^M?5E9C1Q5:9$TW&C>\!\J<I&G5(W79#+KX6,L(S' QNG4E>(3ION[3\9
MD*Y750W.&,M"[0*7XAL9(W^/HMZ+O3*@#[L1+L)"S7UZL>V9?C!1#0\R 4[U
M%4_ED7S9^D!WS@]7ZZU_6E/X>KOMEP.I^,3(.8H^9G84=S784,7LS_\WI0UO
M@D,$V"04YR^*^58 RFBFQ4O#2&TT(?@Y>&S*NO;CL6[,EQ5D=!MC6O/C\UY4
M^0+2;_L(TBX803R25^VP9-1"SS<&Y+@X!S;6*Z/)"[K&.U;Q /ZQSKW7GZ=%
MZX'+[O54 WA 8\,>^!*PC=Z)P0G _\X0W/:R 7<W'*S67U4%>XIV<F3A 8$^
M"^AS@FGX+!/V_3]:Q\/HKS[S6U=OX+L8Z-4P!F(Y=JCP@'[2#=P9<%'^'ZVJ
M'&S7#AE,_BQQ)M(Q].J>>; [ N?G!CYIQP,>@_[!DJSD60:[>WF"NAL.G3[K
MRN,!Q!<M\$/"/\+3\J<#_\G<*H#S731-#N L3[)2,FM!I[HS5T3Q&]WHY3ZH
M->H?+:C2U?OI9Z(.>.IIE_Y54PC\I25VCP_A7WU6FTK+TC70_KV]_,P'U9&"
M=!TBB(S?$)Z@=#* <0EF;][+XP!YFN;C=UP"GM?U*SDL6JN,\!PH7@GW<"U5
M# ^/^GI9/><KV..MO:=VO!*,+M\""QEXL#UW]P"%H$D#5GT@K6VZVN\*6E:C
M8A9H>U[21L-W\8!=TJ?KZY#)CI*2;#X5_L28/IT_4[JR5.V^[Z:/KCQ7ZQ^D
MI5MRCJ8_-D CNC&#YC3ST1G8%JF3-^CAT-27QPNK"!F![Z?8GC>9,4:#E8AO
M5]&O@S@)L[W<.J=FZ<"%ZAI42"DB:WXCH$YSWVC:R$3U75V:XI(=@B/!_#0I
M*/39W:KIL:M[FO^2L8:>ZZ-0G(=33,Y>4[Y^YG8+%,H_ND<G/_B#+?N(^_YG
MYJN8>21[F5I2G]EAMUEF./V*N/;@UY*>;Q J%$QP&BJ:2JUF?:V4 /.JB4RC
M!^8-W%.;=![MAP'Y)^X>_TZOI_< _^$EQPB5$E\K(O-#5)9XT<LH00Y![J@L
M"7D<.8P"WL^%!^PLP". NP'N<;@/,#P ?A\+F<S/V[+P FUP<YR97]'%KPN@
MO[]\Y;D?:9K3#TG@%Z?IBR;3LO08:5S9 CH!%'66QH0'W!(. :T^P -.]OZX
MC#1*$0]X<845T2$XP:UAC2T+X/_'S\VMV+V)EORMH6;6_ZJ7L+,WFV';77"+
M\NKIK,U?JKYG =NP[;9;3WZ4!6'&766)KTMOLMNP?8]*@G9,;U]UZ;7_K13)
M?UJRW?06K6+\"\/+[_L1%0,<X?>\M:Z^LR\(O+E3=;[#:SBWC_+N.R6[HMJS
M"(-5K-/"NSVUD-Q:.9!%V(E.IQ?#3I2FQZ6XKK"Q>A2[E#@PY+S%6,CPBJKH
MV-^@U#X<$+P-V^+,0G(YN(?N,KP]*'*6=,>^?ZRRJ9Y9C >\,]ZL@W.0O'N1
MDD#XMG?**^5<^[5NM4AE]?]RV[\6S:G)#FO1('O"_.N!IM-RGE'%#(R9H<_\
M-#0OD][:<"O;/N%9^M1VHS3%5YOJJKI6EY6$D+VQ0O+;:DXFVZADZU^+"$^9
M\K]PJ1M4G%4',K1JG+9A?#OA,2=!"NU8Z?S\:\<1A5/O/5NJ<MXY"-8%$9:3
MKOL$MV,A:SU,;Y"8BC"H7 =2QO[#Z+!GP#:I_#R8?33?FWY/;9QGMNDDZB(Y
MUJ**^7*<MQ/'8+4NN<$>4UNSL>2>;J4UWF7M:U5^%4AZ?13^';*(FGQ%&?($
M\4&WF/R?O?]&EHSRF _:18?D5D6HC2U?;I7#?\ _K9,!8W:,1GRH]\@:FYIQ
MCV(8E&<-E@W-I]+63J-&J0X*KE/<^D4GZ_)25[YM<7>FL219\N,?>2()C@'&
M5.=4T"N,(M"ZNC*T=W+$?FL9='D0> 6^=5.'^UP<&%_&JC%Q$M[C$&7D3=E;
MZQ-P/1+,TQJ?/O,5-D@+=+.T(@M>&BB1=J$PLA'6R-SF>W['/.K1H\:#\"@4
M)'E/I%)(B**%D'E_!\:_&6)++^&'9BQ=E7%J]=FX,VM<N3/Y>-G<I<XMS6BG
MKV2[)G=J:FI&V0J5I+]D5_:Z)02K\BYS$#QZA < 9G(9^34589?PY",KA]RU
MA!]ZR4KM7%/R>?4CK9,JOY=(GO'?CY= D+3(FT--89P"-9OS' ]2CXL2] B[
M^+?XV(\E;\W=BVF%Q.!&AANZJ_  N]I]JM><)A HL:<?_V#FA65_K6%ZA3*K
M,C318ZKZ(>W1G,.;D4E<'1Z0/D>,HE#D0G.!NO:$O56Y5"(^EK[HD*B;[+Y@
M-"2*8N!I_^Y)/K67[HDI+5,@_60EE&P'S2OS2IX,8;C^F272+2:F@L!?=+GF
M-KV/;%YM/>J 1?:.@1OGON--@A56]+S!J%MM4+FUA\.='4A>(T-(<7A/Q>X]
M=\+KV.S!\DI_0:;>%=B:#1[ TU90GV>=\$._,F>87"1*S:O@> +&3,GYL5OU
MS3Z*ATJ3AIF>%F)9]H$[HX*OCZZ9B2\(Q%GP_+<I'[:&,'1Y6_"N'#E&J:!'
M$"6>I4';;<[1/T??MJ9>E>-[S-B#X'X\XOG"PBP 1S@8!CX_ E;YEU7-[H*Z
M< 3C58E42Q4Z&OK2]T(A7H;!%GZ</]H5;C0'7)K:TM]>E&1GC12LJ8A3'-RR
M(RWPXMXZGA]ATA<*_ME*':GX4&*4_V9.@8D:]$Y2Q<!W>5Z)H8:Q'V*1U5AV
ME%C$424JVG!Z2O9.^@:3XBW=\\C#S1T'L?ZJL'/P[HHU77%@;D&.WMB$06=B
MXI!HPOL$F6.'I_VB1.%,M$>'>:N>T"])@[>A6Q/B&2Q#B'&)Y><6BWR\9\^I
M3SU*'L&X!Q9=JK\:4(W3$(G*BLYYDJJM:,H7KC^?Y+P'-FJ[%JLC&.\??O2S
M5SS)J 3SN%DF:5L,W@3_A27M;&2S<[ZD5D6%&(Q MP4)'[_(^<U0-=)W?1<5
MO@\B;OE7+GW/A62$_$9="HF9,H,"W"6MS@=$K)A;-VS7-*7$U;U/GI%MUMV&
M?)K. 7O)8BSB.'D^A".;<9VP^PJY$5*!\I]N]O2:-H)6S*BJE\7QBFIU[J(T
ML[T8!P_KZFX9=$IRY56G*93IVENUP^89HD76(8FUB=KE_E[B$:HON&@GD]^*
MT]]Z\D,,NDBT\>;W\,YRE=#^S)0B";DRE(.*^0XI_^J-IS55N*N(QR]K\%S1
M<>N/^"?Z?O$%+?ET3Z[@1^!XO_6,,U*%?*;7;(I6<=C[-X"@A=<Y/V-8HK5,
M!I;W?D%?/XO&1#>*(5VKIFW)*#LI8C,!8L4UM66;[OH@^C,X\S#'1Q.GY' ]
M$7F7./?7H_C0P':15D][D>/<(?@HXBRZ2-I0;4-%4D!(PLJ)R48'H\ELPUEL
M%FX;HA7KAWS!WR'8^V:4VHTZEF.ZCWF[D%P@4L]/C-3KC0 FB(JECR/0,_'7
M+(E/[K$:N8G\19&C>>5UGY6V[ED_D?.X-1./3&OJQ]N5T-SQ\"[[>:=(2C?S
MS9MJ\V!5:P/+AHCL2>MCI2H:YUL-N.R+N(YSC N+I?E0Y^[,8%Y%P@"VRUE#
MUBE=\]^E;4\UAP=08;DNPQ;(MCA>M:1]4Z(EI0 O *,T3L]U43IJ(8>WO)7F
M-U*%O D9EUF9+@VC:F?3UY+RN^)3]*;$FC4=UJNDP)EYJ(JTQF.(4G6WT\\E
M9IFQ@ !U78V]8H'-QM!GG=^WJ2C+>7\"+.*47[8&Z6L*/'IG^LTKZ5!%AV08
M-;P%4Q48NN[J:AU3IB_7HIE5=X<V;9HC.')4?=#%4">I\4VU_@.%^;2G-.VB
MM/8*1;QKU*.X)Q ?C:=E"6]9FH/T@MD!W*JDDG>5JM)!&P=B^4C*D<K:2S<L
M:1I4;O_\PBA*D64;^LBL-(BWDT'<N!_N12RZ$:!"GJJED?XZZ?W$.?29SK99
M$[U-.VV"9+N&OT]1R /==[*RR"]U;<N%'T4M6MW(;.\L5R DA-URMW#]BO/3
M5L=I#.9(5@(U99='DN6O,09X@ &_MH&FV]+0;B4>D./;II4W-3[S_;VV;PO7
MOJ%!&RM![,-Q/]".^#.00<+($0^34E3S];.^?,FN++]'3('"4*8?'2)4/_OR
MP 9-E$@A-_(6GG-D+%\&[N-13O60((F>]V01QQ?SV7+O&+Z(F:],Q;29>B%<
MB\@EG'$D9E0]C4Y&J7*VZF'%&8Q[V&%YA^PIYN@A1XM2%M=6EG7<VGJ67%#S
MU!22AN4S!__-(].? '%3W=MN>3-CUX6KXB9#;JIW/3)NFI2$Y$?P@'_!O&TQ
MX]N \E ]SK'Z1C\1KCJ;@*$GC@H"V16N?_ZOH)^UVI;/#)2@<)Y]K'+?W6T^
MF\1/B9$](VH7CO<>7M&Z")@-M6,'3S 7U8&U-8SJLWI4[>#-5W<CM_:1@JU=
M.;._G+G>E55'S@?-WW_U*W@CQ5RR4+28V[3Z0F)7B;8-6.?\)-+384?;8@*'
M+LF]5\0FA]FX]$UWF)HV(4*-0NU8)G/'F^Y&A]O7!63"VEP)])8S,?3[,Z,&
MCZ/O65??6XO>JXA>A,A)"@4DT#GU.!Q8>P:B6FG".+[\'K-@VWLN+J_3*N8U
M]'9HQ\Z RG_0P\!469J)"TWGL!&JPS6:4)1XOK56V+_-8QKHDK^@GQ7IXZN0
M:\7P7,&>YN&151]P\P*3\G1!T;FUECJF=R*?-Z<KWWV$O%1;F]#4]@.RWE[(
MEVZX9!$-+U<!'GN;6/S*M$4PD83;>_3U/\X32O>!0>EZ6G*:U15/6-S;=<[O
M8\*<<2@TXX@UCT<;? W'N?5]I:8Z3K6RP0I2K+USI\&ZRS*N\X73ZILAYS:D
M4EVJ5*]P;:)2Y;AMM(ANK%E33\QMHIAV6F=:709G%3THJPJ*)MD,-U]C5TWK
MDBN;O<YOU 6[&]'51W;>CGG*F:X1R5:&0R/X?% [NW\T8->7\\)6*-;5Y59E
MFY^S=_>)),C9QAW\4!<&O,"*C8)T3*\:*2#92W'YEH)93,*$0YK#YEUJ,9>M
MSPX='E82M]DZ!4KCR0[[#" R25F?)U-#AS6,B?Q1 KAG>P(/]!BGX1Z.BZ?F
M=/+#AUAKI-G;VV]B/[I9Y7HS["+'!)"C,*:6EKE) %-\F"1\[I7O"\_1'"VS
MD">!C('7Y$*IM.6N?>@G=G%4G)ZZL)5\V)];T/:'G4;\.\_/(7MRVC8/C95?
MX! X ]\S]A.C#\4#+IYA.3HVUK=>-LZ^&<HK1:GL&LF9NQR#, T6>Z0A#O-;
MGBO*M4L9\/@]OW4/':"&,>62B_DRO[)P><&6>3D6#YC[&I\S?[Q_U&4MVZV#
MN.\1T_&\$T:;#WNA]F@KJ2>S4L)Y<]LM:'V0HR62I!I:DEW^I>UA+4435)Q<
M2I_OQ=2W$Q'6XA<\7-\EI([+9IHDERI3FAQ?T][\.N+Z#,?)9N;0)MBBH=%U
MZ8,'++OX6,X<XRKP *::.B^1I\.P./5*2UQW)*97X#,_N?:]2"+ENU/T-AX\
MAQO&9L>&R44>Q=DUY1^N.Q)UW_97)8+%.!TA0)FIE>BC2_B7AA];%N@BP_-#
M<7?F2-'<3WHC7"5 C>$G\-@YL4P.BEY5>Y0]D4$0ES;/8GW:AGKD;<21PIA$
MNG!"2,T'CLNI>*HVC9<1:(3:_OT_N[U&L>/#[H4+HK9SC.\3EJW3#,,@D!@!
MP^IF/W_7N+C]%:0-,G?64-K\K175%._473'74+GH&Y$>P R[4-<[%H<]#I\U
M.HMA&Q B#! DB2[*=<5,?!33SKY7><AOLG:<R'>;0OV711QQ?C'VE062_BAD
M/BP[RH3?2+6TV_2SC$"/7]GG)XJL>9(7.BR4AN<7>$!WHOZ,E"H>D'A&%Y%F
M5H4J3=1'IOT>*VNEM[S7VL>XH_%$Q+S""N'+KZ,)>?\T:+#SN'4)>OC[PT("
MC(N;L-2#]PF3]?6H@Q;["@W8Q@X>P)? .,FSH;:/!_BY<;GDR;D #X]JD-0Z
M,3]BU8U^HG[0"?O9BVP^0S";+:H;*[VI2K%)U&"69B7-]W\Q8^[Z@M*4,*#O
M]0);!H<X'F ,:H>13U2BB^'=FSQ'Y1[6WQ60WQ0+;)Y1(+[Z_^!>D KKC&JL
MXG:1E#K*4?)PWH^9K4E22OXD4ZJM(ZP>67>J];,/9'#@^8QM$K8!VP=B<MQ<
M+B$X*T.W(GDWZ^M*/G3YPR[/[.Q,>)LAT91EOU-\%OVM&]AK%)V/WJ7=J*NN
MYI$00C*^S_ZY8')[3%6A%4Y@E$-YIHU&;&3PD$^X&5Z-)$7$Y]3SB$#T/,UN
M9X=C,@SAP'E&^PU'B27 =B#X3HWG85?XCH*D*__ W/155$P3>A>Q%G=X@O#]
M7JB4L6DI CN#\T1?D=B0G7_[P64>LRU])'";]P'Z%5'".L3>W:0F]'C 21\X
M%S+P[)%V?Y9?9]/U>[\HA\IK(CQYBU6&$K5^%W+D[JT$T33BGB;-"(+,DT^J
M>G"_0&Y_Y;T]+GDN3@OL6O&BU4I_D43[E\-,#A*9L+[,X>7,I\3Q\97)]^8Y
MXM!ZI;F=P(8A#]9@&-/E2 WOA+_4P>(R[">MC^)A05Q9S<"G+/8C;0%/M8_>
MXM1!$L*PO+8 -IH5!ZPC?=XYF2F'72A'G--6QHU;^6U_9B1N_+\X"(X6T0PB
M(;M_:O;J [\/Y"LTRM&ATY?IJ,5[5?JZ_W-Y=<B&P2X\%/< U[)'=)R::=:G
M;M9&^#'Q]-/BL*]4?*6HLP3MY%V7K<4#D<=LF4@IYW^EK(G^&]J.FID2,5H,
MI!N[((C[*]B.^L]@>Y1@-Z!QUG1PUABE;&3"/48 =.6\HO0?[IT1;)C$&XVP
MN)FOEW4+E^5ML:#0?]8L^#'_=Z;!_@]*QYY4 %&(MZ13;I^?A5'S;WB1PXGA
MP26_P;!&*5]HBI%EN93ZW^'N95'R8X:Y8:H=>KY3,'6H"V*+ [)4&A/-V=0Q
MNWQOH#:<UN&4> 4/F)?KP .DKW[T3QD\H&7T=0&-C7>.<OF]1Y6WIKVC6#/K
MS7&4MNF'0##V.@AK#-S-LL #OIU?1:XG>,#"VH7"5SS R@P=MP=>]I"DVOA/
MUU?Q@$ :UDNB43R @ P/H):O"(;_CZ_M3$^\.W2:U]RO;QIF<;G4%34?[@+4
M&MHK6?S[EG*CO[UK(44ZM!SXCEKX?L,:ZSB2P=G(R4]T9VJX,[/JDQR0Z_LZ
M D(C_]LYYE5T8\S+#TRRQ(59!"]6;XB%<J2<1_\W3P?YGUP(\>/_ 5!+ P04
M    "  1B&%4WXO>/VS9 0"$AA, %0   &EC;'(M,C R,3$R,S%?;&%B+GAM
M;-R]>9/<N)4O^O]\"CP[8D:.*+@)$MSLF;E1VMH5HY;T)+7[^G:\R,!:13N+
M668R)94__0.X9#*S,ID $V2Q[RPMJ8HDSOD=\H<#X"S_^;^^WR_!5U&LLU7^
M7[]#?_1^!T3.5CS+;__K=S]_>0N3W_VO__ZW?_O/_P?"__WRTSOP>L4V]R(O
MP:M"D%)P\"TK[\ O7*S_ 62QN@>_K(I_9%\)A/]=W?1J]?!89+=W)? ]WS_\
M;?$G@3#B.(X@$5X*L6 I)(DG(26",$D3F2!R=?LG@M(H]#&#B',!,4DH3.(T
M@M*3)&8B]H,XJ1ZZS/)__$G_AY*U $JY?%W]\[]^=U>6#W_ZX8=OW[[]\3LM
MEG]<%;<_^)X7_-!>_;OF\N]/KO\65%>C-$U_J'Z[O72=';M0/1;]\+]_>O>9
MW8E[ K-\79*<Z0'6V9_6U0_?K1@I*\S/R@5.7J'_!=O+H/X11#X,T!^_K_GO
M_OO? *CA*%9+\4E(H/_\^=/-R2'3'_05/^3B5EOVHRBR%?]<DJ)\1ZA8*NFK
MIY6/#^*_?K?.[A^6HOW972'D\<<NBV+OJ5K*5$N)(BWE[T\-]L,%XCN2MWPJ
MJP/A*G7?NY*Q#]/WSL3]HOA!C"]P9YB+1:Y?J#<YG^K=W0YUL>CC2^SJM5B5
M9#G!:[$;IB/R4O_@G?I;,XQ^4 ^95N,TU-T157PO1<Y%S99[CP89_Z_?J;\M
MUD6Y>$_NQ0?Y$_G[JGBU69>K>U&\7MV3+%\@@KCP*8,DYA)B%G&H9BPU,7$J
M0AE@1DFR*+<O]D+D\.?/K0S50 :C_,Y"Q_+$MUJ(]6I3L-TL=[\\-G6I64O/
M<\D/N1)F_4":&Y2HVB&HI?_O5CKP:RW?__>?/^ST&8KD<AI\EG.!9L7VA%AJ
MAV!5'*J^8F:J[[ZRM9*ZTEN2-:T$5P]0 /CH![$LU_I?4/\+>JAQ%7[?/\(/
M3RQZ7;2RDX*= ;VYX@>V4A[00PGW\-<>HX62Y<KB9:AA5</_#JP*+@KEW1Y1
M9?MR;M;PEI"'Q3M1JD_H@U3^+<_*G\0]%<4B(%X0$A1!G$94N9_$@Y1Q"D7J
MT1 QP1$R^LK[!IG;1U[+"%82L$I*LV^\%\;^3]P5."-_X3M<:@'!K[6(#KYT
M$P3Z/O3F_L['WOSD\(/O'6B2[]U$U?9S-[IVV-?^6L@L%_RER-5?RH_*T->L
MW) B(\L?%9>\6ZW7BS!(>1R@6*T]0S7%1Q&"J>0!]".!4NKC $NV>.+"GGW-
M#88V>NO-7'677\!63O#B5DGZAQ^62E8[>C#!W8PM7,$X#7DTTH)&7*#EO=K^
MZP-=9K?5ML 5V(&LU0 OM")_<$<Q%K Y91R3<2<E( L@#OG(YM9A]/3YCA3B
M)5D+_FIU_R#R=?5R7!>%>J>$WH9[^;B[Y"-YU#^Z_D8*_N:?FZQ\O,G795%M
MUZT_E'>B^')'\@\/^A'KOXJU8HN;O%Z\+@*]N^8'$8Q2$2B.\P.8$"&@3R0A
M?D1]/_$6W=7CV>]R*M$'<.3(]%BIM09?*S'!"_7QKJN?G/YZG]?V9CP[*WM.
M0]:5/E#OK7+051ITM ;T$72O:S0'E>I7H%8>=+0'E?J@5/J#!H K4$, U*M2
M@^".YZ<VF]/)8C+A)YUQIC;)X;0U^?@#YSYV)_AFJ1;Y+S=K-<^NU]=,";#.
MJJ%>/G;^]45\+U\JB/^Q$'$4!=C#,(VUKTX95;YZ*F!,,)$L24/)?)N%^A A
MYK:0;W702]96"]!5XTJ36.<'EO/4$#L9SCDCHS_V_&$+//CU"Z'J>JT,J+1Q
MN*EP"9AN67V((-,R] 50/6';2YXUC#FOOY)LJ5^DMZOB,UF*SX)M"C6"6+\6
MM-S]Z]6F*!2-+Q!3])@B"H.0$>7\XP"F:<H@0HSRP".!2*U(TW+\N?'E5GP@
M5P58*P648Z:]^=I_>_%^50H0$$MWWMHH"9-^% F8ACB"&,<84LQ#&"11C(4O
MO!")Q</!L?ESFN90EF<S$"G!6DNA:?=1D&)<.R4D"CQ.(D@\]1\<(1]2Y@N(
M1!P+]0O$&6KLU!X1/[^5CI^+N[31O_\>1=Z?P7E3B9Q/8R@SEV-$Z$??6J0E
MV EXM<,>*NRAQOX*-&*[\RH&XN74H;"585)?8B! AV[$T,<,\R!:5T4M$&F6
MU^O#G9_R22SU-MJKU;I<+W :$T(B!N,H#J!:97&8BH#",&!<4)E2%ED=C9H/
M/3N_H>/(%[6<@&E![7C- GLS2AL'T9'9;+M>ZDA]M;=6:@0'KWHAMB8T>[2<
M<IG%\)/2F#TLAPPVX G#R.O'U8I_RY;+U]F:+5?K32$Z^T,H)#X/(Y@BIM@J
M"!.82,Q@$,M D%1XRHNS8:N>L>9&3ZVH=FS4!Z89_3B":&2^::4$.S'!KZ/L
MPQC@X911^L:;E$(,%#_D#)-;AI'$JU5>%H25OV3E71L_=KU>B[(.+M%GMV^^
MZ\UQL4A3G";$HS!.!84X\7R8^'$(0R\2(0Y\&DEFPQGF0\^-0EX2#KA>9HA:
M/CLJL8#<C%G& 7)DHFF%KA-G6K&5:Z,%OVICRK3LH!$>O/@D=(8.63J,_[#'
MSBDI60P_*4?9PW)(60.>,(S!;G)6"+(6KT7]YTU^<N@%3R)$<.Q#/Q9(N3VI
M!VF2<AA*WP^Y%^/4EW;A'1:CSR]"X^><JDE%K1T*]6'E&TL>LP'>C,A<@SD-
MD[52@Q>MW'_0$0R]!.>.P 9@YI3!;,:?E,(& '/(84,>84=B7&2+9M/J\<UW
M=J=##W1$_P(CY/N)7I;%J7*V.,>0!#Z'G(6"QQ(%<1*;.%NG!IB;2]7*"%HA
M@9;2C)!.@MC/.BZ@&9E:+%$Q)H]SJA]AB+5@?[Q=??U!W5J1PS^Q_BNL_UHQ
MPLF'3O+9GU.I_;;/7C?,"ZEC@G;[SV^_OL\624 \P:3Z?@77.3-4GUU& 0Q]
MCI($QQ$1=*%<6KHR73,=&\;F?>T.-J)O3XKB,<MOP5>RW%1A'\M5?@L5C]SO
M'7NI65)4"MDY'D>Q-O,P+L5OY.^]"9/LGEZ]_2M\?S/"@54?$DX=A*,#3>H)
M]*EZ..7W7CNWX/6WJT**K-RH5_ 7H8M+"'ZMOG!R*WY4#R]?JR7$6Y(5?]5?
MX2*1PF<!X1"%00 Q58Q$XR2 ) V#-* ^)=1JRW<>:LW-CVEDUP'O/W]^#1Y$
M44>]SR;HW>J=,2/5>0@[(QJ?+F"^ ] 5:"$"#4:@ @EHE("&"50X_19BZH?8
M_3<2<6^EVO\E\?A#S#E=M/X@Z1R?MESG_%U&:+94HE:QS[O31<90@GT10.H%
M'L18S=O$#Q+($QE',HQH(CPGQRZG99C;)-L-*&_56>_OLZV;C39 <@Y:M90_
MY^BHIL=>%Y[9N+'",QW>;'_>GN*T_]ZJ=%49Y)-@(OM:Q4..&>I_ <C3G/+T
MR#&/XY[S0!F?^Q@\REF0GGJ_5K=Y]B_!;[BB_$QF>L!*C#KMH% <OY-'\8+Z
MG9H=>+/,[ORBFBT6/ U9C&@(U1\QQ-(C,$%A#!D+4I%Z1)'T-B^XK3<V)"#-
MM> #SIR.UV1S&R#(BHUR4YO3\W5%":O*NV6U&F YE+&G>!DB/XYE0A!,4S]1
M,W+"U"*:IY#(,*8<^Y[P([M3Q'F^"2._!O5Z9M:6-IO+YV*]YXQ(W2D,NAK7
MCD"3[:=T/G3'0*/V=H.S^\NK>LD[:DSK6(8:.QC6N=S/'44[EB$,PF]'&WKB
M_>*GZ]EM;0OA^;Y,? 8E3GR($Q3!)%#N#,*"12GQ$]_G$]4U.2WE_*:H5[I<
M\5+P'Y2K4M'7]%5,>HPZ\N[LA8;ZS6RU'MM,G54)DO.&F,?>9X^<OXV-S/-
M.]N5-!C*;O;(V+)8?"Y7N?@+*>BJ^$MV>_>W3"SYRU7.WVYRWM2>C)'OI3P,
M(4&>A#AD:O$2J.5LG,2I9,)/TB@PV4XT'&]V6X=:8E"+#+3,H!(::*F!%MN,
MUDW1[J?H$3 <FV[/P7>^"N@@''G3;J'ZO*;$<V_@6>-J/!]9HE3/+?JF:L)
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M$(A#%$+"HP!*06@L$H2EX%:SQZF1YD;].T%!)2G0HH)?:V%MTR9/PFO(U"Y
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MVU+M 7&2>(SQ! 8"$XA%@"%%4D(4)'&82I&@Q"HM_?10<R./9@56S?BMK%=
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M;[^^S]K]T47*4\&I+R&C-(18>@0FB8<A0HD(2>2G-+&JP-0WV-SX>YN*G^5
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MME68; QB1BUCP3PRX31B:QP[/8KT0>&>Z$W_=C!*8XDAT+DMNV0CP+05EP9
M\Z38TI!G#"W"_FIU?[_*JQI.59C[^L.F7)>D*O"S\$A  RP91#%6U!80!!/$
M$T@C*H,@"+GTC*C-;+BYD5E389Q5(H.UEOFJ238#JYW8]CEHANCW\YA[3$=F
MK@;.6MJZ0-Q5G=2S!AV)719N-T'FPO+MO4-,7,3=1-VGI=R-[AKF1[U;D5SW
MI7G7%-!LJWU\$M7IZD=25(UK.,^J5)J%[Y&8(IE"S"BN=FIU/#2"$6?$EY(Q
M%%E5<K<<?VX$I,4'MP7)M1=5/H"B%AL\*+D-^U@.M829#S4BOB.3425YW0FR
MDGVO&% C/FCDOP);#=SY4 .A<^I&V<HPJ2<U$*!#9VKH8X;6(5J7Q8:55:DS
M]0]1?!4+Q# 3H:0P("2!.$$)3%(_A9+00/*4Q!);[2T?&V1NU+4GHR*N2DC;
MZD-'L.0BY)@B F,:,35#J'6VFB$89!*%A"8DYIS;'Z1>BNATIZAJ29!K1!^*
MU==L;9SIWO]^IJ'T>1C ).%JU@U1"%.$?<B$Q#STHX#PT/:DU VBXQ^3OJE=
M>)=PFDV=EP(T\ORX__U^.O/]#BB+=5I[QT6QC@PT<4FLTZH^+8C5<^V \/TW
M]P_+U:.H2S3KRCE?OHF\?/P_HEB]R6[OJF(Z;?IM+&0D90"%[M6+A?*_TX1$
M,&9(R-C#BB1\XR1R\W'G-F^UDC<%S.LZ4$J$I/JK1<BV!?3]A#$BH&,O^'NQ
M'))(;O,^FP>ZCP/N1)'LEX)L%YEN#U5OZ+G%XZ:++;?7<2]X?,#MEQU6[\["
MJ_.O]Z)<1 @AM:@@4"JW&&+/YXK,O1!R&?LB0A'V8ZM]E--#S8V_7S\YKAY:
M!KD'7KNSZ\M F^K\NAO;TAQC*TG='V*?1F.4@^PCPSW+8?9IM4\=:/?<8<<7
M5=OPXG'QX\L%\8B4/(J@1XB$.(C4ZED*!H,0AYQQR7D0F?#"[I%S^_Y_UNWY
M./@?Y3_SU;W9%]\!J/_+'J;VR%_PS^]OOKQY#?[GYOV/KS_\=/D'^U3)GA.2
MYN+ZNVS^47V2U<?8>=0D']U3T=N/Z\AOW#?FNF;_W&3K9@,]]#ECZE.&+(@1
MQ!&.((DQ@JE$09QBRCV?N.K'U1UX;A]D)?*V!]=:S\DKEE7;ZU5//G*TKJ>[
M'EU[1C&;N,> >F02,.C(U95\FC9<Q[":K/O6WN"S:;IU#!*;7EM'[Q]X-IL1
MFBVK9H5-\XMKNBYU3V^U?&!4^BR"$ND.L4&BN"M5OD* $?$139'B-:MCV)-#
MS8VM&O% 1^(_61ZTGH;5\$S5"5AC'Y_NA-SV3@&_MH(Z##4[CX;;$]'3PTU[
M^'E6[2?GG.?O&%(C77/1W6JI+E^_4=13/NK%]"?!A;C7IZCO5_FKITF4'U?+
MC#W6_]V%988HYGZD7" 9,*Q8!8>0A +#.$:4"N1S$AL=@[H6;&X<M%-"9S'#
M5T?2F.O(A5IOFU+7#JUIL&G]3#::PM5JM/J/Q@9 *Z;C1LY:[@K4FH%?FS]-
M G3'M:1->?+GL>A4A<B=6-95>7'W4/<7$G<XWH0EP]VCM%\<?(3G.X@LTF<(
M37*EIQSU,.04HM"3$ L90YIZ',HXC04*/,$\HRV],^/,;Y+LQB?41UV#LE9/
MX6KFK#M :^3I:@A0EX5S/(5AO(B.SEC/%]3Q5.'>N(XCE[MMDGU0=I1Z81JC
M$$%.HQ3BA J8RE3"2 04L8BQR$M=M+Z>=Y'78V7>FC.O"RN^&IK!C%#<@SLR
MOSC!U5E?Z0E*Q!H./8L>T&:E8RWO'E)&=KE<?=/E:=^NBM>K#2WE9GG-JD.9
M3MXF$S25L4<@21,$<2@93 -*(1$!(82EE/GF?4R,AIP;27ULPU"!7*F/JA \
M*ZOD3F&8+VN!ML$"WCF&(W/15EZ@! :MQ* 5&?PZ;+%MAJ=-9577N$Y5-=4%
MOI:E4&V@ZB]S:O2D"4N8VFBV7Y[4ZDZGA>RV02D?14Z65>9,SMMEKY*AV B^
MX$QZ%(4"BIC&$/M)!&GDAY!%&(>ID"%'1FTO'<@R-X*O:ZJ06KA=76^]F_O0
M:N&D%)N1H<Q<THG@'WEN.%G2[:H;^K;5I3))JPUHU!F]^IL-IE-4B#.29PY5
MY&R ,ZPT9_7(823;D+;>$]![A7J(]JS8\S F09) G$H*,>(,)AX7D":1I)'T
MPH ;I6.<'VIN%+F3%+2BFIPLVP)LQGUN8!O;[1V&F#5IG0?#*2?U##<IY9Q7
M^Y!1#.X8'/)_T J]+;+T=E-N"M'^HNY2NOZ;(,5;]9HM C_QPHA1B%"JLV93
M!%/$?1BS!*.(HYASJQ)5 ^68&]6H%R^T3@H89  SMID UI&IJ-&@=:Z:=*1M
M);!:C=UO:T6N@-8$:%6<YAM<@J7K9(1!LDR=J7 )8$?2&"YZW%""++*OI*RV
M,/61BW[VIVS]C^OOV7J!A8<\DDCH4RF58Y50F$BA,UY9%"$=W!A9A37V#38W
MJMO)"G;"*B]!B6KI4_5";,IS;H ;G<P&8#: J,Z#X9B->@:<F'+.J_Z45PSN
M&9C;H3,4Z/E.\/1$)_A.W:Q?A$[U%/SZJRC(K?@D] F*^GD5+*+\P U9?A'%
MO;_P12 %DQ&DS/<@]B(,D\@C^O3#CRA+1>HSJS21Z768&]6U<@-2"P[83F"@
M!+C7V2BK6MUN'3_+G)-G>%G,V'7FK\#(I%VI!BO=0%=_T $ T$?0O:X! 50H
M7($&AZMN5<(KL'VM&C# %@W0@0-H/!RFUSR?+=UFZCR#'M,F_3R?H9[D#SVC
M* -B UXVZ7^O=ME_VV-PLKS)Y:JXKWYZDV=E1I:[S95JA_9A*4IQS?^^69=:
MD2;WH:KVUDF)6$3"][U$^C#EL9I=/>Q!FD9(AQKXW$L%#GAJVWYV$LF-J'7Z
M;GF[VM.LR?Y9:L'!<B<YD"0KP%>=M@;(5DV+<_=IW@R#.(CY&'JB[MYM1FY'
MX2O041ET=-;G9Y76H+,/O=-;%\]L-=^EBE7*=[/L9O=:6(1SS.[UF"@<9$ZO
MB5U4R:06ZXU*F4:2Z:):)D5V+RIFVI$'.#J?M/^%F_)D*94>#Z5:@7 >01RQ
M "8I%E"*-$38HW&0FB=#=I\\M]5X)1O %OR^AY/![#Q4^Y$GT4;Q(67N]A"P
MF(B&(C'1?&&,B!V9'].ZEW/W;IB.&H_)N<=@1R\8FBU69D6UV-,G+Y\?U+)N
M5;3QW-5./<<<BR#TH(@"#V)?IC!!8013PFDL/80"8A1L;3SB[(AI*W"=%=6(
MW,E:&' X<AYWLST\IVB.3707 CD@V\P0',=Y9^=&G3@#S1"$I[EHIC<.HYXC
M?MBG;7S=#5?C9C+3N;-U7;NJHDTAN"[1O_.SU._4C,2KS!3=J+NI:%'=L8@\
M$GN4I#!%"=?E:1!,(I3 ,-;UR@GF <<VU#6ZQ'.COCIG:T@SQ_&-:\:/LS+9
ML^S&[-0%77V;XIV@U;AN<=+9E&N4O@+U2[#3N[G3'4U/9B.G-#^^U)-.$Y,9
MX7":F6[@@<G3V]YZW27^X\*+4N4""P$%4LXQ#@,?4B])=3.,5*W)68I2M/@J
M"KHRSI<^/I(-PW3'&X]HJN04R]SG$RB:L;@#9$;FWDZ+32WBU99*'91Y,43!
M;?+RB;&FS5;N5_A)>O*9RX>ND#LU7-C3&BYUM9>JZ:;ZZ?6]WBM<D,#W)4]B
M*!'S(<8HA81A"1GFDL:()'Z<#ND^9"^*S3<R77>BE^(VRZN0"$J6.D/1=O4\
MP"9>G!*:LA"J1RK"1AA#&J9Z.S7Q_"#U@X0S^^Y%4UADLNY&TQG#='=C7'A'
MW_#H%@-C1VN!U2I<@58)4&OA<A-D.(:.]T4&"#+Q5LEPJ)[NGESP+/L>S:^;
MG?DO!<GKLK^?Q,.J*!=A0) @80+CB(<0\YA#JBOV1B'#:>!%# =&L>Q]@\QM
MVZ*5$^P$!;6DYFV73P+:SURN8!J9F08@9-55^1P$@WLIGWSP9!V4SZG6[9M\
M]EK7V7V*1XHR^U>UBOX@?R19KHO"O!??R[?9FI&ESIY9()I(WQ<AY")-(!8^
M@8GD GI,!$$B*:5^W(:XF;E!EPDT(')M9 )Y+TJP5'*"\HZ4X%NV7 (J *EU
M$1SH-T(79]C<;^H&P*MJCXSM%;?*ZFH!65ZN0*X>6/MR&5./JK/:V&I=@I5:
MLJMAA+KD>PD>%1RN$@V-W@4S/VP"^\XB[;"KC0[^U_J %UJC/^@N1\I M595
M'N(4*8@V\$Z4B6@DTDP2$FW@,\]+M'KJ,(9_M;J_7^554=FJG<,"<10)$OLP
M2B+%V5PFD KMQD6)$ E#+/"LCK(.!YB;"_>A4 M24CPVW6"N="O[)D0X F)3
MK #3V:":5.M+_@R0YUUY]?]O>\ALRKM5H2G[JNWNYJLO.?2OXB2Y\M*@O3"K
M&Z+H,Y!.H@]0Y/]:L"K. @1(MTOTO>JB,+B*?/_*]R+K)Z#TCW8,_^1=,./L
M2RP\,@O7HM6-*+=M9^I&)NY(]93^3FGRR2"3$M\I%0^I[.1U%Z0_OCR?-_+R
M,&^D7O/NTC'7U7G-ESN2-QDE:JG\5:V-!3_()_E1/;I\K3RMMR0KZH_ ]T.*
M9)S %,4QQ%[HP]17K,@D]RA/(B*1;[_#.@?5YKEC^V&?U.AV U>Y2;44X,7/
MGU_O"-FRB^8<D%_0B(HHB!CD$>,0(Q3!E$?JP_=CEB">X##V;;>(YZ#8'+><
M#UXHH2?._XM>);-)>@ZBSL@Q<)"3VW3CZ"#3!+"HI7R^R]C=PG,D7[>""&B,
M@ :I=E <I^K.Q.;N<W>?6['IDWF?6^,33M^L9!O8>5"LUT+L'^MW"BDG5)*
M(SU1LT#7/]1'&[JC":5!* +,0V35.;5_N-FMD/<C3BSC,\] :S9[N0-LY'FE
M%E07;-C'S'$A:CM<W/8C[!]RVIZ$1NH_Z4MH=I>K$Y.WFYP+O7(J-^L/4O]D
M$5"2$$X0%&DJ(>8\A(G/I/I/2#R:<I8&>%'JV+>AIR)/![5BE>W0XWTI__Y[
M%'E_KN4$ZTK02\\CCB ]]-3A,OR>Y6RA@?+%S[FL_O8'4(NO%SOZBC%/$4[#
M-?)9P9&!G_E$X#04Y_?]>^YUEOGR.ENSY6J]*<1N$L9!'#,_%3 (1 @Q)JGR
M;Q"%01JDDGDT89Y5>7RS8>?FY[P\TO7]\F248WB;L9)[%$?FI6-I(6 G\D@^
MD!U,8V=F'!OZN=,K>N PR)'HNWM S8']D.DFHSR.?<YP$$ >Z9J#) PA92*&
M<1)ZB?!P1 DWKCUP;(2Y<<U^&1&;CLE'\>LG%">HC+YPV@-D2(V"H\A8U"JX
M%*&):A:8OCIV)0OZE.\M77#TQNE*&/3)O5?*H/="^S#8&R:+ZPW/%*3792G6
MM=7?+LGM@D5)S%*&H:!"0.P'!"812R'SA!?HDYW0BTT#84\/,S=&NWGU]A-H
M1 4=68$6UCP:M@?7?I)SA];(3#<,**N@V/,X# Z+[7GT9(&QY]7KAL8:7#TP
M.H'=";Y9B@_R^/9V%0;1[&3K3>IZ6USGC]8_^Z)C]G>+@@@%-(EU_E:8Z&K+
MRMVD- Q@B 0)@H2F+)%6=9>=BC<WNOF\N;_745LK^?18;7>65C?-ZB@%?E[W
MA/Y,86;#X]IG,][8!Z^-8MIP/8>KE7Z[0]2MBGNV_+72$HRRJAS' &Y/0=V*
M..UYYBCP/CF9'&>4(>V&^5>=[]CV%GDO2GV:>4NR?%W^G"N?=*E/3^L2QNM/
M@HGLJQY[$7,9Q%[$(&$IAE@D/DP$C2 2DDB/\XA2HYVY2X28&_7KG FK_-&+
M+&"PM)X UY%9N=&@9>$UJ'4 C1*@U6);5WX-=GI,8 2;3L;C&V.JWL:C&,6R
MV?%E:/:W/Q[X[ D;(E^F_7Z+Y N?-6#2>2VD*(JJA6A3TH;S*C>0+-6/ZE[N
M55ZP7!5Z.ER_7Y6?-_3O@I5?5F^^/V1%_;T1+$/UMG)(X\B#.,$)3.)$!\*D
MV M2)F1D5)C1I5!SFY1N"K'4:XWUAJXSGI&BZMB[50V4Y#M@E7* =;0#ZL\V
M?T]=8D&EKHQK,+\]@\G&/T&O-*HZ+-<ZZ7+?6VOI']=Z@3W%@-(,-*J!<@5V
MRCV#Y2PFQ6>PX$23Y(26M)LY'4/>.Y.Z&FNZF=4Q.GLSK>MG#]L=O*E"5ZNY
M_B9_+6AYG?.?2/$/4>IIO0Y]_2S8ILB:1MZO1%$J;^!+072F0BWYL> !R?V$
MIU1"CR$",0\$3!,>0N8G41+&(>+8JG/N6(+.;H;>Z6FW 3B:)<VV N=@G[&/
M1'8J*F<(:"6KC=N=FFVVQ4Y1\$)?T>@*&F6;&> /XT>=C&T5ISN%HPD[Z9[A
MV) ?[AZ./I[]J?,[<4N6;_)2C5R5;H]]PGWJ>5!Z)%5S 4602II 2E%*!.64
M,Z.>'4>>/3?ZKL0#M7Q6A?"/X7;^*/D"-$:/E#$'PNK4^(3*@X^*#Y\WV?GP
M"46ZA\*G+AFRM:_5_B1T$A,K%1GDMSIPMPD_(@G#<<1\B"AF$+.$0J+^#06B
MZ@-E)(A):KY_WS/2W#Y7+2K8D[4_"-T25Y-=>4=HC?PYGP!J2 !<+V(V6^B.
MD)MH"\#V5;/< 3< HW^;N^\!$^YE&^BQOV%M<L/02L=?1;X1;Y6$;[XK-E(K
M\U>;=;FZ5\3T\O%'L;HMR,-=QJX+00[C)S@7H4=1!(4(U/(7>02F*!(P"J1:
M$">$4V*U_+U EKEQ;C>V0OF=99'135M@3!^:-JKJO/:=7KK]H5+-MA+O< .:
MK7HG,LO(Y-XB7I7Q:_4 6T7V+5'98=RH%@>H.J[4.UR>B0OV7@S<T[J]ES]R
M>/G>SW=BN=3Y^B1_; OXZO:/(4>01,I8F"MS$80YC/P DS"-*$N-F+5_F+F1
MYK9 ;24J:&0=7,7W"*[G%YMNT!K[S&P04(.*^9[&X>)ROD<>/7E!W]/J'2OI
MVW/UX!3U_?,1]9?V9[KR9+X6RNT3Q==J4^N:L6)#ENOJ3]%MA;/P. T%Y1'T
M!<(0QXA!ZA$&$XRH1P4*<!+:N&*N!)L;Q302 E'K4 <E;]KHG:*>!ZR3W]W8
MT,P;>P[+/$<(@/[[]A>-8KJQ6:U:'4S>*'<%6K,Z;08^%N*N\_#="#=UKKY3
M2(_D\[M]_F4Y_U7_LKH6_/ICL7JKFXVK56#56ESH.L(+7^*(*R!AG#*UE$ZX
M#RE*,$1!3"(/89U\:]=8S'AL&R*8IM687B#7@5@_O- 5V2U+ 9JC;L:XHR Y
M,J5N\_\[0E\!)36HQ*[V(&K!FU+G[HL &,,U2AV \Z,_2RD 8U!.50,P?\#
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M)CB"44@8]E,>8R8&KDY,99C;A_QI2&+!$.RM5RUC(#KE>J:5'WQ3"FS3.:_
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MZ'GU75UU&-5#[0G0H1_:]S'N+<S?-]/FQ[SD=&&<V(_Z7\IY1$(A6!) AH(
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M\4A %. (XIAPF!#)%(T"AA/I0@^GQ4R-&7;1^4;/&3":]@SX.X.K'5/<CM;
M)-$/*&>*N(R#5W8X(VI48KAL[B$G7+FZQ_'C]Y^K8OU#/_*P4,BG;1I0>?<L
M"_H@OTDC+%\^M-5GFC EA2.LUWR9V937;@6/*&1!Q/5",,.*9FE$4ZM0!T_Z
M3(U@*HM ]>'L4JM*0&LCP&-;RL<Y0-##T%D<AHX[($-OQU5C8:S956 R2>7
M& 0Z%H'&)+"U:5=SR3D>T,- .1S#CCM@(QW7CC%P;H>]_F"^>"CL0<QXA\?^
M,-D[9/;XV'X.<]L?Z]WJD>7+.HRP6'TT';$ZC;&^R6>YW.QV<>7W7$-6_5)6
ML4.F6-L=7V_H8AX&C(6<Q9#&4011S#@D'(4P"X)()B'-J%M30>\:3FT6;50W
MYRBT41Z41OOZUUI](+3^;CZ[_Z&U<_=?=< &GF6W[>0ZQLV -@]4]G6;R<U
M9V#O]@>V8V93Y["VU-]:8[!!\+I,\:_EJ"N<P4 ^7!P-)ZC?K/%NM:SR,?\K
M7_]\MRG7JT=95&=X53NG=YNBT!/7/*)A%.! P@Q)L^L2I)#$F$!.LPAQD:H
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M3.B&+9W\N[<4+%/ZY&&9_Z\4GX2FSUSEM.TW6+8M">_TE+?+#--_VSQ*T13
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M^BMF"E*5QI"23$8H3?6DGMC$U5R4XO0ICQ!0<W<<<@?>+.6%NGT.B-H<<GG
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MMQOYM"S71;6<+ZN3E1\_Z;+Q]SZN"B7-,?*G9;W(GR<1T?P64TA9HM?D89I
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M!7,A(PN94R.C5N59E4.]KG,M6K5GP"@._JA5=UR_V@R '2%YAG5@0OJ\6C[
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M] (ZP#Q-6"A2CIVJ^IZ4,C4/NMGNWFK9<W/N-*(NYP,WX#3.B8 #1#V/ ,Y
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MR1 []=ONJ<?4B%:_;<CQH*#G %@>(0P/Z]"'"Y4%L#(![&QH*S9O,ZF[YLR
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M]M5R/3LHLQ<E/!6,"QA%,C-Y5Z:#?%I 5F09%SE*<NI44_WY@Z=&T#YU&H]
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M_C ]Y] KGM0S1<VXL>>EJ#T=^B?^M"_YF/$488P(1#B/(4)Z9@HL8R@((:+
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MG1AF5,8YK^9SINBXLD\KA*^OR\6C9I8'^K%\*#5I;!-9,).XP!1B5"B($I3
M(DISO2K&+!(%+G+DE,'?.<K4++BW7\%.4-!(ZE-C_QR8W5]Y,(@&_M!/H=,G
MIN4L3#X]!P+ -59S@5ZP>780N !'=ZN <S>/V!/@@OR'Q?\O7=R#!V^UY?3S
MZV*^L094\SXR'A=9*A#,,[T!1D0ED-(\@RR5!<(B$BQU\H&='6%J_&=E!#LA
M/;[ID_@YT-ZUJ Q,><\ Z<-V)Y'Q8+IK$1J)Y;R1\B.X+A0ZR>WDC>,16Y?<
M!Z36>6&_K=LW^?"X6-+EDXEU7C_=<KZTD='?%E^DD/5>T6X=9Q0E2981#I5,
M]3Y.Q I2GC-M) L6"RHQQ4X1R]XC3XT F]JAMHT<I_,Y6%A93:?Y2L_VHEIK
M4>;FS+ZLM#QRM6ZJ*OMM!-UGQFU_. C> U/K3F90"WT#=F*;DL1[P6MW6[@=
MI3=803>:[J./NO_T!N7YMM3_ 1.(2Z:K'TTJR$\ZU[>N9I',-!>F&1116D"$
M&89,1!BF&48B1WG"TVCV4R[9XD4BDX\$]OF@VV(/&$1@(IY,R"HW/\B]J"\8
MH'P\SVZ\.IVY&YB,API0WKX+[QQ>@Y>-3SX[.].-3SX6^<\;GWP6_D'CD\^/
M.G+[E,_:[#1[M'MYI^XVZ]5:?S3:RK0%,_Y&?Y4/FX<98UDDM2D.B\AX9"4E
MD,H,0XP5(W',\R+U/Y@?2-BIV?6-6*"R#0&,=4^-)H"N3(.41AOSZ]J:!XN]
M6K9U2G/16+U37%X'CW/]"4SR]$_V/Q^\!RV5FXI!C=(3Z(CB,373Z(+B(O"?
MH_.)!_3!NIWXC-ESV=JU7&_ZK=^Q>7EOY5M]J-[]XGJ]O5.[2(,[99+HZ_7U
ML"G[#$O]I:*,PHB:[5,A<D@Y05 I@ABB-**%5UIG,,FFMB!M%3-<\[W24S5_
MLID@MDK)UT=MIIB_O-]4CN>/X:?2<7UYB0D:^IS35-?7"T2C45,KSE9Y^J-<
MVW2>?]3!7MLK]DJ;KK2UUF;^[#W;%@Q6WV&BZ(//0MAU(YATXRX2H4$]6A&"
M#^ ?^=^$D+PO5YS._UO2Y;M*O*5K.2,)$HBR5/.WU$P>XP*R-.60IPI1(3E6
MN7*-_S\WR-1(>9M/70L*C*1 BPJ,K.[9 &<A[6;44$ -3(Z],/+*$+@$0N\\
M@;,/'BU;X))J[9R!B]?VL_7>2K;^4*W62WLH_%U/M:V1),5;/=!B4ZT_+^5#
MN7FXU:.92U>K#=5ZO5FLUJM/<CU3L4J3E"=09 6#"&<Y9,JX(GB41PE.>,'R
M;56Z;^Z&WI5B.7T@AQ7IOHU *+8LG=#R@K(1&' CL?6)VM^+1CT_*^_:272S
M[<:8D[$L.@WU7I4;T%(&;+4!KQI]_F*GI[YG.VU6J1N@U0IGM07"-ZBM=JU,
MHUIH@0!\;I>%>FS/S7AY7Y6JY+1:O_EA? ,?JN_5<N?B_D9_-=;BZL/JBZ2K
M1:5MP:?/B]7*M+SYN&M]EZ,BYJG>A:<QRR!22&B.+E(8R9S3*)>%\MR*AY%K
M:C9?2RU0ZV6V<&W-@%9MN]-;:2('>^W 5KTK^AJ&FF_'_?KXLSBTZW?$"?3?
MF(>%.^RV/)!LXV[*PP)ZM"4/_/@>D<A_ITM[?OE%&ZG&4[RH]"+4%%(GC/ H
M(Q2J.-?&=\04)"2A,,[U=IWF.8]C)TZ_--#42'HK*C"R@IVPGB7K+\+;3:$A
M01N8$T?"RR.*.1!N(P4S]\;/+ZC9 93.V.:N^\<+<7;0XB#2V>7ZGJ:S?B_L
M49IUC\Z$0IAS4<"$FY9L>91"RCB!-E*"8161W"]@XN#Q4^/(G73-28.O&7J(
MG:,UV1N1H8U"9S#\3;J3.H>US Z'&-? .JG>D9UT^JH>YLZW):U6IO"@K=C^
MH5K+^Z5E=Y/$7JUDDS 3R8+GG"3Z,TXD1&F"]6XVBZ!"<223&,59)IPM'[<Q
MI_:!MZ2V#JIR+S=8RKJSPO_GL;([(N]@%(7'<V!Z:$.I)08MD4$C<Y]4+T=$
M/<RF\,B.9$$Y(!S(B/*#J-.><GS4>*:5GVX'5I;GK7T/DVRD1+,G-L?3V](C
M[S?KS5)N_U!',ZW,*=;[\J><)1F.1)*F,"%*051D"61"\SK-HH2S#(G8KR1E
M3SFFQO#ZC<2^!T'])L#U &AP6 <_^#D5RK,KUE2KL?]KK<A-?:IM5 EYV',5
MEH$/>?K),O+ASE6 '1_J7/>XD1,"3I5UTCS^-[G^L1"+^>+^:5=)FZ-"H8@E
M,,680229@HP5&#*"]?_)5/_:*5)G1)FG1KPM@3TKGX\QP8Y[\6E-V] ;_*%*
M^=FM54OW02JRCSA7T\@ \)#[SY$(X#\1P?(!>@Q];5K [8,)>UBU$NTJV\[#
M2+Z4/[3P>JG\4/'%@_RX6#V/)%<R)EAR#K,8FQ8<-((LEQ@*4T6'X (7K&=2
MP%5R36T1:J<$-(JU,W#+JN[O PZ4 [5VX)71SS<]+=#\.JY/X\_:T&O0]1,V
M4E9 $,0'R@FX3K87R@@( NCY?( PC^_CC:>_S,Y'3UJR7B11FC4NRY3)C&91
M!*42A:D&&4.6"0F50"QB0F0XE6YE,;J&\?FVQREF82*'K#/ B&K*TAAA?3S"
M9_",<::(J2M"<Y3J)9''D.1$09H(RIC$-$G< SD"H#F2=RN!@?!S.92X'I6A
M3R%.O5R]SAW.H.1ST' ]6F.=+/1#S?-0H1N.[E.$,_>.>&S0+?WA.<&%:_T6
MD=5R/?MB-C"WO\K5C&G#7E$JH%XOL&:Y0O,=SAA,621)K')."N+"<@=/G1JM
MF:/P<K4N33;4WR1=;99-X($1UO$K/H2MF]QZ@S%"R$4/')R_RY-Z=]FD^H:6
M/:K_]=P6/7SB*)_G226VW^/I/_8I9CN?+_XP*0GO%\NWBPU;J\W\EMO4A97^
ME2SOJSJ[C#_98\)Y[7H0_]BLUM;[/<,TE0(5PJ1[$HAXK""+90331$:<<Z$W
M\DX'=&'$F=HGWP@-Y"]N@X1]JL%>/34.IL^H@ ],*SM=@)8<;+4!6W7 =BZV
M"H&61J"ETJASY%/>=\RY&JL6\-!SYED[.!3$W86&KQYEQ*K$H1 Y+&$<[*D]
M_=4;MI+_VN@GO?NI_Z?9!$D:4Z7R!*:D,(T,!:J-T%PE(HE$3)!(O;S/IT:9
MV@JU%Q)((Z6G8_@DD(YNWFOA&=I,W2-C!0RX<W2"(*P7]>1(X_I$NY0]\G!V
M7MS#TOVTJ.0OR3?K\J=\6RXEUS/3O*XXSV-,.8-%'E']W1L3-I$8RAQG2&!:
MY&[E$B^,,[4O7TL*=Z("T<CJ8?UT0.I@>H8!:F ..,1H*V8?SUL'6!XV8!C0
M1C+N^H+G9[-=AJ33&.NX?3PKZ[(.!^:3P^7][*+W956NY4?]6!,'K.>RW)7'
M-<5 A%11'!4)%#PQ#5_3 M(DC6 A\QA%)!&%B'P,I.[AIL:7>Q$!K0NUO?JT
M6$N0>1ZF7P!9HJQ(F3)==06&2! $"Q8+&!.N<A,&47#JTS,Q(,@C]$_\M_\5
MX^@_3/44P!:+?X*?G1T=^N#K9IR&0VW@%:H6%%I)0>L5K64-7(?&#96@ANN%
M(4>U8-W4?V[*.M[5C[%_6RS$'^5\/J.J4%AR A&E"B)NS%FE""2(1S1)D@Q+
MQW/WYX^>WEG[5K*&@)$G >\PPU0)O:WG$,4J@4CO[R$S^8(<*\Z2/$U93&:/
M<EDNQ-<U7:Z'P^WY(,-A=_<H*U,_]KZ1LB=T0DG,HY3"E)@]4X85)"*)(,YX
M'+.(I8R)!KIWE1@:N.T0P\'V9KY8!8 M2BC6[Q72+YO((=)K/20R95!1\R+F
M(HF15X!C'\C&L)5^NPXFMS6ZC_(#K\87]?9><I\K&71QW3U\U&7TN4K/%\RC
MO_=;&C73F3S&ZOZCI/J%;WIZ/.T2TN^47IEIQ4LZ_ZP_[CKC<6TBYFR!GI7>
M[_!<H9QAF"DF]2*1Z_4ASCADD1!YD3$:H<SG:[U:HJE]YCN%@-7H9M?;Y^D&
M[ LKF/+D6[W 5C'P^UXU8'3SK$)Q_>RZD<RH<S8P.X6:KG?5YD'6.<(!G>'!
MD Y*D==+-2JW!@/Q.2F'>_"U*2;;Y6&?5H 2G-*(*RB$8'KO$Z60,*0@UL:I
MYFN1I+E3!WJ'L:;&P.W,@GY&5Q>PC@=Y8> :^CCO!%(C)56<A66@1(GC\5XH
M^>&LXN<3&L[?TH\W6D$#IL&H4:&<RT]RW4J*6)CV;I^7BY^ED.+UT_>53:/8
M$MXM7Y<_ZV9PVSQ;K-)4)8C U/0]0#'%D%".(<LI+=)$Q'GFU.Y]2"&GQE0M
M'4TL]G*K):CD&I1UJI/^O?F7[0?ZV*AJ<G,7.\.%[O3T3+\>Y#UPX\>7GMV!
MB?79Q.X4M$[\PQPV_6?;Z/-S:VY?&5WU"_ 7L#=/]_H.DE0]Y(0$I?1!!!UU
M+1@2ZN>+R*!C!0DT^Z:?8@/W,XRPE%D"8R*EZ8V1089%9@KU1H54+!;2K^#D
MZ7&FM@8<A5090;WR'RX!ZVBQ7@_7T-9J'Z2NC3][CL.0$6B[L5XR!NVYPA>B
MT(XN#^&8-,T@9H3G+)<%A01KJQ)%,H4%*6+(8R8P)P23/._O:31#3(T*]HO]
MW(A8=[NYQ@5H<>SCT_-%9VPGG9%O*"];6_<!W69VF!?T@[75['9L'5S9[_/^
M4E=8_4R7ZZ=6;<65Z0DS7YALMY;G2A)69%1_]T1FYH3!V $XA53) JL"H8+$
M/M^]Q]A3(X1&=&!DUP:8'Q7X8.[&$0,A.3!YM$%LDF4:N<%></#[(/ZN'H@%
MI1R?\4?EHA[ /">I/H^XJE#KFT6U7I9L8T8Q)1";]M&W5;6A\_8?5Y_E\MW#
MXWSQ)&73?WJ6RT0;+06",BJ48;78A-8G$*=93B,]?2KWBA,-(-/4V,ZR'"\?
M:;7^WRMM_+2$!X\'_>6I54]?TBI=]ZJLME=YQCZ%F%XW AUYT@8FUFUYV+;$
M38W81B-0JW1PQ0IH3<!6JQO0Z!6\5FP(D(>H&WN57"]10S8$D&?JR09Y=)\4
M_SJO4ANX7]>T$G0I5M\?A5Y-S-1%9)L#A2D2*1&0,D8A2@F%1584,,<JCV,B
MH@(YY3ZZ#SDU1MX+#792@UIL4+_EQ"<SW GU;B8=!LNA3P,NP]@G?<H-3Y]L
M^M"XCI4Q?\5KZID,[X-0=\*[TY-&3&KWT>PP<=WKSAYLK1<+N5S:_H%UBL#>
M/;%8F>*M^@]O]-_+]>H-72Z?U&)I*KVN9D42(9(0#&-E8F!0BB!)!()IIE)S
M-AW)Q#V)M:\44^/TEI-1RVT+-J_I+\!KT0%OR^Y!1KTGR8'OQX!^>%O9JF"[
MJ=9*M,YVC1JVT8OY:Z,)>#/V3'BL%&/,R$B+QV SX[>R7(MHYV+3^^'CK3_7
MZG^P)%W]L-Y^(CML?;:NQVBZ!37=,6:<9X1C%>M5J$@@8HI!BK5Y@B7-\XRS
M'$ONZ0/J&F]J*\_N2S/KS2M6"_F7?Y<7&EKU@MK9'Q,*P+'6CR9XR-#1MM?:
MJT;<\VZO/CX4%V!"^T<ZQQS;]^$"P F_AM-M_?CE]6955G*U>K-X8&5EU\56
MD6NAU\I2V>:P->G=\G]M2BV,YKMM;+J)XC%]#Z0XHL@9R2*L"I;"R!C*2!82
M$JK)"D<L3KB,2"13OVS90>7U^3C'2<$]X+>Z'((?J0T[OVZ4.)DY&YA0MWJ"
MEJ+M_@-M5;=FX599NVEJJ0L:?6_ "6,R'"F/,C5!*7U8B4==$$8!__ER,LZ@
M?=N%+_@_O\A'_4'^H"OY>;FX7]*'V\WZQV)IQ*N[,,0SG"-*4<(AB4D,$<$1
M9!(AF&&:LQ@KDDJ_"H)NXT[-^+5B@^5.;A/+;P2_ 70G.J!6=M_6XV[SX$;_
M Z [,)'7P.Y%!I^WP.ZE;AK,A&QC[@53X/[F;F./W/C<"Y#CCNA^M_?P(FN3
M?&FBV=[*^K\?*GO 2/GZCW+]X\UFM=86^])2XV_+A>9<6VQUO3W@CQ07,>(9
MQ#DWA5!1 :F,,JCR)$N)0$G,L;,O^3I9ID9M;VP9;].Q:5/I16>NO[>EY++\
M:5:F58_ C!#SY>!6'F\6!J; K2+@U5:5OX /%=AJ XPZ8*O/36V7W@"KTTU3
M1GI].1 C^!1Y^)O'FZJ1O,[C3)F?"SH,R)V.Z"N'&,\='0:+ Z=TH$?VL];?
MT:4I<67B:&Q?S,^+><F?]@' !4EB25(.F<@81$E$(,OR'":94EA&+$%(^%CI
M%\:;VA+62LO42Q6X6PJ]W5HV#7#][/%+2+O9X0'Q&WCQV4IJP_JLK)J7K+3@
M]^:_@X16.R(4U/2^-.:H)K<C ,]-;=?;@KFH/U1K>;]LG!<V9-LDE*QF"<H5
M,ZF>"3>5I%B40D9H##%#1:Z$63B\' /N0T^-?5K1Z]:U6.[%UI9TG;U0EW7$
MGJ'-'M/1VST< .07\/7>@);<8)LC\J8SXRZ$Q_8"6D.[7\\-_]*^U NP.#A&
M+SVAA\M 4Z1:+!],4Q;;1_PW_9VN5TU<)>)%3#.*(<I8#E&L;2<JN$E/%2AF
M(L)<*F>'0-=(4V.KSU^_KX"5$N@OYZM<_BRYM+SU[O-7\(TN[YT/OBZC[+"-
M#X7=P"34$K-!KQ:T3^1O)V0>V^I0T(VT:>X/H=]&V 66SFUNYP/&V\2ZZ'&P
M176ZH6<;!5HN_VX*U[>Z6ZYVO_S/4B[U(W\\O5T\T+*:D4PBG.8(%IIB32GE
M C),<DBCC!,9QVE*G'J?]AI]:H1KY 164+"3U/+MI]N_@]]KF3U+A?C-AIMI
M.!C& Q/S=?#Z]POH U/8]@%>$HS;3: /.$?-!7H]I!^M'512FF4I0CQ">@];
M1 5$"6&P()&$$K-,",921F.?/B4'3_>BI1':DGS:UZBCZSI3SP;+K!=@_4,:
M7_7FT8^5#L%,B@P+1"2,BXA!E H"J<PB&$L1*YK$J*!>]:#Z@SF2 [(&\QK(
M1)02EE$)58KTQB1F>MG,1 (3E$5,T#A'-/,+X>L-VC@A=T._@VXK7V^0!E[9
MCHL-WCX#Z3-=!LV]/HE$T,7K<(11%Z>3RCU??$Y?U+=JSNX4_?DI0A3ELB R
M@;F4)JI*24B$HI E><:$YDV6>95W/C_4U)ARUP=Y+[+MZ&1-MN_; (0OIG&K
M;Y>L#KS=B" ,B@.SPE[(80]H+H,1N-3-V>%&KFQS2>WC0C87[PA15.]+>?]C
M?:>^K^IHT5F:IX)GBL$,*0*1,.V*5,9A1O)$DTNA;5:O;*3.T:;&(OL,OZ41
M%"X4W*R>-3%,4L_3EFZ\W2@D&(H#L\A12;XO6QRUL'6\RE %^LZ ,F"MON<C
MOF#9OC/*=U?P.W=3/UKY;#I8+*K;2MQI(WOY>;%:+^6ZK#?:IHQ+0V,SC@E7
M,DYA)G)EO'@Y)"B/8&'*>LHDQSCU"BIQ'7AJ9-/(?>%T\3JLW=AE" 0'/S>I
MP3/FG14:'$IM*TZMQHDY\84O*"4Y#SXJ._E"\IRHO.^_+C7[=$;X81V$-,>9
M(%$*(R8U;2&9&=KB4&&%"$_T\X77WLIC[*DQE]E7[1M-V((A/0J$])D$+&)J
MSGH@$U$.S786%CP2L*"I_CG.B\A,@KLK=:A)&,G1^C*3X+:H# 3MP.O*B53-
MF^>%/P(7^K@"L$$R[5W&?Y&L>P]@SF7@^SSBJJJP36J_6:I,"))^1=>V[#J.
M]?Z9Q!AFE&@"RQ&#3.H]-J=$12Q5)"*^JTC'<%-;.+:RV1KVO<JQGL/5F9,"
MH34\#=DBJHVD3?W4'7QA"]V[H3)$U=-S0[Y$0=,+ZI^I57KIKIYY&4U1TR9D
ML96VW:1_S%*6HP)E%$J*4XA4AB&E4L L)[%4!6*%\"H<?7'$J5')9SW&HJHT
M>-M8Z/E>9L_<C(MHN[%+4 P')IBMK'"+7DO:72I9P+0,5VC")F9<''7<U Q7
M$(Z2,YQO[$<W6^;ZHI^^S3YKPD9)E(LXBQ%,5<P@*E(.24&%:>R=:5-&XJ(H
M?'CF_%!3(YC=8FM$W:5@^C%+![!NE!(&KH&YY#12 <-OW=$(2A\=PXW*&Y?5
M?DX8#G?T90H3Q+!K9?W13)GQTYF&<H@F*&6202Q24QB=:9;(2 QS&<52I$42
M<Z_HW(ZQIL<5-IQFWQE^*VROCGU=(+O21A#H!N>-GJCU((Z+> 1FCO/CC4P=
M%Q4_YH[+M_0,]B^K<BT_EC]-)<2U?A/*5HTJOGG86.OF]F&Q7)?_4^>IY#P2
M::Y2R$1!-*<@#)F2N7&Z)S1*%6>2SRIY;\TBIT_#7PBG+Z:HOYBV*(,&.VT%
M-<6A=I)Z1OO[3X<;^PP$\4AQ_U9X:*4'>_%WON V]K<NV/NG O2&+VP^@+\8
MXR8%](;I*#.@_Y/\B'"U7,^^F*I(VV311-M+6%)(L>00)9P;9W $,Y0GD>(Q
MPY%3KONSYT[-.C)K2;E:EYS.02OYPC-)Z3EXW5QT!20#$TQO-)R)Y(SN7>R@
M;VDQ@_[7<U9X_LQ1/O4SBFR_WW-_[I'3;1^3-&]6DD:%DK&""<&FY;A4D":Q
MWM)$>9RD180+XA2@=/3DJ7V85C:0>*08'^#4_05>I?W WV"C>)\DZP,$/)*J
M^R(Q4A*U,R)^.=.GM.[,D3ZX8;R<Z%-R'N1 G[S CVB$+&?OJG6Y?KH50L_=
M2JZ:'[;=TF<IY5CA/(62)@@B$6>PB$@!,8ZP9#CE4F0NS'-YJ*E142TMV(E[
ML_T1&(F]W"@..'<S5UCTAC[(N0HXYZ_9'9,39L9*\K_>+W[^NWZ(M3+^A<R/
ML/[1?OL.CQ^%#-S5W+*#QQT]*VKS'U)LYO)._8VN-TM[['.G/BZJ^V]R^?!6
MLO4WDR2R3TIB1"8)36.8Q:9!92XXI QS*+7EPD3.8L*],CA\!9@:M6SE-RV"
M]QJ8?QD=H!;A 1@M/ ML^TZ+F^]D2+"'WM@XX@Q^MRH,$XO=%[^PM;A]A1BW
M*'=/B(ZJ<_=]3C\>M"DK/Q9S\>'A<;GX6==OL"519XJP))<FF<2$P"":2\@*
MR6 N42HES6/BEU%R?JBI<=M.4E"V1/5CL@Y@W3@K#%P#L],>J;:43?'D</QS
M&8N@3-,QW*B<<EGMY^SA<$??[94YP5H^+NJJ?_8@ZXW)#5\^O5D(.2MHDG&%
M,-1O3 H15CDD7/\4TY300N28(J<"(H[C38TQFOW"@<PW]1FLAADTD@,CNN]V
MJQMWUSU7,#3'V7A=!62/[9<3/%?NP;K'&'DCYJ3P\6[,[;:>6S)3(=F6PGNS
M>#"=_.H3\N72.(D,D;U^VE_RF3Z97]V:Y(*_T5_EP^;AT\:XD>Z4O<B47-X&
M^,TPD4SQ(H=9AA!$:2P@R7,!(QDE19XB)I17N-U@DDZ-UAIY064%-IN.E179
M%FZ7C="VZ4C]>\\<_N%FW'%;.(5Y''K_:&2#S%;P;&L)6FH"UE3?;ZYK5 56
MUQNP?0L^[=Z"6F%;A7ZK<L#-YM"S$G97.IBTXVY?AP;]:)\[^( ]#BS_3I>V
MQ5\=X?GPN*C,J,:WG:L$)QD3D"*EEQ":1)#%C$,4(4;2W!PC. 45= \S-?[?
M"KJ-06Y$]3HXN "LPW%G$+@&IMD1D/(X%@V"V$AGI&>0"W14>A&)SG/3\W>/
M=XAZ48.#$]7+5_<MCV=KO+W7LFU#W_^KW4F)K>SO9EBE62+S".9YC"%*"@H+
M+!!4B$8"95&1(Z?6?9[C3HTX&[&!F<LSC<8T-33">P:RNTZ%FPT\ , #4VT@
M;'O4V/-"*G#!/;>Q1ZZ^YP7(<2D^O]NO:)W\8;7:2/%VLRRK>VTJE@M1FXVG
MC=#:2Y\@CE)11#!"0C.9$@5D2D\.BR2FB&>2(.K=2[F'(%.CMEV_ML854%J5
M3$=2_:]'J3]%O4'D<KFF^E>V?\GC4OXL%YO5_ E08\'KJ_6&T]0,-LK2ZND*
M#T+?V75T$(PP9V/L_U>@5N*FV;G?G-[N[S=?-X!)M5A*\'ZQ5+)<;SHZ\_5K
MZ'P%JN$[//<19OR6SU= =K(']#7/ZT?&MT*4YEET_IF6XD/UACZ6:SK7PSP8
M=[)MCEF0N$@4@3AF!"(N(DA%:@JLBRB3BI!,.07KN0\Y-8+=2PP>M<A0<R.O
MA?;C1@>PW5@P+(0#\UT+/2.M69<:>6] +3&P(H>C,W=X@A*7P["C4I0[#,_)
MR./.OIM7;4IN^-HRG2DD<UL)_3NY_%D'KN(X9;&(<\BR*#(]YB0D<8P@CK!0
M6$J),J_NF!?&FQKA'(CK'QGLBK+K?C08=H/O0WUAZ['E= (C\%:S>\R1MYA.
M !QO+=UNZUGJW11/K3,9/VDUFFI&&<DS7*099(FI'87S1&\54P6+0@BA2!93
MXD4B)T>9&G7418*K104; 9NJ[IZUW$\"ZL875\,T,$O4"&WSG/<B!BS8WH5
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MZVJ)9@UFS1IL8M#+IL19C]+C0\T]Q4E$)!<PXS2!*->;?*82#-."L306^LW
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M8V@^2U.>I&G"H8HR88*)$LA8G$.]RTA8(HI(I,CO\Q]&T*D1B0DN+FMS8Z$
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M"61)1+,H(H7P+I071K*I+1M;V<#2N[]SN-ERL_=?9 X&7D1.]QMIZ06^VRW
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M[>1V4P^3ZC"!0IMR2V.OO97U?U_35;GZ^JA_%G?5W^G2GB':;.\()2K.D=)
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M%X\\/ TUW!&)7VSVCE0\/_JF!,3Z^6UA81WMHMN%J*$6#_/JGX)/,>&<BJR
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MQNF[3-W#34IPJOX7F0^+;*]!YF6@_*V@\V.7C'4SK!?3J]R?/ES"U,T([*5
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MBDH,+/X@(EJQ[5;0<%__?NAXP[8ZC:EK"E*''8LFLOBIB2RN=CI:6-%A)MS
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MHGK1 W89"2+E5&#,H4A%#E&&(TCSO(01R>*4)#B2PBH"RUF2T=&'EED9W[7
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M+K5-=1&>M,WVP S'L>04%GF4*P><85ARH;QPD5&<Y%E."J/HHZ,GCXVJ:]F
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M;H-KK^"([DQ=AW?M*S(![[:PM\IL+YWHNIR7"G8YM+9S0--SOSL;"09N@N<
MSG%G/)>'N-'>>R&KN>"_B+GZ8:W-S_;'W3EB^XO5%U+QJ21)+-,,064A4H@$
M2R!1? <EYZ*@.,VRTN7PSE*,D1[>=2*"9R6C'>_9SH,9\X6 =: VVXWDH!6O
M=FPGV[_U@RFVH'^Y!+HUS3E"YY7H;&48E.H< 3HD.]?'^*([_?]F)_%\.:5?
M236O6S9F,9*<<@RS!.M&HG$*2R9SJ+LZ)$*691GE-F;?;>*,S0[LZJ"QK@Z:
M^-':@TTZ1/VSI3UXXX2YTF2H:7@3UM1_MKOE5XK5:96\M_#T@VY@8K42Z8UY
MU@6^Z[3K]%1/$6-[VY]W<[[= 9TF:5E$G#!82IY"E+ <*BN3PTQ&J,A$(<J"
MW-AT].S@#E9F8(;M1X<]MV)/P'.]Z:]3Q\75C?];Y\.,4#UC_';!25^V(->2
M3VJ4/1ZON ,6-B3I_/!O&XUT%9:K@4C7G^#8ADWO2_ZV:W6U[0>6,)049:)\
M9=VA!Q,):8HE+(M44%'*,B56W7K/C#,V6[#9^=YKMU:?K6#;;FMG8.5YG":(
MQ;#,=9)Q$0E(<%9"%E&2H3)!4BI8=9FWX6#=CC8@K'[0-&-U#Q@-<DS5$S%$
MZ[3+*/CMF79FK&&;I5U6^*A+VI7+7=H/S]E2MUQ[+YK_?IJ_TSTK"%O_5:T?
MWVU6Z\636-;&ZZ]+99YVKW7&62X1CV"<,T42I2"0)BR#E+.(X;A A!IEIMTB
MQ-B(>7=4L)FK*9HI;W$IF*A>=""/55M=QTDQ.!$? .K 1-1I '[J=/@9?%).
M=ZL&T'J 3I%)UTNM5N8Z9?F;"YN^Q^'G9*AFR"'GQK)/\FV@7FZ>[/CL 3LJ
MWZ;]?IOE&Y_E:SNY'K6B&_T*KWYY_?#T/%N\BN4TP5F64TYA'#/E"V2E@#3F
M&!(AB(ASG./$JGZ#\<AC6W\ZN0#KRWOKIO YV%WW?SV ^?9;O7M* /H*.C5"
M[NU>02[P-NZYT=]XQ_8**-<W9Z\]P*6KAUBM[^6'C=X/N9MWC48V>ARQK23(
M2QJCA$"2BABB*":ZV0>&488B(4F6D<@\0M1@P+&152VC3?\+ TP-[%_/2 5F
M(BVMCDIOY 5*X&W3I%9DIU8B!E#:=!CQ"^E0C4<\0&O9D\0<I\NM2@R>,V '
M$W.M]AN;6-SGLJ_Q[O[S>_$B9HMZ!_K;8M80_&_54[46_(MN^+2H#^;:%SYB
M"2W*.(>,Z/B#5*:0T"B%4<I*P8JR9(51V*G3Z&,C9RT_Z"D MAJ 5@7PW.A0
MGY#9N-.V\V*RIQ$0[=";&=>!;L5O[$\'MK=&W&;G(B#R0VU9V,V K]T)1^ N
M;TO8/G3 _0A'??<W(EP?XK!^?!9_U9T0F!KHCC&],.EB0,O%7/W(ZC8])[N%
MH+S0A=F4,9])9=8GJ80X1A@BDI<9U?OD@ADO(XY"C&XU>7K6FW\+"91"8*<(
MV-?$@M-<9\=@,1D \\!K2@URW<%%ZW >;^M^+O[FP6*)&6 ^!EII'.;%TVIS
M(X87%QW79P^W]MRH_=X2=.NSW/;">T>^4Y3Q,F,Q@S%"RD_!A80D8A1F,8XY
MHEA&);&)SN@]>VP1&74KP7__MSB/_JLG9?,+NUWM/H!F^]:.L 2F]M\,HE.L
M-YI/J.IU*[G__$$WBT\H=K@=?.H2U_XQ3\^+)5F^ZJBW]>MGL6YRS:8)*Q)4
MH (2)G5:%Z>0"%S O$C3 B,BN%G/AFL#C<WJTQW9JUHRV_8P9X T^W!]P!/X
M*]Z*"!H9F^[UGRYCY=#UY3(0GAN]G!ELX-XNEU4^;N=RY7KGHVNQ7-9II,UY
MH7KP'5W51^;3-,[*E&$!L51((IY%:OU&$F8D81GBD:#"B@XN#38V2NADK3/8
MF]91_VE]/'T>6N,3:2^ A3^$;K#2Z>;=L;/FB3\[83U6KC;!Q/?Q\OD!ASY1
MOJKZB4/DZ_>X<<?':EZMA:Y==-1=ZNYIL5Q7_]P6H)ZOQ&?E8'S_2\Q>Q.^+
M^?IQ-2TD$5DD4QAA@2&B>0XQ5>R"TI(00A%-B57QC-O$&1O_J)<QL>.;&Z?#
MC)&& SDP9S6*P%J3H\YVO=K\?:TFX'\$68+[N4?3QP^@7@GO1I$&I40_\!V2
MIJ>GNM'JZ=;N=\NECMBN=VU^>=U=TV8VW?U%EOS^N3YC^%5=N5Y]FG\1RVK!
M_UM4#X^Z1?*+6)('\>&'6+)J);XL*R:F.)4LCQ4'ES3*(8IC#G%<1%!FNKZ[
M*")6QC8</*#L8R/L6G)%&#_]\>T]>!9+L-)Z6N8Y#3GW9H0_TAD-O#K4&D%:
MMSWMZPWZBNM8ROZ%K?*@UGX"6OUUS+A&0.=:-!A,0(<":&$ '0Z@!L+?ZO(&
ML^=U*1I2_D'7K3>8F,-%[BU$"+0B7A'T[V*E!9OS;2^<A?Y5*Z+.>+I(E"+G
M-$XD@YCG"42H8)!DG$,F2IG0J.1)9.6HO*TZ8ULW&VV:N@4[#72S>Z%^I2L<
MU*]7X'4U[!OD::D=S7LQ@M77=/'MO5Y;GVZ]J'\] 3UHQK0H#S+/PZ[3854:
MU](]R/19K^;#2.66UKUX$KJ>T$>%];VB^%KTU8<?;+;AU?QAK_-I78:HZ5ZG
MA%7>N7AHKF^Z]=((1TF6IY!3@B'*LAR2F$:P+ F.BBR/L]*H89EWR<:V[+:U
M9/7K#19;S2:Z6%NC&UCVE9N ]4Z]FDVKG8* F?==]C_EEQ?7-YW(P.MD.X=-
MI3:@50/WO:G<:K??X7D">@K645X]%6U::/N?2KM$]#>9TN&RTP>>6NN4=>_P
M7\MC]S?@H,GMWG$ZS'CW/X!C[:MF\/F#EN8=62Y?Y6*I38S5-)%IFN."P*PH
M(X@XPY 6E$#*>))'O(CRQ*[\U=FAQK;._O&W;W\#4B@4R0S,Q;I;;-6G.U.R
M Z:%!YWTEG6<S@-NYG'Z@3'P*K<5$F@IP9Z8'NLY787";TFG\\,-6]7IJMI'
MA9VNW^%&'\IO>=(MJ1?L_VI/9?5IM=H(/HT0*27/.%1V? Q1+G*($U) $F6"
M9U@FPJ[:\IEQQD8<]TO%WCKPKM[O4FM^\U]0U=*"GZIY^QO+K;!S,..T$#C)
M!,RSLH!(I@FD7)10BKR0,2<9PN6TV8NKVX8/!O;AF.$@_T4\5'/=2!U0,M-=
MU/VCK%#,,IF7.L)6+81QCB"-=5M:AC/)6!Q'6Y0_S U+V7K#N!LQ',)JA*#P
MFBU['@ +O.8U$H):Q$FSSZD8H!'3WYIW!0>O"]ZYL09=[:XH?+C47;O<I=R*
MWHZ+NSQ^(@0OF>+80N?Q4P4<Q86 +%(W<E02C(Q6MJ,GCVTMJV4#L4W=CSY.
M!CL\KMH'_HY;Q9TJG_01L"EQXHC$4+5,3!&Q+%AR0NO+E4GZ-PQ8@N2$G/NU
M1DY=X'ALONTR>J=XZZG9Y_]CI6.!Z:R7X1HK\XYCY9*++%:67X)BB%.*H601
MRU..*<VM#&S#<<=&4M\V3T_:WFYZ2G=RZRZ[>K-;^9TSMIDUCFA79>&X$9&E
M!V\Z188'R/Z!#\R/I\O7]>&W:"UM?Q!KAY??$U/#L8<]VK0#Y.@,TO)V.UKC
MHII^F*^K]>L=Y^HE7+U3/]XOOR_^FD]SG,2DQ B*5-?5I'D,B908,D%PF7(:
M<9::4-B%,<9&5XV8H)5S K2D"D>@934CH4N 7B8<3S %)A<GA(Q)Q "#$X2Q
M$NQO#XN7_U!WUUSQ#Z1_A,V/-4%<>NX@9&"@6/?AFUSJ9KOH%D,KO<,H5O?S
M#S_TJKNI5H_:0+V7[P5=J['37$A:P"+*!$1%GD!2ZCZ4><*B# M6<NG0@O+J
MP$8O^/!-)^N]<662B#V1M3'#E=!V5LEU\,WL$3]8#D,6O9YG&L8/1S"^OP2C
MM>EA#(U7H^/ZJ(.:&\8@'!H:YC?>ZCEUT5!=$=ZNC]"^>2Z*B$O"&40YRB 2
M4D<=12E,<\XR3F2$>.;F01F-/S;3I!._=J7F\PV9[0S\KKO67X\5>P1?A9PI
M_7:AF1\W:UWCZ9M8OER*N?0R:[9.E?>Y"$QI_6G8 GPT$<,X6%;8!7*TS&1X
M(X?+"J#SCI?=8V[>5V)L\Z0W1417%/?I>2D>]>[(B]A%IAQ\=SCF>:'WN0M"
M%&7B.(<ESC%,RERD*4*H+*S*2MPHSZC9<Z?0MN1S3Z5KA5B"3)_U7E3H21F0
M1LWFH[,C!]J[N@7?4'M:3C*]U5[7+0!>V .[Z;$.9XO.*0!-2:%/<QTH6"\7
MM;S?'\E\+SF@R_3[2*KEW\EL(]1?ZP=.A>!4IB2&%.D"'C&+($E*"B.*L10I
M(3(Q8O2W56-T"X$6"CSK_ K-/:)6#U0[_<"BIJ"UTA LNH2GER;A27FS7>*<
M^M$E=^Z-WRF#0]]_B3<E].IT>ZY<@P;HP=&N;?6+=9A)UTMCU[B &AC]JV:(
M?XEWR^(X_5_B'1OH[/Y?YEVSBQUX\RF^&*CP=M(-%Q7QYC.P%X+Q]M+<ZI=_
MFG-]L'ZNAE%M<DX1BQ+!4@8QTJF2G&.H'' $$2O2*"IQ2EGAYH:;##\Z8ZOG
MY>WD/U,?K-LU,XSG<IP@6T?;-^P#^M4>$+_!@[8!+I##;"3"&_G'-O"<=X>M
MGN)&@+\T8>7?'H58_Z;G7]/VCVHUI7F1$924,$L2"E$248@S%,$X*6,F2I*D
MB-A0W;F!QD9JK9R@%A1TDH(_M:R6W'466S.6\H%88#YR \N:=JXAX95@S@XV
M*)5<4_F0-*Y>[UBOMK.W?A=$M[S0)MK'I?C'1LS9Z_O%$ZGF4RX%8B074&:B
M5*8019"B7-=ZDDAR*E!18JNBM-?''!MI]"0%6U'!GXVPEJQA KD9@7@&,C"7
M.&)H7SW6'!6_)6(-QAVV#JPY$$?%7BUN=2,>G6>_K(OIU/5BIYF(!".$PKC(
ME.>%HPS2O$20QS279<92PE$7NF9&,P<C.,2H!2:53D @&@G!3Y\7:P$29)GX
M=P@E4UZJC&(.\YPF"DJLG%@I!1113,H(9:3@5KD++D .R,UUFR&@S&BU/NI$
M!(O".^<0-*/?&W )3+7;-ZL5S1^YGM'9*Y$>CC$H:9Y1\) @SUWF1H9_S)>"
M+1[FU3_KI@1MH,KJTYPM%?^*U5>QVLQT1)^N9W+'_K&I5E6]38]QDJ4HBB"6
M2$"4QQ&D...0% G)BQ1G+$<VG[JK(&/CA$Y@L!1-8,)Z 8@6M^M>\KQH!+<D
M"N>),F.4(> /3#U]%>K>)YT2$["=E*T:3:FUGB+^B.I6*+TRFK,P@U+?K9 =
M<N3-S[NM?5,33J(&;CFZ'?_=0O=\W*AA=X6AMBV(HC)."\8E3)-"\2GC")(L
MBZ%@>8I$+(2(K8*6;Y!E;)2ZU_SI)]HH\/-_M+:K8Q\HESDRH]*!D _,IEO0
MVR Z3:@?.F^A5>7G"=AITZN(%[33U VP!FE$Y2+/F_2IN@&X<VVL;GFD,\7J
M%.4NH%J]L@?)K;W$\,]BW1SM5FPK6&,WZYCLWQ;SA^]B^?15K#?+^?V\.?B8
MQEDJF'9<4\HY1!G6NP%9"3FFBH91(4MLM>486N"QD35"66Y86F2P.448I5DD
M!:2RR"#":EDEJ:!0%I(FNN1A'K'IBUC2Q;_BK/8%#S>OVY05]3W7A\3+6F"=
MG?>L+FR;,HYLXHT7[-%,9OA5_4J%A[K 1K^ZANX<V:F\O4\KW6O+IO6&BEV>
MP-?V[?BZ?3OT$&W4@%=C8) I\VTQA!5Z:+-BD"DX87L,,ZYCU,-FI<1;K=XM
MGF@UKVV?KUM?]!,7RC*2%=DUL&NWAGY=+/A?U6QV-^>]SN*U9H(K-::TP#G%
MRBOD,F?*+HDP)(B6D/ TD9FDI13Q=*TWI V#)L+(:66.;*4-1WB:O9JE:;L+
M9QEI$6@^N9JRC,L21CR/U'PJPX0F,8-%05$D,%*3:U0C94SS.5!O^%'.IYFI
M,8)9"FQA=!J"GHH3L%,2]+7LH@D[/2>@TW12=[7H*0M:;>M6UA[C?\).B-_P
MH4"R#AM]%!;PH^"EP,/YVL7H;)*FXL)!OOA1=^A<IIAR$D%=<!LB7@B(&8Y@
M$>O=8D:2F,C;-BFLY!G;(F'?K?O6"7%U-(/!_"9^Y&'=D(/J%B$:=GN"-+"?
M9R?3&[MQ3@!>]]+<'NO&K\JC(WKX#V2I"\BO>LG?6C!6K:>Z7AF76:0[B"*H
MS.T8EI@6$.597D2TR#)FU6O[^I!C8\E.8B!:D>THTP!C,U;TBUQ@XMN"UDD+
M?NI7H6@%/A]&9TUPYNAXY3"#80>E*7,8#IG(XLX;^B'3ZPF*]"A!\<=SU9R.
M-9M44Q:1DA4\AT7.,HA*B2'!N8 )3>(T(Q0+7EJW-O8AV=BHJZG_KZ-76S';
MZ@H.;8B]3)P9T;W)= 3F0Q])Z+M9_')Y%MUZ^_I$W'^;7B_2#=]QUR>H)YOG
M>AW D=C7:I%HJEC674<>%S-U\ZK)*]\&!:$H9Q13Y7QG=2!L1F&9E@A2RAE/
MJ8B0,.IQ:S7JZ BY$UJ?_?7%_O^Z&A,&(4$W3((A ?N&-C2Y^D#5GC1M4/)+
MB$8C#TMV-F <$9G5S6XDU3SL=[%^7/!/<UUNJBDQN2T02(H2T113F$JBW-N8
M"%CRG,!8IB3'@D0I2VSXZ=J 8Z.F]DMI! 8]B>UXZ"K.9A3D$[W [',6N*"5
M%$T!\DH\5P<=E'-,(3BD&^/[7#JE"2[$DY[VSTJ)Q7RM%%+7/G392&UG+!PC
MP2,20\[B2$?:*;*A20E3DN)"B(RCQ"@KR&+,L?'-3FJP+S;HY+9I.V8&^V7N
M"01F\)VV:S@Z]7$S ]2FPYMW8(?J_>8!8,NV<%9076X89_:H 5O)6>FVWV3.
M[E;7/DT?JYE8OE,6Z<-B^3K-2))2GG+(TT29A2FCD"0X@US]J/Z+$2N-F/K,
M\\?&RHV(0,DXTV6B6REM.S/M0WB9=3T $]K VV)B HE#*Z:3BM_8AFG_F0.W
M8#JIT''[I=.7W7"ZX%+^<%M(HQ<>^[5:_=_'I1 =L^AH[6G)4Y:EJ(2ET$VP
MF7(0<9$RF#.>IEFB:%?8-0 (+?'8N$7+"*02$E3=PEDG2?S45'UF2C_+NAKA
M)]WBQ&(L4SG^DXQ>5=R>WA-0OR!:]9UEI97W?,XQQ#SY/_\(*O7PYR)#3,+)
M\Y)!!G9;PN[UM??++\L%WS ]R"^$_=]L\=#Z6BC*,I)S"1$E)4189)!&*86H
MB BGA!99;)5Q>7FXL2T>M;2 -B+:K1)7<#6C>']H!>;G!JC%$NQ$!:VL'OU4
M.UB\TN&5(0?E,C/U#XG(\*XAFZE\:>PO\B#NY?UFO5J3.5>N=1- <K=9/RZ6
M.A)\FF4EC7*,==6W0H?>I)!DBI,DCR5'>13EDH?OF6(H[=@X;">V/JA<[ 1O
M.IRL -F*/D1#"M,Y-]@U'=-,#F+__G+9_OVELW]_.67_]MZ#>PEZ:H,V8.MN
ME._!$/U' KP/@[89>?/W8J F(I;S%*97B*D0_P(M02SQ]-/YPW90UQWUSQMM
MU]S+#T_/L\6K$*NI*.,21RF'$2,Q1,IX@*4H."RRDB2XD"@W"P:[,,;8%O]&
MP+HE6B>B[;;Z,8ZF6^LWH3/,]OH.GP]7\7'88S^+P(W[[,?/'7BO_:QBQ_OM
MYR]U31]Z;O.2[N5O.GWT7KY;"EZMIXE,F"0<P3S3_<4%CR%A)8><9%&:$U0F
MF>AJ17^W21XZ,Z#1Z[Q?.OK[(#$.K;SZM6:UI&"FY:ZSMB5A;<*L;4;1.=C-
MMC)N0W&HJ(9.1@U=+:7^H9'39];0%2@\)PN=&VW@'*$K2A^G!EV[P8T_OBP7
M3 B^TM5%Z\#/MN'8AQ_*,*F4L3*-"6$H%3'$,BDA2B,!RSRG,$%%DF8HID18
M9?I<'7%L5D,G<%.'=_TH@&A%[35793VSSXY*KL] )&7.&8UAP:B: 2%+2&(1
MP;3DBLA%(B@M[&K">9V#88JZ-07LG_?FHC\/*ZU&U\Q6'WY9FGCFTV'&\%XA
M#LST^V]X+6W741-LY?7'^,;0>&7^ZZ,.N@(8@W"X$IC?Z-CLZ'RKM5]>?R?_
MNUB^FY'5JF[A%6$N4:$CLS#2IV"<P!+C"$J*$=)5]YE=<0^+L<>V2GR\W(10
M$5(M/Z@5<&JD9C,Q9AP5".[ ;.45:?O&2?:8^6V@9#'^L(V4[($Y:JCD\ BG
M! '=9Y>M-\MJ_J#^(I8OXH^U\@/_V=1_GN9I6B@3%\$L+F)=\ [!LH@8S+',
M65I&I!#,K,V2T7@.GG-@,NM)9Q6P?@57@U,L+U@-Y1_W1 6MK* OK$_LK,+\
M_6$X6("_,Y:V<?UFV%R)Z+_RD"%C^<WT.8CB-[S)_K3A3KTLO&Z$-R,/4\D0
M(:A,%88QAB@G":0$<5A@+ J94I(2H\JA1T\>F_6W%0YHZ<P/%?;ANGZ4X Q"
M8"XTU-_JT."DKLY'!?M/&^R X*02_6.!TQ?<OIGW:;7:Z%ZX][*K'?U>T/6T
MI#G#0@A8LI)!%!<,$E&D4&91A@M:9#@R"AXR'W)LG^K^9D?5RJRWD&;;TO!<
MR>V^;70&>OM]H]L!'73CZ%,/RUV9_?>7L+QI[^@R/,$VC\X,^V:[1Y=AN+1]
M=.7.&TO1-#G>.AYB,=<'%_7&!.6XC&A:*/[).$1<)A"7I("<%Y&,<!Q+QQ(T
MIT8;&_6T90IV0CKM UT&V(QEO,$6F&"L$7,O(7,)B3"E8TZ.^#8E8RXI?[94
MS,6;'#>?NS2/]]6*S1:ZJ[9M3[M+CQC1F]U+P.H)&J1*D@DB89J\GQKP;;J[
M7U#];%OW2_<X%E.O5N3A8:GW\)2??2^_BA<QWXBZ1LV4LB(5&,602%PJTSSA
MD,8TASPN4!G%1<(RJS;%EP;[?]2]:W/;N)8N_%=0-77FI*N$&5[ "\Y\<FX]
MKC<[3B7NV365#RI<$\Z616]*<L?SZU\ )'6Q)0J@0(I]:LYNQR:)M9Y%/E@
MUF5J,^.AK'57)B-M4\#'<8KLQ-F.1GRA-S"-] ?.O7ZY!2)^BY-W#3ANY7$+
MU5^5%;>YIQ^-O--2+]=U_4B=!7FOGO.^?"#%<AX+'K(P1##E$D$4(0IIFN4P
M"Y,\%%+YV,3)P>X8:VHD<B!JG<FLA07?:W$=.:0+9#L*\03=P S2&S5G K'
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MO?S23SQZE(^Z6ZWV^SUS5<^B.CIZI2V\T93LF4<D#P@*0QAR'.IM2K5LQ&D
MLR3DJ10YSE#JXBL<&V1ZG^T8Q72.H6WG&5R*X=#+PA<E=-YYKY_3H;_?^CG'
M!AJW?DZ'JJ_JYW1=VX\2#D(A=!"%6C>JWXGJ27S:EJ\D,LF3.&<PC^*H/L7$
M-,I@*E.9B"SE!#NUS[ 9=&J4<1AII(4V7-&(?4&Y4"L+V-&&;UP'IA$?D#I3
MBPM&7JG&:N!1J<<%BI=4Y'1OCXRN_R)58?I*DK70>_'E4G'=W5(TN3@22\HE
M0A#)7$*4YBDD'",8QGD6!IE0/HU5'K[%6%,CHE9:4"EQ 6OE!>I_'3*<SN#;
MS3>>41N89K: :4G!5E2@9.V3&W8&.8<L,7\(CI0OUH&DIY0Q.T@ZD\?./&*\
M-#([70X2RBQOZ7F&:-$.?;6+A]-!U":&>AY%"4^D+@.&,UTS,2 0!RF#+!,X
M2D48\M ID*6O(%-CX@\/CXOR60C0RNQXJ-C7'I8GC2.@/+B#V,J[A1A\'R2X
M_U*P_)Y)]A5FW(/*"R%[=7IYZ?.N4UOQ=W7A>G6[K",2?Z_*U6I.@R#(N:20
M9JEF328@Y5POFE&01X@D0>RTI3: C%/C4B.BX!<TEQS CG9$>V7K#,S!/FL:
MUIKJDKBUKOHW2MOIU"SL,,6DBA(>D_,O576P VC?906[ANJQ,?'NIQZW6-[P
M)WUXV@RX^BS6NE[A#U(L5^L_EK18++3 =4W@U5?!1/&D/?MYR'6S O5*T  )
MB%*:PEQ&"0R2!+.09V%.\7RM"T59[%Q<*(S3)+ 5:<!C&:..Y@=2*P0>&XUT
M#Q8]/9!:)[!IE-)U&FJM0+55RV$Q?ZDULYCS/$XPS$(UW2-!F*X'F<(XXH+I
M[CEY8)7?,[HUQZ@,V59#_PO9TV+?:T0K#7UBO_W<&EW:B7L%:FU HPYH]=F6
MLE^!K]<PC\/FVHAF&FGW;6ASN>W4><*W<ROOTC'&V^OSA,;!9J"O9_9<%[.?
M@F\6XDZV54]NV#\WQ:HP3M7;Y[U_W=>.39:3G 4Y#'$F(4IB-162*(:2Q8PE
MF"=)YA1SZBK U*:_5GX=*+$M4;2OPDPOF_9^ ;X;/5R[3;K:R7)1.R#Z0Z]8
MO0/OO@[MB9[?1::K$..N('M"]&IYV/<Y/=9^1^H_*;XM?RR+_Q7\EBMV+J0Y
MOZE#;<W0E>+J)=]KC*?^IKP%M3HUI:*6/SYI'_FKKG=_)_]8U;?.PS0)HC@F
M4,0XAR@,!<19(G4/7LY"S"7)B5VGNW$%=Z&!<7KG;<4%"[,8J;3 L)1PH_[A
M$O\_\AN08!I%*&%J48E2B"2E,.=)"'.J?I'Q. GLIM/IVG^4DKA;ZQN[ZREA
MXG:W6(%.TIH#3^K'BSSNU ;[>C?I*:#5'"C5]YO,@D9YO37=OA]&?_5$0P]W
M$BH,ZL=,\BUQ6 A/\FT9:<E\V5M#'-^:TN:M<5MECVZ\SO7X>-*,MW(?'>&#
M-?[XH[NYO5P4\_?-MWJS7&[(XJMX+*OU/(VC($W#&,:Y6N.CF.G"=BR DN H
M1#E!&;8ZXCXUP-0<B59&4 L):BGMYH:3(';/]3Z@&7A6=D3%FOO.J7YDG;P2
M[-]^E$__KFXU2^1_(OTCK'\T%';RH:.0S3F56EHX>YV?=>M!M>+[BBQ7=9YH
MN\MX7WX3Z_5"Z!IY=W11_# 7KNY_DO6'7\5JK:ZLBK*Z+_?6U^_)6LQQ*J.,
M!!PRFA&U7DVI(H9<0!D@Q"E%&"'[$[$1!9\:X6SW]M<E6!F- -<%(\N=3F"M
ME *BUDK7QRHK?379V]GB2K/+'-C!7I1^"YTIF/\J2YW#(O9[FL]VQT#W):BU
M!Z:VZ)[^0 , &@2 @4!?O;\)^GZZK\IEJYTIO#)77>]<]]6Y>,$SM/U<ESR#
MR7/51<_0*)];]@P^?L]VAV;=-4]SF854AA SR9570W.((\%A&..<QC$/21;8
M1&T=/G9J\5>F/V&S#>+8IK"&R>YLT5WY@6?<,QJ[=Q$\4-!OC\#ZT>-V #Q0
MYU5_O\._]EB>W# U.6X6NBA7TU'KX;$2/W4^P).X7>JN*9_*U>KF02V#BO\U
MW_V=?$=6/S\NRC__4_ ?8O5!2L'6G\6ZE/?DUSP,PHQ% 5'?)TETPGH&29@*
M* @6H5#_+^>DK4%V;[D6\2ZEU0=P6+/L?H2%Q[X"^KQ$!YH ]6.Q5,L>L5K7
M>:<_M4(.[J)_&UNL'ZYCLI$X:Z<;:/OX[6D':O7 &ZW@;S-P8-4[";260*L)
M:CUGH-94AY)IJRMEKVI=!Y?_JE8>R;&_HK7=_/?!C-'II?L?=3Q??##$#CSN
MX4;IF8RL7N_/ZH5_7SZH^66.L<Q3AAFD"<,094C"G'+E_5"9<(I)$F9N*<8'
MCY_<WI[Z%]#B@>^U@*[EB _!L_.Z^T,R\$SF@(9[7N]1I?UFZQX.,6X.[E'U
M7F76'K^JAZ>NZT$K'_1!+\+_1G3QE_7S?PM2?50D<K/D]XI8!)'J$YJC+(Y$
M&"'(D?; PU!W&40!I"+%4:36S(S%UL< UL-.[4-7KTQJP@C66Q$=O"I[M"U\
MX4$P')@93/EQ+;39E)R!5NX9T)(#+;H)[;D?%ET'7W00E$?R,3VB[>8S.H/6
MZ0O:/VT\'\]9PP/?S?WN'M2N'WZ[U$6]3$XM616K;\I#)/QNN5^5YMM:/+XO
M_USN6O3,0YHKSS#,8992"A$*,^7%I1)F&<5AGF<91LB:ZGN+,37J-Z*#E9%=
M;Y\\[9?MFH&54@!PI4';K$@W.W+O772AZ2SFC5$,,G28BC[2VBDQ [5Q:CW
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M79#%#6/E9JGW#4U4G5Y(B!O^/YO56B^!=^7Y5G/*"2<HR&'": Q1J+>D21;
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ME5G\*OUV=9(^_'H43!<0*1[4)7?RF_KM2A(3Q%(WQ@OG&4DR@E $<9)+B.)
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MHTQ"E- 4TE!$D! >2Q$*'$7V%;Z/## UXC(B IW--@-:2K.YI#=:!9%J?(<
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M^CA ,<O?RVKAXKN>0=1BL> /IX$II-[&VDD*MJ+V*=1W!C@'W]X?@".Y\)<
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M\+]_^O#VAY>+='*,\_4/+Y88UIA_^'VZ_O+#/S*N_OE#62Z.?_C'8OG/Z;<
M\.^;O_1B\?7[<OKYR_H'P82X_J?+?T&N>%;60$#F06'R$!PK$ .&5*(KCH?_
MY_._!.Z-%BH!SQE!!1?!66^@L!)L0BND=9L/G4WG__R7^H\85O@#,3=?;;[]
MM[]\6:^__LN//_[^^^]__2,N9W]=+#__*!B3/Y[]]E].?_V/&[__N]S\-O?>
M_[CYT_-?74UO^T7Z6/[C__[E[<?T!8\#3.>K=9BGNL!J^B^KS0_?+E)8;V3^
M(%T_W/D;]3LX^S6H/P(N0/*__K'*?_GW__'##UMQ+!<S_(#EA_KOWSZ\N;+D
M-"WF7V?IKVEQ_&/]\Q]?+ @-1.GF;ZZ_?\5_^\MJ>OQUAF<_^[+$\F]_F:;9
MDE84G(OM>O_W]B_^>+'LUR6N""D;-M_2#T[_?EWET23@'VN<9]QR=;; ;)&N
M_-*LRG1Q_C=G(>)L\]-)QNED\ZE'<;5>AK2>:$ZTBR+ J!@(=]:"]Y:#BY$E
MD;-/SE[EN%*\(I(W*EAA^NOGQ;<?Z8-_K%+X+U6_A.V7&W'<6'(KFOUH/]MU
M;^9EL3S>2/13B#.<&$L;0A'Q0G$'RJ  +V6 DM')Y(1D3A_,QEVK7^7HLKJ/
MENF'Q3+CDDS*V?)AF6ZH_BJ<3W_CQZ]A21\$Z<MTEL_^=K4M0^ARO1A8JEOU
M$>E_^8$D4'"YQ/QVJ[T[&=UPN2:CBYO?/ 09K^;KZ?K[4<XD_16N3K_X1'_S
MZ(_I:F*Y1%-$!J?1@.(H(3!&WWKN<A(<A3@<YO?3,!Y*AM'OHHFP1X;-)=)?
M+H[#=$[$%^%"%!!").)],>#0"4 ZC4/*1@K%#D;*C67' \>0NEP,)=B14?'3
MR6HZ)^I?+$@):?T+'D=<3DP66?/@0*980"6F(=J"@"8;*ZU(+O"#D7'KTN.A
MXT U+H:4Z<B@N,6*DC>';]9XO)JHF+T7OH VDH$J4I%\E ;E L;",XK2Q/\X
MIV GB(AG<;H,)NA. %,WST23"T;H9D J)6$$62#H8"!Y;M$;"MX\#@:0NF)7
M[L:>^KL%%(\69B<@^("?I]5-K]+X2'K ^L-)<(G\=8X4JR8*YS-Q0_M" P:M
M:7M8ZZT;#!6WDM"5W1@.)H>+NQ/<',WG)V'V ;\NEI5^79)5GDY+16>O918"
MN@(V*"F-2-*&PZ.8VU;>"27RV:%D;^%V H[WN)PN\JMY?DD(G\3@N.9&TBE;
M&7""I*%2 5:2TJ@+64TU&#JN++T3/-2S@\?^XAT9'R].EE5PKZ>K%&;_@6%Y
MQH,B3]WZJ" Z[D%%'B&BBV Q<Y^81)[]X=F^.U;?"27ZV:!D$"%W8D@^+<-\
M-:UR.36&K@AC5*:P#D4-^[V%R&("\J\LDY)CE'$X=_7:ZCL!Q3P;H PBY$Z
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M.&ZZL?D+@":*ZL *7>+K^HUB$B0=+QG4%W2@;,XD*;*L:+6,*4L5\+Y^6H-
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MZ$"1=Y H>"CXG2@ZU8/W)(\L:A.@I.N$60[*&B:*LHFI-J\)'J*LFVN6)TE
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MQT7%Z@2%*U$X!FDSA59F <Z4!'4 %E,$>\?;G&*W$#.N:]0B/7"HQ#L S<7
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M-8V@-XA"QNZJ\-#^.9/F:Y+S3R<K.EA6*_)H8^WP6Y/J/C-7'P%##E&!LJ)
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M6VQOZY\(TMIHG@N=RDPG2P(BUJ+49&)C,CPX+W1N5)NV$WWCQF5#(ZNA;CI
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M$YTEI$-!5OOPVP*.\PP,@T_9H,IEIW.*/O422.B[ZP"YLNRX#D_34']_\?:
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MOL3M<YB_+3;/K"[Q?"'?Y71%?_1R,^AK.WSI5UR_*[4_B$KTWY@S))E(#G5
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M\#$HUH;^]N441@X!PX#"R"&6Z0!DSQ3>>>\P>%*+MM)3C$$G2* C!'BRR;C
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MT<FF-B,#&@DT]833UDA\I-1E2EB,.,6RQ:OBW]>Y7)S]-B]Y9B)6&B4+%FT
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M0X<<HL]U.)1GK8@R7Q!QRQ D'4S<,L1@'95>W"6)()4);U&#D&A .>TAV&#
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M<MR2O+?SY+V-8<$FR8(J9B<4G69=X]Z@&5.O4V/D^=H[)Y)UI([:V^8)\2J
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MHUUH,Q;FX?7LA]%_CYJ 0;+I &'?!]C@ZNM\U\W\'E$?PY^O<8%EOOF9N/_
M//>9D$$*9QED$W;7\6N74# Z*QV+=\JW.<<<9_W[(?BE'>%/(/OS1/PN,X>T
MK_R8\[2>96:CE*@@<%E &4?NEU863)"I3MU!?O=*ZW2@?YB$_7#_TD[OIT'
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MXZ>!PD/#.0Z22P>@.IQQ3TQ52BZ&S!6'6!AQTP5R_5B0V['D7@>ALIWH2.H
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MREY]65XN-GRF7#)!BD(A)MLF=PM$1=YQ*-GJ$J+W>:]"CL/,W?,+W M\_MS
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MW^X8P4\T4?WIZOOWBTU 1P;^=NKALKP.ZZ^_7RS_/'*":9_'#Y$Z/IB=H7+
M]]Y_\\[?KK^QOIMS9*0I=4BE+-:1UX,(3DK:2U-A219F_>ZTL:'VAP[4'6N=
M;I[[M";6=R.84!#G+D;(&S\"G898>U.E7#2%? *C;U,]W97"D:W9T$C:M69-
M%'7^5N[PT:?]7W)BB]=R_&DGM$I+6.*.'#F,H%A1X&L76!,PJ9"C+:TZ$9W
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MG@4.BK>VBCJ/K>MVU:V/N);PXC,;;&@O$-YF;RN,_!\3.61I:WM*"GLB,[6
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MH90P&43=9X!%SDJ]ALR]8Z!$W)1%,X@2G5:\<"7:W(Y\1,K(!>JMD'.HL">
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MC^ S!NN5PQ3;%"2\1%DW()U5/GY094P 7!_Q>_A9Q4,L7;?EJ%*;.1:-LEQ
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MS&W<E,%8F+#-ZH.]O3;KI"J>@!=]R_@O/[=L;IK-K?"_KG"1KL= ^^1SSLH
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M>&AI8FET,C(M,C R,2YH=&U02P$"% ,4    "  1B&%4=K$UA P#   M#
M$P              @ $P&0  97AH:6)I=#(S,2TR,#(Q+FAT;5!+ 0(4 Q0
M   ( !&(852U\]*#V-H% ,$,.P 1              "  6T<  !I8VQR+3(P
M,C$Q,C,Q+FAT;5!+ 0(4 Q0    ( !&(853[C_<*."4  -VZ 0 1
M      "  73W!0!I8VQR+3(P,C$Q,C,Q+GAS9%!+ 0(4 Q0    ( !&(852B
M-5:S#3L  -YJ @ 5              "  =L<!@!I8VQR+3(P,C$Q,C,Q7V-A
M;"YX;6Q02P$"% ,4    "  1B&%4J++E*/#3   ]Q@D %0
M@ $;6 8 :6-L<BTR,#(Q,3(S,5]D968N>&UL4$L! A0#%     @ $8AA5)=,
M'9 LLP$ ^RL" !0              ( !/BP' &EC;'(M,C R,3$R,S%?9S$N
M:G!G4$L! A0#%     @ $8AA5&C/L:ENM@$ 3IP" !0              ( !
MG-\( &EC;'(M,C R,3$R,S%?9S(N:G!G4$L! A0#%     @ $8AA5,X7^<%7
M$@$ 58\! !0              ( !/)8* &EC;'(M,C R,3$R,S%?9S,N:G!G
M4$L! A0#%     @ $8AA5'3[^T4\R   *NH  !0              ( !Q:@+
M &EC;'(M,C R,3$R,S%?9S0N:G!G4$L! A0#%     @ $8AA5+W[*P.-=P<
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G+3(P,C$Q,C,Q7W!R92YX;6Q02P4&     !  $  9!   AV07

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
